<SEC-DOCUMENT>0000764180-23-000020.txt : 20230227
<SEC-HEADER>0000764180-23-000020.hdr.sgml : 20230227
<ACCEPTANCE-DATETIME>20230227141653
ACCESSION NUMBER:		0000764180-23-000020
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		140
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230227
DATE AS OF CHANGE:		20230227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALTRIA GROUP, INC.
		CENTRAL INDEX KEY:			0000764180
		STANDARD INDUSTRIAL CLASSIFICATION:	CIGARETTES [2111]
		IRS NUMBER:				133260245
		STATE OF INCORPORATION:			VA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08940
		FILM NUMBER:		23673046

	BUSINESS ADDRESS:	
		STREET 1:		6601 WEST BROAD STREET
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23230
		BUSINESS PHONE:		(804) 274-2200

	MAIL ADDRESS:	
		STREET 1:		6601 WEST BROAD STREET
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ALTRIA GROUP INC
		DATE OF NAME CHANGE:	20030127

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIP MORRIS COMPANIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>mo-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:dfb2a125-0b18-4fdf-aa8f-28a7e5cf9d49,g:08272963-4e0b-4a36-8744-7641bada9ecd,d:15062ca98227434086141b426450a5cb--><html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2022" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:stpr="http://xbrl.sec.gov/stpr/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:mo="http://www.altria.com/20221231" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mo-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl80L2ZyYWc6Mjg3OGM0ZGMxMTA1NGMyYjg4NGFmMzhlMTY1NTZhNDAvdGFibGU6YzBkNjY1ZGE3YzYyNDY0Nzg1MTYxNzBjNjlmOGYwYmYvdGFibGVyYW5nZTpjMGQ2NjVkYTdjNjI0NjQ3ODUxNjE3MGM2OWY4ZjBiZl8xLTEtMS0xLTE4NDQ2OQ_413c5a9f-75c6-4242-95f0-f9ea9805c956">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl80L2ZyYWc6Mjg3OGM0ZGMxMTA1NGMyYjg4NGFmMzhlMTY1NTZhNDAvdGFibGU6YzBkNjY1ZGE3YzYyNDY0Nzg1MTYxNzBjNjlmOGYwYmYvdGFibGVyYW5nZTpjMGQ2NjVkYTdjNjI0NjQ3ODUxNjE3MGM2OWY4ZjBiZl8yLTEtMS0xLTE4NDQ2OQ_497d18ef-f067-451b-9d0e-4ac4836dea22">2022</ix:nonNumeric><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl80L2ZyYWc6Mjg3OGM0ZGMxMTA1NGMyYjg4NGFmMzhlMTY1NTZhNDAvdGFibGU6YzBkNjY1ZGE3YzYyNDY0Nzg1MTYxNzBjNjlmOGYwYmYvdGFibGVyYW5nZTpjMGQ2NjVkYTdjNjI0NjQ3ODUxNjE3MGM2OWY4ZjBiZl8zLTEtMS0xLTE4NDQ2OQ_2c9fd79a-4e77-4180-85f9-c77a052a860d">FY</ix:nonNumeric><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl80L2ZyYWc6Mjg3OGM0ZGMxMTA1NGMyYjg4NGFmMzhlMTY1NTZhNDAvdGFibGU6YzBkNjY1ZGE3YzYyNDY0Nzg1MTYxNzBjNjlmOGYwYmYvdGFibGVyYW5nZTpjMGQ2NjVkYTdjNjI0NjQ3ODUxNjE3MGM2OWY4ZjBiZl80LTEtMS0xLTE4NDQ2OQ_57ba7f40-9159-430b-955f-43bad5e7cbb8">0000764180</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84Mi9mcmFnOjdhMWM2MTdkY2YwZjRlZmQ5YTkxZGI0MDFhYjA3NWJkL3RhYmxlOjJlNDk2YmNmODhjMTRkNDZhNWU4ODE5MDdlM2M3MzhiL3RhYmxlcmFuZ2U6MmU0OTZiY2Y4OGMxNGQ0NmE1ZTg4MTkwN2UzYzczOGJfMi0xLTEtMS0xODQ0Njk_42ac58cb-b6a4-43d2-82d2-446b2d9ab0b3">0.3333</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84Mi9mcmFnOjdhMWM2MTdkY2YwZjRlZmQ5YTkxZGI0MDFhYjA3NWJkL3RhYmxlOjJlNDk2YmNmODhjMTRkNDZhNWU4ODE5MDdlM2M3MzhiL3RhYmxlcmFuZ2U6MmU0OTZiY2Y4OGMxNGQ0NmE1ZTg4MTkwN2UzYzczOGJfMi0yLTEtMS0xODQ0Njk_5b95ed31-fa95-45f1-b230-5ec079069cfd">0.3333</ix:nonFraction><ix:nonNumeric contextRef="i39264efecc9e4ca88497194b3b7c8fc0_I20211231" name="us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_41b4c8e3-e050-43b8-b106-4405c53c782d">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</ix:nonNumeric><ix:nonNumeric contextRef="i7d478bf113ce483ebab401dd2fd6491d_I20221231" name="us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_9c77b5ce-ddae-4a3d-978b-ba5336576f53">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</ix:nonNumeric><ix:nonNumeric contextRef="i142dcd767464403ea9b22f153172c48d_I20221231" name="us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_1ddffbe6-a65c-4290-90a9-b5306bc7faca">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</ix:nonNumeric><ix:nonNumeric contextRef="ia39aee97eee14867b9fd0099749071c8_I20211231" name="us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_c2aa8d53-307d-44de-88c6-ccc45057da99">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</ix:nonNumeric><ix:nonNumeric contextRef="i0411a1966ac645d8a850e70787e39e47_I20211231" name="us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_6c58378e-c0bf-4554-a791-6444e99557ba">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</ix:nonNumeric><ix:nonNumeric contextRef="i5df4d26ee4254aec95af80be28802c08_I20221231" name="us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_c4015aef-675a-4e45-9c95-609287b0df60">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</ix:nonNumeric><ix:nonNumeric contextRef="i77edbf66fcec42d282c3c8658c645b38_I20221231" name="us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_295077d8-7c2c-4293-a53f-d6212cd1c050">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</ix:nonNumeric><ix:nonNumeric contextRef="i6fb4e78e1b1244acb5f611d994fe511d_I20211231" name="us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_bff869f3-0247-42fe-9766-2e8c8f382544">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</ix:nonNumeric><ix:nonNumeric contextRef="i8c1cbb128b174538ae7334de7cce2ee9_I20221231" name="us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_501091e4-8056-4777-bd80-73ee1b31781b">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</ix:nonNumeric><ix:nonNumeric contextRef="iab4e374e5b4a4126bfc6bd904d7493c0_I20211231" name="us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_eef6c587-6a34-4f41-a17b-d1245eda6984">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</ix:nonNumeric><ix:nonFraction unitRef="court" contextRef="i910731a56cae4c999349f736062b8eeb_I20230127" decimals="INF" name="mo:LossContingencyStateCourtsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzUvZnJhZzpjMDU4MTIzNTM4YTE0ZTY4ODRhOTFkYjg0M2UxMzU1Zi90ZXh0cmVnaW9uOmMwNTgxMjM1MzhhMTRlNjg4NGE5MWRiODQzZTEzNTVmXzU_4028de03-106a-4169-aa0d-0157f464e9c8">21</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mo-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if68a1d60201343fa81c9dac56e62fcdb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock0.3313ParValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08bee235d9824c2493054813893719a6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.700NotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie32723d5c819467dbff1e1e9523aa4ed_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock2.200NotesDue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3966dc6c234463b99c7126c8cb64ec1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock3.125NotesDue2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fc07528ff404f99acbe2f1625a88f2b_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i6fecf4e044e946ff90e09a30c692e5ae_I20230215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-02-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i4b5ad462b1fc42e3875caf97f2673a92_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a2f8d49dba342ea92dd045738411af3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6526b762c96848958db76b2e641f06c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40e064b5da194d8bbe29064d490250de_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccd540c71b2a4978b8805b946441e6f0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2289b034d6ab496e9d25b9a4e0e0ffe5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b6e92147eea44118dbabf94df471192_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia23cc26a813c466694dadfb7e04c27d2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if73ff79a396f45c7beb9c0f45e3d64d9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcb2c65901a147d6b22d66ec3bf6e1b2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5aec152bc347058ac199ade9c42ac1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4226489807b64beda01803b44b87592c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81c616f824f34a2c82770dab642faf1f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a061535c8074fa4b0e3bb2cb94f27ea_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd14995a072744498777768ab05c3cf3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c8b04ab864741d0b17c502256196d58_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1f4d1ddc9b541ebbe3b22a611ae436f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4b30e48366b42559b3e640d996b9125_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f48333a20ec42c5ab2f1cba314394bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dc6d82320204c0485ccfc4d8649e44b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac019ebefddb4e73825f27700d39c2c3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b87a4d656b74f4c891d75c1fd38ce42_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf9654d043934172838e2f4f18b13dc0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia49817e15e234846bd0a2a699c3c90b1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3328162568604ac9b6492de3b2e66b8f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88ba8ee5cfbb4f82a668533be8a45bf1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6e83d605e794462bc2801b8a6ba0c45_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i558fc0a3383e478fb5796f93893141cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idde0e21bdbd04b0dbf2b80e3eb14a8df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9dfca6be487498bbf8f7ce598fc0b81_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9e71d43a1f4444a879c0a8c5f8cf8ef_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fd0a7b22d234c68baa53019ccd50d24_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d9278cdedf2453987ce2a196adc88b9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idceefaa1a008430bad914f7d71668fdb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i644b6f768367404baba2e476d5932a0f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i143a684a9fda4c14af97a0bf149a67f0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7503cd4479784edc962d47d00bb62206_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia66edd7cc54a4c8ea258417ee5d6a637_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05f658ff1f4945fbb64ff38b76d887eb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab3485d42498436788bd25df431981fc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>mo:lease</xbrli:measure></xbrli:unit><xbrli:context id="i30cb752842ae4f4197b09359b88ea9da_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HorizonMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i2a0870e6739645619718e0d6168ecf74_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:JTIUHMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HorizonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i215587128d4845cda58b7a9194e94d1e_D20211001-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf697a1cd93741fbb7973dfb45f4da83_D20201201-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HelixInnovationsLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e549342995d4d82a096798aa533bfa9_D20201201-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ed594edbe8547ae96593b978a67fa53_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96c87ceef6d7461eba332998e29357b5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81704ddceebb4dfe86a3ec2266b22177_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bea3c35eaff4beeba4d616c3283b50d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:USSTCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0336e8ef9c74d2893d4e7f46f1987b7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51e24a8227fd44f78424af2bf9ecc499_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68ad331e56c04b3cab6eb6b46acdcb86_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41f6a21a2abb4e77a00a22e833659f20_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1adec0aeb3214850954d7ba42cd20214_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if103da14634340edb17c23aba9feeff9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dc9d02e492d4fab82f3ad7bd4624c68_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mo:USTIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02811b1061214e51b307f1e6448ef953_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mo:USTIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mo:TrademarksCopenhagenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae418119009f46f9a862f1b8651fc378_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mo:TrademarksSkoalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mo:USTIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52300bd656f4412283014d05ee87427f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mo:TrademarksMSTMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mo:USTIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ba9462e81d849bdb73a266e0704643e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mo:MiddletonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbb8b3a48f934c52817757ed302eeb99_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mo:IntangibleAssetsAxis">mo:DefiniteLivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ba8a2737e194f0f980c2838e67e9215_I20221019"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:IQOSTobaccoHeatingSystemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-10-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefb5652827eb457099968460ca178f35_I20230715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:IQOSTobaccoHeatingSystemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ad47c9ea90a4f93882e5e207392a44c_D20221019-20230715"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:IQOSTobaccoHeatingSystemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-19</xbrli:startDate><xbrli:endDate>2023-07-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90a31ad6d0834866867bab4c41bfdd29_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:IQOSTobaccoHeatingSystemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea22343d0454457485cd1cc01bcc276c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:IQOSTobaccoHeatingSystemMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2793c14b7447420e9b9c20617d2dacdb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:JTIUHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91ce2420785e4e54b8494cbe3fb97890_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42e7b2a18fdf46808c830b8cad5d58a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i688c2fcd3b0343b29196c870d74f6b68_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56c5cabbdfb44d05a0e818aa3c22c4d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84433bab48264529a2516c2663b4fc52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6a4fa4621c7473ba1611dbe6af67745_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25c3587d3f994622b4714f1b3124a4da_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61401757fdc493c83aa67b7620e44d4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if803b88b013a40dfba8d352c3b38fd7a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea2f16158f9341fd86284d599cb55729_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13178e7cbc7c479c89b40c940101986c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bf83008070a46eb83178baf67bbaa65_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc2bb0b67a1f4be892d628382285683c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ee0d2b6272e47c2b0125f423877e769_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i662e4fa2b880451fa00f79a419fcb83e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:JUULAndCronosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4408f6fff55f4f809ea62c43a15e4c2c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3a9cfbb99324bffa0f757ecfa7e5577_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:JUULAndCronosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8513d61234ef4b449cb9e88035fd6619_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a048f874a064a4995997da946ea095e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:JUULAndCronosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07d379f94c904bd4b8baa4f957b160c2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c0955d3143c4319b611181108536948_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:JUULAndCronosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a3babb09031476eab172eb19f78a4fb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8367586242540b9911f25a7b7315179_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:JUULAndCronosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fcfe850ccf04326ba6a9f711efb4237_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86595736693849e2a2960a25c9d7f520_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a59e8c2438f4b0990202ed160b66f3a_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2482b7e244ca46d9be57870d2ee0a5b1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b2060e5902e49abb3e4469084d451c6_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2f72a0231164ba39b3ffd8a34007855_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia645931f457b42ad968380318043c7bb_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i582f9f2ac6ca4ecda20c95fac7a2d662_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i113383343fc24b078e1605af29834efb_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7514f17104fb4e4086fa0002209e91be_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d58937ea5f04743a283f00ebb398d3f_D20181201-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42640979a7ab4a48966a0d609f073992_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie58a0d47e81141b49b488d17516ef57a_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34f2a76702e24388ae8484f16168bdc3_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e8852c143984842b74a594acdc7f562_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90c02ede0bac4600ad8f45d0bae1be88_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9822021e58024e35a62e7648157e3677_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i352490c117bb4f8998f690f115171443_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01271f593e214e02974445c5cdca8e52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe747a76cea044caadbd3c216fee37f5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i352e13ef17314af78049d425169b5c00_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i690729cf5b294067aff036eadfaa0ae7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cadPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i5b88030abdbe4a5bab225cf467fd6aec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b902b829a4c4480963978506c931fe9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f5bd49e3d924bbc92984ec5b9b68266_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe6babf381df44cd9b5ccb5c5a5e58f2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd4d6be44a8e48fcac6b5ef35c67ddef_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dbf8277f9b945c79b9491eacf1a07b9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i787d308d5eeb4107b0661b036cbd627c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="contract"><xbrli:measure>mo:contract</xbrli:measure></xbrli:unit><xbrli:context id="id6d414e5e17345c0b5010b8bf3b1609d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9bb837eb6a554c7b8139c2b96eea88f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ba18ff14a604658afe105249ab1be5c_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i676dca466c264c98a0a732b91fb9c4dd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2b22c6277c34d6bbc04167a977d057b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38a706a086554d389015fb9e0c90e6ab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12be265a64cd483a8c06ad934345bfdb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f1171f94e9a4f509d988ba58f40a86a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3b9202eb4bc425496d496a5783142ad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7f230b64a534de9935f50dfa188e24b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2704b95dd3964621a2f17ac3697ec1bd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38cd1d2ff91f4c8a8a7413ed1a97f758_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2383b8a428a43a694fd25b50b5e56d9_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1ea858197df46758cab5e38cc77fc6b_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eaa17b2950f4f739cc9503d66958b9f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dc86c124c5b4201b063cd0d7581dfb9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i019d8f929d47481aa9b043d3f5399d3e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">mo:TermSecuredOvernightFinancingRateTermSOFRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if40c2ab1cec0419d8e9f4ba69b3cd0b7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88059e2462ce4581be210352406c6935_D20200301-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f78f34f75a64fe4bf18d076708d3591_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350To1020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f210e7652a144c19a8bf09f7c07c740_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350To1020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief3c0b98ac9c41609501bd13ff3613c2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350To1020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f121d00e6394fc8a7c9088b8f4fb8f4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350To1020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92fe93dcf2a34fecaed4dc95f41d6851_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDebenture7750MaturingJanuary2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15baa618b8ac444882da13a33e5e3fd9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDebenture7750MaturingJanuary2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7c66631bfad48cf9a20d10eb7a5d95c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000To3125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48082c430c9b492c905de5a9ccd49dd8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000To3125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib945efb6e5fe46fbae9e80efa6cbc9ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000To3125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd37474dc2a14a4097a4780f47dc1ee1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000To3125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i439835ab3a43455e96b747acea6d4d8f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350To1020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id631a5ccf3fb429cb812360331668599_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350To1020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3828073d79a24491bcaeaf36fce13056_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000To3125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if400f8d238e54035a7cab079f344caeb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000To3125Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaba818d157743e8b83bcea0509a84fd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000MaturingFebruary2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="iadefd780e0034b64926bdc30f75a610f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2950MaturingMay2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9d9007ab56a458484aad403ac237294_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4000MaturingJanuary2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63dfd595051b469195be60b2f91efc8d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes3800MaturingFebruary2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f830258f25a4d1d84e87ead5fd45a4a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350MaturingMay2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice1bb82d9a41443c8498022e8e7d7779_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1700MaturingJune2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0008e44fe6024463a3a1a558fdcee38e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4400MaturingFebruary2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec4782d4b8074f9bacc9db3c3c30d3da_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2625MaturingSeptember2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib92f4cb6a30e4e6f9f00525310225c89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes2200MaturingJune2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd978ed23459400eb32a2c82f06f2a4c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4800MaturingFebruary2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d59ad2d97184e4ca31c709f4e3635fd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes3400MaturingMay2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic57f5a35ebfa4c3fbcaa79d030ef21a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes3125MaturingJune2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaac5abc8e624b32a8ec9a613c59bc47_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2450MaturingFebruary2032Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc5ec60ad53c4b4783f7d38256ebf88f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes9950MaturingNovember2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8f3c72b4651489d90df2e16ffa4a05e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes10200MaturingFebruary2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f384896829c4943abc32d79f5210571_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes5800MaturingFebruary2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66cedc520a05430f99dd7f092780f5c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes3400MaturingFebruary2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia75ae511ae35422b929bab49c142131a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4250MaturingAugust2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1faae93371144c7993efed37d5f5c24f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4500MaturingMay2043Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6cd4d1753f74e26bc079154f136894c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes5375MaturingJanuary2044Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1d7fc010c9442408c1346df432ae19b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes3875MaturingSeptember2046Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dc37d2451ac45539913bbac9f76a69a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes5950MaturingFebruary2049Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia705d60663d745daa5a1d6310b196a7b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4450MaturingMay2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39346349fd3d454fbe7d80d77da544b6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes3700MaturingFebruary2051Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8db11a63f05942319bf0d2eddaf952a7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes6200MaturingFebruary2059Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i985d9e1153d249ccbe35c8a2ed078b3a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4000MaturingFebruary2061Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a2bb57dbcd94da09e99e9faca7b947f_I20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93b4fdf778254947bb262abfd638909a_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4cd8efeaae34f919b123479df396a64_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34f308ec117342cd83eb1c8c2367bffc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8b660eda4894cb386f65ca5af40f210_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2850MaturingAugust2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12b21493a628400c8be8f1d6a8ed3385_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2950MaturingMay2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i539b185f58964558a12c50808bd29011_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4000MaturingJanuary2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f6f50e4575f4c78858838ff914b03c2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes3800MaturingFebruary2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d2e0075768e4aeb84b4d297b8930772_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4400MaturingFebruary2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c58db1ce1ac4ff4bed80427e3ff6a6c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4800MaturingFebruary2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fb4aa15e8644b8dac184d5311a665f3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes9950MaturingNovember2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia123b20dbca2464d91553ad8a790922d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes10200MaturingFebruary2039Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c75f31df572443b876910d052f325e1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes6200MaturingFebruary2059Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05610ebaa85d4ea193c96166dfd53b0c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3490PercentDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic922d20d61114cb5b818e46d2ee2f170_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3490PercentDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8e69b6b782f4aa5975697d9355b34c6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i310c0dd5c06a43918728eab4e66aae82_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bda21fb40e34632bd2a70325195b703_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:SerialPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4a80e5aa58a45bb84e8bd06eac4fa44_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5e8e369ebdc481eb1c50facf9407ffd_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4318d73c3ec420f9b7ea13530338ad1_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dee55786a8947d5be0e870d6c2bb228_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55356fbd37f340dd975f11d54874fece_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2023ShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id15c7c4db331481f86239866210c3ea8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0e3d1499f104a538572ddf276309760_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1814a9e5885940cdb1d92fe2948219f4_D20210101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2ccef0d8b6b41aea1718d46140df7ff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idde860552f9e4af3818e1e0171c49245_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mo:A2020PerformanceIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i638d815ed9f74221b605f9614dbf0863_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mo:A2015DirectorsPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bde4c691bfe43909179ea90b1ba5f53_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie586f180596b4de1bfd14cd16fa40aec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28af804fe6b74399ba55088a1f49d3aa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5040992030f401f8d230ceec09bf4b5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e6c90982182440887d92a56034de67f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9c7c153e8d34eda8c3f26df0b887be6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43cdf17dccb84fe48ce2ad37ee1d8a57_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21cecce3d56444b6aefbd78a88439a59_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8560dfc0561741c4a2fca56a741ddb31_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4baeaffb9a29402ca2ca02dd05a69d99_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9146b84e66842f6ba646c0e65fbbf4a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i211d3ecc540f439596a522f150999ac7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee6f716086d445da92a222c7902d8268_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0701019c847a4101bb381af56e6106e5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1ebf54a40094d25ae6e4d46af08a702_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9b3afb0e68543d79df286a395b0f9f4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92833a7b324c4491889c22a95091a6eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46578bd2fba34e508c65171225d3399b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4622585b580c4ae593332eebd185fc05_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i301bde0c886045bbbbef3861c7f3305a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if666ea56e36a46138786e8a942c8ca49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39d9da4da1444b63abf5627b2e02b0a4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7274c6680d2404c926a183383e0427c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i249cc5c8822b4901891591817ef402b5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic821892e2b3a4c669cc2c54ff8ccbcb0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9406c18150ae48159d08480f724ce8f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f2413f9f1484799837c48a31819243a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ce6eb6dd62848bc8cd40a14488e8721_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie126f873b826412b91e1030a434f2d88_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c8e82e2711e453788e58f2bd1c329a6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i835ff05c75554bb3a905f6d9c969a297_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54324f38aa844a9eb47e2442a1639941_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06ce655c080e4f76bb70784777bec240_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58687162a9304d12bc4af830434b13f3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e695634f71246c49246a1bc11d5adbc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i779b2d2ecbd54a6e915147670f6d0270_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b811ce9ecd74e63a03fe63f108ba6ef_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c382d8d16454f87a46dc4a4ad2985b5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89dc095529b8415fa2d037d1e5cc3243_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c0fb8e2f6f94df6a4cb1166c6e8695d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53c6e05d22124ac2a67512f6e00889ab_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99171c01ef0342ea88d25cef0ba399df_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic66cd77c3dc849aca5b3b237b949276b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17df18daf64e40e6b9d99e9a45abbaa7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91aa1a3fbaee4d3ca09cea2198096661_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c3c12dfb2294441a79714c48c67814a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12f67c433715485982086bcdbfe00787_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48f5736e8fdd4e1b9a291a912e9cd3be_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i111e309b231242cfbccc5619cb83229c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd8c2710852f4850ae750a2d93d4e568_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01d98d739f504698ad868c0b443af1b2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46fc9282d17e4ce08f7ce9e03e4e9fd3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if55bb70b849b4190b6e9721bddaaf8c6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8857cf14a32848aa9b176fb4b04397e2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2b6b1d5fe6046078463af99cc3f0ee3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9666810a94704e499168fa1e4086657b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd98997f40d64f368230b460b98992e1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i346f9407b62340fc87ea781c6a87bc3a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i913162c559bc449289b7eb12f1b829ed_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb973d3950d9475a923b769b439f1690_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71a3f3b84bfc4a76b4da5d7f37f602af_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic22cd9b4e4d94780871456a2f40823af_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7975fef95c3d41c984bc01c3cd6d50c1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc000d98c0ca4b1ab8abdbf602942f3f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0f69c7e020f4496bb5f91ff08930975_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i617c77ba0ff242099cb5b33ab2af1d0c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia43c067e1e4b4763ac5c2b473efb3a37_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i804b801d4bd04571aaa1e6babe7ee711_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadaebe2af5d4425f92e98085c262bdfa_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5586d1fe97814ea899ee8184c7f7d8d9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56e043e80aaa413c8cf448a2008386a1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7f3cf86f5874b96b40d59c3d6a49d6b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa25332878054f3684126e72cd34954c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49a7d33e45284663b655e6dbc1bb9919_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mo:CigarettesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1678c740bd1a4a26becf33b0f81b0ceb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mo:CigarettesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab018587321a483bbfbc7b030fd4e0f6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mo:CigarettesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddc198f0f36347669562a343b6ad3c9d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mo:CigarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie443febe03b14271ac779aa41af8f4fe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mo:CigarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67cd9a14c17b43fc9f780f6a9acde202_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mo:CigarsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9df4fbc7975c4c9c97d6d12ee87fa9e1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mo:PerformanceFoodGroupCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3185640b9c5049b5aab6f7b888f14010_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mo:PerformanceFoodGroupCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ff1620dadbf4977afc2e21c5632a674_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mo:CoreMarkHoldingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2aa57c1f8964e1c832583d037aa1ede_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mo:McLaneCompanyIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1148e066b8774e5fbbbc5a24e0555f90_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mo:McLaneCompanyIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i190f8a7374534d37a6b9e683886f1340_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mo:McLaneCompanyIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08b51c2c0dce44e79fedb290d4c8e09e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf9bf830fdb54a25a53b4eb9f7c6ecbe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35b16a435c354836b674e7320f24d9cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0522b2a5006452dbeaa81943e951dd9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NPMAdjustmentToInterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f14450de7304d989507ff633df9e3ae_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NPMAdjustmentToInterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e449181bba3459d8ca0786104f7a700_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NPMAdjustmentToInterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c43fc865fb74c7ea00634410142b30a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NPMAdjustmentToCostOfSalesAndInterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i212ae09ce10946d9855a6823c99cbf7f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NPMAdjustmentToCostOfSalesAndInterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic48649f0706c497693ac371d798bd4c2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NPMAdjustmentToCostOfSalesAndInterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if99cc370f97e4e6c90993d5b757abf22_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01d7b96af9e749068f5609288e32a7af_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8832deab20a344c6af9cf1f99474ac91_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46dacf8350224a54ab375b062ca77665_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i951b911c6e0e47d19655f1077b2ffe8a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea116a43452e4fb28c83749aebd5f929_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i461f9cb50d204f0dacbd3047259cffa8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27482b5bde934f6ca3bdd7b34b723684_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0693a15a4892422d9cda162ef2b81f7d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice4e4d2da69f4d9683487085e2d48d98_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83073aaf064b4575b0b62690029a9d26_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd676fa0f80248e282373ef461851a42_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f15b41987f746ec9de923885a23875e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:MarketingAdministrationAndResearchCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2829a0154bd2487587b9b5af05af4b95_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc3b5a2e320d4bf0930cfd342a0a64ce_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cb3ae1c7eab4656a1a5ed979a5e155c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mo:InventoryWriteOffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb407c6154934e7ca996a112282656fd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:PurchaseCommitmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eb37c152d544d1d9be43ff88b5b936e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisCapitalCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bff2bc4dded4f37b8c85cec3935bb80_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisCapitalCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb087beec876446cb5a5111ae91af4a1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisCapitalCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7832ad6e5ab1407caf25aa336606b119_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a4e259acef84cbfa369320878dc84d8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie155a5840f2c4f9999c5ff7d2f7a2f4b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6adba30f5e044f0b98201ca6954317b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i949403a737c24de59a13987d688282a7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51af7141b0f74960b97071f12967601e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00cce528acbc427a9f5dda1550d2d9fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84846537e5f745d2987290028523bac3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i009462f76967433f92d600d008ec5c47_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if489977786fd4db69449f01c2756f802_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i708e341152674f6390a40e9721f87532_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9ef67837f3b481b91a45102c2741bec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i218f7dbb66d94126b2f426148102feee_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ce8f1baf1924d369a28a5bcb7cd369c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibef1d20b06414d568aea451eb1e564cf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85712ade9dea49509d0041354e9dd058_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46a26fe11c204936a35f2e5d15e5781e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02d2cf1003314ab9892258dcee6449fe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd98a90576ce475886c7adc642f71634_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">mo:USTreasuryAndForeignGovernmentSecuritiesAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ae3153fe128440e9f61ca8201dcc8a0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">mo:USTreasuryAndForeignGovernmentSecuritiesAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6aab89198f84ab09ff72153ef35e171_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">mo:USTreasuryAndForeignGovernmentSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34b241d0d60b4ff3a0eed6af4527dc96_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">mo:AssetBasedSecuritiesAndOtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cc36e5d0d8e47749726e99b3dca0875_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExternalCreditRatingByGroupingAxis">us-gaap:ExternalCreditRatingNonInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63d3cf858e354c7e92e2e0365451f300_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExternalCreditRatingByGroupingAxis">us-gaap:ExternalCreditRatingNonInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f6a7fc0bc2d4a5eaf7ca6d75b30312e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">mo:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31ed26bb32ff433080c9fdca31b03ecc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExternalCreditRatingByGroupingAxis">us-gaap:ExternalCreditRatingNonInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic64efbd3de4f4ab58c333a511cc0d644_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExternalCreditRatingByGroupingAxis">us-gaap:ExternalCreditRatingNonInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ed4a725235c47b887eb6679e8c3d522_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">mo:EmergingMarketsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87839150a2374e27a36b41a49b45c5bf_D20230101-20231231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83c8e5d5266f45fbb46737c1d2fcace0_D20230101-20231231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5937f04b1ddf4dd89b8d3092539fb3cd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i565d6f3baf2f4947b0dd194ac42693e9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7d841655cc044a6b7129c58b61ec0c3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a857bd3f87c48ba9e0abfc8eebc8cc7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8bc8d974c824ca79ceac63074634c5c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f3e5c978adf4674a37c1255333c112e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0f669dde52c4154be5883d70c4541af_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i837fc7852b3c4ccf973ccfa3c30e16ff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb79e28764284a31a8d89f2ff43f4204_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i091fc79fcdb54ad5bac6c31650d0dc35_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43a0bf9c464a4f689b6fa2279baa3db6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if56170cb4e9e4dc3ab4c2439b1108953_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d5635e4a45042f887595e208639d06c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ab9a9711d20426494a4f993ff5497cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac81e2e1561144d4b6fc044d55a86b44_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98d16200be95427aaa506a07cafc1f0f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cf80c87ecf0415e92e285f99ba853d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie09850cd158044ef9737da94ccd4932a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf7e45d2370d4822a594e626f0867b6f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43dc5b8c106142a8a5eec96bf16c5e0c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05b7833a51e149a89ae331998c279adb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19b8a42637c04a8fbdb6b98fcc14b74b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1df38e22ba91472f933e5f94bb462967_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i453b78fe37b14dbbb470779c2c160077_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idae2e10d00134111b2603a1ec55e2562_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a22bcea6c7f47238753a786d43db429_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6913094e4c2a4346856f5eaa16cfbdef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f7f03e22d4147c2979c55fcc62a5875_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8af8a24b3b4465490365b4873d7d840_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48edc7536f424109abdb6ba04fc667cc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i724473bb56ef42ca9368c198fabf43e2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b271655bb784f2f8a8cb1deb35e7d4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b66ad4089e442e8b7a70d986b26cc77_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66066f1832f24ffb846101be04a19a87_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic09fc05c98894d629f60974a54315b5b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057b0ef85ece430f8ddd918897d56736_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i422058d6b4d24ca3ac6e070ff71aa8e2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb23a7abd88b4dfabbbb2aa8d76fdc64_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15b0bb8f8f754a41a4f7dfd22ec86295_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2da6e6418c72474a99ec75fadc054776_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bfdb9b8c6324abf8947ddb74a27e6a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic332a1659d2f405d80865e862ec27dab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic71aca398a11408da1a534b27a0c25dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10f3d8a40ef14a99905bccea0cfb4b72_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad944a608a784c17b879349817b9d0dd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieefef214d38c46c39607fd46cfe43211_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i249539f1cfef460291c13bcd717ecbd8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63684a262279489c9c4f034d04ba5aab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89925d896a8548cfb62d7b79dc5a9fae_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1339f4ea0fe42bc9ee6d7c661e84e5a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29227afcd5594316868d15193cb10cac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e5c74c5bc734c1b9c970eeb6d8b1f1f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10518c7a15dc4f21a69ded3f9d645ef6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22cca4c436d842d087f356c875896d60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2c076e5ef854cabb8069eab488e2649_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e3082841f894e34a24a50706f337744_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0febe181336b41b5a658c64358915bfe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64f7dc5b917c46deaa9b0a051ea0fb75_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i620de52603d8478d83b1d097f32554e6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4feca36ee17847ab82502d9eed738030_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39264efecc9e4ca88497194b3b7c8fc0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:USLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d478bf113ce483ebab401dd2fd6491d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:USLargeCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i142dcd767464403ea9b22f153172c48d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:USSmallCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia39aee97eee14867b9fd0099749071c8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:USSmallCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0411a1966ac645d8a850e70787e39e47_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:InternationalDevelopedMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5df4d26ee4254aec95af80be28802c08_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:InternationalDevelopedMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc7229bbd58f4df69b5dea2ccab95bf5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dd0be9d1bce45958792a2e9fbe32dcf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id36ee6f9d1124a2595ac2df42e648378_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide5f143afc5b477a9e3945daf0484c78_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07f902bc6dc8430c85a4b5a6902f7e69_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dc0106f1faf462eb26fc43277eaf2cd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb735c6a79f740efb339b169181396ad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i726f9056e75f4525b26f5df7a357b0a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic341b9e0ef914a71aae1c0fe77f8d38e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i214fc2f6fc754f7c885b3d6871ae6404_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7ac312a52d2464dae961fee29607342_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c9735a7061a47e5985f44f2027c193e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66baea8f8e3e44ccada2d2c6a807a3fb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ab2d0a4619144f49e454db1495480ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27b909807cda4d008124cf98b2dfb195_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67c6d721f139463c8a5ef2e2ac65795e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic90b8a4e1cad40c99e3c612c6aff6d10_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ef1e5229020494cbba49f40f9408830_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b045ef00b1c46baa8abe159f085ff7a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id683265debfa46c298eb35c208c438d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d1961208f4440e6950aa35f0cb3a24c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53cd4ff8943f439dbee592de787cea17_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida49dd477308420ca136a97a189050d9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabff1a6156384adc8cce0664586e25ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b655b11e1ab48199a135d655b722fff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66404ccb7de546aa8b469a4fcbbbebc8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ae13872490f4b7eb4a801adfb2d171e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i418d56b014124b6081ceffc5c76fe087_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7233bea80cc74eb8844423b368b977fa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9db59398fd34374bc22c5daa2fdcf89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if248beb73395471a8d3f3cb7a01e64bc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ce3e56286fd4ca4b41897ef25ba9373_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14364497d94445c79d254185c8a0e260_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb1582fd2b3f4d81b9602d7adb41a05d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i441d0fa2abb74093916c6655196afd82_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2576928a12a455283eec1278075ce78_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ff5b3ac729140c5ab95d29557eded13_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i099176409b2d40eb9b090dd044fbd69a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id65b933eaa6f4c9589f7de89c772d624_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92c62a510f4440e0ae76b083af678da0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77edbf66fcec42d282c3c8658c645b38_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:USLargeCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fb4e78e1b1244acb5f611d994fe511d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:USLargeCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c1cbb128b174538ae7334de7cce2ee9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:InternationalDevelopedMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab4e374e5b4a4126bfc6bd904d7493c0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:InternationalDevelopedMarketsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7bd5b5f81284011843bd24a1f898451_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e916bce86724c739256a11e8d5ddfaf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5143a89f62f942d0aed69e5d5403fbdb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i146dab2f246f4239ac7c45936f953058_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i367f5ac75e4a4df58e4998eb5c85657f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5d867da7f4441dda11c6293c01cb96b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadc0d8691da8467d9ca4ad958399f860_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PostemploymentRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia96532ef56c74a5ab19f74aad5a85003_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PostemploymentRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PostemploymentRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PostemploymentRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PostemploymentRetirementBenefitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45f9dcc6444a4bbb90bbcd327eb2f366_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90e616ef3cd34d8ebf364a0a44dbf568_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf580e88ea5e426b83cea191bb81eb11_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief312f4f79034004be1d156bc5113740_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94c89f23c2954c9c8f50a44fa531889f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie74269f61ac244c79a9581ca1cbf6d02_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98f16d288e9b4842b8c9feadf67a70d7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie82e469f2543472386656525fa4e487f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33dd9b0c0e7b45d487aee81df3946294_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03f3ddd8f45a4d4d8617839b37197b44_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcaf546cb45c470aa6dfa50cda94fd71_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib931f8bbad2a4b7a8d8317d177be2791_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic93c01c5184d4b26964880db6a9e8ad9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3240589dec0744cebbdf4a38067cb110_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>mo:state</xbrli:measure></xbrli:unit><xbrli:context id="id322aa0288694bdb849607abacc6dabd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4739c0a3ba074dff8712b23ec3f898ad_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if96971d3062e4a31a0e27c3b191c0dde_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fec6e69190c449a8d51b6a9ea7c1d31_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:AgreementToResolveShareholderClassActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d4c427ec8a94dfd836dc5b4a199c764_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:AgreementToResolveShareholderClassActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fd275444e894de0ab137fd15c70d71c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:AgreementToResolveShareholderClassActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37fa7f6256454447bca119375f7fe081_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14301c0ea4d0417daf460f139e79a779_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4be6c8b0110c4ba9995765495afef7d6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03318a08f6694a48998709b33e36a67f_D20041001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2004-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied3d1d716af5466b9e30cf6840540284_D20041001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2004-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i480c00944cc54888a1e9a12e8d5a6c2f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a9cc9052f7342f9a5a2965a1363d918_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>mo:claim</xbrli:measure></xbrli:unit><xbrli:context id="ib803543b5610404db3d4704c2d823f5c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7443c1f2410b42f79436b4c8406d1884_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i496cf0d3b6c242988d0ca0ecf226c71f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cb201982a874dda811f7385ce781a84_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0dc27727fac48219ac9ec68f62e232f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c7b5b8168e84e9f97ec53935f0e23bc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcd3a4d726d343dc811a0c842908f852_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i815d22256b0f463899dc0f22fbf273d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8bf85127efde436391fadbb7ddd35b59_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if30834386f77477da8f843b6b5597b5c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23b3a0d3f9bb4d1490db4cd7c943b4b1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ec68205f19b43d79d872f39a862112a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="case"><xbrli:measure>mo:case</xbrli:measure></xbrli:unit><xbrli:context id="i04aef4e9d8bf47b6889ffc116b3823fe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84f64e1272e04d79a531d39b5bcf0ca4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4156610d169487eb2ddc1063aac958d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1f51724e36a4d608bc658784f91ce0e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:ETSSmokingandHealthCaseFlightAttendantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>mo:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="i0c93a8ff326144f69851e022e7d7df20_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9244ca0d63dc4969a4c903eab7d4b970_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitsFiledByStateOrLocalGovernmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91aaf91c29514549a260f8c3b405df37_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:ClassActionLawsuitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8ac04c172f1433fbffdd1c5a97bdc20_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbca890a0ab042c4b655ce8a512d9dc0_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44002739e29942868064a12846ec9503_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78854af3be924b238c97cf0018613bd5_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9bfd24968014e2fbddf1581242c201e_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i571a013fea1d4f7fac1f41c38c582ec2_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i581f20cb6875437fbd464b63c2092b97_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15254fcdf0474c4d91f3cdaf53416cf9_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AK</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03552e08ecac456e9607180e0f7cea1d_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff9acca8e9b04ab7bbeb5f69bc352ad6_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia385d23e2d37444cbad3c91fd282c47b_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb31d44524574239b606215996b36c53_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida280a8e75724cc58094fbf48eda09fa_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i325dfa71eec5476ea64d6e500e22c43e_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i322e1958ef354f998e5b9802f9a1c190_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MO</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5c28868e39348ea9f1dc8327b0b6efd_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NH</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6f19f777880458ca0b18267c7d35b69_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d324cecd2fc4178abb7a986fd98c47a_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic85bb6de18db4b88bb50cb99cf81d8d8_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3560c35b1b64649bae3cb957e859160_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f793a811c1c4997bb2a82a658d83b55_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:RI</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a801284144744f8a8f5d897e3fa2fb5_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TN</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb6c598803cf4b6687397df90a86563f_D19990101-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WV</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1999-01-01</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic04846f477ef4b43b64fc0a53777f0d5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCaseMendezMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6e2ff8e6f1647eea34f150435a9f641_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCaseMendezMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idddcb5cec584482b801338bd316d77fc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCaseFontaineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc98656966dd42c4be583a6f2ed13108_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCasePrincipeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1410b910eefc4178acdfe4b6ce022ff7_I20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5da32d8355b7469492d1e45bf26c92fe_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib879d27f5b6249628c06789bea384757_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic794e5582af74563b80ccb6479696bc2_I20000731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2000-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic921b407891d41a9a370b70f29dbbf7b_I20000731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2000-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ed199122dae41e0a7f040a1f16d427f_D20060701-20060731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2006-07-01</xbrli:startDate><xbrli:endDate>2006-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i181b032d3d8a4fb88a848af3798e1ca0_I20080131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2008-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c34362a468a45d08d7bbc1138e37393_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28ee13b79369415fbc5464692b8c4285_D20230127-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-27</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="plantiff"><xbrli:measure>mo:plantiff</xbrli:measure></xbrli:unit><xbrli:context id="ie5e034628af34ae3946be21b68ea8d0e_D20230127-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-27</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62e4a46ab1a44e6fb47d8560c1b77cd8_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanAndSommersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a03bc94992c4903bcda95a201871e01_D20230127-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-27</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a32ea824fa14aaeb1265afa3e1edf01_D20230127-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGarciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-27</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9840bd4343f941b0887d784405cd4d35_D20230127-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPearsonDCohenCollarChaconMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-27</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i180010a7918e4145a2f89842434e3987_D20230127-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesReiderandBanksMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-27</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24acb3f6bdc34dee9714f9a0917ffb23_D20230127-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesWeingartandHancockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-27</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fd53372d12948b586896dc1e7cfd9e2_D20230127-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPollariMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-27</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6f75f0cc66b4f22a0d1523a7047668d_D20230127-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerRintoulandDuignamMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-27</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i883e5919c8b041b1b6877eaa2e7575d0_D20230127-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFreemanAndHarrisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-27</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea6390c8f234429087000381360f8e7c_D20230127-20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-27</xbrli:startDate><xbrli:endDate>2023-01-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50e02c65827141c0988efa4815111343_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHoffmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17a02e89bb314f8e8d214c7bfda3ab4a_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHoffmanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6468ca3275ef46f8aa6c95127507afac_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLevineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i212ceaaf50b24da29b210c63ce60efc3_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLevineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i920cf43da0b549b1bf36382047e4921c_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSchertzerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief08e55c7da94618b141a0544e183c7a_I20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSchertzerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3c92225c6014643a39dde3972af7b95_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLippMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0906996db114adb95e538086e4988cd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLippMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i106eca6235c44aec9a053a8c1e1115f8_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGarciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7875bd726b2c40cf94fdd162bfc1698e_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGarciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i093d8c283e0149ac94dd94b7d960043e_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a7510ef6d624bce9a8bd3477d7ecbab_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3f1fa8a229242798c2a8851ec2c6a7d_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61bd7798d97b44e4905f83615d533665_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i432f8c3944d94d3088537f50fc75eec0_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia21796e7b1304ee59df65a9e7a9c1ae7_I20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5185e4c3850249389a06ab7914fe67e5_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c622465589840aa8eb67d8e00e12d37_I20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6a8429d2dfd4db9966a956a2a38a138_I20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i242b075be0904eea86cd14974d4e88e9_I20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i349b39aa4db540d09dd8cf5fd4305c55_D20221201-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMillerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66f3170db2b54fe7b125a52f2d195e80_D20221001-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesTuttleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i752ab2dec76b4648932ee8291c3fde30_D20220601-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCuddiheeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i775477992d5148ffb8ac99f47908d6e1_D20230101-20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied8a6482d8d842548874153fd3412d3a_D20220801-20220831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e77f2f208294f938fb2ec43209eee70_I20090630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2009-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b527c47e5014c0aaaf9b0b067634552_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic10ea316eb6a47e48c3e53b43b03e6d0_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AR</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4929a66b8e9b49248e19eec92e781436_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85f3e34a436d46d0a07b5548c997598c_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DE</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1741852180994ef68345036762c17998_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DC</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i801ebabf38fa441fb2d94c6e67e28052_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff317a61814e4db486d1db5fda1f4175_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5febaca0c6254dfabb955e0c0034af5d_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia46c676221664155b20176ae820f2c18_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f12e85e557c4736862707aa26443eef_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib411bb4ee3f347218c4a11fe8e17f6ac_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MD</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a370a52cb634e1b887970e51ba3eea2_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a9aa66dc8c8499e838fe36896f6146e_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MN</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i884defb8144d483985e98d3102cad8d6_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NV</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30284ad3aca0439787bbaef52a3ee87b_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i598983dcf5714194acc23ab021d7b890_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a8278fb3e23470e99b558bec8b8e1c3_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib90545ee4e794ecd86a7d962993031ae_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OK</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ce7548765b949efaad6025a7bb2d39a_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OR</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if235e66a71fb40bb80e9a57ea20e104a_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a0cae0d945242f9add4c95a9f783fff_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e96ff7dfa4f4e3bbd38467b869c2b09_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:SC</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib94a2498fbec415da80b4378db2c49aa_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id201aa07137345cc9031fe7687fb9aa8_D19960501-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WI</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1996-05-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c3e60acf54840d5823064246d8f4255_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mo:BritishColumbiaSaskatchewanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47f7028016ec4a9ca7c5da65de1c31cd_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="manufacture"><xbrli:measure>mo:manufacture</xbrli:measure></xbrli:unit><xbrli:unit id="ruling"><xbrli:measure>mo:ruling</xbrli:measure></xbrli:unit><xbrli:context id="i559c9c5248e14c7eac616a9c6e9b88ba_D20190301-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="iad62c741cfb14a10b14ba7e8f787e007_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:ThreatenedLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea22c49cbb364016b9be8082d98ec8b5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i748c02005b4a4bf49a0612b63989ef03_D19981101-19981130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>1998-11-01</xbrli:startDate><xbrli:endDate>1998-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d208e527e4342e8a6fed1e96302bed1_I19981130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>1998-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i387d404d62a74acc8f6dbf3b7be9ca4b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d696721355c4cda96236197d43ab89a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i051656e6a1684bfba293e4a15343ded2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b29a936696b409788862a00b0672af2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9c6e2186f1e45e786df72e8ee7ec3d3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2005NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a685c7dcd494128be51e43eb85380b3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2006NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79ad3a1e3b8a4470a7aca27a30ad959d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2007NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c1a43c0fecf4f50ae6cebda59c8b404_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2008NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3976df847f6a4da191d1961d8126013e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2009NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6602bcb2e70449fa757d0cf969d2e2a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2010NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if70775d7ed4d4bba9b45ad323909f03d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2011NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9402356363b4f8f9a3867eb8211b078_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2012NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b4691fe3b4e4dd7b23e74d90e241e1d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2013NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e03b7ae06ec4c8aba2fd2c946767067_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2014NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b55d65103bd48adbcfb2b0e11d8d4b1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2015NPMAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b8c44a5cad54a2f947e060d3352f19d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4513fc58c994ac2900d640a3a2b33fd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2017NPMAdjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf7e83849a514def895afca19a8dbf72_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2018NPMAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1bcaad299794ce9a240e8f403e0a7cb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2019NPMAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d5e76cb93d64980a7da87f32e2ef279_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2020NPMAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i856b71c11be3464788fa35e57b23b454_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2021NPMAdjustmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e156f0ff61c4547b064d2b367b1b8ae_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9f929366f9c4db99fbbe7cc0765d8e2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie91a77817ecc4e999d0370e2c9318a18_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3eb37f4a9f84da6819684970ef73356_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20042021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1a23e3497624a1fa46068cc25ed067e_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20192021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cdb4695c4e249cea22489ca33dd31a2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1705ce2bbd441deaa21faea57603e06_D20180101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2424508abe914dc19477786edb09c233_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i466ccb5c286b4d9d83b198edeb139479_D20150101-20151231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20042020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-01-01</xbrli:startDate><xbrli:endDate>2015-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9401b496918446c4a0bd9291e50c1846_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MT</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e30d0f16c0e4fffb6403230045d3122_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i308b4161cd2a4761bbf2bbbea9a5b94d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdda8a2cdb9d4db49e9b2c4177d9a7de_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i100852d80e724c41bb97050a1799cd82_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4a2cae32e3e4d64a9d5bfb3d5339a57_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57b16d217ed6412e9b51c342626023ec_D20221001-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ae59e3f662b40c2bd1cc8bfca42f60c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd6ed63b9bb24769bbb2b79d9903289a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="mo:ArbitrationPeriodAxis">mo:PeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9531c54ce48540a0a0550471e1cd3afe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="mo:ArbitrationPeriodAxis">mo:PeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8b742921dc34dc6b5591b065363c15b_D20220701-20220731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dedfe3526ab465c89c9b8e67c3357a8_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherDisputesUndertheStateSettlementAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0121b4c1497c443b91a2dbe5a6049059_D20060801-20060831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2006-08-01</xbrli:startDate><xbrli:endDate>2006-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29611429f47b4962bf5216deebdd1a1c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib515c9531f2c406b96d8ed470cbe6eeb_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingClassActionLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife1f1236593440dba4fa286c4568aa13_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:ClassActionLawsuitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40d0f2ac213e404c8089cdf43889f21f_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingClassActionLawsuitMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2494dd141e354811b038c1301f7dda49_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1be89cf9f8b449fdac3da2c8fca7d5cf_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitFiledBySchoolDistrictMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e946456b537477688ee4ce352a20446_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34620bbc337b4ce2b6567ee643c5068f_D20220901-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IQOSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07a9a17fedcf4c82a8a6872d1e854c64_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IQOSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9130d99afc484bd7b97086bb83a18185_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IQOSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29da272e87c54a8cbab18821615bf146_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49aa85e7288f4015a2cf251ad1ad3d1b_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d928ac82a174cbf9e654bf008eb8b4f_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="complaint"><xbrli:measure>mo:complaint</xbrli:measure></xbrli:unit><xbrli:context id="i9fd12ffe6e314078bec64fc03dd0d7cf_D20220201-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1ab966a566641208dea895e36c2cfca_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf8ee6d0a42b48658f65843e7407c4ff_D20191001-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-10-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shareholder"><xbrli:measure>mo:shareholder</xbrli:measure></xbrli:unit><xbrli:context id="i5714b7cd4a1f4abbba5201ba8cc74bb1_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd1d6e0639ad44f8812ae1cf1e390bc8_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37dc803167004d3bbbf661d9a1d012d3_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeb9e2bf525e43c0844f2e9fb73929c9_D20201001-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9899ddfb78b54d8ea14e76f8bf786983_D20210401-20210430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e0525ef8d214791974c2ec1841b3475_D20200901-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4bcc98934df473da5c7057ee93151ab_D20210701-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e17d631770e4e10909a4da8d0cf445c_D20220401-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalAndStateShareholderDerivativeLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i308dd7b8074947108716f905d87a8f98_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalAndStateShareholderDerivativeLawsuitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ae0d3b51df54bbe8b1959b343c21c55_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="court"><xbrli:measure>mo:court</xbrli:measure></xbrli:unit><xbrli:context id="i00d5a42df39d4763984da38514c7252f_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a6cd34d91d14705933337c9bba7c38c_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:USTLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5809327a200e4dd292baa4729e1d7e5a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19c2fc24e57144deb2090322db5badc1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i910731a56cae4c999349f736062b8eeb_I20230127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000764180</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-27</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtMy0xLTEtMTg0NDY5_3a1de55c-c8c1-4c0e-8b80-3f95381a1678 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtNy0xLTEtMTg0NDY5_c7daf6b9-586d-40ab-8e8a-700555c64c11 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtNS0xLTEtMTg0NDY5_a9b18782-5660-4b57-b202-a8053be6f4c3" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE4_025e2d0e-4c97-4f92-9795-be87a61ae169" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtNy0xLTEtMTg0NDY5_fc7e4d1a-9a22-49f0-8d42-310f8fdd2f5e id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctMy0xLTEtMTg0NDY5_8deaca41-7c96-4e8c-8385-7e467740c77a id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctNS0xLTEtMTg0NDY5_759a87d9-5197-4bf2-9a65-5f2c98ba7823 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtMy0xLTEtMTg0NDY5_69d4bbfd-3c54-4f6f-ac43-def57bedc3b7 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtNS0xLTEtMTg0NDY5_db920e2e-633f-4ad1-8b1a-005b5fce5b06 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtNS0xLTEtMTg0NDY5_1bfff92b-7dd4-4099-b50a-3f753ee343cc id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtNy0xLTEtMTg0NDY5_ad63cc97-ce3c-481c-866d-8a031b1a48df id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtNy0xLTEtMTg0NDY5_203d2fd6-57a4-4f03-aa3d-ed9e380ed56e id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtMy0xLTEtMTg0NDY5_b171074d-301b-42c8-91ac-1761bf0b46a0 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtMy0xLTEtMTg0NDY5_a263de0c-6587-42c8-9396-b995575984e6 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctNy0xLTEtMTg0NDY5_2c9b888b-a91a-4bea-9f45-859a4eda9baa id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktNS0xLTEtMTg0NDY5_4ec58889-7557-43b6-82b5-7dc591b1be87 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtMy0xLTEtMTg0NDY5_355d473f-1333-4c41-ad67-1e1351abf2c5 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtNy0xLTEtMTg0NDY5_e3c8c0cf-ff28-47dd-942f-6deb723d66cc id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktMy0xLTEtMTg0NDY5_8b5b42d2-4b81-456b-8339-13cab0197645 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktNy0xLTEtMTg0NDY5_cdf2c1f2-effa-4703-ad59-804c05c64b84 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtNS0xLTEtMTg0NDY5_9dfffa66-533d-4eff-b94f-6216b81ff55e id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtNS0xLTEtMTg0NDY5_3bf7ef4a-bd0c-4bcc-9072-5628558babb3" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0xMS0xLTEtMTg0NDY5_331d7980-7513-4e9b-9fea-a0de6e28adc7 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMy0xLTEtMTg0NDY5_1a7b921c-90d1-46c6-904a-41981274e29a id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMTMtMS0xLTE4NDQ2OQ_f5d76cff-b586-4505-b0cb-b9c3feb2b5a7 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMTMtMS0xLTE4NDQ2OQ_eaaade6c-00b9-439c-aff9-3fd93d136786 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0xMy0xLTEtMTg0NDY5_4399e170-9610-4ab2-ba0c-56afb2e2fae0 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMTEtMS0xLTE4NDQ2OQ_ba3cb69a-974d-4cce-90ea-aa5f5ba144a1 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0zLTEtMS0xODQ0Njk_0254c52c-e466-47e3-882e-37a450dd94f5 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMTEtMS0xLTE4NDQ2OQ_18eb84d4-39c0-48e1-8601-59a98212a535 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMy0xLTEtMTg0NDY5_ac11e58c-b7bb-4b55-b8f3-f2596f262f54" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtNS0xLTEtMTg0NDY5_bd3bb9be-596a-4f1b-b189-0373023ab0e6 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtNy0xLTEtMTg0NDY5_84400522-0293-4106-b980-ec04b03e31f9 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtNS0xLTEtMTg0NDY5_64fa7aae-ddef-4caf-ba23-40606890a0e4 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtMy0xLTEtMTg0NDY5_e5f3aecf-a9ff-4428-9ed2-426d4780cd6c id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtNy0xLTEtMTg0NDY5_4ab69433-7e8a-4d7b-97a4-07872742a884 id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtMy0xLTEtMTg0NDY5_f0409233-b1e7-4ebb-9154-a390febe08d8" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE0_c105be61-2fc6-4089-a6be-9d171ba7904e" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i15062ca98227434086141b426450a5cb_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington,&#160;D.C. 20549 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDE2_34881666-53d9-40b8-9803-3ecaeef9f24f">10-K</ix:nonNumeric> </span></div><div style="padding-left:18pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDA5_dd28964d-2c23-414d-ab9a-fbf4d93163bb">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF82MDQ3MzEzOTU1ODQ0_a02f58de-fb42-41d8-8806-24a56e589324"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF82MDQ3MzEzOTU1ODQ0_c32c2e27-c313-4a07-8e4d-5701491a01dc">December 31</ix:nonNumeric>, 2022</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR </span></div><div style="padding-left:18pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDEz_28133e9f-b32f-4c41-bc2f-6aa95faa2253">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDE4_ac5864e8-96fb-4c2d-84c6-15c826099840">1-08940</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDE0_df28b17e-9aa7-4388-9ef8-4c6fc080acd8">ALTRIA GROUP, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.978%"><tr><td style="width:1.0%"></td><td style="width:28.247%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.924%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.679%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6MGIyMjA5MTQ1YmY1NDU3MjliZjIzY2JjZGRkOWVjZTAvdGFibGVyYW5nZTowYjIyMDkxNDViZjU0NTcyOWJmMjNjYmNkZGQ5ZWNlMF8wLTAtMS0xLTE4NDQ2OQ_72f6d42f-18cd-4e4d-b584-5df59947a157">Virginia</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6MGIyMjA5MTQ1YmY1NDU3MjliZjIzY2JjZGRkOWVjZTAvdGFibGVyYW5nZTowYjIyMDkxNDViZjU0NTcyOWJmMjNjYmNkZGQ5ZWNlMF8wLTMtMS0xLTE4NDQ2OQ_cc6a0ff1-db4f-40e6-bd50-d440d330ec5d">13-3260245</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6MGIyMjA5MTQ1YmY1NDU3MjliZjIzY2JjZGRkOWVjZTAvdGFibGVyYW5nZTowYjIyMDkxNDViZjU0NTcyOWJmMjNjYmNkZGQ5ZWNlMF8zLTAtMS0xLTE4NDQ2OQ_dab2b94c-2dce-45d9-9ba8-c111ccea1fc0">6601 West Broad Street,</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6MGIyMjA5MTQ1YmY1NDU3MjliZjIzY2JjZGRkOWVjZTAvdGFibGVyYW5nZTowYjIyMDkxNDViZjU0NTcyOWJmMjNjYmNkZGQ5ZWNlMF8zLTEtMS0xLTE4NDQ2OQ_d0b3d8c2-3aa5-496b-89d0-a64dd91dd0c9">Richmond,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6MGIyMjA5MTQ1YmY1NDU3MjliZjIzY2JjZGRkOWVjZTAvdGFibGVyYW5nZTowYjIyMDkxNDViZjU0NTcyOWJmMjNjYmNkZGQ5ZWNlMF8zLTItMS0xLTE4NDQ2OQ_39a7af30-dd8c-4f5b-bbab-19c087a6e39f">Virginia</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6MGIyMjA5MTQ1YmY1NDU3MjliZjIzY2JjZGRkOWVjZTAvdGFibGVyYW5nZTowYjIyMDkxNDViZjU0NTcyOWJmMjNjYmNkZGQ5ZWNlMF8zLTMtMS0xLTE4NDQ2OQ_afd0628e-2964-44b5-b5dc-42d7a7aeb88b">23230</ix:nonNumeric></span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDE5_ec667c4a-e733-4269-afe7-a56df124825d">804</ix:nonNumeric>-<ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDE3_78a88b06-c7bc-4c27-b7a1-53f8bd7aaebc">274-2200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.306%"><tr><td style="width:1.0%"></td><td style="width:33.599%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.773%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbols</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if68a1d60201343fa81c9dac56e62fcdb_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl8xLTAtMS0xLTE4NDQ2OQ_5fd0cdb5-7e9c-4393-a018-6c47b8657b85">Common Stock, $0.33 &#160;1/3 par value</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if68a1d60201343fa81c9dac56e62fcdb_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl8xLTEtMS0xLTE4NDQ2OQ_07fe1ac8-f1ee-456b-a26b-d305283a6a04">MO</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if68a1d60201343fa81c9dac56e62fcdb_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl8xLTItMS0xLTE4NDQ2OQ_9ccdcd79-d64f-4638-a403-dd963086eb80">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i08bee235d9824c2493054813893719a6_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl8zLTAtMS0xLTE4NDQ2OQ_311c66cc-5c3c-4ad9-adcc-c715a5d05312">1.700% Notes due 2025</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i08bee235d9824c2493054813893719a6_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl8zLTEtMS0xLTE4NDQ2OQ_f0bb961b-c48a-4981-b4aa-916d8a4fec3a">MO25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i08bee235d9824c2493054813893719a6_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl8zLTItMS0xLTE4NDQ2OQ_76d71f8c-178b-4c8b-ae51-ba10a760dd78">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie32723d5c819467dbff1e1e9523aa4ed_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl80LTAtMS0xLTE4NDQ2OQ_e8d1df49-a2ff-4f82-9429-05de54f2f3da">2.200% Notes due 2027</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie32723d5c819467dbff1e1e9523aa4ed_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl80LTEtMS0xLTE4NDQ2OQ_0d6a0c23-7051-4c32-9bee-3e70ef2e89bb">MO27</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie32723d5c819467dbff1e1e9523aa4ed_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl80LTItMS0xLTE4NDQ2OQ_90687717-726c-4e1e-87a7-5991edd18c77">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:5pt;margin-top:5pt;padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3966dc6c234463b99c7126c8cb64ec1_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl81LTAtMS0xLTE4NDQ2OQ_9187956a-ba3e-4db6-948b-1829ac01593d">3.125% Notes due 2031</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3966dc6c234463b99c7126c8cb64ec1_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl81LTEtMS0xLTE4NDQ2OQ_41fc0d5c-adcd-4f13-af46-d9c67643d1e9">MO31</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3966dc6c234463b99c7126c8cb64ec1_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl81LTItMS0xLTE4NDQ2OQ_793d66b2-ef8d-4776-a777-2bbe04fd909f">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:  None</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.           </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDEw_e8dcb533-b250-408a-89a6-29e3aeebe5a8">Yes</ix:nonNumeric>   </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.        </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Yes    </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDIw_0ac2f3c0-a590-4db3-ac5e-1753fa50b60b">No</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90&#160;days   </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDEx_bfa7ecaa-d19b-45e8-b67e-c91181f3bede">Yes</ix:nonNumeric>     </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">   No</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)     </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDIx_a9f31d7d-da18-48cd-bd53-44da63c28ad1">Yes</ix:nonNumeric>     </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.431%"><tr><td style="width:1.0%"></td><td style="width:21.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.743%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.118%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.185%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZWYyZTNhMjQxYzY2NGQ2MWFkYWUzMWFlZTcwMjI2YjkvdGFibGVyYW5nZTplZjJlM2EyNDFjNjY0ZDYxYWRhZTMxYWVlNzAyMjZiOV8wLTAtMS0xLTE4NDQ2OQ_329da140-a5d7-432c-a833-8e431e6daeb0">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZWYyZTNhMjQxYzY2NGQ2MWFkYWUzMWFlZTcwMjI2YjkvdGFibGVyYW5nZTplZjJlM2EyNDFjNjY0ZDYxYWRhZTMxYWVlNzAyMjZiOV8xLTYtMS0xLTE4NDQ2OQ_375d007e-a20c-46c8-a7f0-6e32149393a7">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth&#160;company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZWYyZTNhMjQxYzY2NGQ2MWFkYWUzMWFlZTcwMjI2YjkvdGFibGVyYW5nZTplZjJlM2EyNDFjNjY0ZDYxYWRhZTMxYWVlNzAyMjZiOV8yLTYtMS0xLTE4NDQ2OQ_c6cd049c-87eb-40ae-be11-257fad2200e5">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDEy_790260bf-8ef8-4af9-adde-adca93290dbb">&#9745;</ix:nonNumeric> </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDIy_273e25e6-f840-439b-8cb5-f7c80a2fd2f7">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Yes    </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#254; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of June 30, 2022, the aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="i0fc07528ff404f99acbe2f1625a88f2b_I20220630" decimals="-9" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF82MDQ3MzEzOTU1ODMy_fbbf95e7-9509-4100-9f1c-952f67659295">75</ix:nonFraction>&#160;billion based on the closing sale price of the common stock as reported on the New York Stock Exchange.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:15pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.725%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding&#160;at&#160;February 15,&#160;2023</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock, $0.33 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> par value</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6fecf4e044e946ff90e09a30c692e5ae_I20230215" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6Mzg0MjcwOWVmOTlmNDdkOWJmZTcxYzg5NmM3NjZkZDIvdGFibGVyYW5nZTozODQyNzA5ZWY5OWY0N2Q5YmZlNzFjODk2Yzc2NmRkMl8xLTEtMS0xLTE4NDQ2OQ_b5881d24-0521-4acb-a674-71133e2145d8">1,785,563,827</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shares</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE </span></div><div style="margin-top:5pt"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDIz_c477c328-8aaf-4761-81b4-ff634fd129b8" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.360%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portions of the registrant&#8217;s definitive proxy statement for use in connection with its annual meeting of shareholders to be held on May&#160;18, 2023, to be filed with the U.S. Securities and Exchange Commission on or about April 6, 2023, are incorporated by reference into Part III hereof.</span></td></tr></table></ix:nonNumeric></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i15062ca98227434086141b426450a5cb_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.360%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:70.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.818%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TABLE OF CONTENTS</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_19">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_22">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_22">13</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_25">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_25">13</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_28">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_28">14</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_31">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_31">14</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART II</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_37">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_37">15</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_40">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_40">16</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_43">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_43">16</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_73">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_73">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_76">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_76">48</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_199">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_199">103</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_202">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_202">103</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_205">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_205">103</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_208">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_208">103</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART III</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_214">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_214">103</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_217">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_217">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_220">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_220">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_223">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_223">104</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_226">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_226">104</a></span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART IV</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_232">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_232">105</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_235">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_235">108</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_238">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_238">109</a></span></div></td></tr><tr style="height:8pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i15062ca98227434086141b426450a5cb_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;text-decoration:underline">Part I</span></div><div id="i15062ca98227434086141b426450a5cb_16"></div><div style="margin-bottom:5pt;padding-left:468pt;text-indent:-468pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1.  Business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">General Development of Business</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in this Annual Report on Form 10-K (&#8220;Form 10-K&#8221;), the terms &#8220;Altria,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to either (i) Altria Group, Inc. and its consolidated subsidiaries or (ii) Altria Group, Inc. only and not its consolidated subsidiaries, as appropriate in the context.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a leading portfolio of tobacco products for U.S. tobacco consumers age 21+.  Our Vision by 2030 is to responsibly lead the transition of adult smokers to a smoke-free future (&#8220;Vision&#8221;).  We are </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moving</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Beyond</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">moking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, leading the way in moving adult smokers away from cigarettes by taking action to transition millions to potentially less harmful choices - believing it is a substantial opportunity for adult tobacco consumers, our businesses and society.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our wholly owned subsidiaries include Philip Morris USA Inc. (&#8220;PM USA&#8221;), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (&#8220;Middleton&#8221;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA; UST LLC (&#8220;UST&#8221;), which, through its wholly owned subsidiary U.S. Smokeless Tobacco Company LLC (&#8220;USSTC&#8221;), is engaged in the manufacture and sale of moist smokeless tobacco products (&#8220;MST&#8221;) and snus products; and Helix Innovations LLC (&#8220;Helix&#8221;), which operates in the United States and Canada, and Helix Innovations GmbH and its affiliates (&#8220;Helix ROW&#8221;), which operate internationally in the rest-of-world, are engaged in the manufacture and sale of oral nicotine pouches.  Other wholly owned subsidiaries include Altria Group Distribution Company, which provides sales and distribution services to our domestic tobacco operating companies; Altria Client Services LLC (&#8220;ALCS&#8221;), which provides various support services to our companies in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs; and Philip Morris Capital Corporation (&#8220;PMCC&#8221;), which completed the wind-down of its portfolio of finance assets in 2022 and had no finance assets remaining at December 31, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, Altria, through PM USA, entered into a joint venture with JTI (US) Holding, Inc. (&#8220;JTIUH&#8221;), a subsidiary of Japan Tobacco Inc. (&#8220;Japan Tobacco&#8221;), for the U.S. marketing and commercialization of heated tobacco stick (&#8220;HTS&#8221;) products.  The joint venture entity, Horizon Innovations LLC (&#8220;Horizon&#8221;), is structured to exist in perpetuity and is responsible for the U.S. commercialization of HTS products owned by either party.  PM USA holds a 75% economic interest in Horizon with JTIUH having a 25% economic interest.  The parties plan to collaborate on a global smoke-free partnership.  Horizon is governed by a board of managers, which is comprised of four individuals designated by PM USA and three individuals designated by JTIUH.  For further information, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, UST sold its subsidiary, International Wine &amp; Spirits Ltd. (&#8220;IWS&#8221;), which included Ste. Michelle Wine Estates Ltd. (&#8220;Ste. Michelle&#8221;), in an all-cash transaction with a net purchase price of approximately $1.2 billion and the assumption of certain liabilities of IWS and its subsidiaries (the &#8220;Ste. Michelle Transaction&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020 and April 2021, we purchased the remaining 20% interest in (i) Helix ROW and (ii) Helix, respectively.  The total purchase price of the December 2020 and April 2021 transactions was approximately $250 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reportable segments are smokeable products and oral tobacco products.  The financial services business, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System (as defined below) heated tobacco business and Helix ROW are included in an all other category due to the relative financial contribution of these businesses to our consolidated results.  Prior to the Ste. Michelle Transaction, wine produced and/or sold by Ste. Michelle was a reportable segment.  For further information, see Note 14. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements in Item 8. Financial Statements and Supplementary Data of this Form 10-K (&#8220;Item 8&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in equity securities include Anheuser-Busch InBev SA/NV (&#8220;ABI&#8221;), Cronos Group Inc. (&#8220;Cronos&#8221;) and JUUL Labs, Inc. (&#8220;JUUL&#8221;).  We account for our investments in ABI and Cronos under the equity method of accounting using a one-quarter lag.  We account for our investment in JUUL at fair value.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of our investments in equity securities, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the consolidated financial statements in Item 8 (&#8220;Note 5&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portions of the information relating to this Item are included in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of this Form 10-K (&#8220;Item 7&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tobacco Space</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tobacco operating companies include PM USA, USSTC and other subsidiaries of UST, Middleton and Helix.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products of our tobacco operating companies include: (i) smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton; and (ii) oral </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">tobacco products, consisting of MST and snus products manufactured and sold by USSTC and oral nicotine pouches manufactured and sold by Helix.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Cigarettes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA is the largest cigarette company in the United States and substantially all cigarettes are manufactured and sold to customers in the United States.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the principal cigarette brand of PM USA, has been the largest-selling cigarette brand in the United States for over 45 years.  Total smokeable products segment&#8217;s cigarettes shipment volume in the United States was 84.7 billion units in 2022, a decrease of 9.7% from 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Cigars: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Middleton is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco.  Middleton contracts with a third-party importer to supply a majority of its cigars and sells substantially all of its cigars to customers in the United States.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Black &amp; Mild</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is the principal cigar brand of Middleton.  Total smokeable products segment&#8217;s cigars shipment volume was approximately 1.7 billion units in 2022, a decrease of 4.0% from 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Oral tobacco products: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USSTC is the leading producer and marketer of MST products.  The oral tobacco products segment includes the premium brands, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and a value brand, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sold by USSTC.  In addition, the oral tobacco products segment includes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> oral nicotine pouches sold by Helix.  Substantially all of the oral tobacco products are manufactured and sold to customers in the United States.  Total oral tobacco products segment&#8217;s shipment volume was 800.6 million units in 2022, a decrease of 2.4% from 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Other tobacco products: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2013, we entered into a series of agreements with Philip Morris International Inc. (&#8220;PMI&#8221;), including an agreement that granted us an exclusive right to commercialize certain of PMI&#8217;s heated tobacco products in the United States.  In 2019, PM USA began commercialization of PMI&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Tobacco Heating System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System&#8221;) in select markets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with a patent dispute, the U.S. International Trade Commission (&#8220;ITC&#8221;) issued a limited exclusion order barring the importation of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System electronic device, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the infringing components into the United States and a cease and desist order barring domestic sales, marketing and distribution of these imported products effective November 29, 2021.  Due to this litigation, we removed the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">electronic device and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from the marketplace.  For a further discussion of the ITC decision, see Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements in Item 8 (&#8220;Note 17&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, we entered into an agreement with PMI to, among other things, transition and ultimately conclude our relationship with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">System in the United States.  We have agreed to assign to PMI exclusive U.S. commercialization rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System effective April 30, 2024.  PMI will not have access to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand name or other brand assets, as PM USA owns the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark in the United States.  For further discussion see Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangible Assets, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements in Item 8 (&#8220;Note 4&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the joint venture agreement with JTIUH, Horizon will market and commercialize HTS products, which are defined in the joint venture agreement as products that include both (i) a tobacco heating device intended to heat the consumable without combusting and (ii) a consumable that meets the definition of a cigarette under the U.S. Federal Cigarette Labeling and Advertising Act.  Horizon is responsible for the U.S. commercialization of current and future HTS products owned by either party and, upon authorization by the U.S. Food and Drug Administration (&#8220;FDA&#8221;) of a pre-market tobacco application (&#8220;PMTA&#8221;), will become the exclusive entity through which the parties market and commercialize HTS products in the United States.  Upon PMTA authorization of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ploom</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> HTS products, JTIUH will supply </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ploom</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> HTS devices and PM USA will manufacture </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> HTS consumables for U.S. commercialization.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Distribution, Competition and Raw Materials: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tobacco subsidiaries sell their tobacco products principally to wholesalers (including distributors) and large retail organizations, including chain stores.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for tobacco products is highly competitive, characterized by brand recognition and loyalty, with product quality, taste, price, product innovation, marketing, packaging and distribution constituting the significant methods of competition.  Promotional activities include, in certain instances and where permitted by law, allowances, the distribution of incentive items, price promotions, product promotions, coupons and other discounts.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Family Smoking Prevention and Tobacco Control Act (&#8220;FSPTCA&#8221;) provides the FDA with broad authority to regulate the design, manufacture, packaging, advertising, promotion, sale and distribution of tobacco products; the authority to require disclosures of related information; and the authority to enforce the FSPTCA and related regulations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, under a contract growing program, PM USA purchases the majority of its burley and flue-cured leaf tobaccos directly from domestic tobacco growers.  Under the terms of this program, PM USA agrees to purchase the amount of tobacco specified in the grower contracts that meets PM USA&#8217;s grade and quality standards.  PM USA also purchases a portion of its tobacco requirements through leaf merchants.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USSTC purchases dark fire-cured, dark air-cured and burley leaf tobaccos from domestic tobacco growers under a contract growing program.  Under the terms of this program, USSTC agrees to purchase the amount of tobacco specified in the grower contracts that meets USSTC&#8217;s grade and quality standards.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Middleton purchases burley, dark air-cured and flue-cured leaf tobaccos through leaf merchants.  Middleton does not have a contract growing program.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helix, through an affiliate, purchases tobacco-derived nicotine materials from suppliers and believes its suppliers can satisfy current and anticipated future production requirements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tobacco subsidiaries believe there is an adequate supply of tobacco in the world markets to satisfy their current and anticipated production requirements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of the foregoing matters, the tobacco business environment, trends in market demand and competitive conditions, and related risks, see Item 1A. Risk Factors of this Form 10-K (&#8220;Item 1A&#8221;) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco Space - Business Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Item 7.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Matters</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Customers: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of PM USA, USSTC, Helix and Middleton&#8217;s largest customers, including their percentages of our consolidated net revenues for the years ended December&#160;31, 2022, 2021 and 2020, see Note 14. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements in Item 8 (&#8220;Note 14&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Executive Officers of Altria: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disclosure regarding executive officers is included in Item 10. Directors, Executive Officers and Corporate Governance - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Information about Our Executive Officers as of February 15, 2023 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of this Form 10-K.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Human Capital Resources: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our workforce is critical to achieving our Vision.  Attracting, developing, deploying and retaining the best talent with the skills to make significant progress toward our Vision is a key business priority.  Moreover, we recognize the importance of doing business the right way.  We believe culture influences employee actions and decision-making.  This is why we dedicate resources to promoting a vibrant, inclusive workplace; attracting, developing and retaining talented, diverse employees; promoting a culture of compliance and integrity; creating a safe workplace; and rewarding and recognizing employees for both the results they deliver and, importantly, how they deliver them.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oversight and Management</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Human Resources department is responsible for managing employment-related matters, including recruiting and hiring, onboarding, compensation and benefits design and implementation, performance management, career management and succession planning and professional and learning development.  Our inclusion, diversity and equity (&#8220;ID&amp;E&#8221;) programs are managed by our Corporate Citizenship department.  Our Board of Directors (&#8220;Board of Directors&#8221; or &#8220;Board&#8221;) and the Compensation and Talent Development Committee provide oversight of human capital matters, including reviewing initiatives and programs related to corporate culture and enterprise-wide talent development, including our ID&amp;E initiatives.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inclusion, Diversity and Equity</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the critical importance of ID&amp;E in pursuing our Vision and believe in the value of a workforce composed of a broad spectrum of backgrounds and cultures.  In 2020, we established the following aspirational Inclusion &amp; Diversity Aiming Points to help guide our efforts:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Be an inclusive place to work for all employees, regardless of level, demographic group or work function.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Have equal numbers of men and women among our vice president and director-level employees.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Increase our vice president and director-level employees who are Asian, Black, Hispanic or two or more races to at least 30%.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Increase our vice president and director-level employees who are LGBTQ+, a person with a disability or a veteran.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Have diverse functional leadership teams that reflect the organizations they lead.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, women represented 34% of vice president-level and 41% of director-level roles; Asian, Black, Hispanic or employees of two or more races represented 21% of our vice president-level and 26% of our director-level roles.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation and Benefits</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compensation and benefits programs are designed to help us attract, retain and motivate strong talent.  However, we recognize that the decreasing social acceptance of tobacco usage may impact our ability to attract and retain talent.  We work to manage this risk by, among other things, targeting total compensation packages to be above peer companies with which we compete for talent.  Depending on employee level, total compensation includes different elements &#8211; base salary, annual cash incentives, long-term equity and cash incentives and benefits.  We design our compensation program to deliver total compensation at levels between the 50th and 75th percentiles of compensation paid to employees in comparable positions at our peer companies.  Actual total compensation can exceed the 75th percentile or be below the 50th percentile depending on business and individual performance.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to pay equity across our companies.  Based on the most recent annual analysis we conducted in December 2022, adjusting for factors generally considered to be legitimate differentiators of salary, such as performance and tenure, salaries of our female employees were 99.6% of those of our male employees, and salaries of our non-white employees were 100% of those of our white employees.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to cash and equity compensation, we offer generous employee benefits such as significant company contributions to deferred profit sharing plans, consumer-driven health plan coverage, vacation and holiday pay, disability and life insurance, and up to 12 weeks paid parental and family leave for birth, adoption and foster placement and an additional six weeks paid leave for birth mothers.  Our benefits also include physical, emotional and financial wellness programs and family creation assistance benefits, such as adoption assistance and coverage for fertility treatments.  While there is some variability in employee benefits across our companies, the examples we provide are available to most employees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also committed to investing in the educational development of our workforce through an unlimited tuition refund program for job-related courses or company-related degrees.  We also provide eligible employees with a company-funded contribution applied to the employee&#8217;s qualified higher education student loans to help reduce student loan debt.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attracting, Developing and Retaining Talent</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our salaried entry-level recruitment efforts focus on recruiting relationships with universities, internship opportunities and partnerships with organizations that support diverse students.  We complement these recruiting efforts with hiring experienced employees with demonstrated skills and/or leadership capabilities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To help our employees succeed in their roles and develop in their careers, we emphasize ongoing training and leadership development opportunities.  Building skills that drive innovation and aligning our employees to our Vision is important for our long-term success.  The Human Resources department leads our learning and development efforts partnering with learning professionals embedded in functions throughout our operating and services companies.  Employees have access to a wide variety of development programs, including new employee onboarding, in-person, virtual and self-guided training programs, technical training, including training to maintain professional certifications, and our educational refund program for continuing education.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional tool we use to motivate and recognize employees is our employee recognition program, Snap, which allows leaders and employees to reward and recognize colleagues for their outstanding performance and everyday excellence.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly conduct confidential employee engagement surveys to seek feedback on a variety of topics, including employee satisfaction, support from leadership, corporate culture and culture of compliance.  In addition, in 2022, we conducted quarterly employee surveys to gauge overall engagement and to obtain feedback on topics such as workplace flexibility, workload, inclusion, development opportunities, management support, compliance and understanding of business strategy.  Survey results, including comparisons to prior results, are shared with our employees and our Board and are used to modify or enhance our human capital management programs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Workplace Safety</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goal is for every Altria employee to experience an injury-free career, which is supported by our Safety Management System (&#8220;SMS&#8221;).  We strive for continuous improvement in our employee safety program through SMS infrastructure.  Our Occupational Safety and Health Administration recordable injury rate for 2022 was 1.3</span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (versus 1.7% for 2021) and remains below the benchmark for companies in the U.S. Beverage and Tobacco Product Manufacturing industry classification.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Number of Employees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Labor Relations</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we employed approximately 6,300 people.  Twenty-eight percent of our employees were hourly manufacturing employees who are members of labor unions subject to collective bargaining agreements.  We believe we engage and collaborate effectively with our hourly employees, as demonstrated by the positive working relationship between our companies and the unions.  We also have long-term agreements that resolve any collective bargaining dispute through binding arbitration, which further demonstrates our trust-based relationship with the unions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supply Chain Human Capital Matters</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We support efforts to address human capital concerns in the tobacco supply chain.  For example, in our domestic tobacco supply chain, in 2022, all of our domestic tobacco growers participated in the Good Agricultural Practices Certification Program to assess growers&#8217; compliance with practices related to labor management and all of our tobacco suppliers participated in the tobacco industry&#8217;s Sustainable Tobacco Program, which includes standards related to human and labor rights.  Our tobacco companies also establish contract terms and conditions with tobacco growers and leaf suppliers addressing child and forced labor and conduct social compliance audits at leaf supplier facilities in high-risk tobacco growing regions within the United States and internationally.  In addition, all suppliers of goods and services that maintain operations in high-risk countries are subject to social compliance audits of those operations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More information about efforts discussed in this section can be found in our Corporate Responsibility Reports at www.altria.com/responsibility.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Intellectual Property: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks are of material importance to us and are protected by registration or otherwise.  In addition, as of December&#160;31, 2022, the portfolio of United States patents owned by our businesses, as a whole, was material to us and our tobacco businesses.  However, no one patent or group of related patents was material to our business or our tobacco businesses as of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022.  Our businesses also have proprietary trade secrets, technology, know-how, processes and other intellectual property rights that are protected by appropriate confidentiality measures.  Certain trade secrets are material to us and our tobacco businesses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Government Regulations: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various federal, state and local laws and regulations.  For discussion of laws and regulations impacting our tobacco operating companies, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco Space - Business Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Item 7.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our subsidiaries (and former subsidiaries) are also subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the United States: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#8220;Superfund&#8221;), which can impose joint and several liability on each responsible party.  Our subsidiaries (and former subsidiaries) are involved in several matters subjecting them to potential costs of remediation and natural resource damages under Superfund or other laws and regulations.  Our subsidiaries expect to continue to make capital and other expenditures in connection with environmental laws and regulations.  As discussed in Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements in Item 8 (&#8220;Note 2&#8221;), we provide for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that our subsidiaries may undertake in the future.  In the opinion of management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and related expenditures, has not had, and is not expected to have, a material adverse effect on our business, results of operations, capital expenditures, financial position or cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Available Information</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to file annual, quarterly and current reports, proxy statements and other information with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;).  The SEC maintains an Internet website at www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers from which investors can electronically access our SEC filings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make available free of charge on or through our website (www.altria.com) our Form&#160;10-K, Quarterly Reports on Form&#160;10-Q, Current Reports on Form&#160;8-K and amendments to those reports filed or furnished pursuant to Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC.  Investors can access our filings with the SEC by visiting www.altria.com/secfilings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information on our respective websites is not, and shall not be deemed to be, a part of this Form 10-K or incorporated into any other filings we make with the SEC.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_19"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to various risks and uncertainties that are difficult to predict, may materially affect actual results and are often outside of our control.  We identify a number of these risks and uncertainties below.  You should read the following risk factors carefully in connection with evaluating our business and the forward-looking statements contained in this Form 10-K.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Form 10-K contains statements concerning our expectations, plans, objectives, future financial performance and other statements that are not historical facts.  You can identify these forward-looking statements by use of words such as &#8220;strategy,&#8221; &#8220;expects,&#8221; &#8220;continues,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;will,&#8221; &#8220;estimates,&#8221; &#8220;forecasts,&#8221; &#8220;intends,&#8221; &#8220;projects,&#8221; &#8220;goals,&#8221; &#8220;objectives,&#8221; &#8220;guidance,&#8221; &#8220;targets&#8221; and other words of similar meaning.  You can also identify them by the fact that they do not relate strictly to historical or current facts.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans, estimates and assumptions.  Achievement of future results is subject to risks, uncertainties and assumptions that may prove to be inaccurate.  If risks or uncertainties materialize, or if underlying estimates or assumptions prove inaccurate, actual results could differ materially from those anticipated.  You should bear this in mind as you consider forward-looking statements and whether to invest in or remain invested in our securities.  Under the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995, we identify important factors that, individually or in the aggregate, could cause actual results and outcomes, including with respect to our ability to achieve our Vision, to differ materially from those contained in, or implied by, any forward-looking statements we make.  We elaborate on these important factors and the risks we face throughout this Form 10-K, particularly in the &#8220;Executive Summary&#8221; and &#8220;Business Environment&#8221; sections preceding our discussion of the operating results of our segments in Item 7.  You should understand that it is not possible to predict or identify all factors and risks.  Consequently, you should not consider the foregoing list to be complete.  We do not undertake to update any forward-looking statement that we may make from time to time except as required by applicable law.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Relating to Our Business</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Business Operations Risks</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be unsuccessful in anticipating and responding to changes in adult tobacco consumer preferences and purchase behavior, including as a result of difficult economic conditions, which could have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating companies&#8217; portfolios of tobacco products are largely comprised of premium brands, such as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  As adult tobacco consumer preferences evolve, consumers are increasingly moving across tobacco categories.  The willingness of adult tobacco consumers to purchase premium brands is affected by macroeconomic conditions, including inflation and overall economic stability.  In periods of economic uncertainty and high inflation, among other conditions, we have observed adult tobacco consumers reduce consumption, purchase more discount brands and consider lower-priced tobacco products, including different categories of tobacco products than those they traditionally purchase.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to effectively respond to new and evolving adult tobacco consumer purchase behavior catalyzed by challenging macroeconomic conditions and changes in adult tobacco consumer preferences depends on our ability to promote brand equity successfully among our premium and discount brands and broaden our product portfolios across price-points and categories, including by bringing to market new and innovative tobacco products that appeal to adult tobacco consumers.  Our failure to do so or our failure to anticipate changing adult tobacco consumer preferences, improve productivity and protect or enhance margins through cost savings and price increases, could have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We face significant competition, and our failure to compete effectively could have a material adverse effect on our business, results of operations, cash flows or financial position and our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating companies operate in highly competitive environments.  Significant competition exists with respect to product quality, taste, price, product innovation, marketing, packaging, distribution and promotional activities.  In addition, as adult tobacco consumer preferences evolve, consumers are increasingly moving across tobacco categories.  Our operating companies&#8217; failure to compete effectively in these environments could negatively impact profitability, market share (including as a result of down-trading to lower-priced competitive brands) and shipment volume, which could have a material adverse effect on our business, results of operations, cash flows or financial position and our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The growth of innovative tobacco products, including e-vapor products and oral nicotine pouches, has contributed to reductions in the consumption levels and industry sales volume of cigarettes and other tobacco products, including MST.  Furthermore, the sale of synthetic nicotine products without authorization from the FDA could negatively impact the growth of other innovative tobacco products.  If we are unable to compete effectively in innovative tobacco product categories, including through internal product development, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> oral nicotine pouch products, our investment in JUUL, potential future investments in the e-vapor category, our participation in Horizon and other potential future partnerships with Japan Tobacco, such inability could have a material adverse impact on our business, results of operations, cash flows or financial positions and our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA also faces competition from lower-priced brands sold by certain United States and foreign manufacturers that have cost advantages because they are not parties to settlements of certain tobacco litigation in the United States and, as such, are not required to make annual settlement payments as required by the parties to the settlements.  These settlement payments, which are inflation-adjusted, are significant for PM USA and have contributed to substantial cigarette price increases to help cover their cost.  Manufacturers not party to the settlements are subject to state escrow legislation requiring escrow deposits.  Such manufacturers may avoid these escrow obligations by concentrating on certain states where escrow deposits are not required or are required on fewer than all such manufacturers&#8217; cigarettes sold in such states.  Additional competition has resulted from diversion into the United States market of cigarettes intended for sale outside the United States, the sale of counterfeit cigarettes by third parties, the sale of cigarettes by third parties over the Internet and by other means designed to avoid collection of applicable taxes, and imports of foreign lower-priced brands.  Our failure to compete with lower-priced cigarette brands and counter the impacts of illicit trade in tobacco products could have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be unsuccessful in commercializing innovative products, including tobacco products with reduced health risks relative to certain other tobacco products and that appeal to adult tobacco consumers, which may have a material adverse effect on our business, results of operations, cash flows or financial position and our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have growth strategies involving innovative products that may have reduced health risks relative to certain other tobacco products, while continuing to offer adult tobacco consumers (within and outside the United States) products that meet their taste expectations and evolving preferences.  If we are not successful in executing these strategies, there could be a material negative impact on our business and our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, we entered into a joint venture with JTIUH to form Horizon for the marketing and commercialization of HTS products in the U.S.  Horizon&#8217;s success in generating new revenue streams by commercializing current and future HTS products owned by us or Japan Tobacco is dependent upon a number of factors.  Also, if the parties are unsuccessful in collaborating on the development and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">global commercialization of additional innovative smoke-free tobacco products, such an outcome could have a negative effect on our ability to generate new revenue streams and enter new geographic markets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, we exercised our option to be released from our JUUL non-competition obligations.  As a result, we now have less voting power and influence over JUUL&#8217;s financial and operating policies, and JUUL has greater flexibility to pursue strategic options with respect to its business.  If we are unable to identify and execute on new opportunities to acquire, develop or commercialize innovative products within the e-vapor space, we could be at a competitive disadvantage in the e-vapor category, which could have a negative effect on our ability to generate new revenue streams.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict whether regulators, including the FDA, will permit the marketing or sale of any particular innovative products (including products with claims of reduced risk to adult tobacco consumers), the speed with which they may make such determinations or whether they will impose a burdensome regulatory framework on such products.  In addition, the FDA could, for a variety of reasons, determine that innovative products on the market but pending FDA review of the associated PMTA (such as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> oral nicotine pouches), or those that have previously received authorization, including with a claim of reduced exposure, are not appropriate for the public health, and the FDA could require such products be taken off the market.  We also cannot guarantee that any innovative products we commercialize will appeal to adult tobacco consumers or whether adult tobacco consumers&#8217; purchasing decisions would be affected by reduced-risk claims on such products if permitted.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not succeed in commercializing innovative tobacco products that appeal to adult tobacco consumers or we fail to obtain or maintain regulatory approval for the marketing or sale of these products, including with claims of reduced health risks, we could be at a competitive disadvantage, which could have a material adverse effect on our business, results of operations, cash flows or financial position and our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Failure to complete or manage strategic transactions, including acquisitions, dispositions, joint ventures and investments in third parties, could have a material adverse effect on our business and our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate potential strategic transactions, including acquisitions, dispositions, joint ventures and investments in third parties.  Opportunities for strategic transactions may be limited, and the success of any such transaction is dependent upon our ability to realize the expected benefits of the transaction in the expected time frame or at all.  Furthermore, following the completion of a transaction there may be certain financial, managerial, staffing and talent, and operational risks, including diversion of management&#8217;s attention from existing core businesses, difficulties integrating other businesses into existing operations and other challenges presented by a transaction that does not achieve anticipated sales levels and profitability.  We can provide no assurance that we will be able to enter into attractive business relationships or execute strategic transactions on favorable terms or at all or that any such relationships or transactions will improve our competitive position or have the intended financial outcomes.  For example, to date, our investments in JUUL and Cronos have not resulted in the economic and competitive advantages expected at the time the investments were made.  If any acquisition, disposition, joint venture, investment in a third party or other strategic relationship is not successful, there could be a material negative impact on our business, financial position and our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant changes in price, availability or quality of tobacco, other raw materials or component parts could have a material adverse effect on our profitability and business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shifts in crops (such as those driven by macroeconomic conditions and adverse weather patterns), government restrictions and mandated prices, production control programs, economic trade sanctions, import duties and tariffs, international trade disruptions, inflation, geopolitical instability, climate and environmental changes and disruptions due to man-made or natural disasters may increase the cost or reduce the supply or quality of tobacco, other raw materials, ingredients or component parts used to manufacture our products.  Any significant change in such factors could restrict our ability to continue manufacturing and marketing existing products or impact adult consumer product acceptability and have a material adverse effect on our business and profitability.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For varieties of tobacco only available in limited geographies, government-mandated prices and production control programs, political instability or government prohibitions on the import or export of tobacco in certain countries pose additional risks to price, availability and quality.  In addition, as consumer demand increases for smoke-free products and decreases for combustible products, the volume of tobacco leaf required for production may decrease, resulting in reduced demand.  The reduced demand for tobacco leaf may result in the reduced supply and availability of domestic tobacco as growers divert resources to other crops or cease farming.  The unavailability or unacceptability of any one or more particular varieties of tobacco leaf necessary to manufacture our operating companies&#8217; products could restrict our ability to continue marketing existing products or impact adult tobacco consumer product acceptability, which could have a material adverse effect on our business and profitability.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current macroeconomic conditions and geopolitical instability (including high inflation, high gas prices, rising interest rates, labor shortages, supply and demand imbalances and the Russian invasion of Ukraine) are causing worldwide disruptions and delays to supply chains and commercial markets, which limit access to, and increase the cost of, raw materials, ingredients and component parts (for example, tobacco leaf and resins and aluminum used in our packaging).  Furthermore, challenging economic conditions can create the risk that our suppliers, distributors, logistics providers or other third-party partners suffer financial or operational difficulties, which may </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impact their ability to provide us with or distribute finished product, raw materials and component parts and services in a timely manner or at all.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, government taxes, restrictions and prohibitions on the sale and use of certain products may limit access to, and increase the costs of, raw materials and component parts and, potentially, impede our ability to sell certain of our products.  For example, additional taxes on the use of certain single-use plastics have been proposed by the U.S. Congress, which, if passed, could increase the costs of, and impair our ability to, source certain materials used in the packaging for our products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to compensate for supply shortages or elevated commodity and other costs through sustained price increases, cost efficiencies, such as in manufacturing and distribution, or otherwise manage the exposure through sourcing strategies, the limited use of commodity hedging contracts or through other initiatives, our business, results of operations, cash flows and financial condition could be materially adversely impacted.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our operating companies rely on a few significant facilities and a small number of key suppliers, distributors and distribution chain service providers, and an extended disruption at a facility or in service by a supplier, distributor or distribution chain service provider could have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating companies face risks inherent in reliance on a few significant manufacturing facilities and a small number of key suppliers, distributors and distribution chain service providers.  A natural or man-made disaster, cyber-incident, global pandemic or other disruption that affects the manufacturing operations of any of our companies, the operations of any key supplier, distributor or distribution chain service provider of any of our operating companies or any other disruption in the supply or distribution of goods or services (including a key supplier&#8217;s inability to comply with government regulations, lack of available workers or unwillingness to supply goods or services to a tobacco company) could adversely impact operations.  Operations of our operating companies, suppliers, distributors and distribution chain service providers could be suspended temporarily once or multiple times, or halted permanently, depending on various factors.  An extended disruption in operations experienced by one or more of our operating companies or in the supply or distribution of goods or services by one or more key suppliers, distributors or distribution chain service providers, could have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be required to write down intangible assets, including trademarks and goodwill, due to impairment, which could have a material adverse effect on our results of operations or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically calculate the fair value of our reporting units and intangible assets to test for impairment.  This calculation may be affected by several factors, including general macroeconomic and geopolitical conditions, regulatory developments, changes in category growth rates as a result of changing adult tobacco consumer preferences, success of planned new product expansions, competitive activity and income and excise taxes.  Certain events also can trigger an immediate review of intangible assets.  If an impairment is determined to exist, we will incur impairment losses, which could have a material adverse effect on our results of operations or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We could decide, or be required to, recall products, which could have a material adverse effect on our business, reputation, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We could decide, or laws or regulations could require us, to recall products due to the failure to meet quality standards or specifications, suspected or confirmed and deliberate or unintentional product contamination, or other product adulteration, misbranding or tampering.  A product recall or a product liability or other claim (even if unsuccessful or without merit) could generate negative publicity about us and our products.  In addition, if another company recalls or experiences negative publicity related to a product in a category in which we compete, adult tobacco consumers might reduce their overall consumption of products in the category.  Any of these events could have a material adverse effect on our business, reputation, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We face various risks related to health epidemics and pandemics, such as the COVID-19 pandemic, and such events, and the measures that international, federal, state and local governments, agencies, law enforcement and health authorities implement to address them, could have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An epidemic, pandemic or other significant public health emergency, and the measures taken by governmental authorities to address it, could significantly disrupt our ability to operate our businesses in the ordinary course.  Furthermore, any associated economic consequences could have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If COVID-19 resurged or any similar public health emergency occurred in the future, we could experience negative impacts.  In addition, the specific characteristics of any future public health emergency and associated governmental responses could result in other negative impacts that we cannot foresee.  Accordingly, any future emergence or resurgence of an epidemic, pandemic or other public health emergency could have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be unable to attract and retain a highly skilled and diverse workforce due to the decreasing social acceptance of tobacco usage, tobacco control actions and other factors, which could have a material adverse effect on our business and our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to implement our strategy of attracting and retaining a highly skilled and diverse workforce may be impaired by the decreasing social acceptance of tobacco usage, tobacco regulation and control actions and other factors.  The tobacco industry competes for talent with the consumer products industry and other companies that may enjoy greater societal acceptance and fewer long-term challenges.  As a result, we may be unable to attract and retain highly skilled and diverse talent.  In addition, our ability to retain a highly skilled and diverse workforce may be adversely affected by current labor market dynamics in which the number of U.S. workers leaving their jobs and the competition for highly skilled and diverse workers have increased significantly.  Failure to attract and retain highly skilled and diverse talent could have a material adverse effect on our business and our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Litigation, Legislative and Regulatory Risks</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unfavorable outcomes with respect to litigation proceedings or any governmental investigations could materially adversely affect our results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings covering a wide range of matters are pending or threatened in various U.S. and foreign jurisdictions against us and our subsidiaries, including PM USA, as well as our and their respective indemnitees and indemnitors.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband-related claims, patent infringement, employment matters, claims alleging violations of the Racketeer Influenced and Corrupt Organizations Act, claims for contribution and claims of competitors, shareholders and distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and/or one or more of our subsidiaries, including PM USA, are named as defendants in various e-vapor individual and class action lawsuits related to JUUL e-vapor products, including independent lawsuits initiated by certain state attorneys general.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is subject to significant uncertainty, and there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related or other litigation are significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions and the actual experience of management in litigating claims demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain cases, plaintiffs claim that defendants&#8217; liability is joint and several.  In such cases, we may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, we may have to pay more than our proportionate share of any bonding- or judgment-related amounts under certain circumstances.  Furthermore, in cases where plaintiffs are successful, we also may be required to pay interest and attorneys&#8217; fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we historically have been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that 47 states and Puerto Rico now limit the dollar amount of bonds or require no bond at all.  However, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#8217;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  Although we cannot predict the outcome of such challenges, it is possible that our business, results of operations, cash flows or financial position could be materially adversely affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain litigation, we and our subsidiaries may face potentially significant non-monetary remedies that could have a material adverse effect on our businesses.  For example, in the Federal Government&#8217;s lawsuit, the district court did not impose monetary penalties but ordered significant non-monetary remedies, including the issuance of &#8220;corrective statements.&#8221;  In the patent lawsuit adjudicated before the ITC, the ITC banned the importation of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and component parts into the United States and the sale and marketing of any such products previously imported into the United States.  As a result of the ITC&#8217;s decision, PM USA removed the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and any infringing components from the marketplace.  Additionally, the U.S. Federal Trade Commission (&#8220;FTC&#8221;) has issued an administrative complaint against Altria and JUUL on antitrust grounds that, if successful, would allow the FTC to order a broad range of non-monetary remedies with respect to our investment in JUUL, including divestiture of our minority investment in JUUL, rescission of the transaction and all associated agreements, a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party&#8217;s board of directors or attending meetings of the other party&#8217;s board of directors and notice to the FTC in advance of certain corporate actions, including acquisitions, mergers or certain corporate restructurings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of Altria and its subsidiaries named as a defendant in pending litigation believe, and each has been so advised by counsel handling the respective cases, that it has valid defenses to the litigation pending against it, as well as valid bases for appeal of adverse verdicts.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have defended, and will continue to defend, vigorously against litigation challenges.  However, we may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are subject to federal and state governmental investigations on a range of matters.  We currently are subject to a number of governmental investigations concerning various aspects of our investment in, and relationship with, JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the outcome of any litigation proceedings or governmental investigations, and unfavorable outcomes in any such proceedings or investigations could materially adversely affect our results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant federal, state and local governmental actions, including FDA regulatory actions, and various private sector actions may continue to have a material adverse impact on our operating companies&#8217; sales volumes and our business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face significant governmental and private sector actions, including efforts aimed at reducing the incidence of tobacco use and efforts seeking to hold us responsible for the adverse health effects associated with both smoking and exposure to environmental tobacco smoke.  These actions, combined with the diminishing social acceptance of smoking, have resulted in reduced cigarette industry volume, and we expect that these factors will continue to reduce cigarette consumption levels, which could have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, actions by the FDA and other federal, state or local governments or agencies may (i) impact the adult tobacco consumer acceptability of or access to tobacco products (for example, through nicotine or constituent limits or menthol or other flavor bans), (ii) delay or prevent the launch of new or modified tobacco products or products with claims of reduced risk, (iii) limit adult tobacco consumer choices, (iv) restrict communications to adult tobacco consumers, (v) restrict the ability to differentiate tobacco products, (vi) create a competitive advantage or disadvantage for certain tobacco companies, (vii) impose additional manufacturing, labeling or packing requirements, (viii) interrupt manufacturing or otherwise significantly increase the cost of doing business, (ix) result in increased illicit trade in tobacco products or (x) restrict or prevent the use of specified tobacco products in certain locations or the sale of tobacco products by certain retail establishments.  Legislative and regulatory action could also require the recall or other removal of tobacco products from the marketplace (for example as a result of (i) a determination relating to product contamination, (ii) legislation and rulemaking banning menthol or other flavors, (iii) a determination by the FDA that one or more tobacco products do not satisfy the statutory requirements for substantial equivalence, (iv) an FDA requirement that a currently marketed tobacco product proceed through the pre-market review process, (v) the FDA&#8217;s failure to authorize a PMTA or (vi) the FDA&#8217;s determination that removal is otherwise necessary for the protection of public health).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any federal, state or local governmental action, including regulatory actions by the FDA, may have a material adverse impact on our business, results of operations, cash flows or financial position.  Such action also could negatively impact adult smokers&#8217; transition to these products, which could materially adversely affect our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tobacco products are subject to substantial taxation, and any increases in tobacco product-related taxes could have a material adverse impact on sales of our operating companies&#8217; products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tobacco products are subject to substantial taxation, including excise taxes.  Significant increases in taxes or fees on tobacco products (including traditional products as well as e-vapor and oral nicotine products) have been proposed or enacted and are likely to continue to be proposed or enacted within the United States at the federal, state and local levels.  The frequency and magnitude of excise tax increases can be influenced by various factors, including federal and state budgets and the composition of executive and legislative bodies.  Tax increases are expected to continue to have an adverse impact on sales of our operating companies&#8217; tobacco products through lower consumption levels and the potential shift in adult tobacco consumer purchases from the premium to the non-premium or discount segments, to other low-priced or low-taxed tobacco products or to counterfeit and contraband products.  Such shifts may also have an adverse impact on the reported share performance of our tobacco products.  Any increases in tobacco-related taxes or fees may have a material adverse impact on our business, results of operations, cash flows or financial position.  In addition, substantial excise tax increases on e-vapor and oral nicotine products may negatively impact adult smokers&#8217; transition to these products, which could materially adversely affect our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International business operations subject us to various U.S. and foreign laws and regulations, and violations of such laws or regulations could result in reputational harm, legal challenges and significant penalties and other costs.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we are primarily engaged in business activities in the United States, we engage (directly or indirectly) in certain international business activities that are subject to various U.S. and foreign laws and regulations, such as foreign privacy laws, the U.S. Foreign Corrupt Practices Act and other laws prohibiting bribery and corruption.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have a Code of Conduct for Compliance and Integrity and a compliance system designed to prevent and detect violations of applicable law, no system can provide assurance that it will always protect against improper actions by employees, joint venture partners, investees or third parties.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of these laws, or allegations of such violations could result in reputational harm, legal challenges and significant penalties and other costs.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A challenge to our tax positions, an increase in the income tax rate or other changes to federal or state tax laws could materially adversely affect our earnings or cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax laws and regulations are complex and subject to varying interpretations.  A successful challenge to one or more of our tax positions (which could give rise to additional liabilities, including interest and potential penalties), an increase in the corporate income tax rate or other changes to federal or state tax laws, including changes to how foreign investments are taxed, could materially adversely affect our earnings or cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal and regulatory requirements related to climate change and other environmental sustainability matters could have a material adverse impact on our business and results of operations.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increased concern over climate change and other sustainability matters is likely to result in new or additional legal and regulatory requirements intended to reduce or mitigate environmental issues and may relate to, among other things, greenhouse gas emissions, alternative energy policy, single-use plastics and additional disclosure obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This additional regulation may materially adversely affect our business, results of operations, cash flows and financial condition by increasing our compliance and manufacturing costs and negatively impacting our reputation if we are unable to, or are perceived not to, satisfy such requirements.</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Capital Markets and Financing Risks</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disruption and uncertainty in the credit and capital markets could materially adversely affect our business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Access to the credit and capital markets is important for us to satisfy our liquidity and financing needs.  We typically access the commercial paper market in the second quarter to help fund payments under the Master Settlement Agreement (the &#8220;MSA&#8221;), tax obligations and shareholder dividends.  Disruption and uncertainty in the credit or capital markets or high interest rates could negatively impact the availability or cost of capital and adversely affect our liquidity, cash flow, earnings and dividend rate.  In addition, tighter credit markets may lead to business disruptions for our suppliers and service providers, which could, in turn, materially adversely impact our business, results of operations, cash flows and financial condition.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A downgrade or potential downgrade of our credit ratings could adversely impact our borrowing costs and access to credit and capital markets, which could materially adversely affect our financial condition.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rating agencies routinely evaluate us, and their ratings are based on a number of factors, including our cash generating capability, levels of indebtedness, policies with respect to shareholder distributions, the impact of strategic transactions and our financial strength generally, as well as factors beyond our control, such as the state of the economy and our industry.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  A</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ny downgrade or announcement that we are under review for a potential downgrade of our credit ratings, as occurred following our investment in JUUL, especially any downgrade to below investment grade, could increase our future borrowing costs, impair our ability to access the credit and capital markets, including the commercial paper market, on terms commercially acceptable to us or at all or result in a reduction in our liquidity, requiring us to rely on more expensive types of debt financing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Any such outcome could have a material adverse impact our financial condition.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be unable to attract investors due to increasing investor expectations of our performance relating to environmental, social and governance factors.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is an increasing focus from investors and other stakeholders on corporate responsibility, including with respect to environmental, social and governance (&#8220;ESG&#8221;) matters.  There has been an increase in third-party providers of ESG assessments and ratings to satisfy investor demand for measurement of corporate responsibility performance, and the criteria by which these third parties measure such performance may vary or change over time.  Investors may use these non-financial performance factors to guide investment strategies and, in some cases, may choose not to invest in us if their policies prevent them from investing in tobacco companies or if they believe our policies, actions or disclosures on corporate responsibility issues are inadequate.  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also increased focus, including by governmental and non-governmental organizations, investors, customers, consumers, our employees and other stakeholders, on sustainability matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our efforts, any failure to achieve our corporate responsibility goals, including those aimed at reducing the harm associated with our companies&#8217; products, could result in adverse publicity, materially adversely affect our business and reputation and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impair our ability to attract and retain investors, which could have a material negative impact on the market value of our stock.</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Information Technology and Data Privacy Risks</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The failure of our, or our service providers&#8217; or key suppliers&#8217;, information systems to function as intended, or cyber-attacks or security breaches, could have a material adverse effect on our business, reputation, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely extensively on information systems, many of which are managed by third-party service providers (such as cloud data service providers), to support a variety of business processes and activities, including: complying with regulatory, legal, financial reporting and tax requirements; engaging in marketing and e-commerce activities; managing and improving the effectiveness of our operations; manufacturing and distributing our products; collecting and storing sensitive data and confidential information; and communicating with employees, investors, suppliers, trade customers, adult tobacco consumers and others.  Our suppliers and supply chain service providers </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also rely extensively on information systems.  We continue to make appropriate investments in administrative, technical and physical safeguards to protect our information systems and data from cyber-threats, including human error and malicious acts.  Our safeguards include employee training, testing and auditing protocols, backup systems and business continuity plans, maintenance of security policies and procedures, monitoring of networks and systems, and third-party risk management.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time-to-time, we and our suppliers experience attempts to infiltrate and interrupt information systems.  While infiltration attempts have increased, to date, interruptions of these information systems as a result of infiltration attempts have not had a material impact on our operations.  However, because technology is increasingly complex and cyber-attacks are increasingly sophisticated and more frequent, there can be no assurance that such incidents will not have a material adverse effect on us in the future.  Failure of our, or our service providers&#8217; or key suppliers&#8217;, information systems to function as intended, or cyber-attacks or security breaches, could result in loss of revenue, assets, personal data, intellectual property, trade secrets or other sensitive and confidential data, violation of applicable privacy and data security laws, reputational harm to the companies and their brands, operational disruptions, legal challenges and significant remediation and other costs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our failure to comply with personal data protection and privacy laws could materially adversely affect our business.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a variety of continuously evolving and developing laws and regulations in numerous jurisdictions regarding personal data protection and privacy laws.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations may be interpreted and applied differently from country to country or, within the United States, from state to state, and can create inconsistent or conflicting requirements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our efforts to comply with these laws and regulations impose significant costs and challenges that are likely to continue to increase over time, particularly as additional jurisdictions adopt similar regulations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with these laws and regulations or to otherwise protect personal data from unauthorized access, use or other processing, could result in litigation, claims, legal or regulatory proceedings, inquiries or investigations, damage to our reputation, fines or penalties, all of which can </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have a material adverse effect on our business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Relating to Our Investments in Equity Securities</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The expected benefits of our investment in ABI may not materialize in the expected manner or timeframe or at all, which could have a material adverse impact on our financial position or earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected benefits of our investment in ABI may not materialize in the expected manner or timeframe or at all, including due to foreign currency exchange rates; ABI&#8217;s business results; ABI&#8217;s share price; impairment losses on the value of our investment; our incurrence of additional tax liabilities related to our investment in ABI; and potential reductions in the number of directors that we can have appointed to the ABI board of directors.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our investment in ABI under the equity method of accounting.  For purposes of financial reporting, the earnings from and carrying value of our equity investment in ABI are translated into U.S. dollars (&#8220;USD&#8221;) from various local currencies.  In addition, ABI pays dividends in euros, which we convert into USD.  During times of a strengthening USD against these currencies, our reported earnings from and carrying value of our equity investment in ABI will be reduced because these currencies will translate into fewer USD and the dividends that we receive from ABI will convert into fewer USD.  Dividends and earnings from and carrying value of our equity investment in ABI are also subject to the risks encountered by ABI in its business, its business outlook, cash flow requirements and financial performance, the state of the market and the general economic climate.  For example, in 2020, as a result of the uncertainty, volatility and impact of the COVID-19 pandemic on ABI&#8217;s business, ABI reduced by 50% its final 2019 dividend paid in the second quarter of 2020 and did not pay its interim 2020 dividend that would have been paid in the fourth quarter of 2020, which resulted in a reduction of cash dividends we received from ABI.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the value of our equity investment in ABI as required by accounting principles generally accepted in the United States.  If the carrying value of our investment in ABI exceeds its fair value and any loss in value is other than temporary, we record appropriate impairment losses.  In prior periods, we have concluded that the fair value of our equity investment in ABI declined below the carrying value of our investment in ABI and that this decline in fair value was other than temporary.  As a result, we recorded non-cash, pre-tax impairment charges for those periods.  It is possible that we may be required to record significant impairment charges in the future and, if we do so, our net income and carrying value of our equity investment in ABI could be materially adversely affected.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that our ownership percentage in ABI were to decrease below certain levels, (i) we may be subject to additional tax liabilities, (ii) the number of directors that we have the right to have appointed to the ABI board of directors could be reduced from two to one or zero and (iii) we may be unable to continue to account for our investment in ABI under the equity method of accounting.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A challenge to our investment in JUUL, if successful, could result in a broad range of resolutions, including divestiture of the investment or rescission of the transaction.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A challenge to our investment in JUUL, if successful, could result in a broad range of resolutions such as divestiture of the investment or rescission of the transaction.  In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that our 35% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Act and Section 5 of the FTC Act, and substantially lessened competition in violation of Section 7 of the Clayton Act.  The FTC seeks a broad range of remedies, including divestiture of our minority investment in JUUL, rescission of the transaction and all associated agreements, a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">of</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10"> Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products and prohibition against any officer or director of either Altria or JUUL serving on the other party&#8217;s board of directors or attending meetings of the other party&#8217;s board of directors and notice to the FTC in advance of certain corporate actions, including acquisitions, mergers or certain corporate restructurings.  The administrative trial was held before an FTC administrative law judge in June 2021.  In February 2022, the administrative law judge dismissed the FTC&#8217;s complaint.  FTC complaint counsel appealed that decision to the FTC Commissioners.  Any adverse ruling the FTC Commissioners issue following their review may be appealed to a federal appellate court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, various putative class action lawsuits have been filed against Altria (and in some cases, subsidiaries of Altria) and JUUL.  The lawsuits cite the FTC administrative complaint referenced above and allege claims similar to those made by the FTC.  Plaintiffs in these lawsuits are seeking various remedies, including treble damages, attorneys&#8217; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of our investment in JUUL and rescission of the transaction.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A successful challenge by the FTC or the plaintiffs in the lawsuits to the investment would adversely affect us, including by eliminating, or substantially limiting, our rights with respect to our investment in JUUL and our flexibility to pursue other investments in the e-vapor space.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our investment in Cronos subjects us to certain risks associated with Cronos&#8217;s business, including legal, regulatory and reputational risks.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our equity investment in Cronos, a Canadian cannabinoid company, subjects us to various risks relating to Cronos&#8217;s business, such as legal, regulatory and reputational risks.  Cronos is engaged in the manufacture, marketing and distribution of U.S. hemp-derived cannabinoid supplements and cosmetic products in the United States and the cultivation, manufacture and marketing of cannabis and cannabis-derived products for the medical and adult-use markets in various international jurisdictions.  Accordingly, Cronos&#8217;s operations are subject to laws, regulations and guidelines promulgated by various U.S. and international governmental authorities.  In the United States, these laws include the Controlled Substances Act, the Civil Assets Forfeiture Reform Act (as it relates to violation of the Controlled Substances Act), all related applicable anti-money laundering laws and FDA regulations.  A failure by Cronos or Altria to comply with these and other applicable laws, including cannabis laws, could result in criminal, civil or tax liability, negative impacts on the availability and cost of capital and credit or reputational harm for Altria.</span></div><div><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_22"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1B.  Unresolved Staff Comments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_25"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 2.  Properties.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ALCS owns one property in Richmond, Virginia that serves as the headquarters facilities for Altria, PM USA, USSTC, Middleton, Helix and certain other subsidiaries.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA owns and operates a manufacturing facility located in Richmond, Virginia that PM USA uses in the manufacturing of cigarettes (smokeable products segment).  PM USA leases portions of this facility to our other subsidiaries for use in the manufacturing of cigars (smokeable products segment) and MST, snus and oral nicotine pouch products (oral tobacco products segment).  In addition, PM USA owns a research and technology center in Richmond, Virginia that it leases to ALCS.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The oral tobacco products segment has various manufacturing and processing facilities, the most significant of which are located in Nashville, Tennessee.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The plants and properties owned or leased and operated by us are maintained in good condition and are believed to be suitable and adequate for present needs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 3.  Legal Proceedings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is included in Note 17 and Exhibits 99.1 and 99.2 to this Form 10-K.  Altria&#8217;s consolidated financial statements and accompanying notes for the year ended December 31, 2022 were filed on Form 8-K on February 1, 2023 (such consolidated financial statements and accompanying notes are also included in Item 8).  The following summarizes certain developments in Altria&#8217;s litigation since the filing of the Form 8-K.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Woodley</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2023, a jury in a Massachusetts state court returned a verdict in favor of plaintiff and against PM USA, awarding $5 million in compensatory damages.  We intend to file post-trial motions challenging the award and, if necessary, an appeal.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Health Care Cost Recovery Legislation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NPM Adjustment Disputes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the non-participating manufacturer dispute with the State of Iowa in which Iowa sought a total of approximately $<ix:nonFraction unitRef="usd" contextRef="i4b5ad462b1fc42e3875caf97f2673a92_D20220701-20220731" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8yOC9mcmFnOjQ4ZjIzNTE3NzExNjQ0ZTNiMjIyMDMzNTA2OWIzYjRlL3RleHRyZWdpb246NDhmMjM1MTc3MTE2NDRlM2IyMjIwMzM1MDY5YjNiNGVfMjQxODkyNTU4MTU5ODk_b9a9c3e1-fa20-4532-b7a7-5a1e01dae923">133</ix:nonFraction> million in disputed payments from all defendants combined, as well as treble and punitive damages, and other relief, the participating manufacturers filed a cross motion to compel arbitration, which was heard in December 2022.  In February 2023, the Iowa state court granted the participating manufacturers&#8217; motion, compelling arbitration.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Federal and State Shareholder Derivative Lawsuits</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, plaintiffs and defendants in all of the federal and state derivative cases agreed upon a settlement that was granted final approval by the federal court in the Eastern District of Virginia.  The settlement will become effective upon the expiration of the deadlines for any appeals.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_31"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 4.  Mine Safety Disclosures.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;text-decoration:underline">Part II</span></div><div id="i15062ca98227434086141b426450a5cb_37"></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 5.  Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Performance Graph</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below compares the cumulative total shareholder return of our common stock for the last five years with the cumulative total return for the same period of the S&amp;P 500 Index and the S&amp;P Food, Beverage and Tobacco Industry Group Total Return Index.  The graph assumes the investment of $100 in common stock and each of the indices as of the market close on December 31, 2017 and the reinvestment of all dividends on a quarterly basis.</span></div><div style="text-align:justify"><img src="mo-20221231_g1.jpg" alt="mo-20221231_g1.jpg" style="height:418px;margin-bottom:5pt;vertical-align:text-bottom;width:732px"/></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.249%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.249%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Altria</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P Food, Beverage &amp; Tobacco</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P 500</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72.91</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.08&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.61&#160;</span></td><td style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">78.71</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106.29&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.70&#160;</span></td><td style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70.54</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.20&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148.83&#160;</span></td><td style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87.66</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.35&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.55&#160;</span></td><td style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2022</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.18&#160;</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156.86&#160;</span></td><td style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sources: FactSet for 2020 to 2022 and Bloomberg &#8220;Total Return Analysis&#8221; calculated on a daily basis for 2018 and 2019.  Total return assumes reinvestment of dividends as of the ex-dividend date.</span></div><div style="margin-bottom:5pt;margin-top:10pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Market and Dividend Information</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal stock exchange on which our common stock (par value $0.33 1/3 per share) is listed is the New York Stock Exchange under the trading symbol &#8220;MO&#8221;.  At February 15, 2023, there were approximately 50,000 holders of record of our common stock.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a history of paying cash dividends and have maintained a dividend payout ratio target of approximately 80% of our adjusted diluted earnings per share.  Future dividend payments remain subject to the discretion of our Board of Directors.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities During the Quarter Ended December&#160;31, 2022</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, our Board of Directors authorized a $2.0 billion share repurchase program that it expanded to $3.5 billion in October&#160;2021 (as expanded, the &#8220;January 2021 share repurchase program&#8221;), which we completed in December 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, our Board of Directors authorized a new $1.0 billion share repurchase program, which we expect to complete by December 31, 2023.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of our Board.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share repurchase activity for each of the three months in the period ended December&#160;31, 2022, was as follows:</span></div><div style="margin-bottom:1pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.249%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price Paid Per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1- October 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,840,310</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">43.90</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,840,310</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">249,401,660</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 1- November 30, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,774,953</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">44.95</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,774,473</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">124,702,252</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 1- December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,682,998</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,682,893</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the Quarter Ended December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,298,261</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45.09</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,297,676</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The total number of shares purchased includes (a) shares purchased under the January 2021 share repurchase program and (b) shares withheld by Altria in an amount equal to the statutory withholding taxes for vested stock-based awards previously granted to eligible employees (which totaled 480 shares in November and 105 shares in December).</span></div><div><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_40"></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 6.  [Reserved].</span></div><div id="i15062ca98227434086141b426450a5cb_43"></div><div style="margin-bottom:5pt"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_46"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 7.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion should be read in conjunction with the other sections of this Form 10-K, including the consolidated financial statements and related notes contained in Item&#160;8, and the discussion of risk factors that may affect future results in Item 1A.  Additionally, refer to Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) in our 2021 Annual Report on Form 10-K for management&#8217;s discussion and analysis of financial condition and results of operations for the year ended December 31, 2021 compared to the year ended December 31, 2020, which we filed with the SEC on February 25, 2022 and is incorporated by reference into this Form 10-K for the year ended December 31, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this MD&amp;A section, we refer to the following &#8220;adjusted&#8221; financial measures: adjusted operating companies income (loss) (&#8220;OCI&#8221;); adjusted OCI margins; adjusted net earnings attributable to Altria; adjusted diluted earnings per share attributable to Altria; and adjusted effective tax rates.  These adjusted financial measures are not required by, or calculated in accordance with, United States generally accepted accounting principles (&#8220;GAAP&#8221;) and may not be calculated the same as similarly titled measures used by other companies.  These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.  For a further description of these non-GAAP financial measures, see the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below.</span></div><div id="i15062ca98227434086141b426450a5cb_49"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Business</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a leading portfolio of tobacco products for U.S. tobacco consumers age 21+.  Our Vision by 2030 is to responsibly lead the transition of adult smokers to a smoke-free future.  We are </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moving Beyond Smoking</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, leading the way in moving adult smokers away from cigarettes by taking action to transition millions to potentially less harmful choices - believing it is a substantial opportunity for adult tobacco consumers, our businesses and society.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our wholly owned subsidiaries include leading manufacturers of both combustible and smoke-free products.  In combustibles, we own PM USA, the most profitable U.S. cigarette manufacturer, and Middleton, a leading U.S. cigar manufacturer.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our smoke-free portfolio includes ownership of USSTC, the leading global MST manufacturer, and Helix, a leading manufacturer of oral nicotine pouches.  Additionally, we have a majority-owned joint venture, Horizon, for the U.S. marketing and commercialization of HTS products and, through a separate agreement, we have the exclusive U.S. commercialization rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">System and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through April 2024.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investments in equity securities include ABI, the world&#8217;s largest brewer, Cronos, a leading Canadian cannabinoid company, and JUUL, a U.S. based e-vapor company.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The brand portfolios of our tobacco operating companies include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Black &amp; Mild</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Trademarks and service marks related to Altria referenced in this Form 10-K are the property of Altria or our subsidiaries or are used with permission.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of Altria, see Item 1. Business of this Form 10-K (&#8220;Item 1&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trends and Developments</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this MD&amp;A section, we discuss factors that have impacted our business as of the date of this Form 10-K.  In addition, we are aware of certain trends and developments that could, individually or in the aggregate, have a material impact on our business, including the value of our investments in equity securities, in the future.  In this </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trends and Developments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">section, we focus on the potential effects on our business resulting from the continued elevated rate of inflation, supply chain disruptions, ongoing geopolitical events and recent regulatory actions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to monitor the evolving macroeconomic and geopolitical landscapes.  High rates of inflation occurred in 2022, driven by increasing global energy, commodity and food prices, which were further exacerbated by other factors, including supply and demand imbalances, labor shortages and the Russian invasion of Ukraine.  High inflation, high gas prices and rising interest rates could continue to impact our business by negatively impacting adult tobacco consumers&#8217; disposable income and future purchase behaviors.  During 2022, cigarette retail share for the industry discount segment increased.  We continue to expect potential fluctuations in discount product share for cigarettes and MST products as price sensitive adult tobacco consumers react to their economic conditions and will monitor the effect of these dynamics on adult tobacco consumers and their purchase behaviors, including overall tobacco product expenditures, mix between premium and discount brand purchases and adoption of smoke-free products.  Increases in inflation also have a direct and adverse impact on our MSA expense and other direct and indirect costs.  We expect inflation to continue at increased levels in 2023, and the extent of any effects on adult tobacco consumers&#8217; purchase behaviors depends in part on the magnitude and duration of such increased inflation levels.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - Business Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on evolving trends in the tobacco industry and the impacts to our business from increased inflation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Volatility in domestic and global economies and disruptions in the supply and distribution chains are expected to continue in 2023, resulting from several factors, including the on-going impacts of inflation, supply and demand imbalances across many sectors such as energy and commodities, raw materials availability and geopolitical events.  We continue to work to mitigate the potential negative impacts of these macroeconomic and geopolitical dynamics on our businesses through, among other actions, proactive engagement with current and potential suppliers and distributors, the development of alternative sourcing strategies, entry into long-term supply contracts, evolution of our safety, health and environmental protocols at our facilities and prudent oversight of our liquidity.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - Business Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on the supply chain and other impacts of the macroeconomic and geopolitical environment on our business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tobacco companies are subject to broad and evolving regulatory and legislative frameworks that could have a material impact on our business.  For example, the FDA has issued proposed product standards regarding menthol in cigarettes and characterizing flavors in cigars, and, in June 2022, the Biden Administration published plans for future potential regulatory actions that include the FDA&#8217;s plans to develop a proposed product standard that would establish a maximum nicotine level for cigarettes and certain other combustible tobacco products.  In addition, certain states and localities are considering or have passed legislation to ban flavors in one or more tobacco products, including California where a ban on the sale of most tobacco products with characterizing flavors became effective in December 2022.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - Business Environment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on the nature, scope and potential impacts of regulatory and legislative developments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FDA issued marketing denial orders (&#8220;MDOs&#8221;) to JUUL ordering all of JUUL&#8217;s products currently marketed in the United States off the market.  In July 2022, the FDA administratively stayed the MDOs on a temporary basis, citing its determination that there are scientific issues unique to the JUUL PMTA that warrant additional agency review.  This administrative stay temporarily suspends the MDOs, and JUUL&#8217;s products currently remain on the market.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - Business Environment - FSPTCA and FDA Regulation - FDA Regulatory Actions - Electronic Nicotine Delivery System Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information regarding the MDOs.  We considered, among other factors, the impact of the FDA&#8217;s actions in conducting our quarterly quantitative valuations of our investment in JUUL during 2022, which resulted in us recording non-cash, pre-tax unrealized losses of approximately $1.5 billion for the year ended December 31, 2022.  We will continue to monitor and consider developments in the FDA&#8217;s additional review, among other factors, in our quarterly quantitative valuations of JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adverse macroeconomic and geopolitical landscapes have impacted global businesses, including ABI, and the global markets in 2022, and we expect this dynamic to continue in 2023.  ABI&#8217;s business has continued to be impacted by supply chain constraints across certain markets, foreign exchange rate fluctuations, inflation, commodity cost headwinds and the Russian invasion of Ukraine (as evidenced by ABI fully impairing its joint venture with exposure to Russia and Ukraine in the first quarter of 2022).  Additionally, the macroeconomic and geopolitical factors have contributed to significant changes in certain foreign exchange rates, including the Euro to USD exchange rate, and in the global equity markets.  We evaluated these and other factors related to the decline in the fair value of our equity investment in ABI below its carrying value, and concluded that the decline was other than temporary, which resulted in us recording a non-cash, pre-tax charge of $2.5 billion in the third quarter of 2022.  The fair value of our equity investment in ABI had share price and market valuation recovery during the fourth quarter of 2022.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on our investments in equity securities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, we modified our heated tobacco portfolio of smoke-free products by (i) entering into an agreement with PMI to, among other things, transition and ultimately conclude our relationship with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System in the United States and (ii) entering into a joint venture with Japan Tobacco for the U.S. marketing and commercialization of heated tobacco stick products.  For further discussion of (i) the agreement with PMI, see Note 4, and (ii) the joint venture, see Item 1 and Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the consolidated financial statements in Item 8 (&#8220;Note 1&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the impairment of our equity investment in ABI and reduction in the estimated fair value of our equity investment in JUUL had a material adverse effect on our financial results in 2022, to date, our operating companies have not experienced any material adverse effects from the trends and developments discussed above.  Additionally, we do not believe that these trends and developments have impacted our ability to achieve our Vision.  As the trends and developments discussed above evolve and new ones emerge, we will continue to evaluate the potential impacts on our business, investments and Vision.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in net earnings attributable to Altria and diluted earnings per share (&#8220;EPS&#8221;) attributable to Altria for the year ended December&#160;31, 2022, from the year ended December&#160;31, 2021, were due primarily to the following:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.014%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.017%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2021</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 NPM Adjustment Items</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Asset impairment, exit, implementation, acquisition and disposition-related costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Tobacco and health and certain other litigation items</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 ABI-related special items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Cronos-related special items</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Loss on early extinguishment of debt</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Income tax items</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2021 special items</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 NPM Adjustment Items</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.03</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Asset impairment, exit, implementation, acquisition and disposition-related costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Tobacco and health and certain other litigation items</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.05)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 JUUL changes in fair value</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,455)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 ABI-related special items</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,010)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Cronos-related special items</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(186)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Income tax items</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">729</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal 2022 special items</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,978)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1.65)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fewer shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the year ended December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,764</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Reported Net Earnings </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,764</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Reported Net Earnings </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100%+</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100%+</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Adjusted Net Earnings and Adjusted Diluted EPS</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,742</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.84</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Adjusted Net Earnings and Adjusted Diluted EPS</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,519&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">For a discussion of special items and other business drivers affecting the comparability of statements of earnings amounts and reconciliations of adjusted earnings attributable to Altria and adjusted diluted EPS attributable to Altria, see the Consolidated Operating Results section below.</span></div><div style="margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Fewer Shares Outstanding: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fewer shares outstanding were due to shares we repurchased under our share repurchase program.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Operations: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase of $209 million in operations (which excludes the impact of special items shown in the table above) was due primarily to higher OCI and lower interest and other debt expense, net.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For further details, see the Consolidated Operating Results and Operating Results by Business Segment sections below.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023 Forecasted Results</span></div><div style="margin-bottom:5pt;padding-right:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our 2023 full-year adjusted diluted EPS to be in a range of $4.98 to $5.13, representing a growth rate of 3% to 6% over our 2022 full-year adjusted diluted EPS base of $4.84, as shown in the table below.  While the 2023 full-year adjusted diluted EPS guidance accounts for a range of scenarios, the external environment remains dynamic.  We will continue to monitor conditions related to (i) the economy, including the impact of high inflation, rising interest rates and global supply chain disruptions, (ii) adult tobacco consumer dynamics, including disposable income, purchasing patterns and adoption of smoke-free products and (iii) regulatory and legislative developments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our 2023 full-year adjusted diluted EPS guidance range includes planned investments in support of our Vision, such as (i) continued smoke-free product research, development and regulatory preparation expenses, (ii) enhancement of our digital consumer engagement system and (iii) marketplace activities in support of our smoke-free products.  The guidance range also includes lower expected net periodic benefit income due to market factors, including higher interest rates, and the impact of the 2022 completion of the PMCC wind-down.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our 2023 full-year adjusted effective tax rate will be in a range of 24.5% to 25.5%.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of 2022 Reported Diluted EPS to 2022 Adjusted Diluted EPS</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Reported diluted EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.81</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax items </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.40)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Adjusted diluted EPS</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.84</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For a discussion of certain income and expense items in the table above, see the Consolidated Operating Results section below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our full-year adjusted diluted EPS forecast and full-year forecast for our adjusted effective tax rate exclude the impact of certain income and expense items, including those items noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below, that our management believes are not part of underlying operations.  Our management cannot estimate on a forward-looking basis the impact of these items on our reported diluted EPS or our reported effective tax rate because these items, which could be significant, may be unusual or infrequent, are difficult to predict and may be highly variable.  As a result, we do not provide a corresponding GAAP measure for, or reconciliation to, our adjusted diluted EPS forecast or our adjusted effective tax rate forecast.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we report our financial results in accordance with GAAP, our management reviews OCI, which is defined as operating income before general corporate expenses and amortization of intangibles, to evaluate the performance of, and allocate resources to, our segments.  Our management also reviews certain financial results, including OCI, OCI margins, net earnings attributable to Altria and diluted EPS, on an adjusted basis, which excludes certain income and expense items that our management believes are not part of underlying operations.  These items may include, for example, loss on early extinguishment of debt, restructuring charges, asset impairment charges, acquisition-related and disposition-related costs, equity investment-related special items (including any changes in fair value of our equity investment recorded at fair value and any changes in the fair value of related warrants and preemptive rights), certain income tax items, charges associated with tobacco and health and certain other litigation items, and resolutions of certain non-participating manufacturer (&#8220;NPM&#8221;) adjustment disputes under the MSA (such dispute resolutions are referred to as &#8220;NPM Adjustment Items&#8221;).  Our management does not view any of these special items to be part of our underlying results as they may be highly variable, may be unusual or infrequent, are difficult to predict and can distort underlying business trends and results.  Our management also reviews income tax rates on an adjusted basis.  Our adjusted effective tax rate may exclude certain income tax items from our reported effective tax rate.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management believes that adjusted financial measures provide useful additional insight into underlying business trends and results, and provide a more meaningful comparison of year-over-year results.  Our management uses adjusted financial measures and regularly provides these to our chief operating decision maker (&#8220;CODM&#8221;) for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets.  These adjusted financial measures are not required by, or calculated in accordance with GAAP and may not be calculated the same as similarly titled measures </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">used by other companies.  These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.  Except as noted in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Forecasted Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section above, when we provide a non-GAAP measure in this Form 10-K, we also provide a reconciliation of that non-GAAP financial measure to the most directly comparable GAAP financial measure.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Discussion and Analysis</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 2 includes a summary of the significant accounting policies and methods used in the preparation of our consolidated financial statements.  In most instances, we must use an accounting policy or method because it is the only policy or method permitted under GAAP.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements includes the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the dates of the financial statements and the reported amounts of net revenues and expenses during the reporting periods.  If actual amounts are ultimately different from previous estimates, the revisions are included in our consolidated results of operations for the period in which the actual amounts become known.  Historically, the aggregate differences, if any, between our estimates and actual amounts in any year have not had a significant impact on our consolidated financial statements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a review of the more significant assumptions and estimates, as well as the accounting policies and methods, used in the preparation of our consolidated financial statements:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Revenue Recognition: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses generate substantially all of their revenue from sales contracts with customers.  Our businesses define net revenues as revenues, which include excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns (also referred to as returned goods) and sales incentives.  Our businesses exclude from the transaction price sales taxes and value-added taxes imposed at the time of sale.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses record sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction to revenues (a portion of which is based on amounts estimated as being due to wholesalers, retailers and consumers at the end of a period) based principally on historical volume, utilization and redemption rates.  We include expected payments for sales incentives in accrued marketing liabilities on our consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion, see Note 3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues from Contracts with Customers </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the consolidated financial statements in Item 8.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Depreciation, Amortization, Impairment Testing and Asset Valuation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depreciate property, plant and equipment and amortize our definite-lived intangible assets using the straight-line method over the estimated useful lives of the assets.  We depreciate machinery and equipment over periods up to 20 years, and buildings and building improvements over periods up to 50 years.  We amortize definite-lived intangible assets over their estimated useful lives up to 25 years.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying value of the assets may not be fully recoverable.  We perform undiscounted operating cash flow analyses to determine if an impairment exists.  These analyses are affected by general economic conditions and projected growth rates.  For purposes of recognition and measurement of an impairment for assets held for use, we group assets and liabilities at the lowest level for which cash flows are separately identifiable.  If we determine that an impairment exists, any related impairment loss is calculated based on fair value.  We base impairment losses on assets to be disposed of, if any, on the estimated proceeds to be received, less costs of disposal.  We also review the estimated remaining useful lives of long-lived assets whenever events or changes in business circumstances indicate the lives may have changed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct a required annual review of goodwill and indefinite-lived intangible assets for potential impairment, and more frequently if an event occurs or circumstances change that would require us to perform an interim review.  We have the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit or indefinite-lived intangible asset is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative impairment test.  If necessary, we will perform a single step quantitative impairment test.  Additionally, we have the option to unconditionally bypass the qualitative assessment and perform a single step quantitative assessment.  If the carrying value of a reporting unit that includes goodwill exceeds its fair value, which is determined using discounted cash flows, goodwill is considered impaired.  We measure the amount of impairment loss as the difference between the carrying value and the fair value of a reporting unit; however, the amount of the impairment loss is limited to the total amount of goodwill allocated to a reporting unit.  If the carrying value of an indefinite-lived intangible asset exceeds its fair value, which is determined using discounted cash flows, we consider the intangible asset to be impaired and reduce the carrying value to fair value in the period identified.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill by reporting unit and indefinite-lived intangible assets at December&#160;31, 2022 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.818%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indefinite-Lived<br/>Intangible&#160;Assets</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigarettes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MST and snus products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,801</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigars</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">77</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,640</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral nicotine pouches</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we completed our annual impairment test of goodwill and indefinite-lived intangible assets performed as of  October&#160;1,&#160;2022 and the results of this testing were as follows:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">no impairment charges were recorded; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the estimated fair values of all reporting units and the indefinite-lived intangible assets within all reporting units substantially exceeded their carrying values, with the exception of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark within the MST and snus products reporting unit.  At December 31, 2022, the estimated fair value of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark exceeded its carrying value of $3.9 billion by approximately 12%.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;s performance has been negatively impacted due in part to changes in adult tobacco consumers&#8217; purchase behaviors resulting from adverse macroeconomic and geopolitical conditions.  These conditions contributed to a decrease in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;s revenue and operating company income for the year ended December 31, 2022 versus the prior year.  The growth of innovative tobacco products, including oral nicotine pouches, has also continued to impact </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;s performance, and as adult tobacco consumers&#8217; preferences continue to evolve, we expect consumers to increasingly move across tobacco categories.  In addition to the factors impacting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;s performance, rising U.S. interest rates have resulted in an increase in the discount rate used in our estimate of fair value.  An additional 1% increase in the discount rate would have resulted in the estimated fair value exceeding its carrying value by approximately 2% at December 31, 2022.  If </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;s revenue and operating company income continue to decrease, or if the discount rate used to estimate the fair value continues to increase, it could result in a material non-cash impairment of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark in future periods.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, our quantitative annual impairment test of goodwill and indefinite-lived intangible assets resulted in no impairment charges.  </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we elected to unconditionally bypass the qualitative assessment and perform a single step quantitative assessment for all reporting units and indefinite-lived intangible assets.  We used an income approach to estimate the fair values of our reporting units and indefinite-lived intangible assets.  The income approach reflects the discounting of expected future cash flows to their present value at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing expected future cash flows.  The weighted-average discount rate used in performing the valuations was approximately 12%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the 2022 discounted cash flow analysis, we made various judgments, estimates and assumptions, the most significant of which were volume, income, operating margins, growth rates and discount rates.  The analysis incorporated assumptions used in our long-term financial forecast, which is used by our management to evaluate business and financial performance, including allocating resources and evaluating results relative to setting employee compensation targets.  The assumptions incorporated the highest and best use of our indefinite-lived intangible assets and also included perpetual growth rates for periods beyond the long-term financial forecast.  The perpetual growth rate used in performing all of the valuations was 2%.  Fair value calculations are sensitive to changes in these estimates and assumptions, some of which relate to broader macroeconomic conditions outside of our control.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although our discounted cash flow analysis is based on assumptions that are considered reasonable and based on the best available information at the time that the discounted cash flow analysis is developed, there is significant judgment used in determining future cash flows.  The following factors have the most potential to impact our assumptions and thus the expected future cash flows and, therefore, our impairment conclusions: general macroeconomic and geopolitical conditions; regulatory developments; changes in category growth rates as a result of changing adult tobacco consumer preferences; success of planned new product expansions; competitive activity; and income and excise taxes.  For further discussion of these factors, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - Business Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our management believes that the estimated fair values of each reporting unit and indefinite-lived intangible asset at December 31, 2022 are reasonable, actual performance in the short-term or long-term could be significantly different from forecasted performance, which could result in impairment charges in future periods.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of goodwill and other intangible assets, see Note 4.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Investments in Equity Securities: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the end of each reporting period, we</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">review our equity investments accounted for under the equity method of accounting (ABI and Cronos) for impairment by comparing the fair value of each of our investments to their carrying value.  If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, we consider the investment impaired, reduce its carrying value to its fair value, and record the impairment in the period identified.  We use certain factors to make this determination including (i) the duration and magnitude of the fair value decline, (ii) the financial condition and near-term prospects of the investee and (iii) our intent and ability to hold our investment until recovery to its carrying value.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our investment in JUUL as an investment in an equity security and measure our investment in JUUL at fair value on our consolidated balance sheet at December&#160;31, 2022.  Our consolidated statements of earnings include any cash dividends received from our investment in JUUL (none received to date) and any changes in the estimated fair value of our investment, which is calculated quarterly.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Investment in ABI</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, our equity investment in ABI consisted of 185 million restricted shares of ABI (the &#8220;Restricted Shares&#8221;) and 12 million ordinary shares of ABI.  The fair value of our equity investment in ABI is based on: (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  We can convert the Restricted Shares to ordinary shares at our discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our equity investment in ABI at December 31, 2022 and 2021 was $11.9 billion (carrying value of $9.0 billion) and $11.9 billion (carrying value of $11.1 billion), respectively, which was above its carrying value by approximately 33% and 7% at December 31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At February 23, 2023, the fair value of our equity investment in ABI was $12.0 billion, which exceeded its carrying value by approximately 33%.  We will continue to monitor our investment in ABI, including the impact of macroeconomic and geopolitical factors on ABI&#8217;s business and market valuation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in JUUL</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, the estimated fair value of our investment in JUUL was $250 million, as compared with $1.7 billion at December 31, 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FDA issued MDOs to JUUL ordering all of JUUL&#8217;s products currently marketed in the United States off the market.  In July 2022, the FDA administratively stayed the MDOs on a temporary basis, citing its determination that there are scientific issues unique to the JUUL PMTAs that warrant additional review.  This administrative stay temporarily suspended the MDOs, and JUUL&#8217;s products remain on the market.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in the estimated fair value of our investment in JUUL for the year ended December 31, 2022 was primarily driven by (i) a decrease in the likelihood of a favorable outcome from the FDA for JUUL&#8217;s products that are currently marketed in the United States, which have received MDOs and are under additional administrative review, (ii) a decrease in the likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, which could result in JUUL seeking protection under bankruptcy or other insolvency laws, (iii) projections of higher operating expenses resulting in lower long-term operating margins, (iv) projections of lower JUUL revenues in the United States over time due to lower JUUL volume assumptions and (v) an increase in the discount rate due to changes in market factors, partially offset by the effect of passage of time on the projected cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use an income approach to estimate the fair value of our investment in JUUL.  The income approach reflects the discounting of future cash flows for the United States and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the fair value of our investment in JUUL, we made certain judgments, estimates and assumptions, the most significant of which were likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, we made judgments regarding: (i) the likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#8217;s products, which have received MDOs and are under additional administrative review; (ii) the likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, the absence of which could result in JUUL seeking protection under bankruptcy or other insolvency laws; (iii) the risk created by the number and types of legal cases pending against JUUL; (iv) expectations for the future state of the e-vapor category, including competitive dynamics; and (v) the timing of international expansion plans.  Due to these uncertainties, our future cash flow projections of JUUL are based on a range of scenarios that consider certain potential regulatory, liquidity and market outcomes.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although our discounted cash flow analyses were based on assumptions that our management considered reasonable and were based on the best available information at the time that the analyses were developed, there is significant judgment used in determining future cash flows.  If the following factors, in isolation, significantly deviate from current expectations, we believe that they have the potential to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">materially impact our significant assumptions of the likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates, and thus potentially materially increase our valuation of our investment in JUUL:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">favorable regulatory and legislative developments at the international, federal, state and local levels such as FDA authorization of (i) existing JUUL products that have received MDOs from the FDA and that are now under additional administrative review or (ii) future tobacco product applications for JUUL&#8217;s flavored e-vapor products, which are currently not permitted in the market without FDA authorization;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">JUUL&#8217;s ability to maintain adequate financing to fund projected cash needs;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">favorable developments related to litigation; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">favorable financial and market performance, including substantial changes in competitive dynamics.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our management believes that the recorded value of our investment in JUUL at December 31, 2022 represents our best estimate of the fair value of the investment, JUUL&#8217;s actual performance in the short term or long term could be significantly different from forecasted performance due to changes in the factors noted above.  Additionally, the value of our investment in JUUL could be significantly impacted by changes in the discount rate, which could be caused by numerous factors, including changes in market inputs, as well as risks specific to JUUL, including the outcome of the FDA&#8217;s additional review of the JUUL PMTAs that have received MDOs and favorable or unfavorable developments related to JUUL&#8217;s liquidity and litigation environment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on our investments in equity securities, including impairments of our investments in ABI and Cronos and estimated changes in fair value of our JUUL investment, see Note 5.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Marketing Costs: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses promote their products with consumer incentives, trade promotions and consumer engagement programs.  These consumer incentive and trade promotion activities, which include discounts, coupons, rebates, in-store display incentives and volume-based incentives, do not create a distinct deliverable and are, therefore, recorded as a reduction of revenues.  We make consumer engagement program payments to third parties.  Our businesses expense these consumer engagement programs, which include event marketing, as incurred and such expenses are included in marketing, administration and research costs in our consolidated statements of earnings.  For interim reporting purposes, our businesses charge consumer engagement programs and certain consumer incentive expenses to operations as a percentage of sales, based on estimated sales and related expenses for the full year.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Contingencies: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 17 and Item 3. Legal Proceedings of this Form 10-K (&#8220;Item 3&#8221;), legal proceedings covering a wide range of matters are pending or threatened in various U.S. and foreign jurisdictions against Altria and our subsidiaries, including PM USA, as well as their respective indemnitees and our investees.  In 1998, PM USA and certain other tobacco product manufacturers entered into the MSA with 46 states, the District of Columbia and certain United States territories to settle asserted and unasserted health care cost recovery and other claims.  PM USA and certain other U.S. tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#8220;State Settlement Agreements&#8221;).  PM USA&#8217;s portion of ongoing adjusted payments and legal fees is based on its relative share of the settling manufacturers&#8217; domestic cigarette shipments, including roll-your-own cigarettes, in the year preceding that in which the payment is due.  In addition, PM USA, Middleton and USSTC are subject to quarterly user fees imposed by the FDA as a result of the FSPTCA.  Payments under the State Settlement Agreements and the FDA user fees are based on variable factors, such as volume, operating income, market share and inflation, depending on the subject payment.  Our subsidiaries account for the cost of the State Settlement Agreements and FDA user fees as a component of cost of sales.  Our subsidiaries recorded approximately $4.2 billion and $4.6 billion of charges to cost of sales for the years ended December&#160;31, 2022 and 2021, respectively, in connection with the State Settlement Agreements and FDA user fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record provisions in our consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed in Note 17 and Item 3: (i) management has concluded that it is not probable that a loss has been incurred in any pending litigation; (ii) management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any pending case; and (iii) accordingly, management has not provided any amounts in the consolidated financial statements for unfavorable outcomes, if any.  We expense litigation defense costs as incurred and include such costs in marketing, administration and research costs in our consolidated statements of earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Employee Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide a range of benefits to certain employees and retired employees, including pension, postretirement health care and postemployment benefits.  We record annual amounts relating to these plans based on calculations specified by GAAP, which include various actuarial assumptions as to discount rates, assumed rates of return on plan assets, mortality, compensation increases, turnover rates and health care cost trend rates.  We review our actuarial assumptions on an annual basis and make modifications to the assumptions based on current rates and trends when it is deemed appropriate to do so.  Any effect of the modifications is generally amortized over future periods.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the funded status of our defined benefit pension and other postretirement plans on the consolidated balance sheets and record as a component of other comprehensive earnings (losses), net of deferred income taxes, the gains or losses and prior service costs or credits that have not been recognized as components of net periodic benefit cost (income).  We subsequently amortize the gains or losses and prior service costs or credits recorded as components of other comprehensive earnings (losses) into net periodic benefit cost (income) in future years.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to changes in market factors, our discount rate assumptions for our pension and postretirement plans obligations increased to 5.6% for these plans at December&#160;31, 2022 from 3.0% and 2.9%, respectively, at December&#160;31, 2021.  We presently anticipate net pre-tax pension and postretirement income of approximately $70 million in 2023 versus net pre-tax income of $97 million in 2022.  This decrease is due primarily to: (i) higher discount rates resulting in net higher interest and service costs; (ii) lower estimated return on assets due to lower fair value of plan assets at December 31, 2022; partially offset by (iii) lower amortization of net unrecognized losses in 2023.  Assuming no change to the shape of the yield curve, a 50 basis point decrease (increase) in our discount rates would increase (decrease) our pension and postretirement expense by approximately $10 million.  Similarly, a 50 basis point decrease (increase) in the expected return on plan assets would increase (decrease) our pension and postretirement expense by approximately $40 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information see Note 15. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements in Item 8 (&#8220;Note 15&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Significant judgment is required in determining income tax provisions and in evaluating tax positions.  We determine deferred tax assets and liabilities based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.  We record a valuation allowance when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  We determine the realizability of deferred tax assets based on the weight of all available positive and negative evidence.  In reaching this determination, we consider the character of the assets and the possible sources of taxable income of the appropriate character within the available carryback and carryforward periods available under the tax law.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the financial statement benefit for uncertain income tax positions when it is more likely than not, based on the technical merits, that the position will be sustained upon examination by taxing authorities.  The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.  We recognize accrued interest and penalties associated with uncertain tax positions as part of the provision for income taxes in our consolidated statements of earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized income tax benefits and charges in the consolidated statements of earnings during 2022 and 2021 as a result of various tax events.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on income taxes, see Note 13. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the consolidated financial statements in Item 8 (&#8220;Note 13&#8221;). </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Operating Results</span></div><div style="margin-bottom:5pt;margin-top:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.380%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.985%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.520%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December&#160;31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,476</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,096</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,013&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Excise Taxes on Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,289</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,754&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">119</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes on products</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,408</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,902&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Income:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,688</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,632</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,919</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,560&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed further in Note 14, our CODM reviews OCI to evaluate the performance of, and allocate resources to, our segments.  Our management believes it is appropriate to disclose this measure to help investors analyze the business performance and trends of our business segments.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of adjusted net earnings attributable to Altria and adjusted diluted EPS attributable to Altria for the years ended December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.206%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.331%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.056%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions of dollars, except per share data)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings before Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Provision for Income Taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Earnings Attributable <br/>to Altria</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Reported</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,625</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,764</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,764</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation, acquisition and disposition-related costs</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">98</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">98</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.05</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL changes in fair value</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.81</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,544</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">534</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,010</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,010</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">186</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">186</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">186</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">729</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Adjusted for Special Items</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,648</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,906</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,742</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,742</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.84</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Reported</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation, acquisition and disposition-related costs</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation items </span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos-related special items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax items</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 Adjusted for Special Items</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,368&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,849&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,519&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,519&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.61&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following special items affected the comparability of statements of earnings amounts.</span></div><div style="margin-bottom:5pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">NPM Adjustment Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of NPM Adjustment Items and a breakdown of these items by segment, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 17 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NPM Adjustment Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 14, respectively.</span></div><div style="margin-bottom:5pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Asset Impairment, Exit, Implementation, Acquisition and Disposition-Related Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For a discussion of acquisition and disposition-related costs in our oral tobacco products segment and former wine segment for the year ended December&#160;31, 2021, see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Acquisition-Related Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ste. Michelle Transaction</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 14.</span></div><div style="margin-bottom:5pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Tobacco and Health and Certain Other Litigation Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of tobacco and health and certain other litigation items and a breakdown of these costs by segment, see Note 17 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco and Health and Certain Other Litigation Items</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 14, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">JUUL Changes in Fair Value: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded non-cash, pre-tax unrealized losses from investments in equity securities in our consolidated statements of earnings as a result of changes in the estimated fair value of our investment in JUUL of $1,455 million for the year ended December&#160;31, 2022.  We did not record a change in the estimated fair value of our investment in JUUL for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded corresponding adjustments to the JUUL tax valuation allowance in 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion, see Note 5 and Note 13.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">ABI-Related Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded net pre-tax losses of $2,544 million and $6,203 million from our equity investment in ABI for the years ended December&#160;31, 2022 and 2021, respectively, substantially all of which related to non-cash impairments of our equity investment in ABI of $2,541 million and $6,157 million, for the years ended December 31, 2022 and 2021, respectively.  For further discussion, see Note 5.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These amounts include our respective share of the amounts recorded by ABI and additional adjustments related to (i) conversion from international financial reporting standards to GAAP and (ii) adjustments to our investment required under the equity method of accounting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Cronos-Related Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded net pre-tax expense for the years ended December&#160;31, 2022 and 2021, consisting of the following:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Loss on Cronos-related financial instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments in equity securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Cronos-related special items - (income) expense</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">186</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts are related to the non-cash change in the fair value of the warrant (which we irrevocably abandoned in the fourth quarter of 2022) and certain anti-dilution protections (the &#8220;Fixed-price Preemptive Rights&#8221;) acquired in the Cronos transaction.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts include our share of special items recorded by Cronos and additional adjustments, if required under the equity method of accounting, related to our investment in Cronos including the $107 million and $205 million non-cash, pre-tax impairments of our investment in Cronos in 2022 and 2021, respectively.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded corresponding adjustments to the Cronos tax valuation allowance in 2022 and 2021 relating to the special items.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion, see Note 5 and Note 13.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.78pt">Loss on Early Extinguishment of Debt: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded pre-tax losses of $649 million for the year ended December&#160;31, 2021, as a result of the completion of debt tender offers for and redemption of certain of our long-term senior unsecured notes.  For further discussion, see Note 8.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Long-Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the consolidated financial statements in Item 8 (&#8220;Note 8&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.78pt">Income Tax Items:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recorded income tax items of $729 million for the year ended December&#160;31, 2022, due primarily to the release of valuation allowances on deferred tax assets related to a portion of our investment in JUUL and our Cronos warrant (which we irrevocably abandoned in the fourth quarter of 2022) due to the anticipated ability to utilize these losses.  For further discussion, see Note 13.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Compared with 2021</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $917 million (3.5%), due primarily to the sale of our wine business in October 2021 and lower net revenues in the smokeable products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales decreased $677 million (9.5%), due primarily to lower shipment volume in our smokeable products segment and the sale of our wine business, partially offset by higher manufacturing costs and higher per unit settlement charges.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excise taxes on products decreased $494 million (10.1%), due primarily to lower shipment volume in our smokeable products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing, administration and research costs decreased $105 million (4.3%), due primarily to the sale of our wine business (including lower disposition-related costs), lower spending associated with the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System heated tobacco business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lower general corporate expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and acquisition-related costs in 2021 in our oral tobacco products segment, partially offset by higher costs in our smokeable products segment.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income increased $359 million (3.1%), due primarily to higher operating results in our smokeable products segment and lower general corporate expenses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other debt expense, net decreased $104 million (9.0%), due primarily to lower interest costs as a result of debt maturities and refinancing activities and higher interest income due to higher rates and interest associated with the sale of the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">System commercialization rights.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Income) losses from investments in equity securities, which were favorable $2,338 million (39.1%), were positively impacted by favorable special items from our investment in ABI (primarily due to a lower non-cash impairment of ABI) and lower losses from Cronos-related special items, partially offset by non-cash, unrealized losses resulting from the changes in the estimated fair value of our investment in JUUL in 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes increased $276 million (20.5%), due primarily to higher pre-tax earnings, partially offset by favorable income tax items and the state tax treatment of the impairment charges on our equity investment in ABI.  For further discussion, see Note 13.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported net earnings attributable to Altria of $5,764 million increased $3,289 million (100.0%+), due primarily to lower losses from investments in equity securities, favorable income tax items, the loss on early extinguishment of debt in 2021, higher operating income, lower losses on Cronos-related financial instruments and lower interest and other debt expense, net.  Reported basic and diluted EPS attributable to Altria of $3.19 each increased by 100.0%+ due to higher reported net earnings attributable to Altria and fewer shares outstanding.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted net earnings attributable to Altria of $8,742 million increased $223 million (2.6%), due primarily to higher OCI and lower interest and other debt expense, net.  Adjusted diluted EPS attributable to Altria of $4.84 increased by 5.0%, due to higher adjusted net earnings attributable to Altria and fewer shares outstanding.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">   </span></div><div id="i15062ca98227434086141b426450a5cb_58"></div><div style="margin-bottom:5pt;padding-right:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operating Results by Business Segment</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tobacco Space</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Environment</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. tobacco industry faces a number of business and legal challenges that have materially adversely affected and may continue to materially adversely affect our business, results of operations, cash flows or financial position or our ability to achieve our Vision.  These challenges, some of which are discussed in more detail in Note 17, Item 1A and Item 3, include:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">pending and threatened litigation and bonding requirements;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">restrictions and requirements imposed by the FSPTCA, and restrictions and requirements (and related enforcement actions) that have been, and in the future will be, imposed by the FDA;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">actual and proposed excise tax increases, as well as changes in tax structures and tax stamping requirements;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">bans and restrictions on tobacco use imposed by governmental entities and private establishments and employers;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">other federal, state and local government actions, including:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">restrictions on the sale of certain tobacco products, the sale of tobacco products by certain retail establishments, the sale of tobacco products with characterizing flavors and the sale of tobacco products in certain package sizes;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">additional restrictions on the advertising and promotion of tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">other actual and proposed tobacco-related legislation and regulation; and</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">governmental investigations;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">reductions in consumption levels of cigarettes and MST products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">increased efforts by tobacco control advocates and other private sector entities (including retail establishments) to further restrict the availability and use of tobacco products or the ability to communicate with consumers through third-party digital platforms;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">changes in adult tobacco consumer purchase behavior, which is influenced by various factors such as macroeconomic conditions (including inflation), excise taxes and price gap relationships, may result in adult tobacco consumers switching to lower-priced tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the highly competitive nature of all tobacco categories, including competitive disadvantages related to cigarette price increases attributable to the settlement of certain litigation and the proliferation of innovative tobacco products, such as e-vapor and oral nicotine pouch products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">illicit trade in tobacco products; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">potential adverse changes in prices, availability and quality of tobacco, other raw materials and component parts, including as a result of changes in macroeconomic and geopolitical conditions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to and in connection with the foregoing, evolving adult tobacco consumer preferences continue to impact the tobacco industry.  We believe that a significant number of adult tobacco consumers switch among tobacco categories, use multiple forms of tobacco products and try innovative tobacco products, such as e-vapor products and oral nicotine pouches.  Adult smokers continue to transition from cigarettes to exclusive use of smoke-free tobacco product alternatives, which aligns with our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We work to meet these evolving adult tobacco consumer preferences over time by developing, manufacturing, marketing and distributing products both within and outside the United States through innovation and other growth strategies (including, where appropriate, arrangements with, or investments in, third parties).</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ver the past two years, the legislative and regulatory activities discussed below negatively impacted growth in the e-vapor category.  Due to the uncertainty these challenges have created and continue to create in the marketplace, the e-vapor category experienced an estimated volume decline of 1.2% for the year ended December 31, 2022 compared to 2021.  In the fourth quarter of 2022, e-vapor industry volumes declined by 4% sequentially and declined by 7% versus the same period in 2021 as a result of FDA regulatory actions with respect to JUUL, which are discussed below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Oral nicotine pouch retail share of the total oral tobacco category grew significantly from 15.3% for the year ended December 31, 2021 to 21.8% for the year ended December 31, 2022.  The oral nicotine pouch category continues to be increasingly competitive.  In addition, oral nicotine pouch growth has sourced in significant part from smokeless tobacco and cigarette consumers.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are monitoring the sale and distribution of synthetic nicotine products, including in the form of e-vapor products and oral nicotine pouches.  As a result of recent amendments to the U.S. Food, Drug and Cosmetic Act, synthetic nicotine products are now subject to FDA regulatory oversight, as discussed further below.  We believe FDA regulatory actions, which may be subject to legal challenges, will further impact the competitive environment.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the innovative tobacco product categories will continue to be dynamic due to competition, adult tobacco consumer exploration of a variety of tobacco product options, adult tobacco consumer perceptions of the relative risks of smoke-free products compared to cigarettes, FDA determinations on product applications, FDA enforcement activity and legislative actions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2022, we estimate that, when adjusted for trade inventory movements and other factors, domestic cigarette industry volume declined by 8.0%.  We expect 2023 cigarette industry volume trends to be most influenced by (i) disposable income, purchasing patterns and adoption of smoke-free products, (ii) macroeconomic conditions (including inflation, gasoline prices and unemployment levels), (iii) cross-category movement and (iv) regulatory and legislative (including excise tax) developments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Macroeconomic conditions (including a high inflationary environment) can impact adult tobacco consumer purchasing behavior.  For example, economic downturns have coincided with adult tobacco consumers modifying purchase behavior at retail, potentially reducing the amount of their regular brand purchases or selecting discount products and other lower priced tobacco brands.  Beginning in January 2022, the Omicron variant of COVID-19 impacted consumer purchasing behavior, resulting in a short-term decrease in retail trips and tobacco sales volume.  In addition, gas prices increased during the second and third quarters of 2022 due in part to the Russian invasion of Ukraine before decreasing during the fourth quarter.  Increases in inflation as a result of macroeconomic and geopolitical conditions put pressure on discretionary income as the Consumer Price Index reached a 40 year high in June 2022 and rose 6.5% for all items during the year ended December 31, 2022.  Throughout 2022, these economic headwinds were partially offset by positive wage inflation, increases in federal tax refund payments and low unemployment in comparison to the year ended December 31, 2021.  We believe that adult tobacco consumers adapted their purchasing patterns across a variety of goods and services to compensate for the pressures on disposable income.  As price sensitive adult tobacco consumers react to their economic conditions, we expect potential fluctuations in discount product share for cigarettes and MST products.  However, if macroeconomic conditions or other factors cause greater than expected discount share growth or a reduction in purchases at retail, such factors could have a material adverse effect on our business, results of operations, cash flows or financial position, including an adverse effect on the carrying value of our assets such as our tobacco product trademarks.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FSPTCA and FDA Regulation</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">The Regulatory Framework:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA, its implementing regulations and its 2016 deeming regulations establish broad FDA regulatory authority over all tobacco products and, among other provisions:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impose restrictions on the advertising, promotion, sale and distribution of tobacco products (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Final Tobacco Marketing Rule</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below);</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">establish pre-market review pathways for new and modified tobacco products (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pre-Market Review Pathways for Tobacco Products and Market Authorization Enforcement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below);</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">prohibit any express or implied claims that a tobacco product is or may be less harmful than other tobacco products without FDA authorization;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">authorize the FDA to impose tobacco product standards that are appropriate for the protection of the public health (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Potential Product Standards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below); and</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">equip the FDA with a variety of investigatory and enforcement tools, including the authority to inspect product manufacturing and other facilities (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investigation and Enforcement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA also bans descriptors such as &#8220;light,&#8221; &#8220;low&#8221; or &#8220;mild&#8221; when used as descriptors of modified risk, unless expressly authorized by the FDA.  In connection with a 2016 lawsuit initiated by Middleton, the U.S. Department of Justice, on behalf of the FDA, informed Middleton that the FDA does not intend to bring an enforcement action against Middleton for the use of the term &#8220;mild&#8221; in the trademark &#8220;Black &amp; Mild.&#8221;  Consequently, Middleton dismissed its lawsuit without prejudice.  If the FDA were to change its position at some later date, Middleton would have the opportunity to bring another lawsuit.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, the U.S. Congress expanded the statutory definition of tobacco products to include products containing nicotine derived from any source, including synthetic nicotine.  The amendment became effective in April 2022.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pre-Market Review Pathways for Tobacco Products and Market Authorization Enforcement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for additional information on the effects of the statutory change.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Final Tobacco Marketing Rule: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by the FSPTCA, in March 2010, the FDA promulgated a wide range of advertising and promotion restrictions for cigarettes and smokeless tobacco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products (the &#8220;Final Tobacco Marketing Rule&#8221;).  The May 2016 deeming regulations amended the Final Tobacco Marketing Rule to expand specific provisions to all tobacco products, including cigars, pipe tobacco and e-vapor and oral nicotine products containing tobacco-derived nicotine or other tobacco derivatives.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Final Tobacco Marketing Rule, as amended, among other things:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">restricts the use of non-tobacco trade and brand names on cigarettes and smokeless tobacco products;</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Smokeless tobacco,&#8221; as used in this section of this Form 10-K, refers to smokeless tobacco products first regulated by the FDA in 2009, including MST.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">It excludes oral nicotine pouches, which were first regulated by the FDA in 2016.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">prohibits sampling of all tobacco products except that sampling of smokeless tobacco products is permitted in qualified adult-only facilities;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">prohibits the sale or distribution of items such as hats and tee shirts with cigarette or smokeless tobacco brands or logos;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">prohibits cigarettes and smokeless tobacco brand name sponsorship of any athletic, musical, artistic or other social or cultural event, or any entry or team in any event; and</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">requires the development by the FDA of graphic warnings for cigarettes, establishes warning requirements for other tobacco products, and gives the FDA the authority to require new warnings for any type of tobacco product (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FDA Regulatory Actions - Graphic Warnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain limitations arising from legal challenges, the Final Tobacco Marketing Rule took effect in June 2010 for cigarettes and smokeless tobacco products, in August 2016 for all other tobacco products, including e-vapor and oral nicotine pouch products containing tobacco-derived nicotine, and in April 2022 for tobacco products, including e-vapor and oral nicotine pouch products, that contain synthetic nicotine.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Rulemaking and Guidance: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the FDA issues proposed regulations and guidance, which may be issued in draft or final form, generally involve public comment and may include scientific review.  The FDA also may request comments on broad topics through an Advanced Notice of Proposed Rulemaking (&#8220;ANPRM&#8221;).  We actively engage with the FDA to develop and implement the FSPTCA&#8217;s regulatory framework, including submission of comments to various FDA policies and proposals and participation in public hearings and engagement sessions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA&#8217;s implementation of the FSPTCA and related regulations and guidance also may have an impact on enforcement efforts by states, territories and localities of their laws and regulations as well as of the State Settlement Agreements (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Settlement Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).&#160; Such enforcement efforts may adversely affect our operating companies&#8217; ability to market and sell regulated tobacco products in those states, territories and localities.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">FDA&#8217;s Comprehensive Plan for Tobacco and Nicotine Regulation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the FDA announced a &#8220;Comprehensive Plan for Tobacco and Nicotine Regulation&#8221; (&#8220;Comprehensive Plan&#8221;) designed to strike a balance between regulation and encouraging the development of innovative tobacco products that may be less risky than cigarettes.  Since then, the FDA has issued additional information about its Comprehensive Plan in response to concerns associated with the rise in the use of e-vapor products by youth and the potential youth appeal of flavored tobacco products (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FDA Regulatory Actions - Underage Access and Use of Certain Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below).  As part of the Comprehensive Plan, the FDA:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">issued ANPRMs relating to potential product standards for nicotine in cigarettes, flavors in all tobacco products (including menthol in cigarettes and characterizing flavors in all cigars) and, for e-vapor products, to protect against known public health risks such as concerns about youth exposure to liquid nicotine;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">took actions to restrict youth access to e-vapor products; and</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">reconsidered the processes used by the FDA to review certain reports and new product applications.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, the Reagan-Udall Foundation published a report on its operational evaluation of the FDA&#8217;s Center for Tobacco Products.  Among other recommendations, the report urges the FDA to clearly define product pathways, accelerate PMTA decision-making, take enforcement actions against manufacturers and products that violate the law and address the need for risk communications to tobacco consumers.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Pre-Market Review Pathways for Tobacco Products and Market Authorization Enforcement: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA permits the sale of tobacco products on the market as of February 15, 2007 and not subsequently modified (&#8220;Pre-existing Tobacco Products&#8221;) and new or modified products authorized through the PMTA, Substantial Equivalence (&#8220;SE&#8221;) or SE Exemption pathways.  Subsequent FDA rules also provide a Supplemental PMTA pathway designed to increase the efficiency of submission and review for modified versions of previously authorized products.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA pre-market authorization enforcement policy varies based on product type and date of availability in the market, specifically:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Pre-existing Tobacco Products are exempt from the pre-market authorization requirement;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">cigarette and smokeless tobacco products that were modified or first introduced into the market between February 15, 2007 and March 22, 2011 are generally considered &#8220;Provisional Products&#8221; for which SE reports were required to be filed by March 22, 2011.  These reports must demonstrate that the product has the same characteristics as a product on the market as of February 15, 2007 or to a product previously determined to be substantially equivalent, or has different characteristics but does not raise different questions of public health; </span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">tobacco products that were first regulated by the FDA in 2016, including cigars, e-vapor products and oral nicotine pouches that are not Pre-existing Tobacco Products, are generally products for which either an SE report or PMTA needed to be filed by September 9, 2020; and</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">tobacco products containing nicotine from any source other than tobacco (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, synthetic nicotine) that were on the market between March 15, 2022 and April 14, 2022 and are not Pre-existing Tobacco Products are generally products for which a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;padding-left:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacturer must have filed a PMTA by May 14, 2022.  A manufacturer was permitted to keep such a product on the market until July 13, 2022 provided that a PMTA was filed by May 14, 2022.  Thereafter, unless the FDA granted the product a marketing order, the product is unlawful and subject to possible FDA enforcement.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Modifications to currently marketed products, including modifications that result from, for example, changes to the quantity of tobacco product(s) in a package, a manufacturer being unable to acquire ingredients or a supplier being unable to maintain the consistency required in ingredients, could trigger the FDA&#8217;s pre-market review processes.  Through these processes, a manufacturer could receive (i) a &#8220;not substantially equivalent&#8221; determination, (ii) a denial of a PMTA or (iii) a marketing order withdrawal by the FDA on one or more products, which would require the removal of the product or products from the market.  In addition, new scientific data continues to be developed relating to innovative tobacco products, which could impact the FDA&#8217;s determination as to whether a product is, or continues to be, appropriate for the protection of public health and could, therefore, result in the removal of one or more products from the market.  Any such actions affecting our operating companies&#8217; products could have a material adverse impact on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products Regulated in 2009</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most cigarette and smokeless tobacco products currently marketed by PM USA and USSTC are &#8220;Provisional Products.&#8221;  PM USA and USSTC timely submitted SE reports for these Provisional Products and have received SE determinations on certain Provisional Products.  Those products that were found by the FDA to be not substantially equivalent (certain smokeless tobacco products) had been discontinued for business reasons prior to the FDA&#8217;s determinations; therefore, those determinations did not impact business results.  PM USA and USSTC have other Provisional Products that continue to be subject to the FDA&#8217;s pre-market review process.  In the meantime, they can continue marketing these products unless the FDA determines that a specific Provisional Product is not substantially equivalent.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the FDA has communicated that it will not review a certain subset of Provisional Product SE reports and that the products that are the subject of those reports can continue to be legally marketed without further FDA review.  PM USA and USSTC have Provisional Products included in this subset of products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we believe PM USA&#8217;s and USSTC&#8217;s current Provisional Products meet the statutory requirements of the FSPTCA, we cannot predict how the FDA will ultimately apply law, regulation and guidance to their various SE reports.  Should PM USA or USSTC receive unfavorable determinations on any SE reports currently pending with the FDA, we believe PM USA and USSTC can replace the vast majority of these product volumes with other FDA authorized products or with Pre-existing Tobacco Products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cigarette and smokeless tobacco products introduced into the market or modified after March 22, 2011 are &#8220;Non-Provisional Products&#8221; and must receive a marketing order from the FDA prior to being offered for sale.  Marketing orders for Non-Provisional Products may be obtained by filing an SE report, PMTA or using another pre-market pathway established by the FDA.  PM USA and USSTC may not be able to obtain a marketing order for non-provisional products because the FDA may determine that any such product does not meet the statutory requirements for approval.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Products Regulated in 2016</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Manufacturers of products first regulated by the FDA in 2016, including cigars, oral nicotine pouches and e-vapor products, that were on the market as of August 8, 2016 and not subsequently modified must have filed an SE report or PMTA by the filing deadline of September 9, 2020 in order for their products to remain on the market.  These products can remain on the market during FDA review through court-allowed, case-by-case discretion, so long as the report or application was timely filed with the FDA.  In September 2022, the FDA represented that it had resolved more than 99% of the timely applications it had received, with the vast majority resulting in a denial.  A number of the denials are subject to litigation challenges initiated by the affected manufacturers.  For those products still under FDA review, it is uncertain when and for how long the FDA may permit continued marketing and sale of those products pursuant to its case-by-case discretion.  For products (new or modified) not on the market as of August 8, 2016, manufacturers must file an SE report or PMTA and receive FDA authorization prior to marketing and selling the product.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helix submitted PMTAs for</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;on!&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">oral nicotine pouches in May 2020.  As of February 23, 2023, the FDA has not issued marketing order decisions for any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products.  In addition, as of February 23, 2023, Middleton has received market orders or exemptions that cover over 99% of its cigar product volume.  JUUL submitted PMTAs for its e-vapor device and the related tobacco and menthol flavors in July 2020.  In June 2022, the FDA issued MDOs to JUUL for all of JUUL&#8217;s products currently marketed in the United States.  These MDOs are currently stayed.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FDA Regulatory Actions - Electronic Nicotine Delivery System Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for further discussion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2019, the FDA authorized the PMTA for the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and in July 2020, the FDA authorized the marketing of this system as an MRTP with a reduced exposure claim.  In December 2020, the FDA authorized the PMTA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3, an updated version of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices, and in March 2022 authorized the marketing of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 3 device as an MRTP with the same reduced exposure claim.  We have agreed to assign the exclusive U.S. commercialization rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">System to PMI effective April 2024 in exchange for a total cash payment of approximately $2.7 billion (plus interest).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, in connection with a patent dispute, the ITC issued a cease and desist order, effective as of November 29, 2021, banning (i) the importation of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> devices, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and infringing components into the United States and (ii) the sale, marketing and distribution of such imported products in the United States.  As a result, PM USA removed the products from the marketplace.  For a further discussion of the ITC decision, see Note 17.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 2021, the FDA authorized the marketing and sale of four of USSTC&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Verve</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> oral nicotine products, including Green Mint and Blue Mint varieties, representing the first flavored product authorizations issued by the FDA for newly deemed innovative products.  These products are not currently marketed or sold.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Post-Market Surveillance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Manufacturers that receive product authorizations through the PMTA process must adhere to the FDA post-market record keeping and reporting requirements, as detailed in market orders and in the final PMTA rule that went into effect in November 2021.  This includes notification of all marketing activities.  The FDA may amend requirements of a market order or withdraw the market order based on this information if, among other reasons, it determines that the continued marketing of the products is no longer appropriate for the protection of the public health.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Effect of Adverse FDA Determinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: FDA review time frames have varied.  It is therefore difficult to predict the duration of FDA reviews of SE reports or PMTAs.  An unfavorable determination on an application, the withdrawal by the FDA of a prior marketing order or other changes in FDA regulatory requirements could result in the removal of products from the market.  These manufacturers would have the option of marketing their products that have received FDA pre-market authorization or Pre-existing Tobacco Products.  A &#8220;not substantially equivalent&#8221; determination, a denial of a PMTA or a marketing order withdrawal by the FDA on one or more products (which would require the removal of the product or products from the market) could have a material adverse impact on our business, results of operations, cash flows or financial position.  Also, adverse FDA determinations on innovative tobacco products could have a material adverse effect on our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">FDA Regulatory Actions</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Graphic Warnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FDA issued a final rule requiring 11 textual warnings accompanied by color graphics depicting certain negative health consequences of smoking on cigarette packaging and advertising.  The final rule was set to become effective on October 6, 2023.  However, PM USA and other cigarette manufacturers filed lawsuits challenging the final rule on substantive and procedural grounds.  In December 2022, the U.S. District Court for the Eastern District of Texas found in favor of cigarette manufacturers in one such suit and blocked the rule, finding it unconstitutional on the basis that it compelled speech in violation of the First Amendment.  The FDA has appealed the decision.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Underage Access and Use of Certain Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA announced regulatory actions in September 2018 to address underage access and use of e-vapor products.  We have engaged with the FDA on this topic and have reaffirmed to the FDA our ongoing and long-standing commitment to preventing underage use.  For example, we advocated raising the minimum legal age to purchase all tobacco products to 21 at the federal and state levels to further address underage use, which is now federal law.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal, State and Local Legislation to Increase the Legal Age to Purchase Tobacco Products </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for further discussion.  In addition, through our retailer incentive program, stores representing over 80% of PM USA&#8217;s cigarette volume have implemented point-of-sale age validation technology.</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the FDA issued final guidance in April 2020, stating that it intends to prioritize enforcement action against certain product categories, including cartridge-based, flavored e-vapor products and products targeted to minors.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Electronic Nicotine Delivery System Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In June 2022, the FDA issued MDOs to JUUL ordering all of JUUL&#8217;s products currently marketed in the United States off the market.  JUUL filed a petition for review of the MDOs with the U.S. Court of Appeals for the D.C. Circuit.  JUUL subsequently moved the D.C. Circuit for a temporary administrative stay of the MDOs, which the court granted to provide sufficient opportunity for the court to consider JUUL&#8217;s emergency motion for a stay pending the court&#8217;s consideration of JUUL&#8217;s challenge to the MDOs.  In July 2022, the FDA administratively stayed the MDOs on a temporary basis, citing its determination that there are scientific issues unique to the JUUL PMTAs that warrant additional review.  This administrative stay temporarily suspends the MDOs, and JUUL&#8217;s products remain on the market.  The proceedings in the U.S. Court of Appeals for the D.C. Circuit are being held in abeyance pending completion of the FDA&#8217;s additional review, and JUUL has withdrawn its motion for an emergency stay with respect to the MDOs, without prejudice to refiling at a later date.  In light of these developments, the D.C. Circuit dissolved the administrative stay it had previously granted and directed the parties to file motions to govern further proceedings within 14 days of FDA&#8217;s completion of its additional review process.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:33.08pt">As of February 23, 2023, many manufacturers of menthol and other flavored e-vapor products received MDOs for failure to provide sufficiently strong product-specific scientific evidence to demonstrate that the benefit of their products to adult smokers overcomes the risk that their products pose to youth.  The FDA has communicated in these MDOs that vapor products with non-tobacco flavors present unique questions relevant to the FDA&#8217;s &#8220;Appropriate for the Protection of Public Health&#8221; standard and that successful applications require strong, product-specific evidence.  A number of these manufacturers are appealing the MDOs for their products.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Potential Product Standards</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Nicotine in Cigarettes and Other Combustible Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, the FDA issued an ANPRM seeking comments on the potential public health benefits and any possible adverse effects of lowering nicotine in combustible cigarettes to non-addictive or minimally addictive levels.  Among other issues, the FDA sought comments on (i) whether smokers would </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compensate by smoking more cigarettes to obtain the same level of nicotine as with their current product and (ii) whether the proposed rule would create an illicit trade of cigarettes containing nicotine at levels higher than a non-addictive threshold that may be established by the FDA.  The FDA also sought comments on whether a nicotine product standard should apply to other combustible tobacco products, including cigars.  In January 2023, the Biden Administration published its Fall 2022 Unified Regulatory Agenda, which includes the FDA&#8217;s plans to propose, by October 2023, a product standard that would establish a maximum nicotine level in cigarettes and other combustible tobacco products.  Any proposed product standard would proceed through the rulemaking process, which we believe will take multiple years to complete.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">Flavors in Tobacco Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2022, the FDA issued two proposed product standards: (i) banning menthol in cigarettes and (ii) banning all characterizing flavors (including menthol) in cigars.  The Biden Administration&#8217;s Fall 2022 Unified Regulatory Agenda includes the FDA&#8217;s plans to complete rulemaking with respect to these proposed product standards by the end of 2023.  We submitted comments during the notice-and-comment period and plan to continue engaging with the FDA through the rulemaking process.  The FDA could propose an additional product standard for flavors in innovative tobacco products, including e-vapor products and oral nicotine products.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:32.46pt">N-nitrosonornicotine (&#8220;NNN&#8221;) in Smokeless Tobacco</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FDA proposed a product standard for NNN levels in finished smokeless tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any one or more of the foregoing potential product standards were to become final and was appealed and upheld in the courts, it could have a material adverse effect on our business, results of operations, cash flows or financial position, including a material adverse effect on the carrying value of our assets such as our cigar trademarks.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Good Manufacturing Practices: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA requires that the FDA promulgate good manufacturing practice regulations (referred to by the FDA as &#8220;Requirements for Tobacco Product Manufacturing Practice&#8221;) for tobacco product manufacturers, but does not specify a timeframe for such regulations.  Compliance with any such regulations could result in increased costs, which could have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Impact on Our Business; Compliance Costs and User Fees: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FDA regulatory actions under the FSPTCA could have a material adverse effect on our business, results of operations, cash flows or financial position in various ways.  For example, actions by the FDA could:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impact the consumer acceptability of tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">delay, discontinue or prevent the sale or distribution of existing, new or modified tobacco products;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">limit adult tobacco consumer choices;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impose restrictions on communications with adult tobacco consumers;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">create a competitive advantage or disadvantage for certain tobacco companies;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impose additional manufacturing, labeling or packaging requirements;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">impose additional restrictions at retail;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">result in increased illicit trade in tobacco products; and/or</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">otherwise significantly increase the cost of doing business.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FSPTCA imposes user fees on cigarette, cigarette tobacco, smokeless tobacco, cigar and pipe tobacco manufacturers and importers to pay for the cost of regulation and other matters.  The FSPTCA does not impose user fees on e-vapor or oral nicotine pouch manufacturers.  The cost of the FDA user fee is allocated&#160;first among tobacco product categories subject to FDA user fees and then among manufacturers and importers within each respective category based on their relative market shares, all as prescribed by the FSPTCA and FDA regulations.  Payments for user fees are adjusted for several factors, including market share and industry volume.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources - Payments Under State Settlement Agreements and FDA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a discussion of our FDA user fee payments.  In addition, compliance with the FSPTCA&#8217;s regulatory requirements has resulted, and will continue to result, in additional costs.  The amount of additional compliance and related costs has not been material in any given quarter or year-to-date period but could become material, either individually or in the aggregate.  The failure to comply with FDA regulatory requirements, even inadvertently, and FDA enforcement actions also could have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Investigation and Enforcement: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has a number of investigatory and enforcement tools available to it, including document requests and other required information submissions, facility inspections, facility closures, examinations and investigations, injunction proceedings, monetary penalties, product withdrawal and recall orders, and product seizures.  Investigations or enforcement actions could result in significant costs or otherwise have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Excise Taxes</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tobacco products are subject to substantial excise taxes in the United States.  Significant increases in tobacco-related taxes or fees have been proposed or enacted (including with respect to e-vapor products) and are likely to continue to be proposed or enacted at the federal, state and local levels within the United States.  The frequency and magnitude of excise tax increases can be influenced by various factors, including the composition of executive and legislative bodies.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal, state and local cigarette excise taxes have increased substantially over the past two decades, far outpacing the rate of inflation.  Between the end of 1998 and February 23, 2023, the weighted-average state cigarette excise tax increased from $0.36 to $1.89 per pack.  No state enacted new legislation increasing cigarette excise taxes in 2022, and, as of February 23, 2023, no state has enacted new legislation increasing excise taxes in 2023.  However, various increases are under consideration or have been proposed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of states currently tax MST using an ad valorem method, which is calculated as a percentage of the price of the product, typically the wholesale price.  This ad valorem method results in more tax being paid on premium products than is paid on lower-priced products of equal weight.  We support legislation to convert ad valorem taxes on MST to a weight-based methodology because, unlike the ad valorem tax, a weight-based tax subjects cans of equal weight to the same tax.  As of February 23, 2023, the federal government, 23 states, Puerto Rico, Philadelphia, Pennsylvania and Cook County, Illinois have adopted a weight-based tax methodology for MST.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An increasing number of states and localities also are imposing excise taxes on e-vapor products and oral nicotine pouches.  As of February 23, 2023, 30 states, the District of Columbia, Puerto Rico and a number of cities and counties have enacted legislation to tax e-vapor products.  These taxes are calculated in varying ways and may differ based on the e-vapor product form.  Similarly, 11 states and the District of Columbia have enacted legislation to tax oral nicotine pouches.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax increases are expected to continue to have an adverse impact on sales of our operating companies&#8217; products through lower consumption levels and the potential shift in adult tobacco consumer purchases from premium to non-premium or discount cigarettes, to lower taxed tobacco products or to counterfeit and contraband products.  Lower sales volume and reported share performance of our operating companies&#8217; products could have a material adverse effect on our business, results of operations, cash flows or financial position.  In addition, substantial excise tax increases on e-vapor and oral nicotine products may negatively impact adult smokers&#8217; transition to these products, which could materially adversely affect our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Treaty on Tobacco Control</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The World Health Organization&#8217;s Framework Convention on Tobacco Control (the &#8220;FCTC&#8221;) entered into force in February&#160;2005.  As of February 23, 2023, 181 countries, as well as the European Union, have become parties to the FCTC.  While the United States is a signatory of the FCTC, it is not currently a party to the agreement, as the agreement has not been submitted to, or ratified by, the U.S. Senate.  The FCTC is the first international public health treaty and its objective is to establish a global agenda for tobacco regulation with the purpose of reducing initiation of tobacco use and encouraging cessation.  The treaty recommends (and in certain instances, requires) signatory nations to enact legislation that would address various tobacco-related issues.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of proposals currently under consideration by the governing body of the FCTC, some of which call for substantial restrictions on the manufacture, marketing, distribution and sale of tobacco products.  It is not possible to predict the outcome of these proposals or the impact of any FCTC actions on legislation or regulation in the United States, either indirectly or as a result of the United States becoming a party to the FCTC, or whether or how these actions might indirectly influence FDA regulation and enforcement.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">State Settlement Agreements</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 17, during 1997 and 1998, PM USA and other major domestic cigarette manufacturers entered into the State Settlement Agreements.  These settlements require participating manufacturers to make substantial annual payments, which are adjusted for several factors, including inflation, operating income, market share and industry volume.  Increases in inflation can increase our financial liability under the State Settlement Agreements.  The State Settlement Agreements&#8217; inflation calculations require us to apply the higher of 3% or the U.S. Bureau of Labor Statistics&#8217; Consumer Price Index for All Urban Consumers (&#8220;CPI-U&#8221;) percentage rate as published in January of each year.  As of December 2022, the inflation calculation was approximately 6.5% based on the latest CPI-U data; however, the increase in the annual payments did not have a material impact on our financial position.  We believe that inflation will continue at increased levels in 2023, but do not expect the corresponding increase in annual payments to result in a material financial impact.  However, we will continue to monitor the impact of increased inflation on the macroeconomic environment and our businesses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the impact of the State Settlement Agreements on us, see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Liquidity and Capital Resources - Payments Under State Settlement Agreements and FDA Regulation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below and Note 17.  The State Settlement Agreements also place numerous requirements and restrictions on participating manufacturers&#8217; business operations, including prohibitions and restrictions on the advertising and marketing of cigarettes and smokeless tobacco products.  Among these are prohibitions of outdoor and transit brand advertising, payments for product placement and free sampling (except in adult-only facilities).  The State Settlement Agreements also place restrictions on the use of brand name sponsorships and brand name non-tobacco products and prohibitions on targeting youth and the use of cartoon characters.  In addition, the State Settlement Agreements require companies to affirm corporate principles directed at reducing underage use of cigarettes; impose requirements regarding lobbying activities; limit the industry&#8217;s ability to challenge certain tobacco </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">control and underage use laws; and provide for the dissolution of certain tobacco-related organizations and place restrictions on the establishment of any replacement organizations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1998, USSTC entered into the Smokeless Tobacco Master Settlement Agreement (the &#8220;STMSA&#8221;) with the attorneys general of various states and United States territories to resolve the remaining health care cost reimbursement cases initiated against USSTC.  The STMSA required USSTC to adopt various marketing and advertising restrictions.  USSTC is the only smokeless tobacco manufacturer to sign the STMSA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other International, Federal, State and Local Regulation and Governmental and Private Activity</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">International, Federal, State and Local Regulation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various states and localities have enacted or proposed legislation that imposes restrictions on tobacco products (including cigarettes, smokeless tobacco, cigars, e-vapor products and oral nicotine pouches), such as legislation that (i) prohibits the sale of all tobacco products or certain tobacco categories, such as e-vapor, (ii) prohibits the sale of tobacco products with characterizing flavors, such as menthol cigarettes and flavored e-vapor products, (iii) requires the disclosure of health information separate from or in addition to federally mandated health warnings and (iv) restricts commercial speech or imposes additional restrictions on the marketing or sale of tobacco products.  The legislation varies in terms of the type of tobacco products, the conditions under which such products are or would be restricted or prohibited, and exceptions to the restrictions or prohibitions.  For example, a number of proposals involving characterizing flavors would prohibit smokeless tobacco products with characterizing flavors without providing an exception for mint- or wintergreen-flavored products.  As of February 23, 2023, multiple states and localities are considering legislation to ban flavors in one or more tobacco products, and six states (California, Massachusetts, New Jersey, Utah, New York and Illinois) and the District of Columbia have passed such legislation.  Some of these states, such as New York, Utah and Illinois, exempt certain products that have received FDA market authorization through the PMTA pathway.  The legislation in California, which became effective in December 2022, bans the sale of most tobacco products with characterizing flavors, including menthol, mint and wintergreen.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Massachusetts passed legislation capping the amount of nicotine in e-vapor products.  Similar legislation is pending in two other states.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar restrictions to those enacted or proposed in various U.S. states and localities on e-vapor and oral nicotine pouch products have been enacted or proposed internationally.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have challenged and will continue to challenge certain federal, state and local legislation and other governmental action, including through litigation.  It is possible, however, that legislation, regulation or other governmental action could be enacted or implemented that could have a material adverse impact on our business, results of operations, cash flows or financial position.  Such action also could negatively impact adult smokers&#8217; transition to smoke-free products, which could materially adversely affect our ability to achieve our Vision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Federal, State and Local Legislation to Increase the Legal Age to Purchase Tobacco Products: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a number of states and localities proposed and enacted legislation to increase the minimum age to purchase all tobacco products, including e-vapor products, in December 2019, the federal government passed legislation increasing the minimum age to purchase all tobacco products, including e-vapor products, to 21 nationwide.  As of February 23, 2023, 41 states, the District of Columbia and Puerto Rico have enacted laws increasing the legal age to purchase tobacco products to 21.  Although an increase in the minimum age to purchase tobacco products may have a negative impact on our operating companies&#8217; sales volumes, as discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Underage Access and Use of Certain Tobacco Products,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> we support raising the minimum legal age to purchase all tobacco products to 21 at the federal and state levels, reflecting our longstanding commitment to combat underage tobacco use.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Health Effects of Tobacco Products, Including E-vapor Products: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reports with respect to the health effects of smoking have been publicized for many years, including various reports by the U.S. Surgeon General.  We believe that the public should be guided by the messages of the U.S. Surgeon General and public health authorities worldwide in making decisions concerning the use of tobacco products, including e-vapor products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most jurisdictions within the United States have restricted smoking in public places and some have restricted vaping in public places.  Some public health groups have called for, and various jurisdictions have adopted or proposed, bans on smoking and vaping in outdoor places, in private apartments and in cars transporting children.  It is not possible to predict the results of ongoing scientific research or the types of future scientific research into the health risks of tobacco exposure and the impact of such research on legislation and regulation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Other Legislation or Governmental Initiatives: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the actions discussed above, other regulatory initiatives affecting the tobacco industry have been adopted or are being considered at the federal level and in a number of state and local jurisdictions.  For example, in recent years, legislation has been introduced or enacted at the state or local level to subject tobacco products to various reporting requirements and performance standards; establish educational campaigns relating to tobacco consumption or tobacco control programs or provide additional funding for governmental tobacco control activities; restrict the sale of tobacco products in certain retail establishments and the sale of tobacco products in certain package sizes; prohibit the sale of tobacco products based on environmental concerns; impose responsibility on manufacturers for the disposal, recycling or other treatment of post-consumer goods such as plastic packaging; require tax stamping of smokeless tobacco products; require the use of state tax stamps using </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">data encryption technology; and further restrict the sale, marketing and advertising of cigarettes and other tobacco products.  Such legislation may be subject to constitutional or other challenges on various grounds, which may or may not be successful.  In addition, if the COVID-19 pandemic resurges, state and local governments may reimpose additional health and safety requirements for all businesses, which could result in the potential temporary closure of certain businesses and facilities.  It is possible that tobacco manufacturing and other facilities and the facilities of our suppliers, our suppliers&#8217; suppliers and our trade partners could be subject to additional government-mandated temporary closures and restrictions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is not possible to predict what, if any, additional legislation, regulation or other governmental action will be enacted or implemented (and, if challenged, upheld) relating to the manufacturing, design, packaging, marketing, advertising, sale or use of tobacco products, or the tobacco industry generally.  Any such legislation, regulation or other governmental action could have a material adverse impact on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Governmental Investigations: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are subject to governmental investigations on a range of matters.&#160; For example: (i) the FTC issued a Civil Investigative Demand (&#8220;CID&#8221;) to us while conducting its antitrust review of our investment in JUUL seeking information regarding, among other things, our role in the resignation of JUUL&#8217;s former chief executive officer and the hiring by JUUL of any current or former Altria director, executive or employee (see Note 17 for a description of the FTC&#8217;s administrative complaint against us and JUUL); (ii) the SEC commenced an investigation relating to our acquisition, disclosures and accounting</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">controls in connection with the JUUL investment; and (iii) the New York State Office of the Attorney General and the Commonwealth of Massachusetts Office of the Attorney General, separately, issued independent subpoenas to us seeking documents relating to our investment in and provision of services to JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, JUUL is currently under investigation by various federal and state agencies, including the SEC, the FDA and the FTC, and state attorneys general.  Such investigations vary in scope but at least some include JUUL&#8217;s marketing practices, particularly as such practices relate to youth, and we may be asked in the context of those investigations to provide information concerning our investment in JUUL or relating to our marketing of Nu Mark LLC e-vapor products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, JUUL and 33 states and Puerto Rico finalized a settlement regarding an investigation of JUUL&#8217;s marketing practices.  Pursuant to the settlement, JUUL will pay approximately $440 million to the states and territory over a period of six to 10 years and refrain from certain marketing practices.  As of February 23, 2023, one state has opted out of the multistate settlement in objection to certain conditions.  We remain a party to lawsuits initiated by the attorneys general of Alaska, Hawaii, Minnesota and New Mexico.  JUUL is also named in other attorneys general lawsuits in which we currently are not named.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Private Sector Activity on Tobacco Products</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A number of retailers, including national chains, have discontinued the sale of all tobacco products, and others have discontinued the sale of e-vapor products.  Reasons for the discontinuation include change in corporate policy and, with respect to e-vapor products, reported illnesses and the uncertain regulatory environment.  Furthermore, third-party digital platforms, such as app stores, have restricted, and in some cases prohibited, communications with adult tobacco consumers concerning tobacco products.  It is possible that if this private sector activity becomes more widespread it could have an adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Illicit Trade in Tobacco Products</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Illicit trade in tobacco products can have an adverse impact on our business.  Illicit trade can take many forms, including the sale of counterfeit tobacco products; the sale of tobacco products in the United States that are intended for sale outside the country; the sale of untaxed tobacco products over the Internet and by other means designed to avoid the collection of applicable taxes; and diversion into one taxing jurisdiction of tobacco products intended for sale in another.  Counterfeit tobacco products, for example, are manufactured by unknown third parties in unregulated environments.  Counterfeit versions of our products can negatively affect adult tobacco consumer experiences with and opinions of those brands.  Illicit trade in tobacco products also harms law-abiding wholesalers and retailers by depriving them of lawful sales and undermines the significant investment we have made in legitimate distribution channels.  Moreover, illicit trade in tobacco products results in federal, state and local governments losing tax revenues.  Losses in tax revenues can cause such governments to take various actions, including increasing excise taxes, imposing legislative or regulatory requirements, or asserting claims against manufacturers of tobacco products or members of the trade channels through which such tobacco products are distributed and sold, each of which may have an adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We communicate with wholesale and retail trade members regarding illicit trade in tobacco products and how we can help prevent such activities, enforce wholesale and retail trade programs and policies that address illicit trade in tobacco products and, when necessary, litigate to protect our trademarks.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Price, Availability and Quality of Tobacco, Other Raw Materials, Ingredients and Component Parts</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shifts in crops (such as those driven by economic conditions and adverse weather patterns), government restrictions and mandated prices, production control programs, economic trade sanctions, import duties and tariffs, international trade disruptions, inflation, geopolitical instability, climate and environmental changes and disruptions due to man-made or natural disasters may increase the cost or reduce the supply or quality&#160;of tobacco, other raw materials, ingredients or component parts used to manufacture our operating </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies&#8217; products.  Any significant change in such factors could restrict our ability to continue manufacturing and marketing existing products or impact adult consumer product acceptability and have a material adverse effect on our business and profitability.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As with other agricultural commodities, tobacco price, quality&#160;and availability can be influenced by variations in weather patterns, including those caused by climate change, and macroeconomic conditions and imbalances in supply and demand, among other factors.  For varieties of tobacco only available in limited geographies, government-mandated prices and production control programs, political instability or government prohibitions on the import or export of tobacco in certain countries pose additional risks to price, availability and quality.  In addition, as consumer demand increases for smoke-free products and decreases for combustible products, the volume of tobacco leaf required for production may decrease, resulting in reduced demand.  The reduced demand for tobacco leaf may result in the reduced supply and availability of domestic tobacco as growers divert resources to other crops or cease farming.  The unavailability or unacceptability of any one or more particular varieties of tobacco leaf necessary to manufacture our operating companies&#8217; products could restrict our ability to continue marketing existing products or impact adult tobacco consumer product acceptability, which could result in increased costs to us.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current macroeconomic conditions and geopolitical instability (including high inflation, high gas prices, rising interest rates, labor shortages, supply and demand imbalances and the Russian invasion of Ukraine) are causing worldwide disruptions and delays to supply chains and commercial markets, which limit access to, and increase the cost of, raw materials, ingredients and component parts (for example, tobacco leaf and resins and aluminum used in our packaging).  We are implementing various strategies to help secure sufficient supplies of raw materials, ingredients and component parts for production.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, government taxes, restrictions and prohibitions on the sale and use of certain products may limit access to, and increase the costs of, raw materials and component parts and, potentially, impede our ability to sell certain of our operating companies&#8217; products.  For example, additional taxes on the use of certain single-use plastics have been proposed by the U.S. Congress, which, if passed, could increase the costs of, and impair our ability to, source certain materials used in the packaging for our operating companies&#8217; products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We work to mitigate these risks by maintaining inventory levels of certain tobacco varieties that cover several years, purchasing raw materials, ingredients and component parts from disperse geographic regions throughout the world and entering into long-term contracts with some of our tobacco growers and direct material suppliers.  To date, the impact on us of changes in the price, availability and quality of tobacco, other raw materials, ingredients and component parts has not been material.  However, the effects of the current macroeconomic and geopolitical conditions on prices, availability and quality of such items may continue, which could have a material adverse effect on our business, results of operations, cash flows or financial position.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Timing of Sales</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we are subject to many influences that can impact the timing of sales to customers, including the timing of holidays and other annual or special events, the timing of promotions, customer incentive programs and customer inventory programs, as well as the actual or speculated timing of pricing actions and tax-driven price increases.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_61"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:5pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Operating Results</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Smokeable Products Segment</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes operating results, includes reported and adjusted OCI margins and provides a reconciliation of reported OCI to adjusted OCI for our smokeable products segment:</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Results</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,476</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,289)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,754)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues net of excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18,187</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,688</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NPM Adjustment Items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,726</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,424&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58.8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI margins</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Compared with 2021</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $390 million (1.7%), due primarily to lower shipment volume ($2,506 million), partially offset by higher pricing ($2,083 million), which includes lower promotional investments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI increased $294 million (2.8%), due primarily to higher pricing, which includes lower promotional investments, partially offset by lower shipment volume ($1,525 million), higher costs ($247&#160;million) and higher per unit settlement charges.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI increased $302 million (2.9%), due primarily to higher pricing, which includes lower promotional investments, partially offset by lower shipment volume, higher costs and higher per unit settlement charges.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing, administration and research costs for the smokeable products segment include PM USA&#8217;s cost of administering and litigating product liability claims.  Litigation defense costs are influenced by a number of factors, including the number and types of cases filed, the number of cases tried annually, the results of trials and appeals, the development of the law controlling relevant legal issues, and litigation strategy and tactics.  For further discussion on these matters, see Note 17 and Item 3.  For the years ended December 31, 2022 and 2021, product liability defense costs for PM USA were $133 million and $111 million, respectively.  Product liability defense costs for our smokeable products segment increased primarily due to the increase in trials and related preparation over the previous year.  Cases that were previously postponed as a result of court closures due to the COVID-19 pandemic in 2021 were resumed in 2022 and new cases were filed.  Since regular trial activity has resumed, we expect future product liability defense costs for our smokeable products segment to approximate $150 million, which reflects spending levels similar to 2019.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipment Volume and Retail Share Results</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our smokeable products segment&#8217;s shipment volume performance:</span></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shipment Volume</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(sticks in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigarettes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Marlboro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75,406</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other premium</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,866</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,406</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cigarettes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">84,678</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,793&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigars:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Black &amp; Mild</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,727</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cigars</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,731</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total smokeable products</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">86,409</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,596&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Cigarettes shipment volume includes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">; Other premium brands, such as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Virginia Slims</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Parliament</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Benson &amp; Hedges and Nat&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">; and Discount brands, which include </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">L&amp;M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> Basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Chesterfield.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cigarettes volume includes units sold as well as promotional units but excludes units sold for distribution to Puerto Rico, U.S. Territories to overseas military and by Philip Morris Duty Free Inc., none of which, individually or in the aggregate, is material to our smokeable products segment.</span></div><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cigarettes retail share performance:</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Retail Share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cigarettes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Marlboro</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Other premium</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cigarettes</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Retail share results for cigarettes are based on data from IRI/Management Science Associates, Inc., a tracking service that uses a sample of stores and certain wholesale shipments to project market share and depict share trends.  This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes.  For other trade classes selling cigarettes, retail share is based on shipments from wholesalers to retailers through the Store Tracking Analytical Reporting System (&#8220;STARS&#8221;).  This service is not designed to capture sales through other channels, including the internet, direct mail and some illicitly tax-advantaged outlets.  It is IRI&#8217;s standard practice to periodically refresh its services, which could restate retail share results that were previously released in this service.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of volume trends and factors that impact volume and retail share performance, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco Space - Business Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">above.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Compared with 2021</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our smokeable products segment&#8217;s reported domestic cigarettes shipment volume decreased 9.7%, driven primarily by the industry&#8217;s decline rate and retail share losses (both of which were impacted by macroeconomic pressures on adult tobacco consumers&#8217; disposable income) and calendar differences, partially offset by trade inventory movements.  When adjusted for calendar differences and trade inventory movements, our smokeable products segment&#8217;s reported domestic cigarettes shipment volume decreased by an estimated 9.5%.  When adjusted for trade inventory movements, calendar differences and other factors, total estimated domestic cigarette industry volume decreased by an estimated 8%.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipments of premium cigarettes accounted for 93.6% and 93.0% of our smokeable products segment&#8217;s reported domestic cigarettes shipment volume for 2022 and 2021, respectively.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our smokeable products segment&#8217;s reported cigar shipment volume decreased 4.0%, driven primarily by macroeconomic pressures on adult tobacco consumers&#8217; disposable income, trade inventory movements and other factors.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">retail share of the total cigarette category was 42.5%, a decrease of 0.4 share points, primarily due to increased macroeconomic pressures on adult tobacco consumers&#8217; disposable income and increased competitive activity.  However, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;s share of the premium segment grew to 58.2%, an increase of 0.5 share points.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cigarettes industry discount category retail share increased 1.4 share points to 26.9%, primarily due to increased macroeconomic pressures on adult tobacco consumers&#8217; disposable income and increased competitive activity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion regarding discount category dynamics in 2022 and the economic conditions, including a high inflationary environment, that impact adult tobacco consumer purchasing behavior, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - Business Environment - Summary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pricing Actions</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA and Middleton executed the following pricing and promotional allowance actions during 2022 and 2021:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective October 16, 2022, PM USA increased the list price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">L&amp;M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chesterfield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by $0.15 per pack.  PM USA also increased the list price of all its other cigarette brands by $0.20 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective July 17, 2022, PM USA increased the list price on all of its cigarette brands by $0.15 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective May 22, 2022, Middleton increased various list prices across substantially all of its cigar brands resulting in a weighted-average increase of approximately $0.17 per five-pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective April 24, 2022, PM USA increased the list price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> L&amp;M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Basic </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chesterfield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by $0.15 per pack.  PM USA also increased the list price of all its other cigarette brands by $0.20 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective January 9, 2022, Middleton increased various list prices across substantially all of its cigar brands resulting in a weighted-average increase of approximately $0.13 per five-pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective December 12, 2021, PM USA increased the list price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> L&amp;M </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chesterfield </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by $0.15 per pack.  In addition, PM USA increased the list price of all of its other cigarette brands by $0.20 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective August 15, 2021, PM USA increased the list price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> L&amp;M </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Chesterfield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by $0.14 per pack.  In addition, PM USA increased the list price of all of its other cigarette brands by $0.17 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective January 24, 2021, PM USA increased the list price on all of its cigarette brands by $0.14 per pack.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective January 10, 2021, Middleton increased various list prices across substantially all of its cigar brands resulting in a weighted-average increase of approximately $0.07 per five-pack.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective January 22, 2023, PM USA increased the list price of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">L&amp;M</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chesterfield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by $0.15 per pack.  PM USA also increased the list price of all its other cigarette brands by $0.20 per pack.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Oral Tobacco Products Segment</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Results</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes operating results, includes reported and adjusted OCI margins and provides a reconciliation of reported OCI to adjusted OCI for our oral tobacco products segment:</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Results</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(119)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues net of excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,461</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,632</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment, exit, implementation, acquisition and disposition-related costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,632</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,696&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reported OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted OCI margins </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reported and adjusted OCI margins are calculated as reported and adjusted OCI, respectively, divided by revenues net of excise taxes.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Compared with 2021</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenues, which include excise taxes billed to customers, decreased $28 million (1.1%) due primarily to lower shipment volume and a higher percentage of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on! </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shipment volume relative to MST (&#8220;volume/mix&#8221;) versus 2021 ($104 million), partially offset by higher pricing ($86 million), which includes higher promotional investments in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> on!.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reported OCI decreased $27 million (1.6%), due primarily to lower volume/mix ($116 million) and higher costs ($26 million), partially offset by higher pricing, which includes higher promotional investments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acquisition-related costs in 2021 ($37 million).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted OCI decreased $64 million (3.8%), due primarily to lower volume/mix and higher costs, partially offset by higher pricing, which includes higher promotional investments in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipment Volume and Retail Share Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our oral tobacco products segment&#8217;s shipment volume performance:</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.655%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shipment Volume</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(cans and packs in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Copenhagen</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">470.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Skoal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">179.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">on!</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">800.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">820.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Oral tobacco products shipment volume includes cans and packs sold, as well as promotional units, but excludes international volume, which is currently not material to our oral tobacco products segment.  New types of oral tobacco products, as well as new packaging configurations of existing oral tobacco products, may or may not be equivalent to existing MST products on a can-for-can basis.  To calculate volumes of cans and packs shipped, one pack of snus or one can of oral nicotine pouches, irrespective of the number of pouches in the pack or can, is assumed to be equivalent to one can of MST.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our oral tobacco products segment&#8217;s retail share performance (excluding international volume):</span></div><div style="margin-bottom:1pt;margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Retail Share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Copenhagen</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Skoal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11.3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">on!</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Note: Our oral tobacco products segment&#8217;s retail share results exclude international volume, which is currently not material to our oral tobacco products segment.  Retail share results for oral tobacco products are based on data from IRI InfoScan, a tracking service that uses a sample of stores to project market share and depict share trends.  This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes on the number of cans and packs sold.  Oral tobacco products is defined by IRI as MST, snus and oral nicotine pouches.  New types of oral tobacco products, as well as new packaging configurations of existing oral tobacco products, may or may not be equivalent to existing MST products on a can-for-can basis.  For example, one pack of snus or one can of oral nicotine pouches, irrespective of the number of pouches in the pack or can, is assumed to be equivalent to one can of MST.  Because this service represents retail share performance only in key trade channels, it should not be considered a precise measurement of actual retail share.  It is IRI&#8217;s standard practice to periodically refresh its InfoScan services, which could restate retail share results that were previously released in this service.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of volume trends and factors that impact volume and retail share performance, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco Space - Business Environment </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">above.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2022 Compared with 2021</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our oral tobacco products segment&#8217;s reported domestic shipment volume decreased 2.4%, driven primarily by retail share losses, trade inventory movements and calendar differences, partially offset by the industry&#8217;s growth rate and other factors.  When adjusted for trade inventory movements and calendar differences, our oral tobacco products segment&#8217;s reported domestic shipment volume decreased by an estimated 2%.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total oral tobacco products category industry volume increased by an estimated 1% for the six months ended December 31, 2022, primarily driven by growth in oral nicotine pouches, partially offset by declines in MST volumes (which includes the impact of macroeconomic pressures on adult tobacco consumers&#8217; disposable income).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our oral tobacco products segment&#8217;s retail share was 46.4%, and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> continued to be the leading oral tobacco brand with a retail share of 27.0%.  Share declines for MST products were primarily driven by the share growth of oral nicotine pouches.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. nicotine pouch category grew to 21.9% of the U.S. oral tobacco category, an increase of 6.5 share points versus the prior year.  In addition, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> share of the nicotine pouch category grew to 23.0%, an increase of 6.1 share points versus the prior year.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pricing Actions</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USSTC executed the following pricing actions during 2022 and 2021:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective July 26, 2022, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">popular price products by $0.13 per can.  USSTC also decreased the list price on select </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands by $0.11 per can.  In addition, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands by $0.09 per can and increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $0.12 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective May 24, 2022, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands by $0.09 per can.  USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $0.12 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective February 22, 2022, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands by $0.08 per can.  USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $0.12 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective October 26, 2021, USSTC increased the list price on its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Copenhagen </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands by $0.08 per can.  USSTC also increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $0.12 per can.  In addition, USSTC decreased the price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $0.17 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective June 29, 2021, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blend products by $0.46 per can.  USSTC also increased the list price on its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Red Seal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.05 per can.  In addition, USSTC decreased the price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand by $1.65 per can.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective March 2, 2021, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Blend products by $0.16 per can.  USSTC also increased the list price on its</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Red Seal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands and the balance of its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products by $0.08 per can.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition:</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Effective January 24, 2023, USSTC increased the list price on its </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal, Red Seal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Husky</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brands by $0.09 per can.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_67"></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a holding company that is primarily dependent on the capital resources of our subsidiaries to satisfy our liquidity requirements.  Our access to the operating cash flows of our wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans.  At December&#160;31, 2022, our significant wholly owned subsidiaries were not limited by contractual obligations in their ability to pay cash dividends or make other distributions with respect to their equity interests.  In addition, we receive cash dividends on our interest in ABI and will continue to do so as long as ABI pays dividends.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had $4.0 billion of cash and cash equivalents.  In addition to having access to the operating cash flows of our wholly owned subsidiaries, our capital resources include access to credit markets in the form of commercial paper, availability under our $3.0 billion Credit Agreement (as defined below), which we use for general corporate purposes, and access to credit markets through the issuance of long-term senior unsecured notes.  For additional information, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Markets and Other Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to funding current operations, we primarily use our net cash from operating activities for payment of dividends, share repurchases under our share repurchase programs, repayment of debt, acquisitions of or investments in businesses and assets, and capital expenditures.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our cash and cash equivalents balance, along with our future cash flows from operations, capacity for borrowings under the Credit Agreement and access to credit and capital markets, provide sufficient liquidity to meet the needs of our business operations and to satisfy our projected cash requirements for the next 12 months and the foreseeable future.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Markets and Other Matters</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Ratings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Our cost and terms of financing and our access to commercial paper markets may be impacted by applicable credit ratings.  The impact of credit ratings on the cost of borrowings under the Credit Agreement is discussed in Note 7. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Short-Term Borrowings and Borrowing Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements in Item 8 (&#8220;Note 7&#8221;).</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the credit ratings and outlook for our indebtedness by major credit rating agencies were:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.790%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.790%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Short-term Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outlook</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">P-2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard &amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">A-2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BBB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stable</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fitch Ratings Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">F2</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BBB</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stable</span></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Lines </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- From time to time, we have short-term borrowing needs to meet our working capital requirements arising from the timing of annual MSA payments, quarterly income tax payments and quarterly dividend payments, and generally use our commercial paper program to meet those needs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, we entered into an extension and amendment to our $3.0 billion senior unsecured 5-year revolving credit agreement (as amended, the &#8220;Credit Agreement&#8221;).  At December&#160;31, 2022, we had availability under the Credit Agreement for borrowings of up to an aggregate principal amount of $3.0 billion, and we were in compliance with the covenants in the Credit Agreement.  We expect to continue to meet the covenants in the Credit Agreement.  We monitor the credit quality of our bank group and are not aware of any potential non-performing credit provider in that group.  For further discussion on short-term borrowings, see Note 7.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any commercial paper issued by us and borrowings under the Credit Agreement are guaranteed by PM USA.  For further discussion, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Guarantor Financial Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below and Note 8.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - At December&#160;31, 2022 and 2021, our total debt was $26.7 billion and $28.0 billion, respectively.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, we repaid in full our 2.850% senior unsecured notes in the aggregate principal amount of $1.1 billion at maturity.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our long-term debt outstanding at December&#160;31, 2022 and 2021 was fixed-rate debt.  The weighted-average coupon interest rate on total long-term debt was approximately 4.0% at December&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, we repaid in full our 1.000% senior unsecured Euro notes in the aggregate principal amount of $1.3 billion (&#8364;1.25 billion) at maturity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further details on long-term debt, see Note 8.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Altria and PMI Purchase Agreement; Altria and Japan Tobacco Joint Venture</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">In October 2022, we entered into an agreement with PMI to, among other things, transition and ultimately conclude our relationship with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System in the United States.  We received a payment of $1.0 billion and expect to receive an additional payment of $1.7 billion (plus interest) by July 2023 for a total cash payment of approximately $2.7 billion (plus interest).  We expect to use the cash proceeds for several items, which may include investments in pursuit of our Vision, repayment of debt, share repurchases and general corporate purposes.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">In October 2022, we entered into a joint venture with Japan Tobacco for the U.S. marketing and commercialization of heated tobacco stick products.  We hold a 75% economic interest in Horizon, the joint venture entity, with Japan Tobacco having a 25% economic interest.  We are responsible for making initial capital contributions to Horizon of up to $150 million, as needed by the joint venture to fund operations.  Any additional capital contributions made to Horizon after the initial $150 million will be split according to economic ownership.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of these events, see Item 1, Note 1 and Note 4.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, we filed a registration statement on Form S-3 with the SEC, under which we may offer debt securities or warrants to purchase debt securities from time to time over a three-year period from the date of filing.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements and Other Future Contractual Obligations</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no off-balance sheet arrangements, including special purpose entities, other than guarantees and contractual obligations that are discussed below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- As discussed in Note 17, we had unused letters of credit obtained in the ordinary course of business and guarantees (including third-party guarantees) outstanding at December&#160;31, 2022.  From time to time, we also issue lines of credit to affiliated entities.  In addition, as discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supplemental Guarantor Financial Information</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and in Note 8, PM USA has issued guarantees relating to our obligations under our outstanding debt securities, borrowings under the Credit Agreement and amounts outstanding under the commercial paper program.  These items have not had, and are not expected to have, a significant impact on our liquidity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt and Interest on Borrowings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - In addition to maturities of long-term debt, we make interest payments based on stated coupon interest rates.  For information on annual debt maturities and interest payments, see Note 8.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - we have entered into purchase obligations for inventory and production costs (such as raw materials, indirect materials and services, contract manufacturing, packaging, storage and distribution) and other commitments for projected needs to be </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">used in the normal course of business.  Arrangements are considered purchase obligations if a contract specifies all significant terms, including fixed or minimum quantities to be purchased, a pricing structure and approximate timing of the transaction.  Most arrangements are cancelable without a significant penalty and with short notice (usually 30 days).  At December&#160;31, 2022, purchase obligations for inventory and production costs for the next 12 months were $841 million and $925 million thereafter.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had $598 million of other purchase obligation commitments for marketing, capital expenditures, information technology and professional services, which occur through the ordinary course of business.  Substantially all of these commitments are expected to be satisfied within 12 months.  Accounts payable and accrued liabilities are reflected on our consolidated balance sheet at December&#160;31, 2022 and are excluded from the amounts above.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments Under State Settlement Agreements and FDA Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - As discussed previously and in Note 17, PM USA has entered into State Settlement Agreements with the states, the District of Columbia and certain U.S. territories that call for certain payments.  In addition, PM USA, Middleton and USSTC are subject to quarterly user fees imposed by the FDA as a result of the FSPTCA.  For further discussion of the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the MSA, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Note 17.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on current agreements, estimated market share, estimated annual industry volume decline rates and inflation rates, the estimated amounts that we may charge to cost of sales for payments related to State Settlement Agreements and FDA user fees are $4.0 billion on average for the next three years.  These amounts exclude the potential impact of any NPM Adjustment Items.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated amounts due under the State Settlement Agreements charged to cost of sales in each year are generally paid in April of the following year.  The amounts charged to cost of sales for FDA user fees are generally paid in the quarter in which the fees are incurred.  We paid approximately $4.6 billion and $4.7 billion for the years ended December&#160;31, 2022 and 2021, respectively, in connection with the State Settlement Agreements and FDA user fees, primarily all of which was paid in the second quarter of each period.  As previously stated, the payments due under the terms of the State Settlement Agreements and FDA user fees are subject to adjustment for several factors, including volume, operating income, inflation and certain contingent events and, in general, are allocated based on each manufacturer&#8217;s market share.  The future payment amounts discussed above are estimates, and actual payment amounts will differ to the extent underlying assumptions differ from actual future results.  For further discussion on the potential impact of inflation on future payments, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results by Business Segment - Tobacco Space - State Settlement Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation-Related Deposits and Payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - With respect to certain adverse verdicts currently on appeal, to obtain stays of judgments pending appeals, as of December&#160;31, 2022, PM USA had posted appeal bonds totaling $46 million, which have been collateralized with restricted cash that is included in assets on our consolidated balance sheet.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is subject to uncertainty, and an adverse outcome or settlement of litigation could have a material adverse effect on our results of operations, cash flows or financial position in a particular fiscal quarter or fiscal year, as more fully disclosed in Note 17, Item 3 and Item 1A.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Long-Term Liabilities </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- We had $1.1 billion of accrued postretirement health care costs on our consolidated balance sheet at December&#160;31, 2022 and estimate approximately $100&#160;million of annual payments.  In addition, we had accrued pension obligations, substantially all of which are funded from plan assets.  For further information on our postretirement health care and pension obligations, see Note 15.  We are unable to estimate the timing of payments of other long-term liabilities (accrued postemployment costs, income taxes and tax contingencies, and other accruals) included on our consolidated balance sheet at December&#160;31, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity and Dividends</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 10. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Plans</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements in Item 8, during 2022 we granted an aggregate of 1.2 million restricted stock units and 0.2 million performance stock units to eligible employees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the number of shares to be issued upon vesting of restricted stock units and performance stock units was not significant.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends paid in 2022 and 2021 were approximately $6.6 billion and $6.4 billion, respectively, an increase of 2.4%, reflecting a higher dividend rate, partially offset by fewer shares outstanding as a result of shares we repurchased under our share repurchase program.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, our Board of Directors declared a 4.4% increase in the quarterly dividend rate to $0.94 per share of our common stock versus the previous rate of $0.90 per share.  Our current annualized dividend rate is $3.76 per share.  We maintained our long-term objective of a dividend payout ratio target of approximately 80% of our adjusted diluted EPS.  Future dividend payments remain subject to the discretion of our Board.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our share repurchase programs, see Note 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Capital Stock </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the consolidated financial statements in Item 8 and Part II, Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities in this Form 10-K.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Review</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Provided by/Used in Operating Activities</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, net cash provided by operating activities was $8.3 billion compared with $8.4 billion during 2021.  This decrease was due primarily to the sale of our wine business in October 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had a working capital deficit at December 31, 2022 and 2021.  Our management believes that we have the ability to fund working capital deficits with cash provided by operating activities, borrowings under the Credit Agreement and access to the credit and capital markets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Provided by/Used in Investing Activities</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, net cash provided by investing activities was $0.8 billion compared with $1.2 billion during 2021.  This decrease was due primarily to proceeds from the Ste. Michelle Transaction in 2021, the purchase of certain intellectual property in 2022, lower proceeds from finance asset sales and higher capital expenditures, partially offset by proceeds from the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System commercialization rights in 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital expenditures for 2022 increased 21.3% to $205 million.  Capital expenditures were higher due primarily to increased investing in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> manufacturing capacity, partially offset by the sale of the wine business.  We expect capital expenditures for 2023 to be in the range of $175 million to $225 million, which are expected to be funded from operating cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Provided by/Used in Financing Activities</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, net cash used in financing activities was $9.5 billion compared with $10.0 billion during 2021.  This decrease was due primarily to the following:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">repayment of $1.5 billion in full of our senior unsecured notes at scheduled maturity in May 2021;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">2021 debt tender offers and redemption transactions, which included net proceeds of $5.5 billion from the issuance of long-term senior unsecured notes used to repurchase and redeem $5.0 billion of our senior unsecured notes and payment of $0.6 billion for related premiums and fees; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">purchase of the remaining 20% interest in Helix in 2021;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">partially offset by:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">repayment of $1.1 billion in full of our senior unsecured notes at scheduled maturity in August 2022;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">higher repurchases of common stock in 2022; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">higher dividends paid in 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Guidance Not Yet Adopted</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for a discussion of issued accounting guidance applicable to, but not yet adopted by, us.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 17 and Item 3 for a discussion of contingencies.</span></div><div id="i15062ca98227434086141b426450a5cb_70"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Guarantor Financial Information</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA (the &#8220;Guarantor&#8221;), which is a 100% owned subsidiary of Altria Group, Inc. (the &#8220;Parent&#8221;), has guaranteed the Parent&#8217;s obligations under its outstanding debt securities, borrowings under its Credit Agreement and amounts outstanding under its&#160;commercial paper program (the &#8220;Guarantees&#8221;).  Pursuant to&#160;the Guarantees, the Guarantor fully and unconditionally guarantees, as primary obligor, the payment and performance of the Parent&#8217;s obligations under the guaranteed debt instruments (the &#8220;Obligations&#8221;), subject to release under certain customary circumstances as noted below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Guarantees provide that the Guarantor guarantees the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations.  The liability of the Guarantor under the Guarantees is absolute and unconditional irrespective of: any lack of validity, enforceability or genuineness of any provision of any agreement or instrument relating thereto; any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to departure from any agreement or instrument relating thereto; any exchange, release or non-perfection of any collateral, or any release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Obligations; or any other circumstance that might otherwise constitute a defense available to, or a discharge of, the Parent or the Guarantor.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under applicable provisions of federal bankruptcy law or comparable provisions of state fraudulent transfer law, the Guarantees could be voided, or claims in respect of the Guarantees could be subordinated to the debts of the Guarantor, if, among other things, the Guarantor, at the time it incurred the Obligations evidenced by the Guarantees:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">received less than reasonably equivalent value or fair consideration therefor; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">either:</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">was insolvent or rendered insolvent by reason of such occurrence;</span></div><div style="margin-bottom:3pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">was engaged in a business or transaction for which the assets of the Guarantor constituted unreasonably small capital; or</span></div><div style="margin-bottom:5pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">intended to incur, or believed that it would incur, debts beyond its ability to pay such debts as they mature.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under such circumstances, the payment of amounts by the Guarantor pursuant to the Guarantees could be voided and required to be returned to the Guarantor, or to a fund for the benefit of the Guarantor, as the case may be.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measures of insolvency for purposes of the foregoing considerations will vary depending upon the law applied in any proceeding with respect to the foregoing.  Generally, however, the Guarantor would be considered insolvent if:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the sum of its debts, including contingent liabilities, was greater than the saleable value of its assets, all at a fair valuation;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the present fair saleable value of its assets was less than the amount that would be required to pay its probable liability on its existing debts, including contingent liabilities, as they become absolute and mature; or</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">it could not pay its debts as they become due.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent the Guarantees are voided as a fraudulent conveyance or held unenforceable for any other reason, the holders of the guaranteed debt obligations would not have any claim against the Guarantor and would be creditors solely of the Parent.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations of the Guarantor under the Guarantees are limited to the maximum amount as will not result in the Guarantor&#8217;s obligations under the Guarantees constituting a fraudulent transfer or conveyance, after giving effect to such maximum amount and all other contingent and fixed liabilities of the Guarantor that are relevant under Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to the Guarantees.  For this purpose, &#8220;Bankruptcy Law&#8221; means Title 11, U.S. Code, or any similar federal or state law for the relief of debtors.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Guarantor will be unconditionally released and discharged from the Obligations upon the earliest to occur of:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the date, if any, on which the Guarantor consolidates with or merges into the Parent or any successor;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the date, if any, on which the Parent or any successor consolidates with or merges into the Guarantor;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the payment in full of the Obligations pertaining to such Guarantees; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the rating of the Parent&#8217;s long-term senior unsecured debt by S&amp;P of A or higher.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Parent is a holding company; therefore, its access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  Neither the Guarantor nor other 100% owned subsidiaries of the Parent that are not guarantors of the debt (&#8220;Non-Guarantor Subsidiaries&#8221;) are limited by contractual obligations on their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables include summarized financial information for the Parent and the Guarantor.  Transactions between the Parent and the Guarantor (including investment and intercompany balances as well as equity earnings) have been eliminated.  The Parent&#8217;s and the Guarantor&#8217;s intercompany balances with Non-Guarantor Subsidiaries have been presented separately.  This summarized financial information is not intended to present the financial position or results of operations of the Parent or the Guarantor in accordance with GAAP.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.610%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.610%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Parent</span></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Guarantor</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from Non-Guarantor Subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">278</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,086</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">762</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,086</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,040</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from Non-Guarantor Subsidiaries</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,790</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,090</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,435</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,880</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,435</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to Non-Guarantor Subsidiaries</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,342</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">912</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,925</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,093</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,837</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-current liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,591</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">633</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summarized Statements of Earnings (Losses)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions of dollars)</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.430%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.610%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.610%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Year Ended December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Parent</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="6" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Guarantor</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,418</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,505</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,366)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,487</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the year ended December 31, 2022, net earnings (losses) includes $231 million of intercompany interest income from non-guarantor subsidiaries.</span></div><div style="margin-bottom:5pt;text-align:justify"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_73"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 7A.  Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our long-term debt, all of which is fixed-rate debt, is subject to fluctuations resulting primarily from changes in market interest rates.  The following table provides the fair value of our long-term debt and the change in fair value based on a 1% increase or decrease in market interest rates at December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.195%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.069%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.070%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in billions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in fair value from a 1% increase in market interest rates</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in fair value from a 1% decrease in market interest rates</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect interest rates on borrowings under the Credit Agreement to be based on the Term Secured Overnight Financing Rate, plus a percentage based on the higher of the ratings of our long-term senior unsecured debt from Moody&#8217;s and S&amp;P.  The applicable percentage for borrowings under the Credit Agreement at December&#160;31, 2022 was 1.0% based on our long-term senior unsecured debt ratings on that date.  At December&#160;31, 2022 and 2021, we had no borrowings under the Credit Agreement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_79"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 8.  Financial Statements and Supplementary Data.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">at December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMi0xLTEtMS0xODQ0Njk_4dd29c93-6659-416d-be8e-e21ca64a7044">4,030</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMi0zLTEtMS0xODQ0Njk_5a03821c-c9c3-4b43-ab16-391a3e441d96">4,544</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivable from the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">commercialization rights</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="mo:ReceivableCommercializationRightsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNC0xLTEtMS0xOTQ2MzU_76092c5d-4dc3-46f9-851e-ce99b3ed452e">1,721</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="mo:ReceivableCommercializationRightsCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNC0zLTEtMS0xOTQ2MzU_8c997334-13ef-4121-9b2e-097f851368f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMy0xLTEtMS0xODQ0Njk_5aa4c10a-4afc-4f35-9dfd-6c6bda48c962">48</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:OtherReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMy0zLTEtMS0xODQ0Njk_446475ee-6954-480b-80e1-a4779f90859b">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leaf tobacco</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="mo:InventoryRawMaterialsPlantMaterialNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNS0xLTEtMS0xODQ0Njk_6e80df5a-e318-402b-8308-11a24973bfdf">704</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="mo:InventoryRawMaterialsPlantMaterialNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNS0zLTEtMS0xODQ0Njk_3dc0a2b9-d971-46c1-a810-12f991de6651">744</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="mo:OtherInventoryRawMaterialsNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNi0xLTEtMS0xODQ0Njk_3a56a20d-b182-4f9d-9700-1a884f78f997">186</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="mo:OtherInventoryRawMaterialsNetofReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNi0zLTEtMS0xODQ0Njk_85945d07-f515-4b26-96e1-b5c0d7833644">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNy0xLTEtMS0xODQ0Njk_308cdf1e-81e6-4022-aaf6-e8cd53ae3ab3">24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNy0zLTEtMS0xODQ0Njk_a1a1f16f-778a-40ff-8785-dcb346e6d7b7">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished product</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfOC0xLTEtMS0xODQ0Njk_6e81dbb4-e612-4179-ba54-2095abd6119e">266</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfOC0zLTEtMS0xODQ0Njk_0f86ceeb-d30d-4a69-8908-a4a63bd640d4">261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfOS0xLTEtMS0xODQ0Njk_8dca5cdb-5b1a-4a7d-9f47-2b18895c1214">1,180</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfOS0zLTEtMS0xODQ0Njk_750726b7-fc92-4914-b8da-f41d8cc6868f">1,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTEtMS0xLTEtMTg0NDY5_93bb12b5-9a05-4d72-9556-01d247d9e8df">241</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTEtMy0xLTEtMTg0NDY5_18582a3b-0673-4284-97f1-b5941c9149f9">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTItMS0xLTEtMTg0NDY5_dbe96a98-3017-4a2f-88c7-bd35bc82d9aa">7,220</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTItMy0xLTEtMTg0NDY5_70c0ff44-15f4-4e4d-8f58-dc7e2e2844d2">6,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land and land improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LandAndLandImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTUtMS0xLTEtMTg0NDY5_1366e25b-a1c1-48b6-a4e4-d9f37c29fc84">123</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:LandAndLandImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTUtMy0xLTEtMTg0NDY5_7d312071-af91-4d8e-a4e3-08f41c20eaa3">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and building equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTYtMS0xLTEtMTg0NDY5_16d497d4-c2a4-46a4-8beb-5e86e9792a09">1,478</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTYtMy0xLTEtMTg0NDY5_7d4d4c52-d805-4005-a608-b31eb72f6602">1,422</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTctMS0xLTEtMTg0NDY5_c988ca43-6098-4285-a38d-a68c13c548fe">2,578</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTctMy0xLTEtMTg0NDY5_6447804b-5c20-4b8e-81af-789a8a66d2c3">2,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTgtMS0xLTEtMTg0NDY5_319d2792-a67b-419f-927d-48269d9018c3">248</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTgtMy0xLTEtMTg0NDY5_c4a64401-0ea5-4979-ae24-8b716be126ca">235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTktMS0xLTEtMTg0NDY5_aaed0558-fca7-4189-9467-2b9a7fb8891e">4,427</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTktMy0xLTEtMTg0NDY5_cf26db42-3a38-403d-8910-af4ced4b8c8f">4,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjAtMS0xLTEtMTg0NDY5_232f6348-8328-421c-9d24-b682de8db873">2,819</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjAtMy0xLTEtMTg0NDY5_ceb2eb3c-fbcc-44c0-a667-d99fb2334eb6">2,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjEtMS0xLTEtMTg0NDY5_53d66632-c49b-4f47-b78e-f5e018b97a1b">1,608</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjEtMy0xLTEtMTg0NDY5_dc398929-18f6-485d-b31e-4563bf591571">1,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjMtMS0xLTEtMTg0NDY5_2750a417-252f-4838-97b9-b7098f32b86a">5,177</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjMtMy0xLTEtMTg0NDY5_7e149b6d-42c2-4efa-89b7-5b12bfa27955">5,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjQtMS0xLTEtMTg0NDY5_fcb04a37-6354-4aa5-a8ea-9d5df72d0355">12,384</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjQtMy0xLTEtMTg0NDY5_4b0f276e-ef1f-43df-98c1-12d4fdbf8f3b">12,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity securities ($<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjUtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246ODEzZjNkNGQ4ZTIwNDE1YjkyODAzZmY1Mjg5ODljY2RfMzg_cf04c5fc-2812-4d85-a10b-129ce9fd1a30">250</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjUtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246ODEzZjNkNGQ4ZTIwNDE1YjkyODAzZmY1Mjg5ODljY2RfNDU_9114896e-8adc-4d27-bdfd-2f5f51c80a4f">1,720</ix:nonFraction>&#160;million at December&#160;31, 2022 and 2021, respectively, measured at fair value)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjUtMS0xLTEtMTg0NDY5_692586f1-2392-4974-b40e-f0b5651ec552">9,600</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjUtMy0xLTEtMTg0NDY5_e39c762c-b90f-48bb-8699-4f9dcc882de4">13,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjctMS0xLTEtMTg0NDY5_1f279ede-4e00-4da9-8a9e-7fcd3fedf0a4">965</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjctMy0xLTEtMTg0NDY5_a7fc2c6a-bd33-42d5-a4b8-0532b4d8f04d">923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjgtMS0xLTEtMTg0NDY5_a83faaf2-94ab-4862-8874-49b64cf4863e">36,954</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjgtMy0xLTEtMTg0NDY5_e69a9a07-3128-4b66-873b-f2bda7cbf874">39,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consolidated Balance Sheets (Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(in millions of dollars, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________________________________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">at December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMy0xLTEtMS0xODQ0Njk_a80257db-989b-41ae-81ed-de70da1ecc85">1,556</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMy0zLTEtMS0xODQ0Njk_09a22437-c030-42ec-af70-c12f513a59ac">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfNC0xLTEtMS0xODQ0Njk_5461ffab-a097-4775-ae41-0aec0bef130b">552</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfNC0zLTEtMS0xODQ0Njk_f48adb89-b762-45c1-a6ab-fde419b2a429">449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:AccruedMarketingCostsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfNi0xLTEtMS0xODQ0Njk_8ef068ad-166b-42aa-b579-f0d913f5b14f">599</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:AccruedMarketingCostsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfNi0zLTEtMS0xODQ0Njk_97e088aa-3cd7-427c-8a4f-03e62fe70f33">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="mo:AccruedSettlementLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfOC0xLTEtMS0xODQ0Njk_fa370af7-3ad0-4134-ad1d-92057ec1556d">2,925</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="mo:AccruedSettlementLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfOC0zLTEtMS0xODQ0Njk_06023ef8-cc24-4e9c-920e-6444b21c7ff4">3,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTAtMS0xLTEtMTg0NDY5_53e4ed9d-bb4f-4df6-8b9e-33bb841ba7cc">1,299</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTAtMy0xLTEtMTg0NDY5_3b86114f-8494-428e-898b-ea0dbf4d4734">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTEtMS0xLTEtMTg0NDY5_6d83ba1c-e03a-4884-b354-216a9b6f76b6">1,685</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTEtMy0xLTEtMTg0NDY5_50417e40-18b1-40b7-b12b-8a432ec358c0">1,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTItMS0xLTEtMTg0NDY5_39301fce-94ef-4579-916d-d8fa5a67b26a">8,616</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTItMy0xLTEtMTg0NDY5_25785f53-d1a7-4ef6-acc0-bf3e85f0b2a8">8,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTQtMS0xLTEtMTg0NDY5_f468517e-70f7-4154-9764-424dd722e5a0">25,124</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTQtMy0xLTEtMTg0NDY5_e4cff8d8-c117-4afd-8b14-1575ea8a7f75">26,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTUtMS0xLTEtMTg0NDY5_d6458446-8c0b-43ee-ae62-b17500f32ea1">2,897</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTUtMy0xLTEtMTg0NDY5_3507e538-e28b-4863-ab65-f79c6d3eaea4">3,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pension costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTYtMS0xLTEtMTg0NDY5_e8b793c1-296f-47f1-9eb0-86b40039c1c2">133</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTYtMy0xLTEtMTg0NDY5_46cd652b-3e24-424e-84c5-ab5190227738">200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued postretirement health care costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTctMS0xLTEtMTg0NDY5_bded6877-556c-4c63-b48a-c0936ea3bfee">1,083</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTctMy0xLTEtMTg0NDY5_b014a518-53b7-4566-9040-0a1a19058c9a">1,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred gain from the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">commercialization rights</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="mo:DeferredGainOnSaleOfCommercializationRightsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTktMS0xLTEtMTkwMjk3_90ad16e5-2a69-41aa-bdcf-a48d154b9177">2,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="mo:DeferredGainOnSaleOfCommercializationRightsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTktMy0xLTEtMTkwMjk3_123c6f52-839e-49fc-8648-0d8b09171052">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTgtMS0xLTEtMTg0NDY5_d0df75b3-7c06-4af4-8685-b369149e9e22">324</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTgtMy0xLTEtMTg0NDY5_9dc11e64-db85-4f46-8ab7-abc2fc41cf55">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTktMS0xLTEtMTg0NDY5_5d1b357c-860d-4145-bbc5-85f0f981065e">40,877</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTktMy0xLTEtMTg0NDY5_51949a79-e39c-4d46-b657-3a1d40b6cf53">41,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingencies (Note 17)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjAtMS0xLTEtMTg0NDY5_677282ac-73ad-43b1-9773-ed54534f415e"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjAtMy0xLTEtMTg0NDY5_573c20a2-0c9f-44e5-a65e-b97efc83aba4"></ix:nonFraction></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; Equity (Deficit)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $0.33 1/3&#160;per share</span></div><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjMtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246Yjk5ODRjNmVjYzNhNDc5Yzk1ODZkZTQyZDdjNDE0YWNfNTA_2cae0a38-1ff9-4c0e-ad2e-6694b0fa8a97"><ix:nonFraction unitRef="shares" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjMtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246Yjk5ODRjNmVjYzNhNDc5Yzk1ODZkZTQyZDdjNDE0YWNfNTA_3680ce31-bf29-4b4b-a840-2dd0413f67ce">2,805,961,317</ix:nonFraction></ix:nonFraction> shares issued)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjMtMS0xLTEtMTg0NDY5_f2049d85-3eeb-46b1-a8b6-15684e190881">935</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjMtMy0xLTEtMTg0NDY5_df69c5f7-deec-46bd-b991-49bb2455f52c">935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjQtMS0xLTEtMTg0NDY5_86c8a2d9-414a-446e-8786-a92ad77922e8">5,887</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjQtMy0xLTEtMTg0NDY5_1f94c9ae-1095-4f07-85b6-e107620b5d9b">5,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings reinvested in the business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjUtMS0xLTEtMTg0NDY5_a50775ad-e351-453e-bbd7-87d38f3159eb">29,792</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjUtMy0xLTEtMTg0NDY5_590387d3-6619-4bbd-897b-c6851d0f519e">30,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjYtMS0xLTEtMTg0NDY5_ac0a4801-5a69-4edb-9a7e-0070e71f8327">2,771</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjYtMy0xLTEtMTg0NDY5_14f4dc50-223e-4b36-a922-5d8c099b2abe">3,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of repurchased stock</span></div><div style="text-indent:31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjctMC0xLTEtMTg0NDY5L3RleHRyZWdpb246MmU1NzNlYzhiMmI4NDBlNmJhYzQ2Y2U0ODZjNDY1NWFfMzI_73300a0d-09b4-47af-9133-58d2826d961d">1,020,427,195</ix:nonFraction> shares at December&#160;31, 2022 and </span></div><div style="padding-left:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjctMC0xLTEtMTg0NDY5L3RleHRyZWdpb246MmU1NzNlYzhiMmI4NDBlNmJhYzQ2Y2U0ODZjNDY1NWFfNjg_0d9b3253-91ea-4531-b23d-df2ba793bb7e">982,785,699</ix:nonFraction> shares at December&#160;31, 2021)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjctMS0xLTEtMTg0NDY5_f8bbb507-5997-46f4-a27e-c6af664b5c49">37,816</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjctMy0xLTEtMTg0NDY5_87e06ce6-de0b-4bde-a70a-b7711d994d88">36,006</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity (deficit) attributable to Altria</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjgtMS0xLTEtMTg0NDY5_cee8c2bc-d1c3-4424-a714-d5e2571433a5">3,973</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjgtMy0xLTEtMTg0NDY5_f6fa8dc2-5cea-4845-9771-8be73e4b2107">1,606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjktMS0xLTEtMTg0NDY5_5fd94f4d-279e-4d4d-afb1-3c319aeb7d17">50</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:MinorityInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjktMy0xLTEtMTg0NDY5_1284f237-e35c-4bfe-b506-bf64e3f3c627">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stockholders&#8217; equity (deficit)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMzAtMS0xLTEtMTg0NDY5_b9e6f204-43e4-4bc4-b841-a4a18007cc15">3,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMzAtMy0xLTEtMTg0NDY5_93342fdd-62cc-4a05-9d50-72c9d73e0f7c">1,606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 25.75pt;text-align:left;text-indent:49.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Liabilities and Stockholders&#8217; Equity (Deficit)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMzEtMS0xLTEtMTg0NDY5_1810cf5c-780e-4041-ba9d-048bca678cb3">36,954</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMzEtMy0xLTEtMTg0NDY5_794bd18e-2853-465a-8ae8-7c02099bd576">39,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_85"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consolidated Statements of Earnings</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(in millions of dollars, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.889%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">for the years ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMS0xLTEtMS0xODQ0Njk_a5a2d936-c4d9-44c5-a732-633bf57a46e9">25,096</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMS0zLTEtMS0xODQ0Njk_449ba8d0-92f9-43e0-a95b-d1f9b6d6b5cb">26,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMS01LTEtMS0xODQ0Njk_3f4920fe-b10f-4ec5-a9d1-21097d64a353">26,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMi0xLTEtMS0xODQ0Njk_4fd0e6e7-e367-47c6-ba09-30cb5ad8b8b1">6,442</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMi0zLTEtMS0xODQ0Njk_7c9589be-4eb7-468f-9f62-c54e981c3316">7,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMi01LTEtMS0xODQ0Njk_37a897a0-da98-4ac3-9ed9-4d2c4515b8f1">7,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes on products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:ExciseTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMy0xLTEtMS0xODQ0Njk_9fc483d0-e9b7-44fd-9e44-a948e6549a20">4,408</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:ExciseTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMy0zLTEtMS0xODQ0Njk_6437f969-df3c-4f75-a03b-0eaebbdd5a45">4,902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:ExciseTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMy01LTEtMS0xODQ0Njk_3300ef51-6acb-42ab-a122-de92911bfebb">5,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNC0xLTEtMS0xODQ0Njk_9bd45dad-67fe-42d4-8588-24ca5aca616a">14,246</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNC0zLTEtMS0xODQ0Njk_91922781-db81-4c95-824c-6e60a89cf09f">13,992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNC01LTEtMS0xODQ0Njk_5f216bf2-257b-4d02-b354-8ba32e2e2716">13,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, administration and research costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:MarketingAdministrationandResearchCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNS0xLTEtMS0xODQ0Njk_ca4a41a1-8c92-4cd0-af09-20636d3848ef">2,327</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:MarketingAdministrationandResearchCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNS0zLTEtMS0xODQ0Njk_1c44816e-22a5-4fdc-b4ce-cdf7d903a291">2,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:MarketingAdministrationandResearchCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNS01LTEtMS0xODQ0Njk_264e7fcf-7226-469f-ab64-3f4c2a1813ef">2,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNy0xLTEtMS0xODQ0Njk_3c6bf41e-a94f-43ac-8ef1-0237e6a8ccc2">11,919</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNy0zLTEtMS0xODQ0Njk_25cbdcde-7e06-458a-85a8-d3e1cf7dbe8a">11,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNy01LTEtMS0xODQ0Njk_64946c67-6181-40f9-b5eb-6ac55b520d65">10,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOC0xLTEtMS0xODQ0Njk_52e1bdf4-3b56-4c99-8ab8-d89c4b98a9cb">1,058</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOC0zLTEtMS0xODQ0Njk_fdf76186-bf4f-4c4b-ab28-5cf7937adb27">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOC01LTEtMS0xODQ0Njk_6d7d152c-18ae-4041-ac16-29ac26aec41d">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOS0xLTEtMS0xODkyNzA_435c66d1-665c-4426-9c1a-63c79f4e1f52">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOS0zLTEtMS0xODkyNzA_acefb7d9-56f8-4bd0-ac33-27f7bbe16b7f">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOS01LTEtMS0xODkyNzA_6b2074c2-287e-4737-bc7a-1819a3063cc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOS0xLTEtMS0xODQ0Njk_1811ac59-50e2-4421-9552-bc107b617d2d">184</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOS0zLTEtMS0xODQ0Njk_e355ccba-c7ca-4f3d-8a0f-04a0e00ddcd1">202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOS01LTEtMS0xODQ0Njk_92503a24-5f00-4349-a63f-00c39ada3b71">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments in equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTEtMS0xLTEtMTg0NDY5_18b25a00-a3f0-41a3-818f-44b5fd183f75">3,641</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTEtMy0xLTEtMTg0NDY5_c685f3da-bb4d-40eb-982e-54bc9ea90b72">5,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTEtNS0xLTEtMTg0NDY5_1fce8b56-6be4-46c7-a864-8ae13f0cf347">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTItMS0xLTEtMTg0NDY5_6ef7a4a3-f799-4549-8cfe-4db30eab9185">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTItMy0xLTEtMTg0NDY5_71e7f76c-87b7-45d2-a20c-2ce3f0610ff4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTItNS0xLTEtMTg0NDY5_3a34c3c3-24ad-4921-835b-2a06c7513432">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Cronos-related financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTMtMS0xLTEtMTg0NDY5_9082c1c0-ed8f-4b39-b532-cae80585a03b">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTMtMy0xLTEtMTg0NDY5_4cde7134-f697-4dc6-9c3d-63dded6cd5ce">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTMtNS0xLTEtMTg0NDY5_ad7c66dc-7ebb-4ecf-b69b-0c46e414cb90">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTUtMS0xLTEtMTg0NDY5_e92b631b-530e-4300-a2da-de4b4e4fbcdf">7,389</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTUtMy0xLTEtMTg0NDY5_1f521b3d-4cdc-4773-a73c-9d6e44662bbb">3,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTUtNS0xLTEtMTg0NDY5_c7b639fc-636f-423c-ae9d-b1aff94b380e">6,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTYtMS0xLTEtMTg0NDY5_a68b4f34-407b-48e7-b940-090e1f24f343">1,625</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTYtMy0xLTEtMTg0NDY5_15550530-6e50-4d0e-b855-a8c10518202a">1,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTYtNS0xLTEtMTg0NDY5_bda699d3-a758-47f3-83dd-7a468a8c277a">2,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTctMS0xLTEtMTg0NDY5_7bcd221b-8ee8-49ee-8acc-554a31e4b46b">5,764</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTctMy0xLTEtMTg0NDY5_e3f1e4e1-06aa-419b-b7f7-2d94d5e73d64">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTctNS0xLTEtMTg0NDY5_2ed83796-58f5-4a5c-925f-abd3b699e481">4,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net losses attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTgtMS0xLTEtMTg0NDY5_750266e5-738d-4aa3-a9cc-26005597fec5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTgtMy0xLTEtMTg0NDY5_3f37f6cc-d881-40cd-9e9b-2e74b7517891">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTgtNS0xLTEtMTg0NDY5_83e5f3e9-b179-4c1d-9bde-84719ef22589">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Altria</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTktMS0xLTEtMTg0NDY5_5ecf8f0b-efc7-47a8-b6e0-0047de0ed1e7">5,764</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTktMy0xLTEtMTg0NDY5_076eb2cb-0e8a-4aee-a0a8-80cdaa8e5494">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTktNS0xLTEtMTg0NDY5_4c82bf54-e122-4662-9dec-bd5f2ede5b23">4,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Per share data:</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted earnings per share attributable to Altria</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMjEtMS0xLTEtMTg0NDY5_254b70a1-6695-49e2-982f-557b1a1efac1"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMjEtMS0xLTEtMTg0NDY5_da841c23-0c88-48b9-93d5-a118115667bb">3.19</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMjEtMy0xLTEtMTg0NDY5_2179852b-704a-4d8d-bd76-03f93dffdda4"><ix:nonFraction unitRef="usdPerShare" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMjEtMy0xLTEtMTg0NDY5_e34b2b8e-715c-4785-ab54-1a245fb6bdd2">1.34</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMjEtNS0xLTEtMTg0NDY5_238a6b8d-52f6-4eed-a7f7-84dfe4e67724"><ix:nonFraction unitRef="usdPerShare" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMjEtNS0xLTEtMTg0NDY5_78c5f4d4-8154-495f-ae0a-02419f38db0c">2.40</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_88"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Earnings</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.610%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.131%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.131%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.136%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">for the years ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMS0yLTEtMS0xODQ0Njk_33abc1c6-cf06-47f4-bfc5-144eaf493707">5,764</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMS00LTEtMS0xODQ0Njk_1daf5888-377e-4439-a52d-6dbd78ddc32f">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMS02LTEtMS0xODQ0Njk_d067e81b-2138-4bba-9368-365887f22c54">4,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit plans</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMy0yLTEtMS0xODQ0Njk_4cab17eb-1358-42a5-9be7-9fb1ad5d4f56">176</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMy00LTEtMS0xODQ0Njk_619d23c5-23a2-4113-9dee-04c5a7ebd01d">808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMy02LTEtMS0xODQ0Njk_7b5428f7-b351-48d5-9a59-71df58585c84">228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNC0yLTEtMS0xODQ0Njk_a558b27e-b253-4b20-af21-9e47eba88fa5">143</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:OciEquityMethodInvestmentAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNC00LTEtMS0xODQ0Njk_e33acdc1-d859-42d9-8854-f52f6e5f9bf2">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OciEquityMethodInvestmentAfterTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNC02LTEtMS0xODQ0Njk_159fff23-fb38-41bb-9efb-cf74b75a5831">1,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation adjustments and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="mo:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNS0yLTEtMS0xODQ0Njk_3fe88c8f-3797-46ef-b73f-112fac963ed3">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNS00LTEtMS0xODQ0Njk_e4ce5ee6-8326-4a5e-9f83-1306fc831d00">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="mo:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNS02LTEtMS0xODQ0Njk_77217325-452a-4cba-8a05-3b70430391db">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:49.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNi0yLTEtMS0xODQ0Njk_501b5538-bd28-4647-8a7e-13515bb50ea5">285</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNi00LTEtMS0xODQ0Njk_079f6bc4-928f-45dc-84a5-1fea584c2ad0">1,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNi02LTEtMS0xODQ0Njk_fea2e4c9-99cc-4ffe-8f5f-d5a812288173">1,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfOC0yLTEtMS0xODQ0Njk_8f920a97-b251-48c3-a212-440a7f636c37">6,049</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfOC00LTEtMS0xODQ0Njk_ef4f9f33-722b-41dc-9075-3fe4f71ec7df">3,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfOC02LTEtMS0xODQ0Njk_02dc4e7d-5131-4eda-ae3b-5633f1b697c7">2,977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive losses attributable to noncontrolling interests</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfOS0yLTEtMS0xODQ0Njk_72323eb1-d967-4bd5-90a1-067af56846f2">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfOS00LTEtMS0xODQ0Njk_3adfbfef-9962-40e0-96d1-915094440d00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfOS02LTEtMS0xODQ0Njk_82584eb3-ce9d-452f-b393-06d0f5e60382">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive earnings attributable to Altria</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMTAtMi0xLTEtMTg0NDY5_a3f03475-b049-4992-a9f0-1d6b235fc694">6,049</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMTAtNC0xLTEtMTg0NDY5_947df3b7-2697-41a8-a83e-d71564b269d5">3,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMTAtNi0xLTEtMTg0NDY5_2dc07857-4c31-4726-ad96-1cb83aa62ff4">2,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_91"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.512%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.512%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.302%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">for the years ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Provided by (Used in) Operating Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMi0zLTEtMS0xODQ0Njk_8427c002-60e6-47c6-8291-3dc81c888f7a">5,764</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMi01LTEtMS0xODQ0Njk_37440407-a580-4f9e-bb85-cb13635dc732">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMi03LTEtMS0xODQ0Njk_c156a371-14b7-4a88-87de-33fc26ea048a">4,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to operating cash flows:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNC0zLTEtMS0xODQ0Njk_fe56591b-8b8e-44ba-b85e-00c120afd44b">226</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNC01LTEtMS0xODQ0Njk_27570a6a-9f41-4df5-ae03-2fb39703f920">244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNC03LTEtMS0xODQ0Njk_fa02c25a-c7cb-40ea-a227-f7592063ad55">257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax provision (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNS0zLTEtMS0xODQ0Njk_38d7bcfe-b0f2-40be-a827-82d25a93e7f1">947</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNS01LTEtMS0xODQ0Njk_fca4ec86-45cb-4d01-aab3-5ef124a95962">1,160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNS03LTEtMS0xODQ0Njk_6da8cc6a-d98b-426a-85ab-96df140103b8">164</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments in equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNi0zLTEtMS0xODQ0Njk_4ef89de2-bdeb-4bf7-af7e-aa065084fbcc">3,641</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNi01LTEtMS0xODQ0Njk_27eee146-a589-46b5-855a-da63fbe760f8">5,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNi03LTEtMS0xODQ0Njk_7795ebcf-b517-4ee8-add9-805b5fdc0973">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends from ABI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfOC0zLTEtMS0xODQ0Njk_e2a51546-6220-4207-82ce-91707c23b677">104</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfOC01LTEtMS0xODQ0Njk_5d4a6557-c633-43c7-a06f-a5a5c92d556d">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfOC03LTEtMS0xODQ0Njk_e12d5dee-c910-41ae-b826-f3b4147adbbd">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Cronos-related financial instruments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTAtMy0xLTEtMTg0NDY5_00dd562b-5514-451c-80da-467136cf5541">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTAtNS0xLTEtMTg0NDY5_f9cd533f-5c51-4e2c-9a74-b400aa36df07">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTAtNy0xLTEtMTg0NDY5_00db4a0d-2529-4d20-bdaf-5fe7e2a2df17">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTEtMy0xLTEtMTg0NDY5_c74ca88a-be85-4f61-a463-50739b1ea748">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTEtNS0xLTEtMTg0NDY5_a77affe2-5428-4a62-ac7a-4b9f809e8f2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTEtNy0xLTEtMTg0NDY5_f2c89389-5237-4563-a101-3697bea920c8">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTQtMy0xLTEtMTg0NDY5_41d38f47-a444-48fd-8c1a-cfb844fb89d3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTQtNS0xLTEtMTg0NDY5_f3280551-3e58-4eb0-bc76-0e44024237e8">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTQtNy0xLTEtMTg0NDY5_8a7b953c-d758-491d-8ea7-b2016bdef6d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash effects of changes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtMy0xLTEtMTg0NDY5_a263de0c-6587-42c8-9396-b995575984e6">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtNS0xLTEtMTg0NDY5_3bf7ef4a-bd0c-4bcc-9072-5628558babb3">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtNy0xLTEtMTg0NDY5_203d2fd6-57a4-4f03-aa3d-ed9e380ed56e">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctMy0xLTEtMTg0NDY5_8deaca41-7c96-4e8c-8385-7e467740c77a">14</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctNS0xLTEtMTg0NDY5_759a87d9-5197-4bf2-9a65-5f2c98ba7823">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctNy0xLTEtMTg0NDY5_2c9b888b-a91a-4bea-9f45-859a4eda9baa">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtMy0xLTEtMTg0NDY5_b171074d-301b-42c8-91ac-1761bf0b46a0">92</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtNS0xLTEtMTg0NDY5_1bfff92b-7dd4-4099-b50a-3f753ee343cc">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtNy0xLTEtMTg0NDY5_e3c8c0cf-ff28-47dd-942f-6deb723d66cc">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktMy0xLTEtMTg0NDY5_8b5b42d2-4b81-456b-8339-13cab0197645">118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktNS0xLTEtMTg0NDY5_4ec58889-7557-43b6-82b5-7dc591b1be87">149</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktNy0xLTEtMTg0NDY5_cdf2c1f2-effa-4703-ad59-804c05c64b84">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtMy0xLTEtMTg0NDY5_355d473f-1333-4c41-ad67-1e1351abf2c5">129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtNS0xLTEtMTg0NDY5_db920e2e-633f-4ad1-8b1a-005b5fce5b06">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtNy0xLTEtMTg0NDY5_fc7e4d1a-9a22-49f0-8d42-310f8fdd2f5e">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued settlement charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="mo:IncreaseDecreaseInSettlementPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtMy0xLTEtMTg0NDY5_69d4bbfd-3c54-4f6f-ac43-def57bedc3b7">424</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="mo:IncreaseDecreaseInSettlementPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtNS0xLTEtMTg0NDY5_9dfffa66-533d-4eff-b94f-6216b81ff55e">215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:IncreaseDecreaseInSettlementPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtNy0xLTEtMTg0NDY5_ad63cc97-ce3c-481c-866d-8a031b1a48df">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension plan contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjItMy0xLTEtMTg0NDY5_e58d1c05-6437-40bb-b9cd-54a9a5e37abe">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjItNS0xLTEtMTg0NDY5_1841aa2c-84dc-4038-99cd-68ea7adc5729">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementBenefitContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjItNy0xLTEtMTg0NDY5_f237bed3-989d-4e41-b879-e9fa29d902b1">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjMtMy0xLTEtMTg0NDY5_cd08c3a4-a87f-4385-80c8-19e8d53a099a">156</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjMtNS0xLTEtMTg0NDY5_c9a38e04-8dbc-45ec-b3a9-34a671e7b47f">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjMtNy0xLTEtMTg0NDY5_adf7359a-db83-48d2-ac7c-03c7828bad25">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtMy0xLTEtMTg0NDY5_3a1de55c-c8c1-4c0e-8b80-3f95381a1678">215</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtNS0xLTEtMTg0NDY5_a9b18782-5660-4b57-b202-a8053be6f4c3">149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtNy0xLTEtMTg0NDY5_c7daf6b9-586d-40ab-8e8a-700555c64c11">712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjUtMy0xLTEtMTg0NDY5_235151e3-6761-4b88-852c-09b73d02a83a">8,256</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjUtNS0xLTEtMTg0NDY5_6588857c-c585-4fd7-98c4-56bf41d8d5f1">8,405</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjUtNy0xLTEtMTg0NDY5_5ca8a1a5-b41d-4c84-9ec5-5eb2358b83bc">8,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Provided by (Used in) Investing Activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjgtMy0xLTEtMTg0NDY5_05b6df41-4a65-4a4a-bd52-5e2dc48a06d7">205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjgtNS0xLTEtMTg0NDY5_39c96bac-73e7-4064-ad55-27bbf8b49ecf">169</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjgtNy0xLTEtMTg0NDY5_2e389c1f-d658-40f9-b751-87a827d938a9">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">commercialization rights</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:ProceedsFromSaleOfCommercializationRights" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzItMy0xLTEtMTk3NDMy_e358d271-aca7-4e86-ab2c-6840ebada3dd">1,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:ProceedsFromSaleOfCommercializationRights" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzItNS0xLTEtMTk3NDMy_c7a95711-62ea-4cf3-8bd5-b68d875f9a79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:ProceedsFromSaleOfCommercializationRights" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzItNy0xLTEtMTk3NDMy_27541130-3795-4608-b9b4-ffbfd8722b87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the Ste. Michelle Transaction, net of cash transferred</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzMtMy0xLTEtMTg0NDY5_c3e11967-89b3-4f89-be50-72ccdd3e8821">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzMtNS0xLTEtMTg0NDY5_5ff4a33e-3600-41b1-a037-84d1b46ade65">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzMtNy0xLTEtMTg0NDY5_255eb8d9-80d4-4fb8-90ac-f5577bd747d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzctMy0xLTEtMTg0NDY5_03c727d0-365f-476e-8bfa-9902b2448336">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzctNS0xLTEtMTg0NDY5_2425416a-6c0d-45e9-bed6-2cf3d1495802">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzctNy0xLTEtMTg0NDY5_17b401e0-f933-4dbb-881b-51a6488f6318">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzgtMy0xLTEtMTg0NDY5_ec67f0d9-9f99-4ccf-b1f3-c7ee5a7200fe">782</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzgtNS0xLTEtMTg0NDY5_be7053a4-ac96-4e53-92d8-267768380611">1,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzgtNy0xLTEtMTg0NDY5_315780e0-ba71-4ee8-9f8c-3169db98c9d1">143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07" footnoteRole="http://www.xbrl.org/2003/role/footnote">2021 amounts reflect changes from operations for Ste. Michelle prior to the Ste. Michelle Transaction.</ix:footnote></span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE4_025e2d0e-4c97-4f92-9795-be87a61ae169" continuedAt="i2189c42386014b7fbf4b80f124b6644e" footnoteRole="http://www.xbrl.org/2003/role/footnote">2020 primarily reflects inventory-related amounts associated with the wine business strategic reset.  For further discussion, see Note 14. </ix:footnote></span><ix:continuation id="i2189c42386014b7fbf4b80f124b6644e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows (Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(in millions of dollars)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.316%"><tr><td style="width:1.0%"></td><td style="width:19.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.313%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">for the years ended December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Provided by (Used in) Financing Activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term borrowings</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMi0zLTEtMS0xODQ0Njk_b9cd78f6-8e6a-49ef-9c24-a6d702e36798">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMi01LTEtMS0xODQ0Njk_01df31d1-4f81-41a0-a331-5f582f97a261">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMi03LTEtMS0xODQ0Njk_e3790886-4b88-4c72-ab57-3eef5ec3b4d7">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of short-term borrowings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMy0zLTEtMS0xODQ0Njk_a9c76c16-f04c-4114-a66f-acb3dcda03f1">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMy01LTEtMS0xODQ0Njk_a2a6f251-2952-4209-9b14-5c83b990410c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMy03LTEtMS0xODQ0Njk_6c38986a-dd23-4987-9553-65f5dbb32903">3,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNC0zLTEtMS0xODQ0Njk_ac0f0b33-25e5-42fe-8786-d51e682fa109">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNC01LTEtMS0xODQ0Njk_c658f146-f002-4928-b373-75a98cd71be5">5,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNC03LTEtMS0xODQ0Njk_edc760fe-4e92-4b7f-988e-00242f999217">1,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt repaid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNS0zLTEtMS0xODQ0Njk_2208db43-715c-4305-b5d0-ef4d60f1be6e">1,105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNS01LTEtMS0xODQ0Njk_7284c921-151f-4127-8e18-8fcd42e225e9">6,542</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNS03LTEtMS0xODQ0Njk_1f741d8c-29a1-4d69-8151-4441bfef72a2">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNi0zLTEtMS0xODQ0Njk_0cc69347-70e6-4f10-b0de-ae347dca11d2">1,825</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNi01LTEtMS0xODQ0Njk_95434be4-7849-44d6-9043-99863b3e2887">1,675</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNi03LTEtMS0xODQ0Njk_65a5d6fa-2d7a-46fc-9231-e3b5cf11c592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid on common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNy0zLTEtMS0xODQ0Njk_4bbcbc4b-c12a-489b-94c0-981cc66723c3">6,599</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNy01LTEtMS0xODQ0Njk_074f62aa-26d3-4ffd-ba0b-30ff02e29e61">6,446</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNy03LTEtMS0xODQ0Njk_04b7ddae-5987-4fa3-9beb-ecd05c3ba20f">6,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums and fees related to early extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTAtMy0xLTEtMTg0NDY5_01e9e7a8-4dec-4592-98cc-1e4e3ca9c12b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTAtNS0xLTEtMTg0NDY5_2ec39768-86d5-4050-89f7-c9fb0be262cb">623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTAtNy0xLTEtMTg0NDY5_226397cd-8c29-401a-89ad-3450cb9f7b5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTEtMy0xLTEtMTg0NDY5_dcc3b456-b23c-4b66-aaa5-3ea6ca170397">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTEtNS0xLTEtMTg0NDY5_cec62865-e01b-47ad-954d-a9ec30a62947">215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTEtNy0xLTEtMTg0NDY5_b5feb5e8-2710-4da5-a50a-6f51c0627733">99</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTItMy0xLTEtMTg0NDY5_0adc7f65-411e-4159-bca9-1edff1f97f18">9,541</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTItNS0xLTEtMTg0NDY5_365477cf-dec6-4ef5-a3ef-b67262e63456">10,029</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTItNy0xLTEtMTg0NDY5_51cee2e3-b8e8-4da2-8687-0a7bcbafeec8">5,396</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTQtMy0xLTEtMTg0NDY5_9f5a6a2b-75f6-4716-b685-ef68a402e827">503</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTQtNS0xLTEtMTg0NDY5_1ca9a718-b2ce-4b7c-91e3-ea81b8f3fe57">412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTQtNy0xLTEtMTg0NDY5_cb61608a-b7f3-4d19-8051-0afe857b6e1c">2,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTUtMy0xLTEtMTg0NDY5_3c80944b-594c-495a-ad77-f54fa2411ef7">4,594</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTUtNS0xLTEtMTg0NDY5_325d35b2-4f94-4c52-9a9c-8ad3c42b245d">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e064b5da194d8bbe29064d490250de_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTUtNy0xLTEtMTg0NDY5_cfedc2c2-b485-477f-b16c-1f806df38371">2,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTYtMy0xLTEtMTg0NDY5_962f8c5b-8ed8-42ad-9fae-2a92b97f8bf2">4,091</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTYtNS0xLTEtMTg0NDY5_fdfb549a-e1a0-4c47-bb27-0a0c0074cf90">4,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTYtNy0xLTEtMTg0NDY5_69fb4229-945f-466b-be17-d7a301e0b764">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTctMy0xLTEtMTg0NDY5_d93e619f-0452-47a0-a526-ae4db9893698">1,119</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTctNS0xLTEtMTg0NDY5_628296ce-a202-4847-b266-d7eaabefc351">1,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTctNy0xLTEtMTg0NDY5_b1ea7a18-35db-4a9b-8118-78766f9adb6a">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTgtMy0xLTEtMTg0NDY5_d4fb2093-c187-466a-9489-f5b2dc7f1406">2,657</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTgtNS0xLTEtMTg0NDY5_ab4b4113-bb7d-470a-9568-bf53fddb960f">2,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTgtNy0xLTEtMTg0NDY5_50e4e48c-872d-41cd-8942-c05b3e3c93d4">2,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred proceeds from the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> System commercialization rights</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:DeferredProceedsFromSaleOfCommercializationRightsNoncash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjItMy0xLTEtMTk1NzMx_93bd9f73-06bf-4dc7-b341-df30cffd1f09">1,700</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:DeferredProceedsFromSaleOfCommercializationRightsNoncash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjItNS0xLTEtMTk1NzM5_9633ed97-2586-4908-891b-01cd0428ff00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:DeferredProceedsFromSaleOfCommercializationRightsNoncash" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjItNy0xLTEtMTk1NzUz_d57fde28-f1cf-46fa-bc49-dcdcba8bd8b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="24" style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following table provides a reconciliation of cash, cash equivalents and restricted cash </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> to the amounts reported on our consolidated balance sheets:</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">at December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjMtMy0xLTEtMTg0NDY5_29c9c59c-26c3-4c7a-9ff5-8465db577728">4,030</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjMtNS0xLTEtMTg0NDY5_533ebe42-9e1a-4f4c-bdb6-e8150cfa0e04">4,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjMtNy0xLTEtMTg0NDY5_9faef349-742c-408c-bee9-cf2235ecdc46">4,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtMy0xLTEtMTg0NDY5_f0409233-b1e7-4ebb-9154-a390febe08d8">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:RestrictedCashCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtNS0xLTEtMTg0NDY5_64fa7aae-ddef-4caf-ba23-40606890a0e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:RestrictedCashCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtNy0xLTEtMTg0NDY5_4ab69433-7e8a-4d7b-97a4-07872742a884">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtMy0xLTEtMTg0NDY5_e5f3aecf-a9ff-4428-9ed2-426d4780cd6c">46</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtNS0xLTEtMTg0NDY5_bd3bb9be-596a-4f1b-b189-0373023ab0e6">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtNy0xLTEtMTg0NDY5_84400522-0293-4106-b980-ec04b03e31f9">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjYtMy0xLTEtMTg0NDY5_13f4d34a-d6de-48b4-8493-ee8ddfbca7b7">4,091</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjYtNS0xLTEtMTg0NDY5_c7d32140-2797-4d58-9385-24891d4686bf">4,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjYtNy0xLTEtMTg0NDY5_ac2e0c06-7b4d-42c0-871a-3505a43ad492">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)  </span><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE0_c105be61-2fc6-4089-a6be-9d171ba7904e" footnoteRole="http://www.xbrl.org/2003/role/footnote"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted cash consisted primarily of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals.  See Note 17.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></ix:footnote></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_94"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders&#8217; Equity (Deficit)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(in millions of dollars, except per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">____________________________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"></td><td style="width:30.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.119%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.406%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.982%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.908%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Attributable to Altria</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Earnings<br/>Reinvested&#160;in<br/>the Business</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of<br/>Repurchased<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity (Deficit) </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccd540c71b2a4978b8805b946441e6f0_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi0xLTEtMS0xODQ0Njk_88df483a-4927-4a97-b96a-118960536c0d">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2289b034d6ab496e9d25b9a4e0e0ffe5_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi0zLTEtMS0xODQ0Njk_94e216f5-ebbc-4751-ae82-52a2912eeb26">5,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b6e92147eea44118dbabf94df471192_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi01LTEtMS0xODQ0Njk_6ae1fc8d-2754-4f6f-927c-d7299a797834">36,539</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia23cc26a813c466694dadfb7e04c27d2_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi03LTEtMS0xODQ0Njk_8d70d714-9830-4ed7-9bd5-405f39c716c8">2,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if73ff79a396f45c7beb9c0f45e3d64d9_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi05LTEtMS0xODQ0Njk_ba83c1e6-8bdc-4de0-962a-6e626ea4570a">34,358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcb2c65901a147d6b22d66ec3bf6e1b2_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi0xMS0xLTEtMTg0NDY5_a845f51e-4159-495c-a464-4e7ce4ae60db">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e064b5da194d8bbe29064d490250de_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi0xMy0xLTEtMTg0NDY5_5d450220-534d-4507-bab9-da70c2d6d585">6,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5aec152bc347058ac199ade9c42ac1_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMy01LTEtMS0xODQ0Njk_8aa6535f-3178-434f-b436-a31a9a1fa42a">4,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4226489807b64beda01803b44b87592c_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMy0xMS0xLTEtMTg0NDY5_6a2e76bf-94c7-4eb0-b1c5-72bbaafcc95f">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMy0xMy0xLTEtMTg0NDY5_60cff785-1dcd-4e80-8b2b-27e4de033b2a">4,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">of deferred income taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNC03LTEtMS0xODQ0Njk_8ac1509d-ea84-4569-b65c-a7dc0c0fe6c0">1,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNC0xMy0xLTEtMTg0NDY5_ea0152dd-c16d-4692-ab33-10c9736b1029">1,477</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock award activity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c616f824f34a2c82770dab642faf1f_D20200101-20201231" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNS0zLTEtMS0xODQ0Njk_3ab9c2e0-bfc6-454c-8c78-4f679ed7a676">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a061535c8074fa4b0e3bb2cb94f27ea_D20200101-20201231" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNS05LTEtMS0xODQ0Njk_650a20a8-1c34-46c0-a7da-f7dc8991885d">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNS0xMy0xLTEtMTg0NDY5_394150e4-83b4-4dd1-8061-d66340bd38e6">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNi0wLTEtMS0xODQ0NjkvdGV4dHJlZ2lvbjpjNDljZDgzNzFjYjQ0YmZjYjU0ODQ4ODU5ZmY3MjhmM18yOQ_834face7-de97-468c-b2cf-febbf36ca621">3.40</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e5aec152bc347058ac199ade9c42ac1_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNi01LTEtMS0xODQ0Njk_65a8cfb8-c5e4-4674-ab1b-a0e89df942a8">6,327</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNi0xMy0xLTEtMTg0NDY5_457b5dbd-8f95-4f71-b717-af9228162ef8">6,327</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i81c616f824f34a2c82770dab642faf1f_D20200101-20201231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0zLTEtMS0xODQ0Njk_0254c52c-e466-47e3-882e-37a450dd94f5">73</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4226489807b64beda01803b44b87592c_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0xMS0xLTEtMTg0NDY5_331d7980-7513-4e9b-9fea-a0de6e28adc7">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0xMy0xLTEtMTg0NDY5_4399e170-9610-4ab2-ba0c-56afb2e2fae0">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd14995a072744498777768ab05c3cf3_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS0xLTEtMS0xODQ0Njk_2c733bad-8051-4f41-a066-e03daff1de89">935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c8b04ab864741d0b17c502256196d58_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS0zLTEtMS0xODQ0Njk_caf4900e-a16c-4159-8fa4-e91b83acf5ba">5,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f4d1ddc9b541ebbe3b22a611ae436f_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS01LTEtMS0xODQ0Njk_1e72fc6a-a8e9-4525-81cc-e50da80717bf">34,679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b30e48366b42559b3e640d996b9125_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS03LTEtMS0xODQ0Njk_95d369df-dfc2-480b-ba2a-2173458fea70">4,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f48333a20ec42c5ab2f1cba314394bd_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS05LTEtMS0xODQ0Njk_f94adba8-bd86-406e-be99-0e0e71b1681d">34,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dc6d82320204c0485ccfc4d8649e44b_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS0xMS0xLTEtMTg0NDY5_a86317c2-96ea-4ff1-accb-130c37d9a524">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS0xMy0xLTEtMTg0NDY5_918f3e8e-6f8e-4a0a-85ef-d709d633ddc2">2,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac019ebefddb4e73825f27700d39c2c3_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTAtNS0xLTEtMTg0NDY5_3bdde52c-a4fe-4e75-94e3-288c63ec1157">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b87a4d656b74f4c891d75c1fd38ce42_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTAtMTEtMS0xLTE4NDQ2OQ_615d2fe3-74eb-4b04-ae83-a9757d48f7f4">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTAtMTMtMS0xLTE4NDQ2OQ_692fe0fe-dfe3-4b60-b48e-5eb8d5cfb469">2,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">of deferred income taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTEtNy0xLTEtMTg0NDY5_95c6b9e6-2ea1-4e27-b700-7a2897a59368">1,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTEtMTMtMS0xLTE4NDQ2OQ_bfb7dec1-22ac-4c7c-96a3-edcf5d863d8d">1,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock award activity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf9654d043934172838e2f4f18b13dc0_D20210101-20211231" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTItMy0xLTEtMTg0NDY5_4fe5d7dd-e3a3-4a03-b1f7-ff9736472cb5">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia49817e15e234846bd0a2a699c3c90b1_D20210101-20211231" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTItOS0xLTEtMTg0NDY5_8d8b89dd-f8fb-4dfb-8ddc-5952e5a892e1">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTItMTMtMS0xLTE4NDQ2OQ_8b5555bc-524c-4570-979c-53ae30386362">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTMtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246MzA2YTAyYTQxN2QxNDk2OTg0ZmNiZTk2NWVlYjA4OWFfMjk_32e4b8f5-dd9e-40c3-826e-0e7f5b86f57b">3.52</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iac019ebefddb4e73825f27700d39c2c3_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTMtNS0xLTEtMTg0NDY5_b0443315-cd29-415d-af99-4b17331a73e1">6,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTMtMTMtMS0xLTE4NDQ2OQ_fc417e1f-b4fb-4e0f-a854-6937a639389a">6,490</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia49817e15e234846bd0a2a699c3c90b1_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTQtOS0xLTEtMTg0NDY5_4718c20f-0801-4c68-808e-ef528a4a10e3">1,675</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTQtMTMtMS0xLTE4NDQ2OQ_6723c36b-76ae-4cd9-8524-f9a6b8350fb9">1,675</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf9654d043934172838e2f4f18b13dc0_D20210101-20211231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMy0xLTEtMTg0NDY5_ac11e58c-b7bb-4b55-b8f3-f2596f262f54">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b87a4d656b74f4c891d75c1fd38ce42_D20210101-20211231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMTEtMS0xLTE4NDQ2OQ_ba3cb69a-974d-4cce-90ea-aa5f5ba144a1">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMTMtMS0xLTE4NDQ2OQ_eaaade6c-00b9-439c-aff9-3fd93d136786">159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3328162568604ac9b6492de3b2e66b8f_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctMS0xLTEtMTg0NDY5_61d43ee1-0aac-45e5-8a49-a155b99d832b">935</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88ba8ee5cfbb4f82a668533be8a45bf1_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctMy0xLTEtMTg0NDY5_d7c6790d-1281-44b2-a4c3-cdded537326b">5,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6e83d605e794462bc2801b8a6ba0c45_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctNS0xLTEtMTg0NDY5_d7460ff1-424c-4fe7-a4e5-dbb864c837b8">30,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i558fc0a3383e478fb5796f93893141cd_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctNy0xLTEtMTg0NDY5_35425641-3fe8-4326-ac6d-406d3e1382fe">3,056</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idde0e21bdbd04b0dbf2b80e3eb14a8df_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctOS0xLTEtMTg0NDY5_73d65258-e8a6-42b0-ab90-3134a32a650e">36,006</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9dfca6be487498bbf8f7ce598fc0b81_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctMTEtMS0xLTE4NDQ2OQ_966a0a85-6db0-4fa7-8786-627ab3a07eb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctMTMtMS0xLTE4NDQ2OQ_ebdb3098-8089-49c1-a7ba-8d359dfbaea5">1,606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9e71d43a1f4444a879c0a8c5f8cf8ef_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTgtNS0xLTEtMTg0NDY5_37bbd49c-caf1-4867-92f6-f987274a15bb">5,764</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fd0a7b22d234c68baa53019ccd50d24_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTgtMTEtMS0xLTE4NDQ2OQ_6d3b9674-89c7-4f4c-bc71-9c8ff7996000">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTgtMTMtMS0xLTE4NDQ2OQ_6074950a-8802-48d1-b46b-994632fa4fa4">5,764</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net </span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">of deferred income taxes</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTktNy0xLTEtMTg0NDY5_b7cc7d36-5cd6-4cc4-854f-b3e0adc7505c">285</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTktMTMtMS0xLTE4NDQ2OQ_cba84793-6b78-47fb-8118-bff9968be9e3">285</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock award activity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d9278cdedf2453987ce2a196adc88b9_D20220101-20221231" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjAtMy0xLTEtMTg0NDY5_e8aa8508-e94d-4260-beca-7c6cc7edd997">30</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idceefaa1a008430bad914f7d71668fdb_D20220101-20221231" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjAtOS0xLTEtMTg0NDY5_bb7c6f9b-2a02-4b2b-a6cb-59b6bae6862f">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjAtMTMtMS0xLTE4NDQ2OQ_a8b5fe16-2735-4675-9c31-698acfb0bf67">45</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjEtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246YWEwM2E4ODlkZTYzNDdiMjlmNzI3Mjg0NWJjZjE5ZjZfMjk_382a573c-ff31-44c6-81aa-23a020bbff48">3.68</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9e71d43a1f4444a879c0a8c5f8cf8ef_D20220101-20221231" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjEtNS0xLTEtMTg0NDY5_a020ed30-6658-481e-a37b-c5550d2e07dd">6,636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjEtMTMtMS0xLTE4NDQ2OQ_db5e7df6-d917-42eb-8bb8-f1d7520f1b99">6,636</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idceefaa1a008430bad914f7d71668fdb_D20220101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjItOS0xLTEtMTg0NDY5_916f2468-ede6-469a-9599-9a9501d294a5">1,825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjItMTMtMS0xLTE4NDQ2OQ_cdffb90d-f16f-4da3-a640-610c04f16b80">1,825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d9278cdedf2453987ce2a196adc88b9_D20220101-20221231" decimals="-6" name="us-gaap:StockholdersEquityOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMy0xLTEtMTg0NDY5_1a7b921c-90d1-46c6-904a-41981274e29a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fd0a7b22d234c68baa53019ccd50d24_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMTEtMS0xLTE4NDQ2OQ_18eb84d4-39c0-48e1-8601-59a98212a535">50</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMTMtMS0xLTE4NDQ2OQ_f5d76cff-b586-4505-b0cb-b9c3feb2b5a7">50</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances, December 31, 2022</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i644b6f768367404baba2e476d5932a0f_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtMS0xLTEtMTg0NDY5_63ff5569-e117-4594-9207-f37e11f85c20">935</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i143a684a9fda4c14af97a0bf149a67f0_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtMy0xLTEtMTg0NDY5_1488b14c-19e9-4ac7-89a0-e80e4b5d3750">5,887</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7503cd4479784edc962d47d00bb62206_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtNS0xLTEtMTg0NDY5_981daa25-867c-46f2-bafd-a5194ddb5169">29,792</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia66edd7cc54a4c8ea258417ee5d6a637_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtNy0xLTEtMTg0NDY5_7f0fd423-7fb5-4f17-9bb0-492bb0efad25">2,771</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05f658ff1f4945fbb64ff38b76d887eb_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtOS0xLTEtMTg0NDY5_fece82f2-0326-4c95-beae-e045c6a0585d">37,816</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab3485d42498436788bd25df431981fc_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtMTEtMS0xLTE4NDQ2OQ_3c85f05a-b22c-4940-9852-3d99595abf25">50</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtMTMtMS0xLTE4NDQ2OQ_a8de201b-9146-42de-bf36-ce4c0ca884c9">3,923</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> <ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a" continuedAt="if659af87e54040b3a6b4f978198326e2" footnoteRole="http://www.xbrl.org/2003/role/footnote">Represents the non-cash contribution made by JTIUH to Horizon in 2022 and the purchase of the remaining noncontrolling interest in Helix ROW and Helix in 2020 and 2021, respectively.  For additional information, see Note 1. </ix:footnote></span><ix:continuation id="if659af87e54040b3a6b4f978198326e2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></ix:continuation></div><div style="margin-top:1pt"><span><br/></span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See notes to consolidated financial statements.</span></div><div style="margin-top:1pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Altria Group, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________________________</span></div><div style="text-align:center"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_100"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 1.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzU3NzI_1c07b84b-3709-4312-ab4d-853e73a76d16" continuedAt="i4e7c5b504ea542aabfe298f063e45c9b" escape="true">Background and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i4e7c5b504ea542aabfe298f063e45c9b"><div style="margin-bottom:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in these notes, the terms &#8220;Altria,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to either (i) Altria Group, Inc. and its consolidated subsidiaries or (ii) Altria Group, Inc. only and not its consolidated subsidiaries, as appropriate in the context.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Background:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At December&#160;31, 2022, our wholly owned subsidiaries included Philip Morris USA Inc. (&#8220;PM USA&#8221;), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (&#8220;Middleton&#8221;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA; UST LLC (&#8220;UST&#8221;), which through its wholly owned subsidiary U.S. Smokeless Tobacco Company LLC (&#8220;USSTC&#8221;), is engaged in the manufacture and sale of moist smokeless tobacco products (&#8220;MST&#8221;) and snus products; and Helix Innovations LLC (&#8220;Helix&#8221;), which operates in the United States and Canada, and Helix Innovations GmbH and its affiliates (&#8220;Helix ROW&#8221;), which operate internationally in the rest-of-world, are engaged in the manufacture and sale of oral nicotine pouches.  Other wholly owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to our domestic tobacco operating companies; Altria Client Services LLC (&#8220;ALCS&#8221;), which provides various support services to our companies in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs; and Philip Morris Capital Corporation (&#8220;PMCC&#8221;), which completed the wind-down of its portfolio of finance assets in 2022 and had <ix:nonFraction unitRef="lease" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="INF" name="mo:NumberOfLeveragedLeasesRemaining" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzQ5NDc4MDIzNDEwMDk_8e5232c8-75eb-445a-bc87-5a0e43e7dafb">no</ix:nonFraction> finance assets remaining at December&#160;31, 2022.  Our access to the operating cash flows of our wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by our subsidiaries.  At December&#160;31, 2022, our significant wholly owned subsidiaries were not limited by contractual obligations in their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, Altria, through PM USA, entered into a joint venture with JTI (US) Holding, Inc. (&#8220;JTIUH&#8221;), a subsidiary of Japan Tobacco Inc., for the U.S. marketing and commercialization of heated tobacco stick (&#8220;HTS&#8221;) products.  The joint venture entity, Horizon Innovations LLC (&#8220;Horizon&#8221;), is structured to exist in perpetuity and is responsible for the U.S. commercialization of HTS products owned by either party.  PM USA holds a <ix:nonFraction unitRef="number" contextRef="i30cb752842ae4f4197b09359b88ea9da_I20221231" decimals="2" name="mo:OwnershipPercentageInConsolidatedSubsidiary" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzIxOTkwMjMyNzAzMjQ_280e8250-e8fc-4647-9ae0-3d56cfd35e3f">75</ix:nonFraction>% economic interest in Horizon, with JTIUH having a <ix:nonFraction unitRef="number" contextRef="i2a0870e6739645619718e0d6168ecf74_I20221231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzIxOTkwMjMyNzAzMzA_0e936921-93f8-4974-a89d-5ba099d095c7">25</ix:nonFraction>% economic interest.  We included the 2022 financial results of Horizon, which were immaterial, in our consolidated financial statements, with the <ix:nonFraction unitRef="number" contextRef="i2a0870e6739645619718e0d6168ecf74_I20221231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzIxOTkwMjMyNzAzNzg_7cdc3fd2-f024-4c04-8dfa-d3eeb376983b">25</ix:nonFraction>% economic interest held by JTIUH reported on our consolidated balance sheet as a noncontrolling interest.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, UST sold its subsidiary, International Wine &amp; Spirits Ltd. (&#8220;IWS&#8221;), which included Ste. Michelle Wine Estates Ltd. (&#8220;Ste. Michelle&#8221;) in an all-cash transaction with a net purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="i215587128d4845cda58b7a9194e94d1e_D20211001-20211031" decimals="-8" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzIyNDc_61e9e5df-d096-435e-bedb-ea0a7c0e9704">1.2</ix:nonFraction> billion and the assumption of certain liabilities of IWS and its subsidiaries (the &#8220;Ste. Michelle Transaction&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020 and April 2021, we purchased the remaining <ix:nonFraction unitRef="number" contextRef="icf697a1cd93741fbb7973dfb45f4da83_D20201201-20210430" decimals="2" name="mo:NoncontrollingInterestRemainingInterestPurchasedByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzQ5NDc4MDIzMzkyODY_9340dc52-efe2-49a6-8872-4195905423a7">20</ix:nonFraction>% interest in (i) Helix ROW and (ii) Helix, respectively.  The total purchase price of the December 2020 and April 2021 transactions was approximately $<ix:nonFraction unitRef="usd" contextRef="i2e549342995d4d82a096798aa533bfa9_D20201201-20210430" decimals="-6" name="us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzI5MTc_40bd90c0-537a-4765-acb0-4cf9cfb4edc4">250</ix:nonFraction> million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had investments in the following equity securities: Anheuser-Busch InBev SA/NV (&#8220;ABI&#8221;); Cronos Group Inc. (&#8220;Cronos&#8221;); and JUUL Labs, Inc. (&#8220;JUUL&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of our investments in equity securities, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Basis of Presentation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzU3NzQ_6824a849-95fd-4737-8ba0-dc2f84e81b73" continuedAt="i3acdd109018642389df3868f88d2d0f6" escape="true">The consolidated financial statements include Altria, as well as our wholly owned and majority-owned subsidiaries.  We account for our investments in equity securities in which we have the ability to exercise significant influence over the operating and financial policies of the investee, including ABI and Cronos, under the equity method of accounting using a one-quarter lag.  We account for our investment in the equity securities of JUUL at fair value.  All intercompany transactions and balances have been eliminated.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3acdd109018642389df3868f88d2d0f6">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the dates of the financial statements and the reported amounts of net revenues and expenses during the reporting periods.  Significant estimates and assumptions include, among other things, pension and benefit plan assumptions, lives and valuation assumptions for goodwill, other intangible assets and investments in equity securities, marketing programs and income taxes.  Actual results could differ from those estimates.</ix:continuation></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain immaterial prior year amounts have been reclassified to conform with the current year&#8217;s presentation.</span></div><div style="margin-bottom:5pt"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzU3NzM_ad2f4bdf-0bd3-4d91-8748-59ba78e6ef42" continuedAt="ic3b9f7b106904133a88e4a769ebf16f6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022, we adopted Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU No. 2020-06&#8221;).  This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.  Our adoption of ASU No. 2020-06 did not have a material impact on our consolidated financial statements.</span></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 2.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTgz_0cf412c3-196c-47e1-96e8-bc46c703e51c" continuedAt="i93a40a15e5bf4db1b3184ffef7997f32" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i93a40a15e5bf4db1b3184ffef7997f32" continuedAt="ia408cdae70c84fff87dc3e8628b332a8"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Cash and Cash Equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTcw_aaf44ec4-da61-4717-96a9-d64700909efc" escape="true">Cash equivalents include demand deposits with banks and all highly liquid investments with original maturities of three months or less.  We record cash equivalents at cost plus accrued interest, which approximates fair value.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Depreciation, Amortization and Impairment Testing:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTgy_1c3b6870-b1a4-43b4-ba42-e8cbb2a221f3" escape="true">We record property, plant and equipment at historical costs and depreciate by the straight-line method over the estimated useful lives of the assets.  We depreciate machinery and equipment over periods up to <ix:nonNumeric contextRef="i0ed594edbe8547ae96593b978a67fa53_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzU3MQ_3846e9c7-a93c-449f-aed8-8e68da31d00b">20</ix:nonNumeric> years, and buildings and building improvements over periods up to <ix:nonNumeric contextRef="i96c87ceef6d7461eba332998e29357b5_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzY0MA_b6883fe4-e3b3-460f-a73c-1c3f1ea0e532">50</ix:nonNumeric> years.  We amortize definite-lived intangible assets over their estimated useful lives up to <ix:nonNumeric contextRef="i81704ddceebb4dfe86a3ec2266b22177_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzczOA_d73351e7-f58a-4a8d-b35f-a5f71a8e4638">25</ix:nonNumeric> years.</ix:nonNumeric></span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjQ1_e7c9c6ac-2358-4ae6-9c43-08362921d360" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying value of the assets may not be fully recoverable.  We perform undiscounted operating cash flow analyses to determine if an impairment exists.  For purposes of recognition and measurement of an impairment for assets held for use, we group assets and liabilities at the lowest level for which cash flows are separately identifiable.  If we determine that an impairment exists, any related impairment loss is calculated based on fair value.  We base impairment losses on assets to be disposed of, if any, on the estimated proceeds to be received, less costs of disposal.  We also review the estimated remaining useful lives of long-lived assets whenever events or changes in business circumstances indicate the lives may have changed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct a required annual review of goodwill and indefinite-lived intangible assets for potential impairment, and more frequently if an event occurs or circumstances change that would require us to perform an interim review.  We have the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit or indefinite-lived intangible asset is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative impairment test.  If necessary, we will perform a single step quantitative impairment test.  Additionally, we have the option to unconditionally bypass the qualitative assessment and perform a single step quantitative assessment.  If the carrying value of a reporting unit that includes goodwill exceeds its fair value, which is determined using discounted cash flows, goodwill is considered impaired.  We measure the amount of impairment loss as the difference between the carrying value and the fair value of a reporting unit; however, the amount of the impairment loss is limited to the total amount of goodwill allocated to a reporting unit.  If the carrying value of an indefinite-lived intangible asset exceeds its fair value, which is determined using discounted cash flows, we consider the intangible asset impaired and reduce the carrying value to fair value in the period identified.</span></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Derivative Financial Instruments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> From time to time, we <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjEy_48bc856b-a793-4d37-aa06-3d6c2b6bcc33" continuedAt="if6df09b0538845e98e546a9745e0f0b4" escape="true">enter into derivatives to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  We use various types of derivative financial instruments, including forward contracts, options and swaps.</ix:nonNumeric></span></div><ix:continuation id="if6df09b0538845e98e546a9745e0f0b4"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record derivative financial instruments at fair value on the consolidated balance sheets as either assets or liabilities.  We designate derivative financial instruments that qualify for hedge accounting as either fair value hedges, cash flow hedges or net investment hedges at the inception of the contracts.  For fair value hedges, we record changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, in the consolidated statements of earnings each period.  For cash flow hedges, we record changes in the fair value of the derivative each period in accumulated other comprehensive earnings (losses) and reclassify changes to the consolidated statements of earnings in the same periods in which operating results are affected by the respective hedged item.  For net investment hedges, we record changes in the fair value of the derivative or foreign currency transaction gains or losses on a nonderivative hedging instrument in accumulated other comprehensive earnings (losses) to offset the change in the value of the net investment being hedged.  Such amounts remain in accumulated other comprehensive earnings (losses) until the complete or substantially complete liquidation of the underlying foreign operations occurs for investments in foreign entities accounted for under the equity method of accounting.  We classify cash flows from hedging instruments in the same manner as the respective hedged item in the consolidated statements of cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To qualify for hedge accounting, the hedging relationship, both at inception of the hedge and on an ongoing basis, is expected to be highly effective at offsetting changes in the fair value of the hedged risk during the period that the hedge is designated.  We formally designate and document, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective, the strategy for undertaking the hedge transaction and method for assessing hedge effectiveness.  Additionally, for qualified hedges of forecasted transactions, if it becomes probable that a forecasted transaction will not occur, we would no longer consider the hedge effective and would record all of the derivative gains and losses in the consolidated statement of earnings in the current period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial instruments that are not designated as hedging instruments or do not qualify for hedge accounting, we record changes in fair value in the consolidated statement of earnings each period.  We do not enter into or hold derivative financial instruments for trading or speculative purposes.</span></div></ix:continuation><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Employee Benefit Plans:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="mo:PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjAz_12759182-1b93-49c4-ba65-813e8307fb14" continuedAt="ia982b3009c48486faa916bf947e1c3bd" escape="true">We provide a range of benefits to certain employees and retired employees, including pension, postretirement health care and postemployment benefits.  We record annual amounts relating to these plans based on calculations specified by GAAP, which include various actuarial assumptions as to discount rates, assumed rates of return on plan assets, mortality, compensation increases, turnover rates and health care cost trend rates.</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="ia408cdae70c84fff87dc3e8628b332a8" continuedAt="i11994d0ecf9d43dabfdc1994867e3459"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia982b3009c48486faa916bf947e1c3bd">We recognize the funded status of our defined benefit pension and other postretirement plans on the consolidated balance sheets and record as a component of other comprehensive earnings (losses), net of deferred income taxes, the gains or losses and prior service costs or credits that have not been recognized as components of net periodic benefit cost (income).  We subsequently amortize the gains or losses and prior service costs or credits recorded as components of other comprehensive earnings (losses) into net periodic benefit cost (income) in future years.</ix:continuation></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Environmental Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:EnvironmentalCostsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTc4_0570c3e7-d107-486f-bd1c-5d899af1bc76" continuedAt="i514762fb219b4abe8b000ad6ebbb39ff" escape="true">We are subject to laws and regulations relating to the protection of the environment.  We provide for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  We adjust such accruals as new information develops or circumstances change.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i514762fb219b4abe8b000ad6ebbb39ff">Compliance with environmental laws and regulations, including the payment of any remediation and compliance costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on our consolidated results of operations, capital expenditures, financial position or cash flows.</ix:continuation>  See Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Fair Value Measurements:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTcx_b4b98c3a-340e-43a6-a459-41bf42a9fc11" continuedAt="i918db56ebb7241e69215c4e21340b197" escape="true">We measure certain assets and liabilities at fair value.  Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  We use a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).  The three levels of inputs used to measure fair value are:</ix:nonNumeric></span></div><ix:continuation id="i918db56ebb7241e69215c4e21340b197"><div style="margin-top:5pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt">Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt">Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Guarantees:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjU5_587397f8-837c-419a-a407-0152665ec6c3" escape="true">We recognize a liability for the fair value of the obligation of qualifying guarantee activities.</ix:nonNumeric>  See Note 17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a further discussion of guarantees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTcy_8f50a011-0406-437b-9fb3-736244ae15c8" continuedAt="i5f6a428be9714c5ca2fb764665094de2" escape="true">Significant judgment is required in determining income tax provisions and in evaluating tax positions.</ix:nonNumeric></span></div><ix:continuation id="i5f6a428be9714c5ca2fb764665094de2" continuedAt="i5482dc2d1d9541fca7d85116031763e0"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine deferred tax assets and liabilities based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.  We record a valuation allowance when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  We determine the realizability of deferred tax assets based on the weight of all available positive and negative evidence.  In reaching this determination, we consider the character of the assets and the possible sources of taxable income of the appropriate character within the available carryback and carryforward periods available under the tax law.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the financial statement benefit for uncertain income tax positions when it is more likely than not, based on the technical merits, that the position will be sustained upon examination by taxing authorities.  The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.  We recognize accrued interest and penalties associated with uncertain tax positions as part of the provision for income taxes in our consolidated statements of earnings.</span></div></ix:continuation><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Inventories:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjA3_c3e890ed-bd9f-4419-8938-13ee4bf2dce3" escape="true">We use the last-in, first-out (&#8220;LIFO&#8221;) method to determine the cost of substantially all our tobacco inventories.  We determine the cost of the remaining inventories using the first-in, first-out (&#8220;FIFO&#8221;) and average cost methods.  We record inventories that are measured using the LIFO method at the lower of cost or market.  We state inventories that are measured using the FIFO and average cost methods at the lower of cost and net realizable value.  It is a generally recognized industry practice to classify leaf tobacco inventories as a current asset although part of such inventories, because of the duration of the curing and aging process, ordinarily would not be used within one year.</ix:nonNumeric>  We determined the cost of approximately <ix:nonFraction unitRef="number" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="2" name="us-gaap:PercentageOfLIFOInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzExMzU3_5a8bed29-4b99-4b60-9625-ee72401a4d4d">79</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="2" name="us-gaap:PercentageOfLIFOInventory" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzExMzY0_e17c5e80-3a00-4fa6-be28-f0d5754d9b0b">81</ix:nonFraction>% of our inventories at December&#160;31, 2022 and 2021, respectively, using the LIFO&#160;method.  The recorded LIFO amounts of our inventories were approximately $<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-8" name="us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzIxOTkwMjMyODQ2MDA_748a5218-befc-43f3-8dc7-c00dace897b0">0.7</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-8" name="us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzExNjQw_efc09cab-cb2f-4787-b58f-c0710fb67005">0.6</ix:nonFraction> billion lower than the current cost of our inventories at December&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Investments in Equity Securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTU3_2b804e20-0570-4666-bfe7-c8b02677d58b" continuedAt="i34dabfe170944e889dd621bc20c3658e" escape="true">Investments in equity securities in which we have the ability to exercise significant influence over the operating and financial policies of the investee are accounted for under the equity method of accounting or the fair value option.  The election of the fair value option is irrevocable and is made on an investment by investment basis.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i34dabfe170944e889dd621bc20c3658e" continuedAt="i6165e643b44f4394aa099336a88d50fd">We elected to account for our investments in ABI and Cronos under the equity method of accounting.  Our share of equity (income) losses and other adjustments associated with these equity investments are included in (income) losses from investments in equity securities in our consolidated statements of earnings.  We report the carrying value for each of our equity investments in ABI and Cronos in investments in equity securities on our consolidated balance sheets.  We report equity method investments accounted for under the equity method of accounting at cost and adjust these investments each period for our share of (income) losses and dividends paid, if any.  We report our share of ABI&#8217;s and Cronos&#8217;s results using a one-quarter lag because results are not available in time for us to record them in the concurrent period.  At the end of each reporting period, we review our equity investments accounted for under the equity method of accounting for impairment by comparing the fair value of each of our investments to their carrying value.  If the carrying value of an </ix:continuation></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i11994d0ecf9d43dabfdc1994867e3459" continuedAt="ifb3a3f8178db4ed1bd5b0284fdeea886"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6165e643b44f4394aa099336a88d50fd" continuedAt="iedf497260e89409d84646f9c7decce00">investment exceeds its fair value and the loss in value is other than temporary, we consider the investment impaired, reduce its carrying value to its fair value and record the impairment in our consolidated statements of earnings in the period identified.  We use certain factors to make this determination including (i) the duration and magnitude of the fair value decline, (ii) the financial condition and near-term prospects of the investee and (iii) our intent and ability to hold our investment until recovery to its carrying value.</ix:continuation></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning September 30, 2022, we account for our investment in JUUL as an investment in an equity security and measure our investment in JUUL at fair value.  Our consolidated statements of earnings include any cash dividends we receive from our investment in JUUL (none received to date) and any changes in the estimated fair value of our investment, which is calculated quarterly.  See <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTk2_50df19c3-afa5-439c-a48c-85a5e0b8f6a6" continuedAt="i4095249c89b24d92af833a4a94024e70" escape="true">Note 5. </ix:nonNumeric></span><ix:continuation id="i4095249c89b24d92af833a4a94024e70" continuedAt="i5ab299f5c40b4f8c9d705104fbe410e2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on how we have historically accounted for our investment in JUUL.</span></ix:continuation></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Litigation Contingencies and Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjYz_8b58fe9b-41da-4706-9e70-d1b21d150368" escape="true">We record provisions in our consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  We expense litigation defense costs as incurred and include these costs in marketing, administration and research costs in our consolidated statements of earnings.</ix:nonNumeric>  See Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Marketing Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="mo:MarketingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTY0_08e942a2-8f81-4b69-88e0-31e9f95466f6" escape="true">Our businesses promote their products with consumer incentives, trade promotions and consumer engagement programs.  These consumer incentive and trade promotion activities, which include discounts, coupons, rebates, in-store display incentives and volume-based incentives, do not create a distinct deliverable and are, therefore, recorded as a reduction of revenues.  We make consumer engagement program payments to third parties.  Our businesses expense these consumer engagement programs, which include event marketing, as incurred, and such expenses are included in marketing, administration and research costs in our consolidated statements of earnings.  For interim reporting purposes, our businesses charge consumer engagement programs and certain consumer incentive expenses to operations as a percentage of sales, based on estimated sales and related expenses for the full year.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjQy_17de309a-fbae-4d60-a578-837eb668476f" continuedAt="i838417f6cbe2418a9efe0e5d4ef19e76" escape="true">Our businesses generate substantially all of their revenue from sales contracts with customers.  While our businesses enter into separate sales contracts with each customer for each product type, all sales contracts are similarly structured.  These contracts create an obligation to transfer product to the customer.  Our businesses satisfy all performance obligations within <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="mo:RevenueContractDuration" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE2NDg5_02774069-1360-44f5-8f6e-c58f0e57cbc9">one year</ix:nonNumeric>; therefore, we expense costs to obtain contracts as incurred and do not disclose unsatisfied performance obligations.  There is no financing component because our businesses expect, at contract inception, that the period between when our businesses transfer product to the customer and when the customer pays for that product will be one year or less.</ix:nonNumeric></span></div><ix:continuation id="i838417f6cbe2418a9efe0e5d4ef19e76" continuedAt="ibc4e9e7c3a844a75b397aaad9ffddb5f"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses define net revenues as revenues, which include excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns (also referred to as returned goods) and sales incentives.  Our businesses exclude from the transaction price sales taxes and value-added taxes imposed at the time of sale.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses recognize revenues from sales contracts with customers upon shipment of goods when control of such products is obtained by the customer.  Our businesses determine that a customer obtains control of the product upon shipment when title of such product and risk of loss transfers to the customer.  Our businesses account for shipping and handling costs as fulfillment costs and such amounts are classified as part of cost of sales in our consolidated statements of earnings.  Our businesses record an allowance for returned goods, based principally on historical volume and return rates, which is included in other accrued liabilities on our consolidated balance sheets.  Our businesses record sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction to revenues (a portion of which is based on amounts estimated as being due to wholesalers, retailers and consumers at the end of a period) based principally on historical volume, utilization and redemption rates.  We include expected payments for sales incentives in accrued marketing liabilities on our consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms vary depending on product type.  Our businesses consider payments received in advance of product shipment as deferred revenue, which we include in other accrued liabilities on our consolidated balance sheets until revenue is recognized.  PM USA receives payment in advance of a customer obtaining control of the product.  USSTC and Helix receive substantially all payments within <ix:nonNumeric contextRef="i1bea3c35eaff4beeba4d616c3283b50d_D20220101-20221231" name="us-gaap:RevenuePerformanceObligationDescriptionOfTiming" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE4ODI1_e0170723-1937-40aa-b7b0-7435be732d03">one business day</ix:nonNumeric> of the customer obtaining control of the product.  We include amounts due from customers in receivables on our consolidated balance sheets.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="ifb3a3f8178db4ed1bd5b0284fdeea886"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">New Accounting Guidance Not Yet Adopted:<ix:continuation id="ic3b9f7b106904133a88e4a769ebf16f6" continuedAt="icbfe9d6e80444086a71f0fd93b81b7f3"> </ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icbfe9d6e80444086a71f0fd93b81b7f3" continuedAt="i786927ac829e4676869d4c800cdefd4a"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTY1_d5c17bf6-34f8-444e-a753-914c85a576f1" continuedAt="if3f9fc5b6cc9412ba3cccdf63037dbd8" escape="true">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, us:</ix:nonNumeric></ix:continuation></span></div><div style="margin-top:5pt"><ix:continuation id="i786927ac829e4676869d4c800cdefd4a"><ix:continuation id="if3f9fc5b6cc9412ba3cccdf63037dbd8"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.585%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Standards</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect on Financial Statements</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2021-08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2022-03 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.</span></td></tr></table></ix:continuation></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_106"></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 3.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0XzM5OTA_1dfcff80-2f1e-4d46-9f8d-ef9c55ea4b0d" continuedAt="ide22a0d0c6b34a43928edd1627e7e5fc" escape="true">Revenues from Contracts with Customers</ix:nonNumeric></span></div><ix:continuation id="ide22a0d0c6b34a43928edd1627e7e5fc"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate net revenues based on product type.  For further discussion, see Note 14. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="mo:CashDiscountsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0XzM5OTI_70abf2fa-d7d1-4980-9206-39aab301ccc6" escape="true">We calculate substantially all cash discounts, offered to customers for prompt payment, as a flat rate per unit based on agreed-upon payment terms.  Prior to the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a percentage of the list price based on historical experience and agreed-upon payment terms.  We record receivables net of the cash discounts on our consolidated balance sheets.</ix:nonNumeric></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="mo:RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0XzYwNDczMTM5NTc5NzM_77b69451-cb8e-4b8e-8c94-ca769722d323" escape="true">We record payments received by our businesses in advance of product shipment as deferred revenue.  These payments are included in other accrued liabilities on our consolidated balance sheets until control of such products is obtained by the customer.</ix:nonNumeric>  Deferred revenue from contracts with customers was $<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0Xzk3MQ_460a7493-9b2d-4408-9a39-26b63c5f40b3">252</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0Xzk3OA_cd19234d-dc56-4b8e-bfa4-bc42273bce62">287</ix:nonFraction> million at December&#160;31, 2022 and 2021, respectively.  When cash is received in advance of product shipment, our companies satisfy their performance obligations within <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:RevenuePerformanceObligationDescriptionOfTiming" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0XzExMjk_b05bd08e-5831-4966-969f-a3ae59b1d824">three days</ix:nonNumeric> of receiving payment.  At December&#160;31, 2022 and 2021, there were no differences between amounts recorded as deferred revenue from contracts with customers and amounts subsequently recognized as revenue.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables (excluding receivable from the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System commercialization rights) were $<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0XzEzMDU_3b9181b5-0607-4853-b15f-99d1ca9295a1">48</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0XzEzMTI_c2e12e29-a270-47b4-a955-de1a6374bda7">47</ix:nonFraction> million at December&#160;31, 2022 and 2021, respectively.  At December&#160;31, 2022 and 2021, there were no expected differences between amounts recorded and subsequently received, and we did not record an allowance for credit losses against these receivables.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibc4e9e7c3a844a75b397aaad9ffddb5f">We record an allowance for returned goods, which is included in other accrued liabilities on our consolidated balance sheets.  It is USSTC&#8217;s policy to accept authorized sales returns from its customers for products that have passed the freshness date printed on product packaging due to the limited shelf life of USSTC&#8217;s MST and snus products.  We record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  We reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on our consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, we do not record an asset for USSTC&#8217;s right to recover goods from customers upon return.</ix:continuation></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales incentives include variable payments related to goods sold by our businesses.  We include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers.  The sales incentives that require significant estimates and judgments are as follows:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Price promotion payments- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make price promotion payments, substantially all of which are made to our retail partners to incent the promotion of certain product offerings in select geographic areas.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Wholesale and retail participation payments-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make payments to our wholesale and retail partners to incent merchandising and sharing of sales data in accordance with our trade agreements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates.  Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions.  Differences between actual and estimated payments are reflected in the period such information becomes available.  These differences, if any, have not had a material impact on our consolidated financial statements.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_112"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 4.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzE4Mzc_17ee6839-c933-4aaf-afb9-a09fb84be059" continuedAt="i6dece6c2a7ba4c29984dc6a28097c105" escape="true">Goodwill and Other Intangible Assets, net</ix:nonNumeric></span></div><ix:continuation id="i6dece6c2a7ba4c29984dc6a28097c105" continuedAt="i4c01e38c7b99431097ec788d2d693fe7"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzE4Mzg_2ffb8bc6-6109-4c84-bba7-b0d457810d50" continuedAt="ia914d8b3265c40d69639f9758b8f2783" escape="true"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other intangible assets, net, were as follows at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.453%"><tr><td style="width:1.0%"></td><td style="width:32.553%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.976%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Intangible Assets, net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0336e8ef9c74d2893d4e7f46f1987b7_I20221231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzItMS0xLTEtMTg0NDY5_3ca4ff25-deca-4966-a20b-a92e6dddd288">99</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e24a8227fd44f78424af2bf9ecc499_I20211231" decimals="-6" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzItMy0xLTEtMTg0NDY5_63d461ac-5484-4e5b-a354-6f538c2b6235">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0336e8ef9c74d2893d4e7f46f1987b7_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzItNS0xLTEtMTg0NDY5_2aa96f11-ad1e-47b0-b6db-5fd726ad6802">2,989</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51e24a8227fd44f78424af2bf9ecc499_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzItNy0xLTEtMTg0NDY5_495e54c1-dca3-44fe-8eca-f42374b09473">3,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products segment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ad331e56c04b3cab6eb6b46acdcb86_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzMtMS0xLTEtMTg0NDY5_4647326b-93e6-4157-a8f2-186c8f3d240e">5,078</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41f6a21a2abb4e77a00a22e833659f20_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzMtMy0xLTEtMTg0NDY5_3b3cbbd7-10a1-43c1-8aff-9d517fb5c3ef">5,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ad331e56c04b3cab6eb6b46acdcb86_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzMtNS0xLTEtMTg0NDY5_e69ef2e9-84f0-46be-8156-edb2e85a613c">9,097</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41f6a21a2abb4e77a00a22e833659f20_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzMtNy0xLTEtMTg0NDY5_133ddcb5-9b6b-4114-b9c2-f484b8fd9e92">9,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1adec0aeb3214850954d7ba42cd20214_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzUtMS0xLTEtMTg0NDY5_e6203799-325b-445d-acc0-0b053ec44548">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if103da14634340edb17c23aba9feeff9_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzUtMy0xLTEtMTg0NDY5_5cb5dba4-1c5a-40e2-a268-c27d0d62616c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1adec0aeb3214850954d7ba42cd20214_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzUtNS0xLTEtMTg0NDY5_230f7a85-7e44-4543-8a0f-15bcdc736747">298</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if103da14634340edb17c23aba9feeff9_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzUtNy0xLTEtMTg0NDY5_4680c839-772d-4f1d-be73-e7a7f9c295a6">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzYtMS0xLTEtMTg0NDY5_081d6d96-614a-4895-affe-4e60a6cae84a">5,177</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzYtMy0xLTEtMTg0NDY5_e3d39ed8-6a88-43dc-990f-75001957b060">5,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzYtNS0xLTEtMTg0NDY5_a7a84347-fc88-40a3-9ee4-7c09c0af387c">12,384</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzYtNy0xLTEtMTg0NDY5_f96de7bb-61e8-4ffa-81f9-b0afb7226e0c">12,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzE4MzA_2ec827e1-1083-4a88-bcde-28d404a9497c" escape="true"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzE4MzE_71b07772-ee72-406c-a855-3ef535199062" escape="true"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consisted of the following at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"></td><td style="width:37.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzItMS0xLTEtMTg0NDY5_dd27d3ff-1296-4357-bc66-c20a7d00bc45">11,443</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzItNS0xLTEtMTg0NDY5_4493de2c-421c-4568-9dfd-86a35b8db789">11,443</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived intangible assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzMtMS0xLTEtMTg0NDY5_f985cf4b-1301-4599-b2de-fc5526e3211d">1,411</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzMtMy0xLTEtMTg0NDY5_c30be89c-e466-4d3f-b7a2-5790200b6319">470</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzMtNS0xLTEtMTg0NDY5_b42ca72a-6869-47ac-9a7d-3ca56de6559f">1,260</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzMtNy0xLTEtMTg0NDY5_fa9e57ef-6792-4503-964d-505516558be3">397</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzQtMS0xLTEtMTg0NDY5_ce83d435-948c-46fb-828e-d53146bee660">12,854</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzQtMy0xLTEtMTg0NDY5_76f3cc2e-6630-44e7-86f7-f684b89b2a04">470</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzQtNS0xLTEtMTg0NDY5_ec415092-71fe-49f0-923d-91c339ee4499">12,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzQtNy0xLTEtMTg0NDY5_7288c231-3cf9-4282-bf14-bdb39640ab23">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, substantially all of our indefinite-lived intangible assets consisted of (i) MST and snus trademarks of $<ix:nonFraction unitRef="usd" contextRef="i8dc9d02e492d4fab82f3ad7bd4624c68_I20221231" decimals="-8" name="us-gaap:IndefiniteLivedTrademarks" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzMxNw_8056c22f-3d31-4893-a993-36b3b88d1b55">8.8</ix:nonFraction> billion, which consists of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and other MST and snus trademarks of $<ix:nonFraction unitRef="usd" contextRef="i02811b1061214e51b307f1e6448ef953_I20221231" decimals="-8" name="us-gaap:IndefiniteLivedTrademarks" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjQ2MjI_874358ec-7fea-424f-aae3-fb36186a89fc">4.0</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="iae418119009f46f9a862f1b8651fc378_I20221231" decimals="-8" name="us-gaap:IndefiniteLivedTrademarks" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjQ2Mzg_19e3b598-cf21-4978-980c-de73700a0c80">3.9</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i52300bd656f4412283014d05ee87427f_I20221231" decimals="-8" name="us-gaap:IndefiniteLivedTrademarks" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjQ2NTQ_d1c66a42-6b80-4ec3-94e3-fee007989939">0.9</ix:nonFraction> billion, respectively, and (ii) cigar trademarks of $<ix:nonFraction unitRef="usd" contextRef="i3ba9462e81d849bdb73a266e0704643e_I20221231" decimals="-8" name="us-gaap:IndefiniteLivedTrademarks" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzM0Mw_b82c8d78-b91c-4071-bf5d-961fa3a826de">2.6</ix:nonFraction> billion from our 2009 acquisition of UST and 2007 acquisition of Middleton, respectively.  Definite-lived intangible assets, which consist primarily of intellectual property, certain cigarette trademarks and customer relationships, are amortized over a weighted-average period of <ix:nonNumeric contextRef="ibbb8b3a48f934c52817757ed302eeb99_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzYyNA_8ac21bcf-340c-4bb8-86cd-28e4607382f5">20</ix:nonNumeric> years.  Pre-tax amortization expense for definite-lived intangible assets during the years ended December&#160;31, 2022, 2021 and 2020, was $<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzczNw_8dd6365e-9fbf-458a-8534-7d17f1ef6e66">73</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzc0MQ_2b6efa80-6c4b-4d45-9dfc-d64dcb59b857">72</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzc0OA_45b97548-1022-4053-a6ee-58ed219c67d7">72</ix:nonFraction> million, respectively.  Annual amortization expense for each of the next five years is estimated to be approximately $<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzg2MA_2d12fe49-2284-4f13-8a53-1441e28f721c"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzg2MA_81a37d60-c844-4d4b-9e69-19869b0649e9"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzg2MA_a7114d03-c6af-4358-9d6a-fe9c3d3d8035"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzg2MA_b82912ed-c034-42db-b5d6-9fd271e9eb3b"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzg2MA_e341d452-50e0-41d7-bca5-f7c2bdd2c1a7">75</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> million, assuming no additional transactions occur that require the amortization of intangible assets.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, ALCS and Altria (solely with respect to certain provisions thereunder) entered into an agreement with Triaga, Inc. (&#8220;Triaga&#8221;), a subsidiary of Philip Morris International Inc. (&#8220;PMI&#8221;), and PMI (solely with respect to certain provisions thereunder), to, among other things, transition and ultimately conclude our relationship with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Tobacco Heating System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System&#8221;) in the United States.  Under the terms of the agreement, Triaga paid ALCS $<ix:nonFraction unitRef="usd" contextRef="i4ba8a2737e194f0f980c2838e67e9215_I20221019" decimals="-8" name="mo:DisposalGroupPurchaseAgreementConsiderationInitialPayment" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjIyODU_48de5e0e-6ab0-40fb-958d-9de7f216c82b">1.0</ix:nonFraction> billion upon entry into the agreement and is obligated to make an additional payment of $<ix:nonFraction unitRef="usd" contextRef="iefb5652827eb457099968460ca178f35_I20230715" decimals="-8" name="mo:DisposalGroupPurchaseAgreementConsiderationAdditionalPayment" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjIzMDM_c2dd6dd2-c8b5-4894-b46d-20ae932eaf4a">1.7</ix:nonFraction> billion (plus interest thereon from the effective date of October 19, 2022 at a per annum rate equal to <ix:nonFraction unitRef="number" contextRef="i4ba8a2737e194f0f980c2838e67e9215_I20221019" decimals="2" name="mo:DisposalGroupPurchaseAgreementEffectiveInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjIzNTE_47929f1b-bae3-445c-8c7c-6d2996f07ace">6</ix:nonFraction>%) to ALCS by July 15, 2023, for a total cash payment of approximately $<ix:nonFraction unitRef="usd" contextRef="i0ad47c9ea90a4f93882e5e207392a44c_D20221019-20230715" decimals="-8" name="mo:ProceedsFromSaleOfRightsUnderAnAgreement" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjIzMTk_a3f0c691-974d-409b-ae0a-28125abe513f">2.7</ix:nonFraction> billion (plus interest).  For the consideration received, ALCS has agreed to assign to Triaga exclusive U.S. commercialization rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System effective April 30, 2024.  PMI will not have access to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand name or other brand assets, as PM USA owns the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark in the United States.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the agreement, we recorded (i) a pre-tax $<ix:nonFraction unitRef="usd" contextRef="i90a31ad6d0834866867bab4c41bfdd29_I20221231" decimals="-8" name="mo:DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjIzMzU_01b6b880-00a3-4eb8-b733-95ffe9781bde">2.7</ix:nonFraction> billion deferred gain, which we expect to recognize in earnings when we relinquish our rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System, (ii) a $<ix:nonFraction unitRef="usd" contextRef="i90a31ad6d0834866867bab4c41bfdd29_I20221231" decimals="-8" name="mo:DisposalGroupReceivable" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjI4MjY_d054d1b8-7af0-40f5-b9b2-29096d5d5d54">1.7</ix:nonFraction> billion receivable and (iii) a $<ix:nonFraction unitRef="usd" contextRef="i90a31ad6d0834866867bab4c41bfdd29_I20221231" decimals="-6" name="mo:DisposalGroupInterestReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjMyMTc_83b2308f-735e-4ea2-8f9a-2b3a850e263f">21</ix:nonFraction> million interest receivable on our consolidated balance sheet at December&#160;31, 2022.  For the year ended December&#160;31, 2022, we recorded $<ix:nonFraction unitRef="usd" contextRef="iea22343d0454457485cd1cc01bcc276c_D20220101-20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjI1OTc_34c0c842-2d4b-45c4-9ddb-d7a3a79d4fb9">21</ix:nonFraction> million of interest income in our consolidated statement of earnings.  For the year ended December 31, 2022, we recorded $<ix:nonFraction unitRef="usd" contextRef="i90a31ad6d0834866867bab4c41bfdd29_I20221231" decimals="-8" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCash" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjQwMzA_80472cec-7254-450c-8299-59158fb40f8e">1.0</ix:nonFraction> billion in cash received upon entry into the agreement.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i4c01e38c7b99431097ec788d2d693fe7"><ix:continuation id="ia914d8b3265c40d69639f9758b8f2783"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in goodwill and net carrying amount of intangible assets were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"></td><td style="width:37.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.831%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Intangible Assets, net</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Intangible Assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzItMS0xLTEtMTg0NDY5_2a8254a1-8ae6-47d0-a36a-6b34f5ac014e">5,177</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzItMy0xLTEtMTg0NDY5_3f65554e-c0ae-4253-b64d-8b4b1f442654">12,306</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzItNS0xLTEtMTg0NDY5_c8959b12-08f4-4968-8800-6230797f6da6">5,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzItNy0xLTEtMTg0NDY5_dc83b06d-26f9-4f2f-9993-11207be20e67">12,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes due to:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.51pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtMS0xLTEtMTk1MzEx_6d8e786f-e2b9-4102-9841-8156b20196b5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtMy0xLTEtMTk1MzEx_4e2fd113-b211-4f22-a7aa-de3e3a851aa3">151</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtNS0xLTEtMTk1MzAz_f2489afd-8da3-487d-ac0e-6caf15a1d5ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtNy0xLTEtMTk1MzAz_a4624d53-bf9d-4fd1-a64f-3c4ecd5ac5e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dispositions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtMS0xLTEtMTg0NDY5_8862d91f-e371-40c8-8da4-e3a9c7d4aee7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtMy0xLTEtMTg0NDY5_a6b05e1b-ee30-4375-8831-e9c4c63300fa">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtNS0xLTEtMTg0NDY5_36a6819d-c066-4e4b-a502-2a27da98d054">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtNy0xLTEtMTg0NDY5_77fd22cc-6df0-4f95-b7eb-60c2c6c6df13">237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzYtMy0xLTEtMTg0NDY5_46c5d545-5051-4775-bac9-2691f4109aca">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzYtNy0xLTEtMTg0NDY5_5691a1cb-3459-4f65-a0f2-e02bb17f311a">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzctMS0xLTEtMTg0NDY5_7db7aa15-b3d7-48f2-befa-2247c6bd8b7a">5,177</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzctMy0xLTEtMTg0NDY5_6892781b-8c73-40f8-b4a3-48df9ce1622c">12,384</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzctNS0xLTEtMTg0NDY5_6fe62b47-09f8-41f4-af77-113ff87bf216">5,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzctNy0xLTEtMTg0NDY5_bc63a171-53a8-48f2-8e6e-8223e39206c6">12,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisitions of certain intellectual property related to other tobacco products, which included a $<ix:nonFraction unitRef="usd" contextRef="i2793c14b7447420e9b9c20617d2dacdb_D20220101-20221231" decimals="-6" name="us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjQ0Njc_25318c24-bfb2-4cf5-8fff-ee3af294e6d1">50</ix:nonFraction> million non-cash contribution made by JTIUH to Horizon.  For additional information regarding Horizon, see Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Dispositions related to the Ste. Michelle Transaction.  See Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021 and 2020, our annual impairment test of goodwill and indefinite-lived intangible assets resulted in <ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzEyNjk_0f7d5d48-f888-44d0-a1cc-6fc035d2fa5f"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzEyNjk_33337c1d-446b-4e77-9531-4709f58d8c37"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzEyNjk_be349370-3d45-4f56-8689-adb881988bb4">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment charges.  At December 31, 2022 and 2021, there were <ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="INF" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzE2Mjk_6c519062-e0ce-45be-8d6b-6d38dab69662"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="INF" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzE2Mjk_9860337d-31b2-4588-962f-d41954a3c979">no</ix:nonFraction></ix:nonFraction> accumulated impairment losses related to goodwill.</span></div></ix:continuation><div id="i15062ca98227434086141b426450a5cb_118"></div><div><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_121"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 5.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:InvestmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzYzNDE_6406efc5-a5a5-4631-902a-cedb493a8bff" continuedAt="i854a08bf0b86433ba34f9160e2cb81a3" escape="true">Investments in Equity Securities</ix:nonNumeric></span></div><ix:continuation id="i854a08bf0b86433ba34f9160e2cb81a3" continuedAt="idb14a7d11cbe48c2a0f5ceec8cec4daa"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:InvestmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzYzNDg_73e294fe-cc64-4563-8cda-b416371e519e" continuedAt="i5109a43cadb14fefa1d93e7edffaf2f5" escape="true"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of our investments consisted of the following at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.981%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzEtMi0xLTEtMTg0NDY5_e821555f-5c37-47de-82c2-97bf3a4bdc1a">8,975</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42e7b2a18fdf46808c830b8cad5d58a5_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzEtNC0xLTEtMTg0NDY5_748944fa-3d77-4de9-aff2-2bc8ced6e8d1">11,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i688c2fcd3b0343b29196c870d74f6b68_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzItMi0xLTEtMTg0NDY5_ab160da5-fd72-4088-9c62-5e7f5c64bc48">250</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c5cabbdfb44d05a0e818aa3c22c4d1_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzItNC0xLTEtMTg0NDY5_4483c9c1-df0d-4d7e-aaab-80f81c73347e">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84433bab48264529a2516c2663b4fc52_I20221231" decimals="-6" name="mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzMtMi0xLTEtMTg0NDY5_71fd0638-9da6-4077-9cd2-426faabdf600">375</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231" decimals="-6" name="mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzMtNC0xLTEtMTg0NDY5_9ab01711-5509-4818-b557-b48d5c0a7186">632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzQtMi0xLTEtMTg0NDY5_72456102-228f-4811-afd4-511d4aba9aa6">9,600</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzQtNC0xLTEtMTg0NDY5_466ca515-8d94-436a-9c72-f23e22ef1724">13,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investment in Cronos at December&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">consisted of our equity method investment in Cronos of $<ix:nonFraction unitRef="usd" contextRef="ia6a4fa4621c7473ba1611dbe6af67745_I20211231" decimals="-6" name="mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNjIxMTc_321082c4-5c27-475a-aee4-663afd62df0b">617</ix:nonFraction> million and also included the Cronos warrant and the Fixed-price Preemptive Rights (collectively, &#8220;Investment in Cronos&#8221;), which were measured at fair value.  We irrevocably abandoned the Cronos warrant on December 15, 2022, and the Fixed-price Preemptive Rights had <ix:nonFraction unitRef="usd" contextRef="i84433bab48264529a2516c2663b4fc52_I20221231" decimals="INF" name="mo:EquityMethodInvestmentsFixedPreemptiveRights" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzQ5NDc4MDIzNTQ4Njk_01b0a533-81cc-486f-b1ca-f834983978ca">no</ix:nonFraction> value at December&#160;31, 2022.  See below for further discussion.</span></div><div style="margin-bottom:5pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Income) losses from investments in equity securities consisted of the following:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.036%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.985%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.985%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.068%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c3587d3f994622b4714f1b3124a4da_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzItMS0xLTEtMTg0NDY5_979bdf4c-d1e7-4660-a721-58639be2f0f2">1,973</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61401757fdc493c83aa67b7620e44d4_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzItMy0xLTEtMTg0NDY5_c57b1ff0-61d4-4418-afbb-22b0dfb03daf">5,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if803b88b013a40dfba8d352c3b38fd7a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzItNS0xLTEtMTg0NDY5_55047ad4-10e5-4006-8812-098b8db9f674">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2f16158f9341fd86284d599cb55729_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzMtMS0xLTEtMTg0NDY5_5d66d4ae-de4c-49c3-9e4b-bfec5919f294">213</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13178e7cbc7c479c89b40c940101986c_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzMtMy0xLTEtMTg0NDY5_105f17fa-0fdc-47cd-998a-cdca34bf3c7a">415</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bf83008070a46eb83178baf67bbaa65_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzMtNS0xLTEtMTg0NDY5_90e6e672-ee04-48d6-849f-adacc1b8c9ee">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments under equity method of accounting</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzQtMS0xLTEtMTg0NDY5_c434aa6b-41ed-405f-ad6d-21ad03358b4f">2,186</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzQtMy0xLTEtMTg0NDY5_0ed9e338-74b2-46d6-ae18-9632943b9a89">5,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzQtNS0xLTEtMTg0NDY5_67087cd9-3a3e-4a8f-9962-995580e92dd6">211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc2bb0b67a1f4be892d628382285683c_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzUtMS0xLTEtMTg0NDY5_8b9f9f9b-4ab9-413b-b879-1385a8773784">1,455</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee0d2b6272e47c2b0125f423877e769_D20210101-20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzUtMy0xLTEtMTg0NDY5_1b170c37-f0be-4432-9544-1aabbc73204e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzUtNS0xLTEtMTg0NDY5_919ad116-7617-4b4c-b6d4-72d0b35ccc7d">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments in equity securities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzYtMS0xLTEtMTg0NDY5_f23a93ef-1369-4101-8249-e2cc92da0fd6">3,641</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzYtMy0xLTEtMTg0NDY5_73335f23-2067-4a28-a8ef-6fc1219d57ca">5,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzYtNS0xLTEtMTg0NDY5_a039af59-c8b2-4ead-866b-e5cc604cc131">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes our share of amounts recorded by our investees and additional adjustments, if required, related to (i) the conversion from international financial reporting standards to GAAP and (ii) adjustments to our investment required under the equity method of accounting.</span></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Investment in JUUL is accounted for as an investment in an equity security measured at fair value.  See below for further discussion.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="idb14a7d11cbe48c2a0f5ceec8cec4daa" continuedAt="i8a4e30558310462baad12840a3639375"><ix:continuation id="i5109a43cadb14fefa1d93e7edffaf2f5"><div style="margin-bottom:5pt;margin-top:8pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investees&#8217; summarized financial data for our equity method investments was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.173%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.785%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.787%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For Altria&#8217;s Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzMtMS0xLTEtMTg0NDY5_808df4ed-3806-409d-aaaa-920ed0184560">57,267</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i662e4fa2b880451fa00f79a419fcb83e_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzMtMy0xLTEtMTg0NDY5_59e11c38-7e10-41e5-bd05-c95723cf40e5">947</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4408f6fff55f4f809ea62c43a15e4c2c_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzMtNS0xLTEtMTg0NDY5_00e284d5-f1a9-4294-8683-42bc3b0c5fb1">52,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3a9cfbb99324bffa0f757ecfa7e5577_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzMtNy0xLTEtMTg0NDY5_f5ff1b14-01b8-4338-ae67-81f9af9ebcf4">1,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8513d61234ef4b449cb9e88035fd6619_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzMtOS0xLTEtMTg0NDY5_93c666f1-4c49-4490-ab39-ce9533239699">48,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a048f874a064a4995997da946ea095e_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzMtMTEtMS0xLTE4NDQ2OQ_a4454b4d-af2c-4772-b2ed-61df4efadb7d">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzQtMS0xLTEtMTg0NDY5_e7f43035-1ea1-4dfc-bd00-7ab6d6b82db2">31,588</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i662e4fa2b880451fa00f79a419fcb83e_D20220101-20221231" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzQtMy0xLTEtMTg0NDY5_d5fd2269-a561-4e5c-8f01-51df60b8eb77">525</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4408f6fff55f4f809ea62c43a15e4c2c_D20210101-20211231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzQtNS0xLTEtMTg0NDY5_39cba526-c003-40cd-a063-5a90d01cc6aa">30,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3a9cfbb99324bffa0f757ecfa7e5577_D20210101-20211231" decimals="-6" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzQtNy0xLTEtMTg0NDY5_88f2ca4e-6756-42c4-a052-a11dd14667d1">757</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8513d61234ef4b449cb9e88035fd6619_D20200101-20201231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzQtOS0xLTEtMTg0NDY5_8e902a84-be44-4b33-b6c5-00fc0abe62d6">28,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7a048f874a064a4995997da946ea095e_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzQtMTEtMS0xLTE4NDQ2OQ_10d6907d-af01-402b-89d9-85d3782acaee">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzUtMS0xLTEtMTg0NDY5_08103ad4-bc71-4428-9442-32d2b7ac1397">7,879</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i662e4fa2b880451fa00f79a419fcb83e_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzUtMy0xLTEtMTg0NDY5_a067a0b0-3678-4d68-bc0d-c975691c7c7c">521</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4408f6fff55f4f809ea62c43a15e4c2c_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzUtNS0xLTEtMTg0NDY5_821441e3-db7d-41d6-80f6-55407bd4307a">7,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3a9cfbb99324bffa0f757ecfa7e5577_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzUtNy0xLTEtMTg0NDY5_9d598b8d-9b3e-4dae-95d0-1826cfccbad0">800</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8513d61234ef4b449cb9e88035fd6619_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzUtOS0xLTEtMTg0NDY5_86971ee4-91c0-4c47-87d4-19331bd28cf3">4,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a048f874a064a4995997da946ea095e_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzUtMTEtMS0xLTE4NDQ2OQ_37fdcd3a-cfd8-41c1-9e0c-f8f2acce58a4">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzYtMS0xLTEtMTg0NDY5_5751850c-1e69-4c0c-ab89-f5d2181e0b00">7,879</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i662e4fa2b880451fa00f79a419fcb83e_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzYtMy0xLTEtMTg0NDY5_22f8e43f-60bd-4c16-bc67-a3fa26534726">521</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4408f6fff55f4f809ea62c43a15e4c2c_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzYtNS0xLTEtMTg0NDY5_cc05433f-6871-4334-b438-aa18ede7e704">7,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3a9cfbb99324bffa0f757ecfa7e5577_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzYtNy0xLTEtMTg0NDY5_cb5422a7-875d-4bb4-bb38-f35d833f4576">800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8513d61234ef4b449cb9e88035fd6619_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzYtOS0xLTEtMTg0NDY5_cd1efc85-c9d0-4022-bf0f-187d52680682">4,266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a048f874a064a4995997da946ea095e_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzYtMTEtMS0xLTE4NDQ2OQ_b53277db-2c58-42c7-b7e4-af8886041e9f">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to equity investments</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzctMS0xLTEtMTg0NDY5_b23c0934-20ee-461d-94b0-3c33616364fb">5,838</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i662e4fa2b880451fa00f79a419fcb83e_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzctMy0xLTEtMTg0NDY5_d5b4e2af-a5af-4e8f-a70c-6c03867b3f6f">520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4408f6fff55f4f809ea62c43a15e4c2c_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzctNS0xLTEtMTg0NDY5_4a13a43f-de83-4ef4-b46d-6b45fa6bdd83">5,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if3a9cfbb99324bffa0f757ecfa7e5577_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzctNy0xLTEtMTg0NDY5_b3316ee5-da3c-4b0d-bca8-683c6250d405">798</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8513d61234ef4b449cb9e88035fd6619_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzctOS0xLTEtMTg0NDY5_3d80e8d3-fdba-44c9-8af3-6163a8eb2d2d">3,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a048f874a064a4995997da946ea095e_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzctMTEtMS0xLTE4NDQ2OQ_ac03ef34-d445-4941-9952-b6749bffed8f">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.457%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.296%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d379f94c904bd4b8baa4f957b160c2_I20220930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzMtMS0xLTEtMTg0NDY5_db736b16-a017-4fc3-80ba-b61cae1e110e">24,164</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0955d3143c4319b611181108536948_I20220930" decimals="-6" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzMtMy0xLTEtMTg0NDY5_9889192a-7101-4c01-818c-d8a3bcf4710f">963</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a3babb09031476eab172eb19f78a4fb_I20210930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzMtNS0xLTEtMTg0NDY5_7bffcbac-fa0e-478b-a544-f7d46556b17f">21,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8367586242540b9911f25a7b7315179_I20210930" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzMtNy0xLTEtMTg0NDY5_bef09d9c-8663-489b-b78f-0d9bae1ae97e">1,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d379f94c904bd4b8baa4f957b160c2_I20220930" decimals="-6" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzQtMS0xLTEtMTg0NDY5_03cd9edb-4c89-4c3a-bcf5-00bbef9d890e">182,087</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0955d3143c4319b611181108536948_I20220930" decimals="-6" name="us-gaap:AssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzQtMy0xLTEtMTg0NDY5_bb63eb7c-15ab-4584-8902-a20bc62305b6">274</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a3babb09031476eab172eb19f78a4fb_I20210930" decimals="-6" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzQtNS0xLTEtMTg0NDY5_615839d0-8465-4761-8939-6642205af6e1">190,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8367586242540b9911f25a7b7315179_I20210930" decimals="-6" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzQtNy0xLTEtMTg0NDY5_ac6c44ea-8ca0-4960-9a79-46a01da18385">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d379f94c904bd4b8baa4f957b160c2_I20220930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzUtMS0xLTEtMTg0NDY5_ee16f764-dda1-4099-a3b8-0df3204aef8c">32,649</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0955d3143c4319b611181108536948_I20220930" decimals="-6" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzUtMy0xLTEtMTg0NDY5_1524d56d-676b-4b77-a3d3-15a6821491f2">38</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a3babb09031476eab172eb19f78a4fb_I20210930" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzUtNS0xLTEtMTg0NDY5_bde933d3-d0ba-452d-9ec5-a3733f804c73">33,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8367586242540b9911f25a7b7315179_I20210930" decimals="-6" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzUtNy0xLTEtMTg0NDY5_d4819fd9-d35a-4e5b-9c8e-b68780fac108">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d379f94c904bd4b8baa4f957b160c2_I20220930" decimals="-6" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzYtMS0xLTEtMTg0NDY5_c6b58e36-5ad8-44d0-a9a7-6108028ca6ab">96,497</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0955d3143c4319b611181108536948_I20220930" decimals="-6" name="us-gaap:LiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzYtMy0xLTEtMTg0NDY5_b655bc5d-44d7-471d-adf0-288c94eb9c4e">8</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a3babb09031476eab172eb19f78a4fb_I20210930" decimals="-6" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzYtNS0xLTEtMTg0NDY5_b90840e7-ac0d-40c4-b081-7b5b28e7a792">105,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8367586242540b9911f25a7b7315179_I20210930" decimals="-6" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzYtNy0xLTEtMTg0NDY5_5a177d47-1448-48ce-a22d-1b04e6b6529e">2,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Preferred Stock</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d379f94c904bd4b8baa4f957b160c2_I20220930" decimals="-6" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzctMS0xLTEtMTg0NDY5_4ecf8943-e796-4082-8769-cff3c94f5cbb">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c0955d3143c4319b611181108536948_I20220930" decimals="-6" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzctMy0xLTEtMTg0NDY5_b4b669f6-a5ad-4bac-862b-7e85015872c7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a3babb09031476eab172eb19f78a4fb_I20210930" decimals="-6" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzctNS0xLTEtMTg0NDY5_a8e2e618-e25b-42fb-95b4-485c6936bc86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8367586242540b9911f25a7b7315179_I20210930" decimals="-6" name="us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzctNy0xLTEtMTg0NDY5_837a8c02-ce1e-4715-8d52-32b06c81c8d0">715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></div></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07d379f94c904bd4b8baa4f957b160c2_I20220930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzgtMS0xLTEtMTg0NDY5_c67eb87b-93ef-45a9-8d61-21baf46b644f">11,778</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c0955d3143c4319b611181108536948_I20220930" decimals="-6" sign="-" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzgtMy0xLTEtMTg0NDY5_05173f22-541b-4d82-bceb-edd174260846">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a3babb09031476eab172eb19f78a4fb_I20210930" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzgtNS0xLTEtMTg0NDY5_192aac7f-4a6e-471d-a725-d7097458ecee">11,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8367586242540b9911f25a7b7315179_I20210930" decimals="-6" sign="-" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzgtNy0xLTEtMTg0NDY5_6fa33686-a3c4-42a4-822c-2e1690ca8791">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reflects a one-quarter lag.  Other Investments reflect summarized financial data of Cronos, as well as JUUL&#8217;s financial data for the periods during which we accounted for our investment in JUUL as an equity method investment under the fair value option.</span></div></ix:continuation><div style="margin-bottom:5pt;margin-top:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in ABI&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had an approximate <ix:nonFraction unitRef="number" contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzE3MDY_fc69816f-5a7d-4d3f-ba1d-1459c5b8ec0b">10.0</ix:nonFraction>% ownership interest in ABI, consisting of <ix:nonFraction unitRef="shares" contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231" decimals="-6" name="mo:EquityMethodInvestmentNumberofSharesOwnedRestricted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzE3NTA_efb2ce62-f3d4-41b0-b30e-e2471f2b6df2">185</ix:nonFraction> million restricted shares of ABI (the &#8220;Restricted Shares&#8221;) and <ix:nonFraction unitRef="shares" contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231" decimals="-6" name="mo:EquityMethodInvestmentNumberofSharesOwnedCommon" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzE4MDg_285473c9-afd2-4c3a-ac2c-5770f7ad37d6">12</ix:nonFraction> million ordinary shares of ABI.  The Restricted Shares:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">are unlisted and not admitted to trading on any stock exchange;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">are convertible by us into ordinary shares of ABI on a one-for-one basis;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">rank equally with ordinary shares of ABI with regards to dividends and voting rights; and</span></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">have director nomination rights with respect to ABI.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of this filing, we have not elected to convert our Restricted Shares into ordinary shares of ABI.</span></div><ix:continuation id="iedf497260e89409d84646f9c7decce00" continuedAt="i052ed0705cd8433486fcc672f6492ebc"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our investment in ABI under the equity method of accounting because we have the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#8217;s board of directors and certain ABI board committees.  Through this representation, we participate in ABI&#8217;s policy making processes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report our share of ABI&#8217;s results using a one-quarter lag because ABI&#8217;s results are not available in time for us to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  We can convert our Restricted Shares to ordinary shares at our discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</span></div></ix:continuation><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the fair value of our equity investment in ABI was $<ix:nonFraction unitRef="usd" contextRef="i0fcfe850ccf04326ba6a9f711efb4237_I20211231" decimals="-8" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzA0MTU_e3f8b302-56f4-4069-8808-7e8e4e1d0d29">11.9</ix:nonFraction> billion (carrying value of $<ix:nonFraction unitRef="usd" contextRef="i0fcfe850ccf04326ba6a9f711efb4237_I20211231" decimals="-8" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzA0MjA_17918a30-0bad-448b-be6d-c0937db40e05">11.1</ix:nonFraction> billion), which exceeded its carrying value by $<ix:nonFraction unitRef="usd" contextRef="i0fcfe850ccf04326ba6a9f711efb4237_I20211231" decimals="-8" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzA0MjQ_b2941b12-c60c-4a91-b818-bd0e4143b45c">0.8</ix:nonFraction> billion or approximately <ix:nonFraction unitRef="number" contextRef="i0fcfe850ccf04326ba6a9f711efb4237_I20211231" decimals="2" sign="-" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzA0MzA_a62bb950-73c6-4e15-b8bb-49a2572b8a62">7</ix:nonFraction>%.  In the second quarter of 2022, the fair value declined below its carrying value and at June 30, 2022, the fair value was below its carrying value by $<ix:nonFraction unitRef="usd" contextRef="i86595736693849e2a2960a25c9d7f520_I20220630" decimals="-8" sign="-" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzA0MzQ_d418836a-18a3-47c0-9a99-46af63b3be3b">1.1</ix:nonFraction> billion or approximately <ix:nonFraction unitRef="number" contextRef="i86595736693849e2a2960a25c9d7f520_I20220630" decimals="2" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzA0NDE_1c22766e-3118-4ce5-b75f-9b9459267816">9</ix:nonFraction>%.  We concluded that the decline in fair value below its carrying value was temporary and, therefore, we did not record an impairment charge at that time.  At September 30, 2022, the fair value of our equity investment in ABI of $<ix:nonFraction unitRef="usd" contextRef="i4a59e8c2438f4b0990202ed160b66f3a_I20220930" decimals="-8" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODQ2NTY_c4318663-4ccd-433d-a7b2-2b3710b70565">9.0</ix:nonFraction> billion was below its carrying value by $<ix:nonFraction unitRef="usd" contextRef="i4a59e8c2438f4b0990202ed160b66f3a_I20220930" decimals="-8" sign="-" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODQ2Nzk_8886b179-6901-4b9f-b3df-414689c70306">2.5</ix:nonFraction> billion or approximately <ix:nonFraction unitRef="number" contextRef="i2482b7e244ca46d9be57870d2ee0a5b1_I20220930" decimals="2" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODQ2NzM_5ded68e1-22b4-4022-92ec-4d0a01a39159">22</ix:nonFraction>%.  We concluded that the decline in fair value at September 30, 2022 was other than temporary as we anticipated that the full recovery to the carrying value would take longer than previously expected.  In reaching this conclusion, we evaluated the factors related to the fair value decline, including the macroeconomic and geopolitical factors that have significantly impacted certain foreign exchange rates and global equity markets.  As a result of our conclusion, we recorded a non-cash, pre-tax impairment charge of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i8a4e30558310462baad12840a3639375" continuedAt="ia4fc4bd0958f404da1005eb080e669bf"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i3b2060e5902e49abb3e4469084d451c6_D20220701-20220930" decimals="-8" name="mo:EquityMethodInvestmentImpairment" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNjc4ODM_864c8618-0467-4abb-a29f-bf6ac46e6354">2.5</ix:nonFraction>&#160;billion during the third quarter of 2022, which was recorded to (income) losses from investments in equity securities in our consolidated statements of earnings.  This impairment charge reflected the difference between the fair value of our equity investment in ABI using ABI&#8217;s share price and the Euro to U.S dollar exchange rate at September 30, 2022 and the carrying value of our equity investment in ABI at September 30, 2022.  After recording the impairment charge, each of the fair value and carrying value at September 30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i4a59e8c2438f4b0990202ed160b66f3a_I20220930" decimals="-8" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNjkxNDc_952455de-18e3-40aa-8964-8dde07a324fa">9.0</ix:nonFraction> billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the fair value of our equity investment in ABI was $<ix:nonFraction unitRef="usd" contextRef="if2f72a0231164ba39b3ffd8a34007855_I20221231" decimals="-8" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzYzMzA_400c269a-34bb-48ab-ae22-abd0d9f1955d">11.9</ix:nonFraction> billion (carrying value of $<ix:nonFraction unitRef="usd" contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231" decimals="-8" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzYzNTU_b9e5a336-538a-445f-b8cc-f972c25a4c78">9.0</ix:nonFraction> billion), which exceeded its carrying value by approximately <ix:nonFraction unitRef="number" contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231" decimals="2" sign="-" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzY0MTQ_748b3ccc-26a3-4a82-b5e8-9a9bb709c6ee">33</ix:nonFraction>%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, the fair value of our equity investment in ABI of $<ix:nonFraction unitRef="usd" contextRef="ia645931f457b42ad968380318043c7bb_I20220930" decimals="-8" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODQ3MjA_562503b0-d94e-4e70-bb5c-bf7ec25d5193">11.2</ix:nonFraction> billion declined below its carrying value by $<ix:nonFraction unitRef="usd" contextRef="i582f9f2ac6ca4ecda20c95fac7a2d662_I20210930" decimals="-8" sign="-" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODQ2OTU_977e5d06-df9b-4130-b1cf-361cc7421905">6.2</ix:nonFraction> billion or approximately <ix:nonFraction unitRef="number" contextRef="i113383343fc24b078e1605af29834efb_I20210930" decimals="2" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODQ3MTI_f6a74cd2-dad9-4d49-aef0-04553a17c26f">35</ix:nonFraction>%.  We concluded that the decline in fair value at September 30, 2021 was other than temporary.  As a result of our conclusion, we recorded a non-cash, pre-tax impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i7514f17104fb4e4086fa0002209e91be_D20210701-20210930" decimals="-8" name="mo:EquityMethodInvestmentImpairment" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzIyMDg_dbe5cc09-200c-4e40-8bc9-fcd0b4cb78eb">6.2</ix:nonFraction> billion during the third quarter of 2021, which was recorded to (income) losses from investments in equity securities in our consolidated statements of earnings.  After recording the impairment charge, each of the fair value and carrying value at September 30, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i113383343fc24b078e1605af29834efb_I20210930" decimals="-8" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODEyMDY_7b8b0385-c820-4e78-9ef9-aa907d5008f8"><ix:nonFraction unitRef="usd" contextRef="i582f9f2ac6ca4ecda20c95fac7a2d662_I20210930" decimals="-8" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODEyMDY_e8f5edc9-b0e9-4fb0-844b-ab00e466558d">11.2</ix:nonFraction></ix:nonFraction> billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the carrying value of our equity investment in ABI exceeded its share of ABI&#8217;s net assets attributable to equity holders of ABI by approximately $<ix:nonFraction unitRef="usd" contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231" decimals="-8" name="us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIzMDg5NzQ0MjA2NzMy_f186aa8b-1ca0-4f11-b68c-14accf801769">2.5</ix:nonFraction> billion.  Substantially all of this difference is comprised of goodwill and other indefinite-lived intangible assets (consisting primarily of trademarks).</span></div></ix:continuation><div id="i15062ca98227434086141b426450a5cb_124"></div><ix:continuation id="ia4fc4bd0958f404da1005eb080e669bf" continuedAt="ie5804dad247c4dbbab64b027348474fd"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in JUUL</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, we made an investment in JUUL for $<ix:nonFraction unitRef="usd" contextRef="i2d58937ea5f04743a283f00ebb398d3f_D20181201-20181231" decimals="-8" name="mo:PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzgw_2f3f3c52-449c-48a7-8f97-9d52046f09e2">12.8</ix:nonFraction> billion and received a <ix:nonFraction unitRef="number" contextRef="i42640979a7ab4a48966a0d609f073992_I20181231" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzk4_102b1d1f-bb36-48d7-a423-8889d3ca75d1">35</ix:nonFraction>% economic interest in JUUL through non-voting shares, which we converted at our election into voting shares in November 2020 (&#8220;Share Conversion&#8221;), and a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the &#8220;JUUL Transaction&#8221;).  At December&#160;31, 2022, we had a <ix:nonFraction unitRef="number" contextRef="i688c2fcd3b0343b29196c870d74f6b68_I20221231" decimals="2" name="mo:InvestmentOwnedBalancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzQ0MA_d51dff3d-22b5-4817-bd82-e7e02930f72c">35</ix:nonFraction>% economic ownership interest in JUUL, consisting of <ix:nonFraction unitRef="shares" contextRef="i688c2fcd3b0343b29196c870d74f6b68_I20221231" decimals="-6" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzQ4NQ_d05b79fb-9062-4dea-b3ca-8c21f13d8902">42</ix:nonFraction> million voting shares.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a standstill restriction under which we may not acquire additional JUUL shares above our <ix:nonFraction unitRef="number" contextRef="i42640979a7ab4a48966a0d609f073992_I20181231" decimals="2" name="mo:InvestmentOwnedBalancePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzIxOTkwMjMyNzI3Nzg_1dff3da3-d0a3-4b7c-90df-aadd8506851c">35</ix:nonFraction>% interest and may not sell or transfer any of our JUUL shares until December 20, 2024.  Furthermore, at the time of the investment, we agreed to non-competition obligations generally requiring that we participate in the e-vapor business only through JUUL.  In January 2020, we amended certain JUUL Transaction agreements and entered into a new cooperation agreement.  One of the provisions in the amendments was the option to be released from our non-compete obligation under certain circumstances, including if the carrying value of our investment in JUUL was not more than <ix:nonFraction unitRef="number" contextRef="ie58a0d47e81141b49b488d17516ef57a_I20200131" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzE5NTQ_d7c020d5-b2cb-4d6c-9b14-3e78e022aaba">10</ix:nonFraction>% of its initial carrying value of $<ix:nonFraction unitRef="usd" contextRef="i2d58937ea5f04743a283f00ebb398d3f_D20181201-20181231" decimals="-8" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzE5OTA_fdb441a7-0aad-4604-b771-89478d7de415">12.8</ix:nonFraction> billion.  At June 30, 2022, the carrying value of our investment in JUUL was $<ix:nonFraction unitRef="usd" contextRef="i34f2a76702e24388ae8484f16168bdc3_I20220630" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzIxOTkwMjMyNzM2MDM_58f2d655-0364-43ff-a6c9-d39328c9f368">450</ix:nonFraction>&#160;million, which was less than <ix:nonFraction unitRef="number" contextRef="ie58a0d47e81141b49b488d17516ef57a_I20200131" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzIxOTkwMjMyNzM2Mjg_1891fc36-47e3-4878-bfaa-d269960c7349">10</ix:nonFraction>% of our initial carrying value of $<ix:nonFraction unitRef="usd" contextRef="i2d58937ea5f04743a283f00ebb398d3f_D20181201-20181231" decimals="-8" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzIxOTkwMjMyNzM2NjU_337e84b2-bb24-4b99-906f-7f0409fd3fc2">12.8</ix:nonFraction>&#160;billion.  As a result, in September 2022, we exercised our option to be released from our JUUL non-competition obligations, resulting in (i) the permanent termination of our non-competition obligations to JUUL, (ii) the loss of our JUUL board designation rights (other than the right to designate one independent director so long as our ownership continues to be at least <ix:nonFraction unitRef="number" contextRef="ie58a0d47e81141b49b488d17516ef57a_I20200131" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzIxOTkwMjMyNzQwMzE_fd4c423b-e782-40d4-869d-bbcd7bcfa459">10</ix:nonFraction>%), our preemptive rights, our consent rights and certain other rights with respect to our investment in JUUL and (iii) the conversion of our JUUL shares to single vote common stock, significantly reducing our voting power.  We do not currently intend to exercise our remaining governance rights or to vote our JUUL shares other than as a passive investor.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, as part of the amendment to certain JUUL Transaction agreements in January 2020, we agreed not to pursue any claims against JUUL for indemnification or reimbursement except for any non-contractual claims for contribution or indemnity where a judgment has been entered against us and JUUL with respect to certain litigation in which we and JUUL are both defendants against third-party plaintiffs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the U.S. Federal Trade Commission (&#8220;FTC&#8221;) issued an administrative complaint challenging our investment in JUUL.  In February 2022, the administrative law judge dismissed the FTC&#8217;s complaint.  FTC complaint counsel appealed that decision to the FTC, which appeal remains pending.  For further discussion, see Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies -&#160;Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) issued marketing denial orders (&#8220;MDOs&#8221;) to JUUL ordering all of JUUL&#8217;s products currently marketed in the United States off the market.  In July 2022, the FDA administratively stayed the MDOs on a temporary basis, citing its determination that there are scientific issues unique to the JUUL PMTAs that warrant additional review.  This administrative stay temporarily suspends the MDOs and JUUL&#8217;s products remain on the market.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5ab299f5c40b4f8c9d705104fbe410e2" continuedAt="id894a58ae3b8449b9b189176968218bf">Following Share Conversion in the fourth quarter of 2020, we elected to account for our equity method investment in JUUL under the fair value option.  In making this election, we believed measuring our investment at fair value provided quarterly transparency to investors as to the fair market value of our investment in JUUL, given the changes and volatility in the e-vapor category since our initial investment, as well as the lack of publicly available information regarding JUUL&#8217;s business or a market-derived valuation.  As a result of our loss of certain rights due to our exercise of our option to be released from our JUUL non-competition obligations in the third quarter of 2022, we determined that we no longer have the ability to exercise significant influence over the operating and financial policies of JUUL.  Therefore, we are no longer able to account for our investment in JUUL as an equity method investment.  Beginning with the period ended September 30, 2022, we account for our investment in JUUL as an investment in an equity security.  We will continue to measure our investment in JUUL at fair value, in accordance with GAAP.  Our consolidated statements of earnings include </ix:continuation></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="ie5804dad247c4dbbab64b027348474fd" continuedAt="iec0da8766ed6429a9108963e5d4186d0"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id894a58ae3b8449b9b189176968218bf" continuedAt="i7baa5db767084f59af772a3f761023c5">any cash dividends received from our investment in JUUL (none received to date) and any changes in the estimated fair value of our investment, which is calculated quarterly.</ix:continuation></span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzEyMzU1_a653f569-a2bb-478d-87ec-bf1e2b307f06" escape="true"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of our investment in JUUL, which is classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:79.774%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.343%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment Balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e8852c143984842b74a594acdc7f562_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90YWJsZTo3MWU4ZGU2MzI5ZDY0ZDgxOWZhYzVmM2NiNjUyZDBlMC90YWJsZXJhbmdlOjcxZThkZTYzMjlkNjRkODE5ZmFjNWYzY2I2NTJkMGUwXzEtMi0xLTEtMTg0NDY5_459c459e-168b-41d9-a074-28a57f2c3f98">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in (income) losses from investments in equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90c02ede0bac4600ad8f45d0bae1be88_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90YWJsZTo3MWU4ZGU2MzI5ZDY0ZDgxOWZhYzVmM2NiNjUyZDBlMC90YWJsZXJhbmdlOjcxZThkZTYzMjlkNjRkODE5ZmFjNWYzY2I2NTJkMGUwXzMtMi0xLTEtMTg0NDY5_eaa74838-338f-46b6-96c4-6dd12a5615f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9822021e58024e35a62e7648157e3677_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90YWJsZTo3MWU4ZGU2MzI5ZDY0ZDgxOWZhYzVmM2NiNjUyZDBlMC90YWJsZXJhbmdlOjcxZThkZTYzMjlkNjRkODE5ZmFjNWYzY2I2NTJkMGUwXzQtMi0xLTEtMTg0NDY5_ef575bd1-b7c8-4394-9c77-84adcf8f554e">1,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in (income) losses from investments in equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i352490c117bb4f8998f690f115171443_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90YWJsZTo3MWU4ZGU2MzI5ZDY0ZDgxOWZhYzVmM2NiNjUyZDBlMC90YWJsZXJhbmdlOjcxZThkZTYzMjlkNjRkODE5ZmFjNWYzY2I2NTJkMGUwXzUtMi0xLTEtMTg0NDY5_c2d1b4b2-1333-4524-80fa-a3604dd9cd26">1,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01271f593e214e02974445c5cdca8e52_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90YWJsZTo3MWU4ZGU2MzI5ZDY0ZDgxOWZhYzVmM2NiNjUyZDBlMC90YWJsZXJhbmdlOjcxZThkZTYzMjlkNjRkODE5ZmFjNWYzY2I2NTJkMGUwXzYtMi0xLTEtMTg0NDY5_2d38f87f-74bc-4e6d-b041-c4748e5b8690">250</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7baa5db767084f59af772a3f761023c5" continuedAt="i30c4f64614df4dce836ec5ffa4160741">Prior to Share Conversion, we accounted for our investment in JUUL as an investment in an equity security.  Since the JUUL shares do not have a readily determinable fair value, we elected to measure our investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There were <ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="INF" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzU2Mjg_358f5764-2ee8-4107-9267-d162fee53229"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="INF" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzU2Mjg_f47eb9d0-9d2c-4197-8c10-a1b9cae883ba">no</ix:nonFraction></ix:nonFraction> upward or downward adjustments to the carrying value of our investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through the date of Share Conversion.  In addition, prior to Share Conversion, we reviewed our investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of our financial statements.  If this qualitative assessment indicated that our investment in JUUL may be impaired, a quantitative assessment was performed.  If the quantitative assessment indicated the estimated fair value of the investment was less than its carrying value, the investment was written down to its estimated fair value.</ix:continuation></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Financial Activity</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">For the year ended December&#160;31, 2022, we recorded non-cash, pre-tax unrealized losses of $<ix:nonFraction unitRef="usd" contextRef="icc2bb0b67a1f4be892d628382285683c_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzIxOTkwMjMyODQxNTU_70c34bca-bf55-45a1-98d8-ae1e6ec3887e">1,455</ix:nonFraction> million as a result of changes in the estimated fair value of our investment in JUUL.  The decrease in the estimated fair value was primarily driven by (i) a decrease in the likelihood of a favorable outcome from the FDA for JUUL&#8217;s products that are currently marketed in the United States, which have received MDOs and are now under additional administrative review, (ii) a decrease in the likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, which could result in JUUL seeking protection under bankruptcy or other insolvency laws, (iii) projections of higher operating expenses resulting in lower long-term operating margins, (iv) projections of lower JUUL revenues in the United States over time due to lower JUUL volume assumptions and (v) an increase in the discount rate due to changes in market factors, partially offset by the effect of passage of time on the projected cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Financial Activity</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">For the year ended December 31, 2021, we recorded <ix:nonFraction unitRef="usd" contextRef="i56c5cabbdfb44d05a0e818aa3c22c4d1_I20211231" decimals="-6" name="mo:EquityInvestmentFairValueOption" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzY0NjQ_f60208ca-6a89-4b19-89cd-8696b8f4cdde">no</ix:nonFraction> change in the estimated fair value of our investment in JUUL.  During the year ended December 31, 2021, the estimated fair value was primarily impacted by our projections of lower JUUL revenues in the United States over time due to lower JUUL volume assumptions offset by (i) the effect of passage of time on the projected cash flows and (ii) a decrease in the discount rate due to changes in market factors.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Financial Activity</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">We recorded a non-cash pre-tax unrealized gain of $<ix:nonFraction unitRef="usd" contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzQ5NDc4MDIzNTQxMjk_08d58a75-acb3-4803-9be1-0d4ee98468bf">100</ix:nonFraction> million for the fourth quarter and year ended December 31, 2020 as a result of an increase in the estimated fair value of our investment in JUUL.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">In September 2020, JUUL announced a strategic update, which included its plans for a significant global workforce reduction, its evaluation of its resource allocation and the possibility of exiting various international markets.  As part of the preparation of our financial statements for the period ended September 30, 2020, we performed a qualitative assessment of impairment indicators for our investment in JUUL and determined that JUUL&#8217;s strategic update was an indicator of impairment at September 30, 2020, given the significant deterioration in JUUL&#8217;s business prospects.</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the existence of this impairment indicator, we performed a quantitative valuation of our investment in JUUL during the third quarter of 2020 and recorded a non-cash, pre-tax impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzgxMjY_1fe89135-bb5a-4564-aefb-f3219e62880d">2.6</ix:nonFraction> billion for the year ended December 31, 2020, reported as impairment of JUUL equity securities in our consolidated statements of earnings.  The impairment charge was driven by our projections of lower JUUL revenues over time due to lower pricing assumptions and delays in JUUL achieving previously forecasted operating margin performance.  These drivers were the result of (i) JUUL&#8217;s revised international expansion plans and (ii) the evolving U.S. e-vapor category and associated competitive dynamics.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i30c4f64614df4dce836ec5ffa4160741" continuedAt="i94347f49a03b48558a2fe16d06167c4a">We use an income approach to estimate the fair value of our investment in JUUL.  The income approach reflects the discounting of future cash flows for the U.S. and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.</ix:continuation></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iec0da8766ed6429a9108963e5d4186d0" continuedAt="ie2affda2c3854885ae8bebff979be06e"><ix:continuation id="i94347f49a03b48558a2fe16d06167c4a">In determining the estimated fair value of our investment in JUUL, in 2022, 2021 and 2020, we made certain judgments, estimates and assumptions, the most significant of which were likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, we made judgments regarding the (i) likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#8217;s products, which have received MDOs and are now under additional administrative review; (ii) likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, the absence of which could result in JUUL seeking protection under bankruptcy or other insolvency laws; (iii) risk created by the number and types of legal cases pending against JUUL; (iv) expectations for the future state of the e-vapor category, including competitive dynamics; and (v) timing of international expansion plans.</ix:continuation>  Due to these uncertainties, our future cash flow projections of JUUL are based on a range of scenarios that consider certain potential regulatory, liquidity and market outcomes.</ix:continuation></span></div><div id="i15062ca98227434086141b426450a5cb_127"></div><ix:continuation id="ie2affda2c3854885ae8bebff979be06e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Cronos</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had a <ix:nonFraction unitRef="number" contextRef="i84433bab48264529a2516c2663b4fc52_I20221231" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzQ2_4cbb4c6b-89aa-4e0e-8059-3b6c5d918c41">41.1</ix:nonFraction>% ownership interest in Cronos, consisting of <ix:nonFraction unitRef="shares" contextRef="i84433bab48264529a2516c2663b4fc52_I20221231" decimals="-5" name="mo:EquityMethodInvestmentNumberofSharesOwnedCommon" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzkz_2fbaef97-0b00-4b7b-81f7-872322c6c5f8">156.6</ix:nonFraction> million shares, which we account for under the equity method of accounting.  Our ownership percentage decreased from <ix:nonFraction unitRef="number" contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231" decimals="3" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxNQ_ca90d13d-5b34-4b83-82f1-6ef109800f31">41.8</ix:nonFraction>% at December&#160;31, 2021 due to the issuance of additional shares by Cronos.  We report our share of Cronos&#8217;s results using a one-quarter lag because Cronos&#8217;s results are not available in time for us to record them in the concurrent period.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i052ed0705cd8433486fcc672f6492ebc">The fair value of our equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.</ix:continuation></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, each of the fair value and carrying value of our equity method investment in Cronos was $<ix:nonFraction unitRef="usd" contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNzQ1NTY_469e1b15-f1ad-4bb1-9735-47865856afb1"><ix:nonFraction unitRef="usd" contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNzQ1NTY_9072d2c6-f34e-4863-a0ed-6634f82e86ce">617</ix:nonFraction></ix:nonFraction> million.  In the second quarter of 2022, the fair value of our equity method investment in Cronos declined below its carrying value and had not recovered as of June 30, 2022.  At June 30, 2022, the fair value was less than its carrying value by approximately <ix:nonFraction unitRef="number" contextRef="ibe747a76cea044caadbd3c216fee37f5_I20220630" decimals="2" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyODE1Njk_b994feda-90bd-4d68-bb38-fac165ce5399">20</ix:nonFraction>%.  We concluded that the decline in fair value was other than temporary.  As a result, we recorded a non-cash, pre-tax impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i352e13ef17314af78049d425169b5c00_D20220401-20220630" decimals="-6" name="mo:EquityMethodInvestmentImpairment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjY4MjA_61a6b955-537f-4427-be23-3156660b44f1">107</ix:nonFraction> million in the second quarter of 2022, which was recorded to (income) losses from investments in equity securities in our consolidated statements of earnings.  The impairment charge reflects the difference between the fair value of our equity method investment in Cronos using Cronos&#8217;s share price and the Canadian dollar (&#8220;CAD&#8221;) to U.S. dollar exchange rate at June 30, 2022 and the carrying value of our equity method investment in Cronos at June 30, 2022.  After recording the impairment charge, each of the fair value and carrying value at June 30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ibe747a76cea044caadbd3c216fee37f5_I20220630" decimals="-6" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjc2MTI_02bd5507-930d-4b01-9944-ee708d0227d2"><ix:nonFraction unitRef="usd" contextRef="ibe747a76cea044caadbd3c216fee37f5_I20220630" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjc2MTI_98f38cba-0610-4779-a793-4eeb9f43ce8f">437</ix:nonFraction></ix:nonFraction> million.  At December&#160;31, 2022, the fair value of our equity method investment in Cronos exceeded its carrying value by $<ix:nonFraction unitRef="usd" contextRef="i84433bab48264529a2516c2663b4fc52_I20221231" decimals="-6" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzc2OTY1ODE0MTg5NzQ_a29200f2-5779-4106-a9ac-3029918a6954">22</ix:nonFraction> million or approximately <ix:nonFraction unitRef="number" contextRef="i84433bab48264529a2516c2663b4fc52_I20221231" decimals="2" sign="-" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjc3NTA_3595c855-3b5e-4e59-9cf5-5f91552e1c09">6</ix:nonFraction>%.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the fair value of our equity method investment in Cronos was less than its carrying value by approximately <ix:nonFraction unitRef="number" contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231" decimals="2" name="mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyODE1NjI_2b190f58-d57e-4b23-820e-2f4a47f17303">25</ix:nonFraction>%.  We concluded that the decline in fair value at December 31, 2021 was other than temporary.  As a result, we recorded a non-cash, pre-tax impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i13178e7cbc7c479c89b40c940101986c_D20210101-20211231" decimals="-6" name="mo:EquityMethodInvestmentImpairment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNzA5ODk_19b95daa-88d6-4005-9fc3-003f445d345d">205</ix:nonFraction>&#160;million for the year ended December 31, 2021, which was recorded to (income) losses from investments in equity securities in our consolidated statement of earnings.  After recording the impairment charge, each of the fair value and carrying value at December 31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNzE3MjM_6ffc957a-f623-4495-9b70-f88bb9b5807d"><ix:nonFraction unitRef="usd" contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNzE3MjM_fd769277-f67c-45f4-8235-bf9437d4ef7b">617</ix:nonFraction></ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our Investment in Cronos, at December&#160;31, 2022, we also owned anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain our ownership percentage.  Certain of the anti-dilution protections provide us the ability to purchase additional Cronos common shares at a per share exercise price of CAD $<ix:nonFraction unitRef="cadPerShare" contextRef="i690729cf5b294067aff036eadfaa0ae7_I20221231" decimals="INF" name="mo:EquityMethodInvestmentPricePerShareIfExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjEwNzg_c5d33a43-057f-4678-8c3a-68612c533f60">16.25</ix:nonFraction> upon the occurrence of specified events (&#8220;Fixed-price Preemptive Rights&#8221;).  Based on our assumptions as of December&#160;31, 2022, we estimate the Fixed-price Preemptive Rights allows us to purchase up to an additional approximately <ix:nonFraction unitRef="shares" contextRef="i690729cf5b294067aff036eadfaa0ae7_I20221231" decimals="-6" name="mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjEzMTA_4c52ef27-1096-4fd8-bcab-5b869efdb97f">7</ix:nonFraction> million common shares of Cronos.  Prior to December 15, 2022, we also owned a warrant providing us the ability to purchase an additional approximate <ix:nonFraction unitRef="number" contextRef="i5b88030abdbe4a5bab225cf467fd6aec_I20221231" decimals="INF" name="mo:EquityMethodInvestmentPercentageofSharesEligibleForPurchase" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjE0MjA_526a7735-939a-440a-9eaa-4d9c5f36c732">10</ix:nonFraction>% of common shares of Cronos at a per share exercise price of CAD $<ix:nonFraction unitRef="cadPerShare" contextRef="i5b88030abdbe4a5bab225cf467fd6aec_I20221231" decimals="INF" name="mo:EquityMethodInvestmentPricePerShareIfExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjE1Mjk_8aa844aa-0b5d-49f7-a688-64f237cd549b">19.00</ix:nonFraction>, which would have expired on March 8, 2023.  On December 15, 2022, we irrevocably abandoned the Cronos warrant, and we no longer owned the warrant as of December 31, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Fixed-price Preemptive Rights are derivative financial instruments, which are required to be recorded at fair value and are classified in Level 3 of the fair value hierarchy.  Prior to irrevocably abandoning the Cronos warrant on December 15, 2022, the Cronos warrant was also a derivative financial instrument recorded at fair value.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record in our consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzYwNDczMTM5NjcyOTc_2eff0eb4-85de-410e-badd-74e37f2fc1a3" continuedAt="id44691c56a2e48ef835eb80c96d16d98" escape="true">We recorded non-cash, pre-tax unrealized losses, representing these changes, as follows:</ix:nonNumeric></span></div><div><ix:continuation id="id44691c56a2e48ef835eb80c96d16d98"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.295%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b902b829a4c4480963978506c931fe9_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzItMS0xLTEtMTg3MDAw_57dfe1b2-ac46-4a8a-9890-9607f29f2d19">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f5bd49e3d924bbc92984ec5b9b68266_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzItMy0xLTEtMTg3MDAw_74b75d23-73be-4a9e-85ae-d074feac24f6">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe6babf381df44cd9b5ccb5c5a5e58f2_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzItNS0xLTEtMTg3MDAw_b73bb530-6f63-4d33-bde0-50ff44842419">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd4d6be44a8e48fcac6b5ef35c67ddef_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzMtMS0xLTEtMTg3MDAw_8d08db9f-3b4b-4605-9295-031320ba728e">14</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dbf8277f9b945c79b9491eacf1a07b9_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzMtMy0xLTEtMTg3MDAw_c7fb1c13-312c-4488-be2b-f38b23b806bb">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i787d308d5eeb4107b0661b036cbd627c_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzMtNS0xLTEtMTg3MDAw_551bd814-e743-46ed-a2d8-2c466a3f0bf6">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzQtMS0xLTEtMTk2ODQ3_20e1fdc2-2f60-446e-8545-497cbba4db45">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzQtMy0xLTEtMTk2ODQ3_8363ace4-20b2-4af9-b0dd-6c21edf4f355">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzQtNS0xLTEtMTk2ODQ3_a682cec6-9e51-45c8-8e6b-4ae7844613bf">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 6.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90ZXh0cmVnaW9uOmE5ZWMyODRmYWUyZjQzYTQ4OTE4NjdlZjkyOGQ5NmI0XzY4NTI_2b264931-85dd-4f31-8bd3-1b5fb3187071" continuedAt="i9f8489df08e04081b7eaa71a44c76447" escape="true">Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="i9f8489df08e04081b7eaa71a44c76447"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  We use various types of derivative financial instruments, including forward contracts, options and swaps.  We do not enter into or hold derivative financial instruments for trading or speculative purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment in ABI, whose functional currency is the Euro, exposes us to foreign currency exchange risk on the carrying value of our investment.  To manage this risk, we may designate certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively, &#8220;foreign currency contracts&#8221;), and Euro denominated unsecured long-term notes (&#8220;foreign currency denominated debt&#8221;) as net investment hedges of our investment in ABI.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, all outstanding foreign currency contracts matured and, at December 31, 2022 and 2021, we had <ix:nonFraction unitRef="contract" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="INF" name="us-gaap:NumberOfForeignCurrencyDerivativesHeld" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90ZXh0cmVnaW9uOmE5ZWMyODRmYWUyZjQzYTQ4OTE4NjdlZjkyOGQ5NmI0Xzk5NA_c614d5c9-c74c-46cb-b4dc-0dd7ebbdec65"><ix:nonFraction unitRef="contract" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="INF" name="us-gaap:NumberOfForeignCurrencyDerivativesHeld" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90ZXh0cmVnaW9uOmE5ZWMyODRmYWUyZjQzYTQ4OTE4NjdlZjkyOGQ5NmI0Xzk5NA_ce9e85d9-f107-4839-9642-ae4ae23c1bfe">no</ix:nonFraction></ix:nonFraction> outstanding foreign currency contracts.  When we have foreign currency contracts in effect, counterparties are domestic and international financial institutions.  Under these contracts, we are exposed to potential losses in the event of non-performance by these counterparties.  We manage our credit risk by entering into transactions with counterparties that have investment grade credit ratings, limiting the amount of exposure we have with each counterparty and monitoring the financial condition of each counterparty.  The counterparty agreements contain provisions that require us to maintain an investment grade credit rating.  In the event our credit rating falls below investment grade, counterparties to our foreign currency contracts can require us to post collateral.</span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90ZXh0cmVnaW9uOmE5ZWMyODRmYWUyZjQzYTQ4OTE4NjdlZjkyOGQ5NmI0XzY4NTY_93d6bf85-bcfb-468d-abbd-b2067192c74c" escape="true"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying value and fair value of our total long-term debt were as follows at December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.293%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.294%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzEtMS0xLTEtMTg0NDY5_3c94ca8c-1e40-4275-8a34-f18ea06e248a">26,680</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzEtMy0xLTEtMTg0NDY5_9c674e21-d981-4c49-a458-60a46b186556">28,044</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzItMS0xLTEtMTg0NDY5_9b95a301-c6c1-48b2-84a4-c2fc1888fca7">22,928</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzItMy0xLTEtMTg0NDY5_ef6e8ee9-2fee-4cb9-9f83-39b9efb9b461">30,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt included in long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d414e5e17345c0b5010b8bf3b1609d_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzQtMS0xLTEtMTg2OTQ5_11d47d65-51a7-4630-93b2-2312a65585dc">4,540</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb837eb6a554c7b8139c2b96eea88f8_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzQtMy0xLTEtMTg2OTQ1_c68221dd-16b8-4a88-b3c5-b75c9b2b7661">4,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d414e5e17345c0b5010b8bf3b1609d_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzUtMS0xLTEtMTg2OTQ5_be9df4a9-9e0d-4419-ad3d-00ccd12b5060">4,165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bb837eb6a554c7b8139c2b96eea88f8_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzUtMy0xLTEtMTg2OTQ1_a44980e3-380d-45f6-96ef-9edf20f92429">5,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimate of the fair value of our total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in the fair value of our long-term debt was primarily driven by (i) rising interest rates in 2022, (ii) the August 2022 $<ix:nonFraction unitRef="usd" contextRef="i1ba18ff14a604658afe105249ab1be5c_D20220801-20220831" decimals="-8" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90ZXh0cmVnaW9uOmE5ZWMyODRmYWUyZjQzYTQ4OTE4NjdlZjkyOGQ5NmI0XzIxOTkwMjMyNjMyODg_8c9cfd9e-6040-4d2d-a9ef-4316246b18b3">1.1</ix:nonFraction> billion repayment at maturity of senior unsecured notes and (iii) changes in Euro denominated debt resulting from the strengthening of the U.S. dollar versus the Euro during 2022.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedging</span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90ZXh0cmVnaW9uOmE5ZWMyODRmYWUyZjQzYTQ4OTE4NjdlZjkyOGQ5NmI0XzY4NTU_23bde817-75b7-46db-bb2b-047a6aa0b469" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effects of our net investment hedges on accumulated other comprehensive losses and our consolidated statements of earnings were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.227%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.835%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized <br/>in Net Earnings</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i676dca466c264c98a0a732b91fb9c4dd_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzMtMi0xLTEtMTg0NDY5_7ca8308a-4ec8-42eb-952c-7dd87b24b662">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2b22c6277c34d6bbc04167a977d057b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzMtNC0xLTEtMTg0NDY5_20982571-3a4a-4bbb-a423-aa4ac2520719">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38a706a086554d389015fb9e0c90e6ab_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzMtNi0xLTEtMTg0NDY5_d44aaff6-c5bb-4ce0-b2a8-e3e5df56812c">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i676dca466c264c98a0a732b91fb9c4dd_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzMtOC0xLTEtMTg0NDY5_895bf8ee-3ccb-4ff9-9c6b-3a9ae3799634">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id2b22c6277c34d6bbc04167a977d057b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzMtMTAtMS0xLTE4NDQ2OQ_72dadc63-5084-48fb-83f7-2c38cb8eda7f">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38a706a086554d389015fb9e0c90e6ab_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzMtMTItMS0xLTE4NDQ2OQ_8acc92b8-161f-4352-bc68-568b5f1c46f0">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12be265a64cd483a8c06ad934345bfdb_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzQtMi0xLTEtMTg0NDY5_4ca7b081-1bbe-400b-8fd2-8a75764f3c77">281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f1171f94e9a4f509d988ba58f40a86a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzQtNC0xLTEtMTg0NDY5_5d039e3e-8eb1-4b7d-bfcc-2359e6aae7f8">359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3b9202eb4bc425496d496a5783142ad_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzQtNi0xLTEtMTg0NDY5_aac9fe30-e995-4f39-ac28-2eca50d3d56e">424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12be265a64cd483a8c06ad934345bfdb_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzQtOC0xLTEtMTg0NDY5_a945536d-c3bc-4e08-a7d8-2646ef951e97">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f1171f94e9a4f509d988ba58f40a86a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzQtMTAtMS0xLTE4NDQ2OQ_f9413a89-0b3a-4c94-8488-6c6ff2a2219a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3b9202eb4bc425496d496a5783142ad_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzQtMTItMS0xLTE4NDQ2OQ_2b8a58be-4358-43d5-81ba-e44dc5e09d98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7f230b64a534de9935f50dfa188e24b_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzUtMi0xLTEtMTg0NDY5_29e26f04-a6d3-4c01-844f-0b34cb3d53b8">281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2704b95dd3964621a2f17ac3697ec1bd_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzUtNC0xLTEtMTg0NDY5_a14512f0-a4b2-4650-8621-18f4474550e6">375</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38cd1d2ff91f4c8a8a7413ed1a97f758_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzUtNi0xLTEtMTg0NDY5_e0f259b6-72a3-4cc1-9aa6-bfaa6458ad1a">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f230b64a534de9935f50dfa188e24b_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzUtOC0xLTEtMTg0NDY5_eb0ae066-e50c-4f4c-936d-25580159f1d7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2704b95dd3964621a2f17ac3697ec1bd_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzUtMTAtMS0xLTE4NDQ2OQ_227a8540-150e-4583-a988-b472aa5c8459">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i38cd1d2ff91f4c8a8a7413ed1a97f758_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzUtMTItMS0xLTE4NDQ2OQ_15aa74e9-fda0-4e07-b27c-dc9bae814fd5">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to U.S. dollar exchange rate in accumulated other comprehensive losses related to ABI.  We recognized gains on the foreign currency contracts arising from components excluded from effectiveness testing in interest and other debt expense, net in our consolidated statements of earnings based on an amortization approach.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_139"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 7.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzM5MDQ_51c2f548-bc1e-44f8-af7e-1f49d499fff8" continuedAt="id2385def2bee42ea83908f0743da0d83" escape="true">Short-Term Borrowings and Borrowing Arrangements</ix:nonNumeric></span></div><ix:continuation id="id2385def2bee42ea83908f0743da0d83" continuedAt="i850c61805cc4472fb982054a9780edd1"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, we had <ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0Xzg0_02cda2ff-7bc4-43ac-8b0e-711faee1e0a9"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0Xzg0_76786856-fac6-47d3-853c-ddd424e03407">no</ix:nonFraction></ix:nonFraction> short-term borrowings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, we entered into an extension and amendment (the &#8220;Extension and Amendment&#8221;) to our $<ix:nonFraction unitRef="usd" contextRef="ib2383b8a428a43a694fd25b50b5e56d9_I20220831" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzIxOTkwMjMyNjA3NDY_1f299f91-dd53-4238-a6ff-e3ded0319dc9">3.0</ix:nonFraction> billion senior unsecured <ix:nonNumeric contextRef="ic1ea858197df46758cab5e38cc77fc6b_D20220801-20220831" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzM5MDI_d3ac962b-280a-4f3e-998b-f341fd453eb8">5-year</ix:nonNumeric> revolving credit agreement (as amended, the &#8220;Credit Agreement&#8221;).  The Extension and Amendment (i) extended the maturity date of the Credit Agreement from August 1, 2024 to August 1, 2025 and (ii) amended the Credit Agreement to update the benchmark interest rate to a rate based on the Term Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;) and make certain other market updates.  All </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i850c61805cc4472fb982054a9780edd1"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other terms and conditions of the Credit Agreement remain in full force and effect.  The Credit Agreement is used for general corporate purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022 and 2021, we had availability under the Credit Agreement for borrowings of up to an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i5eaa17b2950f4f739cc9503d66958b9f_I20221231" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzEwNjE_035da8ad-3d7d-4b2e-a02a-cfa66b800230"><ix:nonFraction unitRef="usd" contextRef="i9dc86c124c5b4201b063cd0d7581dfb9_I20211231" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzEwNjE_843be32b-d0ba-41ba-b3e6-901ba5d16d0e">3.0</ix:nonFraction></ix:nonFraction> billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of our long-term senior unsecured debt.  We expect interest rates on borrowings under the Credit Agreement to be based on the Term SOFR plus a percentage based on the higher of the ratings of our long-term senior unsecured debt from Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) and Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;).  The applicable percentage for borrowings under the Credit Agreement at December&#160;31, 2022 was <ix:nonFraction unitRef="number" contextRef="i019d8f929d47481aa9b043d3f5399d3e_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzE3MzA_4ae4bebe-8771-4f71-a77b-3c01f87caf15">1.0</ix:nonFraction>% based on our long-term senior unsecured debt ratings on that date.  The Credit Agreement does not include any other rating triggers or any provisions that could require the posting of collateral.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement includes various covenants, one of which requires us to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) to Consolidated Interest Expense of not less than <ix:nonFraction unitRef="number" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="INF" name="mo:DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzIxMDE_f84afcd0-47e5-4abe-a3ff-e896157c5906">4.0</ix:nonFraction> to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis.  At December&#160;31, 2022, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was <ix:nonFraction unitRef="number" contextRef="if40c2ab1cec0419d8e9f4ba69b3cd0b7_D20220101-20221231" decimals="INF" name="mo:DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzIxOTkwMjMyNjA1NzM_8c7885d8-3ab0-47ed-9ac5-04e802e1747d">11.0</ix:nonFraction> to 1.0.  At December&#160;31, 2022, we were in compliance with our covenants in the Credit Agreement.  The terms &#8220;Consolidated EBITDA&#8221; and &#8220;Consolidated Interest Expense,&#8221; each as defined in the Credit Agreement, include certain adjustments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, due to the uncertainty at that time in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, we elected to borrow the full $<ix:nonFraction unitRef="usd" contextRef="i88059e2462ce4581be210352406c6935_D20200301-20200331" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzI3NTA_a04990c0-aee1-490b-848e-891dc2b3b3fc">3.0</ix:nonFraction> billion available under the Credit Agreement as a precautionary measure to increase our cash position and preserve financial flexibility.  In June 2020, we repaid the full amount outstanding under the Credit Agreement using the net proceeds from the issuance of long-term senior unsecured notes issued in May 2020 and available cash.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any commercial paper issued by us and borrowings under the Credit Agreement are guaranteed by PM&#160;USA as further discussed in Note 8. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt.</span></div></ix:continuation><div><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_142"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 8.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:LongTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzQ3Njk_b83168c9-7099-478f-ae38-58bc8f7f72b2" continuedAt="i71e5679ed39242cdb234fb3a5cdb4884" escape="true">Long-Term Debt</ix:nonNumeric></span></div><ix:continuation id="i71e5679ed39242cdb234fb3a5cdb4884" continuedAt="ibefe03fcc7974c139761cd5fb6770138"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzQ3OTc_ed5a22b4-6491-440b-b7af-58f2623b9f2e" continuedAt="i766d65d1b6d843829f4bee8bf48f6d66" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term debt consisted of the following at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"></td><td style="width:72.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes, <ix:nonFraction unitRef="number" contextRef="i3f78f34f75a64fe4bf18d076708d3591_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzEtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246ZjA0ZTdmMzhlY2JmNGU5MmJjMzlkYTZjMjRiNzYyZWVfMTU_ba791af9-252f-4c48-a4ab-ccbf1034cf26">2.350</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i8f210e7652a144c19a8bf09f7c07c740_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzEtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246ZjA0ZTdmMzhlY2JmNGU5MmJjMzlkYTZjMjRiNzYyZWVfMjE_e609c6ec-68db-4123-b99d-4e7dad170fd0">10.20</ix:nonFraction>%, interest payable semi-annually, due through 2061</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief3c0b98ac9c41609501bd13ff3613c2_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzEtMS0xLTEtMTg0NDY5_cd020366-d831-435e-9051-b857948d795e">22,098</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f121d00e6394fc8a7c9088b8f4fb8f4_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzEtMy0xLTEtMTg0NDY5_803e1617-ce1d-419b-9185-4920382d52c3">23,185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD debenture, <ix:nonFraction unitRef="number" contextRef="i92fe93dcf2a34fecaed4dc95f41d6851_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzItMC0xLTEtMTg0NDY5L3RleHRyZWdpb246OGQyNGI5Y2ZkZTVjNGE1MWEwMWY1M2IyMzNhYzk3ZmRfMTk_5babc572-b643-4ab8-b235-999d13d20c31">7.75</ix:nonFraction>%, interest payable semi-annually, due 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92fe93dcf2a34fecaed4dc95f41d6851_I20221231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzItMS0xLTEtMTg0NDY5_5df6df3d-46ad-4a3e-a112-04ddc5315433">42</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15baa618b8ac444882da13a33e5e3fd9_I20211231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzItMy0xLTEtMTg0NDY5_84506453-b2cf-4ed6-bec0-dff02840c1b1">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes, <ix:nonFraction unitRef="number" contextRef="ib7c66631bfad48cf9a20d10eb7a5d95c_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzMtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246YTFjNTc4YzlmNzI3NGU2NDkzN2Q5MGIxOGVjMmFmNWNfMTY_b7af324a-4528-4968-a145-587ff2892817">1.000</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i48082c430c9b492c905de5a9ccd49dd8_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzMtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246YTFjNTc4YzlmNzI3NGU2NDkzN2Q5MGIxOGVjMmFmNWNfMjI_a730c425-af79-4ed6-88ea-8d5eab52d570">3.125</ix:nonFraction>%, interest payable annually, due through 2031 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib945efb6e5fe46fbae9e80efa6cbc9ac_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzMtMS0xLTEtMTg0NDY5_448438b1-1e2a-4bc8-bb44-75456987a34e">4,540</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd37474dc2a14a4097a4780f47dc1ee1_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzMtMy0xLTEtMTg0NDY5_e0436c0d-dbfc-4261-92b6-91022ee02d8f">4,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzQtMS0xLTEtMTg0NDY5_7115603e-5e69-48de-9630-c86b4c7aabe8">26,680</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzQtMy0xLTEtMTg0NDY5_9c674e21-d981-4c49-a458-60a46b186556">28,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzUtMS0xLTEtMTg0NDY5_153fd4b1-42bc-41ba-9580-a877dd95f802">1,556</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzUtMy0xLTEtMTg0NDY5_e8c8e987-a78f-4a50-8217-dd2c2522578a">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzYtMS0xLTEtMTg0NDY5_6a50f67b-103c-4a9d-80ef-f6bdb45ebaec">25,124</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzYtMy0xLTEtMTg0NDY5_cc7aeb13-bafc-4f71-aabb-fc0f8abc0c33">26,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average coupon interest rate of and <ix:nonFraction unitRef="number" contextRef="i439835ab3a43455e96b747acea6d4d8f_I20211231" decimals="3" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzE0Nw_d97cd270-1f9f-42d1-9baa-099f1c80f97e"><ix:nonFraction unitRef="number" contextRef="id631a5ccf3fb429cb812360331668599_I20221231" decimals="3" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzE0Nw_de45eca3-9518-4aea-96c4-53b6b24b3115">4.4</ix:nonFraction></ix:nonFraction>% at December&#160;31, 2022 and 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Weighted-average coupon interest rate of <ix:nonFraction unitRef="number" contextRef="i3828073d79a24491bcaeaf36fce13056_I20221231" decimals="3" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIyMw_5c8eba98-534b-4988-a937-d148590f370b"><ix:nonFraction unitRef="number" contextRef="if400f8d238e54035a7cab079f344caeb_I20211231" decimals="3" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIyMw_f4d6381b-a760-4630-8245-92c3ab191025">2.0</ix:nonFraction></ix:nonFraction>% at December&#160;31, 2022 and 2021.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="ibefe03fcc7974c139761cd5fb6770138" continuedAt="icfe12957f32a4bb8a2e084e929927926"><ix:continuation id="i766d65d1b6d843829f4bee8bf48f6d66" continuedAt="i3a629c455bc24305bcc679cebf8ec4a7"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, our outstanding long-term debt consisted of the following:</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.889%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.071%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8364;<ix:nonFraction unitRef="eur" contextRef="iaaba818d157743e8b83bcea0509a84fd_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzMtMS0xLTEtMTg0NDY5_f31d7154-bcca-4e26-82be-2cbf5cb4c0f3">1,250</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaaba818d157743e8b83bcea0509a84fd_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzMtMi0xLTEtMTg0NDY5_10027acc-ac82-4424-8f30-bcdecb670168">1.000</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iadefd780e0034b64926bdc30f75a610f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzQtMS0xLTEtMTg0NDY5_f4624b55-70a7-472c-9577-2391dbc706ee">218</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iadefd780e0034b64926bdc30f75a610f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzQtMi0xLTEtMTg0NDY5_64a426ac-e55c-4608-80a4-2cb186a6a7f1">2.950</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if9d9007ab56a458484aad403ac237294_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzUtMS0xLTEtMTg0NDY5_e59bed35-9429-4c8e-9df4-390109b86566">776</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if9d9007ab56a458484aad403ac237294_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzUtMi0xLTEtMTg0NDY5_7fa4ccc9-1560-447b-9d96-40d89e098820">4.000</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2013</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i63dfd595051b469195be60b2f91efc8d_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzYtMS0xLTEtMTg0NDY5_0077a73b-0c10-4bed-b38a-e0bcffb242e1">345</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63dfd595051b469195be60b2f91efc8d_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzYtMi0xLTEtMTg0NDY5_62dfc39f-8ee1-421f-b4a6-71408028f457">3.800</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5f830258f25a4d1d84e87ead5fd45a4a_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzctMS0xLTEtMTg0NDY5_dcf0f2a7-13be-4eac-abf3-6ed656b71116">750</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f830258f25a4d1d84e87ead5fd45a4a_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzctMi0xLTEtMTg0NDY5_4a0acb44-ad3c-4ed4-8aa9-4eef95168864">2.350</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8364;<ix:nonFraction unitRef="eur" contextRef="ice1bb82d9a41443c8498022e8e7d7779_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzgtMS0xLTEtMTg0NDY5_fb2c7f2c-0b71-4d52-825f-b2fa690a6cf8">750</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ice1bb82d9a41443c8498022e8e7d7779_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzgtMi0xLTEtMTg0NDY5_32e1d7a1-64cd-4299-bc34-f8363ea4d55f">1.700</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i0008e44fe6024463a3a1a558fdcee38e_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzktMS0xLTEtMTg0NDY5_808d23d8-0fd1-4546-8459-664fe29169c3">1,069</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0008e44fe6024463a3a1a558fdcee38e_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzktMi0xLTEtMTg0NDY5_ee91ab79-a003-4f0c-85fa-d2b42abf233e">4.400</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2026</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="iec4782d4b8074f9bacc9db3c3c30d3da_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzEwLTEtMS0xLTE4NDQ2OQ_fe8266bd-192a-43c4-8d8f-006b45876635">500</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iec4782d4b8074f9bacc9db3c3c30d3da_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzEwLTItMS0xLTE4NDQ2OQ_35038f1d-35e1-49ce-a49d-ac00f8ccfff3">2.625</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD debenture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i92fe93dcf2a34fecaed4dc95f41d6851_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzExLTEtMS0xLTE4NDQ2OQ_de88b723-b0b4-417d-99e8-6a2468baf6ad">42</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i92fe93dcf2a34fecaed4dc95f41d6851_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzExLTItMS0xLTE4NDQ2OQ_2cf2074a-b484-4896-a901-73a5e828a792">7.750</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1997</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2027</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8364;<ix:nonFraction unitRef="eur" contextRef="ib92f4cb6a30e4e6f9f00525310225c89_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzEyLTEtMS0xLTE4NDQ2OQ_45552d9e-d293-4c0c-8220-eadd8ea708e6">1,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib92f4cb6a30e4e6f9f00525310225c89_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzEyLTItMS0xLTE4NDQ2OQ_a0f79333-7648-4d77-a1a6-17bb734cd9c1">2.200</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="icd978ed23459400eb32a2c82f06f2a4c_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzEzLTEtMS0xLTE4NDQ2OQ_e96ccc57-04e4-4f89-aefb-880ab99998a1">1,906</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icd978ed23459400eb32a2c82f06f2a4c_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzEzLTItMS0xLTE4NDQ2OQ_0d28b95b-6340-4417-a6ce-6458052cebeb">4.800</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2029</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5d59ad2d97184e4ca31c709f4e3635fd_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE0LTEtMS0xLTE4NDQ2OQ_3fc2cc95-1a65-459d-829e-5a313937e453">750</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d59ad2d97184e4ca31c709f4e3635fd_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE0LTItMS0xLTE4NDQ2OQ_bc21c2e5-667c-4cf1-bcb6-5cb419423ce0">3.400</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2030</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8364;<ix:nonFraction unitRef="eur" contextRef="ic57f5a35ebfa4c3fbcaa79d030ef21a0_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE1LTEtMS0xLTE4NDQ2OQ_bb2305ef-4e39-4925-83f8-23bcbd455f29">1,250</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic57f5a35ebfa4c3fbcaa79d030ef21a0_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE1LTItMS0xLTE4NDQ2OQ_d88be5d2-f388-4199-916b-5a2be2416dd6">3.125</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2031</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="icaac5abc8e624b32a8ec9a613c59bc47_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE2LTEtMS0xLTE4NDQ2OQ_76ea510b-7279-43c8-8753-2f7f0103f674">1,750</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icaac5abc8e624b32a8ec9a613c59bc47_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE2LTItMS0xLTE4NDQ2OQ_6ebabc9a-a933-4554-9f82-a58f8445569b">2.450</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2032</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="idc5ec60ad53c4b4783f7d38256ebf88f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE3LTEtMS0xLTE4NDQ2OQ_64662928-78db-4310-9adf-835ba46d6b7b">177</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idc5ec60ad53c4b4783f7d38256ebf88f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE3LTItMS0xLTE4NDQ2OQ_988a2c84-77ed-452d-a9b5-da1c00becf8f">9.950</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2008</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2038</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie8f3c72b4651489d90df2e16ffa4a05e_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE4LTEtMS0xLTE4NDQ2OQ_3a90f969-6993-4609-8bee-6adcd8a2277f">208</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie8f3c72b4651489d90df2e16ffa4a05e_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE4LTItMS0xLTE4NDQ2OQ_d62d7fce-b097-453f-b323-e9c274aee3af">10.200</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2009</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2039</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i7f384896829c4943abc32d79f5210571_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE5LTEtMS0xLTE4NDQ2OQ_137b4544-7629-4253-b3a8-27e2dc226a58">2,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7f384896829c4943abc32d79f5210571_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE5LTItMS0xLTE4NDQ2OQ_88f92198-57b7-427e-8311-e1b71b0e02ae">5.800</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2039</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i66cedc520a05430f99dd7f092780f5c3_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIwLTEtMS0xLTE4NDQ2OQ_be19d546-31f1-4cbf-ac8f-434bfa87bed5">1,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i66cedc520a05430f99dd7f092780f5c3_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIwLTItMS0xLTE4NDQ2OQ_86d322ba-2a65-4399-8ae8-8b31b78c9f05">3.400</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2041</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia75ae511ae35422b929bab49c142131a_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIxLTEtMS0xLTE4NDQ2OQ_764e0a81-9a75-48fc-b65e-161af05deab2">900</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia75ae511ae35422b929bab49c142131a_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIxLTItMS0xLTE4NDQ2OQ_e180e921-7295-43bd-80d0-7d558db1669e">4.250</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2012</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2042</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i1faae93371144c7993efed37d5f5c24f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIyLTEtMS0xLTE4NDQ2OQ_1b7e5f41-e08a-4a70-93cb-a8331852aec6">650</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1faae93371144c7993efed37d5f5c24f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIyLTItMS0xLTE4NDQ2OQ_24105f96-c7a7-45d4-8a3f-f1c48548d4ee">4.500</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2043</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie6cd4d1753f74e26bc079154f136894c_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIzLTEtMS0xLTE4NDQ2OQ_0391aa81-ea1f-4f0b-b474-1da4c32a396f">1,800</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie6cd4d1753f74e26bc079154f136894c_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIzLTItMS0xLTE4NDQ2OQ_d5d5c23e-772d-4287-a5fa-189ad27a37e6">5.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2013</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2044</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib1d7fc010c9442408c1346df432ae19b_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI0LTEtMS0xLTE4NDQ2OQ_64883302-5722-4410-b9e7-98e51e2bd9f1">1,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1d7fc010c9442408c1346df432ae19b_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI0LTItMS0xLTE4NDQ2OQ_94b54936-a23d-4261-bbef-3931a7dbdd4b">3.875</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2046</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i0dc37d2451ac45539913bbac9f76a69a_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI1LTEtMS0xLTE4NDQ2OQ_ec5d3637-cb63-476d-a1f4-f828fd217fd6">2,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0dc37d2451ac45539913bbac9f76a69a_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI1LTItMS0xLTE4NDQ2OQ_b6f48090-c099-4e22-b123-568ac3bd4d3c">5.950</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2049</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia705d60663d745daa5a1d6310b196a7b_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI2LTEtMS0xLTE4NDQ2OQ_ead7ac89-f140-403e-850d-0ced23fea8cf">500</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia705d60663d745daa5a1d6310b196a7b_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI2LTItMS0xLTE4NDQ2OQ_314305e5-3e41-4eba-a3d7-1c234852db47">4.450</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2050</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i39346349fd3d454fbe7d80d77da544b6_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI3LTEtMS0xLTE4NDQ2OQ_d070ab19-0da5-40e2-803a-a7cb26106e1b">1,250</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i39346349fd3d454fbe7d80d77da544b6_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI3LTItMS0xLTE4NDQ2OQ_2842eafc-4bfd-43a7-b423-fbb87060d18b">3.700</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2051</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8db11a63f05942319bf0d2eddaf952a7_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI4LTEtMS0xLTE4NDQ2OQ_06882c6a-62cf-444e-9a74-68ff93d22766">271</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8db11a63f05942319bf0d2eddaf952a7_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI4LTItMS0xLTE4NDQ2OQ_795121d7-9207-45cd-8690-1a2f78001d11">6.200</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2059</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i985d9e1153d249ccbe35c8a2ed078b3a_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI5LTEtMS0xLTE4NDQ2OQ_563a7e90-f425-4b91-9dbb-4fd85f2651fd">1,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i985d9e1153d249ccbe35c8a2ed078b3a_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI5LTItMS0xLTE4NDQ2OQ_52e82cbe-5682-4d97-bab6-003f245f9c26">4.000</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2061</span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzQ3NzU_351c2039-b169-4eba-a007-8ad845890fcb" escape="true"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, aggregate maturities of our long-term debt were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.501%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Maturities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzEtMi0xLTEtMTg0NDY5_837db3a7-2e62-4880-83fb-21a45eb7d610">1,556</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzItMi0xLTEtMTg0NDY5_7d24ca51-bc66-4f31-941c-ee2fde4bc50c">1,121</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzMtMi0xLTEtMTg0NDY5_b0b15e93-a0a4-4dfe-b0a2-176981a3126e">1,553</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzQtMi0xLTEtMTg0NDY5_8432ba6c-7b3f-4c17-9f6c-e8e6e5b332b5">1,569</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzUtMi0xLTEtMTg0NDY5_db2cad5b-fb99-45e4-9aab-0433d5c6adfa">1,113</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="mo:LongTermDebtMaturitiesRepaymentsofPrincipalThereafter" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzYtMi0xLTEtMTg0NDY5_3ca16142-fc2b-4e18-9870-12b49bf47f9c">20,000</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzctMi0xLTEtMTg0NDY5_1df65daa-d0f9-42ea-b0eb-5a93344dfb35">26,912</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzgtMi0xLTEtMTg0NDY5_3e62e649-d4d9-4edf-885b-621691626d94">148</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzktMi0xLTEtMTg0NDY5_7d4dab1e-da48-4ad0-a7f2-4da521cd72de">84</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzEwLTItMS0xLTE4NDQ2OQ_4638d055-9048-41e8-8ad9-30093a76a11c">26,680</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, accrued interest on long-term debt of $<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzQzOQ_6b8e935d-bfe5-4ae8-8f71-5fe59b102f95">411</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:InterestPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzQ0Ng_7576ed69-bf5c-4c5e-aead-7772df9287f5">429</ix:nonFraction> million, respectively, was included in other accrued liabilities on our consolidated balance sheets.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, we repaid in full our <ix:nonFraction unitRef="number" contextRef="i1a2bb57dbcd94da09e99e9faca7b947f_I20220831" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjIwMTk_de7b51fa-3e73-424a-9513-a3626b17aae3">2.850</ix:nonFraction>% senior unsecured notes in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i93b4fdf778254947bb262abfd638909a_D20220801-20220831" decimals="-8" name="us-gaap:RepaymentsOfUnsecuredDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjIwMzI_da3d9deb-06cc-49a1-9808-fb72b96fb548">1.1</ix:nonFraction> billion at maturity.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="icfe12957f32a4bb8a2e084e929927926"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our notes are senior unsecured obligations and rank equally in right of payment with all of our existing and future senior unsecured indebtedness.  Following the occurrence of both (i) a change of control of Altria and (ii) the notes ceasing to be rated investment grade by each of Moody&#8217;s, S&amp;P and Fitch Ratings Inc., we will be required to make an offer to purchase the notes at a price equal to <ix:nonFraction unitRef="number" contextRef="id4cd8efeaae34f919b123479df396a64_D20220101-20221231" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjQ1MzU_1f0d6ae0-15a1-41bb-b9b8-48f813f34aa0">101</ix:nonFraction>% of the aggregate principal amount of such notes, plus accrued and unpaid interest to the date of repurchase as and to the extent set forth in the terms of the notes.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Debt Tender Offers and Redemption: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we completed debt tender offers to purchase for cash certain of our long-term senior unsecured notes in an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i34f308ec117342cd83eb1c8c2367bffc_I20210331" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjIxMTQ_09659904-d804-4949-91eb-7b7f86e92556">4,042</ix:nonFraction> million.  <ix:continuation id="i3a629c455bc24305bcc679cebf8ec4a7" continuedAt="ie889f06150c44ec4b67e3fac63dff099">Details of the debt tender offers were as follows:</ix:continuation></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="ie889f06150c44ec4b67e3fac63dff099"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.070%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal Amount of Notes Purchased</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id8b660eda4894cb386f65ca5af40f210_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzEtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246MWUwMmNkOWJmZGQyNDEzMTliZWM5NGJmMmQxNDEyYjVfNA_60a37194-7569-40c1-af8f-4a5c7e195fc3">2.850</ix:nonFraction>% Notes due 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8b660eda4894cb386f65ca5af40f210_I20210331" decimals="INF" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzEtMS0xLTEtMTg0NDY5_02b8aa31-4389-4998-b029-fd6a6f962178">795</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12b21493a628400c8be8f1d6a8ed3385_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzItMC0xLTEtMTg0NDY5L3RleHRyZWdpb246MDdhMjlhN2IxMWYyNDgyMWEwZDhiYmYwNzc2NGFmZTlfNA_bdc3797a-8801-447e-bcfc-c28aefca30bf">2.950</ix:nonFraction>% Notes due 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12b21493a628400c8be8f1d6a8ed3385_I20210331" decimals="INF" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzItMS0xLTEtMTg0NDY5_ad67fa96-fa11-44cf-973a-65820b3c727b">132</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i539b185f58964558a12c50808bd29011_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzMtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246MzBhNWQ1ZTZmNTg2NDNmMmIwZjFkNDg4YjAxZThjYjRfNA_9e49b71e-b7b6-4d65-bc62-6641ff3f7079">4.000</ix:nonFraction>% Notes due 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i539b185f58964558a12c50808bd29011_I20210331" decimals="INF" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzMtMS0xLTEtMTg0NDY5_df59d151-673a-410b-b903-c0ddedefc358">624</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f6f50e4575f4c78858838ff914b03c2_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzQtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246NDE2M2U3YjVhNTAzNDc5MWIxZGQ4NzYzOTYzZTYwYjZfNA_a2965a2b-ec8a-4164-9356-11d19b9e025c">3.800</ix:nonFraction>% Notes due 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f6f50e4575f4c78858838ff914b03c2_I20210331" decimals="INF" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzQtMS0xLTEtMTg0NDY5_a32a7182-d4cd-42e3-bbd7-55b872a3e857">655</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d2e0075768e4aeb84b4d297b8930772_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzUtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246ZmNlNmJhNWVmNGVmNDY1YzgzMGNlMDVhMzA1ZDIwYTZfNA_393209b2-c982-46d1-9abe-cd9e3dc8e508">4.400</ix:nonFraction>% Notes due 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d2e0075768e4aeb84b4d297b8930772_I20210331" decimals="INF" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzUtMS0xLTEtMTg0NDY5_3b27b877-80ba-4c78-abcb-35266fe21dd2">430</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5c58db1ce1ac4ff4bed80427e3ff6a6c_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzYtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246N2I1ZTc5NTE3ZTg3NGFlMGE3ZGQ5N2Q0Mjk3MTZiYzVfNA_c886dc6b-5721-4662-90a0-67bbbcc03f0d">4.800</ix:nonFraction>% Notes due 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c58db1ce1ac4ff4bed80427e3ff6a6c_I20210331" decimals="INF" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzYtMS0xLTEtMTg0NDY5_32bdd165-98bd-48b2-82c8-be277ab7cae3">1,094</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7fb4aa15e8644b8dac184d5311a665f3_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzctMC0xLTEtMTg0NDY5L3RleHRyZWdpb246OTFlZGZjZDc3OGUzNDJjY2FiNWNlMmFiYWI3MjdmZmFfNA_031b1507-14a3-4428-b98b-25f58f53bd8e">9.950</ix:nonFraction>% Notes due 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fb4aa15e8644b8dac184d5311a665f3_I20210331" decimals="INF" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzctMS0xLTEtMTg0NDY5_41a07b73-1c89-45f0-9eb6-a0b9dbccb549">65</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia123b20dbca2464d91553ad8a790922d_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzgtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246NjhmZTAyOGRmOTE1NDNhOWFlNmFkMGQ5OTE0MWJhNWNfNA_0db0428c-a242-4ffa-bfe4-7a75457672dd">10.200</ix:nonFraction>% Notes due 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia123b20dbca2464d91553ad8a790922d_I20210331" decimals="INF" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzgtMS0xLTEtMTg0NDY5_c6e532f1-a316-4ac7-9299-608d7437430f">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7c75f31df572443b876910d052f325e1_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzktMC0xLTEtMTg0NDY5L3RleHRyZWdpb246ZjYwYzBlNTlhODU2NGFjMDgzMGJjODliZjExMzMyZDhfNA_3068ca0c-7c66-40cd-b3c4-8140f4eae760">6.200</ix:nonFraction>% Notes due 2059</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c75f31df572443b876910d052f325e1_I20210331" decimals="INF" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzktMS0xLTEtMTg0NDY5_5dbb3351-033d-4a01-bc1f-13e6e060891b">229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34f308ec117342cd83eb1c8c2367bffc_I20210331" decimals="INF" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzEwLTEtMS0xLTE4NDQ2OQ_570c0e75-5771-4cb1-86de-9776e54dc9b3">4,042</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we also redeemed all of our outstanding <ix:nonFraction unitRef="number" contextRef="i05610ebaa85d4ea193c96166dfd53b0c_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIzNDU_4e837e3b-89dc-4678-806f-ca3846e6dfec">3.490</ix:nonFraction>% senior unsecured notes due to mature in 2022 in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="ic922d20d61114cb5b818e46d2ee2f170_D20210101-20210331" decimals="-8" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIzOTk_64c672f4-34d5-4e32-bab8-c3826cc9daae">1.0</ix:nonFraction> billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the debt tender offers and redemption, during the first quarter of 2021, we recorded pre-tax losses on early extinguishment of debt of $<ix:nonFraction unitRef="usd" contextRef="ia8e69b6b782f4aa5975697d9355b34c6_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjIxMzk_860f5efb-6ee8-4a25-b7fb-3ddbf48de004">649</ix:nonFraction> million, which included premiums and fees of $<ix:nonFraction unitRef="usd" contextRef="ia8e69b6b782f4aa5975697d9355b34c6_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjIxODA_0ee929da-99ea-477f-85bf-b8f4229628fd">623</ix:nonFraction> million and the write-off of unamortized debt discounts and debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="ia8e69b6b782f4aa5975697d9355b34c6_D20210101-20210331" decimals="-6" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjIyNTk_695b355b-b9bb-4245-a197-b2a392508e1a">26</ix:nonFraction> million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA (the &#8220;Guarantor&#8221;), which is a 100% owned subsidiary of Altria Group, Inc. (the &#8220;Parent&#8221;), has guaranteed the Parent&#8217;s obligations under its outstanding debt securities, borrowings under its Credit Agreement and amounts outstanding under its&#160;commercial paper program (the &#8220;Guarantees&#8221;).  Pursuant to&#160;the Guarantees, the Guarantor fully and unconditionally guarantees, as primary obligor, the payment and performance of the Parent&#8217;s obligations under the guaranteed debt instruments (the &#8220;Obligations&#8221;), subject to release under certain customary circumstances as noted below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Guarantees provide that the Guarantor guarantees the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations.  The liability of the Guarantor under the Guarantees is absolute and unconditional irrespective of: any lack of validity, enforceability or genuineness of any provision of any agreement or instrument relating thereto; any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to departure from any agreement or instrument relating thereto; any exchange, release or non-perfection of any collateral, or any release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Obligations; or any other circumstance that might otherwise constitute a defense available to, or a discharge of, the Parent or the Guarantor.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Parent is a holding company; therefore, its access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  Neither the Guarantor nor other 100% owned subsidiaries of the Parent that are not guarantors of the Obligations are limited by contractual obligations on their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the fair value of our long-term debt and the designation of our Euro denominated senior unsecured notes as a net investment hedge of our investment in ABI, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_145"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 9.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzE4MDE_2de65f76-cce1-4f89-a71e-fa2807f1572d" continuedAt="id0342743042e48c7a0dd03f1afa3921a" escape="true">Capital Stock</ix:nonNumeric></span></div><ix:continuation id="id0342743042e48c7a0dd03f1afa3921a"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzE4MDc_9f334f24-0f88-4d17-b63d-c5f841acd2a0" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had <ix:nonFraction unitRef="shares" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzQy_19ccecd1-51b9-4908-9430-5c0a20d82cf4">12</ix:nonFraction> billion shares of authorized common stock; issued, repurchased and outstanding shares of common stock consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"></td><td style="width:48.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.320%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Repurchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Outstanding</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40e064b5da194d8bbe29064d490250de_I20191231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzQtMS0xLTEtMTg0NDY5_4e252b5b-62d5-4fac-927a-6e5fbdd6498f">2,805,961,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i40e064b5da194d8bbe29064d490250de_I20191231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzQtMy0xLTEtMTg0NDY5_9e6cd452-742e-4679-826f-7b4f61194ca9">947,979,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i40e064b5da194d8bbe29064d490250de_I20191231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzQtNS0xLTEtMTg0NDY5_b8d4ce87-981b-4a40-b2f4-93e31273b2db">1,857,981,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="INF" name="mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzUtMy0xLTEtMTg0NDY5_45212ffc-0781-40f4-bbb2-7678f3293764">437,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="INF" name="mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzUtNS0xLTEtMTg0NDY5_3f1ec2b2-e688-4b34-a3c4-94d877e2c456">437,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzctMS0xLTEtMTg0NDY5_988195aa-c82a-49c6-9b9c-149f74b6109e">2,805,961,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzctMy0xLTEtMTg0NDY5_0043ea11-8e32-4d1d-a102-13b1b9a3dbcd">947,542,152</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzctNS0xLTEtMTg0NDY5_816f57a1-a0da-4fdf-8ecf-79a5121132c9">1,858,419,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="INF" name="mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzgtMy0xLTEtMTg0NDY5_02025ef7-6cae-4a22-b6e6-dfd551ab508d">412,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="INF" name="mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzgtNS0xLTEtMTg0NDY5_fda504eb-5965-4164-8a77-d77909e6f803">412,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzktMy0xLTEtMTg0NDY5_fc3ebcb8-acf9-4fd4-98ee-6dc6bb192366">35,656,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzktNS0xLTEtMTg0NDY5_df377634-bc1e-4f60-b06d-f06912d22a7e">35,656,116</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEwLTEtMS0xLTE4NDQ2OQ_d80629a5-8601-4454-959a-94c6c9d27db1">2,805,961,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEwLTMtMS0xLTE4NDQ2OQ_bd099ce6-ddff-4658-b172-eb571a3d389c">982,785,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEwLTUtMS0xLTE4NDQ2OQ_9f54f91c-e077-412a-862f-17766d5fafd2">1,823,175,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="INF" name="mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzExLTMtMS0xLTE4NDQ2OQ_83c8a763-1a20-41ac-8c9e-7c83f3c0e5d4">514,816</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="INF" name="mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzExLTUtMS0xLTE4NDQ2OQ_235d65aa-d941-48c2-abdc-53e109792ca6">514,816</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEyLTMtMS0xLTE4NDQ2OQ_51aa082f-61ae-4849-bd27-cf270e1ced14">38,156,312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEyLTUtMS0xLTE4NDQ2OQ_f98b82a5-6be8-4a91-8124-8b2b0bb41f9c">38,156,312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEzLTEtMS0xLTE4NDQ2OQ_ba4642b1-7c0a-45fb-9b79-cbf1d0bdf701">2,805,961,317</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="INF" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEzLTMtMS0xLTE4NDQ2OQ_d20fefa3-d865-4d07-8b8a-e8c074cb195b">1,020,427,195</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEzLTUtMS0xLTE4NDQ2OQ_383c0a9b-e1fb-4e67-b7b4-562ed308a064">1,785,534,122</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had <ix:nonFraction unitRef="shares" contextRef="i310c0dd5c06a43918728eab4e66aae82_I20221231" decimals="INF" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzE3Ng_2bbcf70d-2383-4ce2-920e-7d97d9db4822">26,698,134</ix:nonFraction> shares of common stock reserved for stock-based awards under our stock plans.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had <ix:nonFraction unitRef="shares" contextRef="i1bda21fb40e34632bd2a70325195b703_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzI2OQ_61fc81f4-5057-4661-86ee-caef35e798b6">10</ix:nonFraction> million authorized shares of serial preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i1bda21fb40e34632bd2a70325195b703_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzMwNw_6eceb984-5229-44fc-9885-6532a6990ee9">1.00</ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i1bda21fb40e34632bd2a70325195b703_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzM4NDgyOTA3MDA4NTQ_a775a968-cbc8-41d9-ad71-d462d79fbfc8">no</ix:nonFraction> shares of serial preferred stock have been issued.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Dividends: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, our Board of Directors (&#8220;Board of Directors&#8221; or &#8220;Board&#8221;) approved a <ix:nonFraction unitRef="number" contextRef="id4a80e5aa58a45bb84e8bd06eac4fa44_D20220701-20220930" decimals="3" name="mo:CommonStockDividendIncreasePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzUwOQ_0225a77f-3eed-4d3a-bd11-1c75e98261f7">4.4</ix:nonFraction>% increase in the quarterly dividend rate to $<ix:nonFraction unitRef="usdPerShare" contextRef="id4a80e5aa58a45bb84e8bd06eac4fa44_D20220701-20220930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzU1NQ_a18eff89-aae8-4efd-b5a3-0c22636d23c4">0.94</ix:nonFraction> per share of our common stock versus the previous rate of $<ix:nonFraction unitRef="usdPerShare" contextRef="id5e8e369ebdc481eb1c50facf9407ffd_D20220401-20220630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzYxOQ_24e2c158-7e5b-4114-b8ef-5685f1969a6e">0.90</ix:nonFraction> per share.  The current annualized dividend rate is $<ix:nonFraction unitRef="usdPerShare" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="2" name="mo:CommonStockDividendRateAnnualPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzY3NA_1dfc8eff-6b80-4ba1-b861-51c597251f58">3.76</ix:nonFraction> per share.  Future dividend payments remain subject to the discretion of our Board.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Share Repurchases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, our Board of Directors authorized a $<ix:nonFraction unitRef="usd" contextRef="ic4318d73c3ec420f9b7ea13530338ad1_I20210131" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzExMTU_084e6194-c8f2-44a6-aa36-df56692d4488">2.0</ix:nonFraction> billion share repurchase program that it expanded to $<ix:nonFraction unitRef="usd" contextRef="i6dee55786a8947d5be0e870d6c2bb228_I20211031" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzExNjM_604affb6-ea46-4938-aab4-b776c34c48f2">3.5</ix:nonFraction> billion in October 2021 (as expanded, the &#8220;January 2021 share repurchase program&#8221;).  We completed the January 2021 share repurchase program in December 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, our Board of Directors authorized a new $<ix:nonFraction unitRef="usd" contextRef="i55356fbd37f340dd975f11d54874fece_I20230131" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzM4NDgyOTA3MDIyNDI_47387b5e-5ad9-46e5-9900-8f2a0df7a370">1.0</ix:nonFraction> billion share repurchase program.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of our Board.</span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzE4MDg_5faf50f9-f307-4956-b2e5-12de87a49078" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total share repurchase activity was as follows for the years ending December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.003%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.563%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 2021 Share Repurchase Program</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id15c7c4db331481f86239866210c3ea8_D20220101-20221231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzItMi0xLTEtMTg0NDY5_519cb68e-1c42-45b0-9166-6f844bb62bac">38.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0e3d1499f104a538572ddf276309760_D20210101-20211231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzItNC0xLTEtMTg0NDY5_d430d24d-84f4-4e17-9b0d-80c29aeacf75">35.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1814a9e5885940cdb1d92fe2948219f4_D20210101-20221231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzItMTAtMS0xLTE4NDQ2OQ_5fedab07-729e-415b-b159-885ff0367e0d">73.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost of shares repurchased</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id15c7c4db331481f86239866210c3ea8_D20220101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzMtMi0xLTEtMTg0NDY5_07d6f33c-ac81-46c2-83bb-a2328803924f">1,825</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0e3d1499f104a538572ddf276309760_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzMtNC0xLTEtMTg0NDY5_3da4560c-5039-4d06-b86b-fe19e48aa3d1">1,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1814a9e5885940cdb1d92fe2948219f4_D20210101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzMtMTAtMS0xLTE4NDQ2OQ_16c51ebf-c39f-4a1c-9607-e11c40e22145">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share of shares repurchased</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id15c7c4db331481f86239866210c3ea8_D20220101-20221231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzQtMi0xLTEtMTg0NDY5_b9ff5f3f-cba1-42f1-86e1-325ca803b410">47.83</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if0e3d1499f104a538572ddf276309760_D20210101-20211231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzQtNC0xLTEtMTg0NDY5_6c6fb626-e630-4b50-8f24-f662e9b544af">46.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1814a9e5885940cdb1d92fe2948219f4_D20210101-20221231" decimals="2" name="us-gaap:TreasuryStockAcquiredAverageCostPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzQtMTAtMS0xLTE4NDQ2OQ_8149fef8-9f92-46c7-bbd2-1e3622f46eb8">47.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did <ix:nonFraction unitRef="shares" contextRef="ie2ccef0d8b6b41aea1718d46140df7ff_D20200101-20201231" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzQzOTgwNDY1MTY1NDE_58b2940e-d33d-48aa-b5b6-64a9a06b8aa3">no</ix:nonFraction>t repurchase any shares in 2020.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_148"></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 10.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM5NzM_02d82edd-5434-464f-b0d2-e6edda84a478" continuedAt="iddd154d326d541bca46b61a3ea0dd1db" escape="true">Stock Plans</ix:nonNumeric></span></div><ix:continuation id="iddd154d326d541bca46b61a3ea0dd1db" continuedAt="i6a5385a0b5284edaaa8a7c9c309b6958"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our Board of Directors adopted, and shareholders approved, the Altria Group, Inc. 2020 Performance Incentive Plan (the &#8220;2020 Plan&#8221;) under which we may grant stock options, stock appreciation rights, restricted stock, restricted stock units (&#8220;RSUs&#8221;), performance stock units (&#8220;PSUs&#8221;) and other stock-based awards, as well as cash-based annual and long-term incentive awards to our employees.  Any awards granted under the 2020 Plan may be in the form of performance-based awards, including PSUs subject to the achievement or satisfaction of performance goals and performance cycles.  We may issue up to <ix:nonFraction unitRef="shares" contextRef="idde860552f9e4af3818e1e0171c49245_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzgyMQ_0f1456c8-b4ed-4fe9-997f-8bcd5d86b43a">25</ix:nonFraction> million shares of common stock under the 2020 Plan.  In addition, under the 2015 Stock Compensation Plan for Non-Employee Directors (the &#8220;Directors Plan&#8221;), we may grant up to <ix:nonFraction unitRef="shares" contextRef="i638d815ed9f74221b605f9614dbf0863_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzEwMDk_c28e85ef-1b51-4774-90db-fabf29be8c04">one million</ix:nonFraction> shares of common stock to members of the Board of Directors who are not employees of Altria.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had <ix:nonFraction unitRef="shares" contextRef="idde860552f9e4af3818e1e0171c49245_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzExOTE_a3f081b3-f14e-4116-86bf-5d742f0632c1">21,972,920</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i638d815ed9f74221b605f9614dbf0863_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzExOTg_0d8176f5-a674-44b3-a16c-48b0e1a76970">650,121</ix:nonFraction> shares available to be granted under the 2020 Plan and the Directors Plan, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">RSUs: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the vesting period, RSUs include nonforfeitable rights to dividend equivalents and may not be sold, assigned, pledged or otherwise encumbered.  RSUs are subject to forfeiture if certain employment conditions are not met.  We estimate the number of awards expected to be forfeited and adjust this estimate when subsequent information indicates that the actual number of forfeitures is likely to differ from previous estimates.  RSUs generally vest <ix:nonNumeric contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzE2OTY_6b8e3641-f2b5-40bc-bd14-914bf25c6ddb">three years</ix:nonNumeric> after the grant date.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i6a5385a0b5284edaaa8a7c9c309b6958"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We amortize to expense ratably over the restriction period, which is generally <ix:nonNumeric contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" name="mo:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM4NDgyOTA3MDIwMzQ_0988c228-03b4-4be0-83a2-20bb87e9d35a">three years</ix:nonNumeric>, the fair value of the RSUs at the date of grant, net of estimated forfeitures.  We recorded pre-tax compensation expense related to RSUs for the years ended December&#160;31, 2022, 2021 and 2020 of $<ix:nonFraction unitRef="usd" contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzE5ODM_d3675984-aa99-4395-ba4d-13e42a65378c">41</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2bde4c691bfe43909179ea90b1ba5f53_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzE5ODc_58309722-3aba-4b76-bbbd-89a3b70c9712">34</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie586f180596b4de1bfd14cd16fa40aec_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzE5OTQ_26f37bdf-3f3c-4af9-a622-b66680649afa">31</ix:nonFraction> million, respectively.  We recorded a deferred tax benefit related to this compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzIwODg_0e089b66-2194-4c9d-a298-a3ecaa0ac34d">10</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2bde4c691bfe43909179ea90b1ba5f53_D20210101-20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzIwOTI_1374cce7-24b0-45f2-bb81-94547e47813c">9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie586f180596b4de1bfd14cd16fa40aec_D20200101-20201231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzIwOTk_29d7a6c2-a5e1-4851-ab19-e01817f1a02e">8</ix:nonFraction> million for the years ended December&#160;31, 2022, 2021 and 2020, respectively.  The unamortized compensation expense related to RSUs was $<ix:nonFraction unitRef="usd" contextRef="i28af804fe6b74399ba55088a1f49d3aa_I20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzIyMDk_d48fb0af-4a3a-46a5-a0ad-e5f1b07acf80">73</ix:nonFraction> million at December&#160;31, 2022, which we expect to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzIyOTk_6ac04c16-4d52-490c-a614-b095246591a3">two years</ix:nonNumeric>.</span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM5NjQ_9fb0be4d-1680-41ff-86f3-3f899fcbb473" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.069%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.070%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5040992030f401f8d230ceec09bf4b5_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzEtMS0xLTEtMTg0NDY5_a7061b0a-0b1c-4fbb-8be8-d0c320096348">2,702,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5040992030f401f8d230ceec09bf4b5_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzEtMy0xLTEtMTg0NDY5_237f88b6-7672-433b-a98b-a60ac44097c6">46.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzItMS0xLTEtMTg0NDY5_5ee0585f-10c0-4dfa-b00d-214d7ecd24d4">1,206,601</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzItMy0xLTEtMTg0NDY5_1868031b-2d6d-4498-9a25-3af0e1473370">49.22</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzMtMS0xLTEtMTg0NDY5_e852252c-a3f4-41a3-bce6-bd6a2d7b26ed">556,399</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzMtMy0xLTEtMTg0NDY5_a9cd59a1-d474-493d-8aef-24d3f5e98f23">51.96</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzQtMS0xLTEtMTg0NDY5_b3bb45c9-7f99-4236-8e6d-d68df43440d8">94,869</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzQtMy0xLTEtMTg0NDY5_08465fc1-f13d-4b08-9b27-5cc12958cfd2">45.10</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28af804fe6b74399ba55088a1f49d3aa_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzUtMS0xLTEtMTg0NDY5_94be9013-bf41-4669-be2a-984958d28318">3,257,795</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i28af804fe6b74399ba55088a1f49d3aa_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzUtMy0xLTEtMTg0NDY5_43237a47-f645-459f-a556-e9f7962f729b">46.90</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of RSUs granted during the years ended December&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i28af804fe6b74399ba55088a1f49d3aa_I20221231" decimals="-6" name="mo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI0MzQ_d1070734-130f-468b-afe6-93eb83a7789e">59</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="ie5040992030f401f8d230ceec09bf4b5_I20211231" decimals="-6" name="mo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI0Mzg_157e5ab7-71ec-4100-9e5b-e6726e5fe454">48</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0e6c90982182440887d92a56034de67f_I20201231" decimals="-6" name="mo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI0NDU_8efbb7d0-f192-41ce-bb70-775d75e9422f">49</ix:nonFraction> million, respectively, or $<ix:nonFraction unitRef="usdPerShare" contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI0NjY_7e7c02fa-8f27-46cf-860a-5179deaf51b0">49.22</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i2bde4c691bfe43909179ea90b1ba5f53_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI0NzA_562aeace-09fb-4d4b-829a-d71959b3de96">45.22</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ie586f180596b4de1bfd14cd16fa40aec_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI0Nzc_665d4c0d-5b9e-4bdb-9201-2279d165b675">42.59</ix:nonFraction> per RSU, respectively.  The total vesting date fair value of RSUs that vested during the years ended December&#160;31, 2022, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI1OTk_d83a9e48-9177-41ce-8d1b-8be587133574">29</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i2bde4c691bfe43909179ea90b1ba5f53_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI2MDM_16bbddcc-4f95-4a99-b32b-56845834a2e4">19</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie586f180596b4de1bfd14cd16fa40aec_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI2MTA_45d194f5-75ed-483d-ab3b-8c229803cf9a">25</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">PSUs: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We granted an aggregate of <ix:nonFraction unitRef="shares" contextRef="ic9c7c153e8d34eda8c3f26df0b887be6_D20220101-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI2NjY_b2f16880-c595-49c6-b824-5f55fd335657">215,205</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i43cdf17dccb84fe48ce2ad37ee1d8a57_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI2NzA_2daf7918-8f12-43fc-abd1-fd816d40b56e">229,494</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i21cecce3d56444b6aefbd78a88439a59_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI2Nzc_c81f5b6b-4aea-4d9b-9b30-7beb89db78b5">275,288</ix:nonFraction> of PSUs during 2022, 2021 and 2020, respectively.  The payout of the PSUs is based on the extent to which we achieve certain performance measures over the <ix:nonNumeric contextRef="ic9c7c153e8d34eda8c3f26df0b887be6_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM5NzU_1c0dd96c-d40c-4b59-95fe-953413395e49">three-year</ix:nonNumeric> performance period.  Performance measures consist of our adjusted diluted earnings per share compounded annual growth rate and a cash conversion measure.  Additionally, the payout resulting from the performance measures is then adjusted up or down by a total shareholder return (&#8220;TSR&#8221;) performance multiplier, which depends on our relative TSR to a predetermined peer group.  PSUs are subject to forfeiture if certain employment conditions are not met.  At December&#160;31, 2022, we had <ix:nonFraction unitRef="shares" contextRef="i8560dfc0561741c4a2fca56a741ddb31_I20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM1NDM_69ef233b-b3e8-4bd4-979f-b16b3587a74c">628,693</ix:nonFraction> PSUs outstanding, with a weighted-average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8560dfc0561741c4a2fca56a741ddb31_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM2MTM_1bd2ff54-d926-49cc-87a2-e9ec68fd88a5">47.62</ix:nonFraction> per PSU.  We amortize to expense over the performance period the fair value of PSUs at the date of grant, net of estimated forfeitures.  We recorded pre-tax compensation expense related to PSUs for the years ended December&#160;31, 2022, 2021 and 2020 of $<ix:nonFraction unitRef="usd" contextRef="ic9c7c153e8d34eda8c3f26df0b887be6_D20220101-20221231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM4NTM_ba45250b-0bdc-4aa3-b9e5-016fa4278ed8">9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i43cdf17dccb84fe48ce2ad37ee1d8a57_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM4NTc_f161253a-dbb3-4098-8263-77fb838a9791">6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i21cecce3d56444b6aefbd78a88439a59_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM4NjQ_08ddd697-f9c8-4525-a992-a94905d562ca">4</ix:nonFraction>&#160;million, respectively.  The unamortized compensation expense related to PSUs was $<ix:nonFraction unitRef="usd" contextRef="i8560dfc0561741c4a2fca56a741ddb31_I20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM5NDA_ca9078b7-4014-4c1c-9ed7-02d2552b5f6e">13</ix:nonFraction> million at December 31, 2022.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_151"></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 11.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90ZXh0cmVnaW9uOmYyZDRjYjVlNTBmNjQwMDdiMmFiZGY1ZDU4MDMyODA1XzEzMA_fdd8d919-0fc4-47ea-9be5-86233f2fcd86" continuedAt="i777955d1e0954311ae8e4cd512833d42" escape="true">Earnings per Share</ix:nonNumeric></span></div><ix:continuation id="i777955d1e0954311ae8e4cd512833d42"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90ZXh0cmVnaW9uOmYyZDRjYjVlNTBmNjQwMDdiMmFiZGY1ZDU4MDMyODA1XzEzMQ_8cf2a50f-10e5-4f34-a9ad-4c1cfbaa6633" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculated basic and diluted earnings per share (&#8220;EPS&#8221;) using the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"></td><td style="width:64.653%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.858%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.863%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Altria</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzItMS0xLTEtMTg0NDY5_f659d229-67a7-40a2-89dd-dcb13135e365">5,764</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzItMy0xLTEtMTg0NDY5_ecfe4d75-8c6e-435b-a1c9-b7bfcdadc668">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzItNS0xLTEtMTg0NDY5_bd64b758-a281-450a-93ea-6a099aecccae">4,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributed and undistributed earnings attributable to share-based awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzMtMS0xLTEtMTg0NDY5_4b675642-a185-494a-91da-b0972d0cac27">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzMtMy0xLTEtMTg0NDY5_8a19b24d-8cb4-4f73-9f0f-d7b26024e49e">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzMtNS0xLTEtMTg0NDY5_558f562c-c284-48d6-ac47-09f3786ac799">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings for basic and diluted EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzQtMS0xLTEtMTg0NDY5_9e0f1edc-b5e0-421f-acac-e694217d5fb6"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzQtMS0xLTEtMTg0NDY5_d69fac48-f7d3-474f-9ec0-4377b0e4630e">5,751</ix:nonFraction></ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzQtMy0xLTEtMTg0NDY5_4cfd75a7-79cd-4f63-b29b-c7f0b897f20d"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzQtMy0xLTEtMTg0NDY5_95be44d2-ef72-426e-9ac3-6d35fa17edb4">2,464</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzQtNS0xLTEtMTg0NDY5_69a90683-4439-4b9e-98ec-c17158c91d11"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzQtNS0xLTEtMTg0NDY5_ab8e4a3c-c6eb-4007-986e-b8f89563f5bb">4,459</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic EPS</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzUtMS0xLTEtMTg0NDY5_7953c38a-6202-4552-96df-c4c4ff2f3382">1,804</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzUtMy0xLTEtMTg0NDY5_6dae2454-d294-4091-a0ff-878886a59a7a">1,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzUtNS0xLTEtMTg0NDY5_b6039869-7a9a-4c0b-9253-b25eee4f8065">1,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: contingently issuable PSUs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzYtMS0xLTEtMTg0NDY5_5a68911c-f656-429c-9ffe-7c04218f9503">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzYtMy0xLTEtMTg0NDY5_a33f1119-2965-4288-91e3-a336b137940a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzYtNS0xLTEtMTg0NDY5_6875439e-fb47-462c-a7f3-18907c9efcfc">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for diluted EPS</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzctMS0xLTEtMTg0NDY5_a733ddca-8379-48e1-9d90-daadad16b261">1,804</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzctMy0xLTEtMTg0NDY5_3d67a7d3-4949-4502-b9a9-c3f25ac9db9b">1,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzctNS0xLTEtMTg0NDY5_189d1951-a27a-48b7-a226-daae9b8b7c2b">1,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_154"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 12.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90ZXh0cmVnaW9uOjY2NmJhMGUxMGQ4ZTRkNDU5MTU0ODBlZjdhZTdjMTljXzEwMTU_4b961bd8-ab6b-49be-a745-86a11844e359" continuedAt="ib611f01e00e740109d886556909eab13" escape="true">Other Comprehensive Earnings/Losses</ix:nonNumeric></span></div><ix:continuation id="ib611f01e00e740109d886556909eab13" continuedAt="i48c2e65472864c7ca5e5d57532d904bd"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90ZXh0cmVnaW9uOjY2NmJhMGUxMGQ4ZTRkNDU5MTU0ODBlZjdhZTdjMTljXzEwMzI_f98f626f-9951-407c-9c82-8ee0d2944b91" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.938%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.985%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.985%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.985%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments<br/>and Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4baeaffb9a29402ca2ca02dd05a69d99_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzItMi0xLTEtMTg0NDY5_be124373-c802-4701-b662-2fa6110bcb48">2,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9146b84e66842f6ba646c0e65fbbf4a_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzItNC0xLTEtMTg0NDY5_aa4284c6-7898-4983-8224-715a565bd052">693</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i211d3ecc540f439596a522f150999ac7_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzItNi0xLTEtMTg0NDY5_1733163f-52f8-47b3-b17e-42c1ba8463ef">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia23cc26a813c466694dadfb7e04c27d2_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzItOC0xLTEtMTg0NDY5_55c92cd9-4d84-4ef3-bf86-49ea44847d62">2,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzUtMi0xLTEtMTg0NDY5_e783f6f2-9ea5-426e-a3b0-d364f4f1105f">454</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzUtNC0xLTEtMTg0NDY5_6fc57578-4af7-4d7a-8ade-e55c0d7b205d">1,613</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzUtNi0xLTEtMTg0NDY5_df1b5ffc-1127-4313-adb8-0d5947b13a37">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzUtOC0xLTEtMTg0NDY5_81ff6cfd-dc1d-4b52-9f1a-d78911f0286e">2,071</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzYtMi0xLTEtMTg0NDY5_2219141d-1960-465c-bb99-bb6a8ac06199">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzYtNC0xLTEtMTg0NDY5_21de4f93-add2-4849-bca0-a54fa3a03954">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzYtNi0xLTEtMTg0NDY5_5b2f855f-b024-4aed-aada-d33853020f72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzYtOC0xLTEtMTg0NDY5_99a774b9-b73e-4f7e-b27c-0731a65bbe2f">467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzctMi0xLTEtMTg0NDY5_07ca5f4e-b2eb-459d-a065-8e44fadd1777">339</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzctNC0xLTEtMTg0NDY5_c5b7c459-0e0c-4281-9a52-ee60d321263e">1,261</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzctNi0xLTEtMTg0NDY5_8b1f013e-45e5-42b7-8ed2-a19caa8f575d">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzctOC0xLTEtMTg0NDY5_8e8417df-d897-42ef-b7eb-807163b6e6a0">1,604</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzktMi0xLTEtMTg0NDY5_8ada7ff4-2f9d-4894-b08b-e7a448aac3da">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzktNC0xLTEtMTg0NDY5_35b6f709-c2c2-449a-8a97-3984685a6f1a">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzktNi0xLTEtMTg0NDY5_6be5e44c-5626-4bb1-8488-7edf00a2e476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzktOC0xLTEtMTg0NDY5_9942c589-dbec-4b33-8e8e-39b4efcd5e3f">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEwLTItMS0xLTE4NDQ2OQ_843adae5-073e-4538-a8ac-ee44dd925476">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEwLTQtMS0xLTE4NDQ2OQ_6ed432fa-b666-47eb-89a2-182e23b26553">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEwLTYtMS0xLTE4NDQ2OQ_a5be389c-2e46-4087-9374-6107a73f5bd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEwLTgtMS0xLTE4NDQ2OQ_c11722f7-0194-4f9b-9126-50f87cf360d4">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of </span></div><div style="padding-left:38.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzExLTItMS0xLTE4NDQ2OQ_35529c83-e64c-46b6-9585-34bc0bfe3ac4">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzExLTQtMS0xLTE4NDQ2OQ_16bbbb03-3595-4222-bd9f-d5709ec95acb">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzExLTYtMS0xLTE4NDQ2OQ_62e3131d-a6cb-4cf1-8816-98781d155da9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzExLTgtMS0xLTE4NDQ2OQ_15a10cff-7741-42b9-b7df-7f5987265752">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEzLTItMS0xLTE4NDQ2OQ_a73eaecb-9ba2-4512-a695-cd1a15599b39">228</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEzLTQtMS0xLTE4NDQ2OQ_27e336f5-f53a-4ca8-88a6-9a2156862c0d">1,245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEzLTYtMS0xLTE4NDQ2OQ_a2ce213c-1ebd-4e28-a36a-536114982db1">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEzLTgtMS0xLTE4NDQ2OQ_11241ce7-0eae-4b8a-9e5e-07036767827b">1,477</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1ebf54a40094d25ae6e4d46af08a702_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE0LTItMS0xLTE4NDQ2OQ_d5bfcf21-ffaa-4a90-bc91-97eb48bab107">2,420</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9b3afb0e68543d79df286a395b0f9f4_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE0LTQtMS0xLTE4NDQ2OQ_7661cab3-fa02-4566-9609-4e486e4dd54c">1,938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92833a7b324c4491889c22a95091a6eb_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE0LTYtMS0xLTE4NDQ2OQ_9650b85c-2835-4977-b141-a8d8cd053fa4">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4b30e48366b42559b3e640d996b9125_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE0LTgtMS0xLTE4NDQ2OQ_5f0bcbc8-d270-411e-aa6d-3363993458ed">4,341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE1LTItMS0xLTE4NDQ2OQ_df291999-b315-4ced-816d-8c52486168ce">961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE1LTQtMS0xLTE4NDQ2OQ_42acd5ef-2fe7-4479-9304-a2771640417f">627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE1LTYtMS0xLTE4NDQ2OQ_aa7ae784-6196-494d-94bb-afada729fbb0">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE1LTgtMS0xLTE4NDQ2OQ_179d2661-a0e1-48d9-8a6e-0b3ef97700ec">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE2LTItMS0xLTE4NDQ2OQ_792efe2b-0b59-4ca5-bb97-85ad1a59fca5">245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE2LTQtMS0xLTE4NDQ2OQ_aa535901-3cbb-44fa-9442-30d19e9fde73">141</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE2LTYtMS0xLTE4NDQ2OQ_9207cdb7-46d9-48c2-b1ef-03261f6315e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE2LTgtMS0xLTE4NDQ2OQ_24699aa6-a284-443a-8f79-2a0ba9dc2962">386</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE3LTItMS0xLTE4NDQ2OQ_47fb8a55-cae6-4ccd-b6a7-421dc37054f7">716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE3LTQtMS0xLTE4NDQ2OQ_6b99e9a9-2699-4ab4-9ad4-5488935f29dd">486</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE3LTYtMS0xLTE4NDQ2OQ_f578f041-0b12-4fa2-82a0-04f799e0501e">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE3LTgtMS0xLTE4NDQ2OQ_7951c8b7-9e47-46d7-b5b2-44a75ddc5a5f">1,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE5LTItMS0xLTE4NDQ2OQ_4b0ebe17-3d9d-459d-95d7-a9dfe2595eb3">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE5LTQtMS0xLTE4NDQ2OQ_72d9fd8d-2b8e-4658-9666-c302ec70bfc7">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE5LTYtMS0xLTE4NDQ2OQ_aff2918b-7b3f-44ec-ba8e-1fbeed3acdea">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE5LTgtMS0xLTE4NDQ2OQ_8c86cb3b-388c-4f44-bad1-4ac898b535c1">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIwLTItMS0xLTE4NDQ2OQ_abd0c025-19e4-4793-87f3-13969656a4db">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIwLTQtMS0xLTE4NDQ2OQ_afa620c8-b9a8-41b9-872f-cc806a6f8d9b">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIwLTYtMS0xLTE4NDQ2OQ_c6949602-b126-43b0-82cc-e40f02cce28c">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIwLTgtMS0xLTE4NDQ2OQ_c2475553-37ed-4f41-88aa-5dfbdef1522d">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of </span></div><div style="padding-left:38.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIxLTItMS0xLTE4NDQ2OQ_d35af730-ee1b-4379-84bc-61b0d128a359">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIxLTQtMS0xLTE4NDQ2OQ_1ea43801-e48b-42fe-8635-29ce0d7b7acc">60</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIxLTYtMS0xLTE4NDQ2OQ_fa9ea698-fef3-4503-8de5-dc7b5a2b69ea">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIxLTgtMS0xLTE4NDQ2OQ_1bf85a53-8c24-4a9c-819c-76b03446489b">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIzLTItMS0xLTE4NDQ2OQ_27aaadd4-b1d9-4f06-b3d5-d48b488e9623">808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIzLTQtMS0xLTE4NDQ2OQ_27ecf3ef-ac43-44d9-bc68-89ac9b55bd39">426</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIzLTYtMS0xLTE4NDQ2OQ_614afe29-cdc6-47a9-bf88-82095beeaadb">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIzLTgtMS0xLTE4NDQ2OQ_656ead40-ebe6-4ee0-a1af-be896ab3f31b">1,285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i301bde0c886045bbbbef3861c7f3305a_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI0LTItMS0xLTE4NDQ2OQ_7fb0754d-7e1a-4d31-8e35-06134daf7cd1">1,612</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if666ea56e36a46138786e8a942c8ca49_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI0LTQtMS0xLTE4NDQ2OQ_8d7dbb00-61cb-4908-872c-ecec48dbf07c">1,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39d9da4da1444b63abf5627b2e02b0a4_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI0LTYtMS0xLTE4NDQ2OQ_e7b2d384-f524-4a7d-a78a-b67961254519">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i558fc0a3383e478fb5796f93893141cd_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI0LTgtMS0xLTE4NDQ2OQ_e15245ea-a1e5-4e5e-a711-3d9e800465c7">3,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI1LTItMS0xLTE4NDQ2OQ_cc3ea299-0e3c-4381-91ec-dea1ebeddecf">145</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI1LTQtMS0xLTE4NDQ2OQ_5e9d695c-c29c-41d6-b2fe-3690743efa3c">275</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI1LTYtMS0xLTE4NDQ2OQ_2a871b08-6826-419c-ad85-b40b5932c0ba">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI1LTgtMS0xLTE4NDQ2OQ_19a55656-3217-478c-9e8b-aa597582d6f3">387</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI2LTItMS0xLTE4NDQ2OQ_79887ff2-9f05-40fe-a23b-eb8883014b4b">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI2LTQtMS0xLTE4NDQ2OQ_7c9a5185-acc7-498e-993e-a0e0949c358c">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI2LTYtMS0xLTE4NDQ2OQ_84e354ff-a4cf-4ecd-9c72-82f078b2a0ac">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI2LTgtMS0xLTE4NDQ2OQ_d22973d4-bf6c-4f1a-9617-b9b33d4de5c0">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI3LTItMS0xLTE4NDQ2OQ_64e2d7a5-3cf6-4e71-9ff3-54af8f6d3f1e">110</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI3LTQtMS0xLTE4NDQ2OQ_a3bd0cc0-5886-4ae3-b89d-bad6010e5dcd">210</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI3LTYtMS0xLTE4NDQ2OQ_3a4e448e-9ea6-44ea-92f4-88a999778d3b">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI3LTgtMS0xLTE4NDQ2OQ_31449296-b1a3-4ac8-bde2-8a05e5e478b0">287</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI5LTItMS0xLTE4NDQ2OQ_bb4e9b44-13aa-4e3c-af7b-c4c2bef99c45">88</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI5LTQtMS0xLTE4NDQ2OQ_42ea7ec5-a602-4f56-8c32-476b08275661">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI5LTYtMS0xLTE4NDQ2OQ_dd68ced7-c9f9-4975-9dbb-91be534a0595">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI5LTgtMS0xLTE4NDQ2OQ_bdea6307-5d19-4611-bb3e-5aaa0a249cb8">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMwLTItMS0xLTE4NDQ2OQ_cdbc1b0a-9f66-494b-b089-39661d90aa1d">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMwLTQtMS0xLTE4NDQ2OQ_605f8a2b-e223-4108-9eea-f5b49c315b34">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231" decimals="-6" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMwLTYtMS0xLTE4NDQ2OQ_c1660a13-b453-4462-96d4-64a6754a48a8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAociCurrentPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMwLTgtMS0xLTE4NDQ2OQ_9d6f5a2f-e8cf-402f-a5b3-9b1b88f4850c">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of </span></div><div style="padding-left:38.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">deferred income taxes </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMxLTItMS0xLTE4NDQ2OQ_b6eeb14a-d73d-4610-98c8-ff9772f51d32">66</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMxLTQtMS0xLTE4NDQ2OQ_e26ce538-74c8-43e6-81f7-c8722a4c212f">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMxLTYtMS0xLTE4NDQ2OQ_c79ec741-1fd8-438c-ba91-acb9c67fcb71">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231" decimals="-6" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMxLTgtMS0xLTE4NDQ2OQ_4f03ea8a-ddca-4e6f-bace-9a28085503dd">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMzLTItMS0xLTE4NDQ2OQ_3c715052-af5d-4807-ae89-e280423e7a74">176</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMzLTQtMS0xLTE4NDQ2OQ_8c7305a6-4413-4335-8106-7a8980ffde0a">143</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMzLTYtMS0xLTE4NDQ2OQ_1a417181-0fcc-4b2e-ab66-80e6bd40f902">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMzLTgtMS0xLTE4NDQ2OQ_237ff1a3-0136-4330-b8de-342d47151c7d">285</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i249cc5c8822b4901891591817ef402b5_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzM0LTItMS0xLTE4NDQ2OQ_c6c2b6de-577d-47eb-8aae-5d60c7a6009a">1,436</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic821892e2b3a4c669cc2c54ff8ccbcb0_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzM0LTQtMS0xLTE4NDQ2OQ_c92a99c6-3c6d-4fda-b605-5b583d99f1a6">1,369</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9406c18150ae48159d08480f724ce8f5_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzM0LTYtMS0xLTE4NDQ2OQ_348da21a-84a2-4515-bd3c-70d9c371bf5b">34</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia66edd7cc54a4c8ea258417ee5d6a637_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzM0LTgtMS0xLTE4NDQ2OQ_9edfcbe3-67a5-4cda-9826-99e28a83a39a">2,771</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Primarily reflected our share of ABI&#8217;s currency translation adjustments and the impact of our designated net investment hedges related to our equity investment in ABI.  For further discussion of designated net investment hedges, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:1pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i48c2e65472864c7ca5e5d57532d904bd"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90ZXh0cmVnaW9uOjY2NmJhMGUxMGQ4ZTRkNDU5MTU0ODBlZjdhZTdjMTljXzEwMzA_7d52ec47-1594-47fa-8648-be294eee78f3" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"></td><td style="width:61.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.991%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.727%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f2413f9f1484799837c48a31819243a_D20220101-20221231" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzMtMi0xLTEtMTg0NDY5_9eea35f8-2c80-4440-8bc4-b026759c9e67">127</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ce6eb6dd62848bc8cd40a14488e8721_D20210101-20211231" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzMtNC0xLTEtMTg0NDY5_d7debc9d-9fb1-42da-b8c0-a68fa5107443">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie126f873b826412b91e1030a434f2d88_D20200101-20201231" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzMtNi0xLTEtMTg0NDY5_5540487d-0cc2-4fde-b24d-a264f38ce569">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c8e82e2711e453788e58f2bd1c329a6_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzQtMi0xLTEtMTg0NDY5_3b6cdbab-c32d-40df-9a4f-4c5fa0db834f">39</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i835ff05c75554bb3a905f6d9c969a297_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzQtNC0xLTEtMTg0NDY5_8200e8fc-a342-4546-a36f-33cafec59697">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54324f38aa844a9eb47e2442a1639941_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzQtNi0xLTEtMTg0NDY5_bfe6b97f-8832-45be-a240-e45dd03edc65">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06ce655c080e4f76bb70784777bec240_D20220101-20221231" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzUtMi0xLTEtMTg0NDY5_888d6a2c-d25b-4448-9ef3-5529b260515b">88</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58687162a9304d12bc4af830434b13f3_D20210101-20211231" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzUtNC0xLTEtMTg0NDY5_e8ba6ba3-659d-4ccd-b83b-8a22d4fa4379">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e695634f71246c49246a1bc11d5adbc_D20200101-20201231" decimals="-6" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzUtNi0xLTEtMTg0NDY5_98300e34-33d2-46d2-93be-82400e947f7b">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i779b2d2ecbd54a6e915147670f6d0270_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzctMi0xLTEtMTg0NDY5_a088786c-3953-42c6-933b-9dca7aad9f09">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b811ce9ecd74e63a03fe63f108ba6ef_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzctNC0xLTEtMTg0NDY5_5b18fb43-cb4a-4d24-ab2c-e04c1dbff3b3">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c382d8d16454f87a46dc4a4ad2985b5_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzctNi0xLTEtMTg0NDY5_797e4525-ab36-446c-bc67-ac9bd0446406">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89dc095529b8415fa2d037d1e5cc3243_D20220101-20221231" decimals="-6" sign="-" name="mo:CurrencyTranslationAdjustmentsAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzktMi0xLTEtMTg0NDY5_d8659b52-8ea0-4210-bec9-d838b813d01d">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c0fb8e2f6f94df6a4cb1166c6e8695d_D20210101-20211231" decimals="-6" name="mo:CurrencyTranslationAdjustmentsAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzktNC0xLTEtMTg0NDY5_65ab4c29-ccfb-4aca-a960-fa325dcf7d8e">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53c6e05d22124ac2a67512f6e00889ab_D20200101-20201231" decimals="-6" name="mo:CurrencyTranslationAdjustmentsAndOther" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzktNi0xLTEtMTg0NDY5_cd9ebdd0-66df-45ef-9339-599d5781bd5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99171c01ef0342ea88d25cef0ba399df_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzEwLTItMS0xLTE4NDQ2OQ_4d747878-2db8-465c-aa80-fe847373ec87">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic66cd77c3dc849aca5b3b237b949276b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzEwLTQtMS0xLTE4NDQ2OQ_49fd8f3d-0a98-46c9-aca4-cd3a661b739b">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17df18daf64e40e6b9d99e9a45abbaa7_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzEwLTYtMS0xLTE4NDQ2OQ_c46c7909-a8e6-460a-bf96-70b1833340cf">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts were included in net defined benefit plan costs.  For further details, see Note 15. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts were included in (income) losses from investments in equity securities.  For further information, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 amounts were included in marketing, administration and research costs and are related to the Ste. Michelle Transaction.  For further details, see Note 15. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_157"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 13.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU2OTA_8364119a-1eee-4a37-9ffd-7e43e896f821" continuedAt="i933aee795e204370ad293a09328de14d" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i933aee795e204370ad293a09328de14d" continuedAt="i9ecb93de4482459a8a8f1834faca702c"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the U.S. Government enacted legislation commonly referred to as the Inflation Reduction Act.  The main provisions of the Inflation Reduction Act that we anticipate may impact us are (i) a 15% corporate alternative minimum tax (&#8220;Corporate AMT&#8221;) and (ii) a 1% excise tax on share repurchases, which we expect to record in equity on our consolidated statements of stockholders&#8217; equity (deficit), in each case effective for tax years beginning after December 31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be considered an &#8220;applicable corporation&#8221; for purposes of the new Corporate AMT.  Our regular federal income tax liability will generally exceed our Corporate AMT liability.  Certain unique circumstances, however, may result in a Corporate AMT liability, including when tax losses are reported in a different year than book losses.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU2NTg_33bd1b97-f6b5-49ce-acb2-c5457375f101" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (losses) before income taxes and provision (benefit) for income taxes consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzMtMS0xLTEtMTg0NDY5_3637e66f-7f2d-4a3a-9f0f-f61fa304c420">7,628</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzMtMy0xLTEtMTg0NDY5_0c0645b9-4934-4aff-8cf7-7911e78bf335">4,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzMtNS0xLTEtMTg0NDY5_140ae7f1-94d2-42df-a736-abb683f793fe">6,842</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzQtMS0xLTEtMTg0NDY5_4925b456-7696-4b0d-8fa2-865b74d78d53">239</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzQtMy0xLTEtMTg0NDY5_597a9071-f14d-43b8-bd09-ec59fbe48724">415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzQtNS0xLTEtMTg0NDY5_241163e4-3f27-437d-9eb8-169773a2cd02">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzUtMS0xLTEtMTg0NDY5_21061ae6-6d19-4e4c-a942-154b65bc6d72">7,389</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzUtMy0xLTEtMTg0NDY5_6ef14050-cbfc-4eec-ac73-5864664ac1ac">3,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzUtNS0xLTEtMTg0NDY5_758701df-c407-4f1f-90d9-27e40d8fd052">6,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzgtMS0xLTEtMTg0NDY5_33705a97-892e-4fba-8e84-df0f8d694179">1,968</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzgtMy0xLTEtMTg0NDY5_3bebce17-c70a-4d5b-af40-8c11d754206f">1,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzgtNS0xLTEtMTg0NDY5_18c7308d-7810-4755-bdb2-503d108f1d2d">2,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzktMS0xLTEtMTg0NDY5_099164fb-af2c-4c18-a279-57bf40df327e">603</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzktMy0xLTEtMTg0NDY5_346b2377-0dec-460f-9fd9-40bceb0d5821">542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzktNS0xLTEtMTg0NDY5_57c0a083-2977-421f-a560-0ef3b0455485">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzEwLTEtMS0xLTE4NDQ2OQ_3eeb4c97-3bcf-4754-9eda-d1a4c9b9fca4">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzEwLTMtMS0xLTE4NDQ2OQ_b0ed4823-9b91-4859-b624-6c4b56dae188">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzEwLTUtMS0xLTE4NDQ2OQ_5ce74bee-c355-45a6-934b-e8852c38d7f1">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzExLTEtMS0xLTE4NDQ2OQ_ac1d07e1-1ea7-4bc3-9e5a-5d1d4788f7a6">2,572</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzExLTMtMS0xLTE4NDQ2OQ_4c9a877b-edea-4256-990f-360359497fb2">2,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzExLTUtMS0xLTE4NDQ2OQ_7e7031b3-cccf-4744-8a7b-9c8e633fdcd9">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzEzLTEtMS0xLTE4NDQ2OQ_550b6c91-15cf-4824-9e50-ba13e6417d00">893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzEzLTMtMS0xLTE4NDQ2OQ_0f0c1fd2-fae1-4dbb-94e0-30134cb04642">1,190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzEzLTUtMS0xLTE4NDQ2OQ_1f1dcf02-caca-4369-af9e-16d29350de9a">130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE0LTEtMS0xLTE4NDQ2OQ_a4f2020a-d034-4616-aede-8121321168a8">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE0LTMtMS0xLTE4NDQ2OQ_133eecf4-11f7-4fa2-bdf7-0a912c17727a">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE0LTUtMS0xLTE4NDQ2OQ_48ffe037-ef91-40ff-9390-8d78a49b3616">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE2LTEtMS0xLTE4NDQ2OQ_37bd14d5-8259-4e63-b6d9-4e6037ce4f89">947</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE2LTMtMS0xLTE4NDQ2OQ_39a123fe-75f3-413b-81bd-f41aa74715b4">1,160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91aa1a3fbaee4d3ca09cea2198096661_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE2LTUtMS0xLTE4NDQ2OQ_d5618b16-5906-4ae7-9854-9555a68fef9d">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE3LTEtMS0xLTE4NDQ2OQ_5c51367f-a974-4512-b497-fcea65f2dd16">1,625</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE3LTMtMS0xLTE4NDQ2OQ_3f843a78-d904-475a-aad4-dba599e20a46">1,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE3LTUtMS0xLTE4NDQ2OQ_91291ad0-683c-4cf0-91d0-38e2c35b8f33">2,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. subsidiaries join in the filing of a U.S. federal consolidated income tax return.  The U.S. federal income tax statute of limitations remains open for the year 2017 and forward, with years 2017 through 2020 currently under examination by the Internal Revenue Service (&#8220;IRS&#8221;) as part of an audit conducted in the ordinary course of business.  State statutes of limitations generally remain open for the year 2017 and forward.  Certain of our state tax returns are currently under examination by various states as part of routine audits conducted in the ordinary course of business.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i9ecb93de4482459a8a8f1834faca702c" continuedAt="i5841d12da8b04dbf82bd3b11ee157236"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU2NTQ_13452dab-7f81-48ca-945c-2ace75f6fcfa" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzItMS0xLTEtMTg0NDY5_2fc996ac-b6bf-4eb0-81a0-deeeef6a381f">53</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzItMy0xLTEtMTg0NDY5_82bf5173-3266-4534-9a56-c96e7d749bff">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e064b5da194d8bbe29064d490250de_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzItNS0xLTEtMTg0NDY5_e555e951-8d22-4231-ab94-e8e894be177e">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzMtMS0xLTEtMTg0NDY5_7d06869a-e004-4da2-a844-91851c87b8e5">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzMtMy0xLTEtMTg0NDY5_d342c7bc-b195-4487-9f48-d64a770895f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzMtNS0xLTEtMTg0NDY5_ad77fcb4-686c-439b-afd8-6d243df55e47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzQtMS0xLTEtMTg0NDY5_73a25a52-ce6d-4e49-8eeb-8c2a9aca639b">16</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzQtMy0xLTEtMTg0NDY5_95d67365-f444-4b6a-9f7c-89f56a181d4a">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzQtNS0xLTEtMTg0NDY5_b79ad3a3-04a0-4993-a079-ab2bfb669681">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions due to lapse of statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzUtMS0xLTEtMTg0NDY5_f42a932f-f886-48ed-8aad-4b8358b859e5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzUtMy0xLTEtMTg0NDY5_275a5939-2c92-4e2d-adca-0c971ec6aeb9">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzUtNS0xLTEtMTg0NDY5_6913ea5b-d515-4b74-ad87-128cb6ac0019">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzYtMS0xLTEtMTg0NDY5_336bba51-952a-4092-8069-8f1eeb527177">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzYtMy0xLTEtMTg0NDY5_7268283d-8ca8-477b-a7d2-724d36c47c67">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzYtNS0xLTEtMTg0NDY5_5f542792-e3b6-4db9-a30b-5ff7470b334f">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzctMS0xLTEtMTg0NDY5_9acdecc4-0829-48cb-8efb-03f8a99d6ffe">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzctMy0xLTEtMTg0NDY5_406f56d0-335f-48c7-a303-bbb528dec6e3">33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzctNS0xLTEtMTg0NDY5_81970172-fcf7-485b-8de1-3185a4245847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzgtMS0xLTEtMTg0NDY5_0ccb27cf-8fc9-42f1-9e13-1515b98b0818">69</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzgtMy0xLTEtMTg0NDY5_34df2977-4024-40a9-ab2d-e24ed47286a1">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzgtNS0xLTEtMTg0NDY5_e73b6aae-ce03-490a-95e6-71835d837a0f">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at December&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzEwNDY_dd948f35-f25f-4806-aeb3-66e32ec7c655">44</ix:nonFraction> million, along with $<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="mo:UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzEwNjE_84ae2dc2-88b7-4f53-b684-df185401afad">25</ix:nonFraction> million affecting deferred taxes.  The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at December&#160;31, 2021 was $<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzExOTg_c397c156-f8de-4c9d-9ffc-60fca4fa61dd">31</ix:nonFraction> million, along with $<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="mo:UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzEyMTM_47558aa9-870a-4c50-a72f-894eb8dc1ba4">22</ix:nonFraction> million affecting deferred taxes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, 2021 and 2020, the amount of accrued interest and penalties on our consolidated balance sheets was $<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU3NzI0MzYwNDgxMDI0_58975984-ecf1-4620-ab93-28703f6e8c86">18</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU3NzI0MzYwNDgxMDE5_1f9f5403-ac72-4618-b08a-1d049d9f6cc8">11</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU3NzI0MzYwNDgxMDA1_bc81f5ab-4a19-431d-a33d-0af460a37b55">15</ix:nonFraction> million, respectively.  For the years ended December&#160;31, 2022, 2021 and 2020, we recognized in our consolidated statements of earnings $<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzE0NjY_c703c8e5-c56a-43d2-940c-9c3d38c08f8e">8</ix:nonFraction> million, $(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzE0NzA_faf6a903-632e-445e-8f42-57f3ef9d58cc">4</ix:nonFraction>)&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzE0Nzc_ac54d0ef-3cea-4894-b913-d95a72b71cb6">4</ix:nonFraction> million, respectively, of gross interest (income) expense associated with uncertain tax positions.  We recognize accrued interest and penalties associated with uncertain tax positions as part of the tax provision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxation in many jurisdictions.  Unrecognized tax benefits reflect the difference between tax positions taken or expected to be taken on income tax returns and the amounts recognized in the financial statements.  Resolution of the related tax positions with the relevant tax authorities may take many years to complete, and such timing is not entirely within our control.  It is reasonably possible that within the next 12 months certain examinations will be resolved, which could result in a decrease in unrecognized tax benefits of approximately $<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzIxNTc_d4546139-7c8d-4b9a-b5e8-ea52c902e86a">1</ix:nonFraction> million.</span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU2ODY_43e13ad7-6bdc-4cab-a0fb-36866831f8be" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation between actual income taxes and amounts computed by applying the federal statutory rate to earnings before income taxes was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.522%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzMtMi0xLTEtMTg0NDY5_b87748f8-00da-4928-a698-cf8876012e65">1,552</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzMtNC0xLTEtMTg0NDY5_503eaa17-4fa7-4587-8396-5866b3bd600c">21.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzMtNi0xLTEtMTg0NDY5_b274e1d0-ecb1-4a05-9ea2-6df3cac12a5e">803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzMtOC0xLTEtMTg0NDY5_142162b3-aebd-42af-b4b7-68ddcb61877e">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzMtMTAtMS0xLTE4NDQ2OQ_74a697a3-8b15-4a85-bf52-9f7b7623ce3c">1,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzMtMTItMS0xLTE4NDQ2OQ_4bb9162a-0cb2-45c5-817e-8493f5a1b74b">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of federal tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzUtMi0xLTEtMTg0NDY5_efb3449b-fb38-4882-8525-ed9c7bcf1641">435</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzUtNC0xLTEtMTg0NDY5_a6b61306-1e2e-4815-8694-18b860725239">5.9</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzUtNi0xLTEtMTg0NDY5_1caa1eed-326e-4458-8c47-2ef4da2282a7">451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzUtOC0xLTEtMTg0NDY5_a13b226b-5d1b-448a-903c-536843208530">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzUtMTAtMS0xLTE4NDQ2OQ_240166df-18ff-4fca-897f-68fe0fb516ae">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzUtMTItMS0xLTE4NDQ2OQ_7e1978e6-ec2a-4a1a-8107-4b659feb6772">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax basis in foreign investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzYtMi0xLTEtMTg0NDY5_d248b710-6531-4bfb-b342-986e174743ad">11</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="3" name="mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzYtNC0xLTEtMTg0NDY5_f5d1c0c0-0336-4ece-a681-8fdd7de86cf9">0.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzYtNi0xLTEtMTg0NDY5_61bf2f52-84f2-49d9-9306-21dfbb6520e8">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="3" name="mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzYtOC0xLTEtMTg0NDY5_45a217f4-2cd0-4a78-aa6c-716e1b38db1c">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzYtMTAtMS0xLTE4NDQ2OQ_f0dfa4bd-7cb2-43ce-8027-9f4c2b604e91">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="3" name="mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzYtMTItMS0xLTE4NDQ2OQ_d227ea1a-ae3f-41a8-b935-5390a7369f30">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxContingencies" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzgtMi0xLTEtMTg0NDY5_ab9be699-994e-4d4b-a583-362601dbe46a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzgtNC0xLTEtMTg0NDY5_dfe6d2a8-2dcd-493a-b771-606a74089f6a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzgtNi0xLTEtMTg0NDY5_418c24ed-bd94-4fe3-a441-7b73cf4ccedc">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzgtOC0xLTEtMTg0NDY5_0b900602-7faa-4801-864b-3a37df98f428">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzgtMTAtMS0xLTE4NDQ2OQ_b8955740-a379-4ff9-8ed5-619dd8abc4cf">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzgtMTItMS0xLTE4NDQ2OQ_8d4d12a5-f49a-4b8a-891f-f802cd1425e4">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in ABI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25c3587d3f994622b4714f1b3124a4da_D20220101-20221231" decimals="-6" sign="-" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzktMi0xLTEtMTg0NDY5_4b58470e-5c14-4f0a-ab05-ce8f04226234">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i25c3587d3f994622b4714f1b3124a4da_D20220101-20221231" decimals="3" sign="-" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzktNC0xLTEtMTg0NDY5_45d70608-e63d-4393-bc43-d77471206b51">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id61401757fdc493c83aa67b7620e44d4_D20210101-20211231" decimals="-6" sign="-" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzktNi0xLTEtMTg0NDY5_cd8a0a70-e7f8-4c8c-b4b6-146655e2dd24">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="id61401757fdc493c83aa67b7620e44d4_D20210101-20211231" decimals="3" sign="-" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzktOC0xLTEtMTg0NDY5_6d027b90-3b61-41e0-a9ca-c423c6f4f789">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if803b88b013a40dfba8d352c3b38fd7a_D20200101-20201231" decimals="-6" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzktMTAtMS0xLTE4NDQ2OQ_b0a5f300-b5dc-46d2-abdb-a75392a0d623">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if803b88b013a40dfba8d352c3b38fd7a_D20200101-20201231" decimals="3" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzktMTItMS0xLTE4NDQ2OQ_c4cc2f28-9541-4541-ba7f-86643b3eebe2">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in JUUL</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc2bb0b67a1f4be892d628382285683c_D20220101-20221231" decimals="-6" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEwLTItMS0xLTE4NDQ2OQ_e5f7a91b-5921-4d95-affb-58789b4edc99">306</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc2bb0b67a1f4be892d628382285683c_D20220101-20221231" decimals="3" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEwLTQtMS0xLTE4NDQ2OQ_55a2462a-d927-4205-9a37-2854ad5c4b2d">4.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee0d2b6272e47c2b0125f423877e769_D20210101-20211231" decimals="-6" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEwLTYtMS0xLTE4NDQ2OQ_3f7400b2-b306-4482-b6e5-6509a4e3125f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ee0d2b6272e47c2b0125f423877e769_D20210101-20211231" decimals="3" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEwLTgtMS0xLTE4NDQ2OQ_08d96f63-4da0-4937-b606-66fecb5dde7c">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231" decimals="-6" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEwLTEwLTEtMS0xODQ0Njk_e3a3b3fc-d678-4c19-8360-b3085c277176">537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231" decimals="3" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEwLTEyLTEtMS0xODQ0Njk_7a19d1bb-4156-409f-b34d-1313dd216250">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Cronos</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea2f16158f9341fd86284d599cb55729_D20220101-20221231" decimals="-6" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzExLTItMS0xLTE4NDQ2OQ_4066900e-8957-4ad2-b5e1-2b0529b07f3e">30</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iea2f16158f9341fd86284d599cb55729_D20220101-20221231" decimals="3" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzExLTQtMS0xLTE4NDQ2OQ_6aeab92c-6b0e-4265-a6bf-52351ebef214">0.4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13178e7cbc7c479c89b40c940101986c_D20210101-20211231" decimals="-6" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzExLTYtMS0xLTE4NDQ2OQ_0fb7e9fc-fad9-4907-89c8-6068e55f8a59">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i13178e7cbc7c479c89b40c940101986c_D20210101-20211231" decimals="3" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzExLTgtMS0xLTE4NDQ2OQ_56a7440d-7fc4-4710-83ba-049cfca01cfd">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bf83008070a46eb83178baf67bbaa65_D20200101-20201231" decimals="-6" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzExLTEwLTEtMS0xODQ0Njk_4ab06051-cd7d-4c7f-b4fd-ec53fc286c71">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3bf83008070a46eb83178baf67bbaa65_D20200101-20201231" decimals="3" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzExLTEyLTEtMS0xODQ0Njk_7eb25048-b1cf-4c54-9d07-92d83cf0c7f2">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance releases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="mo:EffectiveIncomeTaxRateReconciliationValuationReversalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTItMS0xLTIxNjQ0Ng_866c1045-9753-42fe-baf5-06d7cdbb8a75">664</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="3" sign="-" name="mo:EffectiveIncomeTaxRateReconciliationValuationReversalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTQtMS0xLTIxNjUyMg_13f0e6c1-c053-4698-999d-3b2b9792d2bd">9.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="mo:EffectiveIncomeTaxRateReconciliationValuationReversalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTYtMS0xLTIxNjUzMA_333c8b9a-7dac-4498-bf04-ac7125f83169">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="3" sign="-" name="mo:EffectiveIncomeTaxRateReconciliationValuationReversalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTgtMS0xLTIxNjUzOA_65825cff-8b14-4a2e-86c9-89b2bdf3220a">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="mo:EffectiveIncomeTaxRateReconciliationValuationReversalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTEwLTEtMS0yMTY1NDY_a76507b9-54cb-4271-9c20-6c8d06d826f4">19</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="3" sign="-" name="mo:EffectiveIncomeTaxRateReconciliationValuationReversalPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTEyLTEtMS0yMTY1NTU_07b6fc82-ba49-47a3-9b56-c1c1e627ab6b">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTItMS0xLTE4NDQ2OQ_141a0c73-75d7-4276-8c25-57ed9214ba31">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTQtMS0xLTE4NDQ2OQ_e4ca5f24-7eca-4b50-9df0-0e36fd871c55">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTYtMS0xLTE4NDQ2OQ_cccd3e81-a696-4315-bac3-dbf204877b70">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTgtMS0xLTE4NDQ2OQ_d1cb5fc6-bdfb-4610-a354-5fdde2dc39c4">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTEwLTEtMS0xODQ0Njk_a5f3ec4e-c6c4-4b20-b2f5-762e714e4b47">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTEyLTEtMS0xODQ0Njk_56727f5a-bc98-452a-a0bf-545609572925">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEzLTItMS0xLTE4NDQ2OQ_e2fb79d6-f8c0-4ce5-971f-36fb8e669330">1,625</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEzLTQtMS0xLTE4NDQ2OQ_907641aa-679b-46b6-822a-8580acb97655">22.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEzLTYtMS0xLTE4NDQ2OQ_e42dffb4-36ae-41e6-9df5-7892820950c4">1,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEzLTgtMS0xLTE4NDQ2OQ_c7c66c3b-da3f-4997-8a96-12e860f46349">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEzLTEwLTEtMS0xODQ0Njk_f56848a2-758f-4309-8e46-344851f379fc">2,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEzLTEyLTEtMS0xODQ0Njk_f49e75a4-aba0-4d61-8664-231763a5c355">35.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax provision (benefit) in 2022 included tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzIxOTkwMjMyNzIzODQ_7dbaef17-e9fa-400d-977b-7ad656d6fb8e">664</ix:nonFraction> million due primarily to the release of valuation allowances related to the anticipated ability to utilize a portion of existing capital losses.  These tax benefits were partially offset by tax expense of $<ix:nonFraction unitRef="usd" contextRef="icc2bb0b67a1f4be892d628382285683c_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzIxOTkwMjMyNzI0MDI_4604a4ec-ac3d-4e7e-b57b-00b360b64fd4">306</ix:nonFraction> million for a valuation allowance recorded against a deferred tax asset related to the decreases in the estimated fair value of our investment in JUUL and by the state tax treatment of the impairment charge on our equity investment in ABI.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax provision (benefit) in 2021 was impacted by the state tax treatment of the impairment charge on our equity investment in ABI.  The tax provision (benefit) in 2021 also included net tax expense of $<ix:nonFraction unitRef="usd" contextRef="i13178e7cbc7c479c89b40c940101986c_D20210101-20211231" decimals="-6" name="mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzIxOTkwMjMyNjI4NjY_0fb7e9fc-fad9-4907-89c8-6068e55f8a59">128</ix:nonFraction> million related to our Investment in Cronos, including an addition to a valuation allowance on a deferred tax asset.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax provision (benefit) in 2020 included tax expense of $<ix:nonFraction unitRef="usd" contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzI4Mjk_562ffecc-a4ef-4739-b461-d97962045f96">612</ix:nonFraction> million for a valuation allowance on a deferred tax asset related to our impairment of our investment in JUUL in the third quarter of 2020, partially offset by a $<ix:nonFraction unitRef="usd" contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzI5OTE_a77eb3e2-eed9-4a1e-9991-94f5e523d707">24</ix:nonFraction> million tax benefit reflecting the decrease of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i5841d12da8b04dbf82bd3b11ee157236" continuedAt="i3282c90b19c8468c9a6e709ff709c000"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a portion of the valuation allowance related to a reduction of a deferred tax asset associated with an increase in the estimated fair value of JUUL in the fourth quarter of 2020.</span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU2ODg_16c26903-77b6-4fa3-a8b4-c666fa3f0272" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences that gave rise to deferred income tax assets and liabilities consisted of the following at December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.517%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.249%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued postretirement and postemployment benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzItMS0xLTEtMTg0NDY5_91a8cc13-4d58-48d2-8047-eac87c6c8875">303</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzItMy0xLTEtMTg0NDY5_00697506-0506-4df1-ba4e-7296d6fd6e2e">387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzMtMS0xLTEtMTg0NDY5_72130d69-ad3c-4341-bd8d-7870011bb8d3">729</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzMtMy0xLTEtMTg0NDY5_2c1e9620-a259-47f5-96b1-a70e1e4ec756">835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in JUUL</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i688c2fcd3b0343b29196c870d74f6b68_I20221231" decimals="-6" name="mo:DeferredTaxAssetsInvestmentsInEquitySecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzUtMS0xLTEtMTg0NDY5_1e1486d7-2a8f-4777-bf0d-3c2d0d13db2f">3,001</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56c5cabbdfb44d05a0e818aa3c22c4d1_I20211231" decimals="-6" name="mo:DeferredTaxAssetsInvestmentsInEquitySecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzUtMy0xLTEtMTg0NDY5_aa665326-3598-48b5-beb6-35e4ca5c016d">2,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Cronos</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84433bab48264529a2516c2663b4fc52_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzYtMS0xLTEtMTg0NDY5_9fcddaff-4b67-4bf7-babf-1c1adebbc9ab">407</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzYtMy0xLTEtMTg0NDY5_21ceb4e9-297e-43b7-817b-acfcea7eb059">403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses and tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="mo:DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzctMS0xLTEtMTg0NDY5_1ebfbe0f-27ae-49d2-98b0-4e19737b4387">31</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="mo:DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzctMy0xLTEtMTg0NDY5_d967753b-46c4-4c91-bf68-3f86b9cfbdb0">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzgtMS0xLTEtMTg0NDY5_1b19d50b-74ef-4bc3-a890-e43e291223b9">4,471</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzgtMy0xLTEtMTg0NDY5_f1eb5565-2a64-41c8-a7fd-32fd3fd3dff2">4,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzEwLTEtMS0xLTE4NDQ2OQ_19cda88e-0e22-49d7-bdab-6f9aa69fed3f">233</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzEwLTMtMS0xLTE4NDQ2OQ_1f1c4785-a761-4fd8-99d1-4cb6ab1ddda1">216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzExLTEtMS0xLTE4NDQ2OQ_22e8dd66-ac68-4f55-9f9e-941b00dc08d9">2,849</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzExLTMtMS0xLTE4NDQ2OQ_a8d1f19c-9c3a-453c-926f-c9be36f08fb4">2,802</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in ABI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzEyLTEtMS0xLTE4NDQ2OQ_53f22832-96ef-40b6-b74e-16e2a18723ee">1,226</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzEyLTMtMS0xLTE4NDQ2OQ_fc1edc75-cf9d-4906-a9e0-0e813570a583">1,695</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzEzLTEtMS0xLTE4NDQ2OQ_499f14f2-f4ee-4086-bbaa-0be92d7d4ae3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzEzLTMtMS0xLTE4NDQ2OQ_5f7e866f-bdda-4302-80bc-bca929f7bdb9">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pension costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="mo:DeferredTaxLiabilitiesAccruedPensionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE0LTEtMS0xLTE4NDQ2OQ_535a5329-1421-4966-b5de-a6cf16e1b1f6">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="mo:DeferredTaxLiabilitiesAccruedPensionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE0LTMtMS0xLTE4NDQ2OQ_0597886c-2b23-4003-92fe-af3072b77ff7">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE1LTEtMS0xLTE4NDQ2OQ_8a55cb2d-54c8-497c-8007-04d32dd6e82d">115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE1LTMtMS0xLTE4NDQ2OQ_06006dcd-ee6d-4625-81d0-0cd760a68c27">94</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE2LTEtMS0xLTE4NDQ2OQ_8dd64407-17e6-4a47-b85e-c77c1234d802">4,493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE2LTMtMS0xLTE4NDQ2OQ_b727f537-86b7-4f66-b32f-749a61cbaf5d">4,891</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE3LTEtMS0xLTE4NDQ2OQ_2ce874e4-3461-4bdb-b777-60ecd319fdf1">2,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE3LTMtMS0xLTE4NDQ2OQ_9ff652c7-286d-4d73-a573-c05a0cf84585">3,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE4LTEtMS0xLTE4NDQ2OQ_b0f79b14-4365-4ce9-a845-3287f8f8ec81">2,822</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE4LTMtMS0xLTE4NDQ2OQ_9fe3ddc3-983a-44e8-bb39-285696f9e1e7">3,665</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, we had estimated gross state tax net operating losses of $<ix:nonFraction unitRef="usd" contextRef="i2c3c12dfb2294441a79714c48c67814a_I20221231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzQxNjA_eb40af1d-1321-458f-91e9-70a1fb8b7463">19</ix:nonFraction> million that, if unused, will expire in 2035 through 2038. </span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:SummaryOfValuationAllowanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU2NjQ_309cb66a-4ea5-4d82-a718-ab0c9bf7cfd5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending valuation allowances was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.604%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.604%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzItMi0xLTEtMTg0NDY5_64486202-1ead-466b-b516-20d9142ab227">3,097</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzItNC0xLTEtMTg0NDY5_8e3b2864-48f7-4833-8b4a-737cee41e375">2,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e064b5da194d8bbe29064d490250de_I20191231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzItNi0xLTEtMTg0NDY5_b33dbac8-cd37-4a41-963d-62724339e7cf">2,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to valuation allowance charged to income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzQtMi0xLTEtMTg0NDY5_0e35aec0-0617-4e76-97db-5c821caf4e59">429</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzQtNC0xLTEtMTg0NDY5_16a36276-43a6-4e91-93d2-f5ebfb4ba871">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzQtNi0xLTEtMTg0NDY5_52b51343-6dba-40e5-a5e6-4a18b6fb07a9">692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to valuation allowance credited to income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetReductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzUtMi0xLTEtMTg0NDY5_2d2668ac-a168-4599-87e3-a81ed398fa21">730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetReductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzUtNC0xLTEtMTg0NDY5_7a4a6e98-ac56-42a3-928f-6f2c4c979c43">118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetReductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzUtNi0xLTEtMTg0NDY5_2dc2bfe2-6368-450a-8a26-f3254b5e5183">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzYtMi0xLTEtMTg0NDY5_187a5eca-05ff-4f0a-8b2b-5060c299abf1">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzYtNC0xLTEtMTg0NDY5_a5c402d3-e214-4dcc-a435-8d247daedbaa">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzYtNi0xLTEtMTg0NDY5_f82bf796-247a-49e2-a62b-972db8b7a9ca">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzctMi0xLTEtMTg0NDY5_a90c53fb-41c2-49b4-8553-13b6fabfdd35">2,800</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzctNC0xLTEtMTg0NDY5_40f9f280-1e5a-4cf7-b910-bab2c5d69a12">3,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzctNi0xLTEtMTg0NDY5_72e391b7-df7c-49f1-aed6-dfac7802eb88">2,817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5482dc2d1d9541fca7d85116031763e0">We determine deferred tax assets and liabilities based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.  We record a valuation allowance when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  We determine the realizability of deferred tax assets based on the weight of all available positive and negative evidence.  In reaching this determination, we consider the character of the assets and the possible sources of taxable income of the appropriate character within the available carryback and carryforward periods available under the tax law.</ix:continuation></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additions to valuation allowances during 2022 were primarily due to deferred tax assets recorded in connection with decreases in the estimated fair value of our investment in JUUL.  The reductions to valuation allowances during 2022 were primarily due to the anticipated ability to utilize a portion of existing losses related to our investment in JUUL and the abandonment of our Cronos warrant.  The cumulative valuation allowance at December 31, 2022 was primarily attributable to deferred tax assets recorded in connection with our investment in JUUL ($<ix:nonFraction unitRef="usd" contextRef="i688c2fcd3b0343b29196c870d74f6b68_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzIxOTkwMjMyNzI0NDM_db0277bf-9288-45a2-b335-f56a0a43b0e9">2,394</ix:nonFraction> million) and our Investment in Cronos ($<ix:nonFraction unitRef="usd" contextRef="i84433bab48264529a2516c2663b4fc52_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzIxOTkwMjMyNzI0NjE_c6006ad1-8687-40e8-8857-52b9ff373f70">379</ix:nonFraction> million).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in valuation allowances during 2021 were primarily due to deferred tax assets recorded in connection with our Investment in Cronos.  The cumulative valuation allowance at December 31, 2021 was primarily attributable to deferred tax assets recorded in connection with our investment in JUUL ($<ix:nonFraction unitRef="usd" contextRef="i56c5cabbdfb44d05a0e818aa3c22c4d1_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzUwNTI_6e3db24a-128c-44da-9626-b9580944fa8d">2,652</ix:nonFraction> million) and our Investment in Cronos ($<ix:nonFraction unitRef="usd" contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzUwOTQ_871237b5-da55-4b09-b4e6-9060e647c89a">407</ix:nonFraction> million).</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i3282c90b19c8468c9a6e709ff709c000"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 valuation allowance was primarily attributable to deferred tax assets recorded in connection with the impairments of our investment in JUUL ($<ix:nonFraction unitRef="usd" contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzUyNTQ_ed55d986-091e-46c6-b9fd-50aff547c51c">2,610</ix:nonFraction> million), and our Investment in Cronos ($<ix:nonFraction unitRef="usd" contextRef="i3bf83008070a46eb83178baf67bbaa65_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzUyODk_23be98c4-8f03-4f0a-a166-6e61ce842179">121</ix:nonFraction> million).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion regarding the change in estimated fair value of our investment in JUUL, the impairment of our investment in ABI and the impairment of our Investment in Cronos, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_160"></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 14.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc1MTg_0922f71b-a2fa-4fda-9d81-9e60e07ced0e" continuedAt="i341c3c53d2de40088eceeddb5fabbbf1" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="i341c3c53d2de40088eceeddb5fabbbf1" continuedAt="i2de98b5c95d943e29751bf1861e3e4b4"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating companies&#8217; products include (i) smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton; and (ii) oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix.  These products constituted our reportable segments of smokeable products and oral tobacco products at December&#160;31, 2022.  The financial services business, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System heated tobacco business and Helix ROW were included in all other.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the sale of our wine business on October 1, 2021, wine produced and/or sold by Ste. Michelle was a reportable segment.  For further discussion, see Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our chief operating decision maker (&#8220;CODM&#8221;) reviews operating companies income (loss) (&#8220;OCI&#8221;) to evaluate the performance of, and allocate resources to, our segments.  OCI for our segments is defined as operating income before general corporate expenses and amortization of intangibles.  Interest and other debt expense, net, along with net periodic benefit cost (income), excluding service cost, and provision for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by our CODM.  We do not disclose information about total assets by segment because such information is not reported to or used by our CODM.  Substantially all of our long-lived assets were located in the United States at December 31, 2022.  Segment goodwill and other intangible assets, net, are disclosed in Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangible Assets, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The accounting policies of the segments were the same at December 31, 2022 as those described in Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies.</span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc1MjE_3ef934a0-8822-407c-842a-630047e28f17" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows:</span></div><div style="margin-bottom:5pt;margin-top:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12f67c433715485982086bcdbfe00787_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzMtMS0xLTEtMTg0NDY5_8173f2f6-6808-4a70-b4f7-630aad4eadf2">22,476</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f5736e8fdd4e1b9a291a912e9cd3be_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzMtMy0xLTEtMTg0NDY5_d850bd18-0a26-4bb7-bc53-cc983f451310">22,866</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i111e309b231242cfbccc5619cb83229c_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzMtNS0xLTEtMTg0NDY5_d5f9cef5-ed48-43a9-ba31-292f15505b58">23,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd8c2710852f4850ae750a2d93d4e568_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzQtMS0xLTEtMTg0NDY5_d7b034e5-1be0-466a-85c8-2874700a56df">2,580</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d98d739f504698ad868c0b443af1b2_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzQtMy0xLTEtMTg0NDY5_d5e91c90-a5eb-4c04-b158-7f3e6f9a4935">2,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46fc9282d17e4ce08f7ce9e03e4e9fd3_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzQtNS0xLTEtMTg0NDY5_4616ce63-5b3c-41ac-b975-5fb10fcf615f">2,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55bb70b849b4190b6e9721bddaaf8c6_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzUtMS0xLTEtMTg0NDY5_3f8e6fbd-0f56-497e-a1d9-b3fcedfe34c7">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8857cf14a32848aa9b176fb4b04397e2_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzUtMy0xLTEtMTg0NDY5_ac95697e-ab36-4fe0-bdea-2f9554bd6197">494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b6b1d5fe6046078463af99cc3f0ee3_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzUtNS0xLTEtMTg0NDY5_43c9bea3-4401-4f51-8929-a938a8109923">614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9666810a94704e499168fa1e4086657b_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzYtMS0xLTEtMTg0NDY5_c0cac418-4499-458d-b1ae-ff6062de2c9e">40</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd98997f40d64f368230b460b98992e1_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzYtMy0xLTEtMTg0NDY5_8a2accb6-f3bf-404c-a686-e37abc4ecc9b">45</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i346f9407b62340fc87ea781c6a87bc3a_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzYtNS0xLTEtMTg0NDY5_eeef07ee-8d1a-4c7b-b67c-bbb6fe561d08">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzctMS0xLTEtMTg0NDY5_c550eeee-66a9-4259-9f09-08cd0cd50848">25,096</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzctMy0xLTEtMTg0NDY5_c27aa260-9449-4c94-bd8a-3a2111e5742c">26,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzctNS0xLTEtMTg0NDY5_53ec5698-73ff-48d0-967e-9c17c91d0d7b">26,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913162c559bc449289b7eb12f1b829ed_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEwLTEtMS0xLTE4NDQ2OQ_d8fc788c-c80a-40ca-8a42-8cf18fe74732">10,688</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb973d3950d9475a923b769b439f1690_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEwLTMtMS0xLTE4NDQ2OQ_6fb6650b-0ce8-4a9a-98d5-ead80ec742b8">10,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71a3f3b84bfc4a76b4da5d7f37f602af_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEwLTUtMS0xLTE4NDQ2OQ_6cddbb66-ca18-43cc-bf76-86e86d8561e7">9,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic22cd9b4e4d94780871456a2f40823af_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzExLTEtMS0xLTE4NDQ2OQ_affcd297-69da-43e6-b232-7e4f78aed03d">1,632</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7975fef95c3d41c984bc01c3cd6d50c1_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzExLTMtMS0xLTE4NDQ2OQ_7a1f4b38-cda8-4e22-87e0-da4a46b784b2">1,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc000d98c0ca4b1ab8abdbf602942f3f_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzExLTUtMS0xLTE4NDQ2OQ_72929bee-720b-4a46-b752-3f8b0fbd90b8">1,718</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f69c7e020f4496bb5f91ff08930975_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEyLTEtMS0xLTE4NDQ2OQ_0b4a0209-3ebe-445f-ac0e-0db2b174b838">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i617c77ba0ff242099cb5b33ab2af1d0c_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEyLTMtMS0xLTE4NDQ2OQ_70666000-936c-47f1-8b85-fd2b5725a107">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia43c067e1e4b4763ac5c2b473efb3a37_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEyLTUtMS0xLTE4NDQ2OQ_4233d439-046e-4ccd-b83e-5ad066fc01f6">360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i804b801d4bd04571aaa1e6babe7ee711_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEzLTEtMS0xLTE4NDQ2OQ_3bc6c168-db22-4a71-b8ca-6336a84233cd">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadaebe2af5d4425f92e98085c262bdfa_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEzLTMtMS0xLTE4NDQ2OQ_182ab943-70f8-44f8-b993-8ef827f82da9">97</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5586d1fe97814ea899ee8184c7f7d8d9_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEzLTUtMS0xLTE4NDQ2OQ_0f96342c-7159-48bd-b8b0-ab63fc91682f">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE0LTEtMS0xLTE4NDQ2OQ_35afba10-df92-40e0-b717-fab15b47368e">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE0LTMtMS0xLTE4NDQ2OQ_066e1d8f-cd26-4d9d-a8a8-2fc16c7ccdb0">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE0LTUtMS0xLTE4NDQ2OQ_8d4722d5-ad3a-4c62-9ba1-6b90097e2641">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56e043e80aaa413c8cf448a2008386a1_D20220101-20221231" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE1LTEtMS0xLTE4NDQ2OQ_33692e25-dbd7-4260-a104-14e64d62b198">292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7f3cf86f5874b96b40d59c3d6a49d6b_D20210101-20211231" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE1LTMtMS0xLTE4NDQ2OQ_7351738f-3af0-4fad-b55c-bd710469936e">345</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa25332878054f3684126e72cd34954c_D20200101-20201231" decimals="-6" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE1LTUtMS0xLTE4NDQ2OQ_5f0ee90e-c7f3-43be-a4f7-32f75fc87d40">226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE3LTEtMS0xLTE4NDQ2OQ_c36e744b-ce89-4a63-8498-3495bab28778">11,919</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE3LTMtMS0xLTE4NDQ2OQ_dd607fef-cce1-4546-8daa-8d672d50169b">11,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE3LTUtMS0xLTE4NDQ2OQ_1057273e-c10e-4321-8932-eaccec7988ab">10,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE4LTEtMS0xLTE4NDQ2OQ_52e1bdf4-3b56-4c99-8ab8-d89c4b98a9cb">1,058</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE4LTMtMS0xLTE4NDQ2OQ_a215cf4f-6096-4520-9e67-617ea439fe84">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE4LTUtMS0xLTE4NDQ2OQ_be941b3f-fed6-4ae1-97b0-d57a71c159d8">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE5LTEtMS0xLTE4NDQ2OQ_435c66d1-665c-4426-9c1a-63c79f4e1f52">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE5LTMtMS0xLTE4NDQ2OQ_acefb7d9-56f8-4bd0-ac33-27f7bbe16b7f">649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE5LTUtMS0xLTE4NDQ2OQ_405ff709-24a8-4455-8dbf-7cca93b099f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIwLTEtMS0xLTE4NDQ2OQ_1811ac59-50e2-4421-9552-bc107b617d2d">184</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIwLTMtMS0xLTE4NDQ2OQ_53737f31-4094-4ec9-a44a-4cbd2acc1c85">202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIwLTUtMS0xLTE4NDQ2OQ_7f6fb778-9e13-4c50-84ff-6a755a262717">77</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments in equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIxLTEtMS0xLTE4NDQ2OQ_18b25a00-a3f0-41a3-818f-44b5fd183f75">3,641</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIxLTMtMS0xLTE4NDQ2OQ_c52d77b8-5c7f-44b3-b678-e9ddbdda94cc">5,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="mo:IncomeLossFromEquityInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIxLTUtMS0xLTE4NDQ2OQ_d7357b09-e1d1-4a74-b5c2-253ea37506ab">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIyLTEtMS0xLTE4NDQ2OQ_85d5e396-f901-404c-bcda-e5b1ebd94b9b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIyLTMtMS0xLTE4NDQ2OQ_84b9e631-898e-4816-92d5-2a1e42efe616">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIyLTUtMS0xLTE4NDQ2OQ_9703caa2-43ad-4a78-b848-397b566241e8">2,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Cronos-related financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIzLTEtMS0xLTE4NDQ2OQ_9082c1c0-ed8f-4b39-b532-cae80585a03b">15</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIzLTMtMS0xLTE4NDQ2OQ_a7518884-e4df-4c7b-84e0-cfcf73df620c">148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIzLTUtMS0xLTE4NDQ2OQ_54f16b47-7697-4da5-9039-a0b229522b37">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzI1LTEtMS0xLTE4NDQ2OQ_4158df40-c261-45aa-b6fd-398b7fe59e01">7,389</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzI1LTMtMS0xLTE4NDQ2OQ_cdd268da-91af-4082-8e93-7cb3b1b61683">3,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzI1LTUtMS0xLTE4NDQ2OQ_3898b137-b83a-479c-86a9-13fe6cf0b67d">6,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i2de98b5c95d943e29751bf1861e3e4b4" continuedAt="ie35ecffd402d4213b1dcd2f2e1436c5e"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The smokeable products segment included net revenues of $<ix:nonFraction unitRef="usd" contextRef="i49a7d33e45284663b655e6dbc1bb9919_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzIyODg_2a752efb-1fb5-4cea-9a88-20b4d415958f">21,457</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i1678c740bd1a4a26becf33b0f81b0ceb_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzIyOTI_8637fde4-ccf1-4fad-b95c-d748033d5d0f">21,877</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iab018587321a483bbfbc7b030fd4e0f6_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzIyOTk_8cf4b211-5a51-4aac-acb4-81c3f49267d4">22,135</ix:nonFraction> million for the years ended December&#160;31, 2022, 2021 and 2020, respectively, related to cigarettes and net revenues of $<ix:nonFraction unitRef="usd" contextRef="iddc198f0f36347669562a343b6ad3c9d_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzIzOTM_f6ec3984-f778-4d25-b947-724c79b7591d">1,019</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie443febe03b14271ac779aa41af8f4fe_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzIzOTc_137f0474-0127-4bb2-9cb0-5bcb7d1d5815">989</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i67cd9a14c17b43fc9f780f6a9acde202_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzI0MDQ_cfaac2fc-a959-4cf3-8901-7a28125d4e05">954</ix:nonFraction> million for the years ended December&#160;31, 2022, 2021 and 2020, respectively, related to cigars.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our net revenues for the years ended December&#160;31, 2022, 2021 and 2020 were from sales generated in the United States.  PM USA, USSTC, Helix and Middleton&#8217;s customer, Performance Food Group Company, which acquired Core-Mark Holding Company, Inc. in 2021, accounted for approximately <ix:nonFraction unitRef="number" contextRef="i9df4fbc7975c4c9c97d6d12ee87fa9e1_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MTQ4MDk_86212073-9191-49d3-8bcb-aa7d8657f4d1">24</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i3185640b9c5049b5aab6f7b888f14010_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MTQ4MTc_e0a36699-8d6b-4655-954f-461642d46662">23</ix:nonFraction>% of our consolidated net revenues for the years ended December&#160;31, 2022 and 2021, respectively.  Core-Mark Holding Company, Inc. accounted for <ix:nonFraction unitRef="number" contextRef="i0ff1620dadbf4977afc2e21c5632a674_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MTQ5NDg_272ac48d-9a62-4a53-ac33-c942ded38a35">17</ix:nonFraction>% of our consolidated net revenues for the year ended December&#160;31, 2020.  In addition, McLane Company, Inc., accounted for approximately <ix:nonFraction unitRef="number" contextRef="if2aa57c1f8964e1c832583d037aa1ede_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzI2OTc_4fb08858-6e21-4b71-a99a-78368b423c36">23</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i1148e066b8774e5fbbbc5a24e0555f90_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzI3MDE_25c94546-7f3b-49b3-a72b-ab3831924c0e">23</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i190f8a7374534d37a6b9e683886f1340_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzI3MDg_9a5cef3a-6dbe-45dd-a1fa-2dfafb0d239c">26</ix:nonFraction>% of our consolidated net revenues for the years ended December&#160;31, 2022, 2021 and 2020, respectively.  Substantially all of these net revenues were reported in the smokeable products and oral tobacco products segments.  No other customer accounted for more than 10% of our consolidated net revenues for the years ended December 31, 2022, 2021 and 2020.</span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc1Mjk_ee402990-3429-4997-ab0e-b3fc7cfaa9e4" escape="true"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of our depreciation expense and capital expenditures were as follows:</span></div><div style="margin-bottom:5pt;margin-top:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.785%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913162c559bc449289b7eb12f1b829ed_D20220101-20221231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzMtMS0xLTEtMTg0NDY5_a7ae6493-fc83-49fb-a7d8-5923e7e107d7">87</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb973d3950d9475a923b769b439f1690_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzMtMy0xLTEtMTg0NDY5_fc444119-432d-44a7-b6f2-672642207e42">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71a3f3b84bfc4a76b4da5d7f37f602af_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzMtNS0xLTEtMTg0NDY5_c57514a6-7ec9-4acb-8227-9aed9f027c31">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic22cd9b4e4d94780871456a2f40823af_D20220101-20221231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzQtMS0xLTEtMTg0NDY5_ded64db3-f0c1-4670-9a26-25433a56c5f7">33</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7975fef95c3d41c984bc01c3cd6d50c1_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzQtMy0xLTEtMTg0NDY5_65f9e3a9-716f-4287-9b43-f2c0346b749a">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc000d98c0ca4b1ab8abdbf602942f3f_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzQtNS0xLTEtMTg0NDY5_0f4a941d-836d-471f-90a7-43bcb96f2752">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f69c7e020f4496bb5f91ff08930975_D20220101-20221231" decimals="-6" name="us-gaap:Depreciation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzUtMS0xLTEtMTg0NDY5_2ec4b1d1-28ef-46b1-9982-34bb82ded569">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i617c77ba0ff242099cb5b33ab2af1d0c_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzUtMy0xLTEtMTg0NDY5_43aab262-cea5-4886-a284-aadc1624f41c">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia43c067e1e4b4763ac5c2b473efb3a37_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzUtNS0xLTEtMTg0NDY5_b7b1d15c-6e96-43ac-ae07-e8bab6437f11">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e043e80aaa413c8cf448a2008386a1_D20220101-20221231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzctMS0xLTEtMTg0NDY5_d22a755e-1328-427f-b56e-f834ab03551b">33</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7f3cf86f5874b96b40d59c3d6a49d6b_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzctMy0xLTEtMTg0NDY5_08329b5d-aaa8-4969-ba0c-7b6382dc270c">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa25332878054f3684126e72cd34954c_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzctNS0xLTEtMTg0NDY5_63df3e8e-f356-4101-929d-16aab663a02d">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzgtMS0xLTEtMTg0NDY5_dbde8e95-60e9-49be-aec4-90b8474621be">153</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzgtMy0xLTEtMTg0NDY5_848e6ed0-6916-4fd5-a2cc-44282b01d566">172</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzgtNS0xLTEtMTg0NDY5_3c4f8bb6-1ea1-4c71-b53f-ed405f21029d">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i913162c559bc449289b7eb12f1b829ed_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEwLTEtMS0xLTE4NDQ2OQ_6dc917bf-5593-4b72-b7c2-62bafe014142">68</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb973d3950d9475a923b769b439f1690_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEwLTMtMS0xLTE4NDQ2OQ_46ae7274-ddb6-4682-8152-df45947924e3">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71a3f3b84bfc4a76b4da5d7f37f602af_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEwLTUtMS0xLTE4NDQ2OQ_c73576bd-39ea-433c-afdb-e538a83228e9">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic22cd9b4e4d94780871456a2f40823af_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzExLTEtMS0xLTE4NDQ2OQ_7448c8d9-e20e-4f12-97c4-2394be333bf4">90</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7975fef95c3d41c984bc01c3cd6d50c1_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzExLTMtMS0xLTE4NDQ2OQ_c18ac871-10eb-4f30-91b5-f6e6280ff6a4">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc000d98c0ca4b1ab8abdbf602942f3f_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzExLTUtMS0xLTE4NDQ2OQ_d736396f-f83a-4be1-925d-771a6b6ae694">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f69c7e020f4496bb5f91ff08930975_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEyLTEtMS0xLTE4NDQ2OQ_f1fee4f0-6813-4045-87df-2de5a316055d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i617c77ba0ff242099cb5b33ab2af1d0c_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEyLTMtMS0xLTE4NDQ2OQ_d5ee59b4-8c36-4f87-bd39-d3ce9c72be12">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia43c067e1e4b4763ac5c2b473efb3a37_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEyLTUtMS0xLTE4NDQ2OQ_ba70ac23-c8a3-452d-8acc-b708672fad48">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56e043e80aaa413c8cf448a2008386a1_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEzLTEtMS0xLTE4NDQ2OQ_a67f8674-dca3-495c-9e40-4577e1167217">47</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7f3cf86f5874b96b40d59c3d6a49d6b_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEzLTMtMS0xLTE4NDQ2OQ_81f8d899-17da-45f6-8e86-22f7e1ad71e2">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa25332878054f3684126e72cd34954c_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEzLTUtMS0xLTE4NDQ2OQ_ebde26b8-554b-4dbb-abe0-35db57b819b7">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzE0LTEtMS0xLTE4NDQ2OQ_4eba58d5-dcba-482d-b906-8d9cee6d56ed">205</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzE0LTMtMS0xLTE4NDQ2OQ_f9b851bd-c713-47d1-b992-65eea914f345">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzE0LTUtMS0xLTE4NDQ2OQ_6717321d-fe31-4eff-aa18-9daa7ce51514">231</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparability of OCI for our reportable segments and the all other category was affected by the following:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Non-Participating Manufacturer (&#8220;NPM&#8221;) Adjustment Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="mo:ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc1MDI_6e826495-16c1-4b4a-a9a3-339869b1810c" continuedAt="i081506c5a7f1436480955690161cc3c7" escape="true">We recorded pre-tax (income) expense for NPM adjustment items as follows: </ix:nonNumeric></span></div><div style="margin-bottom:5pt"><ix:continuation id="i081506c5a7f1436480955690161cc3c7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.102%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08b51c2c0dce44e79fedb290d4c8e09e_D20220101-20221231" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzItMi0xLTEtMTg0NDY5_8ade9a4d-2b22-47ef-abd2-241905dbdf68">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf9bf830fdb54a25a53b4eb9f7c6ecbe_D20210101-20211231" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzItNC0xLTEtMTg0NDY5_bcb967f3-9bf1-41e6-905b-d91c813a845d">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35b16a435c354836b674e7320f24d9cb_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzItNi0xLTEtMTkwODky_27851b48-7744-4fb5-a989-978b3dc5a9f3">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0522b2a5006452dbeaa81943e951dd9_D20220101-20221231" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzQtMi0xLTEtMTg0NDY5_692e348a-9a18-48e6-8933-dad8c885f5cf">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f14450de7304d989507ff633df9e3ae_D20210101-20211231" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzQtNC0xLTEtMTg0NDY5_4be5643f-0cdf-4e12-9680-e374fac50ddf">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e449181bba3459d8ca0786104f7a700_D20200101-20201231" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzQtNi0xLTEtMTkwOTAx_3da97d99-f53e-4af5-816d-df6ca81c2f31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c43fc865fb74c7ea00634410142b30a_D20220101-20221231" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzUtMi0xLTEtMTg0NDY5_d1fda894-9db8-4dc7-b7cd-d01ed55c808f">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i212ae09ce10946d9855a6823c99cbf7f_D20210101-20211231" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzUtNC0xLTEtMTg0NDY5_0f420d3c-30a6-4c0b-8c25-e93a8861b230">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic48649f0706c497693ac371d798bd4c2_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzUtNi0xLTEtMTk1OTc1_e99570c6-1267-4538-a040-a33d90c4df9b">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the amounts in the table shown above for the smokeable products segment as (reductions) increases to cost of sales in our consolidated statements of earnings, which (increased) decreased OCI in our smokeable products segment.  NPM adjustment items result from the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the Master Settlement Agreement (such dispute resolutions are referred to as &#8220;NPM Adjustment Items&#8221; and are more fully described in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Health Care Cost Recovery Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="ie35ecffd402d4213b1dcd2f2e1436c5e"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Tobacco and Health and Certain Other Litigation Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="mo:ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc1MTY_4c5c010e-9501-4f18-8e58-8b1cd7e036cf" continuedAt="ic88c2ce6b7694cf1ac58d33741282689" escape="true">We recorded pre-tax charges related to tobacco and health and certain other litigation items as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><ix:continuation id="ic88c2ce6b7694cf1ac58d33741282689"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.834%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if99cc370f97e4e6c90993d5b757abf22_D20220101-20221231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzItMi0xLTEtMTg0NDY5_18c4e217-4db8-4436-8b9a-92c316d84515">101</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d7b96af9e749068f5609288e32a7af_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzItNC0xLTEtMTkxMDU5_0b20a823-85ab-46b7-b29c-cd02c6fca226">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8832deab20a344c6af9cf1f99474ac91_D20200101-20201231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzItNi0xLTEtMTkxMDg2_edb7e666-3a3d-44ab-8e95-39930240717c">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46dacf8350224a54ab375b062ca77665_D20220101-20221231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzMtMi0xLTEtMTg0NDY5_98672f16-ff45-4827-81a6-10836ecb7f65">27</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i951b911c6e0e47d19655f1077b2ffe8a_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzMtNC0xLTEtMTkxMDYy_c351e17d-0dac-4b95-8350-f92beb22d11b">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea116a43452e4fb28c83749aebd5f929_D20200101-20201231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzMtNi0xLTEtMTg0NDY5_50fc2abe-23cc-4e24-8472-d01917173ef4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i461f9cb50d204f0dacbd3047259cffa8_D20220101-20221231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzQtMi0xLTEtMTg0NDY5_4ea24e4b-7eef-439d-a108-18f504dd5356">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27482b5bde934f6ca3bdd7b34b723684_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzQtNC0xLTEtMTkxMDY1_885160ba-8ca7-45fb-becb-e2b48181e4db">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0693a15a4892422d9cda162ef2b81f7d_D20200101-20201231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzQtNi0xLTEtMTkxMDkz_2954d3f4-f4ad-4033-a879-641c26e4b9a4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4e4d2da69f4d9683487085e2d48d98_D20220101-20221231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzUtMi0xLTEtMTg0NDY5_ff374565-523b-4152-9a3c-08b9bb4d2adc">131</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83073aaf064b4575b0b62690029a9d26_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzUtNC0xLTEtMTg0NDY5_1202cced-cfbf-49c6-bd1b-54b593647c73">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd676fa0f80248e282373ef461851a42_D20200101-20201231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzUtNi0xLTEtMTg0NDY5_5ff6a9ec-1468-420f-8f33-ab926dd76e8e">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the amounts shown in the table above for the smokeable products segment and general corporate expenses in marketing, administration and research costs in our consolidated statements of earnings.  For further discussion, see Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Ste. Michelle Transaction: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded pre-tax disposition-related costs of $<ix:nonFraction unitRef="usd" contextRef="i9f15b41987f746ec9de923885a23875e_D20210101-20211231" decimals="-6" name="mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MDk0ODY_b84c1015-3356-4c5c-88e1-b962947bfd22">51</ix:nonFraction> million for the year ended December&#160;31, 2021 in our former wine segment, which consisted of a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i2829a0154bd2487587b9b5af05af4b95_D20210101-20211231" decimals="-6" name="mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MDk0OTA_3137d22d-0117-4bc1-9cc5-431d01a2677a">41</ix:nonFraction> million to record the assets and liabilities associated with the Ste. Michelle Transaction at their fair value less costs to sell and $<ix:nonFraction unitRef="usd" contextRef="i2829a0154bd2487587b9b5af05af4b95_D20210101-20211231" decimals="-6" name="mo:DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MDk1MDA_96a3f93d-5559-418d-8fb3-2c34767e677a">10</ix:nonFraction> million of other disposition-related costs.  We included these costs in marketing, administration and research costs in our consolidated statements of earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Acquisition-Related Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recorded pre-tax acquisition-related costs of $<ix:nonFraction unitRef="usd" contextRef="i01d98d739f504698ad868c0b443af1b2_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MDg0MjM_33f7b22b-4c5a-4ff4-8f0b-83d3abf78b9d">37</ix:nonFraction> million for the year ended December&#160;31, 2021 in our oral tobacco products segment primarily for the settlement of an arbitration related to the 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> transaction.  We included these costs in marketing, administration and research costs in our consolidated statements of earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Wine Business Strategic Reset:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded pre-tax implementation costs of $<ix:nonFraction unitRef="usd" contextRef="idc3b5a2e320d4bf0930cfd342a0a64ce_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MTE5NTA_a4c30494-83ca-4e86-8629-a57d323d9dde">411</ix:nonFraction> million for the year ended December&#160;31, 2020, in our former wine segment, associated with a strategic reset initiated in the first quarter of 2020 intended to maximize Ste. Michelle&#8217;s profitability and achieve improved long-term cash flow generation.  Substantially all of the charges consisted of the following: (i) write-off of inventory ($<ix:nonFraction unitRef="usd" contextRef="i9cb3ae1c7eab4656a1a5ed979a5e155c_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MTIwMjc_7ad6b291-7eb9-4cf4-ba56-a8c1b0893707">292</ix:nonFraction> million) as Ste. Michelle no longer believed that the benefit of the blending and production plans for its inventory outweighed inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believed no longer had a future economic benefit ($<ix:nonFraction unitRef="usd" contextRef="idb407c6154934e7ca996a112282656fd_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MTIwNzI_497b0819-6846-4a5c-8861-e6094452d4e5">100</ix:nonFraction> million).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">PMCC Residual Value Adjustments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the year ended December&#160;31, 2020, we recorded pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i1eb37c152d544d1d9be43ff88b5b936e_D20200101-20201231" decimals="-6" sign="-" name="mo:LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzczMTE_5bef0236-2f13-4185-a6de-23996f477844">125</ix:nonFraction> million (as a reduction to net revenues in the all other category) related to the decrease in unguaranteed residual values of certain PMCC leased assets.  There were <ix:nonFraction unitRef="usd" contextRef="i1bff2bc4dded4f37b8c85cec3935bb80_D20210101-20211231" decimals="INF" name="mo:LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc0Njc_2517b9bf-8b52-4570-92a5-9b873e3f7f2c"><ix:nonFraction unitRef="usd" contextRef="ifb087beec876446cb5a5111ae91af4a1_D20220101-20221231" decimals="INF" name="mo:LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc0Njc_e7359ec1-80e4-4c56-bf58-f24f456df32e">no</ix:nonFraction></ix:nonFraction> such adjustments in 2022 or 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">COVID-19 Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded net pre-tax charges of $<ix:nonFraction unitRef="usd" contextRef="i7832ad6e5ab1407caf25aa336606b119_D20200101-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzQ5NDc4MDIzMzk5Mjk_a6cd48f6-0edb-46e4-8fd7-d1d98ea71844">50</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="i8a4e259acef84cbfa369320878dc84d8_D20200101-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzQ5NDc4MDIzMzk5MzQ_fa196506-83fe-47bd-8abe-c3e5b14afaa9">41</ix:nonFraction> million in the smokeable products segment and $<ix:nonFraction unitRef="usd" contextRef="ie155a5840f2c4f9999c5ff7d2f7a2f4b_D20200101-20201231" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzQ5NDc4MDIzMzk5NzY_754144ef-5622-4b25-a17c-673773b197c6">9</ix:nonFraction> million in the oral tobacco products segment) in our consolidated statement of earnings for the year ended December&#160;31, 2020 related to the COVID-19 pandemic.  These net pre-tax charges, which were directly related to disruptions caused by or efforts to mitigate the impact of the COVID-19 pandemic, were all recorded in cost of sales and included premium pay, personal protective equipment and health screenings, which were partially offset by certain employment tax credits.</span></div></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_163"></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 15.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDky_ee76def1-52b1-48b8-9bb2-4ff5137f567f" continuedAt="i6dd7bf26a0da4be8b57dcd6b20cdc70d" escape="true">Benefit Plans</ix:nonNumeric></span></div><ix:continuation id="i6dd7bf26a0da4be8b57dcd6b20cdc70d" continuedAt="i9111385b9c4f4a2f8d444c7d3b50d0ae"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our subsidiaries sponsor noncontributory defined benefit pension plans covering certain employees of Altria and our subsidiaries.  Employees hired on or after a date specific to their employee group, except for certain employees of UST&#8217;s subsidiaries and Middleton, are not eligible to participate in these noncontributory defined benefit pension plans but are instead eligible to participate in a defined contribution plan with enhanced benefits.  We also provide postretirement health care and other benefits to certain retired employees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure the plan assets and benefit obligations of our pension plans and postretirement plans at December&#160;31 of each year.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base the discount rates for our plans on a yield curve developed from a model portfolio of high-quality corporate bonds with durations that match the expected future cash flows of the pension and postretirement benefit obligations.</span></div></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i9111385b9c4f4a2f8d444c7d3b50d0ae" continuedAt="i9e82a95ad17a450fb5dcc817ba282cb1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Obligations and Funded Status: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDk2_68b0a798-dec0-4852-baff-f3380c4e9e4c" continuedAt="i9c2cc94ac5874c948c68e493e04f55c2" escape="true"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMTA4_00a5ecb4-192f-4565-a2b7-46bd9bffd3ab" continuedAt="i30a274b3222e4ba089a71e285b087a97" escape="true">Benefit obligations, plan assets and funded status for our pension and postretirement plans were as follows at December 31:</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="i9c2cc94ac5874c948c68e493e04f55c2"><ix:continuation id="i30a274b3222e4ba089a71e285b087a97"><div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"></td><td style="width:60.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.347%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Benefit obligation at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzMtMS0xLTEtMTg0NDY5_6bb98b9c-8db6-471e-8312-717f8669f8e7">8,544</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949403a737c24de59a13987d688282a7_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzMtMy0xLTEtMTg0NDY5_f40864ef-8bf4-4581-b92b-ba8accfb661f">9,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzMtNS0xLTEtMTg0NDY5_d748cd69-55b1-476a-86ef-3ff6adff5b6e">1,688</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00cce528acbc427a9f5dda1550d2d9fd_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzMtNy0xLTEtMTg0NDY5_f40fa110-8c5c-4c5f-973c-35288697f1ad">2,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Service cost</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzQtMS0xLTEtMTg0NDY5_f791f65e-8a27-4562-ba59-f24e0a203df2">64</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzQtMy0xLTEtMTg0NDY5_90754f69-cd09-4c3b-b83e-f9bb44ba5a5a">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzQtNS0xLTEtMTg0NDY5_d44533c1-edea-40f7-be02-9da57738c3d0">23</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzQtNy0xLTEtMTg0NDY5_6ac7233f-e674-4798-8b91-84f2c89d15d8">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest cost</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzUtMS0xLTEtMTg0NDY5_f772f0ca-d7b7-486d-b6ba-d6b79c6f8859">206</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzUtMy0xLTEtMTg0NDY5_81543af4-8446-4a6f-a546-30f050408198">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzUtNS0xLTEtMTg0NDY5_fbada8df-eef5-4e6e-90b3-e528d16c6f32">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzUtNy0xLTEtMTg0NDY5_0705282b-70cb-4e97-8460-d061b6c38426">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Benefits paid</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzYtMS0xLTEtMTg0NDY5_f0392789-521c-44d9-9b20-f42d2b381459">462</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzYtMy0xLTEtMTg0NDY5_59943c29-42a6-42aa-9e3d-34d20ee68ad3">465</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzYtNS0xLTEtMTg0NDY5_a5afdfad-f1b9-400d-ac93-68db6101c634">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzYtNy0xLTEtMTg0NDY5_e9c1948b-3f17-4c1a-8811-6e23bb5e5d42">104</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzctMS0xLTEtMTg0NDY5_572b3efb-4c23-41d3-9732-11f7dba758ca">2,060</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzctMy0xLTEtMTg0NDY5_ed4a1cad-6047-4f2f-a430-86365eca17d9">523</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzctNS0xLTEtMTg0NDY5_28c0ef28-e306-4a02-94ec-6b5517f9742e">392</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzctNy0xLTEtMTg0NDY5_ede15b5b-76ca-473a-b6a0-122c5f5054f1">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Plan amendments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAmendments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzgtMS0xLTEtMTg0NDY5_c873cd2d-6f03-44e8-bf6f-c13063913f5d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzgtMy0xLTEtMTg0NDY5_997aca1f-72f2-40f6-a500-f261555d6cf4">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzgtNS0xLTEtMTg0NDY5_797f8e49-0163-4287-a5b2-d8110770cd29">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAmendments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzgtNy0xLTEtMTg0NDY5_1e3b5044-ef5c-4638-895b-8d5749905e84">345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Divestiture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzktMS0xLTEtMTg0NDY5_05bc2785-95d8-441a-b63d-2003233e1ddf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzktMy0xLTEtMTg0NDY5_7369deb5-b7ad-4667-9c73-d852a8dd11eb">193</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzktNS0xLTEtMTg0NDY5_8a74a6a6-c6d0-4bca-be8b-03758476ddb8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzktNy0xLTEtMTg0NDY5_148177f3-03f5-4d73-82bf-836c8398346c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzExLTEtMS0xLTE4NDQ2OQ_893a4125-442d-4743-b1d1-d937db1c9e90">6,292</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzExLTMtMS0xLTE4NDQ2OQ_e76c9eaf-2570-4ae2-a244-97c664aaacb7">8,544</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzExLTUtMS0xLTE4NDQ2OQ_f6f4044c-0d56-4db1-88fc-7c6b649e66f6">1,275</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzExLTctMS0xLTE4NDQ2OQ_4e5c08c1-0580-4210-90b7-9e62ae7ce7dd">1,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Fair value of plan assets at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzEzLTEtMS0xLTE4NDQ2OQ_8c4a0292-2cf3-42a5-ae6d-e1d8723e36ef">8,793</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i949403a737c24de59a13987d688282a7_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzEzLTMtMS0xLTE4NDQ2OQ_90edfc6a-207e-4a07-8350-0fc68de04424">8,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzEzLTUtMS0xLTE4NDQ2OQ_d850f98a-dc7c-4f4b-a01c-5b304777a290">185</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00cce528acbc427a9f5dda1550d2d9fd_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzEzLTctMS0xLTE4NDQ2OQ_83308c6d-99fa-4ce2-9c37-ef5d094c3bc9">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE0LTEtMS0xLTE4NDQ2OQ_541bf37f-58bb-46df-bc55-c33fe98c4aed">1,748</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE0LTMtMS0xLTE4NDQ2OQ_1879f3a5-6e55-4f16-91fa-6dd23a39330f">466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE0LTUtMS0xLTE4NDQ2OQ_b1c55d09-a6bf-49c1-9ce8-7a93dc50de1c">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE0LTctMS0xLTE4NDQ2OQ_a73082ad-e489-4dea-beef-3e26133a51ab">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Employer contributions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE1LTEtMS0xLTE4NDQ2OQ_5d32ea99-bab9-4355-9410-fe843a004312">20</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE1LTMtMS0xLTE4NDQ2OQ_68cdf6ad-068c-4c96-bf2d-59e7cc76a1ed">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE1LTUtMS0xLTE4NDQ2OQ_1f06c8e7-0fe8-46db-8e29-893d9b041221">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE1LTctMS0xLTE4NDQ2OQ_77c9cf0f-455a-48e7-8904-10486a78ad7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Benefits paid</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE2LTEtMS0xLTE4NDQ2OQ_4eec68d0-e961-4ea4-bd19-bcccbba5f74e">462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE2LTMtMS0xLTE4NDQ2OQ_9f49dac2-41cf-4db6-9733-86530288ad96">465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE2LTUtMS0xLTE4NDQ2OQ_f48c7893-2e51-4f8a-9a94-2ed89c667032">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE2LTctMS0xLTE4NDQ2OQ_3d3f0be5-f54f-4704-a48e-4940255afecd">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Divestiture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE3LTEtMS0xLTE4NDQ2OQ_58196fe5-084c-43e0-9483-c723fd753718">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE3LTMtMS0xLTE4NDQ2OQ_0163270a-7ce8-476b-bcd2-5641bea14f39">145</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE3LTUtMS0xLTE4NDQ2OQ_6060b1af-d43b-48c8-b4f8-24d446f1bb27">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanDivestituresPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE3LTctMS0xLTE4NDQ2OQ_e225f45a-552c-4e34-8de6-5f37052a5a7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE4LTEtMS0xLTE4NDQ2OQ_59ae4fca-548b-4ac0-b757-2a2abf5bb6d7">6,603</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE4LTMtMS0xLTE4NDQ2OQ_9174082e-347d-4445-8f12-36bd460c9aba">8,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE4LTUtMS0xLTE4NDQ2OQ_0089e650-4fdb-442d-ba88-40e244fba36b">122</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE4LTctMS0xLTE4NDQ2OQ_098be242-59ce-46a9-90b9-4da252d4daef">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Funded status at December&#160;31</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE5LTEtMS0xLTE4NDQ2OQ_96ff48c5-630f-4963-9f4b-9d27e81959af">311</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE5LTMtMS0xLTE4NDQ2OQ_ab47dc6a-e8ed-45ab-9940-9c709a46ef12">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE5LTUtMS0xLTE4NDQ2OQ_6784b31c-ba81-41a1-ba1f-7c628d5371e9">1,153</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE5LTctMS0xLTE4NDQ2OQ_8ae3de56-43bd-44b7-bffb-e3387788681f">1,503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on our consolidated balance sheets were as follows:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIxLTEtMS0xLTE4NDQ2OQ_1dd44b11-28bd-4fea-910e-b85506748af5">469</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIxLTMtMS0xLTE4NDQ2OQ_16c35f0b-88f7-4fd8-9b0f-d20c6a317cc6">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIxLTUtMS0xLTE4NDQ2OQ_089b7876-bed5-41f2-b392-d4f0b5c91ce6">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIxLTctMS0xLTE4NDQ2OQ_5a1c4ef3-1c4f-46bd-88b6-e29bf8998fc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other accrued liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIyLTEtMS0xLTE4NDQ2OQ_0696ad29-a1dc-4f3f-add3-8ac031f6400b">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIyLTMtMS0xLTE4NDQ2OQ_315e7ed3-bc12-4420-845a-94b0806f1423">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIyLTUtMS0xLTE4NDQ2OQ_18e032c1-cd88-4e15-b82d-a02f8e2988af">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIyLTctMS0xLTE4NDQ2OQ_41fbe22d-08e1-42b7-9595-9ac8bd8bcc6e">67</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued pension costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIzLTEtMS0xLTE4NDQ2OQ_e61d0fb4-601a-46fe-9cc7-2ef76cae4dc3">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIzLTMtMS0xLTE4NDQ2OQ_b7ad5fc3-d568-4e4e-a3f4-0f21f333e294">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIzLTUtMS0xLTE4NDQ2OQ_fc8ce8ab-1351-4176-8267-618c5cc60804">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIzLTctMS0xLTE4NDQ2OQ_421c01bb-fb01-4d68-b2bd-966c7b2b845c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued postretirement health care costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI1LTEtMS0xLTE4NDQ2OQ_1ada62a3-4533-464c-a517-f64cc7ebceae">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI1LTMtMS0xLTE4NDQ2OQ_af95a94f-5f1a-410f-b481-446a1f380c69">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI1LTUtMS0xLTE4NDQ2OQ_83d819a8-4646-4138-8e50-a92fe0718442">1,083</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" name="us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI1LTctMS0xLTE4NDQ2OQ_f3592048-3767-41be-b1b0-22a27f45dba1">1,436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI2LTEtMS0xLTE4NDQ2OQ_e836cfc4-f1b9-46f5-837b-f506229d5d2b">311</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI2LTMtMS0xLTE4NDQ2OQ_2cd12289-e02a-4f48-a17b-10f35360ec99">249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI2LTUtMS0xLTE4NDQ2OQ_14b6893a-8472-4235-97f1-4ef1d8161cd1">1,153</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI2LTctMS0xLTE4NDQ2OQ_e16ea864-0363-43c2-a9ee-71495f1811ad">1,503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Divestiture of benefit obligations and plan assets related to the Ste. Michelle Transaction.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above presents the projected benefit obligation for our pension plans.  The accumulated benefit obligation, which represents benefits earned to date, for our pension plans was $<ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-8" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzE0OTc_0606930e-177d-4296-8d26-96e70d4df17e">6.1</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-8" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzE1MDU_56d9df3c-ac78-4d9e-88b3-b433f2266674">8.2</ix:nonFraction> billion at December&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial (gains) losses for the years ended December&#160;31, 2022 and 2021 for our pension and postretirement plans were due primarily to changes in the discount rate.  Actuarial (gains) losses for our pension plans for the year ended 2021 were further impacted by changes to mortality rate assumptions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan amendments to our postretirement plans for the year ended December&#160;31, 2021 included several plan changes announced in the second quarter of 2021 to our salaried retiree healthcare plans, primarily changing its post-age 65 coverage to a private medicare marketplace.  These amendments triggered a plan remeasurement in the second quarter of 2021, resulting in a reduction of $<ix:nonFraction unitRef="usd" contextRef="if489977786fd4db69449f01c2756f802_D20210401-20210630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzIxNTU_d8e948ef-7065-4b6a-8887-ecca1d8d892f">432</ix:nonFraction> million (including discount rate impact and other changes) to our postretirement obligation in the second quarter of 2021 and a corresponding reduction to accumulated other comprehensive losses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For pension plans with accumulated benefit obligations in excess of plan assets at December&#160;31, 2022, our accumulated benefit obligation and fair value of plan assets were $<ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzI1MDc_06ddb771-4bdd-446f-8d5b-2c274460e681">134</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzI1MTQ_ffff70f3-5812-445a-9373-cb5ddf80b682">0 million</ix:nonFraction>, respectively.  For pension plans with accumulated benefit obligations in excess of plan assets at December&#160;31, 2021, our accumulated benefit obligation and fair value of plan assets were $<ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzI3MDQ_32aa101c-7c88-4ebe-ad56-26889e182a11">176</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzI3MTI_b339ca53-74ff-4811-b9c1-0fb34409fc96">0 million</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For pension plans with projected benefit obligations in excess of plan assets at December&#160;31, 2022, our projected benefit obligation and fair value of plan assets were $<ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzI4ODQ_4e999d06-e181-4488-9d50-f8e0ba2a0b87">158</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzI4OTI_9226df8e-acf1-4c1e-aa98-9ab78ebf95ce">0 million</ix:nonFraction>, respectively.  For pension plans with projected benefit obligations in excess of plan assets at December&#160;31, 2021, our projected benefit obligation and fair value of plan assets were $<ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzMwNzc_ee613438-5653-442a-ada4-4a0a5dc488ac">227</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzMwODQ_bf2c2a99-7a33-4baf-a12c-bee36578a0d0">0 million</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, our accumulated postretirement benefit obligations were in excess of plan assets for all postretirement plans.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i9e82a95ad17a450fb5dcc817ba282cb1" continuedAt="if6da45b205b04cfbb88e24508bdfa710"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfAssumptionsUsedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMTE0_614b7fc8-971c-44f9-a148-b3517bf363fb" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used the following assumptions to determine our pension and postretirement benefit obligations at December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.140%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.737%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzItMS0xLTEtMTg0NDY5_fde20329-cef3-4073-b2a0-9b8e8c763b9f">5.6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzItMy0xLTEtMTg0NDY5_c6faa93a-2bc5-4228-80cb-7f90419bfc19">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzItNS0xLTEtMTg0NDY5_5482c17d-cd96-46cc-b1f1-d775aadd7849">5.6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzItNy0xLTEtMTg0NDY5_acb37a55-8f90-4c69-bd3b-5e3395adb59d">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase - long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzMtMS0xLTEtMTg0NDY5_295f1455-c293-4f7b-8585-30bf1faa8580">4.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzMtMy0xLTEtMTg0NDY5_8cfb0a7f-c216-4080-90be-aebfdf588c61">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzMtNS0xLTEtMTg0NDY5_2cd9deb0-a3f5-4f16-b86a-72692db2fbda">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzMtNy0xLTEtMTg0NDY5_903dbabb-aecd-439e-97d3-deabe460f705">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost trend rate assumed for next year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzQtNS0xLTEtMTg0NDY5_af4e4521-1112-4361-8d6c-19ecf790efde">6.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzQtNy0xLTEtMTg0NDY5_196c0376-4725-4371-917d-fb8fe2e16d3b">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Ultimate trend rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="3" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzUtNS0xLTEtMTg0NDY5_ceca9416-8768-490a-b839-a3f2d2f6f593">5.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="3" name="us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzUtNy0xLTEtMTg0NDY5_9ad3ef29-8457-4d79-b99f-17d0e5eb400e">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Year that the rate reaches the ultimate trend rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Components of Net Periodic Benefit Cost (Income):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDMx_c8c5c06d-13c7-4d14-8ca1-a5f4df83a9af" continuedAt="i0137781e8db849d0bbdd23c8e738d7d7" escape="true">Net periodic benefit cost (income) consisted of the following for the years ended December 31:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><ix:continuation id="i0137781e8db849d0bbdd23c8e738d7d7"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.589%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzItMS0xLTEtMTg0NDY5_4510f85a-93d9-4b6f-a775-0f071ab3bba7">64</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzItMy0xLTEtMTg0NDY5_4aeeff93-9768-48bd-92a0-0debc7a43d49">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzItNS0xLTEtMTg0NDY5_4b28094c-93d9-4e8d-80f8-f6be7742de59">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzItNy0xLTEtMTg0NDY5_dac6eaaa-5e3e-444c-8181-904589b2f6d8">23</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzItOS0xLTEtMTg0NDY5_4a36b8d2-b7d9-44d2-97fc-ba6f660fa168">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzItMTEtMS0xLTE4NDQ2OQ_af9bc700-1f7f-48c2-9316-cb10c7740e86">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzMtMS0xLTEtMTg0NDY5_e4512fc7-a283-41fe-bc28-ae51e4111b45">206</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzMtMy0xLTEtMTg0NDY5_992643b1-06f1-4358-abad-38f03a0bc1f6">184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzMtNS0xLTEtMTg0NDY5_976911a8-67f4-4fb9-9fc1-8b4bd647c525">251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzMtNy0xLTEtMTg0NDY5_e99c2211-5ead-4621-b608-cfb516f7e3cc">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzMtOS0xLTEtMTg0NDY5_c1a73421-9ac9-43ad-a434-a10378049ba5">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzMtMTEtMS0xLTE4NDQ2OQ_bc1eaf97-2931-4324-8097-83974ff25f95">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzQtMS0xLTEtMTg0NDY5_022ea45e-dcab-44df-bdc3-da98410242e5">493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzQtMy0xLTEtMTg0NDY5_9860af20-a201-4c28-a18b-f06281d84128">522</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzQtNS0xLTEtMTg0NDY5_23cf77ba-85b4-4096-98bb-7c5fa23be098">502</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzQtNy0xLTEtMTg0NDY5_5478a560-4bed-4c4b-9518-ffe311e92abc">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzQtOS0xLTEtMTg0NDY5_812bbe77-1c2c-4d3d-abd7-d452ab583298">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzQtMTEtMS0xLTE4NDQ2OQ_da6d3fa4-ca40-4647-914d-9ebf6ce3f417">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzYtMS0xLTEtMTg0NDY5_ccb60546-d2ec-4282-a0ce-aca926105996">96</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzYtMy0xLTEtMTg0NDY5_77d1e4d2-466b-4a78-af0f-db7d57a5b4df">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzYtNS0xLTEtMTg0NDY5_7ac5a8c6-d177-4e34-a2d0-9934f734267e">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzYtNy0xLTEtMTg0NDY5_767217a9-ea69-4c2a-9404-2d8907ffb147">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzYtOS0xLTEtMTg0NDY5_8ed88ea6-d5a8-4be6-91c4-df064a48b6f3">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzYtMTEtMS0xLTE4NDQ2OQ_8f81edd8-7ac5-486d-ac76-32b1ddb5d174">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzctMS0xLTEtMTg0NDY5_904cb179-0225-4597-978d-817a0e77d873">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzctMy0xLTEtMTg0NDY5_71fcc6f2-2df6-40fe-8e53-15b46aec257a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzctNS0xLTEtMTg0NDY5_5a37b8b7-a4e8-4abf-ab0d-a11625e83a11">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzctNy0xLTEtMTg0NDY5_9e3ed0fa-86a7-4718-9ac2-ce0d5da849af">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzctOS0xLTEtMTg0NDY5_9d03b78d-059d-408c-97a6-d5e469302117">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzctMTEtMS0xLTE4NDQ2OQ_72f8362a-65cb-4982-8438-01890deeb69b">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzgtMS0xLTEtMTg0NDY5_cbf9104f-5917-4a8e-bd02-ba4533d19dd5">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzgtMy0xLTEtMTg0NDY5_462ef324-c99c-4a4d-9d04-5c0600da9ee9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzgtNS0xLTEtMTg0NDY5_a9c0303e-07ae-4be5-83a3-d62fe93e1867">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzgtNy0xLTEtMTg0NDY5_ec94a982-88bb-492a-a896-c3a4ee6eeacb">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzgtOS0xLTEtMTg0NDY5_e5159cb6-58f2-417f-a921-0bf1e90a580b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzgtMTEtMS0xLTE4NDQ2OQ_062c1235-030e-4a34-9bda-82728fcc7c23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzktMS0xLTEtMTg0NDY5_0b2eaa57-8c54-425e-90db-f3fcc0f5b95f">121</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzktMy0xLTEtMTg0NDY5_6141e980-e47a-4d32-b6a2-f282724be8e8">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzktNS0xLTEtMTg0NDY5_d80d32b0-2729-4249-b3a5-eedd410f62f6">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzktNy0xLTEtMTg0NDY5_40cc8506-1cc1-4c33-a3d0-698a10b546cd">24</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzktOS0xLTEtMTg0NDY5_d7a4aa36-e166-411c-9f1b-6167707cbccd">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzktMTEtMS0xLTE4NDQ2OQ_58b43e4b-f1b6-46a6-8c58-56cb24d551f9">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, we recorded the settlement amount as a change to net losses in other comprehensive earnings/losses.</span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="mo:ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDg1_6430b134-b9ab-42fd-8615-f03c912b3d17" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to determine our net periodic benefit cost for the years ended December&#160;31:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"></td><td style="width:37.941%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.352%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.854%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.215%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.357%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Service cost</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzMtMS0xLTEtMTg0NDY5_883950a4-cab0-4843-b7d2-f04bdbcd14e4">3.2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzMtMy0xLTEtMTg0NDY5_4da89a3a-8883-43cf-a4a3-2df13404de95">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzMtNS0xLTEtMTg0NDY5_a63bef89-bd6c-4450-84a7-0859dad369d6">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzMtNy0xLTEtMTg0NDY5_80f2b4e5-a8e0-4ee3-bfc9-20f13e58977b">3.2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzMtOS0xLTEtMTg0NDY5_a2ea9768-7f3b-40e6-900b-8a9ed54a3d08">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzMtMTEtMS0xLTE4NDQ2OQ_c20c492c-27c0-4261-a31e-90cc5eb3dacf">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest cost </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzQtMS0xLTEtMTg0NDY5_8017e5f7-4d2b-4132-a3bc-c57920759388">2.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzQtMy0xLTEtMTg0NDY5_395b6f6c-f015-4143-b850-6cbf74e56b36">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzQtNS0xLTEtMTg0NDY5_957ac957-4593-4f60-8dcc-391ff35ddff3">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzQtNy0xLTEtMTg0NDY5_ac350047-6614-4768-8a02-7c6f98ecde15">2.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzQtOS0xLTEtMTg0NDY5_6e5891a7-5945-4690-959b-b88ecf741d66">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzQtMTEtMS0xLTE4NDQ2OQ_23081cc6-eb23-4e77-892e-98004d79b425">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzUtMS0xLTEtMTg0NDY5_9d59861d-d78f-4173-adbe-f3fc7957d83a">6.1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzUtMy0xLTEtMTg0NDY5_c21ebc11-b84e-4a38-88ec-eb5bfa0d0894">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzUtNS0xLTEtMTg0NDY5_39c8684f-24f2-4dc6-9e20-6d5a0caddb97">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzUtNy0xLTEtMTg0NDY5_d3d27475-0e45-487d-ab3b-aadbbdce4657">7.7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzUtOS0xLTEtMTg0NDY5_259171a2-6a8a-44e0-b339-3d193c15d0ec">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzUtMTEtMS0xLTE4NDQ2OQ_b21556c0-84f9-43d0-bba3-38ae459986cb">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase - long-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzYtMS0xLTEtMTg0NDY5_242990be-5e43-4323-b04c-3d5a5f5d7f7c">4.0</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzYtMy0xLTEtMTg0NDY5_fa98db14-ab08-48ef-a8c0-5af45eb1f83a">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzYtNS0xLTEtMTg0NDY5_10fadc95-00d7-44dc-aa4b-93ba1fdcbea4">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost trend rate</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzctNy0xLTEtMTg0NDY5_13cb46d6-1d38-4a98-a37c-cedc2a50b97b">6.5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzctOS0xLTEtMTg0NDY5_89434e38-9aa1-4129-bd8a-95419a6bbb3d">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="3" name="mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzctMTEtMS0xLTE4NDQ2OQ_8916077f-4860-4b18-9013-c27b5a9a2fcb">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Defined Contribution Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor tax-qualified defined contribution plans covering certain salaried and hourly (non-union and union) employees.  Contributions and costs are determined generally as a percentage of earnings, as defined by our plans.  Amounts charged to expense for these defined contribution plans totaled $<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQyMTU_03e2e940-081d-4ee4-b10a-0ec03f71b846">91</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQyMTk_9bfc9bab-883d-4697-8662-85fac2779cb3">90</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQyMjY_cbaab623-708c-43c5-8c21-2860c18435e8">88</ix:nonFraction> million in 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Pension and Postretirement Plan Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In managing our pension assets, we implement a liability-driven investment framework that aligns plan assets with liabilities.  The current equity/fixed income allocation of <ix:nonFraction unitRef="number" contextRef="i708e341152674f6390a40e9721f87532_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQ2MjU_cdd60e21-5f89-4ccf-9348-3f00e1bcf4ea">20</ix:nonFraction>%/<ix:nonFraction unitRef="number" contextRef="if9ef67837f3b481b91a45102c2741bec_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQ2Mjg_de36d86d-ec61-409c-8dbb-04336ebf5617">80</ix:nonFraction>% is designed to balance pension liability hedging and asset growth in order to maintain our plan&#8217;s funded status and cover incremental service accruals and interest cost.  Liability hedging is achieved through investing in rate-sensitive fixed income securities, primarily corporate bonds and U.S. Treasuries, while growth assets are comprised of publicly traded equity securities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment strategy for our postretirement plan assets is intended to maximize our total asset return based on the expectation that equity securities will outperform debt securities over the long term and reflects the maturity structure of our benefit obligation.  The equity/fixed income target allocation for postretirement plan assets is <ix:nonFraction unitRef="number" contextRef="i218f7dbb66d94126b2f426148102feee_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzU1ODg_52b3f11a-35d6-4664-b21c-f19a217c8a1c">55</ix:nonFraction>%/<ix:nonFraction unitRef="number" contextRef="i1ce8f1baf1924d369a28a5bcb7cd369c_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzU1OTE_86d56982-5519-4049-be6a-c1c26cfb3f68">45</ix:nonFraction>%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we implement these investment strategies in a prudent and risk-controlled manner, consistent with the fiduciary requirements of the Employee Retirement Income Security Act of 1974, by investing retirement plan assets in a well-diversified mix of equities, fixed income and other securities.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="if6da45b205b04cfbb88e24508bdfa710" continuedAt="i63f3a0e70f9a432d86681fd58d89f261"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMTIz_12568c02-65af-4369-a7e9-048f9600922c" continuedAt="i27ceafa6d70d44c3b60039a6f9bcf7a2" escape="true"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual composition of our plan assets at December&#160;31, 2022 was broadly characterized with the following allocation:</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.889%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibef1d20b06414d568aea451eb1e564cf_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiMmNlZDE0OGY4NzE0NDI3OWQxMjE5OThhMWM1OGM1Ni90YWJsZXJhbmdlOmIyY2VkMTQ4Zjg3MTQ0Mjc5ZDEyMTk5OGExYzU4YzU2XzEtMS0xLTEtMTg0NDY5_9fd3aaa0-5c22-4345-a940-cadcbd86b6ee">20</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i85712ade9dea49509d0041354e9dd058_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiMmNlZDE0OGY4NzE0NDI3OWQxMjE5OThhMWM1OGM1Ni90YWJsZXJhbmdlOmIyY2VkMTQ4Zjg3MTQ0Mjc5ZDEyMTk5OGExYzU4YzU2XzEtMy0xLTEtMTg0NDY5_72833b96-0f8f-4d18-a4de-61bdc54aec09">56</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i46a26fe11c204936a35f2e5d15e5781e_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiMmNlZDE0OGY4NzE0NDI3OWQxMjE5OThhMWM1OGM1Ni90YWJsZXJhbmdlOmIyY2VkMTQ4Zjg3MTQ0Mjc5ZDEyMTk5OGExYzU4YzU2XzItMS0xLTEtMTg0NDY5_76fd8e9f-5941-408c-a94e-4b186e7c4bfb">52</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i02d2cf1003314ab9892258dcee6449fe_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiMmNlZDE0OGY4NzE0NDI3OWQxMjE5OThhMWM1OGM1Ni90YWJsZXJhbmdlOmIyY2VkMTQ4Zjg3MTQ0Mjc5ZDEyMTk5OGExYzU4YzU2XzItMy0xLTEtMTg0NDY5_52b28410-9d69-46a8-aac0-f2f9e21839bd">33</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and foreign government securities and all other investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifd98a90576ce475886c7adc642f71634_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiMmNlZDE0OGY4NzE0NDI3OWQxMjE5OThhMWM1OGM1Ni90YWJsZXJhbmdlOmIyY2VkMTQ4Zjg3MTQ0Mjc5ZDEyMTk5OGExYzU4YzU2XzMtMS0xLTEtMTg0NDY5_3e09dbd8-5bad-450e-af3d-a3138db061fc">28</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ae3153fe128440e9f61ca8201dcc8a0_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiMmNlZDE0OGY4NzE0NDI3OWQxMjE5OThhMWM1OGM1Ni90YWJsZXJhbmdlOmIyY2VkMTQ4Zjg3MTQ0Mjc5ZDEyMTk5OGExYzU4YzU2XzMtMy0xLTEtMTg0NDY5_00470a7b-52f6-4ba1-88dc-a452315ec7f9">11</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amount includes U.S Treasury and foreign government securities (<ix:nonFraction unitRef="number" contextRef="ic6aab89198f84ab09ff72153ef35e171_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQ5NDc4MDIzNDQ5NzY_7a21db05-9560-4bb7-b4f1-8a6578bf7c80">19</ix:nonFraction>%) and asset based securities and all other investments (<ix:nonFraction unitRef="number" contextRef="i34b241d0d60b4ff3a0eed6af4527dc96_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQ5NDc4MDIzNDQ5ODI_0088bdd5-31f8-494d-8318-7172fed26dbf">9</ix:nonFraction>%).</span></div></ix:nonNumeric><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pension and postretirement plan asset performance is monitored on an ongoing basis to adjust the mix as necessary to achieve our target allocations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all pension and all postretirement assets can be used to make monthly benefit payments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We implement our investment strategy for our pension and postretirement plan assets by investing in long-duration fixed income securities that primarily include U.S. corporate bonds of companies from diversified industries and U.S. Treasury securities that mirror  our pension obligation benchmark, as well as U.S. and international equity index strategies that are intended to mirror broad market indices, including, the Standard &amp; Poor&#8217;s 500 Index and Morgan Stanley Capital International (&#8220;MSCI&#8221;) Europe, Australasia, and the Far East (&#8220;EAFE&#8221;) Index.  Our pension and postretirement plans also invest in actively managed international equity securities of mid and small cap companies located in developed and emerging markets.  For pension plan assets, our allocation to below investment grade securities represented approximately <ix:nonFraction unitRef="number" contextRef="i8cc36e5d0d8e47749726e99b3dca0875_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzcxMzI_bc43dbc7-b17b-4bfe-beb9-a8992226c96a">13</ix:nonFraction>% of the fixed income holdings or approximately <ix:nonFraction unitRef="number" contextRef="i63d3cf858e354c7e92e2e0365451f300_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzcxODE_5eb727a2-25b4-40b5-ab85-38446520551a">10</ix:nonFraction>% of our total plan assets at December&#160;31, 2022.  Our allocation to emerging markets represented less than <ix:nonFraction unitRef="number" contextRef="i7f6a7fc0bc2d4a5eaf7ca6d75b30312e_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzcyNzQ_db0bd009-94e5-42e8-a6d9-828baffe1d35">1</ix:nonFraction>% of total plan assets at December&#160;31, 2022.  For postretirement plan assets, our allocation to below investment grade securities represented approximately <ix:nonFraction unitRef="number" contextRef="i31ed26bb32ff433080c9fdca31b03ecc_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzc0MTY_503aa70b-d96a-4e5c-8788-e1b9b4ae59e5">12</ix:nonFraction>% of the fixed income holdings or approximately <ix:nonFraction unitRef="number" contextRef="ic64efbd3de4f4ab58c333a511cc0d644_I20221231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzc0NjU_100b00e7-04d1-4a7a-95c8-c3e95e4528ba">5</ix:nonFraction>% of our total plan assets at December&#160;31, 2022.  There were <ix:nonFraction unitRef="usd" contextRef="i8ed4a725235c47b887eb6679e8c3d522_I20221231" decimals="INF" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzc1MTI_bb32e51c-d512-4d32-9ed2-ad4510248185">no</ix:nonFraction> postretirement plan assets invested in emerging markets at December&#160;31, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk management practices for our pension and postretirement plans include (i) ongoing monitoring of asset allocation, investment performance and investment managers&#8217; compliance with their investment guidelines, (ii) periodic rebalancing between equity and debt asset classes and (iii) annual actuarial re-measurement of plan liabilities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our expected rate of return on pension and postretirement plan assets is determined by our plan assets&#8217; historical long-term investment performance, current asset allocation and estimates of future long-term returns by asset class.  The forward-looking estimates are consistent with the long-term historical averages exhibited by returns on equity and fixed income&#160;securities.  For determining our pension and postretirement net periodic benefit cost (income), our 2023 expected rate of return assumptions are <ix:nonFraction unitRef="number" contextRef="i87839150a2374e27a36b41a49b45c5bf_D20230101-20231231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzM4NDgyOTA3MTAyMDc_3de1d8e6-47cd-46e5-a52f-279dd49875f4">6.1</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i83c8e5d5266f45fbb46737c1d2fcace0_D20230101-20231231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzg2ODY_09fa5e85-ed19-4632-8ec9-35bfef12640c">7.4</ix:nonFraction>%, respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i63f3a0e70f9a432d86681fd58d89f261" continuedAt="ie004cef036354084bc6bfe43b5dae243"><ix:continuation id="i27ceafa6d70d44c3b60039a6f9bcf7a2" continuedAt="i8b8ee6c8a0954c55bb58b48ce9e62398"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our pension plan assets by asset category were as follows at December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.892%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.892%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.104%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. and foreign government securities or their agencies:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agencies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5937f04b1ddf4dd89b8d3092539fb3cd_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzMtMS0xLTEtMTg0NDY5_6845cc30-01f1-437f-83ee-2eaefeca6d20">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565d6f3baf2f4947b0dd194ac42693e9_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzMtMi0xLTEtMTg0NDY5_a181f123-e1db-414f-9417-6399f201ca31">1,098</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d841655cc044a6b7129c58b61ec0c3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzMtNi0xLTEtMTg0NDY5_146b416e-df02-41fa-ad8b-92957cc93504">1,098</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a857bd3f87c48ba9e0abfc8eebc8cc7_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzMtOC0xLTEtMTg0NDY5_06da783e-785f-4061-a720-692e41d976e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8bc8d974c824ca79ceac63074634c5c_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzMtOS0xLTEtMTg0NDY5_f0fe15d2-21ed-402a-b7e9-9b523b39c48c">1,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f3e5c978adf4674a37c1255333c112e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzMtMTMtMS0xLTE4NDQ2OQ_0c018703-2d55-466d-981b-209f2e402dbe">1,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. municipal bonds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0f669dde52c4154be5883d70c4541af_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzQtMS0xLTEtMTg0NDY5_d8c72c1b-acea-475e-a261-7fc26098b598">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i837fc7852b3c4ccf973ccfa3c30e16ff_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzQtMi0xLTEtMTg0NDY5_a45cf31a-7393-4965-b4ae-1a887f0a1773">82</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb79e28764284a31a8d89f2ff43f4204_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzQtNi0xLTEtMTg0NDY5_d3cdb257-0839-48c5-ab23-b6ec88cfa57a">82</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i091fc79fcdb54ad5bac6c31650d0dc35_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzQtOC0xLTEtMTg0NDY5_698aad4e-a0f3-4035-88b2-28da60262cd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43a0bf9c464a4f689b6fa2279baa3db6_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzQtOS0xLTEtMTg0NDY5_f19a65a8-da76-415d-953c-0d08a2a58240">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if56170cb4e9e4dc3ab4c2439b1108953_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzQtMTMtMS0xLTE4NDQ2OQ_aac76901-f4c0-418e-a845-6361c281fe62">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government and agencies</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d5635e4a45042f887595e208639d06c_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzUtMS0xLTEtMTg0NDY5_8ab19e81-f092-4593-a065-da806d3d525a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab9a9711d20426494a4f993ff5497cc_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzUtMi0xLTEtMTg0NDY5_ba9c910a-486d-4b01-9641-36d446179563">32</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac81e2e1561144d4b6fc044d55a86b44_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzUtNi0xLTEtMTg0NDY5_e91a2639-71a2-4fce-9d60-dff7ded70f0a">32</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98d16200be95427aaa506a07cafc1f0f_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzUtOC0xLTEtMTg0NDY5_7a0d9401-dae4-429f-b56e-8ffbcd9c6b4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cf80c87ecf0415e92e285f99ba853d6_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzUtOS0xLTEtMTg0NDY5_fd0b4488-d191-4b4e-b045-9154ccd50ce4">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie09850cd158044ef9737da94ccd4932a_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzUtMTMtMS0xLTE4NDQ2OQ_47122453-81bc-45c7-b8be-8c52131ddb01">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Above investment grade</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf7e45d2370d4822a594e626f0867b6f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzctMS0xLTEtMTg0NDY5_a44af960-0f1d-4d43-b5e1-41e16c31543b">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43dc5b8c106142a8a5eec96bf16c5e0c_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzctMi0xLTEtMTg0NDY5_9f115096-7f07-40c6-a169-1c3e52bba9e0">2,747</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05b7833a51e149a89ae331998c279adb_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzctNi0xLTEtMTg0NDY5_15bb578a-0dc9-4ba3-bc8d-3e77346c9e7e">2,747</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19b8a42637c04a8fbdb6b98fcc14b74b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzctOC0xLTEtMTg0NDY5_982574e2-d1e0-4f32-aea2-6ab8a0ce2ec0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1df38e22ba91472f933e5f94bb462967_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzctOS0xLTEtMTg0NDY5_3dd54c33-38f5-42ce-8359-11ad2bcdca6d">3,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i453b78fe37b14dbbb470779c2c160077_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzctMTMtMS0xLTE4NDQ2OQ_3bb6707c-2080-4d97-9dae-da8b0e9a985e">3,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Below investment grade and no rating</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idae2e10d00134111b2603a1ec55e2562_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzgtMS0xLTEtMTg0NDY5_697de4fb-272e-4438-b040-023cfe072857">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a22bcea6c7f47238753a786d43db429_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzgtMi0xLTEtMTg0NDY5_37701626-7d39-4d38-b81c-75f5d0deba2c">756</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6913094e4c2a4346856f5eaa16cfbdef_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzgtNi0xLTEtMTg0NDY5_bf18eb84-2ec6-4d5c-990a-ddc5e8194c37">756</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f7f03e22d4147c2979c55fcc62a5875_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzgtOC0xLTEtMTg0NDY5_e19dc0ae-35af-4a8a-bd27-2dfaab1691c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8af8a24b3b4465490365b4873d7d840_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzgtOS0xLTEtMTg0NDY5_5ae263f2-6797-466a-ab56-07cd2c0f0daf">1,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48edc7536f424109abdb6ba04fc667cc_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzgtMTMtMS0xLTE4NDQ2OQ_3ef1afa5-49b8-4e35-8241-ef0865657316">1,032</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i724473bb56ef42ca9368c198fabf43e2_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzEwLTEtMS0xLTE4NDQ2OQ_73808a7f-8ef1-424f-acd8-6b2d4cf285ef">327</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b271655bb784f2f8a8cb1deb35e7d4f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzEwLTItMS0xLTE4NDQ2OQ_50354d45-cf10-4cfd-b80f-9077d4b48bf2">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b66ad4089e442e8b7a70d986b26cc77_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzEwLTYtMS0xLTE4NDQ2OQ_041158a3-ebce-4c37-bb15-1ed5649da4d7">327</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66066f1832f24ffb846101be04a19a87_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzEwLTgtMS0xLTE4NDQ2OQ_6dc45552-2fc2-4e5e-aab0-41aab2acf4ce">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic09fc05c98894d629f60974a54315b5b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzEwLTktMS0xLTE4NDQ2OQ_1cbba55a-db9c-4eae-b726-722de5e93e2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i057b0ef85ece430f8ddd918897d56736_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzEwLTEzLTEtMS0xODQ0Njk_41558392-7105-4b8d-b4e1-51bc7da6d9b7">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i422058d6b4d24ca3ac6e070ff71aa8e2_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzExLTEtMS0xLTE4NDQ2OQ_2c8874d5-931a-4d61-b9ab-1a109c8bdab7">591</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb23a7abd88b4dfabbbb2aa8d76fdc64_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzExLTItMS0xLTE4NDQ2OQ_d03101b7-9aad-4fe9-9521-2e96d9f471cf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15b0bb8f8f754a41a4f7dfd22ec86295_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzExLTYtMS0xLTE4NDQ2OQ_977decc9-7573-4db8-961c-693f2c2369ee">591</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2da6e6418c72474a99ec75fadc054776_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzExLTgtMS0xLTE4NDQ2OQ_3baaf993-c313-4755-a8f9-c0da4a700ff1">856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bfdb9b8c6324abf8947ddb74a27e6a0_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzExLTktMS0xLTE4NDQ2OQ_7288f645-c883-4352-a660-289afff3f9aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic332a1659d2f405d80865e862ec27dab_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzExLTEzLTEtMS0xODQ0Njk_5469e591-e197-4e76-8200-c7bb53d95876">856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic71aca398a11408da1a534b27a0c25dc_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE0LTEtMS0xLTE4NDQ2OQ_96c9c1a0-cf90-4f70-a3dd-a24b6d847da4">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f3d8a40ef14a99905bccea0cfb4b72_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE0LTItMS0xLTE4NDQ2OQ_5dd7026b-90ec-485d-b397-a729763e8427">161</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad944a608a784c17b879349817b9d0dd_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE0LTYtMS0xLTIxNTExNQ_9b44f8eb-4d60-4031-947e-aae6f02b7945">161</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieefef214d38c46c39607fd46cfe43211_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE0LTgtMS0xLTE4NDQ2OQ_55e96f24-5495-4f40-ac13-9e160158109e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i249539f1cfef460291c13bcd717ecbd8_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE0LTktMS0xLTE4NDQ2OQ_b4498c55-5137-49b1-8966-b33668dd39eb">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63684a262279489c9c4f034d04ba5aab_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE0LTEzLTEtMS0yMTAxOTg_158ddb7a-4f9c-4632-9635-63b6887067d9">89</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89925d896a8548cfb62d7b79dc5a9fae_I20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE3LTEtMS0xLTE4NDQ2OQ_ba7b715d-0001-4777-8379-2fd1a65d5f93">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1339f4ea0fe42bc9ee6d7c661e84e5a_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE3LTItMS0xLTE4NDQ2OQ_ba45e27c-e09e-48f2-a5f7-3516d6da671c">244</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29227afcd5594316868d15193cb10cac_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE3LTYtMS0xLTE4NDQ2OQ_9e914234-dc03-4338-a18b-8db853423939">243</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e5c74c5bc734c1b9c970eeb6d8b1f1f_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE3LTgtMS0xLTE4NDQ2OQ_fd9590e0-2ec4-4553-8230-321ec14afcfa">52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10518c7a15dc4f21a69ded3f9d645ef6_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE3LTktMS0xLTE4NDQ2OQ_cd238a28-1f2a-4f4f-a8a8-67c99008112d">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22cca4c436d842d087f356c875896d60_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE3LTEzLTEtMS0xODQ0Njk_e105eb61-b58c-4574-a4ce-dac0c4b78ced">200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2c076e5ef854cabb8069eab488e2649_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE4LTEtMS0xLTE4NDQ2OQ_c1a87f3e-f0cc-4a8a-8f64-eb45284617d5">917</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e3082841f894e34a24a50706f337744_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE4LTItMS0xLTE4NDQ2OQ_d91874c5-8a8d-4129-b725-9a534d7ffa0a">5,120</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0febe181336b41b5a658c64358915bfe_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE4LTYtMS0xLTE4NDQ2OQ_2866db6c-8781-4949-b8f5-97a6872a6fb2">6,037</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64f7dc5b917c46deaa9b0a051ea0fb75_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE4LTgtMS0xLTE4NDQ2OQ_68e20afb-de38-4b8a-bcdc-1586835cde7d">1,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i620de52603d8478d83b1d097f32554e6_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE4LTktMS0xLTE4NDQ2OQ_017d0e2e-ce22-4336-8e89-f5fa5736c716">6,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4feca36ee17847ab82502d9eed738030_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE4LTEzLTEtMS0xODQ0Njk_490ee6a5-e668-4e13-a993-ba449810c655">7,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV as a practical expedient for fair value:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collective investment funds</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_41b4c8e3-e050-43b8-b106-4405c53c782d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_9c77b5ce-ddae-4a3d-978b-ba5336576f53">U.S. large cap</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d478bf113ce483ebab401dd2fd6491d_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTYtMS0xLTE4NDQ2OQ_e7ce4838-0fef-40c4-88cf-b7db2e5afc97">312</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39264efecc9e4ca88497194b3b7c8fc0_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTEzLTEtMS0xODQ0Njk_f4cd916e-297d-4d86-8ade-79dff12ad4c2">873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_1ddffbe6-a65c-4290-90a9-b5306bc7faca"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_c2aa8d53-307d-44de-88c6-ccc45057da99">U.S. small cap</span></span>  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142dcd767464403ea9b22f153172c48d_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTYtMS0xLTE4NDQ2OQ_a0cb3b34-8824-4af0-96ec-aa14d0a05921">75</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia39aee97eee14867b9fd0099749071c8_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTEzLTEtMS0xODQ0Njk_e9cc458d-3367-4265-9cbd-9018c1455ded">462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_6c58378e-c0bf-4554-a791-6444e99557ba"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_c4015aef-675a-4e45-9c95-609287b0df60">International developed markets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df4d26ee4254aec95af80be28802c08_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTYtMS0xLTE4NDQ2OQ_20b0a511-869a-472f-abd2-d0f026ce5d17">49</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0411a1966ac645d8a850e70787e39e47_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTEzLTEtMS0xODQ0Njk_e766579c-22e4-46b3-96cd-961f635c28d2">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments measured at NAV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc7229bbd58f4df69b5dea2ccab95bf5_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzI0LTYtMS0xLTE4NDQ2OQ_f9ccfa2f-747d-4636-8882-db5fb64b1c17">436</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dd0be9d1bce45958792a2e9fbe32dcf_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzI0LTEzLTEtMS0xODQ0Njk_958bb163-018b-48b4-bba0-881f00b53e5a">1,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id36ee6f9d1124a2595ac2df42e648378_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzI2LTYtMS0xLTE4NDQ2OQ_7990e7b4-6c8a-483a-a2e2-39ab0a0093f6">130</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide5f143afc5b477a9e3945daf0484c78_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzI2LTEzLTEtMS0xODQ0Njk_1e17e1c0-0c01-4f3f-aa9a-8f2b239d98fd">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of plan assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzI3LTYtMS0xLTE4NDQ2OQ_3c7024ec-0315-4691-aec8-422379ea4377">6,603</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzI3LTEzLTEtMS0xODQ0Njk_42f11e5a-fcdc-414a-89df-902e054d0e61">8,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 holdings and transactions were immaterial to total plan assets at December&#160;31, 2022 and 2021.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="ie004cef036354084bc6bfe43b5dae243" continuedAt="if0a6836bad094f4199dd7bcc469c292d"><ix:continuation id="i8b8ee6c8a0954c55bb58b48ce9e62398"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our postretirement plan assets were as follows at December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.096%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.104%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. and foreign government securities or their agencies:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agencies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07f902bc6dc8430c85a4b5a6902f7e69_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzMtMS0xLTEtMTg0NDY5_48acb65b-e567-4a04-89fb-b9a986f37200">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dc0106f1faf462eb26fc43277eaf2cd_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzMtMi0xLTEtMTg0NDY5_e21820a5-b069-424f-a55a-3fa8bd08dd92">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb735c6a79f740efb339b169181396ad_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzMtNC0xLTEtMTg0NDY5_d1a05fab-02ba-4fae-b82e-65c27aa246a9">5</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i726f9056e75f4525b26f5df7a357b0a1_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzMtNi0xLTEtMTg0NDY5_bdb58ce9-c883-4dd0-ba96-702b422c7d14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic341b9e0ef914a71aae1c0fe77f8d38e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzMtNy0xLTEtMTg0NDY5_31b10850-3aa5-43cd-8c19-0cbc23c9b798">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i214fc2f6fc754f7c885b3d6871ae6404_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzMtOS0xLTEtMTg0NDY5_449efdba-3792-4a9d-b3eb-b1be240dd0a0">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government and agencies</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7ac312a52d2464dae961fee29607342_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzUtMS0xLTEtMTg0NDY5_e5faac0d-4a3b-4d54-8552-07f11ec3a0f8">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c9735a7061a47e5985f44f2027c193e_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzUtMi0xLTEtMTg0NDY5_c07cad57-872e-4288-a62c-42df7a13acc2">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66baea8f8e3e44ccada2d2c6a807a3fb_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzUtNC0xLTEtMTg0NDY5_8d450862-39df-4d55-b951-9c22be62d44b">2</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ab2d0a4619144f49e454db1495480ed_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzUtNi0xLTEtMTg0NDY5_41ed9c87-3fe2-4835-8a3c-b066af89678b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b909807cda4d008124cf98b2dfb195_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzUtNy0xLTEtMTg0NDY5_7fa4829f-d9de-4ad4-911f-5429691deee4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67c6d721f139463c8a5ef2e2ac65795e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzUtOS0xLTEtMTg0NDY5_daaa7917-812b-4e6f-a248-6ae4ebd81320">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt instruments:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Above investment grade</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic90b8a4e1cad40c99e3c612c6aff6d10_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzctMS0xLTEtMTg0NDY5_02381b4e-a6a2-4ccf-ae41-c2e67c3f96d9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ef1e5229020494cbba49f40f9408830_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzctMi0xLTEtMTg0NDY5_acccc6c5-8d7b-4d4b-b08a-58891d5232ac">37</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b045ef00b1c46baa8abe159f085ff7a_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzctNC0xLTEtMTg0NDY5_fb31c0de-f5d2-4fc6-adc2-d21ad8eb4bd9">37</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id683265debfa46c298eb35c208c438d8_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzctNi0xLTEtMTg0NDY5_f1076562-49c7-4483-b5e3-ec52d1755d72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d1961208f4440e6950aa35f0cb3a24c_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzctNy0xLTEtMTg0NDY5_3abc2cf4-eab8-4f75-b903-a5eddb1ee82f">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53cd4ff8943f439dbee592de787cea17_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzctOS0xLTEtMTg0NDY5_862088c9-ff19-4b07-b9b7-913cfe73f5be">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Below investment grade and no rating</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida49dd477308420ca136a97a189050d9_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzgtMS0xLTEtMTg0NDY5_c4a7ca4d-e7d8-42a6-a0c4-2a1d09b25495">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabff1a6156384adc8cce0664586e25ec_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzgtMi0xLTEtMTg0NDY5_1071e67b-445a-4fa6-80e1-ed36ae44ebbf">7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b655b11e1ab48199a135d655b722fff_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzgtNC0xLTEtMTg0NDY5_1fbe7df8-525f-4fe0-9ffd-83998d07a80a">7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66404ccb7de546aa8b469a4fcbbbebc8_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzgtNi0xLTEtMTg0NDY5_3b6e4876-6539-46b0-a769-ecb48275e7b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ae13872490f4b7eb4a801adfb2d171e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzgtNy0xLTEtMTg0NDY5_c0ddb86a-ee7a-4257-8779-79cae330f5a0">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i418d56b014124b6081ceffc5c76fe087_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzgtOS0xLTEtMTg0NDY5_26a4069e-3c33-47cb-8ecd-7ed857e73e22">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7233bea80cc74eb8844423b368b977fa_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzktMS0xLTEtMTg0NDY5_df5dba2b-2c35-4df0-b9fb-d8023cd3fb9a">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9db59398fd34374bc22c5daa2fdcf89_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzktMi0xLTEtMTg0NDY5_29f50a1e-d399-4600-bd16-1d1fa0e9ff77">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if248beb73395471a8d3f3cb7a01e64bc_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzktNC0xLTEtMTg0NDY5_763c9be7-4993-4fec-b7cf-69b8da36738a">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ce3e56286fd4ca4b41897ef25ba9373_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzktNi0xLTEtMTg0NDY5_0c9c1073-5fe3-4bba-93c3-41a8759b5692">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14364497d94445c79d254185c8a0e260_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzktNy0xLTEtMTg0NDY5_9075cb90-8cee-4d72-a0dd-385956c7cfb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb1582fd2b3f4d81b9602d7adb41a05d_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzktOS0xLTEtMTg0NDY5_a0cfb335-ac30-4c4c-ba4b-5646c7cb0d01">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i441d0fa2abb74093916c6655196afd82_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEwLTEtMS0xLTE4NDQ2OQ_eebb68b4-ec77-4ac9-b263-269365145282">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2576928a12a455283eec1278075ce78_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEwLTItMS0xLTE4NDQ2OQ_bc910bb7-fca6-414d-a9fd-4533b7fa3fdf">54</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ff5b3ac729140c5ab95d29557eded13_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEwLTQtMS0xLTE4NDQ2OQ_dfb32106-06ea-4fbb-b421-5bb5b786886f">54</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099176409b2d40eb9b090dd044fbd69a_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEwLTYtMS0xLTE4NDQ2OQ_05a03d5d-b486-4265-8403-e31f17a22347">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id65b933eaa6f4c9589f7de89c772d624_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEwLTctMS0xLTE4NDQ2OQ_62ebdd64-eea3-4e5a-8501-bed0d055781d">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92c62a510f4440e0ae76b083af678da0_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEwLTktMS0xLTE4NDQ2OQ_b5db4aba-c289-48bd-9f49-fac1aa8c5620">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV as a practical expedient for fair value:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collective investment funds:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_295077d8-7c2c-4293-a53f-d6212cd1c050"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_bff869f3-0247-42fe-9766-2e8c8f382544">U.S. large cap</span></span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77edbf66fcec42d282c3c8658c645b38_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTQtMS0xLTE4NDQ2OQ_75125b58-ed4e-4540-b70f-9dc567d5036a">47</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fb4e78e1b1244acb5f611d994fe511d_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTktMS0xLTE4NDQ2OQ_99ff43dd-9869-41c7-a6f8-32561c855b73">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_501091e4-8056-4777-bd80-73ee1b31781b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_eef6c587-6a34-4f41-a17b-d1245eda6984">International developed markets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c1cbb128b174538ae7334de7cce2ee9_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTQtMS0xLTE4NDQ2OQ_43f0173d-0a97-4809-90e0-4fb88179860f">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab4e374e5b4a4126bfc6bd904d7493c0_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTktMS0xLTE4NDQ2OQ_9c322472-2f8c-40b5-9de0-63ba2c7bf5d0">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments measured at NAV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7bd5b5f81284011843bd24a1f898451_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE1LTQtMS0xLTE4NDQ2OQ_3efd1090-0705-49ad-b037-58eb9b9cac9f">65</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e916bce86724c739256a11e8d5ddfaf_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE1LTktMS0xLTE4NDQ2OQ_2bf2310c-6735-4e4c-a816-89f3ce1a0645">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5143a89f62f942d0aed69e5d5403fbdb_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE3LTQtMS0xLTE4NDQ2OQ_8d5c9895-0ca3-4b1d-9d0a-eb28f67b38d3">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i146dab2f246f4239ac7c45936f953058_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE3LTktMS0xLTE4NDQ2OQ_b6f5ecba-a593-49bf-b39e-311ef8f2e7ca">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of plan assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE4LTQtMS0xLTE4NDQ2OQ_c462fc14-14e8-4ffc-a4a8-fb23061b64ef">122</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE4LTktMS0xLTE4NDQ2OQ_b225c362-8a93-4a61-a8bf-2d2e02192aa4">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no Level 3 postretirement plan holdings or transactions during 2022 and 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the fair value hierarchy and the three levels of inputs used to measure fair value, see Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="mo:MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDQ4_a344ea75-b112-40ee-8afa-a514830b5263" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a description of the valuation methodologies used for investments measured at fair value.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">U.S. and Foreign Government Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: U.S. and foreign government securities consist of investments in Treasury Nominal Bonds and Inflation Protected Securities and municipal securities.  Government securities are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes.  Matrix pricing, yield curves and indices are used when broker quotes are not available.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Corporate Debt Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Corporate debt instruments are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes.  Matrix pricing, yield curves and indices are used when broker quotes are not available.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Common stocks are valued based on the price of the security as listed on an open active exchange on last trade date.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Asset Backed Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Asset backed securities are fixed income securities such as mortgage backed securities and auto loans that are collateralized by pools of underlying assets that are unable to be sold individually.  They are valued at a price which is based on a compilation of primarily observable market information or a broker quote in a non-active over-the-counter market.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Collective Investment Funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Collective investment funds consist of funds that are intended to mirror indices such as Standard&#160;&amp; Poor&#8217;s 500 Index and MSCI EAFE Index.  They are valued on the basis of the relative interest of each participating investor in the fair value of the underlying assets of each of the respective collective investment funds.  The underlying assets are valued based on the net asset value (&#8220;NAV&#8221;), which is provided by the investment account manager as a practical expedient to estimate fair value.  These investments are not classified by level but are disclosed to permit reconciliation to the fair value of plan assets.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make contributions to our pension plans to the extent that the contributions are tax deductible and pay benefits that relate to plans for salaried employees that cannot be funded under IRS regulations.  Currently, we anticipate making employer contributions to our pension and postretirement plans of up to approximately $<ix:nonFraction unitRef="usd" contextRef="i367f5ac75e4a4df58e4998eb5c85657f_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzExMTEx_29176ae6-eeff-43cd-baef-e18c06c0f719"><ix:nonFraction unitRef="usd" contextRef="ie5d867da7f4441dda11c6293c01cb96b_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzExMTEx_c7b48eff-19ee-4381-b49e-c6a39cc69d08">30</ix:nonFraction></ix:nonFraction> million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for each i</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n 2023.  However, the foregoing  estimates of 2023 contributions to our pension and postretirement plans are subject to change as a result of changes in tax and other benefit laws, changes in interest rates, as well as asset performance significantly above or below the assumed long-term rate of return for each respective plan.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="if0a6836bad094f4199dd7bcc469c292d" continuedAt="ibb87d25524584157b68022be5260cac0"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMTI2_1e59f997-433b-40c6-83e4-a6ef934a2c76" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated future benefit payments at December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"></td><td style="width:69.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.146%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.149%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzEtMS0xLTEtMTg0NDY5_b086e137-4e68-4178-80d2-5814bf44eb84">494</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzEtMy0xLTEtMTg0NDY5_fbeff2aa-018d-424d-bbcf-60190654d12c">106</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzItMS0xLTEtMTg0NDY5_4983b02c-8eda-48c6-91bf-c59e61b53647">471</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzItMy0xLTEtMTg0NDY5_66ed9770-e4fd-44e7-8ffe-f04c0a0de117">100</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzMtMS0xLTEtMTg0NDY5_5d8c8672-cacc-4319-94d7-5762caa092ef">471</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzMtMy0xLTEtMTg0NDY5_0ed42a6c-7d98-45d4-911a-e1a41a59ec61">96</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzQtMS0xLTEtMTg0NDY5_110f3d01-c0d0-4b81-be06-d02fe0d5b3f7">472</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzQtMy0xLTEtMTg0NDY5_6aa5a74e-2d98-4726-9596-4a5126b3de20">95</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzUtMS0xLTEtMTg0NDY5_950e054a-2ccb-4955-a5af-b87cbe7494b7">473</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzUtMy0xLTEtMTg0NDY5_daa01fd2-5e57-4770-a062-3af72b469015">95</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2032</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzYtMS0xLTEtMTg0NDY5_b591eb67-e753-4e4c-a54f-e60f0d544f44">2,355</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzYtMy0xLTEtMTg0NDY5_ff85bd49-d06d-41ad-906d-02c170d996d6">477</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Earnings/Losses</span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDQ5_00d3f07a-7e67-48e8-b82f-3561703e56dd" escape="true"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the following amounts in accumulated other comprehensive losses at December&#160;31, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>retirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>employment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzItMS0xLTEtMTg0NDY5_5c486c77-4b00-446f-b356-c8174ff751b3">2,180</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzItMy0xLTEtMTg0NDY5_4f75fc8c-dcdc-4135-a9a6-0cc345ddd033">1</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadc0d8691da8467d9ca4ad958399f860_I20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzItNS0xLTEtMTg0NDY5_bbdf6dc8-e47d-4f57-ad8e-71f75b5b3df3">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzItNy0xLTEtMTg0NDY5_d84c0777-710d-40ca-8603-9e9f93d74e4f">2,213</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service (cost) credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzMtMS0xLTEtMTg0NDY5_5624959c-2ddf-4bd4-97eb-6d4103f55c4e">24</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzMtMy0xLTEtMTg0NDY5_400df363-f5d2-4684-8bd5-c37cdeec07fc">293</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadc0d8691da8467d9ca4ad958399f860_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzMtNS0xLTEtMTg0NDY5_b58486e4-0d73-4beb-8778-46bdc16ad5bb">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzMtNy0xLTEtMTg0NDY5_1261ad38-4f47-4f14-8162-fd447f95fd92">264</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzQtMS0xLTEtMTg0NDY5_44c2f147-074a-42ce-80bb-855369f9bb9f">571</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" sign="-" name="mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzQtMy0xLTEtMTg0NDY5_10ed0dac-a0a6-4c65-856d-59348da9c2ba">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc0d8691da8467d9ca4ad958399f860_I20221231" decimals="-6" name="mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzQtNS0xLTEtMTg0NDY5_ed28b69a-70d7-4a8f-a6f3-c35f97bb0894">10</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzQtNy0xLTEtMTg0NDY5_1d06bcb6-4e4b-40a8-9351-15e8e8ed964b">513</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded in accumulated other comprehensive losses</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84846537e5f745d2987290028523bac3_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzUtMS0xLTEtMTg0NDY5_960b0a33-e489-48a6-9665-95cf2c899a99">1,633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009462f76967433f92d600d008ec5c47_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzUtMy0xLTEtMTg0NDY5_24bc976d-be2d-4e39-a6bb-5fe7fa0f212c">226</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadc0d8691da8467d9ca4ad958399f860_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzUtNS0xLTEtMTg0NDY5_18c84f7a-b568-4621-aaad-c953a7e54bd2">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzUtNy0xLTEtMTg0NDY5_9a6579c7-32b7-49f1-a334-7e632d05ddd8">1,436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the following amounts in accumulated other comprehensive losses at December&#160;31, 2021:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>retirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>employment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzEtMS0xLTEtMTg0NDY5_3e9a557c-0da8-4461-bf82-5a964e17a78c">2,093</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzEtMy0xLTEtMTg0NDY5_06af15ba-6a9f-4080-8714-e356dfccbd90">362</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia96532ef56c74a5ab19f74aad5a85003_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzEtNS0xLTEtMTg0NDY5_554d117e-1ae2-466e-8569-7f752ce099c6">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzEtNy0xLTEtMTg0NDY5_a515d333-943b-4722-9646-0dc61bcd0785">2,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service (cost) credit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzItMS0xLTEtMTg0NDY5_ae02b550-4ae9-48e7-859d-e1ae8412776b">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzItMy0xLTEtMTg0NDY5_3609bf07-b8e6-4734-9f7a-b61518c1f1af">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia96532ef56c74a5ab19f74aad5a85003_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzItNS0xLTEtMTg0NDY5_940afd05-863d-4e6c-88d9-7bd0cd7641a0">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzItNy0xLTEtMTg0NDY5_d44b6dee-e514-4cc0-9646-9a790068b5a7">305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzMtMS0xLTEtMTg0NDY5_cd01775f-372b-43ef-9725-23924b5a0a24">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" name="mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzMtMy0xLTEtMTg0NDY5_d6a238a1-fc1a-478b-bb35-1d89fb3835df">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia96532ef56c74a5ab19f74aad5a85003_I20211231" decimals="-6" name="mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzMtNS0xLTEtMTg0NDY5_d95eeabe-183d-4a39-8e51-b28efe657418">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzMtNy0xLTEtMTg0NDY5_ada2e535-feb2-41a3-81e9-96cffacd9736">570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded in accumulated other comprehensive losses</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzQtMS0xLTEtMTg0NDY5_9c70e4ef-a4b7-4327-8ecf-175ca1b7418b">1,574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51af7141b0f74960b97071f12967601e_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzQtMy0xLTEtMTg0NDY5_295441a3-8420-45a8-89cb-e2972759b7a7">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia96532ef56c74a5ab19f74aad5a85003_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzQtNS0xLTEtMTg0NDY5_248e57d3-6912-471a-a52e-44125cb73ba2">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzQtNy0xLTEtMTg0NDY5_90dc579e-e52f-45da-a1bb-c9f2f18e8721">1,612</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDkw_b38581e7-eba7-4983-b400-4b108ec0dabd" continuedAt="i79567bf639aa447a920aea73ea7bdf92" escape="true"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2022 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>retirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>employment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings as components of net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzMtMS0xLTEtMTg0NDY5_b3608013-f017-469e-8ed5-9baeb69eee01">96</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzMtMy0xLTEtMTg0NDY5_afa45dc4-feaa-422c-a066-c6fff8042384">18</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzMtNS0xLTEtMTg0NDY5_651e3507-8558-4c74-af0b-f2beb519af05">13</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzMtNy0xLTEtMTg0NDY5_489d8c22-c0a7-4491-90b7-7abfd5e1a2fa">127</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzQtMS0xLTEtMTg0NDY5_7079b0de-050a-4527-878f-823c689ec6a1">6</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzQtMy0xLTEtMTg0NDY5_63b63c48-c2d1-4b09-a65f-25474b55601a">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzQtNS0xLTEtMTg0NDY5_d0ee2a2d-202d-4403-89e4-4d4c5d06f728">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzQtNy0xLTEtMTg0NDY5_66d054a7-5b0a-4d7c-9a39-5b8d2442d612">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzYtMS0xLTEtMTg0NDY5_8812e19a-e69a-469c-86cd-01cbc2c25ef3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzYtMy0xLTEtMTg0NDY5_9481585f-f784-4f35-bb35-ff12816bf01f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231" decimals="-6" name="mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzYtNS0xLTEtMTg0NDY5_50b1d5b9-e0c0-4770-bd84-cf25c389e900">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzYtNy0xLTEtMTg0NDY5_5735f22b-54f5-4f9c-acef-9b5007df8e37">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzctMS0xLTEtMTg0NDY5_052e2f40-9db3-4d64-b11e-cae3b935a3ce">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzctMy0xLTEtMTg0NDY5_5e07e30b-8140-4f3d-9291-5e4c33f5c08c">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231" decimals="-6" name="mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzctNS0xLTEtMTg0NDY5_5af21577-3d83-4657-9145-eb13f62b4a88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzctNy0xLTEtMTg0NDY5_d04fe54a-1acf-4182-8071-64ae0e03e9bf">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzgtMS0xLTEtMTg0NDY5_e386d543-33aa-4142-9112-1376a783899d">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzgtMy0xLTEtMTg0NDY5_372e13f3-56c0-4a94-82cf-23151a46ce69">7</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzgtNS0xLTEtMTg0NDY5_ad385923-3933-4ecb-b101-fa5b202b879a">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzgtNy0xLTEtMTg0NDY5_b6c071a3-56f8-45a9-a45c-73bf0a7b5ead">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzktMS0xLTEtMTg0NDY5_7f9a50d6-79ed-4e89-ac2e-c17df6e28e9b">76</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzktMy0xLTEtMTg0NDY5_cf3e8f2c-fb48-4b36-a940-04c859e9410c">20</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzktNS0xLTEtMTg0NDY5_44be45ef-fc14-45cd-9f1d-a62ccd3fa5da">10</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzktNy0xLTEtMTg0NDY5_60acf627-fce6-4123-b72e-01fcd7a52644">66</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other movements during the year:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzExLTEtMS0xLTE4NDQ2OQ_3829fc4d-845c-44ee-ba35-daaaf22f2367">183</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzExLTMtMS0xLTE4NDQ2OQ_40b9f895-c86a-4ec7-833e-03265215e124">345</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzExLTUtMS0xLTE4NDQ2OQ_3fa147b8-5de7-4e9f-a71a-37920db59576">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzExLTctMS0xLTE4NDQ2OQ_b59aa464-5562-450c-973d-89353294046d">147</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEyLTEtMS0xLTE4NDQ2OQ_c6576d72-d03c-4ee6-8941-2880f8325681">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEyLTMtMS0xLTE4NDQ2OQ_ed7fedec-33f6-47b0-b60a-7415ad32834d">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEyLTUtMS0xLTE4NDQ2OQ_53b7d725-df68-4729-9f8e-a685f66ff909">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEyLTctMS0xLTE4NDQ2OQ_8394d340-5880-453c-8276-1c291cfd0546">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEzLTEtMS0xLTE4NDQ2OQ_dd761889-38c8-419a-b152-6f4e557da8cf">48</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEzLTMtMS0xLTE4NDQ2OQ_e72b6db3-8757-4dd8-a0ee-8593e1b50194">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEzLTUtMS0xLTE4NDQ2OQ_7fb95299-719a-4367-b9e5-ed65aa11021e">4</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEzLTctMS0xLTE4NDQ2OQ_99a99efb-766f-40ac-a78a-2edf9cd25a28">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE0LTEtMS0xLTE4NDQ2OQ_599c5438-b0d8-443a-bdf0-88ad9b3f2fc5">135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE0LTMtMS0xLTE4NDQ2OQ_09db3ef4-6ce9-4956-92fc-43bb62050d8f">256</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE0LTUtMS0xLTE4NDQ2OQ_ca69b9e1-fab1-4de3-a9c2-6a207e22d174">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE0LTctMS0xLTE4NDQ2OQ_7c3ac639-17c0-4e99-8f1b-f4b73f09b68a">110</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total movements in other comprehensive earnings/losses</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231" decimals="-6" name="mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE1LTEtMS0xLTE4NDQ2OQ_124c9b79-50af-439b-abf5-f2c24f8d4c9f">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231" decimals="-6" sign="-" name="mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE1LTMtMS0xLTE4NDQ2OQ_a2b31aad-c3e6-464a-a783-d4d3bb424379">236</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231" decimals="-6" name="mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE1LTUtMS0xLTE4NDQ2OQ_e8773562-112d-466d-b607-6f3fb2e2159d">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE1LTctMS0xLTE4NDQ2OQ_118c34e4-55d1-4447-816a-8a950d85f022">176</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="ibb87d25524584157b68022be5260cac0"><ix:continuation id="i79567bf639aa447a920aea73ea7bdf92"><div style="margin-top:5pt;padding-left:9pt;text-indent:-9.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-retirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-employment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings as components of net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzMtMS0xLTEtMTg0NDY5_5d3de799-deb4-4572-b00a-154f80a9344b">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzMtMy0xLTEtMTg0NDY5_3aa9321d-d366-4a5c-9df9-012cd70ddf8b">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzMtNS0xLTEtMTg0NDY5_f7923640-049c-4db0-a5d9-24f0d5ed1d12">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzMtNy0xLTEtMTg0NDY5_1ad3e0e6-5376-468b-a85c-c89864aae818">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzQtMS0xLTEtMTg0NDY5_2730a099-c557-4588-b0ec-dbcc2052acab">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzQtMy0xLTEtMTg0NDY5_2e141d1a-ab7b-423a-ad6c-a3907bf40670">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzQtNS0xLTEtMTg0NDY5_51850647-fe06-4506-a334-2b3eee707fce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzQtNy0xLTEtMTg0NDY5_5cc249f2-dbfb-4bee-94e2-a79e46b3c665">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzYtMS0xLTEtMTg0NDY5_53edc122-7e55-4d4a-9d95-2b51f40a8033">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzYtMy0xLTEtMTg0NDY5_480e2a52-b962-48f0-ba29-74a843defe63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231" decimals="-6" name="mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzYtNS0xLTEtMTg0NDY5_2c85d057-efa7-4fa0-8ab0-6b7df89c3ac3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzYtNy0xLTEtMTg0NDY5_0ebbce0a-c3cb-4c8e-860f-382e365f2a35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzctMS0xLTEtMTg0NDY5_1b178bc5-9431-41d1-a5eb-b3708b90d42c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzctMy0xLTEtMTg0NDY5_10c240cc-0ea6-46bb-888a-d6c2e71637d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231" decimals="-6" name="mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzctNS0xLTEtMTg0NDY5_65cedca1-0112-4052-bb91-f10ee1833181">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzctNy0xLTEtMTg0NDY5_0a11f69d-b9a8-49e2-a228-a0206ecedf29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzgtMS0xLTEtMTg0NDY5_8cb0ef69-fa93-4eb0-aa4a-eadcdc09c5be">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzgtMy0xLTEtMTg0NDY5_d747e619-1bc3-40dc-b1ce-956079655d62">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzgtNS0xLTEtMTg0NDY5_75351b13-cbcc-4ac7-ac9b-1087bd173eba">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzgtNy0xLTEtMTg0NDY5_3736cc1d-8976-42fe-83b6-799d0359bf9e">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzktMS0xLTEtMTg0NDY5_43ea9232-ab63-4ecc-a1bb-aa6b9b3d6255">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzktMy0xLTEtMTg0NDY5_1f99e412-bc4e-4b3e-82ed-627e823ebef2">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzktNS0xLTEtMTg0NDY5_32686b8d-dadb-44af-bf80-70bf4b312410">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzktNy0xLTEtMTg0NDY5_90fbec3b-a6f6-4125-8945-e4a37266db35">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other movements during the year:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEyLTEtMS0xLTE4NDQ2OQ_d40295c1-bb0e-401d-b133-ac879a815505">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEyLTMtMS0xLTE4NDQ2OQ_a63098bc-146e-4bde-bcb8-3ddaf86be6b7">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEyLTUtMS0xLTE4NDQ2OQ_2c30eb6d-9405-4764-b5a7-44d096bd5184">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEyLTctMS0xLTE4NDQ2OQ_7edb1f04-84f8-4c10-adca-651c6d423588">624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEzLTEtMS0xLTE4NDQ2OQ_5ec4ef9d-06d8-4a63-a406-7730213d98a0">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEzLTMtMS0xLTE4NDQ2OQ_c9e6baf7-a55b-4c01-956e-d03e8dcd6952">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEzLTUtMS0xLTE4NDQ2OQ_bbe34b10-be4c-42bf-9aef-3d47395baf9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEzLTctMS0xLTE4NDQ2OQ_541285b1-3dd7-4468-91ce-6f110f172723">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE0LTEtMS0xLTE4NDQ2OQ_426d8a58-fc64-43c9-9eb8-ab992dae8b2e">118</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE0LTMtMS0xLTE4NDQ2OQ_93bd8533-e846-4d1c-8d59-e1a40bd49871">127</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE0LTUtMS0xLTE4NDQ2OQ_25d9e6d9-77c1-42f7-a770-ab26aef08d5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE0LTctMS0xLTE4NDQ2OQ_ece2e75e-17dd-44c8-b88c-2c98e4b801c4">245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE1LTEtMS0xLTE4NDQ2OQ_7ecd45ee-3353-4a6c-b03b-8fb52d14f8e9">339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE1LTMtMS0xLTE4NDQ2OQ_293bdac7-d524-4aec-9234-45279c1756c3">375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE1LTUtMS0xLTE4NDQ2OQ_a88618a7-9170-4bc9-ab11-ffcec29ec477">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE1LTctMS0xLTE4NDQ2OQ_84d45938-c6e2-44a9-8784-42b205fb8c25">716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total movements in other comprehensive earnings/losses</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231" decimals="-6" sign="-" name="mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE2LTEtMS0xLTE4NDQ2OQ_77469022-cb70-4e79-a702-b2cf7284b731">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231" decimals="-6" sign="-" name="mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE2LTMtMS0xLTE4NDQ2OQ_5579f6b5-79bf-4b25-b76e-2aba6ee8414d">358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231" decimals="-6" sign="-" name="mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE2LTUtMS0xLTE4NDQ2OQ_df3ad8da-6bdd-444f-8466-7cf88cfeb5cd">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE2LTctMS0xLTE4NDQ2OQ_70ae855b-ec8f-4e22-ba4b-f9c4e2e0c023">808</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.833%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>retirement</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>employment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings as components of net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzMtMS0xLTEtMTg0NDY5_b8fa14a6-d820-42e6-8ad5-5146a26a4415">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzMtMy0xLTEtMTg0NDY5_9cdfc88c-65d1-46cc-8fd8-3705683fd0b0">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzMtNS0xLTEtMTg0NDY5_30d21e75-c846-43a2-887b-8c3d0fb6e5c7">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzMtNy0xLTEtMTg0NDY5_0bc484a3-dab5-465d-90f3-981306a036b0">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzQtMS0xLTEtMTg0NDY5_d2908f07-2d1d-42f9-8bff-c12ab0d49aba">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzQtMy0xLTEtMTg0NDY5_bb9fc5a8-d5db-461f-b9bb-dcc12b46ab5f">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzQtNS0xLTEtMTg0NDY5_e3671a41-1248-4fb8-9525-ae8564b695e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzQtNy0xLTEtMTg0NDY5_2e0718b7-d7cf-4721-91b3-4a01c1789863">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" sign="-" name="mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzYtMS0xLTEtMTg0NDY5_21ec70b0-ed46-4edb-aee3-4786196f908a">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" name="mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzYtMy0xLTEtMTg0NDY5_e6e8ce06-1356-4af4-8b47-8d79b7f7f980">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231" decimals="-6" name="mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzYtNS0xLTEtMTg0NDY5_0860be8d-446f-434f-a8a0-70b2869b0d0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzYtNy0xLTEtMTg0NDY5_389a49c2-4a12-409a-83ab-57b924f2fe48">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" name="mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzctMS0xLTEtMTg0NDY5_1cdb0c20-d396-4b3f-a55e-11e9412de672">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" name="mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzctMy0xLTEtMTg0NDY5_bfd69591-3b5b-4d55-9ff0-a67ec095a41d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231" decimals="-6" name="mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzctNS0xLTEtMTg0NDY5_6721677d-b64e-4c2d-b563-f420606140fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzctNy0xLTEtMTg0NDY5_39d5d2aa-cd8f-40f9-925c-45ba293301ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzgtMS0xLTEtMTg0NDY5_d94e96cd-1cb7-4fc5-8e4a-65ac62fa60a9">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzgtMy0xLTEtMTg0NDY5_dec2f8e8-36cc-4b8d-88c3-14a56bd4016d">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzgtNS0xLTEtMTg0NDY5_7ab968e5-6d64-44da-a26f-c0ef3c768fc6">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzgtNy0xLTEtMTg0NDY5_4db5cda3-9b70-448e-b456-92609bd707ba">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzktMS0xLTEtMTg0NDY5_d48a8e04-c34f-49e2-ab14-993144897a29">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzktMy0xLTEtMTg0NDY5_3a90c398-7134-460f-bf87-b637b9b41d26">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzktNS0xLTEtMTg0NDY5_6690c320-91ee-49bf-af89-576952ee6f83">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzktNy0xLTEtMTg0NDY5_4b852a8b-16f4-46a9-85a3-b6cf7df833ff">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other movements during the year:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzExLTEtMS0xLTE4NDQ2OQ_58188b7e-1dad-4e0c-859b-f17da0f6e092">268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzExLTMtMS0xLTE4NDQ2OQ_ed048f22-e08c-479f-8f8c-880b8ab21828">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzExLTUtMS0xLTE4NDQ2OQ_1fb6d841-de65-4ed2-9780-f0099c80b01f">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzExLTctMS0xLTE4NDQ2OQ_4abd35c0-46a5-4fbb-a3aa-db5f55cf17b4">448</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEyLTEtMS0xLTE4NDQ2OQ_e176538c-0d1f-4357-92eb-7aba6a398251">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEyLTMtMS0xLTE4NDQ2OQ_ba67cfc2-6778-4c12-8769-a676ed235988">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEyLTUtMS0xLTE4NDQ2OQ_9e74a7aa-85bc-4817-9cdf-1cf4d8f68576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEyLTctMS0xLTE4NDQ2OQ_4fc1074f-dcd4-491f-b498-06883657cd4c">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEzLTEtMS0xLTE4NDQ2OQ_2208e2bb-f62b-46c1-881e-968ca78d8a78">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEzLTMtMS0xLTE4NDQ2OQ_01c039bd-4b03-4fc9-888c-5d6f6c098373">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEzLTUtMS0xLTE4NDQ2OQ_490a042b-7301-402c-b4e0-2510425292a8">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEzLTctMS0xLTE4NDQ2OQ_bfb3a38f-cba4-4bab-80f6-44a10e212b17">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE0LTEtMS0xLTE4NDQ2OQ_7db00fd4-84b6-43f9-9d23-c868353c98c0">204</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE0LTMtMS0xLTE4NDQ2OQ_fe188d10-157e-4d63-acbd-479225846bb1">122</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE0LTUtMS0xLTE4NDQ2OQ_ce4b6dca-9dfb-4c09-a48b-94eb603303e1">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE0LTctMS0xLTE4NDQ2OQ_e199648b-0744-4ea1-bf27-7c0b7ef22ac2">339</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total movements in other comprehensive earnings/losses</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231" decimals="-6" name="mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE1LTEtMS0xLTE4NDQ2OQ_3dbf4509-d9f9-4322-b3fc-7a1ee49008bf">92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231" decimals="-6" name="mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE1LTMtMS0xLTE4NDQ2OQ_d1aa7138-c041-4f0b-9f8a-3dcb391b4642">137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231" decimals="-6" sign="-" name="mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE1LTUtMS0xLTE4NDQ2OQ_9d70b9c6-cfe5-4d13-82ee-36c2bca6e662">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE1LTctMS0xLTE4NDQ2OQ_c5c6fe1d-416a-4be9-943d-8888ef235e6d">228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_169"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 16.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90ZXh0cmVnaW9uOmVkMWUxZGIwOThiNzRkNTY4OGQyYjBhYWE1NzNkMDFkXzIzMw_8009b06b-e077-4c6c-91b8-213fd4cbc442" continuedAt="icb88d19c4eb5443db71d694c3b8f026d" escape="true">Additional Information</ix:nonNumeric></span></div><ix:continuation id="icb88d19c4eb5443db71d694c3b8f026d"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90ZXh0cmVnaW9uOmVkMWUxZGIwOThiNzRkNTY4OGQyYjBhYWE1NzNkMDFkXzIzNA_87b2ec29-eb72-4775-85bf-86202296f67e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"></td><td style="width:64.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzItMS0xLTEtMTg0NDY5_46c3957d-7c84-484d-bcfe-34d255aa4ae3">162</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzItMy0xLTEtMTg0NDY5_1a80275f-94ac-433d-8567-10bbb417cf31">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzItNS0xLTEtMTg0NDY5_062acf59-066b-4805-84f9-4a8477af0db9">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzQtMS0xLTEtMTg0NDY5_d8affefb-b4d3-49d5-8a9f-ea31f0e2168c">1,128</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzQtMy0xLTEtMTg0NDY5_cd6a407c-1172-46a9-b32b-07f2541d0497">1,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzQtNS0xLTEtMTg0NDY5_b4079db5-f4de-4f0b-a7a2-018cc6aafa8f">1,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:InterestIncomeOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzUtMS0xLTEtMTg0NDY5_bab0ff18-c9eb-49f2-9c00-e26d8212e8be">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:InterestIncomeOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzUtMy0xLTEtMTg0NDY5_c312a5b0-1907-4520-8572-bc0d0d24dd40">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:InterestIncomeOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzUtNS0xLTEtMTg0NDY5_94b6f85c-622c-4181-9615-bedf832445d8">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzYtMS0xLTEtMTg0NDY5_73a13545-2445-4f59-8407-2bb3c3011fc8">1,058</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzYtMy0xLTEtMTg0NDY5_43ef76f5-f611-4bac-863a-bc19e0d5394c">1,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzYtNS0xLTEtMTg0NDY5_33d1f1c7-55ef-4cce-bda5-fbc62acceea3">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="mo:ScheduleofValuationandQualifyingAccountsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90ZXh0cmVnaW9uOmVkMWUxZGIwOThiNzRkNTY4OGQyYjBhYWE1NzNkMDFkXzIzOA_f1ab5518-c904-423c-adc8-6156da29d6a2" escape="true"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity in the allowance for discounts and allowance for returned goods was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Returned Goods</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Returned Goods</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Returned Goods</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f9dcc6444a4bbb90bbcd327eb2f366_I20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzMtMi0xLTEtMTg0NDY5_08a399b5-8351-406a-a0d2-a7ecb7c55e71">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e616ef3cd34d8ebf364a0a44dbf568_I20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzMtNC0xLTEtMTg0NDY5_4f8a7326-24f9-41a3-b905-ec52b4bc986d">50</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf580e88ea5e426b83cea191bb81eb11_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzMtNi0xLTEtMTg0NDY5_fe087c9f-1af6-439e-a16b-1fcdab080c1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief312f4f79034004be1d156bc5113740_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzMtOC0xLTEtMTg0NDY5_85d6cfc8-6a33-4497-9bd7-0c470c4d5bfe">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94c89f23c2954c9c8f50a44fa531889f_I20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzMtMTAtMS0xLTE4NDQ2OQ_5010bf1c-b06d-4933-84e8-665275e89676">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie74269f61ac244c79a9581ca1cbf6d02_I20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzMtMTItMS0xLTE4NDQ2OQ_c3a1f4b4-dd58-4d6d-9d78-753a29c691ee">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98f16d288e9b4842b8c9feadf67a70d7_D20220101-20221231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzQtMi0xLTEtMTg0NDY5_aae6e4aa-7a3d-4e31-b44f-7d0a8c26109b">607</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie82e469f2543472386656525fa4e487f_D20220101-20221231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzQtNC0xLTEtMTg0NDY5_497e95dd-4a30-4c2a-a927-db342321093b">97</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33dd9b0c0e7b45d487aee81df3946294_D20210101-20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzQtNi0xLTEtMTg0NDY5_17f127b9-d3ea-4280-ad05-a20a396efe3b">647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03f3ddd8f45a4d4d8617839b37197b44_D20210101-20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzQtOC0xLTEtMTg0NDY5_ea1fe007-496f-49ba-9cd8-142fa1470753">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcaf546cb45c470aa6dfa50cda94fd71_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzQtMTAtMS0xLTE4NDQ2OQ_31e06b0d-e9c9-4566-b725-6cd361a0fd0a">633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib931f8bbad2a4b7a8d8317d177be2791_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzQtMTItMS0xLTE4NDQ2OQ_e635886c-cce5-4013-948e-c5756f8a469d">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98f16d288e9b4842b8c9feadf67a70d7_D20220101-20221231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzUtMi0xLTEtMTg0NDY5_4f02d170-633e-4d4f-8f0f-e0766e734c68">607</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie82e469f2543472386656525fa4e487f_D20220101-20221231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzUtNC0xLTEtMTg0NDY5_c9cec8c2-c482-46a6-b1bd-d2d7eb56c119">106</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33dd9b0c0e7b45d487aee81df3946294_D20210101-20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzUtNi0xLTEtMTg0NDY5_5e0f6116-dded-4425-bfcc-694f8f9953fb">647</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03f3ddd8f45a4d4d8617839b37197b44_D20210101-20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzUtOC0xLTEtMTg0NDY5_6dced52f-389a-47da-86b6-990f10ca1e7d">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idcaf546cb45c470aa6dfa50cda94fd71_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzUtMTAtMS0xLTE4NDQ2OQ_d7a9fa81-6582-4733-a34c-fa9c879ab829">633</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib931f8bbad2a4b7a8d8317d177be2791_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzUtMTItMS0xLTE4NDQ2OQ_4a9f61a4-d374-4667-86fb-41f15e2e182f">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic93c01c5184d4b26964880db6a9e8ad9_I20221231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzYtMi0xLTEtMTg0NDY5_e22cd6b1-822c-4b75-bb40-811725840e0f">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3240589dec0744cebbdf4a38067cb110_I20221231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzYtNC0xLTEtMTg0NDY5_540e9cef-e630-420e-812b-a3f92aabe871">41</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45f9dcc6444a4bbb90bbcd327eb2f366_I20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzYtNi0xLTEtMTg0NDY5_f67b7951-d8b8-488e-8310-ad60ee499b3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e616ef3cd34d8ebf364a0a44dbf568_I20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzYtOC0xLTEtMTg0NDY5_c9ef224c-49db-439e-b693-87514a489e43">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf580e88ea5e426b83cea191bb81eb11_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzYtMTAtMS0xLTE4NDQ2OQ_dc50311c-5c24-49e2-9fe0-1c2df97158ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief312f4f79034004be1d156bc5113740_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzYtMTItMS0xLTE4NDQ2OQ_ca467726-a9af-41ed-827c-30001e961330">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Represents the recording of discounts and returns for which allowances were created</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i15062ca98227434086141b426450a5cb_172"></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Note 17.  <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzY2MzQ0_62028cd8-9c5c-4533-bf9f-e1de46bde680" continuedAt="i5c2968199d414643b6eb4fbd6ebc2703" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="i5c2968199d414643b6eb4fbd6ebc2703" continuedAt="i66a17bd3fbb34f38b745b816879e71cb"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings covering a wide range of matters are pending or threatened in various United States and foreign jurisdictions against Altria and certain of our subsidiaries, including PM USA and USSTC, as well as our indemnitees and investees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, income tax liability, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), claims for contribution and claims of competitors, shareholders or distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrates that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.  In certain cases, plaintiffs claim that defendants&#8217; liability is joint and several.  In such cases, we may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, under certain circumstances, we may have to pay more than our proportionate share of any bonding- or judgment-related amounts.  Furthermore, in those cases where plaintiffs are successful, we also may be required to pay interest and attorneys&#8217; fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that <ix:nonFraction unitRef="state" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="INF" name="mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMjY2NTg_3e90dccc-19d4-4450-8ebf-1dd1452460c0">47</ix:nonFraction> states and Puerto Rico limit the dollar amount of bonds or require no bond at all.  As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#8217;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  States, including Florida, also may seek to repeal or alter bond cap statutes through legislation.  Although we cannot predict the outcome of such challenges, it is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record provisions in our consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: (i)&#160;management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii)&#160;management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii)&#160;accordingly, management has not </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i66a17bd3fbb34f38b745b816879e71cb" continuedAt="i7a6b75aa7845494d9f49694c42c7b57d"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided any amounts in our consolidated financial statements for unfavorable outcomes, if any.  Litigation defense costs are expensed as incurred.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have achieved substantial success in managing litigation.  Nevertheless, litigation is subject to uncertainty and significant challenges remain.  It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.  We believe, and have been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts.  We have defended, and will continue to defend, vigorously against litigation challenges.  However, we may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Judgments Paid and Provisions for Tobacco and Health (Including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation) and Certain Other Litigation Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in our accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:</span></div><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzY2MzQ1_d788a6e1-67d5-4fd5-9a80-e7f58c703e92" continuedAt="id37098fb83f141a299815b4853f217a7" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.249%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.599%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.599%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:1.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.603%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other litigation items at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzItMS0xLTEtMTg0NDY5_827d6899-8929-43cd-9d5c-ea5039b983a1">91</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzItMy0xLTEtMTg0NDY5_15bd50c5-5794-42db-a40e-0bdec35ba182">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40e064b5da194d8bbe29064d490250de_I20191231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzItOS0xLTEtMTg0NDY5_d513d8c6-a626-4407-9d80-7ca71bbb3766">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax charges for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id322aa0288694bdb849607abacc6dabd_D20220101-20221231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzQtMS0xLTEtMTg0NDY5_f2e8d804-0123-40d5-be51-e49514915228">101</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4739c0a3ba074dff8712b23ec3f898ad_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzQtMy0xLTEtMTg0NDY5_59ed010c-e79d-4953-9995-c621656c0a73">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96971d3062e4a31a0e27c3b191c0dde_D20200101-20201231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzQtOS0xLTEtMTg0NDY5_3ec61ad9-259f-4958-afc3-0dc58239d47f">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholder class action and shareholder derivative lawsuits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fec6e69190c449a8d51b6a9ea7c1d31_D20220101-20221231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzUtMS0xLTEtMTg0NDY5_36919450-c6cc-40f0-a145-a039be2dbc5f">27</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4c427ec8a94dfd836dc5b4a199c764_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzUtMy0xLTEtMTg0NDY5_e0110d5a-673f-4f16-8d4a-f12676205e0c">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd275444e894de0ab137fd15c70d71c_D20200101-20201231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzUtOS0xLTEtMTg0NDY5_36c4bedf-f7d8-40ec-9f69-a0dc6a727797">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related interest costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37fa7f6256454447bca119375f7fe081_D20220101-20221231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzYtMS0xLTEtMTg0NDY5_5f48b7ff-8a5c-43a2-be21-bfa3fbd68d85">3</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14301c0ea4d0417daf460f139e79a779_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzYtMy0xLTEtMTg0NDY5_188ea8fc-3f9b-4620-a509-8c92e4f7ebd1">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4be6c8b0110c4ba9995765495afef7d6_D20200101-20201231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzYtOS0xLTEtMTg0NDY5_96f4ae7e-93d3-4292-a976-a9ecb54fe0eb">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzEwLTEtMS0xLTE4NDQ2OQ_6df2b7f2-b89a-4cf8-8e16-7a9efefc2811">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzEwLTMtMS0xLTE4NDQ2OQ_d75763e3-b9a3-41d0-8270-3e918c5cd168">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzEwLTktMS0xLTE4NDQ2OQ_ad0d1fe8-4f6c-4d81-97e8-2b1702019ffe">88</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other litigation items at end of period</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzExLTEtMS0xLTE4NDQ2OQ_f85282fd-b568-4f16-b318-2964cb83e3c0">71</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6526b762c96848958db76b2e641f06c4_I20211231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzExLTMtMS0xLTE4NDQ2OQ_dab85197-2aa1-4726-a3f4-7ad030b5e027">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231" decimals="-6" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzExLTktMS0xLTE4NDQ2OQ_2eb8919c-a3b9-450d-97de-bf2491f8a8e6">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes judgments, settlements and fee disputes associated with tobacco and health and certain other litigation.</span></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">hareholder Class Action and Shareholder Derivative Lawsuits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below for discussions of the shareholder class action case and related settlement and the pending settlement of the federal and state shareholder derivative lawsuits.</span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accrued liability for tobacco and health and certain other litigation items, including related interest costs, was included in accrued liabilities on our consolidated balance sheets.  Pre-tax charges for tobacco and health and certain other litigation were included in marketing, administration and research costs on our consolidated statements of earnings.  Pre-tax charges for related interest costs were included in interest and other debt expense, net on our consolidated statements of earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i03318a08f6694a48998709b33e36a67f_D20041001-20221231" decimals="-6" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzQxODI_c160a10e-c777-4e4f-9045-fcd1db03a69e">954</ix:nonFraction> million and interest totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i03318a08f6694a48998709b33e36a67f_D20041001-20221231" decimals="-6" name="us-gaap:LitigationSettlementInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzQxNzQ_09441235-9e98-4690-a8bc-da48ace647be">230</ix:nonFraction> million as of December 31, 2022.  These amounts include payments for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny judgments (and related costs and fees) totaling approximately $<ix:nonFraction unitRef="usd" contextRef="ied3d1d716af5466b9e30cf6840540284_D20041001-20221231" decimals="-6" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzQxNzg_5e3fa5f2-2f1e-44ff-97fa-7572a7841204">432</ix:nonFraction> million and related interest totaling approximately $<ix:nonFraction unitRef="usd" contextRef="ied3d1d716af5466b9e30cf6840540284_D20041001-20221231" decimals="-6" name="us-gaap:LitigationSettlementInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzQxODY_9cb86876-8459-4958-a506-87fd6c72ffd6">59</ix:nonFraction> million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security for Judgments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain stays of judgments pending appeal, PM USA has posted various forms of security.  As of December 31, 2022, PM USA has posted appeal bonds totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i480c00944cc54888a1e9a12e8d5a6c2f_I20221231" decimals="-6" name="mo:LitigationEscrowDeposit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzQxOTA_3525a8a4-2481-46fd-8a5e-a4f407b8133f">46</ix:nonFraction> million, which have been collateralized with restricted cash and are included in assets on our consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Tobacco-Related Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Types and Number of U.S. Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims related to tobacco products generally fall within the following categories: (i)&#160;smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii)&#160;health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of RICO, fraud, failure to warn, design defect, negligence, antitrust and unfair trade practices; and (iv)&#160;other tobacco-related litigation described below.  Plaintiffs&#8217; theories of recovery and the defenses raised in tobacco-related litigation are discussed below.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i7a6b75aa7845494d9f49694c42c7b57d" continuedAt="ic260754f912243229a52c6557c04a4b2"><ix:continuation id="id37098fb83f141a299815b4853f217a7" continuedAt="i55739ec7e0d1408bb0a2f58d321f1783"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of certain tobacco-related cases pending in the United States against us as of December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.604%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.604%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i7a9cc9052f7342f9a5a2965a1363d918_I20221231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzEtMS0xLTEtMTg0NDY5_b2191c32-4388-4432-9965-37e78b5ca01d">162</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ib803543b5610404db3d4704c2d823f5c_I20211231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzEtMy0xLTEtMTg0NDY5_2656e4c6-d797-4702-b570-c31e9c9fdd08">176</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i7443c1f2410b42f79436b4c8406d1884_I20201231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzEtNS0xLTEtMTg0NDY5_535915e3-86a0-422c-9162-b895b44b30cc">148</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i496cf0d3b6c242988d0ca0ecf226c71f_I20221231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzItMS0xLTEtMTg0NDY5_fc1ad6d2-806d-416c-ad0d-9747837191ef">1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i1cb201982a874dda811f7385ce781a84_I20211231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzItMy0xLTEtMTg0NDY5_e47f3ad6-d546-4c06-8f72-ebe48952e806">1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ic0dc27727fac48219ac9ec68f62e232f_I20201231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzItNS0xLTEtMTg0NDY5_9fe2a57e-1c00-4e8d-8cca-9f51706fb648">1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-vapor Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i3c7b5b8168e84e9f97ec53935f0e23bc_I20221231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzMtMS0xLTEtMTg0NDY5_f8c8ed96-ab01-4fa3-bf2e-3b7dd592337d">5,283</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="ibcd3a4d726d343dc811a0c842908f852_I20211231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzMtMy0xLTEtMTg0NDY5_29748a6a-33a7-44d6-9d90-7527ee76e2d6">3,296</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i815d22256b0f463899dc0f22fbf273d4_I20201231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzMtNS0xLTEtMTg0NDY5_a41c1c76-ed45-4d07-ba30-eda783634d2c">1,563</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Tobacco-Related Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i8bf85127efde436391fadbb7ddd35b59_I20221231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzQtMS0xLTEtMTg0NDY5_5797fc80-7a87-43a9-9151-d7caf8ecb4c5">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="if30834386f77477da8f843b6b5597b5c_I20211231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzQtMy0xLTEtMTg0NDY5_2bb075c3-d382-4609-b997-8dceefba23ec">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="claim" contextRef="i23b3a0d3f9bb4d1490db4cd7c943b4b1_I20201231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzQtNS0xLTEtMTg0NDY5_96ae19d9-71a7-4b55-8f15-39a58c5546cd">3</ix:nonFraction></span></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes as of December 31, 2022, <ix:nonFraction unitRef="case" contextRef="i1ec68205f19b43d79d872f39a862112a_I20221231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkyODk_811fbf8b-cbcc-4f7e-a1f0-ef7ad51e6749">17</ix:nonFraction> cases filed in Illinois, <ix:nonFraction unitRef="case" contextRef="i04aef4e9d8bf47b6889ffc116b3823fe_I20221231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkyOTM_dc79c871-6f98-484e-969c-cb90e1f88a1b">20</ix:nonFraction> cases filed in New Mexico, <ix:nonFraction unitRef="case" contextRef="i84f64e1272e04d79a531d39b5bcf0ca4_I20221231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkyOTc_216634fb-2440-46b4-a0b2-169c74cfe3af">37</ix:nonFraction> cases filed in Massachusetts and <ix:nonFraction unitRef="case" contextRef="if4156610d169487eb2ddc1063aac958d_I20221231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMDA_7d70b6c7-38e0-4cb9-9696-4e4cdb8aa929">51</ix:nonFraction> non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">case (these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> progeny cases are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  Also does not include <ix:nonFraction unitRef="case" contextRef="if1f51724e36a4d608bc658784f91ce0e_D20220101-20221231" decimals="INF" name="mo:LossContingencyNumberOfCases" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMDM_340ef39e-ad0a-401d-92c7-15b24f26271c">1,395</ix:nonFraction> cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#8220;ETS&#8221;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Broin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.</span></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes as of December 31, 2022, <ix:nonFraction unitRef="lawsuit" contextRef="i3c7b5b8168e84e9f97ec53935f0e23bc_I20221231" decimals="INF" name="mo:LossContingencyClassActionLawsuit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMjI_155db0ad-a30f-4f1d-bde0-533c7d0da497">57</ix:nonFraction> class action lawsuits, <ix:nonFraction unitRef="lawsuit" contextRef="i0c93a8ff326144f69851e022e7d7df20_I20221231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMDk_93c61444-e526-44ff-b808-f89c59dd10cf">3,830</ix:nonFraction> individual lawsuits and <ix:nonFraction unitRef="lawsuit" contextRef="i9244ca0d63dc4969a4c903eab7d4b970_I20221231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMTM_fc60697d-518b-40de-ae12-d6f4bd4d767c">1,396</ix:nonFraction> &#8220;third party&#8221; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  The <ix:nonFraction unitRef="lawsuit" contextRef="i3c7b5b8168e84e9f97ec53935f0e23bc_I20221231" decimals="INF" name="mo:LossContingencyClassActionLawsuit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMTg_155db0ad-a30f-4f1d-bde0-533c7d0da497">57</ix:nonFraction> class action lawsuits include <ix:nonFraction unitRef="case" contextRef="i91aaf91c29514549a260f8c3b405df37_I20221231" decimals="INF" name="mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMjY_8dd8fcf0-0dd6-48b4-94f3-fbcc433f6ec3">32</ix:nonFraction> cases in the Northern District of California (&#8220;Multidistrict Litigation&#8221; or &#8220;MDL&#8221;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes as of December 31, 2022, <ix:nonFraction unitRef="case" contextRef="i8bf85127efde436391fadbb7ddd35b59_I20221231" decimals="INF" name="mo:LossContingencyNumberOfInactiveCases" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMzA_e384b895-1a39-4ce2-818c-dbe3699f6ee8">one</ix:nonFraction> inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and <ix:nonFraction unitRef="case" contextRef="i8bf85127efde436391fadbb7ddd35b59_I20221231" decimals="INF" name="mo:LossContingencyNumberOfInactiveClassActionLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMzQ_5f56b28a-8a0d-4fab-89e6-0df32545570d">two</ix:nonFraction> inactive class action lawsuits alleging that use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div></ix:continuation><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Tobacco-Related Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2023, (i) Altria is named as a defendant in <ix:nonFraction unitRef="claim" contextRef="ia8ac04c172f1433fbffdd1c5a97bdc20_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDYwMzU_ee0983b8-424f-445a-a6d2-82864fa0cbb5">three</ix:nonFraction> e-vapor class action lawsuits in Canada; (ii) PM USA is a named defendant in <ix:nonFraction unitRef="case" contextRef="ibbca890a0ab042c4b655ce8a512d9dc0_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDYwMzk_9581234d-94e9-46a8-a950-662511be4a35">10</ix:nonFraction> health care cost recovery actions in Canada, <ix:nonFraction unitRef="case" contextRef="i44002739e29942868064a12846ec9503_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDYwNDM_808f87b2-9972-453e-8a33-b1c6a8b578a4">eight</ix:nonFraction> of which also name Altria as a defendant; and (iii) PM USA and Altria are named as defendants in <ix:nonFraction unitRef="case" contextRef="i78854af3be924b238c97cf0018613bd5_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDYwNDc_22672022-0114-4191-b34c-a28c8811dcfa">seven</ix:nonFraction> smoking and health class actions filed in various Canadian provinces.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement (defined below) between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tobacco-Related Cases Set for Trial: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2023, <ix:nonFraction unitRef="case" contextRef="ib9bfd24968014e2fbddf1581242c201e_I20230127" decimals="INF" name="mo:LossContingencyNumberofCasesSetforTrial" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDU1OTA_16ff2619-708c-4adb-ab22-88b11fd9c756">two</ix:nonFraction> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases, <ix:nonFraction unitRef="case" contextRef="i571a013fea1d4f7fac1f41c38c582ec2_I20230127" decimals="INF" name="mo:LossContingencyNumberofCasesSetforTrial" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjEyOTg_9c48dd1d-7e27-4025-8a6d-5f4204aa1c21">two</ix:nonFraction> individual smoking and health case and <ix:nonFraction unitRef="case" contextRef="i581f20cb6875437fbd464b63c2092b97_I20230127" decimals="INF" name="mo:LossContingencyNumberofCasesSetforTrial" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjEzMDI_5d90e470-98a4-4bbe-87c7-66276b00f58e">one</ix:nonFraction> e-vapor case are set for trial through March 31, 2023.  Trial dates are subject to change.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trial Results: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1999, excluding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases (separately discussed below), verdicts have been returned in <ix:nonFraction unitRef="case" contextRef="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecided" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNDU_cb7d68da-144b-472e-b8cf-c896862bbcee">73</ix:nonFraction> tobacco-related cases in which PM USA was a defendant.  Verdicts in favor of PM USA and other defendants were returned in <ix:nonFraction unitRef="case" contextRef="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNDk_ea1f0752-c4fb-4137-9726-392aa64f26c9">46</ix:nonFraction> of the <ix:nonFraction unitRef="case" contextRef="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecided" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNTM_cb7d68da-144b-472e-b8cf-c896862bbcee">73</ix:nonFraction> cases.  These <ix:nonFraction unitRef="case" contextRef="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNTc_ea1f0752-c4fb-4137-9726-392aa64f26c9">46</ix:nonFraction> cases were tried in Alaska (<ix:nonFraction unitRef="case" contextRef="i15254fcdf0474c4d91f3cdaf53416cf9_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNjE_ca64a026-9633-4700-ae05-4e8cec08afd9">1</ix:nonFraction>), California (<ix:nonFraction unitRef="case" contextRef="i03552e08ecac456e9607180e0f7cea1d_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNjU_27b67b35-085d-4f20-b308-e93d61a4abc0">7</ix:nonFraction>), Connecticut (<ix:nonFraction unitRef="case" contextRef="iff9acca8e9b04ab7bbeb5f69bc352ad6_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNjk_e71aba69-8807-4b28-b1df-f006659c6b9c">1</ix:nonFraction>), Florida (<ix:nonFraction unitRef="case" contextRef="ia385d23e2d37444cbad3c91fd282c47b_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNzM_60bc8c03-b122-4cce-8121-29b05b42bcb1">10</ix:nonFraction>), Louisiana (<ix:nonFraction unitRef="case" contextRef="ibb31d44524574239b606215996b36c53_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNzc_2d1f66bb-1f3e-41f1-a107-ab5560c39a15">1</ix:nonFraction>), Massachusetts (<ix:nonFraction unitRef="case" contextRef="ida280a8e75724cc58094fbf48eda09fa_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxODE_0021ebbf-0cf1-49a2-9060-b4a988710d49">6</ix:nonFraction>), Mississippi (<ix:nonFraction unitRef="case" contextRef="i325dfa71eec5476ea64d6e500e22c43e_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxODU_ac28c293-5cc7-4a40-b1aa-a5387dc59559">1</ix:nonFraction>), Missouri (<ix:nonFraction unitRef="case" contextRef="i322e1958ef354f998e5b9802f9a1c190_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxODk_1c590f6f-d6f9-485d-be71-6954b53f0984">4</ix:nonFraction>), New Hampshire (<ix:nonFraction unitRef="case" contextRef="id5c28868e39348ea9f1dc8327b0b6efd_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxOTM_34e2b38d-f372-4be2-92e9-698aa919742f">1</ix:nonFraction>), New Jersey (<ix:nonFraction unitRef="case" contextRef="ie6f19f777880458ca0b18267c7d35b69_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxOTc_f3add56e-8447-4f3a-83f8-496097255e01">1</ix:nonFraction>), New York (<ix:nonFraction unitRef="case" contextRef="i3d324cecd2fc4178abb7a986fd98c47a_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcyMDE_75f4e23e-2fc8-4967-8cd7-8939679b6728">5</ix:nonFraction>), Ohio (<ix:nonFraction unitRef="case" contextRef="ic85bb6de18db4b88bb50cb99cf81d8d8_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcyMDU_5f3d13b5-d781-4e73-bf06-9d2efa29e92c">2</ix:nonFraction>), Pennsylvania (<ix:nonFraction unitRef="case" contextRef="ic3560c35b1b64649bae3cb957e859160_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcyMDk_0d984879-36b8-4ee6-ae7f-dd4efb499a02">1</ix:nonFraction>), Rhode Island (<ix:nonFraction unitRef="case" contextRef="i6f793a811c1c4997bb2a82a658d83b55_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcyMTM_1c4edec8-96f1-4ac0-a0c4-7bfe61017f2b">1</ix:nonFraction>), Tennessee (<ix:nonFraction unitRef="case" contextRef="i5a801284144744f8a8f5d897e3fa2fb5_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcyMTc_67e9a974-87ee-4c6b-b9a8-7fdb8638d233">2</ix:nonFraction>) and West Virginia (<ix:nonFraction unitRef="case" contextRef="idb6c598803cf4b6687397df90a86563f_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcyMjE_5735a411-5858-4c14-9fb7-41b732005d5a">2</ix:nonFraction>).  <ix:nonFraction unitRef="case" contextRef="ida280a8e75724cc58094fbf48eda09fa_D19990101-20230127" decimals="INF" name="mo:LossContingencyVerdictReversedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzY1OTcwNjk5OTYyOTg_3e718562-a7dd-44b3-8e06-f7407b9d5c46">One</ix:nonFraction> case in Massachusetts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Main</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, where the verdict was initially returned in favor of PM USA, was reversed on appeal and remanded for a new trial.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the <ix:nonFraction unitRef="case" contextRef="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedUnfavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDY3MDI_8057eb94-d69a-4720-b1df-04770ea6287d">27</ix:nonFraction> non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs, <ix:nonFraction unitRef="case" contextRef="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127" decimals="INF" name="mo:LossContingencyClaimsResolvedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDY3MDY_c7e7fc84-12c4-4b0f-8951-653cb4ea9c6a">23</ix:nonFraction> have reached final resolution.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Liti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">gation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of verdicts in state and federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA as of January 27, 2023.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Smoking and Health Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs&#8217; allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and consumer protection statutes and claims under the federal and state anti-racketeering statutes.  Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.  Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny smoking and health cases pending during 2022 (or recently concluded) in which a verdict was returned in favor of plaintiff and against PM USA.  Charts listing certain verdicts for plaintiffs in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases can be found in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mendez</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA and R.J. Reynolds Tobacco Company awarding approximately $<ix:nonFraction unitRef="usd" contextRef="ic04846f477ef4b43b64fc0a53777f0d5_I20220930" decimals="-5" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjEzMDU_d95d0129-55f4-4c29-b578-00e337eb9472">4.5</ix:nonFraction> million in compensatory damages and allocating <ix:nonFraction unitRef="number" contextRef="ie6e2ff8e6f1647eea34f150435a9f641_I20220930" decimals="2" name="mo:LossContingencyFaultAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjEzNDg_6898cdb9-bee7-4942-ad91-c683edbe84c9">13</ix:nonFraction>% of the fault to PM USA.  After </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="ic260754f912243229a52c6557c04a4b2" continuedAt="icfb5c68642f0414abe2df0021ff90b63"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applying comparative fault, PM USA&#8217;s portion of the compensatory damages is less than $<ix:nonFraction unitRef="usd" contextRef="ie6e2ff8e6f1647eea34f150435a9f641_I20220930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjE0Njk_204685fb-542f-4d97-98bd-b98b00b5a64a">1</ix:nonFraction> million.  There was <ix:nonFraction unitRef="usd" contextRef="ie6e2ff8e6f1647eea34f150435a9f641_I20220930" decimals="INF" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjE0ODU_032f2c4a-bdc0-4c87-bb2c-573370edb6f1">no</ix:nonFraction> claim for punitive damages.  The trial court denied PM USA&#8217;s post-trial motions.  Both parties have appealed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fontaine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, a jury in a Massachusetts state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $<ix:nonFraction unitRef="usd" contextRef="idddcb5cec584482b801338bd316d77fc_I20220930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjE3MTA_089a28c2-fe10-435f-a4ba-51cf5aa0baab">8</ix:nonFraction> million in compensatory damages and $<ix:nonFraction unitRef="usd" contextRef="idddcb5cec584482b801338bd316d77fc_I20220930" decimals="-9" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjE3NDI_b30236b4-1cc4-416f-a86e-250f5fb7b0a7">1</ix:nonFraction> billion in punitive damages.  We intend to file post-trial motions challenging the award and, if necessary, an appeal.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $<ix:nonFraction unitRef="usd" contextRef="ibc98656966dd42c4be583a6f2ed13108_I20200229" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTI2NjA_27e2f8d1-9858-43d2-b896-b600e26c2039">11</ix:nonFraction> million in compensatory damages.  There was <ix:nonFraction unitRef="usd" contextRef="ibc98656966dd42c4be583a6f2ed13108_I20200229" decimals="INF" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTI2NjQ_d274439a-5e1a-4450-b8e0-e3a9ac0da7bb">no</ix:nonFraction> claim for punitive damages.  PM USA appealed the trial court verdict to the Third District Court of Appeal and, in September 2021, the appellate court reversed the trial court&#8217;s decision and found in favor of PM USA.  Plaintiff moved for a rehearing before the Third District Court of Appeal, which the court denied in March 2022.  In April 2022, plaintiff filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court.  In July 2022, the Florida Supreme Court denied plaintiff&#8217;s motion for discretionary review.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Greene</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $<ix:nonFraction unitRef="usd" contextRef="i1410b910eefc4178acdfe4b6ce022ff7_I20190930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTIxMDE_553b9aa9-a4fa-4339-a89c-9e5ce9b0be8a">10</ix:nonFraction> million in compensatory damages.  In May 2020, the court ruled on plaintiffs&#8217; remaining claim and trebled the compensatory damages award to approximately $<ix:nonFraction unitRef="usd" contextRef="i5da32d8355b7469492d1e45bf26c92fe_I20200531" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTIxMDU_31a526cc-6252-4e8d-b306-370d769a1efc">30</ix:nonFraction> million.  In February 2021, the trial court awarded plaintiffs attorneys&#8217; fees and costs in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="ib879d27f5b6249628c06789bea384757_I20210228" decimals="-5" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTIxMDk_abf76bb3-64a4-4290-90a7-3eacc473d4f7">2.3</ix:nonFraction> million.  In July 2021, following denial of PM USA&#8217;s post-trial motions, PM USA appealed the judgment to the Appeals Court of Massachusetts.  In September 2022, the Massachusetts Supreme Judicial Court issued an order taking jurisdiction over the appeal, which remains pending.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the verdict and post-trial developments in the United States of America health care cost recovery case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Class Action: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2000, in the second phase of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $<ix:nonFraction unitRef="usd" contextRef="ic794e5582af74563b80ccb6479696bc2_I20000731" decimals="-9" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTY1MDA_21d28cd1-156c-42c0-9606-63d2aa9150a3">145</ix:nonFraction> billion against various defendants, including $<ix:nonFraction unitRef="usd" contextRef="ic921b407891d41a9a370b70f29dbbf7b_I20000731" decimals="-9" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTY1MDQ_d0273843-9e22-402e-8f30-2c9e049fa1e2">74</ix:nonFraction> billion against PM USA.  Following entry of judgment, PM USA appealed.  In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class.  Plaintiffs petitioned the Florida Supreme Court for further review.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within <ix:nonNumeric contextRef="i2ed199122dae41e0a7f040a1f16d427f_D20060701-20060731" name="mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTY1MDg_df85d1be-5aa2-4757-84d8-baba32051bed">one year</ix:nonNumeric> of issuance of the mandate.  The court further declared the following Phase I findings are entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect in such individual actions brought within <ix:nonNumeric contextRef="i2ed199122dae41e0a7f040a1f16d427f_D20060701-20060731" name="mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTY1MTI_dca0ffe0-29be-4f2a-ac5d-655ef91aaeab">one year</ix:nonNumeric> of the issuance of the mandate: (i)&#160;that smoking causes various diseases; (ii)&#160;that nicotine in cigarettes is addictive; (iii)&#160;that defendants&#8217; cigarettes were defective and unreasonably dangerous; (iv)&#160;that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v)&#160;that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi)&#160;that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii)&#160;that all defendants sold or supplied cigarettes that were defective; and (viii)&#160;that defendants were negligent.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion.  In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect by excluding finding (v)&#160;listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants.  In February 2008, the trial court decertified the class.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e Progeny Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deadline for filing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases expired in January 2008, at which point a total of approximately <ix:nonFraction unitRef="case" contextRef="i181b032d3d8a4fb88a848af3798e1ca0_I20080131" decimals="-2" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTk3Nzk_77157d95-642c-45a9-8221-4fda019adeb8">9,300</ix:nonFraction> federal and state claims were pending.  As of January 27, 2023, approximately <ix:nonFraction unitRef="case" contextRef="i2c34362a468a45d08d7bbc1138e37393_I20230127" decimals="0" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTk3ODM_51c27fea-53a3-49e0-b682-6baa01eecd9e">612</ix:nonFraction> state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately <ix:nonFraction unitRef="plantiff" contextRef="i28ee13b79369415fbc5464692b8c4285_D20230127-20230127" decimals="0" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTk3ODc_33758b40-da01-4112-b7a3-132b9a1802d3">773</ix:nonFraction> state court plaintiffs.  Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates.  The 2015 federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreement resolved nearly all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases pending in federal court as of the date of the agreement, and each case excluded from that agreement subsequently has been resolved.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Trial Results: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2023, <ix:nonFraction unitRef="case" contextRef="ie5e034628af34ae3946be21b68ea8d0e_D20230127-20230127" decimals="INF" name="mo:LossContingencyClaimsDecided" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQwNDE_c2723234-517b-449d-b301-bc0b6aada38a">143</ix:nonFraction> federal and state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decision.  <ix:nonFraction unitRef="case" contextRef="ie5e034628af34ae3946be21b68ea8d0e_D20230127-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedUnfavorableNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQwNDU_944b943c-ff49-499f-9ef7-420c0320f284">Seventy-nine</ix:nonFraction> verdicts were returned in favor of plaintiffs, and <ix:nonFraction unitRef="case" contextRef="ib9bfd24968014e2fbddf1581242c201e_I20230127" decimals="INF" name="mo:LossContingencyUnfavorableVerdictsPendingReversed" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQwNDk_7dcb0186-56a4-4589-83e6-405c4202ce82">seven</ix:nonFraction> verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skolnick</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Calloway</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oshinsky-Blacker,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McCoy, Mahfuz, Neff </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Gloger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending.  In <ix:nonFraction unitRef="case" contextRef="i62e4a46ab1a44e6fb47d8560c1b77cd8_I20230127" decimals="INF" name="mo:LossContingencyUnfavorableVerdictsPendingReversed" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjIzOTc_7c45be98-9cc1-47d2-9d39-f17cc095fcba">two</ix:nonFraction> cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kaplan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McLaughlin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sommers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the punitive damages awards were vacated on appeal and remanded for new trials.  In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sommers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the trial court entered final judgment dismissing the plaintiff&#8217;s punitive damages claim with prejudice, and plaintiff has appealed. </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="case" contextRef="ie5e034628af34ae3946be21b68ea8d0e_D20230127-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQ0ODM_9fdfeef4-ca35-4528-a6f4-72d53e250cd2">Fifty-six</ix:nonFraction> verdicts were returned in favor of PM USA, of which <ix:nonFraction unitRef="case" contextRef="i7a03bc94992c4903bcda95a201871e01_D20230127-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQ0ODc_6a46f112-b9d2-4223-863f-477a90276906">46</ix:nonFraction> were state cases.  In addition, there have been a number of mistrials, only some of which have resulted in new trials as of January 27, 2023.  The jury in <ix:nonFraction unitRef="case" contextRef="i7a32ea824fa14aaeb1265afa3e1edf01_D20230127-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzY1OTcwNjk5OTIwODA_afc49a9e-c63f-4e0a-a769-a2e397ae451e">one</ix:nonFraction> case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Garcia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, awarded plaintiff compensatory </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="icfb5c68642f0414abe2df0021ff90b63" continuedAt="ic7d2315a5be54ffa8c1ecc365d8d0634"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">damages and found plaintiff was entitled to punitive damages; however, the court declared a mistrial in the second phase of the trial regarding punitive damages because the jury was unable to determine the amount of the punitive damages.  Following appeals by the plaintiff and PM USA, the appellate court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Garcia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> affirmed the compensatory damages judgment against PM USA and granted a new trial with respect to punitive damages.  The plaintiff in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Garcia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subsequently filed a motion to voluntarily dismiss the punitive damages claim and to enter final judgment on the compensatory damages claim, which the court granted.  <ix:nonFraction unitRef="case" contextRef="i9840bd4343f941b0887d784405cd4d35_D20230127-20230127" decimals="INF" name="mo:LossContingencyVerdictReversedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQ5OTA_a724808f-fd64-4cf4-9954-e0e75c0d9b35">Three</ix:nonFraction> verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cohen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chacon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were returned in favor of PM USA were subsequently reversed for new trials.  Juries in <ix:nonFraction unitRef="case" contextRef="i180010a7918e4145a2f89842434e3987_D20230127-20230127" decimals="INF" name="mo:LossContingencyZeroDamagesVerdicts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQ5OTQ_fd9d4d81-3200-4415-81ab-bdca23e47660">two</ix:nonFraction> cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reider</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Banks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) returned <ix:nonFraction unitRef="usd" contextRef="i180010a7918e4145a2f89842434e3987_D20230127-20230127" decimals="INF" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQ5OTg_c34832f5-ab05-4a10-a9be-e3e7ae52cbd0">zero</ix:nonFraction> damages verdicts in favor of PM USA.  Juries in <ix:nonFraction unitRef="case" contextRef="i24acb3f6bdc34dee9714f9a0917ffb23_D20230127-20230127" decimals="INF" name="mo:LossContingencyZeroDamagesVerdictModified" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjUwMDI_b80b3489-908c-43c9-96b9-33f7fe3efc57">two</ix:nonFraction> other cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Weingart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hancock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) returned verdicts against PM USA awarding <ix:nonFraction unitRef="usd" contextRef="i24acb3f6bdc34dee9714f9a0917ffb23_D20230127-20230127" decimals="INF" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjUwMDY_c56ae169-91dd-49ac-8a57-0e51c751868c">no</ix:nonFraction> damages, but the trial court in each case decided to award plaintiffs damages.  <ix:nonFraction unitRef="case" contextRef="i1fd53372d12948b586896dc1e7cfd9e2_D20230127-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjUwMTA_6c502668-5a32-48fe-ac07-02a0caad374c">One</ix:nonFraction> case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pollari</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff.  Plaintiff and defendants appealed the verdict and the appellate court affirmed the judgment in favor of the defendants.  <ix:nonFraction unitRef="case" contextRef="ia6f75f0cc66b4f22a0d1523a7047668d_D20230127-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjUwMTQ_76721486-cfdf-4531-9061-1161f3487a71">Three</ix:nonFraction> cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gloger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Duignan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs.  A post-trial appeal is pending in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Duignan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The verdicts in the retrials in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gloger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rintoul</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) were reversed upon appeal and remanded for new trials.  <ix:nonFraction unitRef="case" contextRef="i883e5919c8b041b1b6877eaa2e7575d0_D20230127-20230127" decimals="INF" name="mo:LossContingencyClaimsDecidedFavorableNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjUwMTg_09ce0b9f-5467-4e52-a746-53e1b5763b3e">Two</ix:nonFraction> cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freeman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Harris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in an appellate reversal of a jury verdict in favor of plaintiff, and a judgment in favor of PM USA.  <ix:nonFraction unitRef="claim" contextRef="iea6390c8f234429087000381360f8e7c_D20230127-20230127" decimals="INF" name="us-gaap:LossContingencyClaimsDismissedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjI0MDE_972f8823-0e5c-4b88-abee-3a1dcae89d99">One</ix:nonFraction> case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R. Douglas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was dismissed with prejudice following a verdict in favor of plaintiff.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charts below list the verdicts and post-trial developments in certain </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs.  The first chart lists cases that are pending as of January 27, 2023 where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated, and the second chart lists cases that have concluded in the past 12 months.  Unless otherwise noted for a particular case, the jury&#8217;s award for compensatory damages will not be reduced by any finding of plaintiff&#8217;s comparative fault.  Further, the damages noted reflect adjustments based on post-trial or appellate rulings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References below to &#8220;R.J. Reynolds,&#8221; &#8220;Lorillard&#8221; and &#8220;Liggett Group&#8221; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.</span></div><ix:continuation id="i55739ec7e0d1408bb0a2f58d321f1783" continuedAt="ib05f5fe8ff864e9faae9522612814ff4"><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"></td><td style="width:9.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Trial Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Hoffman</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i50e02c65827141c0988efa4815111343_I20230131" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEtNC0xLTEtMjE0MDk0L3RleHRyZWdpb246ZmZmMDllYjI0YTRkNDc5MWJkZjk2MjViNTlhNWQxYTVfNDk0NzgwMjMyNTAzNg_d4dbf1bc-17f0-4a46-9507-3b4a77da12f0">5</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="i17a02e89bb314f8e8d214c7bfda3ab4a_I20230131" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEtNC0xLTEtMjE0MDk0L3RleHRyZWdpb246ZmZmMDllYjI0YTRkNDc5MWJkZjk2MjViNTlhNWQxYTVfNDk0NzgwMjMyNTA1MQ_25bd4940-d471-40b6-8118-5868bae9d27a">3</ix:nonFraction> million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i17a02e89bb314f8e8d214c7bfda3ab4a_I20230131" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEtNS0xLTEtMjE0MDk0L3RleHRyZWdpb246NWU0ZjA5NTY0ZGRhNDkxY2E2YzBlZWMzZTI5YTJiMGRfNDk0NzgwMjMyNTAwMA_2019acad-8075-4aff-a6c6-e065f9a8cda8">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Awaiting entry of final judgment by the trial court.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Levine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6468ca3275ef46f8aa6c95127507afac_I20220930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246NTc1YTdlNjY1YTI1NGExMTkwNjI0MGFlYTdhZWQyNTFfNA_421d7949-37ec-40b5-989e-cb32c0f1cfaf">1</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i212ceaaf50b24da29b210c63ce60efc3_I20220930" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEtNS0xLTEtMTg1OTM5L3RleHRyZWdpb246NmQ4YWJiNTFhYzVjNGFlMmFlMTllM2U1OTViMDIyNTRfNA_170c2745-728a-4c90-91f6-94b735bb46ef">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Appeals by defendants and plaintiff to Third District Court of Appeal pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Schertzer</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i920cf43da0b549b1bf36382047e4921c_I20220430" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzItNC0xLTEtMTg1OTM5L3RleHRyZWdpb246NGRkNDkyZmIzYmUzNGQyNzgzYmNmZWE1MzcwMzI3OGFfNA_f67c9427-f219-42c3-9b98-fc64957ab5ee">3</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ief08e55c7da94618b141a0544e183c7a_I20220430" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzItNS0xLTEtMTg1OTM5L3RleHRyZWdpb246MzI2OGVhODg3ZGNlNGZjZjgwMTMzMjQ1NjY2YmUwNWZfNA_47acb683-0337-4534-aae7-0e0ab2cbef3f">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Appeal by defendants to the Third District Court of Appeal pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Lipp</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie3c92225c6014643a39dde3972af7b95_I20210930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzMtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246NDVkZTc4MjNiYzM5NDM4YWIyYTI5MzYxZGU2MWVmNGRfNA_a0272f96-0402-443a-a117-c93b041a32fe">15</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ib0906996db114adb95e538086e4988cd_I20210930" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzMtNS0xLTEtMTg1OTM5L3RleHRyZWdpb246YzhlZWNlYmIxMjEyNGQyZDg3YjYzZWVjMzE1ZDI2NDlfNA_84bdb072-e623-4dc8-9c40-18357a7ea0b1">28</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Garcia</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i106eca6235c44aec9a053a8c1e1115f8_I20210531" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzQtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246MjlkYTc3ZTEzN2VhNGQ5ZmJhZmRiODJmNTE2ZDY2YmZfMjE5OTAyMzI1NTU4Ng_886d838e-7962-4ae0-bf71-61b085246ac7">6</ix:nonFraction> million ($<ix:nonFraction unitRef="usd" contextRef="i7875bd726b2c40cf94fdd162bfc1698e_I20210531" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzQtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246MjlkYTc3ZTEzN2VhNGQ5ZmJhZmRiODJmNTE2ZDY2YmZfMjE5OTAyMzI1NTU5OQ_ed3d86bc-ce30-4bb4-b34d-81f7dacdb3d9">3</ix:nonFraction> million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i7875bd726b2c40cf94fdd162bfc1698e_I20210531" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzQtNS0xLTEtMjAzNDc5L3RleHRyZWdpb246NTI5MTZiYjM3ZTI0NDEyYmFiM2M2YTZkM2E5NDY2ODRfMjE5OTAyMzI1NTU1OA_c14a6fb4-654c-4438-8c53-05863d7b6148">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to the Third District Court of Appeal pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Duignan</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pinellas</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i093d8c283e0149ac94dd94b7d960043e_I20200229" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzUtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246YTI2NTBmYThkMmFiNDg1MGEyNmRmYWFhMDc4ZDY4NDJfNA_206a6b7c-8e73-4fac-98c8-07d5dcace950">3</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i3a7510ef6d624bce9a8bd3477d7ecbab_I20200229" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzUtNS0xLTEtMTg1OTM5L3RleHRyZWdpb246YzA4MzIwMGJlNTBhNGFiNmFjMzhkN2UyMmIyZjBlNTVfNA_15a7d400-dbad-4f8d-9d74-e4602c7e7d86">12</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Florida Supreme Court quashed the Second District Court of Appeal&#8217;s affirmation of  judgment against the defendants and remanded the case for reconsideration in light of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McCall</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="ie3f1fa8a229242798c2a8851ec2c6a7d_I20190331" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzYtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246YzUwNTU0M2JlZjU2NDkxNTk4YTE2YWU5Y2EwNjgxNjVfNQ_f0d543d8-de26-41cf-92a0-e901c0f1648f">1</ix:nonFraction>&#160;million (&lt;$<ix:nonFraction unitRef="usd" contextRef="i61bd7798d97b44e4905f83615d533665_I20190331" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzYtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246YzUwNTU0M2JlZjU2NDkxNTk4YTE2YWU5Y2EwNjgxNjVfMTA_35997eab-ca40-43d9-b43c-fa37899b8186">1</ix:nonFraction>&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i61bd7798d97b44e4905f83615d533665_I20190331" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzYtNS0xLTEtMTg1OTM5L3RleHRyZWdpb246YTg0OWUwMzNjOWMxNGZjNzlmYjM1ZDA3M2M2YTRjZWFfNA_9f4bac67-5ca6-4f8c-aa4f-9d59d5ffadc3">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New trial on punitive damages is set for April 2023.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chadwell</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2018</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i432f8c3944d94d3088537f50fc75eec0_I20180930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzgtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246MjdlMTM4OTA5NTc3NGE5NDg5YjA2YmM1YTA1YTRlMjZfNA_50a13929-5341-4999-b83c-72fad59da5cd">2</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ia21796e7b1304ee59df65a9e7a9c1ae7_I20180930" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzgtNS0xLTEtMTg1OTM5L3RleHRyZWdpb246ZmUwNTE3M2M5YWExNGRiNmIwNjRkMDUyZWRlNTNiMmZfNA_9da0ac70-e6c0-4538-8914-458db64fbed2">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal has ordered supplemental briefing in accordance with the decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kaplan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McLaughlin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5185e4c3850249389a06ab7914fe67e5_I20180731" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzktNC0xLTEtMTg1OTM5L3RleHRyZWdpb246Yjk3ZDYyNzQ0ZDZiNDNjMmJmNWFkZjIyOTYxNTYyZmJfNA_1dfd9233-c33c-45f7-86c5-641ada0c0f5b">2</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i2c622465589840aa8eb67d8e00e12d37_I20180731" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzktNS0xLTEtMTg1OTM5L3RleHRyZWdpb246NDY2ZGI2NmE1NGIwNDMzMmE5NmQxZjFlOGE4MjczNWNfNA_2cf9f435-2c0a-4984-adf3-3248ac5fd733">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Florida Supreme Court vacated the punitive damages award in accordance with the decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.  The Fourth District Court of Appeals affirmed the compensatory damages award and granted a new trial on punitive damages.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cooper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Blackwood</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic6a8429d2dfd4db9966a956a2a38a138_I20150930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEwLTQtMS0xLTE4NTkzOS90ZXh0cmVnaW9uOmM2YzFjYjE1ZTZlZTRmOWI5YTFjYTllNGZhOWQzY2RiXzQ_2001f162-dffc-4a8d-b7be-466ecd9706c9">5</ix:nonFraction>&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(&lt;$<ix:nonFraction unitRef="usd" contextRef="i242b075be0904eea86cd14974d4e88e9_I20150930" decimals="-6" name="mo:LossContingencyCompensatoryDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEwLTQtMS0xLTE4NTkzOS90ZXh0cmVnaW9uOmM2YzFjYjE1ZTZlZTRmOWI5YTFjYTllNGZhOWQzY2RiXzEw_911a050a-628f-4f5d-9c1c-f02482207d4d">1</ix:nonFraction>&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i242b075be0904eea86cd14974d4e88e9_I20150930" decimals="-6" name="mo:LossContingencyPunitiveDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEwLTUtMS0xLTE4NTkzOS90ZXh0cmVnaW9uOmNmMjMyMzQ5MzQxYTRmMzY5MmRiOGJkNDU0YWQ5NTIyXzQ_4b5f90b7-a2ea-4793-a0da-f4162f9741b4">0</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal affirmed the compensatory damages award and granted a new trial on punitive damages.</span></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PM USA&#8217;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff&#8217;s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> PM USA is not a defendant in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, which are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle Progeny Appellate Issues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="ic7d2315a5be54ffa8c1ecc365d8d0634" continuedAt="i73b309a074254fba8ced6a53fd64ce44"><ix:continuation id="ib05f5fe8ff864e9faae9522612814ff4"><div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle Cases Concluded Within Past 12 Months </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.180%"><tr><td style="width:1.0%"></td><td style="width:9.919%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.123%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.123%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Amount for Damages (if any)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Miller</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third quarter of 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="i349b39aa4db540d09dd8cf5fd4305c55_D20221201-20221231" decimals="-6" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo2OTE1Y2NjMzQxOGU0ZDE5OWE0NGQzM2JhNzY1YzEyYi90YWJsZXJhbmdlOjY5MTVjY2MzNDE4ZTRkMTk5YTQ0ZDMzYmE3NjVjMTJiXzEtNS0xLTEtMjAzMzY1L3RleHRyZWdpb246MTNkNDYwZjMyNjRjNDAwZDlmNjgxZmU2OTI1N2ZiNjdfNDk0NzgwMjMyNTAwMQ_b4a23e39-88db-4619-9e85-163d08860e21">1</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Tuttle</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third quarter of 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$<ix:nonFraction unitRef="usd" contextRef="i66f3170db2b54fe7b125a52f2d195e80_D20221001-20221031" decimals="-6" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo2OTE1Y2NjMzQxOGU0ZDE5OWE0NGQzM2JhNzY1YzEyYi90YWJsZXJhbmdlOjY5MTVjY2MzNDE4ZTRkMTk5YTQ0ZDMzYmE3NjVjMTJiXzEtNS0xLTEtMTg1OTM5L3RleHRyZWdpb246OTBhMzFlMjFmZGZmNDk1OThmZTljMTUxOTg0MGRiYmFfNQ_1d8e6ff4-5b16-459e-92b3-93f2844d510b">1</ix:nonFraction> million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cuddihee</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second quarter of 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i752ab2dec76b4648932ee8291c3fde30_D20220601-20220630" decimals="-6" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo2OTE1Y2NjMzQxOGU0ZDE5OWE0NGQzM2JhNzY1YzEyYi90YWJsZXJhbmdlOjY5MTVjY2MzNDE4ZTRkMTk5YTQ0ZDMzYmE3NjVjMTJiXzItNS0xLTEtMTg1OTM5_a5c97709-d77f-4158-b95a-6d8e19bdd10d">2</ix:nonFraction> million</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Holliman</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth quarter of 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i775477992d5148ffb8ac99f47908d6e1_D20230101-20230131" decimals="-6" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo2OTE1Y2NjMzQxOGU0ZDE5OWE0NGQzM2JhNzY1YzEyYi90YWJsZXJhbmdlOjY5MTVjY2MzNDE4ZTRkMTk5YTQ0ZDMzYmE3NjVjMTJiXzQtNS0xLTEtMjEzMzQw_f72830f0-23a9-4847-b05a-cd2a6e5bc3ab">3</ix:nonFraction> million</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">D. Brown</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2015</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third quarter of 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ied8a6482d8d842548874153fd3412d3a_D20220801-20220831" decimals="-6" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo2OTE1Y2NjMzQxOGU0ZDE5OWE0NGQzM2JhNzY1YzEyYi90YWJsZXJhbmdlOjY5MTVjY2MzNDE4ZTRkMTk5YTQ0ZDMzYmE3NjVjMTJiXzMtNS0xLTEtMjAyNjEy_0e09ce6b-fa03-4f6c-b8cb-555a308ffb55">5</ix:nonFraction> million</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2022</span></td></tr></table></div></ix:continuation><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Appellate Issues: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Appellate decisions in the following </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases may have wide application to other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mary Sheffield v. R.J. Reynolds Tobacco Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case against R.J. Reynolds only, the Florida Supreme Court resolved a conflict among Florida&#8217;s District Courts of Appeal finding that the 1999 amendments to Florida&#8217;s punitive damages statute (including its caps and bar on multiple punitive damages awards for the same course of conduct) apply in wrongful death cases where the decedent was injured prior to the October 1, 1999 effective date of the amendments but died from his or her injuries after such effective date.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Linda Prentice v. R.J. Reynolds Tobacco Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case against R.J. Reynolds only, the Florida Supreme Court resolved a conflict among Florida&#8217;s District Courts of Appeal finding that in order for an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiff to prevail on fraudulent concealment and conspiracy claims, plaintiff must prove that the smoker relied to his or her detriment on a statement that concealed or omitted material information about the health risks or addictiveness of smoking.  The Florida Supreme Court declined to revisit its prior decisions giving preclusive effect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Phase I findings, described above in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Florida Bond Statute: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2009, Florida amended its existing bond cap statute by adding a $<ix:nonFraction unitRef="usd" contextRef="i2e77f2f208294f938fb2ec43209eee70_I20090630" decimals="-6" name="mo:MaximumBondForAllDefendants" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzQzMjc_7f918198-ff40-4a29-8d3e-f3b5f09ec1f0">200</ix:nonFraction> million bond cap that applies to all state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny lawsuits in the aggregate and establishes individual bond caps for individual </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in amounts that vary depending on the number of judgments in effect at a given time.  Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases tried in federal court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Smoking and Health Class Actions: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts.  In general, these cases have purported to be brought on behalf of residents of a particular state or states (although a few cases have purported to be nationwide in scope) and have raised addiction claims and, in many cases, claims of physical injury as well.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class certification has been denied or reversed by courts in <ix:nonFraction unitRef="case" contextRef="i2b527c47e5014c0aaaf9b0b067634552_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzMjI_18235942-2b1a-4f21-9cbf-512fd5ae8e57">61</ix:nonFraction> smoking and health class actions involving PM USA in Arkansas (<ix:nonFraction unitRef="case" contextRef="ic10ea316eb6a47e48c3e53b43b03e6d0_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzMjY_59c026ea-4258-4a33-8dad-1066f3417c6a">1</ix:nonFraction>), California (<ix:nonFraction unitRef="case" contextRef="i4929a66b8e9b49248e19eec92e781436_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNDI_11cd2e47-8bdf-4275-b1d9-df51e269e545">1</ix:nonFraction>), Delaware (<ix:nonFraction unitRef="case" contextRef="i85f3e34a436d46d0a07b5548c997598c_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNDY_c0ca1f31-0b26-4432-9032-d8644ff1b14e">1</ix:nonFraction>), the District of Columbia (<ix:nonFraction unitRef="case" contextRef="i1741852180994ef68345036762c17998_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNTg_d42b1239-1aba-4fc8-889e-6fb64151b3d6">2</ix:nonFraction>), Florida (<ix:nonFraction unitRef="case" contextRef="i801ebabf38fa441fb2d94c6e67e28052_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNjI_23b39ca8-9462-41a4-b61b-bb7caf6e7486">2</ix:nonFraction>), Illinois (<ix:nonFraction unitRef="case" contextRef="iff317a61814e4db486d1db5fda1f4175_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNjY_c45a4e4a-a418-4781-833a-49ee3360952d">3</ix:nonFraction>), Iowa (<ix:nonFraction unitRef="case" contextRef="i5febaca0c6254dfabb955e0c0034af5d_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNzA_53ced588-7d6d-4046-81a9-14f82247d574">1</ix:nonFraction>), Kansas (<ix:nonFraction unitRef="case" contextRef="ia46c676221664155b20176ae820f2c18_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNzQ_acc74a6b-016c-4588-89c5-b7f1ea84ccd1">1</ix:nonFraction>), Louisiana (<ix:nonFraction unitRef="case" contextRef="i8f12e85e557c4736862707aa26443eef_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNzg_b7fd60c1-7046-4f52-b69e-6f9aeda9e075">1</ix:nonFraction>), Maryland (<ix:nonFraction unitRef="case" contextRef="ib411bb4ee3f347218c4a11fe8e17f6ac_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzODI_f61d3625-5a4c-4466-b027-d34a37587b50">1</ix:nonFraction>), Michigan (<ix:nonFraction unitRef="case" contextRef="i0a370a52cb634e1b887970e51ba3eea2_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzODY_8d73b3a7-0b10-4442-b363-5913f995e51d">1</ix:nonFraction>), Minnesota (<ix:nonFraction unitRef="case" contextRef="i3a9aa66dc8c8499e838fe36896f6146e_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzOTA_7fb99280-8c09-4581-8ece-821652c1416f">1</ix:nonFraction>), Nevada (<ix:nonFraction unitRef="case" contextRef="i884defb8144d483985e98d3102cad8d6_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzOTQ_16552e57-b3e4-40a1-b2ef-923b23c857c7">29</ix:nonFraction>), New Jersey (<ix:nonFraction unitRef="case" contextRef="i30284ad3aca0439787bbaef52a3ee87b_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzOTg_10c5ffd4-4ca5-4844-91c3-c77f7c12625f">6</ix:nonFraction>), New York (<ix:nonFraction unitRef="case" contextRef="i598983dcf5714194acc23ab021d7b890_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MDI_53908a19-ce93-491c-877f-1bd9abf9ec01">2</ix:nonFraction>), Ohio (<ix:nonFraction unitRef="case" contextRef="i3a8278fb3e23470e99b558bec8b8e1c3_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MDY_d4676613-4173-4b4b-8263-5c01fabce30f">1</ix:nonFraction>), Oklahoma (<ix:nonFraction unitRef="case" contextRef="ib90545ee4e794ecd86a7d962993031ae_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MTA_3cb6e0ed-8fcc-46e3-a2ee-1817efc8100e">1</ix:nonFraction>), Oregon (<ix:nonFraction unitRef="case" contextRef="i0ce7548765b949efaad6025a7bb2d39a_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MTQ_ff83f0a5-f1ad-4b06-88bf-c5df613a5d25">1</ix:nonFraction>), Pennsylvania (<ix:nonFraction unitRef="case" contextRef="if235e66a71fb40bb80e9a57ea20e104a_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MTg_3c3179f9-5362-4493-b8f8-c6202b58ea0f">1</ix:nonFraction>), Puerto Rico (<ix:nonFraction unitRef="case" contextRef="i1a0cae0d945242f9add4c95a9f783fff_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MjI_abfb327b-5a04-4757-957c-10e498d8aca9">1</ix:nonFraction>), South Carolina (<ix:nonFraction unitRef="case" contextRef="i6e96ff7dfa4f4e3bbd38467b869c2b09_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MjY_8ec1e4d5-9ac2-4e1d-a737-7c89492b9c8b">1</ix:nonFraction>), Texas (<ix:nonFraction unitRef="case" contextRef="ib94a2498fbec415da80b4378db2c49aa_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MzA_7818a12b-cb4e-4498-9f20-c9e87717acda">1</ix:nonFraction>)&#160;and Wisconsin (<ix:nonFraction unitRef="case" contextRef="id201aa07137345cc9031fe7687fb9aa8_D19960501-20221231" decimals="INF" name="mo:LossContingencyClassNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MzQ_4cd086a2-3068-4f0b-97b1-94e4b366af3b">1</ix:nonFraction>).  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Other Tobacco-Related Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a discussion of &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; class action cases and medical monitoring class action cases pending against PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2023, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in <ix:nonFraction unitRef="case" contextRef="i78854af3be924b238c97cf0018613bd5_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzg0NTQ_22672022-0114-4191-b34c-a28c8811dcfa">seven</ix:nonFraction> class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario.  In Saskatchewan, British Columbia (<ix:nonFraction unitRef="case" contextRef="i8c3e60acf54840d5823064246d8f4255_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzg0NTg_be6fe49f-7df4-4295-a242-1351f5303f29">two</ix:nonFraction> separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants&#8217; cigarettes.  In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants&#8217; cigarettes.  In March 2019, all of these class actions were stayed as a result of <ix:nonFraction unitRef="manufacture" contextRef="i47f7028016ec4a9ca7c5da65de1c31cd_I20190331" decimals="INF" name="mo:LossContingencyNumberofManufacturers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzg0NjI_099f5d13-4710-40da-b5ea-5e944c458fdf">three</ix:nonFraction> Canadian tobacco manufacturers (none of which is related to us) seeking protection under Canada&#8217;s Companies&#8217; Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the United States).  The companies entered into these proceedings following a Canadian appellate court upholding <ix:nonFraction unitRef="ruling" contextRef="i47f7028016ec4a9ca7c5da65de1c31cd_I20190331" decimals="INF" name="mo:LossContingencyVerdictsUpheld" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzg0NzA_1c751b8c-b4d4-4803-ba8a-3b3833b83f94">two</ix:nonFraction> smoking and health class action verdicts against those companies totaling approximately CAD $<ix:nonFraction unitRef="cad" contextRef="i559c9c5248e14c7eac616a9c6e9b88ba_D20190301-20190331" decimals="-9" name="mo:AmountAwardedtoOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzg0NzQ_63e14248-109a-402f-82f2-3fa33ea002dc">13</ix:nonFraction> billion.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i73b309a074254fba8ced6a53fd64ce44" continuedAt="i0c601df6990f46d0aef0923f411a5b48"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Cost Recovery Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages.  Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there have been some decisions to the contrary, most judicial decisions in the United States have dismissed all or most health care cost recovery claims against cigarette manufacturers.  Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs&#8217; claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions.  The U.S. Supreme Court has refused to consider plaintiffs&#8217; appeals from the cases decided by five federal circuit courts of appeal.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the cases brought in the United States, health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (<ix:nonFraction unitRef="case" contextRef="iad62c741cfb14a10b14ba7e8f787e007_I20221231" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODM2ODY_a92d4149-0981-4c17-8f58-691d9aaa755c">10</ix:nonFraction> cases),&#160;and other entities have stated that they are considering filing such actions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers.  PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases.  The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed.  All of these cases have been stayed pending resolution of proceedings in Canada involving <ix:nonFraction unitRef="manufacture" contextRef="iea22c49cbb364016b9be8082d98ec8b5_I20221231" decimals="INF" name="mo:LossContingencyNumberofManufacturers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODM2OTA_4461619b-a9a4-407a-adb6-62197e752882">three</ix:nonFraction> tobacco manufacturers (none of which are affiliated with us) under the Companies&#8217; Creditors Arrangement Act discussed above.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for a discussion of these proceedings.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Settlements of Health Care Cost Recovery Litigation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1998, PM USA and certain other tobacco product manufacturers entered into the Master Settlement Agreement (the &#8220;MSA&#8221;) with <ix:nonFraction unitRef="state" contextRef="i748c02005b4a4bf49a0612b63989ef03_D19981101-19981130" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODY4MjA_a0372f87-b335-46ce-b7ea-b4b9d489a9f9">46</ix:nonFraction> states, the District of Columbia and certain United States territories to settle asserted and unasserted health care cost recovery and other claims.  PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#8220;State Settlement Agreements&#8221;).  The State Settlement Agreements require that the original participating manufacturers or &#8220;OPMs&#8221; (now PM USA, R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (&#8220;ITG&#8221;)) make annual payments of approximately $<ix:nonFraction unitRef="usd" contextRef="i748c02005b4a4bf49a0612b63989ef03_D19981101-19981130" decimals="-8" name="mo:LitigationSettlementAnnualPaymentAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODY4MjQ_4c137a5b-4a1b-43a0-854d-bc4e8cdafa86">9.4</ix:nonFraction> billion, subject to adjustments for several factors, including inflation, market share and industry volume.  In addition, the OPMs are required to pay settling plaintiffs&#8217; attorneys&#8217; fees, subject to an annual cap of $<ix:nonFraction unitRef="usd" contextRef="i5d208e527e4342e8a6fed1e96302bed1_I19981130" decimals="-6" name="mo:LitigationSettlementAnnualLegalFeesPayableMaximum" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODY4Mjg_e058f41b-9ca1-48d2-9d6c-9f557651ba0f">500</ix:nonFraction> million; these quarterly payments are expected to end in 2024.  For the years ended December 31, 2022, 2021 and 2020, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $<ix:nonFraction unitRef="usd" contextRef="i387d404d62a74acc8f6dbf3b7be9ca4b_D20220101-20221231" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0ODEwMjU_02b45b49-b102-42be-8c3a-4aac91b383f7">3.9</ix:nonFraction> billion, $<ix:nonFraction unitRef="usd" contextRef="i3d696721355c4cda96236197d43ab89a_D20210101-20211231" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjcwMDg_f7257e98-8778-4433-b071-7def017f11bf">4.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i051656e6a1684bfba293e4a15343ded2_D20200101-20201231" decimals="-8" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjcwMjQ_5e2f8b7f-08f3-4c16-9de0-e371693ba29e">4.4</ix:nonFraction> billion, respectively.  These amounts include PM USA&#8217;s estimate of amounts related to NPM Adjustments discussed below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NPM Adjustment Disputes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;NPM Adjustment&#8221; is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the &#8220;participating manufacturers&#8221; or &#8220;PMs&#8221;) that applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The independent auditor (&#8220;IA&#8221;) appointed under the MSA has calculated that PM USA&#8217;s share of the maximum potential NPM Adjustments for 2004-2021 is (exclusive of interest or earnings): $<ix:nonFraction unitRef="usd" contextRef="i2b29a936696b409788862a00b0672af2_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0NTU_37418176-575a-4ee5-a899-0854652077a8">388</ix:nonFraction> million for 2004; $<ix:nonFraction unitRef="usd" contextRef="ib9c6e2186f1e45e786df72e8ee7ec3d3_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0NTk_a13d9f24-f52a-4c28-8c4c-db65d399a0de">181</ix:nonFraction> million for 2005; $<ix:nonFraction unitRef="usd" contextRef="i5a685c7dcd494128be51e43eb85380b3_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0NjM_dfc27b20-5194-4bb7-b16a-f4add84c1f19">154</ix:nonFraction> million for 2006; $<ix:nonFraction unitRef="usd" contextRef="i79ad3a1e3b8a4470a7aca27a30ad959d_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0Njc_a0807881-4a32-48bb-99bd-5d8644132fe8">185</ix:nonFraction> million for 2007; $<ix:nonFraction unitRef="usd" contextRef="i7c1a43c0fecf4f50ae6cebda59c8b404_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0NzE_e8e8d2a2-4c3b-4773-9709-2a15cb4b2e46">250</ix:nonFraction> million for 2008; $<ix:nonFraction unitRef="usd" contextRef="i3976df847f6a4da191d1961d8126013e_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0NzU_3752b3c9-d6b4-42bc-ae39-bec02afca601">211</ix:nonFraction> million for 2009; $<ix:nonFraction unitRef="usd" contextRef="ic6602bcb2e70449fa757d0cf969d2e2a_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0Nzk_0f4ece14-2aa3-419a-b47b-69e26d6e7c4c">218</ix:nonFraction> million for 2010; $<ix:nonFraction unitRef="usd" contextRef="if70775d7ed4d4bba9b45ad323909f03d_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0OTA_565860b0-e5fe-4096-9475-37276a6bca25">166</ix:nonFraction> million for 2011; $<ix:nonFraction unitRef="usd" contextRef="ie9402356363b4f8f9a3867eb8211b078_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0OTQ_a6e1f8fb-674b-4bba-b90a-304a9e033c0e">214</ix:nonFraction> million for 2012; $<ix:nonFraction unitRef="usd" contextRef="i3b4691fe3b4e4dd7b23e74d90e241e1d_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0OTg_3deae15c-cfbc-43a3-987e-414a0f29d25f">224</ix:nonFraction> million for 2013; $<ix:nonFraction unitRef="usd" contextRef="i9e03b7ae06ec4c8aba2fd2c946767067_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk1MDI_0d971b12-5a30-4de4-b525-1115db42a25c">258</ix:nonFraction> million for 2014; $<ix:nonFraction unitRef="usd" contextRef="i1b55d65103bd48adbcfb2b0e11d8d4b1_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk1MDY_c6e287cd-582c-4c3b-9b6c-ecf2c9194c71">313</ix:nonFraction> million for 2015; $<ix:nonFraction unitRef="usd" contextRef="i4b8c44a5cad54a2f947e060d3352f19d_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk1MTA_3ce52ab6-cbce-441f-827b-863afeccc707">292</ix:nonFraction> million for 2016; $<ix:nonFraction unitRef="usd" contextRef="ie4513fc58c994ac2900d640a3a2b33fd_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk1MjE_957368af-3910-47ea-9463-2e91d2fef301">285</ix:nonFraction> million for 2017; $<ix:nonFraction unitRef="usd" contextRef="iaf7e83849a514def895afca19a8dbf72_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk1MjU_1425ed75-d208-4efe-8be2-73f54dd1c0cf">318</ix:nonFraction> million for 2018; $<ix:nonFraction unitRef="usd" contextRef="ic1bcaad299794ce9a240e8f403e0a7cb_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk1Mjk_08a2963b-2e01-4499-85ee-e48a8aa4d408">415</ix:nonFraction> million for 2019; $<ix:nonFraction unitRef="usd" contextRef="i9d5e76cb93d64980a7da87f32e2ef279_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ5NjI_59e37bc7-f612-4190-b11f-b1b81f27a32d">573</ix:nonFraction> million for 2020; and $<ix:nonFraction unitRef="usd" contextRef="i856b71c11be3464788fa35e57b23b454_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementEstimateofPossibleGain" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQxNzM_db6f6199-991f-4ea4-a756-de5d0c4cb431">635</ix:nonFraction> million for 2021.  These maximum amounts will be substantially reduced to reflect the NPM Adjustment settlements discussed below, and potentially for current and future calculation disputes and other developments.  PM USA&#8217;s recovery for 2004 is addressed below.  In addition, PM USA&#8217;s recovery of such reduced amounts for all subsequent years will be dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Settlements of NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.78pt">Multi-State Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> By the end of 2018, PM USA entered into a multi-state settlement of NPM Adjustment disputes with a total of <ix:nonFraction unitRef="state" contextRef="i2e156f0ff61c4547b064d2b367b1b8ae_D20180101-20181231" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyMjM_a828a0ae-9323-44dc-a94f-dfa40485c81b">36</ix:nonFraction> MSA states and territories in which PM USA settled the NPM Adjustment disputes through 2022 with <ix:nonFraction unitRef="state" contextRef="i2e156f0ff61c4547b064d2b367b1b8ae_D20180101-20181231" decimals="INF" name="mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyMjc_2b7db042-0b26-4d74-bb73-6653f1599aab">35</ix:nonFraction> of the <ix:nonFraction unitRef="state" contextRef="i2e156f0ff61c4547b064d2b367b1b8ae_D20180101-20181231" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyMzE_d191c04b-999e-4367-9914-f6fd44748250">36</ix:nonFraction> states, and through 2024 with <ix:nonFraction unitRef="contract" contextRef="id9f929366f9c4db99fbbe7cc0765d8e2_D20180101-20181231" decimals="INF" name="mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyMzU_7c3290fe-8125-488a-b4e2-4aed3be2dca7">one</ix:nonFraction> state.  In March 2022, Illinois joined the multi-state settlement, settling the NPM Adjustment disputes through 2028 and bringing the total number of settling states and territories to <ix:nonFraction unitRef="state" contextRef="ie91a77817ecc4e999d0370e2c9318a18_D20220301-20220331" decimals="INF" name="mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzQ5NDc4MDI1NTQ2Njg_0c923d73-de7a-4f0c-98de-9910d5fb3bf9">37</ix:nonFraction>.  As a result, PM USA will receive approximately $<ix:nonFraction unitRef="usd" contextRef="ic3eb37f4a9f84da6819684970ef73356_D20220301-20220331" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQyMjM_181ac755-5746-4aac-bd71-c74a1a719e35">80</ix:nonFraction> million for 2004-2021 ($<ix:nonFraction unitRef="usd" contextRef="if1a23e3497624a1fa46068cc25ed067e_D20220301-20220331" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQyNDI_23751b4b-eabf-41c5-9b5c-c55fcf75572a">20</ix:nonFraction> million of which relates to the 2019-2021 &#8220;transition years&#8221;).  In connection with this development for Illinois, PM USA recorded $<ix:nonFraction unitRef="usd" contextRef="i3cdb4695c4e249cea22489ca33dd31a2_D20220101-20220331" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQzNjg_55687536-432c-4068-8c7f-5ae0cc8d52f0">80</ix:nonFraction> million as a reduction in cost of sales in the first quarter of 2022.  Pursuant to the multi-state </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i0c601df6990f46d0aef0923f411a5b48" continuedAt="i307c322dd7b44ac992f924ff3f7b1f9d"><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">settlement, PM USA has received $<ix:nonFraction unitRef="usd" contextRef="ic1705ce2bbd441deaa21faea57603e06_D20180101-20221231" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyNDA_5c8be469-c370-4a02-8ecf-45a938caae67">1.15</ix:nonFraction> billion and expects to receive approximately $<ix:nonFraction unitRef="usd" contextRef="i2424508abe914dc19477786edb09c233_D20220101-20221231" decimals="-6" name="mo:LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyNDQ_8be924ce-8a97-4b2a-9b0b-25a4740dd1b8">410</ix:nonFraction> million in credits to offset PM USA&#8217;s MSA payments through 2036.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">New York Settlement.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, PM USA entered into a separate NPM Adjustment settlement with New York in which PM USA settled the NPM Adjustment disputes with New York in perpetuity.  PM USA has received $<ix:nonFraction unitRef="usd" contextRef="i466ccb5c286b4d9d83b198edeb139479_D20150101-20151231" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyNDg_5337f39c-31ad-481d-9f1c-3dd74ee092eb">435</ix:nonFraction> million pursuant to the New York settlement and expects to receive annual credits applied against the MSA payments due to New York going forward.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Montana Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In 2020, PM USA entered into a separate NPM Adjustment settlement with Montana in which PM USA settled the NPM Adjustment disputes with Montana through 2030.  This settlement resulted in a payment by PM USA of $<ix:nonFraction unitRef="usd" contextRef="i9401b496918446c4a0bd9291e50c1846_D20200101-20201231" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyNTI_ec323221-252d-4d96-b67e-f38b8c827a15">4</ix:nonFraction> million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Continuing NPM Adjustment Disputes with States That Have Not Settled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2004 NPM Adjustment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The PMs and the <ix:nonFraction unitRef="state" contextRef="i6e30d0f16c0e4fffb6403230045d3122_D20220101-20221231" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ2ODY_56b64f98-1b35-4ab4-8f11-5edb4ef1ccbf">nine</ix:nonFraction> states that have not settled the NPM Adjustment disputes participated in a multi-state arbitration of NPM Adjustment disputes for 2004.  A tenth state, Illinois, also participated in the arbitration, but joined the multi-state settlement after the arbitration panel issued its decisions described below.  Hearings for <ix:nonFraction unitRef="state" contextRef="i308b4161cd2a4761bbf2bbbea9a5b94d_D20200101-20201231" decimals="INF" name="mo:LossContingencyNumberOfStatesWithConcludedHearings" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTYyNDA_c3051cf3-181c-4224-83c0-65980ebdd789">nine</ix:nonFraction> of the <ix:nonFraction unitRef="state" contextRef="i308b4161cd2a4761bbf2bbbea9a5b94d_D20200101-20201231" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTYyNjc_20c1edf4-2be5-4932-b3d3-3171b13632e5">10</ix:nonFraction> states concluded by the end of 2020.  The arbitration panels issued decisions finding that <ix:nonFraction unitRef="state" contextRef="i6e30d0f16c0e4fffb6403230045d3122_D20220101-20221231" decimals="INF" name="mo:LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTYyNzE_4b383ef3-8f81-4a74-9696-3ae054645cfe">three</ix:nonFraction> states, Missouri, New Mexico and Washington, were not diligent in their enforcement of their escrow statutes in 2004 and, therefore, are subject to the NPM adjustment for 2004.  The arbitration panels further found that the remaining <ix:nonFraction unitRef="state" contextRef="i6e30d0f16c0e4fffb6403230045d3122_D20220101-20221231" decimals="INF" name="mo:LossContingencyNumberOfStatesInComplianceWithEscrowStatues" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTYyNzU_ae83a79a-092d-47d7-8a70-cc0c4df98821">seven</ix:nonFraction> states were diligent in their enforcement and, therefore, are not subject to the NPM adjustment for 2004.  Washington and Missouri have challenged those determinations in their respective state courts and with the arbitration panels, and several issues remain to be resolved by the courts that may affect the final amount of the 2004 NPM adjustment PM USA and other PMs will receive.  PM USA recorded $<ix:nonFraction unitRef="usd" contextRef="ifdda8a2cdb9d4db49e9b2c4177d9a7de_D20210701-20210930" decimals="-6" name="mo:LossContingencyReductionToCostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTYyNzk_f6751872-34da-468e-8585-58e374e99074">21</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i100852d80e724c41bb97050a1799cd82_D20221001-20221231" decimals="-6" name="mo:LossContingencyReductionToCostOfSales" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzQ5NDc4MDI1NTMyMTk_896e202f-70eb-4ad9-8117-b1a94985db31">3</ix:nonFraction> million as a reduction in cost of sales in the third quarter of 2021 and fourth quarter of 2022, respectively, for its estimate of the minimum amount of the 2004 NPM adjustment it will receive.  PM USA estimates it is entitled to interest of approximately $<ix:nonFraction unitRef="usd" contextRef="ia4a2cae32e3e4d64a9d5bfb3d5339a57_D20210701-20210930" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTYyODM_78234710-b4d8-46d1-bbaa-53962964d39d">23</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i57b16d217ed6412e9b51c342626023ec_D20221001-20221231" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzQ5NDc4MDI1NTMyMDQ_2f2d388e-2caf-4726-8577-9fa7e06bc8ba">5</ix:nonFraction> million in connection with the 2004 NPM adjustment, which it recorded as interest income in the third quarter of 2021 and fourth quarter of 2022, respectively.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2005-2007 NPM Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The PMs and the <ix:nonFraction unitRef="state" contextRef="i2ae59e3f662b40c2bd1cc8bfca42f60c_D20220101-20221231" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTc3NTc_f589da05-ee95-4f94-b17a-435e9e32e652">nine</ix:nonFraction> states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes before a single arbitration panel.  The arbitration encompasses <ix:nonNumeric contextRef="ifd6ed63b9bb24769bbb2b79d9903289a_D20220101-20221231" name="mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzYwNDczMTQxNjQyMjE_cba891df-9345-4025-bd0e-9a31227579a6">three years</ix:nonNumeric>, 2005-2007, for <ix:nonFraction unitRef="state" contextRef="ifd6ed63b9bb24769bbb2b79d9903289a_D20220101-20221231" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTc3NzE_d5771178-0582-4228-b3f2-554c6ce078bd">eight</ix:nonFraction> of the <ix:nonFraction unitRef="state" contextRef="i2ae59e3f662b40c2bd1cc8bfca42f60c_D20220101-20221231" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTc3NzU_676ff725-95c2-4ebf-988e-ec0a2ddd0ad9">nine</ix:nonFraction> states, and <ix:nonNumeric contextRef="i9531c54ce48540a0a0550471e1cd3afe_D20220101-20221231" name="mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzYwNDczMTQxNjQyMjI_2fe88029-8ad5-41c2-9a01-c79f46c676ee">one year</ix:nonNumeric>, 2005, for <ix:nonFraction unitRef="state" contextRef="i9531c54ce48540a0a0550471e1cd3afe_D20220101-20221231" decimals="INF" name="mo:LossContingencyNumberOfStatesNotSettled" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTc3ODg_0fd22e16-9cd0-4775-a7c8-a2f166ac6716">one</ix:nonFraction> state.  As of January 27, 2023, no decisions have resulted from the arbitration.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Subsequent Years.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No assurance can be given as to when proceedings for 2008 and subsequent years will be scheduled or the precise form those proceedings will take.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">In July 2022, the State of Iowa filed a motion in Iowa state court against the PMs, including PM USA, claiming that the PMs wrongfully disputed the applicability of NPM Adjustments to Iowa and that all adjustment amounts to date should have been paid to Iowa rather than deposited into the disputed payments account.  A similar enforcement motion was filed by the State of New Mexico against the PMs, including PM USA, in November 2022.  PM USA has placed certain disputed NPM Adjustment amounts attributed to Iowa and New Mexico in the disputed payments account established pursuant to the terms of the MSA.  Iowa and New Mexico seek a total of approximately $<ix:nonFraction unitRef="usd" contextRef="i4b5ad462b1fc42e3875caf97f2673a92_D20220701-20220731" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ2OTE_b9a9c3e1-fa20-4532-b7a7-5a1e01dae923">133</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia8b742921dc34dc6b5591b065363c15b_D20220701-20220731" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0ODEwMDc_0e498933-4ea8-48e1-aca4-956c216ad979">84</ix:nonFraction> million, respectively, in disputed payments from all defendants combined, as well as treble and punitive damages, and other relief.  The PMs filed a cross motion to compel arbitration in the Iowa matter, which was heard in December 2022.  A decision has not yet been issued.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Disputes Under the State Settlement Agreements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds&#8217;s acquisition of Lorillard in 2015 and its related sale of certain cigarette brands to ITG (the &#8220;ITG transferred brands&#8221;).  PM USA filed motions to enforce the State Settlement Agreements in Florida, Minnesota, Texas and Mississippi in connection with various positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  After various court decisions in each of those states that were favorable to PM USA, those motions to enforce have now been resolved either through settlement or exhaustion of appeals, although further proceedings may occur based on the resolution of certain outstanding litigation between R.J. Reynolds and ITG.  In May 2022, PM USA filed a motion to compel arbitration under the MSA regarding certain positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  In June 2022, the matter was resolved through mutual agreement of the parties.  PM USA continues to dispute how the ITG transferred brands are treated in allocating the NPM Adjustments under the MSA and related settlements and may pursue such claims.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the tax rates used in the annual calculation of the net operating profit adjustment payments starting in 2018.  The Mississippi state court held a hearing in October 2021 and issued a decision in June 2022 granting the State&#8217;s motion.  Further proceedings remain outstanding, and a final judgment has not yet been issued.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, PM USA and other PMs reached an agreement with several MSA states to waive the PMs&#8217; claim under the most favored nation provision of the MSA in connection with a settlement between those MSA states and a non-participating manufacturer, S&amp;M Brands, Inc. (&#8220;S&amp;M Brands&#8221;), under which the states released certain claims against S&amp;M Brands in exchange for receiving a portion of the funds S&amp;M Brands deposited into escrow accounts in those states pursuant to the states&#8217; escrow statutes.  In consideration for waiving its most favored nation claim, PM USA received approximately $<ix:nonFraction unitRef="usd" contextRef="i0dedfe3526ab465c89c9b8e67c3357a8_D20210101-20210131" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MDA5ODg_9ee5bfc9-8640-4b82-93af-c38540b13da2">32</ix:nonFraction> million from the escrow funds paid to those MSA states under their settlement with S&amp;M Brands.  These funds were received in January 2021 and were recorded in our condensed consolidated statement of earnings (losses) for the first quarter of 2021 as a reduction in cost of sales.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i307c322dd7b44ac992f924ff3f7b1f9d" continuedAt="idb43648e4f6a49f0898fc5d8efff55af"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Government&#8217;s Lawsuit: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1999, the U.S. government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes.  The case ultimately proceeded only under the civil provisions of RICO.  In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight &#8220;sub-schemes&#8221; to defraud that the government had alleged.  Specifically, the court found that:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants hid from the public that cigarette smoking and nicotine are addictive;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely marketed and promoted &#8220;low tar/light&#8221; cigarettes as less harmful than full-flavor cigarettes;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they intentionally marketed to youth;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants publicly and falsely denied that ETS is hazardous to non-smokers; and </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants suppressed scientific research.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court did not impose monetary penalties on defendants, but ordered the following relief: (i)&#160;an injunction against &#8220;committing any act of racketeering&#8221; relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii)&#160;an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii) an injunction against &#8220;making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;&#8221; (iv) an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including &#8220;lights,&#8221; &#8220;ultra lights&#8221; and &#8220;low tar,&#8221; which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v) the issuance of &#8220;corrective statements&#8221; in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking &#8220;low tar&#8221; or &#8220;light&#8221; cigarettes, defendants&#8217; manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi) the disclosure on defendants&#8217; public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until the third quarter of 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii)&#160;the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of <ix:nonNumeric contextRef="i0121b4c1497c443b91a2dbe5a6049059_D20060801-20060831" name="mo:FederalTradeCommissionDisclosurePeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MTA0Njc_2ceff658-c44c-4492-9729-992bed510066">10</ix:nonNumeric> years; (viii)&#160;certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the United States; and (ix)&#160;payment of the government&#8217;s costs in bringing the action.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties&#8217; proposed consent order implementing corrective statements in newspapers and on television.  The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017.  In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts.  The corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2014, the district court ordered further briefing on corrective statements on point-of-sale signage.  In May 2019, the district court ordered a hearing on the point-of-sale signage issue.  The hearing was subsequently vacated due to the parties reaching an agreement in principle regarding the placement of corrective statements at point-of-sale.  In December 2022, the district court entered a consent order approving the settlement.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we recorded provisions totaling approximately $<ix:nonFraction unitRef="usd" contextRef="i29611429f47b4962bf5216deebdd1a1c_D20220101-20221231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0ODA5ODg_fe318a1e-5bb1-4a22-a4d1-4f32490cbe7f">28</ix:nonFraction> million for the estimated costs of implementing the corrective statements on point-of-sale signage remedy.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the U.S. government filed a motion with the district court asking for clarification as to whether the court-ordered injunction that applies to cigarettes also applies to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a heated tobacco product used with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System.  In August 2020, we filed an opposition to the government&#8217;s motion and, in the alternative, a motion to modify the injunction to make clear it does not apply to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The district court heard arguments on the motions in July 2022 and has not yet issued any decisions.  Regardless of the district court&#8217;s decisions on the pending motions, the government has indicated it will not oppose a modification to the injunction that permits PM USA to use the Modified Risk Tobacco Product claim authorized by the FDA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E-vapor Product Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2023, we are defendants in <ix:nonFraction unitRef="claim" contextRef="ib515c9531f2c406b96d8ed470cbe6eeb_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MTc4ODY_b42e4511-408f-4268-9d3b-47aeb93e1d49">57</ix:nonFraction> class action lawsuits relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.  The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices.  Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.  The <ix:nonFraction unitRef="claim" contextRef="ib515c9531f2c406b96d8ed470cbe6eeb_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MTc4OTA_8bf509b0-0458-4da4-9f04-0722d852dda7">57</ix:nonFraction> class action lawsuits include <ix:nonFraction unitRef="case" contextRef="ife1f1236593440dba4fa286c4568aa13_I20230127" decimals="INF" name="mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MTc4OTQ_7b6a0526-c7f3-42de-ac71-877085453fc2">32</ix:nonFraction> cases involving plaintiffs whose claims were previously included in other class </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="idb43648e4f6a49f0898fc5d8efff55af" continuedAt="i0e4e01c448944f3e91759e1c3c6b9a56"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.  <ix:nonFraction unitRef="claim" contextRef="i40d0f2ac213e404c8089cdf43889f21f_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ2OTY_1730a22f-d5e4-4cb2-91e9-0aef9fd18599">Three</ix:nonFraction> of the class action lawsuits are pending in Canada.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have been named as defendants in other lawsuits involving JUUL e-vapor products, including <ix:nonFraction unitRef="claim" contextRef="i2494dd141e354811b038c1301f7dda49_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MTkyODI_cca2b514-171b-4cf9-88e1-321acfd2b164">3,870</ix:nonFraction> individual lawsuits and <ix:nonFraction unitRef="claim" contextRef="i1be89cf9f8b449fdac3da2c8fca7d5cf_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MTkyODY_096270e6-9e76-4079-b5ae-991c8a36988d">1,406</ix:nonFraction> &#8220;third party&#8221; lawsuits, which include school districts, state and local governments and tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the U.S. Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of the federal individual and class action lawsuits mentioned above in the U.S. District Court for the Northern District of California for pretrial purposes.   In December 2022, JUUL reportedly reached agreements to resolve the Multidistrict Litigation through settlement.  In January 2023, the court preliminarily approved the settlement.  We are not a party to any settlements concerning the Multidistrict Litigation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court has set trial dates for <ix:nonFraction unitRef="case" contextRef="i9e946456b537477688ee4ce352a20446_I20221231" decimals="INF" name="mo:LossContingencyNumberOfCasesWithSetTrialDates" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIwODkwNzIxMTQ1NzQw_4294cafd-94c5-41f6-aaa0-c03cda743923">three</ix:nonFraction> cases pending in the Multidistrict Litigation.  The first trial is currently scheduled for April 2023.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We filed motions to dismiss certain claims in the class action and school district cases, including the federal RICO claim.  In October 2020, the U.S. District Court for the Northern District of California granted the motion to dismiss the RICO class action claim without prejudice.  Although it otherwise denied the motion, the court found that plaintiffs had not sufficiently alleged standing or causation with respect to their claim under California law.  The court also granted the motion to dismiss the RICO claim in the cases filed by various school districts, but denied the motion in all other respects.  The court gave plaintiffs the opportunity to amend their complaints to attempt to cure the deficiencies the court identified and plaintiffs filed their amended complaints in November 2020.  In January 2021, we filed a renewed motion to dismiss the RICO claim, which the court denied in April 2021.  In June 2022, the court granted plaintiffs&#8217; motion to certify a California state class based on state law claims against JUUL and a nationwide class based on RICO claims against Altria and other defendants.  Altria and the other defendants filed petitions with the U.S. Court of Appeals for the Ninth Circuit seeking discretionary review of the class certification order, which the court granted in October 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional group of cases is pending in California state courts.  In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JUUL also is named in a significant number of additional individual and class action lawsuits to which we are not currently named.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="lawsuit" contextRef="i3c7b5b8168e84e9f97ec53935f0e23bc_I20221231" decimals="INF" name="mo:NumberOfThirdPartyLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MjQ1Njg_6501fca1-5b54-4909-9e0a-f0fefeec06a5">Four</ix:nonFraction> of the &#8220;third party&#8221; lawsuits noted above against us and JUUL were initiated, individually, by the attorneys general of Alaska, Hawaii, Minnesota and New Mexico alleging violations of state consumer protection and other similar laws.  We filed motions to dismiss the lawsuits.  In Alaska, Hawaii and Minnesota, the motions were denied in February 2022, May 2021 and June 2021, respectively.  Our motion to dismiss remains pending in New Mexico.  In the Alaska lawsuit, although the trial court declined to dismiss most of the plaintiff&#8217;s claims, the trial court did dismiss plaintiff&#8217;s public nuisance claim.  The trial courts in the Alaska, Hawaii and Minnesota lawsuits have set the trials for April 2024, February 2024 and March 2023, respectively.  As of January 27, 2023, the trial court in New Mexico has not set a trial date.  JUUL is also named in other attorneys general lawsuits in which we are not currently named.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, ALCS, PMI and its affiliate, Philip Morris Products S.A., in the U.S. District Court for the Eastern District of Virginia asserting claims of patent infringement based on the sale of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System electronic device and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States.  Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys&#8217; fees.  Altria and PMI were previously dismissed from the lawsuit, and plaintiffs&#8217; claims against the other defendants have been stayed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA, ALCS and Philip Morris Products S.A. filed counterclaims against plaintiffs in the Eastern District of Virginia lawsuit alleging patent infringement by R.J. Reynolds&#8217; e-vapor products.  In June 2022, PM USA and ALCS reached an agreement with R.J. Reynolds resulting in dismissal of their counterclaims.  In addition, ALCS filed a separate lawsuit against R.J. Reynolds in the U.S. District Court for the Middle District of North Carolina also alleging patent infringement by R.J. Reynolds&#8217; e-vapor products.  In September 2022, a jury awarded ALCS $<ix:nonFraction unitRef="usd" contextRef="i34620bbc337b4ce2b6567ee643c5068f_D20220901-20220930" decimals="-6" name="us-gaap:LossContingencyDamagesAwardedValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ3MDg_b4448f56-435c-49bd-9e92-3e891f5c48e5">95</ix:nonFraction> million in damages for past infringement, plus supplemental damages and interest.  In January 2023, the court ordered R.J. Reynolds to pay ALCS a <ix:nonFraction unitRef="number" contextRef="i07a9a17fedcf4c82a8a6872d1e854c64_I20230131" decimals="4" name="mo:LossContingencyRoyaltyFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzQ5NDc4MDI1NTQ1Nzk_11e8d139-8a15-40be-a6b4-7139e5fe0a25">5.25</ix:nonFraction>% royalty on future sales of its infringing product resulting in positive net income through the expiration of the relevant patents in 2035.  As gains related to this lawsuit have not yet been determined to be realized or realizable in accordance with GAAP, they have not been recognized in our financial statements for the fiscal year ended December 31, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in April 2020, a related patent infringement action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the U.S. International Trade Commission (&#8220;ITC&#8221;), but the remedies sought included a prohibition on the importation of the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System electronic device, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and component parts into the United States and on the sale of any such products previously imported into the United States.  <ix:nonFraction unitRef="usd" contextRef="i9130d99afc484bd7b97086bb83a18185_D20200401-20200430" decimals="INF" name="mo:LossContingencyDamagesRecoverableValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0Mjg5MTQ_6f41fc52-8e0d-439d-940d-5a81b76d0b79">No</ix:nonFraction> damages are recoverable in the proceedings before the ITC.  In September 2021, the ITC issued a limited exclusion order barring the importation of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">System electronic device,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the infringing components into the United States and a cease and desist order barring domestic sales, marketing and distribution of these imported products.  The orders became effective on November 29, 2021.  Consequently, PM USA removed the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">System electronic </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i0e4e01c448944f3e91759e1c3c6b9a56" continuedAt="i47a78fa3d98344d88ba387bab8ca2573"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">device and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from the marketplace.  In December 2021, defendants appealed the orders to the U.S. Court of Appeals for the Federal Circuit and, in January 2022, the court denied defendants&#8217; motion to stay the orders pending the conclusion of the appeal.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional unrelated patent infringement case regarding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System electronic device was filed in November 2020 in the U.S. District Court for the Northern District of Georgia against PM USA and Philip Morris Products S.A. seeking damages and equitable relief.  In February 2021, defendants filed a motion to dismiss the lawsuit, which the court granted in July 2021.  In December 2021, the U.S. District Court denied plaintiff&#8217;s motion to amend the complaint and plaintiff appealed this ruling to the U.S. Court of Appeals for the Federal Circuit, which appeal remains pending.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that our <ix:nonFraction unitRef="number" contextRef="i29da272e87c54a8cbab18821615bf146_I20200430" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MzYwOTY_09b41661-8b95-46f0-b2fd-8caafd35eee7">35</ix:nonFraction>% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (&#8220;Sherman Act&#8221;) and Section 5 of the Federal Trade Commission Act of 1914, and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (&#8220;Clayton Act&#8221;).  If the FTC&#8217;s challenge is successful, the FTC may order a broad range of remedies, including divestiture of our minority investment in JUUL, rescission of the transaction and all associated agreements, a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party&#8217;s board of directors or attending meetings of the other party&#8217;s board of directors and notice to the FTC in advance of certain corporate actions, including acquisitions, mergers or certain corporate restructurings.  In February 2022, the administrative law judge dismissed the FTC&#8217;s complaint and, also in February 2022, FTC complaint counsel appealed the administrative law judge&#8217;s decision to the FTC.  Oral argument with respect to the appeal occurred in September 2022.  After oral argument, the FTC asked for additional briefing, which was completed in December 2022.  Altria can appeal any adverse ruling the FTC issues following its review to any U.S. Court of Appeals.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also as of January 27, 2023, <ix:nonFraction unitRef="lawsuit" contextRef="i49aa85e7288f4015a2cf251ad1ad3d1b_I20230127" decimals="INF" name="mo:LossContingencyClassActionLawsuit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MzYxMDE_c564c2d2-0396-43ea-b34c-459ad59e0ef7">17</ix:nonFraction> putative class action lawsuits have been filed against Altria and JUUL in the U.S. District Court for the Northern District of California.  The lawsuits initially named, in addition to the two companies, certain senior executives and certain members of the board of directors of both companies as defendants; however, those individuals currently or formerly affiliated with Altria were later dismissed.  In November 2020 these lawsuits were consolidated into <ix:nonFraction unitRef="complaint" contextRef="i0d928ac82a174cbf9e654bf008eb8b4f_I20201130" decimals="INF" name="mo:LossContingencyNumberOfComplaints" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MzYxMDk_21e0f7db-e084-4ea5-8de0-c838614fce8f">three</ix:nonFraction> complaints (one on behalf of direct purchasers, one on behalf of indirect purchasers and one on behalf of indirect resellers).  The consolidated lawsuits, as amended, cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1, 2 and/or 3 of the Sherman Act and Section 7 of the Clayton Act and various state antitrust, consumer protection and unjust enrichment laws by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market.  Plaintiffs seek various remedies, including treble damages, attorneys&#8217; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of our minority investment in JUUL and rescission of the transaction.  We filed a motion to dismiss these lawsuits in January 2021.  In August 2021, the U.S. District Court for the Northern District of California denied our motion to dismiss except with respect to plaintiffs&#8217; claims for injunctive and equitable relief.  However, plaintiffs were granted the opportunity to replead such claims by the trial court, which plaintiffs did in September 2021.  In January 2022, the trial court ordered that the direct-purchaser plaintiffs&#8217; claims against JUUL be sent to arbitration pursuant to an arbitration provision in JUUL&#8217;s online purchase agreement.  The court granted plaintiffs&#8217; leave to replead the complaint with new direct-purchaser plaintiffs, which plaintiffs did in February 2022, substituting in <ix:nonFraction unitRef="claim" contextRef="i9fd12ffe6e314078bec64fc03dd0d7cf_D20220201-20220228" decimals="INF" name="us-gaap:LossContingencyNumberOfPlaintiffs" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ3MTM_fc4fc91e-e381-4e8d-a911-49ac32fdaa2d">four</ix:nonFraction> new plaintiffs.  In August 2022, the court stayed all of the cases pending any appeal to the court of appeals from the FTC&#8217;s lawsuit against Altria and JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, we exercised our rights to convert our non-voting JUUL shares to voting shares.  In September 2022, we exercised our option to be released from our JUUL non-competition obligations, resulting in (i) the permanent termination of our non-competition obligations to JUUL, (ii) the loss of our JUUL board designation rights (other than the right to appoint one independent director so long as our ownership continues to be at least <ix:nonFraction unitRef="number" contextRef="ia1ab966a566641208dea895e36c2cfca_I20220930" decimals="2" name="mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ3MTc_fe5c1de0-694d-4099-85e5-8ede649668a6">10</ix:nonFraction>%), our preemptive rights, our consent rights and certain other rights with respect to our investment in JUUL and (iii) the conversion of our JUUL shares to single vote common stock, significantly reducing our voting power.  We do not currently intend to exercise our remaining governance rights or to vote our JUUL shares other than as a passive investor.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Class Action and Shareholder Derivative Lawsuits</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In October and December 2019, <ix:nonFraction unitRef="shareholder" contextRef="ibf8ee6d0a42b48658f65843e7407c4ff_D20191001-20191231" decimals="INF" name="mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDE3OTg_ac666a67-b291-4898-8533-008e7238c4af">two</ix:nonFraction> purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, our former Chairman and Chief Executive Officer, and William F. Gifford, Jr., our former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the U.S. District Court for the Eastern District of New York.  In December 2019, the court consolidated the <ix:nonFraction unitRef="lawsuit" contextRef="ibf8ee6d0a42b48658f65843e7407c4ff_D20191001-20191231" decimals="INF" name="mo:LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzQ5NDc4MDI1NTQ2NjA_6a6cc4ad-c0ee-4a82-9592-3fafb6b37e67">two</ix:nonFraction> lawsuits into a single proceeding.  The consolidated lawsuit was subsequently transferred to the U.S. District Court for the Eastern District of Virginia.  The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act.  In April 2020, JUUL, its founders and some of its current and former executives were added to the lawsuit.  The claims allege false and misleading statements and omissions relating to our investment in JUUL.  Plaintiffs seek various remedies, including damages and attorneys&#8217; fees.  In July 2020, the defendants filed motions to dismiss plaintiffs&#8217; claims, which the district court denied in March 2021.  In the fourth quarter of 2021, plaintiffs and defendants agreed upon a class action settlement under which, among other things, (i) all claims asserted against Altria and the other named defendants are resolved without any liability or wrongdoing attributed to them personally or to Altria and (ii) Altria will pay the class an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="i5714b7cd4a1f4abbba5201ba8cc74bb1_D20211001-20211231" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDE4MDY_05cc7cf9-ce82-4825-8be9-5245cb060ed2">90</ix:nonFraction> million, which amount includes attorneys&#8217; fees.  The class is defined to include persons and entities who purchased or otherwise acquired shares of Altria between </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i47a78fa3d98344d88ba387bab8ca2573" continuedAt="i2cb97a38184749e895625595788c0345"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 25, 2018 through April 2, 2020, subject to certain exclusions.  The trial court granted final approval of the settlement in March 2022.  We recorded pre-tax provisions totaling $<ix:nonFraction unitRef="usd" contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDE4MTA_1d93c8dc-d6aa-44a9-af2e-67762a82ae80">90</ix:nonFraction> million in 2021 and, in January 2022, paid $<ix:nonFraction unitRef="usd" contextRef="idd1d6e0639ad44f8812ae1cf1e390bc8_D20220101-20220131" decimals="-6" name="us-gaap:PaymentsForLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDE4MTQ_366aae3f-1579-4cb4-a4c8-41d7705d0804">90</ix:nonFraction> million to plaintiffs&#8217; escrow account.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal and State Shareholder Derivative Lawsuits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, <ix:nonFraction unitRef="shareholder" contextRef="i37dc803167004d3bbbf661d9a1d012d3_D20200801-20200831" decimals="INF" name="mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDY4OTk_35c10be8-359b-4e19-93d0-05db4893182b">two</ix:nonFraction> purported Altria shareholders filed separate derivative lawsuits in the U.S. District Court for the Northern District of California on behalf of themselves and Altria, against Mr. Willard, Mr. Gifford, JUUL and certain of our executives and officers.  These derivative lawsuits relate to our investment in JUUL, and assert claims of breach of fiduciary duty by the Altria defendants and aiding and abetting in that alleged breach of fiduciary duty by the remaining defendants.  In March 2021, the U.S. District Court for the Northern District of California granted defendants&#8217; motion to transfer both lawsuits to the U.S. District Court for the Eastern District of Virginia.  <ix:nonFraction unitRef="shareholder" contextRef="ibeb9e2bf525e43c0844f2e9fb73929c9_D20201001-20210331" decimals="INF" name="mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDY5MDM_9d0a7f19-f9df-43e6-afe5-5aeb4ff0579e">Three</ix:nonFraction> additional federal derivative lawsuits were filed in October 2020, January 2021 and March 2021, respectively, in the U.S. District Court for the Eastern District of Virginia against Mr. Willard, Mr. Gifford, Mr. Crosthwaite, certain members of our Board of Directors, JUUL, its founders and some of its current and former executives.  These suits assert various claims, including breach of fiduciary duty, unjust enrichment, waste of corporate assets and violations of certain federal securities laws.  The remedies sought in these lawsuits include damages, disgorgement of profits, reformation of our corporate governance and internal procedures, and attorneys&#8217; fees.  In April 2021, the court consolidated the <ix:nonFraction unitRef="claim" contextRef="i9899ddfb78b54d8ea14e76f8bf786983_D20210401-20210430" decimals="INF" name="mo:LossContingencyNumberOfPendingCasesConsolidated" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDY5MDc_13e50659-6022-47ed-a127-e7927146fdee">five</ix:nonFraction> cases pending in the Eastern District of Virginia into a single case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shareholder" contextRef="i8e0525ef8d214791974c2ec1841b3475_D20200901-20210831" decimals="INF" name="mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDg0NDc_793e45be-2779-44ea-b042-f0532e85c066">Six</ix:nonFraction> derivative lawsuits have been filed in Virginia state courts against Mr. Willard, Mr. Gifford, Mr. Crosthwaite (our former Chief Growth Officer and JUUL&#8217;s current Chief Executive Officer), certain members of our Board of Directors, JUUL, its founders and some of its current and former executives.  The lawsuits were filed in September 2020, May 2021, June 2021, July 2021, August 2021 and August 2021, respectively.  The lawsuits assert various claims, including breach of fiduciary duty, and seek remedies similar to those sought by plaintiffs in the cases pending in federal court in the Eastern District of Virginia.  In successive orders from July 2021, September 2021 and January 2022, <ix:nonFraction unitRef="contract" contextRef="id4bcc98934df473da5c7057ee93151ab_D20210701-20220131" decimals="INF" name="mo:LossContingencyNumberOfPendingCasesConsolidated" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzQ5NDc4MDI1NTQ1ODg_ce0efc3b-ed27-44ed-8fa1-05f5d0b70a22">five</ix:nonFraction> of the <ix:nonFraction unitRef="shareholder" contextRef="i8e0525ef8d214791974c2ec1841b3475_D20200901-20210831" decimals="INF" name="mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ3MjE_7387295e-de8d-40b8-aefa-555ebbc4b333">six</ix:nonFraction> state derivative cases were consolidated into a single case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, plaintiffs and defendants in all the federal and state derivative cases agreed upon a settlement of these cases.  Under the terms of the settlement, among other things, we agreed to fund underage tobacco prevention and cessation programs, which may include positive youth development programs, led by independent third-party organizations.  In the second and third quarters of 2022, we recorded pre-tax provisions of $<ix:nonFraction unitRef="usd" contextRef="i4e17d631770e4e10909a4da8d0cf445c_D20220401-20220630" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIwODkwNzIxMTU1MjMz_2ab69480-77fd-4874-91eb-977731ad3856">7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i308dd7b8074947108716f905d87a8f98_D20220701-20220930" decimals="-6" name="us-gaap:LossContingencyAccrualProvision" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIwODkwNzIxMTU1MjQx_e33e160b-0146-49a5-9038-f8b0bee21ea6">20</ix:nonFraction> million, respectively, for costs associated with the independent monitoring of our funding commitments and attorneys&#8217; fees.  In January 2023, the federal trial court conducted a final approval hearing, at which the court sustained an objection to a provision of the settlement, but granted the parties additional time to resolve the issue, and scheduled a second final approval hearing for February 2023.  </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Other Tobacco-Related Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lights/Ultra Lights&#8221; Cases and Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms &#8220;Lights&#8221; and/or &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages.  These class actions have been brought against PM USA and, in certain instances, Altria or our other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes.  Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment.  Twenty-one state courts in <ix:nonFraction unitRef="case" contextRef="i3ae0d3b51df54bbe8b1959b343c21c55_I20230127" decimals="INF" name="mo:LossContingencyClaimsNotCertifiedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTE3MjE_b9b7ae22-71b3-454d-b4a2-c1ffeefa5272">23</ix:nonFraction> &#8220;Lights&#8221; cases have refused to certify class actions, dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA.  As of January 27, 2023, <ix:nonFraction unitRef="court" contextRef="i3ae0d3b51df54bbe8b1959b343c21c55_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTE3MjU_4e4f9303-ddd1-4654-80f0-b70eeab1eeed">two</ix:nonFraction> &#8220;Lights/Ultra Lights&#8221; class actions are pending in U.S. state courts.  Neither case is active.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2023, <ix:nonFraction unitRef="claim" contextRef="i00d5a42df39d4763984da38514c7252f_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTE3Mjk_68038c63-f1c9-4e27-b678-d9bb034b4030">one</ix:nonFraction> smoking and health case alleging personal injury or seeking court-supervised programs or an ongoing medical monitoring program on behalf of individuals exposed to environmental tobacco smoke and purporting to be brought on behalf of a class of individual plaintiffs, is pending in a U.S. state court.  The case is currently inactive.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UST Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time.  Plaintiffs&#8217; allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.  Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement.  Defenses raised in these cases have included lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations.  As of January 27, 2023, there is <ix:nonFraction unitRef="contract" contextRef="i0a6cd34d91d14705933337c9bba7c38c_I20230127" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTMzMjI_c0765a3d-c3bb-4f83-9a7a-eeed7e65e329">no</ix:nonFraction> such case pending against UST and/or its tobacco subsidiaries.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Regulation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and our former subsidiaries are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the United States: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#8220;Superfund&#8221;), which can impose joint and several liability on each responsible party.  Altria and our former subsidiaries are involved in several cost recovery/contribution cases subjecting them to potential costs of remediation and natural </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><ix:continuation id="i2cb97a38184749e895625595788c0345"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resource damages under Superfund or other laws and regulations.  We expect to continue to make capital and other expenditures in connection with environmental laws and regulations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that we may undertake in the future.  In the opinion of our management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on our consolidated results of operations, capital expenditures, financial position or cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees and Other Similar Matters</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we have agreed to indemnify a limited number of third parties in the event of future litigation.  At December&#160;31, 2022, we (i) had $<ix:nonFraction unitRef="usd" contextRef="i5809327a200e4dd292baa4729e1d7e5a_I20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTkzNjA_2b099e16-69ef-4f21-9ffe-8197ff2aa6b8">46</ix:nonFraction> million of unused letters of credit obtained in the ordinary course of business and (ii) were contingently liable for guarantees related to our own performance, including $<ix:nonFraction unitRef="usd" contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231" decimals="-6" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTkzNjQ_40b789f1-18f3-4feb-9e68-2818fed24f12">19</ix:nonFraction> million for surety bonds recorded on our consolidated balance sheet.  In addition, from time to time, we issue lines of credit to affiliated entities.  These items have not had, and are not expected to have, a significant impact on our liquidity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of a distribution agreement between Altria and PMI (the &#8220;Distribution Agreement&#8221;), entered into as a result of our 2008 spin-off of our former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer.  PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.  We do not have a related liability recorded on our consolidated balance sheet at December&#160;31, 2022 as the fair value of this indemnification is insignificant.  PMI has agreed not to seek indemnification with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System patent litigation discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Litigation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excluding the patent infringement case filed with the U.S. District Court for the Northern District of Georgia.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA has issued guarantees relating to our obligations under our outstanding debt securities, borrowings under our $<ix:nonFraction unitRef="usd" contextRef="i19c2fc24e57144deb2090322db5badc1_I20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTkzODA_f8c4773a-17af-4eaf-9989-41b6345d6b31">3.0</ix:nonFraction> billion Credit Agreement and amounts outstanding under our commercial paper program.  For further discussion, see Note 8. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt.</span></div></ix:continuation><div style="margin-bottom:5pt"><span><br/></span></div><div style="margin-bottom:5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_193"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Stockholders of Altria Group, Inc.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Altria Group, Inc. and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, and the related consolidated statements of earnings, comprehensive earnings, stockholders&#8217; equity (deficit) and cash flows for each of the three years in the period ended December 31, 2022, including the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;).  We also have audited the Company&#8217;s internal control over financial reporting as of December 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;).</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2022 in conformity with accounting principles generally accepted in the United States of America.  Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control - Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2013) issued by the COSO.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinions</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Report of Management On Internal Control Over Financial Reporting.  Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company&#8217;s internal control over financial reporting based on our audits.  We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB.  Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks.  Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements.  Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.  Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk.  Our audits also included performing such other procedures as we considered necessary in the circumstances.  We believe that our audits provide a reasonable basis for our opinions.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.  A company&#8217;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are matters</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments.  The communication of critical audit matters does not alter in any way our opinion on the consolidated</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">financial statements, taken as a whole, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tobacco and Health Litigation Provisions and Disclosures</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 17 to the consolidated financial statements, legal proceedings covering a wide range of matters are pending or threatened in various U.S. and foreign jurisdictions against the Company as well as its respective indemnitees and investees.  The Company records provisions in the consolidated financial statements for pending litigation when management determines that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  The Company&#8217;s most significant category of legal proceedings is tobacco and health litigation.  The Company&#8217;s accrued liability for tobacco and health litigation was $44 million as of December 31, 2022.  While it is reasonably possible that an unfavorable outcome in a case may occur, except for those cases which have been accrued for: (i) management has concluded that it is not probable that a loss has been incurred in any of the pending tobacco and health related cases; (ii) management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending tobacco and health related cases; and (iii) accordingly, management has not provided any amounts in the consolidated financial statements for unfavorable outcomes, if any.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal considerations for our determination that performing procedures relating to tobacco and health litigation provisions and disclosures is a critical audit matter are (i) the significant judgment by management when determining if a loss for tobacco and health litigation should be recorded in the consolidated financial statements, which in turn led to a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating audit evidence related to management&#8217;s determination of whether a loss should be recorded; and (ii) the significant judgment by management when disclosing facts and circumstances related to the litigation, which in turn led to a high degree of auditor judgment, subjectivity, and effort in performing procedures related to the disclosures, including evaluating the audit evidence obtained related to management&#8217;s disclosures.</span></div><div style="margin-bottom:8pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements.  These procedures included testing the effectiveness of controls relating to management&#8217;s loss determination for tobacco and health litigation matters and controls over the related financial statement disclosures.  These procedures also included, among others, (i) evaluating the completeness of the Company&#8217;s description of tobacco and health litigation matters; (ii) confirming with external and internal legal counsel the likelihood of an unfavorable outcome and the extent to which a loss is estimable; (iii) evaluating the reasonableness of management&#8217;s determination regarding the likelihood of an unfavorable outcome; and (iv) evaluating the sufficiency of the Company&#8217;s tobacco and health litigation disclosures.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">JUUL Labs, Inc. (&#8220;JUUL&#8221;) - Determination of the Fair Value of the Investment</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Notes 2 and 5 to the consolidated financial statements, as of December 31, 2022, the Company accounts for its investment in JUUL as an investment in an equity security measured at fair value.  The Company&#8217;s investment in JUUL was $250 million as of December 31, 2022.  Fair value is estimated by management using an income approach, which reflects the discounting of future cash flows for the U.S. and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.  In determining the estimated fair value of the Company&#8217;s investment in JUUL, management has made various judgments, estimates and assumptions, the most significant of which were likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining the significant assumptions, management has made judgments regarding the: (i) likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the U.S. Food and Drug Administration (&#8220;FDA&#8221;) will ultimately authorize JUUL&#8217;s products, which have received marketing denial orders and are now under additional administrative review; (ii) likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, the absence of which could result in JUUL seeking protection under bankruptcy or other insolvency laws; (iii) risk created by the number and types of legal cases pending against JUUL; (iv) expectations for the future state of the e-vapor category including competitive dynamics; and (v) timing of international expansion plans.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal considerations for our determination that performing procedures relating to the determination of the fair value of the investment in JUUL is a critical audit matter are the (i) significant judgment by management when determining the fair value of the investment in JUUL; (ii) a high degree of auditor judgment, subjectivity and effort in performing procedures to evaluate management&#8217;s significant judgments and assumptions related to discount rates, the likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#8217;s products, the likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, and the risk created by the number and types of legal cases pending against JUUL; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.</span></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements.  These procedures included testing the effectiveness of controls relating to the determination of the fair value of the investment in JUUL, including controls over the Company&#8217;s methods, significant assumptions and data.  These procedures also included, among others, (i) testing management&#8217;s process for determining the fair value of the investment in JUUL; (ii) evaluating the appropriateness of the income approach; (iii) testing the completeness and accuracy of underlying data used in the income </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approach; and (iv) evaluating management&#8217;s significant judgments and assumptions related to discount rates, the likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#8217;s products, the likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, and the risk created by the number and types of legal cases pending against JUUL.  Evaluating management&#8217;s significant judgments and assumptions related to the risk created by the number and types of legal cases pending against JUUL; the reasonableness of the range of scenarios that consider potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#8217;s products; and the likelihood of JUUL maintaining adequate liquidity to fund projected cash needs involved evaluating whether management&#8217;s assumptions and judgments were reasonable based on current market information regarding regulatory and litigation matters affecting JUUL and the e-vapor category.  Professionals with specialized skill and knowledge were used to assist in evaluating the appropriateness of the Company&#8217;s income approach and the reasonableness of the discount rate assumptions.</span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal Trademark Impairment Assessment</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Notes 2 and 4 to the consolidated financial statements, the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark had a carrying value of $3.9 billion as of December 31, 2022.  Management conducts an annual review of indefinite-lived intangible assets for potential impairment, and more frequently if an event occurs or circumstances change that would require management to perform an interim review.  During 2022, management&#8217;s annual impairment test of indefinite-lived intangible assets resulted in no impairment charges.  As disclosed by management, the Company uses an income approach to estimate the fair values of its indefinite-lived intangible assets.  The income approach reflects the discounting of expected future cash flows to their present value at a rate of return that incorporates the risk-free rate for use of those funds, the expected rate of inflation and the risks associated with realizing expected future cash flows.  In performing the discounted cash flow analysis, management included significant judgments and assumptions related to volume, operating margins, income, discount rate, and growth rates.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal considerations for our determination that performing procedures relating to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark impairment assessment is a critical audit matter are (i) the significant judgment by management when developing the fair value estimate of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark; (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating management&#8217;s significant assumptions related to income and the discount rate; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements.  These procedures included testing the effectiveness of controls relating to management&#8217;s indefinite-lived intangible asset impairment assessments, including controls over the valuation of the Company&#8217;s </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark.  These procedures also included, among others (i) testing management&#8217;s process for developing the fair value estimate of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark; (ii) evaluating the appropriateness of the income approach; (iii) testing the completeness and accuracy of underlying data used in the income approach; and (iv) evaluating the reasonableness of the significant assumptions used by management related to income and the discount rate.  Evaluating management&#8217;s assumption related to income involved evaluating whether the assumptions used by management were reasonable considering (i) the current and past performance of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand; (ii) the consistency with external market and industry data; and (iii) whether these assumptions were consistent with evidence obtained in other areas of the audit.  Professionals with specialized skill and knowledge were used to assist in evaluating the appropriateness of the Company&#8217;s income approach and the reasonableness of the discount rate assumption.</span></div><div style="margin-top:5pt"><span><br/></span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">/s/ <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xOTMvZnJhZzoyOTcxZGRlZWQ2ZTY0ZGYzOTlmZDQxZTdmMDZiMTVlNi90ZXh0cmVnaW9uOjI5NzFkZGVlZDZlNjRkZjM5OWZkNDFlN2YwNmIxNWU2XzE2NjU5_8472f1a7-b56f-481d-bcda-686ff657238e">PricewaterhouseCoopers LLP</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xOTMvZnJhZzoyOTcxZGRlZWQ2ZTY0ZGYzOTlmZDQxZTdmMDZiMTVlNi90ZXh0cmVnaW9uOjI5NzFkZGVlZDZlNjRkZjM5OWZkNDFlN2YwNmIxNWU2XzE2NjYx_d1aa9f8c-31e1-4fb3-928b-1497c8f1b4b8">Richmond, Virginia</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 1, 2023</span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since at least 1934, which is when the Company became subject to SEC reporting requirements.  We have not been able to determine the specific year we began serving as auditor of the Company.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_196"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Report of Management On Internal Control Over Financial Reporting</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:60.519%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:2pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management of Altria Group, Inc. is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended.  Altria Group, Inc.&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States of America.  Internal control over financial reporting includes those written policies and procedures that:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:6pt;font-weight:400;line-height:120%">n</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of Altria Group, Inc.;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:6pt;font-weight:400;line-height:120%">n</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:6pt;font-weight:400;line-height:120%">n</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide reasonable assurance that receipts and expenditures of Altria Group, Inc. are being made only in accordance with the authorization of management and directors of Altria Group, Inc.; and</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:6pt;font-weight:400;line-height:120%">n</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the consolidated financial statements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal control over financial reporting includes the controls themselves, monitoring and internal auditing practices and actions taken to correct deficiencies as identified.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements.  Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management assessed the effectiveness of Altria Group, Inc.&#8217;s internal control over financial reporting as of December 31, 2022.  Management based this assessment on criteria for effective internal control over financial reporting described in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;).  Management&#8217;s assessment included an evaluation of the design of Altria Group, Inc.&#8217;s internal control over financial reporting and testing of the operational effectiveness of its internal control over financial reporting.  Management reviewed the results of its assessment with the Audit Committee of Altria Group, Inc.&#8217;s Board of Directors.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this assessment, management determined that, as of December 31, 2022, Altria Group, Inc. maintained effective internal control over financial reporting.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PricewaterhouseCoopers LLP, an independent registered public accounting firm, who audited and reported on the consolidated financial statements of Altria Group, Inc. included in this report, has audited the effectiveness of Altria Group, Inc.&#8217;s internal control over financial reporting as of December&#160;31, 2022, as stated in their report herein.</span></div><div style="margin-top:14pt"><span><br/></span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 1, 2023</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_199"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 9.  Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i15062ca98227434086141b426450a5cb_202"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 9A.  Controls and Procedures.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We carried out an evaluation, with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this Form 10-K.  Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Report of Independent Registered Public Accounting Firm and the Report of Management on Internal Control over Financial Reporting are included in Item 8.</span></div><div id="i15062ca98227434086141b426450a5cb_205"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 9B.  Other Information.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;None.</span></div><div id="i15062ca98227434086141b426450a5cb_208"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 9C.  Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i15062ca98227434086141b426450a5cb_211"></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;text-decoration:underline">Part III</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for the information relating to the executive officers set forth in Item&#160;10, the information called for by Items&#160;10-14 is hereby incorporated by reference to our definitive proxy statement for use in connection with our Annual Meeting of Shareholders to be held on May 18, 2023 that is expected to be filed with the SEC on or about April 6, 2023 (&#8220;proxy statement&#8221;), and, except as indicated therein, made a part hereof.</span></div><div id="i15062ca98227434086141b426450a5cb_214"></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 10.  Directors, Executive Officers and Corporate Governance.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Board and Governance Matters - Proposal 1 - Election of Directors&#8221; and &#8220;Board and Governance Matters - Board and Committee Governance&#8221; sections of the proxy statement.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Information about Our Executive Officers as of February&#160;15, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.956%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Office</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Age</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jody L. Begley</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Operating Officer</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel J. Bryant</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President and Treasurer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Steven D&#8217;Ambrosia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President and Controller</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Murray R. Garnick</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and General Counsel</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William F. Gifford, Jr.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salvatore Mancuso</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heather A. Newman</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Strategy &amp; Growth Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">W. Hildebrandt Surgner, Jr. </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Corporate Secretary and Associate General Counsel</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charles N. Whitaker</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Human Resources Officer and Chief Compliance Officer</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</span></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the above-mentioned executive officers have been employed by Altria or our subsidiaries in various capacities during the past five years.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Whitaker&#8217;s wife and Mr. Surgner&#8217;s wife are first cousins.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Codes of Conduct and Corporate Governance</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted the Altria Code of Conduct for Compliance and Integrity, which complies with requirements set forth in Item&#160;406 of Regulation&#160;S-K.  This Code of Conduct applies to all of our employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, and persons performing similar functions.  We have also adopted a code of business conduct and ethics that applies to the members of our Board of Directors.  These documents are available free of charge on our website at www.altria.com.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any waiver granted by us to our principal executive officer, principal financial officer or controller under the Code of Conduct, and certain amendments to the Code of Conduct, will be disclosed on our website at www.altria.com within the time period required by applicable rules.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have adopted corporate governance guidelines and charters for our Audit, Compensation and Nominating, Corporate Governance and Social Responsibility Committees and the other committees of our Board of Directors.  All of these documents are available free of charge on our website at www.altria.com.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information on our websites is not, and shall not be deemed to be, a part of this Form 10-K or incorporated into any other filings we make with the SEC.</span></div><div id="i15062ca98227434086141b426450a5cb_217"></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 11.  Executive Compensation.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Executive Compensation,&#8221; and &#8220;Board and Governance Matters - Director Compensation&#8221; sections of our proxy statement.</span></div><div id="i15062ca98227434086141b426450a5cb_220"></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares to be issued upon exercise or vesting and the number of shares remaining available for future issuance under our equity compensation plans at December 31, 2022, were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.801%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.801%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.803%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160;Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">to&#160;be&#160;Issued&#160;upon</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise&#160;of&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options&#160;and Vesting&#160;of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Deferred&#160;Stock </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number&#160;of&#160;Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remaining Available for</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Future Issuance Under Equity&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plans </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)&#160;</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity compensation plans approved by shareholders </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;4,075,093 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$&#8212;</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:0.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;22,623,041 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Our shareholders have approved the following plans, shares of which are referenced in column (a) or column (c): the 2015 Performance Incentive Plan, the 2020 Performance Incentive Plan and the 2015 Stock Compensation Plan for Non-Employee Directors.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Represents 3,257,795 shares of restricted stock units and 817,298 shares that may be issued upon vesting of performance stock units if maximum performance measures are achieved.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:2.2pt">Includes 21,972,920 shares available under the 2020 Performance Incentive Plan and 650,121 shares available under the 2015 Stock Compensation Plan for Non-Employee Directors, and excludes shares reflected in column (a).</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Ownership of Equity Securities of Altria - Directors and Executive Officers&#8221; and &#8220;Ownership of Equity Securities of Altria - Certain Other Beneficial Owners&#8221; sections of our proxy statement.</span></div><div id="i15062ca98227434086141b426450a5cb_223"></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 13.  Certain Relationships and Related Transactions, and Director Independence.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Related Person Transactions, Director Code and Code of Conduct&#8221; and &#8220;Board and Governance Matters - Altria Board of Directors - Director Independence Determinations&#8221; sections of our proxy statement.</span></div><div id="i15062ca98227434086141b426450a5cb_226"></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 14.  Principal Accounting Fees and Services.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Audit Committee Matters - Independent Registered Public Accounting Firm&#8217;s Fees&#8221; and &#8220;Audit Committee Matters - Pre-Approval Policy&#8221; sections of our proxy statement.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_229"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;text-decoration:underline">Part IV</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 15.  Exhibits and Financial Statement Schedules.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Index to Consolidated Financial Statements</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.605%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Balance Sheets at December 31, 2022 and 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_79">48</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Earnings for the years ended December 31, 2022, 2021 and 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_85">50</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Comprehensive Earnings for the years ended December 31, 2022, 2021 and 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_88">51</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows for the years ended December 31, 2022, 2021 and 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_91">52</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated Statements of Stockholders&#8217; Equity (Deficit) for the years ended December 31, 2022, 2021 and 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_94">54</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_97">55</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm (PCAOB ID <ix:nonNumeric contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8yMjkvZnJhZzo1MDgyZmU1YWZlMTA0NjE2OWM3Nzg3NzkzOWE3NmUwNS90YWJsZTowMTA4NjhkMjQ5ZDE0ZjY0YTk2ZTRmZmI0NmRlMDBlYS90YWJsZXJhbmdlOjAxMDg2OGQyNDlkMTRmNjRhOTZlNGZmYjQ2ZGUwMGVhXzEzLTAtMS0xLTE4NDQ2OS90ZXh0cmVnaW9uOjYyM2QxZjI4M2FlOTRlZDU4OTA4YWQxZDgwZDU5MzFiXzcw_f6dfff66-6e5e-4081-b428-35b539e87494">238</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_193">99</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Report of Management on Internal Control Over Financial Reporting</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_196">102</a></span></div></td></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedules have been omitted either because such schedules are not required or are not applicable.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Regulation S-X Rule 3-09, the audited financial statements of ABI for the year ended December 31, 2022 will be filed by amendment within six months after ABI&#8217;s year ended December 31, 2022.</span></div><div id="i15062ca98227434086141b426450a5cb_232"></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  The following exhibits are filed as part of this Form 10-K: </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:549.00pt"><tr><td style="width:1.0pt"></td><td style="width:9.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:481.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312507017014/dex21.htm">Distribution Agreement by and between Altria Group, Inc. and Kraft Foods Inc. (now known as Mondel&#275;z International, Inc.), dated as of January 31, 2007.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on January 31, 2007 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312508015121/dex21.htm">Distribution Agreement by and between Altria Group, Inc. and Philip Morris International Inc., dated as of January 30, 2008.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on January 30, 2008 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000095011703001167/ex3-1.htm">Articles of Amendment to the Restated Articles of Incorporation of Altria Group, Inc. and Restated Articles of Incorporation of Altria Group, Inc.  Incorporated by reference to Altria Group, Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2002 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418022000100/exhibit31q32022-amendedres.htm">Amended and Restated By-Laws of Altria Group, Inc. (effective as of October 26, 2022).  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on October 27, 2022 (File No. 1-08940)</a></span><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit41descriptionofregi.htm">Description of Altria Group, Inc.&#8217;s Registered Securities.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture between Altria Group, Inc. and The Bank of New York (as successor in interest to JPMorgan Chase Bank, formerly known as The Chase Manhattan Bank), as Trustee, dated as of December 2, 1996.  Incorporated by reference to Altria Group, Inc.&#8217;s Registration Statement on Form S-3/A filed on January 29, 1998 (No. 333-35143).</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:45pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312508032447/dex41.htm">First Supplemental Indenture to Indenture, dated as of December 2, 1996, between Altria Group, Inc. and The Bank of New York (as successor in interest to JPMorgan Chase Bank, formerly known as The Chase Manhattan Bank), as Trustee, dated as of February 13, 2008.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on February 15, 2008 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312508224082/dex45.htm">Indenture among Altria Group, Inc., as Issuer, Philip Morris USA Inc., as Guarantor, and Deutsche Bank Trust Company Americas, as Trustee, dated as of November 4, 2008.  Incorporated by reference to Altria Group, Inc.&#8217;s Registration Statement on Form S-3 filed on November 4, 2008 (No. 333-155009).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312518234104/d572226dex101.htm">5-Year Revolving Credit Agreement, dated as of August 1, 2018, among Altria Group, Inc., the lenders named therein and JPMorgan Chase Bank, N.A. and Citibank, N.A., as administrative agents.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on August 1, 2018 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:549.00pt"><tr><td style="width:1.0pt"></td><td style="width:9.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:481.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312519023405/d699612dex101.htm">Amendment No. 1 to the Credit Agreement, dated January 25, 2019, among Altria Group, Inc. the Lenders and JPMorgan Chase Bank, N.A. and Citibank, N.A. as administrative agents.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on January 31, 2019 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312521250405/d178833dex101.htm">Extension and Amendment No. 2 to the Credit Agreement, effective August 18, 2021, among Altria Group, Inc., the lenders party thereto and JPMorgan Chase Bank, N.A. and Citibank, N.A., as administrative agents.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on August 18, 2021 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312522223264/d333359dex101.htm">Extension and Amendment No. 3 to the Credit Agreement, effective August 17, 2022, among Altria Group, Inc., the lenders party thereto and JPMorgan Chase Bank, N.A. and Citibank, N.A., as administrative agents.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on August 17, 2022 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Registrant agrees to furnish copies of any instruments defining the rights of holders of long-term debt of the Registrant and its consolidated subsidiaries that does not exceed 10 percent of the total assets of the Registrant and its consolidated subsidiaries to the Commission upon request.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Settlement Agreement and Release related to settlement of Mississippi health care cost recovery action, dated as of October 17, 1997.  Incorporated by reference to Altria Group, Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 1997 (File No. 1-08940).</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement Agreement related to settlement of Florida health care cost recovery action, dated August 25, 1997.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on September 3, 1997 (File No. 1-08940).</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive Settlement Agreement and Release related to settlement of Texas health care cost recovery action, dated as of January 16, 1998.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on January 28, 1998 (File No. 1-08940).</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement Agreement and Stipulation for Entry of Judgment regarding the claims of the State of Minnesota, dated as of May 8, 1998.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 1998 (File No. 1-08940).</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement Agreement and Release regarding the claims of Blue Cross and Blue Shield of Minnesota, dated as of May 8, 1998.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 1998 (File No. 1-08940).</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stipulation of Amendment to Settlement Agreement and For Entry of Agreed Order regarding the settlement of the Mississippi health care cost recovery action, dated as of July 2, 1998.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended June 30, 1998 (File No. 1-08940).</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stipulation of Amendment to Settlement Agreement and For Entry of Consent Decree regarding the settlement of the Texas health care cost recovery action, dated as of July 24, 1998.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended June 30, 1998 (File No. 1-08940).</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stipulation of Amendment to Settlement Agreement and For Entry of Consent Decree regarding the settlement of the Florida health care cost recovery action, dated as of September 11, 1998.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended September 30, 1998 (File No. 1-08940).</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Master Settlement Agreement relating to state health care cost recovery and other claims, dated as of November 23, 1998.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on November 25, 1998, as amended by Form 8-K/A filed on December 24, 1998 (File No. 1-08940).</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000095013001501352/dex992.txt">Stipulation and Agreed Order Regarding Stay of Execution Pending Review and Related Matters, dated as of May 7, 2001.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on May 8, 2001 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:45pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418012000037/exhibit101termsheet.htm">Term Sheet effective December 17, 2012, between Philip Morris USA Inc., the other participating manufacturers, and various states and territories for settlement of the 2003 - 2012 Non-Participating Manufacturer Adjustment with those states.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on December 18, 2012 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312508069389/dex104.htm">Intellectual Property Agreement by and between Philip Morris International Inc. and Philip Morris USA Inc., dated as of January 1, 2008.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on March 28, 2008 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:45pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312518234104/d572226dex102.htm">Guarantee made by Philip Morris USA Inc. in favor of the lenders party to the 5-Year Revolving Credit Agreement, dated as of August 1, 2018, among Altria Group, Inc., the lenders named therein and JPMorgan Chase Bank, N.A. and Citibank, N.A., as administrative agents, dated as of August 1, 2018.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on August 1, 2018 (File No. 1-08940).</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:549.00pt"><tr><td style="width:1.0pt"></td><td style="width:9.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:481.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418015000022/exhibit1019benefitequaliza.htm">Benefit Equalization Plan, effective September 2, 1974, as amended. Incorporated by reference to Altria Group, Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2014 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418016000143/exhibit102amendmenttobenif.htm">Amendment to Benefit Equalization Plan, effective March 31, 2016.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2016 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418017000028/exhibit1021actionbyplanadm.htm">Amendment to Benefit Equalization Plan, effective January 1, 2016 and October 1, 2016.  Incorporated by reference to Altria Group, Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2016 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418019000023/exhibit1021bepplan.htm">Amendment to Benefit Equalization Plan, effective January 1, 2019.  Incorporated by reference to Altria Group, Inc.&#8217;s Annual Report on Form 10-K for year ended December 31, 2018 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Employee Grantor Trust Enrollment Agreement.  Incorporated by reference to Altria Group, Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 1995 (File No. 1-08940).*</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312509160822/dex101.htm">Long-Term Disability Benefit Equalization Plan, effective as of January 1, 1989, as amended.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended June 30, 2009 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:33pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418016000128/exhibit1027deferredfeeplan.htm">Deferred Fee Plan for Non-Employee Directors, as amended and restated effective October 28, 2015.  Incorporated by reference to Altria Group, Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2015 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418022000102/exhibit101q32022-quarter.htm">2015 Stock Compensation Plan for Non-Employee Directors, as amended and restated effective October 26, 2022.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended September 30, 2022 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312515123580/d871366ddef14a.htm#toc871366_72">2015 Performance Incentive Plan, effective on May 1, 2015.  Incorporated by reference to Altria Group, Inc.&#8217;s definitive proxy statement on Schedule 14A filed on April 9, 2015 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000120677420001025/mo3601841-def14a.htm#Exhibit_A">2020 Performance Incentive Plan.  Incorporated by reference to Exhibit A to Altria Group, Inc.'s Definitive Proxy Statement on Schedule 14A filed on April 2, 2020, as amended by Altria Group, Inc.'s Supplement to Proxy Statement on Schedule 14A filed on April 17, 2020 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000119312506218057/dex101.htm">Form of Indemnity Agreement.  Incorporated by reference to Altria Group, Inc.&#8217;s Current Report on Form 8-K filed on October 30, 2006 (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418018000038/exhibit101formofrestricted.htm">Form of Restricted Stock Unit Agreement, dated as of January 30, 2018.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2018 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418018000038/exhibit102formofperformanc.htm">Form of Performance Stock Unit Agreement, dated as of January 30, 2018.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2018 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418019000037/exhibit103formofrestri.htm">Form of Restricted Stock Unit Agreement, dated as of February 26, 2019.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2019 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418019000037/exhibit104formofperfor.htm">Form of Performance Stock Unit Agreement, dated as of February 26, 2019.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2019 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418020000048/exhibit101restrictedst.htm">Form of Restricted Stock Unit Agreement (2020).  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2020 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418020000048/exhibit102performacest.htm">Form of Performance Stock Unit Agreement (2020).  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2020 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418021000065/exhibit102restrictedstock2.htm">Form of Restricted Stock Unit Agreement (2021).  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2021 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000764180/000076418021000065/exhibit103performancestock.htm">Form of Performance Stock Unit Agreement (2021).  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2021 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418022000044/exhibit101restrictedstock2.htm">Form of Restricted Stock Unit Agreement (2022).  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2022 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418022000044/exhibit102performancestock.htm">Form of Performance Stock Unit Agreement (2022).  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2022 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.35</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418019000023/exhibit1040confidentiality.htm">Form of Executive Confidentiality and Non-Competition Agreement (October 2018).  Incorporated by reference to Altria Group, Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2018 (File No. 1-08940).*</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;margin-bottom:5pt;text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i15062ca98227434086141b426450a5cb_10">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:549.00pt"><tr><td style="width:1.0pt"></td><td style="width:9.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:7.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:481.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.36</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418019000037/exhibit102formofconfid.htm">Form of Confidentiality and Non-Competition Agreement (February 2019).  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended March 31, 2019 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.37</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/0000764180/000076418021000037/exhibit1034formofletterreg.htm">Form of Letter Regarding Reimbursement of Legal Expenses.  Incorporated by reference to Altria Group, Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.38</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit1038timesharingagre.htm">Time Sharing Agreement between Altria Client Services LLC and William F. Gifford, Jr., dated February 23, 2023.*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.39</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/764180/000076418020000018/exhibit1044formofagree.htm">Form of Agreement and General Release (September 2019).  Incorporated by reference to Altria Group, Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2019 (File No. 1-08940).*</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit21altriagroupincsub.htm">Subsidiaries of Altria Group, Inc.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/764180/000076418022000102/exhibit22q32022.htm">Guarantor Subsidiary of the Registrant.  Incorporated by reference to Altria Group, Inc.&#8217;s Quarterly Report on Form 10-Q for the period ended </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/764180/000076418022000102/exhibit22q32022.htm">September</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/764180/000076418022000102/exhibit22q32022.htm"> 30, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/764180/000076418022000102/exhibit22q32022.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/764180/000076418022000102/exhibit22q32022.htm"> (File No. 1-08940).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit23consentofindepend.htm">Consent of independent registered public accounting firm.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit24powersofattorney2.htm">Powers of attorney.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311q42022-annual.htm">Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312q42022-annual.htm">Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321q42022-annual.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit322q42022-annual.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991q42022-annual.htm">Certain Litigation Matters.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit992q42022-annual.htm">Trial Schedule for Certain Cases.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Denotes management contract or compensatory plan or arrangement in which directors or executive officers are eligible to participate.</span></div><div id="i15062ca98227434086141b426450a5cb_235"></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 16.  Form 10-K Summary.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><div id="i15062ca98227434086141b426450a5cb_238"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.113%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.726%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALTRIA GROUP, INC.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ WILLIAM F. GIFFORD, JR.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(William F. Gifford, Jr.<br/>Chief Executive Officer)</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:11.25pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date: February 27, 2023</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the date indicated:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.989%"><tr><td style="width:1.0%"></td><td style="width:4.277%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.489%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signature</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></td></tr><tr style="height:23pt"><td colspan="6" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ WILLIAM F. GIFFORD, JR.</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(William F. Gifford, Jr.)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director and Chief Executive&#160;Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2023</span></td></tr><tr style="height:21pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">/s/ SALVATORE MANCUSO</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(Salvatore Mancuso)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:21pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2023</span></td></tr><tr style="height:18pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ STEVEN D&#8217;AMBROSIA</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;(Steven D&#8217;Ambrosia)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President and Controller</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2023</span></td></tr><tr style="height:9pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;* IAN L.T. CLARKE,<br/>MARJORIE M. CONNELLY,<br/>R. MATT DAVIS,<br/>JACINTO J. HERNANDEZ,<br/>DEBRA J. KELLY-ENNIS,<br/>KATHRYN B. MCQUADE,<br/>GEORGE MU&#209;OZ,<br/>NABIL Y. SAKKAB,<br/>VIRGINIA E. SHANKS,<br/>ELLEN R. STRAHLMAN,<br/>M. MAX YZAGUIRRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ WILLIAM F. GIFFORD, JR.</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(WILLIAM F. GIFFORD, JR.</span></div><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ATTORNEY-IN-FACT)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 27, 2023</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>exhibit41descriptionofregi.htm
<DESCRIPTION>DESCRIPTION OF REGISTERED SECURITIES
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i33bcf9d65f664f72a822e43040fb20a4_1"></div><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 4.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF ALTRIA GROUP, INC.&#8217;S SECURITIES </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGISTERED PURSUANT TO SECTION 12 OF THE </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria Group, Inc. (the &#8220;Company&#8221;) had four classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)&#58; (i) common stock, $0.33 1&#47;3 par value per share (&#8220;Common Stock&#8221;)&#59; (ii) 1.700% Notes due 2025&#59; (iii) 2.200% Notes due 2027&#59; and (iv) 3.125% Notes due 2031. Each of the Company&#8217;s securities registered under Section 12 of the Exchange Act is listed on the New York Stock Exchange.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF COMMON STOCK</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a description of the rights of Common Stock and related provisions of the Company&#8217;s Restated Articles of Incorporation, as amended (the &#8220;Articles&#8221;), and Amended and Restated By-Laws (the &#8220;By-Laws&#8221;) and applicable Virginia law. This description is qualified in its entirety by reference to, and should be read together with, the Articles, the By-Laws and applicable Virginia law.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Authorized Capital Stock</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s authorized capital stock consists of 12,000,000,000 shares of Common Stock and 10,000,000 shares of Serial Preferred Stock, $1 par value per share (the &#8220;Serial Preferred Stock&#8221;).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fully Paid and Nonassessable</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the outstanding shares of Common Stock are fully paid and nonassessable.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of shares of Common Stock are entitled to one vote per share on all matters to be voted on by the shareholders. Holders of shares of Common Stock are not entitled to cumulative voting rights in the election of directors.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of shares of Common Stock are entitled to receive such dividends, if any, as may be declared from time to time by the Company&#8217;s Board of Directors (the &#8220;Board of Directors&#8221;) in its discretion from legally available funds.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right to Receive Liquidation Distributions</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon liquidation, dissolution or winding-up, the holders of shares of Common Stock are entitled to share equally in the assets remaining available for distribution to holders of such shares after payment of the Company&#8217;s prior obligations, including outstanding shares of Serial Preferred Stock, if any.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">No Preemptive or Similar Rights</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of shares of Common Stock have no preemptive or other subscription rights or rights to convert their shares of Common Stock into any other securities, and the Common Stock is not subject to any redemption or sinking fund provisions.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Takeover Provisions</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various provisions contained in the Articles, the By-Laws and Virginia law could delay, discourage or limit transactions involving an actual or potential change in control of the Company or change in its management, including transactions in which shareholders might otherwise receive a premium for their shares, or transactions that its shareholders might otherwise deem to be in their best interests.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Articles and By-Laws</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, the Articles and the By-Laws&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that any vacancy occurring in the Board of Directors, including a vacancy resulting from an increase in the number of directors, may be filled by the affirmative vote of a majority of the remaining directors though less than a quorum of the Board of Directors&#59;</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that only the Chairman of the Board of Directors or a majority of the Board of Directors may call a special meeting of shareholders&#59;</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require that shareholders seeking to present proposals before a meeting of shareholders or to nominate candidates for election as directors at a meeting of shareholders provide advance written notice in a timely manner, and also specify requirements as to the form and content of a shareholder&#8217;s notice&#59;</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">provide that the Board of Directors has the authority, without any vote or action by shareholders, to issue one or more series of Serial Preferred Stock and fix and determine the terms, including the preferences and rights, of any series of Serial Preferred Stock&#59;  </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">do not authorize cumulative voting in the election of directors&#59; and</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">do not permit shareholders to take action without a meeting other than by unanimous written consent.</font></div><div style="padding-left:54pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Virginia Law</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Affiliated Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company is subject to Article 14 of the Virginia Stock Corporation Act (the &#8220;VSCA&#8221;), a Virginia statute regulating &#8220;affiliated transactions.&#8221; An affiliated transaction is generally defined as a merger, a share exchange, a material disposition of corporate assets not in the ordinary course of business, any dissolution of the corporation proposed by or on behalf of a holder of more than 10% of any class of the corporation&#8217;s outstanding voting shares (a &#8220;10% holder&#8221;) or any reclassification, including reverse stock splits, recapitalization or merger of the corporation with its subsidiaries, that increases the percentage of voting shares owned beneficially by a 10%  holder by more than five percent. In general, these provisions prohibit a Virginia corporation from engaging in affiliated transactions with any 10% holder for a period of three years following the date that such person became a 10% holder unless (1) the board of directors of the corporation and the holders of two-thirds of the voting shares, other than the shares beneficially owned by the 10% holder, approve the affiliated transaction or (2) before the date the person became a 10% holder, the board of directors approved the transaction that resulted in the shareholder becoming a 10% holder. After three years, any such transaction must be at a &#8220;fair price,&#8221; as described in the VSCA, or must be approved by a majority of the disinterested directors or the holders of two-thirds of the voting shares, other than the shares beneficially owned by the 10% holder.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Control Share Acquisitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company is subject to Article 14.1 of the VSCA, the Virginia anti-takeover statute regulating &#8220;control share acquisitions,&#8221; which are transactions causing the voting power of any person acquiring beneficial ownership of shares of a Virginia public corporation to meet or exceed certain threshold percentages (20%, 33 1&#8260;3% or 50%) of the total votes entitled to be cast for the election of directors. Under that Virginia statute, shares acquired in a control share acquisition have no voting rights unless granted by a majority vote of all outstanding shares entitled to vote in the election of directors other than those held by the acquiring person or held by any officer or employee director of the corporation, unless at the time of any control share </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acquisition, the articles of incorporation or bylaws of the corporation provide that this statute does not apply to acquisitions of its shares. An acquiring person that owns five percent or more of the corporation&#8217;s voting stock may require that a special meeting of the shareholders be held, within 50 days of the acquiring person&#8217;s request, to consider the grant of voting rights to the shares acquired or to be acquired in the control share acquisition. If voting rights are not granted and the corporation&#8217;s articles of incorporation or bylaws permit, the acquiring person&#8217;s shares may be redeemed by the corporation, at the corporation&#8217;s option, at a price per share equal to the acquiring person&#8217;s cost. Unless otherwise provided in the corporation&#8217;s articles of incorporation or bylaws, the VSCA grants appraisal rights to any shareholder who objects to a control share acquisition that is approved by a vote of disinterested shareholders and that gives the acquiring person control of a majority of the corporation&#8217;s voting shares. This regulation was designed to deter certain takeovers of Virginia public corporations.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer agent and registrar for the Common Stock is Computershare Trust Company, N.A.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF NOTES</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following description of particular terms of the Company&#8217;s 1.700% Notes due 2025 (&#8220;2025 notes&#8221;), 2.200% Notes due 2027 (&#8220;2027 notes&#8221;) and 3.125% Notes due 2031 (&#8220;2031 notes&#8221;), which we refer to collectively as the &#8220;notes,&#8221; is not complete and is qualified by reference to, and should be read in together with, the indenture, dated as of November&#160;4, 2008 (the &#8220;indenture&#8221;), among the Company, the Company&#8217;s wholly-owned subsidiary, Philip Morris USA Inc. (&#8220;PM USA&#8221;), and Deutsche Bank Trust Company Americas, as trustee, under which the notes were issued. For reference, in the summary that follows, we have included references to section numbers of the indenture so that these provisions can be more easily located. In cases where portions of the summary are taken from more than one section of the indenture, we have referred only to the section of the indenture that is principally applicable to that part of the summary. In this &#8220;Description of Notes&#8221; section, references to the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; are only to Altria Group, Inc. and not its subsidiaries. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Terms of the 2025 Notes </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued &#8364;750,000,000 aggregate principal amount of the 2025 notes on February 15, 2019. The 2025 notes mature on June&#160;15, 2025 and bear interest at the rate of 1.700% per annum from February&#160;15, 2019, payable annually in arrears on June&#160;15 of each year, beginning June&#160;15, 2020, to the persons in whose names the 2025 notes are registered at the close of business on the preceding May&#160;31, the record date.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Terms of the 2027 Notes </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued &#8364;1,000,000,000 aggregate principal amount of the 2027 notes on February 15, 2019.  The 2027 notes will mature on June&#160;15, 2027 and bear interest at the rate of 2.200% per annum from February 15, 2019, payable annually in arrears on June 15 of each year, beginning June 15, 2020, to the persons in whose names the 2027 notes are registered at the close of business on the preceding May 31, the record date.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Terms of the 2031 Notes </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued &#8364;1,250,000,000 aggregate principal amount of the 2031 notes on February 15, 2019. The 2031 notes will mature on June&#160;15, 2031 and bear interest at the rate of 3.125% per annum from February&#160;15, 2019, payable annually in arrears on June&#160;15 of each year, beginning June&#160;15, 2020, to the persons in whose names the 2031 notes are registered at the close of business on the preceding May&#160;31, the record date.</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsidiary Guarantee</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each series of notes is guaranteed fully and unconditionally by PM USA. The guarantee ranks equally with all of PM USA&#8217;s existing and future senior unsecured indebtedness and guarantees from time to time outstanding.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the events of default set forth in the indenture and described under &#8220;Events of Default&#8221; below, the following will constitute an event of default with respect to the notes&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">PM USA or a court takes certain actions relating to bankruptcy, insolvency or reorganization of PM USA&#59; and</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">PM USA&#8217;s guarantee with respect to the notes is determined to be unenforceable or invalid or for any reason ceases to be in full force and effect except as permitted by the indenture and the guarantee agreement, or PM USA repudiates its obligations under such guarantee.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes are senior unsecured obligations of Altria and rank equally with all of our other existing and future senior unsecured indebtedness. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on the notes of each series is computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on the notes (or February&#160;15, 2019, if no interest has been paid on the notes) to, but excluding the next scheduled interest payment date. This payment convention is referred to as ACTUAL&#47;ACTUAL (ICMA) as defined in the rulebook of the International Capital Market Association.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may, without the consent of the holders of the notes, issue additional notes having the same ranking and the same interest rate, maturity and other terms as the notes, except for the public offering price and issue date. Any additional notes having such similar terms, together with the applicable notes, will constitute a single series of notes under the indenture. No additional notes may be issued if an event of default has occurred with respect to the applicable series of notes.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some circumstances, we may elect to discharge our obligations on the notes through full defeasance or covenant defeasance. See &#8220;Defeasance&#8221; below.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes will not be entitled to any sinking fund.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Optional Redemption</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2025 Notes</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to April 15, 2025 (the date that is two months prior to the scheduled maturity date for the 2025 notes), we may, at our option, redeem the 2025 notes, in whole at any time or in part from time to time (in &#8364;1,000 increments, provided that any remaining principal amount of any note remaining outstanding after a repurchase in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000).&#160;The redemption price will be equal to the greater of (i) 100% of the principal amount of the 2025 notes to be redeemed and (ii)&#160;the sum of the present values of each Remaining Scheduled Payment of principal and interest that would be due if such notes matured on April 15, 2025 (exclusive of interest accrued to the date of redemption), discounted to the redemption date on an annual basis (Actual&#47;Actual (ICMA)), at a rate equal to the applicable Comparable Government Bond Rate (as defined below) plus 30 basis points plus, in either case, accrued and unpaid interest, if any, thereon to, but excluding, the redemption date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after April 15, 2025 (the date that is two months prior to the scheduled maturity date of the 2025 notes), we may, at our option, redeem the 2025 notes, in whole at any time or in part from time to time (in &#8364;1,000 increments, provided that any remaining principal amount of any note remaining outstanding after a repurchase in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000), at a redemption price equal to 100% of the principal </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amount of the 2025 notes to be redeemed plus accrued and unpaid interest, if any, thereon&#160;to, but excluding, the redemption date.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2027 Notes</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to April 15, 2027 (the date that is two months prior to the scheduled maturity date for the 2027 notes), we may, at our option, redeem the 2027 notes, in whole at any time or in part from time to time (in &#8364;1,000 increments, provided that any remaining principal amount of any note remaining outstanding after a repurchase in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000).&#160;The redemption price will be equal to the greater of (i) 100% of the principal amount of the 2027 notes to be redeemed and (ii)&#160;the sum of the present values of each Remaining Scheduled Payment of principal and interest that would be due if such notes matured on April 15, 2027 (exclusive of interest accrued to the date of redemption), discounted to the redemption date on an annual basis (Actual&#47;Actual (ICMA)), at a rate equal to the applicable Comparable Government Bond Rate (as defined below) plus 35 basis points plus, in either case, accrued and unpaid interest, if any, thereon to, but excluding, the redemption date.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after April 15, 2027 (the date that is two months prior to the scheduled maturity date of the 2027 notes), we may, at our option, redeem the 2027 notes, in whole at any time or in part from time to time (in &#8364;1,000 increments, provided that any remaining principal amount of any note remaining outstanding after a repurchase in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000), at a redemption price equal to 100% of the principal amount of the 2027 notes to be redeemed plus accrued and unpaid interest, if any, thereon&#160;to, but excluding, the redemption date.</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2031 Notes</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to March 15, 2031 (the date that is three months prior to the scheduled maturity date for the 2031 notes), we may, at our option, redeem the 2031 notes, in whole at any time or in part from time to time (in &#8364;1,000 increments, provided that any remaining principal amount of any note remaining outstanding after a repurchase in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000).&#160;The redemption price will be equal to the greater of (i) 100% of the principal amount of the 2031 notes to be redeemed and (ii)&#160;the sum of the present values of each Remaining Scheduled Payment of principal and interest that would be due if such notes matured on March 15, 2031 (exclusive of interest accrued to the date of redemption), discounted to the redemption date on an annual basis (Actual&#47;Actual (ICMA)), at a rate equal to the applicable Comparable Government Bond Rate (as defined below) plus 45 basis points plus, in either case, accrued and unpaid interest, if any, thereon to, but excluding, the redemption date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after March 15, 2031 (the date that is three months prior to the scheduled maturity date of the 2031 notes), we may, at our option, redeem the 2031 notes, in whole at any time or in part from time to time (in &#8364;1,000 increments, provided that any remaining principal amount of any note remaining outstanding after a repurchase in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000), at a redemption price equal to 100% of the principal amount of the 2031 notes to be redeemed plus accrued and unpaid interest, if any, thereon&#160;to, but excluding, the redemption date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Comparable Government Bond Rate&#8221; means, with respect to any redemption date, the price, expressed as a percentage (rounded to three decimal places, 0.0005 being rounded upwards), at which the gross redemption yield on the applicable series of notes to be redeemed, if they were to be purchased at such price on the third business day prior to the date fixed for redemption, would be equal to the gross redemption yield on such business day of the Reference Bond on the basis of the middle market price of the Reference Bond prevailing at 11&#58;00 a.m. (London time) on such dealing day as determined by the Independent Investment Bank.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Independent Investment Bank&#8221; means one of the Reference Bond Dealers that we appoint as the Independent Investment Bank from time to time.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Reference Bond&#8221; means, in relation to any Comparable Government Bond Rate calculation, a German government bond whose maturity is closest to the maturity of the applicable series of notes, or if we or the </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Independent Investment Bank considers that such similar bond is not in issue, such other German government bond as we or the Independent Investment Bank, with the advice of three brokers of, and&#47;or market makers in, German government bonds selected by us or the Independent Investment Bank, determine to be appropriate for determining the Comparable Government Bond Rate.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Reference Bond Dealer&#8221; means (A)&#160;each of Barclays Bank PLC, Deutsche Bank AG, London Branch, Goldman Sachs&#160;&#38; Co. LLC and J.P. Morgan Securities plc (or their respective affiliates that are Primary Bond Dealers), and their respective successors and (B)&#160;any other broker of, and&#47;or market maker in, German government bonds (a &#8220;Primary Bond Dealer&#8221;) selected by us.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Remaining Scheduled Payments&#8221; means, with respect to the applicable note to be redeemed, the remaining scheduled payments of principal of and interest on the relevant note that would be due after the related redemption date but for the redemption. If that redemption date is not an interest payment date with respect to a note, the amount of the next succeeding scheduled interest payment on the relevant note will be reduced by the amount of interest accrued on the applicable note to, but excluding, the redemption date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If money sufficient to pay the redemption price on the applicable notes (or portions thereof) to be redeemed on the applicable redemption date is deposited with the trustee or paying agent on or before the applicable redemption date and certain other conditions are satisfied, then on and after such redemption date, interest will cease to accrue on such notes (or such portion thereof) called for redemption.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will, or will cause the trustee or paying agent on our behalf to, mail notice of a redemption to holders of the applicable notes to be redeemed by first-class mail (or otherwise transmit in accordance with applicable procedures of Clearstream Banking, soci&#233;t&#233; anonyme (&#8220;Clearstream&#8221;), or Euroclear Bank SA&#47;NV (&#8220;Euroclear&#8221;) at least 15 and not more than 45 days prior to the date fixed for redemption. Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the applicable notes or any portions thereof called for redemption. On or before the applicable redemption date, we will deposit with the trustee or paying agent or set aside, segregate and hold in trust (if we are acting as paying agent), funds sufficient to pay the redemption price of, and accrued and unpaid interest on, such notes to be redeemed on that redemption date. If fewer than all of the notes of any series are to be redeemed, the trustee or paying agent will select, not more than 60 days prior to the redemption date, the particular notes or any portions thereof for redemption from the outstanding notes not previously called by such method as the trustee or paying agent deems fair and appropriate and in accordance with the applicable procedures of the depositary&#59; provided, however, that no notes of a principal amount of &#8364;100,000 or less shall be redeemed in part.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may at any time, and from time to time, purchase notes of any series at any price or prices in the open market or otherwise.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Repurchase Upon Change of Control Triggering Event</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a change of control triggering event occurs, unless we have exercised our option to redeem the notes of a series as described under &#8220;-Optional Redemption&#8221; above or &#8220;-Redemption for Tax Reasons&#8221; below, we will be required to make an offer (the &#8220;change of control offer&#8221;) to each holder of such notes to repurchase all or any part (equal to &#8364;100,000 or an integral multiple of &#8364;1,000 in excess thereof) of that holder&#8217;s notes on the terms set forth in such notes. In a change of control offer, we will be required to offer payment in cash equal to 101% of the aggregate principal amount of notes repurchased, plus accrued and unpaid interest, if any, on the notes repurchased to, but not including, the date of repurchase (a &#8220;change of control payment&#8221;).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within 30 days following any change of control triggering event or, at our option, prior to any change of control, but after public announcement of the transaction that constitutes or may constitute the change of control, a notice will be mailed to holders of the notes describing the transaction that constitutes or may constitute the change of control triggering event and offering to repurchase such notes on the date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed (a &#8220;change of control payment date&#8221;). The notice, if mailed prior to the date of consummation of the change of control, will state that the </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">change of control offer is conditioned on the change of control triggering event occurring on or prior to the change of control payment date.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the change of control payment date, we will, to the extent lawful&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accept for payment all notes or portions of notes properly tendered pursuant to the change of control offer&#59;</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">deposit with the paying agent an amount equal to the change of control payment in respect of all notes or portions of notes properly tendered&#59; and</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">deliver or cause to be delivered to the trustee the notes properly accepted together with an officers&#8217; certificate stating the aggregate principal amount of notes or portions of notes being purchased.</font></div><div style="padding-left:54pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The paying agent will promptly mail to each holder of properly tendered notes the change of control payment for the notes, and the trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each holder a new note equal in principal amount to any unpurchased portion of any notes surrendered&#59; provided that each new note will be in a principal amount of &#8364;100,000 or an integral multiple of &#8364;1,000 in excess of that amount.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will not be required to make a change of control offer upon the occurrence of a change of control triggering event if a third party makes such an offer at the times and otherwise in compliance with the requirements set for an offer made by us, and the third party repurchases all notes properly tendered and not withdrawn under its offer. In addition, we will not repurchase any notes if there has occurred and is continuing on the change of control payment date an event of default under the indenture, other than a default in the payment of the change of control payment upon a change of control triggering event.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we are required to offer to repurchase the notes of a series upon the occurrence of a change of control triggering event, we may not have sufficient funds to repurchase such notes in cash at such time. In addition, our ability to repurchase the notes for cash may be limited by law or the terms of other agreements relating to our indebtedness outstanding at the time. The failure to make such repurchase would result in a default under the notes.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will comply with the requirements of Rule&#160;14e-1&#160;under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and any other securities laws and regulations thereunder to the extent those laws and regulations are applicable in connection with the repurchase of the notes as a result of a change of control triggering event. To the extent that the provisions of any such securities laws or regulations conflict with the change of control offer provisions of the notes, we will comply with those securities laws and regulations and will not be deemed to have breached our obligations under the change of control offer provisions of the notes by virtue of any such conflict.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of the change of control offer provisions of the notes, the following terms will be applicable&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Change of control&#8221; means the occurrence of any of the following&#58;</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.850%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or more series of related transactions, of all or substantially all of our assets and the assets of our subsidiaries, taken as a whole, to any &#8220;person,&#8221; other than to our company or one of our subsidiaries&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any person becomes the beneficial owner (as defined in Rules&#160;13d-3&#160;and&#160;13d-5&#160;under the Exchange Act), directly or indirectly, of more than 50% of our outstanding voting stock or other voting stock into which our voting stock is reclassified, consolidated, exchanged or changed, measured by voting power rather than the number of shares&#59;</font></td></tr></table></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.906%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.850%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">we consolidate with, or merge with or into, any person, or any person consolidates with, or merges with or into, us, in any such event pursuant to a transaction in which any of our outstanding voting stock is converted into or exchanged for cash, securities or other property, other than any such transaction where the shares of our voting stock outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the voting stock of the surviving person or any direct or indirect parent company of the surviving person immediately after giving effect to such transaction&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the first day on which a majority of the members of our Board of Directors are not continuing directors&#59; or</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the adoption of a plan relating to our liquidation or dissolution (other than our liquidation into a newly formed holding company).</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a transaction will not be deemed to involve a change of control if (i)&#160;we become a direct or indirect wholly-owned subsidiary of a holding company and (ii)&#160;(A)&#160;the direct or indirect holders of the voting stock of such holding company immediately following that transaction are substantially the same as the holders of our voting stock immediately prior to that transaction or (B)&#160;immediately following that transaction no person (other than a holding company) is the beneficial owner, directly or indirectly, of more than 50% of the voting stock of such holding company.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The definition of &#8220;change of control&#8221; includes a phrase relating to the direct or indirect sale, lease, transfer, conveyance or other disposition of &#8220;all or substantially all&#8221; of our assets and the assets of our subsidiaries, taken as a whole. Although there is a limited body of case law interpreting the phrase &#8220;substantially all,&#8221; there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of notes to require us to repurchase its notes as a result of a sale, lease, transfer, conveyance or other disposition of less than all of our assets and the assets of our subsidiaries, taken as a whole, to another person or group may be uncertain.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Change of control triggering event&#8221; means the occurrence of both (1)&#160;a change of control and (2)&#160;a ratings event.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Continuing directors&#8221; means, as of any date of determination, any member of our Board of Directors who (1)&#160;was a member of such Board of Directors on the date the notes were issued or (2)&#160;was nominated for election, elected or appointed to such Board of Directors with the approval of a majority of the continuing directors who were members of such Board of Directors at the time of such nomination, election or appointment (either by a specific vote or by approval of our proxy statement in which such member was named a nominee for election as a director, without objection to such nomination).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Fitch&#8221; means Fitch Ratings Inc., an indirect subsidiary of Hearst Corporation and Fimalac, S.A., and its successors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Investment grade&#8221; means a rating equal to or higher than Baa3 (or the equivalent) by Moody&#8217;s&#59; a rating equal to or higher than&#160;BBB-&#160;(or the equivalent) by S&#38;P or Fitch&#59; and the equivalent investment grade credit rating from any replacement rating agency or rating agencies selected by us.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service, Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Person&#8221; has the meaning given thereto in Section&#160;13(d)(3) of the Exchange Act.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Rating agencies&#8221; means (1)&#160;each of Moody&#8217;s, S&#38;P and Fitch&#59; and (2)&#160;if any of Moody&#8217;s, S&#38;P or Fitch ceases to rate the notes or fails to make a rating of the notes publicly available for reasons outside of our control, a substitute rating agency.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Ratings event&#8221; means the notes cease to be rated investment grade by each of the rating agencies on any day within the&#160;60-day&#160;period (which&#160;60-day&#160;period will be extended so long as the rating of the notes is under publicly announced consideration for a possible downgrade by any of the rating agencies) after the earlier of (1)&#160;the </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">occurrence of a change of control and (2)&#160;public notice of the occurrence of a change of control or our intention to effect a change of control.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;S&#38;P&#8221; means Standard&#160;&#38; Poor&#8217;s Financial Services LLC, a division of S&#38;P Global Inc., and its successors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Substitute rating agency&#8221; means a &#8220;nationally recognized statistical rating organization&#8221; within the meaning of Rule&#160;15c3-1(c)(2)(vi)(F)&#160;under the Exchange Act selected by us (as certified by our Chief Executive Officer or Chief Financial Officer) as a replacement agency for Moody&#8217;s, S&#38;P or Fitch, or all of them, as the case may be.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Voting stock&#8221; means, with respect to any specified person as of any date, the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payment of Additional Amounts</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will, subject to the exceptions and limitations set forth below, pay to the beneficial owner of any note who is a&#160;non-United&#160;States person (as defined below) such additional amounts as may be necessary to ensure that every net payment on such note, after deduction or withholding by us or any of our paying agents for or on account of any present or future tax, assessment or other governmental charge imposed upon or as a result of such payment by the United States or any political subdivision or taxing authority of the United States, will not be less than the amount provided in such note to be then due and payable. However, we will not pay additional amounts if the beneficial owner is subject to taxation solely for reasons other than its ownership of the note, nor will we pay additional amounts for or on account of&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any tax, assessment or other governmental charge that is imposed or withheld solely by reason of the existence of any present or former connection (other than the mere fact of being a beneficial owner of a note) between the beneficial owner (or between a fiduciary, settlor, beneficiary or person holding a power over such beneficial owner, if the beneficial owner is an estate or trust, or a member or shareholder of the beneficial owner, if the beneficial owner is a partnership or corporation) of a note and the United States, including, without limitation, such beneficial owner (or such fiduciary, settlor, beneficiary, person holding a power, member or shareholder) being or having been a citizen or resident of the United States or treated as being or having been a resident thereof&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any tax, assessment or other governmental charge that is imposed or withheld solely by reason of the beneficial owner (or a fiduciary, settlor, beneficiary or person holding a power over such beneficial owner, if the beneficial owner is an estate or trust, or a member or shareholder of the beneficial owner, if the beneficial owner is a partnership or corporation) (1)&#160;being or having been present in, or engaged in a trade or business in, the United States, (2)&#160;being treated as having been present in, or engaged in a trade or business in, the United States, or (3)&#160;having or having had a permanent establishment in the United States&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any tax, assessment or other governmental charge that is imposed or withheld solely by reason of the beneficial owner (or a fiduciary, settlor, beneficiary or person holding a power over such beneficial owner, if the beneficial owner is an estate or trust, or a member or shareholder of the beneficial owner, if the beneficial owner is a partnership or corporation) being or having been with respect to the United States a personal holding company, a controlled foreign corporation, a passive foreign investment company or a foreign private foundation or other foreign&#160;tax-exempt&#160;organization, or being a corporation that accumulates earnings to avoid United States federal income tax&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any tax, assessment or other governmental charge imposed on a beneficial owner that actually or constructively owns 10% or more of the total combined voting power of all of our classes of stock that are entitled to vote within the meaning of Section&#160;871(h)(3) of the Internal Revenue Code of 1986, as amended, or the Code&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any tax, assessment or other governmental charge that is payable by any method other than withholding or deduction by us or any paying agent from payments in respect of such note&#59;</font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any gift, estate, inheritance, sales, transfer, personal property or excise tax or any similar tax, assessment or other governmental charge&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any tax, assessment or other governmental charge required to be withheld by any paying agent from any payment in respect of any note if such payment can be made without such withholding by at least one other paying agent&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any tax, assessment or other governmental charge that is imposed or withheld by reason of a change in law, regulation, or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any tax, assessment or other governmental charge imposed as a result of the failure of the beneficial owner to comply with applicable certification, information, documentation or other reporting requirements concerning the nationality, residence, identity or connection with the United States of the holder or beneficial owner of a note, if such compliance is required by statute or regulation of the United States as a precondition to relief or exemption from such tax, assessment or other governmental charge&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any tax, assessment or other governmental charge imposed by reason of the failure of the beneficial owner to fulfill the statement requirements of Section&#160;871(h) or Section&#160;881(c) of the Code&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any tax, assessment or other governmental charge imposed pursuant to the provisions of Section&#160;1471 through 1474 of the Code&#59; or</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;any combination of items (a), (b), (c), (d), (e), (f), (g), (h), (i), (j)&#160;and (k).</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we will not pay additional amounts to a beneficial owner of a note that is a fiduciary, partnership, limited liability company or other fiscally transparent entity, or to a beneficial owner of a note that is not the sole beneficial owner of such note, as the case may be. This exception, however, will apply only to the extent that a beneficiary or settlor with respect to the fiduciary, or a beneficial owner or member of the partnership, limited liability company or other fiscally transparent entity, would not have been entitled to the payment of an additional amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment. The term &#8220;beneficial owner&#8221; includes any person holding a note on behalf of or for the account of a beneficial owner.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used herein, the term&#160;&#8220;non-United&#160;States person&#8221; means a person that is not a United States person. The term &#8220;United States person&#8221; means a citizen or resident of the United States, a corporation or partnership created or organized in or under the laws of the United States or any political subdivision thereof, an estate the income of which is subject to United States federal income taxation regardless of its source, a trust subject to the primary supervision of a court within the United States and the control of one or more United States persons as described in Section&#160;7701(a)(30) of the Code, or a trust that existed on August&#160;20, 1996, and elected to continue its treatment as a domestic trust. &#8220;United States&#8221; means the United States of America (including the states and the District of Columbia), its territories, its possessions and other areas subject to its jurisdiction (including the Commonwealth of Puerto Rico).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redemption for Tax Reasons</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may redeem a series of notes prior to maturity in whole, but not in part, on not more than 60 days&#8217; notice and not less than 30 days&#8217; notice at a redemption price equal to the principal amount of such notes plus any accrued interest and additional amounts to the date fixed for redemption if&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">as a result of a change in or amendment to the tax laws, regulations or rulings of the United States or any political subdivision or taxing authority of or in the United States or any change in official position regarding the application or interpretation of such laws, regulations or rulings (including a holding by a court of competent jurisdiction in the United States) that is announced or becomes effective on or after </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;15, 2019, we have or will become obligated to pay additional amounts with respect to such series of notes as described above under &#8220;-Payment of Additional Amounts,&#8221; or</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">on or after February&#160;15, 2019, any action is taken by a taxing authority of, or any decision is rendered by a court of competent jurisdiction in, the United States or any political subdivision or taxing authority of or in the United States, including any of those actions specified in the bullet point above, whether or not such action is taken or decision is rendered with respect to us, or any change, amendment, application or interpretation is officially proposed, which, in any such case, in the written opinion of independent legal counsel of recognized standing, will result in a material probability that we will become obligated to pay additional amounts with respect to such series of notes,</font></div><div style="padding-left:54pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and we in our business judgment determine that such obligations cannot be avoided by the use of reasonable measures available to us.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we exercise our option to redeem a series of notes, we will deliver to the trustee a certificate signed by an authorized officer stating that we are entitled to redeem such notes and the written opinion of independent legal counsel if required.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuance in Euros</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initial holders were required to pay for the notes in euros, and all payments of interest and principal, including payments made upon any redemption of the notes, are payable in euro. If we are unable to obtain euros in amounts sufficient to make a required payment under the notes due to the imposition of exchange controls or other circumstances beyond our control (including the dissolution of the Economic and Monetary Union) or if the euro is no longer being used by the then member states of the Economic and Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international banking community, then all payments in respect of the notes will be made in U.S. dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euros will be converted into U.S. dollars at the rate mandated by the U.S. Federal Reserve Board as of the close of business on the second business day prior to the relevant payment date or, in the event the U.S. Federal Reserve Board has not mandated a rate of conversion, on the basis of the then most recent U.S. dollar&#47;euro exchange rate available on or prior to the second business day prior to the relevant payment date as determined by us in our sole discretion. Any payment in respect of the notes so made in U.S. dollars will not constitute an event of default under the notes or the indenture governing the notes. Neither the trustee nor the paying agent shall have any responsibility for any calculation or conversion in connection with the foregoing.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidation, Merger or Sale </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the indenture, neither we nor PM USA may consolidate with or merge into any other corporation or convey or transfer our respective properties and assets substantially as an entirety to any person unless&#58; </font></div><div style="padding-left:47.25pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the corporation formed by such consolidation or into which we or PM USA, as applicable, are merged or the person which acquires by conveyance or transfer our or PM USA&#8217;s, as applicable, properties and assets substantially as an entirety is a corporation organized and existing under the laws of the United States, any state thereof or the District of Columbia and expressly assumes, by a supplemental indenture, payment of the principal of and any premium and interest (including any additional amounts payable) on all the notes and the performance of every covenant of the indenture, or the guarantee of any series of notes, on the part of us or PM USA, as the case may be, to be performed&#59; </font></div><div style="padding-left:47.25pt"><font><br></font></div><div style="padding-left:47.25pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">after giving effect to the transaction, no Event of Default with respect to any series of notes, and no event which, after notice or lapse of time or both, would become an Event of Default, will have happened and be continuing&#59; </font></div><div style="padding-left:47.25pt"><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="padding-left:47.25pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the successor corporation assuming the notes agrees, by supplemental indenture, to indemnify the individuals liable therefor for the amount of United States federal estate tax paid solely as a result of such assumption in respect of notes held by individuals who are not citizens or residents of the United States at the time of their death&#59; and </font></div><div style="padding-left:47.25pt"><font><br></font></div><div style="padding-left:47.25pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we or PM USA, as the case may be, deliver to the trustee an officers&#8217; certificate and an opinion of counsel, each stating that the consolidation, merger, conveyance or transfer and the supplemental indenture comply with these provisions. (Section 801) </font></div><div style="padding-left:47.25pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The successor corporation will assume all of our or PM USA&#8217;s, as applicable, obligations under the indenture and, in the case of PM USA, any guarantee agreement relating to any outstanding notes that are guaranteed by PM USA, as if such successor were an original party to the indenture or such guarantee. After assuming such obligations, the successor corporation will have all of our or PM USA&#8217;s, as applicable, rights and powers under the indenture or such guarantee. (Section 802)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Waivers under the Indenture </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the indenture, the holders of more than 50% in principal amount of the outstanding notes of any particular series, may on behalf of the holders of all the notes of that series&#58; </font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">waive our compliance with certain covenants of the indenture&#59; and (Section 1009) </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">waive any past default under the indenture, except&#58; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a default in the payment of the principal of, or any premium or interest on, any notes of that series&#59; and </font></div><div style="padding-left:72pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a default with respect to a covenant or provision of the indenture which itself cannot be modified or amended without the consent of the holder of each affected note of that series. (Section 513) </font></div><div style="padding-left:72pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Events of Default </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the following events is defined as an &#8220;Event of Default&#8221; in the indenture with respect to a particular series of notes&#58; </font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we fail to pay any installment of interest on any note of that series for 30 days after payment was due&#59; &#160;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we fail to make payment of the principal of, or any premium on, any note of that series when due&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we fail to make any sinking fund payment when due with respect to notes of that series&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we fail to perform, or breach, any other covenant or warranty in respect of any note of that series contained in the indenture or in such notes or in the applicable board resolution under which such series is issued and this failure or breach continues for 90 days after we receive written notice of it from the trustee or holders of at least 25% in principal amount of the outstanding notes of that series&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we or a court take certain actions relating to bankruptcy, insolvency or reorganization of our company&#59; or </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any other event of default that may be specified for the notes of the series or in the board resolution with respect to the notes of that series. (Section 501) </font></div><div style="padding-left:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A default with respect to a single series of notes under the indenture will not necessarily constitute a default with respect to any other series of notes issued under the indenture. A default under our other indebtedness will not be a default under the indenture. The trustee may withhold notice to the holders of notes of any default, except for </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">defaults that involve our failure to pay principal or any premium or interest, if it determines in good faith that the withholding of notice is in the interest of the holders. (Section 602) </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an Event of Default for any series of notes occurs and continues (other than an Event of Default involving our bankruptcy, insolvency or reorganization), either the trustee or the holders of not less than 25% in principal amount of the outstanding notes of that series may require us upon notice in writing to us, to repay immediately the entire principal of all the notes of such series together with accrued interest on the notes. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an Event of Default occurs that involves our bankruptcy, insolvency or reorganization, then all unpaid principal amounts of all the notes of such series together with accrued interest on the notes and accrued interest on all notes of each series then outstanding will immediately become due and payable, without any action by the trustee or any holder of notes. (Section 502) </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to certain conditions, the holders of a majority in principal amount of the outstanding notes of a series may rescind a declaration of acceleration if all Events of Default, other than the failure to pay principal or interest due solely because of the declaration of acceleration, have been cured or waived. (Section 502) </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than its duties in case of an Event of Default, the trustee is not obligated to exercise any of its rights or powers under the indenture at the request, order or direction of any holders, unless the holders offer the trustee indemnity satisfactory to it. (Section 507) The holders of a majority in principal amount outstanding of any series of notes may, subject to certain limitations, direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any power conferred upon the trustee, for any series of notes. (Section 512) </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indenture requires us to file each year with the trustee, an officer&#8217;s certificate that states that&#58; </font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the signing officer has supervised a review of our activities during such year and performance under the indenture&#59; and &#160;</font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to the best of his or her knowledge, based on the review, we comply with all conditions and covenants of the indenture. (Section 1005) </font></div><div style="padding-left:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A judgment for money damages by courts in the United States, including a money judgment based on an obligation expressed in a foreign currency, will ordinarily be rendered only in U.S. dollars. New York statutory law provides that a court shall render a judgment or decree in the foreign currency of the underlying obligation and that the judgment or decree shall be converted into U.S. dollars at the exchange rate prevailing on the date of entry of the judgment or decree. If a court requires a conversion to be made on a date other than a judgment date, the indenture requires us to pay additional amounts necessary to ensure that the amount paid in U.S. dollars to a holder is equal to the amount due in such foreign currency or currency unit. (Section 515) </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the indenture provides that, to the extent elected by us, the sole remedy for an Event of Default relating to the failure to comply with the reporting obligations in the indenture will, for the first 120 days after the occurrence of such an Event of Default, consist exclusively of the right for holders of each series of notes with respect to which we elect to pay additional interest to receive additional interest on the notes of that particular series at an annual rate equal to 0.25% of the principal amount of the notes of such series. If we so elect, this additional interest will accrue on all outstanding notes with respect to which we elect to pay additional interest from and including the date on which the Event of Default relating to the failure to comply with the reporting obligations in the indenture first occurs to but not including the 120th day thereafter (or such earlier date on which such Event of Default is cured or waived by holders as provided above). On such 120th day (or earlier, if the Event of Default relating to the reporting obligations under the indenture is cured or waived by holders as provided above prior to such 120th day), the additional interest will cease to accrue and, if the Event of Default relating to reporting obligations under the indenture has not been cured or waived prior to such 120th day, the notes will be subject to acceleration as provided above. The provisions of the indenture described in this paragraph will not affect the rights of holders of notes in the event of the occurrence of any other Event of Default. If we do not elect to pay the </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional interest upon an Event of Default in accordance with this paragraph, the notes will be subject to acceleration as provided above. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to elect to pay the additional interest on the notes in accordance with the immediately preceding paragraph, we must notify all holders of notes of such series and the trustee and paying agent of such election on or before the close of business on the date on which such Event of Default first occurs. (Section 502) </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restrictive Covenants </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indenture includes the following restrictive covenants&#58; </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitations on Liens </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indenture limits the amount of liens that we or our Subsidiaries (as defined below) may incur or otherwise create, in order to secure indebtedness for borrowed money, upon any Principal Facility (as defined below) or any shares of capital stock that any of our Subsidiaries owning any Principal Facility has issued to us or any of our Subsidiaries. If we or any of our Subsidiaries incur such liens, then we will secure the notes and, in the case of liens upon any Principal Facility owned or leased by PM USA, then PM USA will secure the guarantee of the notes to the same extent and in the same proportion as the debt that is secured by such liens. This covenant does not apply, however, to any of the following&#58; </font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in the case of a Principal Facility, liens incurred in connection with the issuance by a state or political subdivision thereof of any securities the interest on which is exempt from federal income taxes by virtue of Section&#160;103 of the Internal Revenue Code of 1986, as amended, or any other laws or regulations in effect at the time of such issuance&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">liens existing on the date of the indenture&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">liens on property or shares of capital stock existing at the time we or any of our Subsidiaries acquire such property or shares of stock (including acquisition through merger, share exchange or consolidation) or securing the payment of all or part of the purchase price, construction or improvement thereof incurred prior to, at the time of, or within 180 days after the later of the acquisition, completion of construction or improvement or commencement of full operation of such property for the purpose of financing all or a portion of such purchase or construction or improvement&#59; or </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">liens for the sole purpose of extending, renewing or replacing in whole or in part the indebtedness secured by any lien referred to in the foregoing three bullet points or in this bullet point&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the principal amount of indebtedness secured thereby shall not exceed the principal amount of indebtedness so secured at the time of such extension, renewal or replacement, and that such extension, renewal or replacement shall be limited to all or a part of the property that secured the lien so extended, renewed or replaced (plus improvements on such property). </font></div><div style="padding-left:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, we and&#47;or any of our Subsidiaries may create, assume or incur liens that would otherwise be subject to the restriction described above, without securing notes issued under the indenture equally and ratably, if the aggregate value of all outstanding indebtedness secured by the liens plus the value of Sale and Leaseback Transactions does not at the time exceed 5% of Consolidated Net Tangible Assets (as defined below). (Section 1007) </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale and Leaseback Transactions </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A Sale and Leaseback Transaction (as defined below) by us or any of our Subsidiaries of any Principal Facility is prohibited unless, within 180 days of the effective date of the arrangement, an amount equal to the greater of the net proceeds of the sale of the property leased pursuant to the Sale and Leaseback Transaction or the fair value </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the property at the time of entering into the Sale and Leaseback Transaction as determined by our board of directors (&#8220;value&#8221;) is applied by us to the retirement of non-subordinated indebtedness for money borrowed with more than one year stated maturity, including our notes, except that such sales and leasebacks are permitted to the extent that the &#8220;value&#8221; thereof plus the other secured debt referred to in the penultimate paragraph above in the subsection entitled &#8220;Restrictive Covenants-Limitations on Liens&#8221; does not at the time exceed 5% of our Consolidated Net Tangible Assets. (Section 1008) </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other restrictive covenants in the indenture. The indenture does not require us to maintain any financial ratios, minimum levels of net worth or liquidity or restrict the incurrence of indebtedness, the makeup of asset sales, the payment of dividends, the making of other distributions on our capital stock or the redemption or purchase of our capital stock. Moreover, the indenture does not contain any provision requiring us to repurchase or redeem any notes or debt warrants or modify the terms thereof or afford the holders thereof any other protection in the event of our change of control, any highly leveraged transaction or any other event involving us that may materially adversely affect our creditworthiness or the value of the notes or debt warrants. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Terms </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Consolidated Capitalization&#8221; means the total of all the assets appearing on our most recent quarterly or annual consolidated balance sheet, less (a)&#160;current liabilities, including liabilities for indebtedness maturing more than 12 months from the date of the original creation thereof, but maturing within 12 months from the date of such consolidated balance sheet, and (b)&#160;deferred income tax liabilities appearing on such consolidated balance sheet. (Section 101)</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Consolidated Net Tangible Assets&#8221; means the excess over current liabilities of all assets appearing on our most recent quarterly or annual consolidated balance sheet, less (a)&#160;goodwill and other intangible assets and (b)&#160;the minority interests of others in Subsidiaries. (Section 101) </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Principal Facility&#8221; means any facility, together with the land upon which it is erected and fixtures comprising a part thereof, used primarily for manufacturing, processing or production and located in the United States, owned or leased pursuant to a capital lease by us or any Subsidiary, that has a gross book value (without deduction of any depreciation reserve) on the date as of which the determination is being made exceeding 2% of Consolidated Capitalization. (Section 1007) </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Sale and Leaseback Transaction&#8221; means the sale or transfer of a Principal Facility now owned or hereafter acquired with the intention of taking back a lease of the property, except a lease for a temporary period of less than three years, including renewals, with the intent that the use by us or any Subsidiary will be discontinued on or before the expiration of such period. (Section 1008) </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Subsidiaries&#8221; means any corporation of which at least a majority of all outstanding stock or other interests having ordinary voting power in the election of directors, managers or trustees (without regard to the occurrence of any contingency) thereof is at the time, directly or indirectly, owned or controlled by us or by one or more Subsidiaries or by us and one or more Subsidiaries. (Section 101) </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Defeasance </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Defeasance </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We can legally release ourselves from all of our obligations, with certain limited exceptions, on any series of notes. This is called legal defeasance. In order to achieve legal defeasance&#58; </font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we must deposit, or cause to be deposited, in trust for the benefit of all holders of that series of notes an amount of cash in the currency or currency unit in which that series of notes is payable, direct obligations of the government that issued the currency in which that series of notes is payable or a combination thereof that will generate sufficient cash, in the opinion of an internationally recognized </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="padding-left:54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">firm of independent public accountants, to make interest, principal, premium and any other payments on that series of notes on their due date or redemption date&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we have delivered to the trustee an opinion of counsel confirming that (1)&#160;we have received from, or there has been published by, the U.S. Internal Revenue Service a ruling or (2)&#160;since the issuance date of the notes, there has been a change in the applicable U.S. federal income tax law, in either case to the effect that, and based thereon such opinion of counsel shall confirm that holders of the notes will not recognize income, gain or loss for U.S. federal income tax purposes as a result of the legal defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if the legal defeasance had not occurred&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no Event of Default or event that with the giving of notice or passage of time, or both, would become an Event of Default shall have occurred and be continuing at the time of the deposit described above and no Event of Default described in the fifth bullet point under &#8220;-Events of Default&#8221; shall have occurred and be continuing on the 123</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> day after the date of such deposit&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">such defeasance will not result in a breach or violation of, or constitute a default under, any material agreement or instrument to which we are a party or by which we are bound&#59; and </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we have delivered to the trustee an officers&#8217; certificate and an opinion of counsel in each stating that all conditions precedent provided for or relating to the legal defeasance have been complied with. </font></div><div style="padding-left:54pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Covenant Defeasance </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We can make the same type of deposit described above under &#8220;-Defeasance-Legal Defeasance&#8221; and be released from the restrictive covenants on any series of notes. This is called covenant defeasance. In order to achieve covenant defeasance&#58; </font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we must deposit, or cause to be deposited, in trust for the benefit of all holders of that series of notes an amount of cash in the currency or currency unit in which that series of notes is payable, direct obligations of the government that issued the currency in which that series of debt securities is payable or a combination thereof that will generate sufficient cash, in the opinion of an internationally recognized firm of independent accountants, to make interest, principal, premium and any other payments on that series of notes on their due date or redemption date&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we have delivered to the trustee an opinion of counsel confirming that holders of the notes will not recognize income, gain or loss for U.S. federal income tax purposes as a result of the covenant defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if the covenant defeasance had not occurred&#59; </font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no Event of Default or event that with the giving of notice or passage of time, or both, would become an Event of Default shall have occurred and be continuing at the time of the deposit described above and no Event of Default described in the fifth bullet point under &#8220;-Events of Default&#8221; shall have occurred and be continuing on the 123</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> day after the date of such deposit&#59; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">such defeasance will not result in a breach or violation of, or constitute a default under, any material agreement or instrument to which we are a party or by which we are bound&#59; and </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we have delivered to the trustee an officers&#8217; certificate and an opinion of counsel in each stating that all conditions precedent provided for or relating to the covenant defeasance have been complied with. </font></div><div style="padding-left:54pt"><font><br></font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we accomplish covenant defeasance, the following provisions, among others, of the indenture and the notes would no longer apply&#58; </font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our promises previously described under &#8220;-Restrictive Covenants-Limitation on Liens&#59;&#8221; </font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:67.5pt;width:100%"><div><font><br></font></div></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our promises previously described under &#8220;-Restrictive Covenants-Sale and Leaseback Transactions&#59;&#8221; </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the events of default relating to breach of such covenants, described under &#8220;-Events of Default&#59;&#8221; and </font></div><div style="padding-left:54pt"><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">certain other covenants applicable to the series of notes. (Sections 402-404) </font></div><div style="padding-left:54pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Book-Entry Notes</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The notes were issued in book-entry form and are represented by global notes deposited with, or on behalf of, a common depositary on behalf of Clearstream and Euroclear, and are registered in the name of the common depositary or its nominee. Except as described herein, certificated notes will not be issued in exchange for beneficial interests in the global notes.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certificated Notes</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Clearstream or Euroclear is at any time unwilling or unable to continue as depositary or ceases to be a clearing agency registered under the Exchange Act, and a successor depositary registered as a clearing agency under the Exchange Act is not appointed by us within 90 days, we will issue notes of like tenor in minimum denominations of &#8364;100,000 principal amount and integral multiples of &#8364;1,000 in excess thereof in definitive form in exchange for an applicable registered global note that had been held by the depositary. Any notes issued in definitive form in exchange for a registered global note will be registered in the name or names that the depositary gives to the trustee or other relevant agent of the trustee. It is expected that the depositary&#8217;s instructions will be based upon directions received by the depositary from participants with respect to ownership of beneficial interests in the applicable registered global note that had been held by the depositary. In addition, we may at any time determine that the notes of an applicable series shall no longer be represented by a global note and will issue notes in definitive form in exchange for such global note pursuant to the procedure described above.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notices</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notices to holders of the notes will be sent by first class mail, postage prepaid, to the registered holders at the physical addresses as they appear in the security registrar for the notes.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trustee, Paying Agent and Security Registrar</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deutsche Bank Trust Company Americas, as trustee under the indenture, is also be the paying agent and security registrar with respect to the notes.</font></div><div><font><br></font></div><div style="height:67.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.38
<SEQUENCE>3
<FILENAME>exhibit1038timesharingagre.htm
<DESCRIPTION>TIME SHARING AGREEMENT WITH WILLIAM F. GIFFORD, JR. DATED FEBRUARY 23, 2023
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i90cb0225ea13421d8c5b1caf0183fc73_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.38</font></div><div style="text-align:right"><font><br></font></div><div style="padding-left:24.75pt;padding-right:24.75pt;text-align:center;text-indent:-29.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">TIME SHARING AGREEMENT</font></div><div><font><br></font></div><div style="text-indent:36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This TIME SHARING AGREEMENT (the &#34;Agreement&#34;) is made and entered into effective as of the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">  23     </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> day of  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"> February </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">, 2023, by and between </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Altria Client Services LLC, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">with an address of 6601 West Broad Street&#59; Richmond, VA 23230 (&#34;Operator&#34;) and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">William F. Gifford Jr.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">with an address of 6601 West Broad Street&#59; Richmond, VA 23230 (&#34;Lessee&#34;).</font></div><div><font><br></font></div><div style="text-indent:35.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, Operator owns the aircraft more particularly described on Exhibit A attached hereto (collectively, the &#34;Company Aircraft&#34;)&#59;</font></div><div><font><br></font></div><div style="text-indent:35.8pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, Operator employs a fully qualified flight crew to operate the Company Aircraft&#59;</font></div><div><font><br></font></div><div style="text-indent:35.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, Lessee is required by the Compensation and Talent Development Committee of the Altria Group, Inc. Board of Directors to use Company Aircraft for all travel for reasons of safety and security&#59;</font></div><div><font><br></font></div><div style="text-indent:37pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, the Compensation and Talent Development Committee of the Altria Group, Inc. Board of Directors has approved a certain annual allowance for personal use of the Company Aircraft (the &#34;Flight Allowance&#34;)&#59; and the Operator and Lessee agree that any personal use of Company Aircraft by Lessee which exceeds the Flight Allowance shall be charged to Lessee in accordance with this Agreement. Lessee's personal use includes use of the Company Aircraft by Lessee's accompanying guests in accordance with the Company Aircraft Usage Policy and Aircraft Usage Procedure&#59; and</font></div><div><font><br></font></div><div style="text-indent:36.05pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">WHEREAS, Operator desires to lease said Company Aircraft with flight crew to Lessee for Lessee's personal use and Lessee agrees to lease said Company Aircraft with flight crew from Operator for his personal use on a time sharing basis pursuant to Section 91.501(b)(6) of the Federal Aviation Regulations (the &#34;FARs&#34;).</font></div><div><font><br></font></div><div style="text-indent:36.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">NOW THEREFORE, Operator and Lessee declaring their intention to enter into and be bound by this Agreement, and for the good and valuable consideration set forth below, hereby covenant and agree as follows&#58;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:26.42pt">Operator agrees to lease the Company Aircraft to Lessee pursuant to the provisions of FAR Section 91.501(b)(6) and to provide a fully qualified flight crew for all operations on a non-continuous basis commencing on the first date set forth herein above and continuing unless and until terminated. Either party may terminate this Agreement by giving written notice to the other party.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:26.42pt">Lessee may use the Company Aircraft from time to time, subject to the prior permission and approval of Operator and in accordance with the Company Aircraft Usage Policy and Aircraft Usage Procedure, for any and all purposes allowed by FAR Section 91.501(b)(6).</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:26.42pt">For all flights or portions thereof made in connection with Lessee's personal use and operated under this Agreement (including deadhead flights associated with personal use), the Operator shall, in accordance with this Agreement and consistent with the Company Aircraft Usage Policy and Aircraft Usage Procedure, debit Lessee's Flight Allowance until such Flight Allowance has been reduced to zero, and thereafter invoice Lessee an amount not to exceed the lesser of Operator's incremental cost for each such flight or portion thereof and the maximum charge authorized by FAR Section 91.501(d).</font></div><div><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;Incremental cost includes flight-related crew lodging and meals away from the Company Aircraft's base of operations&#59; in-flight food and beverages&#59; landing and ground handling fees away from the Company Aircraft's base of operations&#59; hourly maintenance contract costs&#59; hangar or aircraft parking fees away from the Company Aircraft's base of operations&#59; fuel cost (based on the average monthly cost of fuel per hour flown)&#59; and documented additional variable costs.  Incremental cost does not include fixed costs, for example&#58;  Company Aircraft purchase costs&#59; depreciation&#59; maintenance not related to specific flights conducted for Lessee for his personal travel&#59; and flight crew salaries.</font></div><div><font><br></font></div><div style="padding-left:103.5pt;text-indent:-31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;The maximum charge authorized by FAR Section 91.501(d) is, as of the date hereof, the sum of the following&#58;</font></div><div style="margin-top:5pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:58.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:75.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:328.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:36pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(i)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">twice the cost of fuel, oil, lubricants and other additives&#59;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(ii)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">travel expenses of the crew, including food, lodging and ground transportation&#59;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(iii)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">hangar and tie down costs away from the Company Aircraft's base of operations&#59;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(iv)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">insurance obtained for the specific flight&#59;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(v)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">landing fees, airport taxes and similar assessments&#59;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(vi)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">customs, foreign permit and similar fees directly related to the flight</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#59;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(vii)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">in flight food and beverages&#59;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(viii)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">passenger ground transportation&#59; and</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(ix)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">flight planning and weather contract services.</font></div></td></tr></table></div><div style="padding-left:72pt;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;The parties acknowledge that, with the exception of the expenses </font></div><div style="padding-left:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">for in-flight food and beverages and passenger ground transportation, any payments under this Section 3 are subject to the federal excise tax imposed under Section 4261 of the Internal Revenue Code associated with such flight(s).  Operator agrees to collect and remit to the Internal Revenue Service for the benefit of Lessee all such federal excise taxes.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:30.92pt">Operator will provide a monthly invoice to Lessee for the fees and applicable taxes due from Lessee as determined in accordance with Section 3 above. Lessee shall pay or remit to Operator such amounts within 30 days of receipt of the invoice therefore.</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:30.92pt">Lessee will provide Operator with requests for flight time and proposed flight schedules as far in advance of any given flight as possible.  Requests for flight time and proposed flight schedules shall be made in accordance with the Company Aircraft Usage Policy and Aircraft Usage Procedure. In addition to proposed schedules and flight times, Lessee shall provide at least the following information for each proposed flight at some time prior to scheduled departure as required by Operator or Operator's flight crew&#58;</font></div><div><font><br></font></div><div style="margin-top:5pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;proposed departure point&#59;</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;destination&#59;</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;date and time of flight&#59;</font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(d)&#160;&#160;&#160;&#160;the number and names of anticipated passengers&#59;</font></div><div style="padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(e)&#160;&#160;&#160;&#160;designation of each passenger's trip purpose (personal, business, or mixed business&#47;personal)&#59;</font></div><div style="padding-left:108pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(f) &#160;&#160;&#160;&#160;the nature and extent of unusual luggage and&#47;or cargo to be carried&#59;</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(g)&#160;&#160;&#160;&#160;the date and time of a return flight, if any&#59; and</font></div><div style="padding-left:99pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(h)&#160;&#160;&#160;&#160;any other information concerning the proposed flight that may be pertinent or required by Operator or Operator's flight crew.</font></div><div><font><br></font></div><div style="text-indent:72.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Operator shall have final authority over the scheduling of the Company Aircraft and each use of the Company Aircraft by the Lessee shall be subject to Operator's prior approval and in accordance with the Company Aircraft Usage Policy and Aircraft Usage Procedure.  Lessee acknowledges that business utilization of the Company Aircraft will take precedence over Lessee's personal use.</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:30.92pt">Lessee agrees that when, in the reasonable view of Operator or the pilots of the Company Aircraft, safety may be compromised, Operator or the pilots may terminate a flight, refuse to commence a flight, or take other action necessitated by such safety considerations without liability for loss, injury, damage, or delay.  Operator shall not be liable to Lessee or any other person for loss, injury, or damage occasioned by the delay or failure to furnish the Company Aircraft and crew pursuant to this Agreement for any reason.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:30.92pt">Operator shall pay all expenses related to the ownership and operation of Company Aircraft subject to the reimbursements provided for herein.  Operator shall be solely responsible for securing qualified flight crew, maintenance, preventive maintenance and required or otherwise necessary inspections on the Company Aircraft and shall take such requirements into account in scheduling the Company Aircraft.  No period of maintenance, preventive maintenance or inspection shall be delayed or postponed for the purpose of scheduling the Company Aircraft, unless said maintenance or inspection can be safely conducted at a later time in compliance with all applicable laws and regulations, and within the sound discretion of the pilot in command.</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:30.92pt">Operator shall be responsible for the physical and technical operation of the Company Aircraft and the safe performance of all flights and shall retain full authority and control, including exclusive operational control, and possession, command and control of the Company Aircraft at all times during the term of this Agreement.   In accordance with applicable FAR, the qualified flight crew provided by Operator will exercise all required and&#47;or appropriate duties and responsibilities in regard to the safety of each flight conducted hereunder.  The pilot-in-command shall have absolute discretion in all matters concerning the preparation of the Company Aircraft for flight and the flight itself, the load carried and its distribution, the decision whether or not a flight shall be undertaken, the route to be flown, the place where landings shall be made and all other matters relating to operation of the Company Aircraft.  Lessee specifically agrees that the flight crew shall have final and complete authority to delay or cancel any flight for any reason or condition which, in sole judgment of the pilot-in-command, could compromise the safety of the flight and to take any other action which, in the sole judgment of the pilot-in-command, is necessitated by considerations of safety.  No such action of the pilot-in-command shall create or support any liability to Lessee or any other person for loss, injury, damages or delay.</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:30.92pt">Operator may maintain such insurance coverage with respect to the Company Aircraft and any flights made under this Agreement as Operator may elect, in its sole discretion.  Operator will provide such additional insurance coverage as Lessee shall request or require&#59; provided, however, that the cost of such additional insurance will be borne by Lessee.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-4.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.53pt">Lessee warrants that&#58;</font></div><div><font><br></font></div><div style="padding-left:99pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)&#160;&#160;&#160;&#160;he will use the Company Aircraft for and on account of himself, his accompanying personal guests and his own personal business only, and will not accept any compensation whatsoever for any flight or portion thereof conducted under this Agreement&#59;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:99pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)&#160;&#160;&#160;&#160;during the term of this Agreement, he will abide by and conform to all such laws, governmental and airport orders, rules and regulations, as shall from time to time be in effect relating in any way to the operation and use of the Company Aircraft by a time-sharing Lessee&#59; and</font></div><div><font><br></font></div><div style="padding-left:99pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(c)&#160;&#160;&#160;&#160;Lessee shall not, directly or indirectly, create or incur any kind of lien or security interest on or affecting the Company Aircraft or do anything or take any action that might result in the creation of such a lien, and Lessee shall, at Lessee's own expense, promptly take such action as may be necessary to discharge any such lien.</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.53pt">Lessee agrees that the insurance specified in Section 9 shall provide Lessee's sole recourse against Operator, its employees, agents, parents and affiliates, for all claims, losses, liabilities, obligations, demands, suits, judgments or causes of action, penalties, fines, costs and expenses of any nature whatsoever, including attorneys' fees and expenses for or on account of or arising out of, or in any way connected with the use of the Company Aircraft by Lessee or Lessee's guests, including injury to or death of any persons, including Lessee and Lessee's guests, which may result from or arise out of the use or operation of the Company Aircraft during the term of this Agreement.  This Section 11 shall survive termination of this Agreement.</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.53pt">OPERATOR, ITS EMPLOYEES, AGENTS, PARENTS AND AFFILIATES, SHALL IN NO EVENT BE LIABLE TO LESSEE OR LESSEE'S EMPLOYEES, AGENTS, REPRESENTATIVES, GUESTS, OR INVITEES FOR ANY INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES AND&#47;OR PUNITIVE DAMAGES OF ANY KIND OR NATURE UNDER ANY CIRCUMSTANCES OR FOR ANY REASON INCLUDING ANY DELAY OR FAILURE TO FURNISH THE COMPANY AIRCRAFT OR CAUSED OR OCCASIONED BY THE PERFORMANCE OR NON-PERFORMANCE OF ANY SERVICES COVERED BY THIS AGREEMENT.</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.53pt">NEITHER OPERATOR NOR ITS PARENTS, AFFILIATES, EMPLOYEES OR AGENTS MAKES, HAS MADE OR SHALL BE DEEMED TO MAKE OR HAVE MADE ANY WARRANTY OR REPRESENTATION, EITHER EXPRESS OR IMPLIED, WRITTEN OR ORAL, WITH RESPECT TO ANY AIRCRAFT TO BE USED HEREUNDER OR ANY ENGINE OR COMPONENT THEREOF INCLUDING, WITHOUT LIMITATION, ANY WARRANTY AS TO DESIGN, COMPLIANCE WITH SPECIFICATIONS, QUALITY OF MATERIALS OR WORKMANSHIP, MERCHANTABILITY, FITNESS FOR ANY PURPOSE, USE OR OPERATION, OR AIRWORTHINESS.</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.53pt">Neither this Agreement nor either party's interest herein shall be assignable to any other party. Any purported assignment shall be null and void. This Agreement shall inure to the benefit of and be binding upon the parties hereto, their heirs, representatives and successors.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.53pt">This Agreement sets forth the entire agreement between the parties hereto with respect to the transactions contemplated by this Agreement.  No provision of this Agreement may be amended unless such amendment is agreed to in writing and signed by the parties.  If any provision of this Agreement is held to be invalid, illegal, or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.53pt">Nothing herein shall be construed to create a partnership, joint venture, franchise, employer-employee relationship or to create any relationship of principal and agent.</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.53pt">This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Virginia, without regard to its choice of law provisions.</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.53pt">All notices and other communications required or permitted to be given hereunder shall be (as elected by the party giving such notice) (i) personally delivered to the party to whom it is to be given, (ii) transmitted by email, telecopy or facsimile, (iii) transmitted by postage prepaid certified mail, return receipt requested, or (iv) delivered by a recognized overnight courier service, in each case at the following addresses (or at such other addresses for a party as shall be specified by like notice) or to the email address or telecopy number of the party&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(a)    If to Operator&#58;</font></div><div><font><br></font></div><div style="text-indent:99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To&#58; Altria Client Services LLC </font></div><div style="text-indent:99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6601 West Broad Street </font></div><div style="text-indent:99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Richmond, VA  23230 </font></div><div style="text-indent:99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Attn&#58; Clayton J. Wilson</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(b)    If to Lessee&#58;</font></div><div><font><br></font></div><div style="text-indent:99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To&#58; William F. Gifford Jr. </font></div><div style="text-indent:99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">6601 West Broad Street </font></div><div style="text-indent:99pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Richmond, VA  23230</font></div><div><font><br></font></div><div style="text-indent:31.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.53pt">This Agreement may be executed in one or more counterparts each of which will be deemed an original, all of which together shall constitute one and the same agreement.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-40.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:400;line-height:112%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:24.53pt">TRUTH IN LEASING STATEMENT UNDER SECTION 91.23 OF THE FEDERAL AVIATION REGULATIONS (&#34;FAR&#34;).</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:99pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(A)&#160;&#160;&#160;&#160;ALTRIA CLIENT SERVICES LLC (&#34;OPERATOR&#34;) HEREBY CERTIFIES THAT THE COMPANY AIRCRAFT HAVE BEEN INSPECTED AND MAINTAINED WITHIN THE 12 MONTH PERIOD PRECEDING THE DATE OF THIS AGREEMENT IN ACCORDANCE WITH THE PROVISIONS OF FAR PART 91 AND ALL APPLICABLE REQUIREMENTS FOR THE MAINTENANCE AND INSPECTION THEREUNDER HAVE BEEN MET. </font></div><div><font><br></font></div><div style="padding-left:99pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(B)&#160;&#160;&#160;&#160;THE COMPANY AIRCRAFT WILL BE MAINTAINED AND INSPECTED UNDER PART 91 OF THE FEDERAL AVIATION REGULATIONS FOR OPERATIONS TO BE CONDUCTED UNDER THIS AGREEMENT DURING THE DURATION OF THIS AGREEMENT. </font></div><div><font><br></font></div><div style="padding-left:99pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(C)&#160;&#160;&#160;&#160;ALTRIA CLIENT SERVICES LLC WITH AN ADDRESS OF 6601 WEST BROAD STREET&#59; RICHMOND, VA 23230 (&#34;OPERATOR&#34;) AGREES, CERTIFIES AND KNOWINGLY ACKNOWLEDGES THAT WHEN THE COMPANY AIRCRAFT ARE OPERATED UNDER THIS AGREEMENT, IT SHALL BE KNOWN AS, CONSIDERED, AND SHALL IN FACT BE THE OPERATOR OF THE COMPANY AIRCRAFT, AND THAT ALTRIA CLIENT SERVICES LLC UNDERSTANDS ITS RESPONSIBILITIES FOR COMPLIANCE WITH APPLICABLE FEDERAL AVIATION REGULATIONS.</font></div><div><font><br></font></div><div style="padding-left:99pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(D)&#160;&#160;&#160;&#160;THE PARTIES UNDERSTAND THAT AN EXPLANATION OF FACTORS AND PERTINENT FEDERAL AVIATION REGULATIONS BEARING ON OPERATIONAL CONTROL CAN BE OBTAINED FROM THE NEAREST FAA FLIGHT STANDARDS DISTRICT OFFICE.</font></div><div><font><br></font></div><div style="padding-left:99pt;text-indent:-27pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">(E)&#160;&#160;&#160;&#160;LESSEE AND OPERATOR CERTIFY THAT THEY SHALL COMPLY WITH THE TRUTH-IN-LEASING REQUIREMENTS DEFINED IN EXHIBIT B ATTACHED HERETO.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written. The persons signing below warrant their authority to sign.</font></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:232.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:232.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Operator&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Lessee&#58;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ALTRIA CLIENT SERVICES LLC</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">By&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline"> &#47;s&#47; THOMAS H. WATSON</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">&#160;&#47;s&#47; WILLIAM F. GIFFORD, JR.          </font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Name&#58;  Thomas H. Watson</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">William F. Gifford, Jr.</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:1.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Title&#58;     Vice President, Total</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:40.5pt;text-indent:1.65pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Rewards, HR Services &#38;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt 2px 41.5pt;text-align:left;text-indent:1.65pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Aviation</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center;text-indent:26.6pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">EXHIBIT A</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:59.798%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;text-indent:8.4pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Registration Number</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;text-indent:21.3pt;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Serial Number</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 5.5pt;text-align:center;vertical-align:top"><font style="font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%"><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Company Aircraft Description</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="text-indent:20.9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N806AG</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font><br></font></div><div style="text-align:center;text-indent:24.95pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">73086</font></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><font><br></font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2022 Gulfstream Aerospace Corporation G600 Aircraft</font></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font><br></font></div><div style="text-indent:21.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">N805AG</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font><br></font></div><div style="text-align:center;text-indent:24.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">72081</font></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt"><font><br></font></div><div style="padding-left:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2021 Gulfstream Aerospace Corporation G500 Aircraft</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center;text-indent:7.7pt"><font><br></font></div><div style="text-align:center;text-indent:7.7pt"><font><br></font></div><div style="text-align:center;text-indent:7.7pt"><font><br></font></div><div style="text-align:center;text-indent:7.7pt"><font><br></font></div><div style="text-align:center;text-indent:7.7pt"><font><br></font></div><div style="text-align:center;text-indent:7.7pt"><font><br></font></div><div style="text-align:center;text-indent:7.7pt"><font><br></font></div><div style="text-align:center;text-indent:7.7pt"><font><br></font></div><div style="text-align:center;text-indent:7.7pt"><font><br></font></div><div style="text-align:center;text-indent:7.7pt"><font><br></font></div><div style="text-align:center;text-indent:7.7pt"><font><br></font></div><div style="text-align:center;text-indent:7.7pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center;text-indent:7.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">EXHIBIT B</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:112%">INSTRUCTIONS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:112%">FOR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:112%">COMPLIANCE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:112%">WITH</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:112%">TRUTH</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:112%">IN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:112%">LEASING</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11.5pt;font-weight:700;line-height:112%">REQUIREMENTS</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:26.84pt">Mail a copy of the Time Sharing Agreement to the following address via certified mail, return receipt requested, immediately upon execution of the Agreement (14 C.F.R. &#167;91.23(c)(1) requires that the copy be sent </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:112%">within twenty-four (24) hours after it is signed</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#58;</font></div><div><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Federal Aviation Administration </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Aircraft Registration Branch </font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ATTN&#58; Technical Section</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">P.O. Box 25724</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Oklahoma City, Oklahoma 73125</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:26.84pt">At least forty-eight (48) hours prior to the first flight made under this Agreement, Operator (on behalf of Lessee) shall give notice of the proposed flight by telephone, fax or in person to the FAA Flight Standards District Office located nearest the flight.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:26.84pt">Operator shall carry a copy of the Agreement in the Company Aircraft at all times when the Company Aircraft is being operated under the Agreement. The Agreement shall be made available for review upon request by the Administrator of the Federal Aviation Administration.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>4
<FILENAME>exhibit21altriagroupincsub.htm
<DESCRIPTION>SUBSIDIARIES OF ALTRIA GROUP, INC.
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ibefed189e5484c8faf3e50b406ef1a27_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21</font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ALTRIA GROUP, INC. SUBSIDIARIES</font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain subsidiaries of Altria Group, Inc. as of December 31, 2022 and their respective state of incorporation or organization are listed below.  The names of certain other subsidiaries have been omitted because, considered in the aggregate as a single subsidiary, they would not constitute, as of December 31, 2022, a &#8220;significant subsidiary&#8221; as that term is defined in Rule 1-02(w) of Regulation S-X.</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.328%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">State of Incorporation or Organization</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Philip Morris USA Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">U.S. Smokeless Tobacco Company LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UST LLC</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Virginia</font></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>5
<FILENAME>exhibit23consentofindepend.htm
<DESCRIPTION>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if55d5c6c8b9a47ebb855be205a7b187b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23 </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="margin-top:9pt"><font><br></font></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hereby consent to the incorporation by reference in Post-Effective Amendment No.&#160;13 to the Registration Statement on Form S-14 (File No.&#160;2-96149) and in the Registration Statements on Form S-3 (File No. 333-249743) and Form S-8 (File Nos. 333-28631, 33-10218, 33-13210, 33-14561, 33-48781, 33-59109, 333-43478, 333-43484, 333-128494, 333-139523, 333-148070, 333-156188, 333-167516, 333-170185, 333-204477, 333-209701 and 333-238513) of Altria Group, Inc. of our report dated February 1, 2023 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K. </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; PricewaterhouseCoopers LLP </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Richmond, Virginia </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 27, 2023</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>6
<FILENAME>exhibit24powersofattorney2.htm
<DESCRIPTION>POWERS OF ATTORNEY
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iae4e01e299a54e9899d69135c6f341ad_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 24 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The undersigned, a Director of Altria Group, Inc., a Virginia corporation (the &#8220;Company&#8221;), does hereby constitute and appoint William F. Gifford, Jr., Murray R. Garnick, Salvatore Mancuso, and W. Hildebrandt Surgner, Jr., or any one or more of them, his true and lawful attorney, for him and in his name, place and stead, to execute, by manual or facsimile signature, electronic transmission or otherwise, the Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 and any amendments or supplements to said Annual Report and to cause the same to be filed with the Securities and Exchange Commission, together with any exhibits, financial statements and schedules included or to be incorporated by reference therein, hereby granting to said attorneys full power and authority to do and perform all and every act and thing whatsoever requisite or desirable to be done in and about the premises as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all acts and things which said attorneys may do or cause to be done by virtue of these present.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the undersigned has hereunto set his hand and seal this 27th day of February, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; IAN L.T. CLARKE</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ian L.T. Clarke</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="iae4e01e299a54e9899d69135c6f341ad_4"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he undersigned, a Director of Altria Group, Inc., a Virginia corporation (the &#8220;Company&#8221;), does hereby constitute and appoint William F. Gifford, Jr., Murray R. Garnick, Salvatore Mancuso, and W. Hildebrandt Surgner, Jr., or any one or more of them, her true and lawful attorney, for her and in her name, place and stead, to execute, by manual or facsimile signature, electronic transmission or otherwise, the Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 and any amendments or supplements to said Annual Report and to cause the same to be filed with the Securities and Exchange Commission, together with any exhibits, financial statements and schedules included or to be incorporated by reference therein, hereby granting to said attorneys full power and authority to do and perform all and every act and thing whatsoever requisite or desirable to be done in and about the premises as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all acts and things which said attorneys may do or cause to be done by virtue of these present.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the undersigned has hereunto set her hand and seal this 27th day of February, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; MARJORIE M. CONNELLY</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Marjorie M. Connelly</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="iae4e01e299a54e9899d69135c6f341ad_7"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he undersigned, a Director of Altria Group, Inc., a Virginia corporation (the &#8220;Company&#8221;), does hereby constitute and appoint William F. Gifford, Jr., Murray R. Garnick, Salvatore Mancuso, and W. Hildebrandt Surgner, Jr., or any one or more of them, his true and lawful attorney, for him and in his name, place and stead, to execute, by manual or facsimile signature, electronic transmission or otherwise, the Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 and any amendments or supplements to said Annual Report and to cause the same to be filed with the Securities and Exchange Commission, together with any exhibits, financial statements and schedules included or to be incorporated by reference therein, hereby granting to said attorneys full power and authority to do and perform all and every act and thing whatsoever requisite or desirable to be done in and about the premises as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all acts and things which said attorneys may do or cause to be done by virtue of these present.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the undersigned has hereunto set his hand and seal this 27th day of February, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; R. MATT DAVIS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">R. Matt Davis</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="iae4e01e299a54e9899d69135c6f341ad_10"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he undersigned, a Director of Altria Group, Inc., a Virginia corporation (the &#8220;Company&#8221;), does hereby constitute and appoint William F. Gifford, Jr., Murray R. Garnick, Salvatore Mancuso, and W. Hildebrandt Surgner, Jr., or any one or more of them, his true and lawful attorney, for him and in his name, place and stead, to execute, by manual or facsimile signature, electronic transmission or otherwise, the Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 and any amendments or supplements to said Annual Report and to cause the same to be filed with the Securities and Exchange Commission, together with any exhibits, financial statements and schedules included or to be incorporated by reference therein, hereby granting to said attorneys full power and authority to do and perform all and every act and thing whatsoever requisite or desirable to be done in and about the premises as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all acts and things which said attorneys may do or cause to be done by virtue of these present.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the undersigned has hereunto set his hand and seal this 27th day of February, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; JACINTO J. HERNANDEZ</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Jacinto J. Hernandez</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="iae4e01e299a54e9899d69135c6f341ad_13"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he undersigned, a Director of Altria Group, Inc., a Virginia corporation (the &#8220;Company&#8221;), does hereby constitute and appoint William F. Gifford, Jr., Murray R. Garnick, Salvatore Mancuso, and W. Hildebrandt Surgner, Jr., or any one or more of them, her true and lawful attorney, for her and in her name, place and stead, to execute, by manual or facsimile signature, electronic transmission or otherwise, the Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 and any amendments or supplements to said Annual Report and to cause the same to be filed with the Securities and Exchange Commission, together with any exhibits, financial statements and schedules included or to be incorporated by reference therein, hereby granting to said attorneys full power and authority to do and perform all and every act and thing whatsoever requisite or desirable to be done in and about the premises as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all acts and things which said attorneys may do or cause to be done by virtue of these present.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the undersigned has hereunto set her hand and seal this 27th day of February, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; DEBRA J. KELLY-ENNIS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Debra J. Kelly-Ennis</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="iae4e01e299a54e9899d69135c6f341ad_19"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he undersigned, a Director of Altria Group, Inc., a Virginia corporation (the &#8220;Company&#8221;), does hereby constitute and appoint William F. Gifford, Jr., Murray R. Garnick, Salvatore Mancuso, and W. Hildebrandt Surgner, Jr., or any one or more of them, her true and lawful attorney, for her and in her name, place and stead, to execute, by manual or facsimile signature, electronic transmission or otherwise, the Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 and any amendments or supplements to said Annual Report and to cause the same to be filed with the Securities and Exchange Commission, together with any exhibits, financial statements and schedules included or to be incorporated by reference therein, hereby granting to said attorneys full power and authority to do and perform all and every act and thing whatsoever requisite or desirable to be done in and about the premises as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all acts and things which said attorneys may do or cause to be done by virtue of these present.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the undersigned has hereunto set her hand and seal this 27th day of February, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; KATHRYN B. MCQUADE</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Kathryn B. McQuade</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="iae4e01e299a54e9899d69135c6f341ad_22"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he undersigned, a Director of Altria Group, Inc., a Virginia corporation (the &#8220;Company&#8221;), does hereby constitute and appoint William F. Gifford, Jr., Murray R. Garnick, Salvatore Mancuso, and W. Hildebrandt Surgner, Jr., or any one or more of them, his true and lawful attorney, for him and in his name, place and stead, to execute, by manual or facsimile signature, electronic transmission or otherwise, the Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 and any amendments or supplements to said Annual Report and to cause the same to be filed with the Securities and Exchange Commission, together with any exhibits, financial statements and schedules included or to be incorporated by reference therein, hereby granting to said attorneys full power and authority to do and perform all and every act and thing whatsoever requisite or desirable to be done in and about the premises as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all acts and things which said attorneys may do or cause to be done by virtue of these present.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the undersigned has hereunto set his hand and seal this 27th day of February, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; GEORGE MU&#209;OZ</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">George Mu&#241;oz</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="iae4e01e299a54e9899d69135c6f341ad_25"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he undersigned, a Director of Altria Group, Inc., a Virginia corporation (the &#8220;Company&#8221;), does hereby constitute and appoint William F. Gifford, Jr., Murray R. Garnick, Salvatore Mancuso, and W. Hildebrandt Surgner, Jr., or any one or more of them, his true and lawful attorney, for him and in his name, place and stead, to execute, by manual or facsimile signature, electronic transmission or otherwise, the Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 and any amendments or supplements to said Annual Report and to cause the same to be filed with the Securities and Exchange Commission, together with any exhibits, financial statements and schedules included or to be incorporated by reference therein, hereby granting to said attorneys full power and authority to do and perform all and every act and thing whatsoever requisite or desirable to be done in and about the premises as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all acts and things which said attorneys may do or cause to be done by virtue of these present.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the undersigned has hereunto set his hand and seal this 27th day of February, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; NABIL Y. SAKKAB</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Nabil Y. Sakkab</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="iae4e01e299a54e9899d69135c6f341ad_28"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he undersigned, a Director of Altria Group, Inc., a Virginia corporation (the &#8220;Company&#8221;), does hereby constitute and appoint William F. Gifford, Jr., Murray R. Garnick, Salvatore Mancuso, and W. Hildebrandt Surgner, Jr., or any one or more of them, her true and lawful attorney, for her and in her name, place and stead, to execute, by manual or facsimile signature, electronic transmission or otherwise, the Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 and any amendments or supplements to said Annual Report and to cause the same to be filed with the Securities and Exchange Commission, together with any exhibits, financial statements and schedules included or to be incorporated by reference therein, hereby granting to said attorneys full power and authority to do and perform all and every act and thing whatsoever requisite or desirable to be done in and about the premises as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all acts and things which said attorneys may do or cause to be done by virtue of these present.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the undersigned has hereunto set her hand and seal this 27th day of February, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; VIRGINIA E. SHANKS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Virginia E. Shanks</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="iae4e01e299a54e9899d69135c6f341ad_31"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he undersigned, a Director of Altria Group, Inc., a Virginia corporation (the &#8220;Company&#8221;), does hereby constitute and appoint William F. Gifford, Jr., Murray R. Garnick, Salvatore Mancuso, and W. Hildebrandt Surgner, Jr., or any one or more of them, her true and lawful attorney, for her and in her name, place and stead, to execute, by manual or facsimile signature, electronic transmission or otherwise, the Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 and any amendments or supplements to said Annual Report and to cause the same to be filed with the Securities and Exchange Commission, together with any exhibits, financial statements and schedules included or to be incorporated by reference therein, hereby granting to said attorneys full power and authority to do and perform all and every act and thing whatsoever requisite or desirable to be done in and about the premises as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all acts and things which said attorneys may do or cause to be done by virtue of these present.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the undersigned has hereunto set her hand and seal this 27th day of February, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; ELLEN R. STRAHLMAN</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ellen R. Strahlman</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="iae4e01e299a54e9899d69135c6f341ad_549755814167"></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">POWER OF ATTORNEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he undersigned, a Director of Altria Group, Inc., a Virginia corporation (the &#8220;Company&#8221;), does hereby constitute and appoint William F. Gifford, Jr., Murray R. Garnick, Salvatore Mancuso, and W. Hildebrandt Surgner, Jr., or any one or more of them, his true and lawful attorney, for him and in his name, place and stead, to execute, by manual or facsimile signature, electronic transmission or otherwise, the Annual Report on Form 10-K of the Company for the year ended December&#160;31, 2022 and any amendments or supplements to said Annual Report and to cause the same to be filed with the Securities and Exchange Commission, together with any exhibits, financial statements and schedules included or to be incorporated by reference therein, hereby granting to said attorneys full power and authority to do and perform all and every act and thing whatsoever requisite or desirable to be done in and about the premises as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all acts and things which said attorneys may do or cause to be done by virtue of these present.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the undersigned has hereunto set his hand and seal this 27th day of February, 2023.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; M. MAX YZAGUIRRE</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">M. Max Yzaguirre</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>exhibit311q42022-annual.htm
<DESCRIPTION>CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ib197f743c54943f0ad50a336af3548da_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:right"><font><br></font></div><div style="padding-left:32.62pt;padding-right:32.62pt;text-align:center;text-indent:-29.25pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certifications</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, William F. Gifford, Jr., certify that&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Altria Group, Inc.&#59;</font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:40.5pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;  February 27, 2023</font></div><div style="margin-top:5pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:64.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.742%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; WILLIAM F. GIFFORD, JR.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William F. Gifford, Jr.</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:15.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer </font></div></td></tr></table></div><div style="padding-right:15.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>exhibit312q42022-annual.htm
<DESCRIPTION>CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A)/15D-14(A)
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic16a50b37d854c8faa6a04f3da631243_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:right"><font><br></font></div><div style="padding-left:16.87pt;padding-right:16.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certifications</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Salvatore Mancuso, certify that&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Altria Group, Inc.&#59;</font></div><div style="padding-left:15.75pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:15.75pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:15.75pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;padding-right:15.75pt;text-align:justify;text-indent:-36pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and </font></div><div style="padding-left:58.5pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:18pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:40.5pt;padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;padding-right:15.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting. </font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58;  February 27, 2023</font></div><div style="margin-top:5pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.929%"><tr><td style="width:1.0%"></td><td style="width:64.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.742%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; SALVATORE MANCUSO</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salvatore Mancuso</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and </font></div><div style="padding-right:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td></tr></table></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:24.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>9
<FILENAME>exhibit321q42022-annual.htm
<DESCRIPTION>CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i216d90966ef649d9a0708f33cdc650e3_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the Annual Report of Altria Group, Inc. (the &#8220;Company&#8221;) on Form 10-K for the period ended December&#160;31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, William F. Gifford, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; WILLIAM F. GIFFORD, JR.</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">William F. Gifford, Jr.</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Executive Officer</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">February 27, 2023</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-left:16.87pt;padding-right:16.87pt;text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>10
<FILENAME>exhibit322q42022-annual.htm
<DESCRIPTION>CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i222fc3949d4444829e061ef2abc9729c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="padding-left:7.87pt;padding-right:7.87pt;text-align:center"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In connection with the Annual Report of Altria Group, Inc. (the &#8220;Company&#8221;) on Form 10-K for the period ended December&#160;31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Salvatore Mancuso, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="padding-right:15.75pt"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(1)&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(2)&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; SALVATORE MANCUSO</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Salvatore Mancuso</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Executive Vice President and</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Chief Financial Officer</font></div><div style="padding-right:15.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">February 27, 2023</font></div><div style="padding-right:15.75pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>11
<FILENAME>exhibit991q42022-annual.htm
<DESCRIPTION>CERTAIN LITIGATION MATTERS
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i46053ff16fc64a2d852afacd7580c1d8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN LITIGATION MATTERS</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Item 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Annual Report on Form 10-K, to which this Exhibit 99.1 is attached (&#8220;Item 3&#8221;) and in Note 17. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to Altria Group, Inc.&#8217;s (&#8220;Altria&#8221;) consolidated financial statements in</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Item 8 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of such Annual Report on Form 10-K (&#8220;Note 17&#8221;), there are legal proceedings covering a wide range of matters pending or threatened in various United States and foreign jurisdictions against Altria, its subsidiaries, including Philip Morris USA Inc. (&#8220;PM USA&#8221;), and their respective indemnitees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, tax, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act, claims for contribution and claims of competitors, shareholders or distributors.  Claims related to tobacco products generally fall within the following categories&#58; (i) smoking and health cases alleging personal injury brought on behalf of individual plaintiffs, (ii) smoking and health cases primarily alleging personal injury or seeking court-supervised programs for ongoing medical monitoring and purporting to be brought on behalf of a class of individual plaintiffs, including cases in which the aggregated claims of a number of individual plaintiffs are to be tried in a single proceeding, (iii) health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and&#47;or disgorgement of profits, (iv) class action suits alleging that the use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law fraud or statutory fraud, unjust enrichment, breach of warranty, or violations of the Racketeer Influenced and Corrupt Organizations Act, (v) class action suits involving e-vapor products and (vi) international cases.  The following lists certain of the pending claims against Altria and PM USA included in these and other categories.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SMOKING AND HEALTH LITIGATION</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists the consolidated individual smoking and health cases as well as smoking and health class actions pending against PM USA and, in some cases, Altria and&#47;or its other subsidiaries and affiliates, as of February 23, 2023.  See </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Cases </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a list of smoking and health class actions pending in Canada.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Flight Attendant Litigation</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The settlement agreement entered into in 1997 in the case of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broin, et al. v. Philip Morris Companies Inc., et al.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which was brought by flight attendants seeking damages for personal injuries allegedly caused by environmental tobacco smoke, allowed members of the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broin </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">class to file individual lawsuits seeking compensatory damages, but prohibited them from seeking punitive damages.  See Note 17 for a discussion of this litigation.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Domestic Class Actions</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle, et al. v. R.J. Reynolds Tobacco Co., et al., Circuit Court, Eleventh Judicial Circuit, Dade County, Florida, filed May 5, 1994.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 17 for a discussion of this case (which has concluded) and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny litigation.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Young, et al. v. The American Tobacco Company, et al., Civil District Court, Orleans Parish, Louisiana, filed November 12, 1997.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HEALTH CARE COST RECOVERY LITIGATION</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists a health care cost recovery action pending against PM USA and Altria as of February 23, 2023.  See </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Cases </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a list of international health care cost recovery actions.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Department of Justice Case</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The United States of America v. Philip Morris Incorporated, et al., United States District Court, District of Columbia, filed September 22, 1999</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  See Note 17 for a discussion of this case.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;LIGHTS&#47;ULTRA LIGHTS&#8221; CASES</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists the &#8220;Lights&#47;Ultra Lights&#8221; class actions pending against Altria and&#47;or its various subsidiaries and others as of February 23, 2023.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Moore, et al. v. Philip Morris Incorporated, et al., Circuit Court, Marshall County, West Virginia, filed September 17, 2001.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Virden v. Altria Group, Inc., et al., Circuit Court, Hancock County, West Virginia, filed March 28, 2003.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CLASS ACTION LAWSUITS INVOLVING E-VAPOR PRODUCTS</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists class action lawsuits relating to e-vapor products that are pending against Altria and&#47;or its various subsidiaries and others as of February 23, 2023.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">NesSmith, et al. v. JUUL Labs Inc., et al., United States District Court, Middle District of Florida, filed April 15, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peavy (formerly Swearingen), et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Alabama, filed May 31, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R.E., et al. v. JUUL Labs, Inc., et al., United States District Court, Southern District of West Virginia, filed August 13, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">M.D., et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Mississippi, filed August 15, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oberhauser, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed September 12, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hochhauser, et al. v. JUUL Labs, Inc., et al., United States District Court, Eastern District of New York, filed October 1, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Emidy et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Tennessee, filed October 2, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Montgomery County, Maryland, et al. v. JUUL Labs, Inc., et al., United States District Court, District of Maryland, filed October 11, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">King County, Washington, et al. v. JUUL Labs, Inc., et al., United States District Court, Western District of Washington, filed October 16, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">City of Rochester, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed November 6, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jefferson County School District, et al. v. JUUL Labs, Inc., et al., United States District Court, Southern District of Mississippi, filed December 5, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ledbetter, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Alabama, filed December 12, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Escambia County School District, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Florida, filed December 18, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unified School District No. 320, Pottawatomie County, KS, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed December 18, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">School Board of Miami-Dade County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The School Board of Broward County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Frederick County, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed December 19, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Imani, et al. v. JUUL Labs, Inc., et al., United States District Court, District of Oregon, filed December 20, 2019.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cooper, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of Texas, filed January 9, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">O&#8217;Reilly, et al. v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed January 13, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gabbard, et al. v. JUUL Labs, Inc., et al., United States District Court, Eastern District of Kentucky, filed February 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Peoria Public Schools v. JUUL Labs, Inc., et al., United States District Court, Northern District of California, filed May 15, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Montgomery County Public Schools, MD. v. JUUL Labs, Inc. et al., United States District Court, Northern District of California, filed December 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Baltimore County v. JUUL Labs, Inc., et al. United States District Court, Northern District of California, filed December 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ann Parker, On Behalf Of Her Daughter, S.P., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 29, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adam Jenkins, Individually And On Behalf Of Others Similarly Situated, On Behalf Of D.L.J. v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charleen Richey, On Behalf Of Her Son, T.Y., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shayla Aceti, individually and on behalf of others similarly situated v. Juul Labs Inc et al., United States District Court, Northern District of California, filed March 30, 2021. </font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Robert Dyer, On Behalf Of His Son, B.D., individually and on behalf of others similarly situated v. Juul Labs Inc., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Joan Eubanks, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bruce Gibson, on behalf of his son, K.G., individually and others similarly situated v.  Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jenika Ingram, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shirley Moses on behalf of her daughter, K.S.C., individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Katherine Dentler, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vickie Perry, On Behalf Of Her Daughter LP, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jessica Pierre, individually and on behalf of others similarly situated v. Juul Labs Inc.&#59; Altria Group Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lacretia Pulce, On Behalf Of Her Daughter, K.P., individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charles Tippe, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Janece Wilhelm, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Janece Wilhelm, on behalf of her son. D.L., individually and on behalf of others similarly situated v. Juul Labs Inc.&#59; et al., United States District Court, Northern District of California, filed April 1, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tonya Williams-Walker, On Behalf Of Her Son, M.W., and on behalf of others similarly situated v. Juul Labs Inc.et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Randi Lines, individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adam Jenkins, On Behalf Of His Son, M.R.J., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ann Parker, On Behalf Of Her Daughter, S.P., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 29, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Erin Puente, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shannon Kinnard, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">John Hollis, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Wolfgang and Suzanne Ziegenhagen on behalf of their son, H.Z. individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Janis Kelly on behalf of her son, C.J.W., individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Coleman Holniker, individually and On Behalf of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Addison Altizer, individually and On Behalf Of Others Similarly Situated, v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Charleen Richey, On Behalf Of Her Son, T.Y., Individually And On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed March 31, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nicholas Vogel, on behalf of his son, E.V., individually and on behalf of others similarly situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed May 13, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pike County School Corp. Metropolitan School District Of Wabash County, Individually &#38; On Behalf Of Others Similarly Situated v. Juul Labs Inc. et al., United States District Court, Northern District of California, filed April 18, 2022.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 17 for a discussion of these cases.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IQOS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> LITIGATION</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">RAI Strategic Holdings, Inc., et al. v. Altria Client Services LLC, et al., United States District Court, Eastern District of Virginia, filed April 9, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Tobacco Heating Articles and Components Thereof, United States International Trade Commission, filed April 9, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Healthier Choices Management Corp. v. Philip Morris USA Inc., et al., United States District Court, Northern District of Georgia, filed December 4, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 17 for a discussion of these cases.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANTITRUST LITIGATION</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In re Altria Group, Inc., et al., United States of America Before the Federal Trade Commission, filed April 1, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reece, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 7, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Blomquist, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 13, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Martinez, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 14, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Deadwyler, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 20, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licari, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Flannery, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed April 27, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Walsh, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed May 8, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Redfield, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed May 15, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Carlson, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed May 21, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">B&#38;C Retail, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 11, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sofijon, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 11, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noor Baig, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 11, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Somerset Party Store, Inc., et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 18, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jackson, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed June 25, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McGhee, et al. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed July 1, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Irwindale Fuel Station, Inc. v. Altria Group, Inc., et al., United States District Court, Northern District of California, filed July 15, 2020.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHAREHOLDER DERIVATIVE LAWSUITS</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sandys, et al. v. Willard, et al., United States District Court, Northern District of California, filed August 7, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lorca, et al. v. Gifford, et al., United States District Court, Northern District of California, filed August 27, 2020.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cohen, et al. v. Willard, et al., Circuit Court for Henrico County, Virginia, filed September 14, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gilbert, et al. v. Gifford et al., United States District Court, Eastern District of Virginia, filed October 1, 2020.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hamilton et al. v. Gifford et al., United States District Court, Eastern District of Virginia, filed January 25, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Randolph et al. v. Gifford et al., United States District Court, Eastern District of Virginia, filed March 28, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Braunstein et al. v. Gifford et al., Circuit Court for Henrico County, Virginia, filed May 18, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Lopez et al. v. Casteen et al., Circuit Court for Henrico County, Virginia, filed June 16, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Merritts et al. v. Casteen et al., Circuit Court for Albemarle County, Virginia, filed July 30, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dalton et al. v. W. Hildebrandt Surgner et al., Circuit Court for Henrico County, Virginia, filed August 17, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McCollum et al. v. Gifford et al., Circuit Court for Henrico County, Virginia, filed August 26, 2021.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See  Note 17 for a discussion of these cases.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTERNATIONAL CASES</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following lists cases pending against Altria and&#47;or its subsidiaries in foreign jurisdictions as of February 23, 2023.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Canada</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">O&#8217;Donnell, et. al. v. JUUL Labs, Canada, Ltd., et al., Ontario, Ontario Superior Court, filed April 17, 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  E-vapor class action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Salvatore, et al. v. JUUL Labs Canada, Ltd., et al., Quebec, District of Montreal Superior Court, filed June 12, 2019.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E-vapor class action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stephens, et al. v. JUUL Labs, Inc., et al., British Columbia, Canada Supreme Court, filed October 1, 2019.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E-vapor class action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada, filed January 24, 2001.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of the Province of New Brunswick v. Rothmans, Inc., et al., Court of Queen&#8217;s Bench of New Brunswick Judicial District of Fredericton, Canada, filed March 13, 2008.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dorion v. Canadian Tobacco Manufacturers&#8217; Council, et al., Court of Queen&#8217;s Bench of Alberta, Judicial District of Calgary, Canada, filed on or about June 17, 2009</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Smoking and health class action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Semple v. Canadian Tobacco Manufacturers&#8217; Council, et al., Supreme Court of Nova Scotia, Canada, filed on or about June 18, 2009.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kunta v. Canadian Tobacco Manufacturers&#8217; Council, et al., Court of Queen&#8217;s Bench of Manitoba, Winnipeg Judicial Centre, Canada, filed on an unknown date in June 2009</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Smoking and health class action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adams v. Canadian Tobacco Manufacturers&#8217; Council, et al., Court of Queen&#8217;s Bench for Saskatchewan, Judicial Centre of Regina, Canada, filed on or about July 10, 2009.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Superior Court of Justice of Ontario, Canada, filed on or about September 30, 2009.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bourassa v. Imperial Tobacco Canada Limited, et al., Supreme Court of British Columbia, Victoria Registry, Canada, filed on or about June 25, 2010.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McDermid v. Imperial Tobacco Canada Limited, et al., Supreme Court of British Columbia, Victoria Registry, Canada, filed on or about June 25, 2010.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, Trial Division, Canada, filed February 8, 2011</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Health care cost recovery action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Attorney General of Quebec v. Imperial Tobacco Canada Limited, et al., Superior Court of Quebec, Montreal District, Canada, filed June 8, 2012</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Health care cost recovery action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Court of Queen&#8217;s Bench of Alberta, Judicial District of Calgary, Canada, filed June 8, 2012</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Health care cost recovery action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in the Right of Manitoba v. Rothmans, Benson &#38; Hedges Inc., et al., Court of Queen&#8217;s Bench of Manitoba, Winnipeg Judicial Centre, Canada, filed May 31, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of Saskatchewan v. Rothmans, Benson &#38; Hedges Inc., et al., Court of Queen&#8217;s Bench of Saskatchewan, Judicial Centre of Saskatoon, Canada, filed on June 8, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty in the Right of the Province of Prince Edward Island v. Rothmans, Benson &#38; Hedges, Inc., et al., Supreme Court of Prince Edward Island, filed on September 10, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Her Majesty the Queen in Right of the Province of Nova Scotia v. Benson &#38; Hedges, Inc., et al., Supreme Court of Nova Scotia, filed on January 2, 2015.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care cost recovery action.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jacklin v. Canadian Tobacco Manufacturers&#8217; Council et al., Ontario Superior Court of Justice, Case No. 5379412, Ontario, Canada, filed on or about June 27, 2012.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smoking and health class action.  </font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 17 for a discussion of these cases.</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>12
<FILENAME>exhibit992q42022-annual.htm
<DESCRIPTION>TRIAL SCHEDULE FOR CERTAIN CASES
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="icc15090f1798461abc4ab766a54f46ae_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.2</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:9pt;text-align:center"><font><br></font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRIAL SCHEDULE FOR CERTAIN CASES </font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a schedule, as of February 23, 2023, setting forth by month the number of individual smoking and health cases against Philip Morris USA Inc. that are scheduled for but not in trial through April 30, 2023. </font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2023</font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:5pt;margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.146%"><tr><td style="width:1.0%"></td><td style="width:76.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td></tr></table></div><div style="margin-bottom:4.4pt"><font><br></font></div><div style="margin-bottom:4.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February 23, 2023, there are no </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in trial.</font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other Individual Smoking&#160;&#38; Health </font></div><div style="margin-bottom:5pt;margin-top:9.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:25.146%"><tr><td style="width:1.0%"></td><td style="width:76.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.575%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></td></tr></table></div><div style="margin-bottom:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:4.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February 23, 2023, there are no non-</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases in trial.</font></div><div style="margin-bottom:4.4pt"><font><br></font></div><div style="margin-bottom:4.4pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:4.5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>mo-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:dfb2a125-0b18-4fdf-aa8f-28a7e5cf9d49,g:08272963-4e0b-4a36-8744-7641bada9ecd-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mo="http://www.altria.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.altria.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2022" schemaLocation="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mo-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.altria.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.altria.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.altria.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000003 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.altria.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000004 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEarnings" roleURI="http://www.altria.com/role/ConsolidatedStatementsofEarnings">
        <link:definition>0000005 - Statement - Consolidated Statements of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveEarnings" roleURI="http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings">
        <link:definition>0000006 - Statement - Consolidated Statements of Comprehensive Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.altria.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityDeficit" roleURI="http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit">
        <link:definition>0000008 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquityDeficitParenthetical" roleURI="http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical">
        <link:definition>0000009 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentation" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentation">
        <link:definition>0000010 - Disclosure - Background and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.altria.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000011 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesfromContractswithCustomers" roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomers">
        <link:definition>0000012 - Disclosure - Revenues from Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsnet" roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnet">
        <link:definition>0000013 - Disclosure - Goodwill and Other Intangible Assets, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecurities" roleURI="http://www.altria.com/role/InvestmentsinEquitySecurities">
        <link:definition>0000014 - Disclosure - Investments in Equity Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.altria.com/role/FinancialInstruments">
        <link:definition>0000015 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermBorrowingsandBorrowingArrangements" roleURI="http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangements">
        <link:definition>0000016 - Disclosure - Short-Term Borrowings and Borrowing Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://www.altria.com/role/LongTermDebt">
        <link:definition>0000017 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStock" roleURI="http://www.altria.com/role/CapitalStock">
        <link:definition>0000018 - Disclosure - Capital Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlans" roleURI="http://www.altria.com/role/StockPlans">
        <link:definition>0000019 - Disclosure - Stock Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShare" roleURI="http://www.altria.com/role/EarningsperShare">
        <link:definition>0000020 - Disclosure - Earnings per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLosses" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLosses">
        <link:definition>0000021 - Disclosure - Other Comprehensive Earnings/Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.altria.com/role/IncomeTaxes">
        <link:definition>0000022 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.altria.com/role/SegmentReporting">
        <link:definition>0000023 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlans" roleURI="http://www.altria.com/role/BenefitPlans">
        <link:definition>0000024 - Disclosure - Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AdditionalInformation" roleURI="http://www.altria.com/role/AdditionalInformation">
        <link:definition>0000025 - Disclosure - Additional Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.altria.com/role/Contingencies">
        <link:definition>0000026 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicy" roleURI="http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy">
        <link:definition>0000027 - Disclosure - Summary of Significant Accounting Policies (Policy)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://www.altria.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>0000028 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsnetTables" roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetTables">
        <link:definition>0000029 - Disclosure - Goodwill and Other Intangible Assets, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesTables" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesTables">
        <link:definition>0000030 - Disclosure - Investments in Equity Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.altria.com/role/FinancialInstrumentsTables">
        <link:definition>0000031 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongtermDebtTables" roleURI="http://www.altria.com/role/LongtermDebtTables">
        <link:definition>0000032 - Disclosure - Long-term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockTables" roleURI="http://www.altria.com/role/CapitalStockTables">
        <link:definition>0000033 - Disclosure - Capital Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansTables" roleURI="http://www.altria.com/role/StockPlansTables">
        <link:definition>0000034 - Disclosure - Stock Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareTables" roleURI="http://www.altria.com/role/EarningsperShareTables">
        <link:definition>0000035 - Disclosure - Earnings per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningslossesTables" roleURI="http://www.altria.com/role/OtherComprehensiveEarningslossesTables">
        <link:definition>0000036 - Disclosure - Other Comprehensive Earnings/losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.altria.com/role/IncomeTaxesTables">
        <link:definition>0000037 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.altria.com/role/SegmentReportingTables">
        <link:definition>0000038 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansTables" roleURI="http://www.altria.com/role/BenefitPlansTables">
        <link:definition>0000039 - Disclosure - Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AdditionalInformationTables" roleURI="http://www.altria.com/role/AdditionalInformationTables">
        <link:definition>0000040 - Disclosure - Additional Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesTables" roleURI="http://www.altria.com/role/ContingenciesTables">
        <link:definition>0000041 - Disclosure - Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundandBasisofPresentationBackgroundNarrativeDetails" roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails">
        <link:definition>0000042 - Disclosure - Background and Basis of Presentation (Background Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>0000043 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesfromContractswithCustomersNarrativeDetails" roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails">
        <link:definition>0000044 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails" roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails">
        <link:definition>0000045 - Disclosure - Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Intangible Assets by Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails" roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails">
        <link:definition>0000046 - Disclosure - Goodwill and Other Intangible Assets, net (Other Intangible Assets Disclosure) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsnetNarrativeDetails" roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails">
        <link:definition>0000047 - Disclosure - Goodwill and Other Intangible Assets, net (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails" roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails">
        <link:definition>0000048 - Disclosure - Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Net Carrying Amount of Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails">
        <link:definition>0000049 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails">
        <link:definition>0000050 - Disclosure - Investments in Equity Securities (Earnings from Equity Investments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails">
        <link:definition>0000051 - Disclosure - Investments in Equity Securities (Summary of Financial Data) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails">
        <link:definition>0000052 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails">
        <link:definition>0000053 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details">
        <link:definition>0000054 - Disclosure - Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails">
        <link:definition>0000055 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsinEquitySecuritiesInvestmentinCronosDetails" roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails">
        <link:definition>0000056 - Disclosure - Investments in Equity Securities (Investment in Cronos) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>0000057 - Disclosure - Financial Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsAggregateFairValueandCarryingValueDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails">
        <link:definition>0000058 - Disclosure - Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails">
        <link:definition>0000059 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails" roleURI="http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails">
        <link:definition>0000060 - Disclosure - Short-Term Borrowings and Borrowing Arrangements (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtSummaryofLongTermDebtDetails" roleURI="http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails">
        <link:definition>0000061 - Disclosure - Long-Term Debt (Summary of Long-Term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDetailsofLongTermDebtDetails" roleURI="http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails">
        <link:definition>0000062 - Disclosure - Long-Term Debt (Details of Long-Term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtAggregateMaturitiesofLongTermDebtDetails" roleURI="http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails">
        <link:definition>0000063 - Disclosure - Long-Term Debt (Aggregate Maturities of Long-Term Debt) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://www.altria.com/role/LongTermDebtNarrativeDetails">
        <link:definition>0000064 - Disclosure - Long-Term Debt (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDebtTenderOffersandRedemptionDetails" roleURI="http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails">
        <link:definition>0000065 - Disclosure - Long-Term Debt (Debt Tender Offers and Redemption (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockNarrativeDetails" roleURI="http://www.altria.com/role/CapitalStockNarrativeDetails">
        <link:definition>0000066 - Disclosure - Capital Stock (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails" roleURI="http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails">
        <link:definition>0000067 - Disclosure - Capital Stock (Schedule of Issued Repurchased and Outstanding Shares) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockScheduleofSharesRepurchasedDetails" roleURI="http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails">
        <link:definition>0000068 - Disclosure - Capital Stock (Schedule of Shares Repurchased) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansNarrativeDetails" roleURI="http://www.altria.com/role/StockPlansNarrativeDetails">
        <link:definition>0000069 - Disclosure - Stock Plans (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails" roleURI="http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails">
        <link:definition>0000070 - Disclosure - Stock Plans (Schedule of Restricted and Restricted Stock Units Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsperShareDetails" roleURI="http://www.altria.com/role/EarningsperShareDetails">
        <link:definition>0000071 - Disclosure - Earnings per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails">
        <link:definition>0000072 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherComprehensiveEarningsLossesReclassificationsDetails" roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails">
        <link:definition>0000073 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails" roleURI="http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails">
        <link:definition>0000074 - Disclosure - Income Taxes (Schedule of Earnings Before Income Taxes and Provision for Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails" roleURI="http://www.altria.com/role/IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails">
        <link:definition>0000075 - Disclosure - Income Taxes (Reconciliation of Beginning and Ending Unrecognized Tax Benefits) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.altria.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>0000076 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails" roleURI="http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails">
        <link:definition>0000077 - Disclosure - Income Taxes (Reconciliation of Effective Tax Rate and U.S. Federal Statutory Rate) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails" roleURI="http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails">
        <link:definition>0000078 - Disclosure - Income Taxes (Schedule of Deferred Income Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofValuationAllowanceDetails" roleURI="http://www.altria.com/role/IncomeTaxesSummaryofValuationAllowanceDetails">
        <link:definition>0000079 - Disclosure - Income Taxes (Summary of Valuation Allowance) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNarrativeDetails" roleURI="http://www.altria.com/role/SegmentReportingNarrativeDetails">
        <link:definition>0000080 - Disclosure - Segment Reporting (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingSegmentDataScheduleDetails" roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails">
        <link:definition>0000081 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails" roleURI="http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails">
        <link:definition>0000082 - Disclosure - Segment Reporting (Schedule of Depreciation Expense and Capital Expenditures of Segments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails" roleURI="http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails">
        <link:definition>0000083 - Disclosure - Segment Reporting (Non-Participating Manufacturer Adjustment Items) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails" roleURI="http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails">
        <link:definition>0000084 - Disclosure - Segment Reporting (Schedule of Pre-tax Tobacco and Health Litigation Charges) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansNarrativeDetails" roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails">
        <link:definition>0000085 - Disclosure - Benefit Plans (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails" roleURI="http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails">
        <link:definition>0000086 - Disclosure - Benefit Plans (Projected Benefit Obligations, Plan Assets and Funded Status of Pension Plans) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails" roleURI="http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails">
        <link:definition>0000087 - Disclosure - Benefit Plans (Assumptions to Determine Postretirement Benefit Obligations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails" roleURI="http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails">
        <link:definition>0000088 - Disclosure - Benefit Plans (Schedule of Components of Net Periodic Pension Cost) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails" roleURI="http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails">
        <link:definition>0000089 - Disclosure - Benefit Plans (Assumptions used to Determine Net Periodic Benefit Cost) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAssetAllocationsDetails" roleURI="http://www.altria.com/role/BenefitPlansAssetAllocationsDetails">
        <link:definition>0000090 - Disclosure - Benefit Plans (Asset Allocations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails" roleURI="http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails">
        <link:definition>0000091 - Disclosure - Benefit Plans (Fair Values of Pension and Postretirement Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansEstimatedFutureBenefitPaymentsDetails" roleURI="http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails">
        <link:definition>0000092 - Disclosure - Benefit Plans (Estimated Future Benefit Payments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails" roleURI="http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails">
        <link:definition>0000093 - Disclosure - Benefit Plans (Amounts Recorded in Accumulated Other Comprehensive Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails" roleURI="http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails">
        <link:definition>0000094 - Disclosure - Benefit Plans (Movements in Other Comprehensive Earnings/Losses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AdditionalInformationScheduleofAdditionalInformationDetails" roleURI="http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails">
        <link:definition>0000095 - Disclosure - Additional Information (Schedule of Additional Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AdditionalInformationScheduleofValuationandQualifyingAccountsDetails" roleURI="http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails">
        <link:definition>0000096 - Disclosure - Additional Information (Schedule of Valuation and Qualifying Accounts) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesGeneralInformationDetails" roleURI="http://www.altria.com/role/ContingenciesGeneralInformationDetails">
        <link:definition>0000097 - Disclosure - Contingencies (General Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails">
        <link:definition>0000098 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesScheduleofPendingCasesDetails" roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails">
        <link:definition>0000099 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails" roleURI="http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails">
        <link:definition>0000100 - Disclosure - Contingencies (Overview of Tobacco-Related Litigation Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesNonEngleProgenyLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails">
        <link:definition>0000101 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails">
        <link:definition>0000102 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails">
        <link:definition>0000103 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesFloridaBondStatuteDetails" roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails">
        <link:definition>0000104 - Disclosure - Contingencies (Florida Bond Statute) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOtherSmokingandHealthClassActionsDetails" roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails">
        <link:definition>0000105 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesHealthCareCostRecoveryLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails">
        <link:definition>0000106 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesNPMAdjustmentDisputesDetails" roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails">
        <link:definition>0000107 - Disclosure - Contingencies (NPM Adjustment Disputes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails">
        <link:definition>0000108 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesFederalGovernmentsLawsuitDetails" roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails">
        <link:definition>0000109 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesEvaporLitigationandIQOSLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails">
        <link:definition>0000110 - Disclosure - Contingencies (E-vapor Litigation and IQOS Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesAntitrustLitigationDetails" roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationDetails">
        <link:definition>0000111 - Disclosure - Contingencies (Antitrust Litigation) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails" roleURI="http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails">
        <link:definition>0000112 - Disclosure - Contingencies (Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesLightsUltraLightsCasesDetails" roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails">
        <link:definition>0000113 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesUSTLitigationsNarrativeDetails" roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails">
        <link:definition>0000114 - Disclosure - Contingencies (UST Litigations Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails">
        <link:definition>0000115 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="mo_USDNotes5375MaturingJanuary2044Member" abstract="true" name="USDNotes5375MaturingJanuary2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyVerdictsUpheld" abstract="false" name="LossContingencyVerdictsUpheld" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2005NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USTreasuryAndForeignGovernmentSecuritiesMember" abstract="true" name="USTreasuryAndForeignGovernmentSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDNotes2350To1020Member" abstract="true" name="USDNotes2350To1020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ETSSmokingandHealthCaseFlightAttendantsMember" abstract="true" name="ETSSmokingandHealthCaseFlightAttendantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" abstract="false" name="LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock" abstract="false" name="ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_EngleProgenyCasesChadwellMember" abstract="true" name="EngleProgenyCasesChadwellMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2006NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyCompensatoryDamagesAwardedValue" abstract="false" name="LossContingencyCompensatoryDamagesAwardedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesMcCallMember" abstract="true" name="EngleProgenyCasesMcCallMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentPricePerShareIfExercised" abstract="false" name="EquityMethodInvestmentPricePerShareIfExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" abstract="true" name="ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_EuroNotes1700MaturingJune2025Member" abstract="true" name="EuroNotes1700MaturingJune2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" abstract="true" name="EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ProceedsFromSaleOfRightsUnderAnAgreement" abstract="false" name="ProceedsFromSaleOfRightsUnderAnAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember" abstract="true" name="USTreasuryAndForeignGovernmentSecuritiesAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember" abstract="true" name="PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_FederalTradeCommissionDisclosurePeriod" abstract="false" name="FederalTradeCommissionDisclosurePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_USDNotes4800MaturingFebruary2029Member" abstract="true" name="USDNotes4800MaturingFebruary2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2015NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DisposalGroupPurchaseAgreementEffectiveInterestRate" abstract="false" name="DisposalGroupPurchaseAgreementEffectiveInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_PendingLawsuitFiledBySchoolDistrictMember" abstract="true" name="PendingLawsuitFiledBySchoolDistrictMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PhilipMorrisCapitalCorporationMember" abstract="true" name="PhilipMorrisCapitalCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentImpairment" abstract="false" name="EquityMethodInvestmentImpairment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" abstract="true" name="HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LitigationSettlementAnnualPaymentAmount" abstract="false" name="LitigationSettlementAnnualPaymentAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ForeignCurrencyDenominatedDebtAbstract" abstract="true" name="ForeignCurrencyDenominatedDebtAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent" abstract="false" name="DeferredGainOnSaleOfCommercializationRightsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USSTCMember" abstract="true" name="USSTCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CurrencyTranslationAdjustmentsAndOther" abstract="false" name="CurrencyTranslationAdjustmentsAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesMember" abstract="true" name="EngleProgenyCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock" abstract="false" name="MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_LossContingencyVerdictReversedNumber" abstract="false" name="LossContingencyVerdictReversedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_ReceivableCommercializationRightsCurrent" abstract="false" name="ReceivableCommercializationRightsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_InvestmentsLineItems" abstract="true" name="InvestmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_LitigationSettlementEstimateofPossibleGain" abstract="false" name="LitigationSettlementEstimateofPossibleGain" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDNotes10200MaturingFebruary2039Member" abstract="true" name="USDNotes10200MaturingFebruary2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" abstract="true" name="SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesPollariMember" abstract="true" name="EngleProgenyCasesPollariMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDNotes4000MaturingJanuary2024Member" abstract="true" name="USDNotes4000MaturingJanuary2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2007NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsNotCertifiedNumber" abstract="false" name="LossContingencyClaimsNotCertifiedNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_RevenueContractDuration" abstract="false" name="RevenueContractDuration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_AmountAwardedtoOtherParty" abstract="false" name="AmountAwardedtoOtherParty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EvaporLitigationMember" abstract="true" name="EvaporLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_IQOSMember" abstract="true" name="IQOSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_MaximumBondForAllDefendants" abstract="false" name="MaximumBondForAllDefendants" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesNotSettled" abstract="false" name="LossContingencyNumberOfStatesNotSettled" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LitigationCasesResultsMember" abstract="true" name="LitigationCasesResultsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" abstract="false" name="ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_CigarsMember" abstract="true" name="CigarsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyPunitiveDamagesAwardedValue" abstract="false" name="LossContingencyPunitiveDamagesAwardedValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDNotes2850MaturingAugust2022Member" abstract="true" name="USDNotes2850MaturingAugust2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" abstract="true" name="HealthCareCostRecoveryActionsTransitionYears20042020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CoreMarkHoldingCompanyInc.Member" abstract="true" name="CoreMarkHoldingCompanyInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash" abstract="false" name="DeferredProceedsFromSaleOfCommercializationRightsNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2014NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" abstract="false" name="LossContingencyNumberofStatesThatCapBondorRequireNoBond" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_MarketingAdministrationandResearchCosts" abstract="false" name="MarketingAdministrationandResearchCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_AssetBasedSecuritiesAndOtherInvestmentsMember" abstract="true" name="AssetBasedSecuritiesAndOtherInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_A2020PerformanceIncentivePlanMember" abstract="true" name="A2020PerformanceIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesWeingartandHancockMember" abstract="true" name="EngleProgenyCasesWeingartandHancockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DefinedBenefitPlanDiscountRateAbstractAbstract" abstract="true" name="DefinedBenefitPlanDiscountRateAbstractAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_JUULMember" abstract="true" name="JUULMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" abstract="true" name="NonEngleProgenySmokingAndHealthCasePrincipeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityContractWarrantMember" abstract="true" name="EquityContractWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" abstract="false" name="LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_PendingClassActionLawsuitsMember" abstract="true" name="PendingClassActionLawsuitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyUnfavorableVerdictsPendingReversed" abstract="false" name="LossContingencyUnfavorableVerdictsPendingReversed" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_MarketingAdministrationAndResearchCostsMember" abstract="true" name="MarketingAdministrationAndResearchCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DeferredTaxLiabilitiesAccruedPensionCosts" abstract="false" name="DeferredTaxLiabilitiesAccruedPensionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EuroNotes1000To3125Member" abstract="true" name="EuroNotes1000To3125Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" abstract="false" name="StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_EmergingMarketsMember" abstract="true" name="EmergingMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_AllowanceReturnedGoodsMember" abstract="true" name="AllowanceReturnedGoodsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" abstract="true" name="AccumulatedEquityMethodInvestmentsAttributableToParentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesR.DouglasMember" abstract="true" name="EngleProgenyCasesR.DouglasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" abstract="false" name="LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberOfComplaints" abstract="false" name="LossContingencyNumberOfComplaints" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_USDNotes4400MaturingFebruary2026Member" abstract="true" name="USDNotes4400MaturingFebruary2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USLargeCapMember" abstract="true" name="USLargeCapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesCuddiheeMember" abstract="true" name="EngleProgenyCasesCuddiheeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyStateCourtsNumber" abstract="false" name="LossContingencyStateCourtsNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2021NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationValuationReversalPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" abstract="false" name="OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" abstract="false" name="LossContingencyNumberofStateswithSettledLitigationSettlementOne" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesCooperMember" abstract="true" name="EngleProgenyCasesCooperMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" abstract="false" name="LossContingencyNumberOfShareholdersFilingClassActionLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding" abstract="false" name="LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyRoyaltyFeePercentage" abstract="false" name="LossContingencyRoyaltyFeePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationValuationReversalAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ValuationAllowanceDeferredTaxAssetReductions" abstract="false" name="ValuationAllowanceDeferredTaxAssetReductions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember" abstract="true" name="NPMAdjustmentToCostOfSalesAndInterestExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" abstract="false" name="DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2019NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsDecidedUnfavorableNumber" abstract="false" name="LossContingencyClaimsDecidedUnfavorableNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NoncontrollingInterestRemainingInterestPurchasedByParent" abstract="false" name="NoncontrollingInterestRemainingInterestPurchasedByParent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_July2019ShareRepurchaseProgramMember" abstract="true" name="July2019ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesReiderandBanksMember" abstract="true" name="EngleProgenyCasesReiderandBanksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2009NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards" abstract="false" name="DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_IntangibleAssetsAxis" abstract="true" name="IntangibleAssetsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_InterestAndOtherDebtExpenseNetMember" abstract="true" name="InterestAndOtherDebtExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation" abstract="false" name="ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_TrademarksMSTMember" abstract="true" name="TrademarksMSTMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClassNotCertifiedNumber" abstract="false" name="LossContingencyClassNotCertifiedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_USDNotes5950MaturingFebruary2049Member" abstract="true" name="USDNotes5950MaturingFebruary2049Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" abstract="true" name="ScheduleofPretaxTobaccoandHealthLitigationChargesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_HorizonMember" abstract="true" name="HorizonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PhilipMorrisUSAMember" abstract="true" name="PhilipMorrisUSAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_TobaccoandHealthJudgmentMember" abstract="true" name="TobaccoandHealthJudgmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" abstract="false" name="EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_EngleProgenyCasesTuttleMember" abstract="true" name="EngleProgenyCasesTuttleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesFreemanAndHarrisMember" abstract="true" name="EngleProgenyCasesFreemanAndHarrisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" abstract="false" name="ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDNotes4500MaturingMay2043Member" abstract="true" name="USDNotes4500MaturingMay2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesHoffmanMember" abstract="true" name="EngleProgenyCasesHoffmanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_TermSecuredOvernightFinancingRateTermSOFRMember" abstract="true" name="TermSecuredOvernightFinancingRateTermSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfPendingCasesConsolidated" abstract="false" name="LossContingencyNumberOfPendingCasesConsolidated" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_PeriodTwoMember" abstract="true" name="PeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PerformanceFoodGroupCompanyMember" abstract="true" name="PerformanceFoodGroupCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" abstract="false" name="EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2004NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_AllowanceDiscountsMember" abstract="true" name="AllowanceDiscountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ClassActionLawsuitMember" abstract="true" name="ClassActionLawsuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_January2023ShareRepurchaseProgramMember" abstract="true" name="January2023ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDNotes2625MaturingSeptember2026Member" abstract="true" name="USDNotes2625MaturingSeptember2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesWithConcludedHearings" abstract="false" name="LossContingencyNumberOfStatesWithConcludedHearings" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_IncreaseDecreaseInSettlementPayable" abstract="false" name="IncreaseDecreaseInSettlementPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EngleProgenyCasesLippMember" abstract="true" name="EngleProgenyCasesLippMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount" abstract="false" name="ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_AgreementToResolveShareholderClassActionMember" abstract="true" name="AgreementToResolveShareholderClassActionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDNotes3800MaturingFebruary2024Member" abstract="true" name="USDNotes3800MaturingFebruary2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CorporateDebtSecurityAboveInvestmentGradeMember" abstract="true" name="CorporateDebtSecurityAboveInvestmentGradeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDNotes3400MaturingFebruary2041Member" abstract="true" name="USDNotes3400MaturingFebruary2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDNotes2450MaturingFebruary2032Member" abstract="true" name="USDNotes2450MaturingFebruary2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofSharesOwnedCommon" abstract="false" name="EquityMethodInvestmentNumberofSharesOwnedCommon" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_DisposalGroupReceivable" abstract="false" name="DisposalGroupReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EquityContractPreemptiveRIghtsMember" abstract="true" name="EquityContractPreemptiveRIghtsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ArbitrationPeriodAxis" abstract="true" name="ArbitrationPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2010NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" abstract="false" name="OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_InvestmentsTable" abstract="true" name="InvestmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" abstract="false" name="LossContingencyNumberOfStatesNotSettledArbitrationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_LossContingencyZeroDamagesVerdicts" abstract="false" name="LossContingencyZeroDamagesVerdicts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_USDDenominatedNotes3490PercentDue2022Member" abstract="true" name="USDDenominatedNotes3490PercentDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ArbitrationPeriodDomain" abstract="true" name="ArbitrationPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USTLitigationMember" abstract="true" name="USTLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDNotes2350MaturingMay2025Member" abstract="true" name="USDNotes2350MaturingMay2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingAndHealthCaseFontaineMember" abstract="true" name="NonEngleProgenySmokingAndHealthCaseFontaineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesKaplanAndSommersMember" abstract="true" name="EngleProgenyCasesKaplanAndSommersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DisposalGroupInterestReceivable" abstract="false" name="DisposalGroupInterestReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_JUULAndCronosMember" abstract="true" name="JUULAndCronosMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesGlogerRintoulandDuignamMember" abstract="true" name="EngleProgenyCasesGlogerRintoulandDuignamMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" abstract="false" name="EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_BritishColumbiaSaskatchewanMember" abstract="true" name="BritishColumbiaSaskatchewanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_InventoryWriteOffMember" abstract="true" name="InventoryWriteOffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock" abstract="false" name="PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" abstract="false" name="LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberofManufacturers" abstract="false" name="LossContingencyNumberofManufacturers" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_CommonStock3.125NotesDue2031Member" abstract="true" name="CommonStock3.125NotesDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClaimsDecided" abstract="false" name="LossContingencyClaimsDecided" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" abstract="false" name="UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyDamagesRecoverableValue" abstract="false" name="LossContingencyDamagesRecoverableValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingAndHealthCaseMendezMember" abstract="true" name="NonEngleProgenySmokingAndHealthCaseMendezMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2012NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CommonStock0.3313ParValueMember" abstract="true" name="CommonStock0.3313ParValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OralTobaccoSegmentMember" abstract="true" name="OralTobaccoSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LitigationSettlementAnnualLegalFeesPayableMaximum" abstract="false" name="LitigationSettlementAnnualLegalFeesPayableMaximum" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyNumberofStateswithSettledLitigation" abstract="false" name="LossContingencyNumberofStateswithSettledLitigation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_CommonStock1.700NotesDue2025Member" abstract="true" name="CommonStock1.700NotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDNotes4450MaturingMay2050Member" abstract="true" name="USDNotes4450MaturingMay2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" abstract="false" name="EquityMethodInvestmentNumberofSharesEligibleForPurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_A2015DirectorsPlanMember" abstract="true" name="A2015DirectorsPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" abstract="true" name="NonParticipatingManufacturerArbitrationPanelDecisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyReductionToCostOfSales" abstract="false" name="LossContingencyReductionToCostOfSales" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDNotes2950MaturingMay2023Member" abstract="true" name="USDNotes2950MaturingMay2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2008NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock" abstract="false" name="ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_EuroNotes2200MaturingJune2027Member" abstract="true" name="EuroNotes2200MaturingJune2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions" abstract="false" name="ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2017NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CronosGroupInc.Member" abstract="true" name="CronosGroupInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_NpmAdjustmentToCostOfSalesMember" abstract="true" name="NpmAdjustmentToCostOfSalesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentsFixedPreemptiveRights" abstract="false" name="EquityMethodInvestmentsFixedPreemptiveRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDNotes3400MaturingMay2030Member" abstract="true" name="USDNotes3400MaturingMay2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OtherDisputesUndertheStateSettlementAgreementsMember" abstract="true" name="OtherDisputesUndertheStateSettlementAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ExciseTax" abstract="false" name="ExciseTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyZeroDamagesVerdictModified" abstract="false" name="LossContingencyZeroDamagesVerdictModified" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesKaplanMember" abstract="true" name="EngleProgenyCasesKaplanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OtherInvestmentNetMember" abstract="true" name="OtherInvestmentNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_COVID19Member" abstract="true" name="COVID19Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LightsMember" abstract="true" name="LightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DeferredTaxAssetsValuationAllowanceRollForward" abstract="true" name="DeferredTaxAssetsValuationAllowanceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_CigarettesMember" abstract="true" name="CigarettesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyClassActionLawsuit" abstract="false" name="LossContingencyClassActionLawsuit" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EngleProgenyCasesHollimanMember" abstract="true" name="EngleProgenyCasesHollimanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OtherInventoryRawMaterialsNetofReserves" abstract="false" name="OtherInventoryRawMaterialsNetofReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_OtherTabaccoRelatedCasesMember" abstract="true" name="OtherTabaccoRelatedCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions20052007NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDDenominatedNotesMember" abstract="true" name="USDDenominatedNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" abstract="false" name="LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" abstract="false" name="EquityMethodInvestmentPercentageofSharesEligibleForPurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_LossContingencyFaultAllocationPercentage" abstract="false" name="LossContingencyFaultAllocationPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_January2021ShareRepurchaseProgramMember" abstract="true" name="January2021ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfCases" abstract="false" name="LossContingencyNumberOfCases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" abstract="false" name="PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EuroNotes3125MaturingJune2031Member" abstract="true" name="EuroNotes3125MaturingJune2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesGarciaMember" abstract="true" name="EngleProgenyCasesGarciaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesSchertzerMember" abstract="true" name="EngleProgenyCasesSchertzerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" abstract="false" name="DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="mo_USSmallCapMember" abstract="true" name="USSmallCapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_IndividualSmokingAndHealthCasesMember" abstract="true" name="IndividualSmokingAndHealthCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CommonStockDividendIncreasePercentage" abstract="false" name="CommonStockDividendIncreasePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_USDNotes3700MaturingFebruary2051Member" abstract="true" name="USDNotes3700MaturingFebruary2051Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_IntangibleAssetsRollForward" abstract="true" name="IntangibleAssetsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_AccruedSettlementLiabilityCurrent" abstract="false" name="AccruedSettlementLiabilityCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_NonEngleProgenySmokingandHealthCaseGreeneMember" abstract="true" name="NonEngleProgenySmokingandHealthCaseGreeneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_IncomeLossFromEquityInvestments" abstract="false" name="IncomeLossFromEquityInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_CashDiscountsPolicyTextBlock" abstract="false" name="CashDiscountsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_HelixInnovationsLLCMember" abstract="true" name="HelixInnovationsLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LitigationEscrowDeposit" abstract="false" name="LitigationEscrowDeposit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" abstract="false" name="DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset" abstract="false" name="LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" abstract="false" name="DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_ForeignCurrencyDenominatedDebtMember" abstract="true" name="ForeignCurrencyDenominatedDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" abstract="true" name="PendingLawsuitsFiledByStateOrLocalGovernmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CommonStockDividendRateAnnualPerShare" abstract="false" name="CommonStockDividendRateAnnualPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="mo_EuroNotes1000MaturingFebruary2023Member" abstract="true" name="EuroNotes1000MaturingFebruary2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2013NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" abstract="false" name="EquityMethodInvestmentNumberofSharesOwnedRestricted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="mo_JTIUHMember" abstract="true" name="JTIUHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ProceedsFromSaleOfCommercializationRights" abstract="false" name="ProceedsFromSaleOfCommercializationRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" abstract="false" name="AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDNotes9950MaturingNovember2038Member" abstract="true" name="USDNotes9950MaturingNovember2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" abstract="false" name="LossContingencyNumberOfStatesInComplianceWithEscrowStatues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock" abstract="false" name="RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_CorporateDebtSecurityBelowInvestmentGradeMember" abstract="true" name="CorporateDebtSecurityBelowInvestmentGradeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" abstract="true" name="HealthCareCostRecoveryActionsTransitionYears20192021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_SmokingAndHealthClassActionsMember" abstract="true" name="SmokingAndHealthClassActionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_InternationalDevelopedMarketsMember" abstract="true" name="InternationalDevelopedMarketsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2018NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OtherMovementsDuringtheYearAbstract" abstract="true" name="OtherMovementsDuringtheYearAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_EngleProgenyCasesStateMember" abstract="true" name="EngleProgenyCasesStateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDNotes3875MaturingSeptember2046Member" abstract="true" name="USDNotes3875MaturingSeptember2046Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DefiniteLivedIntangibleAssetsMember" abstract="true" name="DefiniteLivedIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_OwnershipPercentageInConsolidatedSubsidiary" abstract="false" name="OwnershipPercentageInConsolidatedSubsidiary" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_MiddletonMember" abstract="true" name="MiddletonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment" abstract="false" name="DisposalGroupPurchaseAgreementConsiderationAdditionalPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDNotes4000MaturingFebruary2061Member" abstract="true" name="USDNotes4000MaturingFebruary2061Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_FederalAndStateShareholderDerivativeLawsuitsMember" abstract="true" name="FederalAndStateShareholderDerivativeLawsuitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" abstract="true" name="HealthCareCostRecoveryActions2011NPMAdjustmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_InterestExpenseRelatedToLitigationMember" abstract="true" name="InterestExpenseRelatedToLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfInactiveClassActionLawsuits" abstract="false" name="LossContingencyNumberOfInactiveClassActionLawsuits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_TrademarksSkoalMember" abstract="true" name="TrademarksSkoalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" abstract="false" name="EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" abstract="false" name="LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDNotes4250MaturingAugust2042Member" abstract="true" name="USDNotes4250MaturingAugust2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ImplementationofCorrectiveCommunicationsMember" abstract="true" name="ImplementationofCorrectiveCommunicationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_FederalGovernmentsLawsuitMember" abstract="true" name="FederalGovernmentsLawsuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CommonStockSharesOutstandingRollForward" abstract="true" name="CommonStockSharesOutstandingRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="mo_CommonStock2.200NotesDue2027Member" abstract="true" name="CommonStock2.200NotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDDebenture7750MaturingJanuary2027Member" abstract="true" name="USDDebenture7750MaturingJanuary2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USTIncMember" abstract="true" name="USTIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember" abstract="true" name="AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_MarketingCostsPolicyTextBlock" abstract="false" name="MarketingCostsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_TrademarksCopenhagenMember" abstract="true" name="TrademarksCopenhagenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesLevineMember" abstract="true" name="EngleProgenyCasesLevineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ScheduleofValuationandQualifyingAccountsTableTextBlock" abstract="false" name="ScheduleofValuationandQualifyingAccountsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" abstract="false" name="IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_LossContingencyClaimsResolvedNumber" abstract="false" name="LossContingencyClaimsResolvedNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_PhilipMorrisUSAandAltriaGroupMember" abstract="true" name="PhilipMorrisUSAandAltriaGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_NumberOfThirdPartyLawsuits" abstract="false" name="NumberOfThirdPartyLawsuits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyNumberOfCasesWithSetTrialDates" abstract="false" name="LossContingencyNumberOfCasesWithSetTrialDates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_LossContingencyClaimsDecidedFavorableNumber" abstract="false" name="LossContingencyClaimsDecidedFavorableNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_WineSegmentMember" abstract="true" name="WineSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesD.BrownMember" abstract="true" name="EngleProgenyCasesD.BrownMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DeferredTaxAssetsInvestmentsInEquitySecurities" abstract="false" name="DeferredTaxAssetsInvestmentsInEquitySecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" abstract="true" name="HealthCareCostRecoveryActionsTransitionYears20042021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_RevolvingCreditFacilityDueAugust2025Member" abstract="true" name="RevolvingCreditFacilityDueAugust2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_NonEngleProgenyCasesMember" abstract="true" name="NonEngleProgenyCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberofCasesSetforTrial" abstract="false" name="LossContingencyNumberofCasesSetforTrial" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_NPMAdjustmentToInterestExpenseMember" abstract="true" name="NPMAdjustmentToInterestExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PendingClassActionLawsuitMember" abstract="true" name="PendingClassActionLawsuitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_TobaccoandHealthLitigationCasesMember" abstract="true" name="TobaccoandHealthLitigationCasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_PeriodOneMember" abstract="true" name="PeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesMillerMember" abstract="true" name="EngleProgenyCasesMillerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ABInBevMember" abstract="true" name="ABInBevMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_NumberOfLeveragedLeasesRemaining" abstract="false" name="NumberOfLeveragedLeasesRemaining" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_EquityInvestmentFairValueOption" abstract="false" name="EquityInvestmentFairValueOption" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments" abstract="false" name="EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement" abstract="false" name="DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" abstract="true" name="HealthCareCostRecoveryActions2020NPMAdjustmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_SmokeableProductsSegmentMember" abstract="true" name="SmokeableProductsSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter" abstract="false" name="LongTermDebtMaturitiesRepaymentsofPrincipalThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" abstract="false" name="OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_HealthCareCostRecoveryActionsMember" abstract="true" name="HealthCareCostRecoveryActionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_McLaneCompanyIncMember" abstract="true" name="McLaneCompanyIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_EngleProgenyCasesDuignanMember" abstract="true" name="EngleProgenyCasesDuignanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_USDNotes5800MaturingFebruary2039Member" abstract="true" name="USDNotes5800MaturingFebruary2039Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_IntangibleAssetsDomain" abstract="true" name="IntangibleAssetsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment" abstract="false" name="DisposalGroupPurchaseAgreementConsiderationInitialPayment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_IQOSTobaccoHeatingSystemMember" abstract="true" name="IQOSTobaccoHeatingSystemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_LossContingencyNumberOfInactiveCases" abstract="false" name="LossContingencyNumberOfInactiveCases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="mo_PendingIndividualLawsuitsMember" abstract="true" name="PendingIndividualLawsuitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired" abstract="false" name="IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_USDNotes6200MaturingFebruary2059Member" abstract="true" name="USDNotes6200MaturingFebruary2059Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_SerialPreferredStockMember" abstract="true" name="SerialPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_CanadianTobaccoManufacturersMember" abstract="true" name="CanadianTobaccoManufacturersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_SteMichelleTransactionMember" abstract="true" name="SteMichelleTransactionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_WineBusinessStrategicResetMember" abstract="true" name="WineBusinessStrategicResetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="mo_InventoryRawMaterialsPlantMaterialNetofReserves" abstract="false" name="InventoryRawMaterialsPlantMaterialNetofReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="mo_InvestmentOwnedBalancePercentage" abstract="false" name="InvestmentOwnedBalancePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>14
<FILENAME>mo-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:dfb2a125-0b18-4fdf-aa8f-28a7e5cf9d49,g:08272963-4e0b-4a36-8744-7641bada9ecd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.altria.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mo-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_c7544b0a-2ed3-4b2c-99cf-98959680860b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_6f70dee8-0831-41f1-9827-f16e5f91b233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7544b0a-2ed3-4b2c-99cf-98959680860b" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_6f70dee8-0831-41f1-9827-f16e5f91b233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccruedSettlementLiabilityCurrent_f37f63f0-3d7a-47c9-982c-13309804ffc9" xlink:href="mo-20221231.xsd#mo_AccruedSettlementLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7544b0a-2ed3-4b2c-99cf-98959680860b" xlink:to="loc_mo_AccruedSettlementLiabilityCurrent_f37f63f0-3d7a-47c9-982c-13309804ffc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f8eb2a9d-3b5c-4ede-b958-2d36c68d882e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7544b0a-2ed3-4b2c-99cf-98959680860b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f8eb2a9d-3b5c-4ede-b958-2d36c68d882e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7d31c6b3-ed30-4099-8a4e-e2c53573e37d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7544b0a-2ed3-4b2c-99cf-98959680860b" xlink:to="loc_us-gaap_AccountsPayableCurrent_7d31c6b3-ed30-4099-8a4e-e2c53573e37d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8ab43fa9-524f-4307-b871-80cebbd24747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7544b0a-2ed3-4b2c-99cf-98959680860b" xlink:to="loc_us-gaap_LongTermDebtCurrent_8ab43fa9-524f-4307-b871-80cebbd24747" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_027ebeb6-a023-4757-a6fd-08df011f6f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_c7544b0a-2ed3-4b2c-99cf-98959680860b" xlink:to="loc_us-gaap_DividendsPayableCurrent_027ebeb6-a023-4757-a6fd-08df011f6f4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f12cf636-3c00-4a40-9351-cd2953fc97b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2ce4cc91-973f-4709-bb8c-de93a94b58ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f12cf636-3c00-4a40-9351-cd2953fc97b3" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2ce4cc91-973f-4709-bb8c-de93a94b58ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_c894df93-2003-4465-9798-15fe8cd288a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f12cf636-3c00-4a40-9351-cd2953fc97b3" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_c894df93-2003-4465-9798-15fe8cd288a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2812cb53-f5e4-44f6-b5f1-feb1bdb2cda6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f12cf636-3c00-4a40-9351-cd2953fc97b3" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2812cb53-f5e4-44f6-b5f1-feb1bdb2cda6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_57cd6d10-9397-495f-96b6-b333ec857656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f12cf636-3c00-4a40-9351-cd2953fc97b3" xlink:to="loc_us-gaap_LiabilitiesCurrent_57cd6d10-9397-495f-96b6-b333ec857656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_d59a0672-0f6e-492c-989c-363163922c5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f12cf636-3c00-4a40-9351-cd2953fc97b3" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_d59a0672-0f6e-492c-989c-363163922c5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_b0aab22e-45d9-4dc4-ac9f-e9a80cfe4df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f12cf636-3c00-4a40-9351-cd2953fc97b3" xlink:to="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_b0aab22e-45d9-4dc4-ac9f-e9a80cfe4df8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent_32002eef-296a-4e8c-8b58-379e8d5295b5" xlink:href="mo-20221231.xsd#mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_f12cf636-3c00-4a40-9351-cd2953fc97b3" xlink:to="loc_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent_32002eef-296a-4e8c-8b58-379e8d5295b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b2261c00-24f5-4b8d-84fc-81e81a0aad65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9e11555c-19f5-48b7-9ef5-caabe3e39392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b2261c00-24f5-4b8d-84fc-81e81a0aad65" xlink:to="loc_us-gaap_Liabilities_9e11555c-19f5-48b7-9ef5-caabe3e39392" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_8ebcc3ef-c75e-4544-a0d0-d26914cdcb59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b2261c00-24f5-4b8d-84fc-81e81a0aad65" xlink:to="loc_us-gaap_CommitmentsAndContingencies_8ebcc3ef-c75e-4544-a0d0-d26914cdcb59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b80b2e1b-aa71-45f0-9cb0-1942d49e533d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b2261c00-24f5-4b8d-84fc-81e81a0aad65" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b80b2e1b-aa71-45f0-9cb0-1942d49e533d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_25933394-9a89-4daf-96df-a2dfde5aa114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c61806e9-8c45-4411-b61d-72a7a6d51576" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_25933394-9a89-4daf-96df-a2dfde5aa114" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c61806e9-8c45-4411-b61d-72a7a6d51576" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7a9924a5-0ff7-4d19-be9d-af82f6470a01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_25933394-9a89-4daf-96df-a2dfde5aa114" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7a9924a5-0ff7-4d19-be9d-af82f6470a01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0663c707-92ed-4ef3-9f83-a9f597a6fedb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements_069dd128-8992-4fbc-98b2-f84568c40638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0663c707-92ed-4ef3-9f83-a9f597a6fedb" xlink:to="loc_us-gaap_LandAndLandImprovements_069dd128-8992-4fbc-98b2-f84568c40638" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_2d1f0ba9-5b67-4b5a-b4b9-dd9628296a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0663c707-92ed-4ef3-9f83-a9f597a6fedb" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_2d1f0ba9-5b67-4b5a-b4b9-dd9628296a5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_f2eff6b6-08a6-42e4-9164-fee35a65fb73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0663c707-92ed-4ef3-9f83-a9f597a6fedb" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_f2eff6b6-08a6-42e4-9164-fee35a65fb73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_d6629413-4295-44f4-9c57-43f0c269858c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_0663c707-92ed-4ef3-9f83-a9f597a6fedb" xlink:to="loc_us-gaap_ConstructionInProgressGross_d6629413-4295-44f4-9c57-43f0c269858c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c103597a-4f60-4c93-a0c7-bfee08504d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_17d08feb-d987-4380-b347-900c04905af1" xlink:href="mo-20221231.xsd#mo_InventoryRawMaterialsPlantMaterialNetofReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c103597a-4f60-4c93-a0c7-bfee08504d8c" xlink:to="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_17d08feb-d987-4380-b347-900c04905af1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInventoryRawMaterialsNetofReserves_30aaa51d-8717-4158-8f34-3376074c4980" xlink:href="mo-20221231.xsd#mo_OtherInventoryRawMaterialsNetofReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c103597a-4f60-4c93-a0c7-bfee08504d8c" xlink:to="loc_mo_OtherInventoryRawMaterialsNetofReserves_30aaa51d-8717-4158-8f34-3376074c4980" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_eac6b9f8-80a8-4c0a-965e-fb3e8106943a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c103597a-4f60-4c93-a0c7-bfee08504d8c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_eac6b9f8-80a8-4c0a-965e-fb3e8106943a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_48f01aa8-d49d-48cc-8656-bff3f71c3a96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c103597a-4f60-4c93-a0c7-bfee08504d8c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_48f01aa8-d49d-48cc-8656-bff3f71c3a96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bc42660b-dd7a-422c-8220-7e0b51f7e89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c7bd77bc-c484-4414-a0dc-330dc87d2ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bc42660b-dd7a-422c-8220-7e0b51f7e89a" xlink:to="loc_us-gaap_CommonStockValue_c7bd77bc-c484-4414-a0dc-330dc87d2ee5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ff11499c-4b2d-4e5e-a353-91cecbfaddc0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bc42660b-dd7a-422c-8220-7e0b51f7e89a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ff11499c-4b2d-4e5e-a353-91cecbfaddc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6d088ba2-07c6-4d57-8f15-51aa9324eada" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bc42660b-dd7a-422c-8220-7e0b51f7e89a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6d088ba2-07c6-4d57-8f15-51aa9324eada" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5cced72d-6e9b-4eaf-a032-e6825253f753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bc42660b-dd7a-422c-8220-7e0b51f7e89a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_5cced72d-6e9b-4eaf-a032-e6825253f753" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_b6edea71-4ce2-475e-ad36-ba81206fd49b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_bc42660b-dd7a-422c-8220-7e0b51f7e89a" xlink:to="loc_us-gaap_TreasuryStockValue_b6edea71-4ce2-475e-ad36-ba81206fd49b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2b05400e-31cb-47b9-a837-1e4da333ddb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_38761261-ebb3-4eb5-baf9-4b6b797871d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2b05400e-31cb-47b9-a837-1e4da333ddb8" xlink:to="loc_us-gaap_StockholdersEquity_38761261-ebb3-4eb5-baf9-4b6b797871d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_9981cd88-9557-43f3-98ed-d69aef839a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2b05400e-31cb-47b9-a837-1e4da333ddb8" xlink:to="loc_us-gaap_MinorityInterest_9981cd88-9557-43f3-98ed-d69aef839a64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f19d03e5-8053-45d3-8d56-e08af59f72ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5f9b65c4-5155-49e8-a502-c7a55e823f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f19d03e5-8053-45d3-8d56-e08af59f72ca" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5f9b65c4-5155-49e8-a502-c7a55e823f13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5185089d-9995-43ef-832e-dccf57da113d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f19d03e5-8053-45d3-8d56-e08af59f72ca" xlink:to="loc_us-gaap_InventoryNet_5185089d-9995-43ef-832e-dccf57da113d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_301775b4-0389-43ad-a70c-3f34fd5a6724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f19d03e5-8053-45d3-8d56-e08af59f72ca" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_301775b4-0389-43ad-a70c-3f34fd5a6724" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b4fd128f-c56d-4fd5-8faf-8e9f520c1ce0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f19d03e5-8053-45d3-8d56-e08af59f72ca" xlink:to="loc_us-gaap_OtherAssetsCurrent_b4fd128f-c56d-4fd5-8faf-8e9f520c1ce0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ReceivableCommercializationRightsCurrent_e833b4ce-61b2-4879-bebf-8c7cf842307c" xlink:href="mo-20221231.xsd#mo_ReceivableCommercializationRightsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_f19d03e5-8053-45d3-8d56-e08af59f72ca" xlink:to="loc_mo_ReceivableCommercializationRightsCurrent_e833b4ce-61b2-4879-bebf-8c7cf842307c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9d4498ca-1773-4713-8023-eae7cc827c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0a12d178-8bf3-47fc-8bfc-4187e2335426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9d4498ca-1773-4713-8023-eae7cc827c9f" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0a12d178-8bf3-47fc-8bfc-4187e2335426" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f9d5dbc0-9700-4f68-9832-9032fa6eb7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9d4498ca-1773-4713-8023-eae7cc827c9f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f9d5dbc0-9700-4f68-9832-9032fa6eb7df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_0ff37546-4caf-4763-9fb8-5835eb32d9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9d4498ca-1773-4713-8023-eae7cc827c9f" xlink:to="loc_us-gaap_Investments_0ff37546-4caf-4763-9fb8-5835eb32d9eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_971b59fe-6263-4a1b-9be4-64ec352bce29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9d4498ca-1773-4713-8023-eae7cc827c9f" xlink:to="loc_us-gaap_AssetsCurrent_971b59fe-6263-4a1b-9be4-64ec352bce29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_9c5cd154-ef75-4a3e-a136-6b3c625c9f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9d4498ca-1773-4713-8023-eae7cc827c9f" xlink:to="loc_us-gaap_Goodwill_9c5cd154-ef75-4a3e-a136-6b3c625c9f5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ee7a8a88-db1f-4539-bf08-a4caf434ddb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_9d4498ca-1773-4713-8023-eae7cc827c9f" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ee7a8a88-db1f-4539-bf08-a4caf434ddb2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="mo-20221231.xsd#ConsolidatedStatementsofEarnings"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3dac60f1-d22f-424a-b32a-bc4edf01fb9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d7f00d85-789b-4ab0-90b2-a126474bd7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3dac60f1-d22f-424a-b32a-bc4edf01fb9e" xlink:to="loc_us-gaap_ProfitLoss_d7f00d85-789b-4ab0-90b2-a126474bd7e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e85c46b2-82c8-45be-a1f9-83102c662850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_3dac60f1-d22f-424a-b32a-bc4edf01fb9e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e85c46b2-82c8-45be-a1f9-83102c662850" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_424af67d-5f9e-4a18-8020-8f39a95320e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d2a0dd7d-1955-4957-bd29-7e61fc541459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_424af67d-5f9e-4a18-8020-8f39a95320e4" xlink:to="loc_us-gaap_GrossProfit_d2a0dd7d-1955-4957-bd29-7e61fc541459" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationandResearchCosts_90df0a9d-4368-4d87-a338-62bb3f83f637" xlink:href="mo-20221231.xsd#mo_MarketingAdministrationandResearchCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_424af67d-5f9e-4a18-8020-8f39a95320e4" xlink:to="loc_mo_MarketingAdministrationandResearchCosts_90df0a9d-4368-4d87-a338-62bb3f83f637" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_2639aaf3-7e21-417b-8bc4-3480f1c4588d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_afea608c-0f8f-4192-bb8c-516e46e47c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_2639aaf3-7e21-417b-8bc4-3480f1c4588d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_afea608c-0f8f-4192-bb8c-516e46e47c51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ExciseTax_84b051bb-2706-4a61-bab1-f7db9d326dbf" xlink:href="mo-20221231.xsd#mo_ExciseTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_2639aaf3-7e21-417b-8bc4-3480f1c4588d" xlink:to="loc_mo_ExciseTax_84b051bb-2706-4a61-bab1-f7db9d326dbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_68a953d8-801f-4e35-a113-1b46ee4329c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_2639aaf3-7e21-417b-8bc4-3480f1c4588d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_68a953d8-801f-4e35-a113-1b46ee4329c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6b8801f-6dd3-4600-bf87-f75bd72ec5ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_77975cbd-6276-4bdd-9cf4-1bc226ce12ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6b8801f-6dd3-4600-bf87-f75bd72ec5ed" xlink:to="loc_us-gaap_OperatingIncomeLoss_77975cbd-6276-4bdd-9cf4-1bc226ce12ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_11d0285b-35b2-43e2-a6c8-08f35cc86022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6b8801f-6dd3-4600-bf87-f75bd72ec5ed" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_11d0285b-35b2-43e2-a6c8-08f35cc86022" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_66e3e0f1-fdee-4976-b25c-04fbe11dc031" xlink:href="mo-20221231.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6b8801f-6dd3-4600-bf87-f75bd72ec5ed" xlink:to="loc_mo_IncomeLossFromEquityInvestments_66e3e0f1-fdee-4976-b25c-04fbe11dc031" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_ca5bbe46-e2dd-4bd5-9f55-7f3a15c3e5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6b8801f-6dd3-4600-bf87-f75bd72ec5ed" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_ca5bbe46-e2dd-4bd5-9f55-7f3a15c3e5a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_557bdc05-bc87-4b3b-a9d9-fc8bf7441757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6b8801f-6dd3-4600-bf87-f75bd72ec5ed" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_557bdc05-bc87-4b3b-a9d9-fc8bf7441757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_9c16e7a9-86fa-4cd7-80b2-4ba58400bc95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6b8801f-6dd3-4600-bf87-f75bd72ec5ed" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_9c16e7a9-86fa-4cd7-80b2-4ba58400bc95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bb1155e5-641a-4de4-8021-f755da2877e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d6b8801f-6dd3-4600-bf87-f75bd72ec5ed" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_bb1155e5-641a-4de4-8021-f755da2877e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_19ef2489-dd43-4774-b38d-8c40104a8572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8c57b3f6-0d44-4304-9f51-2956f76a2995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_19ef2489-dd43-4774-b38d-8c40104a8572" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8c57b3f6-0d44-4304-9f51-2956f76a2995" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2c170a0f-e774-488c-9ab3-a96eb690f0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_19ef2489-dd43-4774-b38d-8c40104a8572" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2c170a0f-e774-488c-9ab3-a96eb690f0f9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings" xlink:type="simple" xlink:href="mo-20221231.xsd#ConsolidatedStatementsofComprehensiveEarnings"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a1957fc9-e1f5-4d41-b533-f09decd2a8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8b8e34c6-d597-4b94-aea6-3f5495459d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a1957fc9-e1f5-4d41-b533-f09decd2a8f4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8b8e34c6-d597-4b94-aea6-3f5495459d78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1e44a481-6d35-44d4-8b20-cfab088bf74c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a1957fc9-e1f5-4d41-b533-f09decd2a8f4" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1e44a481-6d35-44d4-8b20-cfab088bf74c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_409f6e6e-ebcc-4c60-82a6-ed343ee6b94e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ba33a10a-9364-4aa0-898f-18a9896d2dfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_409f6e6e-ebcc-4c60-82a6-ed343ee6b94e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ba33a10a-9364-4aa0-898f-18a9896d2dfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTax_36a5cdcd-2e0e-4fd2-a983-cd279a430df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciEquityMethodInvestmentAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_409f6e6e-ebcc-4c60-82a6-ed343ee6b94e" xlink:to="loc_us-gaap_OciEquityMethodInvestmentAfterTax_36a5cdcd-2e0e-4fd2-a983-cd279a430df6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax_9c415afb-7a71-4682-8d65-0989cd88480a" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_409f6e6e-ebcc-4c60-82a6-ed343ee6b94e" xlink:to="loc_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax_9c415afb-7a71-4682-8d65-0989cd88480a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_77e4cd61-4313-4957-afdb-afb38e504ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f82a26ba-2b7e-4db9-b649-124ec6996977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_77e4cd61-4313-4957-afdb-afb38e504ea7" xlink:to="loc_us-gaap_ProfitLoss_f82a26ba-2b7e-4db9-b649-124ec6996977" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d8df980-0065-4754-9ada-45a0786d0fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_77e4cd61-4313-4957-afdb-afb38e504ea7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d8df980-0065-4754-9ada-45a0786d0fa7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mo-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_2405135c-0cd3-4d72-a0bd-4986a29753b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_2405135c-0cd3-4d72-a0bd-4986a29753b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_460e0078-9a34-4cd9-acec-e550e45c4a94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_460e0078-9a34-4cd9-acec-e550e45c4a94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_3e8992de-ca89-4ba1-95f5-307e84254125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_3e8992de-ca89-4ba1-95f5-307e84254125" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_0af4357c-8db4-45fe-afef-45a3b340eac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitContributions"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_0af4357c-8db4-45fe-afef-45a3b340eac6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_ddbd8896-cdb3-49ce-a6ce-d5aea1e4f2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_ddbd8896-cdb3-49ce-a6ce-d5aea1e4f2f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_0907bdeb-78fe-40f0-b7ba-1c76ffec684f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_0907bdeb-78fe-40f0-b7ba-1c76ffec684f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_47026ded-1eba-43a3-a7b0-6c9b39c061d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_ProfitLoss_47026ded-1eba-43a3-a7b0-6c9b39c061d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_5f7015e9-a80d-48b3-abd4-9ca740220cda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_5f7015e9-a80d-48b3-abd4-9ca740220cda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_4fd25189-83a9-4c6b-b91f-b060f9bbe2ed" xlink:href="mo-20221231.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_mo_IncomeLossFromEquityInvestments_4fd25189-83a9-4c6b-b91f-b060f9bbe2ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e0e59025-82fb-49d7-9880-40a06622875d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e0e59025-82fb-49d7-9880-40a06622875d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_76940bd0-47c2-464a-830d-52375c60ebcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_76940bd0-47c2-464a-830d-52375c60ebcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2ad75ed5-46cb-4567-a061-ba7cad0f9ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2ad75ed5-46cb-4567-a061-ba7cad0f9ed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_1548c492-34fd-4ea2-9008-7ef61b388de2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_1548c492-34fd-4ea2-9008-7ef61b388de2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_41824388-8c2e-4c6c-8121-629b5a838236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_41824388-8c2e-4c6c-8121-629b5a838236" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_01342019-0b38-4f04-9f8c-5182414fb019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_01342019-0b38-4f04-9f8c-5182414fb019" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncreaseDecreaseInSettlementPayable_90777dff-8ae7-4a84-8a41-b2a574e7aaa0" xlink:href="mo-20221231.xsd#mo_IncreaseDecreaseInSettlementPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_mo_IncreaseDecreaseInSettlementPayable_90777dff-8ae7-4a84-8a41-b2a574e7aaa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_699a8c10-771a-4f53-a60c-ed0738a0b3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d7a115e7-d131-4977-a656-6ccabf386472" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_699a8c10-771a-4f53-a60c-ed0738a0b3d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b3af66e7-0ac4-46f3-b8be-6057ff3591d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ProceedsFromSaleOfCommercializationRights_3efa78d0-dcf2-4f6b-973e-72375d4df63d" xlink:href="mo-20221231.xsd#mo_ProceedsFromSaleOfCommercializationRights"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b3af66e7-0ac4-46f3-b8be-6057ff3591d9" xlink:to="loc_mo_ProceedsFromSaleOfCommercializationRights_3efa78d0-dcf2-4f6b-973e-72375d4df63d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_d79cbe42-3430-4b3f-9a57-c4d1d7030e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b3af66e7-0ac4-46f3-b8be-6057ff3591d9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_d79cbe42-3430-4b3f-9a57-c4d1d7030e84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5651cd4f-fe82-4cee-a4d3-beb1c6ed223e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b3af66e7-0ac4-46f3-b8be-6057ff3591d9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5651cd4f-fe82-4cee-a4d3-beb1c6ed223e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_226691c2-8b7c-4e68-ac8b-8c76d072b4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b3af66e7-0ac4-46f3-b8be-6057ff3591d9" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_226691c2-8b7c-4e68-ac8b-8c76d072b4a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_279750c0-f88a-469f-9751-8272eb680390" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6ef0ea14-89ac-4418-b0ff-c2e01a0b9f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_279750c0-f88a-469f-9751-8272eb680390" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6ef0ea14-89ac-4418-b0ff-c2e01a0b9f7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_9a6a7988-ea74-4d44-b65f-18bf1154e898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_279750c0-f88a-469f-9751-8272eb680390" xlink:to="loc_us-gaap_RestrictedCashCurrent_9a6a7988-ea74-4d44-b65f-18bf1154e898" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_abd5faf8-b087-4d41-961d-81e9e0e76432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_279750c0-f88a-469f-9751-8272eb680390" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_abd5faf8-b087-4d41-961d-81e9e0e76432" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59f135b9-72d5-4285-8826-b05bf07cdf23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_6780d1fc-1cdc-4dd0-9cb8-4e1fceb8762c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59f135b9-72d5-4285-8826-b05bf07cdf23" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_6780d1fc-1cdc-4dd0-9cb8-4e1fceb8762c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e80145a7-806c-40e3-8f84-5cc0aae12057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59f135b9-72d5-4285-8826-b05bf07cdf23" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e80145a7-806c-40e3-8f84-5cc0aae12057" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9f5f6fbf-ec29-4a64-a702-60aee3fcd6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59f135b9-72d5-4285-8826-b05bf07cdf23" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9f5f6fbf-ec29-4a64-a702-60aee3fcd6b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_e56aee3a-6a8d-45b8-a033-a0dcbbb44ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59f135b9-72d5-4285-8826-b05bf07cdf23" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_e56aee3a-6a8d-45b8-a033-a0dcbbb44ba7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f26a316a-9315-4b26-bb95-a6b08656fae9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59f135b9-72d5-4285-8826-b05bf07cdf23" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f26a316a-9315-4b26-bb95-a6b08656fae9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_966790b3-2c99-4f3d-83a3-ee65ca017401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59f135b9-72d5-4285-8826-b05bf07cdf23" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_966790b3-2c99-4f3d-83a3-ee65ca017401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_cc4d2f3d-2929-42a4-94e1-d92dfe73febe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59f135b9-72d5-4285-8826-b05bf07cdf23" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_cc4d2f3d-2929-42a4-94e1-d92dfe73febe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_68ac1734-0d9b-45db-bbfa-6a3a8bbe943e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_59f135b9-72d5-4285-8826-b05bf07cdf23" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_68ac1734-0d9b-45db-bbfa-6a3a8bbe943e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67954ae1-a0a6-4fa7-8a36-811f4eadf692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d3e4a30-c335-40fc-92c0-3f5d4efc8e17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67954ae1-a0a6-4fa7-8a36-811f4eadf692" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6d3e4a30-c335-40fc-92c0-3f5d4efc8e17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ab3c6898-4182-4466-abae-4091365ab598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67954ae1-a0a6-4fa7-8a36-811f4eadf692" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ab3c6898-4182-4466-abae-4091365ab598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80e04b58-2711-4ecf-a235-df694fedb90b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_67954ae1-a0a6-4fa7-8a36-811f4eadf692" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_80e04b58-2711-4ecf-a235-df694fedb90b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2ae749d6-8b4f-49f4-bfff-248b4d79add5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_325a7361-0cc6-43d1-8389-2cd055409b92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2ae749d6-8b4f-49f4-bfff-248b4d79add5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_325a7361-0cc6-43d1-8389-2cd055409b92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_56ade672-284c-400f-9623-8a5a7a61e457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_2ae749d6-8b4f-49f4-bfff-248b4d79add5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_56ade672-284c-400f-9623-8a5a7a61e457" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_f525dcfb-fb9a-4225-856b-2780eea527a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_cd4e7558-5b79-4d67-9eac-bb67aae8b729" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_f525dcfb-fb9a-4225-856b-2780eea527a7" xlink:to="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_cd4e7558-5b79-4d67-9eac-bb67aae8b729" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_aac75989-7a12-4801-8cb0-83d6061f9c23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_f525dcfb-fb9a-4225-856b-2780eea527a7" xlink:to="loc_us-gaap_EquityMethodInvestments_aac75989-7a12-4801-8cb0-83d6061f9c23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_8c634791-4cb0-4542-ab5b-39dcb8660a69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_f525dcfb-fb9a-4225-856b-2780eea527a7" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_8c634791-4cb0-4542-ab5b-39dcb8660a69" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_2466890f-0596-450d-a1eb-48ea83fd7712" xlink:href="mo-20221231.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_421c7c4d-3983-451c-ba53-fa8e58ce54b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_IncomeLossFromEquityInvestments_2466890f-0596-450d-a1eb-48ea83fd7712" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_421c7c4d-3983-451c-ba53-fa8e58ce54b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_3915bfcf-b482-4d3c-a47a-5eb197109e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_IncomeLossFromEquityInvestments_2466890f-0596-450d-a1eb-48ea83fd7712" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_3915bfcf-b482-4d3c-a47a-5eb197109e76" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#LongTermDebtSummaryofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b9d0224d-b185-41b2-a492-ce6931849212" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_7c655bc6-4e0c-471e-b16f-a039c409ca78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_b9d0224d-b185-41b2-a492-ce6931849212" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_7c655bc6-4e0c-471e-b16f-a039c409ca78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f9fe992e-dc6b-4e39-9c1f-cad30af2623b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_b9d0224d-b185-41b2-a492-ce6931849212" xlink:to="loc_us-gaap_LongTermDebtCurrent_f9fe992e-dc6b-4e39-9c1f-cad30af2623b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#LongTermDebtAggregateMaturitiesofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a2af572e-e491-4445-a8c4-ba2518804e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1347d401-98cf-4b89-889f-9c4ccc8171ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a2af572e-e491-4445-a8c4-ba2518804e5b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1347d401-98cf-4b89-889f-9c4ccc8171ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d2379bbc-6fc3-4628-b9a5-42d9a5669fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a2af572e-e491-4445-a8c4-ba2518804e5b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d2379bbc-6fc3-4628-b9a5-42d9a5669fd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2c8577a1-0c91-4c59-aab7-ee4a06d23887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a2af572e-e491-4445-a8c4-ba2518804e5b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_2c8577a1-0c91-4c59-aab7-ee4a06d23887" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c903aa74-dd9f-4d15-b594-a852b008f82d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a2af572e-e491-4445-a8c4-ba2518804e5b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_c903aa74-dd9f-4d15-b594-a852b008f82d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1611e488-e196-4fab-a7d0-e5391155cecd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a2af572e-e491-4445-a8c4-ba2518804e5b" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_1611e488-e196-4fab-a7d0-e5391155cecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter_4fe113fb-07ff-44de-9fcd-6ea47a7c0695" xlink:href="mo-20221231.xsd#mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_a2af572e-e491-4445-a8c4-ba2518804e5b" xlink:to="loc_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter_4fe113fb-07ff-44de-9fcd-6ea47a7c0695" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_ea30ac0f-a3c1-4c1d-9ff8-50c58e665be7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_77be93e7-360c-40b6-8bc6-a73681d97939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ea30ac0f-a3c1-4c1d-9ff8-50c58e665be7" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_77be93e7-360c-40b6-8bc6-a73681d97939" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_0001059f-3e02-466c-aed4-5f8d6d86af34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ea30ac0f-a3c1-4c1d-9ff8-50c58e665be7" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_0001059f-3e02-466c-aed4-5f8d6d86af34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_70374a25-450d-4909-9455-a96d20da276d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_ea30ac0f-a3c1-4c1d-9ff8-50c58e665be7" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_70374a25-450d-4909-9455-a96d20da276d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bcdb53e9-93fd-47c8-8c64-971325cd411b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_5a4f390f-cf8e-4aeb-9d77-50064bf4659c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_bcdb53e9-93fd-47c8-8c64-971325cd411b" xlink:to="loc_us-gaap_CommonStockSharesIssued_5a4f390f-cf8e-4aeb-9d77-50064bf4659c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_ab365e15-2bd4-4df9-8298-b00ede47e9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockSharesOutstanding_bcdb53e9-93fd-47c8-8c64-971325cd411b" xlink:to="loc_us-gaap_TreasuryStockShares_ab365e15-2bd4-4df9-8298-b00ede47e9f4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsperShareDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#EarningsperShareDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/EarningsperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c71074e0-79a0-40de-896f-be176b41d19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c273f01a-8d1c-4766-8d37-aa173d4b6e82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c71074e0-79a0-40de-896f-be176b41d19a" xlink:to="loc_us-gaap_NetIncomeLoss_c273f01a-8d1c-4766-8d37-aa173d4b6e82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_7c82d881-9531-42a7-ae33-78dab1155e0a" xlink:href="mo-20221231.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c71074e0-79a0-40de-896f-be176b41d19a" xlink:to="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_7c82d881-9531-42a7-ae33-78dab1155e0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_cf5f503d-e6ef-4626-b3ec-718d50d7c70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5ed1a448-3441-48eb-abbf-dc1856377d91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_cf5f503d-e6ef-4626-b3ec-718d50d7c70f" xlink:to="loc_us-gaap_NetIncomeLoss_5ed1a448-3441-48eb-abbf-dc1856377d91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_5e473194-9106-46ea-b693-cec190ce6303" xlink:href="mo-20221231.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_cf5f503d-e6ef-4626-b3ec-718d50d7c70f" xlink:to="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_5e473194-9106-46ea-b693-cec190ce6303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_54a843ab-72a6-4ed4-9b92-f475b72a616e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bc565464-9a32-4315-89ba-b805581dcf93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_54a843ab-72a6-4ed4-9b92-f475b72a616e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bc565464-9a32-4315-89ba-b805581dcf93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_ef56e191-8300-4dc1-82c3-c0d4eb8d70d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_54a843ab-72a6-4ed4-9b92-f475b72a616e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_ef56e191-8300-4dc1-82c3-c0d4eb8d70d6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ced5d22c-c229-4879-9395-09c7071b43f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7f919e12-0f9a-42ba-bee1-89c124b2a392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ced5d22c-c229-4879-9395-09c7071b43f3" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7f919e12-0f9a-42ba-bee1-89c124b2a392" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_680688b2-e9a2-4478-a45a-e9c97c4c59cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_ced5d22c-c229-4879-9395-09c7071b43f3" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_680688b2-e9a2-4478-a45a-e9c97c4c59cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2d5634ad-6ae5-4b2e-90a4-a6ff963ba40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2752aa1f-9d68-4cbd-9d12-be70b8496e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2d5634ad-6ae5-4b2e-90a4-a6ff963ba40e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_2752aa1f-9d68-4cbd-9d12-be70b8496e90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b2decd3c-f196-4d90-9ff4-ae98380a2970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2d5634ad-6ae5-4b2e-90a4-a6ff963ba40e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_b2decd3c-f196-4d90-9ff4-ae98380a2970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_be35e41b-dc1d-4a07-aa8d-0108d8c57813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_48d49cb0-4bae-4642-b822-be5b9438cb27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_be35e41b-dc1d-4a07-aa8d-0108d8c57813" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_48d49cb0-4bae-4642-b822-be5b9438cb27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_0dc3726c-9f1b-4314-b809-36639db03369" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_be35e41b-dc1d-4a07-aa8d-0108d8c57813" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_0dc3726c-9f1b-4314-b809-36639db03369" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b7b6ebab-2ee5-4a0f-ae1d-2bebcdb02a9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7eb489c8-6419-40e4-867b-3824432f55df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b7b6ebab-2ee5-4a0f-ae1d-2bebcdb02a9b" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7eb489c8-6419-40e4-867b-3824432f55df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_142384d3-b3d7-4ac5-a315-7ba80953fb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b7b6ebab-2ee5-4a0f-ae1d-2bebcdb02a9b" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_142384d3-b3d7-4ac5-a315-7ba80953fb3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_086ce476-6b1e-4099-9300-72be3ec7d83d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_396d03de-57f8-4c2d-8c6b-0f30b00d686c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_086ce476-6b1e-4099-9300-72be3ec7d83d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_396d03de-57f8-4c2d-8c6b-0f30b00d686c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7aaee458-f6e2-4455-8362-06a7f6669e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_086ce476-6b1e-4099-9300-72be3ec7d83d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7aaee458-f6e2-4455-8362-06a7f6669e0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d77879b1-abb7-46c0-96a3-b7a5b8647edc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3f1e4395-5fcd-4cae-8c0a-477e603359f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d77879b1-abb7-46c0-96a3-b7a5b8647edc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3f1e4395-5fcd-4cae-8c0a-477e603359f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_77e89161-bc66-4ca4-9273-9375b49393ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d77879b1-abb7-46c0-96a3-b7a5b8647edc" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_77e89161-bc66-4ca4-9273-9375b49393ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_61b07f84-5ffd-4c72-9f06-b575fe6f6029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_e56f20ca-cd87-492b-8caa-aaa0801f8316" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_61b07f84-5ffd-4c72-9f06-b575fe6f6029" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_e56f20ca-cd87-492b-8caa-aaa0801f8316" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ae6a6d03-4d81-4fa5-953a-ac55d8b659c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_61b07f84-5ffd-4c72-9f06-b575fe6f6029" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ae6a6d03-4d81-4fa5-953a-ac55d8b659c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9ca80d8e-8cea-4f65-bdb5-09b3d0518001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_61b07f84-5ffd-4c72-9f06-b575fe6f6029" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9ca80d8e-8cea-4f65-bdb5-09b3d0518001" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4ddfd996-f4d1-4153-adca-956be7e82a7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_519c2c16-43a0-493e-a2d5-6d1ec5cbb295" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4ddfd996-f4d1-4153-adca-956be7e82a7b" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_519c2c16-43a0-493e-a2d5-6d1ec5cbb295" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_22176656-981f-4a68-b48c-2870144744a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4ddfd996-f4d1-4153-adca-956be7e82a7b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_22176656-981f-4a68-b48c-2870144744a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_7ccd44ab-fc22-42d1-bc73-edd102d0dd3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4ddfd996-f4d1-4153-adca-956be7e82a7b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_7ccd44ab-fc22-42d1-bc73-edd102d0dd3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_19be0fb2-b7fa-4dc0-8196-329437b10903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4ddfd996-f4d1-4153-adca-956be7e82a7b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_19be0fb2-b7fa-4dc0-8196-329437b10903" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b8527d9e-0a69-4688-ad9a-8910b3576d20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4ddfd996-f4d1-4153-adca-956be7e82a7b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_b8527d9e-0a69-4688-ad9a-8910b3576d20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments_1cff26bd-afb3-4fc3-a928-9c9f9dc6d700" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_4ddfd996-f4d1-4153-adca-956be7e82a7b" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments_1cff26bd-afb3-4fc3-a928-9c9f9dc6d700" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_72c24b11-f3bf-4962-a69f-cfdf79f53230" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount_47c3468b-db9b-44f1-b217-95e3b72ddc4c" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_72c24b11-f3bf-4962-a69f-cfdf79f53230" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount_47c3468b-db9b-44f1-b217-95e3b72ddc4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_1d2157c9-a13c-4a52-ade4-fe93eccf26c5" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_72c24b11-f3bf-4962-a69f-cfdf79f53230" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_1d2157c9-a13c-4a52-ade4-fe93eccf26c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_00860e78-5e9f-431e-a595-9ea55d60773b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_72c24b11-f3bf-4962-a69f-cfdf79f53230" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_00860e78-5e9f-431e-a595-9ea55d60773b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount_3dc34db6-a142-4418-ac9d-1e7df1927331" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_72c24b11-f3bf-4962-a69f-cfdf79f53230" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount_3dc34db6-a142-4418-ac9d-1e7df1927331" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_cd640b34-7bf3-43de-871b-eb91bb432f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_72c24b11-f3bf-4962-a69f-cfdf79f53230" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_cd640b34-7bf3-43de-871b-eb91bb432f02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_975661b6-fbbb-4e91-9c3f-549d9cac4896" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_72c24b11-f3bf-4962-a69f-cfdf79f53230" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_975661b6-fbbb-4e91-9c3f-549d9cac4896" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_a1292ab5-d1a2-4489-a140-de0dfbbc6ee0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_72c24b11-f3bf-4962-a69f-cfdf79f53230" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_a1292ab5-d1a2-4489-a140-de0dfbbc6ee0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_96215633-0608-4d3f-9323-e614551285d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxAssetsInvestmentsInEquitySecurities_e6202dbe-e36d-4d9d-8ec2-f29ecdad66ff" xlink:href="mo-20221231.xsd#mo_DeferredTaxAssetsInvestmentsInEquitySecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_96215633-0608-4d3f-9323-e614551285d2" xlink:to="loc_mo_DeferredTaxAssetsInvestmentsInEquitySecurities_e6202dbe-e36d-4d9d-8ec2-f29ecdad66ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_55b2f87e-e2ee-407b-97cc-12c02f8f058b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_96215633-0608-4d3f-9323-e614551285d2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_55b2f87e-e2ee-407b-97cc-12c02f8f058b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments_2ab1e924-f209-489e-bc5f-b1cef40f4a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_96215633-0608-4d3f-9323-e614551285d2" xlink:to="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments_2ab1e924-f209-489e-bc5f-b1cef40f4a3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_aaed8805-d0d0-400a-b6cc-eecc0b84c6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_96215633-0608-4d3f-9323-e614551285d2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_aaed8805-d0d0-400a-b6cc-eecc0b84c6c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards_fb8bfe6f-775b-448a-b477-53af55602c11" xlink:href="mo-20221231.xsd#mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_96215633-0608-4d3f-9323-e614551285d2" xlink:to="loc_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards_fb8bfe6f-775b-448a-b477-53af55602c11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_bbd047c2-5b84-46c8-a423-310ce4050ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_73216700-97c7-4111-8c0f-7e880942999a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_bbd047c2-5b84-46c8-a423-310ce4050ffd" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_73216700-97c7-4111-8c0f-7e880942999a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0e75d145-3565-42ce-ba08-641141533fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_bbd047c2-5b84-46c8-a423-310ce4050ffd" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0e75d145-3565-42ce-ba08-641141533fe1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_fda3d370-5f3e-49dc-828e-92874bc05659" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_bbd047c2-5b84-46c8-a423-310ce4050ffd" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_fda3d370-5f3e-49dc-828e-92874bc05659" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_fe42886a-5035-4cd0-ba73-811db8abc8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_900dc8d9-58ac-4a69-8a20-4c18fe30f7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fe42886a-5035-4cd0-ba73-811db8abc8fc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_900dc8d9-58ac-4a69-8a20-4c18fe30f7b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld_483e8829-f4d0-450e-b46a-59cefa8b8942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fe42886a-5035-4cd0-ba73-811db8abc8fc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld_483e8829-f4d0-450e-b46a-59cefa8b8942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_8fc84ebf-df4a-4855-bbba-66f0719ec678" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fe42886a-5035-4cd0-ba73-811db8abc8fc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_8fc84ebf-df4a-4855-bbba-66f0719ec678" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_fc2f49f3-d8a6-470f-b16a-f791bec28fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fe42886a-5035-4cd0-ba73-811db8abc8fc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_fc2f49f3-d8a6-470f-b16a-f791bec28fff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxLiabilitiesAccruedPensionCosts_2e381914-fcc9-4b84-ab0e-e3950cf7c0cb" xlink:href="mo-20221231.xsd#mo_DeferredTaxLiabilitiesAccruedPensionCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fe42886a-5035-4cd0-ba73-811db8abc8fc" xlink:to="loc_mo_DeferredTaxLiabilitiesAccruedPensionCosts_2e381914-fcc9-4b84-ab0e-e3950cf7c0cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_aaeb3307-fb72-44e4-be21-c84b9db11d79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fe42886a-5035-4cd0-ba73-811db8abc8fc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_aaeb3307-fb72-44e4-be21-c84b9db11d79" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_6b399e6f-7cc6-41fb-aec3-e1b5ce8c2d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_94363643-84f5-42c0-aa2b-dc4094bfbf3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_6b399e6f-7cc6-41fb-aec3-e1b5ce8c2d5f" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_94363643-84f5-42c0-aa2b-dc4094bfbf3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_30fd58d7-f433-4a6a-beac-d639abf7559a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_6b399e6f-7cc6-41fb-aec3-e1b5ce8c2d5f" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_30fd58d7-f433-4a6a-beac-d639abf7559a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_fc4133f0-d11b-4449-b290-dbcd48ee3363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_b6a78c63-f0e8-42eb-b2b1-7ab8115c3ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_fc4133f0-d11b-4449-b290-dbcd48ee3363" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_b6a78c63-f0e8-42eb-b2b1-7ab8115c3ec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_0bf09e2f-985b-4156-987c-b97e5ed3d946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_fc4133f0-d11b-4449-b290-dbcd48ee3363" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_0bf09e2f-985b-4156-987c-b97e5ed3d946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_4f7311e8-339c-483a-bda4-f6d5a1fee2b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_fc4133f0-d11b-4449-b290-dbcd48ee3363" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_4f7311e8-339c-483a-bda4-f6d5a1fee2b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_82bcba0d-cbb3-48ba-b894-f711bede3b23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_fc4133f0-d11b-4449-b290-dbcd48ee3363" xlink:to="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_82bcba0d-cbb3-48ba-b894-f711bede3b23" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_490d26cf-084d-4c3f-85ed-a517e04a436b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_c7ddbdf3-0903-4069-b72a-d4cfaa66ebba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_490d26cf-084d-4c3f-85ed-a517e04a436b" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_c7ddbdf3-0903-4069-b72a-d4cfaa66ebba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_f553db64-a181-4171-bbf4-9e1349ebc4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_490d26cf-084d-4c3f-85ed-a517e04a436b" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_f553db64-a181-4171-bbf4-9e1349ebc4b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_115a21db-d9bd-4682-bcd3-9e752bce5246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_490d26cf-084d-4c3f-85ed-a517e04a436b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_115a21db-d9bd-4682-bcd3-9e752bce5246" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a069a22c-3668-4986-af59-2bcd0f5c8471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_490d26cf-084d-4c3f-85ed-a517e04a436b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_a069a22c-3668-4986-af59-2bcd0f5c8471" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_3eeee44f-421d-46d7-a71c-cb5e572cf9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_490d26cf-084d-4c3f-85ed-a517e04a436b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_3eeee44f-421d-46d7-a71c-cb5e572cf9f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_30ad5eed-d105-47b5-8bfd-db795361ddc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_490d26cf-084d-4c3f-85ed-a517e04a436b" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_30ad5eed-d105-47b5-8bfd-db795361ddc6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f775fd4a-8f51-4557-860e-020f12b7fbb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_44e2035d-c822-4ecb-a6d1-010318119a57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f775fd4a-8f51-4557-860e-020f12b7fbb7" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_44e2035d-c822-4ecb-a6d1-010318119a57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_3436a970-86e1-444e-b8d2-7563b6cb3593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f775fd4a-8f51-4557-860e-020f12b7fbb7" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_3436a970-86e1-444e-b8d2-7563b6cb3593" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax_aa0b1c47-d4af-47c2-9bd7-a6ebb671535c" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f775fd4a-8f51-4557-860e-020f12b7fbb7" xlink:to="loc_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax_aa0b1c47-d4af-47c2-9bd7-a6ebb671535c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_03990eda-2df1-4b8f-9c47-62e6bb49d095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_9ef591de-75ab-459c-897c-b4e99f68d733" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_03990eda-2df1-4b8f-9c47-62e6bb49d095" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_9ef591de-75ab-459c-897c-b4e99f68d733" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_261e65e2-3e90-4be9-a6fd-4010cbc709da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_03990eda-2df1-4b8f-9c47-62e6bb49d095" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_261e65e2-3e90-4be9-a6fd-4010cbc709da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax_fc1773d9-917c-4e51-add7-d8cf4379c46b" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_03990eda-2df1-4b8f-9c47-62e6bb49d095" xlink:to="loc_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax_fc1773d9-917c-4e51-add7-d8cf4379c46b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax_2216c854-46e5-40c5-8ea3-2543f4b7c172" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_03990eda-2df1-4b8f-9c47-62e6bb49d095" xlink:to="loc_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax_2216c854-46e5-40c5-8ea3-2543f4b7c172" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_2759ceb7-96b3-49e6-9cf3-6be1728fa771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_03990eda-2df1-4b8f-9c47-62e6bb49d095" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_2759ceb7-96b3-49e6-9cf3-6be1728fa771" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment_5e69a545-f4b8-44a6-9084-808c2ae0794f" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_e0db3b8d-13d7-4dfe-a69d-5419af2fb164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment_5e69a545-f4b8-44a6-9084-808c2ae0794f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_e0db3b8d-13d7-4dfe-a69d-5419af2fb164" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_325f3cae-a3e7-42f1-8aee-22e8b3803019" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment_5e69a545-f4b8-44a6-9084-808c2ae0794f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_325f3cae-a3e7-42f1-8aee-22e8b3803019" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#AdditionalInformationScheduleofAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_bc81f7f6-77ca-4e96-97b0-e4d5c7ef60c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_27c19945-4663-41bf-a68c-a01a9b23c321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_bc81f7f6-77ca-4e96-97b0-e4d5c7ef60c3" xlink:to="loc_us-gaap_InterestExpense_27c19945-4663-41bf-a68c-a01a9b23c321" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_c557b61c-85d3-4aa5-9eb9-bc1487c25a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_bc81f7f6-77ca-4e96-97b0-e4d5c7ef60c3" xlink:to="loc_us-gaap_InterestIncomeOther_c557b61c-85d3-4aa5-9eb9-bc1487c25a8a" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>15
<FILENAME>mo-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:dfb2a125-0b18-4fdf-aa8f-28a7e5cf9d49,g:08272963-4e0b-4a36-8744-7641bada9ecd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.altria.com/role/CoverPage" xlink:type="simple" xlink:href="mo-20221231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CoverPage" xlink:type="extended" id="i137dcc61f2434690b682844835327b88_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b57e1dd6-b006-4b05-93a4-871e4f030cb8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentType_b57e1dd6-b006-4b05-93a4-871e4f030cb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_d103fddf-b0d2-47dd-9195-5afc98b7f8fe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentAnnualReport_d103fddf-b0d2-47dd-9195-5afc98b7f8fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_982065cb-bc51-42bf-90d0-b223fe1313e4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentPeriodEndDate_982065cb-bc51-42bf-90d0-b223fe1313e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_9383808d-0c58-4a3c-9480-44560f4eb203" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_CurrentFiscalYearEndDate_9383808d-0c58-4a3c-9480-44560f4eb203" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_28ce53b0-0ecb-4393-bc83-c0bc926fc29c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentTransitionReport_28ce53b0-0ecb-4393-bc83-c0bc926fc29c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ecccea0b-fc71-461f-a161-01b1eb28256e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityFileNumber_ecccea0b-fc71-461f-a161-01b1eb28256e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f6d67a33-c7c8-43ef-ada2-0117f2c56579" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityRegistrantName_f6d67a33-c7c8-43ef-ada2-0117f2c56579" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a748309b-07b3-4870-a110-326117a3a0ca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a748309b-07b3-4870-a110-326117a3a0ca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_0defdbe7-94d3-4f9a-a066-2ebfa458a005" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityTaxIdentificationNumber_0defdbe7-94d3-4f9a-a066-2ebfa458a005" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2d79991e-199e-4182-8374-74051ce3dede" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityAddressAddressLine1_2d79991e-199e-4182-8374-74051ce3dede" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0901c1f0-8ab5-4792-a8b3-5ae5741456ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityAddressCityOrTown_0901c1f0-8ab5-4792-a8b3-5ae5741456ff" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d0c71e9c-ebb2-4ba3-9965-c56a84367f54" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityAddressStateOrProvince_d0c71e9c-ebb2-4ba3-9965-c56a84367f54" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4103ca94-712b-42bd-a90a-86150dc51b1f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityAddressPostalZipCode_4103ca94-712b-42bd-a90a-86150dc51b1f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2aff22c9-3d7d-4815-bc3a-b210949cb851" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_CityAreaCode_2aff22c9-3d7d-4815-bc3a-b210949cb851" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3abdc7fd-b8c6-41fe-b842-6189ad79baec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_LocalPhoneNumber_3abdc7fd-b8c6-41fe-b842-6189ad79baec" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0f2ea237-0a17-4654-bc4f-2e29775a04a2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_Security12bTitle_0f2ea237-0a17-4654-bc4f-2e29775a04a2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2c338b50-4b7e-465a-beb4-8108d6291c14" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_TradingSymbol_2c338b50-4b7e-465a-beb4-8108d6291c14" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b84a1e00-3943-47d7-9616-eddb43cf4979" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_SecurityExchangeName_b84a1e00-3943-47d7-9616-eddb43cf4979" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_3f3a3a20-2819-4a44-9905-de451b2c7ace" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_3f3a3a20-2819-4a44-9905-de451b2c7ace" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_23959526-85ee-4e00-8902-c6db0de8df50" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityVoluntaryFilers_23959526-85ee-4e00-8902-c6db0de8df50" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_04c086ba-0a61-413f-940f-101794c28578" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityCurrentReportingStatus_04c086ba-0a61-413f-940f-101794c28578" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f5a0df66-4556-43d8-a63b-84ee5c55524b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityInteractiveDataCurrent_f5a0df66-4556-43d8-a63b-84ee5c55524b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_1301b9b1-a8b3-4c69-a23e-6d808e3a631a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityFilerCategory_1301b9b1-a8b3-4c69-a23e-6d808e3a631a" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_9eeaf7a5-78de-4340-97c0-e036a840b861" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntitySmallBusiness_9eeaf7a5-78de-4340-97c0-e036a840b861" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8d13c35f-e1f3-4be7-80c3-5371394be662" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityEmergingGrowthCompany_8d13c35f-e1f3-4be7-80c3-5371394be662" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_b33d9a66-8aa1-42eb-a718-4babf2a714d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_IcfrAuditorAttestationFlag_b33d9a66-8aa1-42eb-a718-4babf2a714d2" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_34ad61e2-b19d-4753-81ca-7e50eea6e072" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityShellCompany_34ad61e2-b19d-4753-81ca-7e50eea6e072" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_c72f42cd-322b-4d58-9098-cc0f48f15e6f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityPublicFloat_c72f42cd-322b-4d58-9098-cc0f48f15e6f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_fb02e818-a746-4063-89e0-4d5e19741a65" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_fb02e818-a746-4063-89e0-4d5e19741a65" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4c6ebeb3-08bd-47d9-85ff-30ad2d543084" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4c6ebeb3-08bd-47d9-85ff-30ad2d543084" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1125e16c-9a24-48b6-80de-0ecd0005a717" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_AmendmentFlag_1125e16c-9a24-48b6-80de-0ecd0005a717" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b891193a-ce3a-44cf-938d-9db03e5bb819" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentFiscalYearFocus_b891193a-ce3a-44cf-938d-9db03e5bb819" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_663e9ab5-ddb1-41f2-b582-22ced9fe3dc5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_663e9ab5-ddb1-41f2-b582-22ced9fe3dc5" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_758e83cc-a3cb-470a-a9df-947f3990f1b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityCentralIndexKey_758e83cc-a3cb-470a-a9df-947f3990f1b1" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_c048e6a7-ceee-496a-a1a3-401f128dcbd9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntitiesTable_c048e6a7-ceee-496a-a1a3-401f128dcbd9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e05a804d-baaf-417b-ae80-2c6820f5eab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_c048e6a7-ceee-496a-a1a3-401f128dcbd9" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e05a804d-baaf-417b-ae80-2c6820f5eab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e05a804d-baaf-417b-ae80-2c6820f5eab2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e05a804d-baaf-417b-ae80-2c6820f5eab2" xlink:to="loc_us-gaap_ClassOfStockDomain_e05a804d-baaf-417b-ae80-2c6820f5eab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_236ba8b5-8f0e-417a-8c89-b258f69b6891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e05a804d-baaf-417b-ae80-2c6820f5eab2" xlink:to="loc_us-gaap_ClassOfStockDomain_236ba8b5-8f0e-417a-8c89-b258f69b6891" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock0.3313ParValueMember_675ceda3-9722-48ab-8334-7ec51cf7a940" xlink:href="mo-20221231.xsd#mo_CommonStock0.3313ParValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_236ba8b5-8f0e-417a-8c89-b258f69b6891" xlink:to="loc_mo_CommonStock0.3313ParValueMember_675ceda3-9722-48ab-8334-7ec51cf7a940" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.700NotesDue2025Member_d850f88d-ee18-47d0-b5d8-fbe0340dd621" xlink:href="mo-20221231.xsd#mo_CommonStock1.700NotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_236ba8b5-8f0e-417a-8c89-b258f69b6891" xlink:to="loc_mo_CommonStock1.700NotesDue2025Member_d850f88d-ee18-47d0-b5d8-fbe0340dd621" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock2.200NotesDue2027Member_c6ff2fcd-a251-4d33-8bcf-18d53921a519" xlink:href="mo-20221231.xsd#mo_CommonStock2.200NotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_236ba8b5-8f0e-417a-8c89-b258f69b6891" xlink:to="loc_mo_CommonStock2.200NotesDue2027Member_c6ff2fcd-a251-4d33-8bcf-18d53921a519" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock3.125NotesDue2031Member_b761e8aa-60f2-4d8f-8509-21f25f2cbc9c" xlink:href="mo-20221231.xsd#mo_CommonStock3.125NotesDue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_236ba8b5-8f0e-417a-8c89-b258f69b6891" xlink:to="loc_mo_CommonStock3.125NotesDue2031Member_b761e8aa-60f2-4d8f-8509-21f25f2cbc9c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="mo-20221231.xsd#ConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended" id="id4aa5b15caa04e4185fa3cf4c189e056_ConsolidatedStatementsofStockholdersEquityDeficit">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f529eac3-fa18-471c-9502-4095fed28b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f529eac3-fa18-471c-9502-4095fed28b71" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_786bfb3e-469e-41f5-8f6c-51b424314104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_786bfb3e-469e-41f5-8f6c-51b424314104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_99e59f60-3deb-406a-80d2-056029f9f2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_99e59f60-3deb-406a-80d2-056029f9f2d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f52dbd51-6297-4e22-886e-750a69550d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f52dbd51-6297-4e22-886e-750a69550d6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_583285c1-6062-48b3-9f33-dbb3aaada5cf" xlink:href="mo-20221231.xsd#mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_583285c1-6062-48b3-9f33-dbb3aaada5cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_5ce6492c-8ddf-4172-92c3-c3f68e64f174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_DividendsCommonStockCash_5ce6492c-8ddf-4172-92c3-c3f68e64f174" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_33e26a10-66aa-4b00-861a-49ee3f9a72a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_33e26a10-66aa-4b00-861a-49ee3f9a72a0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_1bd70d21-3145-4cec-b653-b0d4e50408fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_StockholdersEquityOther_1bd70d21-3145-4cec-b653-b0d4e50408fc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2f18139b-7c89-444c-ae83-abbf3f16398a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5c4005f2-309a-4a23-9edb-0c6287c4a503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f529eac3-fa18-471c-9502-4095fed28b71" xlink:to="loc_us-gaap_StatementTable_5c4005f2-309a-4a23-9edb-0c6287c4a503" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f3f9027f-95ca-4c4c-be41-e243ebcfc90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5c4005f2-309a-4a23-9edb-0c6287c4a503" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f3f9027f-95ca-4c4c-be41-e243ebcfc90c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f3f9027f-95ca-4c4c-be41-e243ebcfc90c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f3f9027f-95ca-4c4c-be41-e243ebcfc90c" xlink:to="loc_us-gaap_EquityComponentDomain_f3f9027f-95ca-4c4c-be41-e243ebcfc90c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f3f9027f-95ca-4c4c-be41-e243ebcfc90c" xlink:to="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5ec4e640-c130-4151-90e8-a98c55eff1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:to="loc_us-gaap_CommonStockMember_5ec4e640-c130-4151-90e8-a98c55eff1d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7da176fa-5d4a-48ef-a709-8c7172501800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7da176fa-5d4a-48ef-a709-8c7172501800" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_31cc23a2-6c9e-4d2d-85ea-6eb7e8d838da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:to="loc_us-gaap_RetainedEarningsMember_31cc23a2-6c9e-4d2d-85ea-6eb7e8d838da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b31430-34f6-4566-9e95-5fd25a2f9962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b31430-34f6-4566-9e95-5fd25a2f9962" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_1d64e305-e975-4f77-8eba-8b7544783091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:to="loc_us-gaap_TreasuryStockMember_1d64e305-e975-4f77-8eba-8b7544783091" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_805d729b-6727-4c1b-b34a-5f891c6f252e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:to="loc_us-gaap_NoncontrollingInterestMember_805d729b-6727-4c1b-b34a-5f891c6f252e" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BackgroundandBasisofPresentationBackgroundNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails" xlink:type="extended" id="i7ba4276a6657466d9c4bc5715c32fc9d_BackgroundandBasisofPresentationBackgroundNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberOfLeveragedLeasesRemaining_0e5e69cc-33c9-4cac-8cc4-d8ae3fe8822b" xlink:href="mo-20221231.xsd#mo_NumberOfLeveragedLeasesRemaining"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_mo_NumberOfLeveragedLeasesRemaining_0e5e69cc-33c9-4cac-8cc4-d8ae3fe8822b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OwnershipPercentageInConsolidatedSubsidiary_b6368340-950d-4e2a-84b7-46130f717d93" xlink:href="mo-20221231.xsd#mo_OwnershipPercentageInConsolidatedSubsidiary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_mo_OwnershipPercentageInConsolidatedSubsidiary_b6368340-950d-4e2a-84b7-46130f717d93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_0f5c6789-40cb-4268-b126-e51fafbf04ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_0f5c6789-40cb-4268-b126-e51fafbf04ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_22a15e5b-93d3-4c62-b9d8-9841d3813af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_22a15e5b-93d3-4c62-b9d8-9841d3813af5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_46fdf731-1095-495d-95d8-fc6e1d31ebc8" xlink:href="mo-20221231.xsd#mo_NoncontrollingInterestRemainingInterestPurchasedByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_46fdf731-1095-495d-95d8-fc6e1d31ebc8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_b63285fd-e920-4e00-85b3-66f641abaf77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_b63285fd-e920-4e00-85b3-66f641abaf77" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f7ac8d89-e2c2-4271-aaf8-6d76f4e5b0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f7ac8d89-e2c2-4271-aaf8-6d76f4e5b0bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_09616f3b-2544-459a-b8a8-c78879c9f5c6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f7ac8d89-e2c2-4271-aaf8-6d76f4e5b0bc" xlink:to="loc_srt_OwnershipAxis_09616f3b-2544-459a-b8a8-c78879c9f5c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_09616f3b-2544-459a-b8a8-c78879c9f5c6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_09616f3b-2544-459a-b8a8-c78879c9f5c6" xlink:to="loc_srt_OwnershipDomain_09616f3b-2544-459a-b8a8-c78879c9f5c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e0445891-966f-4b3d-9825-228df8611564" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_09616f3b-2544-459a-b8a8-c78879c9f5c6" xlink:to="loc_srt_OwnershipDomain_e0445891-966f-4b3d-9825-228df8611564" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HorizonMember_63c9e996-fb43-4f72-95b5-9293c85d390e" xlink:href="mo-20221231.xsd#mo_HorizonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_e0445891-966f-4b3d-9825-228df8611564" xlink:to="loc_mo_HorizonMember_63c9e996-fb43-4f72-95b5-9293c85d390e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HelixInnovationsLLCMember_ffa302a0-c5a8-4f4d-ae94-4156c74e5fd3" xlink:href="mo-20221231.xsd#mo_HelixInnovationsLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_e0445891-966f-4b3d-9825-228df8611564" xlink:to="loc_mo_HelixInnovationsLLCMember_ffa302a0-c5a8-4f4d-ae94-4156c74e5fd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5d030334-ce87-4cfa-afd6-47605fc1f42a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f7ac8d89-e2c2-4271-aaf8-6d76f4e5b0bc" xlink:to="loc_dei_LegalEntityAxis_5d030334-ce87-4cfa-afd6-47605fc1f42a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5d030334-ce87-4cfa-afd6-47605fc1f42a_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_5d030334-ce87-4cfa-afd6-47605fc1f42a" xlink:to="loc_dei_EntityDomain_5d030334-ce87-4cfa-afd6-47605fc1f42a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a621bed1-436c-4e6f-8810-8a0b065c0e37" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_5d030334-ce87-4cfa-afd6-47605fc1f42a" xlink:to="loc_dei_EntityDomain_a621bed1-436c-4e6f-8810-8a0b065c0e37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_9678de6e-da90-492f-b427-1d38f69628b7" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a621bed1-436c-4e6f-8810-8a0b065c0e37" xlink:to="loc_mo_PhilipMorrisUSAMember_9678de6e-da90-492f-b427-1d38f69628b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JTIUHMember_31faa5ef-5af0-48b8-99e3-3ef8bc64337e" xlink:href="mo-20221231.xsd#mo_JTIUHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a621bed1-436c-4e6f-8810-8a0b065c0e37" xlink:to="loc_mo_JTIUHMember_31faa5ef-5af0-48b8-99e3-3ef8bc64337e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended" id="if1877572fe914d7fb0ac055ebebb69bb_SummaryofSignificantAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_45851694-daf0-4445-a70f-b5e29a7167ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_45851694-daf0-4445-a70f-b5e29a7167ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_29c2b655-23d4-4dd2-b68b-ff8b6f41e85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_29c2b655-23d4-4dd2-b68b-ff8b6f41e85c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory_5a7704ce-dcad-40cd-a94d-0ae3cb1dd28a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_us-gaap_PercentageOfLIFOInventory_5a7704ce-dcad-40cd-a94d-0ae3cb1dd28a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue_205182de-e14e-4b54-aa82-43b1f4481cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue_205182de-e14e-4b54-aa82-43b1f4481cfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevenueContractDuration_94d6705c-f9fa-4d5f-bed9-2a2f8bbc146c" xlink:href="mo-20221231.xsd#mo_RevenueContractDuration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_mo_RevenueContractDuration_94d6705c-f9fa-4d5f-bed9-2a2f8bbc146c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_98de34f5-43a0-4d3e-b01b-83202ce02bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_98de34f5-43a0-4d3e-b01b-83202ce02bb6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5f5d897f-9c63-477d-a3c1-b7d4184253a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5f5d897f-9c63-477d-a3c1-b7d4184253a9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8d8dcab2-f2f2-456f-a16d-be42905a68f7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5f5d897f-9c63-477d-a3c1-b7d4184253a9" xlink:to="loc_dei_LegalEntityAxis_8d8dcab2-f2f2-456f-a16d-be42905a68f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8d8dcab2-f2f2-456f-a16d-be42905a68f7_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8d8dcab2-f2f2-456f-a16d-be42905a68f7" xlink:to="loc_dei_EntityDomain_8d8dcab2-f2f2-456f-a16d-be42905a68f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ae0c6b07-f92e-4d7a-8586-ba9c7f3afef5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8d8dcab2-f2f2-456f-a16d-be42905a68f7" xlink:to="loc_dei_EntityDomain_ae0c6b07-f92e-4d7a-8586-ba9c7f3afef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USSTCMember_15273ca1-b68d-4835-b28b-ec511bc48be0" xlink:href="mo-20221231.xsd#mo_USSTCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ae0c6b07-f92e-4d7a-8586-ba9c7f3afef5" xlink:to="loc_mo_USSTCMember_15273ca1-b68d-4835-b28b-ec511bc48be0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c37b456f-9749-4199-a21e-eba48cb7bc75" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5f5d897f-9c63-477d-a3c1-b7d4184253a9" xlink:to="loc_srt_RangeAxis_c37b456f-9749-4199-a21e-eba48cb7bc75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c37b456f-9749-4199-a21e-eba48cb7bc75_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c37b456f-9749-4199-a21e-eba48cb7bc75" xlink:to="loc_srt_RangeMember_c37b456f-9749-4199-a21e-eba48cb7bc75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d056e7f3-319e-47f3-a808-92a25430aeaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c37b456f-9749-4199-a21e-eba48cb7bc75" xlink:to="loc_srt_RangeMember_d056e7f3-319e-47f3-a808-92a25430aeaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_527427dc-9474-4166-b20c-8c4dbb70cd6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d056e7f3-319e-47f3-a808-92a25430aeaf" xlink:to="loc_srt_MaximumMember_527427dc-9474-4166-b20c-8c4dbb70cd6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eae4dd6c-443e-42d0-98c1-72a3f771e5de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5f5d897f-9c63-477d-a3c1-b7d4184253a9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eae4dd6c-443e-42d0-98c1-72a3f771e5de" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eae4dd6c-443e-42d0-98c1-72a3f771e5de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eae4dd6c-443e-42d0-98c1-72a3f771e5de" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eae4dd6c-443e-42d0-98c1-72a3f771e5de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bcdd95b7-df96-4d23-9a42-0810c3cc6e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eae4dd6c-443e-42d0-98c1-72a3f771e5de" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bcdd95b7-df96-4d23-9a42-0810c3cc6e7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_9d9c7ed7-2662-4373-ac9a-59b64379bc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bcdd95b7-df96-4d23-9a42-0810c3cc6e7a" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_9d9c7ed7-2662-4373-ac9a-59b64379bc4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_d65d256a-c911-4142-9a2f-8f3f961d9fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bcdd95b7-df96-4d23-9a42-0810c3cc6e7a" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_d65d256a-c911-4142-9a2f-8f3f961d9fe0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails" xlink:type="extended" id="i380446c138e045d287cfd4f63b82be6a_GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_6ca224ef-00d7-4009-a18c-8eb2d3e9532c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c9b8ed28-b289-4d26-a340-c61bcda9994a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_6ca224ef-00d7-4009-a18c-8eb2d3e9532c" xlink:to="loc_us-gaap_Goodwill_c9b8ed28-b289-4d26-a340-c61bcda9994a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_980cfa6e-2305-45df-8a5a-401c192718c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_6ca224ef-00d7-4009-a18c-8eb2d3e9532c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_980cfa6e-2305-45df-8a5a-401c192718c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d7390936-535e-4f21-9744-356e09e1d300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_6ca224ef-00d7-4009-a18c-8eb2d3e9532c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d7390936-535e-4f21-9744-356e09e1d300" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_279357a9-832e-420f-9bc5-9df8ef88d912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d7390936-535e-4f21-9744-356e09e1d300" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_279357a9-832e-420f-9bc5-9df8ef88d912" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_279357a9-832e-420f-9bc5-9df8ef88d912_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_279357a9-832e-420f-9bc5-9df8ef88d912" xlink:to="loc_us-gaap_SegmentDomain_279357a9-832e-420f-9bc5-9df8ef88d912_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2015a96a-3151-4f14-919c-b8e5a3678884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_279357a9-832e-420f-9bc5-9df8ef88d912" xlink:to="loc_us-gaap_SegmentDomain_2015a96a-3151-4f14-919c-b8e5a3678884" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_2f5e832a-3438-4a80-acc6-ed46dc8e0587" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2015a96a-3151-4f14-919c-b8e5a3678884" xlink:to="loc_mo_SmokeableProductsSegmentMember_2f5e832a-3438-4a80-acc6-ed46dc8e0587" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_113d92c1-f0d4-4204-8c1d-a15f01562881" xlink:href="mo-20221231.xsd#mo_OralTobaccoSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2015a96a-3151-4f14-919c-b8e5a3678884" xlink:to="loc_mo_OralTobaccoSegmentMember_113d92c1-f0d4-4204-8c1d-a15f01562881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_0d6a3a01-8ebc-4a25-a868-c7393d44bf7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2015a96a-3151-4f14-919c-b8e5a3678884" xlink:to="loc_us-gaap_AllOtherSegmentsMember_0d6a3a01-8ebc-4a25-a868-c7393d44bf7a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#GoodwillandOtherIntangibleAssetsnetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails" xlink:type="extended" id="i8472d4c4038a42ffa69c4e2304f9be7d_GoodwillandOtherIntangibleAssetsnetNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTrademarks_8be9deb9-4f98-4948-bcd4-de9b63176ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTrademarks"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_IndefiniteLivedTrademarks_8be9deb9-4f98-4948-bcd4-de9b63176ebb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_bdccc977-25cb-4122-bbcc-ad022c4e651b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_bdccc977-25cb-4122-bbcc-ad022c4e651b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_36bfb705-57c3-44df-89db-86d52c85e5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_36bfb705-57c3-44df-89db-86d52c85e5b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_9664aebc-fc80-4259-9d53-1d0fdf5c36d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_9664aebc-fc80-4259-9d53-1d0fdf5c36d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_65a98741-8717-4cd3-a786-393f77c4ea77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_65a98741-8717-4cd3-a786-393f77c4ea77" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_42bd00a9-c760-4852-b420-c082cc2c0cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_42bd00a9-c760-4852-b420-c082cc2c0cc3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_049055bd-bbfc-4943-8f5c-2977e38230ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_049055bd-bbfc-4943-8f5c-2977e38230ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a75109b8-44c9-49c1-990b-4f502862280a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a75109b8-44c9-49c1-990b-4f502862280a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment_eb326de5-5f88-41f1-89fd-d6d48f7d5f84" xlink:href="mo-20221231.xsd#mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment_eb326de5-5f88-41f1-89fd-d6d48f7d5f84" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment_361460ea-c7f2-4515-a647-274199ec2bb4" xlink:href="mo-20221231.xsd#mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment_361460ea-c7f2-4515-a647-274199ec2bb4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate_cb97104c-6de0-4fe8-b11f-244d84027e85" xlink:href="mo-20221231.xsd#mo_DisposalGroupPurchaseAgreementEffectiveInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate_cb97104c-6de0-4fe8-b11f-244d84027e85" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ProceedsFromSaleOfRightsUnderAnAgreement_393d50bf-728b-4297-bb89-cde50330e7b1" xlink:href="mo-20221231.xsd#mo_ProceedsFromSaleOfRightsUnderAnAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_ProceedsFromSaleOfRightsUnderAnAgreement_393d50bf-728b-4297-bb89-cde50330e7b1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement_9d11bec1-9592-41e9-bad0-211768e226ff" xlink:href="mo-20221231.xsd#mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement_9d11bec1-9592-41e9-bad0-211768e226ff" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupReceivable_a600df79-9a9c-4918-b4ed-22d9844becaa" xlink:href="mo-20221231.xsd#mo_DisposalGroupReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_DisposalGroupReceivable_a600df79-9a9c-4918-b4ed-22d9844becaa" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupInterestReceivable_4b71cf0d-9f42-4223-9878-896c345eca4e" xlink:href="mo-20221231.xsd#mo_DisposalGroupInterestReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_DisposalGroupInterestReceivable_4b71cf0d-9f42-4223-9878-896c345eca4e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome_3ef1ca13-976d-46a3-b23a-2e7d1074c2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome_3ef1ca13-976d-46a3-b23a-2e7d1074c2ea" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_4897dfb6-3ed9-4a0e-8dee-4d9c6d25d683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_4897dfb6-3ed9-4a0e-8dee-4d9c6d25d683" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3cf52487-fd15-4b7c-a85d-8ff1ad25b9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3cf52487-fd15-4b7c-a85d-8ff1ad25b9a0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f1413a76-1e06-4013-84ed-5945688a3d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f1413a76-1e06-4013-84ed-5945688a3d8b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cd6ad5d5-bf1a-48a5-9077-6f75cfdce9ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_srt_RangeAxis_cd6ad5d5-bf1a-48a5-9077-6f75cfdce9ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cd6ad5d5-bf1a-48a5-9077-6f75cfdce9ec_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cd6ad5d5-bf1a-48a5-9077-6f75cfdce9ec" xlink:to="loc_srt_RangeMember_cd6ad5d5-bf1a-48a5-9077-6f75cfdce9ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b72ce94f-b92b-431c-89d3-abc20d8a0b81" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cd6ad5d5-bf1a-48a5-9077-6f75cfdce9ec" xlink:to="loc_srt_RangeMember_b72ce94f-b92b-431c-89d3-abc20d8a0b81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_6311235d-22ee-4a11-9be5-b27b74a1d358" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b72ce94f-b92b-431c-89d3-abc20d8a0b81" xlink:to="loc_srt_WeightedAverageMember_6311235d-22ee-4a11-9be5-b27b74a1d358" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IntangibleAssetsAxis_5eb2b668-04f4-4d3b-a6c0-b7a227544da5" xlink:href="mo-20221231.xsd#mo_IntangibleAssetsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_mo_IntangibleAssetsAxis_5eb2b668-04f4-4d3b-a6c0-b7a227544da5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IntangibleAssetsDomain_5eb2b668-04f4-4d3b-a6c0-b7a227544da5_default" xlink:href="mo-20221231.xsd#mo_IntangibleAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mo_IntangibleAssetsAxis_5eb2b668-04f4-4d3b-a6c0-b7a227544da5" xlink:to="loc_mo_IntangibleAssetsDomain_5eb2b668-04f4-4d3b-a6c0-b7a227544da5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IntangibleAssetsDomain_abb344f3-1fa7-4474-b423-48254e9c30d1" xlink:href="mo-20221231.xsd#mo_IntangibleAssetsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mo_IntangibleAssetsAxis_5eb2b668-04f4-4d3b-a6c0-b7a227544da5" xlink:to="loc_mo_IntangibleAssetsDomain_abb344f3-1fa7-4474-b423-48254e9c30d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefiniteLivedIntangibleAssetsMember_069c4efc-d000-45f6-9153-c2aa11c6f4c5" xlink:href="mo-20221231.xsd#mo_DefiniteLivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_IntangibleAssetsDomain_abb344f3-1fa7-4474-b423-48254e9c30d1" xlink:to="loc_mo_DefiniteLivedIntangibleAssetsMember_069c4efc-d000-45f6-9153-c2aa11c6f4c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_333eb948-46d0-46b9-aba2-0a3f70a07928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_333eb948-46d0-46b9-aba2-0a3f70a07928" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_333eb948-46d0-46b9-aba2-0a3f70a07928_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_333eb948-46d0-46b9-aba2-0a3f70a07928" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_333eb948-46d0-46b9-aba2-0a3f70a07928_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c929e92a-234c-4196-990d-6bd9124c8d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_333eb948-46d0-46b9-aba2-0a3f70a07928" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c929e92a-234c-4196-990d-6bd9124c8d5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MiddletonMember_30e62954-643e-4030-843e-850a292d4d5d" xlink:href="mo-20221231.xsd#mo_MiddletonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c929e92a-234c-4196-990d-6bd9124c8d5b" xlink:to="loc_mo_MiddletonMember_30e62954-643e-4030-843e-850a292d4d5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTIncMember_22c3b5f4-97ee-4cf9-a642-3be5aee025fa" xlink:href="mo-20221231.xsd#mo_USTIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c929e92a-234c-4196-990d-6bd9124c8d5b" xlink:to="loc_mo_USTIncMember_22c3b5f4-97ee-4cf9-a642-3be5aee025fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1a313bfc-c825-45df-9570-ca59c5ec1c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1a313bfc-c825-45df-9570-ca59c5ec1c2e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_1a313bfc-c825-45df-9570-ca59c5ec1c2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1a313bfc-c825-45df-9570-ca59c5ec1c2e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_1a313bfc-c825-45df-9570-ca59c5ec1c2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0be056dd-27d6-43ad-863f-76330be2539a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1a313bfc-c825-45df-9570-ca59c5ec1c2e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0be056dd-27d6-43ad-863f-76330be2539a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_34314c6a-b860-44eb-a483-5c8fd3fa7b07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0be056dd-27d6-43ad-863f-76330be2539a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_34314c6a-b860-44eb-a483-5c8fd3fa7b07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_faca1f01-389e-4774-b8c0-7d5098c53fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_faca1f01-389e-4774-b8c0-7d5098c53fce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_faca1f01-389e-4774-b8c0-7d5098c53fce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_faca1f01-389e-4774-b8c0-7d5098c53fce" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_faca1f01-389e-4774-b8c0-7d5098c53fce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fd6066f7-0199-45c7-a6f2-74bb27dde93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_faca1f01-389e-4774-b8c0-7d5098c53fce" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fd6066f7-0199-45c7-a6f2-74bb27dde93f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IQOSTobaccoHeatingSystemMember_242f0dfb-da2b-46df-ba54-c3d27f434ffc" xlink:href="mo-20221231.xsd#mo_IQOSTobaccoHeatingSystemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fd6066f7-0199-45c7-a6f2-74bb27dde93f" xlink:to="loc_mo_IQOSTobaccoHeatingSystemMember_242f0dfb-da2b-46df-ba54-c3d27f434ffc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ab7c1e9b-8e56-4908-8c67-48588ea7a862" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_srt_StatementScenarioAxis_ab7c1e9b-8e56-4908-8c67-48588ea7a862" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_ab7c1e9b-8e56-4908-8c67-48588ea7a862_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_ab7c1e9b-8e56-4908-8c67-48588ea7a862" xlink:to="loc_srt_ScenarioUnspecifiedDomain_ab7c1e9b-8e56-4908-8c67-48588ea7a862_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_22475dda-f229-4c24-ac1f-bf5e3dc8185f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_ab7c1e9b-8e56-4908-8c67-48588ea7a862" xlink:to="loc_srt_ScenarioUnspecifiedDomain_22475dda-f229-4c24-ac1f-bf5e3dc8185f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_297a634a-d791-45e5-85db-8f365b279e66" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_22475dda-f229-4c24-ac1f-bf5e3dc8185f" xlink:to="loc_srt_ScenarioForecastMember_297a634a-d791-45e5-85db-8f365b279e66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32dd42af-fd0d-48b7-8e7b-c9dcdaf17845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32dd42af-fd0d-48b7-8e7b-c9dcdaf17845" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32dd42af-fd0d-48b7-8e7b-c9dcdaf17845_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32dd42af-fd0d-48b7-8e7b-c9dcdaf17845" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_32dd42af-fd0d-48b7-8e7b-c9dcdaf17845_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2ae7cdf4-82a1-4ebd-98e3-908478862113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32dd42af-fd0d-48b7-8e7b-c9dcdaf17845" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2ae7cdf4-82a1-4ebd-98e3-908478862113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TrademarksCopenhagenMember_34a88a9f-10aa-4515-9bce-2216b396618d" xlink:href="mo-20221231.xsd#mo_TrademarksCopenhagenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2ae7cdf4-82a1-4ebd-98e3-908478862113" xlink:to="loc_mo_TrademarksCopenhagenMember_34a88a9f-10aa-4515-9bce-2216b396618d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TrademarksSkoalMember_516ad6c3-04c3-4f57-a72f-92fc77d8a040" xlink:href="mo-20221231.xsd#mo_TrademarksSkoalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2ae7cdf4-82a1-4ebd-98e3-908478862113" xlink:to="loc_mo_TrademarksSkoalMember_516ad6c3-04c3-4f57-a72f-92fc77d8a040" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TrademarksMSTMember_4550aac7-74c8-42ac-a89e-51b58449960b" xlink:href="mo-20221231.xsd#mo_TrademarksMSTMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2ae7cdf4-82a1-4ebd-98e3-908478862113" xlink:to="loc_mo_TrademarksMSTMember_4550aac7-74c8-42ac-a89e-51b58449960b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails" xlink:type="extended" id="ibf77daa76fd74e1ebb0c0e58f7a6980f_GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_9995d773-227a-432e-a84b-6483637be773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_2ea42802-e02b-4305-a9d9-328370151f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9995d773-227a-432e-a84b-6483637be773" xlink:to="loc_us-gaap_GoodwillRollForward_2ea42802-e02b-4305-a9d9-328370151f02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f6477bd1-347a-4610-8e17-609f6335d46c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_2ea42802-e02b-4305-a9d9-328370151f02" xlink:to="loc_us-gaap_Goodwill_f6477bd1-347a-4610-8e17-609f6335d46c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_a6581a1d-a498-43d2-82e8-7fa9e14a39d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_2ea42802-e02b-4305-a9d9-328370151f02" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_a6581a1d-a498-43d2-82e8-7fa9e14a39d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_9c0bd866-475e-4ec0-b7d9-0e05632edde5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_2ea42802-e02b-4305-a9d9-328370151f02" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_9c0bd866-475e-4ec0-b7d9-0e05632edde5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3a436b8e-c9cb-4ddf-a240-9a2eacf9f4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:href="mo-20221231.xsd#mo_IntangibleAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9995d773-227a-432e-a84b-6483637be773" xlink:to="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e044c322-f5ba-4a9e-b24e-923696f416f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e044c322-f5ba-4a9e-b24e-923696f416f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired_b2e7e0c1-b515-4fe7-978a-155afffd8bac" xlink:href="mo-20221231.xsd#mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:to="loc_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired_b2e7e0c1-b515-4fe7-978a-155afffd8bac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit_5ef6f459-3d39-4e37-b525-b05929b3a7ee" xlink:href="mo-20221231.xsd#mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:to="loc_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit_5ef6f459-3d39-4e37-b525-b05929b3a7ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_022f19cb-19e0-48d0-b92d-b7757545e131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_022f19cb-19e0-48d0-b92d-b7757545e131" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c7185f5d-9ebc-4b27-8686-b173827f5a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_4bb5151e-3ddd-4a6e-8526-3d8aaf2d628b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_9995d773-227a-432e-a84b-6483637be773" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_4bb5151e-3ddd-4a6e-8526-3d8aaf2d628b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_991c94b1-55a5-45bf-b337-80e185ebdcc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_9995d773-227a-432e-a84b-6483637be773" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_991c94b1-55a5-45bf-b337-80e185ebdcc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_05232a65-d13d-47d4-8a3e-e2d28a23c2a4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_991c94b1-55a5-45bf-b337-80e185ebdcc6" xlink:to="loc_dei_LegalEntityAxis_05232a65-d13d-47d4-8a3e-e2d28a23c2a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_05232a65-d13d-47d4-8a3e-e2d28a23c2a4_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_05232a65-d13d-47d4-8a3e-e2d28a23c2a4" xlink:to="loc_dei_EntityDomain_05232a65-d13d-47d4-8a3e-e2d28a23c2a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_78d4d696-26df-445a-9da3-5f3ec75201cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_05232a65-d13d-47d4-8a3e-e2d28a23c2a4" xlink:to="loc_dei_EntityDomain_78d4d696-26df-445a-9da3-5f3ec75201cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JTIUHMember_2d036d1d-b1ba-434d-8079-5ce519cecbe8" xlink:href="mo-20221231.xsd#mo_JTIUHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_78d4d696-26df-445a-9da3-5f3ec75201cd" xlink:to="loc_mo_JTIUHMember_2d036d1d-b1ba-434d-8079-5ce519cecbe8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="extended" id="i648c584c658a44688888cea7e424349a_InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_52b90fc8-adb6-477c-9fd5-d890512ec691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:to="loc_us-gaap_EquityMethodInvestments_52b90fc8-adb6-477c-9fd5-d890512ec691" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_c35bec39-4507-4bf9-852a-66cc571d473c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_c35bec39-4507-4bf9-852a-66cc571d473c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_dc8a3c98-59a3-4639-880b-8b9224b25263" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:to="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_dc8a3c98-59a3-4639-880b-8b9224b25263" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_de6eae68-8fd3-4bf8-ad8f-0c90f07a6f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:to="loc_us-gaap_Investments_de6eae68-8fd3-4bf8-ad8f-0c90f07a6f46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsFixedPreemptiveRights_9b04cc9d-82ae-49da-bd7d-fd2926e73e15" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentsFixedPreemptiveRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:to="loc_mo_EquityMethodInvestmentsFixedPreemptiveRights_9b04cc9d-82ae-49da-bd7d-fd2926e73e15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_15f15780-cd06-4cd0-b5df-4946a81331fa" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:to="loc_mo_InvestmentsTable_15f15780-cd06-4cd0-b5df-4946a81331fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5e9aad1a-5a8e-4c76-9ef3-5c68f7735448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_15f15780-cd06-4cd0-b5df-4946a81331fa" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5e9aad1a-5a8e-4c76-9ef3-5c68f7735448" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5e9aad1a-5a8e-4c76-9ef3-5c68f7735448_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5e9aad1a-5a8e-4c76-9ef3-5c68f7735448" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5e9aad1a-5a8e-4c76-9ef3-5c68f7735448_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a5f353a7-ed34-4f34-8f7e-541ae78bbed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5e9aad1a-5a8e-4c76-9ef3-5c68f7735448" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a5f353a7-ed34-4f34-8f7e-541ae78bbed3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4bb899bb-735d-4712-8274-8d36fa150174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a5f353a7-ed34-4f34-8f7e-541ae78bbed3" xlink:to="loc_us-gaap_CommonStockMember_4bb899bb-735d-4712-8274-8d36fa150174" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fdbcb9b-2535-4d3f-95aa-0367f27c52aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_15f15780-cd06-4cd0-b5df-4946a81331fa" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fdbcb9b-2535-4d3f-95aa-0367f27c52aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9fdbcb9b-2535-4d3f-95aa-0367f27c52aa_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fdbcb9b-2535-4d3f-95aa-0367f27c52aa" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9fdbcb9b-2535-4d3f-95aa-0367f27c52aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_51bbc9d3-e292-45a7-8f27-6f08e1cc71ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fdbcb9b-2535-4d3f-95aa-0367f27c52aa" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_51bbc9d3-e292-45a7-8f27-6f08e1cc71ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_6283ff7e-b8bb-4a27-99f9-d8a3b772cef8" xlink:href="mo-20221231.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_51bbc9d3-e292-45a7-8f27-6f08e1cc71ca" xlink:to="loc_mo_ABInBevMember_6283ff7e-b8bb-4a27-99f9-d8a3b772cef8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_f6f9fcf6-08fc-42ba-aea9-dc8097412ae9" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_51bbc9d3-e292-45a7-8f27-6f08e1cc71ca" xlink:to="loc_mo_JUULMember_f6f9fcf6-08fc-42ba-aea9-dc8097412ae9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_e13d252c-9c4c-4cc3-b33a-34e5847fca52" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_51bbc9d3-e292-45a7-8f27-6f08e1cc71ca" xlink:to="loc_mo_CronosGroupInc.Member_e13d252c-9c4c-4cc3-b33a-34e5847fca52" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails" xlink:type="extended" id="i41a016e98f9940019fd7e0c870fd3c8c_InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_388e95a7-94f3-4d59-b611-c7b17ff5f873" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1295969f-3d78-4145-aa6c-10c8397d724a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_388e95a7-94f3-4d59-b611-c7b17ff5f873" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1295969f-3d78-4145-aa6c-10c8397d724a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_dbce8791-aac7-4049-bed3-43d267b355c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_388e95a7-94f3-4d59-b611-c7b17ff5f873" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_dbce8791-aac7-4049-bed3-43d267b355c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_f8383afd-cca8-4d7b-9b3d-62f70a038529" xlink:href="mo-20221231.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_388e95a7-94f3-4d59-b611-c7b17ff5f873" xlink:to="loc_mo_IncomeLossFromEquityInvestments_f8383afd-cca8-4d7b-9b3d-62f70a038529" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_2d6c0050-9ed8-4da0-8537-31c3ab3e0fda" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_388e95a7-94f3-4d59-b611-c7b17ff5f873" xlink:to="loc_mo_InvestmentsTable_2d6c0050-9ed8-4da0-8537-31c3ab3e0fda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_53cc01e7-bd84-47ce-8142-a2bbf25cda5e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_2d6c0050-9ed8-4da0-8537-31c3ab3e0fda" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_53cc01e7-bd84-47ce-8142-a2bbf25cda5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_53cc01e7-bd84-47ce-8142-a2bbf25cda5e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_53cc01e7-bd84-47ce-8142-a2bbf25cda5e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_53cc01e7-bd84-47ce-8142-a2bbf25cda5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6fd207bb-f5a8-4736-a0e1-035b49614190" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_53cc01e7-bd84-47ce-8142-a2bbf25cda5e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6fd207bb-f5a8-4736-a0e1-035b49614190" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_7ae97980-1a26-4db4-bb7b-d440e18147be" xlink:href="mo-20221231.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6fd207bb-f5a8-4736-a0e1-035b49614190" xlink:to="loc_mo_ABInBevMember_7ae97980-1a26-4db4-bb7b-d440e18147be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_267778ac-cbb8-4b1c-8375-f4679bca91d9" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6fd207bb-f5a8-4736-a0e1-035b49614190" xlink:to="loc_mo_CronosGroupInc.Member_267778ac-cbb8-4b1c-8375-f4679bca91d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_ed59375b-25ce-49f1-837d-38cf70c531f8" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6fd207bb-f5a8-4736-a0e1-035b49614190" xlink:to="loc_mo_JUULMember_ed59375b-25ce-49f1-837d-38cf70c531f8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails" xlink:type="extended" id="i1c914a53eaba4f0e804ffca222c55646_InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_66aac08a-ddb5-4985-817e-6f96c0cc14df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_66aac08a-ddb5-4985-817e-6f96c0cc14df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ea5c9141-b0be-467e-8f8c-c5f7aaa0bb7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_GrossProfit_ea5c9141-b0be-467e-8f8c-c5f7aaa0bb7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_efea1a74-e114-42ef-bb0c-a3e043645a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_efea1a74-e114-42ef-bb0c-a3e043645a3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a1c1ab6a-d9d9-46e7-b3b8-13d981cedd82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_ProfitLoss_a1c1ab6a-d9d9-46e7-b3b8-13d981cedd82" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3be3b521-5a3b-4c34-a701-a6756b37448f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3be3b521-5a3b-4c34-a701-a6756b37448f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7f2aae82-0a4c-4fdd-b3da-87ceb3961526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_AssetsCurrent_7f2aae82-0a4c-4fdd-b3da-87ceb3961526" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_1969b70a-a525-4c58-80d0-943dec145491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_AssetsNoncurrent_1969b70a-a525-4c58-80d0-943dec145491" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2f35978f-146d-41c4-85cd-c7d96553311d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_LiabilitiesCurrent_2f35978f-146d-41c4-85cd-c7d96553311d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_48a42b1a-a019-491c-96df-cd3e82f7a9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_48a42b1a-a019-491c-96df-cd3e82f7a9d8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_eccd328a-d79f-45a2-9332-b98788ce453c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_eccd328a-d79f-45a2-9332-b98788ce453c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_45644697-bfb2-4ad8-9512-8a5f25f4c2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_45644697-bfb2-4ad8-9512-8a5f25f4c2e6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_71774361-401a-41ca-a61f-5a99ce450388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_71774361-401a-41ca-a61f-5a99ce450388" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0e202dec-9c6f-4f9c-afa4-c35fdf6b4662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_71774361-401a-41ca-a61f-5a99ce450388" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0e202dec-9c6f-4f9c-afa4-c35fdf6b4662" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_0e202dec-9c6f-4f9c-afa4-c35fdf6b4662_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0e202dec-9c6f-4f9c-afa4-c35fdf6b4662" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_0e202dec-9c6f-4f9c-afa4-c35fdf6b4662_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_b383e449-0cc4-490b-9e74-2641973d0eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0e202dec-9c6f-4f9c-afa4-c35fdf6b4662" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_b383e449-0cc4-490b-9e74-2641973d0eb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_c7b8c85c-62a2-4205-9ab5-17814eb38a78" xlink:href="mo-20221231.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_b383e449-0cc4-490b-9e74-2641973d0eb6" xlink:to="loc_mo_ABInBevMember_c7b8c85c-62a2-4205-9ab5-17814eb38a78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULAndCronosMember_fe699ab1-cfd7-4ed5-a166-8f5f2c82dc23" xlink:href="mo-20221231.xsd#mo_JUULAndCronosMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_b383e449-0cc4-490b-9e74-2641973d0eb6" xlink:to="loc_mo_JUULAndCronosMember_fe699ab1-cfd7-4ed5-a166-8f5f2c82dc23" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="extended" id="id808f4d79e294e6aaa7a49352cda9147_InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9df40ef9-7fc5-4f97-b08d-fc92381f48f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9df40ef9-7fc5-4f97-b08d-fc92381f48f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_8d024fb2-d6a4-492a-a329-86b06100a921" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedRestricted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_8d024fb2-d6a4-492a-a329-86b06100a921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_8c712727-8745-4c5b-874a-f9de5eae974c" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_8c712727-8745-4c5b-874a-f9de5eae974c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_fe802c85-5e9a-4b8b-a6d7-658a6f9c76ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_fe802c85-5e9a-4b8b-a6d7-658a6f9c76ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_1687b123-c3fb-4229-93c3-d820e0b5b2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_us-gaap_EquityMethodInvestments_1687b123-c3fb-4229-93c3-d820e0b5b2e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_6f433ea6-6f3d-494a-aecb-4881e7e563f0" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_6f433ea6-6f3d-494a-aecb-4881e7e563f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_7c58b3b2-e5b5-44e6-8642-a8a9dd768bef" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_7c58b3b2-e5b5-44e6-8642-a8a9dd768bef" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment_135116d0-196c-40c7-9110-3167a9f1d990" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_mo_EquityMethodInvestmentImpairment_135116d0-196c-40c7-9110-3167a9f1d990" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_a98c0a25-e826-48b3-9e77-1cf5c321e063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_a98c0a25-e826-48b3-9e77-1cf5c321e063" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_903d2cc2-18de-4712-a8c4-4d6ad006f4ac" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_mo_InvestmentsTable_903d2cc2-18de-4712-a8c4-4d6ad006f4ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b9a25da-7254-492c-8c39-2693881c79bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_903d2cc2-18de-4712-a8c4-4d6ad006f4ac" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b9a25da-7254-492c-8c39-2693881c79bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6b9a25da-7254-492c-8c39-2693881c79bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b9a25da-7254-492c-8c39-2693881c79bb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6b9a25da-7254-492c-8c39-2693881c79bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a16ce12e-e0ad-4f0b-8efb-84c40b22b996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b9a25da-7254-492c-8c39-2693881c79bb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a16ce12e-e0ad-4f0b-8efb-84c40b22b996" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_bffb1842-459d-4d31-a8d8-32ab70e64dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a16ce12e-e0ad-4f0b-8efb-84c40b22b996" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_bffb1842-459d-4d31-a8d8-32ab70e64dab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5590cd45-03af-4a08-aa20-14cb6d288fbb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_903d2cc2-18de-4712-a8c4-4d6ad006f4ac" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5590cd45-03af-4a08-aa20-14cb6d288fbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_5590cd45-03af-4a08-aa20-14cb6d288fbb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5590cd45-03af-4a08-aa20-14cb6d288fbb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_5590cd45-03af-4a08-aa20-14cb6d288fbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e367a03e-8cbd-4eab-908b-2149cbf3ab30" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5590cd45-03af-4a08-aa20-14cb6d288fbb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e367a03e-8cbd-4eab-908b-2149cbf3ab30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_1c6665e6-7223-411c-af28-94cc0649413c" xlink:href="mo-20221231.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e367a03e-8cbd-4eab-908b-2149cbf3ab30" xlink:to="loc_mo_ABInBevMember_1c6665e6-7223-411c-af28-94cc0649413c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="extended" id="i12bf082227504c2c8faaf3f9f156bd90_InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_4ef1a24f-a7cf-4115-8c53-5e110d1ba59b" xlink:href="mo-20221231.xsd#mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_4ef1a24f-a7cf-4115-8c53-5e110d1ba59b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_9433d643-7ac4-40ae-afe7-56dc92e12e75" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_9433d643-7ac4-40ae-afe7-56dc92e12e75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentOwnedBalancePercentage_f2123941-17d8-4d27-9532-9af859292764" xlink:href="mo-20221231.xsd#mo_InvestmentOwnedBalancePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_InvestmentOwnedBalancePercentage_f2123941-17d8-4d27-9532-9af859292764" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_6bd4f793-fc49-4fdb-9e67-4b939f796bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_6bd4f793-fc49-4fdb-9e67-4b939f796bba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_ba71b2ee-4251-4759-af85-6a90230d52d7" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_ba71b2ee-4251-4759-af85-6a90230d52d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_09b67703-9514-4056-986c-9280fa8adf3c" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_09b67703-9514-4056-986c-9280fa8adf3c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_ee4c8fc2-39bd-47be-ac51-396cbce1c286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_ee4c8fc2-39bd-47be-ac51-396cbce1c286" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_3d39ef37-9f84-49af-8490-4e3e28c9a282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_3d39ef37-9f84-49af-8490-4e3e28c9a282" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_64817b73-0265-4415-9f45-670130897617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_64817b73-0265-4415-9f45-670130897617" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_eb962d3f-36e7-4ea5-a732-2e335164a1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_eb962d3f-36e7-4ea5-a732-2e335164a1ad" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentFairValueOption_3b2b99a5-6576-45e4-86d0-2d38af55447a" xlink:href="mo-20221231.xsd#mo_EquityInvestmentFairValueOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_EquityInvestmentFairValueOption_3b2b99a5-6576-45e4-86d0-2d38af55447a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_d6330a28-eed7-4304-904e-18061c11d607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_d6330a28-eed7-4304-904e-18061c11d607" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_c69aced7-b6c7-4ead-983b-21c1db6304ca" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_InvestmentsTable_c69aced7-b6c7-4ead-983b-21c1db6304ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7d87688-7f6a-43f7-aaeb-fd24ed749f1e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_c69aced7-b6c7-4ead-983b-21c1db6304ca" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7d87688-7f6a-43f7-aaeb-fd24ed749f1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a7d87688-7f6a-43f7-aaeb-fd24ed749f1e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7d87688-7f6a-43f7-aaeb-fd24ed749f1e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a7d87688-7f6a-43f7-aaeb-fd24ed749f1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b335826d-f66c-4a54-ad12-c331e639366f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7d87688-7f6a-43f7-aaeb-fd24ed749f1e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b335826d-f66c-4a54-ad12-c331e639366f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_862de888-b937-4f24-9e3d-23a1d6a643d2" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b335826d-f66c-4a54-ad12-c331e639366f" xlink:to="loc_mo_JUULMember_862de888-b937-4f24-9e3d-23a1d6a643d2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" xlink:type="extended" id="i7278632db0404e8d95abbe4601e78a98_InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_7fdc4b61-84b4-4f5d-810d-b7d719ff526d" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a4ee84b6-d572-40ef-9f78-2b37410a2d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_7fdc4b61-84b4-4f5d-810d-b7d719ff526d" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a4ee84b6-d572-40ef-9f78-2b37410a2d78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_a872bede-33c2-4877-bf0e-c640e6f42521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a4ee84b6-d572-40ef-9f78-2b37410a2d78" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_a872bede-33c2-4877-bf0e-c640e6f42521" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_9c579fee-6711-42ce-87a3-84194a0cdc22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a4ee84b6-d572-40ef-9f78-2b37410a2d78" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_9c579fee-6711-42ce-87a3-84194a0cdc22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0f681333-22a6-4104-a84e-07c8ce031379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_738ab5ea-9923-496f-8d23-a205739f6237" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_7fdc4b61-84b4-4f5d-810d-b7d719ff526d" xlink:to="loc_mo_InvestmentsTable_738ab5ea-9923-496f-8d23-a205739f6237" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_cd1ba621-5a07-47b6-a001-cb4fce953759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_738ab5ea-9923-496f-8d23-a205739f6237" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_cd1ba621-5a07-47b6-a001-cb4fce953759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cd1ba621-5a07-47b6-a001-cb4fce953759_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_cd1ba621-5a07-47b6-a001-cb4fce953759" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_cd1ba621-5a07-47b6-a001-cb4fce953759_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_98e10b52-b6b8-48be-aec5-3dd2fb7fa090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_cd1ba621-5a07-47b6-a001-cb4fce953759" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_98e10b52-b6b8-48be-aec5-3dd2fb7fa090" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_723281c1-e561-47aa-b77a-d5390e5b94d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_98e10b52-b6b8-48be-aec5-3dd2fb7fa090" xlink:to="loc_us-gaap_EquitySecuritiesMember_723281c1-e561-47aa-b77a-d5390e5b94d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c39ffab-5311-4c52-9020-df686910b7ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_738ab5ea-9923-496f-8d23-a205739f6237" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c39ffab-5311-4c52-9020-df686910b7ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6c39ffab-5311-4c52-9020-df686910b7ba_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c39ffab-5311-4c52-9020-df686910b7ba" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6c39ffab-5311-4c52-9020-df686910b7ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_64271820-0223-4249-892a-409857d82d40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c39ffab-5311-4c52-9020-df686910b7ba" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_64271820-0223-4249-892a-409857d82d40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_a9bb9e77-8c45-4c29-9b2e-7d22227b6728" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_64271820-0223-4249-892a-409857d82d40" xlink:to="loc_mo_JUULMember_a9bb9e77-8c45-4c29-9b2e-7d22227b6728" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="extended" id="i9b8e82d529934f3589ffe9505b60c891_InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_70151f65-7f3f-4218-b491-2ce695cdf51f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_70151f65-7f3f-4218-b491-2ce695cdf51f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_6bc6f3d6-35fc-493c-9acd-f2bccea1d7f7" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_6bc6f3d6-35fc-493c-9acd-f2bccea1d7f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_1476b3de-c651-47b4-9fd4-db380a6c3e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_us-gaap_EquityMethodInvestments_1476b3de-c651-47b4-9fd4-db380a6c3e9d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_88d3fddb-5225-4c5f-b91c-b5fa14c56488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_88d3fddb-5225-4c5f-b91c-b5fa14c56488" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_00f43e67-27bb-4144-a46d-5340c4a32fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_00f43e67-27bb-4144-a46d-5340c4a32fee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_c199153c-cb3d-4cca-98d5-e1ccada6b430" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_c199153c-cb3d-4cca-98d5-e1ccada6b430" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_6b8f6611-d055-4142-9dee-c105ed5735a5" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_6b8f6611-d055-4142-9dee-c105ed5735a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_773e4d12-faa2-4707-b3e2-5edf94139665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_773e4d12-faa2-4707-b3e2-5edf94139665" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_5aa906a2-604b-4c06-8cd6-3eae58fdcf41" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentPricePerShareIfExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_5aa906a2-604b-4c06-8cd6-3eae58fdcf41" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_005ad0e6-ce5e-46bc-af1f-58abe87e86f4" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_005ad0e6-ce5e-46bc-af1f-58abe87e86f4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_e1de752e-023d-45b6-bfb0-0754a2b0869e" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_e1de752e-023d-45b6-bfb0-0754a2b0869e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment_6e8f9133-21ca-4416-9bbb-4cb75eda370a" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentImpairment_6e8f9133-21ca-4416-9bbb-4cb75eda370a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_d58d9747-1437-4c98-bb79-121d1b956ed8" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_InvestmentsTable_d58d9747-1437-4c98-bb79-121d1b956ed8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f541c11b-51e6-4c1b-9c10-f89a270264f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_d58d9747-1437-4c98-bb79-121d1b956ed8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f541c11b-51e6-4c1b-9c10-f89a270264f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f541c11b-51e6-4c1b-9c10-f89a270264f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f541c11b-51e6-4c1b-9c10-f89a270264f7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f541c11b-51e6-4c1b-9c10-f89a270264f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5efa0e88-27c5-4d46-875e-979e315e0db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f541c11b-51e6-4c1b-9c10-f89a270264f7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5efa0e88-27c5-4d46-875e-979e315e0db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_07b47763-bf4f-4bfc-b56a-e82efd93aeff" xlink:href="mo-20221231.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5efa0e88-27c5-4d46-875e-979e315e0db3" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_07b47763-bf4f-4bfc-b56a-e82efd93aeff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_826243c8-82a4-4179-bfd1-651f8ff7a212" xlink:href="mo-20221231.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5efa0e88-27c5-4d46-875e-979e315e0db3" xlink:to="loc_mo_EquityContractWarrantMember_826243c8-82a4-4179-bfd1-651f8ff7a212" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0d2c0e29-b690-4d34-a739-480be49756c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_d58d9747-1437-4c98-bb79-121d1b956ed8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0d2c0e29-b690-4d34-a739-480be49756c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_0d2c0e29-b690-4d34-a739-480be49756c3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0d2c0e29-b690-4d34-a739-480be49756c3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_0d2c0e29-b690-4d34-a739-480be49756c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e6451fce-8497-46ee-a841-d174e71102cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0d2c0e29-b690-4d34-a739-480be49756c3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e6451fce-8497-46ee-a841-d174e71102cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_ed54d188-5838-4b41-b036-709e34b945ec" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e6451fce-8497-46ee-a841-d174e71102cf" xlink:to="loc_mo_CronosGroupInc.Member_ed54d188-5838-4b41-b036-709e34b945ec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails" xlink:type="extended" id="i5e454a0ec3ab4b888c1f50bc1dfb419a_InvestmentsinEquitySecuritiesInvestmentinCronosDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_89e8c09b-d4ce-442f-bfb6-e0352c232167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_30f6940d-491d-4fd6-96cc-8ef96d8f2bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_89e8c09b-d4ce-442f-bfb6-e0352c232167" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_30f6940d-491d-4fd6-96cc-8ef96d8f2bb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_93323a87-29d1-441b-8f60-2d8a1a55ddf5" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_89e8c09b-d4ce-442f-bfb6-e0352c232167" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_93323a87-29d1-441b-8f60-2d8a1a55ddf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fe3c68e-211a-464b-b26e-9dfa46497f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_89e8c09b-d4ce-442f-bfb6-e0352c232167" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fe3c68e-211a-464b-b26e-9dfa46497f81" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_423cb457-f9a7-44ff-9f46-75efcf0d6c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fe3c68e-211a-464b-b26e-9dfa46497f81" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_423cb457-f9a7-44ff-9f46-75efcf0d6c5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_423cb457-f9a7-44ff-9f46-75efcf0d6c5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_423cb457-f9a7-44ff-9f46-75efcf0d6c5c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_423cb457-f9a7-44ff-9f46-75efcf0d6c5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_61f16083-2c60-4ea2-96be-308c70dadfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_423cb457-f9a7-44ff-9f46-75efcf0d6c5c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_61f16083-2c60-4ea2-96be-308c70dadfa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_5a814469-050b-4a80-9dbc-bf86843b2f0c" xlink:href="mo-20221231.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61f16083-2c60-4ea2-96be-308c70dadfa4" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_5a814469-050b-4a80-9dbc-bf86843b2f0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_0d583b7b-6c64-459c-8ecc-97c49fcffbe0" xlink:href="mo-20221231.xsd#mo_EquityContractWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61f16083-2c60-4ea2-96be-308c70dadfa4" xlink:to="loc_mo_EquityContractWarrantMember_0d583b7b-6c64-459c-8ecc-97c49fcffbe0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#FinancialInstrumentsAggregateFairValueandCarryingValueDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails" xlink:type="extended" id="i8189095aa9634b08ac8bcb3be0f7325d_FinancialInstrumentsAggregateFairValueandCarryingValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9801d194-3e63-4266-b851-a54a0012217d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a2690d6c-44f2-42f3-956c-d9f6f93dc0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9801d194-3e63-4266-b851-a54a0012217d" xlink:to="loc_us-gaap_LongTermDebt_a2690d6c-44f2-42f3-956c-d9f6f93dc0d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_422bd899-5b9b-47d7-af07-5b091ef2307e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9801d194-3e63-4266-b851-a54a0012217d" xlink:to="loc_us-gaap_LongTermDebtFairValue_422bd899-5b9b-47d7-af07-5b091ef2307e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtAbstract_376b8c6c-9863-404e-ad4c-9f1af344b5b6" xlink:href="mo-20221231.xsd#mo_ForeignCurrencyDenominatedDebtAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_9801d194-3e63-4266-b851-a54a0012217d" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtAbstract_376b8c6c-9863-404e-ad4c-9f1af344b5b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c334f50c-ef6c-4e34-92e1-067a3c096d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_e7e9cc29-03b5-4aa4-be81-5c4ec7025cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ForeignCurrencyDenominatedDebtAbstract_376b8c6c-9863-404e-ad4c-9f1af344b5b6" xlink:to="loc_us-gaap_DebtInstrumentFairValue_e7e9cc29-03b5-4aa4-be81-5c4ec7025cc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c9562505-d689-4427-b530-36601b74e032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_9801d194-3e63-4266-b851-a54a0012217d" xlink:to="loc_us-gaap_DerivativeTable_c9562505-d689-4427-b530-36601b74e032" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_43316a2f-f6ae-4037-bab0-58284c0af3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_c9562505-d689-4427-b530-36601b74e032" xlink:to="loc_us-gaap_DebtInstrumentAxis_43316a2f-f6ae-4037-bab0-58284c0af3e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_43316a2f-f6ae-4037-bab0-58284c0af3e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_43316a2f-f6ae-4037-bab0-58284c0af3e5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_43316a2f-f6ae-4037-bab0-58284c0af3e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_772284cb-30a9-46e6-9d1f-c0e0a8cd3011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_43316a2f-f6ae-4037-bab0-58284c0af3e5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_772284cb-30a9-46e6-9d1f-c0e0a8cd3011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_b45d726a-9fe0-4c48-a78d-9f969a16449a" xlink:href="mo-20221231.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_772284cb-30a9-46e6-9d1f-c0e0a8cd3011" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_b45d726a-9fe0-4c48-a78d-9f969a16449a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended" id="if4a6b501a21343b1adcf172427c93fcd_FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8769e279-3f88-4f4f-bef7-1998939e4194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_91728302-03ae-4600-b50e-e77e1225419e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8769e279-3f88-4f4f-bef7-1998939e4194" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_91728302-03ae-4600-b50e-e77e1225419e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_e2c5a638-6daa-4a5b-b5f1-b057f2f766d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8769e279-3f88-4f4f-bef7-1998939e4194" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_e2c5a638-6daa-4a5b-b5f1-b057f2f766d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea6aec5a-3fb7-41ba-8d35-0eb7017fd644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8769e279-3f88-4f4f-bef7-1998939e4194" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea6aec5a-3fb7-41ba-8d35-0eb7017fd644" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_81aba17d-a3aa-4b16-b1d4-4f3a3f3719fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea6aec5a-3fb7-41ba-8d35-0eb7017fd644" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_81aba17d-a3aa-4b16-b1d4-4f3a3f3719fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_81aba17d-a3aa-4b16-b1d4-4f3a3f3719fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_81aba17d-a3aa-4b16-b1d4-4f3a3f3719fd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_81aba17d-a3aa-4b16-b1d4-4f3a3f3719fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_74c10770-d1e1-4b59-8d43-f2f4bcbac991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_81aba17d-a3aa-4b16-b1d4-4f3a3f3719fd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_74c10770-d1e1-4b59-8d43-f2f4bcbac991" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6c26cbdc-7c8e-453d-990f-39b9cd9b5423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_74c10770-d1e1-4b59-8d43-f2f4bcbac991" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6c26cbdc-7c8e-453d-990f-39b9cd9b5423" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_d9f1d3a5-bc4f-47b5-a9f7-25275aeda585" xlink:href="mo-20221231.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_74c10770-d1e1-4b59-8d43-f2f4bcbac991" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_d9f1d3a5-bc4f-47b5-a9f7-25275aeda585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_386a676f-0c91-45ce-a673-88d27ad5ab04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea6aec5a-3fb7-41ba-8d35-0eb7017fd644" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_386a676f-0c91-45ce-a673-88d27ad5ab04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_386a676f-0c91-45ce-a673-88d27ad5ab04_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_386a676f-0c91-45ce-a673-88d27ad5ab04" xlink:to="loc_us-gaap_HedgingRelationshipDomain_386a676f-0c91-45ce-a673-88d27ad5ab04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dad88992-aa6d-46b0-9443-9b1034bd86af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_386a676f-0c91-45ce-a673-88d27ad5ab04" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dad88992-aa6d-46b0-9443-9b1034bd86af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_6f1f413a-af40-419c-a04f-43e284be8bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_dad88992-aa6d-46b0-9443-9b1034bd86af" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_6f1f413a-af40-419c-a04f-43e284be8bcc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails" xlink:type="extended" id="ic59c5fca7a4c43f08bca5feaeee3794a_ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_c63b4c1d-f2e1-4d61-a7f7-2d3d4ba9e17a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_us-gaap_ShortTermBorrowings_c63b4c1d-f2e1-4d61-a7f7-2d3d4ba9e17a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_501d93ef-d6a7-4f74-bf48-730f7d83fe5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_501d93ef-d6a7-4f74-bf48-730f7d83fe5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_3e94e467-5f7e-4d54-9ead-0ec7961aabd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_us-gaap_DebtInstrumentTerm_3e94e467-5f7e-4d54-9ead-0ec7961aabd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5fa45a96-1509-4933-bf7c-7fc0e7815a93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5fa45a96-1509-4933-bf7c-7fc0e7815a93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_ece92fcc-b579-4042-b2a7-77cd0c882c36" xlink:href="mo-20221231.xsd#mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_ece92fcc-b579-4042-b2a7-77cd0c882c36" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_ecc26071-6735-4651-bcd9-e3e87b03ceeb" xlink:href="mo-20221231.xsd#mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_ecc26071-6735-4651-bcd9-e3e87b03ceeb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_19d4136d-0e34-42b4-a5fb-4375676cecdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_19d4136d-0e34-42b4-a5fb-4375676cecdf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3a0ae9c4-b340-4b65-a617-d519cbe38e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3a0ae9c4-b340-4b65-a617-d519cbe38e1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3a0ae9c4-b340-4b65-a617-d519cbe38e1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3a0ae9c4-b340-4b65-a617-d519cbe38e1f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3a0ae9c4-b340-4b65-a617-d519cbe38e1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8bd3aa73-d253-462e-a73c-06ff4905b707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3a0ae9c4-b340-4b65-a617-d519cbe38e1f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8bd3aa73-d253-462e-a73c-06ff4905b707" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d842d30f-32bf-4675-a932-2cec0ae59388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8bd3aa73-d253-462e-a73c-06ff4905b707" xlink:to="loc_us-gaap_LineOfCreditMember_d842d30f-32bf-4675-a932-2cec0ae59388" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_806bbcee-d8e3-4a7b-8e82-079a045073e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:to="loc_us-gaap_DebtInstrumentAxis_806bbcee-d8e3-4a7b-8e82-079a045073e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_806bbcee-d8e3-4a7b-8e82-079a045073e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_806bbcee-d8e3-4a7b-8e82-079a045073e5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_806bbcee-d8e3-4a7b-8e82-079a045073e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6ee57c23-f373-46c8-a550-5ff19ebf2a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_806bbcee-d8e3-4a7b-8e82-079a045073e5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6ee57c23-f373-46c8-a550-5ff19ebf2a9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevolvingCreditFacilityDueAugust2025Member_0d5f4b55-edb3-4626-9465-a58d2e0f816c" xlink:href="mo-20221231.xsd#mo_RevolvingCreditFacilityDueAugust2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6ee57c23-f373-46c8-a550-5ff19ebf2a9a" xlink:to="loc_mo_RevolvingCreditFacilityDueAugust2025Member_0d5f4b55-edb3-4626-9465-a58d2e0f816c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c0cae540-d1b7-436b-8db4-487c04bc0548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:to="loc_us-gaap_CreditFacilityAxis_c0cae540-d1b7-436b-8db4-487c04bc0548" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_c0cae540-d1b7-436b-8db4-487c04bc0548_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_c0cae540-d1b7-436b-8db4-487c04bc0548" xlink:to="loc_us-gaap_CreditFacilityDomain_c0cae540-d1b7-436b-8db4-487c04bc0548_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_edd2bb8b-0f6e-4fcd-8b5b-46a481c3c62e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_c0cae540-d1b7-436b-8db4-487c04bc0548" xlink:to="loc_us-gaap_CreditFacilityDomain_edd2bb8b-0f6e-4fcd-8b5b-46a481c3c62e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_044aea69-294b-415d-8c00-e73edb0b4478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_edd2bb8b-0f6e-4fcd-8b5b-46a481c3c62e" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_044aea69-294b-415d-8c00-e73edb0b4478" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_547ac10d-68e9-48f8-b8fd-af3640864e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:to="loc_us-gaap_VariableRateAxis_547ac10d-68e9-48f8-b8fd-af3640864e14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_547ac10d-68e9-48f8-b8fd-af3640864e14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_547ac10d-68e9-48f8-b8fd-af3640864e14" xlink:to="loc_us-gaap_VariableRateDomain_547ac10d-68e9-48f8-b8fd-af3640864e14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1ab58c7a-7fbe-486b-b06c-befe0c9920e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_547ac10d-68e9-48f8-b8fd-af3640864e14" xlink:to="loc_us-gaap_VariableRateDomain_1ab58c7a-7fbe-486b-b06c-befe0c9920e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TermSecuredOvernightFinancingRateTermSOFRMember_41822dc2-8062-480c-a946-18a2da229fab" xlink:href="mo-20221231.xsd#mo_TermSecuredOvernightFinancingRateTermSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1ab58c7a-7fbe-486b-b06c-befe0c9920e5" xlink:to="loc_mo_TermSecuredOvernightFinancingRateTermSOFRMember_41822dc2-8062-480c-a946-18a2da229fab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#LongTermDebtSummaryofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails" xlink:type="extended" id="i41b1770e31ac48cca1f8c069ffd8d2fd_LongTermDebtSummaryofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f9a62700-2eed-4bc3-9552-2a0a41f9474a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:to="loc_us-gaap_LongTermDebt_f9a62700-2eed-4bc3-9552-2a0a41f9474a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ffffda39-2d7b-46ac-8b28-7f037f826b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:to="loc_us-gaap_LongTermDebtCurrent_ffffda39-2d7b-46ac-8b28-7f037f826b9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1231180e-2909-4c6c-96a2-594b643010a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1231180e-2909-4c6c-96a2-594b643010a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c012fb09-3c14-488e-aaed-5a1513aa2d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c012fb09-3c14-488e-aaed-5a1513aa2d10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_5d70e0a4-703b-4fde-8676-2abd20275b53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_5d70e0a4-703b-4fde-8676-2abd20275b53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2d705ea3-02f6-4e0d-a730-931824a4682c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:to="loc_us-gaap_DebtInstrumentTable_2d705ea3-02f6-4e0d-a730-931824a4682c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8e270fc6-1988-4b03-b87b-c68ea30acbe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2d705ea3-02f6-4e0d-a730-931824a4682c" xlink:to="loc_us-gaap_DebtInstrumentAxis_8e270fc6-1988-4b03-b87b-c68ea30acbe8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8e270fc6-1988-4b03-b87b-c68ea30acbe8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8e270fc6-1988-4b03-b87b-c68ea30acbe8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8e270fc6-1988-4b03-b87b-c68ea30acbe8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cefdea29-f115-46ff-940c-0944a82b3bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8e270fc6-1988-4b03-b87b-c68ea30acbe8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cefdea29-f115-46ff-940c-0944a82b3bf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2350To1020Member_be78dab3-f293-4d5e-991b-306c0d0aac33" xlink:href="mo-20221231.xsd#mo_USDNotes2350To1020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cefdea29-f115-46ff-940c-0944a82b3bf5" xlink:to="loc_mo_USDNotes2350To1020Member_be78dab3-f293-4d5e-991b-306c0d0aac33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDebenture7750MaturingJanuary2027Member_a6773df3-1ad2-4c1d-ae13-a8f4394bf3e0" xlink:href="mo-20221231.xsd#mo_USDDebenture7750MaturingJanuary2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cefdea29-f115-46ff-940c-0944a82b3bf5" xlink:to="loc_mo_USDDebenture7750MaturingJanuary2027Member_a6773df3-1ad2-4c1d-ae13-a8f4394bf3e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes1000To3125Member_a7306514-8d0a-477b-8afd-1c446420c1dd" xlink:href="mo-20221231.xsd#mo_EuroNotes1000To3125Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cefdea29-f115-46ff-940c-0944a82b3bf5" xlink:to="loc_mo_EuroNotes1000To3125Member_a7306514-8d0a-477b-8afd-1c446420c1dd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4b736561-ede0-402f-a4c2-eb1fe49b58cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2d705ea3-02f6-4e0d-a730-931824a4682c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4b736561-ede0-402f-a4c2-eb1fe49b58cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4b736561-ede0-402f-a4c2-eb1fe49b58cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4b736561-ede0-402f-a4c2-eb1fe49b58cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4b736561-ede0-402f-a4c2-eb1fe49b58cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4a894e32-5105-4143-a0c8-f0520cc6d92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4b736561-ede0-402f-a4c2-eb1fe49b58cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4a894e32-5105-4143-a0c8-f0520cc6d92a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_221c0920-02cd-4c5d-908c-93f0076d0dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a894e32-5105-4143-a0c8-f0520cc6d92a" xlink:to="loc_us-gaap_SeniorNotesMember_221c0920-02cd-4c5d-908c-93f0076d0dc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_e8631225-0e1e-4b1b-9186-3ca49aed8832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a894e32-5105-4143-a0c8-f0520cc6d92a" xlink:to="loc_us-gaap_LoansPayableMember_e8631225-0e1e-4b1b-9186-3ca49aed8832" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_188cfdd2-da3e-4444-a771-5fcd168d2940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a894e32-5105-4143-a0c8-f0520cc6d92a" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_188cfdd2-da3e-4444-a771-5fcd168d2940" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d60f526e-08ac-46ed-bb9c-e088c438a8e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2d705ea3-02f6-4e0d-a730-931824a4682c" xlink:to="loc_srt_RangeAxis_d60f526e-08ac-46ed-bb9c-e088c438a8e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d60f526e-08ac-46ed-bb9c-e088c438a8e3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d60f526e-08ac-46ed-bb9c-e088c438a8e3" xlink:to="loc_srt_RangeMember_d60f526e-08ac-46ed-bb9c-e088c438a8e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55615521-e5cd-4215-9b90-976c3d74d936" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d60f526e-08ac-46ed-bb9c-e088c438a8e3" xlink:to="loc_srt_RangeMember_55615521-e5cd-4215-9b90-976c3d74d936" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_570b8fe2-6ded-41ee-aa66-3aa4e613587a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55615521-e5cd-4215-9b90-976c3d74d936" xlink:to="loc_srt_MinimumMember_570b8fe2-6ded-41ee-aa66-3aa4e613587a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1e791291-c4dd-4190-8ed0-de087b0f7291" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55615521-e5cd-4215-9b90-976c3d74d936" xlink:to="loc_srt_MaximumMember_1e791291-c4dd-4190-8ed0-de087b0f7291" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_edd1287d-2cad-4479-8171-bfaa6e536a33" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_55615521-e5cd-4215-9b90-976c3d74d936" xlink:to="loc_srt_WeightedAverageMember_edd1287d-2cad-4479-8171-bfaa6e536a33" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#LongTermDebtDetailsofLongTermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails" xlink:type="extended" id="i973aa3d6309e4830b8d5f1c15bbb1720_LongTermDebtDetailsofLongTermDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9dbddd01-94bc-4332-85e1-b83ae8cdd38f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_fbfdbee7-3143-489d-a872-f114c4209fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9dbddd01-94bc-4332-85e1-b83ae8cdd38f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_fbfdbee7-3143-489d-a872-f114c4209fbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_eab0a55e-3ee9-465c-a04d-07c075af88f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9dbddd01-94bc-4332-85e1-b83ae8cdd38f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_eab0a55e-3ee9-465c-a04d-07c075af88f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9338ecca-c9c6-4079-b049-638c45553b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9dbddd01-94bc-4332-85e1-b83ae8cdd38f" xlink:to="loc_us-gaap_DebtInstrumentTable_9338ecca-c9c6-4079-b049-638c45553b2b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1ea09668-7baf-4aa8-ac2d-a675f948e4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9338ecca-c9c6-4079-b049-638c45553b2b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1ea09668-7baf-4aa8-ac2d-a675f948e4d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1ea09668-7baf-4aa8-ac2d-a675f948e4d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1ea09668-7baf-4aa8-ac2d-a675f948e4d0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1ea09668-7baf-4aa8-ac2d-a675f948e4d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f70dad81-7eda-46fe-94b2-b51d1a988ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1ea09668-7baf-4aa8-ac2d-a675f948e4d0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f70dad81-7eda-46fe-94b2-b51d1a988ac1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_bc07be16-4ffd-4598-8135-cb2f0a7d6846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f70dad81-7eda-46fe-94b2-b51d1a988ac1" xlink:to="loc_us-gaap_SeniorNotesMember_bc07be16-4ffd-4598-8135-cb2f0a7d6846" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_24863b41-946b-4051-9bce-c84e994e6629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f70dad81-7eda-46fe-94b2-b51d1a988ac1" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_24863b41-946b-4051-9bce-c84e994e6629" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_18ad3de9-d8a9-4a0f-b571-7b6857e970b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f70dad81-7eda-46fe-94b2-b51d1a988ac1" xlink:to="loc_us-gaap_LoansPayableMember_18ad3de9-d8a9-4a0f-b571-7b6857e970b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9cae1d5c-027c-4c56-bba8-be8780e43f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9338ecca-c9c6-4079-b049-638c45553b2b" xlink:to="loc_us-gaap_DebtInstrumentAxis_9cae1d5c-027c-4c56-bba8-be8780e43f3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9cae1d5c-027c-4c56-bba8-be8780e43f3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9cae1d5c-027c-4c56-bba8-be8780e43f3f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9cae1d5c-027c-4c56-bba8-be8780e43f3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9cae1d5c-027c-4c56-bba8-be8780e43f3f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes1000MaturingFebruary2023Member_aee2969d-393a-4549-835e-248679743ba7" xlink:href="mo-20221231.xsd#mo_EuroNotes1000MaturingFebruary2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_EuroNotes1000MaturingFebruary2023Member_aee2969d-393a-4549-835e-248679743ba7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2950MaturingMay2023Member_01b58d8d-e657-4f4c-9e00-3bbf8d447557" xlink:href="mo-20221231.xsd#mo_USDNotes2950MaturingMay2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes2950MaturingMay2023Member_01b58d8d-e657-4f4c-9e00-3bbf8d447557" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4000MaturingJanuary2024Member_29b05543-ba8a-4a2d-8f8c-2157e7cd67a3" xlink:href="mo-20221231.xsd#mo_USDNotes4000MaturingJanuary2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4000MaturingJanuary2024Member_29b05543-ba8a-4a2d-8f8c-2157e7cd67a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3800MaturingFebruary2024Member_4b3938ab-9bd0-4c82-82e4-b80ae9651e50" xlink:href="mo-20221231.xsd#mo_USDNotes3800MaturingFebruary2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes3800MaturingFebruary2024Member_4b3938ab-9bd0-4c82-82e4-b80ae9651e50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2350MaturingMay2025Member_1458c4b3-6404-4159-a04a-9bae43c1e057" xlink:href="mo-20221231.xsd#mo_USDNotes2350MaturingMay2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes2350MaturingMay2025Member_1458c4b3-6404-4159-a04a-9bae43c1e057" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes1700MaturingJune2025Member_c9a5fd09-c10d-4a90-940b-dad966e94094" xlink:href="mo-20221231.xsd#mo_EuroNotes1700MaturingJune2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_EuroNotes1700MaturingJune2025Member_c9a5fd09-c10d-4a90-940b-dad966e94094" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4400MaturingFebruary2026Member_ad7d59b4-a537-4181-b1f7-eecd4034d423" xlink:href="mo-20221231.xsd#mo_USDNotes4400MaturingFebruary2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4400MaturingFebruary2026Member_ad7d59b4-a537-4181-b1f7-eecd4034d423" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2625MaturingSeptember2026Member_941b72d3-f9b4-4c27-8524-23c8d46caaa5" xlink:href="mo-20221231.xsd#mo_USDNotes2625MaturingSeptember2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes2625MaturingSeptember2026Member_941b72d3-f9b4-4c27-8524-23c8d46caaa5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDebenture7750MaturingJanuary2027Member_32a85899-5a95-4d0e-95cd-9c6ba079602a" xlink:href="mo-20221231.xsd#mo_USDDebenture7750MaturingJanuary2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDDebenture7750MaturingJanuary2027Member_32a85899-5a95-4d0e-95cd-9c6ba079602a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes2200MaturingJune2027Member_b4f91da3-d5b8-49ab-8814-5496f995957c" xlink:href="mo-20221231.xsd#mo_EuroNotes2200MaturingJune2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_EuroNotes2200MaturingJune2027Member_b4f91da3-d5b8-49ab-8814-5496f995957c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4800MaturingFebruary2029Member_a797eee4-59fc-4fca-84e8-a9100d90f86e" xlink:href="mo-20221231.xsd#mo_USDNotes4800MaturingFebruary2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4800MaturingFebruary2029Member_a797eee4-59fc-4fca-84e8-a9100d90f86e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3400MaturingMay2030Member_b259d009-cf6d-49f7-9e6f-3df6b8c13288" xlink:href="mo-20221231.xsd#mo_USDNotes3400MaturingMay2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes3400MaturingMay2030Member_b259d009-cf6d-49f7-9e6f-3df6b8c13288" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes3125MaturingJune2031Member_8b06a8b1-f90d-4b1b-986a-73f3251cf642" xlink:href="mo-20221231.xsd#mo_EuroNotes3125MaturingJune2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_EuroNotes3125MaturingJune2031Member_8b06a8b1-f90d-4b1b-986a-73f3251cf642" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2450MaturingFebruary2032Member_77d15ad3-c6cd-48d7-8a90-52e66a71d0d6" xlink:href="mo-20221231.xsd#mo_USDNotes2450MaturingFebruary2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes2450MaturingFebruary2032Member_77d15ad3-c6cd-48d7-8a90-52e66a71d0d6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes9950MaturingNovember2038Member_6fea184b-ab6e-4f6b-8810-755f7f35a9fe" xlink:href="mo-20221231.xsd#mo_USDNotes9950MaturingNovember2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes9950MaturingNovember2038Member_6fea184b-ab6e-4f6b-8810-755f7f35a9fe" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes10200MaturingFebruary2039Member_efcb406c-c9cb-4ff8-a4bb-83d0bed4513a" xlink:href="mo-20221231.xsd#mo_USDNotes10200MaturingFebruary2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes10200MaturingFebruary2039Member_efcb406c-c9cb-4ff8-a4bb-83d0bed4513a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes5800MaturingFebruary2039Member_e3f495d0-c74b-40ba-83d2-3e5ccc64f55d" xlink:href="mo-20221231.xsd#mo_USDNotes5800MaturingFebruary2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes5800MaturingFebruary2039Member_e3f495d0-c74b-40ba-83d2-3e5ccc64f55d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3400MaturingFebruary2041Member_1b1547b2-c4c9-46e4-9121-58920407b9cc" xlink:href="mo-20221231.xsd#mo_USDNotes3400MaturingFebruary2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes3400MaturingFebruary2041Member_1b1547b2-c4c9-46e4-9121-58920407b9cc" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4250MaturingAugust2042Member_6bc51b5e-cd96-4723-b7b8-1b410b3fc002" xlink:href="mo-20221231.xsd#mo_USDNotes4250MaturingAugust2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4250MaturingAugust2042Member_6bc51b5e-cd96-4723-b7b8-1b410b3fc002" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4500MaturingMay2043Member_fae76455-f5cb-40a0-be0b-ccc6392cde4a" xlink:href="mo-20221231.xsd#mo_USDNotes4500MaturingMay2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4500MaturingMay2043Member_fae76455-f5cb-40a0-be0b-ccc6392cde4a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes5375MaturingJanuary2044Member_fdf29c6b-f9c1-4759-b2b8-9b491714c528" xlink:href="mo-20221231.xsd#mo_USDNotes5375MaturingJanuary2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes5375MaturingJanuary2044Member_fdf29c6b-f9c1-4759-b2b8-9b491714c528" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3875MaturingSeptember2046Member_6d33a53f-53db-49dc-9e5a-dd81e9c8c633" xlink:href="mo-20221231.xsd#mo_USDNotes3875MaturingSeptember2046Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes3875MaturingSeptember2046Member_6d33a53f-53db-49dc-9e5a-dd81e9c8c633" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes5950MaturingFebruary2049Member_2b1843af-2195-4fd9-9a52-f35f17745a0c" xlink:href="mo-20221231.xsd#mo_USDNotes5950MaturingFebruary2049Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes5950MaturingFebruary2049Member_2b1843af-2195-4fd9-9a52-f35f17745a0c" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4450MaturingMay2050Member_c293d93e-4639-4b20-8a23-c728c1c0e48d" xlink:href="mo-20221231.xsd#mo_USDNotes4450MaturingMay2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4450MaturingMay2050Member_c293d93e-4639-4b20-8a23-c728c1c0e48d" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3700MaturingFebruary2051Member_c9b61bd1-fe28-4c6f-b910-d8db0adbfc86" xlink:href="mo-20221231.xsd#mo_USDNotes3700MaturingFebruary2051Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes3700MaturingFebruary2051Member_c9b61bd1-fe28-4c6f-b910-d8db0adbfc86" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes6200MaturingFebruary2059Member_5d80f1f4-8262-472c-ada7-10840599d266" xlink:href="mo-20221231.xsd#mo_USDNotes6200MaturingFebruary2059Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes6200MaturingFebruary2059Member_5d80f1f4-8262-472c-ada7-10840599d266" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4000MaturingFebruary2061Member_7eabcbd1-62db-4673-ba5e-c8b2559e0785" xlink:href="mo-20221231.xsd#mo_USDNotes4000MaturingFebruary2061Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4000MaturingFebruary2061Member_7eabcbd1-62db-4673-ba5e-c8b2559e0785" xlink:type="arc" order="26"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/LongTermDebtNarrativeDetails" xlink:type="extended" id="i03f64b3fb6e5420da58d30a407be871b_LongTermDebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_a0fc4ae7-86f7-4822-b6f4-7f53dadcfe94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_a0fc4ae7-86f7-4822-b6f4-7f53dadcfe94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ba6d9f5b-0ab1-462b-9f04-94e2d46c42b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ba6d9f5b-0ab1-462b-9f04-94e2d46c42b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfUnsecuredDebt_353bcc92-4d2c-4733-8786-49809397d18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfUnsecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_RepaymentsOfUnsecuredDebt_353bcc92-4d2c-4733-8786-49809397d18b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_7e15a4b1-40fe-455c-88f6-57cdbd157c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_7e15a4b1-40fe-455c-88f6-57cdbd157c52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_817537f6-f420-44cf-a3ca-d93b083df112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_817537f6-f420-44cf-a3ca-d93b083df112" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_0e173773-aac6-487f-8a0a-f52f91c3bee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_0e173773-aac6-487f-8a0a-f52f91c3bee5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_56ab9043-7276-40d2-b3d6-b3ab3ca104f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_56ab9043-7276-40d2-b3d6-b3ab3ca104f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_414cb3ec-7eef-4715-9ed8-f455d61089a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_414cb3ec-7eef-4715-9ed8-f455d61089a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_658346f2-d215-4305-a3a6-b8644ff84e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_DebtInstrumentTable_658346f2-d215-4305-a3a6-b8644ff84e32" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a4b63940-d601-4901-9ce7-927e5d85d87a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_658346f2-d215-4305-a3a6-b8644ff84e32" xlink:to="loc_us-gaap_DebtInstrumentAxis_a4b63940-d601-4901-9ce7-927e5d85d87a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a4b63940-d601-4901-9ce7-927e5d85d87a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a4b63940-d601-4901-9ce7-927e5d85d87a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a4b63940-d601-4901-9ce7-927e5d85d87a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eec8a107-6518-4774-b5da-37bfdacda135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a4b63940-d601-4901-9ce7-927e5d85d87a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eec8a107-6518-4774-b5da-37bfdacda135" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesMember_11370e92-ab57-4505-bf88-9c4a87775c06" xlink:href="mo-20221231.xsd#mo_USDDenominatedNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eec8a107-6518-4774-b5da-37bfdacda135" xlink:to="loc_mo_USDDenominatedNotesMember_11370e92-ab57-4505-bf88-9c4a87775c06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes3490PercentDue2022Member_b141ed69-ffba-4fc4-b30f-d748b5083cbc" xlink:href="mo-20221231.xsd#mo_USDDenominatedNotes3490PercentDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eec8a107-6518-4774-b5da-37bfdacda135" xlink:to="loc_mo_USDDenominatedNotes3490PercentDue2022Member_b141ed69-ffba-4fc4-b30f-d748b5083cbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_feb5e1f8-dae7-4b91-ac82-3cd16db67abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_658346f2-d215-4305-a3a6-b8644ff84e32" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_feb5e1f8-dae7-4b91-ac82-3cd16db67abf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_feb5e1f8-dae7-4b91-ac82-3cd16db67abf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_feb5e1f8-dae7-4b91-ac82-3cd16db67abf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_feb5e1f8-dae7-4b91-ac82-3cd16db67abf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a91e59fc-bdff-482f-b025-46195c0390f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_feb5e1f8-dae7-4b91-ac82-3cd16db67abf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a91e59fc-bdff-482f-b025-46195c0390f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3d079de4-5b54-429d-a88e-c4838e77aac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a91e59fc-bdff-482f-b025-46195c0390f1" xlink:to="loc_us-gaap_SeniorNotesMember_3d079de4-5b54-429d-a88e-c4838e77aac7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_04a56394-1830-4d28-bf25-62cce0e83077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_658346f2-d215-4305-a3a6-b8644ff84e32" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_04a56394-1830-4d28-bf25-62cce0e83077" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_04a56394-1830-4d28-bf25-62cce0e83077_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_04a56394-1830-4d28-bf25-62cce0e83077" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_04a56394-1830-4d28-bf25-62cce0e83077_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9a581b40-97c1-4b27-8248-5ef86dc7f549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_04a56394-1830-4d28-bf25-62cce0e83077" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9a581b40-97c1-4b27-8248-5ef86dc7f549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_3abaceba-1268-4f00-86f4-f33b6b311320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9a581b40-97c1-4b27-8248-5ef86dc7f549" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_3abaceba-1268-4f00-86f4-f33b6b311320" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#LongTermDebtDebtTenderOffersandRedemptionDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails" xlink:type="extended" id="ib6b937f09b0345ce8be299ef31aa5b3a_LongTermDebtDebtTenderOffersandRedemptionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fc31b05f-3034-4bb1-8e8a-a2cb8c481771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_af72edd3-2afc-4cc3-af08-e76192ea0677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc31b05f-3034-4bb1-8e8a-a2cb8c481771" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_af72edd3-2afc-4cc3-af08-e76192ea0677" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_b2a07fbb-7ea7-4e15-9df3-e960f079cb9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc31b05f-3034-4bb1-8e8a-a2cb8c481771" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_b2a07fbb-7ea7-4e15-9df3-e960f079cb9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5c50c6e3-4d91-4a48-9112-e69d71a88ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc31b05f-3034-4bb1-8e8a-a2cb8c481771" xlink:to="loc_us-gaap_DebtInstrumentTable_5c50c6e3-4d91-4a48-9112-e69d71a88ba8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0155bd67-15c0-4dd6-ada8-1bb8cd8a50da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5c50c6e3-4d91-4a48-9112-e69d71a88ba8" xlink:to="loc_us-gaap_DebtInstrumentAxis_0155bd67-15c0-4dd6-ada8-1bb8cd8a50da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0155bd67-15c0-4dd6-ada8-1bb8cd8a50da_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0155bd67-15c0-4dd6-ada8-1bb8cd8a50da" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0155bd67-15c0-4dd6-ada8-1bb8cd8a50da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0155bd67-15c0-4dd6-ada8-1bb8cd8a50da" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2850MaturingAugust2022Member_764d6939-da4b-417e-b8b1-14eccb50c9ba" xlink:href="mo-20221231.xsd#mo_USDNotes2850MaturingAugust2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes2850MaturingAugust2022Member_764d6939-da4b-417e-b8b1-14eccb50c9ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2950MaturingMay2023Member_71f09277-ccc0-4773-b522-0414bab322ff" xlink:href="mo-20221231.xsd#mo_USDNotes2950MaturingMay2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes2950MaturingMay2023Member_71f09277-ccc0-4773-b522-0414bab322ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4000MaturingJanuary2024Member_0917fb25-0e4f-450d-b91f-943958ce126d" xlink:href="mo-20221231.xsd#mo_USDNotes4000MaturingJanuary2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes4000MaturingJanuary2024Member_0917fb25-0e4f-450d-b91f-943958ce126d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3800MaturingFebruary2024Member_4f705c93-a6f7-4fbc-a8f6-90b66c78c66b" xlink:href="mo-20221231.xsd#mo_USDNotes3800MaturingFebruary2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes3800MaturingFebruary2024Member_4f705c93-a6f7-4fbc-a8f6-90b66c78c66b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4400MaturingFebruary2026Member_cab7b6c3-55c1-454e-b5b8-890a41643be6" xlink:href="mo-20221231.xsd#mo_USDNotes4400MaturingFebruary2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes4400MaturingFebruary2026Member_cab7b6c3-55c1-454e-b5b8-890a41643be6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4800MaturingFebruary2029Member_23940f3d-b940-4895-87b8-677ccf8885c1" xlink:href="mo-20221231.xsd#mo_USDNotes4800MaturingFebruary2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes4800MaturingFebruary2029Member_23940f3d-b940-4895-87b8-677ccf8885c1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes9950MaturingNovember2038Member_2add2d21-ffe1-4d74-a948-7ecbc4fa443a" xlink:href="mo-20221231.xsd#mo_USDNotes9950MaturingNovember2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes9950MaturingNovember2038Member_2add2d21-ffe1-4d74-a948-7ecbc4fa443a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes10200MaturingFebruary2039Member_6fd6a8a3-e0a6-44f4-94d7-691b60129011" xlink:href="mo-20221231.xsd#mo_USDNotes10200MaturingFebruary2039Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes10200MaturingFebruary2039Member_6fd6a8a3-e0a6-44f4-94d7-691b60129011" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes6200MaturingFebruary2059Member_0ec999bd-a57d-4448-905a-1ae6e9381e55" xlink:href="mo-20221231.xsd#mo_USDNotes6200MaturingFebruary2059Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes6200MaturingFebruary2059Member_0ec999bd-a57d-4448-905a-1ae6e9381e55" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_79b191cd-395c-4f4e-9aaa-57e99c4d0080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5c50c6e3-4d91-4a48-9112-e69d71a88ba8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_79b191cd-395c-4f4e-9aaa-57e99c4d0080" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_79b191cd-395c-4f4e-9aaa-57e99c4d0080_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_79b191cd-395c-4f4e-9aaa-57e99c4d0080" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_79b191cd-395c-4f4e-9aaa-57e99c4d0080_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e6a889eb-7c3e-485b-be7f-1c59ae57f874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_79b191cd-395c-4f4e-9aaa-57e99c4d0080" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e6a889eb-7c3e-485b-be7f-1c59ae57f874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_05f3c88b-f089-4e07-a6f0-d3803b9095b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6a889eb-7c3e-485b-be7f-1c59ae57f874" xlink:to="loc_us-gaap_SeniorNotesMember_05f3c88b-f089-4e07-a6f0-d3803b9095b2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#CapitalStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CapitalStockNarrativeDetails" xlink:type="extended" id="ia1b5c510cd4b400f8a478b680d3ada4c_CapitalStockNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_0c239d6d-c313-4529-a4db-908a906b97b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_0c239d6d-c313-4529-a4db-908a906b97b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f235ecef-86ed-4aab-b17a-326d782b4d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f235ecef-86ed-4aab-b17a-326d782b4d90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1904ad71-2f2c-4b7f-bf83-8430cb972882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1904ad71-2f2c-4b7f-bf83-8430cb972882" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2ae725b1-1c90-4487-b3d5-f51e195218aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2ae725b1-1c90-4487-b3d5-f51e195218aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_dd38d67a-2825-4b7f-876c-2a6b740751bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_PreferredStockSharesIssued_dd38d67a-2825-4b7f-876c-2a6b740751bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendIncreasePercentage_83572ec3-1d1f-4f38-968d-fcb288bfaee1" xlink:href="mo-20221231.xsd#mo_CommonStockDividendIncreasePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_mo_CommonStockDividendIncreasePercentage_83572ec3-1d1f-4f38-968d-fcb288bfaee1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_665621a4-7586-4271-b0b1-7c199f4ff21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_665621a4-7586-4271-b0b1-7c199f4ff21f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendRateAnnualPerShare_aa2cf429-9fe8-4c50-a22f-5a2b3eb095a8" xlink:href="mo-20221231.xsd#mo_CommonStockDividendRateAnnualPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_mo_CommonStockDividendRateAnnualPerShare_aa2cf429-9fe8-4c50-a22f-5a2b3eb095a8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_65bbf972-8d73-4371-b46c-bf4f7f5096d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_65bbf972-8d73-4371-b46c-bf4f7f5096d9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_b31260f7-2154-4e69-8143-4ee16b35ffdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_b31260f7-2154-4e69-8143-4ee16b35ffdb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4f6abd67-48c4-4333-94fb-77ebd65e6492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:to="loc_us-gaap_AwardTypeAxis_4f6abd67-48c4-4333-94fb-77ebd65e6492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f6abd67-48c4-4333-94fb-77ebd65e6492_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4f6abd67-48c4-4333-94fb-77ebd65e6492" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4f6abd67-48c4-4333-94fb-77ebd65e6492_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4eb084f6-d77e-4722-9b2a-309d244a06e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4f6abd67-48c4-4333-94fb-77ebd65e6492" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4eb084f6-d77e-4722-9b2a-309d244a06e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_e1971e38-9da6-4817-bd10-f790cfe45c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4eb084f6-d77e-4722-9b2a-309d244a06e6" xlink:to="loc_us-gaap_StockCompensationPlanMember_e1971e38-9da6-4817-bd10-f790cfe45c70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e0ffc4b7-70ad-4867-9897-accd738db4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e0ffc4b7-70ad-4867-9897-accd738db4f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e0ffc4b7-70ad-4867-9897-accd738db4f9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e0ffc4b7-70ad-4867-9897-accd738db4f9" xlink:to="loc_us-gaap_ClassOfStockDomain_e0ffc4b7-70ad-4867-9897-accd738db4f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e8a718f1-a07d-4bcd-9e3c-d936efc77c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e0ffc4b7-70ad-4867-9897-accd738db4f9" xlink:to="loc_us-gaap_ClassOfStockDomain_e8a718f1-a07d-4bcd-9e3c-d936efc77c1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SerialPreferredStockMember_598a09dc-6d64-4c8e-bbbc-5ddabf86ede1" xlink:href="mo-20221231.xsd#mo_SerialPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e8a718f1-a07d-4bcd-9e3c-d936efc77c1c" xlink:to="loc_mo_SerialPreferredStockMember_598a09dc-6d64-4c8e-bbbc-5ddabf86ede1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_8a5678ab-ace1-42b5-828c-f2640afeaff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_8a5678ab-ace1-42b5-828c-f2640afeaff1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_8a5678ab-ace1-42b5-828c-f2640afeaff1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_8a5678ab-ace1-42b5-828c-f2640afeaff1" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_8a5678ab-ace1-42b5-828c-f2640afeaff1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_00fdbb83-1e11-4854-a6f9-380532900d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_8a5678ab-ace1-42b5-828c-f2640afeaff1" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_00fdbb83-1e11-4854-a6f9-380532900d10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember_e2485aa5-5496-4067-bd92-3f8d436eae9e" xlink:href="mo-20221231.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_00fdbb83-1e11-4854-a6f9-380532900d10" xlink:to="loc_mo_January2021ShareRepurchaseProgramMember_e2485aa5-5496-4067-bd92-3f8d436eae9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_July2019ShareRepurchaseProgramMember_243b794a-2a91-489b-9362-214325a53847" xlink:href="mo-20221231.xsd#mo_July2019ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_00fdbb83-1e11-4854-a6f9-380532900d10" xlink:to="loc_mo_July2019ShareRepurchaseProgramMember_243b794a-2a91-489b-9362-214325a53847" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2023ShareRepurchaseProgramMember_d0ca6c6f-d775-464f-8622-08dcd8a0375e" xlink:href="mo-20221231.xsd#mo_January2023ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_00fdbb83-1e11-4854-a6f9-380532900d10" xlink:to="loc_mo_January2023ShareRepurchaseProgramMember_d0ca6c6f-d775-464f-8622-08dcd8a0375e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_cc1e9078-6691-411e-9e92-fcb11e27ea0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_cc1e9078-6691-411e-9e92-fcb11e27ea0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cc1e9078-6691-411e-9e92-fcb11e27ea0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_cc1e9078-6691-411e-9e92-fcb11e27ea0a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cc1e9078-6691-411e-9e92-fcb11e27ea0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cae1ceea-ac1f-4163-992c-e059ff6f6b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_cc1e9078-6691-411e-9e92-fcb11e27ea0a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cae1ceea-ac1f-4163-992c-e059ff6f6b3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8a17f08a-e4ed-4ce6-8cdb-639b38bb7722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_cae1ceea-ac1f-4163-992c-e059ff6f6b3c" xlink:to="loc_us-gaap_SubsequentEventMember_8a17f08a-e4ed-4ce6-8cdb-639b38bb7722" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#CapitalStockScheduleofSharesRepurchasedDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails" xlink:type="extended" id="if644f22c1a004e0ca2289cd247ee651f_CapitalStockScheduleofSharesRepurchasedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_2a6a2ec0-c7bb-40b7-8218-8bd80763d869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6ad67496-28c3-43fc-a362-ef3ef9b6c21d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_2a6a2ec0-c7bb-40b7-8218-8bd80763d869" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6ad67496-28c3-43fc-a362-ef3ef9b6c21d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_379d72ea-82b8-40cf-bd9d-3b88e09076db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_2a6a2ec0-c7bb-40b7-8218-8bd80763d869" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_379d72ea-82b8-40cf-bd9d-3b88e09076db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_132c7175-66a9-4eec-82b4-852484f2f291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_2a6a2ec0-c7bb-40b7-8218-8bd80763d869" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_132c7175-66a9-4eec-82b4-852484f2f291" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_4bc69006-a498-401a-a8a5-98b242d146d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_2a6a2ec0-c7bb-40b7-8218-8bd80763d869" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_4bc69006-a498-401a-a8a5-98b242d146d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_e1dccde8-3c4d-4b36-936e-4545af32f4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4bc69006-a498-401a-a8a5-98b242d146d6" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_e1dccde8-3c4d-4b36-936e-4545af32f4ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_e1dccde8-3c4d-4b36-936e-4545af32f4ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e1dccde8-3c4d-4b36-936e-4545af32f4ce" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_e1dccde8-3c4d-4b36-936e-4545af32f4ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_271fda3e-2daa-43a8-88fa-dd60709e9df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e1dccde8-3c4d-4b36-936e-4545af32f4ce" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_271fda3e-2daa-43a8-88fa-dd60709e9df9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember_a086c9ca-3ddd-4b66-9b79-58ef343001ad" xlink:href="mo-20221231.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_271fda3e-2daa-43a8-88fa-dd60709e9df9" xlink:to="loc_mo_January2021ShareRepurchaseProgramMember_a086c9ca-3ddd-4b66-9b79-58ef343001ad" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/StockPlansNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#StockPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/StockPlansNarrativeDetails" xlink:type="extended" id="if7ff9fc5370c4e1990e164903ab27d5f_StockPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_aa386836-c7f2-4670-82e4-27e312d25ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_aa386836-c7f2-4670-82e4-27e312d25ebb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a06cd42f-de20-40eb-abae-b719e92c21b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a06cd42f-de20-40eb-abae-b719e92c21b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c3f7ec0d-7696-4a1f-b5f8-0d3dd084ccc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c3f7ec0d-7696-4a1f-b5f8-0d3dd084ccc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod_1e9e1794-a6fa-4289-aeb4-1ee31f123516" xlink:href="mo-20221231.xsd#mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod_1e9e1794-a6fa-4289-aeb4-1ee31f123516" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_d1896634-a3a0-4cf3-8887-225d87cdd54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_d1896634-a3a0-4cf3-8887-225d87cdd54e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_07e69ac4-f024-49d1-b416-022374514ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_07e69ac4-f024-49d1-b416-022374514ec2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ec856361-4b8b-42f3-b3a9-1117bad2942d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ec856361-4b8b-42f3-b3a9-1117bad2942d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_63abc3c2-9a57-4487-b66c-3583d005e574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_63abc3c2-9a57-4487-b66c-3583d005e574" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue_30ecaa3f-59a7-44b2-a809-14836ec8b1a2" xlink:href="mo-20221231.xsd#mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue_30ecaa3f-59a7-44b2-a809-14836ec8b1a2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_42b00a68-e43d-41b0-8b50-d2042d894dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_42b00a68-e43d-41b0-8b50-d2042d894dfc" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2eaae2b4-4a86-469f-a524-a677b89c28f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2eaae2b4-4a86-469f-a524-a677b89c28f3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_49162542-0a5b-475d-a6cf-8b89f248856e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_49162542-0a5b-475d-a6cf-8b89f248856e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a5a422fc-bbd3-46b7-a0d8-87a6764a73d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a5a422fc-bbd3-46b7-a0d8-87a6764a73d5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_128df884-39be-44b7-aaa7-0b192c22236d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_128df884-39be-44b7-aaa7-0b192c22236d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c60e18-4309-49cb-abd2-e20cfe482680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c60e18-4309-49cb-abd2-e20cfe482680" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_da32b219-3ce2-43f5-a004-3b17f3369147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c60e18-4309-49cb-abd2-e20cfe482680" xlink:to="loc_us-gaap_StatementClassOfStockAxis_da32b219-3ce2-43f5-a004-3b17f3369147" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_da32b219-3ce2-43f5-a004-3b17f3369147_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_da32b219-3ce2-43f5-a004-3b17f3369147" xlink:to="loc_us-gaap_ClassOfStockDomain_da32b219-3ce2-43f5-a004-3b17f3369147_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4144ca86-4733-4c52-a823-67e551a8f028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_da32b219-3ce2-43f5-a004-3b17f3369147" xlink:to="loc_us-gaap_ClassOfStockDomain_4144ca86-4733-4c52-a823-67e551a8f028" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6f2ec35a-d547-4220-ad08-d7866db75cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4144ca86-4733-4c52-a823-67e551a8f028" xlink:to="loc_us-gaap_CommonStockMember_6f2ec35a-d547-4220-ad08-d7866db75cfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e4db4b20-eaf3-43cc-a7b0-4b575558b2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c60e18-4309-49cb-abd2-e20cfe482680" xlink:to="loc_us-gaap_PlanNameAxis_e4db4b20-eaf3-43cc-a7b0-4b575558b2f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e4db4b20-eaf3-43cc-a7b0-4b575558b2f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_e4db4b20-eaf3-43cc-a7b0-4b575558b2f0" xlink:to="loc_us-gaap_PlanNameDomain_e4db4b20-eaf3-43cc-a7b0-4b575558b2f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_266ad4bb-1904-4617-9dc7-cce205a2ece5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_e4db4b20-eaf3-43cc-a7b0-4b575558b2f0" xlink:to="loc_us-gaap_PlanNameDomain_266ad4bb-1904-4617-9dc7-cce205a2ece5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_A2020PerformanceIncentivePlanMember_0795f7b3-45ff-49f6-9c7e-8e56c22867d3" xlink:href="mo-20221231.xsd#mo_A2020PerformanceIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_266ad4bb-1904-4617-9dc7-cce205a2ece5" xlink:to="loc_mo_A2020PerformanceIncentivePlanMember_0795f7b3-45ff-49f6-9c7e-8e56c22867d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_A2015DirectorsPlanMember_39af29b8-d7c5-4a54-a5e0-e03cd8541b0a" xlink:href="mo-20221231.xsd#mo_A2015DirectorsPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_266ad4bb-1904-4617-9dc7-cce205a2ece5" xlink:to="loc_mo_A2015DirectorsPlanMember_39af29b8-d7c5-4a54-a5e0-e03cd8541b0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_083c49e1-6f74-44fd-98ec-46455f144bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c60e18-4309-49cb-abd2-e20cfe482680" xlink:to="loc_us-gaap_AwardTypeAxis_083c49e1-6f74-44fd-98ec-46455f144bbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_083c49e1-6f74-44fd-98ec-46455f144bbc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_083c49e1-6f74-44fd-98ec-46455f144bbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_083c49e1-6f74-44fd-98ec-46455f144bbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03175ffa-4604-4138-9d10-62ac39ff0775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_083c49e1-6f74-44fd-98ec-46455f144bbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03175ffa-4604-4138-9d10-62ac39ff0775" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_eb91a45d-1670-47fb-98de-cf0a1336ff4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03175ffa-4604-4138-9d10-62ac39ff0775" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_eb91a45d-1670-47fb-98de-cf0a1336ff4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_5fe81781-31cb-4766-8aa4-89dd7cd1fd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03175ffa-4604-4138-9d10-62ac39ff0775" xlink:to="loc_us-gaap_PerformanceSharesMember_5fe81781-31cb-4766-8aa4-89dd7cd1fd73" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails" xlink:type="extended" id="ia49c1ed515434a998a60f394cd0c13f3_StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ddfd7ce-2b67-4863-ba8d-9ce48ecd1e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ddfd7ce-2b67-4863-ba8d-9ce48ecd1e3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb8636f7-fed0-424c-a223-5aacf8a3e64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb8636f7-fed0-424c-a223-5aacf8a3e64e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2e4761ee-31dc-4f14-b5e9-236f82251ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2e4761ee-31dc-4f14-b5e9-236f82251ce3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_86f414f3-fa79-44e3-b0be-41ea27d9efaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_86f414f3-fa79-44e3-b0be-41ea27d9efaa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_00dba986-b6da-45c8-94d2-cde7bc4941a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_00dba986-b6da-45c8-94d2-cde7bc4941a3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1a652207-5102-4b5a-99f8-b070f02e6c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ddfd7ce-2b67-4863-ba8d-9ce48ecd1e3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c8883170-5021-4301-a7bf-e8a1f5fc579a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c8883170-5021-4301-a7bf-e8a1f5fc579a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3b3dc312-a66a-41bb-89fb-4ea8134a7f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3b3dc312-a66a-41bb-89fb-4ea8134a7f5b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5f81ff22-d5ec-47f6-99ed-27f32e4196c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5f81ff22-d5ec-47f6-99ed-27f32e4196c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_754df0bc-34d3-491c-bee7-c6e62abcff3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_754df0bc-34d3-491c-bee7-c6e62abcff3b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_53fb0ac3-faf1-4054-8403-4788d2bf3a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_929211ec-0be2-43b9-b58f-fcf1c4a9ee9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ddfd7ce-2b67-4863-ba8d-9ce48ecd1e3a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_929211ec-0be2-43b9-b58f-fcf1c4a9ee9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7d407ea5-fdc3-455e-afaf-a3cd5f3fc3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_929211ec-0be2-43b9-b58f-fcf1c4a9ee9c" xlink:to="loc_us-gaap_AwardTypeAxis_7d407ea5-fdc3-455e-afaf-a3cd5f3fc3eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d407ea5-fdc3-455e-afaf-a3cd5f3fc3eb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7d407ea5-fdc3-455e-afaf-a3cd5f3fc3eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7d407ea5-fdc3-455e-afaf-a3cd5f3fc3eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5f12b75-7155-4fec-b152-738ab93b1d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7d407ea5-fdc3-455e-afaf-a3cd5f3fc3eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5f12b75-7155-4fec-b152-738ab93b1d66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_18b6aa50-a8e8-4c14-a7a8-16933c07f5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5f12b75-7155-4fec-b152-738ab93b1d66" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_18b6aa50-a8e8-4c14-a7a8-16933c07f5ab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended" id="i1392191e5b6b4cabb4bf83f998922824_OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3c444f9f-3e4b-45cb-9ae9-bce3de2045cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3c444f9f-3e4b-45cb-9ae9-bce3de2045cf" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b53592f3-814c-4f55-a853-73f35e9580e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b53592f3-814c-4f55-a853-73f35e9580e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_3ef102e5-ef89-4aa5-9e94-2dd4a70c0d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_3ef102e5-ef89-4aa5-9e94-2dd4a70c0d4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_028ee2fb-0901-4cb3-ae9a-fc0242a4f5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_028ee2fb-0901-4cb3-ae9a-fc0242a4f5e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5c0111e7-9fb8-46d0-85da-4658114cfa82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5c0111e7-9fb8-46d0-85da-4658114cfa82" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7d69cc2b-db4a-4dab-b065-03ab2f10c26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7d69cc2b-db4a-4dab-b065-03ab2f10c26a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_42b10d34-ef11-4f57-b888-810ef0ccb8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_42b10d34-ef11-4f57-b888-810ef0ccb8c5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_55784834-2d28-4bc3-9eb8-056b4e34ee3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_55784834-2d28-4bc3-9eb8-056b4e34ee3a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_833dbb80-cdf7-4364-845d-c7802791afff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_833dbb80-cdf7-4364-845d-c7802791afff" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dcb96d07-54bc-4d9d-ac4b-c05c2438c3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c49ef60d-32e3-485e-94ac-c648a4bae59e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3c444f9f-3e4b-45cb-9ae9-bce3de2045cf" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c49ef60d-32e3-485e-94ac-c648a4bae59e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4b1dc02f-083c-4b02-9da7-bef0e5d33067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c49ef60d-32e3-485e-94ac-c648a4bae59e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4b1dc02f-083c-4b02-9da7-bef0e5d33067" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4b1dc02f-083c-4b02-9da7-bef0e5d33067_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4b1dc02f-083c-4b02-9da7-bef0e5d33067" xlink:to="loc_us-gaap_EquityComponentDomain_4b1dc02f-083c-4b02-9da7-bef0e5d33067_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d647f946-8a43-4536-a0ff-4d6084b37c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4b1dc02f-083c-4b02-9da7-bef0e5d33067" xlink:to="loc_us-gaap_EquityComponentDomain_d647f946-8a43-4536-a0ff-4d6084b37c13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774c23ab-ae87-4e9d-ba8c-0b8031b5a85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d647f946-8a43-4536-a0ff-4d6084b37c13" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774c23ab-ae87-4e9d-ba8c-0b8031b5a85d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_4ffafdbb-6640-48fe-9af5-6081208c4fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774c23ab-ae87-4e9d-ba8c-0b8031b5a85d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_4ffafdbb-6640-48fe-9af5-6081208c4fd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_29d51b3b-9247-4c84-b962-cb520aeed29a" xlink:href="mo-20221231.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774c23ab-ae87-4e9d-ba8c-0b8031b5a85d" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_29d51b3b-9247-4c84-b962-cb520aeed29a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember_cc3403e8-fdb8-4c6c-82e0-a6156d2663f3" xlink:href="mo-20221231.xsd#mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774c23ab-ae87-4e9d-ba8c-0b8031b5a85d" xlink:to="loc_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember_cc3403e8-fdb8-4c6c-82e0-a6156d2663f3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#OtherComprehensiveEarningsLossesReclassificationsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="extended" id="id54f0c0f4b3141f1a37489fb2d339692_OtherComprehensiveEarningsLossesReclassificationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bec6f054-0672-4e9a-a062-daeffaf5a9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_8b40266b-d118-46fa-a87b-e10e459f4c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bec6f054-0672-4e9a-a062-daeffaf5a9a9" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_8b40266b-d118-46fa-a87b-e10e459f4c61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4593eb37-7832-4c93-9d3c-ff78d939a57c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bec6f054-0672-4e9a-a062-daeffaf5a9a9" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4593eb37-7832-4c93-9d3c-ff78d939a57c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CurrencyTranslationAdjustmentsAndOther_ef3a699f-431b-4f7f-b6c0-5055db6b694b" xlink:href="mo-20221231.xsd#mo_CurrencyTranslationAdjustmentsAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bec6f054-0672-4e9a-a062-daeffaf5a9a9" xlink:to="loc_mo_CurrencyTranslationAdjustmentsAndOther_ef3a699f-431b-4f7f-b6c0-5055db6b694b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a2dcc108-3fa9-4402-b269-34b05216841e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bec6f054-0672-4e9a-a062-daeffaf5a9a9" xlink:to="loc_us-gaap_ProfitLoss_a2dcc108-3fa9-4402-b269-34b05216841e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1cc3afe2-fb7a-4c73-941f-6cf9a7b7164d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bec6f054-0672-4e9a-a062-daeffaf5a9a9" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1cc3afe2-fb7a-4c73-941f-6cf9a7b7164d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_910fc58b-f5da-47a6-8abc-db75ed91eb45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1cc3afe2-fb7a-4c73-941f-6cf9a7b7164d" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_910fc58b-f5da-47a6-8abc-db75ed91eb45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_910fc58b-f5da-47a6-8abc-db75ed91eb45_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_910fc58b-f5da-47a6-8abc-db75ed91eb45" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_910fc58b-f5da-47a6-8abc-db75ed91eb45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_0e5be3d4-2b0d-4a00-83f8-d4f7f317a2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_910fc58b-f5da-47a6-8abc-db75ed91eb45" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_0e5be3d4-2b0d-4a00-83f8-d4f7f317a2c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_c6573823-4137-45e0-8015-6b7e57e77321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_0e5be3d4-2b0d-4a00-83f8-d4f7f317a2c8" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_c6573823-4137-45e0-8015-6b7e57e77321" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4516b053-64c2-47cb-8aac-eb4079f18fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1cc3afe2-fb7a-4c73-941f-6cf9a7b7164d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4516b053-64c2-47cb-8aac-eb4079f18fa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4516b053-64c2-47cb-8aac-eb4079f18fa2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4516b053-64c2-47cb-8aac-eb4079f18fa2" xlink:to="loc_us-gaap_EquityComponentDomain_4516b053-64c2-47cb-8aac-eb4079f18fa2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_adf66d9b-bcc1-4466-af5a-5c616b144389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4516b053-64c2-47cb-8aac-eb4079f18fa2" xlink:to="loc_us-gaap_EquityComponentDomain_adf66d9b-bcc1-4466-af5a-5c616b144389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d46c8961-faa9-495a-9701-52184bf02e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_adf66d9b-bcc1-4466-af5a-5c616b144389" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d46c8961-faa9-495a-9701-52184bf02e27" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_3833c89b-e838-4c62-9bd4-1fcfe7b3882d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d46c8961-faa9-495a-9701-52184bf02e27" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_3833c89b-e838-4c62-9bd4-1fcfe7b3882d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_8119f187-eba0-41ff-b15b-e9991dd64a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d46c8961-faa9-495a-9701-52184bf02e27" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_8119f187-eba0-41ff-b15b-e9991dd64a68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_4edb10b9-eee0-4f69-9ed9-42c7f2d7ec7b" xlink:href="mo-20221231.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_adf66d9b-bcc1-4466-af5a-5c616b144389" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_4edb10b9-eee0-4f69-9ed9-42c7f2d7ec7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember_b97d5f55-e8c2-4f09-a209-16f38ae6adcb" xlink:href="mo-20221231.xsd#mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_adf66d9b-bcc1-4466-af5a-5c616b144389" xlink:to="loc_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember_b97d5f55-e8c2-4f09-a209-16f38ae6adcb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i32fd2e1d8eee408ebe7c83b79cb16e56_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_4734f272-6590-475a-a1ef-310861f61176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_4734f272-6590-475a-a1ef-310861f61176" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate_bc24da3d-2e27-4e15-bc06-b7998987cc7a" xlink:href="mo-20221231.xsd#mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate_bc24da3d-2e27-4e15-bc06-b7998987cc7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_591b2dbf-cd97-40bc-a4de-1a2dcc41d0df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_591b2dbf-cd97-40bc-a4de-1a2dcc41d0df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_73de258f-7a73-4704-886c-0f171b23954b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_73de258f-7a73-4704-886c-0f171b23954b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_577cf35a-9276-4952-be5e-dad3bea580ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_577cf35a-9276-4952-be5e-dad3bea580ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount_5566cec0-3b15-40ad-bc23-60d8d626ba1b" xlink:href="mo-20221231.xsd#mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount_5566cec0-3b15-40ad-bc23-60d8d626ba1b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_9af3c1cc-05e7-45de-a884-ebb881b11f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_9af3c1cc-05e7-45de-a884-ebb881b11f19" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_cc80559b-1801-4460-b2bd-0a4f2d828054" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_cc80559b-1801-4460-b2bd-0a4f2d828054" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1ec3c8f7-0df5-4627-806d-fe497a501ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1ec3c8f7-0df5-4627-806d-fe497a501ccb" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_9704f313-5d14-4010-a3a5-5a67d4c7f723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_OperatingLossCarryforwards_9704f313-5d14-4010-a3a5-5a67d4c7f723" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_507d732f-61a4-4083-86fc-10940bdcbd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_507d732f-61a4-4083-86fc-10940bdcbd4a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_87eeeccf-c71c-4d63-a375-9251985dbdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_87eeeccf-c71c-4d63-a375-9251985dbdc1" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_5aaf8b30-103c-42ee-833b-37ed8067063e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_5aaf8b30-103c-42ee-833b-37ed8067063e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a6f2db3-3e89-4546-a1f0-711568135ef7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5aaf8b30-103c-42ee-833b-37ed8067063e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a6f2db3-3e89-4546-a1f0-711568135ef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2a6f2db3-3e89-4546-a1f0-711568135ef7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a6f2db3-3e89-4546-a1f0-711568135ef7" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2a6f2db3-3e89-4546-a1f0-711568135ef7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4c302710-5c24-42cb-9172-655e29a831ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a6f2db3-3e89-4546-a1f0-711568135ef7" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4c302710-5c24-42cb-9172-655e29a831ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_af888f79-870c-4a33-8e58-a2f03ac6034a" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c302710-5c24-42cb-9172-655e29a831ef" xlink:to="loc_mo_JUULMember_af888f79-870c-4a33-8e58-a2f03ac6034a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_b3f780e9-16db-4e4e-9afd-85c1cd5de9c2" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c302710-5c24-42cb-9172-655e29a831ef" xlink:to="loc_mo_CronosGroupInc.Member_b3f780e9-16db-4e4e-9afd-85c1cd5de9c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_719926cb-6598-4186-ba52-120ffed5d445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5aaf8b30-103c-42ee-833b-37ed8067063e" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_719926cb-6598-4186-ba52-120ffed5d445" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_719926cb-6598-4186-ba52-120ffed5d445_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_719926cb-6598-4186-ba52-120ffed5d445" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_719926cb-6598-4186-ba52-120ffed5d445_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b0d05c04-931b-4604-b60f-0789ff971a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_719926cb-6598-4186-ba52-120ffed5d445" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b0d05c04-931b-4604-b60f-0789ff971a35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_06ebd577-0314-4320-8561-42aaac62a589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b0d05c04-931b-4604-b60f-0789ff971a35" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_06ebd577-0314-4320-8561-42aaac62a589" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails" xlink:type="extended" id="i2376c3ff9ad64b3a85d8d0273ad753bf_IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_2b00ba81-7954-405a-b027-66a5112085e8" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_c28e1eb4-b7ad-47a6-bb0a-fffbf4be1c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_2b00ba81-7954-405a-b027-66a5112085e8" xlink:to="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_c28e1eb4-b7ad-47a6-bb0a-fffbf4be1c40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_c28e1eb4-b7ad-47a6-bb0a-fffbf4be1c40" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_8be7ce57-1fe4-46bd-8a9e-d708844a90c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_8be7ce57-1fe4-46bd-8a9e-d708844a90c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_657c7844-4915-437e-bbad-eff9f57ab515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_657c7844-4915-437e-bbad-eff9f57ab515" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount_ea03a3a8-77b6-40ff-8075-d329cb0c52ff" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount_ea03a3a8-77b6-40ff-8075-d329cb0c52ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_2912e07a-6966-4a3e-b3ad-cf00ce108304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_2912e07a-6966-4a3e-b3ad-cf00ce108304" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_8b987712-4a16-4828-afae-0c7d45de2fbf" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_8b987712-4a16-4828-afae-0c7d45de2fbf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount_4a527cc9-a392-4f41-9d58-212e1a2db6a4" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount_4a527cc9-a392-4f41-9d58-212e1a2db6a4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_b3869fd4-dfc8-4f3c-8b23-c74a98847d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_b3869fd4-dfc8-4f3c-8b23-c74a98847d12" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ef08331c-476d-4b17-93bb-cf4dfee725ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ef08331c-476d-4b17-93bb-cf4dfee725ed" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_c28e1eb4-b7ad-47a6-bb0a-fffbf4be1c40" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_896fcf36-a16c-415f-9502-826eeb5f5c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_896fcf36-a16c-415f-9502-826eeb5f5c5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7d31628e-c284-494c-a051-2af5573741ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7d31628e-c284-494c-a051-2af5573741ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments_0f518a88-fb97-4728-ad16-30e804979f3b" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments_0f518a88-fb97-4728-ad16-30e804979f3b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_a1a36ae2-e3cd-4db6-8b4f-5fa64f50d8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_a1a36ae2-e3cd-4db6-8b4f-5fa64f50d8fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_ddecd9e2-e54e-4b52-9887-4f51292de12f" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_ddecd9e2-e54e-4b52-9887-4f51292de12f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent_0a8b2e32-fce2-4926-9dda-1ec63aaff9f4" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent_0a8b2e32-fce2-4926-9dda-1ec63aaff9f4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_e3ba710b-9da9-47c9-9fa6-757725f399a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_e3ba710b-9da9-47c9-9fa6-757725f399a1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9c5f932d-c263-45b2-bd81-05c33ca339e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9c5f932d-c263-45b2-bd81-05c33ca339e1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_52ff8a4d-ec81-408f-b5c4-3b2359dc6b6b" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_2b00ba81-7954-405a-b027-66a5112085e8" xlink:to="loc_mo_InvestmentsTable_52ff8a4d-ec81-408f-b5c4-3b2359dc6b6b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d87f2a85-4b99-44cb-8f72-3c0e75bae73e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_52ff8a4d-ec81-408f-b5c4-3b2359dc6b6b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d87f2a85-4b99-44cb-8f72-3c0e75bae73e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d87f2a85-4b99-44cb-8f72-3c0e75bae73e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d87f2a85-4b99-44cb-8f72-3c0e75bae73e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d87f2a85-4b99-44cb-8f72-3c0e75bae73e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_82314d8c-7911-44c8-8a6f-611b670381a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d87f2a85-4b99-44cb-8f72-3c0e75bae73e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_82314d8c-7911-44c8-8a6f-611b670381a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_96072a79-49bb-43dd-b3c3-fd9221be8c22" xlink:href="mo-20221231.xsd#mo_ABInBevMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_82314d8c-7911-44c8-8a6f-611b670381a0" xlink:to="loc_mo_ABInBevMember_96072a79-49bb-43dd-b3c3-fd9221be8c22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_ff94fef2-b719-47a3-8771-0c015a632750" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_82314d8c-7911-44c8-8a6f-611b670381a0" xlink:to="loc_mo_JUULMember_ff94fef2-b719-47a3-8771-0c015a632750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_96ef97ef-5d4c-4636-8943-2ada1ee1ff9b" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_82314d8c-7911-44c8-8a6f-611b670381a0" xlink:to="loc_mo_CronosGroupInc.Member_96ef97ef-5d4c-4636-8943-2ada1ee1ff9b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="extended" id="i208bb7b19c3a4bf7bbd633c70edf9683_IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_59b743ee-6e7d-4f11-988c-a3d9bf781403" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_59b743ee-6e7d-4f11-988c-a3d9bf781403" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_0fd8faa2-ba49-49bf-b546-baae0a0e3eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_0fd8faa2-ba49-49bf-b546-baae0a0e3eb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_261d884f-9ecd-48e2-b963-de74984ac4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_261d884f-9ecd-48e2-b963-de74984ac4ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxAssetsInvestmentsInEquitySecurities_9d640d11-a955-4f4e-ba75-0bdc95cfee2d" xlink:href="mo-20221231.xsd#mo_DeferredTaxAssetsInvestmentsInEquitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:to="loc_mo_DeferredTaxAssetsInvestmentsInEquitySecurities_9d640d11-a955-4f4e-ba75-0bdc95cfee2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments_dcba2d6a-81e9-4db2-bfd7-cdf0792b7ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:to="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments_dcba2d6a-81e9-4db2-bfd7-cdf0792b7ea4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards_aea31172-ae8e-47a8-bf8b-c18cfb5f8f73" xlink:href="mo-20221231.xsd#mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:to="loc_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards_aea31172-ae8e-47a8-bf8b-c18cfb5f8f73" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_a7db865a-eab2-49fe-bb61-033f424b06bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_a7db865a-eab2-49fe-bb61-033f424b06bc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_59b743ee-6e7d-4f11-988c-a3d9bf781403" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_c334aae6-9cb5-40fa-8df4-0f6c485dcc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_c334aae6-9cb5-40fa-8df4-0f6c485dcc98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_be58a4e2-0c56-4b9a-9d3b-17a60541038f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_be58a4e2-0c56-4b9a-9d3b-17a60541038f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_e695e1d4-dab7-49d6-9be0-e6d30e7de8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_e695e1d4-dab7-49d6-9be0-e6d30e7de8c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld_739821f4-3a5e-4406-acd8-eda8b32c3658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld_739821f4-3a5e-4406-acd8-eda8b32c3658" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxLiabilitiesAccruedPensionCosts_2995a1e3-0717-45fd-859b-39c2a3f1e561" xlink:href="mo-20221231.xsd#mo_DeferredTaxLiabilitiesAccruedPensionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_mo_DeferredTaxLiabilitiesAccruedPensionCosts_2995a1e3-0717-45fd-859b-39c2a3f1e561" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_47cf4da2-f5b3-400f-b322-b3a0ff3294cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_47cf4da2-f5b3-400f-b322-b3a0ff3294cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_7c226c44-4c36-4968-adfb-f990322d9425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_7c226c44-4c36-4968-adfb-f990322d9425" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1fbd04f4-c2e6-4712-bed1-da48d9dac6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_59b743ee-6e7d-4f11-988c-a3d9bf781403" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1fbd04f4-c2e6-4712-bed1-da48d9dac6ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_ebb7536d-0bfa-4962-8965-078a7808ee70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_InvestmentsLineItems_59b743ee-6e7d-4f11-988c-a3d9bf781403" xlink:to="loc_us-gaap_DeferredTaxLiabilities_ebb7536d-0bfa-4962-8965-078a7808ee70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_77f633b1-e963-4593-aa5a-9834dfd9d1a1" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_InvestmentsLineItems_59b743ee-6e7d-4f11-988c-a3d9bf781403" xlink:to="loc_mo_InvestmentsTable_77f633b1-e963-4593-aa5a-9834dfd9d1a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0a1e2f41-8c3c-4544-b3f5-4038bf7233a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_InvestmentsTable_77f633b1-e963-4593-aa5a-9834dfd9d1a1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0a1e2f41-8c3c-4544-b3f5-4038bf7233a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_0a1e2f41-8c3c-4544-b3f5-4038bf7233a1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0a1e2f41-8c3c-4544-b3f5-4038bf7233a1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_0a1e2f41-8c3c-4544-b3f5-4038bf7233a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_cab362af-b1a6-4363-859c-3ce0d9603b63" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0a1e2f41-8c3c-4544-b3f5-4038bf7233a1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_cab362af-b1a6-4363-859c-3ce0d9603b63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_d4af7a4e-7e59-47a7-a98d-e9dea5ef26f1" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_cab362af-b1a6-4363-859c-3ce0d9603b63" xlink:to="loc_mo_JUULMember_d4af7a4e-7e59-47a7-a98d-e9dea5ef26f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_6a4ccacd-c346-4ccb-a303-ec573a0c87f8" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_cab362af-b1a6-4363-859c-3ce0d9603b63" xlink:to="loc_mo_CronosGroupInc.Member_6a4ccacd-c346-4ccb-a303-ec573a0c87f8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#SegmentReportingNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingNarrativeDetails" xlink:type="extended" id="ie16adf4b5f704ac2b183849cbe4806d7_SegmentReportingNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9050cc15-12de-45a2-914e-366b111d2476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9050cc15-12de-45a2-914e-366b111d2476" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_6ebb7383-9f25-4c9a-a252-9a9e6f8a0f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_6ebb7383-9f25-4c9a-a252-9a9e6f8a0f86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_f982edfc-650c-4e4c-aea6-dcbb89265078" xlink:href="mo-20221231.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_f982edfc-650c-4e4c-aea6-dcbb89265078" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_f5f589f5-3f16-4d00-8e18-55bed4d92e69" xlink:href="mo-20221231.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_f5f589f5-3f16-4d00-8e18-55bed4d92e69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6e642fd2-03c9-46e3-869a-048bcd82dfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6e642fd2-03c9-46e3-869a-048bcd82dfd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_61e87a1c-4cca-4eb2-9c48-8b329e30e5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_us-gaap_RestructuringCharges_61e87a1c-4cca-4eb2-9c48-8b329e30e5b0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset_4e1b01f0-a942-42ed-849b-e591d34b37c9" xlink:href="mo-20221231.xsd#mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset_4e1b01f0-a942-42ed-849b-e591d34b37c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5b6c8b71-081d-44b7-aebe-dae93fc6e994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5b6c8b71-081d-44b7-aebe-dae93fc6e994" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a7072f7d-06da-4a1c-80e1-49fde99e48c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a7072f7d-06da-4a1c-80e1-49fde99e48c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a7072f7d-06da-4a1c-80e1-49fde99e48c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a7072f7d-06da-4a1c-80e1-49fde99e48c5" xlink:to="loc_us-gaap_SegmentDomain_a7072f7d-06da-4a1c-80e1-49fde99e48c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_df8ac46a-9568-4bb0-bcbc-35c7ea46a5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a7072f7d-06da-4a1c-80e1-49fde99e48c5" xlink:to="loc_us-gaap_SegmentDomain_df8ac46a-9568-4bb0-bcbc-35c7ea46a5dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_ab62079c-5365-49d4-907b-a8cd485faa13" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df8ac46a-9568-4bb0-bcbc-35c7ea46a5dd" xlink:to="loc_mo_SmokeableProductsSegmentMember_ab62079c-5365-49d4-907b-a8cd485faa13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_286434f1-86ad-4989-9d3f-5033c67baf28" xlink:href="mo-20221231.xsd#mo_WineSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df8ac46a-9568-4bb0-bcbc-35c7ea46a5dd" xlink:to="loc_mo_WineSegmentMember_286434f1-86ad-4989-9d3f-5033c67baf28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_407e3808-2947-46d1-b3d9-e8a91502a279" xlink:href="mo-20221231.xsd#mo_OralTobaccoSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_df8ac46a-9568-4bb0-bcbc-35c7ea46a5dd" xlink:to="loc_mo_OralTobaccoSegmentMember_407e3808-2947-46d1-b3d9-e8a91502a279" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8debb012-a3a0-4431-9419-8d06360f315a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_srt_ProductOrServiceAxis_8debb012-a3a0-4431-9419-8d06360f315a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8debb012-a3a0-4431-9419-8d06360f315a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8debb012-a3a0-4431-9419-8d06360f315a" xlink:to="loc_srt_ProductsAndServicesDomain_8debb012-a3a0-4431-9419-8d06360f315a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6a4b96ec-77f4-4469-beda-c63f66e28e08" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8debb012-a3a0-4431-9419-8d06360f315a" xlink:to="loc_srt_ProductsAndServicesDomain_6a4b96ec-77f4-4469-beda-c63f66e28e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CigarettesMember_949df94b-b133-4264-a48a-b851dce9490c" xlink:href="mo-20221231.xsd#mo_CigarettesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6a4b96ec-77f4-4469-beda-c63f66e28e08" xlink:to="loc_mo_CigarettesMember_949df94b-b133-4264-a48a-b851dce9490c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CigarsMember_044a7f74-76b5-4094-bb63-5187f123424f" xlink:href="mo-20221231.xsd#mo_CigarsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6a4b96ec-77f4-4469-beda-c63f66e28e08" xlink:to="loc_mo_CigarsMember_044a7f74-76b5-4094-bb63-5187f123424f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab61dbbc-907b-422d-b3e2-ef44f5dca7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab61dbbc-907b-422d-b3e2-ef44f5dca7a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ab61dbbc-907b-422d-b3e2-ef44f5dca7a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab61dbbc-907b-422d-b3e2-ef44f5dca7a8" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ab61dbbc-907b-422d-b3e2-ef44f5dca7a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_365f0c4f-e647-4c96-82d8-788a2c45da89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab61dbbc-907b-422d-b3e2-ef44f5dca7a8" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_365f0c4f-e647-4c96-82d8-788a2c45da89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_655d5bfc-b81d-4d1b-9aa1-ae8a245afcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_365f0c4f-e647-4c96-82d8-788a2c45da89" xlink:to="loc_us-gaap_SalesRevenueNetMember_655d5bfc-b81d-4d1b-9aa1-ae8a245afcfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_854fa9a9-4461-4993-b522-10737fc91745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_854fa9a9-4461-4993-b522-10737fc91745" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_854fa9a9-4461-4993-b522-10737fc91745_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_854fa9a9-4461-4993-b522-10737fc91745" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_854fa9a9-4461-4993-b522-10737fc91745_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_06cbac97-092d-4945-a21b-e96162b90677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_854fa9a9-4461-4993-b522-10737fc91745" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_06cbac97-092d-4945-a21b-e96162b90677" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_74343888-a626-4079-84c3-c64e48d0aed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_06cbac97-092d-4945-a21b-e96162b90677" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_74343888-a626-4079-84c3-c64e48d0aed9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_39d0514f-670c-4079-bb26-e44f5ec4e049" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_srt_MajorCustomersAxis_39d0514f-670c-4079-bb26-e44f5ec4e049" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_39d0514f-670c-4079-bb26-e44f5ec4e049_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_39d0514f-670c-4079-bb26-e44f5ec4e049" xlink:to="loc_srt_NameOfMajorCustomerDomain_39d0514f-670c-4079-bb26-e44f5ec4e049_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e30bd501-3ea2-4615-83c4-83d133dad512" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_39d0514f-670c-4079-bb26-e44f5ec4e049" xlink:to="loc_srt_NameOfMajorCustomerDomain_e30bd501-3ea2-4615-83c4-83d133dad512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_McLaneCompanyIncMember_cab58d89-fdb5-4f43-b2bb-5ed30a757d56" xlink:href="mo-20221231.xsd#mo_McLaneCompanyIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e30bd501-3ea2-4615-83c4-83d133dad512" xlink:to="loc_mo_McLaneCompanyIncMember_cab58d89-fdb5-4f43-b2bb-5ed30a757d56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PerformanceFoodGroupCompanyMember_4884786d-84a3-4134-9d29-0fac4cce16da" xlink:href="mo-20221231.xsd#mo_PerformanceFoodGroupCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e30bd501-3ea2-4615-83c4-83d133dad512" xlink:to="loc_mo_PerformanceFoodGroupCompanyMember_4884786d-84a3-4134-9d29-0fac4cce16da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CoreMarkHoldingCompanyInc.Member_fa9803fa-15aa-4d31-b941-212c6039b325" xlink:href="mo-20221231.xsd#mo_CoreMarkHoldingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e30bd501-3ea2-4615-83c4-83d133dad512" xlink:to="loc_mo_CoreMarkHoldingCompanyInc.Member_fa9803fa-15aa-4d31-b941-212c6039b325" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_aff926db-0f9d-471c-946e-4e47aa969a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_aff926db-0f9d-471c-946e-4e47aa969a4f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_aff926db-0f9d-471c-946e-4e47aa969a4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_aff926db-0f9d-471c-946e-4e47aa969a4f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_aff926db-0f9d-471c-946e-4e47aa969a4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_31ad834a-34f5-4b0b-952e-4368382cc903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_aff926db-0f9d-471c-946e-4e47aa969a4f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_31ad834a-34f5-4b0b-952e-4368382cc903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_COVID19Member_75691c5b-93bc-402a-8cf1-4fa4930c9af9" xlink:href="mo-20221231.xsd#mo_COVID19Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_31ad834a-34f5-4b0b-952e-4368382cc903" xlink:to="loc_mo_COVID19Member_75691c5b-93bc-402a-8cf1-4fa4930c9af9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dcf8a700-1de4-4048-bdd2-4ad3a78f407d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dcf8a700-1de4-4048-bdd2-4ad3a78f407d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_dcf8a700-1de4-4048-bdd2-4ad3a78f407d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dcf8a700-1de4-4048-bdd2-4ad3a78f407d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_dcf8a700-1de4-4048-bdd2-4ad3a78f407d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_927dc259-ffba-4a0e-8c6e-ddab4f253b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dcf8a700-1de4-4048-bdd2-4ad3a78f407d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_927dc259-ffba-4a0e-8c6e-ddab4f253b7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationAndResearchCostsMember_e7ba688c-eecd-4239-9870-62d5a2251654" xlink:href="mo-20221231.xsd#mo_MarketingAdministrationAndResearchCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_927dc259-ffba-4a0e-8c6e-ddab4f253b7c" xlink:to="loc_mo_MarketingAdministrationAndResearchCostsMember_e7ba688c-eecd-4239-9870-62d5a2251654" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d73982e1-3102-4310-bbcd-a4c146710771" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_dei_LegalEntityAxis_d73982e1-3102-4310-bbcd-a4c146710771" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d73982e1-3102-4310-bbcd-a4c146710771_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_d73982e1-3102-4310-bbcd-a4c146710771" xlink:to="loc_dei_EntityDomain_d73982e1-3102-4310-bbcd-a4c146710771_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_99575e93-ca45-4e14-97a3-c262623f73ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_d73982e1-3102-4310-bbcd-a4c146710771" xlink:to="loc_dei_EntityDomain_99575e93-ca45-4e14-97a3-c262623f73ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisCapitalCorporationMember_9adaf69d-242e-4f04-8533-9edf17152e36" xlink:href="mo-20221231.xsd#mo_PhilipMorrisCapitalCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_99575e93-ca45-4e14-97a3-c262623f73ae" xlink:to="loc_mo_PhilipMorrisCapitalCorporationMember_9adaf69d-242e-4f04-8533-9edf17152e36" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_cf3d3a51-b96a-4ba0-a63a-312546758262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_cf3d3a51-b96a-4ba0-a63a-312546758262" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_cf3d3a51-b96a-4ba0-a63a-312546758262_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_cf3d3a51-b96a-4ba0-a63a-312546758262" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_cf3d3a51-b96a-4ba0-a63a-312546758262_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_75b4a69f-de85-4efd-9f23-67c593ae601c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_cf3d3a51-b96a-4ba0-a63a-312546758262" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_75b4a69f-de85-4efd-9f23-67c593ae601c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f0b19f90-85b3-4803-8db1-d7ade7dcda0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_75b4a69f-de85-4efd-9f23-67c593ae601c" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f0b19f90-85b3-4803-8db1-d7ade7dcda0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f686c63-6266-49b9-9b46-7e671696cf5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f686c63-6266-49b9-9b46-7e671696cf5e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6f686c63-6266-49b9-9b46-7e671696cf5e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f686c63-6266-49b9-9b46-7e671696cf5e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_6f686c63-6266-49b9-9b46-7e671696cf5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f64cc1a-4258-43b6-afef-197f8dea1eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f686c63-6266-49b9-9b46-7e671696cf5e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f64cc1a-4258-43b6-afef-197f8dea1eb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionMember_26f586fd-9f12-47b1-b948-3f00e791c645" xlink:href="mo-20221231.xsd#mo_SteMichelleTransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f64cc1a-4258-43b6-afef-197f8dea1eb0" xlink:to="loc_mo_SteMichelleTransactionMember_26f586fd-9f12-47b1-b948-3f00e791c645" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_b5beb2ae-3a52-424b-9449-cc8d66c41b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_RestructuringPlanAxis_b5beb2ae-3a52-424b-9449-cc8d66c41b65" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_b5beb2ae-3a52-424b-9449-cc8d66c41b65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_b5beb2ae-3a52-424b-9449-cc8d66c41b65" xlink:to="loc_us-gaap_RestructuringPlanDomain_b5beb2ae-3a52-424b-9449-cc8d66c41b65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_20fc155c-88dd-415c-8916-d1b4cac3a1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_b5beb2ae-3a52-424b-9449-cc8d66c41b65" xlink:to="loc_us-gaap_RestructuringPlanDomain_20fc155c-88dd-415c-8916-d1b4cac3a1fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineBusinessStrategicResetMember_3715fa4d-190d-4afd-9c34-781e07c0601f" xlink:href="mo-20221231.xsd#mo_WineBusinessStrategicResetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_20fc155c-88dd-415c-8916-d1b4cac3a1fd" xlink:to="loc_mo_WineBusinessStrategicResetMember_3715fa4d-190d-4afd-9c34-781e07c0601f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_0c5b6684-8b9c-44f6-b182-1b1f234f949c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_0c5b6684-8b9c-44f6-b182-1b1f234f949c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_0c5b6684-8b9c-44f6-b182-1b1f234f949c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0c5b6684-8b9c-44f6-b182-1b1f234f949c" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_0c5b6684-8b9c-44f6-b182-1b1f234f949c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_37b4761c-109c-487a-9b81-026d00edf3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0c5b6684-8b9c-44f6-b182-1b1f234f949c" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_37b4761c-109c-487a-9b81-026d00edf3d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryWriteOffMember_2030b984-95c8-4dac-9c50-4cefb1655c1d" xlink:href="mo-20221231.xsd#mo_InventoryWriteOffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_37b4761c-109c-487a-9b81-026d00edf3d8" xlink:to="loc_mo_InventoryWriteOffMember_2030b984-95c8-4dac-9c50-4cefb1655c1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentMember_cf717652-b766-4bc6-ab78-2f205a9c1c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseCommitmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_37b4761c-109c-487a-9b81-026d00edf3d8" xlink:to="loc_us-gaap_PurchaseCommitmentMember_cf717652-b766-4bc6-ab78-2f205a9c1c4c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#SegmentReportingSegmentDataScheduleDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="extended" id="i0454288dbf284a1f9f446774ae727655_SegmentReportingSegmentDataScheduleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90606ea5-fda8-4067-9fbd-7d4304727c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90606ea5-fda8-4067-9fbd-7d4304727c57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ad164a02-c936-4145-bb41-ba17fd32e036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_OperatingIncomeLoss_ad164a02-c936-4145-bb41-ba17fd32e036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ee9b6d8f-8b57-43d6-a865-2bcfbedfcaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ee9b6d8f-8b57-43d6-a865-2bcfbedfcaf0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_a5252825-8597-420f-8714-51cd28128e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_a5252825-8597-420f-8714-51cd28128e83" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_bec41900-cd55-47a3-b8a1-e93e5b8bf7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_bec41900-cd55-47a3-b8a1-e93e5b8bf7d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b2e112a2-5c59-49e1-b267-8d2a577d5e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b2e112a2-5c59-49e1-b267-8d2a577d5e50" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_c920b3db-b848-4383-b097-d1812a21f27e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_c920b3db-b848-4383-b097-d1812a21f27e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_1d03e24a-4e5d-4695-a280-6ea12103f107" xlink:href="mo-20221231.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_mo_IncomeLossFromEquityInvestments_1d03e24a-4e5d-4695-a280-6ea12103f107" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_247b82f7-e195-460e-b05b-a46dacf40f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_247b82f7-e195-460e-b05b-a46dacf40f00" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_20f87f1a-9536-4cbe-947e-a692e290efc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_20f87f1a-9536-4cbe-947e-a692e290efc6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a5cb307c-8a67-478a-a38e-f4416208ee4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a5cb307c-8a67-478a-a38e-f4416208ee4d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_caaa6c8c-4313-4ee3-9729-35bd367d725d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_caaa6c8c-4313-4ee3-9729-35bd367d725d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_17ba7e5b-0439-4f7e-a39a-4ed31998da52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_caaa6c8c-4313-4ee3-9729-35bd367d725d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_17ba7e5b-0439-4f7e-a39a-4ed31998da52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_17ba7e5b-0439-4f7e-a39a-4ed31998da52_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_17ba7e5b-0439-4f7e-a39a-4ed31998da52" xlink:to="loc_us-gaap_SegmentDomain_17ba7e5b-0439-4f7e-a39a-4ed31998da52_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_33337684-44ba-4ecb-93eb-87323d5707c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_17ba7e5b-0439-4f7e-a39a-4ed31998da52" xlink:to="loc_us-gaap_SegmentDomain_33337684-44ba-4ecb-93eb-87323d5707c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_4c23ff2a-394a-44ca-ad51-ba34e9956d66" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_33337684-44ba-4ecb-93eb-87323d5707c3" xlink:to="loc_mo_SmokeableProductsSegmentMember_4c23ff2a-394a-44ca-ad51-ba34e9956d66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_e271f53c-15e9-452b-9dd5-8b932bc97e9f" xlink:href="mo-20221231.xsd#mo_OralTobaccoSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_33337684-44ba-4ecb-93eb-87323d5707c3" xlink:to="loc_mo_OralTobaccoSegmentMember_e271f53c-15e9-452b-9dd5-8b932bc97e9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_64f14c57-69c1-4833-9d12-7572973da038" xlink:href="mo-20221231.xsd#mo_WineSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_33337684-44ba-4ecb-93eb-87323d5707c3" xlink:to="loc_mo_WineSegmentMember_64f14c57-69c1-4833-9d12-7572973da038" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_7b0349b8-41ae-4779-b075-ed9d8f79022b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_33337684-44ba-4ecb-93eb-87323d5707c3" xlink:to="loc_us-gaap_AllOtherSegmentsMember_7b0349b8-41ae-4779-b075-ed9d8f79022b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3a41a85c-3581-4f77-90cb-e1d3cbe7769f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_caaa6c8c-4313-4ee3-9729-35bd367d725d" xlink:to="loc_srt_ConsolidationItemsAxis_3a41a85c-3581-4f77-90cb-e1d3cbe7769f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3a41a85c-3581-4f77-90cb-e1d3cbe7769f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_3a41a85c-3581-4f77-90cb-e1d3cbe7769f" xlink:to="loc_srt_ConsolidationItemsDomain_3a41a85c-3581-4f77-90cb-e1d3cbe7769f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_eb1711b3-b644-4e47-b14b-b200add2507c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_3a41a85c-3581-4f77-90cb-e1d3cbe7769f" xlink:to="loc_srt_ConsolidationItemsDomain_eb1711b3-b644-4e47-b14b-b200add2507c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f44e7262-e037-4cd7-8a39-0e5880d48a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_eb1711b3-b644-4e47-b14b-b200add2507c" xlink:to="loc_us-gaap_OperatingSegmentsMember_f44e7262-e037-4cd7-8a39-0e5880d48a16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f22528f3-dd4f-4395-9c94-d11ffde34ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_eb1711b3-b644-4e47-b14b-b200add2507c" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f22528f3-dd4f-4395-9c94-d11ffde34ef6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails" xlink:type="extended" id="i9f0b2cc0c015435a9354840fc0d2f9c5_SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_32103c94-dc37-42b4-9508-167f73b75a02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ea325f0b-face-4322-92d0-b05cbffbdc31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_32103c94-dc37-42b4-9508-167f73b75a02" xlink:to="loc_us-gaap_Depreciation_ea325f0b-face-4322-92d0-b05cbffbdc31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e2d1641d-43e8-4c5c-89d7-9085346db5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_32103c94-dc37-42b4-9508-167f73b75a02" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e2d1641d-43e8-4c5c-89d7-9085346db5b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9d08a060-be0b-4c9d-b7a1-ac0ff9af6945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_32103c94-dc37-42b4-9508-167f73b75a02" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9d08a060-be0b-4c9d-b7a1-ac0ff9af6945" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_35d167e9-ed64-4732-afe4-9c0460a36f33" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9d08a060-be0b-4c9d-b7a1-ac0ff9af6945" xlink:to="loc_srt_ConsolidationItemsAxis_35d167e9-ed64-4732-afe4-9c0460a36f33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_35d167e9-ed64-4732-afe4-9c0460a36f33_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_35d167e9-ed64-4732-afe4-9c0460a36f33" xlink:to="loc_srt_ConsolidationItemsDomain_35d167e9-ed64-4732-afe4-9c0460a36f33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b8b5e5f2-6d2e-496d-810c-3e3538c0385c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_35d167e9-ed64-4732-afe4-9c0460a36f33" xlink:to="loc_srt_ConsolidationItemsDomain_b8b5e5f2-6d2e-496d-810c-3e3538c0385c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9e16cc06-1f12-44c9-9d07-bf1d378f1a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b8b5e5f2-6d2e-496d-810c-3e3538c0385c" xlink:to="loc_us-gaap_OperatingSegmentsMember_9e16cc06-1f12-44c9-9d07-bf1d378f1a64" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_27133f26-3cb2-48c6-a819-8e2377546a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b8b5e5f2-6d2e-496d-810c-3e3538c0385c" xlink:to="loc_us-gaap_CorporateNonSegmentMember_27133f26-3cb2-48c6-a819-8e2377546a49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5348731e-8850-48f2-bc84-c5a0ce8b99a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9d08a060-be0b-4c9d-b7a1-ac0ff9af6945" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5348731e-8850-48f2-bc84-c5a0ce8b99a1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5348731e-8850-48f2-bc84-c5a0ce8b99a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5348731e-8850-48f2-bc84-c5a0ce8b99a1" xlink:to="loc_us-gaap_SegmentDomain_5348731e-8850-48f2-bc84-c5a0ce8b99a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a4f3f744-8731-4ebf-9aee-0012e74b6e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5348731e-8850-48f2-bc84-c5a0ce8b99a1" xlink:to="loc_us-gaap_SegmentDomain_a4f3f744-8731-4ebf-9aee-0012e74b6e8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_c36f9ec6-2f21-45ab-a24e-03453ddf676f" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4f3f744-8731-4ebf-9aee-0012e74b6e8a" xlink:to="loc_mo_SmokeableProductsSegmentMember_c36f9ec6-2f21-45ab-a24e-03453ddf676f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_4b48fcea-4adc-4287-b1eb-bc6eb50aa6bd" xlink:href="mo-20221231.xsd#mo_OralTobaccoSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4f3f744-8731-4ebf-9aee-0012e74b6e8a" xlink:to="loc_mo_OralTobaccoSegmentMember_4b48fcea-4adc-4287-b1eb-bc6eb50aa6bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_38727843-0192-4109-9353-150519038bc6" xlink:href="mo-20221231.xsd#mo_WineSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4f3f744-8731-4ebf-9aee-0012e74b6e8a" xlink:to="loc_mo_WineSegmentMember_38727843-0192-4109-9353-150519038bc6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails" xlink:type="extended" id="i75d76bbd75704e03b939879337fa0b82_SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cee53053-c015-4426-9bf1-72f5517d50a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_6138be15-2ee5-49c5-ab35-2be6eff43434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cee53053-c015-4426-9bf1-72f5517d50a5" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_6138be15-2ee5-49c5-ab35-2be6eff43434" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cee53053-c015-4426-9bf1-72f5517d50a5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_10c37e4f-fcd9-4428-aa37-827a68077ad9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_srt_ConsolidationItemsAxis_10c37e4f-fcd9-4428-aa37-827a68077ad9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_10c37e4f-fcd9-4428-aa37-827a68077ad9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_10c37e4f-fcd9-4428-aa37-827a68077ad9" xlink:to="loc_srt_ConsolidationItemsDomain_10c37e4f-fcd9-4428-aa37-827a68077ad9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7c2f5048-81a0-43b6-964c-58d794025d38" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_10c37e4f-fcd9-4428-aa37-827a68077ad9" xlink:to="loc_srt_ConsolidationItemsDomain_7c2f5048-81a0-43b6-964c-58d794025d38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9f5bcc6d-4b34-4992-ab26-262eea64fad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7c2f5048-81a0-43b6-964c-58d794025d38" xlink:to="loc_us-gaap_OperatingSegmentsMember_9f5bcc6d-4b34-4992-ab26-262eea64fad1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_a6fc5f9c-1252-43f6-91c1-01f96b4ca410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_7c2f5048-81a0-43b6-964c-58d794025d38" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_a6fc5f9c-1252-43f6-91c1-01f96b4ca410" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_83ff795d-9295-48c0-a54f-86d0d93b9711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_83ff795d-9295-48c0-a54f-86d0d93b9711" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_83ff795d-9295-48c0-a54f-86d0d93b9711_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83ff795d-9295-48c0-a54f-86d0d93b9711" xlink:to="loc_us-gaap_SegmentDomain_83ff795d-9295-48c0-a54f-86d0d93b9711_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1212f434-3137-44e0-a751-1a61bfce8234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83ff795d-9295-48c0-a54f-86d0d93b9711" xlink:to="loc_us-gaap_SegmentDomain_1212f434-3137-44e0-a751-1a61bfce8234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_8e95c5b2-92bc-4275-90c7-66991a00fd79" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1212f434-3137-44e0-a751-1a61bfce8234" xlink:to="loc_mo_SmokeableProductsSegmentMember_8e95c5b2-92bc-4275-90c7-66991a00fd79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9da3a054-e0d7-421d-b40f-21d0d40bf70e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_srt_LitigationCaseAxis_9da3a054-e0d7-421d-b40f-21d0d40bf70e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9da3a054-e0d7-421d-b40f-21d0d40bf70e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_9da3a054-e0d7-421d-b40f-21d0d40bf70e" xlink:to="loc_srt_LitigationCaseTypeDomain_9da3a054-e0d7-421d-b40f-21d0d40bf70e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a12c731c-bcd0-4dac-b7a2-884f84b7a4e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_9da3a054-e0d7-421d-b40f-21d0d40bf70e" xlink:to="loc_srt_LitigationCaseTypeDomain_a12c731c-bcd0-4dac-b7a2-884f84b7a4e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_4dd1fb34-cc34-4f2f-bd4e-9408dd4b458d" xlink:href="mo-20221231.xsd#mo_NonParticipatingManufacturerArbitrationPanelDecisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_a12c731c-bcd0-4dac-b7a2-884f84b7a4e3" xlink:to="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_4dd1fb34-cc34-4f2f-bd4e-9408dd4b458d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8294d075-d592-4460-a98b-64cd3c6e071c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8294d075-d592-4460-a98b-64cd3c6e071c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8294d075-d592-4460-a98b-64cd3c6e071c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8294d075-d592-4460-a98b-64cd3c6e071c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8294d075-d592-4460-a98b-64cd3c6e071c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bf24d415-ee25-4c60-9f5a-1f8b880a5a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8294d075-d592-4460-a98b-64cd3c6e071c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bf24d415-ee25-4c60-9f5a-1f8b880a5a7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember_df8ef0a6-3b93-4db3-bc4a-49da2dce9770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bf24d415-ee25-4c60-9f5a-1f8b880a5a7e" xlink:to="loc_us-gaap_OperatingIncomeLossMember_df8ef0a6-3b93-4db3-bc4a-49da2dce9770" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestAndOtherDebtExpenseNetMember_340366a8-d0ee-4dc0-b4e4-b9bc7ec105f1" xlink:href="mo-20221231.xsd#mo_InterestAndOtherDebtExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bf24d415-ee25-4c60-9f5a-1f8b880a5a7e" xlink:to="loc_mo_InterestAndOtherDebtExpenseNetMember_340366a8-d0ee-4dc0-b4e4-b9bc7ec105f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_beb8a014-9a11-4121-b3a6-04973682525e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_us-gaap_NatureOfExpenseAxis_beb8a014-9a11-4121-b3a6-04973682525e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_beb8a014-9a11-4121-b3a6-04973682525e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_NatureOfExpenseAxis_beb8a014-9a11-4121-b3a6-04973682525e" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_beb8a014-9a11-4121-b3a6-04973682525e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_05daef65-be38-4c7b-b6ad-b5022e26f53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_NatureOfExpenseAxis_beb8a014-9a11-4121-b3a6-04973682525e" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_05daef65-be38-4c7b-b6ad-b5022e26f53e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NpmAdjustmentToCostOfSalesMember_25ba7071-fb21-4d9f-ba10-27f8faa53a7b" xlink:href="mo-20221231.xsd#mo_NpmAdjustmentToCostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_05daef65-be38-4c7b-b6ad-b5022e26f53e" xlink:to="loc_mo_NpmAdjustmentToCostOfSalesMember_25ba7071-fb21-4d9f-ba10-27f8faa53a7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NPMAdjustmentToInterestExpenseMember_c98c5273-c740-44df-b27c-e7c147e2bf86" xlink:href="mo-20221231.xsd#mo_NPMAdjustmentToInterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_05daef65-be38-4c7b-b6ad-b5022e26f53e" xlink:to="loc_mo_NPMAdjustmentToInterestExpenseMember_c98c5273-c740-44df-b27c-e7c147e2bf86" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember_e18173ad-2526-4d14-bc40-76602d3fd647" xlink:href="mo-20221231.xsd#mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_05daef65-be38-4c7b-b6ad-b5022e26f53e" xlink:to="loc_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember_e18173ad-2526-4d14-bc40-76602d3fd647" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0a520906-d9f2-49bd-9072-d92f4adcce84" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_dei_LegalEntityAxis_0a520906-d9f2-49bd-9072-d92f4adcce84" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0a520906-d9f2-49bd-9072-d92f4adcce84_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_0a520906-d9f2-49bd-9072-d92f4adcce84" xlink:to="loc_dei_EntityDomain_0a520906-d9f2-49bd-9072-d92f4adcce84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a200fcc3-f0c7-4b4e-969e-4d5c81398575" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_0a520906-d9f2-49bd-9072-d92f4adcce84" xlink:to="loc_dei_EntityDomain_a200fcc3-f0c7-4b4e-969e-4d5c81398575" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_2447357f-1e3f-4bde-945b-23ae8c8977e0" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_a200fcc3-f0c7-4b4e-969e-4d5c81398575" xlink:to="loc_mo_PhilipMorrisUSAMember_2447357f-1e3f-4bde-945b-23ae8c8977e0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails" xlink:type="extended" id="ia8a86f1aacdc4332bea84276ff3fdac5_SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_fcafd909-797d-4986-bc1c-ac56086fd1eb" xlink:href="mo-20221231.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_b2280819-e9f2-4156-9bc8-7d82405c995f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_fcafd909-797d-4986-bc1c-ac56086fd1eb" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_b2280819-e9f2-4156-9bc8-7d82405c995f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:href="mo-20221231.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_fcafd909-797d-4986-bc1c-ac56086fd1eb" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_68ab289e-0d43-4da9-84bd-199f4cc33141" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:to="loc_dei_LegalEntityAxis_68ab289e-0d43-4da9-84bd-199f4cc33141" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_68ab289e-0d43-4da9-84bd-199f4cc33141_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_68ab289e-0d43-4da9-84bd-199f4cc33141" xlink:to="loc_dei_EntityDomain_68ab289e-0d43-4da9-84bd-199f4cc33141_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ab4aa879-3929-43ac-a452-fddb863ee34c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_68ab289e-0d43-4da9-84bd-199f4cc33141" xlink:to="loc_dei_EntityDomain_ab4aa879-3929-43ac-a452-fddb863ee34c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_463bda2c-2e22-4bef-bcc7-ccc51df5e1d0" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ab4aa879-3929-43ac-a452-fddb863ee34c" xlink:to="loc_mo_PhilipMorrisUSAMember_463bda2c-2e22-4bef-bcc7-ccc51df5e1d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_c3f46bd5-0b5a-428c-8474-24b315766385" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:to="loc_srt_LitigationCaseAxis_c3f46bd5-0b5a-428c-8474-24b315766385" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_c3f46bd5-0b5a-428c-8474-24b315766385_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_c3f46bd5-0b5a-428c-8474-24b315766385" xlink:to="loc_srt_LitigationCaseTypeDomain_c3f46bd5-0b5a-428c-8474-24b315766385_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b1f07959-7a02-428f-8569-06927f816c62" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_c3f46bd5-0b5a-428c-8474-24b315766385" xlink:to="loc_srt_LitigationCaseTypeDomain_b1f07959-7a02-428f-8569-06927f816c62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember_58de4d64-3157-41a5-9dec-f02b31a1aad9" xlink:href="mo-20221231.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b1f07959-7a02-428f-8569-06927f816c62" xlink:to="loc_mo_TobaccoandHealthLitigationCasesMember_58de4d64-3157-41a5-9dec-f02b31a1aad9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1393c43f-a26a-4b40-acea-f5c8cc2322f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1393c43f-a26a-4b40-acea-f5c8cc2322f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1393c43f-a26a-4b40-acea-f5c8cc2322f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1393c43f-a26a-4b40-acea-f5c8cc2322f7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1393c43f-a26a-4b40-acea-f5c8cc2322f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_19674d2c-f06e-45f5-bf38-3ffe17bb61bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1393c43f-a26a-4b40-acea-f5c8cc2322f7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_19674d2c-f06e-45f5-bf38-3ffe17bb61bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember_0d788e5d-ca43-49a6-b671-64dcc811dc4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_19674d2c-f06e-45f5-bf38-3ffe17bb61bf" xlink:to="loc_us-gaap_OperatingIncomeLossMember_0d788e5d-ca43-49a6-b671-64dcc811dc4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestAndOtherDebtExpenseNetMember_ffe6e318-7e4f-4351-8030-69e0300617e7" xlink:href="mo-20221231.xsd#mo_InterestAndOtherDebtExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_19674d2c-f06e-45f5-bf38-3ffe17bb61bf" xlink:to="loc_mo_InterestAndOtherDebtExpenseNetMember_ffe6e318-7e4f-4351-8030-69e0300617e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5bbdef5d-dba9-44c2-8523-7df7e176d4d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:to="loc_srt_ConsolidationItemsAxis_5bbdef5d-dba9-44c2-8523-7df7e176d4d7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5bbdef5d-dba9-44c2-8523-7df7e176d4d7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5bbdef5d-dba9-44c2-8523-7df7e176d4d7" xlink:to="loc_srt_ConsolidationItemsDomain_5bbdef5d-dba9-44c2-8523-7df7e176d4d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_cba1f9bf-4a26-4f04-9672-51aff998ee6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5bbdef5d-dba9-44c2-8523-7df7e176d4d7" xlink:to="loc_srt_ConsolidationItemsDomain_cba1f9bf-4a26-4f04-9672-51aff998ee6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d5f8a371-6b8f-46d8-88a7-4736c05e4279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_cba1f9bf-4a26-4f04-9672-51aff998ee6a" xlink:to="loc_us-gaap_OperatingSegmentsMember_d5f8a371-6b8f-46d8-88a7-4736c05e4279" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_d18e0de0-bc1a-451a-b54a-1aba3f99f612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_cba1f9bf-4a26-4f04-9672-51aff998ee6a" xlink:to="loc_us-gaap_CorporateNonSegmentMember_d18e0de0-bc1a-451a-b54a-1aba3f99f612" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_0a8abc2b-ba6c-483f-a64c-b1b0dc582391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_cba1f9bf-4a26-4f04-9672-51aff998ee6a" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_0a8abc2b-ba6c-483f-a64c-b1b0dc582391" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bb0751be-4e67-43bb-ab49-dd8af02a9808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bb0751be-4e67-43bb-ab49-dd8af02a9808" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bb0751be-4e67-43bb-ab49-dd8af02a9808_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bb0751be-4e67-43bb-ab49-dd8af02a9808" xlink:to="loc_us-gaap_SegmentDomain_bb0751be-4e67-43bb-ab49-dd8af02a9808_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8f6d92c7-161f-4b3e-97ca-06f4206ff5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bb0751be-4e67-43bb-ab49-dd8af02a9808" xlink:to="loc_us-gaap_SegmentDomain_8f6d92c7-161f-4b3e-97ca-06f4206ff5d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_2b1301c9-c2d2-4af2-ab8e-d6c1bce79cfe" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8f6d92c7-161f-4b3e-97ca-06f4206ff5d1" xlink:to="loc_mo_SmokeableProductsSegmentMember_2b1301c9-c2d2-4af2-ab8e-d6c1bce79cfe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="extended" id="ic210f0154fdd4d8089ae9775433637d3_BenefitPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_62b11f1d-5cc8-4802-8bb9-180afdb4c432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_62b11f1d-5cc8-4802-8bb9-180afdb4c432" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_610c528b-0cca-48d1-8871-21fe3b916c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_610c528b-0cca-48d1-8871-21fe3b916c06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_34b9c7ba-2ef4-44b5-a9fe-86b84f5a19d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_34b9c7ba-2ef4-44b5-a9fe-86b84f5a19d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_5159867e-5cda-41ef-974d-5f5eac740f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_5159867e-5cda-41ef-974d-5f5eac740f9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_3b8a007e-603b-43d8-9db1-b2dd9a94598d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_3b8a007e-603b-43d8-9db1-b2dd9a94598d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_64cdbb4f-ba0d-4e99-b0e3-9cbb10d11eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_64cdbb4f-ba0d-4e99-b0e3-9cbb10d11eec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_e972268a-70e0-4c62-aae1-79efeb4f2656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_e972268a-70e0-4c62-aae1-79efeb4f2656" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_5db265b7-51ae-4f76-a722-ecc5834c9ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_5db265b7-51ae-4f76-a722-ecc5834c9ace" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_4fb932d5-6f99-43b7-8f89-bef9d4dbfe68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_4fb932d5-6f99-43b7-8f89-bef9d4dbfe68" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_362f1436-4c3f-44aa-bab1-c98c0c4bd62d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_362f1436-4c3f-44aa-bab1-c98c0c4bd62d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0fb9ada5-a257-4af3-8d3f-21c6f429c06b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0fb9ada5-a257-4af3-8d3f-21c6f429c06b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_4e160528-5f33-49fb-9359-7119bc42770b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_4e160528-5f33-49fb-9359-7119bc42770b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_5b12e900-fc16-4a56-95c6-baf0a7924c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_5b12e900-fc16-4a56-95c6-baf0a7924c53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_5b12e900-fc16-4a56-95c6-baf0a7924c53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5b12e900-fc16-4a56-95c6-baf0a7924c53" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_5b12e900-fc16-4a56-95c6-baf0a7924c53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1b82e60e-019b-4297-88a8-fca3d1a6472f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5b12e900-fc16-4a56-95c6-baf0a7924c53" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1b82e60e-019b-4297-88a8-fca3d1a6472f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_4626fa72-0a17-4626-9477-70ad223c58ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1b82e60e-019b-4297-88a8-fca3d1a6472f" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_4626fa72-0a17-4626-9477-70ad223c58ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b006475f-98d7-434e-a1fd-cab795b10441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1b82e60e-019b-4297-88a8-fca3d1a6472f" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b006475f-98d7-434e-a1fd-cab795b10441" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aa452ea7-e016-49a8-b976-6f694f40ac7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aa452ea7-e016-49a8-b976-6f694f40ac7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_aa452ea7-e016-49a8-b976-6f694f40ac7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aa452ea7-e016-49a8-b976-6f694f40ac7a" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_aa452ea7-e016-49a8-b976-6f694f40ac7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_1d45c402-19dc-4ef8-845e-23dfe86f03b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aa452ea7-e016-49a8-b976-6f694f40ac7a" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_1d45c402-19dc-4ef8-845e-23dfe86f03b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_de12f66a-ee62-48a0-a793-3c0674c36e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1d45c402-19dc-4ef8-845e-23dfe86f03b9" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_de12f66a-ee62-48a0-a793-3c0674c36e39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_d518a011-2406-4105-ade8-b9350b459328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1d45c402-19dc-4ef8-845e-23dfe86f03b9" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_d518a011-2406-4105-ade8-b9350b459328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingAxis_055e8367-cc08-4bc6-9d6a-039821cc34ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_us-gaap_ExternalCreditRatingByGroupingAxis_055e8367-cc08-4bc6-9d6a-039821cc34ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingDomain_055e8367-cc08-4bc6-9d6a-039821cc34ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingAxis_055e8367-cc08-4bc6-9d6a-039821cc34ec" xlink:to="loc_us-gaap_ExternalCreditRatingByGroupingDomain_055e8367-cc08-4bc6-9d6a-039821cc34ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingDomain_cffd5e41-93a1-4f54-9f3e-3e19ec9b9e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingAxis_055e8367-cc08-4bc6-9d6a-039821cc34ec" xlink:to="loc_us-gaap_ExternalCreditRatingByGroupingDomain_cffd5e41-93a1-4f54-9f3e-3e19ec9b9e51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingNonInvestmentGradeMember_281ed77b-d098-4b35-9653-2e49527d0b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingNonInvestmentGradeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingDomain_cffd5e41-93a1-4f54-9f3e-3e19ec9b9e51" xlink:to="loc_us-gaap_ExternalCreditRatingNonInvestmentGradeMember_281ed77b-d098-4b35-9653-2e49527d0b71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2462893a-937c-4fe8-938a-594dab1d5298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_us-gaap_InvestmentTypeAxis_2462893a-937c-4fe8-938a-594dab1d5298" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2462893a-937c-4fe8-938a-594dab1d5298_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_2462893a-937c-4fe8-938a-594dab1d5298" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2462893a-937c-4fe8-938a-594dab1d5298_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_d425697d-e85e-483d-afaf-f2489dbdc10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_2462893a-937c-4fe8-938a-594dab1d5298" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_d425697d-e85e-483d-afaf-f2489dbdc10a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EmergingMarketsMember_01e6b693-0fcd-4a4a-b558-86ec471904dc" xlink:href="mo-20221231.xsd#mo_EmergingMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_d425697d-e85e-483d-afaf-f2489dbdc10a" xlink:to="loc_mo_EmergingMarketsMember_01e6b693-0fcd-4a4a-b558-86ec471904dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_73018fbe-0bcf-4511-a6bd-e44297c999f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_srt_RangeAxis_73018fbe-0bcf-4511-a6bd-e44297c999f4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_73018fbe-0bcf-4511-a6bd-e44297c999f4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_73018fbe-0bcf-4511-a6bd-e44297c999f4" xlink:to="loc_srt_RangeMember_73018fbe-0bcf-4511-a6bd-e44297c999f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a7ffcf3e-3e6d-4ca5-a5cd-b1c5b5fc7547" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_73018fbe-0bcf-4511-a6bd-e44297c999f4" xlink:to="loc_srt_RangeMember_a7ffcf3e-3e6d-4ca5-a5cd-b1c5b5fc7547" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3cb596cd-78d8-421f-883a-0797f3635eca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a7ffcf3e-3e6d-4ca5-a5cd-b1c5b5fc7547" xlink:to="loc_srt_MaximumMember_3cb596cd-78d8-421f-883a-0797f3635eca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_df194cfc-b78d-4a23-a7b4-3295b29d65ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_srt_StatementScenarioAxis_df194cfc-b78d-4a23-a7b4-3295b29d65ed" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_df194cfc-b78d-4a23-a7b4-3295b29d65ed_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_df194cfc-b78d-4a23-a7b4-3295b29d65ed" xlink:to="loc_srt_ScenarioUnspecifiedDomain_df194cfc-b78d-4a23-a7b4-3295b29d65ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_95eb5804-4879-4c6c-b642-9894db6df617" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_df194cfc-b78d-4a23-a7b4-3295b29d65ed" xlink:to="loc_srt_ScenarioUnspecifiedDomain_95eb5804-4879-4c6c-b642-9894db6df617" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_b4d13fc8-503f-4bff-8422-c4d119a79480" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_95eb5804-4879-4c6c-b642-9894db6df617" xlink:to="loc_srt_ScenarioForecastMember_b4d13fc8-503f-4bff-8422-c4d119a79480" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails" xlink:type="extended" id="i1993bc5404a1433eb2c705191e593bc4_BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_34a7c85e-885e-4647-a49c-5812119db64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_34a7c85e-885e-4647-a49c-5812119db64d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_e49e1444-bb31-4407-a08c-8a734ea5af24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_e49e1444-bb31-4407-a08c-8a734ea5af24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_37004918-fe1d-4bf7-a93b-9ea18d170759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_37004918-fe1d-4bf7-a93b-9ea18d170759" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_e265c1bd-736a-424a-bff2-b767864599c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_e265c1bd-736a-424a-bff2-b767864599c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_b08d7d3a-d051-493d-81d0-c5504335a6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_b08d7d3a-d051-493d-81d0-c5504335a6e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_5650edbd-ae74-4f3c-87ac-32c7ac0a2702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_5650edbd-ae74-4f3c-87ac-32c7ac0a2702" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_71ff826c-ab46-4200-a3f4-76e7694654c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_71ff826c-ab46-4200-a3f4-76e7694654c1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f5c6d3e8-b26f-49fa-97cd-17b5ad2bb9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9d3ec220-611a-432a-ad96-26c57b0690db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9d3ec220-611a-432a-ad96-26c57b0690db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_dc5ae6bf-a2b8-4cf5-b23f-fcebdd1dca18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_dc5ae6bf-a2b8-4cf5-b23f-fcebdd1dca18" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_14e9c8e5-f839-400c-adb1-da286357ca82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_14e9c8e5-f839-400c-adb1-da286357ca82" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_1745e12f-b36d-465c-9b95-d1ea8e6f6955" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_1745e12f-b36d-465c-9b95-d1ea8e6f6955" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_6d11bd84-7bd7-42ea-a8c9-4cc0a269c511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_6d11bd84-7bd7-42ea-a8c9-4cc0a269c511" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_de1ed27c-876b-42f3-b153-acc58872076f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_edfe7bf0-a253-401d-a89e-2a6a26c68c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_edfe7bf0-a253-401d-a89e-2a6a26c68c63" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_b40d308e-365c-4cd5-a847-0ec31a61ea18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_b40d308e-365c-4cd5-a847-0ec31a61ea18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_bb95cb1d-550f-4274-8d42-1f96bf1d019e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_bb95cb1d-550f-4274-8d42-1f96bf1d019e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_4939f64c-4b34-4100-8b53-e1779e965e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_4939f64c-4b34-4100-8b53-e1779e965e9c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_b29562c6-e266-4fa2-bb71-95e0d0a26a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_b29562c6-e266-4fa2-bb71-95e0d0a26a71" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_1a21763f-cdf5-4af2-8d5b-3182b4c07afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_1a21763f-cdf5-4af2-8d5b-3182b4c07afd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a538b82d-8f5a-4804-8899-511c9931159a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a538b82d-8f5a-4804-8899-511c9931159a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_37529c49-0e09-41f1-baa3-e06dc04cc39b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a538b82d-8f5a-4804-8899-511c9931159a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_37529c49-0e09-41f1-baa3-e06dc04cc39b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_37529c49-0e09-41f1-baa3-e06dc04cc39b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_37529c49-0e09-41f1-baa3-e06dc04cc39b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_37529c49-0e09-41f1-baa3-e06dc04cc39b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_abca9a1e-bdc2-4224-90ce-0e7add3468da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_37529c49-0e09-41f1-baa3-e06dc04cc39b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_abca9a1e-bdc2-4224-90ce-0e7add3468da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e94cb6c4-6360-4671-8f81-615badbc7e81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_abca9a1e-bdc2-4224-90ce-0e7add3468da" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e94cb6c4-6360-4671-8f81-615badbc7e81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b62ebd47-c28f-431d-ad61-560e5ffb981b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_abca9a1e-bdc2-4224-90ce-0e7add3468da" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b62ebd47-c28f-431d-ad61-560e5ffb981b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails" xlink:type="extended" id="i250e4902c22c47698e7c195a2cf53447_BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_7a6c7374-a7aa-4fb9-8323-84c6867c851d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_7a6c7374-a7aa-4fb9-8323-84c6867c851d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_17666297-e273-4da7-bf90-3cf69a6c429b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_17666297-e273-4da7-bf90-3cf69a6c429b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_2a4e8f60-065e-4be1-b7a7-0dd7c3688772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:to="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_2a4e8f60-065e-4be1-b7a7-0dd7c3688772" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_219aab3f-0a36-4d6c-8ba5-0d4d42381fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_219aab3f-0a36-4d6c-8ba5-0d4d42381fc3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_4030e7fb-a278-4c25-a93c-50a08202c673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_4030e7fb-a278-4c25-a93c-50a08202c673" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_29f1af3a-d85e-44a3-b8a6-24a6a543af10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_29f1af3a-d85e-44a3-b8a6-24a6a543af10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_14871d2d-f2cb-4dfe-9a83-1ac6c43f4bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_29f1af3a-d85e-44a3-b8a6-24a6a543af10" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_14871d2d-f2cb-4dfe-9a83-1ac6c43f4bab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_14871d2d-f2cb-4dfe-9a83-1ac6c43f4bab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_14871d2d-f2cb-4dfe-9a83-1ac6c43f4bab" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_14871d2d-f2cb-4dfe-9a83-1ac6c43f4bab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e9787721-6701-4613-b1b9-b8ee82266772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_14871d2d-f2cb-4dfe-9a83-1ac6c43f4bab" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e9787721-6701-4613-b1b9-b8ee82266772" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_1dd8219c-0d1a-44ae-a6f0-55f83c8c2090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e9787721-6701-4613-b1b9-b8ee82266772" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_1dd8219c-0d1a-44ae-a6f0-55f83c8c2090" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_1ea6ae2e-deef-44f3-ac67-9d21a8d79b32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e9787721-6701-4613-b1b9-b8ee82266772" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_1ea6ae2e-deef-44f3-ac67-9d21a8d79b32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7eb8fdc2-701b-4217-9960-f0395d9082ff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_29f1af3a-d85e-44a3-b8a6-24a6a543af10" xlink:to="loc_srt_StatementScenarioAxis_7eb8fdc2-701b-4217-9960-f0395d9082ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_7eb8fdc2-701b-4217-9960-f0395d9082ff_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_7eb8fdc2-701b-4217-9960-f0395d9082ff" xlink:to="loc_srt_ScenarioUnspecifiedDomain_7eb8fdc2-701b-4217-9960-f0395d9082ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cfede465-2b84-4418-8683-fd6a12c7f64d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_7eb8fdc2-701b-4217-9960-f0395d9082ff" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cfede465-2b84-4418-8683-fd6a12c7f64d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_682b4ed2-aae6-4c12-8660-8fde95ee2ca1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_cfede465-2b84-4418-8683-fd6a12c7f64d" xlink:to="loc_srt_ScenarioForecastMember_682b4ed2-aae6-4c12-8660-8fde95ee2ca1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails" xlink:type="extended" id="ibbe378ee40a14ba2a44f4189ccb20eea_BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_dc31135b-2124-4ea5-8284-b79c5c5f920d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_dc31135b-2124-4ea5-8284-b79c5c5f920d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_dec919eb-eb62-4d49-8fd6-2b366309d4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_dec919eb-eb62-4d49-8fd6-2b366309d4ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_bca2e07d-633a-4d81-a582-c8fb9eed6763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_bca2e07d-633a-4d81-a582-c8fb9eed6763" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortizationAbstract_1299fcab-9053-4073-b678-8ce97374603c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortizationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_AdjustmentForAmortizationAbstract_1299fcab-9053-4073-b678-8ce97374603c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_6f7b8c2d-30be-4889-831d-0b66f1fa4973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentForAmortizationAbstract_1299fcab-9053-4073-b678-8ce97374603c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_6f7b8c2d-30be-4889-831d-0b66f1fa4973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_ff5b3169-a3ca-4954-9d62-49b796a15eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentForAmortizationAbstract_1299fcab-9053-4073-b678-8ce97374603c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_ff5b3169-a3ca-4954-9d62-49b796a15eb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_7792e1c2-287d-49e6-9162-4ba0d5a4b3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_7792e1c2-287d-49e6-9162-4ba0d5a4b3f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b1cc8538-7dbf-4d81-ae43-e3db5c2fa439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b1cc8538-7dbf-4d81-ae43-e3db5c2fa439" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c7820fb-c501-485d-9f13-57a22fbae886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c7820fb-c501-485d-9f13-57a22fbae886" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_6bb948ec-15ac-4945-9291-34f3422a2b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c7820fb-c501-485d-9f13-57a22fbae886" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_6bb948ec-15ac-4945-9291-34f3422a2b6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_6bb948ec-15ac-4945-9291-34f3422a2b6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_6bb948ec-15ac-4945-9291-34f3422a2b6a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_6bb948ec-15ac-4945-9291-34f3422a2b6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_826f905a-c1c4-45cc-a3e9-30dd9964f72c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_6bb948ec-15ac-4945-9291-34f3422a2b6a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_826f905a-c1c4-45cc-a3e9-30dd9964f72c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b63951b3-9944-4c75-ab7f-dddf3c0e8d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_826f905a-c1c4-45cc-a3e9-30dd9964f72c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b63951b3-9944-4c75-ab7f-dddf3c0e8d8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_37c5250b-382d-46ec-89dd-7cbcf7dbe99b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_826f905a-c1c4-45cc-a3e9-30dd9964f72c" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_37c5250b-382d-46ec-89dd-7cbcf7dbe99b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails" xlink:type="extended" id="i42a57e72012843b6927c75fc9940c1f0_BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4307acfc-f393-4ebe-9c64-a9d17bd054d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanDiscountRateAbstractAbstract_917d3416-cd31-4618-9247-4f756c9d3fde" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanDiscountRateAbstractAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4307acfc-f393-4ebe-9c64-a9d17bd054d8" xlink:to="loc_mo_DefinedBenefitPlanDiscountRateAbstractAbstract_917d3416-cd31-4618-9247-4f756c9d3fde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_9a3f0faf-1a6c-4986-bc29-80453e13abeb" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_DefinedBenefitPlanDiscountRateAbstractAbstract_917d3416-cd31-4618-9247-4f756c9d3fde" xlink:to="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_9a3f0faf-1a6c-4986-bc29-80453e13abeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_9b97b39f-82ad-4810-9fe0-13262f5f75c4" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_DefinedBenefitPlanDiscountRateAbstractAbstract_917d3416-cd31-4618-9247-4f756c9d3fde" xlink:to="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_9b97b39f-82ad-4810-9fe0-13262f5f75c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e0225616-92fe-46f1-b76f-4c804fea68e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4307acfc-f393-4ebe-9c64-a9d17bd054d8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e0225616-92fe-46f1-b76f-4c804fea68e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_3b6e762f-a5f9-4fdf-8ecc-79252053baeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4307acfc-f393-4ebe-9c64-a9d17bd054d8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_3b6e762f-a5f9-4fdf-8ecc-79252053baeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate_d5cb272e-890f-4c6e-b8d9-b449df08b71b" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4307acfc-f393-4ebe-9c64-a9d17bd054d8" xlink:to="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate_d5cb272e-890f-4c6e-b8d9-b449df08b71b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9ebb7320-2c5e-4ba7-9eb1-68ba453d0763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4307acfc-f393-4ebe-9c64-a9d17bd054d8" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9ebb7320-2c5e-4ba7-9eb1-68ba453d0763" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d7821220-9154-49ae-a200-153a54904142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9ebb7320-2c5e-4ba7-9eb1-68ba453d0763" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d7821220-9154-49ae-a200-153a54904142" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_d7821220-9154-49ae-a200-153a54904142_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d7821220-9154-49ae-a200-153a54904142" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_d7821220-9154-49ae-a200-153a54904142_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_522416e3-7c55-4a4b-aca1-b363fbc16bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d7821220-9154-49ae-a200-153a54904142" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_522416e3-7c55-4a4b-aca1-b363fbc16bab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b329071e-9aea-41a3-a726-adb2448bd9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_522416e3-7c55-4a4b-aca1-b363fbc16bab" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b329071e-9aea-41a3-a726-adb2448bd9f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_7885a89e-ee30-4d05-b7af-45bc86cebc91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_522416e3-7c55-4a4b-aca1-b363fbc16bab" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_7885a89e-ee30-4d05-b7af-45bc86cebc91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c330bc90-23f9-4554-8ef7-49f6e6809ef2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9ebb7320-2c5e-4ba7-9eb1-68ba453d0763" xlink:to="loc_srt_StatementScenarioAxis_c330bc90-23f9-4554-8ef7-49f6e6809ef2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_c330bc90-23f9-4554-8ef7-49f6e6809ef2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_c330bc90-23f9-4554-8ef7-49f6e6809ef2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_c330bc90-23f9-4554-8ef7-49f6e6809ef2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9a9783df-ef51-4ef8-a028-d0a2e7b3fb84" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_c330bc90-23f9-4554-8ef7-49f6e6809ef2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9a9783df-ef51-4ef8-a028-d0a2e7b3fb84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_587c66fa-ae5f-453a-8b3a-ea514c3e56d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9a9783df-ef51-4ef8-a028-d0a2e7b3fb84" xlink:to="loc_srt_ScenarioForecastMember_587c66fa-ae5f-453a-8b3a-ea514c3e56d0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansAssetAllocationsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansAssetAllocationsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansAssetAllocationsDetails" xlink:type="extended" id="ibd4860b187464ae9805586978837be49_BenefitPlansAssetAllocationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0ac6ad7e-7845-4684-bf55-f2b94240faad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_6ee5e680-8be5-4f51-9a20-b8c3e60d7af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0ac6ad7e-7845-4684-bf55-f2b94240faad" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_6ee5e680-8be5-4f51-9a20-b8c3e60d7af1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8fbbcb88-70e3-461e-99e6-41c95ea8b114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0ac6ad7e-7845-4684-bf55-f2b94240faad" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8fbbcb88-70e3-461e-99e6-41c95ea8b114" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_b542b191-a3d1-44d3-9fcb-db53b2986f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8fbbcb88-70e3-461e-99e6-41c95ea8b114" xlink:to="loc_us-gaap_InvestmentTypeAxis_b542b191-a3d1-44d3-9fcb-db53b2986f1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_b542b191-a3d1-44d3-9fcb-db53b2986f1b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_b542b191-a3d1-44d3-9fcb-db53b2986f1b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_b542b191-a3d1-44d3-9fcb-db53b2986f1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_b542b191-a3d1-44d3-9fcb-db53b2986f1b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_25efd553-3cea-405e-a8b4-cec82b4d3b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_25efd553-3cea-405e-a8b4-cec82b4d3b30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_4857a45c-73a6-47d7-9cc5-f1528394def6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_4857a45c-73a6-47d7-9cc5-f1528394def6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember_e8e0b223-0503-45e9-a10d-bad8b4c76480" xlink:href="mo-20221231.xsd#mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:to="loc_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember_e8e0b223-0503-45e9-a10d-bad8b4c76480" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTreasuryAndForeignGovernmentSecuritiesMember_7d14056d-0b8c-47e4-9363-8db638797e5b" xlink:href="mo-20221231.xsd#mo_USTreasuryAndForeignGovernmentSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:to="loc_mo_USTreasuryAndForeignGovernmentSecuritiesMember_7d14056d-0b8c-47e4-9363-8db638797e5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetBasedSecuritiesAndOtherInvestmentsMember_16677714-cba4-4d50-a8de-50fe33d795fd" xlink:href="mo-20221231.xsd#mo_AssetBasedSecuritiesAndOtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:to="loc_mo_AssetBasedSecuritiesAndOtherInvestmentsMember_16677714-cba4-4d50-a8de-50fe33d795fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_48112c9d-f389-4286-8214-efaaf82faf83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8fbbcb88-70e3-461e-99e6-41c95ea8b114" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_48112c9d-f389-4286-8214-efaaf82faf83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_48112c9d-f389-4286-8214-efaaf82faf83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_48112c9d-f389-4286-8214-efaaf82faf83" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_48112c9d-f389-4286-8214-efaaf82faf83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_618e4ab2-6c12-4f4f-a00c-42b9ed688d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_48112c9d-f389-4286-8214-efaaf82faf83" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_618e4ab2-6c12-4f4f-a00c-42b9ed688d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_3f94ad90-b3e3-4735-95ae-c8935bc3f663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_618e4ab2-6c12-4f4f-a00c-42b9ed688d7d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_3f94ad90-b3e3-4735-95ae-c8935bc3f663" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b0210a57-6157-4e0f-9eae-3468d8308bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_618e4ab2-6c12-4f4f-a00c-42b9ed688d7d" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b0210a57-6157-4e0f-9eae-3468d8308bdb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails" xlink:type="extended" id="i1ea39feb581c4813b488a0d4cfd6eb13_BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9507c6c1-c2b5-4595-85bd-51f14af647e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_477275a2-ccff-490a-a102-4fccc5cc3dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9507c6c1-c2b5-4595-85bd-51f14af647e8" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_477275a2-ccff-490a-a102-4fccc5cc3dc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList_49915c09-1f9d-4f8f-b935-abfb2238c087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9507c6c1-c2b5-4595-85bd-51f14af647e8" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList_49915c09-1f9d-4f8f-b935-abfb2238c087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f2bf4ee3-8a46-499f-908f-8941d1dbf85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9507c6c1-c2b5-4595-85bd-51f14af647e8" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f2bf4ee3-8a46-499f-908f-8941d1dbf85d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_79e6376e-51bc-4689-a286-a1989ce74b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f2bf4ee3-8a46-499f-908f-8941d1dbf85d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_79e6376e-51bc-4689-a286-a1989ce74b7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_79e6376e-51bc-4689-a286-a1989ce74b7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_79e6376e-51bc-4689-a286-a1989ce74b7d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_79e6376e-51bc-4689-a286-a1989ce74b7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_5e6b54bb-ac88-4212-ab84-40a2107e6e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_79e6376e-51bc-4689-a286-a1989ce74b7d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_5e6b54bb-ac88-4212-ab84-40a2107e6e8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_3cef33a9-8b01-4d36-90cd-98d4230b51e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_5e6b54bb-ac88-4212-ab84-40a2107e6e8b" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_3cef33a9-8b01-4d36-90cd-98d4230b51e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_34e777c0-6527-4de8-bc83-9ee815ca4e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_5e6b54bb-ac88-4212-ab84-40a2107e6e8b" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_34e777c0-6527-4de8-bc83-9ee815ca4e4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6976920c-7d0a-41f3-87a8-167119e6f9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f2bf4ee3-8a46-499f-908f-8941d1dbf85d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6976920c-7d0a-41f3-87a8-167119e6f9fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6976920c-7d0a-41f3-87a8-167119e6f9fb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6976920c-7d0a-41f3-87a8-167119e6f9fb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6976920c-7d0a-41f3-87a8-167119e6f9fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5fdf46f-a816-4092-bc56-3b7b42bc1b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6976920c-7d0a-41f3-87a8-167119e6f9fb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5fdf46f-a816-4092-bc56-3b7b42bc1b85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_7517a472-695d-41f3-a6e9-1d9f8fec6d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5fdf46f-a816-4092-bc56-3b7b42bc1b85" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_7517a472-695d-41f3-a6e9-1d9f8fec6d2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_177589d1-7483-4b99-b65f-467d111a7903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_7517a472-695d-41f3-a6e9-1d9f8fec6d2c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_177589d1-7483-4b99-b65f-467d111a7903" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_360f3ae4-b74d-400b-afc7-64b087021aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_7517a472-695d-41f3-a6e9-1d9f8fec6d2c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_360f3ae4-b74d-400b-afc7-64b087021aa0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_74594a75-8f9b-4def-b5bb-c21b6fef1f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5fdf46f-a816-4092-bc56-3b7b42bc1b85" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_74594a75-8f9b-4def-b5bb-c21b6fef1f82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_0ab86c3c-cd2a-450e-b849-8a0678618e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f2bf4ee3-8a46-499f-908f-8941d1dbf85d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_0ab86c3c-cd2a-450e-b849-8a0678618e1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_0ab86c3c-cd2a-450e-b849-8a0678618e1f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_0ab86c3c-cd2a-450e-b849-8a0678618e1f" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_0ab86c3c-cd2a-450e-b849-8a0678618e1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_0ab86c3c-cd2a-450e-b849-8a0678618e1f" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_a7a2ac2d-99fd-4bfe-9b86-7a4657eae1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_a7a2ac2d-99fd-4bfe-9b86-7a4657eae1af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_46c7063e-9065-4e76-b64e-3ea9596faaef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_MunicipalBondsMember_46c7063e-9065-4e76-b64e-3ea9596faaef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_237c3c32-bb8b-4c66-9f7a-663ec4dbf79c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_237c3c32-bb8b-4c66-9f7a-663ec4dbf79c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CorporateDebtSecurityAboveInvestmentGradeMember_1b64d03e-3431-4dfb-9be1-31e3cf2d60bd" xlink:href="mo-20221231.xsd#mo_CorporateDebtSecurityAboveInvestmentGradeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_mo_CorporateDebtSecurityAboveInvestmentGradeMember_1b64d03e-3431-4dfb-9be1-31e3cf2d60bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CorporateDebtSecurityBelowInvestmentGradeMember_5bc7d8ac-97a2-4bde-9f03-b40b64dfd890" xlink:href="mo-20221231.xsd#mo_CorporateDebtSecurityBelowInvestmentGradeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_mo_CorporateDebtSecurityBelowInvestmentGradeMember_5bc7d8ac-97a2-4bde-9f03-b40b64dfd890" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_2da44cae-3f7c-4e69-a2bb-34947036ca4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_2da44cae-3f7c-4e69-a2bb-34947036ca4b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_0dc655ea-44de-400d-bcf8-c908e49c4d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_0dc655ea-44de-400d-bcf8-c908e49c4d43" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_25a7dadd-35b0-45ab-84c7-32567bd15808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_25a7dadd-35b0-45ab-84c7-32567bd15808" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInvestmentNetMember_dba5c3e8-5cbb-4e32-9a3f-84fee26c689f" xlink:href="mo-20221231.xsd#mo_OtherInvestmentNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_mo_OtherInvestmentNetMember_dba5c3e8-5cbb-4e32-9a3f-84fee26c689f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USLargeCapMember_52c743f9-4104-4dee-92b7-cac808c97063" xlink:href="mo-20221231.xsd#mo_USLargeCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_mo_USLargeCapMember_52c743f9-4104-4dee-92b7-cac808c97063" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USSmallCapMember_bb85cfab-27e9-46ff-80f1-ed4c81be5033" xlink:href="mo-20221231.xsd#mo_USSmallCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_mo_USSmallCapMember_bb85cfab-27e9-46ff-80f1-ed4c81be5033" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InternationalDevelopedMarketsMember_dfddd828-a96f-469f-a810-4640bc69a93e" xlink:href="mo-20221231.xsd#mo_InternationalDevelopedMarketsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_mo_InternationalDevelopedMarketsMember_dfddd828-a96f-469f-a810-4640bc69a93e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_b4d038f7-45c1-47e1-b2d1-0b8162335d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_OtherInvestmentsMember_b4d038f7-45c1-47e1-b2d1-0b8162335d86" xlink:type="arc" order="12"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansEstimatedFutureBenefitPaymentsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails" xlink:type="extended" id="i23031f19309944e2abf48361fb01491d_BenefitPlansEstimatedFutureBenefitPaymentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_2083ce44-7017-40cb-ae87-a4a617bba53b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_2083ce44-7017-40cb-ae87-a4a617bba53b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_bde6d566-dc4d-4536-b242-0b6685d219a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_bde6d566-dc4d-4536-b242-0b6685d219a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_02e7b10a-4e0d-4fc6-9f64-a7349a727c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_02e7b10a-4e0d-4fc6-9f64-a7349a727c15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_859a2e5d-009a-49a3-baf6-b9fa0b71f207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_859a2e5d-009a-49a3-baf6-b9fa0b71f207" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_a90f62a7-d5b2-4dc7-a165-3f9b6dac64c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_a90f62a7-d5b2-4dc7-a165-3f9b6dac64c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_70af8d55-acc8-40c6-b09a-3737f7821aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_70af8d55-acc8-40c6-b09a-3737f7821aed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1399afa-f267-4554-854a-f67da1fe0ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1399afa-f267-4554-854a-f67da1fe0ab1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b2766f95-ae73-455e-b40a-775bc90f065e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1399afa-f267-4554-854a-f67da1fe0ab1" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b2766f95-ae73-455e-b40a-775bc90f065e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_b2766f95-ae73-455e-b40a-775bc90f065e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b2766f95-ae73-455e-b40a-775bc90f065e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_b2766f95-ae73-455e-b40a-775bc90f065e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3e7cb604-54b8-4add-8aad-ebc3d0384b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b2766f95-ae73-455e-b40a-775bc90f065e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3e7cb604-54b8-4add-8aad-ebc3d0384b44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_3cec9b12-8500-4cc7-a012-4cae9669fc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3e7cb604-54b8-4add-8aad-ebc3d0384b44" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_3cec9b12-8500-4cc7-a012-4cae9669fc0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_52574cb4-0bf6-4e08-bac1-bf18c30c44b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3e7cb604-54b8-4add-8aad-ebc3d0384b44" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_52574cb4-0bf6-4e08-bac1-bf18c30c44b9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended" id="iff54e3cebac24fe8af3ac6e70af473a1_BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0abe2c31-0136-4337-a0cc-1aa969fea2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_0bcd850d-d9ee-4605-929c-53b9af5ef107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0abe2c31-0136-4337-a0cc-1aa969fea2f4" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_0bcd850d-d9ee-4605-929c-53b9af5ef107" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_8cbf2ce0-782b-4376-a38c-a2eb4f60bbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0abe2c31-0136-4337-a0cc-1aa969fea2f4" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_8cbf2ce0-782b-4376-a38c-a2eb4f60bbe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax_30cb1639-ab89-4e24-b37f-96a4d453e68f" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0abe2c31-0136-4337-a0cc-1aa969fea2f4" xlink:to="loc_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax_30cb1639-ab89-4e24-b37f-96a4d453e68f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_efbc4209-13df-42e6-860c-499a2409c5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0abe2c31-0136-4337-a0cc-1aa969fea2f4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_efbc4209-13df-42e6-860c-499a2409c5c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_4f453dd4-20a4-4dee-92d4-024568e7ec5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0abe2c31-0136-4337-a0cc-1aa969fea2f4" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_4f453dd4-20a4-4dee-92d4-024568e7ec5b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_10878ed4-ad3e-4782-8f9c-0ecdb1a16a17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_4f453dd4-20a4-4dee-92d4-024568e7ec5b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_10878ed4-ad3e-4782-8f9c-0ecdb1a16a17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_10878ed4-ad3e-4782-8f9c-0ecdb1a16a17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_10878ed4-ad3e-4782-8f9c-0ecdb1a16a17" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_10878ed4-ad3e-4782-8f9c-0ecdb1a16a17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_21e61696-4455-4630-94cf-2bc70c486620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_10878ed4-ad3e-4782-8f9c-0ecdb1a16a17" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_21e61696-4455-4630-94cf-2bc70c486620" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_5774edbe-d25d-48b0-a853-8c82c8975324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_21e61696-4455-4630-94cf-2bc70c486620" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_5774edbe-d25d-48b0-a853-8c82c8975324" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_37d1c7fe-56e7-48d9-b9ec-15598085df11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_21e61696-4455-4630-94cf-2bc70c486620" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_37d1c7fe-56e7-48d9-b9ec-15598085df11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentRetirementBenefitsMember_f1d1c80b-03f6-43ea-ac23-7ca88a781196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_21e61696-4455-4630-94cf-2bc70c486620" xlink:to="loc_us-gaap_PostemploymentRetirementBenefitsMember_f1d1c80b-03f6-43ea-ac23-7ca88a781196" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails" xlink:type="extended" id="iff761dd7e60347f6b55acd7ef4b38721_BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortizationAbstract_4d27a5f3-17cf-40de-9cdc-8a0fcb2c9fac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortizationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_us-gaap_AdjustmentForAmortizationAbstract_4d27a5f3-17cf-40de-9cdc-8a0fcb2c9fac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_3d7ac0ee-250d-4b27-9248-c76745adc2da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentForAmortizationAbstract_4d27a5f3-17cf-40de-9cdc-8a0fcb2c9fac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_3d7ac0ee-250d-4b27-9248-c76745adc2da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_b5217280-af51-4b61-86a0-b85c053f0951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentForAmortizationAbstract_4d27a5f3-17cf-40de-9cdc-8a0fcb2c9fac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_b5217280-af51-4b61-86a0-b85c053f0951" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_16c7a7b7-ffd1-46c8-bed6-52d736ba23ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_16c7a7b7-ffd1-46c8-bed6-52d736ba23ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax_f841cce6-6236-4e1d-bfd6-e5f8d0261855" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_16c7a7b7-ffd1-46c8-bed6-52d736ba23ef" xlink:to="loc_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax_f841cce6-6236-4e1d-bfd6-e5f8d0261855" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax_ba9d943b-7b3e-4f63-9ebe-5d1707843d0e" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_16c7a7b7-ffd1-46c8-bed6-52d736ba23ef" xlink:to="loc_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax_ba9d943b-7b3e-4f63-9ebe-5d1707843d0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_e1975898-f7f9-4a75-b649-8ae62970d4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_e1975898-f7f9-4a75-b649-8ae62970d4d9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_68c00004-d975-4247-b512-d83a83e264b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_68c00004-d975-4247-b512-d83a83e264b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherMovementsDuringtheYearAbstract_b0058ba3-dee9-4334-9c02-ace700e5aa63" xlink:href="mo-20221231.xsd#mo_OtherMovementsDuringtheYearAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_mo_OtherMovementsDuringtheYearAbstract_b0058ba3-dee9-4334-9c02-ace700e5aa63" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_ed615a9a-820c-4bd3-990f-66d6c59f6f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_OtherMovementsDuringtheYearAbstract_b0058ba3-dee9-4334-9c02-ace700e5aa63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_ed615a9a-820c-4bd3-990f-66d6c59f6f93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_2835e504-01c3-4b76-bc84-03a43e68e5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_OtherMovementsDuringtheYearAbstract_b0058ba3-dee9-4334-9c02-ace700e5aa63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_2835e504-01c3-4b76-bc84-03a43e68e5a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax_4eb58ad3-9e0f-4c40-a87c-7ff69fad744b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_OtherMovementsDuringtheYearAbstract_b0058ba3-dee9-4334-9c02-ace700e5aa63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax_4eb58ad3-9e0f-4c40-a87c-7ff69fad744b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_ee26bad8-852a-450f-b593-cdf228a8f009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_OtherMovementsDuringtheYearAbstract_b0058ba3-dee9-4334-9c02-ace700e5aa63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_ee26bad8-852a-450f-b593-cdf228a8f009" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment_f6c6784a-42c1-437e-8311-708ebd87a719" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment_f6c6784a-42c1-437e-8311-708ebd87a719" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_34124d43-d339-4f1e-9f06-75f03b4005f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_34124d43-d339-4f1e-9f06-75f03b4005f1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c895c6a8-0958-4779-8748-feac2e5c7865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_34124d43-d339-4f1e-9f06-75f03b4005f1" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c895c6a8-0958-4779-8748-feac2e5c7865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_c895c6a8-0958-4779-8748-feac2e5c7865_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c895c6a8-0958-4779-8748-feac2e5c7865" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_c895c6a8-0958-4779-8748-feac2e5c7865_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_59999165-9b23-4619-bd6b-8321983d8cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c895c6a8-0958-4779-8748-feac2e5c7865" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_59999165-9b23-4619-bd6b-8321983d8cdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_48dc375b-552d-4af1-a6ff-ac9557ca443c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_59999165-9b23-4619-bd6b-8321983d8cdd" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_48dc375b-552d-4af1-a6ff-ac9557ca443c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_943ce9ed-901c-47f9-a369-fb1d8942302b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_59999165-9b23-4619-bd6b-8321983d8cdd" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_943ce9ed-901c-47f9-a369-fb1d8942302b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentRetirementBenefitsMember_e27a26b3-5e10-4154-8356-367cddfba95f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentRetirementBenefitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_59999165-9b23-4619-bd6b-8321983d8cdd" xlink:to="loc_us-gaap_PostemploymentRetirementBenefitsMember_e27a26b3-5e10-4154-8356-367cddfba95f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#AdditionalInformationScheduleofValuationandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails" xlink:type="extended" id="if44c01cfd998469cb772f259c998e4dd_AdditionalInformationScheduleofValuationandQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b1734022-498b-42d6-90fb-325aa3bc4b29" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_163b46ec-fb54-4446-b22e-d3ee07a5a02e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b1734022-498b-42d6-90fb-325aa3bc4b29" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_163b46ec-fb54-4446-b22e-d3ee07a5a02e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_f5b19c64-a837-4d95-b721-653316c53b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_163b46ec-fb54-4446-b22e-d3ee07a5a02e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_f5b19c64-a837-4d95-b721-653316c53b3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_44436fb5-32e7-4342-ac6e-cabd75d1e7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_163b46ec-fb54-4446-b22e-d3ee07a5a02e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_44436fb5-32e7-4342-ac6e-cabd75d1e7b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_02185e7d-824b-4b7c-8fa2-386f056c3bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_163b46ec-fb54-4446-b22e-d3ee07a5a02e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_02185e7d-824b-4b7c-8fa2-386f056c3bfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_c2863665-e135-4743-8e99-f1a854659c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_a66a3615-f3d8-4188-9f14-1bf2c40f5a4a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b1734022-498b-42d6-90fb-325aa3bc4b29" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_a66a3615-f3d8-4188-9f14-1bf2c40f5a4a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6d161bf9-d551-4d51-838b-3dab5543ad32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_a66a3615-f3d8-4188-9f14-1bf2c40f5a4a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6d161bf9-d551-4d51-838b-3dab5543ad32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_6d161bf9-d551-4d51-838b-3dab5543ad32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6d161bf9-d551-4d51-838b-3dab5543ad32" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_6d161bf9-d551-4d51-838b-3dab5543ad32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_fc770eea-456c-419e-bc79-086c3f1786e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6d161bf9-d551-4d51-838b-3dab5543ad32" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_fc770eea-456c-419e-bc79-086c3f1786e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AllowanceDiscountsMember_bb39a6b4-d948-441f-821f-a766f1826b7d" xlink:href="mo-20221231.xsd#mo_AllowanceDiscountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_fc770eea-456c-419e-bc79-086c3f1786e6" xlink:to="loc_mo_AllowanceDiscountsMember_bb39a6b4-d948-441f-821f-a766f1826b7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AllowanceReturnedGoodsMember_e9fcea52-5e45-4a59-b766-cdc8dcd539e9" xlink:href="mo-20221231.xsd#mo_AllowanceReturnedGoodsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_fc770eea-456c-419e-bc79-086c3f1786e6" xlink:to="loc_mo_AllowanceReturnedGoodsMember_e9fcea52-5e45-4a59-b766-cdc8dcd539e9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="extended" id="i12827dea52cb41bf9771d62710315d70_ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f57f306f-f220-4fdc-9037-51aa49349515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward_9bf61361-8c20-486b-874e-3e78e2f93cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f57f306f-f220-4fdc-9037-51aa49349515" xlink:to="loc_us-gaap_LossContingencyAccrualRollForward_9bf61361-8c20-486b-874e-3e78e2f93cb1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_27118c6d-b9ab-4b11-8d0a-679c12e4bed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_9bf61361-8c20-486b-874e-3e78e2f93cb1" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_27118c6d-b9ab-4b11-8d0a-679c12e4bed8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_00515b0b-3ab1-4dd4-8afd-b15d66794f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_9bf61361-8c20-486b-874e-3e78e2f93cb1" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_00515b0b-3ab1-4dd4-8afd-b15d66794f8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_f3c6b282-a138-485a-81dc-7ea47092032b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_9bf61361-8c20-486b-874e-3e78e2f93cb1" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_f3c6b282-a138-485a-81dc-7ea47092032b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7f2f3a86-5e82-4ff3-9adb-21337b648c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_0dc22830-ce73-40e1-9975-3e19b88ebc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f57f306f-f220-4fdc-9037-51aa49349515" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_0dc22830-ce73-40e1-9975-3e19b88ebc9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_436b4ec1-dd75-49f8-a4a4-3a670eca6716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f57f306f-f220-4fdc-9037-51aa49349515" xlink:to="loc_us-gaap_LitigationSettlementInterest_436b4ec1-dd75-49f8-a4a4-3a670eca6716" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationEscrowDeposit_d6a5d541-3b72-4d96-97f4-31d4284aca08" xlink:href="mo-20221231.xsd#mo_LitigationEscrowDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f57f306f-f220-4fdc-9037-51aa49349515" xlink:to="loc_mo_LitigationEscrowDeposit_d6a5d541-3b72-4d96-97f4-31d4284aca08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_f57f306f-f220-4fdc-9037-51aa49349515" xlink:to="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5eb471a5-f52f-43ec-909b-aa384f1dc107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5eb471a5-f52f-43ec-909b-aa384f1dc107" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_5eb471a5-f52f-43ec-909b-aa384f1dc107_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5eb471a5-f52f-43ec-909b-aa384f1dc107" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_5eb471a5-f52f-43ec-909b-aa384f1dc107_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0824aaa1-fef7-4468-be60-d10e757442a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5eb471a5-f52f-43ec-909b-aa384f1dc107" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0824aaa1-fef7-4468-be60-d10e757442a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_82f4a485-75ff-4866-8d0b-20f36ae02ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0824aaa1-fef7-4468-be60-d10e757442a0" xlink:to="loc_us-gaap_AssetsMember_82f4a485-75ff-4866-8d0b-20f36ae02ac5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_c969d307-886a-48f8-b814-c828d40211f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:to="loc_us-gaap_LitigationStatusAxis_c969d307-886a-48f8-b814-c828d40211f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c969d307-886a-48f8-b814-c828d40211f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_c969d307-886a-48f8-b814-c828d40211f0" xlink:to="loc_us-gaap_LitigationStatusDomain_c969d307-886a-48f8-b814-c828d40211f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_4dbfe1c6-535e-4386-bc45-8d680d17abd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_c969d307-886a-48f8-b814-c828d40211f0" xlink:to="loc_us-gaap_LitigationStatusDomain_4dbfe1c6-535e-4386-bc45-8d680d17abd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_3c38ea1a-b36b-4895-941a-ad30225cb902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_4dbfe1c6-535e-4386-bc45-8d680d17abd7" xlink:to="loc_us-gaap_PendingLitigationMember_3c38ea1a-b36b-4895-941a-ad30225cb902" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c2548381-2a1d-4a4a-938a-25bffbcc6290" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:to="loc_dei_LegalEntityAxis_c2548381-2a1d-4a4a-938a-25bffbcc6290" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c2548381-2a1d-4a4a-938a-25bffbcc6290_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c2548381-2a1d-4a4a-938a-25bffbcc6290" xlink:to="loc_dei_EntityDomain_c2548381-2a1d-4a4a-938a-25bffbcc6290_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e1f4a644-e301-43c5-8075-8d77ad229589" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c2548381-2a1d-4a4a-938a-25bffbcc6290" xlink:to="loc_dei_EntityDomain_e1f4a644-e301-43c5-8075-8d77ad229589" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_fbbd4f0d-8730-4085-9f8e-1d62b5365c6b" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e1f4a644-e301-43c5-8075-8d77ad229589" xlink:to="loc_mo_PhilipMorrisUSAMember_fbbd4f0d-8730-4085-9f8e-1d62b5365c6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b49f68a0-4d8c-42b3-a339-293ccee17114" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:to="loc_srt_LitigationCaseAxis_b49f68a0-4d8c-42b3-a339-293ccee17114" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b49f68a0-4d8c-42b3-a339-293ccee17114_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_b49f68a0-4d8c-42b3-a339-293ccee17114" xlink:to="loc_srt_LitigationCaseTypeDomain_b49f68a0-4d8c-42b3-a339-293ccee17114_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_df80ea75-fc3b-4b7b-a716-b88bc9367bc7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_b49f68a0-4d8c-42b3-a339-293ccee17114" xlink:to="loc_srt_LitigationCaseTypeDomain_df80ea75-fc3b-4b7b-a716-b88bc9367bc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember_9bde81fb-29bc-496c-ae0c-0fb885d37a14" xlink:href="mo-20221231.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_df80ea75-fc3b-4b7b-a716-b88bc9367bc7" xlink:to="loc_mo_TobaccoandHealthJudgmentMember_9bde81fb-29bc-496c-ae0c-0fb885d37a14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_bbba0f99-7ad5-4cd6-940c-8ec4cb7e3cd1" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_df80ea75-fc3b-4b7b-a716-b88bc9367bc7" xlink:to="loc_mo_EngleProgenyCasesMember_bbba0f99-7ad5-4cd6-940c-8ec4cb7e3cd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1975d540-146d-4ebc-96c4-42a0506754af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1975d540-146d-4ebc-96c4-42a0506754af" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_1975d540-146d-4ebc-96c4-42a0506754af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1975d540-146d-4ebc-96c4-42a0506754af" xlink:to="loc_us-gaap_LossContingencyNatureDomain_1975d540-146d-4ebc-96c4-42a0506754af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_45dbdfd9-e059-4c04-ad99-7eaa3100e018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1975d540-146d-4ebc-96c4-42a0506754af" xlink:to="loc_us-gaap_LossContingencyNatureDomain_45dbdfd9-e059-4c04-ad99-7eaa3100e018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember_9a3bb495-13c1-4cb6-8627-55e0fcc7a496" xlink:href="mo-20221231.xsd#mo_LitigationCasesResultsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_45dbdfd9-e059-4c04-ad99-7eaa3100e018" xlink:to="loc_mo_LitigationCasesResultsMember_9a3bb495-13c1-4cb6-8627-55e0fcc7a496" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AgreementToResolveShareholderClassActionMember_1cbd5662-ba01-4576-a9b3-e32e2ab15367" xlink:href="mo-20221231.xsd#mo_AgreementToResolveShareholderClassActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_45dbdfd9-e059-4c04-ad99-7eaa3100e018" xlink:to="loc_mo_AgreementToResolveShareholderClassActionMember_1cbd5662-ba01-4576-a9b3-e32e2ab15367" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestExpenseRelatedToLitigationMember_f0d97a48-8eab-44fd-8830-b815c420fb42" xlink:href="mo-20221231.xsd#mo_InterestExpenseRelatedToLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_45dbdfd9-e059-4c04-ad99-7eaa3100e018" xlink:to="loc_mo_InterestExpenseRelatedToLitigationMember_f0d97a48-8eab-44fd-8830-b815c420fb42" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesScheduleofPendingCasesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="extended" id="i74813d11754b424997cd27e9f89d92bf_ContingenciesScheduleofPendingCasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_babb77e6-3443-4c14-a7cd-67dc799842f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_babb77e6-3443-4c14-a7cd-67dc799842f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCases_4863dced-25db-4bef-98eb-2f24864247a6" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_mo_LossContingencyNumberOfCases_4863dced-25db-4bef-98eb-2f24864247a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_bbb1e71c-11ff-40ce-a9b6-884eb96adc98" xlink:href="mo-20221231.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_mo_LossContingencyClassActionLawsuit_bbb1e71c-11ff-40ce-a9b6-884eb96adc98" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_5da8a2e5-6ba8-4e8f-90c6-cdebcc0b2a89" xlink:href="mo-20221231.xsd#mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_5da8a2e5-6ba8-4e8f-90c6-cdebcc0b2a89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveCases_529fb9c4-93dc-48dd-8ae9-f2e4e30df4af" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfInactiveCases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_mo_LossContingencyNumberOfInactiveCases_529fb9c4-93dc-48dd-8ae9-f2e4e30df4af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_73b25ebb-4270-4e9c-88f4-1dbd467c5282" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfInactiveClassActionLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_73b25ebb-4270-4e9c-88f4-1dbd467c5282" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_df87b3a1-32c3-4fc7-a860-a7af81740ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_us-gaap_LossContingenciesTable_df87b3a1-32c3-4fc7-a860-a7af81740ddc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b61cbc4c-f5b6-493c-aa43-5094ea129ba9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_df87b3a1-32c3-4fc7-a860-a7af81740ddc" xlink:to="loc_srt_LitigationCaseAxis_b61cbc4c-f5b6-493c-aa43-5094ea129ba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b61cbc4c-f5b6-493c-aa43-5094ea129ba9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_b61cbc4c-f5b6-493c-aa43-5094ea129ba9" xlink:to="loc_srt_LitigationCaseTypeDomain_b61cbc4c-f5b6-493c-aa43-5094ea129ba9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_35b3aa9d-e432-44f7-ab75-9279d5026ba8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_b61cbc4c-f5b6-493c-aa43-5094ea129ba9" xlink:to="loc_srt_LitigationCaseTypeDomain_35b3aa9d-e432-44f7-ab75-9279d5026ba8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_e9a4cbd9-c622-4cb1-b29d-a5e51472ff39" xlink:href="mo-20221231.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_35b3aa9d-e432-44f7-ab75-9279d5026ba8" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_e9a4cbd9-c622-4cb1-b29d-a5e51472ff39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_caf1ed01-2e45-47c5-b283-c0b31dca4ca7" xlink:href="mo-20221231.xsd#mo_ETSSmokingandHealthCaseFlightAttendantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_IndividualSmokingAndHealthCasesMember_e9a4cbd9-c622-4cb1-b29d-a5e51472ff39" xlink:to="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_caf1ed01-2e45-47c5-b283-c0b31dca4ca7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_450fa620-345a-4f7e-b2b3-4ea31ff52a5b" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_35b3aa9d-e432-44f7-ab75-9279d5026ba8" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_450fa620-345a-4f7e-b2b3-4ea31ff52a5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_3e909ba0-e1ce-44e1-99cd-a58994cc8bab" xlink:href="mo-20221231.xsd#mo_EvaporLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_35b3aa9d-e432-44f7-ab75-9279d5026ba8" xlink:to="loc_mo_EvaporLitigationMember_3e909ba0-e1ce-44e1-99cd-a58994cc8bab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherTabaccoRelatedCasesMember_9a27997a-fc02-47b3-aa9e-312e7bbaeeba" xlink:href="mo-20221231.xsd#mo_OtherTabaccoRelatedCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_35b3aa9d-e432-44f7-ab75-9279d5026ba8" xlink:to="loc_mo_OtherTabaccoRelatedCasesMember_9a27997a-fc02-47b3-aa9e-312e7bbaeeba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_4dbdcafb-5bdf-4637-af4c-706242cfde97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_df87b3a1-32c3-4fc7-a860-a7af81740ddc" xlink:to="loc_us-gaap_LitigationStatusAxis_4dbdcafb-5bdf-4637-af4c-706242cfde97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_4dbdcafb-5bdf-4637-af4c-706242cfde97_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_4dbdcafb-5bdf-4637-af4c-706242cfde97" xlink:to="loc_us-gaap_LitigationStatusDomain_4dbdcafb-5bdf-4637-af4c-706242cfde97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_550460c8-b432-4486-8c5d-b193044d16e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_4dbdcafb-5bdf-4637-af4c-706242cfde97" xlink:to="loc_us-gaap_LitigationStatusDomain_550460c8-b432-4486-8c5d-b193044d16e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_f481323d-99ec-480d-87fa-ad4830117ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_550460c8-b432-4486-8c5d-b193044d16e8" xlink:to="loc_us-gaap_PendingLitigationMember_f481323d-99ec-480d-87fa-ad4830117ce8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_21120597-34f0-475f-9715-3d54e95eac7e" xlink:href="mo-20221231.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_550460c8-b432-4486-8c5d-b193044d16e8" xlink:to="loc_mo_PendingIndividualLawsuitsMember_21120597-34f0-475f-9715-3d54e95eac7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_131e6457-9db6-4913-9d85-4439194ff968" xlink:href="mo-20221231.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_550460c8-b432-4486-8c5d-b193044d16e8" xlink:to="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_131e6457-9db6-4913-9d85-4439194ff968" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember_c9dda1a2-0751-4ca0-a5dc-ebef216e5730" xlink:href="mo-20221231.xsd#mo_ClassActionLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_550460c8-b432-4486-8c5d-b193044d16e8" xlink:to="loc_mo_ClassActionLawsuitMember_c9dda1a2-0751-4ca0-a5dc-ebef216e5730" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8f3057b2-955b-4dad-bd12-4285ec04621d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_df87b3a1-32c3-4fc7-a860-a7af81740ddc" xlink:to="loc_srt_StatementGeographicalAxis_8f3057b2-955b-4dad-bd12-4285ec04621d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8f3057b2-955b-4dad-bd12-4285ec04621d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_8f3057b2-955b-4dad-bd12-4285ec04621d" xlink:to="loc_srt_SegmentGeographicalDomain_8f3057b2-955b-4dad-bd12-4285ec04621d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f6c18618-4c27-4a76-b1ad-8a16d7803341" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_8f3057b2-955b-4dad-bd12-4285ec04621d" xlink:to="loc_srt_SegmentGeographicalDomain_f6c18618-4c27-4a76-b1ad-8a16d7803341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_8efc3a0f-18c5-4515-8e70-ae0c2805c177" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f6c18618-4c27-4a76-b1ad-8a16d7803341" xlink:to="loc_stpr_IL_8efc3a0f-18c5-4515-8e70-ae0c2805c177" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM_a2d4795e-8eac-4d09-8387-b43d22a8ee87" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f6c18618-4c27-4a76-b1ad-8a16d7803341" xlink:to="loc_stpr_NM_a2d4795e-8eac-4d09-8387-b43d22a8ee87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_da57451a-6d96-488f-8596-91d31e8c5e91" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f6c18618-4c27-4a76-b1ad-8a16d7803341" xlink:to="loc_stpr_MA_da57451a-6d96-488f-8596-91d31e8c5e91" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_810f5a98-cd8a-41c4-a673-d2f2a974d8b5" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_f6c18618-4c27-4a76-b1ad-8a16d7803341" xlink:to="loc_stpr_FL_810f5a98-cd8a-41c4-a673-d2f2a974d8b5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails" xlink:type="extended" id="ie5ae17a373f04a2182475ca10d0fc75c_ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_4c4fd738-808e-4870-894e-d7fc81765d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_4c4fd738-808e-4870-894e-d7fc81765d3e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial_673d18ca-a80a-4921-be8d-5ab39386bdf6" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_mo_LossContingencyNumberofCasesSetforTrial_673d18ca-a80a-4921-be8d-5ab39386bdf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_32b67579-3154-46cb-af96-8a8d79f1d1e7" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecided"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_mo_LossContingencyClaimsDecided_32b67579-3154-46cb-af96-8a8d79f1d1e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_961431ce-2799-4405-a872-7e1583ae8c67" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_961431ce-2799-4405-a872-7e1583ae8c67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_eda13688-9335-466a-b837-a739445b05f0" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_eda13688-9335-466a-b837-a739445b05f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsResolvedNumber_8eedc4c4-64ac-4797-8ac3-0c3053780b5f" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsResolvedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_mo_LossContingencyClaimsResolvedNumber_8eedc4c4-64ac-4797-8ac3-0c3053780b5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_aa6e66ed-c004-4dfb-9351-9ad70195dfa3" xlink:href="mo-20221231.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_aa6e66ed-c004-4dfb-9351-9ad70195dfa3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0e540425-82a5-4c56-9fcf-b62d8e05b7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0e540425-82a5-4c56-9fcf-b62d8e05b7e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0e540425-82a5-4c56-9fcf-b62d8e05b7e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0e540425-82a5-4c56-9fcf-b62d8e05b7e1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0e540425-82a5-4c56-9fcf-b62d8e05b7e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bbf7e4cb-4310-48d2-9a20-9e7951c5af07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0e540425-82a5-4c56-9fcf-b62d8e05b7e1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bbf7e4cb-4310-48d2-9a20-9e7951c5af07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2f0045b1-9897-4ba7-97c5-29b7270aa280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bbf7e4cb-4310-48d2-9a20-9e7951c5af07" xlink:to="loc_us-gaap_SubsequentEventMember_2f0045b1-9897-4ba7-97c5-29b7270aa280" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_91afe7f8-4852-46e8-abb6-840c5c67672b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:to="loc_dei_LegalEntityAxis_91afe7f8-4852-46e8-abb6-840c5c67672b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_91afe7f8-4852-46e8-abb6-840c5c67672b_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_91afe7f8-4852-46e8-abb6-840c5c67672b" xlink:to="loc_dei_EntityDomain_91afe7f8-4852-46e8-abb6-840c5c67672b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fb38c798-ee87-4004-b15a-b6fb5fe2520f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_91afe7f8-4852-46e8-abb6-840c5c67672b" xlink:to="loc_dei_EntityDomain_fb38c798-ee87-4004-b15a-b6fb5fe2520f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_66be166c-283f-49dd-b7ac-f0c55b8e856a" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_fb38c798-ee87-4004-b15a-b6fb5fe2520f" xlink:to="loc_mo_PhilipMorrisUSAMember_66be166c-283f-49dd-b7ac-f0c55b8e856a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_fd4cee69-3c79-4755-a096-72c7a90c57a4" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_fb38c798-ee87-4004-b15a-b6fb5fe2520f" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_fd4cee69-3c79-4755-a096-72c7a90c57a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_5d9933a2-a731-47c0-8d06-6ebd58c1fd66" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:to="loc_srt_LitigationCaseAxis_5d9933a2-a731-47c0-8d06-6ebd58c1fd66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_5d9933a2-a731-47c0-8d06-6ebd58c1fd66_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_5d9933a2-a731-47c0-8d06-6ebd58c1fd66" xlink:to="loc_srt_LitigationCaseTypeDomain_5d9933a2-a731-47c0-8d06-6ebd58c1fd66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_5d9933a2-a731-47c0-8d06-6ebd58c1fd66" xlink:to="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_235ae934-f56c-4921-930e-c4accba2626b" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_235ae934-f56c-4921-930e-c4accba2626b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_d764c108-81f4-426d-82f7-d09774a9ea36" xlink:href="mo-20221231.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:to="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_d764c108-81f4-426d-82f7-d09774a9ea36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_eb88661c-f963-4f39-9dc9-005aa9730618" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:to="loc_mo_EngleProgenyCasesMember_eb88661c-f963-4f39-9dc9-005aa9730618" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenyCasesMember_7e3f4a9f-8f53-41a7-8672-62de5a79dcd7" xlink:href="mo-20221231.xsd#mo_NonEngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:to="loc_mo_NonEngleProgenyCasesMember_7e3f4a9f-8f53-41a7-8672-62de5a79dcd7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_3e7496b9-d980-48ed-9a61-d82115e5bf40" xlink:href="mo-20221231.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_3e7496b9-d980-48ed-9a61-d82115e5bf40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_b7e61d2b-b560-492d-8562-b6e747621278" xlink:href="mo-20221231.xsd#mo_EvaporLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:to="loc_mo_EvaporLitigationMember_b7e61d2b-b560-492d-8562-b6e747621278" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6d524174-667e-422b-9dba-d89c310c5ab3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:to="loc_srt_StatementGeographicalAxis_6d524174-667e-422b-9dba-d89c310c5ab3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6d524174-667e-422b-9dba-d89c310c5ab3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6d524174-667e-422b-9dba-d89c310c5ab3" xlink:to="loc_srt_SegmentGeographicalDomain_6d524174-667e-422b-9dba-d89c310c5ab3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6d524174-667e-422b-9dba-d89c310c5ab3" xlink:to="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_1a531bdb-ea70-4411-9bc6-0d7c3d1b2a26" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_country_CA_1a531bdb-ea70-4411-9bc6-0d7c3d1b2a26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AK_6ac955cc-e9cc-4379-aaf2-b0ed7507977f" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_AK_6ac955cc-e9cc-4379-aaf2-b0ed7507977f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_b70cc7b4-e018-4d94-be70-100a719b8ac0" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_CA_b70cc7b4-e018-4d94-be70-100a719b8ac0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT_be578583-2d33-4649-b2b5-d010602ad227" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_CT_be578583-2d33-4649-b2b5-d010602ad227" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_40d3772c-84ff-4bba-a699-7596f84af380" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_FL_40d3772c-84ff-4bba-a699-7596f84af380" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_7386d7db-d2c4-4283-9fb9-e7f1ab5c2cd6" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_LA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_LA_7386d7db-d2c4-4283-9fb9-e7f1ab5c2cd6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_cf016285-bb63-4932-ae34-127be6cb8ff7" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_MA_cf016285-bb63-4932-ae34-127be6cb8ff7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MS_09c91044-421f-4021-a32e-381eb0290da7" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_MS_09c91044-421f-4021-a32e-381eb0290da7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MO_624e404f-738a-4528-ab45-bab1b3a5e75f" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_MO_624e404f-738a-4528-ab45-bab1b3a5e75f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NH_5a71072d-d7aa-481b-8905-a5f2ffde4961" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_NH_5a71072d-d7aa-481b-8905-a5f2ffde4961" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_3f72637b-e929-4252-9f0a-968b3827ee87" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NJ"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_NJ_3f72637b-e929-4252-9f0a-968b3827ee87" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_f80bc29a-83b6-4be0-bf99-6f9227ce9bed" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_NY_f80bc29a-83b6-4be0-bf99-6f9227ce9bed" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_3c5d4e2e-96b5-480a-8c3a-cfe593167f5e" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_OH_3c5d4e2e-96b5-480a-8c3a-cfe593167f5e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_c52f9f71-9705-4748-9a81-7b9d74ca895a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_PA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_PA_c52f9f71-9705-4748-9a81-7b9d74ca895a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_RI_d8e6a72f-f409-48b6-97fe-f34a77ae7fa6" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_RI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_RI_d8e6a72f-f409-48b6-97fe-f34a77ae7fa6" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN_7a01fed1-a0bd-4d0a-9c70-c14228417d8d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_TN_7a01fed1-a0bd-4d0a-9c70-c14228417d8d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV_519909b7-51d1-49dd-8c29-eea1bc2eff73" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WV"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_WV_519909b7-51d1-49dd-8c29-eea1bc2eff73" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesNonEngleProgenyLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="extended" id="i54c436885d0847049190db90727ffa99_ContingenciesNonEngleProgenyLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_cf9bae42-37d8-40ba-ae14-a26d0c5fb436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_0f1a6579-ff0e-4fc7-b45d-98820cf4ffa1" xlink:href="mo-20221231.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf9bae42-37d8-40ba-ae14-a26d0c5fb436" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_0f1a6579-ff0e-4fc7-b45d-98820cf4ffa1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyFaultAllocationPercentage_1b9c7686-f883-48d5-b63c-67c4beea7a5d" xlink:href="mo-20221231.xsd#mo_LossContingencyFaultAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf9bae42-37d8-40ba-ae14-a26d0c5fb436" xlink:to="loc_mo_LossContingencyFaultAllocationPercentage_1b9c7686-f883-48d5-b63c-67c4beea7a5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_b309b4bf-cbfe-4594-b01e-78d63b336053" xlink:href="mo-20221231.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf9bae42-37d8-40ba-ae14-a26d0c5fb436" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_b309b4bf-cbfe-4594-b01e-78d63b336053" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_cbe769b8-c100-4e4d-ba1c-c449e0e343fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf9bae42-37d8-40ba-ae14-a26d0c5fb436" xlink:to="loc_us-gaap_LossContingenciesTable_cbe769b8-c100-4e4d-ba1c-c449e0e343fb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_069ecfa4-2eb2-4232-806a-d52e5f9901a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_cbe769b8-c100-4e4d-ba1c-c449e0e343fb" xlink:to="loc_srt_LitigationCaseAxis_069ecfa4-2eb2-4232-806a-d52e5f9901a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_069ecfa4-2eb2-4232-806a-d52e5f9901a0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_069ecfa4-2eb2-4232-806a-d52e5f9901a0" xlink:to="loc_srt_LitigationCaseTypeDomain_069ecfa4-2eb2-4232-806a-d52e5f9901a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ba2196d0-5984-4e5a-9aad-51fec78fd7ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_069ecfa4-2eb2-4232-806a-d52e5f9901a0" xlink:to="loc_srt_LitigationCaseTypeDomain_ba2196d0-5984-4e5a-9aad-51fec78fd7ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCaseMendezMember_baea5a89-7bf4-4373-b2df-9752635aa202" xlink:href="mo-20221231.xsd#mo_NonEngleProgenySmokingAndHealthCaseMendezMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ba2196d0-5984-4e5a-9aad-51fec78fd7ea" xlink:to="loc_mo_NonEngleProgenySmokingAndHealthCaseMendezMember_baea5a89-7bf4-4373-b2df-9752635aa202" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember_aace1515-0486-4782-9243-5709c96c5e1b" xlink:href="mo-20221231.xsd#mo_NonEngleProgenySmokingAndHealthCaseFontaineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ba2196d0-5984-4e5a-9aad-51fec78fd7ea" xlink:to="loc_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember_aace1515-0486-4782-9243-5709c96c5e1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_f832589a-db8c-4a1d-aefd-93cacaccd134" xlink:href="mo-20221231.xsd#mo_NonEngleProgenySmokingAndHealthCasePrincipeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ba2196d0-5984-4e5a-9aad-51fec78fd7ea" xlink:to="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_f832589a-db8c-4a1d-aefd-93cacaccd134" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_3fcf22ce-6e8d-41c0-ae0d-d9af4195bd5a" xlink:href="mo-20221231.xsd#mo_NonEngleProgenySmokingandHealthCaseGreeneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_ba2196d0-5984-4e5a-9aad-51fec78fd7ea" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_3fcf22ce-6e8d-41c0-ae0d-d9af4195bd5a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_310b4f97-c41c-415f-b321-8623b168a658" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_cbe769b8-c100-4e4d-ba1c-c449e0e343fb" xlink:to="loc_dei_LegalEntityAxis_310b4f97-c41c-415f-b321-8623b168a658" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_310b4f97-c41c-415f-b321-8623b168a658_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_310b4f97-c41c-415f-b321-8623b168a658" xlink:to="loc_dei_EntityDomain_310b4f97-c41c-415f-b321-8623b168a658_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_402d4c18-ab97-4b78-9f65-574a07613e8b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_310b4f97-c41c-415f-b321-8623b168a658" xlink:to="loc_dei_EntityDomain_402d4c18-ab97-4b78-9f65-574a07613e8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_7065baeb-9ddb-4ac6-b8b6-f0b76d5c62dd" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_402d4c18-ab97-4b78-9f65-574a07613e8b" xlink:to="loc_mo_PhilipMorrisUSAMember_7065baeb-9ddb-4ac6-b8b6-f0b76d5c62dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember_682558b2-b184-4e44-a429-eeb8e97b2169" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_402d4c18-ab97-4b78-9f65-574a07613e8b" xlink:to="loc_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember_682558b2-b184-4e44-a429-eeb8e97b2169" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="extended" id="iccccdd0b1cf949f2a0ba64a131576410_ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_6e386c86-03e0-4de6-adbe-b8f26f8edad6" xlink:href="mo-20221231.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_6e386c86-03e0-4de6-adbe-b8f26f8edad6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_7a5e5a2b-bf28-4eee-9e14-8a7ed29e7fd8" xlink:href="mo-20221231.xsd#mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_7a5e5a2b-bf28-4eee-9e14-8a7ed29e7fd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_ef1ff641-d5db-4bbd-b66f-c3fe7c972ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_ef1ff641-d5db-4bbd-b66f-c3fe7c972ef9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_4aff6ad4-017b-4fa5-a50f-c9d216573bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_4aff6ad4-017b-4fa5-a50f-c9d216573bfb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_eab3bb4c-b70c-4016-b936-2b0c0d9e2d9f" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecided"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyClaimsDecided_eab3bb4c-b70c-4016-b936-2b0c0d9e2d9f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_e18d87e2-cd62-4d2b-9477-94daf751d3c0" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_e18d87e2-cd62-4d2b-9477-94daf751d3c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_21371bee-c03d-4b94-9fee-3d37dceb8e82" xlink:href="mo-20221231.xsd#mo_LossContingencyUnfavorableVerdictsPendingReversed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_21371bee-c03d-4b94-9fee-3d37dceb8e82" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_fbf7a975-edcd-4308-8880-d0232a2e7a54" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_fbf7a975-edcd-4308-8880-d0232a2e7a54" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_d5683082-da8c-420a-bdad-287f273b8906" xlink:href="mo-20221231.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_d5683082-da8c-420a-bdad-287f273b8906" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdicts_fc776dc9-9e3b-4913-b4a5-b9a81d539023" xlink:href="mo-20221231.xsd#mo_LossContingencyZeroDamagesVerdicts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyZeroDamagesVerdicts_fc776dc9-9e3b-4913-b4a5-b9a81d539023" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_4fe8072a-91a7-4b4f-8340-c84d6719726b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_4fe8072a-91a7-4b4f-8340-c84d6719726b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdictModified_314e1513-a17e-49bb-8754-fae80c14844c" xlink:href="mo-20221231.xsd#mo_LossContingencyZeroDamagesVerdictModified"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyZeroDamagesVerdictModified_314e1513-a17e-49bb-8754-fae80c14844c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_f774229b-6452-44fd-a3e9-36852bda0757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_f774229b-6452-44fd-a3e9-36852bda0757" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_41885660-f382-42c0-a282-7791df4a3695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_us-gaap_LossContingenciesTable_41885660-f382-42c0-a282-7791df4a3695" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c506bfc9-7d50-478c-b1cd-d1762e842ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_41885660-f382-42c0-a282-7791df4a3695" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c506bfc9-7d50-478c-b1cd-d1762e842ba8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c506bfc9-7d50-478c-b1cd-d1762e842ba8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c506bfc9-7d50-478c-b1cd-d1762e842ba8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c506bfc9-7d50-478c-b1cd-d1762e842ba8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bee7226d-14d9-4a9d-bba8-e52f88f9cd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c506bfc9-7d50-478c-b1cd-d1762e842ba8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bee7226d-14d9-4a9d-bba8-e52f88f9cd15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d80ec81d-d02a-4f7a-998f-7173c42ced88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bee7226d-14d9-4a9d-bba8-e52f88f9cd15" xlink:to="loc_us-gaap_SubsequentEventMember_d80ec81d-d02a-4f7a-998f-7173c42ced88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_561984f8-d115-4f5f-9deb-efeb82e7f2e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_41885660-f382-42c0-a282-7791df4a3695" xlink:to="loc_srt_LitigationCaseAxis_561984f8-d115-4f5f-9deb-efeb82e7f2e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_561984f8-d115-4f5f-9deb-efeb82e7f2e3_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_561984f8-d115-4f5f-9deb-efeb82e7f2e3" xlink:to="loc_srt_LitigationCaseTypeDomain_561984f8-d115-4f5f-9deb-efeb82e7f2e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_561984f8-d115-4f5f-9deb-efeb82e7f2e3" xlink:to="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_19be9ed5-7eaa-428d-b8c2-65c010e9c1b8" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesMember_19be9ed5-7eaa-428d-b8c2-65c010e9c1b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanAndSommersMember_7e543bc6-7a8c-4445-86f0-60e5f32859e6" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesKaplanAndSommersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesKaplanAndSommersMember_7e543bc6-7a8c-4445-86f0-60e5f32859e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_011c31ae-6ea2-4be5-86c1-d6705d7dbea6" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesStateMember_011c31ae-6ea2-4be5-86c1-d6705d7dbea6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGarciaMember_291de0ec-f539-4f57-b04f-f73e90c24141" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesGarciaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesGarciaMember_291de0ec-f539-4f57-b04f-f73e90c24141" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_8cd1e872-0e8f-4afc-90de-efefd8d7fc59" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_8cd1e872-0e8f-4afc-90de-efefd8d7fc59" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesReiderandBanksMember_afcc4201-27ff-404d-a7dd-7a77b8af2b60" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesReiderandBanksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesReiderandBanksMember_afcc4201-27ff-404d-a7dd-7a77b8af2b60" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesWeingartandHancockMember_f1338442-43fc-4509-a125-d6bbcaa7b29e" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesWeingartandHancockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesWeingartandHancockMember_f1338442-43fc-4509-a125-d6bbcaa7b29e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPollariMember_cb719220-0444-4843-bab4-970269c9d16b" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesPollariMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesPollariMember_cb719220-0444-4843-bab4-970269c9d16b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_9211e4cd-b76b-4079-9c0e-9489d4b627a1" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesGlogerRintoulandDuignamMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_9211e4cd-b76b-4079-9c0e-9489d4b627a1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFreemanAndHarrisMember_cadc0d5c-da96-4b1c-927a-fb4fc9feafd5" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesFreemanAndHarrisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesFreemanAndHarrisMember_cadc0d5c-da96-4b1c-927a-fb4fc9feafd5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesR.DouglasMember_c014757b-2855-4cca-a83f-1cbe2d592a6c" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesR.DouglasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesR.DouglasMember_c014757b-2855-4cca-a83f-1cbe2d592a6c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_aa3943ae-bc92-4c43-85e1-153f6f1b18f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_41885660-f382-42c0-a282-7791df4a3695" xlink:to="loc_dei_LegalEntityAxis_aa3943ae-bc92-4c43-85e1-153f6f1b18f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_aa3943ae-bc92-4c43-85e1-153f6f1b18f2_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_aa3943ae-bc92-4c43-85e1-153f6f1b18f2" xlink:to="loc_dei_EntityDomain_aa3943ae-bc92-4c43-85e1-153f6f1b18f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bc4ba74a-2099-479e-98fa-db9f936fdaf6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_aa3943ae-bc92-4c43-85e1-153f6f1b18f2" xlink:to="loc_dei_EntityDomain_bc4ba74a-2099-479e-98fa-db9f936fdaf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_f73d659c-7db4-4f1c-b7ae-484ae10e7d70" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_bc4ba74a-2099-479e-98fa-db9f936fdaf6" xlink:to="loc_mo_PhilipMorrisUSAMember_f73d659c-7db4-4f1c-b7ae-484ae10e7d70" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="extended" id="i8a98f5942a8f417293cab0af80a121e5_ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_6837d644-f0f6-4bc0-a334-22d914040c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_dda47f3d-5c56-411b-aa9a-863ad0e1253a" xlink:href="mo-20221231.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6837d644-f0f6-4bc0-a334-22d914040c38" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_dda47f3d-5c56-411b-aa9a-863ad0e1253a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_a9480469-8081-4210-bd90-5004d0fe065f" xlink:href="mo-20221231.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6837d644-f0f6-4bc0-a334-22d914040c38" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_a9480469-8081-4210-bd90-5004d0fe065f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_4e148508-3e5a-4164-9b62-73cb6acc78d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6837d644-f0f6-4bc0-a334-22d914040c38" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_4e148508-3e5a-4164-9b62-73cb6acc78d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_091cb7ea-c39f-47e1-960b-48f43df7c380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6837d644-f0f6-4bc0-a334-22d914040c38" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_091cb7ea-c39f-47e1-960b-48f43df7c380" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_6837d644-f0f6-4bc0-a334-22d914040c38" xlink:to="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6bdabb20-1824-434f-b138-0aef146015c5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:to="loc_srt_LitigationCaseAxis_6bdabb20-1824-434f-b138-0aef146015c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6bdabb20-1824-434f-b138-0aef146015c5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_6bdabb20-1824-434f-b138-0aef146015c5" xlink:to="loc_srt_LitigationCaseTypeDomain_6bdabb20-1824-434f-b138-0aef146015c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_6bdabb20-1824-434f-b138-0aef146015c5" xlink:to="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHoffmanMember_02c5d2c4-c3e2-4a0b-b451-152930784a3f" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesHoffmanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesHoffmanMember_02c5d2c4-c3e2-4a0b-b451-152930784a3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLevineMember_1aca713d-6c8b-4d21-aac0-5a0c4e54f626" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesLevineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesLevineMember_1aca713d-6c8b-4d21-aac0-5a0c4e54f626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSchertzerMember_f820796e-90cf-4f03-a1a8-697f3c822dc1" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesSchertzerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesSchertzerMember_f820796e-90cf-4f03-a1a8-697f3c822dc1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLippMember_d6600381-7e3f-4a2a-9ca7-785f7e97b666" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesLippMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesLippMember_d6600381-7e3f-4a2a-9ca7-785f7e97b666" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGarciaMember_a79a7e4c-4f7a-452c-a3c3-f17994145a50" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesGarciaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesGarciaMember_a79a7e4c-4f7a-452c-a3c3-f17994145a50" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDuignanMember_63ff9fe3-961c-4cf1-9184-4ec6380c7866" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesDuignanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesDuignanMember_63ff9fe3-961c-4cf1-9184-4ec6380c7866" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMcCallMember_3a2b6a0f-1228-44ec-a071-a105865cae20" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMcCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesMcCallMember_3a2b6a0f-1228-44ec-a071-a105865cae20" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesChadwellMember_d5b8b4ab-bad8-44ff-8ba4-7e458e549073" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesChadwellMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesChadwellMember_d5b8b4ab-bad8-44ff-8ba4-7e458e549073" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanMember_c657b5d9-5d99-4d53-b8fe-9c18baacd7df" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesKaplanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesKaplanMember_c657b5d9-5d99-4d53-b8fe-9c18baacd7df" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCooperMember_0e900d71-a73a-4161-90c1-7ad63c74e03a" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesCooperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesCooperMember_0e900d71-a73a-4161-90c1-7ad63c74e03a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHollimanMember_348a6b85-5f44-47ae-ab2b-4992951ac7ab" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesHollimanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesHollimanMember_348a6b85-5f44-47ae-ab2b-4992951ac7ab" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesTuttleMember_e058245b-3b7a-434f-bacc-533de1d21812" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesTuttleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesTuttleMember_e058245b-3b7a-434f-bacc-533de1d21812" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMillerMember_ba2ffc83-a530-47b7-9cff-70d56f3f3f8d" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMillerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesMillerMember_ba2ffc83-a530-47b7-9cff-70d56f3f3f8d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesD.BrownMember_2d5668b9-cb10-4846-9c8b-165455bb9496" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesD.BrownMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesD.BrownMember_2d5668b9-cb10-4846-9c8b-165455bb9496" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCuddiheeMember_91310eaa-d73d-4d19-9f8f-e3d66d6bccb7" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesCuddiheeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesCuddiheeMember_91310eaa-d73d-4d19-9f8f-e3d66d6bccb7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_fa23dd5d-12b3-431a-bd51-33ba5d12071e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:to="loc_us-gaap_LitigationStatusAxis_fa23dd5d-12b3-431a-bd51-33ba5d12071e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_fa23dd5d-12b3-431a-bd51-33ba5d12071e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_fa23dd5d-12b3-431a-bd51-33ba5d12071e" xlink:to="loc_us-gaap_LitigationStatusDomain_fa23dd5d-12b3-431a-bd51-33ba5d12071e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_fdcc06ed-83b1-4433-a56a-b601b97f1ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_fa23dd5d-12b3-431a-bd51-33ba5d12071e" xlink:to="loc_us-gaap_LitigationStatusDomain_fdcc06ed-83b1-4433-a56a-b601b97f1ca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_a15664a7-fab0-4855-8be1-b92e994e7834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_fdcc06ed-83b1-4433-a56a-b601b97f1ca1" xlink:to="loc_us-gaap_PendingLitigationMember_a15664a7-fab0-4855-8be1-b92e994e7834" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_d74fa340-8900-44de-805d-af8cff19a0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_fdcc06ed-83b1-4433-a56a-b601b97f1ca1" xlink:to="loc_us-gaap_SettledLitigationMember_d74fa340-8900-44de-805d-af8cff19a0e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4c0d6d28-5836-4d22-8b1c-eda68116902e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:to="loc_dei_LegalEntityAxis_4c0d6d28-5836-4d22-8b1c-eda68116902e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4c0d6d28-5836-4d22-8b1c-eda68116902e_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_4c0d6d28-5836-4d22-8b1c-eda68116902e" xlink:to="loc_dei_EntityDomain_4c0d6d28-5836-4d22-8b1c-eda68116902e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6dd8b25e-f7b9-4f75-99cc-d2c75001ada1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_4c0d6d28-5836-4d22-8b1c-eda68116902e" xlink:to="loc_dei_EntityDomain_6dd8b25e-f7b9-4f75-99cc-d2c75001ada1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_a6e99f25-13c2-4d5e-8892-8d9cebbc70a2" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_6dd8b25e-f7b9-4f75-99cc-d2c75001ada1" xlink:to="loc_mo_PhilipMorrisUSAMember_a6e99f25-13c2-4d5e-8892-8d9cebbc70a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_39582ca5-65e6-471b-9976-a2e27b727179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_39582ca5-65e6-471b-9976-a2e27b727179" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_39582ca5-65e6-471b-9976-a2e27b727179_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_39582ca5-65e6-471b-9976-a2e27b727179" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_39582ca5-65e6-471b-9976-a2e27b727179_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b439f7d4-efa8-459e-8839-e3d9890f9905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_39582ca5-65e6-471b-9976-a2e27b727179" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b439f7d4-efa8-459e-8839-e3d9890f9905" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6b7a468a-4ad7-43e9-9b0e-15ee3cf7346a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b439f7d4-efa8-459e-8839-e3d9890f9905" xlink:to="loc_us-gaap_SubsequentEventMember_6b7a468a-4ad7-43e9-9b0e-15ee3cf7346a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesFloridaBondStatuteDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="extended" id="i65e502f692d24f298077099a0105f676_ContingenciesFloridaBondStatuteDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3f5bd84e-f4a3-41a7-ad37-cde02f99f53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MaximumBondForAllDefendants_20330581-444b-416e-b183-7a6b074d2d72" xlink:href="mo-20221231.xsd#mo_MaximumBondForAllDefendants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f5bd84e-f4a3-41a7-ad37-cde02f99f53e" xlink:to="loc_mo_MaximumBondForAllDefendants_20330581-444b-416e-b183-7a6b074d2d72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_bbf6e07e-575f-469a-b962-44000a235488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f5bd84e-f4a3-41a7-ad37-cde02f99f53e" xlink:to="loc_us-gaap_LossContingenciesTable_bbf6e07e-575f-469a-b962-44000a235488" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7ba88f9b-0ecc-42b1-ba76-ff93c9cc4439" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_bbf6e07e-575f-469a-b962-44000a235488" xlink:to="loc_srt_StatementGeographicalAxis_7ba88f9b-0ecc-42b1-ba76-ff93c9cc4439" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7ba88f9b-0ecc-42b1-ba76-ff93c9cc4439_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_7ba88f9b-0ecc-42b1-ba76-ff93c9cc4439" xlink:to="loc_srt_SegmentGeographicalDomain_7ba88f9b-0ecc-42b1-ba76-ff93c9cc4439_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_098bd270-fcd1-4517-90e5-639cad71cf80" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_7ba88f9b-0ecc-42b1-ba76-ff93c9cc4439" xlink:to="loc_srt_SegmentGeographicalDomain_098bd270-fcd1-4517-90e5-639cad71cf80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_c4119874-0d76-45a3-b14a-51ed2d196f01" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_098bd270-fcd1-4517-90e5-639cad71cf80" xlink:to="loc_stpr_FL_c4119874-0d76-45a3-b14a-51ed2d196f01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_ea847558-cdc6-4bff-8655-f1f1378a8c5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_bbf6e07e-575f-469a-b962-44000a235488" xlink:to="loc_srt_LitigationCaseAxis_ea847558-cdc6-4bff-8655-f1f1378a8c5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ea847558-cdc6-4bff-8655-f1f1378a8c5c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_ea847558-cdc6-4bff-8655-f1f1378a8c5c" xlink:to="loc_srt_LitigationCaseTypeDomain_ea847558-cdc6-4bff-8655-f1f1378a8c5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b89434f2-3e01-436c-a19a-ba2729351645" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_ea847558-cdc6-4bff-8655-f1f1378a8c5c" xlink:to="loc_srt_LitigationCaseTypeDomain_b89434f2-3e01-436c-a19a-ba2729351645" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_45e07ff1-cdd4-4784-8f1f-0467ae6688fd" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b89434f2-3e01-436c-a19a-ba2729351645" xlink:to="loc_mo_EngleProgenyCasesStateMember_45e07ff1-cdd4-4784-8f1f-0467ae6688fd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesOtherSmokingandHealthClassActionsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="extended" id="i78d62190a5304b7aa3118ae7615e01ba_ContingenciesOtherSmokingandHealthClassActionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassNotCertifiedNumber_d0a29548-f6ec-40bb-ac2e-091eee6d71ac" xlink:href="mo-20221231.xsd#mo_LossContingencyClassNotCertifiedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:to="loc_mo_LossContingencyClassNotCertifiedNumber_d0a29548-f6ec-40bb-ac2e-091eee6d71ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_7fd688b1-0384-441c-aa4c-dbae92bec552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_7fd688b1-0384-441c-aa4c-dbae92bec552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_18aef966-f38d-4ea9-8657-54ed7ba88b31" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:to="loc_mo_LossContingencyNumberofManufacturers_18aef966-f38d-4ea9-8657-54ed7ba88b31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictsUpheld_909b420d-9327-4b72-8d05-45a94a8640b0" xlink:href="mo-20221231.xsd#mo_LossContingencyVerdictsUpheld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:to="loc_mo_LossContingencyVerdictsUpheld_909b420d-9327-4b72-8d05-45a94a8640b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AmountAwardedtoOtherParty_a53f0e85-593b-4351-97b8-c040b62c9c52" xlink:href="mo-20221231.xsd#mo_AmountAwardedtoOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:to="loc_mo_AmountAwardedtoOtherParty_a53f0e85-593b-4351-97b8-c040b62c9c52" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:to="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8381e9f6-c4d5-4253-accd-1e3f493fedb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8381e9f6-c4d5-4253-accd-1e3f493fedb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8381e9f6-c4d5-4253-accd-1e3f493fedb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8381e9f6-c4d5-4253-accd-1e3f493fedb1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8381e9f6-c4d5-4253-accd-1e3f493fedb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e81ca8c2-5021-4424-93f2-d8cbbaedb98f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8381e9f6-c4d5-4253-accd-1e3f493fedb1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e81ca8c2-5021-4424-93f2-d8cbbaedb98f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c95016b4-7ce3-438f-90a7-2a78271f7cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e81ca8c2-5021-4424-93f2-d8cbbaedb98f" xlink:to="loc_us-gaap_SubsequentEventMember_c95016b4-7ce3-438f-90a7-2a78271f7cf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1f5cf884-104d-492c-8d06-80ef9e88d7ff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:to="loc_srt_StatementGeographicalAxis_1f5cf884-104d-492c-8d06-80ef9e88d7ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1f5cf884-104d-492c-8d06-80ef9e88d7ff_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_1f5cf884-104d-492c-8d06-80ef9e88d7ff" xlink:to="loc_srt_SegmentGeographicalDomain_1f5cf884-104d-492c-8d06-80ef9e88d7ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_1f5cf884-104d-492c-8d06-80ef9e88d7ff" xlink:to="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR_fbec87d5-5a75-4966-bb5d-60db1959aec2" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_AR_fbec87d5-5a75-4966-bb5d-60db1959aec2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_0c78f26b-f257-45c8-9d40-6c4c2722882a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_CA_0c78f26b-f257-45c8-9d40-6c4c2722882a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE_b51fd926-042e-4cc5-b515-45f3e937a113" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_DE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_DE_b51fd926-042e-4cc5-b515-45f3e937a113" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DC_8830d98d-ee84-40fa-8a2b-2fdd1c641063" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_DC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_DC_8830d98d-ee84-40fa-8a2b-2fdd1c641063" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_234d2898-72e8-4dd0-aff0-8a6ea911eff2" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_FL_234d2898-72e8-4dd0-aff0-8a6ea911eff2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_21571edf-d9ab-4aa2-a626-fe9034f3286a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_IL_21571edf-d9ab-4aa2-a626-fe9034f3286a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA_e6c118a7-4732-4271-ac08-a0cfb844dd11" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_IA_e6c118a7-4732-4271-ac08-a0cfb844dd11" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS_0b95b19f-dd15-496f-9809-10c9ae09208e" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_KS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_KS_0b95b19f-dd15-496f-9809-10c9ae09208e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_40e78e69-3407-4568-9e1a-c5750c3c5a24" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_LA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_LA_40e78e69-3407-4568-9e1a-c5750c3c5a24" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MD_e67ec479-9886-4a5d-a3ec-dfe185efda51" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MD"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_MD_e67ec479-9886-4a5d-a3ec-dfe185efda51" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI_8011578e-4580-489f-af05-d5cbebbf47ba" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_MI_8011578e-4580-489f-af05-d5cbebbf47ba" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN_b4a13c12-5358-4554-924e-7f470cc9653c" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_MN_b4a13c12-5358-4554-924e-7f470cc9653c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NV_f30706cb-49fc-4db4-b0e2-86e913e0632a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NV"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_NV_f30706cb-49fc-4db4-b0e2-86e913e0632a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_1f8cbf25-f570-4d85-a99f-22aaa0cef5a4" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NJ"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_NJ_1f8cbf25-f570-4d85-a99f-22aaa0cef5a4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_89dd8809-7817-42fe-b66e-8f5311ddfeab" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_NY_89dd8809-7817-42fe-b66e-8f5311ddfeab" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_89a54c10-99f6-4573-b963-b8794a8e6359" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OH"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_OH_89a54c10-99f6-4573-b963-b8794a8e6359" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK_1cd80af2-f8a3-4013-9384-3c78c93e705e" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OK"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_OK_1cd80af2-f8a3-4013-9384-3c78c93e705e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OR_24409303-aa14-44b0-be39-e48d86d380ee" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_OR_24409303-aa14-44b0-be39-e48d86d380ee" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_f1a2271e-5100-4cc1-98dd-ae877254eef0" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_PA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_PA_f1a2271e-5100-4cc1-98dd-ae877254eef0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR_73c4b77b-3709-4b29-8e47-6865b6e3ed5b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_country_PR_73c4b77b-3709-4b29-8e47-6865b6e3ed5b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_SC_360a3ab2-4e92-4719-b047-fd7e1b2534a8" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_SC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_SC_360a3ab2-4e92-4719-b047-fd7e1b2534a8" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_de6f3b44-3fa0-493c-858e-bf73c2318c7f" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_TX_de6f3b44-3fa0-493c-858e-bf73c2318c7f" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WI_88129764-68b7-4a61-a41b-a588b5dc32c2" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WI"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_WI_88129764-68b7-4a61-a41b-a588b5dc32c2" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_18a5f998-d992-4743-8350-0db93fbbd009" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_country_CA_18a5f998-d992-4743-8350-0db93fbbd009" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_BritishColumbiaSaskatchewanMember_78aa4546-ebe5-4fc2-b935-2a7a53272a01" xlink:href="mo-20221231.xsd#mo_BritishColumbiaSaskatchewanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_mo_BritishColumbiaSaskatchewanMember_78aa4546-ebe5-4fc2-b935-2a7a53272a01" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6497ff19-4b9f-483b-a290-00fd747c2856" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:to="loc_dei_LegalEntityAxis_6497ff19-4b9f-483b-a290-00fd747c2856" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6497ff19-4b9f-483b-a290-00fd747c2856_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_6497ff19-4b9f-483b-a290-00fd747c2856" xlink:to="loc_dei_EntityDomain_6497ff19-4b9f-483b-a290-00fd747c2856_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2d13d272-06ee-4a92-9627-5459555fcc48" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_6497ff19-4b9f-483b-a290-00fd747c2856" xlink:to="loc_dei_EntityDomain_2d13d272-06ee-4a92-9627-5459555fcc48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_741ffd2d-31af-4865-b979-c32ba85c309a" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_2d13d272-06ee-4a92-9627-5459555fcc48" xlink:to="loc_mo_PhilipMorrisUSAMember_741ffd2d-31af-4865-b979-c32ba85c309a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_84c762d8-8d3c-4c5e-b8fc-d6465c997649" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_2d13d272-06ee-4a92-9627-5459555fcc48" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_84c762d8-8d3c-4c5e-b8fc-d6465c997649" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_cb0fd194-ac5a-4bfc-9471-7dc98eb205a0" xlink:href="mo-20221231.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_2d13d272-06ee-4a92-9627-5459555fcc48" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_cb0fd194-ac5a-4bfc-9471-7dc98eb205a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f7ef2cc5-c0dd-408a-aed8-67800b63bd9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:to="loc_srt_LitigationCaseAxis_f7ef2cc5-c0dd-408a-aed8-67800b63bd9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f7ef2cc5-c0dd-408a-aed8-67800b63bd9b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_f7ef2cc5-c0dd-408a-aed8-67800b63bd9b" xlink:to="loc_srt_LitigationCaseTypeDomain_f7ef2cc5-c0dd-408a-aed8-67800b63bd9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0eb2cbe8-5d35-4627-b337-4098dbc34200" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_f7ef2cc5-c0dd-408a-aed8-67800b63bd9b" xlink:to="loc_srt_LitigationCaseTypeDomain_0eb2cbe8-5d35-4627-b337-4098dbc34200" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_335a79f4-9fb8-4ac8-a409-d25682555804" xlink:href="mo-20221231.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_0eb2cbe8-5d35-4627-b337-4098dbc34200" xlink:to="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_335a79f4-9fb8-4ac8-a409-d25682555804" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesHealthCareCostRecoveryLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="extended" id="id561312318d54dbb87cff13fb1b8eba3_ContingenciesHealthCareCostRecoveryLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_44ca2c99-68e9-46a8-b497-1849f32f760e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_44ca2c99-68e9-46a8-b497-1849f32f760e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_c64770ab-afd3-4050-9ca9-0e948f7e7959" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_mo_LossContingencyNumberofManufacturers_c64770ab-afd3-4050-9ca9-0e948f7e7959" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation_6ab21286-6c52-4da3-86c6-73d80416064f" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigation_6ab21286-6c52-4da3-86c6-73d80416064f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualPaymentAmount_917679a7-3e50-4754-839e-24f39d1dd79d" xlink:href="mo-20221231.xsd#mo_LitigationSettlementAnnualPaymentAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_mo_LitigationSettlementAnnualPaymentAmount_917679a7-3e50-4754-839e-24f39d1dd79d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_756abd3b-eedd-4635-8f32-5876c9b8b6db" xlink:href="mo-20221231.xsd#mo_LitigationSettlementAnnualLegalFeesPayableMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_756abd3b-eedd-4635-8f32-5876c9b8b6db" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_694aefd6-ef7b-4e2b-bd06-ae84978c9a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_694aefd6-ef7b-4e2b-bd06-ae84978c9a4e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d3d90a74-95ed-4977-b481-198e101aaede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:to="loc_us-gaap_LitigationStatusAxis_d3d90a74-95ed-4977-b481-198e101aaede" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_d3d90a74-95ed-4977-b481-198e101aaede_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_d3d90a74-95ed-4977-b481-198e101aaede" xlink:to="loc_us-gaap_LitigationStatusDomain_d3d90a74-95ed-4977-b481-198e101aaede_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_e4ec4482-6140-44ff-a7b4-c163a9d670ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_d3d90a74-95ed-4977-b481-198e101aaede" xlink:to="loc_us-gaap_LitigationStatusDomain_e4ec4482-6140-44ff-a7b4-c163a9d670ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember_dd9c251a-8c7a-4120-8fa4-1e6e85e447bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_e4ec4482-6140-44ff-a7b4-c163a9d670ce" xlink:to="loc_us-gaap_ThreatenedLitigationMember_dd9c251a-8c7a-4120-8fa4-1e6e85e447bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f1776854-434e-4604-bb38-721d250760df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:to="loc_srt_StatementGeographicalAxis_f1776854-434e-4604-bb38-721d250760df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f1776854-434e-4604-bb38-721d250760df_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f1776854-434e-4604-bb38-721d250760df" xlink:to="loc_srt_SegmentGeographicalDomain_f1776854-434e-4604-bb38-721d250760df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_359998c5-69f2-4882-b3a8-958ae6a57850" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f1776854-434e-4604-bb38-721d250760df" xlink:to="loc_srt_SegmentGeographicalDomain_359998c5-69f2-4882-b3a8-958ae6a57850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_a1fc5f13-d16d-4d68-bb7f-edd79a25e723" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_359998c5-69f2-4882-b3a8-958ae6a57850" xlink:to="loc_country_CA_a1fc5f13-d16d-4d68-bb7f-edd79a25e723" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_63241a3d-f2be-44c7-827c-c79d4ef21738" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:to="loc_srt_LitigationCaseAxis_63241a3d-f2be-44c7-827c-c79d4ef21738" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_63241a3d-f2be-44c7-827c-c79d4ef21738_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_63241a3d-f2be-44c7-827c-c79d4ef21738" xlink:to="loc_srt_LitigationCaseTypeDomain_63241a3d-f2be-44c7-827c-c79d4ef21738_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b3b92df1-1a05-4c71-bf26-81e20caa0f1d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_63241a3d-f2be-44c7-827c-c79d4ef21738" xlink:to="loc_srt_LitigationCaseTypeDomain_b3b92df1-1a05-4c71-bf26-81e20caa0f1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_e434dac1-ab5d-4fb1-8622-8239f5e76a97" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b3b92df1-1a05-4c71-bf26-81e20caa0f1d" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_e434dac1-ab5d-4fb1-8622-8239f5e76a97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_7546a06d-7e19-45bd-8941-581acd33d194" xlink:href="mo-20221231.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_b3b92df1-1a05-4c71-bf26-81e20caa0f1d" xlink:to="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_7546a06d-7e19-45bd-8941-581acd33d194" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_672ad951-65b9-49d4-939d-b3b78192f9f3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:to="loc_dei_LegalEntityAxis_672ad951-65b9-49d4-939d-b3b78192f9f3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_672ad951-65b9-49d4-939d-b3b78192f9f3_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_672ad951-65b9-49d4-939d-b3b78192f9f3" xlink:to="loc_dei_EntityDomain_672ad951-65b9-49d4-939d-b3b78192f9f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5030fb4d-0627-4001-9527-20be85449244" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_672ad951-65b9-49d4-939d-b3b78192f9f3" xlink:to="loc_dei_EntityDomain_5030fb4d-0627-4001-9527-20be85449244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_3f98d837-eca2-44c6-a664-dc48df43c00a" xlink:href="mo-20221231.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5030fb4d-0627-4001-9527-20be85449244" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_3f98d837-eca2-44c6-a664-dc48df43c00a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesNPMAdjustmentDisputesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails" xlink:type="extended" id="i55c769a52ac54554a8cef0d5bc380687_ContingenciesNPMAdjustmentDisputesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementEstimateofPossibleGain_58a05f56-6b0f-4aa4-a2ab-912c1b7341b3" xlink:href="mo-20221231.xsd#mo_LitigationSettlementEstimateofPossibleGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LitigationSettlementEstimateofPossibleGain_58a05f56-6b0f-4aa4-a2ab-912c1b7341b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_9d238278-7b7a-4fef-a626-4ae565a43f9f" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_9d238278-7b7a-4fef-a626-4ae565a43f9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_82e947d3-f458-4ae1-9187-e0cce1a2e5c9" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_82e947d3-f458-4ae1-9187-e0cce1a2e5c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_c6c9b87a-1bb2-44e5-b9cd-3cd8ce7ed7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_c6c9b87a-1bb2-44e5-b9cd-3cd8ce7ed7e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_041d11bd-e6bf-4925-8ec8-e4b54e7144b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_041d11bd-e6bf-4925-8ec8-e4b54e7144b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_4785b111-db3b-44ab-b93c-be805be583cf" xlink:href="mo-20221231.xsd#mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_4785b111-db3b-44ab-b93c-be805be583cf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettled_45ccb5de-e801-4f20-b479-0936f5e7a8af" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesNotSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberOfStatesNotSettled_45ccb5de-e801-4f20-b479-0936f5e7a8af" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_03a3ce33-ddfc-4177-95e6-bbbf05b298d1" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesWithConcludedHearings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_03a3ce33-ddfc-4177-95e6-bbbf05b298d1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_bba1e4d1-46d1-4543-b09a-2f68b457cc00" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_bba1e4d1-46d1-4543-b09a-2f68b457cc00" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_26ab9292-2fae-48d9-9c59-74dfec0c927f" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_26ab9292-2fae-48d9-9c59-74dfec0c927f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyReductionToCostOfSales_e1060b55-26e1-4a28-a636-7dfb05a523fd" xlink:href="mo-20221231.xsd#mo_LossContingencyReductionToCostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyReductionToCostOfSales_e1060b55-26e1-4a28-a636-7dfb05a523fd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_c2e67f8d-d3d9-4c94-ae0b-a5ee442c9edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_c2e67f8d-d3d9-4c94-ae0b-a5ee442c9edf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_63a67aa4-b833-4467-8cfa-ad7cdff5a148" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_63a67aa4-b833-4467-8cfa-ad7cdff5a148" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b6922689-2d2c-4b69-9038-e26773dab27b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_srt_StatementGeographicalAxis_b6922689-2d2c-4b69-9038-e26773dab27b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b6922689-2d2c-4b69-9038-e26773dab27b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_b6922689-2d2c-4b69-9038-e26773dab27b" xlink:to="loc_srt_SegmentGeographicalDomain_b6922689-2d2c-4b69-9038-e26773dab27b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_b6922689-2d2c-4b69-9038-e26773dab27b" xlink:to="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_650025e9-acd4-447a-af16-ed7e6ad184c4" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:to="loc_stpr_NY_650025e9-acd4-447a-af16-ed7e6ad184c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_b291da30-9f42-41c0-8c8c-0d71f0cdee6d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:to="loc_stpr_IL_b291da30-9f42-41c0-8c8c-0d71f0cdee6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA_33b23e42-be30-4eb0-858f-63111e0b70fd" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:to="loc_stpr_IA_33b23e42-be30-4eb0-858f-63111e0b70fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM_60ad113a-2da6-4df9-90a5-819601fe7772" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:to="loc_stpr_NM_60ad113a-2da6-4df9-90a5-819601fe7772" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MT_14324e97-a841-4d74-9e30-5b3ba88f35cc" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:to="loc_stpr_MT_14324e97-a841-4d74-9e30-5b3ba88f35cc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0167c202-c2c5-4ddc-9505-e0ea60bde5f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_dei_LegalEntityAxis_0167c202-c2c5-4ddc-9505-e0ea60bde5f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0167c202-c2c5-4ddc-9505-e0ea60bde5f2_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_0167c202-c2c5-4ddc-9505-e0ea60bde5f2" xlink:to="loc_dei_EntityDomain_0167c202-c2c5-4ddc-9505-e0ea60bde5f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5ed959ae-1433-4cbd-a28c-990fd43be78e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_0167c202-c2c5-4ddc-9505-e0ea60bde5f2" xlink:to="loc_dei_EntityDomain_5ed959ae-1433-4cbd-a28c-990fd43be78e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_a8ce3d48-9133-44c5-812e-df14269804ec" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5ed959ae-1433-4cbd-a28c-990fd43be78e" xlink:to="loc_mo_PhilipMorrisUSAMember_a8ce3d48-9133-44c5-812e-df14269804ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_431b7b0e-18a8-44e6-a98b-2d5fd08bea45" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_srt_LitigationCaseAxis_431b7b0e-18a8-44e6-a98b-2d5fd08bea45" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_431b7b0e-18a8-44e6-a98b-2d5fd08bea45_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_431b7b0e-18a8-44e6-a98b-2d5fd08bea45" xlink:to="loc_srt_LitigationCaseTypeDomain_431b7b0e-18a8-44e6-a98b-2d5fd08bea45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e21fbc3e-776c-4322-b439-5eb6c62c452b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_431b7b0e-18a8-44e6-a98b-2d5fd08bea45" xlink:to="loc_srt_LitigationCaseTypeDomain_e21fbc3e-776c-4322-b439-5eb6c62c452b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e21fbc3e-776c-4322-b439-5eb6c62c452b" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_5f9d819f-f378-451d-971f-14d1e2c734a4" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_5f9d819f-f378-451d-971f-14d1e2c734a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_cd12f1ac-59c1-4f16-b939-1d56c2754f58" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_cd12f1ac-59c1-4f16-b939-1d56c2754f58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_af4d3dab-f615-48b1-a577-acac90b7e4dc" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_af4d3dab-f615-48b1-a577-acac90b7e4dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_9b1ace48-a6b5-4d9e-a244-a2024b71da86" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_9b1ace48-a6b5-4d9e-a244-a2024b71da86" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_ba3b221c-400d-45a7-a2e7-0ce03fc931b2" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_ba3b221c-400d-45a7-a2e7-0ce03fc931b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_3f565ca0-87ab-4888-87a2-ba8451cdd422" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_3f565ca0-87ab-4888-87a2-ba8451cdd422" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_297b3bdc-c4bb-428c-b444-6ea17ce997d8" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_297b3bdc-c4bb-428c-b444-6ea17ce997d8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_0159eed4-8952-47aa-b21a-ddef280e6c19" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_0159eed4-8952-47aa-b21a-ddef280e6c19" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_a285a514-48f0-4ae4-a39d-742573c10c26" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_a285a514-48f0-4ae4-a39d-742573c10c26" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_146a4b38-ed7b-418f-a48e-951a96fdb30f" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_146a4b38-ed7b-418f-a48e-951a96fdb30f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_847c7024-132c-49cc-bf90-6a908bb53b8b" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_847c7024-132c-49cc-bf90-6a908bb53b8b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_2bf892dc-6931-452e-af79-ec2cdbf9577d" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_2bf892dc-6931-452e-af79-ec2cdbf9577d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_2626c1b5-40fb-4c7a-9429-6c4d285e4858" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_2626c1b5-40fb-4c7a-9429-6c4d285e4858" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_f16d12a9-7069-462a-8cb5-573c6abac804" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_f16d12a9-7069-462a-8cb5-573c6abac804" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_c2b85074-74ca-4f02-9157-fe654d8ea665" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_c2b85074-74ca-4f02-9157-fe654d8ea665" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_b9f28f84-b8df-4fdd-8af7-194f20aff28d" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_b9f28f84-b8df-4fdd-8af7-194f20aff28d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_126a96ae-599d-47f0-aaa8-2e5e8ddedb19" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_126a96ae-599d-47f0-aaa8-2e5e8ddedb19" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_6e75f899-8cef-4633-9add-58dea14841b7" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_6e75f899-8cef-4633-9add-58dea14841b7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_f38c3e57-20bf-459d-b37c-2200ac0d8565" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_f38c3e57-20bf-459d-b37c-2200ac0d8565" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_b83ae834-0fe2-45cb-a297-6c6a3b163245" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_b83ae834-0fe2-45cb-a297-6c6a3b163245" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_36942028-b887-4c69-870e-3bb0aab6380b" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e21fbc3e-776c-4322-b439-5eb6c62c452b" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_36942028-b887-4c69-870e-3bb0aab6380b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_9ce30f0a-2d6d-43aa-94fd-7d0ead4787ba" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20192021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e21fbc3e-776c-4322-b439-5eb6c62c452b" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_9ce30f0a-2d6d-43aa-94fd-7d0ead4787ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_34e681a2-892f-430c-8f1c-32dc53e012ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_us-gaap_LitigationStatusAxis_34e681a2-892f-430c-8f1c-32dc53e012ec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_34e681a2-892f-430c-8f1c-32dc53e012ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_34e681a2-892f-430c-8f1c-32dc53e012ec" xlink:to="loc_us-gaap_LitigationStatusDomain_34e681a2-892f-430c-8f1c-32dc53e012ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_5fcc4320-43c2-45d1-91f6-13dc89485a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_34e681a2-892f-430c-8f1c-32dc53e012ec" xlink:to="loc_us-gaap_LitigationStatusDomain_5fcc4320-43c2-45d1-91f6-13dc89485a89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_b56065db-568c-4f26-afe7-3ef2cdc6acfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_5fcc4320-43c2-45d1-91f6-13dc89485a89" xlink:to="loc_us-gaap_SettledLitigationMember_b56065db-568c-4f26-afe7-3ef2cdc6acfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_580bbce5-7fb1-4626-b4b0-2bb0bd68fe06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_5fcc4320-43c2-45d1-91f6-13dc89485a89" xlink:to="loc_us-gaap_PendingLitigationMember_580bbce5-7fb1-4626-b4b0-2bb0bd68fe06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ffc656b4-d4ac-4b70-95b6-521d01a8c78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ffc656b4-d4ac-4b70-95b6-521d01a8c78d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ffc656b4-d4ac-4b70-95b6-521d01a8c78d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ffc656b4-d4ac-4b70-95b6-521d01a8c78d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ffc656b4-d4ac-4b70-95b6-521d01a8c78d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e07e05e6-8b19-4092-9e9b-8601ee4adddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ffc656b4-d4ac-4b70-95b6-521d01a8c78d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e07e05e6-8b19-4092-9e9b-8601ee4adddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6c58ef83-6017-43a4-91b3-cca0b4e9ba2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e07e05e6-8b19-4092-9e9b-8601ee4adddb" xlink:to="loc_us-gaap_CostOfSalesMember_6c58ef83-6017-43a4-91b3-cca0b4e9ba2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodAxis_71c20381-e834-4f97-beb7-33be47e434cb" xlink:href="mo-20221231.xsd#mo_ArbitrationPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_mo_ArbitrationPeriodAxis_71c20381-e834-4f97-beb7-33be47e434cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodDomain_71c20381-e834-4f97-beb7-33be47e434cb_default" xlink:href="mo-20221231.xsd#mo_ArbitrationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_mo_ArbitrationPeriodAxis_71c20381-e834-4f97-beb7-33be47e434cb" xlink:to="loc_mo_ArbitrationPeriodDomain_71c20381-e834-4f97-beb7-33be47e434cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodDomain_79365032-8ce7-48a0-92ca-27372b6684a4" xlink:href="mo-20221231.xsd#mo_ArbitrationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_mo_ArbitrationPeriodAxis_71c20381-e834-4f97-beb7-33be47e434cb" xlink:to="loc_mo_ArbitrationPeriodDomain_79365032-8ce7-48a0-92ca-27372b6684a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodOneMember_518e21d2-6b78-4c24-8e58-2799fcd90546" xlink:href="mo-20221231.xsd#mo_PeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ArbitrationPeriodDomain_79365032-8ce7-48a0-92ca-27372b6684a4" xlink:to="loc_mo_PeriodOneMember_518e21d2-6b78-4c24-8e58-2799fcd90546" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodTwoMember_e78fb9d0-e74a-449a-8086-7034c4ee3014" xlink:href="mo-20221231.xsd#mo_PeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_mo_ArbitrationPeriodDomain_79365032-8ce7-48a0-92ca-27372b6684a4" xlink:to="loc_mo_PeriodTwoMember_e78fb9d0-e74a-449a-8086-7034c4ee3014" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="extended" id="i6b5478f256b646d98c1c204c1c39fccb_ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8347bb3b-82ac-436e-9b6d-8f71adf636e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_32d745b6-dc02-409e-86e7-4754afc3e68a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_8347bb3b-82ac-436e-9b6d-8f71adf636e8" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_32d745b6-dc02-409e-86e7-4754afc3e68a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_ba18da10-c02e-4a35-9fd3-99656f03673c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_8347bb3b-82ac-436e-9b6d-8f71adf636e8" xlink:to="loc_us-gaap_LossContingenciesTable_ba18da10-c02e-4a35-9fd3-99656f03673c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_353dd824-bc97-44fa-a585-e9e546892a63" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ba18da10-c02e-4a35-9fd3-99656f03673c" xlink:to="loc_dei_LegalEntityAxis_353dd824-bc97-44fa-a585-e9e546892a63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_353dd824-bc97-44fa-a585-e9e546892a63_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_353dd824-bc97-44fa-a585-e9e546892a63" xlink:to="loc_dei_EntityDomain_353dd824-bc97-44fa-a585-e9e546892a63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9ef7cbee-8b2d-4f6b-a3ac-590d4283be5c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_353dd824-bc97-44fa-a585-e9e546892a63" xlink:to="loc_dei_EntityDomain_9ef7cbee-8b2d-4f6b-a3ac-590d4283be5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_69694445-f08e-4293-ac3d-97d5aa4842c9" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9ef7cbee-8b2d-4f6b-a3ac-590d4283be5c" xlink:to="loc_mo_PhilipMorrisUSAMember_69694445-f08e-4293-ac3d-97d5aa4842c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e1541c53-d166-4979-afaf-959cf8ce2803" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_ba18da10-c02e-4a35-9fd3-99656f03673c" xlink:to="loc_srt_LitigationCaseAxis_e1541c53-d166-4979-afaf-959cf8ce2803" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e1541c53-d166-4979-afaf-959cf8ce2803_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_e1541c53-d166-4979-afaf-959cf8ce2803" xlink:to="loc_srt_LitigationCaseTypeDomain_e1541c53-d166-4979-afaf-959cf8ce2803_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9a58f5e2-8939-4809-a751-e5050c7b89ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_e1541c53-d166-4979-afaf-959cf8ce2803" xlink:to="loc_srt_LitigationCaseTypeDomain_9a58f5e2-8939-4809-a751-e5050c7b89ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_4b146141-345f-45a1-86cb-1bbe039dcb73" xlink:href="mo-20221231.xsd#mo_OtherDisputesUndertheStateSettlementAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9a58f5e2-8939-4809-a751-e5050c7b89ce" xlink:to="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_4b146141-345f-45a1-86cb-1bbe039dcb73" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesFederalGovernmentsLawsuitDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="extended" id="i33f35665b4854c9a9faaf71b93c03e09_ContingenciesFederalGovernmentsLawsuitDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a01b822a-2186-4aff-8024-09431368c1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalTradeCommissionDisclosurePeriod_2a925e85-4bb5-47ab-a90c-5231e8af92ff" xlink:href="mo-20221231.xsd#mo_FederalTradeCommissionDisclosurePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a01b822a-2186-4aff-8024-09431368c1d8" xlink:to="loc_mo_FederalTradeCommissionDisclosurePeriod_2a925e85-4bb5-47ab-a90c-5231e8af92ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_49f08726-c64b-483b-b2e5-112151e1af47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a01b822a-2186-4aff-8024-09431368c1d8" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_49f08726-c64b-483b-b2e5-112151e1af47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_73df3418-85cc-4344-913e-5b22f01f2dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_a01b822a-2186-4aff-8024-09431368c1d8" xlink:to="loc_us-gaap_LossContingenciesTable_73df3418-85cc-4344-913e-5b22f01f2dda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_377c10bf-f566-43b6-bfbd-ffde515bda0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_73df3418-85cc-4344-913e-5b22f01f2dda" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_377c10bf-f566-43b6-bfbd-ffde515bda0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_377c10bf-f566-43b6-bfbd-ffde515bda0e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_377c10bf-f566-43b6-bfbd-ffde515bda0e" xlink:to="loc_us-gaap_LossContingencyNatureDomain_377c10bf-f566-43b6-bfbd-ffde515bda0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_f5bedfb6-c53c-4f0e-924a-1cc3b142e8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_377c10bf-f566-43b6-bfbd-ffde515bda0e" xlink:to="loc_us-gaap_LossContingencyNatureDomain_f5bedfb6-c53c-4f0e-924a-1cc3b142e8a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ImplementationofCorrectiveCommunicationsMember_8f371383-bb4d-487c-973f-9d5a7a381a6f" xlink:href="mo-20221231.xsd#mo_ImplementationofCorrectiveCommunicationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_f5bedfb6-c53c-4f0e-924a-1cc3b142e8a9" xlink:to="loc_mo_ImplementationofCorrectiveCommunicationsMember_8f371383-bb4d-487c-973f-9d5a7a381a6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d221a77d-c114-4e63-b416-e73b2d1663f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_73df3418-85cc-4344-913e-5b22f01f2dda" xlink:to="loc_srt_LitigationCaseAxis_d221a77d-c114-4e63-b416-e73b2d1663f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_d221a77d-c114-4e63-b416-e73b2d1663f6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_d221a77d-c114-4e63-b416-e73b2d1663f6" xlink:to="loc_srt_LitigationCaseTypeDomain_d221a77d-c114-4e63-b416-e73b2d1663f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_001e4057-11c3-4759-a33c-c78711611df4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_d221a77d-c114-4e63-b416-e73b2d1663f6" xlink:to="loc_srt_LitigationCaseTypeDomain_001e4057-11c3-4759-a33c-c78711611df4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalGovernmentsLawsuitMember_37c337d7-7162-4ba6-a973-3807f1f14783" xlink:href="mo-20221231.xsd#mo_FederalGovernmentsLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_001e4057-11c3-4759-a33c-c78711611df4" xlink:to="loc_mo_FederalGovernmentsLawsuitMember_37c337d7-7162-4ba6-a973-3807f1f14783" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesEvaporLitigationandIQOSLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails" xlink:type="extended" id="id8c449b342d54ef88532b05515ace68e_ContingenciesEvaporLitigationandIQOSLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_bec73eb7-bac8-49f0-a390-e3a90291208e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_bec73eb7-bac8-49f0-a390-e3a90291208e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_82be3ccb-6fd5-4581-81ac-40cda61f2150" xlink:href="mo-20221231.xsd#mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_82be3ccb-6fd5-4581-81ac-40cda61f2150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithSetTrialDates_186873e1-0ea7-4d89-89d1-4483a3ce859f" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfCasesWithSetTrialDates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_mo_LossContingencyNumberOfCasesWithSetTrialDates_186873e1-0ea7-4d89-89d1-4483a3ce859f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberOfThirdPartyLawsuits_23d39ff5-af58-44a7-b313-76b70257e31d" xlink:href="mo-20221231.xsd#mo_NumberOfThirdPartyLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_mo_NumberOfThirdPartyLawsuits_23d39ff5-af58-44a7-b313-76b70257e31d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_0928f0ac-b928-4f24-8a2a-3fabb3373b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_0928f0ac-b928-4f24-8a2a-3fabb3373b4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyRoyaltyFeePercentage_c5529d6a-1600-42c3-b6ff-9b57393e668f" xlink:href="mo-20221231.xsd#mo_LossContingencyRoyaltyFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_mo_LossContingencyRoyaltyFeePercentage_c5529d6a-1600-42c3-b6ff-9b57393e668f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyDamagesRecoverableValue_dd8882f8-1c77-42d0-864d-7a60f86fedff" xlink:href="mo-20221231.xsd#mo_LossContingencyDamagesRecoverableValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_mo_LossContingencyDamagesRecoverableValue_dd8882f8-1c77-42d0-864d-7a60f86fedff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_c9975575-6c83-435d-89d3-5bc6dcbf9085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:to="loc_us-gaap_LitigationStatusAxis_c9975575-6c83-435d-89d3-5bc6dcbf9085" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_c9975575-6c83-435d-89d3-5bc6dcbf9085_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_c9975575-6c83-435d-89d3-5bc6dcbf9085" xlink:to="loc_us-gaap_LitigationStatusDomain_c9975575-6c83-435d-89d3-5bc6dcbf9085_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_c9975575-6c83-435d-89d3-5bc6dcbf9085" xlink:to="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingClassActionLawsuitsMember_fe37636f-035e-4fac-9396-af6e7c881ee4" xlink:href="mo-20221231.xsd#mo_PendingClassActionLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:to="loc_mo_PendingClassActionLawsuitsMember_fe37636f-035e-4fac-9396-af6e7c881ee4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember_2b777d4f-a895-4f33-990b-385346c35e04" xlink:href="mo-20221231.xsd#mo_ClassActionLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:to="loc_mo_ClassActionLawsuitMember_2b777d4f-a895-4f33-990b-385346c35e04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingClassActionLawsuitMember_9710c597-c7b0-45d9-8235-9a660bc45a25" xlink:href="mo-20221231.xsd#mo_PendingClassActionLawsuitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:to="loc_mo_PendingClassActionLawsuitMember_9710c597-c7b0-45d9-8235-9a660bc45a25" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_d3ae55d8-bcc8-4e6b-8560-94456e7bba12" xlink:href="mo-20221231.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:to="loc_mo_PendingIndividualLawsuitsMember_d3ae55d8-bcc8-4e6b-8560-94456e7bba12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_a49accf8-6b7a-4453-bb9b-325f00fbb8eb" xlink:href="mo-20221231.xsd#mo_PendingLawsuitFiledBySchoolDistrictMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:to="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_a49accf8-6b7a-4453-bb9b-325f00fbb8eb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_2f3377f1-c004-4fe8-b995-e778fa30c9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:to="loc_us-gaap_PendingLitigationMember_2f3377f1-c004-4fe8-b995-e778fa30c9ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_57a8eeca-1e2b-474a-bca5-38ffc26ace69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_57a8eeca-1e2b-474a-bca5-38ffc26ace69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_57a8eeca-1e2b-474a-bca5-38ffc26ace69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_57a8eeca-1e2b-474a-bca5-38ffc26ace69" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_57a8eeca-1e2b-474a-bca5-38ffc26ace69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0a018471-b8b4-4c04-88a8-0990e462598d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_57a8eeca-1e2b-474a-bca5-38ffc26ace69" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0a018471-b8b4-4c04-88a8-0990e462598d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d76e98fe-200a-4719-85a3-f8c4316ffd61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0a018471-b8b4-4c04-88a8-0990e462598d" xlink:to="loc_us-gaap_SubsequentEventMember_d76e98fe-200a-4719-85a3-f8c4316ffd61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_036910ab-9ccf-4682-895e-3c59de2ddf4f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:to="loc_srt_LitigationCaseAxis_036910ab-9ccf-4682-895e-3c59de2ddf4f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_036910ab-9ccf-4682-895e-3c59de2ddf4f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_036910ab-9ccf-4682-895e-3c59de2ddf4f" xlink:to="loc_srt_LitigationCaseTypeDomain_036910ab-9ccf-4682-895e-3c59de2ddf4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_43fd3920-6186-4d3d-ba1c-e2d386797119" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_036910ab-9ccf-4682-895e-3c59de2ddf4f" xlink:to="loc_srt_LitigationCaseTypeDomain_43fd3920-6186-4d3d-ba1c-e2d386797119" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_d669098f-7dbc-4411-9358-0513f8a782e1" xlink:href="mo-20221231.xsd#mo_EvaporLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_43fd3920-6186-4d3d-ba1c-e2d386797119" xlink:to="loc_mo_EvaporLitigationMember_d669098f-7dbc-4411-9358-0513f8a782e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IQOSMember_7eed8383-957a-4687-93ba-70645c0e3317" xlink:href="mo-20221231.xsd#mo_IQOSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_43fd3920-6186-4d3d-ba1c-e2d386797119" xlink:to="loc_mo_IQOSMember_7eed8383-957a-4687-93ba-70645c0e3317" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c0c8061d-4be8-44ad-a17b-8f773c328f00" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:to="loc_srt_StatementGeographicalAxis_c0c8061d-4be8-44ad-a17b-8f773c328f00" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c0c8061d-4be8-44ad-a17b-8f773c328f00_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c0c8061d-4be8-44ad-a17b-8f773c328f00" xlink:to="loc_srt_SegmentGeographicalDomain_c0c8061d-4be8-44ad-a17b-8f773c328f00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_43199342-d29f-444e-b326-7f1928389e5d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c0c8061d-4be8-44ad-a17b-8f773c328f00" xlink:to="loc_srt_SegmentGeographicalDomain_43199342-d29f-444e-b326-7f1928389e5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_3d0d29ca-035a-4716-8dd9-3e72b404e791" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_43199342-d29f-444e-b326-7f1928389e5d" xlink:to="loc_country_CA_3d0d29ca-035a-4716-8dd9-3e72b404e791" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesAntitrustLitigationDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesAntitrustLitigationDetails" xlink:type="extended" id="ia1e8cb2da1544b1dbf624b2c9ca7a2bb_ContingenciesAntitrustLitigationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_23b6f077-fd42-4783-bb06-e92cd44c4e6e" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_23b6f077-fd42-4783-bb06-e92cd44c4e6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_aad8fbeb-e8f7-4db1-9951-ad63676a82b5" xlink:href="mo-20221231.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:to="loc_mo_LossContingencyClassActionLawsuit_aad8fbeb-e8f7-4db1-9951-ad63676a82b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfComplaints_150b6f1a-cc33-4097-a0af-4e6f12136e69" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfComplaints"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:to="loc_mo_LossContingencyNumberOfComplaints_150b6f1a-cc33-4097-a0af-4e6f12136e69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_eb72e30f-2fb4-4f6e-88fd-68d1dc4093d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_eb72e30f-2fb4-4f6e-88fd-68d1dc4093d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_114183b6-3952-4009-bf93-d2ab5b801c2b" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_114183b6-3952-4009-bf93-d2ab5b801c2b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_bad1ac2d-7658-4692-9541-99b66b3e4c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:to="loc_us-gaap_LossContingenciesTable_bad1ac2d-7658-4692-9541-99b66b3e4c0c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a1461713-4f97-4bb6-aae9-452681befaca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_bad1ac2d-7658-4692-9541-99b66b3e4c0c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a1461713-4f97-4bb6-aae9-452681befaca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a1461713-4f97-4bb6-aae9-452681befaca_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a1461713-4f97-4bb6-aae9-452681befaca" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a1461713-4f97-4bb6-aae9-452681befaca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_033e085c-e455-44c6-b901-7acc52040215" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a1461713-4f97-4bb6-aae9-452681befaca" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_033e085c-e455-44c6-b901-7acc52040215" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_c473edf5-332e-4357-ad00-2d04a41435b1" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_033e085c-e455-44c6-b901-7acc52040215" xlink:to="loc_mo_JUULMember_c473edf5-332e-4357-ad00-2d04a41435b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b89a6176-6ba6-4000-a574-d33c429e4dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_bad1ac2d-7658-4692-9541-99b66b3e4c0c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b89a6176-6ba6-4000-a574-d33c429e4dcc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b89a6176-6ba6-4000-a574-d33c429e4dcc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b89a6176-6ba6-4000-a574-d33c429e4dcc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b89a6176-6ba6-4000-a574-d33c429e4dcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6804a4e8-3edb-469c-8990-23a88fa37c91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b89a6176-6ba6-4000-a574-d33c429e4dcc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6804a4e8-3edb-469c-8990-23a88fa37c91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2c967645-3a90-4413-9142-f16f0c684509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6804a4e8-3edb-469c-8990-23a88fa37c91" xlink:to="loc_us-gaap_SubsequentEventMember_2c967645-3a90-4413-9142-f16f0c684509" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="extended" id="i73fcd49fe9954d578c1d665827aca95e_ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_ac26214f-9ec6-43ae-bb92-1b4d5b917ff7" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_ac26214f-9ec6-43ae-bb92-1b4d5b917ff7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_eb403099-023d-4912-9ba8-2413beadc996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_eb403099-023d-4912-9ba8-2413beadc996" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_ce6f1a1c-d0f9-49ea-a3d8-770150add1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_ce6f1a1c-d0f9-49ea-a3d8-770150add1d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_d98908c8-aba3-4647-8c27-c23397809d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_d98908c8-aba3-4647-8c27-c23397809d7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_c7c2ed3f-e12d-4bd9-a6cb-fb57d2d67a8e" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_c7c2ed3f-e12d-4bd9-a6cb-fb57d2d67a8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfPendingCasesConsolidated_2e4a9588-3015-473b-a924-87ebd676fbf7" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfPendingCasesConsolidated"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_mo_LossContingencyNumberOfPendingCasesConsolidated_2e4a9588-3015-473b-a924-87ebd676fbf7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_2f8e2de4-c950-4a0a-ac34-3516b4cc2a6f" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesWithConcludedHearings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_2f8e2de4-c950-4a0a-ac34-3516b4cc2a6f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding_9046ce1c-4d50-486d-841b-741906e34c87" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding_9046ce1c-4d50-486d-841b-741906e34c87" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_61c96780-66b0-456e-ac08-1c8cb12e55e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_us-gaap_LossContingenciesTable_61c96780-66b0-456e-ac08-1c8cb12e55e4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_198925b6-3f9c-4eda-a829-d1a464a122a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_61c96780-66b0-456e-ac08-1c8cb12e55e4" xlink:to="loc_srt_LitigationCaseAxis_198925b6-3f9c-4eda-a829-d1a464a122a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_198925b6-3f9c-4eda-a829-d1a464a122a8_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_198925b6-3f9c-4eda-a829-d1a464a122a8" xlink:to="loc_srt_LitigationCaseTypeDomain_198925b6-3f9c-4eda-a829-d1a464a122a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e37b4bf7-3136-4307-bc51-bbf23eb84478" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_198925b6-3f9c-4eda-a829-d1a464a122a8" xlink:to="loc_srt_LitigationCaseTypeDomain_e37b4bf7-3136-4307-bc51-bbf23eb84478" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalAndStateShareholderDerivativeLawsuitsMember_5e1916a7-a96f-4b0f-91a8-4a5e6ad461ae" xlink:href="mo-20221231.xsd#mo_FederalAndStateShareholderDerivativeLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_e37b4bf7-3136-4307-bc51-bbf23eb84478" xlink:to="loc_mo_FederalAndStateShareholderDerivativeLawsuitsMember_5e1916a7-a96f-4b0f-91a8-4a5e6ad461ae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesLightsUltraLightsCasesDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="extended" id="i5f94dd22850d41cba5855859676c48f3_ContingenciesLightsUltraLightsCasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a30abd49-3afe-4c50-8481-d7be82847976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsNotCertifiedNumber_48ba98e8-14d4-46f4-9e29-0d12b5696986" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsNotCertifiedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a30abd49-3afe-4c50-8481-d7be82847976" xlink:to="loc_mo_LossContingencyClaimsNotCertifiedNumber_48ba98e8-14d4-46f4-9e29-0d12b5696986" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_dd522c35-755f-4d06-90cd-91c247d8d9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a30abd49-3afe-4c50-8481-d7be82847976" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_dd522c35-755f-4d06-90cd-91c247d8d9cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyStateCourtsNumber_3c421b79-1d11-4c99-9cfb-40f3bc03fce8" xlink:href="mo-20221231.xsd#mo_LossContingencyStateCourtsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a30abd49-3afe-4c50-8481-d7be82847976" xlink:to="loc_mo_LossContingencyStateCourtsNumber_3c421b79-1d11-4c99-9cfb-40f3bc03fce8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_999a74c3-b896-4b94-80e1-0974454b0713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_a30abd49-3afe-4c50-8481-d7be82847976" xlink:to="loc_us-gaap_LossContingenciesTable_999a74c3-b896-4b94-80e1-0974454b0713" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_622bf999-a558-4675-a8aa-e0994f73cec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_999a74c3-b896-4b94-80e1-0974454b0713" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_622bf999-a558-4675-a8aa-e0994f73cec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_622bf999-a558-4675-a8aa-e0994f73cec6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_622bf999-a558-4675-a8aa-e0994f73cec6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_622bf999-a558-4675-a8aa-e0994f73cec6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2cd6187f-b1e0-4a4e-89ed-b47b49f986b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_622bf999-a558-4675-a8aa-e0994f73cec6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2cd6187f-b1e0-4a4e-89ed-b47b49f986b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_555c394b-cf2b-4054-a616-858146d199c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2cd6187f-b1e0-4a4e-89ed-b47b49f986b5" xlink:to="loc_us-gaap_SubsequentEventMember_555c394b-cf2b-4054-a616-858146d199c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_26593069-3d99-49e4-aabf-0ca334c558bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_999a74c3-b896-4b94-80e1-0974454b0713" xlink:to="loc_srt_LitigationCaseAxis_26593069-3d99-49e4-aabf-0ca334c558bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_26593069-3d99-49e4-aabf-0ca334c558bb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_26593069-3d99-49e4-aabf-0ca334c558bb" xlink:to="loc_srt_LitigationCaseTypeDomain_26593069-3d99-49e4-aabf-0ca334c558bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8c153118-aec6-43b9-915c-a9986e41691a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_26593069-3d99-49e4-aabf-0ca334c558bb" xlink:to="loc_srt_LitigationCaseTypeDomain_8c153118-aec6-43b9-915c-a9986e41691a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsMember_ef812f7a-ede5-4259-85d7-52a6cfad44bb" xlink:href="mo-20221231.xsd#mo_LightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_8c153118-aec6-43b9-915c-a9986e41691a" xlink:to="loc_mo_LightsMember_ef812f7a-ede5-4259-85d7-52a6cfad44bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_ee2a7db8-4c35-4774-b7b9-fa97d0d0aed2" xlink:href="mo-20221231.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_8c153118-aec6-43b9-915c-a9986e41691a" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_ee2a7db8-4c35-4774-b7b9-fa97d0d0aed2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4b2af1ba-97b1-409d-95af-58ddd6b24b1c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_999a74c3-b896-4b94-80e1-0974454b0713" xlink:to="loc_dei_LegalEntityAxis_4b2af1ba-97b1-409d-95af-58ddd6b24b1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_4b2af1ba-97b1-409d-95af-58ddd6b24b1c_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_4b2af1ba-97b1-409d-95af-58ddd6b24b1c" xlink:to="loc_dei_EntityDomain_4b2af1ba-97b1-409d-95af-58ddd6b24b1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_959ab83a-eb5a-49cb-ba6f-9a4879c2a85d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_4b2af1ba-97b1-409d-95af-58ddd6b24b1c" xlink:to="loc_dei_EntityDomain_959ab83a-eb5a-49cb-ba6f-9a4879c2a85d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_2a71343a-6a82-4ca9-8880-d94a3979f77f" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_959ab83a-eb5a-49cb-ba6f-9a4879c2a85d" xlink:to="loc_mo_PhilipMorrisUSAMember_2a71343a-6a82-4ca9-8880-d94a3979f77f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesUSTLitigationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="extended" id="iab7689c5b1784313b89f585073fc5140_ContingenciesUSTLitigationsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_99eea727-ea63-4151-9a47-1c348f0b4e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_63e21b20-254d-4e4d-8489-11e3de243fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_99eea727-ea63-4151-9a47-1c348f0b4e0f" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_63e21b20-254d-4e4d-8489-11e3de243fde" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_142230de-03ca-4d36-8d5b-91a38b3f5959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_99eea727-ea63-4151-9a47-1c348f0b4e0f" xlink:to="loc_us-gaap_LossContingenciesTable_142230de-03ca-4d36-8d5b-91a38b3f5959" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_79386ee5-b6c8-4392-a685-a191c08f6a29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_142230de-03ca-4d36-8d5b-91a38b3f5959" xlink:to="loc_us-gaap_LitigationStatusAxis_79386ee5-b6c8-4392-a685-a191c08f6a29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_79386ee5-b6c8-4392-a685-a191c08f6a29_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_79386ee5-b6c8-4392-a685-a191c08f6a29" xlink:to="loc_us-gaap_LitigationStatusDomain_79386ee5-b6c8-4392-a685-a191c08f6a29_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_2d0dc0fc-5ad3-465b-8f92-23ebe8aaeef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_79386ee5-b6c8-4392-a685-a191c08f6a29" xlink:to="loc_us-gaap_LitigationStatusDomain_2d0dc0fc-5ad3-465b-8f92-23ebe8aaeef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_aa332fda-322f-4d39-93fa-a1986e9118cc" xlink:href="mo-20221231.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_2d0dc0fc-5ad3-465b-8f92-23ebe8aaeef9" xlink:to="loc_mo_PendingIndividualLawsuitsMember_aa332fda-322f-4d39-93fa-a1986e9118cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f6600143-4c86-4710-ba84-7ab25cbf4eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_142230de-03ca-4d36-8d5b-91a38b3f5959" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f6600143-4c86-4710-ba84-7ab25cbf4eaa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f6600143-4c86-4710-ba84-7ab25cbf4eaa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f6600143-4c86-4710-ba84-7ab25cbf4eaa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f6600143-4c86-4710-ba84-7ab25cbf4eaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7ac8718c-f63f-4020-9300-24ee2b455713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f6600143-4c86-4710-ba84-7ab25cbf4eaa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7ac8718c-f63f-4020-9300-24ee2b455713" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_947448f6-e5d4-4fa4-8188-6f28f6fbc283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7ac8718c-f63f-4020-9300-24ee2b455713" xlink:to="loc_us-gaap_SubsequentEventMember_947448f6-e5d4-4fa4-8188-6f28f6fbc283" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_22104338-ef5d-4f63-a1af-fdadfca35457" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_142230de-03ca-4d36-8d5b-91a38b3f5959" xlink:to="loc_srt_LitigationCaseAxis_22104338-ef5d-4f63-a1af-fdadfca35457" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_22104338-ef5d-4f63-a1af-fdadfca35457_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_22104338-ef5d-4f63-a1af-fdadfca35457" xlink:to="loc_srt_LitigationCaseTypeDomain_22104338-ef5d-4f63-a1af-fdadfca35457_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3897b73e-45d4-4131-baeb-0da4549674ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_22104338-ef5d-4f63-a1af-fdadfca35457" xlink:to="loc_srt_LitigationCaseTypeDomain_3897b73e-45d4-4131-baeb-0da4549674ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember_1f761c92-b094-4b40-86a0-f63be8a2c630" xlink:href="mo-20221231.xsd#mo_USTLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_3897b73e-45d4-4131-baeb-0da4549674ed" xlink:to="loc_mo_USTLitigationMember_1f761c92-b094-4b40-86a0-f63be8a2c630" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="extended" id="i029b52ae25264e4f911caa635853a189_ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c88ed95d-4596-4421-ba47-9203fdbc6421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1aaef741-5994-442c-986a-f6f1ec22a6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c88ed95d-4596-4421-ba47-9203fdbc6421" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1aaef741-5994-442c-986a-f6f1ec22a6eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_5b3a6142-283c-4f7f-a042-88c727fa1e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_c88ed95d-4596-4421-ba47-9203fdbc6421" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_5b3a6142-283c-4f7f-a042-88c727fa1e22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_869f6415-0abd-46e4-9532-648ab5d6fea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_c88ed95d-4596-4421-ba47-9203fdbc6421" xlink:to="loc_us-gaap_LossContingenciesTable_869f6415-0abd-46e4-9532-648ab5d6fea2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e44caaca-5865-457a-9170-df29c1814f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_869f6415-0abd-46e4-9532-648ab5d6fea2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e44caaca-5865-457a-9170-df29c1814f66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e44caaca-5865-457a-9170-df29c1814f66_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e44caaca-5865-457a-9170-df29c1814f66" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e44caaca-5865-457a-9170-df29c1814f66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1e0b6174-cff4-4fa5-8abc-352b4d1a2b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e44caaca-5865-457a-9170-df29c1814f66" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1e0b6174-cff4-4fa5-8abc-352b4d1a2b91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_17d90b97-f616-411e-b1bf-d0e3f535a5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1e0b6174-cff4-4fa5-8abc-352b4d1a2b91" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_17d90b97-f616-411e-b1bf-d0e3f535a5f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5ccf717f-e237-43b4-a24a-aa8a8c14fc73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_869f6415-0abd-46e4-9532-648ab5d6fea2" xlink:to="loc_us-gaap_DebtInstrumentAxis_5ccf717f-e237-43b4-a24a-aa8a8c14fc73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5ccf717f-e237-43b4-a24a-aa8a8c14fc73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5ccf717f-e237-43b4-a24a-aa8a8c14fc73" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5ccf717f-e237-43b4-a24a-aa8a8c14fc73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_832f2b2e-7aaa-4a77-bd8f-8301012c34eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5ccf717f-e237-43b4-a24a-aa8a8c14fc73" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_832f2b2e-7aaa-4a77-bd8f-8301012c34eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CreditAgreementMember_52c887ec-ce15-4f24-9c0c-0f8afe17fcb6" xlink:href="mo-20221231.xsd#mo_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_832f2b2e-7aaa-4a77-bd8f-8301012c34eb" xlink:to="loc_mo_CreditAgreementMember_52c887ec-ce15-4f24-9c0c-0f8afe17fcb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_6b57c24d-2370-48f4-9370-76a264712a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_869f6415-0abd-46e4-9532-648ab5d6fea2" xlink:to="loc_us-gaap_CreditFacilityAxis_6b57c24d-2370-48f4-9370-76a264712a89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6b57c24d-2370-48f4-9370-76a264712a89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_6b57c24d-2370-48f4-9370-76a264712a89" xlink:to="loc_us-gaap_CreditFacilityDomain_6b57c24d-2370-48f4-9370-76a264712a89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1a89a002-a365-4bc4-a8a2-3a4426a77dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_6b57c24d-2370-48f4-9370-76a264712a89" xlink:to="loc_us-gaap_CreditFacilityDomain_1a89a002-a365-4bc4-a8a2-3a4426a77dd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_cc49e702-7518-49a2-93d2-a77b88e15a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_1a89a002-a365-4bc4-a8a2-3a4426a77dd7" xlink:to="loc_us-gaap_LetterOfCreditMember_cc49e702-7518-49a2-93d2-a77b88e15a48" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>mo-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:dfb2a125-0b18-4fdf-aa8f-28a7e5cf9d49,g:08272963-4e0b-4a36-8744-7641bada9ecd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_mo_USDNotes3400MaturingMay2030Member_467c6d22-654f-40d7-bef0-306ebce09f2e_terseLabel_en-US" xlink:label="lab_mo_USDNotes3400MaturingMay2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.400%, Maturing May 2030 [Member]</link:label>
    <link:label id="lab_mo_USDNotes3400MaturingMay2030Member_label_en-US" xlink:label="lab_mo_USDNotes3400MaturingMay2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.400%, Maturing May 2030 [Member]</link:label>
    <link:label id="lab_mo_USDNotes3400MaturingMay2030Member_documentation_en-US" xlink:label="lab_mo_USDNotes3400MaturingMay2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.400%, Maturing May 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3400MaturingMay2030Member" xlink:href="mo-20221231.xsd#mo_USDNotes3400MaturingMay2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes3400MaturingMay2030Member" xlink:to="lab_mo_USDNotes3400MaturingMay2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InvestmentsLineItems_fbb3bf49-087a-4cdc-b885-223b93951045_terseLabel_en-US" xlink:label="lab_mo_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Line Items]</link:label>
    <link:label id="lab_mo_InvestmentsLineItems_label_en-US" xlink:label="lab_mo_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Line Items]</link:label>
    <link:label id="lab_mo_InvestmentsLineItems_documentation_en-US" xlink:label="lab_mo_InvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InvestmentsLineItems" xlink:to="lab_mo_InvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_1f1b643c-685c-45d9-be08-02b5922873a4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_283a732e-c95d-4b66-a7f3-f55e60f3441e_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CashDiscountsPolicyTextBlock_b55f8637-9887-4929-88ee-c59f3bafb049_terseLabel_en-US" xlink:label="lab_mo_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts</link:label>
    <link:label id="lab_mo_CashDiscountsPolicyTextBlock_label_en-US" xlink:label="lab_mo_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts [Policy Text Block]</link:label>
    <link:label id="lab_mo_CashDiscountsPolicyTextBlock_documentation_en-US" xlink:label="lab_mo_CashDiscountsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CashDiscountsPolicyTextBlock" xlink:href="mo-20221231.xsd#mo_CashDiscountsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CashDiscountsPolicyTextBlock" xlink:to="lab_mo_CashDiscountsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_d72b8883-c5ba-493e-9489-7179116843da_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside United States</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_0ba589f1-20e6-4027-8c21-c597e3df03c2_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans, Other than Share-Based Compensation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_c9dad3b4-9fd7-4dae-a5ec-db8c5e151087_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases pending</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_4b4eda95-a6d9-4bb2-aa1c-7ccd4b40678d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims filed, number</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_4ddb6c8c-755f-41a0-b3cf-ec51672217b2_terseLabel_en-US" xlink:label="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Participating Manufacturer Arbitration Panel Decision [Member]</link:label>
    <link:label id="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_label_en-US" xlink:label="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Participating Manufacturer Arbitration Panel Decision [Member]</link:label>
    <link:label id="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_documentation_en-US" xlink:label="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Participating Manufacturer Arbitration Panel Decision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:href="mo-20221231.xsd#mo_NonParticipatingManufacturerArbitrationPanelDecisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:to="lab_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_July2019ShareRepurchaseProgramMember_e3d874e0-6b30-4c0b-b0c7-813b62e8d493_terseLabel_en-US" xlink:label="lab_mo_July2019ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">July 2019 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_July2019ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_mo_July2019ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">July 2019 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_July2019ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_mo_July2019ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">July 2019 Share Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_July2019ShareRepurchaseProgramMember" xlink:href="mo-20221231.xsd#mo_July2019ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_July2019ShareRepurchaseProgramMember" xlink:to="lab_mo_July2019ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_cab0883a-ecd9-462c-9186-b38daa407512_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt before debt issuance costs and debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MiddletonMember_1a826cf8-4b3e-4c56-b18d-7821542fd0fb_terseLabel_en-US" xlink:label="lab_mo_MiddletonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Middleton [Member]</link:label>
    <link:label id="lab_mo_MiddletonMember_label_en-US" xlink:label="lab_mo_MiddletonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Middleton [Member]</link:label>
    <link:label id="lab_mo_MiddletonMember_documentation_en-US" xlink:label="lab_mo_MiddletonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Middleton [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MiddletonMember" xlink:href="mo-20221231.xsd#mo_MiddletonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MiddletonMember" xlink:to="lab_mo_MiddletonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HorizonMember_6accbc39-2aac-405e-b6e2-8c5510373044_terseLabel_en-US" xlink:label="lab_mo_HorizonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Horizon {Member]</link:label>
    <link:label id="lab_mo_HorizonMember_label_en-US" xlink:label="lab_mo_HorizonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Horizon [Member]</link:label>
    <link:label id="lab_mo_HorizonMember_documentation_en-US" xlink:label="lab_mo_HorizonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Horizon</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HorizonMember" xlink:href="mo-20221231.xsd#mo_HorizonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HorizonMember" xlink:to="lab_mo_HorizonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_193eb14a-ab34-46c4-b1e6-66e2736f5674_terseLabel_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, including discontinued operations, disposition related costs</link:label>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_label_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Disposition Related Costs</link:label>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_documentation_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Disposition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" xlink:href="mo-20221231.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" xlink:to="lab_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_39c8e53e-0099-4203-8727-77559d28ff9b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NumberOfLeveragedLeasesRemaining_49fdc0b0-f547-4f6d-ab61-656932815bd1_terseLabel_en-US" xlink:label="lab_mo_NumberOfLeveragedLeasesRemaining" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of leveraged leases remaining</link:label>
    <link:label id="lab_mo_NumberOfLeveragedLeasesRemaining_label_en-US" xlink:label="lab_mo_NumberOfLeveragedLeasesRemaining" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Leveraged Leases Remaining</link:label>
    <link:label id="lab_mo_NumberOfLeveragedLeasesRemaining_documentation_en-US" xlink:label="lab_mo_NumberOfLeveragedLeasesRemaining" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Leveraged Leases Remaining</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberOfLeveragedLeasesRemaining" xlink:href="mo-20221231.xsd#mo_NumberOfLeveragedLeasesRemaining"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NumberOfLeveragedLeasesRemaining" xlink:to="lab_mo_NumberOfLeveragedLeasesRemaining" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesTuttleMember_fb2927a6-926c-4ce6-bdbb-4c1c0f2d1460_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesTuttleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Tuttle [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesTuttleMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesTuttleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Tuttle [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesTuttleMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesTuttleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Tuttle</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesTuttleMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesTuttleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesTuttleMember" xlink:to="lab_mo_EngleProgenyCasesTuttleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes3800MaturingFebruary2024Member_23c1fe6d-3cb9-41d4-829f-a4f751f04a0d_netLabel_en-US" xlink:label="lab_mo_USDNotes3800MaturingFebruary2024Member" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.800%, Maturing February 2024 [Member]</link:label>
    <link:label id="lab_mo_USDNotes3800MaturingFebruary2024Member_6dd1b20a-ffe1-45a8-9d65-c3aa251079c6_verboseLabel_en-US" xlink:label="lab_mo_USDNotes3800MaturingFebruary2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.800% [Member]</link:label>
    <link:label id="lab_mo_USDNotes3800MaturingFebruary2024Member_label_en-US" xlink:label="lab_mo_USDNotes3800MaturingFebruary2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.800%, Maturing February 2024 [Member]</link:label>
    <link:label id="lab_mo_USDNotes3800MaturingFebruary2024Member_documentation_en-US" xlink:label="lab_mo_USDNotes3800MaturingFebruary2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.800%, Maturing February 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3800MaturingFebruary2024Member" xlink:href="mo-20221231.xsd#mo_USDNotes3800MaturingFebruary2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes3800MaturingFebruary2024Member" xlink:to="lab_mo_USDNotes3800MaturingFebruary2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_3c439a99-5f7f-4549-9de1-2a1fd6ab8575_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_da2975cd-6a3c-4d8e-b377-884b9ead8be5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesSchertzerMember_593fa073-0e23-470b-943e-20cd1778468d_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesSchertzerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Schertzer [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesSchertzerMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesSchertzerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Schertzer [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesSchertzerMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesSchertzerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Schertzer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSchertzerMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesSchertzerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesSchertzerMember" xlink:to="lab_mo_EngleProgenyCasesSchertzerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax_30a2cc63-850b-4c2f-9a3c-3ee0197ee0d1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_1bdc3bbc-73e1-4efe-bb04-d85aed7a8cb5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid on common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_ef0de476-6a34-44d6-a7b9-7455f9e2f022_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsMember_5bdc8eb4-4f6b-4d87-b5c4-9ffc63820956_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember" xlink:to="lab_mo_HealthCareCostRecoveryActionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_8960bacc-f82e-47af-a55a-f64ff35a7ab4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_1a23cdec-d2d7-4a0f-b390-6c2777914c37_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories:</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_bc897ddb-4c33-465a-ad76-eba05ded074f_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contract [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_4d7ead45-9237-44b3-ae4e-a559782d9232_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income):</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTextBlock_5956aa67-b6e0-463e-b8ab-bc30e2fb37be_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Equity Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTextBlock" xlink:to="lab_us-gaap_InvestmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e6b11df7-4b59-4a3f-8f0b-8d747d5997a4_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_b101d9e2-a136-4e38-a2bb-d96aab816929_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ce72b2d0-c0d5-49bd-a00d-ce9a59e348dd_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Applicable portion of interest rate for borrowing</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits_9b28f07b-0e74-4c40-a9c5-ae4f6f7c9a30_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases alleging unfair practices</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Class Action Lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Class Action Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfInactiveClassActionLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:to="lab_mo_LossContingencyNumberOfInactiveClassActionLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_150dc729-d79c-4aba-837f-926e2c68ab4a_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes5375MaturingJanuary2044Member_53183b27-2f70-48f1-bbea-7788644ce258_terseLabel_en-US" xlink:label="lab_mo_USDNotes5375MaturingJanuary2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 5.375%, Maturing January 2044 [Member]</link:label>
    <link:label id="lab_mo_USDNotes5375MaturingJanuary2044Member_label_en-US" xlink:label="lab_mo_USDNotes5375MaturingJanuary2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 5.375%, Maturing January 2044 [Member]</link:label>
    <link:label id="lab_mo_USDNotes5375MaturingJanuary2044Member_documentation_en-US" xlink:label="lab_mo_USDNotes5375MaturingJanuary2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 5.375%, Maturing January 2044</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes5375MaturingJanuary2044Member" xlink:href="mo-20221231.xsd#mo_USDNotes5375MaturingJanuary2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes5375MaturingJanuary2044Member" xlink:to="lab_mo_USDNotes5375MaturingJanuary2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_985a64e6-0799-45f9-8005-dbbf5a85806b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_8ac1338f-1358-47b3-ba1e-3c26280a765f_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_7a9f4078-ae00-4ae6-9ce0-1054a98d5dc9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_f3b46f3f-b768-45d9-b85a-748e526a8020_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_1dbb82ad-c9d2-4149-b0c4-f8d9b7259466_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_1d0fe9c3-5c06-48b9-a0e7-d0673987c2a7_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_6873cf66-4631-4671-a095-1ec9b8532d12_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_8db777ab-7a83-4c19-acb9-bf3a44843bb6_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Paid: Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_f326a906-8dee-430e-ad0f-753ae5bb7275_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_08c6a994-ee76-4209-b27b-58602080a6a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a6851a15-bf2e-4468-94e5-32d18b19b55b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_66336678-c896-4fa1-bbb7-eb7c27d37662_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:to="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_93ab76dc-8da4-4f5e-893f-a581d5148c7f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_dac6b27a-5e34-4517-a11c-c1b16628d00b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DisposalGroupInterestReceivable_a595fb6c-e141-4ca8-bc4f-ff41a76edd24_terseLabel_en-US" xlink:label="lab_mo_DisposalGroupInterestReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, interest receivable</link:label>
    <link:label id="lab_mo_DisposalGroupInterestReceivable_label_en-US" xlink:label="lab_mo_DisposalGroupInterestReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Interest Receivable</link:label>
    <link:label id="lab_mo_DisposalGroupInterestReceivable_documentation_en-US" xlink:label="lab_mo_DisposalGroupInterestReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Interest Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupInterestReceivable" xlink:href="mo-20221231.xsd#mo_DisposalGroupInterestReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DisposalGroupInterestReceivable" xlink:to="lab_mo_DisposalGroupInterestReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_6b1e0c13-3a74-45ba-946f-eb2b67077c78_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_14cf8464-1e57-42b9-8fa6-bc04159b756c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions based on tax positions related to the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_359da41f-cad8-435e-9d53-edc1896146d6_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_342a2142-c6e0-4d19-8702-d452ca61302c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">%</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_3eb22758-95e3-4c8a-8edf-7f3f6696bdb9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesHollimanMember_5c61083e-c3fc-4722-8fd2-ba01467d12b3_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesHollimanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Holliman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesHollimanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesHollimanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Holliman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesHollimanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesHollimanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Holliman [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHollimanMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesHollimanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesHollimanMember" xlink:to="lab_mo_EngleProgenyCasesHollimanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_faba066c-64c9-407f-9849-52c19d729793_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of JUUL equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_ff6c8f73-c763-431d-bc4a-7229f0c0ff69_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of JUUL equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_c8aed3c7-3090-44fd-85ee-63332e4b5605_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts recorded in accumulated other comprehensive losses</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NPMAdjustmentToInterestExpenseMember_6d873590-7e0b-4454-987d-5ac1b117b765_terseLabel_en-US" xlink:label="lab_mo_NPMAdjustmentToInterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment To Interest Expense [Member]</link:label>
    <link:label id="lab_mo_NPMAdjustmentToInterestExpenseMember_label_en-US" xlink:label="lab_mo_NPMAdjustmentToInterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment To Interest Expense [Member]</link:label>
    <link:label id="lab_mo_NPMAdjustmentToInterestExpenseMember_documentation_en-US" xlink:label="lab_mo_NPMAdjustmentToInterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment To Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NPMAdjustmentToInterestExpenseMember" xlink:href="mo-20221231.xsd#mo_NPMAdjustmentToInterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NPMAdjustmentToInterestExpenseMember" xlink:to="lab_mo_NPMAdjustmentToInterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_e819ead8-3642-4ec6-9613-dc4b757181ec_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, plan assets, amount</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_559fa1d0-52dc-4376-8842-7cab3af6a7b8_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_00dd2e19-22a9-47c1-8c95-767d887e51bb_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_1987bb0b-59cf-4748-a7fa-e88f2105a18a_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets, net</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofCasesSetforTrial_0ddefd1e-bedf-407a-b215-1c85e74e7a59_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases set for trial</link:label>
    <link:label id="lab_mo_LossContingencyNumberofCasesSetforTrial_label_en-US" xlink:label="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Set for Trial</link:label>
    <link:label id="lab_mo_LossContingencyNumberofCasesSetforTrial_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases Set for Trial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofCasesSetforTrial" xlink:to="lab_mo_LossContingencyNumberofCasesSetforTrial" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationCasesResultsMember_35ed5277-bfb7-4b6f-91c7-b7a587fd4716_terseLabel_en-US" xlink:label="lab_mo_LitigationCasesResultsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation [Member]</link:label>
    <link:label id="lab_mo_LitigationCasesResultsMember_label_en-US" xlink:label="lab_mo_LitigationCasesResultsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Cases Results [Member]</link:label>
    <link:label id="lab_mo_LitigationCasesResultsMember_documentation_en-US" xlink:label="lab_mo_LitigationCasesResultsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Cases Results [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember" xlink:href="mo-20221231.xsd#mo_LitigationCasesResultsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationCasesResultsMember" xlink:to="lab_mo_LitigationCasesResultsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PeriodOneMember_2aac1289-d615-45ba-986c-61ee00e41056_terseLabel_en-US" xlink:label="lab_mo_PeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period One</link:label>
    <link:label id="lab_mo_PeriodOneMember_label_en-US" xlink:label="lab_mo_PeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period One [Member]</link:label>
    <link:label id="lab_mo_PeriodOneMember_documentation_en-US" xlink:label="lab_mo_PeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodOneMember" xlink:href="mo-20221231.xsd#mo_PeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PeriodOneMember" xlink:to="lab_mo_PeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_b38478c3-da8b-41ad-9f4e-2cd5c1fa546d_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_b5f0dad0-336a-43f0-b430-139e501d8828_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_bd287841-9a22-4ad4-9958-757f01a38ce8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_dc9f11a0-9daf-4a15-87d8-ab0204ed8655_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_14dc2bd3-2bef-416b-8cc9-2fb6d1a939fb_terseLabel_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Member]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_label_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Member]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtMember_documentation_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember" xlink:href="mo-20221231.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ForeignCurrencyDenominatedDebtMember" xlink:to="lab_mo_ForeignCurrencyDenominatedDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c3851bf0-de0b-4cf9-8b61-b31e38944e54_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses), net of deferred income taxes:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_f3479afa-916e-4006-88f9-9509b30210a9_terseLabel_en-US" xlink:label="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, pending claims, consolidated for pre-trial purposes, number</link:label>
    <link:label id="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_label_en-US" xlink:label="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number</link:label>
    <link:label id="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:href="mo-20221231.xsd#mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:to="lab_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_3ab812c6-5bd7-49db-b28a-0ae661ad927f_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_cbc757dc-2b03-4192-ab1f-90c8226873c8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gains) losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_72126fa0-c4d7-4a30-a3d5-87449f859a0b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_c6a35331-a139-458d-9c90-5e87ba15b496_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax settlements</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_0691b6c1-1060-493f-a1e0-65d998fdd6f3_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USSTCMember_14133236-fc34-4d9c-8b6b-030081529c73_terseLabel_en-US" xlink:label="lab_mo_USSTCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USSTC [Member]</link:label>
    <link:label id="lab_mo_USSTCMember_label_en-US" xlink:label="lab_mo_USSTCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USSTC [Member]</link:label>
    <link:label id="lab_mo_USSTCMember_documentation_en-US" xlink:label="lab_mo_USSTCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USSTC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USSTCMember" xlink:href="mo-20221231.xsd#mo_USSTCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USSTCMember" xlink:to="lab_mo_USSTCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesD.BrownMember_c06a6fdb-95b2-4b7f-934c-50c5869bffa4_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesD.BrownMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D. Brown [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesD.BrownMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesD.BrownMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D. Brown [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesD.BrownMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesD.BrownMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, D. Brown [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesD.BrownMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesD.BrownMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesD.BrownMember" xlink:to="lab_mo_EngleProgenyCasesD.BrownMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_1b78f236-1b1b-414c-98f4-36137b8e30e5_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states that cap bond or require no bond</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States That Cap Bond or Require No Bond</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States That Cap Bond or Require No Bond</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:to="lab_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IQOSMember_babcda31-9313-4445-907f-1425a6dfebef_terseLabel_en-US" xlink:label="lab_mo_IQOSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IQOS [Member]</link:label>
    <link:label id="lab_mo_IQOSMember_label_en-US" xlink:label="lab_mo_IQOSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IQOS [Member]</link:label>
    <link:label id="lab_mo_IQOSMember_documentation_en-US" xlink:label="lab_mo_IQOSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IQOS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IQOSMember" xlink:href="mo-20221231.xsd#mo_IQOSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IQOSMember" xlink:to="lab_mo_IQOSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_05717420-c092-4964-bf17-4523c1daf55f_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_c5153f98-50ba-4db7-bfca-1d5a8704261c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt excluding current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_fb5323bb-2282-4c96-a60b-175cba41acd6_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of additional states extended with settled litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_label_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional States Extended with Settled Litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Additional States Extended with Settled Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:to="lab_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_7d1912f4-360d-44d8-9128-53fd9bee3561_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_0ac7c3ac-3e56-426a-b751-336d97e9c5cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan amendments</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:to="lab_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_22135c2c-707e-4205-8972-a00036e32204_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_79621672-833d-46a9-97cb-e578486af021_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Investing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes10200MaturingFebruary2039Member_0a01301d-8d3a-49a9-8ed0-addbd8fea126_terseLabel_en-US" xlink:label="lab_mo_USDNotes10200MaturingFebruary2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 10.200%, Maturing February 2039 [Member]</link:label>
    <link:label id="lab_mo_USDNotes10200MaturingFebruary2039Member_00d8b943-e5a8-41e2-8565-2db7a98283f3_verboseLabel_en-US" xlink:label="lab_mo_USDNotes10200MaturingFebruary2039Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 10.200% [Member]</link:label>
    <link:label id="lab_mo_USDNotes10200MaturingFebruary2039Member_label_en-US" xlink:label="lab_mo_USDNotes10200MaturingFebruary2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 10.200%, Maturing February 2039 [Member]</link:label>
    <link:label id="lab_mo_USDNotes10200MaturingFebruary2039Member_documentation_en-US" xlink:label="lab_mo_USDNotes10200MaturingFebruary2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 10.200%, Maturing February 2039</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes10200MaturingFebruary2039Member" xlink:href="mo-20221231.xsd#mo_USDNotes10200MaturingFebruary2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes10200MaturingFebruary2039Member" xlink:to="lab_mo_USDNotes10200MaturingFebruary2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_30f3c42c-621d-4beb-87d9-7684202cef2e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Future Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_3bf4c0ec-b866-48a5-a722-a8a919c762f6_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_dad3db64-5407-4f8b-93a5-fcc612f46b10_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost/credit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b1bb9c7e-c779-4c9f-a47a-8c7fcd7c320d_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes2625MaturingSeptember2026Member_10acbac4-4992-488f-b966-7caa909cb5f6_terseLabel_en-US" xlink:label="lab_mo_USDNotes2625MaturingSeptember2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.625%, Maturing September 2026 [Member]</link:label>
    <link:label id="lab_mo_USDNotes2625MaturingSeptember2026Member_label_en-US" xlink:label="lab_mo_USDNotes2625MaturingSeptember2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.625%, Maturing September 2026 [Member]</link:label>
    <link:label id="lab_mo_USDNotes2625MaturingSeptember2026Member_documentation_en-US" xlink:label="lab_mo_USDNotes2625MaturingSeptember2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.625%, Maturing September 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2625MaturingSeptember2026Member" xlink:href="mo-20221231.xsd#mo_USDNotes2625MaturingSeptember2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes2625MaturingSeptember2026Member" xlink:to="lab_mo_USDNotes2625MaturingSeptember2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_28afbc8a-1dd7-4ec8-95af-511137c941e9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_525189f4-fe14-4984-98b8-2b9b7c6e4545_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld_528e5c73-7242-4017-88e0-7a561417ee92_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance assets, net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Interests in Financial Assets Continued to be Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e2a845bd-92e0-42b1-afa1-de37c5d59eb8_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_d0c62c53-fa61-4392-9b06-383546831576_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_ec3bbaf4-a6ee-49fa-ae1b-bb5309373871_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_fe09cb87-a65e-4aff-9024-2a252dddad7b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful life of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_acbb17e8-1db3-43a4-8be5-5584ebede525_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtTextBlock" xlink:to="lab_us-gaap_LongTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAndLandImprovements_662f6fb5-9228-4c66-b212-c8e22b787df3_terseLabel_en-US" xlink:label="lab_us-gaap_LandAndLandImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and land improvements</link:label>
    <link:label id="lab_us-gaap_LandAndLandImprovements_label_en-US" xlink:label="lab_us-gaap_LandAndLandImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land and Land Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAndLandImprovements" xlink:to="lab_us-gaap_LandAndLandImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2497c0e8-f9a1-4cdd-96c2-6216ab6796eb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_674f932e-36b6-4098-aef7-f67f9a9a52f3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_446b8fa3-20b7-4778-9b5f-b4a5592f2d07_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_43f31cac-19f9-49f1-886a-1ec85ae4fcf6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_8c1d85e3-6d36-4aa9-b753-291a01bbc98d_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in ABI</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investment in Noncontrolled Affiliates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent_e8236b1c-190a-412d-9089-877217ee8c4e_terseLabel_en-US" xlink:label="lab_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred gain from the sale of IQOS System commercialization rights</link:label>
    <link:label id="lab_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent_label_en-US" xlink:label="lab_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Gain On Sale Of Commercialization Rights, Noncurrent</link:label>
    <link:label id="lab_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent_documentation_en-US" xlink:label="lab_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Gain On Sale Of Commercialization Rights, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent" xlink:href="mo-20221231.xsd#mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent" xlink:to="lab_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_fd5fbcb5-7afd-4e58-b79a-59e9d53d400e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_19235d71-6d3f-42cf-bdc0-cb9c6d61628b_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred provision for income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_39f73e01-8294-4dfe-905f-f326728a64bc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock3.125NotesDue2031Member_fd940b90-df68-4f73-a9fc-004e28cf6a53_terseLabel_en-US" xlink:label="lab_mo_CommonStock3.125NotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.125% Notes due 2031</link:label>
    <link:label id="lab_mo_CommonStock3.125NotesDue2031Member_label_en-US" xlink:label="lab_mo_CommonStock3.125NotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 3.125% Notes Due 2031 [Member]</link:label>
    <link:label id="lab_mo_CommonStock3.125NotesDue2031Member_documentation_en-US" xlink:label="lab_mo_CommonStock3.125NotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 3.125% Notes Due 2031 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock3.125NotesDue2031Member" xlink:href="mo-20221231.xsd#mo_CommonStock3.125NotesDue2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock3.125NotesDue2031Member" xlink:to="lab_mo_CommonStock3.125NotesDue2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_2332bf40-cdb0-4aea-a281-31ee6b6edc36_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) included in (income) losses from investments in equity securities</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_07907007-a9d4-44ef-80f8-bf30abeab030_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_435638d4-b8b2-4999-9562-9f6c611a8a06_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentsMember" xlink:to="lab_us-gaap_OtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_JUULMember_16287c5a-1631-4d8d-bd1b-8b7c8ff4ce82_terseLabel_en-US" xlink:label="lab_mo_JUULMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL [Member]</link:label>
    <link:label id="lab_mo_JUULMember_label_en-US" xlink:label="lab_mo_JUULMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL [Member]</link:label>
    <link:label id="lab_mo_JUULMember_documentation_en-US" xlink:label="lab_mo_JUULMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_JUULMember" xlink:to="lab_mo_JUULMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOther_ada21e20-246b-44d1-9084-9b1a9637fc9c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOther_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOther" xlink:to="lab_us-gaap_InterestIncomeOther" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax_6e650dcc-8d3e-4e16-ade1-aa42e166b9c0_terseLabel_en-US" xlink:label="lab_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments and other</link:label>
    <link:label id="lab_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax_label_en-US" xlink:label="lab_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment And Other, Net of Tax</link:label>
    <link:label id="lab_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax_documentation_en-US" xlink:label="lab_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment And Other, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax" xlink:to="lab_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f226ee6c-73fe-4b39-b337-ac2a3aa8e980_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_JUULAndCronosMember_ffd77124-c5c3-4803-8afd-ace2e32d3d41_terseLabel_en-US" xlink:label="lab_mo_JUULAndCronosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments [Member]</link:label>
    <link:label id="lab_mo_JUULAndCronosMember_label_en-US" xlink:label="lab_mo_JUULAndCronosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL and Cronos [Member]</link:label>
    <link:label id="lab_mo_JUULAndCronosMember_documentation_en-US" xlink:label="lab_mo_JUULAndCronosMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL and Cronos</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULAndCronosMember" xlink:href="mo-20221231.xsd#mo_JUULAndCronosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_JUULAndCronosMember" xlink:to="lab_mo_JUULAndCronosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_772b5203-079c-4ebd-8ced-ea857145a5de_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_78866915-f4a9-424e-862a-20321efb0c08_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CanadianTobaccoManufacturersMember_5bb2472c-7f50-4d82-9c15-5d8649f9a2ea_terseLabel_en-US" xlink:label="lab_mo_CanadianTobaccoManufacturersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Tobacco Manufacturers [Member]</link:label>
    <link:label id="lab_mo_CanadianTobaccoManufacturersMember_label_en-US" xlink:label="lab_mo_CanadianTobaccoManufacturersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Tobacco Manufacturers [Member]</link:label>
    <link:label id="lab_mo_CanadianTobaccoManufacturersMember_documentation_en-US" xlink:label="lab_mo_CanadianTobaccoManufacturersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canadian Tobacco Manufacturers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember" xlink:href="mo-20221231.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CanadianTobaccoManufacturersMember" xlink:to="lab_mo_CanadianTobaccoManufacturersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_81c328ff-c8d3-4551-9778-2c24edbf9ac4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InvestmentsTable_8f818435-e7ad-46d8-abec-d7d2a84d5bfd_terseLabel_en-US" xlink:label="lab_mo_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table]</link:label>
    <link:label id="lab_mo_InvestmentsTable_label_en-US" xlink:label="lab_mo_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:label id="lab_mo_InvestmentsTable_documentation_en-US" xlink:label="lab_mo_InvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InvestmentsTable" xlink:to="lab_mo_InvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USTIncMember_09e65c03-302b-4f70-b745-2c27ef451b96_terseLabel_en-US" xlink:label="lab_mo_USTIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Inc. [Member]</link:label>
    <link:label id="lab_mo_USTIncMember_label_en-US" xlink:label="lab_mo_USTIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Inc. [Member]</link:label>
    <link:label id="lab_mo_USTIncMember_documentation_en-US" xlink:label="lab_mo_USTIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTIncMember" xlink:href="mo-20221231.xsd#mo_USTIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USTIncMember" xlink:to="lab_mo_USTIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_2e4214f3-ce02-4e47-9b89-303ff35c075d_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_f7513d4b-f5aa-44dc-83fa-ac82310af35b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_efaf4b2c-042a-4fe9-8f04-c63c10569233_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_b1a86452-00b2-46a3-8f72-b4f034bb4df3_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AuditInformationAbstract_f8e0bfdc-b61f-496e-adff-a6d59abff0db_terseLabel_en-US" xlink:label="lab_mo_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_mo_AuditInformationAbstract_label_en-US" xlink:label="lab_mo_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_mo_AuditInformationAbstract_documentation_en-US" xlink:label="lab_mo_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AuditInformationAbstract" xlink:href="mo-20221231.xsd#mo_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AuditInformationAbstract" xlink:to="lab_mo_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember_66520969-2570-42c6-86ec-81913d08f2cd_terseLabel_en-US" xlink:label="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Disputes Under the State Settlement Agreements [Member]</link:label>
    <link:label id="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember_label_en-US" xlink:label="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Disputes Under the State Settlement Agreements [Member]</link:label>
    <link:label id="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember_documentation_en-US" xlink:label="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Disputes Under the State Settlement Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:href="mo-20221231.xsd#mo_OtherDisputesUndertheStateSettlementAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:to="lab_mo_OtherDisputesUndertheStateSettlementAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentImpairment_b1e624aa-f1aa-4f00-ad13-a32561779615_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, impairment</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentImpairment_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Impairment</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentImpairment_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentImpairment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentImpairment" xlink:to="lab_mo_EquityMethodInvestmentImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_8fec3c66-2e4d-4eeb-8b9b-a5d23a085c7c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_d2e4d4b0-2f33-4a62-8ff4-a9da81c5ef7e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_TermSecuredOvernightFinancingRateTermSOFRMember_d165a394-c47a-4ed7-96d4-960572390cd3_terseLabel_en-US" xlink:label="lab_mo_TermSecuredOvernightFinancingRateTermSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Secured Overnight Financing Rate ("Term SOFR") [Member]</link:label>
    <link:label id="lab_mo_TermSecuredOvernightFinancingRateTermSOFRMember_label_en-US" xlink:label="lab_mo_TermSecuredOvernightFinancingRateTermSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Secured Overnight Financing Rate ("Term SOFR") [Member]</link:label>
    <link:label id="lab_mo_TermSecuredOvernightFinancingRateTermSOFRMember_documentation_en-US" xlink:label="lab_mo_TermSecuredOvernightFinancingRateTermSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Secured Overnight Financing Rate ("Term SOFR")</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TermSecuredOvernightFinancingRateTermSOFRMember" xlink:href="mo-20221231.xsd#mo_TermSecuredOvernightFinancingRateTermSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_TermSecuredOvernightFinancingRateTermSOFRMember" xlink:to="lab_mo_TermSecuredOvernightFinancingRateTermSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IntangibleAssetsDomain_79b6603a-c910-49bd-927d-fd3797b26a87_terseLabel_en-US" xlink:label="lab_mo_IntangibleAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Domain]</link:label>
    <link:label id="lab_mo_IntangibleAssetsDomain_label_en-US" xlink:label="lab_mo_IntangibleAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Domain]</link:label>
    <link:label id="lab_mo_IntangibleAssetsDomain_documentation_en-US" xlink:label="lab_mo_IntangibleAssetsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IntangibleAssetsDomain" xlink:href="mo-20221231.xsd#mo_IntangibleAssetsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IntangibleAssetsDomain" xlink:to="lab_mo_IntangibleAssetsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_9cde005b-371c-4885-b579-30356b0a72ce_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2019-2021</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2019-2021 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2019-2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20192021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" xlink:to="lab_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_e6361073-2520-403a-844d-79aee74a7242_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_c4a8b39a-cf8b-4d8c-9cf4-892702c05bc3_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_b69b4146-a154-418c-82ab-0ce1392115b4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MunicipalBondsMember_d2957d33-3cc4-4b27-8b17-4552740b839e_terseLabel_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:label id="lab_us-gaap_MunicipalBondsMember_label_en-US" xlink:label="lab_us-gaap_MunicipalBondsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Municipal Bonds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MunicipalBondsMember" xlink:to="lab_us-gaap_MunicipalBondsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_AR_8661d95f-10e8-4e7b-84c8-103596ebb5cc_terseLabel_en-US" xlink:label="lab_stpr_AR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arkansas [Member]</link:label>
    <link:label id="lab_stpr_AR_label_en-US" xlink:label="lab_stpr_AR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ARKANSAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_AR" xlink:to="lab_stpr_AR" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IQOSTobaccoHeatingSystemMember_55dd1dbc-9ca3-4a4d-9ebc-9d758c6f96ad_terseLabel_en-US" xlink:label="lab_mo_IQOSTobaccoHeatingSystemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IQOS Tobacco Heating System</link:label>
    <link:label id="lab_mo_IQOSTobaccoHeatingSystemMember_label_en-US" xlink:label="lab_mo_IQOSTobaccoHeatingSystemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IQOS Tobacco Heating System [Member]</link:label>
    <link:label id="lab_mo_IQOSTobaccoHeatingSystemMember_documentation_en-US" xlink:label="lab_mo_IQOSTobaccoHeatingSystemMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IQOS Tobacco Heating System</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IQOSTobaccoHeatingSystemMember" xlink:href="mo-20221231.xsd#mo_IQOSTobaccoHeatingSystemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IQOSTobaccoHeatingSystemMember" xlink:to="lab_mo_IQOSTobaccoHeatingSystemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_8b30205f-ff37-45f5-b1d4-a5e6f8ed7ae8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_99cf4c2d-313f-4cf8-a108-ff2de6d84dc7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Before Income Taxes and Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_AK_9a32feae-4b5b-4c3b-8d27-f6f0cbe3b8db_terseLabel_en-US" xlink:label="lab_stpr_AK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alaska [Member]</link:label>
    <link:label id="lab_stpr_AK_label_en-US" xlink:label="lab_stpr_AK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALASKA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AK" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_AK" xlink:to="lab_stpr_AK" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_b17a3787-f6fa-4814-a2ec-cb27d1129dde_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:to="lab_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_dea89011-5ac1-40fe-a8c3-eb7c276a2004_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and building equipment</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0aa73313-1635-4736-a1cd-844e61940828_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period of recognition, in years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_4fdf1b6a-2190-480a-97f1-8962bc4c7136_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_bf69fa66-b07c-46d2-946a-792fdb27e6da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Definite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_838d88ca-a3d9-4ce8-baf1-3f4629c273ca_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_fcef3f4c-9218-4eea-a562-92f0fbbb0d5b_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on extinguishment of debt, before write off of debt issuance cost</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_67d8a09d-168e-4330-a92f-ae65a9cb9276_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_4e8487b0-9ff2-4df1-9a15-66da67812bab_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_37b4b8a6-2056-4c58-9f72-95dcd7aa832e_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_df0e5a6c-34a3-4c7e-804d-8bbe9d40a803_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock_dabbe59f-61a2-4937-9388-fe807d6f1280_terseLabel_en-US" xlink:label="lab_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock_label_en-US" xlink:label="lab_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Deferred Revenue [Policy Text Block]</link:label>
    <link:label id="lab_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock_documentation_en-US" xlink:label="lab_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock" xlink:href="mo-20221231.xsd#mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock" xlink:to="lab_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyVerdictsUpheld_f388c566-d880-41b1-b873-0987da7393fc_terseLabel_en-US" xlink:label="lab_mo_LossContingencyVerdictsUpheld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of verdicts upheld</link:label>
    <link:label id="lab_mo_LossContingencyVerdictsUpheld_label_en-US" xlink:label="lab_mo_LossContingencyVerdictsUpheld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdicts Upheld</link:label>
    <link:label id="lab_mo_LossContingencyVerdictsUpheld_documentation_en-US" xlink:label="lab_mo_LossContingencyVerdictsUpheld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdicts Upheld</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictsUpheld" xlink:href="mo-20221231.xsd#mo_LossContingencyVerdictsUpheld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyVerdictsUpheld" xlink:to="lab_mo_LossContingencyVerdictsUpheld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_a0f59100-5ded-4641-ae6d-448bacdde8d0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_d6eba591-ba90-4558-aa09-5826d2377278_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount of Notes Purchased</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_f3e0adc8-28be-45a2-9d5a-e2c913fcca15_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_601f8eda-59c2-4da4-8517-90afb51ac57d_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_TrademarksMSTMember_2c298ca8-7516-4b6c-83f5-e3de57244b7e_terseLabel_en-US" xlink:label="lab_mo_TrademarksMSTMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, MST [Member]</link:label>
    <link:label id="lab_mo_TrademarksMSTMember_label_en-US" xlink:label="lab_mo_TrademarksMSTMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, MST [Member]</link:label>
    <link:label id="lab_mo_TrademarksMSTMember_documentation_en-US" xlink:label="lab_mo_TrademarksMSTMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, MST</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TrademarksMSTMember" xlink:href="mo-20221231.xsd#mo_TrademarksMSTMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_TrademarksMSTMember" xlink:to="lab_mo_TrademarksMSTMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_6720c18c-22ad-4e84-81b5-3747a69a8257_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d9fa93f5-21d9-4709-976b-fbbc55427fcc_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e094caa4-4cee-42cb-8c22-191507cfaeb6_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c6c8de2d-49c3-4a81-82f0-41f0130d7acd_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balances</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_ab5da543-43e5-4229-bd3e-57081d65c7bb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IncreaseDecreaseInSettlementPayable_d77554ca-aca6-45ff-88c7-6d162e5f0d2b_terseLabel_en-US" xlink:label="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued settlement charges</link:label>
    <link:label id="lab_mo_IncreaseDecreaseInSettlementPayable_label_en-US" xlink:label="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Settlement Payable</link:label>
    <link:label id="lab_mo_IncreaseDecreaseInSettlementPayable_documentation_en-US" xlink:label="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The net change during the period in Settlement payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncreaseDecreaseInSettlementPayable" xlink:href="mo-20221231.xsd#mo_IncreaseDecreaseInSettlementPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IncreaseDecreaseInSettlementPayable" xlink:to="lab_mo_IncreaseDecreaseInSettlementPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_f4116eb9-e846-4641-9f1e-d5a2380ccd55_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions_e092afd5-1990-4259-b894-1a66524bea95_terseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to valuation allowance charged to income tax expense</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions_label_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Additions</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions" xlink:href="mo-20221231.xsd#mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions" xlink:to="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyRoyaltyFeePercentage_e176d3de-38f0-4158-a012-ed8b8ec17f86_terseLabel_en-US" xlink:label="lab_mo_LossContingencyRoyaltyFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, royalty fee percentage</link:label>
    <link:label id="lab_mo_LossContingencyRoyaltyFeePercentage_label_en-US" xlink:label="lab_mo_LossContingencyRoyaltyFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Royalty Fee Percentage</link:label>
    <link:label id="lab_mo_LossContingencyRoyaltyFeePercentage_documentation_en-US" xlink:label="lab_mo_LossContingencyRoyaltyFeePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Royalty Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyRoyaltyFeePercentage" xlink:href="mo-20221231.xsd#mo_LossContingencyRoyaltyFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyRoyaltyFeePercentage" xlink:to="lab_mo_LossContingencyRoyaltyFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a1fe2ef5-306c-43d2-a317-decfbeeb48bd_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesCooperMember_3ac93f48-6153-45db-9a7e-98346ceb4fbb_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesCooperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cooper [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCooperMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesCooperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cooper [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCooperMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesCooperMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cooper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCooperMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesCooperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesCooperMember" xlink:to="lab_mo_EngleProgenyCasesCooperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_bd4f9072-2e93-4f61-8c4b-ffa4cf91a181_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, number of shares eligible for purchase</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Eligible For Purchase</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Eligible For Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:to="lab_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_f48d606c-7ecf-4e66-b137-64b48403c89f_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_8f08c9bd-316c-4f49-9827-e98242d47425_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_50f5a385-9475-4c48-b076-4cb0c2da8b76_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5773d8be-4b04-4658-8c26-407f7ab4935a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7ddc155e-0f9e-4240-bcc4-4a81eb68449a_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_a5d219bf-ce4b-465c-8b5e-4001671ee9aa_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_701947ed-9ead-4080-8a1c-6e6a8950ffcc_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_c86726a5-bf68-48b4-a5dc-21e6e9ad0d21_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price per share of shares repurchased (USD per share)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare_label_en-US" xlink:label="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Acquired, Average Cost Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:to="lab_us-gaap_TreasuryStockAcquiredAverageCostPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0f4f25d8-07c5-4f2a-8a3b-4c3b9972a7ff_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2ed1c16c-ec20-49e9-b9b9-ca7386500b73_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future amortization, year 4</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NumberOfThirdPartyLawsuits_c746b144-e200-4f79-9c84-0265f08700eb_terseLabel_en-US" xlink:label="lab_mo_NumberOfThirdPartyLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of third party lawsuits</link:label>
    <link:label id="lab_mo_NumberOfThirdPartyLawsuits_label_en-US" xlink:label="lab_mo_NumberOfThirdPartyLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third Party Lawsuits</link:label>
    <link:label id="lab_mo_NumberOfThirdPartyLawsuits_documentation_en-US" xlink:label="lab_mo_NumberOfThirdPartyLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Third Party Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberOfThirdPartyLawsuits" xlink:href="mo-20221231.xsd#mo_NumberOfThirdPartyLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NumberOfThirdPartyLawsuits" xlink:to="lab_mo_NumberOfThirdPartyLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DefiniteLivedIntangibleAssetsMember_1a81f063-4b63-44cf-9a8e-df286a297895_terseLabel_en-US" xlink:label="lab_mo_DefiniteLivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-Lived Intangible Assets [Member]</link:label>
    <link:label id="lab_mo_DefiniteLivedIntangibleAssetsMember_label_en-US" xlink:label="lab_mo_DefiniteLivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite Lived Intangible Assets [Member]</link:label>
    <link:label id="lab_mo_DefiniteLivedIntangibleAssetsMember_documentation_en-US" xlink:label="lab_mo_DefiniteLivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite Lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefiniteLivedIntangibleAssetsMember" xlink:href="mo-20221231.xsd#mo_DefiniteLivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DefiniteLivedIntangibleAssetsMember" xlink:to="lab_mo_DefiniteLivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes3700MaturingFebruary2051Member_11b9810d-7e89-4130-8e4d-5de133d253df_terseLabel_en-US" xlink:label="lab_mo_USDNotes3700MaturingFebruary2051Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.700%, Maturing February 2051 [Member]</link:label>
    <link:label id="lab_mo_USDNotes3700MaturingFebruary2051Member_label_en-US" xlink:label="lab_mo_USDNotes3700MaturingFebruary2051Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.700%, Maturing February 2051 [Member]</link:label>
    <link:label id="lab_mo_USDNotes3700MaturingFebruary2051Member_documentation_en-US" xlink:label="lab_mo_USDNotes3700MaturingFebruary2051Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.700%, Maturing February 2051</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3700MaturingFebruary2051Member" xlink:href="mo-20221231.xsd#mo_USDNotes3700MaturingFebruary2051Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes3700MaturingFebruary2051Member" xlink:to="lab_mo_USDNotes3700MaturingFebruary2051Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_16e78cf9-2e61-491c-b865-9ec9c4c65510_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive losses attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_aea9cc3c-98d6-43f4-bdf9-d5c54f7a7eb4_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement, amount expected to be awarded from other party</link:label>
    <link:label id="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_label_en-US" xlink:label="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Expected To Be Awarded From Other Party</link:label>
    <link:label id="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_documentation_en-US" xlink:label="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Expected To Be Awarded From Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:href="mo-20221231.xsd#mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:to="lab_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IndividualSmokingAndHealthCasesMember_4027a09f-179f-4176-9965-1d710a75f669_terseLabel_en-US" xlink:label="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Smoking and Health Cases [Member]</link:label>
    <link:label id="lab_mo_IndividualSmokingAndHealthCasesMember_label_en-US" xlink:label="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Smoking And Health Cases [Member]</link:label>
    <link:label id="lab_mo_IndividualSmokingAndHealthCasesMember_documentation_en-US" xlink:label="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Smoking and Health Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember" xlink:href="mo-20221231.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IndividualSmokingAndHealthCasesMember" xlink:to="lab_mo_IndividualSmokingAndHealthCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_b4df3374-b54b-4a1d-bb7d-3833c72b7e6d_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesGlogerRintoulandDuignamMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:to="lab_mo_EngleProgenyCasesGlogerRintoulandDuignamMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfUnsecuredDebt_7b488eb2-03c7-4c32-8b8e-dcc0650f40e7_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfUnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of unsecured debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfUnsecuredDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfUnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Unsecured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfUnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfUnsecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfUnsecuredDebt" xlink:to="lab_us-gaap_RepaymentsOfUnsecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_43c10ccb-e66e-4b61-a098-2c8f2051d0ae_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9ee9c489-f73f-44e8-a412-5014bd8b728d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, number of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_753d8734-51bf-4270-9496-da0347958999_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InternationalDevelopedMarketsMember_17fc010a-9b52-478a-b30f-6f1349e765ac_terseLabel_en-US" xlink:label="lab_mo_InternationalDevelopedMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Developed Markets [Member]</link:label>
    <link:label id="lab_mo_InternationalDevelopedMarketsMember_label_en-US" xlink:label="lab_mo_InternationalDevelopedMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Developed Markets [Member]</link:label>
    <link:label id="lab_mo_InternationalDevelopedMarketsMember_documentation_en-US" xlink:label="lab_mo_InternationalDevelopedMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Developed Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InternationalDevelopedMarketsMember" xlink:href="mo-20221231.xsd#mo_InternationalDevelopedMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InternationalDevelopedMarketsMember" xlink:to="lab_mo_InternationalDevelopedMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_a413e0af-f77c-4d7f-94c8-863129285720_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AssetBasedSecuritiesAndOtherInvestmentsMember_abe197c2-34ec-4668-8c92-a4d35c8a931f_terseLabel_en-US" xlink:label="lab_mo_AssetBasedSecuritiesAndOtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Based Securities And Other Investments [Member]</link:label>
    <link:label id="lab_mo_AssetBasedSecuritiesAndOtherInvestmentsMember_label_en-US" xlink:label="lab_mo_AssetBasedSecuritiesAndOtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Based Securities And Other Investments [Member]</link:label>
    <link:label id="lab_mo_AssetBasedSecuritiesAndOtherInvestmentsMember_documentation_en-US" xlink:label="lab_mo_AssetBasedSecuritiesAndOtherInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Based Securities And Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetBasedSecuritiesAndOtherInvestmentsMember" xlink:href="mo-20221231.xsd#mo_AssetBasedSecuritiesAndOtherInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AssetBasedSecuritiesAndOtherInvestmentsMember" xlink:to="lab_mo_AssetBasedSecuritiesAndOtherInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember_d463da1a-7964-4867-b76a-50d83c9b026c_terseLabel_en-US" xlink:label="lab_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation Adjustments and Other [Member]</link:label>
    <link:label id="lab_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember_label_en-US" xlink:label="lab_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment And Other Attributable to Parent [Member]</link:label>
    <link:label id="lab_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember_documentation_en-US" xlink:label="lab_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment And Other Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember" xlink:href="mo-20221231.xsd#mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember" xlink:to="lab_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_770c4810-3538-4cef-9eea-d03f8b940010_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, number of shares owned, restricted (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Restricted</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Restricted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedRestricted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:to="lab_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment_083bdb17-75a6-44e8-8e35-506f85f90aad_terseLabel_en-US" xlink:label="lab_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, purchase agreement, consideration, initial payment</link:label>
    <link:label id="lab_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment_label_en-US" xlink:label="lab_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Purchase Agreement, Consideration, Initial Payment</link:label>
    <link:label id="lab_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment_documentation_en-US" xlink:label="lab_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Purchase Agreement, Consideration, Initial Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment" xlink:href="mo-20221231.xsd#mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment" xlink:to="lab_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_1061ca85-ccbf-498d-b265-43d1445225b4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_3983e06d-4c5a-48bb-938d-6b9fb7ed4b55_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected future employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_0ac78c5b-7d60-40d3-b7b3-6af62005c148_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_4b583f8a-99e2-4002-bd62-bb02c57cb5b3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_164c0e82-ab48-40a6-95c2-c202bc515a14_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution of net revenues by major customer percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_aa0cbb20-e50c-4ba0-9cba-d9730466634d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued postretirement health care costs</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_02a9dff5-2159-4832-b714-c0542fee62b9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued postretirement health care costs</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Other Postretirement Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_056de17a-be20-4d3e-9013-6c34e9cbfdce_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_37f77939-2a6e-46ed-8a95-c04f2aa4d2f0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished product</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_8608b2ec-080e-4010-a136-02085d63adad_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c09c9dce-f4e2-485d-a6c3-f5d4f67782fd_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_90a6b8d9-c1ba-4e35-a18d-6017aa66b648_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per share attributable to Altria (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EuroNotes3125MaturingJune2031Member_44cfb7d4-31c6-4c9e-937d-f9b22d52e078_terseLabel_en-US" xlink:label="lab_mo_EuroNotes3125MaturingJune2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 3.125%, Maturing June 2031 [Member]</link:label>
    <link:label id="lab_mo_EuroNotes3125MaturingJune2031Member_label_en-US" xlink:label="lab_mo_EuroNotes3125MaturingJune2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 3.125%, Maturing June 2031 [Member]</link:label>
    <link:label id="lab_mo_EuroNotes3125MaturingJune2031Member_documentation_en-US" xlink:label="lab_mo_EuroNotes3125MaturingJune2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 3.125%, Maturing June 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes3125MaturingJune2031Member" xlink:href="mo-20221231.xsd#mo_EuroNotes3125MaturingJune2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EuroNotes3125MaturingJune2031Member" xlink:to="lab_mo_EuroNotes3125MaturingJune2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_2e7df7ca-c5cd-4dbb-9f42-e4389193f0f9_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8feabc55-efed-4326-8d4f-50543df3ea00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_79dfc20b-9e82-467d-9500-89e5924a98e9_negatedLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to net earnings</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2e9b336a-ab28-439c-b616-77502f4e2dfb_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_08ce6f58-6d29-4a7f-a49a-62563542d7d4_netLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_1c7f500a-1690-4234-9dff-81eb87cb176d_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Corporate and Other [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_1c29f6b2-75ae-44d8-a997-8c390e808322_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General Corporate [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesGarciaMember_26efa828-5279-483c-b988-a222a96b4341_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesGarciaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Garcia [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGarciaMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesGarciaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Garcia [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesGarciaMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesGarciaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Garcia</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGarciaMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesGarciaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesGarciaMember" xlink:to="lab_mo_EngleProgenyCasesGarciaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_670d05fe-3c46-4f1b-accf-606fd4dc87b7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, damages sought, value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_bf464a32-816e-4d0c-881e-5944b91d1ae6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherInventoryRawMaterialsNetofReserves_69df82c0-ae52-4209-9d5e-d1afc4479892_terseLabel_en-US" xlink:label="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other raw materials</link:label>
    <link:label id="lab_mo_OtherInventoryRawMaterialsNetofReserves_label_en-US" xlink:label="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Raw Materials, Net of Reserves</link:label>
    <link:label id="lab_mo_OtherInventoryRawMaterialsNetofReserves_documentation_en-US" xlink:label="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInventoryRawMaterialsNetofReserves" xlink:href="mo-20221231.xsd#mo_OtherInventoryRawMaterialsNetofReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherInventoryRawMaterialsNetofReserves" xlink:to="lab_mo_OtherInventoryRawMaterialsNetofReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStockDividendIncreasePercentage_aa433229-aed4-4155-8318-62b4e113f72d_terseLabel_en-US" xlink:label="lab_mo_CommonStockDividendIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, dividend increase, percentage</link:label>
    <link:label id="lab_mo_CommonStockDividendIncreasePercentage_label_en-US" xlink:label="lab_mo_CommonStockDividendIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividend Increase, Percentage</link:label>
    <link:label id="lab_mo_CommonStockDividendIncreasePercentage_documentation_en-US" xlink:label="lab_mo_CommonStockDividendIncreasePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividend Increase, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendIncreasePercentage" xlink:href="mo-20221231.xsd#mo_CommonStockDividendIncreasePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStockDividendIncreasePercentage" xlink:to="lab_mo_CommonStockDividendIncreasePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_a9e2cd52-14bf-435d-b59f-7afa1aef434f_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CorporateDebtSecurityAboveInvestmentGradeMember_952add98-7a63-41e7-bfd0-709934c0f106_terseLabel_en-US" xlink:label="lab_mo_CorporateDebtSecurityAboveInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Security, Above Investment Grade [Member]</link:label>
    <link:label id="lab_mo_CorporateDebtSecurityAboveInvestmentGradeMember_label_en-US" xlink:label="lab_mo_CorporateDebtSecurityAboveInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Security, Above Investment Grade [Member]</link:label>
    <link:label id="lab_mo_CorporateDebtSecurityAboveInvestmentGradeMember_documentation_en-US" xlink:label="lab_mo_CorporateDebtSecurityAboveInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Security, Above Investment Grade [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CorporateDebtSecurityAboveInvestmentGradeMember" xlink:href="mo-20221231.xsd#mo_CorporateDebtSecurityAboveInvestmentGradeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CorporateDebtSecurityAboveInvestmentGradeMember" xlink:to="lab_mo_CorporateDebtSecurityAboveInvestmentGradeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_26ac65d2-58ba-40ca-b9a9-2e812885606c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_c1cac3c8-cd60-49a2-9c22-e04d4eefb853_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_de26dfbc-ee60-4363-bed3-0895917755d8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e4abf5db-682f-40ef-8880-f989c30cecf8_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash effects of changes:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_f221644b-8498-4049-868d-0c54795c1cc1_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired_38659ef3-4cfd-4939-9bca-b8e0bd68964f_terseLabel_en-US" xlink:label="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions (1)</link:label>
    <link:label id="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived And Finite Lived Intangible Assets, Acquired</link:label>
    <link:label id="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired_documentation_en-US" xlink:label="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived And Finite Lived Intangible Assets, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired" xlink:href="mo-20221231.xsd#mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired" xlink:to="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_eeace2ce-3317-4909-8ab4-b682cc2e7d5f_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_cbf167ed-3e3e-491e-b953-08f5b58a8587_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_dd2044c7-eb30-4774-a07f-daddc74869d7_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Greene [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Greene [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking and Health Case, Greene [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:href="mo-20221231.xsd#mo_NonEngleProgenySmokingandHealthCaseGreeneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:to="lab_mo_NonEngleProgenySmokingandHealthCaseGreeneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_23931729-d54a-4ac5-b2f3-e51e229ae408_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_67fea6e8-da2f-4295-90c1-c23f4ce47bf9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves_05b83838-4ade-4013-a1bd-0231fd61f3ba_terseLabel_en-US" xlink:label="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leaf tobacco</link:label>
    <link:label id="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves_label_en-US" xlink:label="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Plant Material, Net of Reserves</link:label>
    <link:label id="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves_documentation_en-US" xlink:label="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:href="mo-20221231.xsd#mo_InventoryRawMaterialsPlantMaterialNetofReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:to="lab_mo_InventoryRawMaterialsPlantMaterialNetofReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_f198fe1a-a25e-41f4-8d52-32196af7e7a5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherInvestmentNetMember_a088928b-48e6-419c-8020-a146615ad0f0_terseLabel_en-US" xlink:label="lab_mo_OtherInvestmentNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, Net [Member]</link:label>
    <link:label id="lab_mo_OtherInvestmentNetMember_label_en-US" xlink:label="lab_mo_OtherInvestmentNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment, Net [Member]</link:label>
    <link:label id="lab_mo_OtherInvestmentNetMember_documentation_en-US" xlink:label="lab_mo_OtherInvestmentNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investments, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInvestmentNetMember" xlink:href="mo-20221231.xsd#mo_OtherInvestmentNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherInvestmentNetMember" xlink:to="lab_mo_OtherInvestmentNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_bc3f9890-ee00-4413-8b9b-c9dc155b7927_verboseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent_6e0c37c9-5aa0-43c5-9478-9e07805e6beb_terseLabel_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance releases</link:label>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent_label_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Valuation Reversal, Percent</link:label>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent_documentation_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Valuation Reversal, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent" xlink:to="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_FL_edfef305-326a-4719-9639-2bbf8322092c_terseLabel_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Florida [Member]</link:label>
    <link:label id="lab_stpr_FL_label_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FLORIDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_FL" xlink:to="lab_stpr_FL" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_c76d1d8c-dbcc-4fbc-b579-9b4e35622243_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states with settled litigation including Illinois, subsequent expansion</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation, Settlement One</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation, Settlement One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:to="lab_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_7b189af8-0b4d-4afc-afb5-b577799d372f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest (income) expense associated with uncertain tax position</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_206813bb-7469-49a3-b36b-ff5272a6077b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTableTextBlock_e8581af0-61c9-4333-ad95-8ca4d8ff2f6b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment</link:label>
    <link:label id="lab_us-gaap_InvestmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTableTextBlock" xlink:to="lab_us-gaap_InvestmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_95fe88bc-20d4-4b99-b7c1-6c52f1aaa0c8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Information</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_7b42efc8-9f6a-4730-925d-66062fef6001_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings reinvested in the business</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExternalCreditRatingByGroupingAxis_62850b90-b0ab-47d5-8bef-dba059a33872_terseLabel_en-US" xlink:label="lab_us-gaap_ExternalCreditRatingByGroupingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating by Grouping [Axis]</link:label>
    <link:label id="lab_us-gaap_ExternalCreditRatingByGroupingAxis_label_en-US" xlink:label="lab_us-gaap_ExternalCreditRatingByGroupingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating by Grouping [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingAxis" xlink:to="lab_us-gaap_ExternalCreditRatingByGroupingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_87c99e32-34be-4a20-b7cc-296fe404a093_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_7fd09b51-510c-4186-b52b-390f9201ff80_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AllowanceReturnedGoodsMember_055af930-6f2c-45b1-8103-d9bea993db6b_terseLabel_en-US" xlink:label="lab_mo_AllowanceReturnedGoodsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Returned Goods [Member]</link:label>
    <link:label id="lab_mo_AllowanceReturnedGoodsMember_label_en-US" xlink:label="lab_mo_AllowanceReturnedGoodsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance, Returned Goods [Member]</link:label>
    <link:label id="lab_mo_AllowanceReturnedGoodsMember_documentation_en-US" xlink:label="lab_mo_AllowanceReturnedGoodsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance, Returned Goods [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AllowanceReturnedGoodsMember" xlink:href="mo-20221231.xsd#mo_AllowanceReturnedGoodsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AllowanceReturnedGoodsMember" xlink:to="lab_mo_AllowanceReturnedGoodsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_adbad8ed-d57c-498e-80ee-4971f12b7798_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome_ce494ce6-59d4-40a9-9aab-a527978bfcb4_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, including discontinued operation, interest income</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Interest Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CT_6d1631e4-4341-44a6-a42d-766ea3ebfd70_terseLabel_en-US" xlink:label="lab_stpr_CT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Connecticut [Member]</link:label>
    <link:label id="lab_stpr_CT_label_en-US" xlink:label="lab_stpr_CT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONNECTICUT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CT" xlink:to="lab_stpr_CT" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_5506cd3a-7676-4b7d-a776-392a5d38fef2_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_9d3c838d-c4a0-4d84-8895-cc73f53a766e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, including discontinued operation, cash</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_fdcfbe4e-5b91-460d-9633-9987a0697156_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8d02658c-5989-4356-b854-5186bb63c80d_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Operating Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_6034375d-5b1a-4cf7-9d9b-f4db631af5d2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement charges</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_de98a300-8562-479a-b3a7-670c7aaf5320_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_11db9b6c-67a5-498b-a1a7-d8009458e78f_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California [Member]</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_022674b8-b605-4fee-9925-749d8efa6bbd_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_0eb7e646-be19-4532-b7a3-fd68d9588048_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current provision for income taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_23ceb402-eeda-4d78-a623-f00a9e0e8dae_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, downward price adjustment, cumulative amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_c0312f16-3596-4738-900c-74e38964e6e4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsMember_158d5c4e-c939-4c95-903f-beb7e5208d76_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:label id="lab_us-gaap_AssetsMember_label_en-US" xlink:label="lab_us-gaap_AssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsMember" xlink:to="lab_us-gaap_AssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_47d34833-ac6b-4d33-9679-3f46bce6c076_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Units Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_97f2c619-fbad-452c-b9af-5413cb447415_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_6333da93-ecee-4001-a920-1edd7794279d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Difference between carrying amount and underlying equity</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Underlying Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:to="lab_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_8c2e13ac-7aa6-46f2-8820-b26dfcc20fab_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9358c47b-33a6-4d68-b9b7-439f8b3490b8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: debt discounts</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_3899cd13-39ba-48db-be6e-2e6e8c0a92b4_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_b684ec9c-1ae2-4796-99ba-af904bc5f9d5_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_41e630c6-84ce-4927-92dd-d80add17def9_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6efd99c3-a7ec-4b39-8342-e86b50b2495b_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_DE_b25f430b-4b2e-4284-ab5b-e6bc48d2dedf_terseLabel_en-US" xlink:label="lab_stpr_DE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delaware [Member]</link:label>
    <link:label id="lab_stpr_DE_label_en-US" xlink:label="lab_stpr_DE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DELAWARE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_DE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_DE" xlink:to="lab_stpr_DE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_19cc3d0f-ebd7-49a5-88f0-39b9939416a2_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_fb37f7b5-1315-4960-bb19-a62e8d294ddb_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_4a38da1f-b83b-493d-a6f5-f7f95357daf4_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance of end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_DC_4aa4cd0e-217c-4230-a209-a21a39bbfa39_terseLabel_en-US" xlink:label="lab_stpr_DC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">District of Columbia [Member]</link:label>
    <link:label id="lab_stpr_DC_label_en-US" xlink:label="lab_stpr_DC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DISTRICT OF COLUMBIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DC" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_DC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_DC" xlink:to="lab_stpr_DC" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_b9eef347-6cdf-4eca-8a91-c49f68893fe5_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, ownership percentage</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_0bafa42c-c533-4c20-a076-ca5b26af3a12_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_a174c7e0-1b2d-4e86-9ac1-7ed5f2ee5871_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, Shares Repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_356bc161-3f9b-4087-9374-31a9efb9e9af_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, Shares Repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3ada4900-b981-422c-b5dc-2a12294eff01_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_1b5c674a-1b1d-427b-b680-7322a59c777e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_bbe1eadb-0e83-46af-966f-c6e7b3b4ee85_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_78caff34-1eb0-4d77-9d74-e0460d9de535_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_dc60957c-9e51-48ab-8a88-75227ef5b86e_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_43696e31-239e-4839-b559-6d2d41c667a7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_6a139207-c30c-4d9a-bf7a-f9e246a09eb3_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_933e6f00-56a0-45ed-932a-814cafc60068_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_e409bda2-73fb-481a-bc93-38c95bd5eace_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_f1f51eac-236d-445c-9528-7a5f9b30c7c1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InvestmentOwnedBalancePercentage_24e0546b-0f26-4d17-b388-bc2433ae399e_terseLabel_en-US" xlink:label="lab_mo_InvestmentOwnedBalancePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment owned, balance, percentage</link:label>
    <link:label id="lab_mo_InvestmentOwnedBalancePercentage_label_en-US" xlink:label="lab_mo_InvestmentOwnedBalancePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Percentage</link:label>
    <link:label id="lab_mo_InvestmentOwnedBalancePercentage_documentation_en-US" xlink:label="lab_mo_InvestmentOwnedBalancePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentOwnedBalancePercentage" xlink:href="mo-20221231.xsd#mo_InvestmentOwnedBalancePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InvestmentOwnedBalancePercentage" xlink:to="lab_mo_InvestmentOwnedBalancePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_400b4849-11e8-4b8f-8c7d-f1314c3a8839_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_f8ad0563-15b2-44d9-bd7b-c89b7a860982_terseLabel_en-US" xlink:label="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, remaining interest purchased by parent</link:label>
    <link:label id="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_label_en-US" xlink:label="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Remaining Interest Purchased By Parent</link:label>
    <link:label id="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_documentation_en-US" xlink:label="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Remaining Interest Purchased By Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NoncontrollingInterestRemainingInterestPurchasedByParent" xlink:href="mo-20221231.xsd#mo_NoncontrollingInterestRemainingInterestPurchasedByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NoncontrollingInterestRemainingInterestPurchasedByParent" xlink:to="lab_mo_NoncontrollingInterestRemainingInterestPurchasedByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_055526a8-2e6f-4bd4-8744-71b72b531225_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_20153e50-b2a6-4650-b6a6-c368a7eb2f2f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, performance obligation, description of timing</link:label>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_label_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Description of Timing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:to="lab_us-gaap_RevenuePerformanceObligationDescriptionOfTiming" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_1367dd0b-fab7-4512-bd32-d3f1ceb37d92_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes2350To1020Member_d0d85de9-b9f5-4b7c-b1eb-928ebb2b3ec2_terseLabel_en-US" xlink:label="lab_mo_USDNotes2350To1020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes 2.350% To 10.20%, interest payable semi-annually, due through 2061 [Member]</link:label>
    <link:label id="lab_mo_USDNotes2350To1020Member_label_en-US" xlink:label="lab_mo_USDNotes2350To1020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.350% to 10.20% [Member]</link:label>
    <link:label id="lab_mo_USDNotes2350To1020Member_documentation_en-US" xlink:label="lab_mo_USDNotes2350To1020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.350% to 10.20%</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2350To1020Member" xlink:href="mo-20221231.xsd#mo_USDNotes2350To1020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes2350To1020Member" xlink:to="lab_mo_USDNotes2350To1020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsResolvedNumber_941ff28a-aac0-4b48-a037-d3a3f745cbec_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsResolvedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims resolved</link:label>
    <link:label id="lab_mo_LossContingencyClaimsResolvedNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsResolvedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Resolved, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsResolvedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsResolvedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Resolved, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsResolvedNumber" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsResolvedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsResolvedNumber" xlink:to="lab_mo_LossContingencyClaimsResolvedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_baf39545-e427-4d6d-a9fe-6e74b216d2f3_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PeriodTwoMember_3c8ae9b5-c755-43ed-936d-d2f7a81a88e2_terseLabel_en-US" xlink:label="lab_mo_PeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Two</link:label>
    <link:label id="lab_mo_PeriodTwoMember_label_en-US" xlink:label="lab_mo_PeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Two [Member]</link:label>
    <link:label id="lab_mo_PeriodTwoMember_documentation_en-US" xlink:label="lab_mo_PeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodTwoMember" xlink:href="mo-20221231.xsd#mo_PeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PeriodTwoMember" xlink:to="lab_mo_PeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f41c8057-ee43-48c6-9d59-ca06e8571052_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_IL_f7a5c312-561e-40e4-b82c-9cca82a8bf5d_terseLabel_en-US" xlink:label="lab_stpr_IL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Illinois [Member]</link:label>
    <link:label id="lab_stpr_IL_label_en-US" xlink:label="lab_stpr_IL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ILLINOIS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_IL" xlink:to="lab_stpr_IL" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SmokeableProductsSegmentMember_61a36599-4c37-4b7d-b346-15ac86086a6f_terseLabel_en-US" xlink:label="lab_mo_SmokeableProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smokeable Products [Member]</link:label>
    <link:label id="lab_mo_SmokeableProductsSegmentMember_label_en-US" xlink:label="lab_mo_SmokeableProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smokeable Products Segment [Member]</link:label>
    <link:label id="lab_mo_SmokeableProductsSegmentMember_documentation_en-US" xlink:label="lab_mo_SmokeableProductsSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smokeable Products Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SmokeableProductsSegmentMember" xlink:to="lab_mo_SmokeableProductsSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_7075f067-6751-4e2c-8813-2144d4b19701_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_71e7befc-f158-416e-a1da-b6044641902b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes2850MaturingAugust2022Member_11070f44-5f96-4f52-a7e2-03640fe29783_verboseLabel_en-US" xlink:label="lab_mo_USDNotes2850MaturingAugust2022Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.850% [Member]</link:label>
    <link:label id="lab_mo_USDNotes2850MaturingAugust2022Member_label_en-US" xlink:label="lab_mo_USDNotes2850MaturingAugust2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.850%, Maturing August 2022 [Member]</link:label>
    <link:label id="lab_mo_USDNotes2850MaturingAugust2022Member_documentation_en-US" xlink:label="lab_mo_USDNotes2850MaturingAugust2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.850%, Maturing August 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2850MaturingAugust2022Member" xlink:href="mo-20221231.xsd#mo_USDNotes2850MaturingAugust2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes2850MaturingAugust2022Member" xlink:to="lab_mo_USDNotes2850MaturingAugust2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_3bbd0140-43c7-4781-b4a3-d74f866e54db_terseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity securities ($250 million and $1,720&#160;million at December&#160;31, 2022 and 2021, respectively, measured at fair value)</link:label>
    <link:label id="lab_us-gaap_Investments_3e463783-3248-48f3-bba8-a37dfae0c6cb_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_94dd2ca7-b264-45a9-9654-e9b647892660_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.33 1/3&#160;per share (2,805,961,317 shares issued)</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned_8ff2390d-7d99-470b-986d-f52b0ddda44b_terseLabel_en-US" xlink:label="lab_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award activity (in shares)</link:label>
    <link:label id="lab_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned_label_en-US" xlink:label="lab_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued (Forfeited and Returned)</link:label>
    <link:label id="lab_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned_documentation_en-US" xlink:label="lab_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued (Forfeited and Returned)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" xlink:href="mo-20221231.xsd#mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" xlink:to="lab_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_0d9878ad-8741-41b7-994c-8f17b2c3cda8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_a3cdce5d-ff2e-4d4b-b9ca-d38b5aac865e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_683d0671-b644-499c-b285-a97000f8bc35_terseLabel_en-US" xlink:label="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for decertified class members could file individual actions</link:label>
    <link:label id="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_label_en-US" xlink:label="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants</link:label>
    <link:label id="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_documentation_en-US" xlink:label="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:href="mo-20221231.xsd#mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:to="lab_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MarketingAdministrationandResearchCosts_83ee9456-221e-4e00-837d-46167d546c4d_terseLabel_en-US" xlink:label="lab_mo_MarketingAdministrationandResearchCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, administration and research costs</link:label>
    <link:label id="lab_mo_MarketingAdministrationandResearchCosts_label_en-US" xlink:label="lab_mo_MarketingAdministrationandResearchCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing, Administration and Research Costs</link:label>
    <link:label id="lab_mo_MarketingAdministrationandResearchCosts_documentation_en-US" xlink:label="lab_mo_MarketingAdministrationandResearchCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationandResearchCosts" xlink:href="mo-20221231.xsd#mo_MarketingAdministrationandResearchCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MarketingAdministrationandResearchCosts" xlink:to="lab_mo_MarketingAdministrationandResearchCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_1f5127c4-9cb0-4fcf-8c38-4f41f829822d_verboseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_63547d78-ecec-44a2-9e55-079aff8524f4_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments_59b0620f-e022-4dd1-8ef7-50edacc8c0d0_terseLabel_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax basis in foreign investments</link:label>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments_label_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Basis In Foreign Investments</link:label>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments_documentation_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Basis In Foreign Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments" xlink:to="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotesMember_a281f262-8971-4686-be85-ad5a2f1254c4_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesMember_label_en-US" xlink:label="lab_mo_USDDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotesMember_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesMember" xlink:href="mo-20221231.xsd#mo_USDDenominatedNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotesMember" xlink:to="lab_mo_USDDenominatedNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld_81e15592-c77f-4a12-b836-8f167fe81c83_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of foreign currency derivatives held</link:label>
    <link:label id="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Foreign Currency Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfForeignCurrencyDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:to="lab_us-gaap_NumberOfForeignCurrencyDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_a6362b5a-896b-4dd6-9489-04ad803c3ef7_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Contingencies and Costs</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_f904bbff-eef6-434d-a7f6-a98690a3af3d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_e31693a7-f2b4-4202-bf38-09913207e421_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_e9da8eec-2aa8-4ea4-98a6-6cde6be8e7a0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost:</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CronosGroupInc.Member_e328c21b-1182-49b9-8572-6436044f6383_verboseLabel_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos [Member]</link:label>
    <link:label id="lab_mo_CronosGroupInc.Member_535abcd7-bdde-453f-b050-c8db640c9d29_terseLabel_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group Inc. [Member]</link:label>
    <link:label id="lab_mo_CronosGroupInc.Member_label_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group Inc. [Member]</link:label>
    <link:label id="lab_mo_CronosGroupInc.Member_documentation_en-US" xlink:label="lab_mo_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CronosGroupInc.Member" xlink:to="lab_mo_CronosGroupInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e4ede9f6-5b09-43f4-974f-6e4682202b0e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f5efe78d-8459-48c3-8da8-e8cc3c64dc23_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_32176df1-830f-485e-9861-4bdb7273118e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_e8998ac4-35b4-4669-a333-141792a066ab_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TextBlockAbstract_label_en-US" xlink:label="lab_us-gaap_TextBlockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Text Block [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TextBlockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TextBlockAbstract" xlink:to="lab_us-gaap_TextBlockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DeferredTaxAssetsInvestmentsInEquitySecurities_60ca461a-5ae8-447a-9a48-b817e1a550bb_terseLabel_en-US" xlink:label="lab_mo_DeferredTaxAssetsInvestmentsInEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in JUUL</link:label>
    <link:label id="lab_mo_DeferredTaxAssetsInvestmentsInEquitySecurities_label_en-US" xlink:label="lab_mo_DeferredTaxAssetsInvestmentsInEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Investments In Equity Securities</link:label>
    <link:label id="lab_mo_DeferredTaxAssetsInvestmentsInEquitySecurities_documentation_en-US" xlink:label="lab_mo_DeferredTaxAssetsInvestmentsInEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Investments In Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxAssetsInvestmentsInEquitySecurities" xlink:href="mo-20221231.xsd#mo_DeferredTaxAssetsInvestmentsInEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DeferredTaxAssetsInvestmentsInEquitySecurities" xlink:to="lab_mo_DeferredTaxAssetsInvestmentsInEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_TobaccoandHealthLitigationCasesMember_54cdc655-bdcb-4146-ba4a-926dfd3ff6b5_terseLabel_en-US" xlink:label="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation Cases [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthLitigationCasesMember_label_en-US" xlink:label="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation Cases [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthLitigationCasesMember_documentation_en-US" xlink:label="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Litigation Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember" xlink:href="mo-20221231.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_TobaccoandHealthLitigationCasesMember" xlink:to="lab_mo_TobaccoandHealthLitigationCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_3540c7a7-d2aa-404a-b543-5e0d0973a955_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_55b8d27f-f47c-4214-a017-ee52997c1cf4_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance</link:label>
    <link:label id="lab_us-gaap_SummaryOfValuationAllowanceTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Valuation Allowance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:to="lab_us-gaap_SummaryOfValuationAllowanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_527be4f2-32a1-4b6f-9d7e-a6b95d46d6b1_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_75ab804c-055d-4ddb-afa1-7345a924694d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_2fa52608-66fc-459f-a7e8-e1b02e947821_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_FederalGovernmentsLawsuitMember_e7b0e613-d073-45c3-bb67-ef67a867c431_terseLabel_en-US" xlink:label="lab_mo_FederalGovernmentsLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Governments Lawsuit [Member]</link:label>
    <link:label id="lab_mo_FederalGovernmentsLawsuitMember_label_en-US" xlink:label="lab_mo_FederalGovernmentsLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Governments Lawsuit [Member]</link:label>
    <link:label id="lab_mo_FederalGovernmentsLawsuitMember_documentation_en-US" xlink:label="lab_mo_FederalGovernmentsLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Government's Lawsuit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalGovernmentsLawsuitMember" xlink:href="mo-20221231.xsd#mo_FederalGovernmentsLawsuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_FederalGovernmentsLawsuitMember" xlink:to="lab_mo_FederalGovernmentsLawsuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigation_39761bc0-aa47-4fca-a744-dffa7e3ce0fa_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states with settled litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigation_label_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation</link:label>
    <link:label id="lab_mo_LossContingencyNumberofStateswithSettledLitigation_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of States with Settled Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:to="lab_mo_LossContingencyNumberofStateswithSettledLitigation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_b4ae88a7-50a4-40dc-9155-c06850ba411d_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Tag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a87b8f38-f9b1-4c27-bfe1-d09f7f1d7f4e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangible assets useful life maximum, years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_427f6b83-9c42-4211-99bc-eb30780dcc64_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangible assets amortization period, weighted average, in years</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EvaporLitigationMember_6ed7ff99-b3c5-4fe9-ab63-c6f4157becc6_verboseLabel_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Cases [Member]</link:label>
    <link:label id="lab_mo_EvaporLitigationMember_341f3a51-86eb-4ae1-8984-06e151b8e8a7_terseLabel_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Litigation [Member]</link:label>
    <link:label id="lab_mo_EvaporLitigationMember_label_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Litigation [Member]</link:label>
    <link:label id="lab_mo_EvaporLitigationMember_documentation_en-US" xlink:label="lab_mo_EvaporLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-vapor Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember" xlink:href="mo-20221231.xsd#mo_EvaporLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EvaporLitigationMember" xlink:to="lab_mo_EvaporLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_2ef84d14-59ac-48c4-b2a6-6b5d76aed5d9_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c09ccfc8-fe53-4adc-bc1a-3c69a21f1992_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses), net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_78769631-3294-410a-a3c2-94f1c0048669_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses), net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_IA_15d64a6c-dddf-4d2f-b4e9-46b19308a467_terseLabel_en-US" xlink:label="lab_stpr_IA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Iowa [Member]</link:label>
    <link:label id="lab_stpr_IA_label_en-US" xlink:label="lab_stpr_IA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IOWA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_IA" xlink:to="lab_stpr_IA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_1859f6c3-5a69-4dd0-b489-9d47e811a2ff_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions (1)</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_RevolvingCreditFacilityDueAugust2025Member_8019d46c-95cd-46f8-97fb-49c2e04541e8_terseLabel_en-US" xlink:label="lab_mo_RevolvingCreditFacilityDueAugust2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due August 2025</link:label>
    <link:label id="lab_mo_RevolvingCreditFacilityDueAugust2025Member_label_en-US" xlink:label="lab_mo_RevolvingCreditFacilityDueAugust2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due August 2025 [Member]</link:label>
    <link:label id="lab_mo_RevolvingCreditFacilityDueAugust2025Member_documentation_en-US" xlink:label="lab_mo_RevolvingCreditFacilityDueAugust2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility Due August 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevolvingCreditFacilityDueAugust2025Member" xlink:href="mo-20221231.xsd#mo_RevolvingCreditFacilityDueAugust2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_RevolvingCreditFacilityDueAugust2025Member" xlink:to="lab_mo_RevolvingCreditFacilityDueAugust2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsDecided_f9a0a025-96f3-4ba0-ad6b-6396356bc1e0_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsDecided" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of verdicts returned</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecided_label_en-US" xlink:label="lab_mo_LossContingencyClaimsDecided" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecided_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsDecided" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecided"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsDecided" xlink:to="lab_mo_LossContingencyClaimsDecided" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityInvestmentFairValueOption_c82434ea-2aa5-4773-b8cb-0f2581a7e36f_verboseLabel_en-US" xlink:label="lab_mo_EquityInvestmentFairValueOption" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated fair value of JUUL</link:label>
    <link:label id="lab_mo_EquityInvestmentFairValueOption_label_en-US" xlink:label="lab_mo_EquityInvestmentFairValueOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment, Fair Value Option</link:label>
    <link:label id="lab_mo_EquityInvestmentFairValueOption_documentation_en-US" xlink:label="lab_mo_EquityInvestmentFairValueOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment, Fair Value Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentFairValueOption" xlink:href="mo-20221231.xsd#mo_EquityInvestmentFairValueOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityInvestmentFairValueOption" xlink:to="lab_mo_EquityInvestmentFairValueOption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_e28975d5-6b9e-440c-8945-e4b03db2cc89_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movements in Other Comprehensive Earnings/Losses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_91d47652-5685-4494-95bf-d8545be35f9a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_d0ace01f-bfa1-4d21-a708-bdda1b5d2d40_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_ac7c4af8-1a71-4fb4-bc36-39e373ed3e8e_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingLawsuitFiledBySchoolDistrictMember_58b76204-919d-4938-a4c6-78d48640627b_terseLabel_en-US" xlink:label="lab_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuit Filed By School District [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitFiledBySchoolDistrictMember_label_en-US" xlink:label="lab_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuit Filed By School District [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitFiledBySchoolDistrictMember_documentation_en-US" xlink:label="lab_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuit Filed By School District [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:href="mo-20221231.xsd#mo_PendingLawsuitFiledBySchoolDistrictMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:to="lab_mo_PendingLawsuitFiledBySchoolDistrictMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_COVID19Member_840e74dd-6e9c-4744-b583-4cae354f90cd_terseLabel_en-US" xlink:label="lab_mo_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 [Member]</link:label>
    <link:label id="lab_mo_COVID19Member_label_en-US" xlink:label="lab_mo_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 [Member]</link:label>
    <link:label id="lab_mo_COVID19Member_documentation_en-US" xlink:label="lab_mo_COVID19Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_COVID19Member" xlink:href="mo-20221231.xsd#mo_COVID19Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_COVID19Member" xlink:to="lab_mo_COVID19Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings_4aa205a2-3ee3-4a01-8574-e8f08c3b8229_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency number of states with concluded hearings</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number Of States With Concluded Hearings</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Number Of States With Concluded Hearings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesWithConcludedHearings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:to="lab_mo_LossContingencyNumberOfStatesWithConcludedHearings" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesHoffmanMember_28790077-9f1d-4514-8bd1-92895e59eb7a_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesHoffmanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Hoffman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesHoffmanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesHoffmanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Hoffman [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesHoffmanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesHoffmanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Hoffman</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHoffmanMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesHoffmanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesHoffmanMember" xlink:to="lab_mo_EngleProgenyCasesHoffmanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NH_cb57d95e-5308-4029-9f59-b1197529a9e7_terseLabel_en-US" xlink:label="lab_stpr_NH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Hampshire [Member]</link:label>
    <link:label id="lab_stpr_NH_label_en-US" xlink:label="lab_stpr_NH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW HAMPSHIRE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NH" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NH" xlink:to="lab_stpr_NH" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyReductionToCostOfSales_6f5f9ce8-080b-469d-9b3b-83a400b9e06f_terseLabel_en-US" xlink:label="lab_mo_LossContingencyReductionToCostOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, reduction to cost of sales</link:label>
    <link:label id="lab_mo_LossContingencyReductionToCostOfSales_label_en-US" xlink:label="lab_mo_LossContingencyReductionToCostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Reduction To Cost Of Sales</link:label>
    <link:label id="lab_mo_LossContingencyReductionToCostOfSales_documentation_en-US" xlink:label="lab_mo_LossContingencyReductionToCostOfSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Reduction To Cost Of Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyReductionToCostOfSales" xlink:href="mo-20221231.xsd#mo_LossContingencyReductionToCostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyReductionToCostOfSales" xlink:to="lab_mo_LossContingencyReductionToCostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c224bc0b-0a49-4ffb-812f-6566f80eb36c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_c7a5e2ef-658e-4c52-9661-0cc07a83b589_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contingencies</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loss Contingencies by Contingency [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:to="lab_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_fdb66f90-5f00-46f0-8dae-016cf46adce5_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock0.3313ParValueMember_89137010-1285-4f7a-aee3-3d47f36ee107_terseLabel_en-US" xlink:label="lab_mo_CommonStock0.3313ParValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $0.33 &#160;1/3 par value</link:label>
    <link:label id="lab_mo_CommonStock0.3313ParValueMember_label_en-US" xlink:label="lab_mo_CommonStock0.3313ParValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 0.33 1/3 Par Value [Member]</link:label>
    <link:label id="lab_mo_CommonStock0.3313ParValueMember_documentation_en-US" xlink:label="lab_mo_CommonStock0.3313ParValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 0.33 1/3 Par Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock0.3313ParValueMember" xlink:href="mo-20221231.xsd#mo_CommonStock0.3313ParValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock0.3313ParValueMember" xlink:to="lab_mo_CommonStock0.3313ParValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseCommitmentMember_a08d132d-d11e-4765-b7dd-4ac89003c35b_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment [Member]</link:label>
    <link:label id="lab_us-gaap_PurchaseCommitmentMember_label_en-US" xlink:label="lab_us-gaap_PurchaseCommitmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Commitment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseCommitmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseCommitmentMember" xlink:to="lab_us-gaap_PurchaseCommitmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_9e93a406-1114-42e4-a0ce-163d29ef8564_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_ce285ff4-3f5c-4ccd-9f51-1a3e8fb7d712_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MS_b9f9f49f-e28d-4ce9-92d7-4d730003a535_terseLabel_en-US" xlink:label="lab_stpr_MS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mississippi [Member]</link:label>
    <link:label id="lab_stpr_MS_label_en-US" xlink:label="lab_stpr_MS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MISSISSIPPI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MS" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MS" xlink:to="lab_stpr_MS" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock_a45effe7-cc3c-4b6e-86c5-015fc71de7b6_terseLabel_en-US" xlink:label="lab_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plans</link:label>
    <link:label id="lab_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock_label_en-US" xlink:label="lab_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension, Other Postretirement and Postemployment Plans, Policy [Policy Text Block]</link:label>
    <link:label id="lab_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension, Other Postretirement and Postemployment Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock" xlink:href="mo-20221231.xsd#mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock" xlink:to="lab_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_0ef323ab-809b-4d5d-9667-ade2f66f8f3b_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt repaid</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_c67b6ef0-3c5c-4519-8c98-468fdf885472_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MT_d8b06603-db55-4dd7-a7a6-eaab64441fd7_terseLabel_en-US" xlink:label="lab_stpr_MT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MONTANA</link:label>
    <link:label id="lab_stpr_MT_label_en-US" xlink:label="lab_stpr_MT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MONTANA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MT" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MT" xlink:to="lab_stpr_MT" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExternalCreditRatingByGroupingDomain_39e927d3-08f4-4e99-af20-1bda24d932ef_terseLabel_en-US" xlink:label="lab_us-gaap_ExternalCreditRatingByGroupingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating by Grouping [Domain]</link:label>
    <link:label id="lab_us-gaap_ExternalCreditRatingByGroupingDomain_label_en-US" xlink:label="lab_us-gaap_ExternalCreditRatingByGroupingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating by Grouping [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingDomain" xlink:to="lab_us-gaap_ExternalCreditRatingByGroupingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MO_cef57922-619e-4eec-9d70-0292b9271610_terseLabel_en-US" xlink:label="lab_stpr_MO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Missouri [Member]</link:label>
    <link:label id="lab_stpr_MO_label_en-US" xlink:label="lab_stpr_MO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MISSOURI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MO" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MO" xlink:to="lab_stpr_MO" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_d10ea5d4-263f-41e7-8f9b-2e53efb4352b_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other movements</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_644fa3ba-bb11-4d79-90eb-078f1acbbd43_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of repurchased stock (1,020,427,195 shares at December&#160;31, 2022 and 982,785,699 shares at December&#160;31, 2021)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_11d55223-8eb1-4250-8a57-57bd898d5fa9_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MN_f6d2ba85-72e6-497e-8cae-bc8951e67e11_terseLabel_en-US" xlink:label="lab_stpr_MN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minnesota [Member]</link:label>
    <link:label id="lab_stpr_MN_label_en-US" xlink:label="lab_stpr_MN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MINNESOTA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MN" xlink:to="lab_stpr_MN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions_3931b896-cebc-423a-90ef-2d228f9f9dcf_negatedLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plan contributions</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Pension and Other Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MI_8e52748f-f4ef-4211-b593-4cba54c9aad6_terseLabel_en-US" xlink:label="lab_stpr_MI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Michigan [Member]</link:label>
    <link:label id="lab_stpr_MI_label_en-US" xlink:label="lab_stpr_MI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MICHIGAN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MI" xlink:to="lab_stpr_MI" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OH_a5464c48-bfb8-4175-a1de-d02151863a9f_terseLabel_en-US" xlink:label="lab_stpr_OH" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ohio [Member]</link:label>
    <link:label id="lab_stpr_OH_label_en-US" xlink:label="lab_stpr_OH" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OHIO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OH"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OH" xlink:to="lab_stpr_OH" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_5f75fd10-7496-4a97-a174-18090e5e4e2f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EuroNotes1000To3125Member_40912d19-2211-4f85-8ab9-033a659c05aa_terseLabel_en-US" xlink:label="lab_mo_EuroNotes1000To3125Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro notes, 1.000% to 3.125%, interest payable annually, due through 2031 [Member]</link:label>
    <link:label id="lab_mo_EuroNotes1000To3125Member_label_en-US" xlink:label="lab_mo_EuroNotes1000To3125Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 1.000% to 3.125% [Member]</link:label>
    <link:label id="lab_mo_EuroNotes1000To3125Member_documentation_en-US" xlink:label="lab_mo_EuroNotes1000To3125Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 1.000% to 3.125% [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes1000To3125Member" xlink:href="mo-20221231.xsd#mo_EuroNotes1000To3125Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EuroNotes1000To3125Member" xlink:to="lab_mo_EuroNotes1000To3125Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesPollariMember_f917627d-fd3e-4b68-98a4-cea8a18874e0_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesPollariMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pollari [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPollariMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesPollariMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pollari [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesPollariMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesPollariMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Pollari [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPollariMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesPollariMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesPollariMember" xlink:to="lab_mo_EngleProgenyCasesPollariMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e9f36d2b-19c4-498c-8f19-2da0b30d199c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_5530bf90-e3fa-4721-84d5-6864e6cb3c57_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PhilipMorrisUSAMember_0c2305d4-6a20-4509-bdfe-ca6e212d978e_terseLabel_en-US" xlink:label="lab_mo_PhilipMorrisUSAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PM USA [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAMember_label_en-US" xlink:label="lab_mo_PhilipMorrisUSAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAMember_documentation_en-US" xlink:label="lab_mo_PhilipMorrisUSAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PhilipMorrisUSAMember" xlink:to="lab_mo_PhilipMorrisUSAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ClassActionLawsuitMember_cb63298a-a0ff-4e8d-92fd-ff881e1e73ee_terseLabel_en-US" xlink:label="lab_mo_ClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuit [Member]</link:label>
    <link:label id="lab_mo_ClassActionLawsuitMember_label_en-US" xlink:label="lab_mo_ClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuit [Member]</link:label>
    <link:label id="lab_mo_ClassActionLawsuitMember_documentation_en-US" xlink:label="lab_mo_ClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Action Lawsuit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember" xlink:href="mo-20221231.xsd#mo_ClassActionLawsuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ClassActionLawsuitMember" xlink:to="lab_mo_ClassActionLawsuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExternalCreditRatingNonInvestmentGradeMember_9c885d54-7cfa-44ed-9909-098cab772b21_terseLabel_en-US" xlink:label="lab_us-gaap_ExternalCreditRatingNonInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Below Investment Grade [Member]</link:label>
    <link:label id="lab_us-gaap_ExternalCreditRatingNonInvestmentGradeMember_label_en-US" xlink:label="lab_us-gaap_ExternalCreditRatingNonInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating, Non Investment Grade [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingNonInvestmentGradeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingNonInvestmentGradeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExternalCreditRatingNonInvestmentGradeMember" xlink:to="lab_us-gaap_ExternalCreditRatingNonInvestmentGradeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes4000MaturingFebruary2061Member_0ceafd3d-8b68-4a9a-bd04-f6e655869964_terseLabel_en-US" xlink:label="lab_mo_USDNotes4000MaturingFebruary2061Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.000%, Maturing February 2061 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4000MaturingFebruary2061Member_label_en-US" xlink:label="lab_mo_USDNotes4000MaturingFebruary2061Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.000%, Maturing February 2061 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4000MaturingFebruary2061Member_documentation_en-US" xlink:label="lab_mo_USDNotes4000MaturingFebruary2061Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.000%, Maturing February 2061</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4000MaturingFebruary2061Member" xlink:href="mo-20221231.xsd#mo_USDNotes4000MaturingFebruary2061Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes4000MaturingFebruary2061Member" xlink:to="lab_mo_USDNotes4000MaturingFebruary2061Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_a639288d-fea8-4804-99ab-65c4faffa526_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_8265dee3-5d62-4924-8977-11615ddc0dd2_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NY_e3d39190-0a36-423b-a043-4c109a53d944_terseLabel_en-US" xlink:label="lab_stpr_NY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New York [Member]</link:label>
    <link:label id="lab_stpr_NY_label_en-US" xlink:label="lab_stpr_NY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW YORK</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NY" xlink:to="lab_stpr_NY" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NV_5abc5eec-2189-4bf4-aaff-d79f2557eff8_terseLabel_en-US" xlink:label="lab_stpr_NV" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nevada [Member]</link:label>
    <link:label id="lab_stpr_NV_label_en-US" xlink:label="lab_stpr_NV" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEVADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NV" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NV"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NV" xlink:to="lab_stpr_NV" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6c97799f-613a-44c0-9133-f1eaa8104898_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_68e44dd0-a855-40f0-ab3f-9fb863d22715_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JUUL</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USTLitigationMember_049c0c6c-3bbe-4d27-9ecf-41561b71f22e_terseLabel_en-US" xlink:label="lab_mo_USTLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Litigation [Member]</link:label>
    <link:label id="lab_mo_USTLitigationMember_label_en-US" xlink:label="lab_mo_USTLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Litigation [Member]</link:label>
    <link:label id="lab_mo_USTLitigationMember_documentation_en-US" xlink:label="lab_mo_USTLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UST Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember" xlink:href="mo-20221231.xsd#mo_USTLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USTLitigationMember" xlink:to="lab_mo_USTLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_97072ea0-58de-4120-bb89-9ce93831bcd0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_8066191e-e6b3-4cf4-b8c6-9a00bb00cdb7_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments including warrants and fixed price preemptive rights</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Including Warrants and Fixed-Price Preemptive Rights</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Including Warrants and Fixed-Price Preemptive Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" xlink:to="lab_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NM_a3bdf7aa-5ac4-4410-9949-382d78830b41_terseLabel_en-US" xlink:label="lab_stpr_NM" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Mexico [Member]</link:label>
    <link:label id="lab_stpr_NM_label_en-US" xlink:label="lab_stpr_NM" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW MEXICO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NM" xlink:to="lab_stpr_NM" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_75a04aa1-0e6d-42b7-b417-8d7bb0ddf937_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NJ_c015e2fd-65ec-4733-a94a-80b936884bc6_terseLabel_en-US" xlink:label="lab_stpr_NJ" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey [Member]</link:label>
    <link:label id="lab_stpr_NJ_label_en-US" xlink:label="lab_stpr_NJ" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NEW JERSEY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NJ"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NJ" xlink:to="lab_stpr_NJ" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_bc91b0e8-aeae-4af2-b6dd-c82b85e2ca7a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_134f0cee-86ac-4077-b35d-bc4c66cd00ae_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USTreasuryAndForeignGovernmentSecuritiesMember_951dbb4f-f906-4962-85db-ce21c139775a_terseLabel_en-US" xlink:label="lab_mo_USTreasuryAndForeignGovernmentSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Foreign Government Securities [Member]</link:label>
    <link:label id="lab_mo_USTreasuryAndForeignGovernmentSecuritiesMember_label_en-US" xlink:label="lab_mo_USTreasuryAndForeignGovernmentSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Foreign Government Securities [Member]</link:label>
    <link:label id="lab_mo_USTreasuryAndForeignGovernmentSecuritiesMember_documentation_en-US" xlink:label="lab_mo_USTreasuryAndForeignGovernmentSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Foreign Government Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTreasuryAndForeignGovernmentSecuritiesMember" xlink:href="mo-20221231.xsd#mo_USTreasuryAndForeignGovernmentSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USTreasuryAndForeignGovernmentSecuritiesMember" xlink:to="lab_mo_USTreasuryAndForeignGovernmentSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_1ab8f572-8519-46aa-aa75-b65e09ea89c8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_LA_751b73c9-a021-4dc5-9f99-fe1d770da9eb_terseLabel_en-US" xlink:label="lab_stpr_LA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Louisiana [Member]</link:label>
    <link:label id="lab_stpr_LA_label_en-US" xlink:label="lab_stpr_LA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOUISIANA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_LA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_LA" xlink:to="lab_stpr_LA" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingIndividualLawsuitsMember_8bd557f1-8cdc-408d-b22c-3848679381de_terseLabel_en-US" xlink:label="lab_mo_PendingIndividualLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Individual Lawsuits [Member]</link:label>
    <link:label id="lab_mo_PendingIndividualLawsuitsMember_label_en-US" xlink:label="lab_mo_PendingIndividualLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Individual Lawsuits [Member]</link:label>
    <link:label id="lab_mo_PendingIndividualLawsuitsMember_documentation_en-US" xlink:label="lab_mo_PendingIndividualLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Individual Lawsuits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember" xlink:href="mo-20221231.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingIndividualLawsuitsMember" xlink:to="lab_mo_PendingIndividualLawsuitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_05a681a9-2ad0-42dd-87d5-e7fb82c0ab8d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_fb816ccf-862c-47a4-b025-c24513ca7ca3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Composition of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_e0e48d26-9570-4619-8f75-335fbed67c6b_terseLabel_en-US" xlink:label="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuits Filed By State Or Local Governments [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_label_en-US" xlink:label="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuits Filed By State Or Local Governments [Member]</link:label>
    <link:label id="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_documentation_en-US" xlink:label="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Lawsuits Filed By State Or Local Governments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:href="mo-20221231.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:to="lab_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1a2cce36-8f15-45ba-bad5-ef801f268323_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_KS_b49d7d19-4709-4c66-a6b7-3de9bf3ddeff_terseLabel_en-US" xlink:label="lab_stpr_KS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kansas [Member]</link:label>
    <link:label id="lab_stpr_KS_label_en-US" xlink:label="lab_stpr_KS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KANSAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_KS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_KS" xlink:to="lab_stpr_KS" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveCases_4c991a5a-7e91-43a2-8263-16655e8d81f1_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of inactive cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveCases_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfInactiveCases_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfInactiveCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Inactive Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveCases" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfInactiveCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfInactiveCases" xlink:to="lab_mo_LossContingencyNumberOfInactiveCases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_420a311b-2fcd-4f27-90e9-783fa62cd309_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_3be56b2a-f052-410e-9dc3-c99db2af7700_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7479550f-fd98-4991-8805-e91c060fa613_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_521849ea-c5cc-45f1-8d76-0b1eae57444b_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Background and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_0b94fb51-61b2-4ebc-97c8-315260291468_terseLabel_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities [Member]</link:label>
    <link:label id="lab_us-gaap_FixedIncomeSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed Income Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FixedIncomeSecuritiesMember" xlink:to="lab_us-gaap_FixedIncomeSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_709a1319-46f1-4346-a872-78a16c01c8b5_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, ownership percentage by noncontrolling owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesMember_0e59eb49-f530-4594-b72c-a9dae8dc359e_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesMember" xlink:to="lab_mo_EngleProgenyCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MD_225eafe4-1ff9-412c-80e9-c2e7eb6e4101_terseLabel_en-US" xlink:label="lab_stpr_MD" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maryland [Member]</link:label>
    <link:label id="lab_stpr_MD_label_en-US" xlink:label="lab_stpr_MD" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MARYLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MD" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MD"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MD" xlink:to="lab_stpr_MD" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_3c95ef19-f251-49b3-b80e-576849bc36c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumptions used to Determine Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_MA_5993906b-7cdb-4a7e-9cc0-315a504d6571_verboseLabel_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Massachusetts [Member]</link:label>
    <link:label id="lab_stpr_MA_label_en-US" xlink:label="lab_stpr_MA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MASSACHUSETTS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_MA" xlink:to="lab_stpr_MA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_a193bb67-e748-485c-afaa-d4764299f294_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_7d01bbaf-3c3c-45b4-aba6-d5b2d05140b3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_2c17b6a2-5c18-4d34-95db-053801a5a881_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_b07e78b9-4d4d-4459-85ae-e64f5ce612a6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_ea2e92c4-af61-4de3-9180-c0c5fa1c262d_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_dd03bff9-0211-4b6e-936e-7064192144a6_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesWeingartandHancockMember_91a25972-ec86-4449-8762-745a9ae0a90f_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Weingart and Hancock [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesWeingartandHancockMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Weingart and Hancock [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesWeingartandHancockMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Weingart and Hancock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesWeingartandHancockMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesWeingartandHancockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesWeingartandHancockMember" xlink:to="lab_mo_EngleProgenyCasesWeingartandHancockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_abe330e8-5de3-4c05-be85-806ea4cfb43e_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_e1f3b6dd-562f-4187-8b2e-45adffcf8794_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_28aa2c89-033a-4638-b26c-8120a910e165_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination by Jurisdiction [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_RI_a6ebc81a-5716-4018-a57a-7a696ab98342_terseLabel_en-US" xlink:label="lab_stpr_RI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rhode Island [Member]</link:label>
    <link:label id="lab_stpr_RI_label_en-US" xlink:label="lab_stpr_RI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RHODE ISLAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_RI" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_RI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_RI" xlink:to="lab_stpr_RI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_aecde6a0-2f35-4727-a7e9-7e312c325915_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divestiture</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Divestiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanDivestituresPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_bb7e63cb-dab6-442b-a673-2586a611a8a2_terseLabel_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_label_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_documentation_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:href="mo-20221231.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:to="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_9556c500-fa4a-4c77-8c89-0d1aea2bb83a_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State settlement agreements attorney fees annual cap</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_label_en-US" xlink:label="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Legal Fees Payable, Maximum</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_documentation_en-US" xlink:label="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Legal Fees Payable, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:href="mo-20221231.xsd#mo_LitigationSettlementAnnualLegalFeesPayableMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:to="lab_mo_LitigationSettlementAnnualLegalFeesPayableMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2428c143-03c5-45d1-a033-1f69ea2096a5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares for basic EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax_ee09e34d-29bc-45ed-96ae-068fc073c868_negatedTerseLabel_en-US" xlink:label="lab_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax_label_en-US" xlink:label="lab_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Other Net Gain (Loss), before Tax</link:label>
    <link:label id="lab_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax_documentation_en-US" xlink:label="lab_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Other Net Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" xlink:to="lab_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_f3c71ab8-5d6b-4a3d-bb48-616ead0550b5_periodStartLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liability for tobacco and health litigation items at beginning of period</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_c7b7d157-6e21-4353-8ff8-b6a5b3dc9b7e_periodEndLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liability for tobacco and health litigation items at end of period</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_02f5027a-3306-4516-b435-5483930ce093_terseLabel_en-US" xlink:label="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_label_en-US" xlink:label="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost</link:label>
    <link:label id="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_documentation_en-US" xlink:label="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:to="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_ffb063d8-9701-43c3-a9e9-f917a4daf795_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, ownership percentage (approximately)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_559e78bf-79b8-4c6b-9fbb-78a1c7da90bc_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities:</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_07ffd9b8-edda-43f7-9106-fa62c6b86125_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states not in compliance with escrow statues</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not In Compliance With Escrow Statues</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not In Compliance With Escrow Statues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:to="lab_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_50260a5e-5eee-4ca4-941e-94a757b67569_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in plan assets:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_98da77a8-135b-489e-9f0f-c8e23264bd34_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_900f43e5-5abd-4f2b-9f52-2525a580898d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets, target allocation percentage</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DefinedBenefitPlanDiscountRateAbstractAbstract_6ba32ab9-1a1f-47f4-811a-6d492470a0e4_terseLabel_en-US" xlink:label="lab_mo_DefinedBenefitPlanDiscountRateAbstractAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rates:</link:label>
    <link:label id="lab_mo_DefinedBenefitPlanDiscountRateAbstractAbstract_label_en-US" xlink:label="lab_mo_DefinedBenefitPlanDiscountRateAbstractAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Discount Rate Abstract [Abstract]</link:label>
    <link:label id="lab_mo_DefinedBenefitPlanDiscountRateAbstractAbstract_documentation_en-US" xlink:label="lab_mo_DefinedBenefitPlanDiscountRateAbstractAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Discount Rate Abstract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanDiscountRateAbstractAbstract" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanDiscountRateAbstractAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DefinedBenefitPlanDiscountRateAbstractAbstract" xlink:to="lab_mo_DefinedBenefitPlanDiscountRateAbstractAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_38337a37-2019-4143-9a39-b9114e9a36ed_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care cost trend rate assumed for next year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_9556238c-810e-4b9c-82fe-bec7657ef152_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_c12fd3fc-8d01-4aaf-ac16-2698179f2245_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other current assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_6aee95a7-1794-4f97-9207-5ecfd8202b87_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_f2a7317b-1254-4c5f-9f07-950f80dd6b8d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Fair Value and Carrying Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_SC_5e8ef29e-5040-49af-82a8-88ae83642404_terseLabel_en-US" xlink:label="lab_stpr_SC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">South Carolina [Member]</link:label>
    <link:label id="lab_stpr_SC_label_en-US" xlink:label="lab_stpr_SC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOUTH CAROLINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_SC" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_SC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_SC" xlink:to="lab_stpr_SC" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_8c6fa112-904b-4439-bddf-647556b7f34e_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bonds [Member]</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_b68fc27d-bd30-4d57-80df-580e4704918a_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_c5854fed-c6c9-490c-b4f8-fbc134082c13_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_217a9e67-9e5a-409c-ba92-7b85b8f1270b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_37a4ed09-927b-4d1a-ad13-471839730770_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_89903ffc-1679-485d-b8dc-719dc6dda446_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_6b78f19c-925e-4fc5-aead-f337629fbbf0_terseLabel_en-US" xlink:label="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_label_en-US" xlink:label="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost</link:label>
    <link:label id="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_documentation_en-US" xlink:label="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:to="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_85767998-5e40-4a9b-b0aa-68fdb57070a9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_d458f9ca-e876-447c-9ae0-47fa8f45b593_verboseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Plans</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_359ba9c7-c602-4869-ab99-d12cd24856cb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PerformanceFoodGroupCompanyMember_4a6692a5-4b38-4c40-ae86-d5f92bc756f7_terseLabel_en-US" xlink:label="lab_mo_PerformanceFoodGroupCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Food Group Company [Member]</link:label>
    <link:label id="lab_mo_PerformanceFoodGroupCompanyMember_label_en-US" xlink:label="lab_mo_PerformanceFoodGroupCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Food Group Company [Member]</link:label>
    <link:label id="lab_mo_PerformanceFoodGroupCompanyMember_documentation_en-US" xlink:label="lab_mo_PerformanceFoodGroupCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Food Group Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PerformanceFoodGroupCompanyMember" xlink:href="mo-20221231.xsd#mo_PerformanceFoodGroupCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PerformanceFoodGroupCompanyMember" xlink:to="lab_mo_PerformanceFoodGroupCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter_fe6edd6a-8fa4-436d-95e3-a567c1805492_verboseLabel_en-US" xlink:label="lab_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter_label_en-US" xlink:label="lab_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Maturities Repayments of Principal Thereafter</link:label>
    <link:label id="lab_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter_documentation_en-US" xlink:label="lab_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt maturities repayments of principal thereafter.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter" xlink:href="mo-20221231.xsd#mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter" xlink:to="lab_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_1ae76742-6766-45b1-a3b6-6dc95e2a255b_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interests [Member]</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EuroNotes1000MaturingFebruary2023Member_af713bc8-ba40-410b-a86f-16090a546da0_terseLabel_en-US" xlink:label="lab_mo_EuroNotes1000MaturingFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 1.000%, Maturing February 2023 [Member]</link:label>
    <link:label id="lab_mo_EuroNotes1000MaturingFebruary2023Member_label_en-US" xlink:label="lab_mo_EuroNotes1000MaturingFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 1.000%, Maturing February 2023 [Member]</link:label>
    <link:label id="lab_mo_EuroNotes1000MaturingFebruary2023Member_documentation_en-US" xlink:label="lab_mo_EuroNotes1000MaturingFebruary2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 1.000%, Maturing February 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes1000MaturingFebruary2023Member" xlink:href="mo-20221231.xsd#mo_EuroNotes1000MaturingFebruary2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EuroNotes1000MaturingFebruary2023Member" xlink:to="lab_mo_EuroNotes1000MaturingFebruary2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_4b3b16e9-9f79-433b-b0a7-d9142d410a83_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dispositions</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_2622b3fd-a515-4a45-95fb-b8bafbec8546_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other debt expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_e32cb320-fda2-40d5-ac06-a566d44c24bf_negatedNetLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other debt expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_2db0422a-ca04-4709-b1ed-9fb38b9a8bd5_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other debt expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_127b062f-f0e7-4f02-8b15-e06d2c773629_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision related to litigation recorded</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_a2fef3f5-adc2-430c-97ce-4b8ce255e6d0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9b27f7b3-8e9e-4e53-a58f-c7dd6524dc5e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Income Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_PA_11ac6039-ac74-4d79-9e06-77ccab0c824a_terseLabel_en-US" xlink:label="lab_stpr_PA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pennsylvania [Member]</link:label>
    <link:label id="lab_stpr_PA_label_en-US" xlink:label="lab_stpr_PA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PENNSYLVANIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_PA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_PA" xlink:to="lab_stpr_PA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_48097c80-0f74-4a8e-862d-c89f874c0fea_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_a723dbdb-0e8e-44cc-9a3a-e2c621d09002_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3643be04-08aa-4ab4-97dd-dc1871db13bd_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_eb682154-742e-47ce-8cb2-c5a6d1931345_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Components of Issued, Repurchased and Outstanding Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_9ab162d4-5ae1-42a7-b83d-8425ad321597_terseLabel_en-US" xlink:label="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock award activity</link:label>
    <link:label id="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_label_en-US" xlink:label="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition and Income Tax Effect, Net</link:label>
    <link:label id="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_documentation_en-US" xlink:label="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:href="mo-20221231.xsd#mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:to="lab_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fbdc5e62-bfa3-46ef-bdc0-ec5e74c3c7d0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_c93dbe6e-a21a-4cff-acda-33566a1c1180_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OR_ffac2377-a561-4cad-b055-dcf7cb3153e1_terseLabel_en-US" xlink:label="lab_stpr_OR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oregon [Member]</link:label>
    <link:label id="lab_stpr_OR_label_en-US" xlink:label="lab_stpr_OR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OREGON</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OR" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OR" xlink:to="lab_stpr_OR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_5a54bedb-0898-4a89-b09e-b37f168e7175_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetReductions_47f0663e-0160-4790-a77a-8b051a3e1772_negatedTerseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetReductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions to valuation allowance credited to income tax benefit</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetReductions_label_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetReductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Reductions</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetReductions_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetReductions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Reductions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetReductions" xlink:href="mo-20221231.xsd#mo_ValuationAllowanceDeferredTaxAssetReductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceDeferredTaxAssetReductions" xlink:to="lab_mo_ValuationAllowanceDeferredTaxAssetReductions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_4bfc696f-f2af-4765-a3b0-cf98122d524b_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_OK_e6d3ac99-a116-49b2-b2e4-b63ceb0163f9_terseLabel_en-US" xlink:label="lab_stpr_OK" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oklahoma [Member]</link:label>
    <link:label id="lab_stpr_OK_label_en-US" xlink:label="lab_stpr_OK" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OKLAHOMA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OK"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_OK" xlink:to="lab_stpr_OK" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_96118b6c-9535-4be2-ae2c-f776612d8ccf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8e7edc7a-acb4-4145-ae06-2481dabc387a_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8a7aa34f-fe24-435a-a415-353da780fe66_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f1e0fb9d-600b-4720-ac74-9ba80430cfc8_periodStartLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance beginning of period</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_4f56fb23-d245-43f4-81b8-751b179bb5cb_periodEndLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance end of period</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a26d36be-48be-4e64-9e40-710bd6872bc8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_95617292-db01-41ef-b984-3e7d8aa66865_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_837a49f6-59ac-4d1e-a9f5-9f2a7fe041df_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_641c7ad9-bede-413a-b918-8edbdd0d9824_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_5fc807bb-1683-49ac-8e5a-a730d4cc5e98_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of shareholders filing derivative lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:to="lab_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_c9730f0f-5b86-41fb-a4cb-93c3a051d9d4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_2be6c624-16b6-4d5d-8473-b711b9852c52_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk [Member]</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_5ce2e3a4-ebf3-4175-aa07-fdeccc7c3d67_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes:</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdictModified_4c768906-1cd4-482c-9dd2-40a9e7f56090_terseLabel_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero damages verdict modified</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdictModified_label_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdict Modified</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdictModified_documentation_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdict Modified</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdictModified" xlink:href="mo-20221231.xsd#mo_LossContingencyZeroDamagesVerdictModified"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyZeroDamagesVerdictModified" xlink:to="lab_mo_LossContingencyZeroDamagesVerdictModified" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesReiderandBanksMember_a962bb38-6236-4068-a76d-e65028981bf1_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Reider and Banks [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesReiderandBanksMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Reider and Banks [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesReiderandBanksMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Reider and Banks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesReiderandBanksMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesReiderandBanksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesReiderandBanksMember" xlink:to="lab_mo_EngleProgenyCasesReiderandBanksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_8d412a50-2bfc-451b-9ed6-583a650850ca_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits if recognized would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_32bbae52-4e55-4657-9310-e4c4de4aeaf6_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, FV-NI, unrealized gain (loss)</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_a46db111-5cf5-4ed2-b3ef-bd377ef4d309_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Government, Non-US [Member]</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Government, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes3875MaturingSeptember2046Member_c0c86b46-2430-4d22-b212-9831fb6c3f04_terseLabel_en-US" xlink:label="lab_mo_USDNotes3875MaturingSeptember2046Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.875%, Maturing September 2046 [Member]</link:label>
    <link:label id="lab_mo_USDNotes3875MaturingSeptember2046Member_label_en-US" xlink:label="lab_mo_USDNotes3875MaturingSeptember2046Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.875%, Maturing September 2046 [Member]</link:label>
    <link:label id="lab_mo_USDNotes3875MaturingSeptember2046Member_documentation_en-US" xlink:label="lab_mo_USDNotes3875MaturingSeptember2046Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.875%, Maturing September 2046</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3875MaturingSeptember2046Member" xlink:href="mo-20221231.xsd#mo_USDNotes3875MaturingSeptember2046Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes3875MaturingSeptember2046Member" xlink:to="lab_mo_USDNotes3875MaturingSeptember2046Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_ea9e203a-40e1-45b5-a89d-fdb89ae888c5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_afc76695-e43b-4f68-b11c-420fb9e8ea29_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes2450MaturingFebruary2032Member_7645cb62-4986-4b73-9b03-b00bd45991c9_terseLabel_en-US" xlink:label="lab_mo_USDNotes2450MaturingFebruary2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.450%, Maturing February 2032 [Member]</link:label>
    <link:label id="lab_mo_USDNotes2450MaturingFebruary2032Member_label_en-US" xlink:label="lab_mo_USDNotes2450MaturingFebruary2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.450%, Maturing February 2032 [Member]</link:label>
    <link:label id="lab_mo_USDNotes2450MaturingFebruary2032Member_documentation_en-US" xlink:label="lab_mo_USDNotes2450MaturingFebruary2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.450%, Maturing February 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2450MaturingFebruary2032Member" xlink:href="mo-20221231.xsd#mo_USDNotes2450MaturingFebruary2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes2450MaturingFebruary2032Member" xlink:to="lab_mo_USDNotes2450MaturingFebruary2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_0c36ae5d-5830-41f1-8e13-12fe4df7c90f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance release</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_002f86f2-7df6-4005-9c81-1749408f269b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_6a007d75-516b-4c37-80ea-0c69f1abbdf9_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate_47383fe0-29c4-493e-b76c-55aa8ede1683_terseLabel_en-US" xlink:label="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care cost trend rate</link:label>
    <link:label id="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate_label_en-US" xlink:label="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Ultimate Health Care Cost Trend Rate</link:label>
    <link:label id="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate_documentation_en-US" xlink:label="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Ultimate Health Care Cost Trend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate" xlink:to="lab_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsEquityMethodInvestments_b9f6140d-d0dd-446f-91be-3e1d29f13268_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Cronos</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:to="lab_us-gaap_DeferredTaxAssetsEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_bfd28b7f-d142-41aa-882a-b001218148fa_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_38e5898f-6ba0-42bb-893d-f6ef33e74ce0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EmergingMarketsMember_96ed2798-33b7-4d42-9f12-b86ba1eec620_terseLabel_en-US" xlink:label="lab_mo_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_mo_EmergingMarketsMember_label_en-US" xlink:label="lab_mo_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:label id="lab_mo_EmergingMarketsMember_documentation_en-US" xlink:label="lab_mo_EmergingMarketsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Markets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EmergingMarketsMember" xlink:href="mo-20221231.xsd#mo_EmergingMarketsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EmergingMarketsMember" xlink:to="lab_mo_EmergingMarketsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b2477372-84e3-44c8-b0c1-24c9e9d2dd48_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_4cb6a2a6-8cf0-4f88-aa9d-798a29331057_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_e5195ee2-1baf-4db6-9b25-202d6f84020f_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_d3101776-bc46-4aa1-9c9c-01ec6a7e225e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of shares issuable under the stock compensation plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_c60e6921-fbdc-47cf-bd5b-2f939b5b6f43_negatedLabel_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) losses from investments in equity securities</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_6dc054b8-51a2-4ffe-bc5e-4d94bc05095b_negatedTotalLabel_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) losses from investments in equity securities</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_label_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Investments</link:label>
    <link:label id="lab_mo_IncomeLossFromEquityInvestments_documentation_en-US" xlink:label="lab_mo_IncomeLossFromEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments" xlink:href="mo-20221231.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IncomeLossFromEquityInvestments" xlink:to="lab_mo_IncomeLossFromEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WI_1e15f6a8-415f-49b6-888f-12f83458d4c2_terseLabel_en-US" xlink:label="lab_stpr_WI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wisconsin [Member]</link:label>
    <link:label id="lab_stpr_WI_label_en-US" xlink:label="lab_stpr_WI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WISCONSIN</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WI" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WI" xlink:to="lab_stpr_WI" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDenominatedNotes3490PercentDue2022Member_2cecd761-6b6a-493e-a2e1-de43b9dcbad9_terseLabel_en-US" xlink:label="lab_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 3.490 Percent, Due 2022 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes3490PercentDue2022Member_label_en-US" xlink:label="lab_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 3.490 Percent, Due 2022 [Member]</link:label>
    <link:label id="lab_mo_USDDenominatedNotes3490PercentDue2022Member_documentation_en-US" xlink:label="lab_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Denominated Notes, 3.490 Percent, Due 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:href="mo-20221231.xsd#mo_USDDenominatedNotes3490PercentDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:to="lab_mo_USDDenominatedNotes3490PercentDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_2d39e8b9-d964-4350-b898-01635a4102ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InventoryWriteOffMember_7032544f-5feb-4425-88fa-feb899ef88c0_terseLabel_en-US" xlink:label="lab_mo_InventoryWriteOffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-Off [Member]</link:label>
    <link:label id="lab_mo_InventoryWriteOffMember_label_en-US" xlink:label="lab_mo_InventoryWriteOffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-Off [Member]</link:label>
    <link:label id="lab_mo_InventoryWriteOffMember_documentation_en-US" xlink:label="lab_mo_InventoryWriteOffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-Off [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryWriteOffMember" xlink:href="mo-20221231.xsd#mo_InventoryWriteOffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InventoryWriteOffMember" xlink:to="lab_mo_InventoryWriteOffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber_448f537b-cdaf-4435-84ca-66bdc2eabd1c_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unfavorable verdicts</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Unfavorable, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Unfavorable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:to="lab_mo_LossContingencyClaimsDecidedUnfavorableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DeferredTaxLiabilitiesAccruedPensionCosts_87cf93a8-bb4e-44fc-bf08-1fc65a42eae2_negatedTerseLabel_en-US" xlink:label="lab_mo_DeferredTaxLiabilitiesAccruedPensionCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued pension costs</link:label>
    <link:label id="lab_mo_DeferredTaxLiabilitiesAccruedPensionCosts_label_en-US" xlink:label="lab_mo_DeferredTaxLiabilitiesAccruedPensionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Accrued Pension Costs</link:label>
    <link:label id="lab_mo_DeferredTaxLiabilitiesAccruedPensionCosts_documentation_en-US" xlink:label="lab_mo_DeferredTaxLiabilitiesAccruedPensionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Accrued Pension Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxLiabilitiesAccruedPensionCosts" xlink:href="mo-20221231.xsd#mo_DeferredTaxLiabilitiesAccruedPensionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DeferredTaxLiabilitiesAccruedPensionCosts" xlink:to="lab_mo_DeferredTaxLiabilitiesAccruedPensionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MaximumBondForAllDefendants_8f2fa3a7-934d-4f37-82c0-1a3d373d061a_terseLabel_en-US" xlink:label="lab_mo_MaximumBondForAllDefendants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum bond for all defendants</link:label>
    <link:label id="lab_mo_MaximumBondForAllDefendants_label_en-US" xlink:label="lab_mo_MaximumBondForAllDefendants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Bond For All Defendants</link:label>
    <link:label id="lab_mo_MaximumBondForAllDefendants_documentation_en-US" xlink:label="lab_mo_MaximumBondForAllDefendants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Bond For All Defendants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MaximumBondForAllDefendants" xlink:href="mo-20221231.xsd#mo_MaximumBondForAllDefendants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MaximumBondForAllDefendants" xlink:to="lab_mo_MaximumBondForAllDefendants" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember_87348a83-94ee-47a4-a3e5-6b0201dc1771_terseLabel_en-US" xlink:label="lab_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury And Foreign Government Securities and all other investments [Member]</link:label>
    <link:label id="lab_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember_label_en-US" xlink:label="lab_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Foreign Government Securities And Other [Member]</link:label>
    <link:label id="lab_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember_documentation_en-US" xlink:label="lab_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Foreign Government Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember" xlink:href="mo-20221231.xsd#mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember" xlink:to="lab_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_d1146f0f-1829-4836-a249-4c8d2a867898_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent liability related to performance surety bonds</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_9b0b3285-1546-46d0-b360-bcfa3c3d906b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_3b4bc09a-68f0-456b-ab53-6946a49c29ee_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_3d10c53c-1dea-4c89-ad20-5b2a50a131c8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Effective Tax Rate and U.S. Federal Statutory Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7153e17-132b-42bf-968a-a69de03ba106_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease)</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_9b71981f-982f-42f3-a705-ab5d6017cacb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TN_fb114e9f-165a-4d81-8d47-7cf5dc1b3150_terseLabel_en-US" xlink:label="lab_stpr_TN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tennessee [Member]</link:label>
    <link:label id="lab_stpr_TN_label_en-US" xlink:label="lab_stpr_TN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TENNESSEE</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TN" xlink:to="lab_stpr_TN" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash_4dff7170-9d0a-4d07-afca-d486920dbfc5_terseLabel_en-US" xlink:label="lab_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred proceeds from the sale of IQOS System commercialization rights</link:label>
    <link:label id="lab_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash_label_en-US" xlink:label="lab_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Proceeds From Sale Of Commercialization Rights, Noncash</link:label>
    <link:label id="lab_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash_documentation_en-US" xlink:label="lab_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Proceeds From Sale Of Commercialization Rights, Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash" xlink:href="mo-20221231.xsd#mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash" xlink:to="lab_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_WineBusinessStrategicResetMember_7d6da59f-5027-4539-9967-164a6e9d5aaa_terseLabel_en-US" xlink:label="lab_mo_WineBusinessStrategicResetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Business Strategic Reset [Member]</link:label>
    <link:label id="lab_mo_WineBusinessStrategicResetMember_label_en-US" xlink:label="lab_mo_WineBusinessStrategicResetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Business Strategic Reset [Member]</link:label>
    <link:label id="lab_mo_WineBusinessStrategicResetMember_documentation_en-US" xlink:label="lab_mo_WineBusinessStrategicResetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Business Strategic Reset [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineBusinessStrategicResetMember" xlink:href="mo-20221231.xsd#mo_WineBusinessStrategicResetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_WineBusinessStrategicResetMember" xlink:to="lab_mo_WineBusinessStrategicResetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes3400MaturingFebruary2041Member_19023652-6908-44cf-8d1f-3db231a1c3c7_terseLabel_en-US" xlink:label="lab_mo_USDNotes3400MaturingFebruary2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.400%, Maturing February 2041 [Member]</link:label>
    <link:label id="lab_mo_USDNotes3400MaturingFebruary2041Member_label_en-US" xlink:label="lab_mo_USDNotes3400MaturingFebruary2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.400%, Maturing February 2041 [Member]</link:label>
    <link:label id="lab_mo_USDNotes3400MaturingFebruary2041Member_documentation_en-US" xlink:label="lab_mo_USDNotes3400MaturingFebruary2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 3.400%, Maturing February 2041</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3400MaturingFebruary2041Member" xlink:href="mo-20221231.xsd#mo_USDNotes3400MaturingFebruary2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes3400MaturingFebruary2041Member" xlink:to="lab_mo_USDNotes3400MaturingFebruary2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_97e223df-8220-420c-a8c2-bd65ac99152f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment_a32eba7a-8337-420b-9e2d-c82842e3bbbd_negatedTotalLabel_en-US" xlink:label="lab_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total movements in other comprehensive earnings/losses</link:label>
    <link:label id="lab_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment_label_en-US" xlink:label="lab_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax, Including Cumulative Effect Adjustment</link:label>
    <link:label id="lab_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment_documentation_en-US" xlink:label="lab_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax, Including Cumulative Effect Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" xlink:to="lab_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fba8b236-9301-49eb-a582-3574a036d1cf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_22cba525-c485-4933-b7de-b8d3e53ef195_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_ed3d388c-f704-4c3f-9908-c8d16ed3db44_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStockSharesOutstandingRollForward_88b7af4d-f20a-4fc3-9938-4ae915308975_terseLabel_en-US" xlink:label="lab_mo_CommonStockSharesOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Outstanding [Roll Forward]</link:label>
    <link:label id="lab_mo_CommonStockSharesOutstandingRollForward_label_en-US" xlink:label="lab_mo_CommonStockSharesOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Outstanding [Roll Forward]</link:label>
    <link:label id="lab_mo_CommonStockSharesOutstandingRollForward_documentation_en-US" xlink:label="lab_mo_CommonStockSharesOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockSharesOutstandingRollForward" xlink:href="mo-20221231.xsd#mo_CommonStockSharesOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStockSharesOutstandingRollForward" xlink:to="lab_mo_CommonStockSharesOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_824de195-9ae5-4e48-9e11-bab3c1338aab_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_dc5af663-084b-4841-aec6-25528e8a57f6_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_6b2de1be-9d7f-4f95-8dc6-f9ac276416a9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_ea22a794-6226-4d7c-a707-562771bbc253_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_b72874f4-d1fd-4870-a3f4-8e3a64cdc0f8_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, amounts for asset (liability) recognized in statement of financial position</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:to="lab_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_ea0d51ca-2499-4970-8fc4-b1131a762783_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_800cc3f8-4647-4968-9a7b-e8d972a557ff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_81dfb6a7-0b54-4f53-9ab1-3e6594b8239f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_ee267125-0aa4-4f40-a781-09959af78be7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of short-term borrowings</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_d6740dea-39ba-45b9-949c-e227103692fe_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d79e0d5c-0f5f-4350-b1ae-05b37cd2409f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationEscrowDeposit_cba1f1c1-db7d-4352-bfca-b36000146b3d_terseLabel_en-US" xlink:label="lab_mo_LitigationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security posted for appeal of judgments</link:label>
    <link:label id="lab_mo_LitigationEscrowDeposit_label_en-US" xlink:label="lab_mo_LitigationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Escrow Deposit</link:label>
    <link:label id="lab_mo_LitigationEscrowDeposit_documentation_en-US" xlink:label="lab_mo_LitigationEscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Escrow Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationEscrowDeposit" xlink:href="mo-20221231.xsd#mo_LitigationEscrowDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationEscrowDeposit" xlink:to="lab_mo_LitigationEscrowDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_fc3c90d6-96e6-40d3-a0ca-228236e40622_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Income) losses from investments in equity securities</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_52b51ec8-3a9b-446d-aab1-5f50675c5641_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5cac9b41-0752-4ef2-be1b-0a9b93b7c7f5_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_bd7bdb2d-becb-46ec-b0de-b318d145794f_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_957e82b8-5420-4b0d-b7bb-3000a33ff2ac_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_de0498f9-0cfa-498e-ae19-1b0d7b8ea734_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future amortization, year 1</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_ae9fceb6-1a4d-4c06-b204-993acba180ae_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at beginning of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_35ed5050-a60e-4db6-b3fc-dc58919f4576_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligation at end of year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e05b02b8-b6f8-4cbc-b533-6158db52822e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Losses) Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_05b4ea81-75c7-4d9d-94ef-0fde6564f45a_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_01a63ab5-4b43-4dca-b3c7-c14db27fc143_terseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Texas [Member]</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes5950MaturingFebruary2049Member_eec444b8-01a8-48cb-b017-6596a0732d4e_terseLabel_en-US" xlink:label="lab_mo_USDNotes5950MaturingFebruary2049Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 5.950%, Maturing February 2049 [member]</link:label>
    <link:label id="lab_mo_USDNotes5950MaturingFebruary2049Member_label_en-US" xlink:label="lab_mo_USDNotes5950MaturingFebruary2049Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 5.950%, Maturing February 2049 [Member]</link:label>
    <link:label id="lab_mo_USDNotes5950MaturingFebruary2049Member_documentation_en-US" xlink:label="lab_mo_USDNotes5950MaturingFebruary2049Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 5.950%, Maturing February 2049</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes5950MaturingFebruary2049Member" xlink:href="mo-20221231.xsd#mo_USDNotes5950MaturingFebruary2049Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes5950MaturingFebruary2049Member" xlink:to="lab_mo_USDNotes5950MaturingFebruary2049Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember_e082c446-129a-40f2-b5d3-5eca73aaea8e_terseLabel_en-US" xlink:label="lab_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA And R.J. Reynolds Tobacco Company</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember_label_en-US" xlink:label="lab_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA And R.J. Reynolds Tobacco Company [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember_documentation_en-US" xlink:label="lab_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA And R.J. Reynolds Tobacco Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember" xlink:to="lab_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_4c7a4ea5-9633-467d-89f7-06adfc252ded_terseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postretirement Benefit Plan [Member]</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_dc476481-9881-4f3f-b294-a5567fed61fa_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_74c259ae-20b7-4d95-a1a0-a03617fe72db_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or part noncash acquisition, intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_0a6f8e2a-c381-4f85-acab-bb4b0958e9ac_terseLabel_en-US" xlink:label="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, consolidated EBITDA to interest expense ratio</link:label>
    <link:label id="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_label_en-US" xlink:label="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Consolidated EBITDA to Interest Expense Ratio</link:label>
    <link:label id="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_documentation_en-US" xlink:label="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Consolidated EBITDA to Interest Expense Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:href="mo-20221231.xsd#mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:to="lab_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_e94492d2-3e71-41ef-8237-7fe81d0d3ad1_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to net earnings, net of deferred income taxes</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8456488f-6998-42a8-95a4-9b3d12dd9572_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_e0a393e3-dbd4-45d3-91cf-7bd52f92e51e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase - long-term</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_25ade7ed-9b5c-4805-8fd8-73cf91bd7e85_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_f1a670a7-ca30-4358-a10e-e157562c3bbf_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_5fd493ea-ab17-4c19-9d16-694c60d83897_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_3472f885-6102-4572-b962-5c5d9166f0dd_negatedLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock_81d513a9-aecd-4755-9d33-88ce0aa52a3e_terseLabel_en-US" xlink:label="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Non-Participating Manufacturer Adjustment Items</link:label>
    <link:label id="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock_label_en-US" xlink:label="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Non-Participating Manufacturer Adjustment Items [Table Text Block]</link:label>
    <link:label id="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock_documentation_en-US" xlink:label="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Non-Participating Manufacturer Adjustment Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" xlink:href="mo-20221231.xsd#mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" xlink:to="lab_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherMovementsDuringtheYearAbstract_a47ba085-9987-4db5-ab82-45beccb7bc8c_terseLabel_en-US" xlink:label="lab_mo_OtherMovementsDuringtheYearAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other movements during the year:</link:label>
    <link:label id="lab_mo_OtherMovementsDuringtheYearAbstract_label_en-US" xlink:label="lab_mo_OtherMovementsDuringtheYearAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Movements During the Year [Abstract]</link:label>
    <link:label id="lab_mo_OtherMovementsDuringtheYearAbstract_documentation_en-US" xlink:label="lab_mo_OtherMovementsDuringtheYearAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Movements During the Year [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherMovementsDuringtheYearAbstract" xlink:href="mo-20221231.xsd#mo_OtherMovementsDuringtheYearAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherMovementsDuringtheYearAbstract" xlink:to="lab_mo_OtherMovementsDuringtheYearAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue_4cb083be-c96f-438d-99c8-b54e44b17591_verboseLabel_en-US" xlink:label="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value</link:label>
    <link:label id="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Aggregate Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation arrangement by share based payment award equity instruments other than options grants in period weighted average grant date fair value total.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" xlink:href="mo-20221231.xsd#mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" xlink:to="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3f263b50-092b-477f-bd65-0ae0ef98c9b4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_a74c10af-8b36-45ea-89e1-e82b20af45b0_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, number of shares owned, common (in shares)</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Common</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Number of Shares Owned, Common</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:to="lab_mo_EquityMethodInvestmentNumberofSharesOwnedCommon" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_b8c0295d-8218-4edc-b4cd-a411bc59cfce_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3c777aea-5e13-4e72-a338-d7b2ca4e1209_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_375d26a1-9a57-44bb-869a-a5a2d4cb07b6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_ce5baf25-6f5c-40cb-9211-760870d5447b_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan amendments</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAmendments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAmendments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_2ba1c7be-a00b-473b-9cdf-2e5529c5555f_verboseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_928dcea6-b5b6-4ca6-8fcd-19c9b422db0d_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other [Member]</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_348a9471-44ae-45d3-94bd-cd65b6f4f302_terseLabel_en-US" xlink:label="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum</link:label>
    <link:label id="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_label_en-US" xlink:label="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum</link:label>
    <link:label id="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_documentation_en-US" xlink:label="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:href="mo-20221231.xsd#mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:to="lab_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates_5065d72f-5ac1-4caf-b9f4-cac7c623927e_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of cases with set trial dates</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases With Set Trial Dates</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Cases With Set Trial Dates</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithSetTrialDates" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfCasesWithSetTrialDates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfCasesWithSetTrialDates" xlink:to="lab_mo_LossContingencyNumberOfCasesWithSetTrialDates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e2643b66-07f4-4f94-a1e0-d2cfed64c451_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit line available under the agreement</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_e7bc8bc1-1f0d-4fd6-befe-30e94dc39971_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_781e62b1-940f-4288-a001-b8971d1c530a_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_1dc99279-7897-4446-856b-0fd45415cc2d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages awarded, value</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_8661284e-f427-4550-a607-bb9a72660f1b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductions</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_508058be-91bb-4384-935a-8332154426bb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock: U.S. equities [Member]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_591a249f-959b-4adc-9c9f-8d371a1859f2_verboseLabel_en-US" xlink:label="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABI [Member]</link:label>
    <link:label id="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_label_en-US" xlink:label="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Equity Method Investments Attributable To Parent [Member]</link:label>
    <link:label id="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_documentation_en-US" xlink:label="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Equity Method Investments Attributable To Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:href="mo-20221231.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:to="lab_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsDecidedFavorableNumber_991be1a3-85b5-4cdb-a721-0752505840d4_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of favorable verdicts</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedFavorableNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Favorable, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsDecidedFavorableNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Decided Favorable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:to="lab_mo_LossContingencyClaimsDecidedFavorableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_bedef986-70d1-4314-bc51-98097a34411d_terseLabel_en-US" xlink:label="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity securities without readily determinable fair value</link:label>
    <link:label id="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_label_en-US" xlink:label="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Securities Without Readily Determinable Fair Value</link:label>
    <link:label id="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_documentation_en-US" xlink:label="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Securities Without Readily Determinable Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:href="mo-20221231.xsd#mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:to="lab_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_5682bf74-14d2-4c23-b444-4d4bc690a935_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTextBlock_1e333b9a-9f8b-4e88-8999-0688eea8d612_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Borrowings and Borrowing Arrangements</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTextBlock" xlink:to="lab_us-gaap_ShortTermDebtTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CorporateDebtSecurityBelowInvestmentGradeMember_4653137a-8013-4d2a-9293-9b0730d97e5f_terseLabel_en-US" xlink:label="lab_mo_CorporateDebtSecurityBelowInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Security, Below Investment Grade [Member]</link:label>
    <link:label id="lab_mo_CorporateDebtSecurityBelowInvestmentGradeMember_label_en-US" xlink:label="lab_mo_CorporateDebtSecurityBelowInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Security, Below Investment Grade [Member]</link:label>
    <link:label id="lab_mo_CorporateDebtSecurityBelowInvestmentGradeMember_documentation_en-US" xlink:label="lab_mo_CorporateDebtSecurityBelowInvestmentGradeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Security, Below Investment Grade [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CorporateDebtSecurityBelowInvestmentGradeMember" xlink:href="mo-20221231.xsd#mo_CorporateDebtSecurityBelowInvestmentGradeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CorporateDebtSecurityBelowInvestmentGradeMember" xlink:to="lab_mo_CorporateDebtSecurityBelowInvestmentGradeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_c8fb9172-10a1-4457-914b-1341c67e76b5_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_7fe94093-c061-4c1a-8c33-f066875da22d_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_926112a6-2861-4238-88d6-a50949eed8bb_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2021 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2021 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2021 NPM Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_ee182d60-6673-4f76-85d0-184bb0bfba7f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb4811fb-71a1-410b-94de-2462c8c51660_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_41acb974-0d24-4383-aac8-4ca3a1b8a69b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for tax positions due to lapse of statutes of limitations</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementEstimateofPossibleGain_9bcbe23e-677e-44a6-94c9-40bc22532878_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible gain</link:label>
    <link:label id="lab_mo_LitigationSettlementEstimateofPossibleGain_label_en-US" xlink:label="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Estimate of Possible Gain</link:label>
    <link:label id="lab_mo_LitigationSettlementEstimateofPossibleGain_documentation_en-US" xlink:label="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Estimate of Possible Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementEstimateofPossibleGain" xlink:href="mo-20221231.xsd#mo_LitigationSettlementEstimateofPossibleGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementEstimateofPossibleGain" xlink:to="lab_mo_LitigationSettlementEstimateofPossibleGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_732caca4-7401-4437-ae1f-877eb41e58b9_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost (income)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_7567179b-e5a8-4c0d-8a26-d77597f13d21_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees</link:label>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_label_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:to="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_de4caddb-2fd0-473d-b113-9c514a196e49_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_ce997e95-9381-4238-8162-87c4c22be5d9_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate cost of shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_d2c91489-638a-4df2-a029-924b1047f2d2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Altria</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_1998c66a-693d-4334-a724-88a113749212_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings attributable to Altria</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_1fdab2a1-198f-476f-ac49-430609d105ee_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Maturities of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_d12bb002-64af-45cf-b185-e490f47168c4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost (credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_9f2f49d5-8728-41b2-ba2d-d140334d679a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_fc7bc6dc-ddc2-43d7-8254-fb8eae1c79b2_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, percentage of shares eligible for purchase</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Percentage of Shares Eligible For Purchase</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Percentage of Shares Eligible For Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:to="lab_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfComplaints_bfdea255-0ad2-4888-be83-d881ea008287_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfComplaints" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of complaints</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfComplaints_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfComplaints" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Complaints</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfComplaints_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfComplaints" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Complaints</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfComplaints" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfComplaints"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfComplaints" xlink:to="lab_mo_LossContingencyNumberOfComplaints" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_20cba5a1-1a8f-4d63-8bf4-c3f069359d45_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rate of compensation increase - long-term</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesChadwellMember_4b0af106-1e33-49f8-875f-639af28a7f14_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesChadwellMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Chadwell [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesChadwellMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesChadwellMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Chadwell [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesChadwellMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesChadwellMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Chadwell [Member] [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesChadwellMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesChadwellMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesChadwellMember" xlink:to="lab_mo_EngleProgenyCasesChadwellMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_a583970a-05f9-46df-95d3-bf4a7376cc8c_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WV_7952e5d0-2b20-42d4-9867-25d245a2c1d2_terseLabel_en-US" xlink:label="lab_stpr_WV" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Virginia [Member]</link:label>
    <link:label id="lab_stpr_WV_label_en-US" xlink:label="lab_stpr_WV" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEST VIRGINIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WV"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WV" xlink:to="lab_stpr_WV" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_d2fe7a08-f84a-4d1f-b853-0f793d4b424b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required purchase price as percentage of aggregate principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_5a0fdfe2-c010-4ab5-a4be-49835cb025f6_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_9485460f-4a2f-4ca4-9ec5-ab0b6182996f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_e30c0241-621b-4bc3-a44e-e0715d9a311a_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states in compliance with escrow statues</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States In Compliance With Escrow Statues</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States In Compliance With Escrow Statues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:to="lab_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_d0c7ce3b-8771-420d-8c68-33f3d35de383_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_fcbb615b-748b-42e7-8e05-5d0a9b4ba87c_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_6c756604-2d8e-40dd-a191-646feece46eb_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, difference between carrying amount and fair value</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Fair Value</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" xlink:to="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_16a73f06-374c-47b2-81d1-307e7f60890c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyStateCourtsNumber_c6268417-1603-4dd6-90ea-cb0dfbe30d27_terseLabel_en-US" xlink:label="lab_mo_LossContingencyStateCourtsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of state courts</link:label>
    <link:label id="lab_mo_LossContingencyStateCourtsNumber_label_en-US" xlink:label="lab_mo_LossContingencyStateCourtsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, State Courts, Number</link:label>
    <link:label id="lab_mo_LossContingencyStateCourtsNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyStateCourtsNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, State Courts, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyStateCourtsNumber" xlink:href="mo-20221231.xsd#mo_LossContingencyStateCourtsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyStateCourtsNumber" xlink:to="lab_mo_LossContingencyStateCourtsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_6f113699-5536-4d85-9167-c9f2cf39e21b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_959146e4-0264-4cb5-a536-b5864f7c9775_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_efa724d4-da60-4eab-a3c2-f6d4b253115e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_6a742786-f816-4d5a-b907-9be73a3b0fea_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AmountAwardedtoOtherParty_83d26fd0-9354-4b0b-98dc-b606a67c5a88_terseLabel_en-US" xlink:label="lab_mo_AmountAwardedtoOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount awarded to other party</link:label>
    <link:label id="lab_mo_AmountAwardedtoOtherParty_label_en-US" xlink:label="lab_mo_AmountAwardedtoOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Awarded to Other Party</link:label>
    <link:label id="lab_mo_AmountAwardedtoOtherParty_documentation_en-US" xlink:label="lab_mo_AmountAwardedtoOtherParty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AmountAwardedtoOtherParty" xlink:href="mo-20221231.xsd#mo_AmountAwardedtoOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AmountAwardedtoOtherParty" xlink:to="lab_mo_AmountAwardedtoOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_82fc3095-a841-476d-b752-c36dbdcba330_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service (cost) credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4160f8e8-68c5-4d6d-9989-031970b5c1e8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettled_6f5e1292-f5c4-4a75-9ec1-bdb7fcf4c0cd_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states not settled</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettled_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not Settled</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettled_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettled" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesNotSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesNotSettled" xlink:to="lab_mo_LossContingencyNumberOfStatesNotSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfPendingCasesConsolidated_8c7261b5-00ad-403e-974b-dc65c80ce5ed_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of pending cases consolidated</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfPendingCasesConsolidated_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Pending Cases Consolidated</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfPendingCasesConsolidated_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Pending Cases Consolidated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfPendingCasesConsolidated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:to="lab_mo_LossContingencyNumberOfPendingCasesConsolidated" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CigarettesMember_7a794756-1706-4046-93f5-ea8876fd9182_terseLabel_en-US" xlink:label="lab_mo_CigarettesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cigarettes [Member]</link:label>
    <link:label id="lab_mo_CigarettesMember_label_en-US" xlink:label="lab_mo_CigarettesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cigarettes [Member]</link:label>
    <link:label id="lab_mo_CigarettesMember_documentation_en-US" xlink:label="lab_mo_CigarettesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cigarettes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CigarettesMember" xlink:href="mo-20221231.xsd#mo_CigarettesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CigarettesMember" xlink:to="lab_mo_CigarettesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_RevenueContractDuration_ebd7039c-410e-404f-b21e-91e7493bab45_terseLabel_en-US" xlink:label="lab_mo_RevenueContractDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, contract duration</link:label>
    <link:label id="lab_mo_RevenueContractDuration_label_en-US" xlink:label="lab_mo_RevenueContractDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Contract Duration</link:label>
    <link:label id="lab_mo_RevenueContractDuration_documentation_en-US" xlink:label="lab_mo_RevenueContractDuration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Contract Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevenueContractDuration" xlink:href="mo-20221231.xsd#mo_RevenueContractDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_RevenueContractDuration" xlink:to="lab_mo_RevenueContractDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_abd9c5c7-33c7-4760-81fc-4810f12eb991_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_7075f969-ec36-4a4a-ade2-1482a34985a1_terseLabel_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic defined benefits expense (reversal of expense)</link:label>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_1088f9e2-6f87-44a9-868e-89d75cf7e849_verboseLabel_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit income, excluding service cost</link:label>
    <link:label id="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_label_en-US" xlink:label="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:to="lab_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes6200MaturingFebruary2059Member_2aa8840c-ee28-4859-a7cc-6fd4e659c018_terseLabel_en-US" xlink:label="lab_mo_USDNotes6200MaturingFebruary2059Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 6.200%, Maturing February 2059 [Member]</link:label>
    <link:label id="lab_mo_USDNotes6200MaturingFebruary2059Member_e4fd870c-b0f7-47d4-a952-0cb3a02be09c_verboseLabel_en-US" xlink:label="lab_mo_USDNotes6200MaturingFebruary2059Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 6.200% [Member]</link:label>
    <link:label id="lab_mo_USDNotes6200MaturingFebruary2059Member_label_en-US" xlink:label="lab_mo_USDNotes6200MaturingFebruary2059Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 6.200%, Maturing February 2059 [Member]</link:label>
    <link:label id="lab_mo_USDNotes6200MaturingFebruary2059Member_documentation_en-US" xlink:label="lab_mo_USDNotes6200MaturingFebruary2059Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 6.200%, Maturing February 2059</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes6200MaturingFebruary2059Member" xlink:href="mo-20221231.xsd#mo_USDNotes6200MaturingFebruary2059Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes6200MaturingFebruary2059Member" xlink:to="lab_mo_USDNotes6200MaturingFebruary2059Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_76fef4cb-8071-4fcc-87d7-b3c8099d4e33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation_09611215-800a-4a77-8430-040880627521_terseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation_label_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Foreign Currency Translation</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation" xlink:href="mo-20221231.xsd#mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation" xlink:to="lab_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate_75cbbf96-069b-4393-8acc-76dba3260415_terseLabel_en-US" xlink:label="lab_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, purchase agreement, effective interest rate</link:label>
    <link:label id="lab_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate_label_en-US" xlink:label="lab_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Purchase Agreement, Effective Interest Rate</link:label>
    <link:label id="lab_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate_documentation_en-US" xlink:label="lab_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Purchase Agreement, Effective Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate" xlink:href="mo-20221231.xsd#mo_DisposalGroupPurchaseAgreementEffectiveInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate" xlink:to="lab_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_ca062746-4c38-4037-bcad-0a38f5560a74_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards_da073960-6a36-46c0-91d6-50c0f0c9ca8a_terseLabel_en-US" xlink:label="lab_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses and tax credit carryforwards</link:label>
    <link:label id="lab_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards_label_en-US" xlink:label="lab_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss and Tax Credit Carryforwards</link:label>
    <link:label id="lab_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards_documentation_en-US" xlink:label="lab_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets net operating losses and tax credit carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards" xlink:href="mo-20221231.xsd#mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards" xlink:to="lab_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_06943b00-051c-47e2-8ade-b8c56c6d3318_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_e14285ba-b758-4752-a9cf-77f768f17f8e_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_7a76c8b3-b00e-406e-8a9f-1c0f29062498_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus: contingently issuable PSUs (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Contingently Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_1100396c-1548-4ad2-8d71-6519cfbf39af_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_623b09a9-aa32-4cf5-bad0-17a89b98c17f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_e2b5d227-d999-4373-b6be-1041f331249a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_c2d52221-13cf-4a6d-9038-d31ff08917b1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesStateMember_e7d4a80d-10b7-4445-be14-ea335efabc6a_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesStateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, State [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesStateMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesStateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, State [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesStateMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesStateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, State [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesStateMember" xlink:to="lab_mo_EngleProgenyCasesStateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_69e537a6-4b33-4415-aeb4-13aac11dd28f_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberofManufacturers_fbe489aa-9707-4041-b6e0-ef4852509981_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of manufacturers</link:label>
    <link:label id="lab_mo_LossContingencyNumberofManufacturers_label_en-US" xlink:label="lab_mo_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Manufacturers</link:label>
    <link:label id="lab_mo_LossContingencyNumberofManufacturers_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberofManufacturers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Manufacturers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberofManufacturers" xlink:to="lab_mo_LossContingencyNumberofManufacturers" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_McLaneCompanyIncMember_b212a043-ff66-4f3e-8bea-f6d7d3dc1a6c_terseLabel_en-US" xlink:label="lab_mo_McLaneCompanyIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McLane Company Inc [Member]</link:label>
    <link:label id="lab_mo_McLaneCompanyIncMember_label_en-US" xlink:label="lab_mo_McLaneCompanyIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McLane Company Inc [Member]</link:label>
    <link:label id="lab_mo_McLaneCompanyIncMember_documentation_en-US" xlink:label="lab_mo_McLaneCompanyIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">McLane Company Inc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_McLaneCompanyIncMember" xlink:href="mo-20221231.xsd#mo_McLaneCompanyIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_McLaneCompanyIncMember" xlink:to="lab_mo_McLaneCompanyIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_8151f682-10a3-4d59-b844-691121209edf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes4500MaturingMay2043Member_b1cfcb17-7d74-4724-8cf2-fa804557f9f1_terseLabel_en-US" xlink:label="lab_mo_USDNotes4500MaturingMay2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.500%, Maturing May 2043 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4500MaturingMay2043Member_label_en-US" xlink:label="lab_mo_USDNotes4500MaturingMay2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.500%, Maturing May 2043 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4500MaturingMay2043Member_documentation_en-US" xlink:label="lab_mo_USDNotes4500MaturingMay2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.500%, Maturing May 2043</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4500MaturingMay2043Member" xlink:href="mo-20221231.xsd#mo_USDNotes4500MaturingMay2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes4500MaturingMay2043Member" xlink:to="lab_mo_USDNotes4500MaturingMay2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CreditAgreementMember_d5f5a915-d139-4998-a429-968edf82f9e1_terseLabel_en-US" xlink:label="lab_mo_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_mo_CreditAgreementMember_label_en-US" xlink:label="lab_mo_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_mo_CreditAgreementMember_documentation_en-US" xlink:label="lab_mo_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CreditAgreementMember" xlink:href="mo-20221231.xsd#mo_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CreditAgreementMember" xlink:to="lab_mo_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_454d2f78-c2d9-43eb-b2b0-869221f35abd_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Name [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_c94ddcec-34ae-411f-8c0d-dc31732302dc_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_63ecc69b-5a59-4691-a722-5e78cc6e879c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_4b23237b-c0a3-42b0-9dab-065687f2783b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Plan Assets by Asset Category</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_ffa243a0-72a6-412f-b970-c76af2b21a83_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_f72588d4-189c-431c-bd91-d9a42cb90a21_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_a726ef6d-6e9d-47fb-b2a8-982f28d1d196_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_7ff328f1-57af-4738-8787-8d8ed2445f8b_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_3e05ed79-38d2-4d55-9f50-fac6c9fc94c7_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_a5160582-1c3f-4cf2-b14e-f3e1d173e21d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember_47166910-e273-4735-8af5-95cddda6a7d1_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Fontaine [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Fontaine [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Fontaine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember" xlink:href="mo-20221231.xsd#mo_NonEngleProgenySmokingAndHealthCaseFontaineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember" xlink:to="lab_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_5004273e-0806-48f2-bccd-57a6caa01537_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_e0291434-d278-4670-ad59-b85f1e2d3090_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2020 NPM Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCaseMendezMember_f0a9f2ad-d24d-46b2-b484-275694cf475d_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCaseMendezMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Mendez [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCaseMendezMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCaseMendezMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Mendez [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCaseMendezMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCaseMendezMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Mendez</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCaseMendezMember" xlink:href="mo-20221231.xsd#mo_NonEngleProgenySmokingAndHealthCaseMendezMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingAndHealthCaseMendezMember" xlink:to="lab_mo_NonEngleProgenySmokingAndHealthCaseMendezMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_31a29668-328c-48e1-982d-82eb02c393dd_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:to="lab_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_FederalAndStateShareholderDerivativeLawsuitsMember_98eefc55-9ebe-4c72-9b61-629926daa44a_terseLabel_en-US" xlink:label="lab_mo_FederalAndStateShareholderDerivativeLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal And State Shareholder Derivative Lawsuits [Member]</link:label>
    <link:label id="lab_mo_FederalAndStateShareholderDerivativeLawsuitsMember_label_en-US" xlink:label="lab_mo_FederalAndStateShareholderDerivativeLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal And State Shareholder Derivative Lawsuits [Member]</link:label>
    <link:label id="lab_mo_FederalAndStateShareholderDerivativeLawsuitsMember_documentation_en-US" xlink:label="lab_mo_FederalAndStateShareholderDerivativeLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal And State Shareholder Derivative Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalAndStateShareholderDerivativeLawsuitsMember" xlink:href="mo-20221231.xsd#mo_FederalAndStateShareholderDerivativeLawsuitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_FederalAndStateShareholderDerivativeLawsuitsMember" xlink:to="lab_mo_FederalAndStateShareholderDerivativeLawsuitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClassNotCertifiedNumber_d6c21e2c-4e6e-4ea3-82cb-e89739f73771_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class not certified</link:label>
    <link:label id="lab_mo_LossContingencyClassNotCertifiedNumber_label_en-US" xlink:label="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Not Certified, Number</link:label>
    <link:label id="lab_mo_LossContingencyClassNotCertifiedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Not Certified, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassNotCertifiedNumber" xlink:href="mo-20221231.xsd#mo_LossContingencyClassNotCertifiedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClassNotCertifiedNumber" xlink:to="lab_mo_LossContingencyClassNotCertifiedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_943c5b21-a851-47cb-b022-1b0c6e09ba2b_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_b3fd8295-5f73-42c0-b93d-8f00d6c3b200_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost/credit</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_335dbf1b-50cb-4706-bc0b-b81feb7c2ff5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_6cc7338c-4cf1-486b-a5be-ae92f11b79be_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_a1732dc3-73da-4d3e-8db4-5086e607363f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per share data:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_fd114684-39e8-4103-a058-aa842ff6c81f_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount ordered to be paid from other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_658cd533-e895-4209-8894-4bae61a9f550_terseLabel_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</link:label>
    <link:label id="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_label_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking And Health Class Actions And Aggregated Claims Litigation [Member]</link:label>
    <link:label id="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_documentation_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking and Health Class Actions and Aggregated Claims Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" xlink:href="mo-20221231.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" xlink:to="lab_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_7799631a-0f77-44fc-aff6-37503a1a53b1_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ArbitrationPeriodDomain_7a7ca101-e7bc-43d3-a800-3ac9f1d653a7_terseLabel_en-US" xlink:label="lab_mo_ArbitrationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Domain]</link:label>
    <link:label id="lab_mo_ArbitrationPeriodDomain_label_en-US" xlink:label="lab_mo_ArbitrationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Domain]</link:label>
    <link:label id="lab_mo_ArbitrationPeriodDomain_documentation_en-US" xlink:label="lab_mo_ArbitrationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodDomain" xlink:href="mo-20221231.xsd#mo_ArbitrationPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ArbitrationPeriodDomain" xlink:to="lab_mo_ArbitrationPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes4000MaturingJanuary2024Member_37b90708-3f2d-455d-ac03-1f02317a223b_verboseLabel_en-US" xlink:label="lab_mo_USDNotes4000MaturingJanuary2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.000%, Maturing January 2024 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4000MaturingJanuary2024Member_7cb45bce-4767-484b-a9b8-77a0b38731eb_terseLabel_en-US" xlink:label="lab_mo_USDNotes4000MaturingJanuary2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.000% [Member]</link:label>
    <link:label id="lab_mo_USDNotes4000MaturingJanuary2024Member_label_en-US" xlink:label="lab_mo_USDNotes4000MaturingJanuary2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.000%, Maturing January 2024 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4000MaturingJanuary2024Member_documentation_en-US" xlink:label="lab_mo_USDNotes4000MaturingJanuary2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.000%, Maturing January 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4000MaturingJanuary2024Member" xlink:href="mo-20221231.xsd#mo_USDNotes4000MaturingJanuary2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes4000MaturingJanuary2024Member" xlink:to="lab_mo_USDNotes4000MaturingJanuary2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_b1be098f-1e8a-4ac4-ab6a-d8b54150a778_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_0a4e912c-8e94-4042-8d31-965f81b26093_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_A2015DirectorsPlanMember_f0802168-950f-412d-83be-3aeeb549aa89_terseLabel_en-US" xlink:label="lab_mo_A2015DirectorsPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Directors Plan [Member]</link:label>
    <link:label id="lab_mo_A2015DirectorsPlanMember_label_en-US" xlink:label="lab_mo_A2015DirectorsPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Directors Plan [Member]</link:label>
    <link:label id="lab_mo_A2015DirectorsPlanMember_documentation_en-US" xlink:label="lab_mo_A2015DirectorsPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Directors Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_A2015DirectorsPlanMember" xlink:href="mo-20221231.xsd#mo_A2015DirectorsPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_A2015DirectorsPlanMember" xlink:to="lab_mo_A2015DirectorsPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_f26089ea-3b51-4a54-bc94-6bb0c4f3e6c5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_50e4395f-d0a3-40f2-975e-115bc97a87bd_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_84486235-6f46-402f-b913-487e7b80652d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_429871ab-0ea4-4ff8-b7a2-1a0a20b91b06_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_8117d8de-022e-4a16-b8a2-8c3fd30f53bb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_62f8f47e-45dc-4e35-a320-00d4e43ebccd_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_070e471a-6520-47b5-8636-bca11164c0a9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_93e49b50-0ec7-44d3-98e4-7c7562a6bd32_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_0a12fee2-4856-420b-9ef4-adac420f76dd_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_51aa8d65-7d87-406c-bee8-1dc8963608b7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_f0499899-c780-4c17-8b28-a3e3acffa498_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_bafa5406-41d6-4113-a64a-a86e96a54989_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset_02a7c45c-8c2e-4550-a154-393fa90390ec_negatedTerseLabel_en-US" xlink:label="lab_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax expense for decrease in unguaranteed residual value of assets</link:label>
    <link:label id="lab_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset_label_en-US" xlink:label="lab_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Leases, Pre-Tax Expense For Decrease In Unguaranteed Residual Asset</link:label>
    <link:label id="lab_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset_documentation_en-US" xlink:label="lab_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Leases, Pre-Tax Expense For Decrease In Unguaranteed Residual Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset" xlink:href="mo-20221231.xsd#mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset" xlink:to="lab_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04ad2d2c-26a5-4522-a78d-f63cca2e6e81_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_2f5c0f18-2bee-4702-95f5-fe17c82d87ca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_051c0585-a1e9-425b-b19f-3b0d4579a665_terseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgingMember_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Investment Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgingMember" xlink:to="lab_us-gaap_NetInvestmentHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LightsMember_f8520b19-682a-45ee-8648-2a64242636de_terseLabel_en-US" xlink:label="lab_mo_LightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights [Member]</link:label>
    <link:label id="lab_mo_LightsMember_label_en-US" xlink:label="lab_mo_LightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights [Member]</link:label>
    <link:label id="lab_mo_LightsMember_documentation_en-US" xlink:label="lab_mo_LightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsMember" xlink:href="mo-20221231.xsd#mo_LightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LightsMember" xlink:to="lab_mo_LightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_11c2ea4c-a32f-43cb-aba1-9805465461fd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesMillerMember_95ffb9d9-b530-4bf7-8136-2b823b52054e_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesMillerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Miller [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMillerMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesMillerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Miller [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMillerMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesMillerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Miller</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMillerMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMillerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesMillerMember" xlink:to="lab_mo_EngleProgenyCasesMillerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue_68ed1558-5184-41af-bd56-c83b63e7dd0d_verboseLabel_en-US" xlink:label="lab_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current cost of inventories over LIFO amounts</link:label>
    <link:label id="lab_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue_label_en-US" xlink:label="lab_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess of Replacement or Current Costs over Stated LIFO Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue" xlink:to="lab_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_JTIUHMember_c24a73ba-d171-4d22-a3b4-f82ccee38e1a_terseLabel_en-US" xlink:label="lab_mo_JTIUHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JTIUH [Member]</link:label>
    <link:label id="lab_mo_JTIUHMember_label_en-US" xlink:label="lab_mo_JTIUHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JTIUH [Member]</link:label>
    <link:label id="lab_mo_JTIUHMember_documentation_en-US" xlink:label="lab_mo_JTIUHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JTIUH</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JTIUHMember" xlink:href="mo-20221231.xsd#mo_JTIUHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_JTIUHMember" xlink:to="lab_mo_JTIUHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_05b665ba-2e4d-40e6-9915-9110c8825c13_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028-2032</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_A2020PerformanceIncentivePlanMember_15a77ef3-7a26-4e78-a033-a818c7c074e9_terseLabel_en-US" xlink:label="lab_mo_A2020PerformanceIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Performance Incentive Plan [Member]</link:label>
    <link:label id="lab_mo_A2020PerformanceIncentivePlanMember_label_en-US" xlink:label="lab_mo_A2020PerformanceIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Performance Incentive Plan [Member]</link:label>
    <link:label id="lab_mo_A2020PerformanceIncentivePlanMember_documentation_en-US" xlink:label="lab_mo_A2020PerformanceIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Performance Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_A2020PerformanceIncentivePlanMember" xlink:href="mo-20221231.xsd#mo_A2020PerformanceIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_A2020PerformanceIncentivePlanMember" xlink:to="lab_mo_A2020PerformanceIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_e0af10c3-b8a5-430d-8be8-d018104f3dde_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_77c205f4-3020-4868-bc88-10498c8201d7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InterestAndOtherDebtExpenseNetMember_c58e8fe0-378b-4a1a-93e7-0ecb0d4ed4c1_terseLabel_en-US" xlink:label="lab_mo_InterestAndOtherDebtExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest And Other Debt Expense, Net [Member]</link:label>
    <link:label id="lab_mo_InterestAndOtherDebtExpenseNetMember_label_en-US" xlink:label="lab_mo_InterestAndOtherDebtExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest And Other Debt Expense, Net [Member]</link:label>
    <link:label id="lab_mo_InterestAndOtherDebtExpenseNetMember_documentation_en-US" xlink:label="lab_mo_InterestAndOtherDebtExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest And Other Debt Expense, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestAndOtherDebtExpenseNetMember" xlink:href="mo-20221231.xsd#mo_InterestAndOtherDebtExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InterestAndOtherDebtExpenseNetMember" xlink:to="lab_mo_InterestAndOtherDebtExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_43cf4cce-c598-4c6b-b2e9-5cf4f0e81fe8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on derivatives</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CoreMarkHoldingCompanyInc.Member_fa12bde0-aef4-4110-996a-2138127d3f60_terseLabel_en-US" xlink:label="lab_mo_CoreMarkHoldingCompanyInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core-Mark Holding Company, Inc. [Member]</link:label>
    <link:label id="lab_mo_CoreMarkHoldingCompanyInc.Member_label_en-US" xlink:label="lab_mo_CoreMarkHoldingCompanyInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core-Mark Holding Company, Inc. [Member]</link:label>
    <link:label id="lab_mo_CoreMarkHoldingCompanyInc.Member_documentation_en-US" xlink:label="lab_mo_CoreMarkHoldingCompanyInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Core-Mark Holding Company, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CoreMarkHoldingCompanyInc.Member" xlink:href="mo-20221231.xsd#mo_CoreMarkHoldingCompanyInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CoreMarkHoldingCompanyInc.Member" xlink:to="lab_mo_CoreMarkHoldingCompanyInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_64496269-4e50-4eef-847c-014c0fc55db9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ImplementationofCorrectiveCommunicationsMember_b9b31c81-2a06-405f-83c3-3844abbfa85c_terseLabel_en-US" xlink:label="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation of Corrective Communications [Member]</link:label>
    <link:label id="lab_mo_ImplementationofCorrectiveCommunicationsMember_label_en-US" xlink:label="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation of Corrective Communications [Member]</link:label>
    <link:label id="lab_mo_ImplementationofCorrectiveCommunicationsMember_documentation_en-US" xlink:label="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implementation of Corrective Communications [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ImplementationofCorrectiveCommunicationsMember" xlink:href="mo-20221231.xsd#mo_ImplementationofCorrectiveCommunicationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ImplementationofCorrectiveCommunicationsMember" xlink:to="lab_mo_ImplementationofCorrectiveCommunicationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_eea92e6b-dea5-4573-8299-44d2902532ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_62afbee9-4f62-44f6-94dd-56c1bc09ef39_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_60af5019-0868-4dbc-b85f-fb72082dc3a3_terseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension [Member]</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_FederalTradeCommissionDisclosurePeriod_9b2711fc-a805-4cb3-9999-4d77d631fa6d_terseLabel_en-US" xlink:label="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure period</link:label>
    <link:label id="lab_mo_FederalTradeCommissionDisclosurePeriod_label_en-US" xlink:label="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Trade Commission, Disclosure Period</link:label>
    <link:label id="lab_mo_FederalTradeCommissionDisclosurePeriod_documentation_en-US" xlink:label="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Trade Commission, Disclosure Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalTradeCommissionDisclosurePeriod" xlink:href="mo-20221231.xsd#mo_FederalTradeCommissionDisclosurePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_FederalTradeCommissionDisclosurePeriod" xlink:to="lab_mo_FederalTradeCommissionDisclosurePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_664907fb-f658-4b8d-95f9-1671bb382d75_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentRetirementBenefitsMember_ac6fd180-26b4-4139-9c05-af9ce0ba2207_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Retirement Benefits [Member]</link:label>
    <link:label id="lab_us-gaap_PostemploymentRetirementBenefitsMember_label_en-US" xlink:label="lab_us-gaap_PostemploymentRetirementBenefitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Retirement Benefits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentRetirementBenefitsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentRetirementBenefitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentRetirementBenefitsMember" xlink:to="lab_us-gaap_PostemploymentRetirementBenefitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_362fbc98-f2ee-4ac5-8e4d-ba8eb94fc4bd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses carry forward</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AgreementToResolveShareholderClassActionMember_db78e8e9-f39f-4154-ad85-edee02d54330_terseLabel_en-US" xlink:label="lab_mo_AgreementToResolveShareholderClassActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement To Resolve Shareholder Class Action [Member]</link:label>
    <link:label id="lab_mo_AgreementToResolveShareholderClassActionMember_label_en-US" xlink:label="lab_mo_AgreementToResolveShareholderClassActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement To Resolve Shareholder Class Action [Member]</link:label>
    <link:label id="lab_mo_AgreementToResolveShareholderClassActionMember_documentation_en-US" xlink:label="lab_mo_AgreementToResolveShareholderClassActionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement To Resolve Shareholder Class Action</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AgreementToResolveShareholderClassActionMember" xlink:href="mo-20221231.xsd#mo_AgreementToResolveShareholderClassActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AgreementToResolveShareholderClassActionMember" xlink:to="lab_mo_AgreementToResolveShareholderClassActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyPunitiveDamagesAwardedValue_ed430761-2a28-42f4-a83a-4c4f616805f2_terseLabel_en-US" xlink:label="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Punitive damages awarded</link:label>
    <link:label id="lab_mo_LossContingencyPunitiveDamagesAwardedValue_label_en-US" xlink:label="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Awarded, Value</link:label>
    <link:label id="lab_mo_LossContingencyPunitiveDamagesAwardedValue_documentation_en-US" xlink:label="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:href="mo-20221231.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:to="lab_mo_LossContingencyPunitiveDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_350bfcd2-0c13-432d-bfe0-35beb7cf76a7_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from AOCI, Current Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:to="lab_us-gaap_ReclassificationFromAociCurrentPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_2887d25a-fd67-4964-a41e-84fea4d77310_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_55ad8b56-b6ae-4997-8597-c9fc816c7d26_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada [Member]</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_004fe588-d5f9-4e88-8d8c-13959061ac3e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_4ffe5d41-76e0-45fd-af38-d1cefc3b7d44_terseLabel_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Preemptive Rights [Member]</link:label>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_label_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Preemptive RIghts [Member]</link:label>
    <link:label id="lab_mo_EquityContractPreemptiveRIghtsMember_documentation_en-US" xlink:label="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Preemptive RIghts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember" xlink:href="mo-20221231.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityContractPreemptiveRIghtsMember" xlink:to="lab_mo_EquityContractPreemptiveRIghtsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_df19ec10-480e-4936-be21-8aef071f4e77_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NAV [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measured at Net Asset Value Per Share [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:to="lab_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_d45246f9-a654-4ae9-8443-c51883136ca3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_821bc250-0c6a-477d-ac44-0a5a979727f4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_98305e7a-61ba-49b7-a93f-14c01b0bd7a0_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_5d3aa1ee-2d26-40fd-bbfe-78358781206d_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount_560d8c61-0258-41f9-8816-25367245b423_terseLabel_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax basis in foreign investments</link:label>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount_label_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Basis In Foreign Investments, Amount</link:label>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount_documentation_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Basis In Foreign Investments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount" xlink:to="lab_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClaimsNotCertifiedNumber_620bae96-d176-449c-bbfa-09840d509574_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims not certified, number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsNotCertifiedNumber_label_en-US" xlink:label="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Not Certified, Number</link:label>
    <link:label id="lab_mo_LossContingencyClaimsNotCertifiedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Not Certified, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsNotCertifiedNumber" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsNotCertifiedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClaimsNotCertifiedNumber" xlink:to="lab_mo_LossContingencyClaimsNotCertifiedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_2b3e4709-b44f-4db0-a6b5-d71fe1717e48_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_5f9856ab-494b-43be-9aee-c2985e8d2340_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums and fees related to early extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_c238bd3c-7562-4a19-9d2c-1309866592b8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesFreemanAndHarrisMember_946df6c8-2c9e-4c58-882a-575db411fee0_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesFreemanAndHarrisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Freeman And Harris [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFreemanAndHarrisMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesFreemanAndHarrisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Freeman And Harris [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesFreemanAndHarrisMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesFreemanAndHarrisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Freeman And Harris</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFreemanAndHarrisMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesFreemanAndHarrisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesFreemanAndHarrisMember" xlink:to="lab_mo_EngleProgenyCasesFreemanAndHarrisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_287fcc38-1ada-459b-b540-8bc7a0b65df1_verboseLabel_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories determined using LIFO method</link:label>
    <link:label id="lab_us-gaap_PercentageOfLIFOInventory_label_en-US" xlink:label="lab_us-gaap_PercentageOfLIFOInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of LIFO Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PercentageOfLIFOInventory" xlink:to="lab_us-gaap_PercentageOfLIFOInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ReceivableCommercializationRightsCurrent_3251f5c4-8c29-40ec-9bab-923f6e799da2_terseLabel_en-US" xlink:label="lab_mo_ReceivableCommercializationRightsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable from the sale of IQOS System commercialization rights</link:label>
    <link:label id="lab_mo_ReceivableCommercializationRightsCurrent_label_en-US" xlink:label="lab_mo_ReceivableCommercializationRightsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable, Commercialization Rights, Current</link:label>
    <link:label id="lab_mo_ReceivableCommercializationRightsCurrent_documentation_en-US" xlink:label="lab_mo_ReceivableCommercializationRightsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable, Commercialization Rights, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ReceivableCommercializationRightsCurrent" xlink:href="mo-20221231.xsd#mo_ReceivableCommercializationRightsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ReceivableCommercializationRightsCurrent" xlink:to="lab_mo_ReceivableCommercializationRightsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_31413990-57d1-459c-8370-5d79d13f2281_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_fe4257d1-5d2e-495d-a43a-5218b48e433b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_b79218bb-3c64-4351-ad7e-4a128adfcd1c_negatedLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangibles</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_f8c84af8-6b36-48e7-8d89-f5fc7540e6ca_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid: Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_16cbe924-7c0f-4ebd-b882-0bfd826075ef_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock: International equities [Member]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_7ceafeeb-5962-4a84-b7de-ab373beb59cd_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_9f8b27e4-3d20-4113-9de7-4caa873884c0_negatedLabel_en-US" xlink:label="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Distributed and undistributed earnings attributable to share-based awards</link:label>
    <link:label id="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_label_en-US" xlink:label="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted</link:label>
    <link:label id="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_documentation_en-US" xlink:label="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:href="mo-20221231.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:to="lab_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_74d5056d-c556-4b76-a132-ed1635ad9e21_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_62278c63-c4a2-44c8-8006-34cd6e347110_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit Plans [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_baa4ea1d-69e8-4a28-899d-271ddfe7e290_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, pension plan with projected benefit obligation in excess of plan assets, plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_January2021ShareRepurchaseProgramMember_8543ff81-d941-44d2-a535-6813a87330bb_terseLabel_en-US" xlink:label="lab_mo_January2021ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2021 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_January2021ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_mo_January2021ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2021 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_January2021ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_mo_January2021ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2021 Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember" xlink:href="mo-20221231.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_January2021ShareRepurchaseProgramMember" xlink:to="lab_mo_January2021ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyFaultAllocationPercentage_d82f5a2f-0deb-45c0-8608-d1cc26be9f14_terseLabel_en-US" xlink:label="lab_mo_LossContingencyFaultAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, fault allocation percentage</link:label>
    <link:label id="lab_mo_LossContingencyFaultAllocationPercentage_label_en-US" xlink:label="lab_mo_LossContingencyFaultAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Fault Allocation Percentage</link:label>
    <link:label id="lab_mo_LossContingencyFaultAllocationPercentage_documentation_en-US" xlink:label="lab_mo_LossContingencyFaultAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Fault Allocation Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyFaultAllocationPercentage" xlink:href="mo-20221231.xsd#mo_LossContingencyFaultAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyFaultAllocationPercentage" xlink:to="lab_mo_LossContingencyFaultAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PhilipMorrisCapitalCorporationMember_7dde1928-4a1e-449e-a2ee-7ec8fa933a5c_terseLabel_en-US" xlink:label="lab_mo_PhilipMorrisCapitalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris Capital Corporation [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisCapitalCorporationMember_label_en-US" xlink:label="lab_mo_PhilipMorrisCapitalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris Capital Corporation [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisCapitalCorporationMember_documentation_en-US" xlink:label="lab_mo_PhilipMorrisCapitalCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris Capital Corporation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisCapitalCorporationMember" xlink:href="mo-20221231.xsd#mo_PhilipMorrisCapitalCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PhilipMorrisCapitalCorporationMember" xlink:to="lab_mo_PhilipMorrisCapitalCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_96a896d5-d431-4cc0-b33f-36b3a4ba83c5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingClassActionLawsuitsMember_556f9fd9-2aa8-4fcb-96ff-426ac9755875_terseLabel_en-US" xlink:label="lab_mo_PendingClassActionLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Class Action Lawsuits [Member]</link:label>
    <link:label id="lab_mo_PendingClassActionLawsuitsMember_label_en-US" xlink:label="lab_mo_PendingClassActionLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Class Action Lawsuits [Member]</link:label>
    <link:label id="lab_mo_PendingClassActionLawsuitsMember_documentation_en-US" xlink:label="lab_mo_PendingClassActionLawsuitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Class Action Lawsuits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingClassActionLawsuitsMember" xlink:href="mo-20221231.xsd#mo_PendingClassActionLawsuitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingClassActionLawsuitsMember" xlink:to="lab_mo_PendingClassActionLawsuitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_0e885b5d-b6de-4c6c-bf61-bfa36508d3b5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_98b7824a-2a60-45cd-b8bc-fab9a6179338_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Repurchased Stock [Member]</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_f4aac6d4-2ad8-4591-b7b4-ff6134a22184_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity (deficit) attributable to Altria</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9159fa4c-f220-4b1e-9ff5-1ef468d3200b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_dd0f0e1c-5eab-4600-a5f8-c7e79261c6dd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesMcCallMember_af3dc6ec-f275-4a12-92d9-dfebf393ba51_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesMcCallMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, McCall [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMcCallMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesMcCallMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, McCall [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesMcCallMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesMcCallMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, McCall [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMcCallMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMcCallMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesMcCallMember" xlink:to="lab_mo_EngleProgenyCasesMcCallMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ArbitrationPeriodAxis_6a34dfb3-1c69-4349-8fd1-534d01dbb1dd_terseLabel_en-US" xlink:label="lab_mo_ArbitrationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Axis]</link:label>
    <link:label id="lab_mo_ArbitrationPeriodAxis_label_en-US" xlink:label="lab_mo_ArbitrationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period [Axis]</link:label>
    <link:label id="lab_mo_ArbitrationPeriodAxis_documentation_en-US" xlink:label="lab_mo_ArbitrationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arbitration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodAxis" xlink:href="mo-20221231.xsd#mo_ArbitrationPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ArbitrationPeriodAxis" xlink:to="lab_mo_ArbitrationPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed_c3d302c0-7292-4a2e-9cd3-a256f9393bf9_terseLabel_en-US" xlink:label="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims with unfavorable verdicts pending/reversed</link:label>
    <link:label id="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed_label_en-US" xlink:label="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Unfavorable Verdicts Pending/Reversed</link:label>
    <link:label id="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed_documentation_en-US" xlink:label="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Unfavorable Verdicts Pending/Reversed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:href="mo-20221231.xsd#mo_LossContingencyUnfavorableVerdictsPendingReversed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:to="lab_mo_LossContingencyUnfavorableVerdictsPendingReversed" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfCases_d9547605-c882-4ecd-9d3f-a7a75b5cb364_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCases_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfCases_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfCases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Cases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCases" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfCases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfCases" xlink:to="lab_mo_LossContingencyNumberOfCases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_595155f2-f404-4f03-857c-6bd92ae1bfaa_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangible assets, accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod_e6c35fab-7a7d-46e5-a289-8ed456575228_terseLabel_en-US" xlink:label="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense amortization period</link:label>
    <link:label id="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod_label_en-US" xlink:label="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Expense Amortization Period</link:label>
    <link:label id="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod_documentation_en-US" xlink:label="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Expense Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod" xlink:href="mo-20221231.xsd#mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod" xlink:to="lab_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e2b23aba-c9b8-496a-8126-a85b50b57372_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future amortization, year 3</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_3582d3ff-54a7-4d31-9681-5479f5f03df3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_38984ed3-fb1e-4ea4-a7ed-7cace8a085cf_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_af935d03-9a5a-4955-adf6-f89f208a2f19_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Reinvested in the Business [Member]</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_cd7230c2-f34e-468c-9f25-1f17e50746b8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_025269ef-40a9-4dbc-a707-131fc89bfacb_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_b0122fb7-449b-4b8a-a577-7a2c319eb91d_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss related to litigation settlement</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) Related to Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_1b9b56ac-bcce-425c-a036-f348f18a1028_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_191d9a81-1936-404a-852c-f07d91ddef08_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available to be granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_ec27cf72-dee5-4f4d-a12b-ec9e6a8e1340_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_0b50bf07-ea27-49e2-b357-06921bb2662a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_bd1a755e-b0cb-4f6b-96f9-f83478780439_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyVerdictReversedNumber_40257805-c882-45e2-aaa0-804af8c3ec87_terseLabel_en-US" xlink:label="lab_mo_LossContingencyVerdictReversedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verdicts reversed, number</link:label>
    <link:label id="lab_mo_LossContingencyVerdictReversedNumber_label_en-US" xlink:label="lab_mo_LossContingencyVerdictReversedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdict Reversed, Number</link:label>
    <link:label id="lab_mo_LossContingencyVerdictReversedNumber_documentation_en-US" xlink:label="lab_mo_LossContingencyVerdictReversedNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Verdict Reversed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber" xlink:href="mo-20221231.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyVerdictReversedNumber" xlink:to="lab_mo_LossContingencyVerdictReversedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_469f5498-4b79-4744-92c4-36b20a671546_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USSmallCapMember_b18367ed-96e2-44b3-a3c4-49c23723caab_terseLabel_en-US" xlink:label="lab_mo_USSmallCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S Small Cap [Member]</link:label>
    <link:label id="lab_mo_USSmallCapMember_label_en-US" xlink:label="lab_mo_USSmallCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S Small Cap [Member]</link:label>
    <link:label id="lab_mo_USSmallCapMember_documentation_en-US" xlink:label="lab_mo_USSmallCapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Small Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USSmallCapMember" xlink:href="mo-20221231.xsd#mo_USSmallCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USSmallCapMember" xlink:to="lab_mo_USSmallCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_9fd94b05-2e92-4b62-ae62-17ed953084d9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts charged to expense for defined contribution plans</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_9443bedc-b7a5-4629-bab1-5b3aab0d31ad_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) Loss Recognized in Net Earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b4769167-c7ea-44b6-9a12-e2fff8d5110c_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_498403ba-3731-4ff9-ab4b-31a241620e37_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_b44f9b12-e69c-4065-a099-a5722dd87166_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_257c0c07-ec61-4550-8e48-d819c1c45ef6_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total number of shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_c468f1ee-6176-4fdf-aea5-f5e446cb5cc7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, 2 and 3 [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel12And3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member" xlink:to="lab_us-gaap_FairValueInputsLevel12And3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_f620e1a6-1cfe-4fe5-868c-27f7e512b1c8_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of shareholders filing class action lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:to="lab_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c7d8bbe1-71af-442f-b073-6092ea0590ad_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_a9161bab-c947-4363-8d74-555eac3700bc_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_45373464-64c9-42b0-81aa-f638a8f1f742_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_fdcc7933-0f98-4c29-9cf6-5dbb4053856b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_033c3111-3999-4b3b-bc31-11709c9eb4ba_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b1f4548a-b93f-4718-9d63-a269c19d45f9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_f99ee3b9-8f52-4673-a758-6ebf7e144b02_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDDebenture7750MaturingJanuary2027Member_bc62e247-ec65-4d74-835f-39197aebe238_terseLabel_en-US" xlink:label="lab_mo_USDDebenture7750MaturingJanuary2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Debenture, 7.750%, Maturing January 2027 [Member]</link:label>
    <link:label id="lab_mo_USDDebenture7750MaturingJanuary2027Member_label_en-US" xlink:label="lab_mo_USDDebenture7750MaturingJanuary2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Debenture, 7.750%, Maturing January 2027 [Member]</link:label>
    <link:label id="lab_mo_USDDebenture7750MaturingJanuary2027Member_documentation_en-US" xlink:label="lab_mo_USDDebenture7750MaturingJanuary2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Debenture, 7.750%, Maturing January 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDebenture7750MaturingJanuary2027Member" xlink:href="mo-20221231.xsd#mo_USDDebenture7750MaturingJanuary2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDDebenture7750MaturingJanuary2027Member" xlink:to="lab_mo_USDDebenture7750MaturingJanuary2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_565a83a7-9b2f-4692-8eec-6286995eac6f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Pension Liability Recognized in Consolidated Balance Sheets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_99ccf7f9-e548-452f-9bb5-81687a31487d_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_06f953ac-e310-4bb7-a399-2e31755d670f_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_eddd3ec6-f549-4e93-98ff-c4a11832cabf_verboseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock_92afa7d0-2e57-4471-8434-bf2ca65c33f7_terseLabel_en-US" xlink:label="lab_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Assumptions To Determine Net Periodic Benefit Cost</link:label>
    <link:label id="lab_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock_label_en-US" xlink:label="lab_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Assumptions To Determine Net Periodic Benefit Cost [Table Text Block]</link:label>
    <link:label id="lab_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock_documentation_en-US" xlink:label="lab_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Assumptions To Determine Net Periodic Benefit Cost [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock" xlink:href="mo-20221231.xsd#mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock" xlink:to="lab_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SerialPreferredStockMember_927c033c-7feb-4559-bb89-fd072db1e2be_terseLabel_en-US" xlink:label="lab_mo_SerialPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Serial Preferred Stock [Member]</link:label>
    <link:label id="lab_mo_SerialPreferredStockMember_label_en-US" xlink:label="lab_mo_SerialPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Serial Preferred Stock [Member]</link:label>
    <link:label id="lab_mo_SerialPreferredStockMember_documentation_en-US" xlink:label="lab_mo_SerialPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Serial Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SerialPreferredStockMember" xlink:href="mo-20221231.xsd#mo_SerialPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SerialPreferredStockMember" xlink:to="lab_mo_SerialPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_26a9306a-a733-4047-a18c-51804c95aaed_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_33d229d0-9e85-45e9-9524-2a3ae6962ac9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares remaining (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eface82b-9a60-4d47-96dc-3bc7e957ea99_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_b01f8bda-dda8-40ff-af74-b6f9125b0ff9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year, (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherTabaccoRelatedCasesMember_78d286e4-d341-41c3-b341-2242a5018d80_terseLabel_en-US" xlink:label="lab_mo_OtherTabaccoRelatedCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tabacco-Related Cases [Member]</link:label>
    <link:label id="lab_mo_OtherTabaccoRelatedCasesMember_label_en-US" xlink:label="lab_mo_OtherTabaccoRelatedCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tabacco-Related Cases [Member]</link:label>
    <link:label id="lab_mo_OtherTabaccoRelatedCasesMember_documentation_en-US" xlink:label="lab_mo_OtherTabaccoRelatedCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tabacco-Related Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherTabaccoRelatedCasesMember" xlink:href="mo-20221231.xsd#mo_OtherTabaccoRelatedCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherTabaccoRelatedCasesMember" xlink:to="lab_mo_OtherTabaccoRelatedCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_e002ae07-d534-4c64-8d71-08e99e3f4e24_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5efc6738-2ba3-45c4-80de-d29533743040_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_f46b81ff-6f04-4151-a7f8-a08c06589ca0_terseLabel_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment</link:label>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_label_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Valuation Allowance, Percent</link:label>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_documentation_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:to="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_3de9f175-b3f7-42c9-9388-a0d03e367492_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and postretirement, net</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock_a212d4de-23d7-4801-8c0b-96d88fcd5e78_terseLabel_en-US" xlink:label="lab_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock_label_en-US" xlink:label="lab_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation and Qualifying Accounts [Table Text Block]</link:label>
    <link:label id="lab_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock_documentation_en-US" xlink:label="lab_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Valuation and Qualifying Accounts [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock" xlink:href="mo-20221231.xsd#mo_ScheduleofValuationandQualifyingAccountsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock" xlink:to="lab_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9c869f29-3c38-4de0-a988-9479621e4415_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Losses [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_dd61fc98-1657-4b82-9e62-8f7d16ad878d_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_e932895e-a3c2-4224-9e8f-59890b17b167_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Earnings/Losses</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_cb8d0020-60a0-4158-8bd8-8ff57a309e71_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_d5d72fbb-bf14-4467-bff1-8f5856efc8c2_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_16ccf597-dea1-4608-9ff8-5beb50d6908a_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_bdd5bc33-fbfe-4828-8c44-62d2fe4d46fa_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_5b1dfe13-c29c-4221-a466-4d62994b7ddc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_61659d48-c9f2-4992-b5d5-eff309459e2c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2c9167cd-0694-48a7-b8a5-64b136307650_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_ffd7da0a-7bd0-4c46-a972-92e957570d04_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit_d4fa198d-457c-4635-b46b-bd5d692542d7_negatedTerseLabel_en-US" xlink:label="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dispositions</link:label>
    <link:label id="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived And Finite Lived Intangible Assets, Written Off Related to Sale of Business Unit</link:label>
    <link:label id="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit_documentation_en-US" xlink:label="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived And Finite Lived Intangible Assets, Written Off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="mo-20221231.xsd#mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AllowanceDiscountsMember_4df81d5f-b198-4dab-80d8-47d8a7f15ce0_terseLabel_en-US" xlink:label="lab_mo_AllowanceDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounts [Member]</link:label>
    <link:label id="lab_mo_AllowanceDiscountsMember_label_en-US" xlink:label="lab_mo_AllowanceDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance, Discounts [Member]</link:label>
    <link:label id="lab_mo_AllowanceDiscountsMember_documentation_en-US" xlink:label="lab_mo_AllowanceDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance, Discounts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AllowanceDiscountsMember" xlink:href="mo-20221231.xsd#mo_AllowanceDiscountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AllowanceDiscountsMember" xlink:to="lab_mo_AllowanceDiscountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2a9893d0-3932-40bd-8d7d-af75ac258028_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and New Accounting Guidance Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax_712d7833-4662-4146-a597-4ddf9f28411a_terseLabel_en-US" xlink:label="lab_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost/credit</link:label>
    <link:label id="lab_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax_label_en-US" xlink:label="lab_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Adjustment from AOCI, Pension, Other Postretirement and Postemployment Benefit Plans, for Net Prior Service Cost (Credit), before Tax</link:label>
    <link:label id="lab_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax_documentation_en-US" xlink:label="lab_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Adjustment from AOCI, Pension, Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" xlink:to="lab_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_AccruedSettlementLiabilityCurrent_f72887b2-8967-4a7d-b155-7268e540ad3e_terseLabel_en-US" xlink:label="lab_mo_AccruedSettlementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement charges</link:label>
    <link:label id="lab_mo_AccruedSettlementLiabilityCurrent_label_en-US" xlink:label="lab_mo_AccruedSettlementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Settlement Liability, Current</link:label>
    <link:label id="lab_mo_AccruedSettlementLiabilityCurrent_documentation_en-US" xlink:label="lab_mo_AccruedSettlementLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Settlement Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccruedSettlementLiabilityCurrent" xlink:href="mo-20221231.xsd#mo_AccruedSettlementLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_AccruedSettlementLiabilityCurrent" xlink:to="lab_mo_AccruedSettlementLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_d4b4f604-88a8-484b-b91a-64c1b9a4f513_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_40685be6-07ef-4fb3-9eb1-99a5ac3bb097_terseLabel_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:label id="lab_us-gaap_InterimPeriodCostsNotAllocableDomain_label_en-US" xlink:label="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interim Period, Costs Not Allocable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:to="lab_us-gaap_InterimPeriodCostsNotAllocableDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesR.DouglasMember_1b92109f-68b1-47bb-8d17-edcafc0c22b2_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R. Douglas [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesR.DouglasMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R. Douglas [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesR.DouglasMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, R. Douglas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesR.DouglasMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesR.DouglasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesR.DouglasMember" xlink:to="lab_mo_EngleProgenyCasesR.DouglasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock_3647b1f4-55a6-4c90-8307-36f8cb380f40_terseLabel_en-US" xlink:label="lab_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Methodology of Determining Fair Value of Pension Assets</link:label>
    <link:label id="lab_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock_label_en-US" xlink:label="lab_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Methodology of Determining Fair Value of Pension Assets [Policy Text Block]</link:label>
    <link:label id="lab_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock_documentation_en-US" xlink:label="lab_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Methodology of determining fair value of pension assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock" xlink:href="mo-20221231.xsd#mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock" xlink:to="lab_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement_94d7a502-ce42-48f3-ba4c-4b9f57f038c0_terseLabel_en-US" xlink:label="lab_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, deferred gain on sale of rights under an agreement</link:label>
    <link:label id="lab_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement_label_en-US" xlink:label="lab_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Deferred Gain on Sale Of Rights Under An Agreement</link:label>
    <link:label id="lab_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement_documentation_en-US" xlink:label="lab_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Deferred Gain on Sale Of Rights Under An Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement" xlink:href="mo-20221231.xsd#mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement" xlink:to="lab_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock_c5f1e2dd-0e62-49b4-8e70-713a73832463_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion, and Amortization [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_a725009f-ceda-4218-b530-4948f933fc4b_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_f4e591fc-3e5d-420a-b81d-4ea697f83638_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2021</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2021 [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, Transition Years 2004-2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" xlink:to="lab_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock_d7b1eb6b-e630-4f69-acc3-1cb4a517ad00_terseLabel_en-US" xlink:label="lab_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Tobacco and Health and Certain Other Litigation Items</link:label>
    <link:label id="lab_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock_label_en-US" xlink:label="lab_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Tobacco and Health and Certain Other Litigation Items [Table Text Block]</link:label>
    <link:label id="lab_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock_documentation_en-US" xlink:label="lab_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Tobacco and Health and Certain Other Litigation Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock" xlink:href="mo-20221231.xsd#mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock" xlink:to="lab_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_57590130-d23b-47be-ae68-f99a29bfebcd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to operating cash flows:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_03284882-14d4-4cd9-8692-61aed35bfd77_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets, net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock1.700NotesDue2025Member_77c914fb-5e3f-446a-9e4d-d80c8679f1f9_terseLabel_en-US" xlink:label="lab_mo_CommonStock1.700NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.700% Notes due 2025</link:label>
    <link:label id="lab_mo_CommonStock1.700NotesDue2025Member_label_en-US" xlink:label="lab_mo_CommonStock1.700NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.700% Notes Due 2025 [Member]</link:label>
    <link:label id="lab_mo_CommonStock1.700NotesDue2025Member_documentation_en-US" xlink:label="lab_mo_CommonStock1.700NotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 1.700% Notes Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.700NotesDue2025Member" xlink:href="mo-20221231.xsd#mo_CommonStock1.700NotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock1.700NotesDue2025Member" xlink:to="lab_mo_CommonStock1.700NotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes9950MaturingNovember2038Member_a0fdc668-ac8c-4b24-8b16-b962f2f54ed0_terseLabel_en-US" xlink:label="lab_mo_USDNotes9950MaturingNovember2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 9.950%, Maturing November 2038 [Member]</link:label>
    <link:label id="lab_mo_USDNotes9950MaturingNovember2038Member_cbb4d12c-0516-4837-a62c-d27aaf7ee85c_verboseLabel_en-US" xlink:label="lab_mo_USDNotes9950MaturingNovember2038Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 9.950% [Member]</link:label>
    <link:label id="lab_mo_USDNotes9950MaturingNovember2038Member_label_en-US" xlink:label="lab_mo_USDNotes9950MaturingNovember2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 9.950%, Maturing November 2038 [Member]</link:label>
    <link:label id="lab_mo_USDNotes9950MaturingNovember2038Member_documentation_en-US" xlink:label="lab_mo_USDNotes9950MaturingNovember2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 9.950%, Maturing November 2038</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes9950MaturingNovember2038Member" xlink:href="mo-20221231.xsd#mo_USDNotes9950MaturingNovember2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes9950MaturingNovember2038Member" xlink:to="lab_mo_USDNotes9950MaturingNovember2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_TrademarksCopenhagenMember_077de1a2-211f-41f9-8923-838a826dabe8_terseLabel_en-US" xlink:label="lab_mo_TrademarksCopenhagenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Copenhagen [Member]</link:label>
    <link:label id="lab_mo_TrademarksCopenhagenMember_label_en-US" xlink:label="lab_mo_TrademarksCopenhagenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, Copenhagen [Member]</link:label>
    <link:label id="lab_mo_TrademarksCopenhagenMember_documentation_en-US" xlink:label="lab_mo_TrademarksCopenhagenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, Copenhagen</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TrademarksCopenhagenMember" xlink:href="mo-20221231.xsd#mo_TrademarksCopenhagenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_TrademarksCopenhagenMember" xlink:to="lab_mo_TrademarksCopenhagenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_be154a89-0862-441d-beab-dc22b99ada49_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service costs/credit [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_34961275-7db4-4ee7-8c11-1dfed5b696d5_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_e20fea1c-c2db-4f00-88fa-f6a20e0215b6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term borrowings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_64e082b8-88db-4f87-a53d-39ff83a456bf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_dcadc5e3-39c9-42b3-aa72-4c60e8bf3ce8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1e85b9e3-51b1-43d3-a9ac-b9caddbff944_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_73ec4eb8-8aeb-47b5-8895-505a30a96e36_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_38d8c24c-0bc9-433f-8520-ef3acd1fade0_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a5a8da1e-1fee-4686-96e9-356ea2823d92_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares for diluted EPS (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_26da4d90-4f4c-459a-9b92-19f14298b0c1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_9600e2c7-fa24-4c54-bf1d-a7eec82d3fbe_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NpmAdjustmentToCostOfSalesMember_c9c5b63a-04dc-46d4-9793-c59f9df13d2d_terseLabel_en-US" xlink:label="lab_mo_NpmAdjustmentToCostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment to Cost Of Sales [Member]</link:label>
    <link:label id="lab_mo_NpmAdjustmentToCostOfSalesMember_label_en-US" xlink:label="lab_mo_NpmAdjustmentToCostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment to Cost Of Sales [Member]</link:label>
    <link:label id="lab_mo_NpmAdjustmentToCostOfSalesMember_documentation_en-US" xlink:label="lab_mo_NpmAdjustmentToCostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment to Cost Of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NpmAdjustmentToCostOfSalesMember" xlink:href="mo-20221231.xsd#mo_NpmAdjustmentToCostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NpmAdjustmentToCostOfSalesMember" xlink:to="lab_mo_NpmAdjustmentToCostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ProceedsFromSaleOfRightsUnderAnAgreement_6c5a61d9-dea5-4feb-81b0-ab443b11046d_terseLabel_en-US" xlink:label="lab_mo_ProceedsFromSaleOfRightsUnderAnAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of rights under an agreement</link:label>
    <link:label id="lab_mo_ProceedsFromSaleOfRightsUnderAnAgreement_label_en-US" xlink:label="lab_mo_ProceedsFromSaleOfRightsUnderAnAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale Of Rights Under An Agreement</link:label>
    <link:label id="lab_mo_ProceedsFromSaleOfRightsUnderAnAgreement_documentation_en-US" xlink:label="lab_mo_ProceedsFromSaleOfRightsUnderAnAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale Of Rights Under An Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ProceedsFromSaleOfRightsUnderAnAgreement" xlink:href="mo-20221231.xsd#mo_ProceedsFromSaleOfRightsUnderAnAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ProceedsFromSaleOfRightsUnderAnAgreement" xlink:to="lab_mo_ProceedsFromSaleOfRightsUnderAnAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesCuddiheeMember_2c7bc201-29e7-4cb3-bc31-e427d804b85f_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cuddihee [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCuddiheeMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cuddihee [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesCuddiheeMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Cuddihee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCuddiheeMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesCuddiheeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesCuddiheeMember" xlink:to="lab_mo_EngleProgenyCasesCuddiheeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_a7b783a1-f23d-4cae-81ec-ce261747b02a_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:label id="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_7c775845-87cb-4d40-a798-fcd90dd7ed2f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of New Accounting Pronouncements and Changes in Accounting Principles</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_dddbce8d-d5a2-4842-beee-546d8c876a9e_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, FV-NI</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:to="lab_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OralTobaccoSegmentMember_7767e823-b8ca-4ceb-84ef-cba2afafca1d_terseLabel_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Products [Member]</link:label>
    <link:label id="lab_mo_OralTobaccoSegmentMember_label_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:label id="lab_mo_OralTobaccoSegmentMember_documentation_en-US" xlink:label="lab_mo_OralTobaccoSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Tobacco Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember" xlink:href="mo-20221231.xsd#mo_OralTobaccoSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OralTobaccoSegmentMember" xlink:to="lab_mo_OralTobaccoSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_83611dbc-823b-4466-8536-bc94b83d8f65_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_d72396dc-8069-492f-b1ea-6eb0ac1cf55b_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Principe [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_label_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Principe [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Engle Progeny Smoking And Health Case, Principe</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:href="mo-20221231.xsd#mo_NonEngleProgenySmokingAndHealthCasePrincipeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:to="lab_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_e040683b-ca7e-4d46-8f89-4c3186f57cb7_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_11c68ad6-4129-4e2e-b8dd-9a929ecb0e3b_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, number of states not settled arbitration period</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not Settled Arbitration Period</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of States Not Settled Arbitration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:to="lab_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementInterest_4ec6cbc7-3244-4d83-bbc6-5de60244d43f_netLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementInterest" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement interest (approximately)</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementInterest_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementInterest" xlink:to="lab_us-gaap_LitigationSettlementInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_January2023ShareRepurchaseProgramMember_fbc12608-85c0-4426-8f7c-4f9c2bcdf89c_terseLabel_en-US" xlink:label="lab_mo_January2023ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2023 Share Repurchase Program</link:label>
    <link:label id="lab_mo_January2023ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_mo_January2023ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2023 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_mo_January2023ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_mo_January2023ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2023 Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2023ShareRepurchaseProgramMember" xlink:href="mo-20221231.xsd#mo_January2023ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_January2023ShareRepurchaseProgramMember" xlink:to="lab_mo_January2023ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes4450MaturingMay2050Member_7da45022-bcfb-48a3-9dbf-cfb96a2f7c17_terseLabel_en-US" xlink:label="lab_mo_USDNotes4450MaturingMay2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.450%, Maturing May 2050 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4450MaturingMay2050Member_label_en-US" xlink:label="lab_mo_USDNotes4450MaturingMay2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.450%, Maturing May 2050 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4450MaturingMay2050Member_documentation_en-US" xlink:label="lab_mo_USDNotes4450MaturingMay2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.450%, Maturing May 2050</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4450MaturingMay2050Member" xlink:href="mo-20221231.xsd#mo_USDNotes4450MaturingMay2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes4450MaturingMay2050Member" xlink:to="lab_mo_USDNotes4450MaturingMay2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USLargeCapMember_29a583f1-2383-4711-a4fb-535c5affe3cd_terseLabel_en-US" xlink:label="lab_mo_USLargeCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S Large Cap [Member]</link:label>
    <link:label id="lab_mo_USLargeCapMember_label_en-US" xlink:label="lab_mo_USLargeCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S Large Cap [Member]</link:label>
    <link:label id="lab_mo_USLargeCapMember_documentation_en-US" xlink:label="lab_mo_USLargeCapMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Large Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USLargeCapMember" xlink:href="mo-20221231.xsd#mo_USLargeCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USLargeCapMember" xlink:to="lab_mo_USLargeCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MarketingCostsPolicyTextBlock_bf14099c-a488-434b-b0b7-b2547320290f_terseLabel_en-US" xlink:label="lab_mo_MarketingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Costs</link:label>
    <link:label id="lab_mo_MarketingCostsPolicyTextBlock_label_en-US" xlink:label="lab_mo_MarketingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Costs [Policy Text Block]</link:label>
    <link:label id="lab_mo_MarketingCostsPolicyTextBlock_documentation_en-US" xlink:label="lab_mo_MarketingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Costs [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingCostsPolicyTextBlock" xlink:href="mo-20221231.xsd#mo_MarketingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MarketingCostsPolicyTextBlock" xlink:to="lab_mo_MarketingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_743884c4-a5c5-4afa-b69f-0687418e420b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value, per share (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6dad8a3c-f6a2-4484-8792-46c849e57e5d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_268c0c37-66ae-4341-8d7c-8c0781eb1e4b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_15860e4e-8d53-45d0-bb91-487426dddd13_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_eda4936f-5e7a-4ab1-8dec-cd55632ac239_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_a6098c98-a12c-43a4-be30-7f7090cda9cb_terseLabel_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential decrease in liability for uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_label_en-US" xlink:label="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in Unrecognized Tax Benefits is Reasonably Possible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:to="lab_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesKaplanAndSommersMember_763e5fe1-d5ac-439b-9722-eb7aef4980a7_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanAndSommersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases Kaplan And Sommers</link:label>
    <link:label id="lab_mo_EngleProgenyCasesKaplanAndSommersMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanAndSommersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases Kaplan And Sommers [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesKaplanAndSommersMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanAndSommersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases Kaplan And Sommers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanAndSommersMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesKaplanAndSommersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesKaplanAndSommersMember" xlink:to="lab_mo_EngleProgenyCasesKaplanAndSommersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceShares_26567145-21c4-469f-9747-ae8648acb7f6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment owned, balance, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceShares_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedBalanceShares" xlink:to="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_4fed91a0-6ee6-4612-83c3-f82f21415ed8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued postretirement and postemployment benefits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_f5826fbc-6528-473b-8b4d-9578c123b81e_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debenture [Member]</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_68a93a18-f064-4857-838a-c0399de501c6_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net losses attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_859debdd-f343-4f86-b5c1-f3894161e1a0_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (losses) attributable to equity investments</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_8624e6a5-5950-461c-8e48-f287062e7f02_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5626974c-f952-484b-93ca-eaf4dbd32513_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) for EPS, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_cbfb29c7-a5dd-42c4-92e0-3baac310f872_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt issued</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesLippMember_41d4932e-46a4-4d4c-aa63-4df3beeeef6b_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesLippMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Lipp [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesLippMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesLippMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Lipp [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesLippMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesLippMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Lipp</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLippMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesLippMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesLippMember" xlink:to="lab_mo_EngleProgenyCasesLippMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_1b94645c-2db8-4dd8-ad28-97b85bfe9492_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_73c3bb7a-b184-43c1-816a-5a9873a70b8a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_fe50d08e-6831-4ee7-bbcf-82c805851c7c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, Shares Issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_8db3594a-6148-4f18-8279-41a3e686f1aa_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, Shares Issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_30cc99ee-296b-4e68-97a0-6d06ea5fd8fb_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_MarketingAdministrationAndResearchCostsMember_bfead17c-324c-4023-b12c-e1d7dd4e5b70_terseLabel_en-US" xlink:label="lab_mo_MarketingAdministrationAndResearchCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Administration And Research Costs [Member]</link:label>
    <link:label id="lab_mo_MarketingAdministrationAndResearchCostsMember_label_en-US" xlink:label="lab_mo_MarketingAdministrationAndResearchCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Administration And Research Costs [Member]</link:label>
    <link:label id="lab_mo_MarketingAdministrationAndResearchCostsMember_documentation_en-US" xlink:label="lab_mo_MarketingAdministrationAndResearchCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Administration And Research Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationAndResearchCostsMember" xlink:href="mo-20221231.xsd#mo_MarketingAdministrationAndResearchCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_MarketingAdministrationAndResearchCostsMember" xlink:to="lab_mo_MarketingAdministrationAndResearchCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStockDividendRateAnnualPerShare_09e4dffe-438d-43ad-a493-db94e3b7ec5d_terseLabel_en-US" xlink:label="lab_mo_CommonStockDividendRateAnnualPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, dividend rate, annual, per share (USD per share)</link:label>
    <link:label id="lab_mo_CommonStockDividendRateAnnualPerShare_label_en-US" xlink:label="lab_mo_CommonStockDividendRateAnnualPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividend Rate, Annual, Per Share</link:label>
    <link:label id="lab_mo_CommonStockDividendRateAnnualPerShare_documentation_en-US" xlink:label="lab_mo_CommonStockDividendRateAnnualPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividend Rate, Annual, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendRateAnnualPerShare" xlink:href="mo-20221231.xsd#mo_CommonStockDividendRateAnnualPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStockDividendRateAnnualPerShare" xlink:to="lab_mo_CommonStockDividendRateAnnualPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_b39a98ae-795b-4125-8b30-a5364471a874_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_c735c65d-57a4-48aa-87ba-36e218512dde_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_384f77bb-f50f-48fe-a17c-9b461f747536_terseLabel_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, including discontinued operations, marketing, administration and research costs</link:label>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_label_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Marketing, Administration And Research Costs</link:label>
    <link:label id="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_documentation_en-US" xlink:label="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operations, Marketing, Administration And Research Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" xlink:href="mo-20221231.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" xlink:to="lab_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_08d4194e-bce2-404f-843d-13cd4158439f_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_ab4a14ad-cb43-44f8-b028-93f05c381599_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DeferredTaxAssetsValuationAllowanceRollForward_2480c488-2cfc-421b-bda9-de071a969fb0_terseLabel_en-US" xlink:label="lab_mo_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_mo_DeferredTaxAssetsValuationAllowanceRollForward_label_en-US" xlink:label="lab_mo_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance [Roll Forward]</link:label>
    <link:label id="lab_mo_DeferredTaxAssetsValuationAllowanceRollForward_documentation_en-US" xlink:label="lab_mo_DeferredTaxAssetsValuationAllowanceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxAssetsValuationAllowanceRollForward" xlink:href="mo-20221231.xsd#mo_DeferredTaxAssetsValuationAllowanceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DeferredTaxAssetsValuationAllowanceRollForward" xlink:to="lab_mo_DeferredTaxAssetsValuationAllowanceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_95c600fc-7b46-4a5f-be35-91f7a78d9224_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_90c392a9-a0e7-451f-bce2-31f6e177a682_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive earnings attributable to Altria</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_114a8ae2-3151-448f-a137-7cd348e733f0_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_15ce3202-6a6f-4169-8086-5877a9d021fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Data Schedule</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_9b8cf9e4-386a-44be-8483-7de423925916_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtAbstract_73d57731-9660-462e-8fed-6719feb0c4e7_terseLabel_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Abstract]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtAbstract_label_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt [Abstract]</link:label>
    <link:label id="lab_mo_ForeignCurrencyDenominatedDebtAbstract_documentation_en-US" xlink:label="lab_mo_ForeignCurrencyDenominatedDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Denominated Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtAbstract" xlink:href="mo-20221231.xsd#mo_ForeignCurrencyDenominatedDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ForeignCurrencyDenominatedDebtAbstract" xlink:to="lab_mo_ForeignCurrencyDenominatedDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EnvironmentalCostsPolicy_cc5edc64-a41c-4079-bb97-d6e40d9d9c9e_terseLabel_en-US" xlink:label="lab_us-gaap_EnvironmentalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Costs</link:label>
    <link:label id="lab_us-gaap_EnvironmentalCostsPolicy_label_en-US" xlink:label="lab_us-gaap_EnvironmentalCostsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Environmental Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalCostsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalCostsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EnvironmentalCostsPolicy" xlink:to="lab_us-gaap_EnvironmentalCostsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_ad48a7db-35e2-46bf-a434-6371807576f2_terseLabel_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete release trigger percentage of initial investment carrying value</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_label_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value</link:label>
    <link:label id="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_documentation_en-US" xlink:label="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:to="lab_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_eb6be89f-cfe7-454b-b9b8-92ba791575ba_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2079e991-24ae-4c42-a03a-c622b395f797_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged to costs and expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_de65efc2-bd18-4333-a36f-2f8e31945be4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesDuignanMember_005c7821-ead6-4c02-b010-8f64022776cd_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesDuignanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Duignan {Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesDuignanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesDuignanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Duignan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesDuignanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesDuignanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Duignan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDuignanMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesDuignanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesDuignanMember" xlink:to="lab_mo_EngleProgenyCasesDuignanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_51b36e01-c269-4354-a165-63e175e718ee_terseLabel_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_label_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:label id="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_documentation_en-US" xlink:label="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:href="mo-20221231.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:to="lab_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_65f107f0-2365-49b3-8a82-28c9e397dd9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesLevineMember_9bcf5f6f-ec42-4851-88e1-764ac177d235_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesLevineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Levine [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesLevineMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesLevineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Levine [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesLevineMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesLevineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Levine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLevineMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesLevineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesLevineMember" xlink:to="lab_mo_EngleProgenyCasesLevineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f9256b64-824b-454d-a615-07d9b5ae6fba_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local income taxes, net of federal tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_06b945d0-438b-42a4-bd9a-1757b0275760_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_07ed05bc-44c5-49e5-b7ba-4d2a6670ebbb_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_756a3c8e-eeb3-4b48-a1c7-d3c746f616b3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_4deaf65a-1b57-4597-a6a5-b3d939504774_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortizationAbstract_f8b6f0ca-6c50-4ab9-acc3-30f6c6bda082_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization:</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortizationAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortizationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortizationAbstract" xlink:to="lab_us-gaap_AdjustmentForAmortizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_b7c94c05-cbda-45c9-9c11-a48346c9bafd_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_3307d763-dbea-4d89-989c-2c22c53bc6db_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList_6050bba7-23d7-4bcf-ad44-35b6d4b74ee8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible List]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe9f8c0f-4ee1-42ab-83c8-d86d10eabc65_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2f34754f-4885-402e-b40c-bf04e209144c_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_e76fa5cf-66cd-428e-a9cd-876866ad724a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_e057920d-0ab2-4c1f-8ed4-25785d805a35_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_be1f2891-1ff9-45c9-8588-28ef5ca4c6fa_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d502b47c-f9f5-4c4d-84b2-c0c2799574f7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive losses</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NonEngleProgenyCasesMember_02887d0f-4943-45f3-b24f-8734b4ffded8_terseLabel_en-US" xlink:label="lab_mo_NonEngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenyCasesMember_label_en-US" xlink:label="lab_mo_NonEngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Engle Progeny Cases [Member]</link:label>
    <link:label id="lab_mo_NonEngleProgenyCasesMember_documentation_en-US" xlink:label="lab_mo_NonEngleProgenyCasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Engle Progeny Cases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenyCasesMember" xlink:href="mo-20221231.xsd#mo_NonEngleProgenyCasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NonEngleProgenyCasesMember" xlink:to="lab_mo_NonEngleProgenyCasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_3be7ef64-66ba-49a4-87d6-1e906069b043_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_a4832c7a-60e1-47db-a99d-5242e8c18d50_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected rate of return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_e054db71-58fb-411c-a244-0677a2787f53_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_7150a0d1-3f7c-47c4-84ad-2ac2d96f8a3f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_71f37096-e66e-48c6-bac9-bb7df0318ff1_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_PR_a2bebd23-9e1a-4dc4-8e68-fd10a6a3c2f9_terseLabel_en-US" xlink:label="lab_country_PR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Puerto Rico [Member]</link:label>
    <link:label id="lab_country_PR_label_en-US" xlink:label="lab_country_PR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PUERTO RICO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_PR" xlink:to="lab_country_PR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedTrademarks_091d8de9-260c-4550-8e29-9e9f4a2119b4_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTrademarks" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived trademarks</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedTrademarks_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedTrademarks" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Trademarks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTrademarks" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTrademarks"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedTrademarks" xlink:to="lab_us-gaap_IndefiniteLivedTrademarks" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentPricePerShareIfExercised_8301a954-f7fb-43af-be34-87cfc126dee8_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, price per share if exercised</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPricePerShareIfExercised_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Price Per Share If Exercised</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentPricePerShareIfExercised_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Price Per Share If Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentPricePerShareIfExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:to="lab_mo_EquityMethodInvestmentPricePerShareIfExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_1790fe18-570f-4c56-a5f9-b4715fba8256_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for legal settlements</link:label>
    <link:label id="lab_us-gaap_PaymentsForLegalSettlements_label_en-US" xlink:label="lab_us-gaap_PaymentsForLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLegalSettlements" xlink:to="lab_us-gaap_PaymentsForLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_a267a57f-eff2-4e58-9b49-bd45708633f7_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_5f601bfa-ffa3-472a-a7ed-cc2a0ccab96f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_fa7b8054-fae7-4ba5-bb94-5ad9f6815329_terseLabel_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected Benefit Obligations, Plan Assets and Funded Status of Pension Plans</link:label>
    <link:label id="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:to="lab_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_c48e8407-5443-41a8-a2f2-a815b84506fe_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared (USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CommonStock2.200NotesDue2027Member_7446e814-df71-4aa7-bc6f-7cbc71d5f420_terseLabel_en-US" xlink:label="lab_mo_CommonStock2.200NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.200% Notes due 2027</link:label>
    <link:label id="lab_mo_CommonStock2.200NotesDue2027Member_label_en-US" xlink:label="lab_mo_CommonStock2.200NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 2.200% Notes Due 2027 [Member]</link:label>
    <link:label id="lab_mo_CommonStock2.200NotesDue2027Member_documentation_en-US" xlink:label="lab_mo_CommonStock2.200NotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, 2.200% Notes Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock2.200NotesDue2027Member" xlink:href="mo-20221231.xsd#mo_CommonStock2.200NotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CommonStock2.200NotesDue2027Member" xlink:to="lab_mo_CommonStock2.200NotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_5c9c5317-c089-4ddb-a7cd-56f1604b4462_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_41e09212-1b49-4406-80f2-42bc6eb5453c_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_a3680b6d-49da-457b-aec9-669e7635bf18_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_ac0d4740-f3cf-471b-9bf3-ea97e94bbf6e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_TrademarksSkoalMember_fb3e2271-4321-48be-a92a-c2916b0a3ace_terseLabel_en-US" xlink:label="lab_mo_TrademarksSkoalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skoal [ Member]</link:label>
    <link:label id="lab_mo_TrademarksSkoalMember_label_en-US" xlink:label="lab_mo_TrademarksSkoalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, Skoal [Member]</link:label>
    <link:label id="lab_mo_TrademarksSkoalMember_documentation_en-US" xlink:label="lab_mo_TrademarksSkoalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks, Skoal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TrademarksSkoalMember" xlink:href="mo-20221231.xsd#mo_TrademarksSkoalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_TrademarksSkoalMember" xlink:to="lab_mo_TrademarksSkoalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciEquityMethodInvestmentAfterTax_53101c23-2e11-4725-9c65-f0d2321b8c2a_terseLabel_en-US" xlink:label="lab_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABI</link:label>
    <link:label id="lab_us-gaap_OciEquityMethodInvestmentAfterTax_label_en-US" xlink:label="lab_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Equity Method Investment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciEquityMethodInvestmentAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:to="lab_us-gaap_OciEquityMethodInvestmentAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_2614d4ce-089f-432c-81f6-b9a517568e4d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends from ABI</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_0d86b082-f9b4-4104-aaab-47d28e6d3912_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_9cef10ab-b3cf-4259-af09-cb8e8fbe915c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payable</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_InterestPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_6891e380-0b72-49ba-9d0c-91ccbdd2b50e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes2350MaturingMay2025Member_39aba481-c3c5-44c7-ab9f-a9bd027fa875_terseLabel_en-US" xlink:label="lab_mo_USDNotes2350MaturingMay2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.350%, Maturing May 2025 [Member]</link:label>
    <link:label id="lab_mo_USDNotes2350MaturingMay2025Member_label_en-US" xlink:label="lab_mo_USDNotes2350MaturingMay2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.350%, Maturing May 2025 [Member]</link:label>
    <link:label id="lab_mo_USDNotes2350MaturingMay2025Member_documentation_en-US" xlink:label="lab_mo_USDNotes2350MaturingMay2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.350%, Maturing May 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2350MaturingMay2025Member" xlink:href="mo-20221231.xsd#mo_USDNotes2350MaturingMay2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes2350MaturingMay2025Member" xlink:to="lab_mo_USDNotes2350MaturingMay2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_28bd8056-d05d-4b70-9f59-42f07c607d8b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_2440a4f6-f909-4fae-8515-20b8dfabdc68_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_dfb0ba00-a3e3-4687-b811-06fe1f6a52c8_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ultimate trend rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Ultimate Health Care Cost Trend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:to="lab_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6672abe0-7683-44b6-be0a-6d7684af5881_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future amortization, year 2</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_9d38ebd0-b799-41a9-8b00-5fa6b7f53365_negatedLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Cronos-related financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_41921501-ba9e-42c7-8504-bc2a33252e53_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Cronos-related financial instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_c25a6e0b-d5f9-4bd9-b981-5ae88a473137_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_fc0c9f27-d0e6-4bf0-918c-ed4f34e0fa58_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities without readily determinable fair value, upward price adjustment</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_212fa0ef-b333-4dbf-a0fd-77634ea92168_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Depreciation Expense and Capital Expenditures of Segments</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_BritishColumbiaSaskatchewanMember_6c09dccb-78ba-4cf6-bb68-5aa26e0e5221_terseLabel_en-US" xlink:label="lab_mo_BritishColumbiaSaskatchewanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Columbia and Saskatchewan [Member]</link:label>
    <link:label id="lab_mo_BritishColumbiaSaskatchewanMember_label_en-US" xlink:label="lab_mo_BritishColumbiaSaskatchewanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Columbia, Saskatchewan [Member]</link:label>
    <link:label id="lab_mo_BritishColumbiaSaskatchewanMember_documentation_en-US" xlink:label="lab_mo_BritishColumbiaSaskatchewanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">British Columbia, Saskatchewan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_BritishColumbiaSaskatchewanMember" xlink:href="mo-20221231.xsd#mo_BritishColumbiaSaskatchewanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_BritishColumbiaSaskatchewanMember" xlink:to="lab_mo_BritishColumbiaSaskatchewanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HelixInnovationsLLCMember_60f0c4e2-1169-4890-9472-47da5d14f997_terseLabel_en-US" xlink:label="lab_mo_HelixInnovationsLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Helix Innovations LLC [Member]</link:label>
    <link:label id="lab_mo_HelixInnovationsLLCMember_label_en-US" xlink:label="lab_mo_HelixInnovationsLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Helix Innovations LLC [Member]</link:label>
    <link:label id="lab_mo_HelixInnovationsLLCMember_documentation_en-US" xlink:label="lab_mo_HelixInnovationsLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Helix Innovations LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HelixInnovationsLLCMember" xlink:href="mo-20221231.xsd#mo_HelixInnovationsLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HelixInnovationsLLCMember" xlink:to="lab_mo_HelixInnovationsLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_037fae45-fe8c-487e-83e3-2a52e15f00aa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdicts_f3edd893-65e0-4658-9043-d384b9e1f7d0_terseLabel_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zero damages verdicts</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdicts_label_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdicts</link:label>
    <link:label id="lab_mo_LossContingencyZeroDamagesVerdicts_documentation_en-US" xlink:label="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Zero Damages Verdicts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdicts" xlink:href="mo-20221231.xsd#mo_LossContingencyZeroDamagesVerdicts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyZeroDamagesVerdicts" xlink:to="lab_mo_LossContingencyZeroDamagesVerdicts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_731fee89-d0b1-410e-8848-1741b93edd3f_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment, exit costs and implementation costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IntangibleAssetsRollForward_2a0da7a0-a7df-43de-a3f7-0873aa4d9c12_terseLabel_en-US" xlink:label="lab_mo_IntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, net</link:label>
    <link:label id="lab_mo_IntangibleAssetsRollForward_label_en-US" xlink:label="lab_mo_IntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Roll Forward]</link:label>
    <link:label id="lab_mo_IntangibleAssetsRollForward_documentation_en-US" xlink:label="lab_mo_IntangibleAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IntangibleAssetsRollForward" xlink:href="mo-20221231.xsd#mo_IntangibleAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IntangibleAssetsRollForward" xlink:to="lab_mo_IntangibleAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes4400MaturingFebruary2026Member_a1c4fbcb-f0cd-4151-921a-53d5369d918d_terseLabel_en-US" xlink:label="lab_mo_USDNotes4400MaturingFebruary2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.400%, Maturing February 2026 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4400MaturingFebruary2026Member_5cb71251-7cd9-4832-99af-a069c42c3a3e_verboseLabel_en-US" xlink:label="lab_mo_USDNotes4400MaturingFebruary2026Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.400% [Member]</link:label>
    <link:label id="lab_mo_USDNotes4400MaturingFebruary2026Member_label_en-US" xlink:label="lab_mo_USDNotes4400MaturingFebruary2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.400%, Maturing February 2026 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4400MaturingFebruary2026Member_documentation_en-US" xlink:label="lab_mo_USDNotes4400MaturingFebruary2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.400%, Maturing February 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4400MaturingFebruary2026Member" xlink:href="mo-20221231.xsd#mo_USDNotes4400MaturingFebruary2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes4400MaturingFebruary2026Member" xlink:to="lab_mo_USDNotes4400MaturingFebruary2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_cf163104-82f9-4ce7-b92f-26b71f3ddf8d_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a193d484-2234-4cf0-899c-95ea4edc46c6_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_8646fbef-1683-46d0-a667-a0d26b7a5beb_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_252d3285-f38f-4335-b09e-71f20cc384af_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_0f861c7a-370c-4da9-8f35-539e903fd473_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of deferred debt issuance cost</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of Deferred Debt Issuance Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_ad8a2863-4f2c-4463-be05-ebee92d4dda9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued pension costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_9a5a5526-34fe-4dcc-b8be-f6c95d55fe8c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued pension costs</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Pension Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_df319e6b-7637-490a-95a9-5452efb91f23_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_14833485-6948-45e5-b202-88399f4bdae0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate_f152b47d-89a6-4097-8b98-2418dc852f28_terseLabel_en-US" xlink:label="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits if recognized would affect deferred taxes</link:label>
    <link:label id="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate_label_en-US" xlink:label="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Deferred Tax Rate</link:label>
    <link:label id="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate_documentation_en-US" xlink:label="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Deferred Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" xlink:href="mo-20221231.xsd#mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" xlink:to="lab_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_0bca2f3a-202b-452a-af40-c6474dadc300_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EuroNotes1700MaturingJune2025Member_dae8e314-d021-4c5b-9c29-c74342a6e255_terseLabel_en-US" xlink:label="lab_mo_EuroNotes1700MaturingJune2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 1.700%, Maturing June 2025 [Member]</link:label>
    <link:label id="lab_mo_EuroNotes1700MaturingJune2025Member_label_en-US" xlink:label="lab_mo_EuroNotes1700MaturingJune2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 1.700%, Maturing June 2025 [Member]</link:label>
    <link:label id="lab_mo_EuroNotes1700MaturingJune2025Member_documentation_en-US" xlink:label="lab_mo_EuroNotes1700MaturingJune2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 1.700%, Maturing June 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes1700MaturingJune2025Member" xlink:href="mo-20221231.xsd#mo_EuroNotes1700MaturingJune2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EuroNotes1700MaturingJune2025Member" xlink:to="lab_mo_EuroNotes1700MaturingJune2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualRollForward_067e506e-0d7a-4f51-b2b2-5a72a0b346cc_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward" xlink:to="lab_us-gaap_LossContingencyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_af6236ac-c817-44b2-91a7-de2475b0e982_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_8425b161-0d76-45c8-8c31-7af8d322fba1_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing activities:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_ed8222c9-34fc-43ab-9920-bd82a6ed730a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies (Note 17)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_cbcbed68-2880-4632-bc59-ef8ef3b7f64b_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PendingClassActionLawsuitMember_251b0f17-42c0-46a1-b617-55cdcdb27b98_terseLabel_en-US" xlink:label="lab_mo_PendingClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Class Action Lawsuit [Member]</link:label>
    <link:label id="lab_mo_PendingClassActionLawsuitMember_label_en-US" xlink:label="lab_mo_PendingClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Class Action Lawsuit [Member]</link:label>
    <link:label id="lab_mo_PendingClassActionLawsuitMember_documentation_en-US" xlink:label="lab_mo_PendingClassActionLawsuitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Class Action Lawsuit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingClassActionLawsuitMember" xlink:href="mo-20221231.xsd#mo_PendingClassActionLawsuitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PendingClassActionLawsuitMember" xlink:to="lab_mo_PendingClassActionLawsuitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossMember_702a2900-0fb5-4b3a-b7c1-ec2cf5325a6e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Member]</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossMember_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossMember" xlink:to="lab_us-gaap_OperatingIncomeLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CigarsMember_5678d099-50dc-4900-8a56-8d1fbd2a08fd_terseLabel_en-US" xlink:label="lab_mo_CigarsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cigars [Member]</link:label>
    <link:label id="lab_mo_CigarsMember_label_en-US" xlink:label="lab_mo_CigarsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cigars [Member]</link:label>
    <link:label id="lab_mo_CigarsMember_documentation_en-US" xlink:label="lab_mo_CigarsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cigars [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CigarsMember" xlink:href="mo-20221231.xsd#mo_CigarsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CigarsMember" xlink:to="lab_mo_CigarsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_1153fe88-1f33-43b4-b56d-eede48708c52_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other debt expense, net [Member]</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_86a67e9d-5e7f-491a-b427-a1ff27c819a4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_PhilipMorrisUSAandAltriaGroupMember_4451d224-5515-4fa0-987e-53d5d8c68686_terseLabel_en-US" xlink:label="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA and Altria Group [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAandAltriaGroupMember_label_en-US" xlink:label="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA and Altria Group [Member]</link:label>
    <link:label id="lab_mo_PhilipMorrisUSAandAltriaGroupMember_documentation_en-US" xlink:label="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Philip Morris USA and Altria Group [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:to="lab_mo_PhilipMorrisUSAandAltriaGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_8c8b3757-7019-4b58-85ff-95a1b09a773c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_948097bf-2ae0-4b6b-83fb-e8930aeced76_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_a3ae0ee9-d263-4ad8-8f7d-d339b512798f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_4bbb62f9-7a1d-4baf-976b-656704712b67_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judgments paid (approximately)</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesPaidValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Paid, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesPaidValue" xlink:to="lab_us-gaap_LossContingencyDamagesPaidValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2679381e-6dc8-4fe8-b784-c5beb0dc1c2c_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock reserved for stock-based awards (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_IntangibleAssetsAxis_73f93ce6-3d21-42e3-88c0-908195c5dc13_terseLabel_en-US" xlink:label="lab_mo_IntangibleAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Axis]</link:label>
    <link:label id="lab_mo_IntangibleAssetsAxis_label_en-US" xlink:label="lab_mo_IntangibleAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Axis]</link:label>
    <link:label id="lab_mo_IntangibleAssetsAxis_documentation_en-US" xlink:label="lab_mo_IntangibleAssetsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IntangibleAssetsAxis" xlink:href="mo-20221231.xsd#mo_IntangibleAssetsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_IntangibleAssetsAxis" xlink:to="lab_mo_IntangibleAssetsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_17327ba7-df9c-425c-9fd6-67f7357ae205_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_4cd8a5da-eef9-4887-a14b-3cf9ea4c09ef_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_ed045a8b-3da3-43b0-89ee-4e278830819c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_fd624015-073b-4c72-aaa6-8da2f52b76d7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss [Member]</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_b1f630d8-8a7d-4461-964d-1536a350a038_negatedTerseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, difference between carrying amount and fair value, percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_f9197418-384f-49e0-99b3-fa7222a89df2_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment, difference between carrying amount and fair value, percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" xlink:to="lab_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DisposalGroupReceivable_b844678f-e6e2-4d09-8433-602b0373d5c1_terseLabel_en-US" xlink:label="lab_mo_DisposalGroupReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, receivable</link:label>
    <link:label id="lab_mo_DisposalGroupReceivable_label_en-US" xlink:label="lab_mo_DisposalGroupReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Receivable</link:label>
    <link:label id="lab_mo_DisposalGroupReceivable_documentation_en-US" xlink:label="lab_mo_DisposalGroupReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupReceivable" xlink:href="mo-20221231.xsd#mo_DisposalGroupReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DisposalGroupReceivable" xlink:to="lab_mo_DisposalGroupReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_0dfa6ca0-6787-44e3-8f5a-65922450d51f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from Contracts with Customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_8182e1d0-aa11-4205-b6b6-2072833ae69d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_d8caac14-7774-4f82-a264-9aa59ed3bfb6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in benefit obligation:</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_WineSegmentMember_d0ec21ee-8e3e-4c02-b9f3-01201236a003_terseLabel_en-US" xlink:label="lab_mo_WineSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine [Member]</link:label>
    <link:label id="lab_mo_WineSegmentMember_label_en-US" xlink:label="lab_mo_WineSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Segment [Member]</link:label>
    <link:label id="lab_mo_WineSegmentMember_documentation_en-US" xlink:label="lab_mo_WineSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wine Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember" xlink:href="mo-20221231.xsd#mo_WineSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_WineSegmentMember" xlink:to="lab_mo_WineSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_05e01fdb-df64-4a0c-a399-26342d9fb728_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_96697e93-2eec-402c-ad8b-29d925fcaec0_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_55afd46e-ce70-4ae2-a6cc-284300a0623c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan by Plan Asset Categories [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes5800MaturingFebruary2039Member_121c31f8-b046-4f4c-8920-2c1f40958cfe_terseLabel_en-US" xlink:label="lab_mo_USDNotes5800MaturingFebruary2039Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 5.800%, Maturing February 2039 [Member]</link:label>
    <link:label id="lab_mo_USDNotes5800MaturingFebruary2039Member_label_en-US" xlink:label="lab_mo_USDNotes5800MaturingFebruary2039Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 5.800%, Maturing February 2039 [Member]</link:label>
    <link:label id="lab_mo_USDNotes5800MaturingFebruary2039Member_documentation_en-US" xlink:label="lab_mo_USDNotes5800MaturingFebruary2039Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 5.800%, Maturing February 2039</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes5800MaturingFebruary2039Member" xlink:href="mo-20221231.xsd#mo_USDNotes5800MaturingFebruary2039Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes5800MaturingFebruary2039Member" xlink:to="lab_mo_USDNotes5800MaturingFebruary2039Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_88a7fb65-3fa3-457f-868e-3d49597295f0_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_9952d736-c50b-4d54-bf33-58f9ad78f913_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_cb3c762f-61c9-48f0-80c1-56ef41cae3d5_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_8ec9aea1-4a91-4668-8a61-45924a71a8b8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Liabilities and Stockholders&#8217; Equity (Deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding_0e6428e0-0a84-4875-a8c3-1e9bceab3836_terseLabel_en-US" xlink:label="lab_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Lawsuits Subsequently Consolidated Into A Single Proceeding</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding_label_en-US" xlink:label="lab_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Lawsuits Subsequently Consolidated Into A Single Proceeding</link:label>
    <link:label id="lab_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding_documentation_en-US" xlink:label="lab_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number Of Lawsuits Subsequently Consolidated Into A Single Proceeding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding" xlink:to="lab_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_ee33c8ba-8ae2-4989-90c3-f81d93fd93c6_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:label id="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_label_en-US" xlink:label="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:to="lab_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_515ce69f-411a-44ff-9dd8-10e3337423c4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_55621f3c-26e6-4cbf-ad62-85c1dd4f4b35_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyDamagesRecoverableValue_b5de85bb-e3bf-4ea2-82e7-7779fd430ea2_terseLabel_en-US" xlink:label="lab_mo_LossContingencyDamagesRecoverableValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency, damages recoverable, value</link:label>
    <link:label id="lab_mo_LossContingencyDamagesRecoverableValue_label_en-US" xlink:label="lab_mo_LossContingencyDamagesRecoverableValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Recoverable, Value</link:label>
    <link:label id="lab_mo_LossContingencyDamagesRecoverableValue_documentation_en-US" xlink:label="lab_mo_LossContingencyDamagesRecoverableValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Recoverable, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyDamagesRecoverableValue" xlink:href="mo-20221231.xsd#mo_LossContingencyDamagesRecoverableValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyDamagesRecoverableValue" xlink:to="lab_mo_LossContingencyDamagesRecoverableValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_727a9961-ef10-445a-932e-280f07fd0629_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ProceedsFromSaleOfCommercializationRights_f4121f50-ac72-478d-a941-59c087582203_terseLabel_en-US" xlink:label="lab_mo_ProceedsFromSaleOfCommercializationRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the sale of IQOS System commercialization rights</link:label>
    <link:label id="lab_mo_ProceedsFromSaleOfCommercializationRights_label_en-US" xlink:label="lab_mo_ProceedsFromSaleOfCommercializationRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Commercialization Rights</link:label>
    <link:label id="lab_mo_ProceedsFromSaleOfCommercializationRights_documentation_en-US" xlink:label="lab_mo_ProceedsFromSaleOfCommercializationRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Commercialization Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ProceedsFromSaleOfCommercializationRights" xlink:href="mo-20221231.xsd#mo_ProceedsFromSaleOfCommercializationRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ProceedsFromSaleOfCommercializationRights" xlink:to="lab_mo_ProceedsFromSaleOfCommercializationRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_2401c1f6-fa87-409a-a494-80184907ee89_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (losses) for EPS, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ab9fd52e-fc67-4eab-b7c4-c285e25c87f9_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per share attributable to Altria (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EngleProgenyCasesKaplanMember_fb062488-6045-4d79-93b1-d4743736b89d_terseLabel_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Kaplan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesKaplanMember_label_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Kaplan [Member]</link:label>
    <link:label id="lab_mo_EngleProgenyCasesKaplanMember_documentation_en-US" xlink:label="lab_mo_EngleProgenyCasesKaplanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Engle Progeny Cases, Kaplan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanMember" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesKaplanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EngleProgenyCasesKaplanMember" xlink:to="lab_mo_EngleProgenyCasesKaplanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_2ce4adfd-78c5-44e0-a8ef-dee51807490d_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SmokingAndHealthClassActionsMember_132d288e-b5e0-4bdb-b50f-79ba5d4ed665_terseLabel_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking And Health Class Actions [Member]</link:label>
    <link:label id="lab_mo_SmokingAndHealthClassActionsMember_label_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking And Health Class Actions [Member]</link:label>
    <link:label id="lab_mo_SmokingAndHealthClassActionsMember_documentation_en-US" xlink:label="lab_mo_SmokingAndHealthClassActionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smoking And Health Class Actions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember" xlink:href="mo-20221231.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SmokingAndHealthClassActionsMember" xlink:to="lab_mo_SmokingAndHealthClassActionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c761401e-0520-497c-92cb-2efbee55f51d_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period, in years</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_34e847d0-4ba0-48d8-a3ae-7e74c72ce960_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_InterestExpenseRelatedToLitigationMember_faab6606-71af-4455-b5c4-5c1787c64acc_terseLabel_en-US" xlink:label="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Interest Costs [Member]</link:label>
    <link:label id="lab_mo_InterestExpenseRelatedToLitigationMember_label_en-US" xlink:label="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense Related To Litigation [Member]</link:label>
    <link:label id="lab_mo_InterestExpenseRelatedToLitigationMember_documentation_en-US" xlink:label="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense Related To Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestExpenseRelatedToLitigationMember" xlink:href="mo-20221231.xsd#mo_InterestExpenseRelatedToLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_InterestExpenseRelatedToLitigationMember" xlink:to="lab_mo_InterestExpenseRelatedToLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes4800MaturingFebruary2029Member_0bb313d5-1cb9-4afe-9ad0-3803958ebfeb_terseLabel_en-US" xlink:label="lab_mo_USDNotes4800MaturingFebruary2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.800%, Maturing February 2029 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4800MaturingFebruary2029Member_938f5138-8f9b-4260-8d62-79b2870e090c_verboseLabel_en-US" xlink:label="lab_mo_USDNotes4800MaturingFebruary2029Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.800% [Member]</link:label>
    <link:label id="lab_mo_USDNotes4800MaturingFebruary2029Member_label_en-US" xlink:label="lab_mo_USDNotes4800MaturingFebruary2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.800%, Maturing February 2029 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4800MaturingFebruary2029Member_documentation_en-US" xlink:label="lab_mo_USDNotes4800MaturingFebruary2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.800%, Maturing February 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4800MaturingFebruary2029Member" xlink:href="mo-20221231.xsd#mo_USDNotes4800MaturingFebruary2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes4800MaturingFebruary2029Member" xlink:to="lab_mo_USDNotes4800MaturingFebruary2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_7427c349-92d0-4e3d-9c98-0917ddb9c84b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_564fe140-e435-4b68-a2cd-b7055c1de3cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_de8d9571-2c25-4519-8da1-7081388f3834_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_b3511d64-ebaf-41e4-974c-c3eea1ca398d_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_5ae37f98-076d-4251-a555-31bb20fa11c2_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember_9b6a3c6f-d717-414c-8480-8c82c908ac52_terseLabel_en-US" xlink:label="lab_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment to Cost Of Sales And Interest Expense [Member]</link:label>
    <link:label id="lab_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember_label_en-US" xlink:label="lab_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment to Cost Of Sales And Interest Expense [Member]</link:label>
    <link:label id="lab_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember_documentation_en-US" xlink:label="lab_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NPM Adjustment to Cost Of Sales And Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember" xlink:href="mo-20221231.xsd#mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember" xlink:to="lab_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_3a9a48ae-3b60-4a0b-942e-1c088013864e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_fce1ed10-143c-4866-98a8-7903586b16c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LitigationSettlementAnnualPaymentAmount_15c84139-7437-424e-ba5c-181f008f418d_terseLabel_en-US" xlink:label="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State settlement agreements annual payments</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualPaymentAmount_label_en-US" xlink:label="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Payment Amount</link:label>
    <link:label id="lab_mo_LitigationSettlementAnnualPaymentAmount_documentation_en-US" xlink:label="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Annual Payment Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualPaymentAmount" xlink:href="mo-20221231.xsd#mo_LitigationSettlementAnnualPaymentAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LitigationSettlementAnnualPaymentAmount" xlink:to="lab_mo_LitigationSettlementAnnualPaymentAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax_55bf7915-520b-44b5-a043-0eb5c455612f_terseLabel_en-US" xlink:label="lab_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax_label_en-US" xlink:label="lab_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax</link:label>
    <link:label id="lab_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax_documentation_en-US" xlink:label="lab_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" xlink:to="lab_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_1d3e1bb3-da98-4134-b43a-cd0fb9e9d2dd_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive earnings (losses) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_aeb1c266-7fde-420b-bd7f-381d25e70f8f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_77d3c3be-1bcc-4496-8502-bb9113caf842_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_662394e8-8f6a-43e8-b85d-c336462d6b44_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire additional interest in subsidiaries</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Additional Interest in Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:to="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_b7c201e5-8d3a-4fef-b56a-51ee21939ee0_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_83068e86-0a35-4fe6-9abe-2a261ee69a19_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of claims dismissed</link:label>
    <link:label id="lab_us-gaap_LossContingencyClaimsDismissedNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Claims Dismissed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyClaimsDismissedNumber" xlink:to="lab_us-gaap_LossContingencyClaimsDismissedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_d752a42c-282a-4ba8-a159-b01f3ead0160_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_7fadb9b1-30d4-439c-84eb-904e96239a7c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5f4880a0-13e1-4167-a6d7-7555e33becf0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_11f43402-5db7-4a86-bdb1-7b2a9b13f7e1_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_ff464964-397a-4339-849d-bdd0c71d401f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Equity Securities</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_ef2d5bb0-83e3-4a2b-93bd-b8b32840d650_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_c95c4b9d-b39e-4d7c-94c3-a0da0d6f9d84_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_67eeaddc-adbe-4335-854c-16f5e7aabf5e_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_49194157-12bd-453f-935e-5a12bea75a4e_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to net earnings as components of net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_978c95ba-9c97-47f3-a103-61d20f90ed1b_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status at December&#160;31</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityContractWarrantMember_cf8234ec-0e9a-4e51-987d-adc7912d90a5_terseLabel_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantMember_0a812e60-5185-4222-a04b-c6c0daedee01_verboseLabel_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantMember_label_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant [Member]</link:label>
    <link:label id="lab_mo_EquityContractWarrantMember_documentation_en-US" xlink:label="lab_mo_EquityContractWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Contract, Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember" xlink:href="mo-20221231.xsd#mo_EquityContractWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityContractWarrantMember" xlink:to="lab_mo_EquityContractWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedValue_2c8d9145-39a9-4f17-9b23-d5da4d5d464d_terseLabel_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensatory damages awarded</link:label>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedValue_label_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Compensatory Damages Awarded, Value</link:label>
    <link:label id="lab_mo_LossContingencyCompensatoryDamagesAwardedValue_documentation_en-US" xlink:label="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Compensatory Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:href="mo-20221231.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:to="lab_mo_LossContingencyCompensatoryDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_e4e58267-d2d3-4594-ac3d-0bc97b6a002a_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_86294c15-a5b2-4c90-8132-b2c33ff34618_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ThreatenedLitigationMember_8f2213aa-b4ea-4250-ba52-7b9999e03aa7_terseLabel_en-US" xlink:label="lab_us-gaap_ThreatenedLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threatened Litigation [Member]</link:label>
    <link:label id="lab_us-gaap_ThreatenedLitigationMember_label_en-US" xlink:label="lab_us-gaap_ThreatenedLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threatened Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ThreatenedLitigationMember" xlink:to="lab_us-gaap_ThreatenedLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount_3a7782d8-827a-4981-bfb4-b701dd28d7a4_terseLabel_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance releases</link:label>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount_label_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Valuation Reversal, Amount</link:label>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount_documentation_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Valuation Reversal, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount" xlink:to="lab_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_2e4e8f7f-8198-434e-adc5-f69ab94561fb_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_546586df-9c3f-4f52-a810-c197cf5ffcc2_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:label id="lab_us-gaap_NatureOfExpenseAxis_label_en-US" xlink:label="lab_us-gaap_NatureOfExpenseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Expense [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfExpenseAxis" xlink:to="lab_us-gaap_NatureOfExpenseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes4250MaturingAugust2042Member_f2d820c7-aea9-4dff-a645-ce8c3b88b3c8_terseLabel_en-US" xlink:label="lab_mo_USDNotes4250MaturingAugust2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.250%, Maturing August 2042 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4250MaturingAugust2042Member_label_en-US" xlink:label="lab_mo_USDNotes4250MaturingAugust2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.250%, Maturing August 2042 [Member]</link:label>
    <link:label id="lab_mo_USDNotes4250MaturingAugust2042Member_documentation_en-US" xlink:label="lab_mo_USDNotes4250MaturingAugust2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 4.250%, Maturing August 2042</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4250MaturingAugust2042Member" xlink:href="mo-20221231.xsd#mo_USDNotes4250MaturingAugust2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes4250MaturingAugust2042Member" xlink:to="lab_mo_USDNotes4250MaturingAugust2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_3a45aa6a-ddd9-450b-9bbf-695dd7d458af_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Testing and Asset Valuation</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_4bc36cde-6374-45bd-b21c-2fae4c161f6f_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0a195419-449a-49df-9c48-bb20cce5777f_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future amortization, year 5</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_LossContingencyClassActionLawsuit_7b2ebe03-b39a-490c-9e97-0d356b028b5d_terseLabel_en-US" xlink:label="lab_mo_LossContingencyClassActionLawsuit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of class action lawsuits</link:label>
    <link:label id="lab_mo_LossContingencyClassActionLawsuit_label_en-US" xlink:label="lab_mo_LossContingencyClassActionLawsuit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action Lawsuit</link:label>
    <link:label id="lab_mo_LossContingencyClassActionLawsuit_documentation_en-US" xlink:label="lab_mo_LossContingencyClassActionLawsuit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Class Action Lawsuit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit" xlink:href="mo-20221231.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_LossContingencyClassActionLawsuit" xlink:to="lab_mo_LossContingencyClassActionLawsuit" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_CurrencyTranslationAdjustmentsAndOther_382fed8c-cf9f-47dd-ab46-c6119d4b9ee9_terseLabel_en-US" xlink:label="lab_mo_CurrencyTranslationAdjustmentsAndOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation adjustments and other</link:label>
    <link:label id="lab_mo_CurrencyTranslationAdjustmentsAndOther_label_en-US" xlink:label="lab_mo_CurrencyTranslationAdjustmentsAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation Adjustments And Other</link:label>
    <link:label id="lab_mo_CurrencyTranslationAdjustmentsAndOther_documentation_en-US" xlink:label="lab_mo_CurrencyTranslationAdjustmentsAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation Adjustments And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CurrencyTranslationAdjustmentsAndOther" xlink:href="mo-20221231.xsd#mo_CurrencyTranslationAdjustmentsAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_CurrencyTranslationAdjustmentsAndOther" xlink:to="lab_mo_CurrencyTranslationAdjustmentsAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_83cba305-e4ae-4508-9c9c-89fda405aead_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_f16edffc-1a3d-4bdc-9e60-4a4daa4955e1_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_1c52964a-713b-46c5-bc90-e84b8ae04738_terseLabel_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_label_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</link:label>
    <link:label id="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_documentation_en-US" xlink:label="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:to="lab_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_970f6d89-8c19-4126-af0e-edb51e0ead7b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_276f6775-62cc-458e-8cbe-a07504add981_negatedLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_5c30522f-3a18-4982-8229-2748f61a4b64_terseLabel_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment</link:label>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_label_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Valuation Allowance, Amount</link:label>
    <link:label id="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_documentation_en-US" xlink:label="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" xlink:to="lab_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_e41dde0c-1f0a-4370-86e8-5d694fc8b41d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ABInBevMember_8904148b-3ee6-48d9-a76c-2c0e6b6ea95a_terseLabel_en-US" xlink:label="lab_mo_ABInBevMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ABI [Member]</link:label>
    <link:label id="lab_mo_ABInBevMember_label_en-US" xlink:label="lab_mo_ABInBevMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AB InBev [Member]</link:label>
    <link:label id="lab_mo_ABInBevMember_documentation_en-US" xlink:label="lab_mo_ABInBevMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AB InBev [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember" xlink:href="mo-20221231.xsd#mo_ABInBevMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ABInBevMember" xlink:to="lab_mo_ABInBevMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_ab04d518-a24e-46b2-b775-f23f7f99053e_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember_63547344-52cd-4252-b163-dba3690f0461_terseLabel_en-US" xlink:label="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ETS Smoking and Health Case, Flight Attendants [Member]</link:label>
    <link:label id="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember_label_en-US" xlink:label="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ETS Smoking and Health Case, Flight Attendants [Member]</link:label>
    <link:label id="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember_documentation_en-US" xlink:label="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ETS Smoking and Health Case, Flight Attendants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:href="mo-20221231.xsd#mo_ETSSmokingandHealthCaseFlightAttendantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:to="lab_mo_ETSSmokingandHealthCaseFlightAttendantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EuroNotes2200MaturingJune2027Member_7b171293-71fd-4954-ae55-2939af97e85c_terseLabel_en-US" xlink:label="lab_mo_EuroNotes2200MaturingJune2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 2.200%, Maturing June 2027 [Member]</link:label>
    <link:label id="lab_mo_EuroNotes2200MaturingJune2027Member_label_en-US" xlink:label="lab_mo_EuroNotes2200MaturingJune2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 2.200%, Maturing June 2027 [Member]</link:label>
    <link:label id="lab_mo_EuroNotes2200MaturingJune2027Member_documentation_en-US" xlink:label="lab_mo_EuroNotes2200MaturingJune2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Euro Notes, 2.200%, Maturing June 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes2200MaturingJune2027Member" xlink:href="mo-20221231.xsd#mo_EuroNotes2200MaturingJune2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EuroNotes2200MaturingJune2027Member" xlink:to="lab_mo_EuroNotes2200MaturingJune2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_a373d401-de76-4838-b09d-5af11afb857b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment_672eba91-f328-4bcf-9459-e98a4693473c_terseLabel_en-US" xlink:label="lab_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group, purchase agreement, consideration, additional payment</link:label>
    <link:label id="lab_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment_label_en-US" xlink:label="lab_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Purchase Agreement, Consideration, Additional Payment</link:label>
    <link:label id="lab_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment_documentation_en-US" xlink:label="lab_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Purchase Agreement, Consideration, Additional Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment" xlink:href="mo-20221231.xsd#mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment" xlink:to="lab_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ExciseTax_0d5fcedf-8a25-4047-8150-410617fb148d_terseLabel_en-US" xlink:label="lab_mo_ExciseTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise taxes on products</link:label>
    <link:label id="lab_mo_ExciseTax_label_en-US" xlink:label="lab_mo_ExciseTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise Tax</link:label>
    <link:label id="lab_mo_ExciseTax_documentation_en-US" xlink:label="lab_mo_ExciseTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ExciseTax" xlink:href="mo-20221231.xsd#mo_ExciseTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ExciseTax" xlink:to="lab_mo_ExciseTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_13182a1f-c118-4c07-9784-8f82689a22ff_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_94873f34-0a70-4939-98f3-2de8e2b7c363_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_OwnershipPercentageInConsolidatedSubsidiary_1de7b08a-3e2a-470d-bb6d-5c6b3b5aca9c_terseLabel_en-US" xlink:label="lab_mo_OwnershipPercentageInConsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage in consolidated subsidiary</link:label>
    <link:label id="lab_mo_OwnershipPercentageInConsolidatedSubsidiary_label_en-US" xlink:label="lab_mo_OwnershipPercentageInConsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership Percentage In Consolidated Subsidiary</link:label>
    <link:label id="lab_mo_OwnershipPercentageInConsolidatedSubsidiary_documentation_en-US" xlink:label="lab_mo_OwnershipPercentageInConsolidatedSubsidiary" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership Percentage In Consolidated Subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OwnershipPercentageInConsolidatedSubsidiary" xlink:href="mo-20221231.xsd#mo_OwnershipPercentageInConsolidatedSubsidiary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_OwnershipPercentageInConsolidatedSubsidiary" xlink:to="lab_mo_OwnershipPercentageInConsolidatedSubsidiary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_7030cdd3-d479-4958-ba30-19f35cdb2f1e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_TobaccoandHealthJudgmentMember_1cded9cc-85ae-4c47-b022-ca811ad5ad40_terseLabel_en-US" xlink:label="lab_mo_TobaccoandHealthJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Judgment [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthJudgmentMember_label_en-US" xlink:label="lab_mo_TobaccoandHealthJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Judgment [Member]</link:label>
    <link:label id="lab_mo_TobaccoandHealthJudgmentMember_documentation_en-US" xlink:label="lab_mo_TobaccoandHealthJudgmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tobacco and Health Judgment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember" xlink:href="mo-20221231.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_TobaccoandHealthJudgmentMember" xlink:to="lab_mo_TobaccoandHealthJudgmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_b7dd67f2-568d-4fd3-8a49-ac280990e657_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Provided by (Used in) Financing Activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_USDNotes2950MaturingMay2023Member_0985ab63-fcb2-4ed9-9f60-4a5ff37687b6_terseLabel_en-US" xlink:label="lab_mo_USDNotes2950MaturingMay2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.950%, Maturing May 2023 [Member]</link:label>
    <link:label id="lab_mo_USDNotes2950MaturingMay2023Member_f49521f0-bd1c-490c-8430-0049e10bff98_verboseLabel_en-US" xlink:label="lab_mo_USDNotes2950MaturingMay2023Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.950% [Member]</link:label>
    <link:label id="lab_mo_USDNotes2950MaturingMay2023Member_label_en-US" xlink:label="lab_mo_USDNotes2950MaturingMay2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.950%, Maturing May 2023 [Member]</link:label>
    <link:label id="lab_mo_USDNotes2950MaturingMay2023Member_documentation_en-US" xlink:label="lab_mo_USDNotes2950MaturingMay2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USD Notes, 2.950%, Maturing May 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2950MaturingMay2023Member" xlink:href="mo-20221231.xsd#mo_USDNotes2950MaturingMay2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_USDNotes2950MaturingMay2023Member" xlink:to="lab_mo_USDNotes2950MaturingMay2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount_bcc27a6b-d0ea-4fdd-9697-3f5fd1bb60ba_terseLabel_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance, deferred tax asset, capital losses, amount</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount_label_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Capital Losses, Increase (Decrease), Amount</link:label>
    <link:label id="lab_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount_documentation_en-US" xlink:label="lab_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Capital Losses, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount" xlink:href="mo-20221231.xsd#mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount" xlink:to="lab_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_41f648d2-61df-4f67-88d5-9b1b0e138662_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualPayments" xlink:to="lab_us-gaap_LossContingencyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_e1fc6e2c-89f6-4d22-9bcd-4d96d8a17d98_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_EquityMethodInvestmentsFixedPreemptiveRights_ae7cb49a-583b-4a73-8bdf-070d0e339cc2_terseLabel_en-US" xlink:label="lab_mo_EquityMethodInvestmentsFixedPreemptiveRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments, fixed preemptive rights</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentsFixedPreemptiveRights_label_en-US" xlink:label="lab_mo_EquityMethodInvestmentsFixedPreemptiveRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fixed Preemptive Rights</link:label>
    <link:label id="lab_mo_EquityMethodInvestmentsFixedPreemptiveRights_documentation_en-US" xlink:label="lab_mo_EquityMethodInvestmentsFixedPreemptiveRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fixed Preemptive Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsFixedPreemptiveRights" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentsFixedPreemptiveRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_EquityMethodInvestmentsFixedPreemptiveRights" xlink:to="lab_mo_EquityMethodInvestmentsFixedPreemptiveRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_9526ab50-33a7-44a3-9ba0-3a6107ee012b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the Ste. Michelle Transaction, net of cash transferred</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_5ee4bbcb-2e1e-4037-967a-3e459f9238fa_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_c3279442-408c-47a6-8f61-05f2d19f591a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Projected benefit obligation</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_mo_SteMichelleTransactionMember_837068d3-fb24-406d-9dc5-7b7b5eae5183_terseLabel_en-US" xlink:label="lab_mo_SteMichelleTransactionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ste. Michelle Transaction</link:label>
    <link:label id="lab_mo_SteMichelleTransactionMember_label_en-US" xlink:label="lab_mo_SteMichelleTransactionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ste. Michelle Transaction [Member]</link:label>
    <link:label id="lab_mo_SteMichelleTransactionMember_documentation_en-US" xlink:label="lab_mo_SteMichelleTransactionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ste. Michelle Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionMember" xlink:href="mo-20221231.xsd#mo_SteMichelleTransactionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_mo_SteMichelleTransactionMember" xlink:to="lab_mo_SteMichelleTransactionMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>17
<FILENAME>mo-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:dfb2a125-0b18-4fdf-aa8f-28a7e5cf9d49,g:08272963-4e0b-4a36-8744-7641bada9ecd-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.altria.com/role/CoverPage" xlink:type="simple" xlink:href="mo-20221231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_03b9ef6a-849b-42ea-9bd6-2af841324368" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_c048e6a7-ceee-496a-a1a3-401f128dcbd9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_03b9ef6a-849b-42ea-9bd6-2af841324368" xlink:to="loc_dei_EntitiesTable_c048e6a7-ceee-496a-a1a3-401f128dcbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e05a804d-baaf-417b-ae80-2c6820f5eab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_c048e6a7-ceee-496a-a1a3-401f128dcbd9" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e05a804d-baaf-417b-ae80-2c6820f5eab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_236ba8b5-8f0e-417a-8c89-b258f69b6891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e05a804d-baaf-417b-ae80-2c6820f5eab2" xlink:to="loc_us-gaap_ClassOfStockDomain_236ba8b5-8f0e-417a-8c89-b258f69b6891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock0.3313ParValueMember_675ceda3-9722-48ab-8334-7ec51cf7a940" xlink:href="mo-20221231.xsd#mo_CommonStock0.3313ParValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_236ba8b5-8f0e-417a-8c89-b258f69b6891" xlink:to="loc_mo_CommonStock0.3313ParValueMember_675ceda3-9722-48ab-8334-7ec51cf7a940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock1.700NotesDue2025Member_d850f88d-ee18-47d0-b5d8-fbe0340dd621" xlink:href="mo-20221231.xsd#mo_CommonStock1.700NotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_236ba8b5-8f0e-417a-8c89-b258f69b6891" xlink:to="loc_mo_CommonStock1.700NotesDue2025Member_d850f88d-ee18-47d0-b5d8-fbe0340dd621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock2.200NotesDue2027Member_c6ff2fcd-a251-4d33-8bcf-18d53921a519" xlink:href="mo-20221231.xsd#mo_CommonStock2.200NotesDue2027Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_236ba8b5-8f0e-417a-8c89-b258f69b6891" xlink:to="loc_mo_CommonStock2.200NotesDue2027Member_c6ff2fcd-a251-4d33-8bcf-18d53921a519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStock3.125NotesDue2031Member_b761e8aa-60f2-4d8f-8509-21f25f2cbc9c" xlink:href="mo-20221231.xsd#mo_CommonStock3.125NotesDue2031Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_236ba8b5-8f0e-417a-8c89-b258f69b6891" xlink:to="loc_mo_CommonStock3.125NotesDue2031Member_b761e8aa-60f2-4d8f-8509-21f25f2cbc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_c048e6a7-ceee-496a-a1a3-401f128dcbd9" xlink:to="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b57e1dd6-b006-4b05-93a4-871e4f030cb8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentType_b57e1dd6-b006-4b05-93a4-871e4f030cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_d103fddf-b0d2-47dd-9195-5afc98b7f8fe" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentAnnualReport_d103fddf-b0d2-47dd-9195-5afc98b7f8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_982065cb-bc51-42bf-90d0-b223fe1313e4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentPeriodEndDate_982065cb-bc51-42bf-90d0-b223fe1313e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_9383808d-0c58-4a3c-9480-44560f4eb203" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_CurrentFiscalYearEndDate_9383808d-0c58-4a3c-9480-44560f4eb203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_28ce53b0-0ecb-4393-bc83-c0bc926fc29c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentTransitionReport_28ce53b0-0ecb-4393-bc83-c0bc926fc29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ecccea0b-fc71-461f-a161-01b1eb28256e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityFileNumber_ecccea0b-fc71-461f-a161-01b1eb28256e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f6d67a33-c7c8-43ef-ada2-0117f2c56579" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityRegistrantName_f6d67a33-c7c8-43ef-ada2-0117f2c56579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a748309b-07b3-4870-a110-326117a3a0ca" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a748309b-07b3-4870-a110-326117a3a0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_0defdbe7-94d3-4f9a-a066-2ebfa458a005" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityTaxIdentificationNumber_0defdbe7-94d3-4f9a-a066-2ebfa458a005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2d79991e-199e-4182-8374-74051ce3dede" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityAddressAddressLine1_2d79991e-199e-4182-8374-74051ce3dede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0901c1f0-8ab5-4792-a8b3-5ae5741456ff" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityAddressCityOrTown_0901c1f0-8ab5-4792-a8b3-5ae5741456ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d0c71e9c-ebb2-4ba3-9965-c56a84367f54" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityAddressStateOrProvince_d0c71e9c-ebb2-4ba3-9965-c56a84367f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4103ca94-712b-42bd-a90a-86150dc51b1f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityAddressPostalZipCode_4103ca94-712b-42bd-a90a-86150dc51b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2aff22c9-3d7d-4815-bc3a-b210949cb851" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_CityAreaCode_2aff22c9-3d7d-4815-bc3a-b210949cb851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_3abdc7fd-b8c6-41fe-b842-6189ad79baec" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_LocalPhoneNumber_3abdc7fd-b8c6-41fe-b842-6189ad79baec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0f2ea237-0a17-4654-bc4f-2e29775a04a2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_Security12bTitle_0f2ea237-0a17-4654-bc4f-2e29775a04a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2c338b50-4b7e-465a-beb4-8108d6291c14" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_TradingSymbol_2c338b50-4b7e-465a-beb4-8108d6291c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b84a1e00-3943-47d7-9616-eddb43cf4979" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_SecurityExchangeName_b84a1e00-3943-47d7-9616-eddb43cf4979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_3f3a3a20-2819-4a44-9905-de451b2c7ace" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_3f3a3a20-2819-4a44-9905-de451b2c7ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_23959526-85ee-4e00-8902-c6db0de8df50" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityVoluntaryFilers_23959526-85ee-4e00-8902-c6db0de8df50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_04c086ba-0a61-413f-940f-101794c28578" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityCurrentReportingStatus_04c086ba-0a61-413f-940f-101794c28578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f5a0df66-4556-43d8-a63b-84ee5c55524b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityInteractiveDataCurrent_f5a0df66-4556-43d8-a63b-84ee5c55524b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_1301b9b1-a8b3-4c69-a23e-6d808e3a631a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityFilerCategory_1301b9b1-a8b3-4c69-a23e-6d808e3a631a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_9eeaf7a5-78de-4340-97c0-e036a840b861" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntitySmallBusiness_9eeaf7a5-78de-4340-97c0-e036a840b861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8d13c35f-e1f3-4be7-80c3-5371394be662" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityEmergingGrowthCompany_8d13c35f-e1f3-4be7-80c3-5371394be662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_b33d9a66-8aa1-42eb-a718-4babf2a714d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_IcfrAuditorAttestationFlag_b33d9a66-8aa1-42eb-a718-4babf2a714d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_34ad61e2-b19d-4753-81ca-7e50eea6e072" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityShellCompany_34ad61e2-b19d-4753-81ca-7e50eea6e072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_c72f42cd-322b-4d58-9098-cc0f48f15e6f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityPublicFloat_c72f42cd-322b-4d58-9098-cc0f48f15e6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_fb02e818-a746-4063-89e0-4d5e19741a65" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_fb02e818-a746-4063-89e0-4d5e19741a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4c6ebeb3-08bd-47d9-85ff-30ad2d543084" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4c6ebeb3-08bd-47d9-85ff-30ad2d543084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_1125e16c-9a24-48b6-80de-0ecd0005a717" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_AmendmentFlag_1125e16c-9a24-48b6-80de-0ecd0005a717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b891193a-ce3a-44cf-938d-9db03e5bb819" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentFiscalYearFocus_b891193a-ce3a-44cf-938d-9db03e5bb819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_663e9ab5-ddb1-41f2-b582-22ced9fe3dc5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_663e9ab5-ddb1-41f2-b582-22ced9fe3dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_758e83cc-a3cb-470a-a9df-947f3990f1b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_9922c90b-e541-4c3c-ae84-66fd86f4ae8e" xlink:to="loc_dei_EntityCentralIndexKey_758e83cc-a3cb-470a-a9df-947f3990f1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AuditInformation" xlink:type="simple" xlink:href="mo-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mo_AuditInformationAbstract_17ad8367-324f-437e-8252-8af2b758cc81" xlink:href="mo-20221231.xsd#mo_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_61fd7f0f-ccca-45e4-97b0-da69db248720" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_AuditInformationAbstract_17ad8367-324f-437e-8252-8af2b758cc81" xlink:to="loc_dei_AuditorName_61fd7f0f-ccca-45e4-97b0-da69db248720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_f868340a-a1ba-4aef-a4f8-bbfa5feaeb79" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_AuditInformationAbstract_17ad8367-324f-437e-8252-8af2b758cc81" xlink:to="loc_dei_AuditorLocation_f868340a-a1ba-4aef-a4f8-bbfa5feaeb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_6fcda98f-9931-4d66-84fe-094e45e023b1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_AuditInformationAbstract_17ad8367-324f-437e-8252-8af2b758cc81" xlink:to="loc_dei_AuditorFirmId_6fcda98f-9931-4d66-84fe-094e45e023b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="mo-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_cfc02dd0-cb93-4b16-8608-534a76361814" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cfc02dd0-cb93-4b16-8608-534a76361814" xlink:to="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1e456475-ae4d-4f6f-abdb-7a0ef20e74ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1e456475-ae4d-4f6f-abdb-7a0ef20e74ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ReceivableCommercializationRightsCurrent_8ec6385e-bce0-4e06-906a-b3c8f92b62f8" xlink:href="mo-20221231.xsd#mo_ReceivableCommercializationRightsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:to="loc_mo_ReceivableCommercializationRightsCurrent_8ec6385e-bce0-4e06-906a-b3c8f92b62f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_1d7df8b4-93da-4d73-948b-292e71e1e3d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_1d7df8b4-93da-4d73-948b-292e71e1e3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_68a462fd-1062-4a43-89f9-84f98d89a72e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:to="loc_us-gaap_InventoryNetAbstract_68a462fd-1062-4a43-89f9-84f98d89a72e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_9bc31265-6b94-4dde-8a30-753c831a3bbe" xlink:href="mo-20221231.xsd#mo_InventoryRawMaterialsPlantMaterialNetofReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_68a462fd-1062-4a43-89f9-84f98d89a72e" xlink:to="loc_mo_InventoryRawMaterialsPlantMaterialNetofReserves_9bc31265-6b94-4dde-8a30-753c831a3bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInventoryRawMaterialsNetofReserves_e8530b67-49bf-4c10-b54c-bdfd53c280a6" xlink:href="mo-20221231.xsd#mo_OtherInventoryRawMaterialsNetofReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_68a462fd-1062-4a43-89f9-84f98d89a72e" xlink:to="loc_mo_OtherInventoryRawMaterialsNetofReserves_e8530b67-49bf-4c10-b54c-bdfd53c280a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d8bc0dfc-9632-41cf-9040-74baeda66389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_68a462fd-1062-4a43-89f9-84f98d89a72e" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_d8bc0dfc-9632-41cf-9040-74baeda66389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_6614fb46-3d64-47dd-ae11-11b7d52cdc04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_68a462fd-1062-4a43-89f9-84f98d89a72e" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_6614fb46-3d64-47dd-ae11-11b7d52cdc04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_5280f36e-7e49-463d-bf9f-ac1712acc2bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_68a462fd-1062-4a43-89f9-84f98d89a72e" xlink:to="loc_us-gaap_InventoryNet_5280f36e-7e49-463d-bf9f-ac1712acc2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_29303186-7b18-4d38-985c-45cbf346e5df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:to="loc_us-gaap_OtherAssetsCurrent_29303186-7b18-4d38-985c-45cbf346e5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0e66db46-c8fb-4de0-8297-e919fa832bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:to="loc_us-gaap_AssetsCurrent_0e66db46-c8fb-4de0-8297-e919fa832bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_f0824b1d-0a0d-44d8-a506-7e30a89a8762" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNetAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_f0824b1d-0a0d-44d8-a506-7e30a89a8762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAndLandImprovements_f87cf52a-5cea-4534-93c8-1b119f4e241a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandAndLandImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_f0824b1d-0a0d-44d8-a506-7e30a89a8762" xlink:to="loc_us-gaap_LandAndLandImprovements_f87cf52a-5cea-4534-93c8-1b119f4e241a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_da8f7695-558a-4162-995b-da62deec6f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_f0824b1d-0a0d-44d8-a506-7e30a89a8762" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_da8f7695-558a-4162-995b-da62deec6f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_e4c5eadf-9669-4a32-8d80-5b906ebddd85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_f0824b1d-0a0d-44d8-a506-7e30a89a8762" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_e4c5eadf-9669-4a32-8d80-5b906ebddd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_4144bcec-1f2d-4afe-ac39-a2863ce7bbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_f0824b1d-0a0d-44d8-a506-7e30a89a8762" xlink:to="loc_us-gaap_ConstructionInProgressGross_4144bcec-1f2d-4afe-ac39-a2863ce7bbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8c1ca3ce-e4c6-454e-91a2-24d204317b95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_f0824b1d-0a0d-44d8-a506-7e30a89a8762" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8c1ca3ce-e4c6-454e-91a2-24d204317b95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ba684c17-f242-43e5-a0c7-232babf0948a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_f0824b1d-0a0d-44d8-a506-7e30a89a8762" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ba684c17-f242-43e5-a0c7-232babf0948a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_472b5804-4a96-4c6f-a2f1-bcb3a2307748" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetAbstract_f0824b1d-0a0d-44d8-a506-7e30a89a8762" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_472b5804-4a96-4c6f-a2f1-bcb3a2307748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0007feb8-b604-473c-b8fa-618474cf8d99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:to="loc_us-gaap_Goodwill_0007feb8-b604-473c-b8fa-618474cf8d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f567e293-1c20-4056-b07b-c3f9beeeb54b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f567e293-1c20-4056-b07b-c3f9beeeb54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_82a72dcc-d1b0-4f7a-9618-1459bd8fb5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:to="loc_us-gaap_Investments_82a72dcc-d1b0-4f7a-9618-1459bd8fb5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8facaa50-19a8-4fac-b1c6-1d56a27999a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8facaa50-19a8-4fac-b1c6-1d56a27999a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ebdbba0c-1201-4160-ac84-bcd6e84a414a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1719e60e-44f0-482f-b51f-44acdba09fa8" xlink:to="loc_us-gaap_Assets_ebdbba0c-1201-4160-ac84-bcd6e84a414a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cfc02dd0-cb93-4b16-8608-534a76361814" xlink:to="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_2d4103e8-76ff-4969-8a74-28bf5069a34c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:to="loc_us-gaap_LongTermDebtCurrent_2d4103e8-76ff-4969-8a74-28bf5069a34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_76370bf1-e6c6-4416-a164-7a8571524b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:to="loc_us-gaap_AccountsPayableCurrent_76370bf1-e6c6-4416-a164-7a8571524b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bd68d51b-6375-4b6f-8477-83c9b8daec83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bd68d51b-6375-4b6f-8477-83c9b8daec83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_09b57698-f9e5-4fad-a6f4-4410aa487544" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bd68d51b-6375-4b6f-8477-83c9b8daec83" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_09b57698-f9e5-4fad-a6f4-4410aa487544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccruedSettlementLiabilityCurrent_7c92d32a-8f55-463a-8069-55a988b2bbe9" xlink:href="mo-20221231.xsd#mo_AccruedSettlementLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bd68d51b-6375-4b6f-8477-83c9b8daec83" xlink:to="loc_mo_AccruedSettlementLiabilityCurrent_7c92d32a-8f55-463a-8069-55a988b2bbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_46ea27c5-9160-4237-9303-472106827ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_bd68d51b-6375-4b6f-8477-83c9b8daec83" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_46ea27c5-9160-4237-9303-472106827ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_a99d49de-7e0d-4a07-b5e0-0c9487d33845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:to="loc_us-gaap_DividendsPayableCurrent_a99d49de-7e0d-4a07-b5e0-0c9487d33845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5aa27ac8-b3a7-4265-bed7-1f9298f54598" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:to="loc_us-gaap_LiabilitiesCurrent_5aa27ac8-b3a7-4265-bed7-1f9298f54598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6c2fccfc-2fd3-4ec7-ab40-455ff08930b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6c2fccfc-2fd3-4ec7-ab40-455ff08930b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_81961c0b-2833-41fd-829b-d9a84022a881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_81961c0b-2833-41fd-829b-d9a84022a881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_b1c547af-2563-4412-b2c0-af638676afbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_b1c547af-2563-4412-b2c0-af638676afbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_f73423ce-e710-48ed-96fe-06ba2c49363e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:to="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_f73423ce-e710-48ed-96fe-06ba2c49363e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent_13b32892-35a5-4230-81dd-22ffe1d1034c" xlink:href="mo-20221231.xsd#mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:to="loc_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent_13b32892-35a5-4230-81dd-22ffe1d1034c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d832665d-e894-4481-b11b-9b5ea0bdf578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d832665d-e894-4481-b11b-9b5ea0bdf578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3501a660-d19d-404f-ab19-ecfba61301be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_437a330d-0190-47fe-bed3-abb627fcbd97" xlink:to="loc_us-gaap_Liabilities_3501a660-d19d-404f-ab19-ecfba61301be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_9e307fc0-8bcc-4724-86e9-d891d8641a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cfc02dd0-cb93-4b16-8608-534a76361814" xlink:to="loc_us-gaap_CommitmentsAndContingencies_9e307fc0-8bcc-4724-86e9-d891d8641a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1e192512-ae65-4f6e-81a6-4f82180e67ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cfc02dd0-cb93-4b16-8608-534a76361814" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1e192512-ae65-4f6e-81a6-4f82180e67ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c2f658b0-7854-49e1-a722-06d7635921cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1e192512-ae65-4f6e-81a6-4f82180e67ea" xlink:to="loc_us-gaap_CommonStockValue_c2f658b0-7854-49e1-a722-06d7635921cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5a90a2b2-4469-4efd-9804-fc2193254d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1e192512-ae65-4f6e-81a6-4f82180e67ea" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_5a90a2b2-4469-4efd-9804-fc2193254d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4f858e1d-505e-4235-aa45-62f17cec1213" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1e192512-ae65-4f6e-81a6-4f82180e67ea" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4f858e1d-505e-4235-aa45-62f17cec1213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0469b110-b5a7-4571-bf03-1010deb43564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1e192512-ae65-4f6e-81a6-4f82180e67ea" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_0469b110-b5a7-4571-bf03-1010deb43564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_8ca78fb0-649b-46f9-838e-2d0c98016807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1e192512-ae65-4f6e-81a6-4f82180e67ea" xlink:to="loc_us-gaap_TreasuryStockValue_8ca78fb0-649b-46f9-838e-2d0c98016807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6bdf130d-529f-4fce-a4aa-49955eefcf56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1e192512-ae65-4f6e-81a6-4f82180e67ea" xlink:to="loc_us-gaap_StockholdersEquity_6bdf130d-529f-4fce-a4aa-49955eefcf56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f4b55701-ffb8-472e-b2bd-99ea20e927f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1e192512-ae65-4f6e-81a6-4f82180e67ea" xlink:to="loc_us-gaap_MinorityInterest_f4b55701-ffb8-472e-b2bd-99ea20e927f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_99615cbc-b585-4bef-b776-6a52ad8e2243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_1e192512-ae65-4f6e-81a6-4f82180e67ea" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_99615cbc-b585-4bef-b776-6a52ad8e2243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_88398dc1-c146-45d4-a6eb-042967de92f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cfc02dd0-cb93-4b16-8608-534a76361814" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_88398dc1-c146-45d4-a6eb-042967de92f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="mo-20221231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_5d9f217b-b084-4414-b2a0-151edc2d3bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_b37dea69-2301-46a1-bbc1-16c299cac160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_5d9f217b-b084-4414-b2a0-151edc2d3bd6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_b37dea69-2301-46a1-bbc1-16c299cac160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_106d12d0-a214-447c-93c4-8bc2860437f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_b37dea69-2301-46a1-bbc1-16c299cac160" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_106d12d0-a214-447c-93c4-8bc2860437f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_afa8e2fd-ab78-4a91-a445-efe5c3fc1677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_b37dea69-2301-46a1-bbc1-16c299cac160" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_afa8e2fd-ab78-4a91-a445-efe5c3fc1677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d84c1908-0af6-4fb6-8bbf-8013d90676b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_b37dea69-2301-46a1-bbc1-16c299cac160" xlink:to="loc_us-gaap_CommonStockSharesIssued_d84c1908-0af6-4fb6-8bbf-8013d90676b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_7e78e39d-1acb-4516-a555-f0d1449ae062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_b37dea69-2301-46a1-bbc1-16c299cac160" xlink:to="loc_us-gaap_TreasuryStockShares_7e78e39d-1acb-4516-a555-f0d1449ae062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="mo-20221231.xsd#ConsolidatedStatementsofEarnings"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bae74ef8-8de1-4a43-aae7-fe0b7c07604e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_bae74ef8-8de1-4a43-aae7-fe0b7c07604e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_204393e3-de23-43c2-a2a3-ded729b9c661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_204393e3-de23-43c2-a2a3-ded729b9c661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ExciseTax_a437271e-7a3e-42a3-a439-dc85d29c6a87" xlink:href="mo-20221231.xsd#mo_ExciseTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_mo_ExciseTax_a437271e-7a3e-42a3-a439-dc85d29c6a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_340b0b0a-1d8e-47aa-8f06-8416bf79ed43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_GrossProfit_340b0b0a-1d8e-47aa-8f06-8416bf79ed43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationandResearchCosts_d4e20233-c5b1-47c3-962c-40f91fde4ca0" xlink:href="mo-20221231.xsd#mo_MarketingAdministrationandResearchCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_mo_MarketingAdministrationandResearchCosts_d4e20233-c5b1-47c3-962c-40f91fde4ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_01e26249-eab9-4a06-b601-ae451a6cde71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_OperatingIncomeLoss_01e26249-eab9-4a06-b601-ae451a6cde71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_ff790625-808c-4085-99ea-3e91628d495e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_ff790625-808c-4085-99ea-3e91628d495e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7bd073f6-c3fe-4c55-9f47-de7d76684649" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7bd073f6-c3fe-4c55-9f47-de7d76684649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_ef7aebea-8e53-4c23-a756-3563a544632c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_ef7aebea-8e53-4c23-a756-3563a544632c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_3edfe256-16a2-486e-acaa-ebd3414b7df4" xlink:href="mo-20221231.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_mo_IncomeLossFromEquityInvestments_3edfe256-16a2-486e-acaa-ebd3414b7df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_a3d5c56b-ab30-40bd-980c-5d2f8d8c39f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_a3d5c56b-ab30-40bd-980c-5d2f8d8c39f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_9453e094-0e99-48e0-a2e0-fa94020499cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_9453e094-0e99-48e0-a2e0-fa94020499cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1dc3c7ef-971d-4072-8caf-33fd86f94371" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1dc3c7ef-971d-4072-8caf-33fd86f94371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a984949b-b509-4a13-a801-62b562778cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a984949b-b509-4a13-a801-62b562778cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2e56b602-a2b3-43a0-8141-24753b4cf7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_ProfitLoss_2e56b602-a2b3-43a0-8141-24753b4cf7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ba456422-9d4b-4423-9ccf-ad73567a3761" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ba456422-9d4b-4423-9ccf-ad73567a3761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_96803bbe-86fe-4917-b025-1aa9b6bd9c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_NetIncomeLoss_96803bbe-86fe-4917-b025-1aa9b6bd9c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_aea42ee1-5628-46e0-be03-8abd093b34dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d9f54d49-76af-4997-b322-e6ff118c9372" xlink:to="loc_us-gaap_EarningsPerShareAbstract_aea42ee1-5628-46e0-be03-8abd093b34dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6f8c67cf-29ee-42d2-b431-ca7b0c7c80a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_aea42ee1-5628-46e0-be03-8abd093b34dc" xlink:to="loc_us-gaap_EarningsPerShareBasic_6f8c67cf-29ee-42d2-b431-ca7b0c7c80a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_df39616b-5c4a-4475-9924-1f2640f1f067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_aea42ee1-5628-46e0-be03-8abd093b34dc" xlink:to="loc_us-gaap_EarningsPerShareDiluted_df39616b-5c4a-4475-9924-1f2640f1f067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings" xlink:type="simple" xlink:href="mo-20221231.xsd#ConsolidatedStatementsofComprehensiveEarnings"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_68086bd5-34af-4f45-8eec-fb196211411e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e7aeb843-c41a-4967-80a8-f05fb2a73479" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_68086bd5-34af-4f45-8eec-fb196211411e" xlink:to="loc_us-gaap_ProfitLoss_e7aeb843-c41a-4967-80a8-f05fb2a73479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c39bdaae-6c8f-463e-975d-b9595aa0cb51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_68086bd5-34af-4f45-8eec-fb196211411e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c39bdaae-6c8f-463e-975d-b9595aa0cb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2f594672-d5bc-4770-ab4d-97ca892087b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c39bdaae-6c8f-463e-975d-b9595aa0cb51" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_2f594672-d5bc-4770-ab4d-97ca892087b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciEquityMethodInvestmentAfterTax_7c36a7ef-f059-45a1-bc74-1af920d32a15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciEquityMethodInvestmentAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c39bdaae-6c8f-463e-975d-b9595aa0cb51" xlink:to="loc_us-gaap_OciEquityMethodInvestmentAfterTax_7c36a7ef-f059-45a1-bc74-1af920d32a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax_4566727f-6f52-4aba-80e8-4aebc28feb3a" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c39bdaae-6c8f-463e-975d-b9595aa0cb51" xlink:to="loc_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax_4566727f-6f52-4aba-80e8-4aebc28feb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4a74cf5f-7e18-402a-b491-d4959d1a1411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_c39bdaae-6c8f-463e-975d-b9595aa0cb51" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4a74cf5f-7e18-402a-b491-d4959d1a1411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eedb8265-a2d6-4495-9356-d79de06bf0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_68086bd5-34af-4f45-8eec-fb196211411e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_eedb8265-a2d6-4495-9356-d79de06bf0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_c2442209-729b-42ff-9c35-01729eaa1514" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_68086bd5-34af-4f45-8eec-fb196211411e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_c2442209-729b-42ff-9c35-01729eaa1514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_797253aa-2cbe-47c0-956f-7653703696f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_68086bd5-34af-4f45-8eec-fb196211411e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_797253aa-2cbe-47c0-956f-7653703696f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="mo-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f05be8e4-bac5-4b57-9b58-67d7d39e621b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88520983-cd37-4e5e-9cb4-ff61fae1f8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f05be8e4-bac5-4b57-9b58-67d7d39e621b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88520983-cd37-4e5e-9cb4-ff61fae1f8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7d78eeec-0926-4a45-8490-d9358d7c1a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88520983-cd37-4e5e-9cb4-ff61fae1f8f4" xlink:to="loc_us-gaap_ProfitLoss_7d78eeec-0926-4a45-8490-d9358d7c1a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88520983-cd37-4e5e-9cb4-ff61fae1f8f4" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9e9c6250-f55c-4d70-96ec-cecb793eab42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9e9c6250-f55c-4d70-96ec-cecb793eab42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8700ca11-81ce-471d-9dca-150e08ce5273" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_8700ca11-81ce-471d-9dca-150e08ce5273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_bbd51303-30e4-4588-a671-80e52396b46e" xlink:href="mo-20221231.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:to="loc_mo_IncomeLossFromEquityInvestments_bbd51303-30e4-4588-a671-80e52396b46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_1f84a61c-3e44-4983-bcf7-35d050c6ae57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_1f84a61c-3e44-4983-bcf7-35d050c6ae57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_13559dc7-685d-4ee6-acdc-7b899032f41e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_13559dc7-685d-4ee6-acdc-7b899032f41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_560d3b86-5b6b-40c6-9f97-e05bd8a6e5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_560d3b86-5b6b-40c6-9f97-e05bd8a6e5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a8942013-736c-4d50-8d5e-d0847f39ded7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_a8942013-736c-4d50-8d5e-d0847f39ded7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_908f4e96-0012-4207-98b7-e9f04566cbdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_908f4e96-0012-4207-98b7-e9f04566cbdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_f72709c1-cd87-4c6c-9f52-f9597a333546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_908f4e96-0012-4207-98b7-e9f04566cbdf" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_f72709c1-cd87-4c6c-9f52-f9597a333546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b470e5e8-4900-42fe-883f-61395210c376" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_908f4e96-0012-4207-98b7-e9f04566cbdf" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b470e5e8-4900-42fe-883f-61395210c376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_fc845a88-1dc1-4a24-be71-7e46827c80d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_908f4e96-0012-4207-98b7-e9f04566cbdf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_fc845a88-1dc1-4a24-be71-7e46827c80d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_61bbd499-a45e-4dcf-ba92-fa26980b1d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_908f4e96-0012-4207-98b7-e9f04566cbdf" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_61bbd499-a45e-4dcf-ba92-fa26980b1d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_eddc35bb-f5ce-4de8-99de-14b2657bc22d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_908f4e96-0012-4207-98b7-e9f04566cbdf" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_eddc35bb-f5ce-4de8-99de-14b2657bc22d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncreaseDecreaseInSettlementPayable_3f3504b5-40eb-48a9-948a-ce7d140cccd2" xlink:href="mo-20221231.xsd#mo_IncreaseDecreaseInSettlementPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_908f4e96-0012-4207-98b7-e9f04566cbdf" xlink:to="loc_mo_IncreaseDecreaseInSettlementPayable_3f3504b5-40eb-48a9-948a-ce7d140cccd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_237284d6-a0b8-48fa-b495-6d5ed63dca6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitContributions"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitContributions_237284d6-a0b8-48fa-b495-6d5ed63dca6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_dd7f2ef3-bd1b-4782-bf09-b39623d59ceb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash_dd7f2ef3-bd1b-4782-bf09-b39623d59ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_e2926f65-1f82-4d1f-83d3-74741475bb66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c9dc294a-ab88-4e91-ad87-e80170d0fe82" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_e2926f65-1f82-4d1f-83d3-74741475bb66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_62ac8b87-f023-4573-aab3-098630df10ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_88520983-cd37-4e5e-9cb4-ff61fae1f8f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_62ac8b87-f023-4573-aab3-098630df10ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2f31e284-a03e-416f-aade-b71b469c6cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f05be8e4-bac5-4b57-9b58-67d7d39e621b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2f31e284-a03e-416f-aade-b71b469c6cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5d97238c-f597-4f79-aeef-5d6dffa69ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2f31e284-a03e-416f-aade-b71b469c6cd5" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5d97238c-f597-4f79-aeef-5d6dffa69ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ProceedsFromSaleOfCommercializationRights_76b766c6-7889-4cb9-b826-1168098a233c" xlink:href="mo-20221231.xsd#mo_ProceedsFromSaleOfCommercializationRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2f31e284-a03e-416f-aade-b71b469c6cd5" xlink:to="loc_mo_ProceedsFromSaleOfCommercializationRights_76b766c6-7889-4cb9-b826-1168098a233c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_db29688f-8581-4b73-87b8-8dfe122392e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2f31e284-a03e-416f-aade-b71b469c6cd5" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_db29688f-8581-4b73-87b8-8dfe122392e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d4bb2460-0686-423d-a3f8-19b87c4abb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2f31e284-a03e-416f-aade-b71b469c6cd5" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_d4bb2460-0686-423d-a3f8-19b87c4abb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1703768-fe77-4984-b5f9-27cdb0d97757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2f31e284-a03e-416f-aade-b71b469c6cd5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e1703768-fe77-4984-b5f9-27cdb0d97757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a0a4b89-bd55-4187-9ed0-b92aaeb86f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f05be8e4-bac5-4b57-9b58-67d7d39e621b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a0a4b89-bd55-4187-9ed0-b92aaeb86f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_07268cd3-5086-4e4e-8a9b-255e1fe5ba9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a0a4b89-bd55-4187-9ed0-b92aaeb86f51" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_07268cd3-5086-4e4e-8a9b-255e1fe5ba9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_12c98265-e033-45e0-807d-8ab7df3b1920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a0a4b89-bd55-4187-9ed0-b92aaeb86f51" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_12c98265-e033-45e0-807d-8ab7df3b1920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2b749cdc-e7ad-4777-b27a-2308f0fff9f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a0a4b89-bd55-4187-9ed0-b92aaeb86f51" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_2b749cdc-e7ad-4777-b27a-2308f0fff9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_18a07c2d-e87a-416a-bdbd-9db4f3ee13ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a0a4b89-bd55-4187-9ed0-b92aaeb86f51" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_18a07c2d-e87a-416a-bdbd-9db4f3ee13ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_12fd4926-e492-4f9d-9512-9e5132fdc5f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a0a4b89-bd55-4187-9ed0-b92aaeb86f51" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_12fd4926-e492-4f9d-9512-9e5132fdc5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_d074fdc7-4ad4-4efb-bc51-72a7e81a9373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a0a4b89-bd55-4187-9ed0-b92aaeb86f51" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_d074fdc7-4ad4-4efb-bc51-72a7e81a9373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_8f5da4c1-f909-43cb-b825-ea5b8c4799c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a0a4b89-bd55-4187-9ed0-b92aaeb86f51" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_8f5da4c1-f909-43cb-b825-ea5b8c4799c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_59e82d07-148e-4f73-a9a5-be4893352d70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a0a4b89-bd55-4187-9ed0-b92aaeb86f51" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_59e82d07-148e-4f73-a9a5-be4893352d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c49cef1f-896e-43f7-9f3b-1b0d56b32ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0a0a4b89-bd55-4187-9ed0-b92aaeb86f51" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c49cef1f-896e-43f7-9f3b-1b0d56b32ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_01b1acf7-ab36-4795-8f76-b9dc870f7b13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f05be8e4-bac5-4b57-9b58-67d7d39e621b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_01b1acf7-ab36-4795-8f76-b9dc870f7b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5badc9a6-c83a-4866-bfe6-9df27776fc03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_01b1acf7-ab36-4795-8f76-b9dc870f7b13" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5badc9a6-c83a-4866-bfe6-9df27776fc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_29b31763-93e9-4c37-bf11-419247935972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_01b1acf7-ab36-4795-8f76-b9dc870f7b13" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_29b31763-93e9-4c37-bf11-419247935972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dcb5062c-a963-40d4-8efd-2d0a995fdc1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_01b1acf7-ab36-4795-8f76-b9dc870f7b13" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dcb5062c-a963-40d4-8efd-2d0a995fdc1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_b5d2c91f-2427-499c-b4ad-4f130dbafab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f05be8e4-bac5-4b57-9b58-67d7d39e621b" xlink:to="loc_us-gaap_SupplementalCashFlowElementsAbstract_b5d2c91f-2427-499c-b4ad-4f130dbafab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_29c3c135-186b-4b98-b622-3c20cd4f3c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_b5d2c91f-2427-499c-b4ad-4f130dbafab2" xlink:to="loc_us-gaap_InterestPaidNet_29c3c135-186b-4b98-b622-3c20cd4f3c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_d0fa7038-469c-4ae9-ab08-fe75e2734dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_b5d2c91f-2427-499c-b4ad-4f130dbafab2" xlink:to="loc_us-gaap_IncomeTaxesPaid_d0fa7038-469c-4ae9-ab08-fe75e2734dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_616e560b-0d37-4db9-a3f7-b7485a75870f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_b5d2c91f-2427-499c-b4ad-4f130dbafab2" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_616e560b-0d37-4db9-a3f7-b7485a75870f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash_a5f56061-658a-4083-a606-756f43158bd9" xlink:href="mo-20221231.xsd#mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_616e560b-0d37-4db9-a3f7-b7485a75870f" xlink:to="loc_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash_a5f56061-658a-4083-a606-756f43158bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_321f1c3d-89eb-440f-93a7-3c0b8bd315ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f05be8e4-bac5-4b57-9b58-67d7d39e621b" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_321f1c3d-89eb-440f-93a7-3c0b8bd315ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_92ca330a-77c3-4590-bde9-37c9d4d887db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f05be8e4-bac5-4b57-9b58-67d7d39e621b" xlink:to="loc_us-gaap_RestrictedCashCurrent_92ca330a-77c3-4590-bde9-37c9d4d887db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_54bb84c6-e8cd-49d6-b88e-73dc71a47055" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f05be8e4-bac5-4b57-9b58-67d7d39e621b" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_54bb84c6-e8cd-49d6-b88e-73dc71a47055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6660fc91-2eb2-4638-bc67-3ce1d3aa26e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f05be8e4-bac5-4b57-9b58-67d7d39e621b" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6660fc91-2eb2-4638-bc67-3ce1d3aa26e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="mo-20221231.xsd#ConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a14b40d8-4a1b-43e1-ad00-33793dc4d821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5c4005f2-309a-4a23-9edb-0c6287c4a503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a14b40d8-4a1b-43e1-ad00-33793dc4d821" xlink:to="loc_us-gaap_StatementTable_5c4005f2-309a-4a23-9edb-0c6287c4a503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f3f9027f-95ca-4c4c-be41-e243ebcfc90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5c4005f2-309a-4a23-9edb-0c6287c4a503" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f3f9027f-95ca-4c4c-be41-e243ebcfc90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f3f9027f-95ca-4c4c-be41-e243ebcfc90c" xlink:to="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5ec4e640-c130-4151-90e8-a98c55eff1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:to="loc_us-gaap_CommonStockMember_5ec4e640-c130-4151-90e8-a98c55eff1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7da176fa-5d4a-48ef-a709-8c7172501800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7da176fa-5d4a-48ef-a709-8c7172501800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_31cc23a2-6c9e-4d2d-85ea-6eb7e8d838da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:to="loc_us-gaap_RetainedEarningsMember_31cc23a2-6c9e-4d2d-85ea-6eb7e8d838da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b31430-34f6-4566-9e95-5fd25a2f9962" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_85b31430-34f6-4566-9e95-5fd25a2f9962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_1d64e305-e975-4f77-8eba-8b7544783091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:to="loc_us-gaap_TreasuryStockMember_1d64e305-e975-4f77-8eba-8b7544783091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_805d729b-6727-4c1b-b34a-5f891c6f252e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f63fc6b2-ae8a-4af3-9744-ca6234b8c70f" xlink:to="loc_us-gaap_NoncontrollingInterestMember_805d729b-6727-4c1b-b34a-5f891c6f252e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f529eac3-fa18-471c-9502-4095fed28b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5c4005f2-309a-4a23-9edb-0c6287c4a503" xlink:to="loc_us-gaap_StatementLineItems_f529eac3-fa18-471c-9502-4095fed28b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f529eac3-fa18-471c-9502-4095fed28b71" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_786bfb3e-469e-41f5-8f6c-51b424314104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_786bfb3e-469e-41f5-8f6c-51b424314104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_99e59f60-3deb-406a-80d2-056029f9f2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest_99e59f60-3deb-406a-80d2-056029f9f2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f52dbd51-6297-4e22-886e-750a69550d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f52dbd51-6297-4e22-886e-750a69550d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_583285c1-6062-48b3-9f33-dbb3aaada5cf" xlink:href="mo-20221231.xsd#mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet_583285c1-6062-48b3-9f33-dbb3aaada5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_5ce6492c-8ddf-4172-92c3-c3f68e64f174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_DividendsCommonStockCash_5ce6492c-8ddf-4172-92c3-c3f68e64f174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_33e26a10-66aa-4b00-861a-49ee3f9a72a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_33e26a10-66aa-4b00-861a-49ee3f9a72a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_1bd70d21-3145-4cec-b653-b0d4e50408fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_StockholdersEquityOther_1bd70d21-3145-4cec-b653-b0d4e50408fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2f18139b-7c89-444c-ae83-abbf3f16398a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_723b8ceb-fdd9-4fa4-95a4-85f4b4e5a503" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2f18139b-7c89-444c-ae83-abbf3f16398a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="mo-20221231.xsd#ConsolidatedStatementsofStockholdersEquityDeficitParenthetical"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_21206e70-e290-459a-91d4-fd8084663ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_feefd73d-8d68-489a-bb87-819a8691e511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_21206e70-e290-459a-91d4-fd8084663ec0" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_feefd73d-8d68-489a-bb87-819a8691e511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentation" xlink:type="simple" xlink:href="mo-20221231.xsd#BackgroundandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a832b5be-3da2-4afe-84fb-8c743436125a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_34c9c7f4-0e3b-40c4-88af-3855b8c6f4f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a832b5be-3da2-4afe-84fb-8c743436125a" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_34c9c7f4-0e3b-40c4-88af-3855b8c6f4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="mo-20221231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fe808e5b-a34d-4084-8473-2ce273662e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_73cc2f05-a394-4740-bb69-c42258044bce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe808e5b-a34d-4084-8473-2ce273662e5a" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_73cc2f05-a394-4740-bb69-c42258044bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomers" xlink:type="simple" xlink:href="mo-20221231.xsd#RevenuesfromContractswithCustomers"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomers" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6d1a2b8c-6dcd-4e8f-8eb4-42988ec77176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_bdc91c6b-784c-4351-bcf4-a74aa9af3bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6d1a2b8c-6dcd-4e8f-8eb4-42988ec77176" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_bdc91c6b-784c-4351-bcf4-a74aa9af3bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnet" xlink:type="simple" xlink:href="mo-20221231.xsd#GoodwillandOtherIntangibleAssetsnet"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_db9828cd-ebd3-457e-ac32-3533bdc8e9f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_723ce132-2ca8-4490-b39c-b20df0a5603c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_db9828cd-ebd3-457e-ac32-3533bdc8e9f5" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_723ce132-2ca8-4490-b39c-b20df0a5603c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecurities" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecurities"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_188ad9c8-e347-440f-98d8-79f843643ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTextBlock_4346e283-e7c6-492b-bf2f-d20ca3be8694" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_188ad9c8-e347-440f-98d8-79f843643ee6" xlink:to="loc_us-gaap_InvestmentTextBlock_4346e283-e7c6-492b-bf2f-d20ca3be8694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstruments" xlink:type="simple" xlink:href="mo-20221231.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f2d931df-025b-4646-880b-f863d90e96be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_af40c70e-3de1-4b65-ab72-d3cc16542dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f2d931df-025b-4646-880b-f863d90e96be" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_af40c70e-3de1-4b65-ab72-d3cc16542dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangements" xlink:type="simple" xlink:href="mo-20221231.xsd#ShortTermBorrowingsandBorrowingArrangements"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ae97b1a1-d930-4f5b-835d-40ab1c357164" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTextBlock_e908d1f6-3af9-44c3-9d56-041d60546c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ae97b1a1-d930-4f5b-835d-40ab1c357164" xlink:to="loc_us-gaap_ShortTermDebtTextBlock_e908d1f6-3af9-44c3-9d56-041d60546c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongTermDebt" xlink:type="simple" xlink:href="mo-20221231.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c189ecf8-02fe-47c0-aa40-ac2fb51c41c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtTextBlock_92365501-f456-4646-a431-aa4c46a72fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c189ecf8-02fe-47c0-aa40-ac2fb51c41c7" xlink:to="loc_us-gaap_LongTermDebtTextBlock_92365501-f456-4646-a431-aa4c46a72fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CapitalStock" xlink:type="simple" xlink:href="mo-20221231.xsd#CapitalStock"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CapitalStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d1652674-d8cf-4d85-847a-52cd1784416e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c6a3ea73-d735-42d2-80af-ad9e208a794f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d1652674-d8cf-4d85-847a-52cd1784416e" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c6a3ea73-d735-42d2-80af-ad9e208a794f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/StockPlans" xlink:type="simple" xlink:href="mo-20221231.xsd#StockPlans"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/StockPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a94a519a-b302-4bc8-86a0-2cabc2873693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1916883c-f7de-4918-a321-e24260108818" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a94a519a-b302-4bc8-86a0-2cabc2873693" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_1916883c-f7de-4918-a321-e24260108818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsperShare" xlink:type="simple" xlink:href="mo-20221231.xsd#EarningsperShare"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/EarningsperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7ac30dc1-afc2-4f10-b529-a741a8165e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_5e68c225-c84a-4e5d-9ff7-d07a7c9a9f23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7ac30dc1-afc2-4f10-b529-a741a8165e87" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_5e68c225-c84a-4e5d-9ff7-d07a7c9a9f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLosses" xlink:type="simple" xlink:href="mo-20221231.xsd#OtherComprehensiveEarningsLosses"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5188fa72-8dda-4025-85fd-471af79965c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_22a28359-078e-45aa-8523-51af4f7b001d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5188fa72-8dda-4025-85fd-471af79965c1" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_22a28359-078e-45aa-8523-51af4f7b001d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxes" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_79ea512b-8858-4d46-bdf3-c7d52ff4af52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_095b1b41-95ef-4233-86d6-44a86ccf74c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_79ea512b-8858-4d46-bdf3-c7d52ff4af52" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_095b1b41-95ef-4233-86d6-44a86ccf74c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReporting" xlink:type="simple" xlink:href="mo-20221231.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_79ebc595-050c-4635-beae-faae1227b332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_8c308588-b396-4cb1-a595-25eedefc4a98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_79ebc595-050c-4635-beae-faae1227b332" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_8c308588-b396-4cb1-a595-25eedefc4a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlans" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlans"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_79a83ba1-fb89-4910-8005-019e50083e4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_f6737078-ddd6-4e9f-8a37-98415b2768d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_79a83ba1-fb89-4910-8005-019e50083e4e" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock_f6737078-ddd6-4e9f-8a37-98415b2768d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AdditionalInformation" xlink:type="simple" xlink:href="mo-20221231.xsd#AdditionalInformation"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AdditionalInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_385ddd3b-67b0-4c06-b8e6-a302c2498904" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_11215c55-656b-48db-8578-83f78a37e9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_385ddd3b-67b0-4c06-b8e6-a302c2498904" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_11215c55-656b-48db-8578-83f78a37e9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/Contingencies" xlink:type="simple" xlink:href="mo-20221231.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a7b8b91d-1769-4f66-a971-45226947e7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_be84e1a1-ca88-4374-9ecd-276c9067daaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a7b8b91d-1769-4f66-a971-45226947e7ed" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_be84e1a1-ca88-4374-9ecd-276c9067daaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy" xlink:type="simple" xlink:href="mo-20221231.xsd#SummaryofSignificantAccountingPoliciesPolicy"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_52c1f147-1033-456e-b8da-9798e260e870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_52c1f147-1033-456e-b8da-9798e260e870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1f506461-5b77-40ae-8791-bda8c8ab5e85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_1f506461-5b77-40ae-8791-bda8c8ab5e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock_7e22a925-eef1-499f-9f4e-55b54691b572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock_7e22a925-eef1-499f-9f4e-55b54691b572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_d4b298d4-f727-4c3f-b93a-ace1f5d2a065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_d4b298d4-f727-4c3f-b93a-ace1f5d2a065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_5013104f-34bd-4916-9283-0d72f631fc99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_5013104f-34bd-4916-9283-0d72f631fc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock_e8d09b4c-6375-4256-8281-d26f43de0295" xlink:href="mo-20221231.xsd#mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock_e8d09b4c-6375-4256-8281-d26f43de0295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EnvironmentalCostsPolicy_d0c67152-7502-49cc-9bd1-1cac8852592a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EnvironmentalCostsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_EnvironmentalCostsPolicy_d0c67152-7502-49cc-9bd1-1cac8852592a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_fd2691a0-8189-4e8b-ac26-93a270592263" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_fd2691a0-8189-4e8b-ac26-93a270592263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_9a48a0f6-0335-466d-b05d-827cf6f8955e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_9a48a0f6-0335-466d-b05d-827cf6f8955e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_d90080f0-0f99-4e62-8845-19f453867ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_d90080f0-0f99-4e62-8845-19f453867ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_a1b2bca7-2f61-46d9-b8b0-253115ee68e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_a1b2bca7-2f61-46d9-b8b0-253115ee68e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_7498d9c4-159a-48bf-9676-7d74a982a67a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_7498d9c4-159a-48bf-9676-7d74a982a67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_affbe4ab-ff01-4bbd-8e15-873d42e66507" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock_affbe4ab-ff01-4bbd-8e15-873d42e66507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_0db5de1c-030a-4e50-b201-907261da6a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_0db5de1c-030a-4e50-b201-907261da6a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingCostsPolicyTextBlock_7e16a7b2-e2de-4832-9df7-39597677f7be" xlink:href="mo-20221231.xsd#mo_MarketingCostsPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_mo_MarketingCostsPolicyTextBlock_7e16a7b2-e2de-4832-9df7-39597677f7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0710d17c-3c45-44f1-b626-fd2cc46dd0af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_0710d17c-3c45-44f1-b626-fd2cc46dd0af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_90d33e18-81cb-413c-8061-675d57243572" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_90d33e18-81cb-413c-8061-675d57243572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CashDiscountsPolicyTextBlock_4da25d25-3b76-4500-b99d-ce98d293d6f7" xlink:href="mo-20221231.xsd#mo_CashDiscountsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_mo_CashDiscountsPolicyTextBlock_4da25d25-3b76-4500-b99d-ce98d293d6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock_830fe068-1bbf-47d1-b53f-690d55babd4b" xlink:href="mo-20221231.xsd#mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock_830fe068-1bbf-47d1-b53f-690d55babd4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock_1732e4cf-5bc7-42da-b6ca-2c2d29fccea5" xlink:href="mo-20221231.xsd#mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8c080bff-f7ae-422e-996c-c4d7a274c917" xlink:to="loc_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock_1732e4cf-5bc7-42da-b6ca-2c2d29fccea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="mo-20221231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_09794440-c509-4252-8676-2159f7f2d4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_50a9e3b4-ed83-4d75-85d7-31eeb170e15e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_09794440-c509-4252-8676-2159f7f2d4cf" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_50a9e3b4-ed83-4d75-85d7-31eeb170e15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetTables" xlink:type="simple" xlink:href="mo-20221231.xsd#GoodwillandOtherIntangibleAssetsnetTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f37c8b3-bb45-4a61-92de-40f30684fe8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_b7d899a6-4cb0-4e06-8ec6-2f599991c67c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f37c8b3-bb45-4a61-92de-40f30684fe8e" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_b7d899a6-4cb0-4e06-8ec6-2f599991c67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_1d07da53-6bdd-430a-ad47-00528f5bc6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f37c8b3-bb45-4a61-92de-40f30684fe8e" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_1d07da53-6bdd-430a-ad47-00528f5bc6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3265798c-98f2-439a-9dc6-115df02197ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f37c8b3-bb45-4a61-92de-40f30684fe8e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_3265798c-98f2-439a-9dc6-115df02197ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesTables" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f96bfd8e-16f8-4956-8884-298c1267caf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTableTextBlock_69061e52-c709-4637-8ce7-9ba7eb3dc55c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f96bfd8e-16f8-4956-8884-298c1267caf8" xlink:to="loc_us-gaap_InvestmentTableTextBlock_69061e52-c709-4637-8ce7-9ba7eb3dc55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_84d39ce3-eada-46ea-96e4-adb969f0ea32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f96bfd8e-16f8-4956-8884-298c1267caf8" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_84d39ce3-eada-46ea-96e4-adb969f0ea32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_3f711506-83d4-4390-97e9-e06d89c522e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f96bfd8e-16f8-4956-8884-298c1267caf8" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_3f711506-83d4-4390-97e9-e06d89c522e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="mo-20221231.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ec392d81-009f-4b15-835b-4a509f7378e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_aec91f15-b1a2-4f52-9ada-6c09eeb390ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ec392d81-009f-4b15-835b-4a509f7378e4" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_aec91f15-b1a2-4f52-9ada-6c09eeb390ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_7493784b-bf68-4c2f-9776-95722dabd972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ec392d81-009f-4b15-835b-4a509f7378e4" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_7493784b-bf68-4c2f-9776-95722dabd972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongtermDebtTables" xlink:type="simple" xlink:href="mo-20221231.xsd#LongtermDebtTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/LongtermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7dac4be4-55fc-4a06-94a6-6ce7db5f38af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e253d3c7-ae56-4b80-ab01-5897988720dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7dac4be4-55fc-4a06-94a6-6ce7db5f38af" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_e253d3c7-ae56-4b80-ab01-5897988720dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_77c26084-8244-4c4c-b917-7e4135ce4e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7dac4be4-55fc-4a06-94a6-6ce7db5f38af" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_77c26084-8244-4c4c-b917-7e4135ce4e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CapitalStockTables" xlink:type="simple" xlink:href="mo-20221231.xsd#CapitalStockTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CapitalStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8f8b1a66-ae0e-483b-b900-55791753a00c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_ce259b98-7888-4f9c-9f53-c96e8b1810e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8f8b1a66-ae0e-483b-b900-55791753a00c" xlink:to="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_ce259b98-7888-4f9c-9f53-c96e8b1810e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_ccdfdb7f-c1eb-4f88-94a5-8b96e744f018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8f8b1a66-ae0e-483b-b900-55791753a00c" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_ccdfdb7f-c1eb-4f88-94a5-8b96e744f018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/StockPlansTables" xlink:type="simple" xlink:href="mo-20221231.xsd#StockPlansTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/StockPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_675e2517-c72b-4495-82f8-cd19cf99de0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_79fe405e-5342-4efe-8139-4199608e5d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_675e2517-c72b-4495-82f8-cd19cf99de0a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_79fe405e-5342-4efe-8139-4199608e5d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsperShareTables" xlink:type="simple" xlink:href="mo-20221231.xsd#EarningsperShareTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/EarningsperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_81b7c664-2711-4520-9ba1-101bd44f7a0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_68724e62-b120-4fdf-8b4a-4f6fba64ff0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_81b7c664-2711-4520-9ba1-101bd44f7a0b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_68724e62-b120-4fdf-8b4a-4f6fba64ff0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningslossesTables" xlink:type="simple" xlink:href="mo-20221231.xsd#OtherComprehensiveEarningslossesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningslossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8c9b6102-6f27-4373-8605-ef58d00ac278" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_27553632-7585-40c6-9472-332af6612a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8c9b6102-6f27-4373-8605-ef58d00ac278" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_27553632-7585-40c6-9472-332af6612a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_f9daeaf2-4fd6-4647-89c9-e0f03ec7cba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8c9b6102-6f27-4373-8605-ef58d00ac278" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock_f9daeaf2-4fd6-4647-89c9-e0f03ec7cba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_eb03021f-c752-430b-9847-97a87bc3ae1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_2d17bc68-8604-4354-b700-83d17c3ff0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb03021f-c752-430b-9847-97a87bc3ae1d" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_2d17bc68-8604-4354-b700-83d17c3ff0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_17f187ba-1fbb-4e00-ad78-4df5661103b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb03021f-c752-430b-9847-97a87bc3ae1d" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock_17f187ba-1fbb-4e00-ad78-4df5661103b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_84c06fc2-9563-453b-ac2c-6c063ef3aad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb03021f-c752-430b-9847-97a87bc3ae1d" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_84c06fc2-9563-453b-ac2c-6c063ef3aad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4fbab7ee-4a38-4f24-80b7-9eebdfe689f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb03021f-c752-430b-9847-97a87bc3ae1d" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4fbab7ee-4a38-4f24-80b7-9eebdfe689f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_9a52dbc6-58dd-4dff-ade7-8bea6bda92a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SummaryOfValuationAllowanceTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb03021f-c752-430b-9847-97a87bc3ae1d" xlink:to="loc_us-gaap_SummaryOfValuationAllowanceTextBlock_9a52dbc6-58dd-4dff-ade7-8bea6bda92a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="mo-20221231.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_63fc8d86-8098-4331-9b81-7177569152b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_47d93cf9-b93b-4453-8021-8708974a19c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_63fc8d86-8098-4331-9b81-7177569152b5" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_47d93cf9-b93b-4453-8021-8708974a19c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_e41b20c9-944a-45aa-a3bf-ce0183e31df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_63fc8d86-8098-4331-9b81-7177569152b5" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_e41b20c9-944a-45aa-a3bf-ce0183e31df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock_3ae6ee63-f74c-466b-936b-0930f5257ea4" xlink:href="mo-20221231.xsd#mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_63fc8d86-8098-4331-9b81-7177569152b5" xlink:to="loc_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock_3ae6ee63-f74c-466b-936b-0930f5257ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock_c500b21e-8431-4915-9e9a-e30a946974aa" xlink:href="mo-20221231.xsd#mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_63fc8d86-8098-4331-9b81-7177569152b5" xlink:to="loc_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock_c500b21e-8431-4915-9e9a-e30a946974aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansTables" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f8ca8d1d-0b0d-4399-a37e-4026e106a9de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_ccb6e2cf-c039-4676-8289-f858aabb97c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f8ca8d1d-0b0d-4399-a37e-4026e106a9de" xlink:to="loc_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock_ccb6e2cf-c039-4676-8289-f858aabb97c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_bd19864d-f3f5-4a8b-bf93-535e1ad7471b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f8ca8d1d-0b0d-4399-a37e-4026e106a9de" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock_bd19864d-f3f5-4a8b-bf93-535e1ad7471b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_254b6457-e3d0-496f-a18e-b15a55d32883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAssumptionsUsedTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f8ca8d1d-0b0d-4399-a37e-4026e106a9de" xlink:to="loc_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock_254b6457-e3d0-496f-a18e-b15a55d32883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_1fdf9010-56cb-465b-9256-d8d13fff6f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f8ca8d1d-0b0d-4399-a37e-4026e106a9de" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_1fdf9010-56cb-465b-9256-d8d13fff6f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock_5a2bf9d7-dd05-451a-aaaa-10c8ffeef368" xlink:href="mo-20221231.xsd#mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f8ca8d1d-0b0d-4399-a37e-4026e106a9de" xlink:to="loc_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock_5a2bf9d7-dd05-451a-aaaa-10c8ffeef368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_eb0a46d1-180d-4f34-8652-2ac99ae872fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f8ca8d1d-0b0d-4399-a37e-4026e106a9de" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_eb0a46d1-180d-4f34-8652-2ac99ae872fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_03a483ca-068b-45be-8d66-470bb568f249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f8ca8d1d-0b0d-4399-a37e-4026e106a9de" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_03a483ca-068b-45be-8d66-470bb568f249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_cae15bec-3bd8-43e2-bb26-ba9000f23c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f8ca8d1d-0b0d-4399-a37e-4026e106a9de" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_cae15bec-3bd8-43e2-bb26-ba9000f23c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_005c9521-abda-41a5-8529-f20790870ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f8ca8d1d-0b0d-4399-a37e-4026e106a9de" xlink:to="loc_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock_005c9521-abda-41a5-8529-f20790870ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AdditionalInformationTables" xlink:type="simple" xlink:href="mo-20221231.xsd#AdditionalInformationTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AdditionalInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c7aa947a-dabb-4148-ac5d-532d0c16e305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_a9073c8c-c8ef-444a-8e6a-44351ae5ee67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c7aa947a-dabb-4148-ac5d-532d0c16e305" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_a9073c8c-c8ef-444a-8e6a-44351ae5ee67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock_0b701959-ab30-4c56-a7de-7ad9703c17e5" xlink:href="mo-20221231.xsd#mo_ScheduleofValuationandQualifyingAccountsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c7aa947a-dabb-4148-ac5d-532d0c16e305" xlink:to="loc_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock_0b701959-ab30-4c56-a7de-7ad9703c17e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesTables" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesTables"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bab7b93c-497f-4946-b1af-451aaa0f5d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_18ad45f2-a0c6-4cef-bb50-b87e6535bce6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bab7b93c-497f-4946-b1af-451aaa0f5d1f" xlink:to="loc_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock_18ad45f2-a0c6-4cef-bb50-b87e6535bce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BackgroundandBasisofPresentationBackgroundNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c7e2fa32-1637-47c7-807a-f7d6e193b995" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f7ac8d89-e2c2-4271-aaf8-6d76f4e5b0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c7e2fa32-1637-47c7-807a-f7d6e193b995" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f7ac8d89-e2c2-4271-aaf8-6d76f4e5b0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_09616f3b-2544-459a-b8a8-c78879c9f5c6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f7ac8d89-e2c2-4271-aaf8-6d76f4e5b0bc" xlink:to="loc_srt_OwnershipAxis_09616f3b-2544-459a-b8a8-c78879c9f5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e0445891-966f-4b3d-9825-228df8611564" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_09616f3b-2544-459a-b8a8-c78879c9f5c6" xlink:to="loc_srt_OwnershipDomain_e0445891-966f-4b3d-9825-228df8611564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HorizonMember_63c9e996-fb43-4f72-95b5-9293c85d390e" xlink:href="mo-20221231.xsd#mo_HorizonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_e0445891-966f-4b3d-9825-228df8611564" xlink:to="loc_mo_HorizonMember_63c9e996-fb43-4f72-95b5-9293c85d390e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HelixInnovationsLLCMember_ffa302a0-c5a8-4f4d-ae94-4156c74e5fd3" xlink:href="mo-20221231.xsd#mo_HelixInnovationsLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_e0445891-966f-4b3d-9825-228df8611564" xlink:to="loc_mo_HelixInnovationsLLCMember_ffa302a0-c5a8-4f4d-ae94-4156c74e5fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5d030334-ce87-4cfa-afd6-47605fc1f42a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f7ac8d89-e2c2-4271-aaf8-6d76f4e5b0bc" xlink:to="loc_dei_LegalEntityAxis_5d030334-ce87-4cfa-afd6-47605fc1f42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a621bed1-436c-4e6f-8810-8a0b065c0e37" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_5d030334-ce87-4cfa-afd6-47605fc1f42a" xlink:to="loc_dei_EntityDomain_a621bed1-436c-4e6f-8810-8a0b065c0e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_9678de6e-da90-492f-b427-1d38f69628b7" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a621bed1-436c-4e6f-8810-8a0b065c0e37" xlink:to="loc_mo_PhilipMorrisUSAMember_9678de6e-da90-492f-b427-1d38f69628b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JTIUHMember_31faa5ef-5af0-48b8-99e3-3ef8bc64337e" xlink:href="mo-20221231.xsd#mo_JTIUHMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a621bed1-436c-4e6f-8810-8a0b065c0e37" xlink:to="loc_mo_JTIUHMember_31faa5ef-5af0-48b8-99e3-3ef8bc64337e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_f7ac8d89-e2c2-4271-aaf8-6d76f4e5b0bc" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberOfLeveragedLeasesRemaining_0e5e69cc-33c9-4cac-8cc4-d8ae3fe8822b" xlink:href="mo-20221231.xsd#mo_NumberOfLeveragedLeasesRemaining"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_mo_NumberOfLeveragedLeasesRemaining_0e5e69cc-33c9-4cac-8cc4-d8ae3fe8822b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OwnershipPercentageInConsolidatedSubsidiary_b6368340-950d-4e2a-84b7-46130f717d93" xlink:href="mo-20221231.xsd#mo_OwnershipPercentageInConsolidatedSubsidiary"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_mo_OwnershipPercentageInConsolidatedSubsidiary_b6368340-950d-4e2a-84b7-46130f717d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_0f5c6789-40cb-4268-b126-e51fafbf04ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_0f5c6789-40cb-4268-b126-e51fafbf04ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_22a15e5b-93d3-4c62-b9d8-9841d3813af5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_22a15e5b-93d3-4c62-b9d8-9841d3813af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_46fdf731-1095-495d-95d8-fc6e1d31ebc8" xlink:href="mo-20221231.xsd#mo_NoncontrollingInterestRemainingInterestPurchasedByParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_mo_NoncontrollingInterestRemainingInterestPurchasedByParent_46fdf731-1095-495d-95d8-fc6e1d31ebc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_b63285fd-e920-4e00-85b3-66f641abaf77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e643176b-4f2e-4e14-99b0-3eeeeff35ca9" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_b63285fd-e920-4e00-85b3-66f641abaf77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f66e47ef-fb2a-4ceb-9ea7-892ce1091435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5f5d897f-9c63-477d-a3c1-b7d4184253a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f66e47ef-fb2a-4ceb-9ea7-892ce1091435" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5f5d897f-9c63-477d-a3c1-b7d4184253a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8d8dcab2-f2f2-456f-a16d-be42905a68f7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5f5d897f-9c63-477d-a3c1-b7d4184253a9" xlink:to="loc_dei_LegalEntityAxis_8d8dcab2-f2f2-456f-a16d-be42905a68f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ae0c6b07-f92e-4d7a-8586-ba9c7f3afef5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8d8dcab2-f2f2-456f-a16d-be42905a68f7" xlink:to="loc_dei_EntityDomain_ae0c6b07-f92e-4d7a-8586-ba9c7f3afef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USSTCMember_15273ca1-b68d-4835-b28b-ec511bc48be0" xlink:href="mo-20221231.xsd#mo_USSTCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ae0c6b07-f92e-4d7a-8586-ba9c7f3afef5" xlink:to="loc_mo_USSTCMember_15273ca1-b68d-4835-b28b-ec511bc48be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c37b456f-9749-4199-a21e-eba48cb7bc75" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5f5d897f-9c63-477d-a3c1-b7d4184253a9" xlink:to="loc_srt_RangeAxis_c37b456f-9749-4199-a21e-eba48cb7bc75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d056e7f3-319e-47f3-a808-92a25430aeaf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c37b456f-9749-4199-a21e-eba48cb7bc75" xlink:to="loc_srt_RangeMember_d056e7f3-319e-47f3-a808-92a25430aeaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_527427dc-9474-4166-b20c-8c4dbb70cd6e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d056e7f3-319e-47f3-a808-92a25430aeaf" xlink:to="loc_srt_MaximumMember_527427dc-9474-4166-b20c-8c4dbb70cd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eae4dd6c-443e-42d0-98c1-72a3f771e5de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5f5d897f-9c63-477d-a3c1-b7d4184253a9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eae4dd6c-443e-42d0-98c1-72a3f771e5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bcdd95b7-df96-4d23-9a42-0810c3cc6e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_eae4dd6c-443e-42d0-98c1-72a3f771e5de" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bcdd95b7-df96-4d23-9a42-0810c3cc6e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_9d9c7ed7-2662-4373-ac9a-59b64379bc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bcdd95b7-df96-4d23-9a42-0810c3cc6e7a" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_9d9c7ed7-2662-4373-ac9a-59b64379bc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_d65d256a-c911-4142-9a2f-8f3f961d9fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_bcdd95b7-df96-4d23-9a42-0810c3cc6e7a" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_d65d256a-c911-4142-9a2f-8f3f961d9fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5f5d897f-9c63-477d-a3c1-b7d4184253a9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_45851694-daf0-4445-a70f-b5e29a7167ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_45851694-daf0-4445-a70f-b5e29a7167ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_29c2b655-23d4-4dd2-b68b-ff8b6f41e85c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_29c2b655-23d4-4dd2-b68b-ff8b6f41e85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PercentageOfLIFOInventory_5a7704ce-dcad-40cd-a94d-0ae3cb1dd28a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PercentageOfLIFOInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_us-gaap_PercentageOfLIFOInventory_5a7704ce-dcad-40cd-a94d-0ae3cb1dd28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue_205182de-e14e-4b54-aa82-43b1f4481cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue_205182de-e14e-4b54-aa82-43b1f4481cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevenueContractDuration_94d6705c-f9fa-4d5f-bed9-2a2f8bbc146c" xlink:href="mo-20221231.xsd#mo_RevenueContractDuration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_mo_RevenueContractDuration_94d6705c-f9fa-4d5f-bed9-2a2f8bbc146c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_98de34f5-43a0-4d3e-b01b-83202ce02bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_7534fe00-a8d8-4852-b6ed-faf9f093a589" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_98de34f5-43a0-4d3e-b01b-83202ce02bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#RevenuesfromContractswithCustomersNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fb5098bb-9c88-4170-b1a9-4239059cc6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_fa43f737-ca53-46d2-a7ad-5c551ef0f687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fb5098bb-9c88-4170-b1a9-4239059cc6eb" xlink:to="loc_us-gaap_ContractWithCustomerLiability_fa43f737-ca53-46d2-a7ad-5c551ef0f687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_4ce4a0ed-a72e-4149-8ce0-a52ad8f11023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfTiming"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fb5098bb-9c88-4170-b1a9-4239059cc6eb" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfTiming_4ce4a0ed-a72e-4149-8ce0-a52ad8f11023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_f5c3a815-a946-4dc4-bce9-514154a7e945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_fb5098bb-9c88-4170-b1a9-4239059cc6eb" xlink:to="loc_us-gaap_ReceivablesNetCurrent_f5c3a815-a946-4dc4-bce9-514154a7e945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6173f3f2-6975-4a96-a341-0e0cdaf89d13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_d7390936-535e-4f21-9744-356e09e1d300" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6173f3f2-6975-4a96-a341-0e0cdaf89d13" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_d7390936-535e-4f21-9744-356e09e1d300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_279357a9-832e-420f-9bc5-9df8ef88d912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d7390936-535e-4f21-9744-356e09e1d300" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_279357a9-832e-420f-9bc5-9df8ef88d912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2015a96a-3151-4f14-919c-b8e5a3678884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_279357a9-832e-420f-9bc5-9df8ef88d912" xlink:to="loc_us-gaap_SegmentDomain_2015a96a-3151-4f14-919c-b8e5a3678884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_2f5e832a-3438-4a80-acc6-ed46dc8e0587" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2015a96a-3151-4f14-919c-b8e5a3678884" xlink:to="loc_mo_SmokeableProductsSegmentMember_2f5e832a-3438-4a80-acc6-ed46dc8e0587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_113d92c1-f0d4-4204-8c1d-a15f01562881" xlink:href="mo-20221231.xsd#mo_OralTobaccoSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2015a96a-3151-4f14-919c-b8e5a3678884" xlink:to="loc_mo_OralTobaccoSegmentMember_113d92c1-f0d4-4204-8c1d-a15f01562881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_0d6a3a01-8ebc-4a25-a868-c7393d44bf7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2015a96a-3151-4f14-919c-b8e5a3678884" xlink:to="loc_us-gaap_AllOtherSegmentsMember_0d6a3a01-8ebc-4a25-a868-c7393d44bf7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_6ca224ef-00d7-4009-a18c-8eb2d3e9532c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_d7390936-535e-4f21-9744-356e09e1d300" xlink:to="loc_us-gaap_GoodwillLineItems_6ca224ef-00d7-4009-a18c-8eb2d3e9532c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c9b8ed28-b289-4d26-a340-c61bcda9994a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_6ca224ef-00d7-4009-a18c-8eb2d3e9532c" xlink:to="loc_us-gaap_Goodwill_c9b8ed28-b289-4d26-a340-c61bcda9994a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_980cfa6e-2305-45df-8a5a-401c192718c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_6ca224ef-00d7-4009-a18c-8eb2d3e9532c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_980cfa6e-2305-45df-8a5a-401c192718c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6585f01c-972c-4ca5-ba1c-a6caae311357" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_457fa46c-8958-4178-a470-82df70db9a90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6585f01c-972c-4ca5-ba1c-a6caae311357" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_457fa46c-8958-4178-a470-82df70db9a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3b2d9476-4881-4f33-b818-e11646ca8255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6585f01c-972c-4ca5-ba1c-a6caae311357" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3b2d9476-4881-4f33-b818-e11646ca8255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_72402c64-e9e0-4139-9176-9c441976656d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6585f01c-972c-4ca5-ba1c-a6caae311357" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_72402c64-e9e0-4139-9176-9c441976656d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8946065a-1cf4-47c7-868e-00e2439c8dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6585f01c-972c-4ca5-ba1c-a6caae311357" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8946065a-1cf4-47c7-868e-00e2439c8dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#GoodwillandOtherIntangibleAssetsnetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6837978f-b2cb-4d0b-aa18-d1df38faed59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6837978f-b2cb-4d0b-aa18-d1df38faed59" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cd6ad5d5-bf1a-48a5-9077-6f75cfdce9ec" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_srt_RangeAxis_cd6ad5d5-bf1a-48a5-9077-6f75cfdce9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b72ce94f-b92b-431c-89d3-abc20d8a0b81" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cd6ad5d5-bf1a-48a5-9077-6f75cfdce9ec" xlink:to="loc_srt_RangeMember_b72ce94f-b92b-431c-89d3-abc20d8a0b81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_6311235d-22ee-4a11-9be5-b27b74a1d358" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b72ce94f-b92b-431c-89d3-abc20d8a0b81" xlink:to="loc_srt_WeightedAverageMember_6311235d-22ee-4a11-9be5-b27b74a1d358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IntangibleAssetsAxis_5eb2b668-04f4-4d3b-a6c0-b7a227544da5" xlink:href="mo-20221231.xsd#mo_IntangibleAssetsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_mo_IntangibleAssetsAxis_5eb2b668-04f4-4d3b-a6c0-b7a227544da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IntangibleAssetsDomain_abb344f3-1fa7-4474-b423-48254e9c30d1" xlink:href="mo-20221231.xsd#mo_IntangibleAssetsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_IntangibleAssetsAxis_5eb2b668-04f4-4d3b-a6c0-b7a227544da5" xlink:to="loc_mo_IntangibleAssetsDomain_abb344f3-1fa7-4474-b423-48254e9c30d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefiniteLivedIntangibleAssetsMember_069c4efc-d000-45f6-9153-c2aa11c6f4c5" xlink:href="mo-20221231.xsd#mo_DefiniteLivedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_IntangibleAssetsDomain_abb344f3-1fa7-4474-b423-48254e9c30d1" xlink:to="loc_mo_DefiniteLivedIntangibleAssetsMember_069c4efc-d000-45f6-9153-c2aa11c6f4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_333eb948-46d0-46b9-aba2-0a3f70a07928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_333eb948-46d0-46b9-aba2-0a3f70a07928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c929e92a-234c-4196-990d-6bd9124c8d5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_333eb948-46d0-46b9-aba2-0a3f70a07928" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c929e92a-234c-4196-990d-6bd9124c8d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MiddletonMember_30e62954-643e-4030-843e-850a292d4d5d" xlink:href="mo-20221231.xsd#mo_MiddletonMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c929e92a-234c-4196-990d-6bd9124c8d5b" xlink:to="loc_mo_MiddletonMember_30e62954-643e-4030-843e-850a292d4d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTIncMember_22c3b5f4-97ee-4cf9-a642-3be5aee025fa" xlink:href="mo-20221231.xsd#mo_USTIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c929e92a-234c-4196-990d-6bd9124c8d5b" xlink:to="loc_mo_USTIncMember_22c3b5f4-97ee-4cf9-a642-3be5aee025fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_1a313bfc-c825-45df-9570-ca59c5ec1c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_1a313bfc-c825-45df-9570-ca59c5ec1c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_0be056dd-27d6-43ad-863f-76330be2539a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_1a313bfc-c825-45df-9570-ca59c5ec1c2e" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_0be056dd-27d6-43ad-863f-76330be2539a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_34314c6a-b860-44eb-a483-5c8fd3fa7b07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_0be056dd-27d6-43ad-863f-76330be2539a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_34314c6a-b860-44eb-a483-5c8fd3fa7b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_faca1f01-389e-4774-b8c0-7d5098c53fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_faca1f01-389e-4774-b8c0-7d5098c53fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fd6066f7-0199-45c7-a6f2-74bb27dde93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_faca1f01-389e-4774-b8c0-7d5098c53fce" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fd6066f7-0199-45c7-a6f2-74bb27dde93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IQOSTobaccoHeatingSystemMember_242f0dfb-da2b-46df-ba54-c3d27f434ffc" xlink:href="mo-20221231.xsd#mo_IQOSTobaccoHeatingSystemMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_fd6066f7-0199-45c7-a6f2-74bb27dde93f" xlink:to="loc_mo_IQOSTobaccoHeatingSystemMember_242f0dfb-da2b-46df-ba54-c3d27f434ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_ab7c1e9b-8e56-4908-8c67-48588ea7a862" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_srt_StatementScenarioAxis_ab7c1e9b-8e56-4908-8c67-48588ea7a862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_22475dda-f229-4c24-ac1f-bf5e3dc8185f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_ab7c1e9b-8e56-4908-8c67-48588ea7a862" xlink:to="loc_srt_ScenarioUnspecifiedDomain_22475dda-f229-4c24-ac1f-bf5e3dc8185f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_297a634a-d791-45e5-85db-8f365b279e66" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_22475dda-f229-4c24-ac1f-bf5e3dc8185f" xlink:to="loc_srt_ScenarioForecastMember_297a634a-d791-45e5-85db-8f365b279e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32dd42af-fd0d-48b7-8e7b-c9dcdaf17845" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32dd42af-fd0d-48b7-8e7b-c9dcdaf17845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2ae7cdf4-82a1-4ebd-98e3-908478862113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_32dd42af-fd0d-48b7-8e7b-c9dcdaf17845" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2ae7cdf4-82a1-4ebd-98e3-908478862113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TrademarksCopenhagenMember_34a88a9f-10aa-4515-9bce-2216b396618d" xlink:href="mo-20221231.xsd#mo_TrademarksCopenhagenMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2ae7cdf4-82a1-4ebd-98e3-908478862113" xlink:to="loc_mo_TrademarksCopenhagenMember_34a88a9f-10aa-4515-9bce-2216b396618d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TrademarksSkoalMember_516ad6c3-04c3-4f57-a72f-92fc77d8a040" xlink:href="mo-20221231.xsd#mo_TrademarksSkoalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2ae7cdf4-82a1-4ebd-98e3-908478862113" xlink:to="loc_mo_TrademarksSkoalMember_516ad6c3-04c3-4f57-a72f-92fc77d8a040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TrademarksMSTMember_4550aac7-74c8-42ac-a89e-51b58449960b" xlink:href="mo-20221231.xsd#mo_TrademarksMSTMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2ae7cdf4-82a1-4ebd-98e3-908478862113" xlink:to="loc_mo_TrademarksMSTMember_4550aac7-74c8-42ac-a89e-51b58449960b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_671a42aa-d23a-4bd2-b34c-e665f9a8083d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedTrademarks_8be9deb9-4f98-4948-bcd4-de9b63176ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedTrademarks"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_IndefiniteLivedTrademarks_8be9deb9-4f98-4948-bcd4-de9b63176ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_bdccc977-25cb-4122-bbcc-ad022c4e651b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_bdccc977-25cb-4122-bbcc-ad022c4e651b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_36bfb705-57c3-44df-89db-86d52c85e5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_36bfb705-57c3-44df-89db-86d52c85e5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_9664aebc-fc80-4259-9d53-1d0fdf5c36d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_9664aebc-fc80-4259-9d53-1d0fdf5c36d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_65a98741-8717-4cd3-a786-393f77c4ea77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_65a98741-8717-4cd3-a786-393f77c4ea77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_42bd00a9-c760-4852-b420-c082cc2c0cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_42bd00a9-c760-4852-b420-c082cc2c0cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_049055bd-bbfc-4943-8f5c-2977e38230ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_049055bd-bbfc-4943-8f5c-2977e38230ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a75109b8-44c9-49c1-990b-4f502862280a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_a75109b8-44c9-49c1-990b-4f502862280a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment_eb326de5-5f88-41f1-89fd-d6d48f7d5f84" xlink:href="mo-20221231.xsd#mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment_eb326de5-5f88-41f1-89fd-d6d48f7d5f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment_361460ea-c7f2-4515-a647-274199ec2bb4" xlink:href="mo-20221231.xsd#mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment_361460ea-c7f2-4515-a647-274199ec2bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate_cb97104c-6de0-4fe8-b11f-244d84027e85" xlink:href="mo-20221231.xsd#mo_DisposalGroupPurchaseAgreementEffectiveInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate_cb97104c-6de0-4fe8-b11f-244d84027e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ProceedsFromSaleOfRightsUnderAnAgreement_393d50bf-728b-4297-bb89-cde50330e7b1" xlink:href="mo-20221231.xsd#mo_ProceedsFromSaleOfRightsUnderAnAgreement"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_ProceedsFromSaleOfRightsUnderAnAgreement_393d50bf-728b-4297-bb89-cde50330e7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement_9d11bec1-9592-41e9-bad0-211768e226ff" xlink:href="mo-20221231.xsd#mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement_9d11bec1-9592-41e9-bad0-211768e226ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupReceivable_a600df79-9a9c-4918-b4ed-22d9844becaa" xlink:href="mo-20221231.xsd#mo_DisposalGroupReceivable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_DisposalGroupReceivable_a600df79-9a9c-4918-b4ed-22d9844becaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupInterestReceivable_4b71cf0d-9f42-4223-9878-896c345eca4e" xlink:href="mo-20221231.xsd#mo_DisposalGroupInterestReceivable"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_mo_DisposalGroupInterestReceivable_4b71cf0d-9f42-4223-9878-896c345eca4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome_3ef1ca13-976d-46a3-b23a-2e7d1074c2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome_3ef1ca13-976d-46a3-b23a-2e7d1074c2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_4897dfb6-3ed9-4a0e-8dee-4d9c6d25d683" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_4897dfb6-3ed9-4a0e-8dee-4d9c6d25d683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_3cf52487-fd15-4b7c-a85d-8ff1ad25b9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_3cf52487-fd15-4b7c-a85d-8ff1ad25b9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f1413a76-1e06-4013-84ed-5945688a3d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_0611013f-d198-4fc2-b14f-d42575bf2d24" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f1413a76-1e06-4013-84ed-5945688a3d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cbda10de-654e-4ff9-bdad-6144edfa5552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_991c94b1-55a5-45bf-b337-80e185ebdcc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cbda10de-654e-4ff9-bdad-6144edfa5552" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_991c94b1-55a5-45bf-b337-80e185ebdcc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_05232a65-d13d-47d4-8a3e-e2d28a23c2a4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_991c94b1-55a5-45bf-b337-80e185ebdcc6" xlink:to="loc_dei_LegalEntityAxis_05232a65-d13d-47d4-8a3e-e2d28a23c2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_78d4d696-26df-445a-9da3-5f3ec75201cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_05232a65-d13d-47d4-8a3e-e2d28a23c2a4" xlink:to="loc_dei_EntityDomain_78d4d696-26df-445a-9da3-5f3ec75201cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JTIUHMember_2d036d1d-b1ba-434d-8079-5ce519cecbe8" xlink:href="mo-20221231.xsd#mo_JTIUHMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_78d4d696-26df-445a-9da3-5f3ec75201cd" xlink:to="loc_mo_JTIUHMember_2d036d1d-b1ba-434d-8079-5ce519cecbe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_9995d773-227a-432e-a84b-6483637be773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_991c94b1-55a5-45bf-b337-80e185ebdcc6" xlink:to="loc_us-gaap_GoodwillLineItems_9995d773-227a-432e-a84b-6483637be773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_2ea42802-e02b-4305-a9d9-328370151f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9995d773-227a-432e-a84b-6483637be773" xlink:to="loc_us-gaap_GoodwillRollForward_2ea42802-e02b-4305-a9d9-328370151f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f6477bd1-347a-4610-8e17-609f6335d46c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2ea42802-e02b-4305-a9d9-328370151f02" xlink:to="loc_us-gaap_Goodwill_f6477bd1-347a-4610-8e17-609f6335d46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_a6581a1d-a498-43d2-82e8-7fa9e14a39d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2ea42802-e02b-4305-a9d9-328370151f02" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_a6581a1d-a498-43d2-82e8-7fa9e14a39d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_9c0bd866-475e-4ec0-b7d9-0e05632edde5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2ea42802-e02b-4305-a9d9-328370151f02" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_9c0bd866-475e-4ec0-b7d9-0e05632edde5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3a436b8e-c9cb-4ddf-a240-9a2eacf9f4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_2ea42802-e02b-4305-a9d9-328370151f02" xlink:to="loc_us-gaap_Goodwill_3a436b8e-c9cb-4ddf-a240-9a2eacf9f4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:href="mo-20221231.xsd#mo_IntangibleAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9995d773-227a-432e-a84b-6483637be773" xlink:to="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e044c322-f5ba-4a9e-b24e-923696f416f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_e044c322-f5ba-4a9e-b24e-923696f416f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired_b2e7e0c1-b515-4fe7-978a-155afffd8bac" xlink:href="mo-20221231.xsd#mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:to="loc_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired_b2e7e0c1-b515-4fe7-978a-155afffd8bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit_5ef6f459-3d39-4e37-b525-b05929b3a7ee" xlink:href="mo-20221231.xsd#mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:to="loc_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit_5ef6f459-3d39-4e37-b525-b05929b3a7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_022f19cb-19e0-48d0-b92d-b7757545e131" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_022f19cb-19e0-48d0-b92d-b7757545e131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c7185f5d-9ebc-4b27-8686-b173827f5a79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_IntangibleAssetsRollForward_4c1cc6db-2bca-4768-8249-a5a663b9b731" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_c7185f5d-9ebc-4b27-8686-b173827f5a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_4bb5151e-3ddd-4a6e-8526-3d8aaf2d628b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_9995d773-227a-432e-a84b-6483637be773" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1_4bb5151e-3ddd-4a6e-8526-3d8aaf2d628b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_b35c5f26-e4b6-45f7-adb5-8b006c732d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_15f15780-cd06-4cd0-b5df-4946a81331fa" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_b35c5f26-e4b6-45f7-adb5-8b006c732d0b" xlink:to="loc_mo_InvestmentsTable_15f15780-cd06-4cd0-b5df-4946a81331fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_5e9aad1a-5a8e-4c76-9ef3-5c68f7735448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_15f15780-cd06-4cd0-b5df-4946a81331fa" xlink:to="loc_us-gaap_FinancialInstrumentAxis_5e9aad1a-5a8e-4c76-9ef3-5c68f7735448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a5f353a7-ed34-4f34-8f7e-541ae78bbed3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_5e9aad1a-5a8e-4c76-9ef3-5c68f7735448" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a5f353a7-ed34-4f34-8f7e-541ae78bbed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_4bb899bb-735d-4712-8274-8d36fa150174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a5f353a7-ed34-4f34-8f7e-541ae78bbed3" xlink:to="loc_us-gaap_CommonStockMember_4bb899bb-735d-4712-8274-8d36fa150174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fdbcb9b-2535-4d3f-95aa-0367f27c52aa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_15f15780-cd06-4cd0-b5df-4946a81331fa" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fdbcb9b-2535-4d3f-95aa-0367f27c52aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_51bbc9d3-e292-45a7-8f27-6f08e1cc71ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9fdbcb9b-2535-4d3f-95aa-0367f27c52aa" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_51bbc9d3-e292-45a7-8f27-6f08e1cc71ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_6283ff7e-b8bb-4a27-99f9-d8a3b772cef8" xlink:href="mo-20221231.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_51bbc9d3-e292-45a7-8f27-6f08e1cc71ca" xlink:to="loc_mo_ABInBevMember_6283ff7e-b8bb-4a27-99f9-d8a3b772cef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_f6f9fcf6-08fc-42ba-aea9-dc8097412ae9" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_51bbc9d3-e292-45a7-8f27-6f08e1cc71ca" xlink:to="loc_mo_JUULMember_f6f9fcf6-08fc-42ba-aea9-dc8097412ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_e13d252c-9c4c-4cc3-b33a-34e5847fca52" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_51bbc9d3-e292-45a7-8f27-6f08e1cc71ca" xlink:to="loc_mo_CronosGroupInc.Member_e13d252c-9c4c-4cc3-b33a-34e5847fca52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_15f15780-cd06-4cd0-b5df-4946a81331fa" xlink:to="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_52b90fc8-adb6-477c-9fd5-d890512ec691" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:to="loc_us-gaap_EquityMethodInvestments_52b90fc8-adb6-477c-9fd5-d890512ec691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_c35bec39-4507-4bf9-852a-66cc571d473c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:to="loc_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent_c35bec39-4507-4bf9-852a-66cc571d473c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_dc8a3c98-59a3-4639-880b-8b9224b25263" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:to="loc_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights_dc8a3c98-59a3-4639-880b-8b9224b25263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_de6eae68-8fd3-4bf8-ad8f-0c90f07a6f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:to="loc_us-gaap_Investments_de6eae68-8fd3-4bf8-ad8f-0c90f07a6f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentsFixedPreemptiveRights_9b04cc9d-82ae-49da-bd7d-fd2926e73e15" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentsFixedPreemptiveRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_f89ca9ef-9305-4f0f-b8cc-8dd06d2afce8" xlink:to="loc_mo_EquityMethodInvestmentsFixedPreemptiveRights_9b04cc9d-82ae-49da-bd7d-fd2926e73e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_bcf72b67-5992-4539-af13-b2e0151363b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_2d6c0050-9ed8-4da0-8537-31c3ab3e0fda" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_bcf72b67-5992-4539-af13-b2e0151363b6" xlink:to="loc_mo_InvestmentsTable_2d6c0050-9ed8-4da0-8537-31c3ab3e0fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_53cc01e7-bd84-47ce-8142-a2bbf25cda5e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_2d6c0050-9ed8-4da0-8537-31c3ab3e0fda" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_53cc01e7-bd84-47ce-8142-a2bbf25cda5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6fd207bb-f5a8-4736-a0e1-035b49614190" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_53cc01e7-bd84-47ce-8142-a2bbf25cda5e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6fd207bb-f5a8-4736-a0e1-035b49614190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_7ae97980-1a26-4db4-bb7b-d440e18147be" xlink:href="mo-20221231.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6fd207bb-f5a8-4736-a0e1-035b49614190" xlink:to="loc_mo_ABInBevMember_7ae97980-1a26-4db4-bb7b-d440e18147be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_267778ac-cbb8-4b1c-8375-f4679bca91d9" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6fd207bb-f5a8-4736-a0e1-035b49614190" xlink:to="loc_mo_CronosGroupInc.Member_267778ac-cbb8-4b1c-8375-f4679bca91d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_ed59375b-25ce-49f1-837d-38cf70c531f8" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6fd207bb-f5a8-4736-a0e1-035b49614190" xlink:to="loc_mo_JUULMember_ed59375b-25ce-49f1-837d-38cf70c531f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_388e95a7-94f3-4d59-b611-c7b17ff5f873" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_2d6c0050-9ed8-4da0-8537-31c3ab3e0fda" xlink:to="loc_mo_InvestmentsLineItems_388e95a7-94f3-4d59-b611-c7b17ff5f873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1295969f-3d78-4145-aa6c-10c8397d724a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_388e95a7-94f3-4d59-b611-c7b17ff5f873" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_1295969f-3d78-4145-aa6c-10c8397d724a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_dbce8791-aac7-4049-bed3-43d267b355c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_388e95a7-94f3-4d59-b611-c7b17ff5f873" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_dbce8791-aac7-4049-bed3-43d267b355c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_f8383afd-cca8-4d7b-9b3d-62f70a038529" xlink:href="mo-20221231.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_388e95a7-94f3-4d59-b611-c7b17ff5f873" xlink:to="loc_mo_IncomeLossFromEquityInvestments_f8383afd-cca8-4d7b-9b3d-62f70a038529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2ed1141e-1a2e-4830-8dbc-8207b94cc7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_71774361-401a-41ca-a61f-5a99ce450388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_2ed1141e-1a2e-4830-8dbc-8207b94cc7d5" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_71774361-401a-41ca-a61f-5a99ce450388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0e202dec-9c6f-4f9c-afa4-c35fdf6b4662" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_71774361-401a-41ca-a61f-5a99ce450388" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0e202dec-9c6f-4f9c-afa4-c35fdf6b4662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_b383e449-0cc4-490b-9e74-2641973d0eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_0e202dec-9c6f-4f9c-afa4-c35fdf6b4662" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_b383e449-0cc4-490b-9e74-2641973d0eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_c7b8c85c-62a2-4205-9ab5-17814eb38a78" xlink:href="mo-20221231.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_b383e449-0cc4-490b-9e74-2641973d0eb6" xlink:to="loc_mo_ABInBevMember_c7b8c85c-62a2-4205-9ab5-17814eb38a78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULAndCronosMember_fe699ab1-cfd7-4ed5-a166-8f5f2c82dc23" xlink:href="mo-20221231.xsd#mo_JUULAndCronosMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_b383e449-0cc4-490b-9e74-2641973d0eb6" xlink:to="loc_mo_JUULAndCronosMember_fe699ab1-cfd7-4ed5-a166-8f5f2c82dc23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_71774361-401a-41ca-a61f-5a99ce450388" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_66aac08a-ddb5-4985-817e-6f96c0cc14df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_66aac08a-ddb5-4985-817e-6f96c0cc14df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ea5c9141-b0be-467e-8f8c-c5f7aaa0bb7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_GrossProfit_ea5c9141-b0be-467e-8f8c-c5f7aaa0bb7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_efea1a74-e114-42ef-bb0c-a3e043645a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_efea1a74-e114-42ef-bb0c-a3e043645a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a1c1ab6a-d9d9-46e7-b3b8-13d981cedd82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_ProfitLoss_a1c1ab6a-d9d9-46e7-b3b8-13d981cedd82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3be3b521-5a3b-4c34-a701-a6756b37448f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3be3b521-5a3b-4c34-a701-a6756b37448f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_7f2aae82-0a4c-4fdd-b3da-87ceb3961526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_AssetsCurrent_7f2aae82-0a4c-4fdd-b3da-87ceb3961526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_1969b70a-a525-4c58-80d0-943dec145491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_AssetsNoncurrent_1969b70a-a525-4c58-80d0-943dec145491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2f35978f-146d-41c4-85cd-c7d96553311d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_LiabilitiesCurrent_2f35978f-146d-41c4-85cd-c7d96553311d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_48a42b1a-a019-491c-96df-cd3e82f7a9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_48a42b1a-a019-491c-96df-cd3e82f7a9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_eccd328a-d79f-45a2-9332-b98788ce453c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue_eccd328a-d79f-45a2-9332-b98788ce453c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_45644697-bfb2-4ad8-9512-8a5f25f4c2e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_c20d1fa0-68eb-4482-b026-8306af68b350" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_45644697-bfb2-4ad8-9512-8a5f25f4c2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a9db85f6-1b06-4f86-ab85-4d91f7dec256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_903d2cc2-18de-4712-a8c4-4d6ad006f4ac" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a9db85f6-1b06-4f86-ab85-4d91f7dec256" xlink:to="loc_mo_InvestmentsTable_903d2cc2-18de-4712-a8c4-4d6ad006f4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b9a25da-7254-492c-8c39-2693881c79bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_903d2cc2-18de-4712-a8c4-4d6ad006f4ac" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b9a25da-7254-492c-8c39-2693881c79bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a16ce12e-e0ad-4f0b-8efb-84c40b22b996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6b9a25da-7254-492c-8c39-2693881c79bb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a16ce12e-e0ad-4f0b-8efb-84c40b22b996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_bffb1842-459d-4d31-a8d8-32ab70e64dab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a16ce12e-e0ad-4f0b-8efb-84c40b22b996" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_bffb1842-459d-4d31-a8d8-32ab70e64dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5590cd45-03af-4a08-aa20-14cb6d288fbb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_903d2cc2-18de-4712-a8c4-4d6ad006f4ac" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5590cd45-03af-4a08-aa20-14cb6d288fbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e367a03e-8cbd-4eab-908b-2149cbf3ab30" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_5590cd45-03af-4a08-aa20-14cb6d288fbb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e367a03e-8cbd-4eab-908b-2149cbf3ab30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_1c6665e6-7223-411c-af28-94cc0649413c" xlink:href="mo-20221231.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e367a03e-8cbd-4eab-908b-2149cbf3ab30" xlink:to="loc_mo_ABInBevMember_1c6665e6-7223-411c-af28-94cc0649413c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_903d2cc2-18de-4712-a8c4-4d6ad006f4ac" xlink:to="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9df40ef9-7fc5-4f97-b08d-fc92381f48f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_9df40ef9-7fc5-4f97-b08d-fc92381f48f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_8d024fb2-d6a4-492a-a329-86b06100a921" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedRestricted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted_8d024fb2-d6a4-492a-a329-86b06100a921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_8c712727-8745-4c5b-874a-f9de5eae974c" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_8c712727-8745-4c5b-874a-f9de5eae974c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_fe802c85-5e9a-4b8b-a6d7-658a6f9c76ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_fe802c85-5e9a-4b8b-a6d7-658a6f9c76ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_1687b123-c3fb-4229-93c3-d820e0b5b2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_us-gaap_EquityMethodInvestments_1687b123-c3fb-4229-93c3-d820e0b5b2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_6f433ea6-6f3d-494a-aecb-4881e7e563f0" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_6f433ea6-6f3d-494a-aecb-4881e7e563f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_7c58b3b2-e5b5-44e6-8642-a8a9dd768bef" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_7c58b3b2-e5b5-44e6-8642-a8a9dd768bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment_135116d0-196c-40c7-9110-3167a9f1d990" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_mo_EquityMethodInvestmentImpairment_135116d0-196c-40c7-9110-3167a9f1d990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_a98c0a25-e826-48b3-9e77-1cf5c321e063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_16fcb77c-769a-464f-b15e-a08245dc4077" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_a98c0a25-e826-48b3-9e77-1cf5c321e063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_3e7167e3-3939-4792-935d-a4901d372f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_c69aced7-b6c7-4ead-983b-21c1db6304ca" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_3e7167e3-3939-4792-935d-a4901d372f2b" xlink:to="loc_mo_InvestmentsTable_c69aced7-b6c7-4ead-983b-21c1db6304ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7d87688-7f6a-43f7-aaeb-fd24ed749f1e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_c69aced7-b6c7-4ead-983b-21c1db6304ca" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7d87688-7f6a-43f7-aaeb-fd24ed749f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_b335826d-f66c-4a54-ad12-c331e639366f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a7d87688-7f6a-43f7-aaeb-fd24ed749f1e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_b335826d-f66c-4a54-ad12-c331e639366f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_862de888-b937-4f24-9e3d-23a1d6a643d2" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_b335826d-f66c-4a54-ad12-c331e639366f" xlink:to="loc_mo_JUULMember_862de888-b937-4f24-9e3d-23a1d6a643d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_c69aced7-b6c7-4ead-983b-21c1db6304ca" xlink:to="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_4ef1a24f-a7cf-4115-8c53-5e110d1ba59b" xlink:href="mo-20221231.xsd#mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue_4ef1a24f-a7cf-4115-8c53-5e110d1ba59b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_9433d643-7ac4-40ae-afe7-56dc92e12e75" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_9433d643-7ac4-40ae-afe7-56dc92e12e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentOwnedBalancePercentage_f2123941-17d8-4d27-9532-9af859292764" xlink:href="mo-20221231.xsd#mo_InvestmentOwnedBalancePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_InvestmentOwnedBalancePercentage_f2123941-17d8-4d27-9532-9af859292764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_6bd4f793-fc49-4fdb-9e67-4b939f796bba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_6bd4f793-fc49-4fdb-9e67-4b939f796bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_ba71b2ee-4251-4759-af85-6a90230d52d7" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_ba71b2ee-4251-4759-af85-6a90230d52d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_09b67703-9514-4056-986c-9280fa8adf3c" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount_09b67703-9514-4056-986c-9280fa8adf3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_ee4c8fc2-39bd-47be-ac51-396cbce1c286" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_ee4c8fc2-39bd-47be-ac51-396cbce1c286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_3d39ef37-9f84-49af-8490-4e3e28c9a282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount_3d39ef37-9f84-49af-8490-4e3e28c9a282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_64817b73-0265-4415-9f45-670130897617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount_64817b73-0265-4415-9f45-670130897617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_eb962d3f-36e7-4ea5-a732-2e335164a1ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_eb962d3f-36e7-4ea5-a732-2e335164a1ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityInvestmentFairValueOption_3b2b99a5-6576-45e4-86d0-2d38af55447a" xlink:href="mo-20221231.xsd#mo_EquityInvestmentFairValueOption"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_mo_EquityInvestmentFairValueOption_3b2b99a5-6576-45e4-86d0-2d38af55447a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_d6330a28-eed7-4304-904e-18061c11d607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_e6dbd284-30b0-4503-9a0f-4e605b9aabb7" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_d6330a28-eed7-4304-904e-18061c11d607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TextBlockAbstract_301e5316-2fed-422b-9146-88c544c61cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TextBlockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_738ab5ea-9923-496f-8d23-a205739f6237" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TextBlockAbstract_301e5316-2fed-422b-9146-88c544c61cdf" xlink:to="loc_mo_InvestmentsTable_738ab5ea-9923-496f-8d23-a205739f6237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_cd1ba621-5a07-47b6-a001-cb4fce953759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_738ab5ea-9923-496f-8d23-a205739f6237" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_cd1ba621-5a07-47b6-a001-cb4fce953759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_98e10b52-b6b8-48be-aec5-3dd2fb7fa090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_cd1ba621-5a07-47b6-a001-cb4fce953759" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_98e10b52-b6b8-48be-aec5-3dd2fb7fa090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_723281c1-e561-47aa-b77a-d5390e5b94d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_98e10b52-b6b8-48be-aec5-3dd2fb7fa090" xlink:to="loc_us-gaap_EquitySecuritiesMember_723281c1-e561-47aa-b77a-d5390e5b94d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c39ffab-5311-4c52-9020-df686910b7ba" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_738ab5ea-9923-496f-8d23-a205739f6237" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c39ffab-5311-4c52-9020-df686910b7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_64271820-0223-4249-892a-409857d82d40" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_6c39ffab-5311-4c52-9020-df686910b7ba" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_64271820-0223-4249-892a-409857d82d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_a9bb9e77-8c45-4c29-9b2e-7d22227b6728" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_64271820-0223-4249-892a-409857d82d40" xlink:to="loc_mo_JUULMember_a9bb9e77-8c45-4c29-9b2e-7d22227b6728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_7fdc4b61-84b4-4f5d-810d-b7d719ff526d" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_738ab5ea-9923-496f-8d23-a205739f6237" xlink:to="loc_mo_InvestmentsLineItems_7fdc4b61-84b4-4f5d-810d-b7d719ff526d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a4ee84b6-d572-40ef-9f78-2b37410a2d78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_7fdc4b61-84b4-4f5d-810d-b7d719ff526d" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a4ee84b6-d572-40ef-9f78-2b37410a2d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_a872bede-33c2-4877-bf0e-c640e6f42521" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a4ee84b6-d572-40ef-9f78-2b37410a2d78" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_a872bede-33c2-4877-bf0e-c640e6f42521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_9c579fee-6711-42ce-87a3-84194a0cdc22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a4ee84b6-d572-40ef-9f78-2b37410a2d78" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_9c579fee-6711-42ce-87a3-84194a0cdc22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0f681333-22a6-4104-a84e-07c8ce031379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_a4ee84b6-d572-40ef-9f78-2b37410a2d78" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_0f681333-22a6-4104-a84e-07c8ce031379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f185104b-5bca-4023-8e10-0444df795d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_d58d9747-1437-4c98-bb79-121d1b956ed8" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f185104b-5bca-4023-8e10-0444df795d2d" xlink:to="loc_mo_InvestmentsTable_d58d9747-1437-4c98-bb79-121d1b956ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f541c11b-51e6-4c1b-9c10-f89a270264f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_d58d9747-1437-4c98-bb79-121d1b956ed8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f541c11b-51e6-4c1b-9c10-f89a270264f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_5efa0e88-27c5-4d46-875e-979e315e0db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f541c11b-51e6-4c1b-9c10-f89a270264f7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_5efa0e88-27c5-4d46-875e-979e315e0db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_07b47763-bf4f-4bfc-b56a-e82efd93aeff" xlink:href="mo-20221231.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5efa0e88-27c5-4d46-875e-979e315e0db3" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_07b47763-bf4f-4bfc-b56a-e82efd93aeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_826243c8-82a4-4179-bfd1-651f8ff7a212" xlink:href="mo-20221231.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_5efa0e88-27c5-4d46-875e-979e315e0db3" xlink:to="loc_mo_EquityContractWarrantMember_826243c8-82a4-4179-bfd1-651f8ff7a212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0d2c0e29-b690-4d34-a739-480be49756c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_d58d9747-1437-4c98-bb79-121d1b956ed8" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0d2c0e29-b690-4d34-a739-480be49756c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e6451fce-8497-46ee-a841-d174e71102cf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0d2c0e29-b690-4d34-a739-480be49756c3" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e6451fce-8497-46ee-a841-d174e71102cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_ed54d188-5838-4b41-b036-709e34b945ec" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e6451fce-8497-46ee-a841-d174e71102cf" xlink:to="loc_mo_CronosGroupInc.Member_ed54d188-5838-4b41-b036-709e34b945ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_d58d9747-1437-4c98-bb79-121d1b956ed8" xlink:to="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_70151f65-7f3f-4218-b491-2ce695cdf51f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_70151f65-7f3f-4218-b491-2ce695cdf51f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_6bc6f3d6-35fc-493c-9acd-f2bccea1d7f7" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentNumberofSharesOwnedCommon"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesOwnedCommon_6bc6f3d6-35fc-493c-9acd-f2bccea1d7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_1476b3de-c651-47b4-9fd4-db380a6c3e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_us-gaap_EquityMethodInvestments_1476b3de-c651-47b4-9fd4-db380a6c3e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_88d3fddb-5225-4c5f-b91c-b5fa14c56488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_88d3fddb-5225-4c5f-b91c-b5fa14c56488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_00f43e67-27bb-4144-a46d-5340c4a32fee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_00f43e67-27bb-4144-a46d-5340c4a32fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_c199153c-cb3d-4cca-98d5-e1ccada6b430" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_c199153c-cb3d-4cca-98d5-e1ccada6b430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_6b8f6611-d055-4142-9dee-c105ed5735a5" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue_6b8f6611-d055-4142-9dee-c105ed5735a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_773e4d12-faa2-4707-b3e2-5edf94139665" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity_773e4d12-faa2-4707-b3e2-5edf94139665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_5aa906a2-604b-4c06-8cd6-3eae58fdcf41" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentPricePerShareIfExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentPricePerShareIfExercised_5aa906a2-604b-4c06-8cd6-3eae58fdcf41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_005ad0e6-ce5e-46bc-af1f-58abe87e86f4" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase_005ad0e6-ce5e-46bc-af1f-58abe87e86f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_e1de752e-023d-45b6-bfb0-0754a2b0869e" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase_e1de752e-023d-45b6-bfb0-0754a2b0869e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentImpairment_6e8f9133-21ca-4416-9bbb-4cb75eda370a" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentImpairment"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_d08d4120-d727-4fef-b62c-fd89561750ce" xlink:to="loc_mo_EquityMethodInvestmentImpairment_6e8f9133-21ca-4416-9bbb-4cb75eda370a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#InvestmentsinEquitySecuritiesInvestmentinCronosDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cf268300-c1a2-4e48-bec1-01dd6e2f5434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fe3c68e-211a-464b-b26e-9dfa46497f81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cf268300-c1a2-4e48-bec1-01dd6e2f5434" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fe3c68e-211a-464b-b26e-9dfa46497f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_423cb457-f9a7-44ff-9f46-75efcf0d6c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fe3c68e-211a-464b-b26e-9dfa46497f81" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_423cb457-f9a7-44ff-9f46-75efcf0d6c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_61f16083-2c60-4ea2-96be-308c70dadfa4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_423cb457-f9a7-44ff-9f46-75efcf0d6c5c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_61f16083-2c60-4ea2-96be-308c70dadfa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractPreemptiveRIghtsMember_5a814469-050b-4a80-9dbc-bf86843b2f0c" xlink:href="mo-20221231.xsd#mo_EquityContractPreemptiveRIghtsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61f16083-2c60-4ea2-96be-308c70dadfa4" xlink:to="loc_mo_EquityContractPreemptiveRIghtsMember_5a814469-050b-4a80-9dbc-bf86843b2f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityContractWarrantMember_0d583b7b-6c64-459c-8ecc-97c49fcffbe0" xlink:href="mo-20221231.xsd#mo_EquityContractWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_61f16083-2c60-4ea2-96be-308c70dadfa4" xlink:to="loc_mo_EquityContractWarrantMember_0d583b7b-6c64-459c-8ecc-97c49fcffbe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_89e8c09b-d4ce-442f-bfb6-e0352c232167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8fe3c68e-211a-464b-b26e-9dfa46497f81" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_89e8c09b-d4ce-442f-bfb6-e0352c232167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_30f6940d-491d-4fd6-96cc-8ef96d8f2bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_89e8c09b-d4ce-442f-bfb6-e0352c232167" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_30f6940d-491d-4fd6-96cc-8ef96d8f2bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_93323a87-29d1-441b-8f60-2d8a1a55ddf5" xlink:href="mo-20221231.xsd#mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_89e8c09b-d4ce-442f-bfb6-e0352c232167" xlink:to="loc_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage_93323a87-29d1-441b-8f60-2d8a1a55ddf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_78dc07a3-40d7-4065-b5b9-c393393794c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_4161fe3f-d2d9-4c98-b783-12a57bea97b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfForeignCurrencyDerivativesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_78dc07a3-40d7-4065-b5b9-c393393794c1" xlink:to="loc_us-gaap_NumberOfForeignCurrencyDerivativesHeld_4161fe3f-d2d9-4c98-b783-12a57bea97b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_f06783ad-4b2d-4928-8a25-17af456aa9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_78dc07a3-40d7-4065-b5b9-c393393794c1" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_f06783ad-4b2d-4928-8a25-17af456aa9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#FinancialInstrumentsAggregateFairValueandCarryingValueDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d28c4ec9-b39d-44c7-9782-5dcd9cb8863b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_c9562505-d689-4427-b530-36601b74e032" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d28c4ec9-b39d-44c7-9782-5dcd9cb8863b" xlink:to="loc_us-gaap_DerivativeTable_c9562505-d689-4427-b530-36601b74e032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_43316a2f-f6ae-4037-bab0-58284c0af3e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c9562505-d689-4427-b530-36601b74e032" xlink:to="loc_us-gaap_DebtInstrumentAxis_43316a2f-f6ae-4037-bab0-58284c0af3e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_772284cb-30a9-46e6-9d1f-c0e0a8cd3011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_43316a2f-f6ae-4037-bab0-58284c0af3e5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_772284cb-30a9-46e6-9d1f-c0e0a8cd3011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_b45d726a-9fe0-4c48-a78d-9f969a16449a" xlink:href="mo-20221231.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_772284cb-30a9-46e6-9d1f-c0e0a8cd3011" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_b45d726a-9fe0-4c48-a78d-9f969a16449a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_9801d194-3e63-4266-b851-a54a0012217d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_c9562505-d689-4427-b530-36601b74e032" xlink:to="loc_us-gaap_DerivativeLineItems_9801d194-3e63-4266-b851-a54a0012217d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a2690d6c-44f2-42f3-956c-d9f6f93dc0d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9801d194-3e63-4266-b851-a54a0012217d" xlink:to="loc_us-gaap_LongTermDebt_a2690d6c-44f2-42f3-956c-d9f6f93dc0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_422bd899-5b9b-47d7-af07-5b091ef2307e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9801d194-3e63-4266-b851-a54a0012217d" xlink:to="loc_us-gaap_LongTermDebtFairValue_422bd899-5b9b-47d7-af07-5b091ef2307e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtAbstract_376b8c6c-9863-404e-ad4c-9f1af344b5b6" xlink:href="mo-20221231.xsd#mo_ForeignCurrencyDenominatedDebtAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_9801d194-3e63-4266-b851-a54a0012217d" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtAbstract_376b8c6c-9863-404e-ad4c-9f1af344b5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c334f50c-ef6c-4e34-92e1-067a3c096d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ForeignCurrencyDenominatedDebtAbstract_376b8c6c-9863-404e-ad4c-9f1af344b5b6" xlink:to="loc_us-gaap_LongTermDebt_c334f50c-ef6c-4e34-92e1-067a3c096d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_e7e9cc29-03b5-4aa4-be81-5c4ec7025cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ForeignCurrencyDenominatedDebtAbstract_376b8c6c-9863-404e-ad4c-9f1af344b5b6" xlink:to="loc_us-gaap_DebtInstrumentFairValue_e7e9cc29-03b5-4aa4-be81-5c4ec7025cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_57462086-2956-43ea-8b33-bb2b986e5bb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea6aec5a-3fb7-41ba-8d35-0eb7017fd644" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_57462086-2956-43ea-8b33-bb2b986e5bb8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea6aec5a-3fb7-41ba-8d35-0eb7017fd644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_81aba17d-a3aa-4b16-b1d4-4f3a3f3719fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea6aec5a-3fb7-41ba-8d35-0eb7017fd644" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_81aba17d-a3aa-4b16-b1d4-4f3a3f3719fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_74c10770-d1e1-4b59-8d43-f2f4bcbac991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_81aba17d-a3aa-4b16-b1d4-4f3a3f3719fd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_74c10770-d1e1-4b59-8d43-f2f4bcbac991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_6c26cbdc-7c8e-453d-990f-39b9cd9b5423" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_74c10770-d1e1-4b59-8d43-f2f4bcbac991" xlink:to="loc_us-gaap_ForeignExchangeContractMember_6c26cbdc-7c8e-453d-990f-39b9cd9b5423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ForeignCurrencyDenominatedDebtMember_d9f1d3a5-bc4f-47b5-a9f7-25275aeda585" xlink:href="mo-20221231.xsd#mo_ForeignCurrencyDenominatedDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_74c10770-d1e1-4b59-8d43-f2f4bcbac991" xlink:to="loc_mo_ForeignCurrencyDenominatedDebtMember_d9f1d3a5-bc4f-47b5-a9f7-25275aeda585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_386a676f-0c91-45ce-a673-88d27ad5ab04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea6aec5a-3fb7-41ba-8d35-0eb7017fd644" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_386a676f-0c91-45ce-a673-88d27ad5ab04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_dad88992-aa6d-46b0-9443-9b1034bd86af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_386a676f-0c91-45ce-a673-88d27ad5ab04" xlink:to="loc_us-gaap_HedgingRelationshipDomain_dad88992-aa6d-46b0-9443-9b1034bd86af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgingMember_6f1f413a-af40-419c-a04f-43e284be8bcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetInvestmentHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_dad88992-aa6d-46b0-9443-9b1034bd86af" xlink:to="loc_us-gaap_NetInvestmentHedgingMember_6f1f413a-af40-419c-a04f-43e284be8bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8769e279-3f88-4f4f-bef7-1998939e4194" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_ea6aec5a-3fb7-41ba-8d35-0eb7017fd644" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8769e279-3f88-4f4f-bef7-1998939e4194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_91728302-03ae-4600-b50e-e77e1225419e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8769e279-3f88-4f4f-bef7-1998939e4194" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax_91728302-03ae-4600-b50e-e77e1225419e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_e2c5a638-6daa-4a5b-b5f1-b057f2f766d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_8769e279-3f88-4f4f-bef7-1998939e4194" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_e2c5a638-6daa-4a5b-b5f1-b057f2f766d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7ef10288-51c5-4184-9d6d-2747ca4e6f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7ef10288-51c5-4184-9d6d-2747ca4e6f2d" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3a0ae9c4-b340-4b65-a617-d519cbe38e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3a0ae9c4-b340-4b65-a617-d519cbe38e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8bd3aa73-d253-462e-a73c-06ff4905b707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3a0ae9c4-b340-4b65-a617-d519cbe38e1f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8bd3aa73-d253-462e-a73c-06ff4905b707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_d842d30f-32bf-4675-a932-2cec0ae59388" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8bd3aa73-d253-462e-a73c-06ff4905b707" xlink:to="loc_us-gaap_LineOfCreditMember_d842d30f-32bf-4675-a932-2cec0ae59388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_806bbcee-d8e3-4a7b-8e82-079a045073e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:to="loc_us-gaap_DebtInstrumentAxis_806bbcee-d8e3-4a7b-8e82-079a045073e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6ee57c23-f373-46c8-a550-5ff19ebf2a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_806bbcee-d8e3-4a7b-8e82-079a045073e5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6ee57c23-f373-46c8-a550-5ff19ebf2a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_RevolvingCreditFacilityDueAugust2025Member_0d5f4b55-edb3-4626-9465-a58d2e0f816c" xlink:href="mo-20221231.xsd#mo_RevolvingCreditFacilityDueAugust2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_6ee57c23-f373-46c8-a550-5ff19ebf2a9a" xlink:to="loc_mo_RevolvingCreditFacilityDueAugust2025Member_0d5f4b55-edb3-4626-9465-a58d2e0f816c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_c0cae540-d1b7-436b-8db4-487c04bc0548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:to="loc_us-gaap_CreditFacilityAxis_c0cae540-d1b7-436b-8db4-487c04bc0548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_edd2bb8b-0f6e-4fcd-8b5b-46a481c3c62e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_c0cae540-d1b7-436b-8db4-487c04bc0548" xlink:to="loc_us-gaap_CreditFacilityDomain_edd2bb8b-0f6e-4fcd-8b5b-46a481c3c62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_044aea69-294b-415d-8c00-e73edb0b4478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_edd2bb8b-0f6e-4fcd-8b5b-46a481c3c62e" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_044aea69-294b-415d-8c00-e73edb0b4478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_547ac10d-68e9-48f8-b8fd-af3640864e14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:to="loc_us-gaap_VariableRateAxis_547ac10d-68e9-48f8-b8fd-af3640864e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1ab58c7a-7fbe-486b-b06c-befe0c9920e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_547ac10d-68e9-48f8-b8fd-af3640864e14" xlink:to="loc_us-gaap_VariableRateDomain_1ab58c7a-7fbe-486b-b06c-befe0c9920e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TermSecuredOvernightFinancingRateTermSOFRMember_41822dc2-8062-480c-a946-18a2da229fab" xlink:href="mo-20221231.xsd#mo_TermSecuredOvernightFinancingRateTermSOFRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1ab58c7a-7fbe-486b-b06c-befe0c9920e5" xlink:to="loc_mo_TermSecuredOvernightFinancingRateTermSOFRMember_41822dc2-8062-480c-a946-18a2da229fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_96ce553d-0c0e-4289-af65-82b3b5c4cf44" xlink:to="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_c63b4c1d-f2e1-4d61-a7f7-2d3d4ba9e17a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_us-gaap_ShortTermBorrowings_c63b4c1d-f2e1-4d61-a7f7-2d3d4ba9e17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_501d93ef-d6a7-4f74-bf48-730f7d83fe5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_501d93ef-d6a7-4f74-bf48-730f7d83fe5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_3e94e467-5f7e-4d54-9ead-0ec7961aabd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_us-gaap_DebtInstrumentTerm_3e94e467-5f7e-4d54-9ead-0ec7961aabd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5fa45a96-1509-4933-bf7c-7fc0e7815a93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_5fa45a96-1509-4933-bf7c-7fc0e7815a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_ece92fcc-b579-4042-b2a7-77cd0c882c36" xlink:href="mo-20221231.xsd#mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum_ece92fcc-b579-4042-b2a7-77cd0c882c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_ecc26071-6735-4651-bcd9-e3e87b03ceeb" xlink:href="mo-20221231.xsd#mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio_ecc26071-6735-4651-bcd9-e3e87b03ceeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_19d4136d-0e34-42b4-a5fb-4375676cecdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_06c79b84-05fa-4b08-8343-e6607dc239ec" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_19d4136d-0e34-42b4-a5fb-4375676cecdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#LongTermDebtSummaryofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fe6f67f0-5e06-4e38-8f75-f92a8b74e2d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2d705ea3-02f6-4e0d-a730-931824a4682c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fe6f67f0-5e06-4e38-8f75-f92a8b74e2d8" xlink:to="loc_us-gaap_DebtInstrumentTable_2d705ea3-02f6-4e0d-a730-931824a4682c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8e270fc6-1988-4b03-b87b-c68ea30acbe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2d705ea3-02f6-4e0d-a730-931824a4682c" xlink:to="loc_us-gaap_DebtInstrumentAxis_8e270fc6-1988-4b03-b87b-c68ea30acbe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cefdea29-f115-46ff-940c-0944a82b3bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8e270fc6-1988-4b03-b87b-c68ea30acbe8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cefdea29-f115-46ff-940c-0944a82b3bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2350To1020Member_be78dab3-f293-4d5e-991b-306c0d0aac33" xlink:href="mo-20221231.xsd#mo_USDNotes2350To1020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cefdea29-f115-46ff-940c-0944a82b3bf5" xlink:to="loc_mo_USDNotes2350To1020Member_be78dab3-f293-4d5e-991b-306c0d0aac33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDebenture7750MaturingJanuary2027Member_a6773df3-1ad2-4c1d-ae13-a8f4394bf3e0" xlink:href="mo-20221231.xsd#mo_USDDebenture7750MaturingJanuary2027Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cefdea29-f115-46ff-940c-0944a82b3bf5" xlink:to="loc_mo_USDDebenture7750MaturingJanuary2027Member_a6773df3-1ad2-4c1d-ae13-a8f4394bf3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes1000To3125Member_a7306514-8d0a-477b-8afd-1c446420c1dd" xlink:href="mo-20221231.xsd#mo_EuroNotes1000To3125Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_cefdea29-f115-46ff-940c-0944a82b3bf5" xlink:to="loc_mo_EuroNotes1000To3125Member_a7306514-8d0a-477b-8afd-1c446420c1dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4b736561-ede0-402f-a4c2-eb1fe49b58cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2d705ea3-02f6-4e0d-a730-931824a4682c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4b736561-ede0-402f-a4c2-eb1fe49b58cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4a894e32-5105-4143-a0c8-f0520cc6d92a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4b736561-ede0-402f-a4c2-eb1fe49b58cf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4a894e32-5105-4143-a0c8-f0520cc6d92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_221c0920-02cd-4c5d-908c-93f0076d0dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a894e32-5105-4143-a0c8-f0520cc6d92a" xlink:to="loc_us-gaap_SeniorNotesMember_221c0920-02cd-4c5d-908c-93f0076d0dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_e8631225-0e1e-4b1b-9186-3ca49aed8832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a894e32-5105-4143-a0c8-f0520cc6d92a" xlink:to="loc_us-gaap_LoansPayableMember_e8631225-0e1e-4b1b-9186-3ca49aed8832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_188cfdd2-da3e-4444-a771-5fcd168d2940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4a894e32-5105-4143-a0c8-f0520cc6d92a" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_188cfdd2-da3e-4444-a771-5fcd168d2940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d60f526e-08ac-46ed-bb9c-e088c438a8e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2d705ea3-02f6-4e0d-a730-931824a4682c" xlink:to="loc_srt_RangeAxis_d60f526e-08ac-46ed-bb9c-e088c438a8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_55615521-e5cd-4215-9b90-976c3d74d936" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d60f526e-08ac-46ed-bb9c-e088c438a8e3" xlink:to="loc_srt_RangeMember_55615521-e5cd-4215-9b90-976c3d74d936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_570b8fe2-6ded-41ee-aa66-3aa4e613587a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55615521-e5cd-4215-9b90-976c3d74d936" xlink:to="loc_srt_MinimumMember_570b8fe2-6ded-41ee-aa66-3aa4e613587a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1e791291-c4dd-4190-8ed0-de087b0f7291" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55615521-e5cd-4215-9b90-976c3d74d936" xlink:to="loc_srt_MaximumMember_1e791291-c4dd-4190-8ed0-de087b0f7291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_edd1287d-2cad-4479-8171-bfaa6e536a33" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_55615521-e5cd-4215-9b90-976c3d74d936" xlink:to="loc_srt_WeightedAverageMember_edd1287d-2cad-4479-8171-bfaa6e536a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2d705ea3-02f6-4e0d-a730-931824a4682c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f9a62700-2eed-4bc3-9552-2a0a41f9474a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:to="loc_us-gaap_LongTermDebt_f9a62700-2eed-4bc3-9552-2a0a41f9474a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ffffda39-2d7b-46ac-8b28-7f037f826b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:to="loc_us-gaap_LongTermDebtCurrent_ffffda39-2d7b-46ac-8b28-7f037f826b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1231180e-2909-4c6c-96a2-594b643010a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1231180e-2909-4c6c-96a2-594b643010a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c012fb09-3c14-488e-aaed-5a1513aa2d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_c012fb09-3c14-488e-aaed-5a1513aa2d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_5d70e0a4-703b-4fde-8676-2abd20275b53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9c88dc10-2f76-40f8-b30b-12082650b4cd" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_5d70e0a4-703b-4fde-8676-2abd20275b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#LongTermDebtDetailsofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_220e7ce5-6846-4805-9d3d-7e8bb57c83b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9338ecca-c9c6-4079-b049-638c45553b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_220e7ce5-6846-4805-9d3d-7e8bb57c83b7" xlink:to="loc_us-gaap_DebtInstrumentTable_9338ecca-c9c6-4079-b049-638c45553b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_1ea09668-7baf-4aa8-ac2d-a675f948e4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9338ecca-c9c6-4079-b049-638c45553b2b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_1ea09668-7baf-4aa8-ac2d-a675f948e4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f70dad81-7eda-46fe-94b2-b51d1a988ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_1ea09668-7baf-4aa8-ac2d-a675f948e4d0" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f70dad81-7eda-46fe-94b2-b51d1a988ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_bc07be16-4ffd-4598-8135-cb2f0a7d6846" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f70dad81-7eda-46fe-94b2-b51d1a988ac1" xlink:to="loc_us-gaap_SeniorNotesMember_bc07be16-4ffd-4598-8135-cb2f0a7d6846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_24863b41-946b-4051-9bce-c84e994e6629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f70dad81-7eda-46fe-94b2-b51d1a988ac1" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_24863b41-946b-4051-9bce-c84e994e6629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_18ad3de9-d8a9-4a0f-b571-7b6857e970b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f70dad81-7eda-46fe-94b2-b51d1a988ac1" xlink:to="loc_us-gaap_LoansPayableMember_18ad3de9-d8a9-4a0f-b571-7b6857e970b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9cae1d5c-027c-4c56-bba8-be8780e43f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9338ecca-c9c6-4079-b049-638c45553b2b" xlink:to="loc_us-gaap_DebtInstrumentAxis_9cae1d5c-027c-4c56-bba8-be8780e43f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9cae1d5c-027c-4c56-bba8-be8780e43f3f" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes1000MaturingFebruary2023Member_aee2969d-393a-4549-835e-248679743ba7" xlink:href="mo-20221231.xsd#mo_EuroNotes1000MaturingFebruary2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_EuroNotes1000MaturingFebruary2023Member_aee2969d-393a-4549-835e-248679743ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2950MaturingMay2023Member_01b58d8d-e657-4f4c-9e00-3bbf8d447557" xlink:href="mo-20221231.xsd#mo_USDNotes2950MaturingMay2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes2950MaturingMay2023Member_01b58d8d-e657-4f4c-9e00-3bbf8d447557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4000MaturingJanuary2024Member_29b05543-ba8a-4a2d-8f8c-2157e7cd67a3" xlink:href="mo-20221231.xsd#mo_USDNotes4000MaturingJanuary2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4000MaturingJanuary2024Member_29b05543-ba8a-4a2d-8f8c-2157e7cd67a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3800MaturingFebruary2024Member_4b3938ab-9bd0-4c82-82e4-b80ae9651e50" xlink:href="mo-20221231.xsd#mo_USDNotes3800MaturingFebruary2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes3800MaturingFebruary2024Member_4b3938ab-9bd0-4c82-82e4-b80ae9651e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2350MaturingMay2025Member_1458c4b3-6404-4159-a04a-9bae43c1e057" xlink:href="mo-20221231.xsd#mo_USDNotes2350MaturingMay2025Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes2350MaturingMay2025Member_1458c4b3-6404-4159-a04a-9bae43c1e057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes1700MaturingJune2025Member_c9a5fd09-c10d-4a90-940b-dad966e94094" xlink:href="mo-20221231.xsd#mo_EuroNotes1700MaturingJune2025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_EuroNotes1700MaturingJune2025Member_c9a5fd09-c10d-4a90-940b-dad966e94094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4400MaturingFebruary2026Member_ad7d59b4-a537-4181-b1f7-eecd4034d423" xlink:href="mo-20221231.xsd#mo_USDNotes4400MaturingFebruary2026Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4400MaturingFebruary2026Member_ad7d59b4-a537-4181-b1f7-eecd4034d423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2625MaturingSeptember2026Member_941b72d3-f9b4-4c27-8524-23c8d46caaa5" xlink:href="mo-20221231.xsd#mo_USDNotes2625MaturingSeptember2026Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes2625MaturingSeptember2026Member_941b72d3-f9b4-4c27-8524-23c8d46caaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDebenture7750MaturingJanuary2027Member_32a85899-5a95-4d0e-95cd-9c6ba079602a" xlink:href="mo-20221231.xsd#mo_USDDebenture7750MaturingJanuary2027Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDDebenture7750MaturingJanuary2027Member_32a85899-5a95-4d0e-95cd-9c6ba079602a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes2200MaturingJune2027Member_b4f91da3-d5b8-49ab-8814-5496f995957c" xlink:href="mo-20221231.xsd#mo_EuroNotes2200MaturingJune2027Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_EuroNotes2200MaturingJune2027Member_b4f91da3-d5b8-49ab-8814-5496f995957c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4800MaturingFebruary2029Member_a797eee4-59fc-4fca-84e8-a9100d90f86e" xlink:href="mo-20221231.xsd#mo_USDNotes4800MaturingFebruary2029Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4800MaturingFebruary2029Member_a797eee4-59fc-4fca-84e8-a9100d90f86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3400MaturingMay2030Member_b259d009-cf6d-49f7-9e6f-3df6b8c13288" xlink:href="mo-20221231.xsd#mo_USDNotes3400MaturingMay2030Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes3400MaturingMay2030Member_b259d009-cf6d-49f7-9e6f-3df6b8c13288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EuroNotes3125MaturingJune2031Member_8b06a8b1-f90d-4b1b-986a-73f3251cf642" xlink:href="mo-20221231.xsd#mo_EuroNotes3125MaturingJune2031Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_EuroNotes3125MaturingJune2031Member_8b06a8b1-f90d-4b1b-986a-73f3251cf642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2450MaturingFebruary2032Member_77d15ad3-c6cd-48d7-8a90-52e66a71d0d6" xlink:href="mo-20221231.xsd#mo_USDNotes2450MaturingFebruary2032Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes2450MaturingFebruary2032Member_77d15ad3-c6cd-48d7-8a90-52e66a71d0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes9950MaturingNovember2038Member_6fea184b-ab6e-4f6b-8810-755f7f35a9fe" xlink:href="mo-20221231.xsd#mo_USDNotes9950MaturingNovember2038Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes9950MaturingNovember2038Member_6fea184b-ab6e-4f6b-8810-755f7f35a9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes10200MaturingFebruary2039Member_efcb406c-c9cb-4ff8-a4bb-83d0bed4513a" xlink:href="mo-20221231.xsd#mo_USDNotes10200MaturingFebruary2039Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes10200MaturingFebruary2039Member_efcb406c-c9cb-4ff8-a4bb-83d0bed4513a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes5800MaturingFebruary2039Member_e3f495d0-c74b-40ba-83d2-3e5ccc64f55d" xlink:href="mo-20221231.xsd#mo_USDNotes5800MaturingFebruary2039Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes5800MaturingFebruary2039Member_e3f495d0-c74b-40ba-83d2-3e5ccc64f55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3400MaturingFebruary2041Member_1b1547b2-c4c9-46e4-9121-58920407b9cc" xlink:href="mo-20221231.xsd#mo_USDNotes3400MaturingFebruary2041Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes3400MaturingFebruary2041Member_1b1547b2-c4c9-46e4-9121-58920407b9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4250MaturingAugust2042Member_6bc51b5e-cd96-4723-b7b8-1b410b3fc002" xlink:href="mo-20221231.xsd#mo_USDNotes4250MaturingAugust2042Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4250MaturingAugust2042Member_6bc51b5e-cd96-4723-b7b8-1b410b3fc002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4500MaturingMay2043Member_fae76455-f5cb-40a0-be0b-ccc6392cde4a" xlink:href="mo-20221231.xsd#mo_USDNotes4500MaturingMay2043Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4500MaturingMay2043Member_fae76455-f5cb-40a0-be0b-ccc6392cde4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes5375MaturingJanuary2044Member_fdf29c6b-f9c1-4759-b2b8-9b491714c528" xlink:href="mo-20221231.xsd#mo_USDNotes5375MaturingJanuary2044Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes5375MaturingJanuary2044Member_fdf29c6b-f9c1-4759-b2b8-9b491714c528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3875MaturingSeptember2046Member_6d33a53f-53db-49dc-9e5a-dd81e9c8c633" xlink:href="mo-20221231.xsd#mo_USDNotes3875MaturingSeptember2046Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes3875MaturingSeptember2046Member_6d33a53f-53db-49dc-9e5a-dd81e9c8c633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes5950MaturingFebruary2049Member_2b1843af-2195-4fd9-9a52-f35f17745a0c" xlink:href="mo-20221231.xsd#mo_USDNotes5950MaturingFebruary2049Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes5950MaturingFebruary2049Member_2b1843af-2195-4fd9-9a52-f35f17745a0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4450MaturingMay2050Member_c293d93e-4639-4b20-8a23-c728c1c0e48d" xlink:href="mo-20221231.xsd#mo_USDNotes4450MaturingMay2050Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4450MaturingMay2050Member_c293d93e-4639-4b20-8a23-c728c1c0e48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3700MaturingFebruary2051Member_c9b61bd1-fe28-4c6f-b910-d8db0adbfc86" xlink:href="mo-20221231.xsd#mo_USDNotes3700MaturingFebruary2051Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes3700MaturingFebruary2051Member_c9b61bd1-fe28-4c6f-b910-d8db0adbfc86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes6200MaturingFebruary2059Member_5d80f1f4-8262-472c-ada7-10840599d266" xlink:href="mo-20221231.xsd#mo_USDNotes6200MaturingFebruary2059Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes6200MaturingFebruary2059Member_5d80f1f4-8262-472c-ada7-10840599d266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4000MaturingFebruary2061Member_7eabcbd1-62db-4673-ba5e-c8b2559e0785" xlink:href="mo-20221231.xsd#mo_USDNotes4000MaturingFebruary2061Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_123729d5-c20b-40eb-a302-1edf0aaa3e77" xlink:to="loc_mo_USDNotes4000MaturingFebruary2061Member_7eabcbd1-62db-4673-ba5e-c8b2559e0785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9dbddd01-94bc-4332-85e1-b83ae8cdd38f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9338ecca-c9c6-4079-b049-638c45553b2b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9dbddd01-94bc-4332-85e1-b83ae8cdd38f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_fbfdbee7-3143-489d-a872-f114c4209fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9dbddd01-94bc-4332-85e1-b83ae8cdd38f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_fbfdbee7-3143-489d-a872-f114c4209fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_eab0a55e-3ee9-465c-a04d-07c075af88f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9dbddd01-94bc-4332-85e1-b83ae8cdd38f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_eab0a55e-3ee9-465c-a04d-07c075af88f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#LongTermDebtAggregateMaturitiesofLongTermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_95d8d53b-e87c-4514-941b-ef85595953ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a23a473a-2a59-49e2-9232-235f33724b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_95d8d53b-e87c-4514-941b-ef85595953ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_a23a473a-2a59-49e2-9232-235f33724b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_21750e76-60fa-4ce2-8d5c-9eb14bbe796d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_95d8d53b-e87c-4514-941b-ef85595953ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_21750e76-60fa-4ce2-8d5c-9eb14bbe796d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_fffca820-ce37-40e7-ba7b-5379ccc85153" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_95d8d53b-e87c-4514-941b-ef85595953ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_fffca820-ce37-40e7-ba7b-5379ccc85153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_703df0c3-d36b-4dce-a6d8-035139f1012c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_95d8d53b-e87c-4514-941b-ef85595953ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_703df0c3-d36b-4dce-a6d8-035139f1012c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_69bf26b1-f7d6-4418-bbeb-07797f367aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_95d8d53b-e87c-4514-941b-ef85595953ed" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_69bf26b1-f7d6-4418-bbeb-07797f367aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter_e095f901-a8b9-4bb2-a36f-a663c569a807" xlink:href="mo-20221231.xsd#mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_95d8d53b-e87c-4514-941b-ef85595953ed" xlink:to="loc_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter_e095f901-a8b9-4bb2-a36f-a663c569a807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4f249a3f-b115-4d16-84ac-1de69e838d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_95d8d53b-e87c-4514-941b-ef85595953ed" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_4f249a3f-b115-4d16-84ac-1de69e838d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_4e174ab4-c6ee-477f-aac9-93c72ab048d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_95d8d53b-e87c-4514-941b-ef85595953ed" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_4e174ab4-c6ee-477f-aac9-93c72ab048d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9f4d3855-6f12-44c3-8ccc-acecb59780fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_95d8d53b-e87c-4514-941b-ef85595953ed" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9f4d3855-6f12-44c3-8ccc-acecb59780fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b8b3b882-0111-464d-84f6-eb6229af7568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_95d8d53b-e87c-4514-941b-ef85595953ed" xlink:to="loc_us-gaap_LongTermDebt_b8b3b882-0111-464d-84f6-eb6229af7568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_66dfc466-3717-49bb-af16-16786628d509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_658346f2-d215-4305-a3a6-b8644ff84e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_66dfc466-3717-49bb-af16-16786628d509" xlink:to="loc_us-gaap_DebtInstrumentTable_658346f2-d215-4305-a3a6-b8644ff84e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a4b63940-d601-4901-9ce7-927e5d85d87a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_658346f2-d215-4305-a3a6-b8644ff84e32" xlink:to="loc_us-gaap_DebtInstrumentAxis_a4b63940-d601-4901-9ce7-927e5d85d87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eec8a107-6518-4774-b5da-37bfdacda135" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a4b63940-d601-4901-9ce7-927e5d85d87a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eec8a107-6518-4774-b5da-37bfdacda135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotesMember_11370e92-ab57-4505-bf88-9c4a87775c06" xlink:href="mo-20221231.xsd#mo_USDDenominatedNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eec8a107-6518-4774-b5da-37bfdacda135" xlink:to="loc_mo_USDDenominatedNotesMember_11370e92-ab57-4505-bf88-9c4a87775c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDDenominatedNotes3490PercentDue2022Member_b141ed69-ffba-4fc4-b30f-d748b5083cbc" xlink:href="mo-20221231.xsd#mo_USDDenominatedNotes3490PercentDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eec8a107-6518-4774-b5da-37bfdacda135" xlink:to="loc_mo_USDDenominatedNotes3490PercentDue2022Member_b141ed69-ffba-4fc4-b30f-d748b5083cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_feb5e1f8-dae7-4b91-ac82-3cd16db67abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_658346f2-d215-4305-a3a6-b8644ff84e32" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_feb5e1f8-dae7-4b91-ac82-3cd16db67abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a91e59fc-bdff-482f-b025-46195c0390f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_feb5e1f8-dae7-4b91-ac82-3cd16db67abf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a91e59fc-bdff-482f-b025-46195c0390f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3d079de4-5b54-429d-a88e-c4838e77aac7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a91e59fc-bdff-482f-b025-46195c0390f1" xlink:to="loc_us-gaap_SeniorNotesMember_3d079de4-5b54-429d-a88e-c4838e77aac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_04a56394-1830-4d28-bf25-62cce0e83077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_658346f2-d215-4305-a3a6-b8644ff84e32" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_04a56394-1830-4d28-bf25-62cce0e83077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9a581b40-97c1-4b27-8248-5ef86dc7f549" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_04a56394-1830-4d28-bf25-62cce0e83077" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9a581b40-97c1-4b27-8248-5ef86dc7f549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_3abaceba-1268-4f00-86f4-f33b6b311320" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_9a581b40-97c1-4b27-8248-5ef86dc7f549" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_3abaceba-1268-4f00-86f4-f33b6b311320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_658346f2-d215-4305-a3a6-b8644ff84e32" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrentAndNoncurrent_a0fc4ae7-86f7-4822-b6f4-7f53dadcfe94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_InterestPayableCurrentAndNoncurrent_a0fc4ae7-86f7-4822-b6f4-7f53dadcfe94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ba6d9f5b-0ab1-462b-9f04-94e2d46c42b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ba6d9f5b-0ab1-462b-9f04-94e2d46c42b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfUnsecuredDebt_353bcc92-4d2c-4733-8786-49809397d18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfUnsecuredDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_RepaymentsOfUnsecuredDebt_353bcc92-4d2c-4733-8786-49809397d18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_7e15a4b1-40fe-455c-88f6-57cdbd157c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_7e15a4b1-40fe-455c-88f6-57cdbd157c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_817537f6-f420-44cf-a3ca-d93b083df112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_817537f6-f420-44cf-a3ca-d93b083df112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_0e173773-aac6-487f-8a0a-f52f91c3bee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost_0e173773-aac6-487f-8a0a-f52f91c3bee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_56ab9043-7276-40d2-b3d6-b3ab3ca104f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_56ab9043-7276-40d2-b3d6-b3ab3ca104f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_414cb3ec-7eef-4715-9ed8-f455d61089a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3e44a8b3-d8fc-4a40-98bc-89008cc85d8d" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_414cb3ec-7eef-4715-9ed8-f455d61089a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#LongTermDebtDebtTenderOffersandRedemptionDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d900ba2e-89ca-4aa3-9707-e731063e58b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5c50c6e3-4d91-4a48-9112-e69d71a88ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d900ba2e-89ca-4aa3-9707-e731063e58b9" xlink:to="loc_us-gaap_DebtInstrumentTable_5c50c6e3-4d91-4a48-9112-e69d71a88ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0155bd67-15c0-4dd6-ada8-1bb8cd8a50da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5c50c6e3-4d91-4a48-9112-e69d71a88ba8" xlink:to="loc_us-gaap_DebtInstrumentAxis_0155bd67-15c0-4dd6-ada8-1bb8cd8a50da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0155bd67-15c0-4dd6-ada8-1bb8cd8a50da" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2850MaturingAugust2022Member_764d6939-da4b-417e-b8b1-14eccb50c9ba" xlink:href="mo-20221231.xsd#mo_USDNotes2850MaturingAugust2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes2850MaturingAugust2022Member_764d6939-da4b-417e-b8b1-14eccb50c9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes2950MaturingMay2023Member_71f09277-ccc0-4773-b522-0414bab322ff" xlink:href="mo-20221231.xsd#mo_USDNotes2950MaturingMay2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes2950MaturingMay2023Member_71f09277-ccc0-4773-b522-0414bab322ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4000MaturingJanuary2024Member_0917fb25-0e4f-450d-b91f-943958ce126d" xlink:href="mo-20221231.xsd#mo_USDNotes4000MaturingJanuary2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes4000MaturingJanuary2024Member_0917fb25-0e4f-450d-b91f-943958ce126d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes3800MaturingFebruary2024Member_4f705c93-a6f7-4fbc-a8f6-90b66c78c66b" xlink:href="mo-20221231.xsd#mo_USDNotes3800MaturingFebruary2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes3800MaturingFebruary2024Member_4f705c93-a6f7-4fbc-a8f6-90b66c78c66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4400MaturingFebruary2026Member_cab7b6c3-55c1-454e-b5b8-890a41643be6" xlink:href="mo-20221231.xsd#mo_USDNotes4400MaturingFebruary2026Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes4400MaturingFebruary2026Member_cab7b6c3-55c1-454e-b5b8-890a41643be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes4800MaturingFebruary2029Member_23940f3d-b940-4895-87b8-677ccf8885c1" xlink:href="mo-20221231.xsd#mo_USDNotes4800MaturingFebruary2029Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes4800MaturingFebruary2029Member_23940f3d-b940-4895-87b8-677ccf8885c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes9950MaturingNovember2038Member_2add2d21-ffe1-4d74-a948-7ecbc4fa443a" xlink:href="mo-20221231.xsd#mo_USDNotes9950MaturingNovember2038Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes9950MaturingNovember2038Member_2add2d21-ffe1-4d74-a948-7ecbc4fa443a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes10200MaturingFebruary2039Member_6fd6a8a3-e0a6-44f4-94d7-691b60129011" xlink:href="mo-20221231.xsd#mo_USDNotes10200MaturingFebruary2039Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes10200MaturingFebruary2039Member_6fd6a8a3-e0a6-44f4-94d7-691b60129011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USDNotes6200MaturingFebruary2059Member_0ec999bd-a57d-4448-905a-1ae6e9381e55" xlink:href="mo-20221231.xsd#mo_USDNotes6200MaturingFebruary2059Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eed0bf70-1c40-4201-af45-6d4c6079345a" xlink:to="loc_mo_USDNotes6200MaturingFebruary2059Member_0ec999bd-a57d-4448-905a-1ae6e9381e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_79b191cd-395c-4f4e-9aaa-57e99c4d0080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5c50c6e3-4d91-4a48-9112-e69d71a88ba8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_79b191cd-395c-4f4e-9aaa-57e99c4d0080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e6a889eb-7c3e-485b-be7f-1c59ae57f874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_79b191cd-395c-4f4e-9aaa-57e99c4d0080" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e6a889eb-7c3e-485b-be7f-1c59ae57f874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_05f3c88b-f089-4e07-a6f0-d3803b9095b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6a889eb-7c3e-485b-be7f-1c59ae57f874" xlink:to="loc_us-gaap_SeniorNotesMember_05f3c88b-f089-4e07-a6f0-d3803b9095b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_fc31b05f-3034-4bb1-8e8a-a2cb8c481771" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5c50c6e3-4d91-4a48-9112-e69d71a88ba8" xlink:to="loc_us-gaap_DebtInstrumentLineItems_fc31b05f-3034-4bb1-8e8a-a2cb8c481771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_af72edd3-2afc-4cc3-af08-e76192ea0677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc31b05f-3034-4bb1-8e8a-a2cb8c481771" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_af72edd3-2afc-4cc3-af08-e76192ea0677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_b2a07fbb-7ea7-4e15-9df3-e960f079cb9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_fc31b05f-3034-4bb1-8e8a-a2cb8c481771" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_b2a07fbb-7ea7-4e15-9df3-e960f079cb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#CapitalStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CapitalStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e100ca14-634a-44f2-975f-5c86dd898a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e100ca14-634a-44f2-975f-5c86dd898a5f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4f6abd67-48c4-4333-94fb-77ebd65e6492" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:to="loc_us-gaap_AwardTypeAxis_4f6abd67-48c4-4333-94fb-77ebd65e6492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4eb084f6-d77e-4722-9b2a-309d244a06e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4f6abd67-48c4-4333-94fb-77ebd65e6492" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4eb084f6-d77e-4722-9b2a-309d244a06e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_e1971e38-9da6-4817-bd10-f790cfe45c70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4eb084f6-d77e-4722-9b2a-309d244a06e6" xlink:to="loc_us-gaap_StockCompensationPlanMember_e1971e38-9da6-4817-bd10-f790cfe45c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e0ffc4b7-70ad-4867-9897-accd738db4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e0ffc4b7-70ad-4867-9897-accd738db4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e8a718f1-a07d-4bcd-9e3c-d936efc77c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e0ffc4b7-70ad-4867-9897-accd738db4f9" xlink:to="loc_us-gaap_ClassOfStockDomain_e8a718f1-a07d-4bcd-9e3c-d936efc77c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SerialPreferredStockMember_598a09dc-6d64-4c8e-bbbc-5ddabf86ede1" xlink:href="mo-20221231.xsd#mo_SerialPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e8a718f1-a07d-4bcd-9e3c-d936efc77c1c" xlink:to="loc_mo_SerialPreferredStockMember_598a09dc-6d64-4c8e-bbbc-5ddabf86ede1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_8a5678ab-ace1-42b5-828c-f2640afeaff1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_8a5678ab-ace1-42b5-828c-f2640afeaff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_00fdbb83-1e11-4854-a6f9-380532900d10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_8a5678ab-ace1-42b5-828c-f2640afeaff1" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_00fdbb83-1e11-4854-a6f9-380532900d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember_e2485aa5-5496-4067-bd92-3f8d436eae9e" xlink:href="mo-20221231.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_00fdbb83-1e11-4854-a6f9-380532900d10" xlink:to="loc_mo_January2021ShareRepurchaseProgramMember_e2485aa5-5496-4067-bd92-3f8d436eae9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_July2019ShareRepurchaseProgramMember_243b794a-2a91-489b-9362-214325a53847" xlink:href="mo-20221231.xsd#mo_July2019ShareRepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_00fdbb83-1e11-4854-a6f9-380532900d10" xlink:to="loc_mo_July2019ShareRepurchaseProgramMember_243b794a-2a91-489b-9362-214325a53847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2023ShareRepurchaseProgramMember_d0ca6c6f-d775-464f-8622-08dcd8a0375e" xlink:href="mo-20221231.xsd#mo_January2023ShareRepurchaseProgramMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_00fdbb83-1e11-4854-a6f9-380532900d10" xlink:to="loc_mo_January2023ShareRepurchaseProgramMember_d0ca6c6f-d775-464f-8622-08dcd8a0375e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_cc1e9078-6691-411e-9e92-fcb11e27ea0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_cc1e9078-6691-411e-9e92-fcb11e27ea0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_cae1ceea-ac1f-4163-992c-e059ff6f6b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_cc1e9078-6691-411e-9e92-fcb11e27ea0a" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_cae1ceea-ac1f-4163-992c-e059ff6f6b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8a17f08a-e4ed-4ce6-8cdb-639b38bb7722" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_cae1ceea-ac1f-4163-992c-e059ff6f6b3c" xlink:to="loc_us-gaap_SubsequentEventMember_8a17f08a-e4ed-4ce6-8cdb-639b38bb7722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_10d34ffa-af92-4bfb-99b2-72c0dc6cddd4" xlink:to="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_0c239d6d-c313-4529-a4db-908a906b97b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_0c239d6d-c313-4529-a4db-908a906b97b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f235ecef-86ed-4aab-b17a-326d782b4d90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f235ecef-86ed-4aab-b17a-326d782b4d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1904ad71-2f2c-4b7f-bf83-8430cb972882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1904ad71-2f2c-4b7f-bf83-8430cb972882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2ae725b1-1c90-4487-b3d5-f51e195218aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_2ae725b1-1c90-4487-b3d5-f51e195218aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_dd38d67a-2825-4b7f-876c-2a6b740751bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_PreferredStockSharesIssued_dd38d67a-2825-4b7f-876c-2a6b740751bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendIncreasePercentage_83572ec3-1d1f-4f38-968d-fcb288bfaee1" xlink:href="mo-20221231.xsd#mo_CommonStockDividendIncreasePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_mo_CommonStockDividendIncreasePercentage_83572ec3-1d1f-4f38-968d-fcb288bfaee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_665621a4-7586-4271-b0b1-7c199f4ff21f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_665621a4-7586-4271-b0b1-7c199f4ff21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockDividendRateAnnualPerShare_aa2cf429-9fe8-4c50-a22f-5a2b3eb095a8" xlink:href="mo-20221231.xsd#mo_CommonStockDividendRateAnnualPerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_mo_CommonStockDividendRateAnnualPerShare_aa2cf429-9fe8-4c50-a22f-5a2b3eb095a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_65bbf972-8d73-4371-b46c-bf4f7f5096d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_65bbf972-8d73-4371-b46c-bf4f7f5096d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_b31260f7-2154-4e69-8143-4ee16b35ffdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a878eb2b-4474-4aec-8934-cdc63ddfad16" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_b31260f7-2154-4e69-8143-4ee16b35ffdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d9fb3486-08e0-423a-b0d2-550cd84ea013" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CommonStockSharesOutstandingRollForward_04dadd77-ce7f-41e6-b77d-a1e88fa9ebb0" xlink:href="mo-20221231.xsd#mo_CommonStockSharesOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d9fb3486-08e0-423a-b0d2-550cd84ea013" xlink:to="loc_mo_CommonStockSharesOutstandingRollForward_04dadd77-ce7f-41e6-b77d-a1e88fa9ebb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a417e068-4942-4fc5-ba57-3338f313a2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_CommonStockSharesOutstandingRollForward_04dadd77-ce7f-41e6-b77d-a1e88fa9ebb0" xlink:to="loc_us-gaap_CommonStockSharesIssued_a417e068-4942-4fc5-ba57-3338f313a2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_537938b2-190c-4040-a133-62a94b462f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_CommonStockSharesOutstandingRollForward_04dadd77-ce7f-41e6-b77d-a1e88fa9ebb0" xlink:to="loc_us-gaap_TreasuryStockShares_537938b2-190c-4040-a133-62a94b462f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_00837cb1-db54-43ba-9495-cb4956f78ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_CommonStockSharesOutstandingRollForward_04dadd77-ce7f-41e6-b77d-a1e88fa9ebb0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_00837cb1-db54-43ba-9495-cb4956f78ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned_8f6e55f8-172e-4b08-a29c-b5188356610b" xlink:href="mo-20221231.xsd#mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_CommonStockSharesOutstandingRollForward_04dadd77-ce7f-41e6-b77d-a1e88fa9ebb0" xlink:to="loc_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned_8f6e55f8-172e-4b08-a29c-b5188356610b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_cc417e90-d3a1-4468-b5be-d0a94e3b1ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_CommonStockSharesOutstandingRollForward_04dadd77-ce7f-41e6-b77d-a1e88fa9ebb0" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_cc417e90-d3a1-4468-b5be-d0a94e3b1ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_9ea5499e-e3df-40b7-ba4a-100ccd2f6f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_CommonStockSharesOutstandingRollForward_04dadd77-ce7f-41e6-b77d-a1e88fa9ebb0" xlink:to="loc_us-gaap_CommonStockSharesIssued_9ea5499e-e3df-40b7-ba4a-100ccd2f6f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_a4039c96-dee7-449b-b4dc-1d82ce45de86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_CommonStockSharesOutstandingRollForward_04dadd77-ce7f-41e6-b77d-a1e88fa9ebb0" xlink:to="loc_us-gaap_TreasuryStockShares_a4039c96-dee7-449b-b4dc-1d82ce45de86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6b7b6a01-1fa7-4f14-ad32-40560e55e95f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_CommonStockSharesOutstandingRollForward_04dadd77-ce7f-41e6-b77d-a1e88fa9ebb0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6b7b6a01-1fa7-4f14-ad32-40560e55e95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#CapitalStockScheduleofSharesRepurchasedDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6dfff196-e8cb-4e1f-bab9-169cc50e9d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_4bc69006-a498-401a-a8a5-98b242d146d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6dfff196-e8cb-4e1f-bab9-169cc50e9d22" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_4bc69006-a498-401a-a8a5-98b242d146d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_e1dccde8-3c4d-4b36-936e-4545af32f4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4bc69006-a498-401a-a8a5-98b242d146d6" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_e1dccde8-3c4d-4b36-936e-4545af32f4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_271fda3e-2daa-43a8-88fa-dd60709e9df9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_e1dccde8-3c4d-4b36-936e-4545af32f4ce" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_271fda3e-2daa-43a8-88fa-dd60709e9df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_January2021ShareRepurchaseProgramMember_a086c9ca-3ddd-4b66-9b79-58ef343001ad" xlink:href="mo-20221231.xsd#mo_January2021ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_271fda3e-2daa-43a8-88fa-dd60709e9df9" xlink:to="loc_mo_January2021ShareRepurchaseProgramMember_a086c9ca-3ddd-4b66-9b79-58ef343001ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_2a6a2ec0-c7bb-40b7-8218-8bd80763d869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4bc69006-a498-401a-a8a5-98b242d146d6" xlink:to="loc_us-gaap_ClassOfStockLineItems_2a6a2ec0-c7bb-40b7-8218-8bd80763d869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_6ad67496-28c3-43fc-a362-ef3ef9b6c21d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_2a6a2ec0-c7bb-40b7-8218-8bd80763d869" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_6ad67496-28c3-43fc-a362-ef3ef9b6c21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_379d72ea-82b8-40cf-bd9d-3b88e09076db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_2a6a2ec0-c7bb-40b7-8218-8bd80763d869" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_379d72ea-82b8-40cf-bd9d-3b88e09076db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_132c7175-66a9-4eec-82b4-852484f2f291" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockAcquiredAverageCostPerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_2a6a2ec0-c7bb-40b7-8218-8bd80763d869" xlink:to="loc_us-gaap_TreasuryStockAcquiredAverageCostPerShare_132c7175-66a9-4eec-82b4-852484f2f291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/StockPlansNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#StockPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/StockPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9ae2e977-dc06-4693-ae84-95ad8c7fa119" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c60e18-4309-49cb-abd2-e20cfe482680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9ae2e977-dc06-4693-ae84-95ad8c7fa119" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c60e18-4309-49cb-abd2-e20cfe482680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_da32b219-3ce2-43f5-a004-3b17f3369147" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c60e18-4309-49cb-abd2-e20cfe482680" xlink:to="loc_us-gaap_StatementClassOfStockAxis_da32b219-3ce2-43f5-a004-3b17f3369147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4144ca86-4733-4c52-a823-67e551a8f028" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_da32b219-3ce2-43f5-a004-3b17f3369147" xlink:to="loc_us-gaap_ClassOfStockDomain_4144ca86-4733-4c52-a823-67e551a8f028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6f2ec35a-d547-4220-ad08-d7866db75cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4144ca86-4733-4c52-a823-67e551a8f028" xlink:to="loc_us-gaap_CommonStockMember_6f2ec35a-d547-4220-ad08-d7866db75cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e4db4b20-eaf3-43cc-a7b0-4b575558b2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c60e18-4309-49cb-abd2-e20cfe482680" xlink:to="loc_us-gaap_PlanNameAxis_e4db4b20-eaf3-43cc-a7b0-4b575558b2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_266ad4bb-1904-4617-9dc7-cce205a2ece5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_e4db4b20-eaf3-43cc-a7b0-4b575558b2f0" xlink:to="loc_us-gaap_PlanNameDomain_266ad4bb-1904-4617-9dc7-cce205a2ece5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_A2020PerformanceIncentivePlanMember_0795f7b3-45ff-49f6-9c7e-8e56c22867d3" xlink:href="mo-20221231.xsd#mo_A2020PerformanceIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_266ad4bb-1904-4617-9dc7-cce205a2ece5" xlink:to="loc_mo_A2020PerformanceIncentivePlanMember_0795f7b3-45ff-49f6-9c7e-8e56c22867d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_A2015DirectorsPlanMember_39af29b8-d7c5-4a54-a5e0-e03cd8541b0a" xlink:href="mo-20221231.xsd#mo_A2015DirectorsPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_266ad4bb-1904-4617-9dc7-cce205a2ece5" xlink:to="loc_mo_A2015DirectorsPlanMember_39af29b8-d7c5-4a54-a5e0-e03cd8541b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_083c49e1-6f74-44fd-98ec-46455f144bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c60e18-4309-49cb-abd2-e20cfe482680" xlink:to="loc_us-gaap_AwardTypeAxis_083c49e1-6f74-44fd-98ec-46455f144bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03175ffa-4604-4138-9d10-62ac39ff0775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_083c49e1-6f74-44fd-98ec-46455f144bbc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03175ffa-4604-4138-9d10-62ac39ff0775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_eb91a45d-1670-47fb-98de-cf0a1336ff4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03175ffa-4604-4138-9d10-62ac39ff0775" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_eb91a45d-1670-47fb-98de-cf0a1336ff4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_5fe81781-31cb-4766-8aa4-89dd7cd1fd73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_03175ffa-4604-4138-9d10-62ac39ff0775" xlink:to="loc_us-gaap_PerformanceSharesMember_5fe81781-31cb-4766-8aa4-89dd7cd1fd73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b0c60e18-4309-49cb-abd2-e20cfe482680" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_aa386836-c7f2-4670-82e4-27e312d25ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_aa386836-c7f2-4670-82e4-27e312d25ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a06cd42f-de20-40eb-abae-b719e92c21b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_a06cd42f-de20-40eb-abae-b719e92c21b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c3f7ec0d-7696-4a1f-b5f8-0d3dd084ccc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c3f7ec0d-7696-4a1f-b5f8-0d3dd084ccc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod_1e9e1794-a6fa-4289-aeb4-1ee31f123516" xlink:href="mo-20221231.xsd#mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod_1e9e1794-a6fa-4289-aeb4-1ee31f123516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_d1896634-a3a0-4cf3-8887-225d87cdd54e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_d1896634-a3a0-4cf3-8887-225d87cdd54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_07e69ac4-f024-49d1-b416-022374514ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_07e69ac4-f024-49d1-b416-022374514ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ec856361-4b8b-42f3-b3a9-1117bad2942d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ec856361-4b8b-42f3-b3a9-1117bad2942d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_63abc3c2-9a57-4487-b66c-3583d005e574" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_63abc3c2-9a57-4487-b66c-3583d005e574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue_30ecaa3f-59a7-44b2-a809-14836ec8b1a2" xlink:href="mo-20221231.xsd#mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue_30ecaa3f-59a7-44b2-a809-14836ec8b1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_42b00a68-e43d-41b0-8b50-d2042d894dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_42b00a68-e43d-41b0-8b50-d2042d894dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2eaae2b4-4a86-469f-a524-a677b89c28f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_2eaae2b4-4a86-469f-a524-a677b89c28f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_49162542-0a5b-475d-a6cf-8b89f248856e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_49162542-0a5b-475d-a6cf-8b89f248856e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a5a422fc-bbd3-46b7-a0d8-87a6764a73d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a5a422fc-bbd3-46b7-a0d8-87a6764a73d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_128df884-39be-44b7-aaa7-0b192c22236d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6017df6-a530-4eab-a5a2-8fe4a428fa58" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_128df884-39be-44b7-aaa7-0b192c22236d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6a7f1da4-f400-4563-b6d3-6b7ec3322a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_929211ec-0be2-43b9-b58f-fcf1c4a9ee9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6a7f1da4-f400-4563-b6d3-6b7ec3322a7d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_929211ec-0be2-43b9-b58f-fcf1c4a9ee9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7d407ea5-fdc3-455e-afaf-a3cd5f3fc3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_929211ec-0be2-43b9-b58f-fcf1c4a9ee9c" xlink:to="loc_us-gaap_AwardTypeAxis_7d407ea5-fdc3-455e-afaf-a3cd5f3fc3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5f12b75-7155-4fec-b152-738ab93b1d66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7d407ea5-fdc3-455e-afaf-a3cd5f3fc3eb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5f12b75-7155-4fec-b152-738ab93b1d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_18b6aa50-a8e8-4c14-a7a8-16933c07f5ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d5f12b75-7155-4fec-b152-738ab93b1d66" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_18b6aa50-a8e8-4c14-a7a8-16933c07f5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ddfd7ce-2b67-4863-ba8d-9ce48ecd1e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_929211ec-0be2-43b9-b58f-fcf1c4a9ee9c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ddfd7ce-2b67-4863-ba8d-9ce48ecd1e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ddfd7ce-2b67-4863-ba8d-9ce48ecd1e3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb8636f7-fed0-424c-a223-5aacf8a3e64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eb8636f7-fed0-424c-a223-5aacf8a3e64e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2e4761ee-31dc-4f14-b5e9-236f82251ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2e4761ee-31dc-4f14-b5e9-236f82251ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_86f414f3-fa79-44e3-b0be-41ea27d9efaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_86f414f3-fa79-44e3-b0be-41ea27d9efaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_00dba986-b6da-45c8-94d2-cde7bc4941a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_00dba986-b6da-45c8-94d2-cde7bc4941a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1a652207-5102-4b5a-99f8-b070f02e6c3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a1f8d8ec-600b-4963-b140-fecc6c5fb883" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1a652207-5102-4b5a-99f8-b070f02e6c3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8ddfd7ce-2b67-4863-ba8d-9ce48ecd1e3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c8883170-5021-4301-a7bf-e8a1f5fc579a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_c8883170-5021-4301-a7bf-e8a1f5fc579a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3b3dc312-a66a-41bb-89fb-4ea8134a7f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3b3dc312-a66a-41bb-89fb-4ea8134a7f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5f81ff22-d5ec-47f6-99ed-27f32e4196c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5f81ff22-d5ec-47f6-99ed-27f32e4196c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_754df0bc-34d3-491c-bee7-c6e62abcff3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_754df0bc-34d3-491c-bee7-c6e62abcff3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_53fb0ac3-faf1-4054-8403-4788d2bf3a41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_672cd901-1f4c-40f2-b739-00ccd9e7ba7c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_53fb0ac3-faf1-4054-8403-4788d2bf3a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/EarningsperShareDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#EarningsperShareDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/EarningsperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_965201f1-6223-49fd-91d6-03fedb7ae180" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4ada3b61-1ee3-4c17-83ee-5c43fa3053ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_965201f1-6223-49fd-91d6-03fedb7ae180" xlink:to="loc_us-gaap_NetIncomeLoss_4ada3b61-1ee3-4c17-83ee-5c43fa3053ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_3b65c202-6910-4ebd-a566-071128c15c5e" xlink:href="mo-20221231.xsd#mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_965201f1-6223-49fd-91d6-03fedb7ae180" xlink:to="loc_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted_3b65c202-6910-4ebd-a566-071128c15c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5eb192c2-c734-4d1d-8cbd-8461adebdf89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_965201f1-6223-49fd-91d6-03fedb7ae180" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5eb192c2-c734-4d1d-8cbd-8461adebdf89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_35189aae-94f3-47ac-837c-8a970b3d0d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_965201f1-6223-49fd-91d6-03fedb7ae180" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_35189aae-94f3-47ac-837c-8a970b3d0d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0ca4f4de-a8de-4ebe-8f75-aad355ef7c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_965201f1-6223-49fd-91d6-03fedb7ae180" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0ca4f4de-a8de-4ebe-8f75-aad355ef7c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_a01ee5f2-aac0-43a6-bb5c-017a02ef6e87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_965201f1-6223-49fd-91d6-03fedb7ae180" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable_a01ee5f2-aac0-43a6-bb5c-017a02ef6e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_32cbdb96-421d-449c-a78e-bbf5d3acee99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_965201f1-6223-49fd-91d6-03fedb7ae180" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_32cbdb96-421d-449c-a78e-bbf5d3acee99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2fc62cfa-9bc7-43fc-adba-0b8a73d37658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c49ef60d-32e3-485e-94ac-c648a4bae59e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2fc62cfa-9bc7-43fc-adba-0b8a73d37658" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c49ef60d-32e3-485e-94ac-c648a4bae59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4b1dc02f-083c-4b02-9da7-bef0e5d33067" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c49ef60d-32e3-485e-94ac-c648a4bae59e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4b1dc02f-083c-4b02-9da7-bef0e5d33067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d647f946-8a43-4536-a0ff-4d6084b37c13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4b1dc02f-083c-4b02-9da7-bef0e5d33067" xlink:to="loc_us-gaap_EquityComponentDomain_d647f946-8a43-4536-a0ff-4d6084b37c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774c23ab-ae87-4e9d-ba8c-0b8031b5a85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d647f946-8a43-4536-a0ff-4d6084b37c13" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774c23ab-ae87-4e9d-ba8c-0b8031b5a85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_4ffafdbb-6640-48fe-9af5-6081208c4fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774c23ab-ae87-4e9d-ba8c-0b8031b5a85d" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_4ffafdbb-6640-48fe-9af5-6081208c4fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_29d51b3b-9247-4c84-b962-cb520aeed29a" xlink:href="mo-20221231.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774c23ab-ae87-4e9d-ba8c-0b8031b5a85d" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_29d51b3b-9247-4c84-b962-cb520aeed29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember_cc3403e8-fdb8-4c6c-82e0-a6156d2663f3" xlink:href="mo-20221231.xsd#mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_774c23ab-ae87-4e9d-ba8c-0b8031b5a85d" xlink:to="loc_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember_cc3403e8-fdb8-4c6c-82e0-a6156d2663f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3c444f9f-3e4b-45cb-9ae9-bce3de2045cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_c49ef60d-32e3-485e-94ac-c648a4bae59e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3c444f9f-3e4b-45cb-9ae9-bce3de2045cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3c444f9f-3e4b-45cb-9ae9-bce3de2045cf" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b53592f3-814c-4f55-a853-73f35e9580e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b53592f3-814c-4f55-a853-73f35e9580e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_3ef102e5-ef89-4aa5-9e94-2dd4a70c0d4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax_3ef102e5-ef89-4aa5-9e94-2dd4a70c0d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_028ee2fb-0901-4cb3-ae9a-fc0242a4f5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_028ee2fb-0901-4cb3-ae9a-fc0242a4f5e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5c0111e7-9fb8-46d0-85da-4658114cfa82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_5c0111e7-9fb8-46d0-85da-4658114cfa82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7d69cc2b-db4a-4dab-b065-03ab2f10c26a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_7d69cc2b-db4a-4dab-b065-03ab2f10c26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_42b10d34-ef11-4f57-b888-810ef0ccb8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAociCurrentPeriodTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_ReclassificationFromAociCurrentPeriodTax_42b10d34-ef11-4f57-b888-810ef0ccb8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_55784834-2d28-4bc3-9eb8-056b4e34ee3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_55784834-2d28-4bc3-9eb8-056b4e34ee3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_833dbb80-cdf7-4364-845d-c7802791afff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_833dbb80-cdf7-4364-845d-c7802791afff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dcb96d07-54bc-4d9d-ac4b-c05c2438c3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_283de827-bfe0-42ae-ae72-78f20663a41d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dcb96d07-54bc-4d9d-ac4b-c05c2438c3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#OtherComprehensiveEarningsLossesReclassificationsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2a89a5e0-9530-4223-bed5-9dc0dfb1777e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1cc3afe2-fb7a-4c73-941f-6cf9a7b7164d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2a89a5e0-9530-4223-bed5-9dc0dfb1777e" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1cc3afe2-fb7a-4c73-941f-6cf9a7b7164d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_910fc58b-f5da-47a6-8abc-db75ed91eb45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1cc3afe2-fb7a-4c73-941f-6cf9a7b7164d" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_910fc58b-f5da-47a6-8abc-db75ed91eb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_0e5be3d4-2b0d-4a00-83f8-d4f7f317a2c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_910fc58b-f5da-47a6-8abc-db75ed91eb45" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_0e5be3d4-2b0d-4a00-83f8-d4f7f317a2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_c6573823-4137-45e0-8015-6b7e57e77321" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_0e5be3d4-2b0d-4a00-83f8-d4f7f317a2c8" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_c6573823-4137-45e0-8015-6b7e57e77321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4516b053-64c2-47cb-8aac-eb4079f18fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1cc3afe2-fb7a-4c73-941f-6cf9a7b7164d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4516b053-64c2-47cb-8aac-eb4079f18fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_adf66d9b-bcc1-4466-af5a-5c616b144389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4516b053-64c2-47cb-8aac-eb4079f18fa2" xlink:to="loc_us-gaap_EquityComponentDomain_adf66d9b-bcc1-4466-af5a-5c616b144389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d46c8961-faa9-495a-9701-52184bf02e27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_adf66d9b-bcc1-4466-af5a-5c616b144389" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d46c8961-faa9-495a-9701-52184bf02e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_3833c89b-e838-4c62-9bd4-1fcfe7b3882d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d46c8961-faa9-495a-9701-52184bf02e27" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember_3833c89b-e838-4c62-9bd4-1fcfe7b3882d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_8119f187-eba0-41ff-b15b-e9991dd64a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d46c8961-faa9-495a-9701-52184bf02e27" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_8119f187-eba0-41ff-b15b-e9991dd64a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_4edb10b9-eee0-4f69-9ed9-42c7f2d7ec7b" xlink:href="mo-20221231.xsd#mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_adf66d9b-bcc1-4466-af5a-5c616b144389" xlink:to="loc_mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember_4edb10b9-eee0-4f69-9ed9-42c7f2d7ec7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember_b97d5f55-e8c2-4f09-a209-16f38ae6adcb" xlink:href="mo-20221231.xsd#mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_adf66d9b-bcc1-4466-af5a-5c616b144389" xlink:to="loc_mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember_b97d5f55-e8c2-4f09-a209-16f38ae6adcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bec6f054-0672-4e9a-a062-daeffaf5a9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable_1cc3afe2-fb7a-4c73-941f-6cf9a7b7164d" xlink:to="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bec6f054-0672-4e9a-a062-daeffaf5a9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_8b40266b-d118-46fa-a87b-e10e459f4c61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bec6f054-0672-4e9a-a062-daeffaf5a9a9" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_8b40266b-d118-46fa-a87b-e10e459f4c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4593eb37-7832-4c93-9d3c-ff78d939a57c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bec6f054-0672-4e9a-a062-daeffaf5a9a9" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_4593eb37-7832-4c93-9d3c-ff78d939a57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CurrencyTranslationAdjustmentsAndOther_ef3a699f-431b-4f7f-b6c0-5055db6b694b" xlink:href="mo-20221231.xsd#mo_CurrencyTranslationAdjustmentsAndOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bec6f054-0672-4e9a-a062-daeffaf5a9a9" xlink:to="loc_mo_CurrencyTranslationAdjustmentsAndOther_ef3a699f-431b-4f7f-b6c0-5055db6b694b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a2dcc108-3fa9-4402-b269-34b05216841e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems_bec6f054-0672-4e9a-a062-daeffaf5a9a9" xlink:to="loc_us-gaap_ProfitLoss_a2dcc108-3fa9-4402-b269-34b05216841e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_bccb7592-82ee-492f-9431-f5a36b2f26df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e1768875-7a43-46c4-91e0-5285a353dfac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bccb7592-82ee-492f-9431-f5a36b2f26df" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_e1768875-7a43-46c4-91e0-5285a353dfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0e8fe5c0-5d4d-4f8c-94eb-57adb94975cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bccb7592-82ee-492f-9431-f5a36b2f26df" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_0e8fe5c0-5d4d-4f8c-94eb-57adb94975cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d7bc4d6-ba50-48c0-aee4-311a91fff296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bccb7592-82ee-492f-9431-f5a36b2f26df" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9d7bc4d6-ba50-48c0-aee4-311a91fff296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_fd3d8068-7fc0-4fe4-8c9c-2c5c3c059b4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_bccb7592-82ee-492f-9431-f5a36b2f26df" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_fd3d8068-7fc0-4fe4-8c9c-2c5c3c059b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_77bb88d7-ab60-4cfa-bba7-f2aca845b36d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_fd3d8068-7fc0-4fe4-8c9c-2c5c3c059b4e" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_77bb88d7-ab60-4cfa-bba7-f2aca845b36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_5d3f0f8c-1994-4ae4-bd9b-1e4b2b566f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_77bb88d7-ab60-4cfa-bba7-f2aca845b36d" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_5d3f0f8c-1994-4ae4-bd9b-1e4b2b566f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b5a2fc59-a4a1-4319-b1ff-3a022425dad5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_77bb88d7-ab60-4cfa-bba7-f2aca845b36d" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b5a2fc59-a4a1-4319-b1ff-3a022425dad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_cb7322e8-f020-464e-a258-593df8a878a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_77bb88d7-ab60-4cfa-bba7-f2aca845b36d" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_cb7322e8-f020-464e-a258-593df8a878a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c5c04bd0-cd42-4c20-a222-3942224d0738" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_77bb88d7-ab60-4cfa-bba7-f2aca845b36d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c5c04bd0-cd42-4c20-a222-3942224d0738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_96d92a5b-bdf9-4571-ba44-f22277879ecc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_fd3d8068-7fc0-4fe4-8c9c-2c5c3c059b4e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_96d92a5b-bdf9-4571-ba44-f22277879ecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b21c60f9-6e48-4b87-a8e6-7e5b2c539ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_96d92a5b-bdf9-4571-ba44-f22277879ecc" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_b21c60f9-6e48-4b87-a8e6-7e5b2c539ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5282d254-1e68-47a1-b371-a1099166dc69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_96d92a5b-bdf9-4571-ba44-f22277879ecc" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5282d254-1e68-47a1-b371-a1099166dc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f4e283a4-fd6e-4992-8a23-2000e8e74b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_96d92a5b-bdf9-4571-ba44-f22277879ecc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f4e283a4-fd6e-4992-8a23-2000e8e74b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_39a7a703-6e47-43a6-afa9-9927e980f817" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract_fd3d8068-7fc0-4fe4-8c9c-2c5c3c059b4e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_39a7a703-6e47-43a6-afa9-9927e980f817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_286c552c-2df4-4c06-9bd5-222790b68c77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_53a2441b-bbe8-4e1f-b26e-d0369db8fd54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_286c552c-2df4-4c06-9bd5-222790b68c77" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_53a2441b-bbe8-4e1f-b26e-d0369db8fd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_7add9a4a-5bc1-413d-b575-e4138f3e4261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_53a2441b-bbe8-4e1f-b26e-d0369db8fd54" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_7add9a4a-5bc1-413d-b575-e4138f3e4261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_06405de4-cecc-481b-a2c1-449548d816b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_53a2441b-bbe8-4e1f-b26e-d0369db8fd54" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_06405de4-cecc-481b-a2c1-449548d816b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_ee5b9c16-2018-464c-98e0-858a92b1809b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_53a2441b-bbe8-4e1f-b26e-d0369db8fd54" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_ee5b9c16-2018-464c-98e0-858a92b1809b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_5f9a8531-26c8-482c-bd15-725a91344ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_53a2441b-bbe8-4e1f-b26e-d0369db8fd54" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_5f9a8531-26c8-482c-bd15-725a91344ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_c9447f97-7782-4f07-b6f8-f532c868df32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_53a2441b-bbe8-4e1f-b26e-d0369db8fd54" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_c9447f97-7782-4f07-b6f8-f532c868df32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_915e5304-a733-4b10-864e-d72b48f3310f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_53a2441b-bbe8-4e1f-b26e-d0369db8fd54" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_915e5304-a733-4b10-864e-d72b48f3310f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_77d92019-ab6d-4419-9683-3619dc328a08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_53a2441b-bbe8-4e1f-b26e-d0369db8fd54" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_77d92019-ab6d-4419-9683-3619dc328a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5991a525-72cd-48d5-9951-dad1b85202b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_5aaf8b30-103c-42ee-833b-37ed8067063e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5991a525-72cd-48d5-9951-dad1b85202b0" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_5aaf8b30-103c-42ee-833b-37ed8067063e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a6f2db3-3e89-4546-a1f0-711568135ef7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5aaf8b30-103c-42ee-833b-37ed8067063e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a6f2db3-3e89-4546-a1f0-711568135ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4c302710-5c24-42cb-9172-655e29a831ef" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2a6f2db3-3e89-4546-a1f0-711568135ef7" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4c302710-5c24-42cb-9172-655e29a831ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_af888f79-870c-4a33-8e58-a2f03ac6034a" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c302710-5c24-42cb-9172-655e29a831ef" xlink:to="loc_mo_JUULMember_af888f79-870c-4a33-8e58-a2f03ac6034a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_b3f780e9-16db-4e4e-9afd-85c1cd5de9c2" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4c302710-5c24-42cb-9172-655e29a831ef" xlink:to="loc_mo_CronosGroupInc.Member_b3f780e9-16db-4e4e-9afd-85c1cd5de9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_719926cb-6598-4186-ba52-120ffed5d445" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5aaf8b30-103c-42ee-833b-37ed8067063e" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_719926cb-6598-4186-ba52-120ffed5d445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b0d05c04-931b-4604-b60f-0789ff971a35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_719926cb-6598-4186-ba52-120ffed5d445" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b0d05c04-931b-4604-b60f-0789ff971a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_06ebd577-0314-4320-8561-42aaac62a589" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_b0d05c04-931b-4604-b60f-0789ff971a35" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_06ebd577-0314-4320-8561-42aaac62a589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_5aaf8b30-103c-42ee-833b-37ed8067063e" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_4734f272-6590-475a-a1ef-310861f61176" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_4734f272-6590-475a-a1ef-310861f61176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate_bc24da3d-2e27-4e15-bc06-b7998987cc7a" xlink:href="mo-20221231.xsd#mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate_bc24da3d-2e27-4e15-bc06-b7998987cc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_591b2dbf-cd97-40bc-a4de-1a2dcc41d0df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_591b2dbf-cd97-40bc-a4de-1a2dcc41d0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_73de258f-7a73-4704-886c-0f171b23954b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_73de258f-7a73-4704-886c-0f171b23954b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_577cf35a-9276-4952-be5e-dad3bea580ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible_577cf35a-9276-4952-be5e-dad3bea580ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount_5566cec0-3b15-40ad-bc23-60d8d626ba1b" xlink:href="mo-20221231.xsd#mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount_5566cec0-3b15-40ad-bc23-60d8d626ba1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_9af3c1cc-05e7-45de-a884-ebb881b11f19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_9af3c1cc-05e7-45de-a884-ebb881b11f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_cc80559b-1801-4460-b2bd-0a4f2d828054" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_cc80559b-1801-4460-b2bd-0a4f2d828054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1ec3c8f7-0df5-4627-806d-fe497a501ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1ec3c8f7-0df5-4627-806d-fe497a501ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_9704f313-5d14-4010-a3a5-5a67d4c7f723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_OperatingLossCarryforwards_9704f313-5d14-4010-a3a5-5a67d4c7f723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_507d732f-61a4-4083-86fc-10940bdcbd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_507d732f-61a4-4083-86fc-10940bdcbd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_87eeeccf-c71c-4d63-a375-9251985dbdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_e81f697e-6f42-4189-bb9d-203a2f2011c1" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_87eeeccf-c71c-4d63-a375-9251985dbdc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_cc573a15-3e3f-40f7-8095-94bf3309b7a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_52ff8a4d-ec81-408f-b5c4-3b2359dc6b6b" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cc573a15-3e3f-40f7-8095-94bf3309b7a2" xlink:to="loc_mo_InvestmentsTable_52ff8a4d-ec81-408f-b5c4-3b2359dc6b6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d87f2a85-4b99-44cb-8f72-3c0e75bae73e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_52ff8a4d-ec81-408f-b5c4-3b2359dc6b6b" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d87f2a85-4b99-44cb-8f72-3c0e75bae73e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_82314d8c-7911-44c8-8a6f-611b670381a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d87f2a85-4b99-44cb-8f72-3c0e75bae73e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_82314d8c-7911-44c8-8a6f-611b670381a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ABInBevMember_96072a79-49bb-43dd-b3c3-fd9221be8c22" xlink:href="mo-20221231.xsd#mo_ABInBevMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_82314d8c-7911-44c8-8a6f-611b670381a0" xlink:to="loc_mo_ABInBevMember_96072a79-49bb-43dd-b3c3-fd9221be8c22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_ff94fef2-b719-47a3-8771-0c015a632750" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_82314d8c-7911-44c8-8a6f-611b670381a0" xlink:to="loc_mo_JUULMember_ff94fef2-b719-47a3-8771-0c015a632750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_96ef97ef-5d4c-4636-8943-2ada1ee1ff9b" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_82314d8c-7911-44c8-8a6f-611b670381a0" xlink:to="loc_mo_CronosGroupInc.Member_96ef97ef-5d4c-4636-8943-2ada1ee1ff9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_2b00ba81-7954-405a-b027-66a5112085e8" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_52ff8a4d-ec81-408f-b5c4-3b2359dc6b6b" xlink:to="loc_mo_InvestmentsLineItems_2b00ba81-7954-405a-b027-66a5112085e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_c28e1eb4-b7ad-47a6-bb0a-fffbf4be1c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_2b00ba81-7954-405a-b027-66a5112085e8" xlink:to="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_c28e1eb4-b7ad-47a6-bb0a-fffbf4be1c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_c28e1eb4-b7ad-47a6-bb0a-fffbf4be1c40" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_8be7ce57-1fe4-46bd-8a9e-d708844a90c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_8be7ce57-1fe4-46bd-8a9e-d708844a90c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_657c7844-4915-437e-bbad-eff9f57ab515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_657c7844-4915-437e-bbad-eff9f57ab515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount_ea03a3a8-77b6-40ff-8075-d329cb0c52ff" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount_ea03a3a8-77b6-40ff-8075-d329cb0c52ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_2912e07a-6966-4a3e-b3ad-cf00ce108304" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_2912e07a-6966-4a3e-b3ad-cf00ce108304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_8b987712-4a16-4828-afae-0c7d45de2fbf" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount_8b987712-4a16-4828-afae-0c7d45de2fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount_4a527cc9-a392-4f41-9d58-212e1a2db6a4" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount_4a527cc9-a392-4f41-9d58-212e1a2db6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_b3869fd4-dfc8-4f3c-8b23-c74a98847d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_b3869fd4-dfc8-4f3c-8b23-c74a98847d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ef08331c-476d-4b17-93bb-cf4dfee725ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract_7776e799-d3b0-4ebe-a265-0dbed8b41cba" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ef08331c-476d-4b17-93bb-cf4dfee725ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract_c28e1eb4-b7ad-47a6-bb0a-fffbf4be1c40" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_896fcf36-a16c-415f-9502-826eeb5f5c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_896fcf36-a16c-415f-9502-826eeb5f5c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7d31628e-c284-494c-a051-2af5573741ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_7d31628e-c284-494c-a051-2af5573741ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments_0f518a88-fb97-4728-ad16-30e804979f3b" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments_0f518a88-fb97-4728-ad16-30e804979f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_a1a36ae2-e3cd-4db6-8b4f-5fa64f50d8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies_a1a36ae2-e3cd-4db6-8b4f-5fa64f50d8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_ddecd9e2-e54e-4b52-9887-4f51292de12f" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent_ddecd9e2-e54e-4b52-9887-4f51292de12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent_0a8b2e32-fce2-4926-9dda-1ec63aaff9f4" xlink:href="mo-20221231.xsd#mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent_0a8b2e32-fce2-4926-9dda-1ec63aaff9f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_e3ba710b-9da9-47c9-9fa6-757725f399a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_e3ba710b-9da9-47c9-9fa6-757725f399a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9c5f932d-c263-45b2-bd81-05c33ca339e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_3b890bf9-be89-4f8f-a703-4eb0378b85d6" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9c5f932d-c263-45b2-bd81-05c33ca339e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fef4c6b1-a621-4f12-8417-7c694f0ee1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsTable_77f633b1-e963-4593-aa5a-9834dfd9d1a1" xlink:href="mo-20221231.xsd#mo_InvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fef4c6b1-a621-4f12-8417-7c694f0ee1bb" xlink:to="loc_mo_InvestmentsTable_77f633b1-e963-4593-aa5a-9834dfd9d1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0a1e2f41-8c3c-4544-b3f5-4038bf7233a1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_77f633b1-e963-4593-aa5a-9834dfd9d1a1" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0a1e2f41-8c3c-4544-b3f5-4038bf7233a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_cab362af-b1a6-4363-859c-3ce0d9603b63" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0a1e2f41-8c3c-4544-b3f5-4038bf7233a1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_cab362af-b1a6-4363-859c-3ce0d9603b63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_d4af7a4e-7e59-47a7-a98d-e9dea5ef26f1" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_cab362af-b1a6-4363-859c-3ce0d9603b63" xlink:to="loc_mo_JUULMember_d4af7a4e-7e59-47a7-a98d-e9dea5ef26f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CronosGroupInc.Member_6a4ccacd-c346-4ccb-a303-ec573a0c87f8" xlink:href="mo-20221231.xsd#mo_CronosGroupInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_cab362af-b1a6-4363-859c-3ce0d9603b63" xlink:to="loc_mo_CronosGroupInc.Member_6a4ccacd-c346-4ccb-a303-ec573a0c87f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InvestmentsLineItems_59b743ee-6e7d-4f11-988c-a3d9bf781403" xlink:href="mo-20221231.xsd#mo_InvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsTable_77f633b1-e963-4593-aa5a-9834dfd9d1a1" xlink:to="loc_mo_InvestmentsLineItems_59b743ee-6e7d-4f11-988c-a3d9bf781403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_59b743ee-6e7d-4f11-988c-a3d9bf781403" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_0fd8faa2-ba49-49bf-b546-baae0a0e3eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits_0fd8faa2-ba49-49bf-b546-baae0a0e3eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_261d884f-9ecd-48e2-b963-de74984ac4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements_261d884f-9ecd-48e2-b963-de74984ac4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxAssetsInvestmentsInEquitySecurities_9d640d11-a955-4f4e-ba75-0bdc95cfee2d" xlink:href="mo-20221231.xsd#mo_DeferredTaxAssetsInvestmentsInEquitySecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:to="loc_mo_DeferredTaxAssetsInvestmentsInEquitySecurities_9d640d11-a955-4f4e-ba75-0bdc95cfee2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments_dcba2d6a-81e9-4db2-bfd7-cdf0792b7ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:to="loc_us-gaap_DeferredTaxAssetsEquityMethodInvestments_dcba2d6a-81e9-4db2-bfd7-cdf0792b7ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards_aea31172-ae8e-47a8-bf8b-c18cfb5f8f73" xlink:href="mo-20221231.xsd#mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:to="loc_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards_aea31172-ae8e-47a8-bf8b-c18cfb5f8f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_a7db865a-eab2-49fe-bb61-033f424b06bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_54172bfd-5aa3-4f9b-8729-d1a7e1dc9dc4" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_a7db865a-eab2-49fe-bb61-033f424b06bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_59b743ee-6e7d-4f11-988c-a3d9bf781403" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_c334aae6-9cb5-40fa-8df4-0f6c485dcc98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_c334aae6-9cb5-40fa-8df4-0f6c485dcc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_be58a4e2-0c56-4b9a-9d3b-17a60541038f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_be58a4e2-0c56-4b9a-9d3b-17a60541038f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_e695e1d4-dab7-49d6-9be0-e6d30e7de8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates_e695e1d4-dab7-49d6-9be0-e6d30e7de8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld_739821f4-3a5e-4406-acd8-eda8b32c3658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld_739821f4-3a5e-4406-acd8-eda8b32c3658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxLiabilitiesAccruedPensionCosts_2995a1e3-0717-45fd-859b-39c2a3f1e561" xlink:href="mo-20221231.xsd#mo_DeferredTaxLiabilitiesAccruedPensionCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_mo_DeferredTaxLiabilitiesAccruedPensionCosts_2995a1e3-0717-45fd-859b-39c2a3f1e561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_47cf4da2-f5b3-400f-b322-b3a0ff3294cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_47cf4da2-f5b3-400f-b322-b3a0ff3294cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_7c226c44-4c36-4968-adfb-f990322d9425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_f4b8d1c3-dd9a-4d2f-9336-50bafbe23b06" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_7c226c44-4c36-4968-adfb-f990322d9425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1fbd04f4-c2e6-4712-bed1-da48d9dac6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_59b743ee-6e7d-4f11-988c-a3d9bf781403" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1fbd04f4-c2e6-4712-bed1-da48d9dac6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_ebb7536d-0bfa-4962-8965-078a7808ee70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_InvestmentsLineItems_59b743ee-6e7d-4f11-988c-a3d9bf781403" xlink:to="loc_us-gaap_DeferredTaxLiabilities_ebb7536d-0bfa-4962-8965-078a7808ee70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/IncomeTaxesSummaryofValuationAllowanceDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#IncomeTaxesSummaryofValuationAllowanceDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/IncomeTaxesSummaryofValuationAllowanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_26920d91-56fc-47f2-830c-79d3fed0022b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DeferredTaxAssetsValuationAllowanceRollForward_d50b8c00-c473-45cd-bde7-137b909e2531" xlink:href="mo-20221231.xsd#mo_DeferredTaxAssetsValuationAllowanceRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_26920d91-56fc-47f2-830c-79d3fed0022b" xlink:to="loc_mo_DeferredTaxAssetsValuationAllowanceRollForward_d50b8c00-c473-45cd-bde7-137b909e2531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_031685aa-ab97-422a-9682-d32576e01b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_DeferredTaxAssetsValuationAllowanceRollForward_d50b8c00-c473-45cd-bde7-137b909e2531" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_031685aa-ab97-422a-9682-d32576e01b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions_451f6850-e64a-412e-902f-fe80e264cacb" xlink:href="mo-20221231.xsd#mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_DeferredTaxAssetsValuationAllowanceRollForward_d50b8c00-c473-45cd-bde7-137b909e2531" xlink:to="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions_451f6850-e64a-412e-902f-fe80e264cacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetReductions_3354b4b9-cdb8-4d6c-a0b6-ebf99589a057" xlink:href="mo-20221231.xsd#mo_ValuationAllowanceDeferredTaxAssetReductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_DeferredTaxAssetsValuationAllowanceRollForward_d50b8c00-c473-45cd-bde7-137b909e2531" xlink:to="loc_mo_ValuationAllowanceDeferredTaxAssetReductions_3354b4b9-cdb8-4d6c-a0b6-ebf99589a057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation_fefe979e-c604-4195-a14a-b2536e36589a" xlink:href="mo-20221231.xsd#mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_DeferredTaxAssetsValuationAllowanceRollForward_d50b8c00-c473-45cd-bde7-137b909e2531" xlink:to="loc_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation_fefe979e-c604-4195-a14a-b2536e36589a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b0abc63a-a6f9-4117-8a44-32a137792b34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_DeferredTaxAssetsValuationAllowanceRollForward_d50b8c00-c473-45cd-bde7-137b909e2531" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b0abc63a-a6f9-4117-8a44-32a137792b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#SegmentReportingNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a7b9b886-e5bd-4168-b199-6f53824a8438" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a7b9b886-e5bd-4168-b199-6f53824a8438" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a7072f7d-06da-4a1c-80e1-49fde99e48c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a7072f7d-06da-4a1c-80e1-49fde99e48c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_df8ac46a-9568-4bb0-bcbc-35c7ea46a5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a7072f7d-06da-4a1c-80e1-49fde99e48c5" xlink:to="loc_us-gaap_SegmentDomain_df8ac46a-9568-4bb0-bcbc-35c7ea46a5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_ab62079c-5365-49d4-907b-a8cd485faa13" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df8ac46a-9568-4bb0-bcbc-35c7ea46a5dd" xlink:to="loc_mo_SmokeableProductsSegmentMember_ab62079c-5365-49d4-907b-a8cd485faa13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_286434f1-86ad-4989-9d3f-5033c67baf28" xlink:href="mo-20221231.xsd#mo_WineSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df8ac46a-9568-4bb0-bcbc-35c7ea46a5dd" xlink:to="loc_mo_WineSegmentMember_286434f1-86ad-4989-9d3f-5033c67baf28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_407e3808-2947-46d1-b3d9-e8a91502a279" xlink:href="mo-20221231.xsd#mo_OralTobaccoSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_df8ac46a-9568-4bb0-bcbc-35c7ea46a5dd" xlink:to="loc_mo_OralTobaccoSegmentMember_407e3808-2947-46d1-b3d9-e8a91502a279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8debb012-a3a0-4431-9419-8d06360f315a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_srt_ProductOrServiceAxis_8debb012-a3a0-4431-9419-8d06360f315a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6a4b96ec-77f4-4469-beda-c63f66e28e08" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8debb012-a3a0-4431-9419-8d06360f315a" xlink:to="loc_srt_ProductsAndServicesDomain_6a4b96ec-77f4-4469-beda-c63f66e28e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CigarettesMember_949df94b-b133-4264-a48a-b851dce9490c" xlink:href="mo-20221231.xsd#mo_CigarettesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6a4b96ec-77f4-4469-beda-c63f66e28e08" xlink:to="loc_mo_CigarettesMember_949df94b-b133-4264-a48a-b851dce9490c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CigarsMember_044a7f74-76b5-4094-bb63-5187f123424f" xlink:href="mo-20221231.xsd#mo_CigarsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6a4b96ec-77f4-4469-beda-c63f66e28e08" xlink:to="loc_mo_CigarsMember_044a7f74-76b5-4094-bb63-5187f123424f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab61dbbc-907b-422d-b3e2-ef44f5dca7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab61dbbc-907b-422d-b3e2-ef44f5dca7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_365f0c4f-e647-4c96-82d8-788a2c45da89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ab61dbbc-907b-422d-b3e2-ef44f5dca7a8" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_365f0c4f-e647-4c96-82d8-788a2c45da89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_655d5bfc-b81d-4d1b-9aa1-ae8a245afcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_365f0c4f-e647-4c96-82d8-788a2c45da89" xlink:to="loc_us-gaap_SalesRevenueNetMember_655d5bfc-b81d-4d1b-9aa1-ae8a245afcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_854fa9a9-4461-4993-b522-10737fc91745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_854fa9a9-4461-4993-b522-10737fc91745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_06cbac97-092d-4945-a21b-e96162b90677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_854fa9a9-4461-4993-b522-10737fc91745" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_06cbac97-092d-4945-a21b-e96162b90677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_74343888-a626-4079-84c3-c64e48d0aed9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_06cbac97-092d-4945-a21b-e96162b90677" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_74343888-a626-4079-84c3-c64e48d0aed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_39d0514f-670c-4079-bb26-e44f5ec4e049" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_srt_MajorCustomersAxis_39d0514f-670c-4079-bb26-e44f5ec4e049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e30bd501-3ea2-4615-83c4-83d133dad512" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_39d0514f-670c-4079-bb26-e44f5ec4e049" xlink:to="loc_srt_NameOfMajorCustomerDomain_e30bd501-3ea2-4615-83c4-83d133dad512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_McLaneCompanyIncMember_cab58d89-fdb5-4f43-b2bb-5ed30a757d56" xlink:href="mo-20221231.xsd#mo_McLaneCompanyIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e30bd501-3ea2-4615-83c4-83d133dad512" xlink:to="loc_mo_McLaneCompanyIncMember_cab58d89-fdb5-4f43-b2bb-5ed30a757d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PerformanceFoodGroupCompanyMember_4884786d-84a3-4134-9d29-0fac4cce16da" xlink:href="mo-20221231.xsd#mo_PerformanceFoodGroupCompanyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e30bd501-3ea2-4615-83c4-83d133dad512" xlink:to="loc_mo_PerformanceFoodGroupCompanyMember_4884786d-84a3-4134-9d29-0fac4cce16da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CoreMarkHoldingCompanyInc.Member_fa9803fa-15aa-4d31-b941-212c6039b325" xlink:href="mo-20221231.xsd#mo_CoreMarkHoldingCompanyInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e30bd501-3ea2-4615-83c4-83d133dad512" xlink:to="loc_mo_CoreMarkHoldingCompanyInc.Member_fa9803fa-15aa-4d31-b941-212c6039b325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_aff926db-0f9d-471c-946e-4e47aa969a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_aff926db-0f9d-471c-946e-4e47aa969a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_31ad834a-34f5-4b0b-952e-4368382cc903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_aff926db-0f9d-471c-946e-4e47aa969a4f" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_31ad834a-34f5-4b0b-952e-4368382cc903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_COVID19Member_75691c5b-93bc-402a-8cf1-4fa4930c9af9" xlink:href="mo-20221231.xsd#mo_COVID19Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_31ad834a-34f5-4b0b-952e-4368382cc903" xlink:to="loc_mo_COVID19Member_75691c5b-93bc-402a-8cf1-4fa4930c9af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_dcf8a700-1de4-4048-bdd2-4ad3a78f407d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_dcf8a700-1de4-4048-bdd2-4ad3a78f407d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_927dc259-ffba-4a0e-8c6e-ddab4f253b7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_dcf8a700-1de4-4048-bdd2-4ad3a78f407d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_927dc259-ffba-4a0e-8c6e-ddab4f253b7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MarketingAdministrationAndResearchCostsMember_e7ba688c-eecd-4239-9870-62d5a2251654" xlink:href="mo-20221231.xsd#mo_MarketingAdministrationAndResearchCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_927dc259-ffba-4a0e-8c6e-ddab4f253b7c" xlink:to="loc_mo_MarketingAdministrationAndResearchCostsMember_e7ba688c-eecd-4239-9870-62d5a2251654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d73982e1-3102-4310-bbcd-a4c146710771" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_dei_LegalEntityAxis_d73982e1-3102-4310-bbcd-a4c146710771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_99575e93-ca45-4e14-97a3-c262623f73ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d73982e1-3102-4310-bbcd-a4c146710771" xlink:to="loc_dei_EntityDomain_99575e93-ca45-4e14-97a3-c262623f73ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisCapitalCorporationMember_9adaf69d-242e-4f04-8533-9edf17152e36" xlink:href="mo-20221231.xsd#mo_PhilipMorrisCapitalCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_99575e93-ca45-4e14-97a3-c262623f73ae" xlink:to="loc_mo_PhilipMorrisCapitalCorporationMember_9adaf69d-242e-4f04-8533-9edf17152e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_cf3d3a51-b96a-4ba0-a63a-312546758262" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_cf3d3a51-b96a-4ba0-a63a-312546758262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_75b4a69f-de85-4efd-9f23-67c593ae601c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_cf3d3a51-b96a-4ba0-a63a-312546758262" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_75b4a69f-de85-4efd-9f23-67c593ae601c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f0b19f90-85b3-4803-8db1-d7ade7dcda0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_75b4a69f-de85-4efd-9f23-67c593ae601c" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_f0b19f90-85b3-4803-8db1-d7ade7dcda0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f686c63-6266-49b9-9b46-7e671696cf5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f686c63-6266-49b9-9b46-7e671696cf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f64cc1a-4258-43b6-afef-197f8dea1eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_6f686c63-6266-49b9-9b46-7e671696cf5e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f64cc1a-4258-43b6-afef-197f8dea1eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SteMichelleTransactionMember_26f586fd-9f12-47b1-b948-3f00e791c645" xlink:href="mo-20221231.xsd#mo_SteMichelleTransactionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f64cc1a-4258-43b6-afef-197f8dea1eb0" xlink:to="loc_mo_SteMichelleTransactionMember_26f586fd-9f12-47b1-b948-3f00e791c645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_b5beb2ae-3a52-424b-9449-cc8d66c41b65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_RestructuringPlanAxis_b5beb2ae-3a52-424b-9449-cc8d66c41b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_20fc155c-88dd-415c-8916-d1b4cac3a1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_b5beb2ae-3a52-424b-9449-cc8d66c41b65" xlink:to="loc_us-gaap_RestructuringPlanDomain_20fc155c-88dd-415c-8916-d1b4cac3a1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineBusinessStrategicResetMember_3715fa4d-190d-4afd-9c34-781e07c0601f" xlink:href="mo-20221231.xsd#mo_WineBusinessStrategicResetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_20fc155c-88dd-415c-8916-d1b4cac3a1fd" xlink:to="loc_mo_WineBusinessStrategicResetMember_3715fa4d-190d-4afd-9c34-781e07c0601f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_0c5b6684-8b9c-44f6-b182-1b1f234f949c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_0c5b6684-8b9c-44f6-b182-1b1f234f949c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_37b4761c-109c-487a-9b81-026d00edf3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_0c5b6684-8b9c-44f6-b182-1b1f234f949c" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_37b4761c-109c-487a-9b81-026d00edf3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InventoryWriteOffMember_2030b984-95c8-4dac-9c50-4cefb1655c1d" xlink:href="mo-20221231.xsd#mo_InventoryWriteOffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_37b4761c-109c-487a-9b81-026d00edf3d8" xlink:to="loc_mo_InventoryWriteOffMember_2030b984-95c8-4dac-9c50-4cefb1655c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseCommitmentMember_cf717652-b766-4bc6-ab78-2f205a9c1c4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PurchaseCommitmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_37b4761c-109c-487a-9b81-026d00edf3d8" xlink:to="loc_us-gaap_PurchaseCommitmentMember_cf717652-b766-4bc6-ab78-2f205a9c1c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_06800b23-5684-4fc3-8956-3965d8263c03" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9050cc15-12de-45a2-914e-366b111d2476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9050cc15-12de-45a2-914e-366b111d2476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_6ebb7383-9f25-4c9a-a252-9a9e6f8a0f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_6ebb7383-9f25-4c9a-a252-9a9e6f8a0f86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_f982edfc-650c-4e4c-aea6-dcbb89265078" xlink:href="mo-20221231.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts_f982edfc-650c-4e4c-aea6-dcbb89265078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_f5f589f5-3f16-4d00-8e18-55bed4d92e69" xlink:href="mo-20221231.xsd#mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts_f5f589f5-3f16-4d00-8e18-55bed4d92e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6e642fd2-03c9-46e3-869a-048bcd82dfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_6e642fd2-03c9-46e3-869a-048bcd82dfd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_61e87a1c-4cca-4eb2-9c48-8b329e30e5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_us-gaap_RestructuringCharges_61e87a1c-4cca-4eb2-9c48-8b329e30e5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset_4e1b01f0-a942-42ed-849b-e591d34b37c9" xlink:href="mo-20221231.xsd#mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset_4e1b01f0-a942-42ed-849b-e591d34b37c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5b6c8b71-081d-44b7-aebe-dae93fc6e994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_752bb72f-bfe4-4c35-b2df-f1c8ef089396" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5b6c8b71-081d-44b7-aebe-dae93fc6e994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#SegmentReportingSegmentDataScheduleDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_eb43da1a-00db-43bf-b2e6-7abdd0a02972" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_caaa6c8c-4313-4ee3-9729-35bd367d725d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_eb43da1a-00db-43bf-b2e6-7abdd0a02972" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_caaa6c8c-4313-4ee3-9729-35bd367d725d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_17ba7e5b-0439-4f7e-a39a-4ed31998da52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_caaa6c8c-4313-4ee3-9729-35bd367d725d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_17ba7e5b-0439-4f7e-a39a-4ed31998da52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_33337684-44ba-4ecb-93eb-87323d5707c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_17ba7e5b-0439-4f7e-a39a-4ed31998da52" xlink:to="loc_us-gaap_SegmentDomain_33337684-44ba-4ecb-93eb-87323d5707c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_4c23ff2a-394a-44ca-ad51-ba34e9956d66" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_33337684-44ba-4ecb-93eb-87323d5707c3" xlink:to="loc_mo_SmokeableProductsSegmentMember_4c23ff2a-394a-44ca-ad51-ba34e9956d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_e271f53c-15e9-452b-9dd5-8b932bc97e9f" xlink:href="mo-20221231.xsd#mo_OralTobaccoSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_33337684-44ba-4ecb-93eb-87323d5707c3" xlink:to="loc_mo_OralTobaccoSegmentMember_e271f53c-15e9-452b-9dd5-8b932bc97e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_64f14c57-69c1-4833-9d12-7572973da038" xlink:href="mo-20221231.xsd#mo_WineSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_33337684-44ba-4ecb-93eb-87323d5707c3" xlink:to="loc_mo_WineSegmentMember_64f14c57-69c1-4833-9d12-7572973da038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_7b0349b8-41ae-4779-b075-ed9d8f79022b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_33337684-44ba-4ecb-93eb-87323d5707c3" xlink:to="loc_us-gaap_AllOtherSegmentsMember_7b0349b8-41ae-4779-b075-ed9d8f79022b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3a41a85c-3581-4f77-90cb-e1d3cbe7769f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_caaa6c8c-4313-4ee3-9729-35bd367d725d" xlink:to="loc_srt_ConsolidationItemsAxis_3a41a85c-3581-4f77-90cb-e1d3cbe7769f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_eb1711b3-b644-4e47-b14b-b200add2507c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_3a41a85c-3581-4f77-90cb-e1d3cbe7769f" xlink:to="loc_srt_ConsolidationItemsDomain_eb1711b3-b644-4e47-b14b-b200add2507c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f44e7262-e037-4cd7-8a39-0e5880d48a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_eb1711b3-b644-4e47-b14b-b200add2507c" xlink:to="loc_us-gaap_OperatingSegmentsMember_f44e7262-e037-4cd7-8a39-0e5880d48a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_f22528f3-dd4f-4395-9c94-d11ffde34ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_eb1711b3-b644-4e47-b14b-b200add2507c" xlink:to="loc_us-gaap_CorporateNonSegmentMember_f22528f3-dd4f-4395-9c94-d11ffde34ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_caaa6c8c-4313-4ee3-9729-35bd367d725d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90606ea5-fda8-4067-9fbd-7d4304727c57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_90606ea5-fda8-4067-9fbd-7d4304727c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ad164a02-c936-4145-bb41-ba17fd32e036" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_OperatingIncomeLoss_ad164a02-c936-4145-bb41-ba17fd32e036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_ee9b6d8f-8b57-43d6-a865-2bcfbedfcaf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_ee9b6d8f-8b57-43d6-a865-2bcfbedfcaf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_a5252825-8597-420f-8714-51cd28128e83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_a5252825-8597-420f-8714-51cd28128e83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_bec41900-cd55-47a3-b8a1-e93e5b8bf7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_bec41900-cd55-47a3-b8a1-e93e5b8bf7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b2e112a2-5c59-49e1-b267-8d2a577d5e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b2e112a2-5c59-49e1-b267-8d2a577d5e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_c920b3db-b848-4383-b097-d1812a21f27e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent_c920b3db-b848-4383-b097-d1812a21f27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IncomeLossFromEquityInvestments_1d03e24a-4e5d-4695-a280-6ea12103f107" xlink:href="mo-20221231.xsd#mo_IncomeLossFromEquityInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_mo_IncomeLossFromEquityInvestments_1d03e24a-4e5d-4695-a280-6ea12103f107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_247b82f7-e195-460e-b05b-a46dacf40f00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount_247b82f7-e195-460e-b05b-a46dacf40f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_20f87f1a-9536-4cbe-947e-a692e290efc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_20f87f1a-9536-4cbe-947e-a692e290efc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a5cb307c-8a67-478a-a38e-f4416208ee4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3879168-c1fc-4ca6-a725-6674594714b2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a5cb307c-8a67-478a-a38e-f4416208ee4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c8b6a534-0030-4c16-b9f7-a070ce9c8422" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9d08a060-be0b-4c9d-b7a1-ac0ff9af6945" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c8b6a534-0030-4c16-b9f7-a070ce9c8422" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9d08a060-be0b-4c9d-b7a1-ac0ff9af6945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_35d167e9-ed64-4732-afe4-9c0460a36f33" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9d08a060-be0b-4c9d-b7a1-ac0ff9af6945" xlink:to="loc_srt_ConsolidationItemsAxis_35d167e9-ed64-4732-afe4-9c0460a36f33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b8b5e5f2-6d2e-496d-810c-3e3538c0385c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_35d167e9-ed64-4732-afe4-9c0460a36f33" xlink:to="loc_srt_ConsolidationItemsDomain_b8b5e5f2-6d2e-496d-810c-3e3538c0385c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9e16cc06-1f12-44c9-9d07-bf1d378f1a64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b8b5e5f2-6d2e-496d-810c-3e3538c0385c" xlink:to="loc_us-gaap_OperatingSegmentsMember_9e16cc06-1f12-44c9-9d07-bf1d378f1a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_27133f26-3cb2-48c6-a819-8e2377546a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b8b5e5f2-6d2e-496d-810c-3e3538c0385c" xlink:to="loc_us-gaap_CorporateNonSegmentMember_27133f26-3cb2-48c6-a819-8e2377546a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_5348731e-8850-48f2-bc84-c5a0ce8b99a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9d08a060-be0b-4c9d-b7a1-ac0ff9af6945" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_5348731e-8850-48f2-bc84-c5a0ce8b99a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a4f3f744-8731-4ebf-9aee-0012e74b6e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_5348731e-8850-48f2-bc84-c5a0ce8b99a1" xlink:to="loc_us-gaap_SegmentDomain_a4f3f744-8731-4ebf-9aee-0012e74b6e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_c36f9ec6-2f21-45ab-a24e-03453ddf676f" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4f3f744-8731-4ebf-9aee-0012e74b6e8a" xlink:to="loc_mo_SmokeableProductsSegmentMember_c36f9ec6-2f21-45ab-a24e-03453ddf676f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OralTobaccoSegmentMember_4b48fcea-4adc-4287-b1eb-bc6eb50aa6bd" xlink:href="mo-20221231.xsd#mo_OralTobaccoSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4f3f744-8731-4ebf-9aee-0012e74b6e8a" xlink:to="loc_mo_OralTobaccoSegmentMember_4b48fcea-4adc-4287-b1eb-bc6eb50aa6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_WineSegmentMember_38727843-0192-4109-9353-150519038bc6" xlink:href="mo-20221231.xsd#mo_WineSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4f3f744-8731-4ebf-9aee-0012e74b6e8a" xlink:to="loc_mo_WineSegmentMember_38727843-0192-4109-9353-150519038bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_32103c94-dc37-42b4-9508-167f73b75a02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9d08a060-be0b-4c9d-b7a1-ac0ff9af6945" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_32103c94-dc37-42b4-9508-167f73b75a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_ea325f0b-face-4322-92d0-b05cbffbdc31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_32103c94-dc37-42b4-9508-167f73b75a02" xlink:to="loc_us-gaap_Depreciation_ea325f0b-face-4322-92d0-b05cbffbdc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e2d1641d-43e8-4c5c-89d7-9085346db5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_32103c94-dc37-42b4-9508-167f73b75a02" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e2d1641d-43e8-4c5c-89d7-9085346db5b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ec98580f-bce5-4970-b496-05d6ee3f2073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ec98580f-bce5-4970-b496-05d6ee3f2073" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_10c37e4f-fcd9-4428-aa37-827a68077ad9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_srt_ConsolidationItemsAxis_10c37e4f-fcd9-4428-aa37-827a68077ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7c2f5048-81a0-43b6-964c-58d794025d38" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_10c37e4f-fcd9-4428-aa37-827a68077ad9" xlink:to="loc_srt_ConsolidationItemsDomain_7c2f5048-81a0-43b6-964c-58d794025d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_9f5bcc6d-4b34-4992-ab26-262eea64fad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7c2f5048-81a0-43b6-964c-58d794025d38" xlink:to="loc_us-gaap_OperatingSegmentsMember_9f5bcc6d-4b34-4992-ab26-262eea64fad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_a6fc5f9c-1252-43f6-91c1-01f96b4ca410" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_7c2f5048-81a0-43b6-964c-58d794025d38" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_a6fc5f9c-1252-43f6-91c1-01f96b4ca410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_83ff795d-9295-48c0-a54f-86d0d93b9711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_83ff795d-9295-48c0-a54f-86d0d93b9711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1212f434-3137-44e0-a751-1a61bfce8234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_83ff795d-9295-48c0-a54f-86d0d93b9711" xlink:to="loc_us-gaap_SegmentDomain_1212f434-3137-44e0-a751-1a61bfce8234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_8e95c5b2-92bc-4275-90c7-66991a00fd79" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1212f434-3137-44e0-a751-1a61bfce8234" xlink:to="loc_mo_SmokeableProductsSegmentMember_8e95c5b2-92bc-4275-90c7-66991a00fd79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_9da3a054-e0d7-421d-b40f-21d0d40bf70e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_srt_LitigationCaseAxis_9da3a054-e0d7-421d-b40f-21d0d40bf70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_a12c731c-bcd0-4dac-b7a2-884f84b7a4e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_9da3a054-e0d7-421d-b40f-21d0d40bf70e" xlink:to="loc_srt_LitigationCaseTypeDomain_a12c731c-bcd0-4dac-b7a2-884f84b7a4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_4dd1fb34-cc34-4f2f-bd4e-9408dd4b458d" xlink:href="mo-20221231.xsd#mo_NonParticipatingManufacturerArbitrationPanelDecisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_a12c731c-bcd0-4dac-b7a2-884f84b7a4e3" xlink:to="loc_mo_NonParticipatingManufacturerArbitrationPanelDecisionMember_4dd1fb34-cc34-4f2f-bd4e-9408dd4b458d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8294d075-d592-4460-a98b-64cd3c6e071c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8294d075-d592-4460-a98b-64cd3c6e071c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bf24d415-ee25-4c60-9f5a-1f8b880a5a7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8294d075-d592-4460-a98b-64cd3c6e071c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bf24d415-ee25-4c60-9f5a-1f8b880a5a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember_df8ef0a6-3b93-4db3-bc4a-49da2dce9770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bf24d415-ee25-4c60-9f5a-1f8b880a5a7e" xlink:to="loc_us-gaap_OperatingIncomeLossMember_df8ef0a6-3b93-4db3-bc4a-49da2dce9770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestAndOtherDebtExpenseNetMember_340366a8-d0ee-4dc0-b4e4-b9bc7ec105f1" xlink:href="mo-20221231.xsd#mo_InterestAndOtherDebtExpenseNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bf24d415-ee25-4c60-9f5a-1f8b880a5a7e" xlink:to="loc_mo_InterestAndOtherDebtExpenseNetMember_340366a8-d0ee-4dc0-b4e4-b9bc7ec105f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfExpenseAxis_beb8a014-9a11-4121-b3a6-04973682525e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfExpenseAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_us-gaap_NatureOfExpenseAxis_beb8a014-9a11-4121-b3a6-04973682525e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_05daef65-be38-4c7b-b6ad-b5022e26f53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterimPeriodCostsNotAllocableDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NatureOfExpenseAxis_beb8a014-9a11-4121-b3a6-04973682525e" xlink:to="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_05daef65-be38-4c7b-b6ad-b5022e26f53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NpmAdjustmentToCostOfSalesMember_25ba7071-fb21-4d9f-ba10-27f8faa53a7b" xlink:href="mo-20221231.xsd#mo_NpmAdjustmentToCostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_05daef65-be38-4c7b-b6ad-b5022e26f53e" xlink:to="loc_mo_NpmAdjustmentToCostOfSalesMember_25ba7071-fb21-4d9f-ba10-27f8faa53a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NPMAdjustmentToInterestExpenseMember_c98c5273-c740-44df-b27c-e7c147e2bf86" xlink:href="mo-20221231.xsd#mo_NPMAdjustmentToInterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_05daef65-be38-4c7b-b6ad-b5022e26f53e" xlink:to="loc_mo_NPMAdjustmentToInterestExpenseMember_c98c5273-c740-44df-b27c-e7c147e2bf86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember_e18173ad-2526-4d14-bc40-76602d3fd647" xlink:href="mo-20221231.xsd#mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterimPeriodCostsNotAllocableDomain_05daef65-be38-4c7b-b6ad-b5022e26f53e" xlink:to="loc_mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember_e18173ad-2526-4d14-bc40-76602d3fd647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0a520906-d9f2-49bd-9072-d92f4adcce84" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_dei_LegalEntityAxis_0a520906-d9f2-49bd-9072-d92f4adcce84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a200fcc3-f0c7-4b4e-969e-4d5c81398575" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_0a520906-d9f2-49bd-9072-d92f4adcce84" xlink:to="loc_dei_EntityDomain_a200fcc3-f0c7-4b4e-969e-4d5c81398575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_2447357f-1e3f-4bde-945b-23ae8c8977e0" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_a200fcc3-f0c7-4b4e-969e-4d5c81398575" xlink:to="loc_mo_PhilipMorrisUSAMember_2447357f-1e3f-4bde-945b-23ae8c8977e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cee53053-c015-4426-9bf1-72f5517d50a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bd28023e-08e6-4a43-a6dd-fa8bf7ca05f0" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_cee53053-c015-4426-9bf1-72f5517d50a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_6138be15-2ee5-49c5-ab35-2be6eff43434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cee53053-c015-4426-9bf1-72f5517d50a5" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_6138be15-2ee5-49c5-ab35-2be6eff43434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cbf3f954-deed-4a2d-a8ad-8bc855f4f879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:href="mo-20221231.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cbf3f954-deed-4a2d-a8ad-8bc855f4f879" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_68ab289e-0d43-4da9-84bd-199f4cc33141" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:to="loc_dei_LegalEntityAxis_68ab289e-0d43-4da9-84bd-199f4cc33141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ab4aa879-3929-43ac-a452-fddb863ee34c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_68ab289e-0d43-4da9-84bd-199f4cc33141" xlink:to="loc_dei_EntityDomain_ab4aa879-3929-43ac-a452-fddb863ee34c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_463bda2c-2e22-4bef-bcc7-ccc51df5e1d0" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ab4aa879-3929-43ac-a452-fddb863ee34c" xlink:to="loc_mo_PhilipMorrisUSAMember_463bda2c-2e22-4bef-bcc7-ccc51df5e1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_c3f46bd5-0b5a-428c-8474-24b315766385" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:to="loc_srt_LitigationCaseAxis_c3f46bd5-0b5a-428c-8474-24b315766385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b1f07959-7a02-428f-8569-06927f816c62" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_c3f46bd5-0b5a-428c-8474-24b315766385" xlink:to="loc_srt_LitigationCaseTypeDomain_b1f07959-7a02-428f-8569-06927f816c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthLitigationCasesMember_58de4d64-3157-41a5-9dec-f02b31a1aad9" xlink:href="mo-20221231.xsd#mo_TobaccoandHealthLitigationCasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b1f07959-7a02-428f-8569-06927f816c62" xlink:to="loc_mo_TobaccoandHealthLitigationCasesMember_58de4d64-3157-41a5-9dec-f02b31a1aad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1393c43f-a26a-4b40-acea-f5c8cc2322f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1393c43f-a26a-4b40-acea-f5c8cc2322f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_19674d2c-f06e-45f5-bf38-3ffe17bb61bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1393c43f-a26a-4b40-acea-f5c8cc2322f7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_19674d2c-f06e-45f5-bf38-3ffe17bb61bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember_0d788e5d-ca43-49a6-b671-64dcc811dc4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_19674d2c-f06e-45f5-bf38-3ffe17bb61bf" xlink:to="loc_us-gaap_OperatingIncomeLossMember_0d788e5d-ca43-49a6-b671-64dcc811dc4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestAndOtherDebtExpenseNetMember_ffe6e318-7e4f-4351-8030-69e0300617e7" xlink:href="mo-20221231.xsd#mo_InterestAndOtherDebtExpenseNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_19674d2c-f06e-45f5-bf38-3ffe17bb61bf" xlink:to="loc_mo_InterestAndOtherDebtExpenseNetMember_ffe6e318-7e4f-4351-8030-69e0300617e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5bbdef5d-dba9-44c2-8523-7df7e176d4d7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:to="loc_srt_ConsolidationItemsAxis_5bbdef5d-dba9-44c2-8523-7df7e176d4d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_cba1f9bf-4a26-4f04-9672-51aff998ee6a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5bbdef5d-dba9-44c2-8523-7df7e176d4d7" xlink:to="loc_srt_ConsolidationItemsDomain_cba1f9bf-4a26-4f04-9672-51aff998ee6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d5f8a371-6b8f-46d8-88a7-4736c05e4279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_cba1f9bf-4a26-4f04-9672-51aff998ee6a" xlink:to="loc_us-gaap_OperatingSegmentsMember_d5f8a371-6b8f-46d8-88a7-4736c05e4279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_d18e0de0-bc1a-451a-b54a-1aba3f99f612" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_cba1f9bf-4a26-4f04-9672-51aff998ee6a" xlink:to="loc_us-gaap_CorporateNonSegmentMember_d18e0de0-bc1a-451a-b54a-1aba3f99f612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_0a8abc2b-ba6c-483f-a64c-b1b0dc582391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_cba1f9bf-4a26-4f04-9672-51aff998ee6a" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_0a8abc2b-ba6c-483f-a64c-b1b0dc582391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bb0751be-4e67-43bb-ab49-dd8af02a9808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bb0751be-4e67-43bb-ab49-dd8af02a9808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8f6d92c7-161f-4b3e-97ca-06f4206ff5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bb0751be-4e67-43bb-ab49-dd8af02a9808" xlink:to="loc_us-gaap_SegmentDomain_8f6d92c7-161f-4b3e-97ca-06f4206ff5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokeableProductsSegmentMember_2b1301c9-c2d2-4af2-ab8e-d6c1bce79cfe" xlink:href="mo-20221231.xsd#mo_SmokeableProductsSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8f6d92c7-161f-4b3e-97ca-06f4206ff5d1" xlink:to="loc_mo_SmokeableProductsSegmentMember_2b1301c9-c2d2-4af2-ab8e-d6c1bce79cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_fcafd909-797d-4986-bc1c-ac56086fd1eb" xlink:href="mo-20221231.xsd#mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable_cd79b8b7-64fe-4046-bd09-0023ccc31a33" xlink:to="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_fcafd909-797d-4986-bc1c-ac56086fd1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_b2280819-e9f2-4156-9bc8-7d82405c995f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems_fcafd909-797d-4986-bc1c-ac56086fd1eb" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_b2280819-e9f2-4156-9bc8-7d82405c995f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bdc392ce-05f0-4441-80c7-ed35dc78c3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bdc392ce-05f0-4441-80c7-ed35dc78c3e4" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_5b12e900-fc16-4a56-95c6-baf0a7924c53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_5b12e900-fc16-4a56-95c6-baf0a7924c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_1b82e60e-019b-4297-88a8-fca3d1a6472f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_5b12e900-fc16-4a56-95c6-baf0a7924c53" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_1b82e60e-019b-4297-88a8-fca3d1a6472f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_4626fa72-0a17-4626-9477-70ad223c58ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1b82e60e-019b-4297-88a8-fca3d1a6472f" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_4626fa72-0a17-4626-9477-70ad223c58ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b006475f-98d7-434e-a1fd-cab795b10441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_1b82e60e-019b-4297-88a8-fca3d1a6472f" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b006475f-98d7-434e-a1fd-cab795b10441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aa452ea7-e016-49a8-b976-6f694f40ac7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aa452ea7-e016-49a8-b976-6f694f40ac7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_1d45c402-19dc-4ef8-845e-23dfe86f03b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_aa452ea7-e016-49a8-b976-6f694f40ac7a" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_1d45c402-19dc-4ef8-845e-23dfe86f03b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_de12f66a-ee62-48a0-a793-3c0674c36e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1d45c402-19dc-4ef8-845e-23dfe86f03b9" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_de12f66a-ee62-48a0-a793-3c0674c36e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FixedIncomeSecuritiesMember_d518a011-2406-4105-ade8-b9350b459328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FixedIncomeSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_1d45c402-19dc-4ef8-845e-23dfe86f03b9" xlink:to="loc_us-gaap_FixedIncomeSecuritiesMember_d518a011-2406-4105-ade8-b9350b459328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingAxis_055e8367-cc08-4bc6-9d6a-039821cc34ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_us-gaap_ExternalCreditRatingByGroupingAxis_055e8367-cc08-4bc6-9d6a-039821cc34ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingByGroupingDomain_cffd5e41-93a1-4f54-9f3e-3e19ec9b9e51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingByGroupingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingAxis_055e8367-cc08-4bc6-9d6a-039821cc34ec" xlink:to="loc_us-gaap_ExternalCreditRatingByGroupingDomain_cffd5e41-93a1-4f54-9f3e-3e19ec9b9e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExternalCreditRatingNonInvestmentGradeMember_281ed77b-d098-4b35-9653-2e49527d0b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ExternalCreditRatingNonInvestmentGradeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExternalCreditRatingByGroupingDomain_cffd5e41-93a1-4f54-9f3e-3e19ec9b9e51" xlink:to="loc_us-gaap_ExternalCreditRatingNonInvestmentGradeMember_281ed77b-d098-4b35-9653-2e49527d0b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2462893a-937c-4fe8-938a-594dab1d5298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_us-gaap_InvestmentTypeAxis_2462893a-937c-4fe8-938a-594dab1d5298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_d425697d-e85e-483d-afaf-f2489dbdc10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_2462893a-937c-4fe8-938a-594dab1d5298" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_d425697d-e85e-483d-afaf-f2489dbdc10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EmergingMarketsMember_01e6b693-0fcd-4a4a-b558-86ec471904dc" xlink:href="mo-20221231.xsd#mo_EmergingMarketsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_d425697d-e85e-483d-afaf-f2489dbdc10a" xlink:to="loc_mo_EmergingMarketsMember_01e6b693-0fcd-4a4a-b558-86ec471904dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_73018fbe-0bcf-4511-a6bd-e44297c999f4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_srt_RangeAxis_73018fbe-0bcf-4511-a6bd-e44297c999f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a7ffcf3e-3e6d-4ca5-a5cd-b1c5b5fc7547" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_73018fbe-0bcf-4511-a6bd-e44297c999f4" xlink:to="loc_srt_RangeMember_a7ffcf3e-3e6d-4ca5-a5cd-b1c5b5fc7547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3cb596cd-78d8-421f-883a-0797f3635eca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a7ffcf3e-3e6d-4ca5-a5cd-b1c5b5fc7547" xlink:to="loc_srt_MaximumMember_3cb596cd-78d8-421f-883a-0797f3635eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_df194cfc-b78d-4a23-a7b4-3295b29d65ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_srt_StatementScenarioAxis_df194cfc-b78d-4a23-a7b4-3295b29d65ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_95eb5804-4879-4c6c-b642-9894db6df617" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_df194cfc-b78d-4a23-a7b4-3295b29d65ed" xlink:to="loc_srt_ScenarioUnspecifiedDomain_95eb5804-4879-4c6c-b642-9894db6df617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_b4d13fc8-503f-4bff-8422-c4d119a79480" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_95eb5804-4879-4c6c-b642-9894db6df617" xlink:to="loc_srt_ScenarioForecastMember_b4d13fc8-503f-4bff-8422-c4d119a79480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_cb0c4248-43c5-4380-ae3c-31ec2cbb0467" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_62b11f1d-5cc8-4802-8bb9-180afdb4c432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_62b11f1d-5cc8-4802-8bb9-180afdb4c432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_610c528b-0cca-48d1-8871-21fe3b916c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations_610c528b-0cca-48d1-8871-21fe3b916c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_34b9c7ba-2ef4-44b5-a9fe-86b84f5a19d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation_34b9c7ba-2ef4-44b5-a9fe-86b84f5a19d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_5159867e-5cda-41ef-974d-5f5eac740f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets_5159867e-5cda-41ef-974d-5f5eac740f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_3b8a007e-603b-43d8-9db1-b2dd9a94598d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation_3b8a007e-603b-43d8-9db1-b2dd9a94598d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_64cdbb4f-ba0d-4e99-b0e3-9cbb10d11eec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets_64cdbb4f-ba0d-4e99-b0e3-9cbb10d11eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_e972268a-70e0-4c62-aae1-79efeb4f2656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_e972268a-70e0-4c62-aae1-79efeb4f2656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_5db265b7-51ae-4f76-a722-ecc5834c9ace" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_5db265b7-51ae-4f76-a722-ecc5834c9ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_4fb932d5-6f99-43b7-8f89-bef9d4dbfe68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_4fb932d5-6f99-43b7-8f89-bef9d4dbfe68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_362f1436-4c3f-44aa-bab1-c98c0c4bd62d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_362f1436-4c3f-44aa-bab1-c98c0c4bd62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0fb9ada5-a257-4af3-8d3f-21c6f429c06b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_0fb9ada5-a257-4af3-8d3f-21c6f429c06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_4e160528-5f33-49fb-9359-7119bc42770b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_27223f1f-efcc-42ee-b8c7-495179fe35d5" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_4e160528-5f33-49fb-9359-7119bc42770b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2a9f882f-aaea-47bf-b57a-6e2f218168c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a538b82d-8f5a-4804-8899-511c9931159a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2a9f882f-aaea-47bf-b57a-6e2f218168c5" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a538b82d-8f5a-4804-8899-511c9931159a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_37529c49-0e09-41f1-baa3-e06dc04cc39b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a538b82d-8f5a-4804-8899-511c9931159a" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_37529c49-0e09-41f1-baa3-e06dc04cc39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_abca9a1e-bdc2-4224-90ce-0e7add3468da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_37529c49-0e09-41f1-baa3-e06dc04cc39b" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_abca9a1e-bdc2-4224-90ce-0e7add3468da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_e94cb6c4-6360-4671-8f81-615badbc7e81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_abca9a1e-bdc2-4224-90ce-0e7add3468da" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_e94cb6c4-6360-4671-8f81-615badbc7e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b62ebd47-c28f-431d-ad61-560e5ffb981b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_abca9a1e-bdc2-4224-90ce-0e7add3468da" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b62ebd47-c28f-431d-ad61-560e5ffb981b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_a538b82d-8f5a-4804-8899-511c9931159a" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_34a7c85e-885e-4647-a49c-5812119db64d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_34a7c85e-885e-4647-a49c-5812119db64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_e49e1444-bb31-4407-a08c-8a734ea5af24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_e49e1444-bb31-4407-a08c-8a734ea5af24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_37004918-fe1d-4bf7-a93b-9ea18d170759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_37004918-fe1d-4bf7-a93b-9ea18d170759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_e265c1bd-736a-424a-bff2-b767864599c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_e265c1bd-736a-424a-bff2-b767864599c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_b08d7d3a-d051-493d-81d0-c5504335a6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_b08d7d3a-d051-493d-81d0-c5504335a6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAmendments_5650edbd-ae74-4f3c-87ac-32c7ac0a2702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAmendments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAmendments_5650edbd-ae74-4f3c-87ac-32c7ac0a2702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_71ff826c-ab46-4200-a3f4-76e7694654c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresBenefitObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation_71ff826c-ab46-4200-a3f4-76e7694654c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f5c6d3e8-b26f-49fa-97cd-17b5ad2bb9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_ad3849e6-442f-422c-8ec0-293facb400d4" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_f5c6d3e8-b26f-49fa-97cd-17b5ad2bb9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9d3ec220-611a-432a-ad96-26c57b0690db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_9d3ec220-611a-432a-ad96-26c57b0690db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_dc5ae6bf-a2b8-4cf5-b23f-fcebdd1dca18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_dc5ae6bf-a2b8-4cf5-b23f-fcebdd1dca18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_14e9c8e5-f839-400c-adb1-da286357ca82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_14e9c8e5-f839-400c-adb1-da286357ca82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_1745e12f-b36d-465c-9b95-d1ea8e6f6955" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_1745e12f-b36d-465c-9b95-d1ea8e6f6955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_6d11bd84-7bd7-42ea-a8c9-4cc0a269c511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDivestituresPlanAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:to="loc_us-gaap_DefinedBenefitPlanDivestituresPlanAssets_6d11bd84-7bd7-42ea-a8c9-4cc0a269c511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_de1ed27c-876b-42f3-b153-acc58872076f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_904cead6-4556-4bbe-b5b7-70a9145bae13" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_de1ed27c-876b-42f3-b153-acc58872076f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_edfe7bf0-a253-401d-a89e-2a6a26c68c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_edfe7bf0-a253-401d-a89e-2a6a26c68c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_b40d308e-365c-4cd5-a847-0ec31a61ea18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_b40d308e-365c-4cd5-a847-0ec31a61ea18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_bb95cb1d-550f-4274-8d42-1f96bf1d019e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_bb95cb1d-550f-4274-8d42-1f96bf1d019e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_4939f64c-4b34-4100-8b53-e1779e965e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent_4939f64c-4b34-4100-8b53-e1779e965e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_b29562c6-e266-4fa2-bb71-95e0d0a26a71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent_b29562c6-e266-4fa2-bb71-95e0d0a26a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_1a21763f-cdf5-4af2-8d5b-3182b4c07afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_42add420-f0dc-412f-b08c-7ac3d4eea96c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet_1a21763f-cdf5-4af2-8d5b-3182b4c07afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_eb976c15-b3b5-4bb6-b947-df8bce6ad775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_29f1af3a-d85e-44a3-b8a6-24a6a543af10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_eb976c15-b3b5-4bb6-b947-df8bce6ad775" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_29f1af3a-d85e-44a3-b8a6-24a6a543af10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_14871d2d-f2cb-4dfe-9a83-1ac6c43f4bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_29f1af3a-d85e-44a3-b8a6-24a6a543af10" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_14871d2d-f2cb-4dfe-9a83-1ac6c43f4bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_e9787721-6701-4613-b1b9-b8ee82266772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_14871d2d-f2cb-4dfe-9a83-1ac6c43f4bab" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_e9787721-6701-4613-b1b9-b8ee82266772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_1dd8219c-0d1a-44ae-a6f0-55f83c8c2090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e9787721-6701-4613-b1b9-b8ee82266772" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_1dd8219c-0d1a-44ae-a6f0-55f83c8c2090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_1ea6ae2e-deef-44f3-ac67-9d21a8d79b32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_e9787721-6701-4613-b1b9-b8ee82266772" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_1ea6ae2e-deef-44f3-ac67-9d21a8d79b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_7eb8fdc2-701b-4217-9960-f0395d9082ff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_29f1af3a-d85e-44a3-b8a6-24a6a543af10" xlink:to="loc_srt_StatementScenarioAxis_7eb8fdc2-701b-4217-9960-f0395d9082ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_cfede465-2b84-4418-8683-fd6a12c7f64d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_7eb8fdc2-701b-4217-9960-f0395d9082ff" xlink:to="loc_srt_ScenarioUnspecifiedDomain_cfede465-2b84-4418-8683-fd6a12c7f64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_682b4ed2-aae6-4c12-8660-8fde95ee2ca1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_cfede465-2b84-4418-8683-fd6a12c7f64d" xlink:to="loc_srt_ScenarioForecastMember_682b4ed2-aae6-4c12-8660-8fde95ee2ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_29f1af3a-d85e-44a3-b8a6-24a6a543af10" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_7a6c7374-a7aa-4fb9-8323-84c6867c851d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate_7a6c7374-a7aa-4fb9-8323-84c6867c851d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_17666297-e273-4da7-bf90-3cf69a6c429b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease_17666297-e273-4da7-bf90-3cf69a6c429b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_2a4e8f60-065e-4be1-b7a7-0dd7c3688772" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:to="loc_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear_2a4e8f60-065e-4be1-b7a7-0dd7c3688772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_219aab3f-0a36-4d6c-8ba5-0d4d42381fc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:to="loc_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1_219aab3f-0a36-4d6c-8ba5-0d4d42381fc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_4030e7fb-a278-4c25-a93c-50a08202c673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_a909cc5d-14b1-402e-88cc-34187e8e0d4a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_4030e7fb-a278-4c25-a93c-50a08202c673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3d3190c7-12ee-4881-b0bf-f9e11170c886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c7820fb-c501-485d-9f13-57a22fbae886" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3d3190c7-12ee-4881-b0bf-f9e11170c886" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c7820fb-c501-485d-9f13-57a22fbae886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_6bb948ec-15ac-4945-9291-34f3422a2b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c7820fb-c501-485d-9f13-57a22fbae886" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_6bb948ec-15ac-4945-9291-34f3422a2b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_826f905a-c1c4-45cc-a3e9-30dd9964f72c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_6bb948ec-15ac-4945-9291-34f3422a2b6a" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_826f905a-c1c4-45cc-a3e9-30dd9964f72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b63951b3-9944-4c75-ab7f-dddf3c0e8d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_826f905a-c1c4-45cc-a3e9-30dd9964f72c" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b63951b3-9944-4c75-ab7f-dddf3c0e8d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_37c5250b-382d-46ec-89dd-7cbcf7dbe99b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_826f905a-c1c4-45cc-a3e9-30dd9964f72c" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_37c5250b-382d-46ec-89dd-7cbcf7dbe99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_4c7820fb-c501-485d-9f13-57a22fbae886" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_dc31135b-2124-4ea5-8284-b79c5c5f920d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_dc31135b-2124-4ea5-8284-b79c5c5f920d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_dec919eb-eb62-4d49-8fd6-2b366309d4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_dec919eb-eb62-4d49-8fd6-2b366309d4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_bca2e07d-633a-4d81-a582-c8fb9eed6763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_bca2e07d-633a-4d81-a582-c8fb9eed6763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortizationAbstract_1299fcab-9053-4073-b678-8ce97374603c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortizationAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_AdjustmentForAmortizationAbstract_1299fcab-9053-4073-b678-8ce97374603c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_6f7b8c2d-30be-4889-831d-0b66f1fa4973" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentForAmortizationAbstract_1299fcab-9053-4073-b678-8ce97374603c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_6f7b8c2d-30be-4889-831d-0b66f1fa4973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_ff5b3169-a3ca-4954-9d62-49b796a15eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentForAmortizationAbstract_1299fcab-9053-4073-b678-8ce97374603c" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_ff5b3169-a3ca-4954-9d62-49b796a15eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_7792e1c2-287d-49e6-9162-4ba0d5a4b3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_7792e1c2-287d-49e6-9162-4ba0d5a4b3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b1cc8538-7dbf-4d81-ae43-e3db5c2fa439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_b9431b10-31fc-4eda-91ae-97437d4266a8" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_b1cc8538-7dbf-4d81-ae43-e3db5c2fa439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ab8a9d44-bf00-4445-9d1c-15be13d1acd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9ebb7320-2c5e-4ba7-9eb1-68ba453d0763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ab8a9d44-bf00-4445-9d1c-15be13d1acd6" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9ebb7320-2c5e-4ba7-9eb1-68ba453d0763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_d7821220-9154-49ae-a200-153a54904142" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9ebb7320-2c5e-4ba7-9eb1-68ba453d0763" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_d7821220-9154-49ae-a200-153a54904142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_522416e3-7c55-4a4b-aca1-b363fbc16bab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_d7821220-9154-49ae-a200-153a54904142" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_522416e3-7c55-4a4b-aca1-b363fbc16bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_b329071e-9aea-41a3-a726-adb2448bd9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_522416e3-7c55-4a4b-aca1-b363fbc16bab" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_b329071e-9aea-41a3-a726-adb2448bd9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_7885a89e-ee30-4d05-b7af-45bc86cebc91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_522416e3-7c55-4a4b-aca1-b363fbc16bab" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_7885a89e-ee30-4d05-b7af-45bc86cebc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_c330bc90-23f9-4554-8ef7-49f6e6809ef2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9ebb7320-2c5e-4ba7-9eb1-68ba453d0763" xlink:to="loc_srt_StatementScenarioAxis_c330bc90-23f9-4554-8ef7-49f6e6809ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9a9783df-ef51-4ef8-a028-d0a2e7b3fb84" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_c330bc90-23f9-4554-8ef7-49f6e6809ef2" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9a9783df-ef51-4ef8-a028-d0a2e7b3fb84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_587c66fa-ae5f-453a-8b3a-ea514c3e56d0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9a9783df-ef51-4ef8-a028-d0a2e7b3fb84" xlink:to="loc_srt_ScenarioForecastMember_587c66fa-ae5f-453a-8b3a-ea514c3e56d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4307acfc-f393-4ebe-9c64-a9d17bd054d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_9ebb7320-2c5e-4ba7-9eb1-68ba453d0763" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4307acfc-f393-4ebe-9c64-a9d17bd054d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanDiscountRateAbstractAbstract_917d3416-cd31-4618-9247-4f756c9d3fde" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanDiscountRateAbstractAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4307acfc-f393-4ebe-9c64-a9d17bd054d8" xlink:to="loc_mo_DefinedBenefitPlanDiscountRateAbstractAbstract_917d3416-cd31-4618-9247-4f756c9d3fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_9a3f0faf-1a6c-4986-bc29-80453e13abeb" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_DefinedBenefitPlanDiscountRateAbstractAbstract_917d3416-cd31-4618-9247-4f756c9d3fde" xlink:to="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost_9a3f0faf-1a6c-4986-bc29-80453e13abeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_9b97b39f-82ad-4810-9fe0-13262f5f75c4" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_DefinedBenefitPlanDiscountRateAbstractAbstract_917d3416-cd31-4618-9247-4f756c9d3fde" xlink:to="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost_9b97b39f-82ad-4810-9fe0-13262f5f75c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e0225616-92fe-46f1-b76f-4c804fea68e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4307acfc-f393-4ebe-9c64-a9d17bd054d8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_e0225616-92fe-46f1-b76f-4c804fea68e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_3b6e762f-a5f9-4fdf-8ecc-79252053baeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4307acfc-f393-4ebe-9c64-a9d17bd054d8" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_3b6e762f-a5f9-4fdf-8ecc-79252053baeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate_d5cb272e-890f-4c6e-b8d9-b449df08b71b" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_4307acfc-f393-4ebe-9c64-a9d17bd054d8" xlink:to="loc_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate_d5cb272e-890f-4c6e-b8d9-b449df08b71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansAssetAllocationsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansAssetAllocationsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansAssetAllocationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_276442c8-21d4-4207-a848-dc950194e543" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8fbbcb88-70e3-461e-99e6-41c95ea8b114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_276442c8-21d4-4207-a848-dc950194e543" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8fbbcb88-70e3-461e-99e6-41c95ea8b114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_b542b191-a3d1-44d3-9fcb-db53b2986f1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8fbbcb88-70e3-461e-99e6-41c95ea8b114" xlink:to="loc_us-gaap_InvestmentTypeAxis_b542b191-a3d1-44d3-9fcb-db53b2986f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_b542b191-a3d1-44d3-9fcb-db53b2986f1b" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_25efd553-3cea-405e-a8b4-cec82b4d3b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_25efd553-3cea-405e-a8b4-cec82b4d3b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_4857a45c-73a6-47d7-9cc5-f1528394def6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_4857a45c-73a6-47d7-9cc5-f1528394def6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember_e8e0b223-0503-45e9-a10d-bad8b4c76480" xlink:href="mo-20221231.xsd#mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:to="loc_mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember_e8e0b223-0503-45e9-a10d-bad8b4c76480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTreasuryAndForeignGovernmentSecuritiesMember_7d14056d-0b8c-47e4-9363-8db638797e5b" xlink:href="mo-20221231.xsd#mo_USTreasuryAndForeignGovernmentSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:to="loc_mo_USTreasuryAndForeignGovernmentSecuritiesMember_7d14056d-0b8c-47e4-9363-8db638797e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AssetBasedSecuritiesAndOtherInvestmentsMember_16677714-cba4-4d50-a8de-50fe33d795fd" xlink:href="mo-20221231.xsd#mo_AssetBasedSecuritiesAndOtherInvestmentsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ad6e071f-9c99-489e-87cf-72751dfcaeb7" xlink:to="loc_mo_AssetBasedSecuritiesAndOtherInvestmentsMember_16677714-cba4-4d50-a8de-50fe33d795fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_48112c9d-f389-4286-8214-efaaf82faf83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8fbbcb88-70e3-461e-99e6-41c95ea8b114" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_48112c9d-f389-4286-8214-efaaf82faf83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_618e4ab2-6c12-4f4f-a00c-42b9ed688d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_48112c9d-f389-4286-8214-efaaf82faf83" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_618e4ab2-6c12-4f4f-a00c-42b9ed688d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_3f94ad90-b3e3-4735-95ae-c8935bc3f663" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_618e4ab2-6c12-4f4f-a00c-42b9ed688d7d" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_3f94ad90-b3e3-4735-95ae-c8935bc3f663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b0210a57-6157-4e0f-9eae-3468d8308bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_618e4ab2-6c12-4f4f-a00c-42b9ed688d7d" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_b0210a57-6157-4e0f-9eae-3468d8308bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0ac6ad7e-7845-4684-bf55-f2b94240faad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_8fbbcb88-70e3-461e-99e6-41c95ea8b114" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0ac6ad7e-7845-4684-bf55-f2b94240faad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_6ee5e680-8be5-4f51-9a20-b8c3e60d7af1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_0ac6ad7e-7845-4684-bf55-f2b94240faad" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_6ee5e680-8be5-4f51-9a20-b8c3e60d7af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_362d4652-0b8b-4527-ac07-8df8ff0dc552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f2bf4ee3-8a46-499f-908f-8941d1dbf85d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_362d4652-0b8b-4527-ac07-8df8ff0dc552" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f2bf4ee3-8a46-499f-908f-8941d1dbf85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_79e6376e-51bc-4689-a286-a1989ce74b7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f2bf4ee3-8a46-499f-908f-8941d1dbf85d" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_79e6376e-51bc-4689-a286-a1989ce74b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_5e6b54bb-ac88-4212-ab84-40a2107e6e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_79e6376e-51bc-4689-a286-a1989ce74b7d" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_5e6b54bb-ac88-4212-ab84-40a2107e6e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_3cef33a9-8b01-4d36-90cd-98d4230b51e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_5e6b54bb-ac88-4212-ab84-40a2107e6e8b" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_3cef33a9-8b01-4d36-90cd-98d4230b51e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_34e777c0-6527-4de8-bc83-9ee815ca4e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_5e6b54bb-ac88-4212-ab84-40a2107e6e8b" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_34e777c0-6527-4de8-bc83-9ee815ca4e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6976920c-7d0a-41f3-87a8-167119e6f9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f2bf4ee3-8a46-499f-908f-8941d1dbf85d" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6976920c-7d0a-41f3-87a8-167119e6f9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5fdf46f-a816-4092-bc56-3b7b42bc1b85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6976920c-7d0a-41f3-87a8-167119e6f9fb" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5fdf46f-a816-4092-bc56-3b7b42bc1b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel12And3Member_7517a472-695d-41f3-a6e9-1d9f8fec6d2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel12And3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5fdf46f-a816-4092-bc56-3b7b42bc1b85" xlink:to="loc_us-gaap_FairValueInputsLevel12And3Member_7517a472-695d-41f3-a6e9-1d9f8fec6d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_177589d1-7483-4b99-b65f-467d111a7903" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_7517a472-695d-41f3-a6e9-1d9f8fec6d2c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_177589d1-7483-4b99-b65f-467d111a7903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_360f3ae4-b74d-400b-afc7-64b087021aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueInputsLevel12And3Member_7517a472-695d-41f3-a6e9-1d9f8fec6d2c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_360f3ae4-b74d-400b-afc7-64b087021aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_74594a75-8f9b-4def-b5bb-c21b6fef1f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f5fdf46f-a816-4092-bc56-3b7b42bc1b85" xlink:to="loc_us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember_74594a75-8f9b-4def-b5bb-c21b6fef1f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_0ab86c3c-cd2a-450e-b849-8a0678618e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f2bf4ee3-8a46-499f-908f-8941d1dbf85d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_0ab86c3c-cd2a-450e-b849-8a0678618e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_0ab86c3c-cd2a-450e-b849-8a0678618e1f" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_a7a2ac2d-99fd-4bfe-9b86-7a4657eae1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_a7a2ac2d-99fd-4bfe-9b86-7a4657eae1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MunicipalBondsMember_46c7063e-9065-4e76-b64e-3ea9596faaef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MunicipalBondsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_MunicipalBondsMember_46c7063e-9065-4e76-b64e-3ea9596faaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_237c3c32-bb8b-4c66-9f7a-663ec4dbf79c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_237c3c32-bb8b-4c66-9f7a-663ec4dbf79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CorporateDebtSecurityAboveInvestmentGradeMember_1b64d03e-3431-4dfb-9be1-31e3cf2d60bd" xlink:href="mo-20221231.xsd#mo_CorporateDebtSecurityAboveInvestmentGradeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_mo_CorporateDebtSecurityAboveInvestmentGradeMember_1b64d03e-3431-4dfb-9be1-31e3cf2d60bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CorporateDebtSecurityBelowInvestmentGradeMember_5bc7d8ac-97a2-4bde-9f03-b40b64dfd890" xlink:href="mo-20221231.xsd#mo_CorporateDebtSecurityBelowInvestmentGradeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_mo_CorporateDebtSecurityBelowInvestmentGradeMember_5bc7d8ac-97a2-4bde-9f03-b40b64dfd890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_2da44cae-3f7c-4e69-a2bb-34947036ca4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember_2da44cae-3f7c-4e69-a2bb-34947036ca4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_0dc655ea-44de-400d-bcf8-c908e49c4d43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember_0dc655ea-44de-400d-bcf8-c908e49c4d43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_25a7dadd-35b0-45ab-84c7-32567bd15808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_25a7dadd-35b0-45ab-84c7-32567bd15808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherInvestmentNetMember_dba5c3e8-5cbb-4e32-9a3f-84fee26c689f" xlink:href="mo-20221231.xsd#mo_OtherInvestmentNetMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_mo_OtherInvestmentNetMember_dba5c3e8-5cbb-4e32-9a3f-84fee26c689f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USLargeCapMember_52c743f9-4104-4dee-92b7-cac808c97063" xlink:href="mo-20221231.xsd#mo_USLargeCapMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_mo_USLargeCapMember_52c743f9-4104-4dee-92b7-cac808c97063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USSmallCapMember_bb85cfab-27e9-46ff-80f1-ed4c81be5033" xlink:href="mo-20221231.xsd#mo_USSmallCapMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_mo_USSmallCapMember_bb85cfab-27e9-46ff-80f1-ed4c81be5033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InternationalDevelopedMarketsMember_dfddd828-a96f-469f-a810-4640bc69a93e" xlink:href="mo-20221231.xsd#mo_InternationalDevelopedMarketsMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_mo_InternationalDevelopedMarketsMember_dfddd828-a96f-469f-a810-4640bc69a93e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentsMember_b4d038f7-45c1-47e1-b2d1-0b8162335d86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInvestmentsMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_f91c39db-7ca5-469b-b4ca-33cc6d881065" xlink:to="loc_us-gaap_OtherInvestmentsMember_b4d038f7-45c1-47e1-b2d1-0b8162335d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9507c6c1-c2b5-4595-85bd-51f14af647e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f2bf4ee3-8a46-499f-908f-8941d1dbf85d" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9507c6c1-c2b5-4595-85bd-51f14af647e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_477275a2-ccff-490a-a102-4fccc5cc3dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9507c6c1-c2b5-4595-85bd-51f14af647e8" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_477275a2-ccff-490a-a102-4fccc5cc3dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList_49915c09-1f9d-4f8f-b935-abfb2238c087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_9507c6c1-c2b5-4595-85bd-51f14af647e8" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList_49915c09-1f9d-4f8f-b935-abfb2238c087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansEstimatedFutureBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f3757181-6b68-4fad-ab29-7ab38307a26c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1399afa-f267-4554-854a-f67da1fe0ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f3757181-6b68-4fad-ab29-7ab38307a26c" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1399afa-f267-4554-854a-f67da1fe0ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_b2766f95-ae73-455e-b40a-775bc90f065e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1399afa-f267-4554-854a-f67da1fe0ab1" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_b2766f95-ae73-455e-b40a-775bc90f065e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_3e7cb604-54b8-4add-8aad-ebc3d0384b44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_b2766f95-ae73-455e-b40a-775bc90f065e" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_3e7cb604-54b8-4add-8aad-ebc3d0384b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_3cec9b12-8500-4cc7-a012-4cae9669fc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3e7cb604-54b8-4add-8aad-ebc3d0384b44" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_3cec9b12-8500-4cc7-a012-4cae9669fc0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_52574cb4-0bf6-4e08-bac1-bf18c30c44b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_3e7cb604-54b8-4add-8aad-ebc3d0384b44" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_52574cb4-0bf6-4e08-bac1-bf18c30c44b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_f1399afa-f267-4554-854a-f67da1fe0ab1" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_2083ce44-7017-40cb-ae87-a4a617bba53b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_2083ce44-7017-40cb-ae87-a4a617bba53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_bde6d566-dc4d-4536-b242-0b6685d219a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_bde6d566-dc4d-4536-b242-0b6685d219a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_02e7b10a-4e0d-4fc6-9f64-a7349a727c15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_02e7b10a-4e0d-4fc6-9f64-a7349a727c15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_859a2e5d-009a-49a3-baf6-b9fa0b71f207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_859a2e5d-009a-49a3-baf6-b9fa0b71f207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_a90f62a7-d5b2-4dc7-a165-3f9b6dac64c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_a90f62a7-d5b2-4dc7-a165-3f9b6dac64c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_70af8d55-acc8-40c6-b09a-3737f7821aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_7f5dc04c-cef1-4bb3-9a6a-e5cad9080943" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_70af8d55-acc8-40c6-b09a-3737f7821aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e809df64-f327-49a7-846c-98c41173cf31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_4f453dd4-20a4-4dee-92d4-024568e7ec5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e809df64-f327-49a7-846c-98c41173cf31" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_4f453dd4-20a4-4dee-92d4-024568e7ec5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_10878ed4-ad3e-4782-8f9c-0ecdb1a16a17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_4f453dd4-20a4-4dee-92d4-024568e7ec5b" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_10878ed4-ad3e-4782-8f9c-0ecdb1a16a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_21e61696-4455-4630-94cf-2bc70c486620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_10878ed4-ad3e-4782-8f9c-0ecdb1a16a17" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_21e61696-4455-4630-94cf-2bc70c486620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_5774edbe-d25d-48b0-a853-8c82c8975324" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_21e61696-4455-4630-94cf-2bc70c486620" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_5774edbe-d25d-48b0-a853-8c82c8975324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_37d1c7fe-56e7-48d9-b9ec-15598085df11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_21e61696-4455-4630-94cf-2bc70c486620" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_37d1c7fe-56e7-48d9-b9ec-15598085df11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentRetirementBenefitsMember_f1d1c80b-03f6-43ea-ac23-7ca88a781196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentRetirementBenefitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_21e61696-4455-4630-94cf-2bc70c486620" xlink:to="loc_us-gaap_PostemploymentRetirementBenefitsMember_f1d1c80b-03f6-43ea-ac23-7ca88a781196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0abe2c31-0136-4337-a0cc-1aa969fea2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_4f453dd4-20a4-4dee-92d4-024568e7ec5b" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0abe2c31-0136-4337-a0cc-1aa969fea2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_0bcd850d-d9ee-4605-929c-53b9af5ef107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0abe2c31-0136-4337-a0cc-1aa969fea2f4" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_0bcd850d-d9ee-4605-929c-53b9af5ef107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_8cbf2ce0-782b-4376-a38c-a2eb4f60bbe6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0abe2c31-0136-4337-a0cc-1aa969fea2f4" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax_8cbf2ce0-782b-4376-a38c-a2eb4f60bbe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax_30cb1639-ab89-4e24-b37f-96a4d453e68f" xlink:href="mo-20221231.xsd#mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0abe2c31-0136-4337-a0cc-1aa969fea2f4" xlink:to="loc_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax_30cb1639-ab89-4e24-b37f-96a4d453e68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_efbc4209-13df-42e6-860c-499a2409c5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_0abe2c31-0136-4337-a0cc-1aa969fea2f4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_efbc4209-13df-42e6-860c-499a2409c5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e60bdc1c-e199-4dad-a722-8053f1d4be28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_34124d43-d339-4f1e-9f06-75f03b4005f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e60bdc1c-e199-4dad-a722-8053f1d4be28" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_34124d43-d339-4f1e-9f06-75f03b4005f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_c895c6a8-0958-4779-8748-feac2e5c7865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_34124d43-d339-4f1e-9f06-75f03b4005f1" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_c895c6a8-0958-4779-8748-feac2e5c7865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_59999165-9b23-4619-bd6b-8321983d8cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_c895c6a8-0958-4779-8748-feac2e5c7865" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_59999165-9b23-4619-bd6b-8321983d8cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_48dc375b-552d-4af1-a6ff-ac9557ca443c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_59999165-9b23-4619-bd6b-8321983d8cdd" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_48dc375b-552d-4af1-a6ff-ac9557ca443c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_943ce9ed-901c-47f9-a369-fb1d8942302b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_59999165-9b23-4619-bd6b-8321983d8cdd" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_943ce9ed-901c-47f9-a369-fb1d8942302b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentRetirementBenefitsMember_e27a26b3-5e10-4154-8356-367cddfba95f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PostemploymentRetirementBenefitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_59999165-9b23-4619-bd6b-8321983d8cdd" xlink:to="loc_us-gaap_PostemploymentRetirementBenefitsMember_e27a26b3-5e10-4154-8356-367cddfba95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable_34124d43-d339-4f1e-9f06-75f03b4005f1" xlink:to="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortizationAbstract_4d27a5f3-17cf-40de-9cdc-8a0fcb2c9fac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortizationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_us-gaap_AdjustmentForAmortizationAbstract_4d27a5f3-17cf-40de-9cdc-8a0fcb2c9fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_3d7ac0ee-250d-4b27-9248-c76745adc2da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentForAmortizationAbstract_4d27a5f3-17cf-40de-9cdc-8a0fcb2c9fac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax_3d7ac0ee-250d-4b27-9248-c76745adc2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_b5217280-af51-4b61-86a0-b85c053f0951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentForAmortizationAbstract_4d27a5f3-17cf-40de-9cdc-8a0fcb2c9fac" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax_b5217280-af51-4b61-86a0-b85c053f0951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_16c7a7b7-ffd1-46c8-bed6-52d736ba23ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_16c7a7b7-ffd1-46c8-bed6-52d736ba23ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax_f841cce6-6236-4e1d-bfd6-e5f8d0261855" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_16c7a7b7-ffd1-46c8-bed6-52d736ba23ef" xlink:to="loc_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax_f841cce6-6236-4e1d-bfd6-e5f8d0261855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax_ba9d943b-7b3e-4f63-9ebe-5d1707843d0e" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_16c7a7b7-ffd1-46c8-bed6-52d736ba23ef" xlink:to="loc_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax_ba9d943b-7b3e-4f63-9ebe-5d1707843d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_e1975898-f7f9-4a75-b649-8ae62970d4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax_e1975898-f7f9-4a75-b649-8ae62970d4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_68c00004-d975-4247-b512-d83a83e264b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax_68c00004-d975-4247-b512-d83a83e264b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherMovementsDuringtheYearAbstract_b0058ba3-dee9-4334-9c02-ace700e5aa63" xlink:href="mo-20221231.xsd#mo_OtherMovementsDuringtheYearAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_mo_OtherMovementsDuringtheYearAbstract_b0058ba3-dee9-4334-9c02-ace700e5aa63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_ed615a9a-820c-4bd3-990f-66d6c59f6f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_OtherMovementsDuringtheYearAbstract_b0058ba3-dee9-4334-9c02-ace700e5aa63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax_ed615a9a-820c-4bd3-990f-66d6c59f6f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_2835e504-01c3-4b76-bc84-03a43e68e5a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_OtherMovementsDuringtheYearAbstract_b0058ba3-dee9-4334-9c02-ace700e5aa63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax_2835e504-01c3-4b76-bc84-03a43e68e5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax_4eb58ad3-9e0f-4c40-a87c-7ff69fad744b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_OtherMovementsDuringtheYearAbstract_b0058ba3-dee9-4334-9c02-ace700e5aa63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax_4eb58ad3-9e0f-4c40-a87c-7ff69fad744b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_ee26bad8-852a-450f-b593-cdf228a8f009" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_OtherMovementsDuringtheYearAbstract_b0058ba3-dee9-4334-9c02-ace700e5aa63" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax_ee26bad8-852a-450f-b593-cdf228a8f009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment_f6c6784a-42c1-437e-8311-708ebd87a719" xlink:href="mo-20221231.xsd#mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems_d187557c-1865-45f7-ba94-7094b1dc4ab4" xlink:to="loc_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment_f6c6784a-42c1-437e-8311-708ebd87a719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#AdditionalInformationScheduleofAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6140b202-983a-4b3f-b79c-1bac9c45dde8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e4cdf617-cd24-451b-a4ea-09de0c993fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6140b202-983a-4b3f-b79c-1bac9c45dde8" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e4cdf617-cd24-451b-a4ea-09de0c993fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_bce9b410-c533-47f6-9316-4c3149071dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6140b202-983a-4b3f-b79c-1bac9c45dde8" xlink:to="loc_us-gaap_InterestExpense_bce9b410-c533-47f6-9316-4c3149071dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOther_2c4b90a6-0841-4f8d-9290-af1ec253c9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6140b202-983a-4b3f-b79c-1bac9c45dde8" xlink:to="loc_us-gaap_InterestIncomeOther_2c4b90a6-0841-4f8d-9290-af1ec253c9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_7fa4e71e-e641-46a2-a867-55684baa5b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6140b202-983a-4b3f-b79c-1bac9c45dde8" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_7fa4e71e-e641-46a2-a867-55684baa5b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#AdditionalInformationScheduleofValuationandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4d6bd388-7997-45d8-b404-f78f9e04f8ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_a66a3615-f3d8-4188-9f14-1bf2c40f5a4a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4d6bd388-7997-45d8-b404-f78f9e04f8ae" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_a66a3615-f3d8-4188-9f14-1bf2c40f5a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6d161bf9-d551-4d51-838b-3dab5543ad32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_a66a3615-f3d8-4188-9f14-1bf2c40f5a4a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6d161bf9-d551-4d51-838b-3dab5543ad32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_fc770eea-456c-419e-bc79-086c3f1786e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_6d161bf9-d551-4d51-838b-3dab5543ad32" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_fc770eea-456c-419e-bc79-086c3f1786e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AllowanceDiscountsMember_bb39a6b4-d948-441f-821f-a766f1826b7d" xlink:href="mo-20221231.xsd#mo_AllowanceDiscountsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_fc770eea-456c-419e-bc79-086c3f1786e6" xlink:to="loc_mo_AllowanceDiscountsMember_bb39a6b4-d948-441f-821f-a766f1826b7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AllowanceReturnedGoodsMember_e9fcea52-5e45-4a59-b766-cdc8dcd539e9" xlink:href="mo-20221231.xsd#mo_AllowanceReturnedGoodsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_fc770eea-456c-419e-bc79-086c3f1786e6" xlink:to="loc_mo_AllowanceReturnedGoodsMember_e9fcea52-5e45-4a59-b766-cdc8dcd539e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b1734022-498b-42d6-90fb-325aa3bc4b29" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_a66a3615-f3d8-4188-9f14-1bf2c40f5a4a" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b1734022-498b-42d6-90fb-325aa3bc4b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_163b46ec-fb54-4446-b22e-d3ee07a5a02e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_b1734022-498b-42d6-90fb-325aa3bc4b29" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_163b46ec-fb54-4446-b22e-d3ee07a5a02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_f5b19c64-a837-4d95-b721-653316c53b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_163b46ec-fb54-4446-b22e-d3ee07a5a02e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_f5b19c64-a837-4d95-b721-653316c53b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_44436fb5-32e7-4342-ac6e-cabd75d1e7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_163b46ec-fb54-4446-b22e-d3ee07a5a02e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_44436fb5-32e7-4342-ac6e-cabd75d1e7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_02185e7d-824b-4b7c-8fa2-386f056c3bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_163b46ec-fb54-4446-b22e-d3ee07a5a02e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_02185e7d-824b-4b7c-8fa2-386f056c3bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_c2863665-e135-4743-8e99-f1a854659c7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_163b46ec-fb54-4446-b22e-d3ee07a5a02e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_c2863665-e135-4743-8e99-f1a854659c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGeneralInformationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesGeneralInformationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesGeneralInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e7af22bd-fd59-448f-af28-0c0c038d29c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_5b0d8a49-0a09-457c-a307-90a7fc997ac5" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e7af22bd-fd59-448f-af28-0c0c038d29c1" xlink:to="loc_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond_5b0d8a49-0a09-457c-a307-90a7fc997ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_095abe54-79d2-4581-b3e7-c5ccde73513e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_095abe54-79d2-4581-b3e7-c5ccde73513e" xlink:to="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_5eb471a5-f52f-43ec-909b-aa384f1dc107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_5eb471a5-f52f-43ec-909b-aa384f1dc107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_0824aaa1-fef7-4468-be60-d10e757442a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_5eb471a5-f52f-43ec-909b-aa384f1dc107" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_0824aaa1-fef7-4468-be60-d10e757442a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsMember_82f4a485-75ff-4866-8d0b-20f36ae02ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_0824aaa1-fef7-4468-be60-d10e757442a0" xlink:to="loc_us-gaap_AssetsMember_82f4a485-75ff-4866-8d0b-20f36ae02ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_c969d307-886a-48f8-b814-c828d40211f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:to="loc_us-gaap_LitigationStatusAxis_c969d307-886a-48f8-b814-c828d40211f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_4dbfe1c6-535e-4386-bc45-8d680d17abd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_c969d307-886a-48f8-b814-c828d40211f0" xlink:to="loc_us-gaap_LitigationStatusDomain_4dbfe1c6-535e-4386-bc45-8d680d17abd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_3c38ea1a-b36b-4895-941a-ad30225cb902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_4dbfe1c6-535e-4386-bc45-8d680d17abd7" xlink:to="loc_us-gaap_PendingLitigationMember_3c38ea1a-b36b-4895-941a-ad30225cb902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c2548381-2a1d-4a4a-938a-25bffbcc6290" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:to="loc_dei_LegalEntityAxis_c2548381-2a1d-4a4a-938a-25bffbcc6290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e1f4a644-e301-43c5-8075-8d77ad229589" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c2548381-2a1d-4a4a-938a-25bffbcc6290" xlink:to="loc_dei_EntityDomain_e1f4a644-e301-43c5-8075-8d77ad229589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_fbbd4f0d-8730-4085-9f8e-1d62b5365c6b" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e1f4a644-e301-43c5-8075-8d77ad229589" xlink:to="loc_mo_PhilipMorrisUSAMember_fbbd4f0d-8730-4085-9f8e-1d62b5365c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b49f68a0-4d8c-42b3-a339-293ccee17114" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:to="loc_srt_LitigationCaseAxis_b49f68a0-4d8c-42b3-a339-293ccee17114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_df80ea75-fc3b-4b7b-a716-b88bc9367bc7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_b49f68a0-4d8c-42b3-a339-293ccee17114" xlink:to="loc_srt_LitigationCaseTypeDomain_df80ea75-fc3b-4b7b-a716-b88bc9367bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_TobaccoandHealthJudgmentMember_9bde81fb-29bc-496c-ae0c-0fb885d37a14" xlink:href="mo-20221231.xsd#mo_TobaccoandHealthJudgmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_df80ea75-fc3b-4b7b-a716-b88bc9367bc7" xlink:to="loc_mo_TobaccoandHealthJudgmentMember_9bde81fb-29bc-496c-ae0c-0fb885d37a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_bbba0f99-7ad5-4cd6-940c-8ec4cb7e3cd1" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_df80ea75-fc3b-4b7b-a716-b88bc9367bc7" xlink:to="loc_mo_EngleProgenyCasesMember_bbba0f99-7ad5-4cd6-940c-8ec4cb7e3cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1975d540-146d-4ebc-96c4-42a0506754af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1975d540-146d-4ebc-96c4-42a0506754af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_45dbdfd9-e059-4c04-ad99-7eaa3100e018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_1975d540-146d-4ebc-96c4-42a0506754af" xlink:to="loc_us-gaap_LossContingencyNatureDomain_45dbdfd9-e059-4c04-ad99-7eaa3100e018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationCasesResultsMember_9a3bb495-13c1-4cb6-8627-55e0fcc7a496" xlink:href="mo-20221231.xsd#mo_LitigationCasesResultsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_45dbdfd9-e059-4c04-ad99-7eaa3100e018" xlink:to="loc_mo_LitigationCasesResultsMember_9a3bb495-13c1-4cb6-8627-55e0fcc7a496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AgreementToResolveShareholderClassActionMember_1cbd5662-ba01-4576-a9b3-e32e2ab15367" xlink:href="mo-20221231.xsd#mo_AgreementToResolveShareholderClassActionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_45dbdfd9-e059-4c04-ad99-7eaa3100e018" xlink:to="loc_mo_AgreementToResolveShareholderClassActionMember_1cbd5662-ba01-4576-a9b3-e32e2ab15367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_InterestExpenseRelatedToLitigationMember_f0d97a48-8eab-44fd-8830-b815c420fb42" xlink:href="mo-20221231.xsd#mo_InterestExpenseRelatedToLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_45dbdfd9-e059-4c04-ad99-7eaa3100e018" xlink:to="loc_mo_InterestExpenseRelatedToLitigationMember_f0d97a48-8eab-44fd-8830-b815c420fb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f57f306f-f220-4fdc-9037-51aa49349515" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3fd66841-d698-4fcd-955c-5a78bb3a1fc6" xlink:to="loc_us-gaap_LossContingenciesLineItems_f57f306f-f220-4fdc-9037-51aa49349515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualRollForward_9bf61361-8c20-486b-874e-3e78e2f93cb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f57f306f-f220-4fdc-9037-51aa49349515" xlink:to="loc_us-gaap_LossContingencyAccrualRollForward_9bf61361-8c20-486b-874e-3e78e2f93cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_27118c6d-b9ab-4b11-8d0a-679c12e4bed8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_9bf61361-8c20-486b-874e-3e78e2f93cb1" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_27118c6d-b9ab-4b11-8d0a-679c12e4bed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_00515b0b-3ab1-4dd4-8afd-b15d66794f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_9bf61361-8c20-486b-874e-3e78e2f93cb1" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_00515b0b-3ab1-4dd4-8afd-b15d66794f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_f3c6b282-a138-485a-81dc-7ea47092032b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_9bf61361-8c20-486b-874e-3e78e2f93cb1" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_f3c6b282-a138-485a-81dc-7ea47092032b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7f2f3a86-5e82-4ff3-9adb-21337b648c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAccrualRollForward_9bf61361-8c20-486b-874e-3e78e2f93cb1" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_7f2f3a86-5e82-4ff3-9adb-21337b648c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesPaidValue_0dc22830-ce73-40e1-9975-3e19b88ebc9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesPaidValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f57f306f-f220-4fdc-9037-51aa49349515" xlink:to="loc_us-gaap_LossContingencyDamagesPaidValue_0dc22830-ce73-40e1-9975-3e19b88ebc9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementInterest_436b4ec1-dd75-49f8-a4a4-3a670eca6716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f57f306f-f220-4fdc-9037-51aa49349515" xlink:to="loc_us-gaap_LitigationSettlementInterest_436b4ec1-dd75-49f8-a4a4-3a670eca6716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationEscrowDeposit_d6a5d541-3b72-4d96-97f4-31d4284aca08" xlink:href="mo-20221231.xsd#mo_LitigationEscrowDeposit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f57f306f-f220-4fdc-9037-51aa49349515" xlink:to="loc_mo_LitigationEscrowDeposit_d6a5d541-3b72-4d96-97f4-31d4284aca08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesScheduleofPendingCasesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f1cb377a-4539-48e4-858f-e321ad282d17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_df87b3a1-32c3-4fc7-a860-a7af81740ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f1cb377a-4539-48e4-858f-e321ad282d17" xlink:to="loc_us-gaap_LossContingenciesTable_df87b3a1-32c3-4fc7-a860-a7af81740ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_b61cbc4c-f5b6-493c-aa43-5094ea129ba9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_df87b3a1-32c3-4fc7-a860-a7af81740ddc" xlink:to="loc_srt_LitigationCaseAxis_b61cbc4c-f5b6-493c-aa43-5094ea129ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_35b3aa9d-e432-44f7-ab75-9279d5026ba8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_b61cbc4c-f5b6-493c-aa43-5094ea129ba9" xlink:to="loc_srt_LitigationCaseTypeDomain_35b3aa9d-e432-44f7-ab75-9279d5026ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_e9a4cbd9-c622-4cb1-b29d-a5e51472ff39" xlink:href="mo-20221231.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_35b3aa9d-e432-44f7-ab75-9279d5026ba8" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_e9a4cbd9-c622-4cb1-b29d-a5e51472ff39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_caf1ed01-2e45-47c5-b283-c0b31dca4ca7" xlink:href="mo-20221231.xsd#mo_ETSSmokingandHealthCaseFlightAttendantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_IndividualSmokingAndHealthCasesMember_e9a4cbd9-c622-4cb1-b29d-a5e51472ff39" xlink:to="loc_mo_ETSSmokingandHealthCaseFlightAttendantsMember_caf1ed01-2e45-47c5-b283-c0b31dca4ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_450fa620-345a-4f7e-b2b3-4ea31ff52a5b" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_35b3aa9d-e432-44f7-ab75-9279d5026ba8" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_450fa620-345a-4f7e-b2b3-4ea31ff52a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_3e909ba0-e1ce-44e1-99cd-a58994cc8bab" xlink:href="mo-20221231.xsd#mo_EvaporLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_35b3aa9d-e432-44f7-ab75-9279d5026ba8" xlink:to="loc_mo_EvaporLitigationMember_3e909ba0-e1ce-44e1-99cd-a58994cc8bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherTabaccoRelatedCasesMember_9a27997a-fc02-47b3-aa9e-312e7bbaeeba" xlink:href="mo-20221231.xsd#mo_OtherTabaccoRelatedCasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_35b3aa9d-e432-44f7-ab75-9279d5026ba8" xlink:to="loc_mo_OtherTabaccoRelatedCasesMember_9a27997a-fc02-47b3-aa9e-312e7bbaeeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_4dbdcafb-5bdf-4637-af4c-706242cfde97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_df87b3a1-32c3-4fc7-a860-a7af81740ddc" xlink:to="loc_us-gaap_LitigationStatusAxis_4dbdcafb-5bdf-4637-af4c-706242cfde97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_550460c8-b432-4486-8c5d-b193044d16e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_4dbdcafb-5bdf-4637-af4c-706242cfde97" xlink:to="loc_us-gaap_LitigationStatusDomain_550460c8-b432-4486-8c5d-b193044d16e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_f481323d-99ec-480d-87fa-ad4830117ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_550460c8-b432-4486-8c5d-b193044d16e8" xlink:to="loc_us-gaap_PendingLitigationMember_f481323d-99ec-480d-87fa-ad4830117ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_21120597-34f0-475f-9715-3d54e95eac7e" xlink:href="mo-20221231.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_550460c8-b432-4486-8c5d-b193044d16e8" xlink:to="loc_mo_PendingIndividualLawsuitsMember_21120597-34f0-475f-9715-3d54e95eac7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_131e6457-9db6-4913-9d85-4439194ff968" xlink:href="mo-20221231.xsd#mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_550460c8-b432-4486-8c5d-b193044d16e8" xlink:to="loc_mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember_131e6457-9db6-4913-9d85-4439194ff968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember_c9dda1a2-0751-4ca0-a5dc-ebef216e5730" xlink:href="mo-20221231.xsd#mo_ClassActionLawsuitMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_550460c8-b432-4486-8c5d-b193044d16e8" xlink:to="loc_mo_ClassActionLawsuitMember_c9dda1a2-0751-4ca0-a5dc-ebef216e5730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8f3057b2-955b-4dad-bd12-4285ec04621d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_df87b3a1-32c3-4fc7-a860-a7af81740ddc" xlink:to="loc_srt_StatementGeographicalAxis_8f3057b2-955b-4dad-bd12-4285ec04621d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f6c18618-4c27-4a76-b1ad-8a16d7803341" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_8f3057b2-955b-4dad-bd12-4285ec04621d" xlink:to="loc_srt_SegmentGeographicalDomain_f6c18618-4c27-4a76-b1ad-8a16d7803341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_8efc3a0f-18c5-4515-8e70-ae0c2805c177" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f6c18618-4c27-4a76-b1ad-8a16d7803341" xlink:to="loc_stpr_IL_8efc3a0f-18c5-4515-8e70-ae0c2805c177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM_a2d4795e-8eac-4d09-8387-b43d22a8ee87" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f6c18618-4c27-4a76-b1ad-8a16d7803341" xlink:to="loc_stpr_NM_a2d4795e-8eac-4d09-8387-b43d22a8ee87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_da57451a-6d96-488f-8596-91d31e8c5e91" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f6c18618-4c27-4a76-b1ad-8a16d7803341" xlink:to="loc_stpr_MA_da57451a-6d96-488f-8596-91d31e8c5e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_810f5a98-cd8a-41c4-a673-d2f2a974d8b5" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_f6c18618-4c27-4a76-b1ad-8a16d7803341" xlink:to="loc_stpr_FL_810f5a98-cd8a-41c4-a673-d2f2a974d8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_df87b3a1-32c3-4fc7-a860-a7af81740ddc" xlink:to="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_babb77e6-3443-4c14-a7cd-67dc799842f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_babb77e6-3443-4c14-a7cd-67dc799842f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCases_4863dced-25db-4bef-98eb-2f24864247a6" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfCases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_mo_LossContingencyNumberOfCases_4863dced-25db-4bef-98eb-2f24864247a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_bbb1e71c-11ff-40ce-a9b6-884eb96adc98" xlink:href="mo-20221231.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_mo_LossContingencyClassActionLawsuit_bbb1e71c-11ff-40ce-a9b6-884eb96adc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_5da8a2e5-6ba8-4e8f-90c6-cdebcc0b2a89" xlink:href="mo-20221231.xsd#mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_5da8a2e5-6ba8-4e8f-90c6-cdebcc0b2a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveCases_529fb9c4-93dc-48dd-8ae9-f2e4e30df4af" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfInactiveCases"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_mo_LossContingencyNumberOfInactiveCases_529fb9c4-93dc-48dd-8ae9-f2e4e30df4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_73b25ebb-4270-4e9c-88f4-1dbd467c5282" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfInactiveClassActionLawsuits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0733ad71-5d7a-4e97-832b-95bcf76beb83" xlink:to="loc_mo_LossContingencyNumberOfInactiveClassActionLawsuits_73b25ebb-4270-4e9c-88f4-1dbd467c5282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_508a71fb-0bdb-46e8-b2c0-047a7ab6113a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_508a71fb-0bdb-46e8-b2c0-047a7ab6113a" xlink:to="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_0e540425-82a5-4c56-9fcf-b62d8e05b7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_0e540425-82a5-4c56-9fcf-b62d8e05b7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bbf7e4cb-4310-48d2-9a20-9e7951c5af07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_0e540425-82a5-4c56-9fcf-b62d8e05b7e1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bbf7e4cb-4310-48d2-9a20-9e7951c5af07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2f0045b1-9897-4ba7-97c5-29b7270aa280" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bbf7e4cb-4310-48d2-9a20-9e7951c5af07" xlink:to="loc_us-gaap_SubsequentEventMember_2f0045b1-9897-4ba7-97c5-29b7270aa280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_91afe7f8-4852-46e8-abb6-840c5c67672b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:to="loc_dei_LegalEntityAxis_91afe7f8-4852-46e8-abb6-840c5c67672b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_fb38c798-ee87-4004-b15a-b6fb5fe2520f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_91afe7f8-4852-46e8-abb6-840c5c67672b" xlink:to="loc_dei_EntityDomain_fb38c798-ee87-4004-b15a-b6fb5fe2520f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_66be166c-283f-49dd-b7ac-f0c55b8e856a" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_fb38c798-ee87-4004-b15a-b6fb5fe2520f" xlink:to="loc_mo_PhilipMorrisUSAMember_66be166c-283f-49dd-b7ac-f0c55b8e856a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_fd4cee69-3c79-4755-a096-72c7a90c57a4" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_fb38c798-ee87-4004-b15a-b6fb5fe2520f" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_fd4cee69-3c79-4755-a096-72c7a90c57a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_5d9933a2-a731-47c0-8d06-6ebd58c1fd66" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:to="loc_srt_LitigationCaseAxis_5d9933a2-a731-47c0-8d06-6ebd58c1fd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_5d9933a2-a731-47c0-8d06-6ebd58c1fd66" xlink:to="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_235ae934-f56c-4921-930e-c4accba2626b" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_235ae934-f56c-4921-930e-c4accba2626b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_d764c108-81f4-426d-82f7-d09774a9ea36" xlink:href="mo-20221231.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:to="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_d764c108-81f4-426d-82f7-d09774a9ea36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_eb88661c-f963-4f39-9dc9-005aa9730618" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:to="loc_mo_EngleProgenyCasesMember_eb88661c-f963-4f39-9dc9-005aa9730618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenyCasesMember_7e3f4a9f-8f53-41a7-8672-62de5a79dcd7" xlink:href="mo-20221231.xsd#mo_NonEngleProgenyCasesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:to="loc_mo_NonEngleProgenyCasesMember_7e3f4a9f-8f53-41a7-8672-62de5a79dcd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IndividualSmokingAndHealthCasesMember_3e7496b9-d980-48ed-9a61-d82115e5bf40" xlink:href="mo-20221231.xsd#mo_IndividualSmokingAndHealthCasesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:to="loc_mo_IndividualSmokingAndHealthCasesMember_3e7496b9-d980-48ed-9a61-d82115e5bf40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_b7e61d2b-b560-492d-8562-b6e747621278" xlink:href="mo-20221231.xsd#mo_EvaporLitigationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9fa13010-0f06-4af2-8eb7-cb8fc835d473" xlink:to="loc_mo_EvaporLitigationMember_b7e61d2b-b560-492d-8562-b6e747621278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6d524174-667e-422b-9dba-d89c310c5ab3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:to="loc_srt_StatementGeographicalAxis_6d524174-667e-422b-9dba-d89c310c5ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6d524174-667e-422b-9dba-d89c310c5ab3" xlink:to="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_1a531bdb-ea70-4411-9bc6-0d7c3d1b2a26" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_country_CA_1a531bdb-ea70-4411-9bc6-0d7c3d1b2a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AK_6ac955cc-e9cc-4379-aaf2-b0ed7507977f" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AK"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_AK_6ac955cc-e9cc-4379-aaf2-b0ed7507977f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_b70cc7b4-e018-4d94-be70-100a719b8ac0" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_CA_b70cc7b4-e018-4d94-be70-100a719b8ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CT_be578583-2d33-4649-b2b5-d010602ad227" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CT"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_CT_be578583-2d33-4649-b2b5-d010602ad227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_40d3772c-84ff-4bba-a699-7596f84af380" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_FL_40d3772c-84ff-4bba-a699-7596f84af380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_7386d7db-d2c4-4283-9fb9-e7f1ab5c2cd6" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_LA"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_LA_7386d7db-d2c4-4283-9fb9-e7f1ab5c2cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MA_cf016285-bb63-4932-ae34-127be6cb8ff7" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MA"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_MA_cf016285-bb63-4932-ae34-127be6cb8ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MS_09c91044-421f-4021-a32e-381eb0290da7" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MS"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_MS_09c91044-421f-4021-a32e-381eb0290da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MO_624e404f-738a-4528-ab45-bab1b3a5e75f" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MO"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_MO_624e404f-738a-4528-ab45-bab1b3a5e75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NH_5a71072d-d7aa-481b-8905-a5f2ffde4961" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NH"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_NH_5a71072d-d7aa-481b-8905-a5f2ffde4961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_3f72637b-e929-4252-9f0a-968b3827ee87" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NJ"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_NJ_3f72637b-e929-4252-9f0a-968b3827ee87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_f80bc29a-83b6-4be0-bf99-6f9227ce9bed" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_NY_f80bc29a-83b6-4be0-bf99-6f9227ce9bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_3c5d4e2e-96b5-480a-8c3a-cfe593167f5e" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OH"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_OH_3c5d4e2e-96b5-480a-8c3a-cfe593167f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_c52f9f71-9705-4748-9a81-7b9d74ca895a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_PA"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_PA_c52f9f71-9705-4748-9a81-7b9d74ca895a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_RI_d8e6a72f-f409-48b6-97fe-f34a77ae7fa6" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_RI"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_RI_d8e6a72f-f409-48b6-97fe-f34a77ae7fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TN_7a01fed1-a0bd-4d0a-9c70-c14228417d8d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TN"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_TN_7a01fed1-a0bd-4d0a-9c70-c14228417d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WV_519909b7-51d1-49dd-8c29-eea1bc2eff73" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WV"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_93b43a32-1c08-424d-941c-53c34b4bab2b" xlink:to="loc_stpr_WV_519909b7-51d1-49dd-8c29-eea1bc2eff73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_91730506-4826-4cec-abad-eb999dab207c" xlink:to="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_4c4fd738-808e-4870-894e-d7fc81765d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_4c4fd738-808e-4870-894e-d7fc81765d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofCasesSetforTrial_673d18ca-a80a-4921-be8d-5ab39386bdf6" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofCasesSetforTrial"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_mo_LossContingencyNumberofCasesSetforTrial_673d18ca-a80a-4921-be8d-5ab39386bdf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_32b67579-3154-46cb-af96-8a8d79f1d1e7" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecided"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_mo_LossContingencyClaimsDecided_32b67579-3154-46cb-af96-8a8d79f1d1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_961431ce-2799-4405-a872-7e1583ae8c67" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_961431ce-2799-4405-a872-7e1583ae8c67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_eda13688-9335-466a-b837-a739445b05f0" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_eda13688-9335-466a-b837-a739445b05f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsResolvedNumber_8eedc4c4-64ac-4797-8ac3-0c3053780b5f" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsResolvedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_mo_LossContingencyClaimsResolvedNumber_8eedc4c4-64ac-4797-8ac3-0c3053780b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_aa6e66ed-c004-4dfb-9351-9ad70195dfa3" xlink:href="mo-20221231.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cbd208fa-2d2b-4fcf-ae36-1d46ce3278e3" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_aa6e66ed-c004-4dfb-9351-9ad70195dfa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesNonEngleProgenyLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2afbdc47-b837-40ef-93e3-6cd52804dcdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_cbe769b8-c100-4e4d-ba1c-c449e0e343fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_2afbdc47-b837-40ef-93e3-6cd52804dcdc" xlink:to="loc_us-gaap_LossContingenciesTable_cbe769b8-c100-4e4d-ba1c-c449e0e343fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_069ecfa4-2eb2-4232-806a-d52e5f9901a0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_cbe769b8-c100-4e4d-ba1c-c449e0e343fb" xlink:to="loc_srt_LitigationCaseAxis_069ecfa4-2eb2-4232-806a-d52e5f9901a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_ba2196d0-5984-4e5a-9aad-51fec78fd7ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_069ecfa4-2eb2-4232-806a-d52e5f9901a0" xlink:to="loc_srt_LitigationCaseTypeDomain_ba2196d0-5984-4e5a-9aad-51fec78fd7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCaseMendezMember_baea5a89-7bf4-4373-b2df-9752635aa202" xlink:href="mo-20221231.xsd#mo_NonEngleProgenySmokingAndHealthCaseMendezMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ba2196d0-5984-4e5a-9aad-51fec78fd7ea" xlink:to="loc_mo_NonEngleProgenySmokingAndHealthCaseMendezMember_baea5a89-7bf4-4373-b2df-9752635aa202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember_aace1515-0486-4782-9243-5709c96c5e1b" xlink:href="mo-20221231.xsd#mo_NonEngleProgenySmokingAndHealthCaseFontaineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ba2196d0-5984-4e5a-9aad-51fec78fd7ea" xlink:to="loc_mo_NonEngleProgenySmokingAndHealthCaseFontaineMember_aace1515-0486-4782-9243-5709c96c5e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_f832589a-db8c-4a1d-aefd-93cacaccd134" xlink:href="mo-20221231.xsd#mo_NonEngleProgenySmokingAndHealthCasePrincipeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ba2196d0-5984-4e5a-9aad-51fec78fd7ea" xlink:to="loc_mo_NonEngleProgenySmokingAndHealthCasePrincipeMember_f832589a-db8c-4a1d-aefd-93cacaccd134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_3fcf22ce-6e8d-41c0-ae0d-d9af4195bd5a" xlink:href="mo-20221231.xsd#mo_NonEngleProgenySmokingandHealthCaseGreeneMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_ba2196d0-5984-4e5a-9aad-51fec78fd7ea" xlink:to="loc_mo_NonEngleProgenySmokingandHealthCaseGreeneMember_3fcf22ce-6e8d-41c0-ae0d-d9af4195bd5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_310b4f97-c41c-415f-b321-8623b168a658" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_cbe769b8-c100-4e4d-ba1c-c449e0e343fb" xlink:to="loc_dei_LegalEntityAxis_310b4f97-c41c-415f-b321-8623b168a658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_402d4c18-ab97-4b78-9f65-574a07613e8b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_310b4f97-c41c-415f-b321-8623b168a658" xlink:to="loc_dei_EntityDomain_402d4c18-ab97-4b78-9f65-574a07613e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_7065baeb-9ddb-4ac6-b8b6-f0b76d5c62dd" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_402d4c18-ab97-4b78-9f65-574a07613e8b" xlink:to="loc_mo_PhilipMorrisUSAMember_7065baeb-9ddb-4ac6-b8b6-f0b76d5c62dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember_682558b2-b184-4e44-a429-eeb8e97b2169" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_402d4c18-ab97-4b78-9f65-574a07613e8b" xlink:to="loc_mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember_682558b2-b184-4e44-a429-eeb8e97b2169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_cf9bae42-37d8-40ba-ae14-a26d0c5fb436" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_cbe769b8-c100-4e4d-ba1c-c449e0e343fb" xlink:to="loc_us-gaap_LossContingenciesLineItems_cf9bae42-37d8-40ba-ae14-a26d0c5fb436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_0f1a6579-ff0e-4fc7-b45d-98820cf4ffa1" xlink:href="mo-20221231.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf9bae42-37d8-40ba-ae14-a26d0c5fb436" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_0f1a6579-ff0e-4fc7-b45d-98820cf4ffa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyFaultAllocationPercentage_1b9c7686-f883-48d5-b63c-67c4beea7a5d" xlink:href="mo-20221231.xsd#mo_LossContingencyFaultAllocationPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf9bae42-37d8-40ba-ae14-a26d0c5fb436" xlink:to="loc_mo_LossContingencyFaultAllocationPercentage_1b9c7686-f883-48d5-b63c-67c4beea7a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_b309b4bf-cbfe-4594-b01e-78d63b336053" xlink:href="mo-20221231.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_cf9bae42-37d8-40ba-ae14-a26d0c5fb436" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_b309b4bf-cbfe-4594-b01e-78d63b336053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5e73ec3b-a5a3-41c2-8cd0-22a83be5569a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_41885660-f382-42c0-a282-7791df4a3695" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5e73ec3b-a5a3-41c2-8cd0-22a83be5569a" xlink:to="loc_us-gaap_LossContingenciesTable_41885660-f382-42c0-a282-7791df4a3695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c506bfc9-7d50-478c-b1cd-d1762e842ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_41885660-f382-42c0-a282-7791df4a3695" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c506bfc9-7d50-478c-b1cd-d1762e842ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_bee7226d-14d9-4a9d-bba8-e52f88f9cd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c506bfc9-7d50-478c-b1cd-d1762e842ba8" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_bee7226d-14d9-4a9d-bba8-e52f88f9cd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d80ec81d-d02a-4f7a-998f-7173c42ced88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_bee7226d-14d9-4a9d-bba8-e52f88f9cd15" xlink:to="loc_us-gaap_SubsequentEventMember_d80ec81d-d02a-4f7a-998f-7173c42ced88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_561984f8-d115-4f5f-9deb-efeb82e7f2e3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_41885660-f382-42c0-a282-7791df4a3695" xlink:to="loc_srt_LitigationCaseAxis_561984f8-d115-4f5f-9deb-efeb82e7f2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_561984f8-d115-4f5f-9deb-efeb82e7f2e3" xlink:to="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMember_19be9ed5-7eaa-428d-b8c2-65c010e9c1b8" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesMember_19be9ed5-7eaa-428d-b8c2-65c010e9c1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanAndSommersMember_7e543bc6-7a8c-4445-86f0-60e5f32859e6" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesKaplanAndSommersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesKaplanAndSommersMember_7e543bc6-7a8c-4445-86f0-60e5f32859e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_011c31ae-6ea2-4be5-86c1-d6705d7dbea6" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesStateMember_011c31ae-6ea2-4be5-86c1-d6705d7dbea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGarciaMember_291de0ec-f539-4f57-b04f-f73e90c24141" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesGarciaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesGarciaMember_291de0ec-f539-4f57-b04f-f73e90c24141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_8cd1e872-0e8f-4afc-90de-efefd8d7fc59" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember_8cd1e872-0e8f-4afc-90de-efefd8d7fc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesReiderandBanksMember_afcc4201-27ff-404d-a7dd-7a77b8af2b60" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesReiderandBanksMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesReiderandBanksMember_afcc4201-27ff-404d-a7dd-7a77b8af2b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesWeingartandHancockMember_f1338442-43fc-4509-a125-d6bbcaa7b29e" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesWeingartandHancockMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesWeingartandHancockMember_f1338442-43fc-4509-a125-d6bbcaa7b29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesPollariMember_cb719220-0444-4843-bab4-970269c9d16b" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesPollariMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesPollariMember_cb719220-0444-4843-bab4-970269c9d16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_9211e4cd-b76b-4079-9c0e-9489d4b627a1" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesGlogerRintoulandDuignamMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesGlogerRintoulandDuignamMember_9211e4cd-b76b-4079-9c0e-9489d4b627a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesFreemanAndHarrisMember_cadc0d5c-da96-4b1c-927a-fb4fc9feafd5" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesFreemanAndHarrisMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesFreemanAndHarrisMember_cadc0d5c-da96-4b1c-927a-fb4fc9feafd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesR.DouglasMember_c014757b-2855-4cca-a83f-1cbe2d592a6c" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesR.DouglasMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7cabc7b2-9961-4f91-9a8d-eb33fae84c5d" xlink:to="loc_mo_EngleProgenyCasesR.DouglasMember_c014757b-2855-4cca-a83f-1cbe2d592a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_aa3943ae-bc92-4c43-85e1-153f6f1b18f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_41885660-f382-42c0-a282-7791df4a3695" xlink:to="loc_dei_LegalEntityAxis_aa3943ae-bc92-4c43-85e1-153f6f1b18f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bc4ba74a-2099-479e-98fa-db9f936fdaf6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_aa3943ae-bc92-4c43-85e1-153f6f1b18f2" xlink:to="loc_dei_EntityDomain_bc4ba74a-2099-479e-98fa-db9f936fdaf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_f73d659c-7db4-4f1c-b7ae-484ae10e7d70" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_bc4ba74a-2099-479e-98fa-db9f936fdaf6" xlink:to="loc_mo_PhilipMorrisUSAMember_f73d659c-7db4-4f1c-b7ae-484ae10e7d70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_41885660-f382-42c0-a282-7791df4a3695" xlink:to="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_6e386c86-03e0-4de6-adbe-b8f26f8edad6" xlink:href="mo-20221231.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_6e386c86-03e0-4de6-adbe-b8f26f8edad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_7a5e5a2b-bf28-4eee-9e14-8a7ed29e7fd8" xlink:href="mo-20221231.xsd#mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants_7a5e5a2b-bf28-4eee-9e14-8a7ed29e7fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_ef1ff641-d5db-4bbd-b66f-c3fe7c972ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_ef1ff641-d5db-4bbd-b66f-c3fe7c972ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_4aff6ad4-017b-4fa5-a50f-c9d216573bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_4aff6ad4-017b-4fa5-a50f-c9d216573bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecided_eab3bb4c-b70c-4016-b936-2b0c0d9e2d9f" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecided"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyClaimsDecided_eab3bb4c-b70c-4016-b936-2b0c0d9e2d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_e18d87e2-cd62-4d2b-9477-94daf751d3c0" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecidedUnfavorableNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyClaimsDecidedUnfavorableNumber_e18d87e2-cd62-4d2b-9477-94daf751d3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_21371bee-c03d-4b94-9fee-3d37dceb8e82" xlink:href="mo-20221231.xsd#mo_LossContingencyUnfavorableVerdictsPendingReversed"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyUnfavorableVerdictsPendingReversed_21371bee-c03d-4b94-9fee-3d37dceb8e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsDecidedFavorableNumber_fbf7a975-edcd-4308-8880-d0232a2e7a54" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsDecidedFavorableNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyClaimsDecidedFavorableNumber_fbf7a975-edcd-4308-8880-d0232a2e7a54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictReversedNumber_d5683082-da8c-420a-bdad-287f273b8906" xlink:href="mo-20221231.xsd#mo_LossContingencyVerdictReversedNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyVerdictReversedNumber_d5683082-da8c-420a-bdad-287f273b8906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdicts_fc776dc9-9e3b-4913-b4a5-b9a81d539023" xlink:href="mo-20221231.xsd#mo_LossContingencyZeroDamagesVerdicts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyZeroDamagesVerdicts_fc776dc9-9e3b-4913-b4a5-b9a81d539023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_4fe8072a-91a7-4b4f-8340-c84d6719726b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_4fe8072a-91a7-4b4f-8340-c84d6719726b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyZeroDamagesVerdictModified_314e1513-a17e-49bb-8754-fae80c14844c" xlink:href="mo-20221231.xsd#mo_LossContingencyZeroDamagesVerdictModified"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_mo_LossContingencyZeroDamagesVerdictModified_314e1513-a17e-49bb-8754-fae80c14844c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyClaimsDismissedNumber_f774229b-6452-44fd-a3e9-36852bda0757" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyClaimsDismissedNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a77ba5a6-f51b-4f8d-ba72-4f9a86c75d9b" xlink:to="loc_us-gaap_LossContingencyClaimsDismissedNumber_f774229b-6452-44fd-a3e9-36852bda0757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bd7a1074-1334-43de-8a73-494b9c77d58c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bd7a1074-1334-43de-8a73-494b9c77d58c" xlink:to="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6bdabb20-1824-434f-b138-0aef146015c5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:to="loc_srt_LitigationCaseAxis_6bdabb20-1824-434f-b138-0aef146015c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_6bdabb20-1824-434f-b138-0aef146015c5" xlink:to="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHoffmanMember_02c5d2c4-c3e2-4a0b-b451-152930784a3f" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesHoffmanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesHoffmanMember_02c5d2c4-c3e2-4a0b-b451-152930784a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLevineMember_1aca713d-6c8b-4d21-aac0-5a0c4e54f626" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesLevineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesLevineMember_1aca713d-6c8b-4d21-aac0-5a0c4e54f626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesSchertzerMember_f820796e-90cf-4f03-a1a8-697f3c822dc1" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesSchertzerMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesSchertzerMember_f820796e-90cf-4f03-a1a8-697f3c822dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesLippMember_d6600381-7e3f-4a2a-9ca7-785f7e97b666" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesLippMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesLippMember_d6600381-7e3f-4a2a-9ca7-785f7e97b666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesGarciaMember_a79a7e4c-4f7a-452c-a3c3-f17994145a50" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesGarciaMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesGarciaMember_a79a7e4c-4f7a-452c-a3c3-f17994145a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesDuignanMember_63ff9fe3-961c-4cf1-9184-4ec6380c7866" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesDuignanMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesDuignanMember_63ff9fe3-961c-4cf1-9184-4ec6380c7866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMcCallMember_3a2b6a0f-1228-44ec-a071-a105865cae20" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMcCallMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesMcCallMember_3a2b6a0f-1228-44ec-a071-a105865cae20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesChadwellMember_d5b8b4ab-bad8-44ff-8ba4-7e458e549073" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesChadwellMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesChadwellMember_d5b8b4ab-bad8-44ff-8ba4-7e458e549073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesKaplanMember_c657b5d9-5d99-4d53-b8fe-9c18baacd7df" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesKaplanMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesKaplanMember_c657b5d9-5d99-4d53-b8fe-9c18baacd7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCooperMember_0e900d71-a73a-4161-90c1-7ad63c74e03a" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesCooperMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesCooperMember_0e900d71-a73a-4161-90c1-7ad63c74e03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesHollimanMember_348a6b85-5f44-47ae-ab2b-4992951ac7ab" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesHollimanMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesHollimanMember_348a6b85-5f44-47ae-ab2b-4992951ac7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesTuttleMember_e058245b-3b7a-434f-bacc-533de1d21812" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesTuttleMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesTuttleMember_e058245b-3b7a-434f-bacc-533de1d21812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesMillerMember_ba2ffc83-a530-47b7-9cff-70d56f3f3f8d" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesMillerMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesMillerMember_ba2ffc83-a530-47b7-9cff-70d56f3f3f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesD.BrownMember_2d5668b9-cb10-4846-9c8b-165455bb9496" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesD.BrownMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesD.BrownMember_2d5668b9-cb10-4846-9c8b-165455bb9496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesCuddiheeMember_91310eaa-d73d-4d19-9f8f-e3d66d6bccb7" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesCuddiheeMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7bf7397f-9d51-47a1-93b7-7cfe773da3c1" xlink:to="loc_mo_EngleProgenyCasesCuddiheeMember_91310eaa-d73d-4d19-9f8f-e3d66d6bccb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_fa23dd5d-12b3-431a-bd51-33ba5d12071e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:to="loc_us-gaap_LitigationStatusAxis_fa23dd5d-12b3-431a-bd51-33ba5d12071e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_fdcc06ed-83b1-4433-a56a-b601b97f1ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_fa23dd5d-12b3-431a-bd51-33ba5d12071e" xlink:to="loc_us-gaap_LitigationStatusDomain_fdcc06ed-83b1-4433-a56a-b601b97f1ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_a15664a7-fab0-4855-8be1-b92e994e7834" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_fdcc06ed-83b1-4433-a56a-b601b97f1ca1" xlink:to="loc_us-gaap_PendingLitigationMember_a15664a7-fab0-4855-8be1-b92e994e7834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_d74fa340-8900-44de-805d-af8cff19a0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_fdcc06ed-83b1-4433-a56a-b601b97f1ca1" xlink:to="loc_us-gaap_SettledLitigationMember_d74fa340-8900-44de-805d-af8cff19a0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4c0d6d28-5836-4d22-8b1c-eda68116902e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:to="loc_dei_LegalEntityAxis_4c0d6d28-5836-4d22-8b1c-eda68116902e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6dd8b25e-f7b9-4f75-99cc-d2c75001ada1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_4c0d6d28-5836-4d22-8b1c-eda68116902e" xlink:to="loc_dei_EntityDomain_6dd8b25e-f7b9-4f75-99cc-d2c75001ada1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_a6e99f25-13c2-4d5e-8892-8d9cebbc70a2" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_6dd8b25e-f7b9-4f75-99cc-d2c75001ada1" xlink:to="loc_mo_PhilipMorrisUSAMember_a6e99f25-13c2-4d5e-8892-8d9cebbc70a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_39582ca5-65e6-471b-9976-a2e27b727179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_39582ca5-65e6-471b-9976-a2e27b727179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_b439f7d4-efa8-459e-8839-e3d9890f9905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_39582ca5-65e6-471b-9976-a2e27b727179" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_b439f7d4-efa8-459e-8839-e3d9890f9905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6b7a468a-4ad7-43e9-9b0e-15ee3cf7346a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_b439f7d4-efa8-459e-8839-e3d9890f9905" xlink:to="loc_us-gaap_SubsequentEventMember_6b7a468a-4ad7-43e9-9b0e-15ee3cf7346a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_6837d644-f0f6-4bc0-a334-22d914040c38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_03f205ba-58a3-4207-9608-cdb69350f14c" xlink:to="loc_us-gaap_LossContingenciesLineItems_6837d644-f0f6-4bc0-a334-22d914040c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_dda47f3d-5c56-411b-aa9a-863ad0e1253a" xlink:href="mo-20221231.xsd#mo_LossContingencyCompensatoryDamagesAwardedValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6837d644-f0f6-4bc0-a334-22d914040c38" xlink:to="loc_mo_LossContingencyCompensatoryDamagesAwardedValue_dda47f3d-5c56-411b-aa9a-863ad0e1253a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPunitiveDamagesAwardedValue_a9480469-8081-4210-bd90-5004d0fe065f" xlink:href="mo-20221231.xsd#mo_LossContingencyPunitiveDamagesAwardedValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6837d644-f0f6-4bc0-a334-22d914040c38" xlink:to="loc_mo_LossContingencyPunitiveDamagesAwardedValue_a9480469-8081-4210-bd90-5004d0fe065f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_4e148508-3e5a-4164-9b62-73cb6acc78d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6837d644-f0f6-4bc0-a334-22d914040c38" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_4e148508-3e5a-4164-9b62-73cb6acc78d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_091cb7ea-c39f-47e1-960b-48f43df7c380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6837d644-f0f6-4bc0-a334-22d914040c38" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_091cb7ea-c39f-47e1-960b-48f43df7c380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesFloridaBondStatuteDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df3dd382-4b93-4325-b9f3-9f21bb1db4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_bbf6e07e-575f-469a-b962-44000a235488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_df3dd382-4b93-4325-b9f3-9f21bb1db4b7" xlink:to="loc_us-gaap_LossContingenciesTable_bbf6e07e-575f-469a-b962-44000a235488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7ba88f9b-0ecc-42b1-ba76-ff93c9cc4439" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_bbf6e07e-575f-469a-b962-44000a235488" xlink:to="loc_srt_StatementGeographicalAxis_7ba88f9b-0ecc-42b1-ba76-ff93c9cc4439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_098bd270-fcd1-4517-90e5-639cad71cf80" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_7ba88f9b-0ecc-42b1-ba76-ff93c9cc4439" xlink:to="loc_srt_SegmentGeographicalDomain_098bd270-fcd1-4517-90e5-639cad71cf80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_c4119874-0d76-45a3-b14a-51ed2d196f01" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_098bd270-fcd1-4517-90e5-639cad71cf80" xlink:to="loc_stpr_FL_c4119874-0d76-45a3-b14a-51ed2d196f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_ea847558-cdc6-4bff-8655-f1f1378a8c5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_bbf6e07e-575f-469a-b962-44000a235488" xlink:to="loc_srt_LitigationCaseAxis_ea847558-cdc6-4bff-8655-f1f1378a8c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b89434f2-3e01-436c-a19a-ba2729351645" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_ea847558-cdc6-4bff-8655-f1f1378a8c5c" xlink:to="loc_srt_LitigationCaseTypeDomain_b89434f2-3e01-436c-a19a-ba2729351645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EngleProgenyCasesStateMember_45e07ff1-cdd4-4784-8f1f-0467ae6688fd" xlink:href="mo-20221231.xsd#mo_EngleProgenyCasesStateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b89434f2-3e01-436c-a19a-ba2729351645" xlink:to="loc_mo_EngleProgenyCasesStateMember_45e07ff1-cdd4-4784-8f1f-0467ae6688fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3f5bd84e-f4a3-41a7-ad37-cde02f99f53e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_bbf6e07e-575f-469a-b962-44000a235488" xlink:to="loc_us-gaap_LossContingenciesLineItems_3f5bd84e-f4a3-41a7-ad37-cde02f99f53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_MaximumBondForAllDefendants_20330581-444b-416e-b183-7a6b074d2d72" xlink:href="mo-20221231.xsd#mo_MaximumBondForAllDefendants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f5bd84e-f4a3-41a7-ad37-cde02f99f53e" xlink:to="loc_mo_MaximumBondForAllDefendants_20330581-444b-416e-b183-7a6b074d2d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesOtherSmokingandHealthClassActionsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4122b877-8e0d-41be-8a9f-474175cb7443" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4122b877-8e0d-41be-8a9f-474175cb7443" xlink:to="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8381e9f6-c4d5-4253-accd-1e3f493fedb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8381e9f6-c4d5-4253-accd-1e3f493fedb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e81ca8c2-5021-4424-93f2-d8cbbaedb98f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8381e9f6-c4d5-4253-accd-1e3f493fedb1" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e81ca8c2-5021-4424-93f2-d8cbbaedb98f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_c95016b4-7ce3-438f-90a7-2a78271f7cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_e81ca8c2-5021-4424-93f2-d8cbbaedb98f" xlink:to="loc_us-gaap_SubsequentEventMember_c95016b4-7ce3-438f-90a7-2a78271f7cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_1f5cf884-104d-492c-8d06-80ef9e88d7ff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:to="loc_srt_StatementGeographicalAxis_1f5cf884-104d-492c-8d06-80ef9e88d7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_1f5cf884-104d-492c-8d06-80ef9e88d7ff" xlink:to="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_AR_fbec87d5-5a75-4966-bb5d-60db1959aec2" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_AR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_AR_fbec87d5-5a75-4966-bb5d-60db1959aec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_0c78f26b-f257-45c8-9d40-6c4c2722882a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_CA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_CA_0c78f26b-f257-45c8-9d40-6c4c2722882a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DE_b51fd926-042e-4cc5-b515-45f3e937a113" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_DE"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_DE_b51fd926-042e-4cc5-b515-45f3e937a113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_DC_8830d98d-ee84-40fa-8a2b-2fdd1c641063" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_DC"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_DC_8830d98d-ee84-40fa-8a2b-2fdd1c641063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_234d2898-72e8-4dd0-aff0-8a6ea911eff2" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_FL"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_FL_234d2898-72e8-4dd0-aff0-8a6ea911eff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_21571edf-d9ab-4aa2-a626-fe9034f3286a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_IL_21571edf-d9ab-4aa2-a626-fe9034f3286a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA_e6c118a7-4732-4271-ac08-a0cfb844dd11" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IA"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_IA_e6c118a7-4732-4271-ac08-a0cfb844dd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_KS_0b95b19f-dd15-496f-9809-10c9ae09208e" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_KS"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_KS_0b95b19f-dd15-496f-9809-10c9ae09208e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_LA_40e78e69-3407-4568-9e1a-c5750c3c5a24" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_LA"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_LA_40e78e69-3407-4568-9e1a-c5750c3c5a24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MD_e67ec479-9886-4a5d-a3ec-dfe185efda51" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MD"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_MD_e67ec479-9886-4a5d-a3ec-dfe185efda51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MI_8011578e-4580-489f-af05-d5cbebbf47ba" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MI"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_MI_8011578e-4580-489f-af05-d5cbebbf47ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MN_b4a13c12-5358-4554-924e-7f470cc9653c" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MN"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_MN_b4a13c12-5358-4554-924e-7f470cc9653c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NV_f30706cb-49fc-4db4-b0e2-86e913e0632a" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NV"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_NV_f30706cb-49fc-4db4-b0e2-86e913e0632a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NJ_1f8cbf25-f570-4d85-a99f-22aaa0cef5a4" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NJ"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_NJ_1f8cbf25-f570-4d85-a99f-22aaa0cef5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_89dd8809-7817-42fe-b66e-8f5311ddfeab" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_NY_89dd8809-7817-42fe-b66e-8f5311ddfeab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OH_89a54c10-99f6-4573-b963-b8794a8e6359" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OH"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_OH_89a54c10-99f6-4573-b963-b8794a8e6359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OK_1cd80af2-f8a3-4013-9384-3c78c93e705e" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OK"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_OK_1cd80af2-f8a3-4013-9384-3c78c93e705e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_OR_24409303-aa14-44b0-be39-e48d86d380ee" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_OR"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_OR_24409303-aa14-44b0-be39-e48d86d380ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_PA_f1a2271e-5100-4cc1-98dd-ae877254eef0" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_PA"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_PA_f1a2271e-5100-4cc1-98dd-ae877254eef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_PR_73c4b77b-3709-4b29-8e47-6865b6e3ed5b" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_PR"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_country_PR_73c4b77b-3709-4b29-8e47-6865b6e3ed5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_SC_360a3ab2-4e92-4719-b047-fd7e1b2534a8" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_SC"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_SC_360a3ab2-4e92-4719-b047-fd7e1b2534a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_de6f3b44-3fa0-493c-858e-bf73c2318c7f" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_TX"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_TX_de6f3b44-3fa0-493c-858e-bf73c2318c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WI_88129764-68b7-4a61-a41b-a588b5dc32c2" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_WI"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_stpr_WI_88129764-68b7-4a61-a41b-a588b5dc32c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_18a5f998-d992-4743-8350-0db93fbbd009" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_country_CA_18a5f998-d992-4743-8350-0db93fbbd009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_BritishColumbiaSaskatchewanMember_78aa4546-ebe5-4fc2-b935-2a7a53272a01" xlink:href="mo-20221231.xsd#mo_BritishColumbiaSaskatchewanMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2356638d-d583-41f6-9fdf-8c0dc47a77f3" xlink:to="loc_mo_BritishColumbiaSaskatchewanMember_78aa4546-ebe5-4fc2-b935-2a7a53272a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6497ff19-4b9f-483b-a290-00fd747c2856" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:to="loc_dei_LegalEntityAxis_6497ff19-4b9f-483b-a290-00fd747c2856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2d13d272-06ee-4a92-9627-5459555fcc48" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6497ff19-4b9f-483b-a290-00fd747c2856" xlink:to="loc_dei_EntityDomain_2d13d272-06ee-4a92-9627-5459555fcc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_741ffd2d-31af-4865-b979-c32ba85c309a" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_2d13d272-06ee-4a92-9627-5459555fcc48" xlink:to="loc_mo_PhilipMorrisUSAMember_741ffd2d-31af-4865-b979-c32ba85c309a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAandAltriaGroupMember_84c762d8-8d3c-4c5e-b8fc-d6465c997649" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAandAltriaGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_2d13d272-06ee-4a92-9627-5459555fcc48" xlink:to="loc_mo_PhilipMorrisUSAandAltriaGroupMember_84c762d8-8d3c-4c5e-b8fc-d6465c997649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_cb0fd194-ac5a-4bfc-9471-7dc98eb205a0" xlink:href="mo-20221231.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_2d13d272-06ee-4a92-9627-5459555fcc48" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_cb0fd194-ac5a-4bfc-9471-7dc98eb205a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f7ef2cc5-c0dd-408a-aed8-67800b63bd9b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:to="loc_srt_LitigationCaseAxis_f7ef2cc5-c0dd-408a-aed8-67800b63bd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_0eb2cbe8-5d35-4627-b337-4098dbc34200" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_f7ef2cc5-c0dd-408a-aed8-67800b63bd9b" xlink:to="loc_srt_LitigationCaseTypeDomain_0eb2cbe8-5d35-4627-b337-4098dbc34200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_335a79f4-9fb8-4ac8-a409-d25682555804" xlink:href="mo-20221231.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_0eb2cbe8-5d35-4627-b337-4098dbc34200" xlink:to="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_335a79f4-9fb8-4ac8-a409-d25682555804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_490b2d32-8715-40e3-b4a0-18f86e5a669c" xlink:to="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassNotCertifiedNumber_d0a29548-f6ec-40bb-ac2e-091eee6d71ac" xlink:href="mo-20221231.xsd#mo_LossContingencyClassNotCertifiedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:to="loc_mo_LossContingencyClassNotCertifiedNumber_d0a29548-f6ec-40bb-ac2e-091eee6d71ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_7fd688b1-0384-441c-aa4c-dbae92bec552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_7fd688b1-0384-441c-aa4c-dbae92bec552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_18aef966-f38d-4ea9-8657-54ed7ba88b31" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:to="loc_mo_LossContingencyNumberofManufacturers_18aef966-f38d-4ea9-8657-54ed7ba88b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyVerdictsUpheld_909b420d-9327-4b72-8d05-45a94a8640b0" xlink:href="mo-20221231.xsd#mo_LossContingencyVerdictsUpheld"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:to="loc_mo_LossContingencyVerdictsUpheld_909b420d-9327-4b72-8d05-45a94a8640b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_AmountAwardedtoOtherParty_a53f0e85-593b-4351-97b8-c040b62c9c52" xlink:href="mo-20221231.xsd#mo_AmountAwardedtoOtherParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_65ab9f7a-1d74-41d5-9ce2-ff8587d17d0f" xlink:to="loc_mo_AmountAwardedtoOtherParty_a53f0e85-593b-4351-97b8-c040b62c9c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesHealthCareCostRecoveryLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d0c0147b-75d6-4d40-aa6d-b2024622fd80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d0c0147b-75d6-4d40-aa6d-b2024622fd80" xlink:to="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_d3d90a74-95ed-4977-b481-198e101aaede" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:to="loc_us-gaap_LitigationStatusAxis_d3d90a74-95ed-4977-b481-198e101aaede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_e4ec4482-6140-44ff-a7b4-c163a9d670ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_d3d90a74-95ed-4977-b481-198e101aaede" xlink:to="loc_us-gaap_LitigationStatusDomain_e4ec4482-6140-44ff-a7b4-c163a9d670ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ThreatenedLitigationMember_dd9c251a-8c7a-4120-8fa4-1e6e85e447bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ThreatenedLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_e4ec4482-6140-44ff-a7b4-c163a9d670ce" xlink:to="loc_us-gaap_ThreatenedLitigationMember_dd9c251a-8c7a-4120-8fa4-1e6e85e447bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f1776854-434e-4604-bb38-721d250760df" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:to="loc_srt_StatementGeographicalAxis_f1776854-434e-4604-bb38-721d250760df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_359998c5-69f2-4882-b3a8-958ae6a57850" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f1776854-434e-4604-bb38-721d250760df" xlink:to="loc_srt_SegmentGeographicalDomain_359998c5-69f2-4882-b3a8-958ae6a57850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_a1fc5f13-d16d-4d68-bb7f-edd79a25e723" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_359998c5-69f2-4882-b3a8-958ae6a57850" xlink:to="loc_country_CA_a1fc5f13-d16d-4d68-bb7f-edd79a25e723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_63241a3d-f2be-44c7-827c-c79d4ef21738" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:to="loc_srt_LitigationCaseAxis_63241a3d-f2be-44c7-827c-c79d4ef21738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_b3b92df1-1a05-4c71-bf26-81e20caa0f1d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_63241a3d-f2be-44c7-827c-c79d4ef21738" xlink:to="loc_srt_LitigationCaseTypeDomain_b3b92df1-1a05-4c71-bf26-81e20caa0f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_e434dac1-ab5d-4fb1-8622-8239f5e76a97" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b3b92df1-1a05-4c71-bf26-81e20caa0f1d" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_e434dac1-ab5d-4fb1-8622-8239f5e76a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_7546a06d-7e19-45bd-8941-581acd33d194" xlink:href="mo-20221231.xsd#mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_b3b92df1-1a05-4c71-bf26-81e20caa0f1d" xlink:to="loc_mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember_7546a06d-7e19-45bd-8941-581acd33d194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_672ad951-65b9-49d4-939d-b3b78192f9f3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:to="loc_dei_LegalEntityAxis_672ad951-65b9-49d4-939d-b3b78192f9f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5030fb4d-0627-4001-9527-20be85449244" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_672ad951-65b9-49d4-939d-b3b78192f9f3" xlink:to="loc_dei_EntityDomain_5030fb4d-0627-4001-9527-20be85449244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CanadianTobaccoManufacturersMember_3f98d837-eca2-44c6-a664-dc48df43c00a" xlink:href="mo-20221231.xsd#mo_CanadianTobaccoManufacturersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5030fb4d-0627-4001-9527-20be85449244" xlink:to="loc_mo_CanadianTobaccoManufacturersMember_3f98d837-eca2-44c6-a664-dc48df43c00a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_2a9ada74-0e8a-43e3-a1c6-d4a9b4be708d" xlink:to="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_44ca2c99-68e9-46a8-b497-1849f32f760e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_44ca2c99-68e9-46a8-b497-1849f32f760e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofManufacturers_c64770ab-afd3-4050-9ca9-0e948f7e7959" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofManufacturers"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_mo_LossContingencyNumberofManufacturers_c64770ab-afd3-4050-9ca9-0e948f7e7959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigation_6ab21286-6c52-4da3-86c6-73d80416064f" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofStateswithSettledLitigation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigation_6ab21286-6c52-4da3-86c6-73d80416064f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualPaymentAmount_917679a7-3e50-4754-839e-24f39d1dd79d" xlink:href="mo-20221231.xsd#mo_LitigationSettlementAnnualPaymentAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_mo_LitigationSettlementAnnualPaymentAmount_917679a7-3e50-4754-839e-24f39d1dd79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_756abd3b-eedd-4635-8f32-5876c9b8b6db" xlink:href="mo-20221231.xsd#mo_LitigationSettlementAnnualLegalFeesPayableMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_mo_LitigationSettlementAnnualLegalFeesPayableMaximum_756abd3b-eedd-4635-8f32-5876c9b8b6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_694aefd6-ef7b-4e2b-bd06-ae84978c9a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0abf1d65-504d-422f-be17-d7bd3f04343c" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_694aefd6-ef7b-4e2b-bd06-ae84978c9a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesNPMAdjustmentDisputesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_99118dbf-85d8-4ef3-b8cc-6ee9ccc9b394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_99118dbf-85d8-4ef3-b8cc-6ee9ccc9b394" xlink:to="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b6922689-2d2c-4b69-9038-e26773dab27b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_srt_StatementGeographicalAxis_b6922689-2d2c-4b69-9038-e26773dab27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_b6922689-2d2c-4b69-9038-e26773dab27b" xlink:to="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NY_650025e9-acd4-447a-af16-ed7e6ad184c4" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NY"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:to="loc_stpr_NY_650025e9-acd4-447a-af16-ed7e6ad184c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IL_b291da30-9f42-41c0-8c8c-0d71f0cdee6d" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IL"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:to="loc_stpr_IL_b291da30-9f42-41c0-8c8c-0d71f0cdee6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_IA_33b23e42-be30-4eb0-858f-63111e0b70fd" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_IA"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:to="loc_stpr_IA_33b23e42-be30-4eb0-858f-63111e0b70fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NM_60ad113a-2da6-4df9-90a5-819601fe7772" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_NM"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:to="loc_stpr_NM_60ad113a-2da6-4df9-90a5-819601fe7772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_MT_14324e97-a841-4d74-9e30-5b3ba88f35cc" xlink:href="https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd#stpr_MT"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9eae6fb2-b465-46b9-9efc-c9161a03a3d5" xlink:to="loc_stpr_MT_14324e97-a841-4d74-9e30-5b3ba88f35cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_0167c202-c2c5-4ddc-9505-e0ea60bde5f2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_dei_LegalEntityAxis_0167c202-c2c5-4ddc-9505-e0ea60bde5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5ed959ae-1433-4cbd-a28c-990fd43be78e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_0167c202-c2c5-4ddc-9505-e0ea60bde5f2" xlink:to="loc_dei_EntityDomain_5ed959ae-1433-4cbd-a28c-990fd43be78e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_a8ce3d48-9133-44c5-812e-df14269804ec" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5ed959ae-1433-4cbd-a28c-990fd43be78e" xlink:to="loc_mo_PhilipMorrisUSAMember_a8ce3d48-9133-44c5-812e-df14269804ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_431b7b0e-18a8-44e6-a98b-2d5fd08bea45" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_srt_LitigationCaseAxis_431b7b0e-18a8-44e6-a98b-2d5fd08bea45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e21fbc3e-776c-4322-b439-5eb6c62c452b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_431b7b0e-18a8-44e6-a98b-2d5fd08bea45" xlink:to="loc_srt_LitigationCaseTypeDomain_e21fbc3e-776c-4322-b439-5eb6c62c452b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e21fbc3e-776c-4322-b439-5eb6c62c452b" xlink:to="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_5f9d819f-f378-451d-971f-14d1e2c734a4" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember_5f9d819f-f378-451d-971f-14d1e2c734a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_cd12f1ac-59c1-4f16-b939-1d56c2754f58" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember_cd12f1ac-59c1-4f16-b939-1d56c2754f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_af4d3dab-f615-48b1-a577-acac90b7e4dc" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember_af4d3dab-f615-48b1-a577-acac90b7e4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_9b1ace48-a6b5-4d9e-a244-a2024b71da86" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember_9b1ace48-a6b5-4d9e-a244-a2024b71da86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_ba3b221c-400d-45a7-a2e7-0ce03fc931b2" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember_ba3b221c-400d-45a7-a2e7-0ce03fc931b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_3f565ca0-87ab-4888-87a2-ba8451cdd422" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember_3f565ca0-87ab-4888-87a2-ba8451cdd422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_297b3bdc-c4bb-428c-b444-6ea17ce997d8" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember_297b3bdc-c4bb-428c-b444-6ea17ce997d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_0159eed4-8952-47aa-b21a-ddef280e6c19" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember_0159eed4-8952-47aa-b21a-ddef280e6c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_a285a514-48f0-4ae4-a39d-742573c10c26" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember_a285a514-48f0-4ae4-a39d-742573c10c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_146a4b38-ed7b-418f-a48e-951a96fdb30f" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember_146a4b38-ed7b-418f-a48e-951a96fdb30f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_847c7024-132c-49cc-bf90-6a908bb53b8b" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember_847c7024-132c-49cc-bf90-6a908bb53b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_2bf892dc-6931-452e-af79-ec2cdbf9577d" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember_2bf892dc-6931-452e-af79-ec2cdbf9577d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_2626c1b5-40fb-4c7a-9429-6c4d285e4858" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember_2626c1b5-40fb-4c7a-9429-6c4d285e4858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_f16d12a9-7069-462a-8cb5-573c6abac804" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember_f16d12a9-7069-462a-8cb5-573c6abac804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_c2b85074-74ca-4f02-9157-fe654d8ea665" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember_c2b85074-74ca-4f02-9157-fe654d8ea665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_b9f28f84-b8df-4fdd-8af7-194f20aff28d" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember_b9f28f84-b8df-4fdd-8af7-194f20aff28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_126a96ae-599d-47f0-aaa8-2e5e8ddedb19" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember_126a96ae-599d-47f0-aaa8-2e5e8ddedb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_6e75f899-8cef-4633-9add-58dea14841b7" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember_6e75f899-8cef-4633-9add-58dea14841b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_f38c3e57-20bf-459d-b37c-2200ac0d8565" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042020Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042020Member_f38c3e57-20bf-459d-b37c-2200ac0d8565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_b83ae834-0fe2-45cb-a297-6c6a3b163245" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_HealthCareCostRecoveryActionsMember_7ba7061b-ce85-4617-ab72-b8d12b7925c4" xlink:to="loc_mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember_b83ae834-0fe2-45cb-a297-6c6a3b163245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_36942028-b887-4c69-870e-3bb0aab6380b" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20042021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e21fbc3e-776c-4322-b439-5eb6c62c452b" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20042021Member_36942028-b887-4c69-870e-3bb0aab6380b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_9ce30f0a-2d6d-43aa-94fd-7d0ead4787ba" xlink:href="mo-20221231.xsd#mo_HealthCareCostRecoveryActionsTransitionYears20192021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e21fbc3e-776c-4322-b439-5eb6c62c452b" xlink:to="loc_mo_HealthCareCostRecoveryActionsTransitionYears20192021Member_9ce30f0a-2d6d-43aa-94fd-7d0ead4787ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_34e681a2-892f-430c-8f1c-32dc53e012ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_us-gaap_LitigationStatusAxis_34e681a2-892f-430c-8f1c-32dc53e012ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_5fcc4320-43c2-45d1-91f6-13dc89485a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_34e681a2-892f-430c-8f1c-32dc53e012ec" xlink:to="loc_us-gaap_LitigationStatusDomain_5fcc4320-43c2-45d1-91f6-13dc89485a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_b56065db-568c-4f26-afe7-3ef2cdc6acfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_5fcc4320-43c2-45d1-91f6-13dc89485a89" xlink:to="loc_us-gaap_SettledLitigationMember_b56065db-568c-4f26-afe7-3ef2cdc6acfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_580bbce5-7fb1-4626-b4b0-2bb0bd68fe06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_5fcc4320-43c2-45d1-91f6-13dc89485a89" xlink:to="loc_us-gaap_PendingLitigationMember_580bbce5-7fb1-4626-b4b0-2bb0bd68fe06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_ffc656b4-d4ac-4b70-95b6-521d01a8c78d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_ffc656b4-d4ac-4b70-95b6-521d01a8c78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e07e05e6-8b19-4092-9e9b-8601ee4adddb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_ffc656b4-d4ac-4b70-95b6-521d01a8c78d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e07e05e6-8b19-4092-9e9b-8601ee4adddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_6c58ef83-6017-43a4-91b3-cca0b4e9ba2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e07e05e6-8b19-4092-9e9b-8601ee4adddb" xlink:to="loc_us-gaap_CostOfSalesMember_6c58ef83-6017-43a4-91b3-cca0b4e9ba2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodAxis_71c20381-e834-4f97-beb7-33be47e434cb" xlink:href="mo-20221231.xsd#mo_ArbitrationPeriodAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_mo_ArbitrationPeriodAxis_71c20381-e834-4f97-beb7-33be47e434cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ArbitrationPeriodDomain_79365032-8ce7-48a0-92ca-27372b6684a4" xlink:href="mo-20221231.xsd#mo_ArbitrationPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ArbitrationPeriodAxis_71c20381-e834-4f97-beb7-33be47e434cb" xlink:to="loc_mo_ArbitrationPeriodDomain_79365032-8ce7-48a0-92ca-27372b6684a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodOneMember_518e21d2-6b78-4c24-8e58-2799fcd90546" xlink:href="mo-20221231.xsd#mo_PeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ArbitrationPeriodDomain_79365032-8ce7-48a0-92ca-27372b6684a4" xlink:to="loc_mo_PeriodOneMember_518e21d2-6b78-4c24-8e58-2799fcd90546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PeriodTwoMember_e78fb9d0-e74a-449a-8086-7034c4ee3014" xlink:href="mo-20221231.xsd#mo_PeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_mo_ArbitrationPeriodDomain_79365032-8ce7-48a0-92ca-27372b6684a4" xlink:to="loc_mo_PeriodTwoMember_e78fb9d0-e74a-449a-8086-7034c4ee3014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3f8ea6f3-b87e-453f-8012-3da573a6e770" xlink:to="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementEstimateofPossibleGain_58a05f56-6b0f-4aa4-a2ab-912c1b7341b3" xlink:href="mo-20221231.xsd#mo_LitigationSettlementEstimateofPossibleGain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LitigationSettlementEstimateofPossibleGain_58a05f56-6b0f-4aa4-a2ab-912c1b7341b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_9d238278-7b7a-4fef-a626-4ae565a43f9f" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne_9d238278-7b7a-4fef-a626-4ae565a43f9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_82e947d3-f458-4ae1-9187-e0cce1a2e5c9" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation_82e947d3-f458-4ae1-9187-e0cce1a2e5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_c6c9b87a-1bb2-44e5-b9cd-3cd8ce7ed7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_c6c9b87a-1bb2-44e5-b9cd-3cd8ce7ed7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_041d11bd-e6bf-4925-8ec8-e4b54e7144b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_041d11bd-e6bf-4925-8ec8-e4b54e7144b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_4785b111-db3b-44ab-b93c-be805be583cf" xlink:href="mo-20221231.xsd#mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty_4785b111-db3b-44ab-b93c-be805be583cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettled_45ccb5de-e801-4f20-b479-0936f5e7a8af" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesNotSettled"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberOfStatesNotSettled_45ccb5de-e801-4f20-b479-0936f5e7a8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_03a3ce33-ddfc-4177-95e6-bbbf05b298d1" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesWithConcludedHearings"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_03a3ce33-ddfc-4177-95e6-bbbf05b298d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_bba1e4d1-46d1-4543-b09a-2f68b457cc00" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues_bba1e4d1-46d1-4543-b09a-2f68b457cc00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_26ab9292-2fae-48d9-9c59-74dfec0c927f" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues_26ab9292-2fae-48d9-9c59-74dfec0c927f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyReductionToCostOfSales_e1060b55-26e1-4a28-a636-7dfb05a523fd" xlink:href="mo-20221231.xsd#mo_LossContingencyReductionToCostOfSales"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyReductionToCostOfSales_e1060b55-26e1-4a28-a636-7dfb05a523fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_c2e67f8d-d3d9-4c94-ae0b-a5ee442c9edf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_c2e67f8d-d3d9-4c94-ae0b-a5ee442c9edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_63a67aa4-b833-4467-8cfa-ad7cdff5a148" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_b6b6a6dd-cf28-4105-931c-b8a4b7d6a0b5" xlink:to="loc_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod_63a67aa4-b833-4467-8cfa-ad7cdff5a148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5a84c5c4-db8e-4352-9e1d-589792587339" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_ba18da10-c02e-4a35-9fd3-99656f03673c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5a84c5c4-db8e-4352-9e1d-589792587339" xlink:to="loc_us-gaap_LossContingenciesTable_ba18da10-c02e-4a35-9fd3-99656f03673c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_353dd824-bc97-44fa-a585-e9e546892a63" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ba18da10-c02e-4a35-9fd3-99656f03673c" xlink:to="loc_dei_LegalEntityAxis_353dd824-bc97-44fa-a585-e9e546892a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9ef7cbee-8b2d-4f6b-a3ac-590d4283be5c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_353dd824-bc97-44fa-a585-e9e546892a63" xlink:to="loc_dei_EntityDomain_9ef7cbee-8b2d-4f6b-a3ac-590d4283be5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_69694445-f08e-4293-ac3d-97d5aa4842c9" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9ef7cbee-8b2d-4f6b-a3ac-590d4283be5c" xlink:to="loc_mo_PhilipMorrisUSAMember_69694445-f08e-4293-ac3d-97d5aa4842c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_e1541c53-d166-4979-afaf-959cf8ce2803" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ba18da10-c02e-4a35-9fd3-99656f03673c" xlink:to="loc_srt_LitigationCaseAxis_e1541c53-d166-4979-afaf-959cf8ce2803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9a58f5e2-8939-4809-a751-e5050c7b89ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_e1541c53-d166-4979-afaf-959cf8ce2803" xlink:to="loc_srt_LitigationCaseTypeDomain_9a58f5e2-8939-4809-a751-e5050c7b89ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_4b146141-345f-45a1-86cb-1bbe039dcb73" xlink:href="mo-20221231.xsd#mo_OtherDisputesUndertheStateSettlementAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9a58f5e2-8939-4809-a751-e5050c7b89ce" xlink:to="loc_mo_OtherDisputesUndertheStateSettlementAgreementsMember_4b146141-345f-45a1-86cb-1bbe039dcb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_8347bb3b-82ac-436e-9b6d-8f71adf636e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_ba18da10-c02e-4a35-9fd3-99656f03673c" xlink:to="loc_us-gaap_LossContingenciesLineItems_8347bb3b-82ac-436e-9b6d-8f71adf636e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_32d745b6-dc02-409e-86e7-4754afc3e68a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_8347bb3b-82ac-436e-9b6d-8f71adf636e8" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_32d745b6-dc02-409e-86e7-4754afc3e68a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesFederalGovernmentsLawsuitDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_918e2475-3c8f-47f7-b58e-c65776769a63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_73df3418-85cc-4344-913e-5b22f01f2dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_918e2475-3c8f-47f7-b58e-c65776769a63" xlink:to="loc_us-gaap_LossContingenciesTable_73df3418-85cc-4344-913e-5b22f01f2dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_377c10bf-f566-43b6-bfbd-ffde515bda0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_73df3418-85cc-4344-913e-5b22f01f2dda" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_377c10bf-f566-43b6-bfbd-ffde515bda0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_f5bedfb6-c53c-4f0e-924a-1cc3b142e8a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_377c10bf-f566-43b6-bfbd-ffde515bda0e" xlink:to="loc_us-gaap_LossContingencyNatureDomain_f5bedfb6-c53c-4f0e-924a-1cc3b142e8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ImplementationofCorrectiveCommunicationsMember_8f371383-bb4d-487c-973f-9d5a7a381a6f" xlink:href="mo-20221231.xsd#mo_ImplementationofCorrectiveCommunicationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_f5bedfb6-c53c-4f0e-924a-1cc3b142e8a9" xlink:to="loc_mo_ImplementationofCorrectiveCommunicationsMember_8f371383-bb4d-487c-973f-9d5a7a381a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_d221a77d-c114-4e63-b416-e73b2d1663f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_73df3418-85cc-4344-913e-5b22f01f2dda" xlink:to="loc_srt_LitigationCaseAxis_d221a77d-c114-4e63-b416-e73b2d1663f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_001e4057-11c3-4759-a33c-c78711611df4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_d221a77d-c114-4e63-b416-e73b2d1663f6" xlink:to="loc_srt_LitigationCaseTypeDomain_001e4057-11c3-4759-a33c-c78711611df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalGovernmentsLawsuitMember_37c337d7-7162-4ba6-a973-3807f1f14783" xlink:href="mo-20221231.xsd#mo_FederalGovernmentsLawsuitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_001e4057-11c3-4759-a33c-c78711611df4" xlink:to="loc_mo_FederalGovernmentsLawsuitMember_37c337d7-7162-4ba6-a973-3807f1f14783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a01b822a-2186-4aff-8024-09431368c1d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_73df3418-85cc-4344-913e-5b22f01f2dda" xlink:to="loc_us-gaap_LossContingenciesLineItems_a01b822a-2186-4aff-8024-09431368c1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalTradeCommissionDisclosurePeriod_2a925e85-4bb5-47ab-a90c-5231e8af92ff" xlink:href="mo-20221231.xsd#mo_FederalTradeCommissionDisclosurePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a01b822a-2186-4aff-8024-09431368c1d8" xlink:to="loc_mo_FederalTradeCommissionDisclosurePeriod_2a925e85-4bb5-47ab-a90c-5231e8af92ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_49f08726-c64b-483b-b2e5-112151e1af47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a01b822a-2186-4aff-8024-09431368c1d8" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_49f08726-c64b-483b-b2e5-112151e1af47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesEvaporLitigationandIQOSLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_567d0ce6-0620-4a63-9237-42ca239ded98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_567d0ce6-0620-4a63-9237-42ca239ded98" xlink:to="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_c9975575-6c83-435d-89d3-5bc6dcbf9085" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:to="loc_us-gaap_LitigationStatusAxis_c9975575-6c83-435d-89d3-5bc6dcbf9085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_c9975575-6c83-435d-89d3-5bc6dcbf9085" xlink:to="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingClassActionLawsuitsMember_fe37636f-035e-4fac-9396-af6e7c881ee4" xlink:href="mo-20221231.xsd#mo_PendingClassActionLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:to="loc_mo_PendingClassActionLawsuitsMember_fe37636f-035e-4fac-9396-af6e7c881ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_ClassActionLawsuitMember_2b777d4f-a895-4f33-990b-385346c35e04" xlink:href="mo-20221231.xsd#mo_ClassActionLawsuitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:to="loc_mo_ClassActionLawsuitMember_2b777d4f-a895-4f33-990b-385346c35e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingClassActionLawsuitMember_9710c597-c7b0-45d9-8235-9a660bc45a25" xlink:href="mo-20221231.xsd#mo_PendingClassActionLawsuitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:to="loc_mo_PendingClassActionLawsuitMember_9710c597-c7b0-45d9-8235-9a660bc45a25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_d3ae55d8-bcc8-4e6b-8560-94456e7bba12" xlink:href="mo-20221231.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:to="loc_mo_PendingIndividualLawsuitsMember_d3ae55d8-bcc8-4e6b-8560-94456e7bba12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_a49accf8-6b7a-4453-bb9b-325f00fbb8eb" xlink:href="mo-20221231.xsd#mo_PendingLawsuitFiledBySchoolDistrictMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:to="loc_mo_PendingLawsuitFiledBySchoolDistrictMember_a49accf8-6b7a-4453-bb9b-325f00fbb8eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_2f3377f1-c004-4fe8-b995-e778fa30c9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_7a953d58-804c-4164-a317-d3058af119f3" xlink:to="loc_us-gaap_PendingLitigationMember_2f3377f1-c004-4fe8-b995-e778fa30c9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_57a8eeca-1e2b-474a-bca5-38ffc26ace69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_57a8eeca-1e2b-474a-bca5-38ffc26ace69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0a018471-b8b4-4c04-88a8-0990e462598d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_57a8eeca-1e2b-474a-bca5-38ffc26ace69" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0a018471-b8b4-4c04-88a8-0990e462598d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d76e98fe-200a-4719-85a3-f8c4316ffd61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_0a018471-b8b4-4c04-88a8-0990e462598d" xlink:to="loc_us-gaap_SubsequentEventMember_d76e98fe-200a-4719-85a3-f8c4316ffd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_036910ab-9ccf-4682-895e-3c59de2ddf4f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:to="loc_srt_LitigationCaseAxis_036910ab-9ccf-4682-895e-3c59de2ddf4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_43fd3920-6186-4d3d-ba1c-e2d386797119" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_036910ab-9ccf-4682-895e-3c59de2ddf4f" xlink:to="loc_srt_LitigationCaseTypeDomain_43fd3920-6186-4d3d-ba1c-e2d386797119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EvaporLitigationMember_d669098f-7dbc-4411-9358-0513f8a782e1" xlink:href="mo-20221231.xsd#mo_EvaporLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_43fd3920-6186-4d3d-ba1c-e2d386797119" xlink:to="loc_mo_EvaporLitigationMember_d669098f-7dbc-4411-9358-0513f8a782e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_IQOSMember_7eed8383-957a-4687-93ba-70645c0e3317" xlink:href="mo-20221231.xsd#mo_IQOSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_43fd3920-6186-4d3d-ba1c-e2d386797119" xlink:to="loc_mo_IQOSMember_7eed8383-957a-4687-93ba-70645c0e3317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c0c8061d-4be8-44ad-a17b-8f773c328f00" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:to="loc_srt_StatementGeographicalAxis_c0c8061d-4be8-44ad-a17b-8f773c328f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_43199342-d29f-444e-b326-7f1928389e5d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c0c8061d-4be8-44ad-a17b-8f773c328f00" xlink:to="loc_srt_SegmentGeographicalDomain_43199342-d29f-444e-b326-7f1928389e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_3d0d29ca-035a-4716-8dd9-3e72b404e791" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_43199342-d29f-444e-b326-7f1928389e5d" xlink:to="loc_country_CA_3d0d29ca-035a-4716-8dd9-3e72b404e791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6e74f0f4-ed67-4080-9233-34018651d9ad" xlink:to="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_bec73eb7-bac8-49f0-a390-e3a90291208e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_bec73eb7-bac8-49f0-a390-e3a90291208e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_82be3ccb-6fd5-4581-81ac-40cda61f2150" xlink:href="mo-20221231.xsd#mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber_82be3ccb-6fd5-4581-81ac-40cda61f2150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfCasesWithSetTrialDates_186873e1-0ea7-4d89-89d1-4483a3ce859f" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfCasesWithSetTrialDates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_mo_LossContingencyNumberOfCasesWithSetTrialDates_186873e1-0ea7-4d89-89d1-4483a3ce859f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_NumberOfThirdPartyLawsuits_23d39ff5-af58-44a7-b313-76b70257e31d" xlink:href="mo-20221231.xsd#mo_NumberOfThirdPartyLawsuits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_mo_NumberOfThirdPartyLawsuits_23d39ff5-af58-44a7-b313-76b70257e31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_0928f0ac-b928-4f24-8a2a-3fabb3373b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_0928f0ac-b928-4f24-8a2a-3fabb3373b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyRoyaltyFeePercentage_c5529d6a-1600-42c3-b6ff-9b57393e668f" xlink:href="mo-20221231.xsd#mo_LossContingencyRoyaltyFeePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_mo_LossContingencyRoyaltyFeePercentage_c5529d6a-1600-42c3-b6ff-9b57393e668f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyDamagesRecoverableValue_dd8882f8-1c77-42d0-864d-7a60f86fedff" xlink:href="mo-20221231.xsd#mo_LossContingencyDamagesRecoverableValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_0b6e6ec3-34df-4af7-af95-3c23bedc6862" xlink:to="loc_mo_LossContingencyDamagesRecoverableValue_dd8882f8-1c77-42d0-864d-7a60f86fedff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesAntitrustLitigationDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesAntitrustLitigationDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesAntitrustLitigationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3f16aae5-8de6-449f-8c75-10ee68dc6c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_bad1ac2d-7658-4692-9541-99b66b3e4c0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3f16aae5-8de6-449f-8c75-10ee68dc6c72" xlink:to="loc_us-gaap_LossContingenciesTable_bad1ac2d-7658-4692-9541-99b66b3e4c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a1461713-4f97-4bb6-aae9-452681befaca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_bad1ac2d-7658-4692-9541-99b66b3e4c0c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a1461713-4f97-4bb6-aae9-452681befaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_033e085c-e455-44c6-b901-7acc52040215" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_a1461713-4f97-4bb6-aae9-452681befaca" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_033e085c-e455-44c6-b901-7acc52040215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_JUULMember_c473edf5-332e-4357-ad00-2d04a41435b1" xlink:href="mo-20221231.xsd#mo_JUULMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_033e085c-e455-44c6-b901-7acc52040215" xlink:to="loc_mo_JUULMember_c473edf5-332e-4357-ad00-2d04a41435b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_b89a6176-6ba6-4000-a574-d33c429e4dcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_bad1ac2d-7658-4692-9541-99b66b3e4c0c" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_b89a6176-6ba6-4000-a574-d33c429e4dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6804a4e8-3edb-469c-8990-23a88fa37c91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_b89a6176-6ba6-4000-a574-d33c429e4dcc" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6804a4e8-3edb-469c-8990-23a88fa37c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2c967645-3a90-4413-9142-f16f0c684509" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6804a4e8-3edb-469c-8990-23a88fa37c91" xlink:to="loc_us-gaap_SubsequentEventMember_2c967645-3a90-4413-9142-f16f0c684509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_bad1ac2d-7658-4692-9541-99b66b3e4c0c" xlink:to="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_23b6f077-fd42-4783-bb06-e92cd44c4e6e" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage_23b6f077-fd42-4783-bb06-e92cd44c4e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClassActionLawsuit_aad8fbeb-e8f7-4db1-9951-ad63676a82b5" xlink:href="mo-20221231.xsd#mo_LossContingencyClassActionLawsuit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:to="loc_mo_LossContingencyClassActionLawsuit_aad8fbeb-e8f7-4db1-9951-ad63676a82b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfComplaints_150b6f1a-cc33-4097-a0af-4e6f12136e69" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfComplaints"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:to="loc_mo_LossContingencyNumberOfComplaints_150b6f1a-cc33-4097-a0af-4e6f12136e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_eb72e30f-2fb4-4f6e-88fd-68d1dc4093d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_eb72e30f-2fb4-4f6e-88fd-68d1dc4093d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_114183b6-3952-4009-bf93-d2ab5b801c2b" xlink:href="mo-20221231.xsd#mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_6ebdbfcf-8bce-4b89-a568-fdfd926552b3" xlink:to="loc_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue_114183b6-3952-4009-bf93-d2ab5b801c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_608cc32c-1f6a-49c0-ba72-ac4487ab2868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_61c96780-66b0-456e-ac08-1c8cb12e55e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_608cc32c-1f6a-49c0-ba72-ac4487ab2868" xlink:to="loc_us-gaap_LossContingenciesTable_61c96780-66b0-456e-ac08-1c8cb12e55e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_198925b6-3f9c-4eda-a829-d1a464a122a8" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_61c96780-66b0-456e-ac08-1c8cb12e55e4" xlink:to="loc_srt_LitigationCaseAxis_198925b6-3f9c-4eda-a829-d1a464a122a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_e37b4bf7-3136-4307-bc51-bbf23eb84478" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_198925b6-3f9c-4eda-a829-d1a464a122a8" xlink:to="loc_srt_LitigationCaseTypeDomain_e37b4bf7-3136-4307-bc51-bbf23eb84478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_FederalAndStateShareholderDerivativeLawsuitsMember_5e1916a7-a96f-4b0f-91a8-4a5e6ad461ae" xlink:href="mo-20221231.xsd#mo_FederalAndStateShareholderDerivativeLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_e37b4bf7-3136-4307-bc51-bbf23eb84478" xlink:to="loc_mo_FederalAndStateShareholderDerivativeLawsuitsMember_5e1916a7-a96f-4b0f-91a8-4a5e6ad461ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_61c96780-66b0-456e-ac08-1c8cb12e55e4" xlink:to="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_ac26214f-9ec6-43ae-bb92-1b4d5b917ff7" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits_ac26214f-9ec6-43ae-bb92-1b4d5b917ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_eb403099-023d-4912-9ba8-2413beadc996" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_eb403099-023d-4912-9ba8-2413beadc996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_ce6f1a1c-d0f9-49ea-a3d8-770150add1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_ce6f1a1c-d0f9-49ea-a3d8-770150add1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLegalSettlements_d98908c8-aba3-4647-8c27-c23397809d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLegalSettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_us-gaap_PaymentsForLegalSettlements_d98908c8-aba3-4647-8c27-c23397809d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_c7c2ed3f-e12d-4bd9-a6cb-fb57d2d67a8e" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits_c7c2ed3f-e12d-4bd9-a6cb-fb57d2d67a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfPendingCasesConsolidated_2e4a9588-3015-473b-a924-87ebd676fbf7" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfPendingCasesConsolidated"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_mo_LossContingencyNumberOfPendingCasesConsolidated_2e4a9588-3015-473b-a924-87ebd676fbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_2f8e2de4-c950-4a0a-ac34-3516b4cc2a6f" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfStatesWithConcludedHearings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_mo_LossContingencyNumberOfStatesWithConcludedHearings_2f8e2de4-c950-4a0a-ac34-3516b4cc2a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding_9046ce1c-4d50-486d-841b-741906e34c87" xlink:href="mo-20221231.xsd#mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_3f22dbb2-2fc0-4688-a364-f22e676a0073" xlink:to="loc_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding_9046ce1c-4d50-486d-841b-741906e34c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesLightsUltraLightsCasesDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_50dbe2b0-2f3b-4f98-b165-7780a2c0f11a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_999a74c3-b896-4b94-80e1-0974454b0713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_50dbe2b0-2f3b-4f98-b165-7780a2c0f11a" xlink:to="loc_us-gaap_LossContingenciesTable_999a74c3-b896-4b94-80e1-0974454b0713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_622bf999-a558-4675-a8aa-e0994f73cec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_999a74c3-b896-4b94-80e1-0974454b0713" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_622bf999-a558-4675-a8aa-e0994f73cec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2cd6187f-b1e0-4a4e-89ed-b47b49f986b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_622bf999-a558-4675-a8aa-e0994f73cec6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2cd6187f-b1e0-4a4e-89ed-b47b49f986b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_555c394b-cf2b-4054-a616-858146d199c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2cd6187f-b1e0-4a4e-89ed-b47b49f986b5" xlink:to="loc_us-gaap_SubsequentEventMember_555c394b-cf2b-4054-a616-858146d199c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_26593069-3d99-49e4-aabf-0ca334c558bb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_999a74c3-b896-4b94-80e1-0974454b0713" xlink:to="loc_srt_LitigationCaseAxis_26593069-3d99-49e4-aabf-0ca334c558bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8c153118-aec6-43b9-915c-a9986e41691a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_26593069-3d99-49e4-aabf-0ca334c558bb" xlink:to="loc_srt_LitigationCaseTypeDomain_8c153118-aec6-43b9-915c-a9986e41691a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LightsMember_ef812f7a-ede5-4259-85d7-52a6cfad44bb" xlink:href="mo-20221231.xsd#mo_LightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_8c153118-aec6-43b9-915c-a9986e41691a" xlink:to="loc_mo_LightsMember_ef812f7a-ede5-4259-85d7-52a6cfad44bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_SmokingAndHealthClassActionsMember_ee2a7db8-4c35-4774-b7b9-fa97d0d0aed2" xlink:href="mo-20221231.xsd#mo_SmokingAndHealthClassActionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_8c153118-aec6-43b9-915c-a9986e41691a" xlink:to="loc_mo_SmokingAndHealthClassActionsMember_ee2a7db8-4c35-4774-b7b9-fa97d0d0aed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_4b2af1ba-97b1-409d-95af-58ddd6b24b1c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_999a74c3-b896-4b94-80e1-0974454b0713" xlink:to="loc_dei_LegalEntityAxis_4b2af1ba-97b1-409d-95af-58ddd6b24b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_959ab83a-eb5a-49cb-ba6f-9a4879c2a85d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_4b2af1ba-97b1-409d-95af-58ddd6b24b1c" xlink:to="loc_dei_EntityDomain_959ab83a-eb5a-49cb-ba6f-9a4879c2a85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PhilipMorrisUSAMember_2a71343a-6a82-4ca9-8880-d94a3979f77f" xlink:href="mo-20221231.xsd#mo_PhilipMorrisUSAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_959ab83a-eb5a-49cb-ba6f-9a4879c2a85d" xlink:to="loc_mo_PhilipMorrisUSAMember_2a71343a-6a82-4ca9-8880-d94a3979f77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a30abd49-3afe-4c50-8481-d7be82847976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_999a74c3-b896-4b94-80e1-0974454b0713" xlink:to="loc_us-gaap_LossContingenciesLineItems_a30abd49-3afe-4c50-8481-d7be82847976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyClaimsNotCertifiedNumber_48ba98e8-14d4-46f4-9e29-0d12b5696986" xlink:href="mo-20221231.xsd#mo_LossContingencyClaimsNotCertifiedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a30abd49-3afe-4c50-8481-d7be82847976" xlink:to="loc_mo_LossContingencyClaimsNotCertifiedNumber_48ba98e8-14d4-46f4-9e29-0d12b5696986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_dd522c35-755f-4d06-90cd-91c247d8d9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a30abd49-3afe-4c50-8481-d7be82847976" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_dd522c35-755f-4d06-90cd-91c247d8d9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_LossContingencyStateCourtsNumber_3c421b79-1d11-4c99-9cfb-40f3bc03fce8" xlink:href="mo-20221231.xsd#mo_LossContingencyStateCourtsNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a30abd49-3afe-4c50-8481-d7be82847976" xlink:to="loc_mo_LossContingencyStateCourtsNumber_3c421b79-1d11-4c99-9cfb-40f3bc03fce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesUSTLitigationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_09b5c5fd-8352-4c3a-92ea-7b77bc8c2f76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_142230de-03ca-4d36-8d5b-91a38b3f5959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_09b5c5fd-8352-4c3a-92ea-7b77bc8c2f76" xlink:to="loc_us-gaap_LossContingenciesTable_142230de-03ca-4d36-8d5b-91a38b3f5959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_79386ee5-b6c8-4392-a685-a191c08f6a29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_142230de-03ca-4d36-8d5b-91a38b3f5959" xlink:to="loc_us-gaap_LitigationStatusAxis_79386ee5-b6c8-4392-a685-a191c08f6a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_2d0dc0fc-5ad3-465b-8f92-23ebe8aaeef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_79386ee5-b6c8-4392-a685-a191c08f6a29" xlink:to="loc_us-gaap_LitigationStatusDomain_2d0dc0fc-5ad3-465b-8f92-23ebe8aaeef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_PendingIndividualLawsuitsMember_aa332fda-322f-4d39-93fa-a1986e9118cc" xlink:href="mo-20221231.xsd#mo_PendingIndividualLawsuitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_2d0dc0fc-5ad3-465b-8f92-23ebe8aaeef9" xlink:to="loc_mo_PendingIndividualLawsuitsMember_aa332fda-322f-4d39-93fa-a1986e9118cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_f6600143-4c86-4710-ba84-7ab25cbf4eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_142230de-03ca-4d36-8d5b-91a38b3f5959" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_f6600143-4c86-4710-ba84-7ab25cbf4eaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_7ac8718c-f63f-4020-9300-24ee2b455713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_f6600143-4c86-4710-ba84-7ab25cbf4eaa" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_7ac8718c-f63f-4020-9300-24ee2b455713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_947448f6-e5d4-4fa4-8188-6f28f6fbc283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_7ac8718c-f63f-4020-9300-24ee2b455713" xlink:to="loc_us-gaap_SubsequentEventMember_947448f6-e5d4-4fa4-8188-6f28f6fbc283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_22104338-ef5d-4f63-a1af-fdadfca35457" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_142230de-03ca-4d36-8d5b-91a38b3f5959" xlink:to="loc_srt_LitigationCaseAxis_22104338-ef5d-4f63-a1af-fdadfca35457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3897b73e-45d4-4131-baeb-0da4549674ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_22104338-ef5d-4f63-a1af-fdadfca35457" xlink:to="loc_srt_LitigationCaseTypeDomain_3897b73e-45d4-4131-baeb-0da4549674ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_USTLitigationMember_1f761c92-b094-4b40-86a0-f63be8a2c630" xlink:href="mo-20221231.xsd#mo_USTLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_3897b73e-45d4-4131-baeb-0da4549674ed" xlink:to="loc_mo_USTLitigationMember_1f761c92-b094-4b40-86a0-f63be8a2c630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_99eea727-ea63-4151-9a47-1c348f0b4e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_142230de-03ca-4d36-8d5b-91a38b3f5959" xlink:to="loc_us-gaap_LossContingenciesLineItems_99eea727-ea63-4151-9a47-1c348f0b4e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_63e21b20-254d-4e4d-8489-11e3de243fde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_99eea727-ea63-4151-9a47-1c348f0b4e0f" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_63e21b20-254d-4e4d-8489-11e3de243fde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="simple" xlink:href="mo-20221231.xsd#ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cbfaed9f-4835-4e00-9279-f548a5949ece" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_869f6415-0abd-46e4-9532-648ab5d6fea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cbfaed9f-4835-4e00-9279-f548a5949ece" xlink:to="loc_us-gaap_LossContingenciesTable_869f6415-0abd-46e4-9532-648ab5d6fea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_e44caaca-5865-457a-9170-df29c1814f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_869f6415-0abd-46e4-9532-648ab5d6fea2" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_e44caaca-5865-457a-9170-df29c1814f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1e0b6174-cff4-4fa5-8abc-352b4d1a2b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_e44caaca-5865-457a-9170-df29c1814f66" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1e0b6174-cff4-4fa5-8abc-352b4d1a2b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_17d90b97-f616-411e-b1bf-d0e3f535a5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1e0b6174-cff4-4fa5-8abc-352b4d1a2b91" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_17d90b97-f616-411e-b1bf-d0e3f535a5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5ccf717f-e237-43b4-a24a-aa8a8c14fc73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_869f6415-0abd-46e4-9532-648ab5d6fea2" xlink:to="loc_us-gaap_DebtInstrumentAxis_5ccf717f-e237-43b4-a24a-aa8a8c14fc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_832f2b2e-7aaa-4a77-bd8f-8301012c34eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5ccf717f-e237-43b4-a24a-aa8a8c14fc73" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_832f2b2e-7aaa-4a77-bd8f-8301012c34eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_mo_CreditAgreementMember_52c887ec-ce15-4f24-9c0c-0f8afe17fcb6" xlink:href="mo-20221231.xsd#mo_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_832f2b2e-7aaa-4a77-bd8f-8301012c34eb" xlink:to="loc_mo_CreditAgreementMember_52c887ec-ce15-4f24-9c0c-0f8afe17fcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_6b57c24d-2370-48f4-9370-76a264712a89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_869f6415-0abd-46e4-9532-648ab5d6fea2" xlink:to="loc_us-gaap_CreditFacilityAxis_6b57c24d-2370-48f4-9370-76a264712a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_1a89a002-a365-4bc4-a8a2-3a4426a77dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_6b57c24d-2370-48f4-9370-76a264712a89" xlink:to="loc_us-gaap_CreditFacilityDomain_1a89a002-a365-4bc4-a8a2-3a4426a77dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_cc49e702-7518-49a2-93d2-a77b88e15a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_1a89a002-a365-4bc4-a8a2-3a4426a77dd7" xlink:to="loc_us-gaap_LetterOfCreditMember_cc49e702-7518-49a2-93d2-a77b88e15a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_c88ed95d-4596-4421-ba47-9203fdbc6421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_869f6415-0abd-46e4-9532-648ab5d6fea2" xlink:to="loc_us-gaap_LossContingenciesLineItems_c88ed95d-4596-4421-ba47-9203fdbc6421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1aaef741-5994-442c-986a-f6f1ec22a6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c88ed95d-4596-4421-ba47-9203fdbc6421" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1aaef741-5994-442c-986a-f6f1ec22a6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_5b3a6142-283c-4f7f-a042-88c727fa1e22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_c88ed95d-4596-4421-ba47-9203fdbc6421" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_5b3a6142-283c-4f7f-a042-88c727fa1e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>mo-20221231_g1.jpg
<TEXT>
begin 644 mo-20221231_g1.jpg
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\
M27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV
M_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\
M27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV
M_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\
MRH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&
MN?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_
M ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'
MJ/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_
M (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(
M3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_
MX*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"I
MG_27;_RH:Y_\>K]_J* /Y/?^"PO_  2[_P""@?\ P1[^&W@[XD?$C_@HIKGC
M&#QCKD^FVUMH>OZK ]N\4(E+L99L$$'&!17Z"?\ ![S_ ,FL_ __ +*!J/\
MZ0BB@#S_ /X--O\ E*9^UW_V\?\ I\GK]_J_ '_@TV_Y2F?M=_\ ;Q_Z?)Z_
M?Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#\0?^#WG_ )-9^!__ &4#4?\ TA%%'_![S_R:S\#_ /LH&H_^D(HH \__
M .#3;_E*9^UW_P!O'_I\GK]_J_ '_@TV_P"4IG[7?_;Q_P"GR>OW^H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _$'_@
M]Y_Y-9^!_P#V4#4?_2$44?\ ![S_ ,FL_ __ +*!J/\ Z0BB@#S_ /X--O\
ME*9^UW_V\?\ I\GK]_J_ '_@TV_Y2F?M=_\ ;Q_Z?)Z_?Z@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\0?^#WG_ )-9
M^!__ &4#4?\ TA%%'_![S_R:S\#_ /LH&H_^D(HH \__ .#3;_E*9^UW_P!O
M'_I\GK]_J_ '_@TV_P"4IG[7?_;Q_P"GR>OW^H **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\F_;6_;3^!'[ OP
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MM*EJ55.W++]U>=WHG155?:OR7DG_ &G2=5T^27-:Z5EJOO\ SL?K517Y7?\
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MDN[ZWM"J7\EXK$(9RV3;C=LQ@9R/,O\ @CA^WG_P5J_X*VZ%\0]7@_;!\">
M7\"3Z;$D+_!N+5!?F[6Z8$L+Z#R0OV;'1\[^V.?IG_@Y2_Y0S_%G_KY\/?\
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MHMU(N'-[.,)*\%[-^VY]97A.4KN7F8'%T,4X*G-J2W3;=]-=_/72WFC\\?\
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M^;[_ (+=_P#*Q?HW_8Q^!_\ T&SK]3_^"\O_  5PUC_@EY\!M#L/A)I5A?\
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M%% 'X@_\'O/_ ":S\#_^R@:C_P"D(HH_X/>?^36?@?\ ]E U'_TA%% 'G_\
MP:;?\I3/VN_^WC_T^3U^_P!7X _\&FW_ "E,_:[_ .WC_P!/D]?O]0 4444
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MFOTFUOX9_#SQ'\.+KX/ZUX)TR?PK>Z,^DW/ATV2"S>P:+R3;>4 %$7EG9L
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M6C;1<SWY;LWJ8/$RKXF:CI.-EJNUCP'_ (-(/^49'B3_ ++'JG_INTNO@/\
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M[.'+S\BDH\KFH-KF;2TNIY=B)8;$67O5'=*^R3OK_P  ^./VLO\ E42\.?\
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M;DG:<W.,Y1I1<54:BHV3E&/,WLDKOE^HUW'$3MK4T2T_'H?,7_!J/_RBM/\
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M!3(P'+8' R><"OG_ /8:_P"";_P+_8(\6?%?Q=\(8W,_Q6\<R:_?(]NL8TZ
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M]6&H:W<V]E;_ & _;GE5FD1[.-TR8T!8N 5<#Y[^%_\ P:U^!O@3\7[GQS\
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M"87@GXN^$OVGOBOX?\3WWC'1?%&CQ^%/$OBWXK>(-3NAJ2WB&PA0W-[(9/\
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M[:XN?C-J=WX8U[R=\FC:I'I.E^1=*.I'S%'4$;XY'7(R"/DC_@E;^V[\9?\
M@AI_P4+U_P#9Z_:?T^\T[PE?:RNA_$_1&W.EC(K8M]7@ 'SA%<.&4'S;>4X#
M'RR/W#_X)N_\$H='_P""8NA7_@'X(_M0>-=6\(ZKK1U;4?#'B/3]-EB>[:%(
M6E26.W26,LD4((#8/E+P.2<#_@IG_P $+/V3/^"GOQ$T3XN?$SQ%XB\*>)M)
MTYK"ZU?PFULCZI;!MT27 FBD#&(E]C##8D*DD! O]$X7QOX)Q7&&?Y1GE26(
MR#-)2J)J$^>A4:5I*,HIIMQ7P\R4XPFG\5_)EEN)6'I5*2M5AIZK^OU.%_X.
M8=,U/XD?\$=O$OBOX>7J:EI=MKFA:M=76GRB6*XT]KI%6567(>/=-"^X9&!N
MZ#-?+_\ P;A?L^?LD_MN?L$Z_P#"GXE^,OB!)K_AC7[VP\2>%='^,7B#3+*;
M3+U?,BD-A9WL=OY4N^XB;]W\[1/NSG)_2/\ 9+_X)U>&?V9_V8;[]C7QI\:/
M$WQ3^'%SH\NDVGA_Q[;6<GV.PE#K):++!#&[PE7(57+>6,!"H  ^,O#W_!J_
M\,?A)\<)?BI^S#^W[\7/AI83.Z_8_#-PL.I0VSG+V\>HQ21L$X &^-S@#=O/
M)^6X3XZX)P'AQF/!4\WJ864,3]8PN+ITZMIKEC'DG"%JD963O]E-IJ34%S;U
M\+B9XR&)5-2TM*+:T].A]-?#G]BW]A[]B+]F'X_?"3]BOPO_ &0[>%KU_&6G
M+K][J/D7ATJ5X4=KF63RY##(CE%(.V2-F&&0G\N_^#/!E7]J/XO[F _XH"T/
M)[?;EK]POV?_ -F'X1?LU_!B#X%?#O19YM&"SOJEQK=VU[>:Q<3DFXNKV>3+
M7,\S$EW;KD* %"J/BCX,?\&V?[,'[/G[0NL_%OX/?M&_%7P]X6\002VNM?#[
M1O$"VUM?6$CAWTV:ZC43R69*A2A/F%1@RDY8^9PMXE<-RX0XIR7.\=7E5S!4
M73KU(RJSJ.B]>=*3:E))<B<G&*]V53W;NZ^#K?6*%2G%6A>Z6EK_ -?\ ^3O
M^#RM#-)^SEJ$)#PO%XL"RH<J<_V,1S[CFNZ_X*F:A80?\&M'P9AGO84>Y\$_
M#V*W1Y #*XL8&*J#]XA4<X'.%)[&OO/_ (*9?\$K?@!_P4W^ ^E?!GXCWMYX
M;NO#%U]I\'^(-!AC\S2G,8C:+RF&R2!T5 T?R_ZM"&4J*^<[/_@VL^"GB;]E
MZV_9N^//[87Q6\<#2#%%X2U*_P!31;;PO;)('>'3K&3S8;?S-JH[G>VQ0B%%
M+!OI.#O$[P^H<#\+8+,L7.C6RC&3JS@J4INI"56=12C)/E27.E)-\VDN6,M$
M\<1@L6\37E"-U4C;>UG9(@_X-0_^46$O_93=7_\ 15I7YU?L&:98ZM_P=:ZS
M:ZA LL:?'OXBS*K#(#QQZU(C?4.JD>XK]I?^"=7_  3,T3_@FI\&-?\ @1\&
M_P!H3Q9K&@ZO>SZAI\?B.QL)'TJ^EB2-IXFC@0N,11GRY-R94G W-GP?X3?\
M&Z7PG^"W[7T?[<_@G]L?XFK\1E\1W^MS:K=V>D213W=Z)A=%X3:;-LBW$RD
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M [NBBO*1^W'^R9+^U':_L567QST6[^*5UIEQJ \'6#27%S!;P#,C3M$K1VY
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0:_3B7X=^#I?B-!\66T2(>(+?1)=(745&':SDFCF,38^\!)$&7.=I9\8WMD
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M;^^#7PC\!_#CQ'X&2;Q_K/QFOK:S^$/AKPQ<1>=XF:>W^TBX221E2&TBMO\
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M:EX;@\OPOJOB?9;?\@\(/)EE$HGD\R,$8-P0=DR;^'_X))_M#_\ !)3]E_X
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M(M2O=+^*&O>(+S1GT/1+^VR6B%Q'?_:9HW16>.?[*L;JC$E<&OE_]JW]IO\
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M??!X>)_&'Q'U32IEE71-(G@LX[*.X="0IO)X9(HT)RRK*P&U6-?HO0 4444
M%%%% !17RQK_ .P%^TWJ^NWNK6/_  5!^*EA!=7<DT-C;V-D8[=&8L(URN=J
M@X&>PJI_P[Q_:E_Z2K_%K_P L?\ XFO*>.QZ?^ZR_P# J?\ \D?>PX7X2E!-
MY]13[>QQ6G_E ^LJ^8_^"LO[<=Y^PG^RG=^.O"'DOXN\07@TCPFLZ!U@N'1G
M>Z93]Y8HU9@"""YC4C#&LG_AWC^U+_TE7^+7_@!8_P#Q-?!7_!=K]E3XY? [
MX?\ P]\7_$+]JKQC\3M*N-8OK,'Q/;P(FF7#11.GE^4!DR+'+G/:'CO7C\09
MOF>$R:M5AAY0:7Q<T':[2OI)O2_8_2?"+P\X%X@\2,MP.*S>CB*<JEW25+$1
M]IR1E/DO4I1A:3C9IR5U=+5I'YV^,O&?BSXA^*;_ ,<>._$E[J^L:I<M<:CJ
M>HW#2SW$K')=W8DDUF445^ RE*4FV[MG^N=*E3HTXTZ<5&,4DDE9)+1));)=
M$?LA_P &_O\ P46\<_&&'4/V./C9XCGU74="TK[?X,U>^E+SRV4;*DMG(['+
MF/>C1DY.S>"<(HK]/*_G2_X) ?!CXD_'+]M[1/"GPQ^*FM^";NVT;4;R]\4>
M'XT>YL;=;=D.!)\N'DDCC.?^>GKBOU[_ .'>/[4O_25?XM?^ %C_ /$U^V<'
M9MF>(R6*E1E4Y6XJ5XK16:7O--VO8_S!^DEX>\#Y1XG59T<QI8/V].%65)TZ
MTK3DY1E)>RISBE/EYFKIW;=DFCZRHKY-_P"'>/[4O_25?XM?^ %C_P#$T?\
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M* /Q!_X/>?\ DUGX'_\ 90-1_P#2$44?\'O/_)K/P/\ ^R@:C_Z0BB@#S_\
MX--O^4IG[7?_ &\?^GR>OW^K\ ?^#3;_ )2F?M=_]O'_ *?)Z_?Z@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *_ '_ (/G/^;7?^YV_P#<!7[_
M %% '\ =%?W^44 ?R!?\&N/_ "G7^!G_ ',W_J,:M7]?M%% !1110 5R?ACX
M"? OP3X@3Q9X,^"_A/2-5CW^7J>E^'+6WN%W@AL21H&&02#SR"<UUE% '/\
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M.<5O44 <CJ'[/_P'U;XGV_QMU7X)^$;GQG:($M?%UQX;M7U2%0-H5+HQ^:H
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M_P#%7Q%NK2_^(OBN&-=:FM&WPZ9;*=R643X^;YCND<<,RJ!D1JS?8U%%?H&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!^(/_![S_R:S\#_ /LH&H_^
MD(HH_P"#WG_DUGX'_P#90-1_](110!Y__P &FW_*4S]KO_MX_P#3Y/7[_5^
M/_!IM_RE,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V**Q_^$'TC_GYO?\
MP+:C_A!](_Y^;W_P+:@#8HK'_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VH V
M**Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:@#8HK'_P"$'TC_ )^;W_P+:C_A
M!](_Y^;W_P "VH V**Q_^$'TC_GYO?\ P+:J7B#PMI^F:+<ZA;7-WYD499=U
MTQ&?SH Z6BL.T\&:5/:Q3/<WF7C5CB[;J14G_"#Z1_S\WO\ X%M0!L45C_\
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M^CZ]ZKP7_@G5_P D/U?_ +'O6/\ T?0![U1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8]E_P CO>_]
M>47\S6Q6/9?\CO>_]>47\S0!L4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !6;XQ_P"18O?^N!K2K-\8
M_P#(L7O_ %P- %S3O^0?!_UQ7^0J:H=._P"0?!_UQ7^0J:@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* ,?P/\ \@B7_K]F_P#0JV*Q_ __ "")?^OV;_T*MB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\%_X)U?\D/U?_L>]8_\
M1]>]5X+_ ,$ZO^2'ZO\ ]CWK'_H^@#WJBBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q[+_D=[W_ *\H
MOYFMBL>R_P"1WO?^O*+^9H V**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K-\8_\BQ>_P#7 UI5F^,?
M^18O?^N!H N:=_R#X/\ KBO\A4U0Z=_R#X/^N*_R%34 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C
M^!_^01+_ -?LW_H5;%8_@?\ Y!$O_7[-_P"A5L4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^)?^
M0OH__7Z?_036Q6/XE_Y"^C_]?I_]!-;% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_@?_D$2_\
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M]E_R.][_ ->47\S0!L4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>OW^K\ ?^#3;_E*9^UW_ -O'_I\GK]_J "BBB@ HHHH **** "BBB@ HHHH
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M%8_B7_D+Z/\ ]?I_]!-;% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %8_@?\ Y!$O_7[-_P"A5L5C
M^!_^01+_ -?LW_H5 &Q1110 4444 %%%% 'X@_\ ![S_ ,FL_ __ +*!J/\
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M_D*FJ'3O^0?!_P!<5_D*FH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'\#_\ ((E_Z_9O_0JV*Q_
M_P#R")?^OV;_ -"K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#'\2_\ (7T?_K]/_H)K8K'\2_\
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M */H ]ZHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "L>R_Y'>]_Z\HOYFMBL>R_Y'>]_Z\HOYF@#8HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "LWQC_P BQ>_]<#6E6;XQ_P"18O?^N!H N:=_R#X/^N*_R%35
M#IW_ "#X/^N*_P A4U !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 8_@?\ Y!$O_7[-_P"A5L5C^!_^
M01+_ -?LW_H5;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 8_B7_D+Z/_ -?I_P#036Q6/XE_Y"^C
M_P#7Z?\ T$UL4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5C^!_\ D$2_]?LW_H5;%8_@?_D$2_\
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MHH Q_ __ "")?^OV;_T*MBL?P/\ \@B7_K]F_P#0JV* "BBB@ HHHH ****
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M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
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M_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC
M_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"
M8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H
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M_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC
M_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"
M8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H
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M_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\
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MA^K_ /8]ZQ_Z/KWJO!?^"=7_ "0_5_\ L>]8_P#1] 'O5%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
MCV7_ ".][_UY1?S-;%8]E_R.][_UY1?S- &Q1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9OC'_ )%B
M]_ZX&M*LWQC_ ,BQ>_\ 7 T 7-._Y!\'_7%?Y"IJAT[_ )!\'_7%?Y"IJ "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH Q_ _P#R")?^OV;_ -"K8K'\#_\ ((E_Z_9O_0JV* "BBB@
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M^3U^_P!7X _\&FW_ "E,_:[_ .WC_P!/D]?O]0 4444 %%%% !1110 4444
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MH **** "BBB@ HHHH **** "BBB@#'\#_P#((E_Z_9O_ $*MBL?P/_R")?\
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MVO)Z=K'UO!7TA/$/@G/%C</4C.A;E>&Y5##\M[^Y3IJ$:<ETG%<S^WS*Z?\
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M]>]5X+_P3J_Y(?J__8]ZQ_Z/H ]ZHHHH **** "BBB@ HHHH **** "BBB@
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M% !1110 4444 %8]E_R.][_UY1?S-;%8]E_R.][_ ->47\S0!L4444 %%%%
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M[?)=WY'K9-D.=<18SZKEF'G6J6O:$7*R6\G;2,5UD[)+5M(]]KSO]H3]K/\
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M@#\0?^#WG_DUGX'_ /90-1_](111_P 'O/\ R:S\#_\ LH&H_P#I"** //\
M_@TV_P"4IG[7?_;Q_P"GR>OW^K\ ?^#3;_E*9^UW_P!O'_I\GK]_J "BBB@
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M% !1110 4444 8_B7_D+Z/\ ]?I_]!-;%8_B7_D+Z/\ ]?I_]!-;% !1110
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MH **** "BBB@ HHHH **** "BBB@#'\#_P#((E_Z_9O_ $*MBL?P/_R")?\
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M0OH__7Z?_036Q6/XE_Y"^C_]?I_]!-;% !1110 4444 %%%% !1110 4444
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M*1^#/PC2^.G3ZZ+2:Z-S//>(LCRQPV<D^,OG[.,-&NZ.0 _3>BBB@ HKSO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV$L5RRQJ>WR2N#UXZ"#]G/\ X-YOVR?BGKD,WQDU30? 6AQS[;Z:34(]1O2
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M_*4S]KO_ +>/_3Y/7[_5^ /_  :;?\I3/VN_^WC_ -/D]?O]0 4444 %%%%
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M%F4&.,ROG8S;&:@#]NJ*** .9^-'_)'?%G_8LW__ *3O7QQ_P;._\H//@/\
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M .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH
MQ_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'
M_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H
M-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\
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M10!C_8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-;%% &/]B\;_ /0;LO\
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MBBB@#\0?^#WG_DUGX'_]E U'_P!(111_P>\_\FL_ _\ [*!J/_I"** //_\
M@TV_Y2F?M=_]O'_I\GK]_J_ '_@TV_Y2F?M=_P#;Q_Z?)Z_?Z@ HHHH ****
M "BBB@ HHKY-_P""J_[8?[4G[&ND?"OQ?^RA^RWJWQFUKQ!X]GTG4_A]HU^]
MI->V9TJ]G,PG6&80B*2"-RS(5QD'!8$ 'SU^TG^V)\4?V%O^"MWQ/U7X!?\
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M_*4S]KO_ +>/_3Y/7[_5^ /_  :;?\I3/VN_^WC_ -/D]?O]0 4444 %%%%
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M*65O]I,D4=XZ1&[M9E1'5]/.V= S13@'ZE4444 %%%% !1110 4444 %%%%
M!7@O_!.K_DA^K_\ 8]ZQ_P"CZ]ZKP7_@G5_R0_5_^Q[UC_T?0![U1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %8]E_R.][_ ->47\S6Q6/9?\CO>_\ 7E%_,T ;%%%% !1110 4444
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ME^ 4445B;!1110 4444 %?%_[67_  2%_P"&H?V@-?\ CI_PT+_8?]N?9?\
MB5_\(G]I\CR;2&W_ -;]KCW9\K=]T8W8YQD_:%%>[P]Q-G?"N-EB\KJ^SJ2B
MX-\L9>ZVFU::DMXK6U]-]SP.(^%\BXMP,<'FM'VE.,E-+FE'WDFD[PE%[2:M
M>VNVQ^=/_#@?_J['_P L3_[NJGH?_!!W^V;1KK_AJGR]LSQ[?^$&SG:<9_X_
MA7Z15C^!_P#D$2_]?LW_ *%7V/\ Q&3Q(_Z#O_*5'_Y6?%_\05\,O^@#_P J
MUO\ Y8?(_P"R;_P2%_X9>_: T#XZ?\-"_P!N?V']J_XE?_")_9O/\ZTFM_\
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MV\;L&G94!9E0$A1D\5L5P7Q2_9>_9_\ C7\3? GQE^*WPKTO7/%'PRU"YO?
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M\0N-<TPSPU;'5(T7_P NZ;]E2_\ !5)0I_\ DH  # & .@%%%%>B?&A1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C^!_^01+_P!?
MLW_H5;%8_@?_ )!$O_7[-_Z%6Q0 4444 %%%% !1110 4444 %%%% !1110
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M_P!"K8K'\#_\@B7_ *_9O_0J -BBBB@ HHHH **** /Q!_X/>?\ DUGX'_\
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M(_Q*MO$T%IX"T.R^/:>)KB+4+@^4+F.R2\<'RD+R&1E(0(6 WA* /U5HHHH
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M#\,M!C\*_#?P1I'A_3(?]5IVB:;%:P)](XE51^5;%/ZEF&(_WC$-+M37*O\
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M'DL/%/C_ %!=8O["XCV365H(PEK!(#R'V[Y2#@J9]I *FF?L6_\ !#G]D/\
M96\0:?\ %#73J'CWQ39E)["^\1I&MI8S#D2PVJ#;O!Y#2-(5(!7:1FOM2OH>
M#^#\1E&(>,QC7/:T8K6U]VWWZ::6_#\=^D9](S*?$/*8\.<.1E]5YE.K5FN5
MU''6,8Q>J@G:3<DI.22223<BBBBOT0_C8**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,?P/\ \@B7_K]F_P#0
MJV*Q_ __ "")?^OV;_T*MB@ HHHH **** "BBB@ HHHH **Y3QU\=?@I\,0_
M_"QOBYX:T-D^]'JNMP0/] KN"3[ 9KRC6O\ @I[^R%:WS:-X.\9:KXOU%?\
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M@ HHHH **** "BBB@ HHHH *Q_ __((E_P"OV;_T*MBL?P/_ ,@B7_K]F_\
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M[;1?&$_Q&UW7I[S5);^2&.>927;RECD$DL;*L:Y5\DEP& !^AU%%% !1110
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M2E(/]>\/ENF1990PUMISC]9K>O/7YX1E_>I4J3734^=OA#_P2H_8:^$.K?\
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M(Z47\XM>0?V+Q!B?]ZS*2\J-.G37WS5::^4T_,^<O^%0_P#!23Q]SXV_:O\
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M]V<4?\+\_P""B.J_\@_]@32=+!Z-J?Q3LIOS$25]%T4?V]E,/@RNA\Y8AO\
M]/I?@+_5_-Y_Q,UK_*.&2_\ 3#?XGSI_PF?_  5'U7_CP^"_PDTK/3^U/$=Y
M/M^OD@9H_LG_ (*M:K_Q^>+?@7I0/_0/L-6G91_VU.":^BZ*/]9HQ_AX'#Q_
M[AN7_I<I!_JO*7\3'XB7_<11_P#2(Q/G3_A4'_!2?5?^/_\ ;"\&Z3GK_9?P
M^2?;]/.?G\?04?\ #+7[;FI_\C'_ ,%(-38'JFE_#;3K7'L&5B?7GZ>E?1=%
M'^MN91_ATJ$?3#8>_P![IM_B'^I^62_B5<1+UQ6(M]RJI?@?.G_##GQ?U+_D
M9O\ @H#\6)<_?_LN[M[+/KC8AQU/Z>E'_#N7P_>\^)?VM_CMJ^?OI??$9]A]
M0 D2X'7CW-?1=%'^N7$2^"LH_P"&%./_ *3!!_J5PV_CHN7^*I4G_P"E39\Z
M?\.NOV8+W_D9;OQKK6?O?VIXWO7W>N=CK[_F:LZ=_P $L?V#--?SD^ <,\A.
M6>\U[4)BQ]2'N"/TKZ"HI2XTXO:LLPK)=E4FE]R:14>".#D[O+J+?=TH2?WM
M-GY:?\%EOV=/@C^S_%\-8?@U\-].\/C5/[8_M V*MFX\K[#Y>XL23M\Q\?[Q
MKX>K]7/^"O7[)O[0'[4/_"O?^%%^ /[<_L/^UO[4_P")K:6WD>=]B\K_ (^)
M8]V?*D^[G&WG&1GXN_X=-_\ !0'_ *(%_P"75I7_ ,E5_5WACQGD5/@?"1S/
M,::K_O.;VE://_%G;FYI<WPVM?I:VA_(OBGP3GU3CS&2RO+:KH?N^5TJ,W#^
M%"_+R1Y?BO>W6]]3YTHKZ%L?^"57[>VI0F>R^ ^]%<H3_P )1I8Y!P1S=5-_
MPZ;_ ."@/_1 O_+JTK_Y*K[W_7;@S_H98?\ \'4__DC\^_U%XV_Z%>(_\$5/
M_D3]H:***_SN/](PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH Q_$O_(7T?\ Z_3_ .@FMBL?Q+_R%]'_ .OT
M_P#H)K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ K'\#_P#((E_Z_9O_ $*MBL?P/_R")?\ K]F_
M]"H V**** "BBB@ HHHH _$'_@]Y_P"36?@?_P!E U'_ -(111_P>\_\FL_
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M< Y546#S*$)5*&'I3G3HUJ4I\[C&$6J5.K&I!QAI%2C4Y+1M&/U!17SUI_\
MP5>_X)S:F ;;]KOPBN<8^T73P]?^NB#']*W-/_X*/?L":D ;?]LKX:KG/_'Q
MXPM(O_0Y!6T<SRV?PUH/_MY?YGXC6X&XUP_\7+,1'UHU%^<3VFBO,;#]M?\
M8[U0A=,_:G^'MR2< 0>,;)\G\)*V+']I+]GS5 #IGQM\*W.<8\C78'SGIT:M
MXXG#3^&:?S1Y5;),ZP_\7#5(^L)+\T=M16'8_$OX?ZIC^S/&.GW&<X\BY5^G
M7I5K_A,?#'_0:@_[ZK9--71YLH3@[25F:5%9O_"8^&/^@U!_WU1_PF/AC_H-
M0?\ ?5,DTJ*S?^$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJ@#2HK-_X3'PQ_T&H/
M^^J/^$Q\,?\ 0:@_[ZH TJ*S?^$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJ@#2HK
M-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH TJ*S?^$Q\,?]!J#_ +ZH_P"$Q\,?
M]!J#_OJ@#2HK-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH TJ*S?^$Q\,?]!J#_
M +ZH_P"$Q\,?]!J#_OJ@#2HK-_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZH TJ*S
M?^$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJ@#2K'LO\ D=[W_KRB_F:_/_\ X*0?
M\%Z/"G[-GBR^^"/[+?AS3?%OBO3W,.LZ]J;N=,TR8<- J1E6N95Y#8=41A@E
MR&5?@R/_ (+M_P#!2F/Q9)XI3XQZ4%DP'TW_ (1'3_(*@Y"Y\GS,=OOY]Z^/
MS'CC(LNQ+H-RFUH^5)I/U;7X7/Z-X.^BUXJ\99+#-*=.EAZ=1<T%7G*,IQ>J
M:C&$VD^G/RW6JT:;_H+HK\Y_^";_ /P7H\)_M)^++'X(_M2>'--\)>*]0<0Z
M-KVF.XTS4YCPL#)(6:VE;@+EV1V. 4)56_0;_A,?#'_0:@_[ZKW\LS7 YOAO
M;X6?,MGW3[-=/ZL?D?'' /%7AUG3RO/<.Z52UXNZ<9Q_FA):27XIZ22>AI45
MS_B'XK?#7PCI$NO^*_'.EZ786ZYGO=1O%@AC'JSN0H_$U\\?$#_@L1^QGX?U
MB3P?\)-9\0?%;Q$O"Z'\,/#\VINQZ ^< L!7/=9#@<XK;$X[!X.WMZBC?9-Z
MOT6[^1YV2<*\2\22DLKPE2LH_$XQ;C'SG/X8+SDTO,^IZ1W2-2[L%51DDG
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MY7M\K(X\?XB<78["RPD,1["@]Z5",:%-_P"*%%04_6?-)[MMFD  , 45F_\
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M (3'PQ_T&H/^^J/^$Q\,?]!J#_OJC_6JO0_W+#4:'^&FIR^4ZWM)I^:DF/\
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M1110!P_[2?B.7PS\"_%-W:>%];UJZN-"N[:QTKP]I$U[=74\D#K'&J1*<9;
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M.^+^)^)(QAF6,J581^&#D_9Q_P %-6A!>48I$/\ 9VG_ //C#_WZ%']G:?\
M\^,/_?H5-178?.$/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%344 0_P!G:?\
M\^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%<
MS\0?CO\ !3X3QL_Q,^+/AW02HSY6JZQ##(WLJ,P9C[ $UY'J/_!3K]FV^O)-
M)^$>G>,?B+?1MM:S\#>$;FZ(;TW2+&A'N"17LX'AW/LSA[3"X:<X_P RB^5>
MLOA7S9XF/XDR#*ZGL\5BJ<)_RN2YGZ1OS/Y(^@O[.T__ )\8?^_0H_L[3_\
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M_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\
MSXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344
M0_V=I_\ SXP_]^A7R!^U'_P7:_X)'?L7?';7?V:/VE_VGH?#7C;PU]E_MO1/
M^$!UR\^S?:+6*ZA_?6MC+"^Z&>)_E<XW8.&! ^Q:_D"_X.CO^4Z_QS_[EG_U
M&-)H _?C_B)]_P""#'_1Z\/_ (:[Q-_\K*I>%?\ @Y]_X(9Z9IKV]Y^W!L8W
M,CA?^%:>)C\I;(Z:;7\BM% ']GO[+G_!>K_@D]^VC\=M"_9H_9H_:L_X27QM
MXE^U?V)HG_""Z[9_:?L]K+=3?OKJQBA3;#!*_P SC.W RQ /U_7\@7_!KC_R
MG7^!G_<S?^HQJU?U^T %%%% !1110!^(/_![S_R:S\#_ /LH&H_^D(HH_P"#
MWG_DUGX'_P#90-1_](110!Y__P &FW_*4S]KO_MX_P#3Y/7[_5^ /_!IM_RE
M,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5X+_ ,$ZO^2'ZO\ ]CWK'_H^O>J\%_X)U?\ )#]7_P"Q[UC_
M -'T >]4444 %%%% !1110!6UC1M'\0Z7/H>OZ5;7UE=1F.YL[R!98ID/561
M@0P/H17R#\?/^"!?_!*CX^:Y_P )JW[+6G>!?%$<AEL_%?PKO)O#5];3'K*O
MV!HXF?D_-)&_//6OL>B@#\]_^'9O_!6']F',_P"PI_P6(U_Q/I5O_P >W@?]
MI;P[%XBBE ^ZKZO"$NXU'3")T^@H_P"'CG_!8#]EX^1^V_\ \$@KWQOI-O\
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MF>)/!?@[QE;_ &/Q?X3TS58<8\K4K".=<>F'!%/Z_P *5_XN"J0?>G6T_P#
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MC@^H_AH_X>8?\%D]4X\+?\&]'B68GY5_M;]HKP]8C=U()>(X&/XNYXK[_HH
M^ /^&Z/^"^FK\Z=_P0E\-:.#\P&K?M/:-<%1TVGR(!DGKD<8H_X:6_X.+M7X
MT_\ X)F? W2"> =5^,[W !/0_N(^B]_7M7W_ $4 ? '_  L;_@YHUCC3OV</
MV0M'W< ZMXPU^X"8ZD^0HR#T&.AZU_.#_P %ZIOVH[C_ (*Q?%:;]M"T\"6_
MQ+;^PCXDA^&DEX^B(/["T_[,+<WO[\G[-Y'F%^/-\S;\NVO[/:_D"_X.CO\
ME.O\<_\ N6?_ %&-)H ^ **** /O_P#X-<?^4Z_P,_[F;_U&-6K^OVOY O\
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M$;:^O$QZ7-TLDH_[[[5]#:9I>F:+81:5H^G06EK FR"VMH5CCC7T55  'L*
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M10 4444 %%%% !1110 4444 %?('[4?_  05_P""3W[:/QVUW]I?]I?]E/\
MX27QMXE^R_VWK?\ PG6NV?VG[/:Q6L/[FUOHH4VPP1)\J#.W)RQ)/U_10!\
M?\0N/_!"C_HQG_S)OB?_ .6=9OA7_@V!_P""&>I:=)/>_L/[W6YD0'_A9?B8
M<!L <:E7Z(UC^!_^01+_ -?LW_H5 'RQ^RY_P05_X)/?L7?';0OVE_V:/V4_
M^$:\;>&OM7]B:W_PG6NWGV;[1:RVLW[FZOI87W0SRI\R'&[(PP!'U_110 44
M44 %%%% 'X@_\'O/_)K/P/\ ^R@:C_Z0BBC_ (/>?^36?@?_ -E U'_TA%%
M'G__  :;?\I3/VN_^WC_ -/D]?O]7X _\&FW_*4S]KO_ +>/_3Y/7[_4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7@O\ P3J_
MY(?J_P#V/>L?^CZ]ZKP7_@G5_P D/U?_ +'O6/\ T?0![U1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5Y'^TG^P1^Q5^V%9/:?M.
M_LM^!_&TC1[$U#7/#L$E[",8_=70431''&4=37KE% 'Y\S_\&_?@3X)S/JO_
M  3<_;K^.7[.\RN7MO#VA>,)-;\-JV<@R:9J+/YN#T!F P2.]-_M3_@X\_9/
M/_$P\-_ []J[P_;='T^Z?P3XGN@.I82!M.3(Z!<G.>V*_0BB@#\_+#_@X5^!
MGPEO8?#W_!1']DGXW?LWW[2"*35?'/@2XOM!DD)P!!J5@LHF7/&_RU4>O7'U
MM^SO^VE^R/\ M;:4-8_9E_:4\$^.8_+WRP^&O$=O=3P#TEA1S)"?9U4C/2O2
M+ZPL=4LI=-U.SBN+>>,QSV\\8=)$(P593P01P0:^2?VB/^"$?_!*C]I/5#XJ
M\3_LB:!X;\1K+YUOXI^';R^';^&?_GOOT]HEDD]Y%>@#Z[KY=_X+0?M'?#_]
MDG_@FG\2?V@_BE\#_P#A9&@^'_['^W>"_P#A)I='_M'S]9L;9/\ 3(8Y'A\N
M29)>$.[RMAP&)'C)_P""5O\ P4P_9ES<_L!_\%D?&]YIL'_'OX&_:)T6#Q7:
M2KVB&HX2ZMHQT C0G&!GCGY"_P""\G[1'_!8W3_^"47Q5^!?[=_[!_@&7P[J
MO]AI=_&KX1>/B^DV,D6NZ?-&)=,O5^V*)7C6(/D!6E7(K6A7K8:M&M1DXSBT
MXR3:::=TTUJFGJFM4S*O0H8JA*C6BI0DFI1:3335FFGHTUHT]&CX[_XB./\
M@G]_T@]_\V6U7_Y7U"G_  <9?L$K?/.__!$O="R )!_PTEJ@VGN=W]GY.?2O
MR2HKZ+_7;C/_ *&6(_\ !U3_ .2/FO\ 47@G_H5X?_P13_\ D3]<_P#B(X_X
M)_?](/?_ #9;5?\ Y7U^\_\ P1?_ &COA_\ M;?\$T_AM^T'\+?@?_PK?0?$
M']L?8?!?_"32ZQ_9WD:S?6S_ .F31QO-YDD+R\H-OF[!D*"?XI:_K,_X-J_V
MB?V?OA?_ ,$-_@CI/Q+^.G@WP[=0#Q*9K;7?$]I:21[O$VJ,-RRR*1D,I&>H
M(/>N#,.(N(,WHJCCL75JP3NHSJ3FD[-7M)M7LVK[V;[GH9=PWP[D]=UL!@Z5
M&;5G*%.$&U=.S<4G:Z3MM=+L?IA17@WB/_@J?_P3)\(Y7Q+_ ,%$/@?9NO6&
M;XJZ1YG;H@N-QZCH*X#Q'_P7G_X(Z>%L_P!I_P#!0WX<2XZ_V=JS7GI_S[H^
M>O\ /T->.>T?7%%?!FL_\'-O_!$/2)Q90_ML1ZA<M_J[?2? /B"Z9^ 3@QV!
M7@'/)['TJG_Q$F?\$]-5_P"2?^"OC=XLS]W_ (1SX+:M)N^GF1I_M?\ ?)]L
M@'W_ $5\ ?\ #_[PYK'R_#[_ ()*_MO>(]WW)].^ +I!_P "DDNEV]QTZC%
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M/J_VE]?_ .2?_P#!"W]JVYS]W_A(_#5GI/Y^9.V.C?IZBOO^B@#X _X>=?\
M!8#7_P#DG_\ P;V^+[G/W?\ A(_CYX?TG\_,C;'1OR7^\*/^&N_^#A3Q+_R!
M?^"0'PP\,YZ?\)'^T!:WFWZ_9(AGH?\ OI?0U]_T4 ? '_";?\'.OB7_ ) G
MP2_8R\,YZ?\ "1^)/$M[M^OV0#/0]/[P]#0/A=_P<P^)?^0Y^U+^R9X9W=?^
M$<\$:W>[?I]K89Z=_4^U??\ 10!_ '1110 5^OW_  :E>'?^"FNL_P#"^;S_
M ()Q_$7X/Z+):_\ "+?\)=9?%S2-0N8;[=_:_P!E\A[([XMNVYWY^]YB8^Z:
M_(&OW^_X,8_^;HO^Y)_]S] 'W]_PLK_@YF\$\^)OV9_V1_&X3EAX.\9:[IID
M]A]O4X/UXH_X>!?\%SO!OR>/?^"#%KK<*\2:CX-_:/T5@3_LV\T0D(/UXQ[U
M^@%% 'Y__P##Z?\ :B\)<_%S_@A3^U/9!>9?^$-T&R\08'^SY,R;C[4?\1%?
M[+N@_P#)7/V-_P!J?X?E>)1XR^!%[#Y9]&\EY>:_0"B@#X-T'_@YE_X(JZO>
MC2=6_;!DT&^S\UEXC\ Z[9.GN6DL@@[_ ,7:O3_!O_!;7_@D9X["'0_^"C'P
MC@WC*_VSXSMM._/[6T>/H:^E=>\,^&_%5D=.\3^'['4K<@@P7]HDR'/7Y7!%
M>8>,O^"?O[!GQ&+GX@_L2_"/73(<N=8^&^EW)8^I\R T :?@W]L[]CWXBE!\
M/OVKOAKKID("#1O'6GW6XGICRIFS7HMC?6.IVJ7VFWD5Q!(,QS02!T8>H(X-
M?)WC+_@@]_P1W\=AQK?_  3Q^&T&\$'^QM&.G8SZ?9&CQ^'2O.K[_@V3_P""
M.<%T^I> ?V>?$/@V\D.6N_"?Q/UZV;/L&O'4=NBCI0!]]T5^?_\ Q#V?"+P^
M=_PB_P""D'[8O@0KS%%X8^/=PL0/8%)H)-RCTSR.*/\ ASW^W3X2X^$7_!>G
M]H&RV_ZK_A,M,TSQ!C_>\Y$W4 ?H!17Y_P#_  Q'_P %^/!1SX2_X+<>$/%Z
M*?W=OXR_9QTRSX'16DLIBS>A;KWH_P"$=_X.=O!/_(*^(O[&/C>!/O?VWI'B
M73;F0?[/V<F,'Z\8S0!^@%%?G_\ \--?\'%O@KCQ/_P3$^"/C?9][_A#?C2V
MF^9CKM^WQG&>V>G>C_AZ7_P5<\(_\E<_X-^?B%:!/]:W@WXQ:'K_ !ZJ(53/
MTH _0"BOS_\ ^'\NL>%_W?Q=_P"".'[:7AXKQ+>6?P:74;.,]\S0W7Y87D T
M?\1+/_!,_0?^2NQ_%OX? <RGQE\'-9A\H>K>3!+QVXS0!^@%%?%7@W_@XK_X
M(J^.PAT3]OWPK!O (_MG3-1T[&?7[7;1X_&O6?!O_!57_@F1\02D?@[_ (*$
M_!6]E<X6V3XFZ6LQ_P"V33A_TH ]\HKFO!OQF^#_ ,10A^'WQ7\-:Z'&4.C:
M[;W6X>WENV:Z6@ HHHH **** "BBB@ HK\@?^#K7_@J/^W9_P37_ .%"_P##
M%/QS_P"$+_X33_A*?^$F_P"*9TO4?MGV/^R/L_\ Q_VT_E[/M4_W-N[?\V=J
MX_(#_B*._P""Z_\ T?-_YC+PQ_\ *R@#^N7P/_R")?\ K]F_]"K8K^/RQ_X.
M?O\ @N9IL)@LOVX-B,Y<C_A6GAD\DY)YTVIO^(H[_@NO_P!'S?\ F,O#'_RL
MH _K]HHHH **1W2-#)(P55&68G  KQ/XS?\ !2G_ ()[_L\&6'XU_ML?"[PY
M<PYWZ=J'C>R%WQUQ;K(96Q[*: /;:*^!M9_X.3?^"96IZE-H'[/.I?$SXTZK
M VQ]+^$OPJU7492_95::*&-B>.0Y'/6JO_#UO_@II\8?D_92_P""#_Q3>";_
M %6J?&?QIIG@_P A>SR6LWFR-[HK;J /T#HK\_!HW_!RW\;SG4/&7[+GP.TR
M;[HTO3]5\2ZQ;Y_O><5M'QQTZG/M1_PYX_;G^+HW?M=_\%VOCSK22_\ 'Q9_
M"/3=.\#Q$'K'_HB2DKV/0D>E 'WAXL\:>#O 6C2>(_'7BS3-%T^'_6W^K7\=
MM"GU>0A1^=?,WQG_ ."Y/_!(KX!F5/B'_P % _AP\L&1/;>&]:_MN:,CJIBT
MU9W#?[.,^U>=^$_^#;?_ ()/V&LQ^+?BQ\'_ !/\4]>C.?[<^*/Q"U75IGYR
M=T9G2%LD#.8STKZ:^#'["7[$_P"SIY3_  &_9'^&W@^:#&R[\.^"K&TG)'\3
M2QQ!V;_:+$^] 'RE_P 1#GP*^(P\K]C_ /8=_::^-9E_X]=2\$_""YBTUO1I
M+F\:'RD/'S%#U'%'_#<'_!>'XTGR_@7_ ,$=O"GP[LY>+;7?C/\ &2VER#_%
M)8:<GGQX[@DD]J_0.B@#\_1^S!_P<2?&WYOBQ_P4Q^"_P<@FYGL_@Y\(WUME
M4]42;6G5E/;>.1U%)_PX1_X6>//_ &P?^"IW[4OQ0\S_ (^=%_X61_8NC2^O
M^A6<8VYYZ2=.*_0.B@#XW^$7_!OO_P $<O@O<KJ'A[]A#PAK-WOWRW?C=KGQ
M \SYR7<:E+.I)//W0/:OJ3X;_!SX0_!O2O[!^$/PK\-^%;':!]B\-Z';V,6!
MT&R!%'Z5TE% !1110 4444 %%%% !1110 4444 %%%% &/XE_P"0OH__ %^G
M_P!!-;%8_B7_ )"^C_\ 7Z?_ $$UL4 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^!_^01+_ -?L
MW_H5;%8_@?\ Y!$O_7[-_P"A4 ;%%%% !1110 4444 ?B#_P>\_\FL_ _P#[
M*!J/_I"**/\ @]Y_Y-9^!_\ V4#4?_2$44 >?_\ !IM_RE,_:[_[>/\ T^3U
M^_U?@#_P:;?\I3/VN_\ MX_]/D]?O]0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %>"_P#!.K_DA^K_ /8]ZQ_Z/KWJO!?^"=7_
M "0_5_\ L>]8_P#1] 'O5%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7P!_P='?\ *"CXY_\ <L_^I/I-??\
M7P!_P='?\H*/CG_W+/\ ZD^DT ?R!4444 %?TW_\&[G_  2)_P"":?[1W_!(
M[X2?M"_'C]C?P;XM\9:^=>_MC7==M'N)+KR-?U*VBW*S[!MABC084<(,\\U_
M,A7]?O\ P:X_\H*/@9_W,W_J3ZM0![SX<_X)(?\ !++PG@Z'_P $Y/@?&Z_=
MFF^%VE32#KT>2!F'4]Z[_P .?L=?LB^#\?\ "(_LL?#C2MO3^SO ]A!CK_<A
M'J?S/K7H]% %/1O#V@>'8#:^']#L[&(]8[.V2)3R3T4 =2?S-7*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *S?&/\
MR+%[_P!<#6E6;XQ_Y%B]_P"N!H N:=_R#X/^N*_R%35#IW_(/@_ZXK_(5-0
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M*X\,?\%(?@+XWV<*?&7P?FTWS/=OL$AQ^%'_  E__!SEX)YUSX/?L;^-XDY
M\-^(/$>FS2 =C]K!0,?;BOT HH _/_\ X;I_X+U^"_E\9?\ !#7PYXIC3B6[
M\&_M(:3;X_VEANX=[>F,Y[T?\/C_ -M+PE_R5W_@@[^T=9;3^]_X0U].\08
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M/_!<S4H3/9?L/[T5RA/_  LOPR.0<$<ZE4W_ !"X_P#!=?\ Z,9_\R;X8_\
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M %%%% !1110 4444 %9OC'_D6+W_ *X&M*LWQC_R+%[_ -<#0!<T[_D'P?\
M7%?Y"IJAT[_D'P?]<5_D*FH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'\#_\@B7_ *_9O_0JV*Q_
M _\ R")?^OV;_P!"K8H **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@#'\2_\A?1_^OT_^@FMBL?Q+_R%
M]'_Z_3_Z":V* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *Q_ _P#R")?^OV;_ -"K8K'\#_\ ((E_
MZ_9O_0J -BBBB@ HHHH **** /Q!_P"#WG_DUGX'_P#90-1_](111_P>\_\
M)K/P/_[*!J/_ *0BB@#S_P#X--O^4IG[7?\ V\?^GR>OW^K\ ?\ @TV_Y2F?
MM=_]O'_I\GK]_J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\A/^"E7
M[>G[#?[1'_!1V_\ V&?VF?\ @IC\8_V<M'^'5C:6FC:I\+/$,V@P>(==O,R7
MGV[4?LLT2V]M$MK#'YFQ%E>[W.-JY^FOVD/B%X>_X(?_ /!'CQU\7_ 'QH\<
M_%6[\-:8]WX9\4_%;Q>VO:CJNIZE<QV]D9;@*BR6\;SPD)&J+Y,1/WF9S]1?
MM+?LM?L_?MA?"?4_@C^TG\*M'\6^&]5MWBFL=6M%D,+,N!-#)]^"9>JRQE74
M@$$$5^-/QW_9I^-VK_\ !J5\4O@S;:_J/BK3?A?\1=7;X?:I<DR3:IX0T?Q.
M8X[H$=8EMXKF9#]WR8DV_(%H ^D_VJOAO\8/V$O^"36B?\%(/ /Q5\5ZM\>_
M >CZ#XO\>Z]KOB>\GA\8BXFMO[6TR]MFD, LC'<S>3$D:_9O(A\GRRI)_1WX
M,?%/PW\<_@]X4^-G@UG.C^,?#5AKFE&3&XVUW;I/%G'&=DBU\-_\%G_C!X5U
MO_@W<\=_$S0;I+BP\8?"O0$T$6_SFZ.I3V$=NL8'+EO/4@#MSVKZP_8*^%'B
M3X#_ +#/P8^!_C&%H]7\&_"CP[H>JQN>4N;33;>"5?P>-A0!ZS1163XZL_&-
M_P"$;^S^'^L6FGZU) 1IU[?6YEAADR,,Z#[PQGB@#6KP7_@G5_R0_5_^Q[UC
M_P!'U-_P@/\ P4$_Z+_X$_\ "4D_^*KR3]C_ ,&_MAZC\+[^?X5?%SPGI.GK
MXIU)+FWU#0GF=[E9R)9 ><*Q (7M0!]GT5X+_P *^_X*'_\ 1P7@3_PEWH_X
M5]_P4/\ ^C@O G_A+O0![U17@O\ PK[_ (*'_P#1P7@3_P )=Z/^%??\%#_^
MC@O G_A+O0![U17@O_"OO^"A_P#T<%X$_P#"7>C_ (5]_P %#_\ HX+P)_X2
M[T >]45X+_PK[_@H?_T<%X$_\)=Z/^%??\%#_P#HX+P)_P"$N] 'O5%>"_\
M"OO^"A__ $<%X$_\)=Z/^%??\%#_ /HX+P)_X2[T >]45X+_ ,*^_P""A_\
MT<%X$_\ "7>C_A7W_!0__HX+P)_X2[T >]45X+_PK[_@H?\ ]'!>!/\ PEWH
M_P"%??\ !0__ *."\"?^$N] 'O5%>"_\*^_X*'_]'!>!/_"7>C_A7W_!0_\
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MX5]_P4/_ .C@O G_ (2[T?\ "OO^"A__ $<%X$_\)=Z />J*\%_X5]_P4/\
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MX5]_P4/_ .C@O G_ (2[T >]45X+_P *^_X*'_\ 1P7@3_PEWH_X5]_P4/\
M^C@O G_A+O0![U17@O\ PK[_ (*'_P#1P7@3_P )=Z/^%??\%#_^C@O G_A+
MO0![U17@O_"OO^"A_P#T<%X$_P#"7>C_ (5]_P %#_\ HX+P)_X2[T >]45X
M+_PK[_@H?_T<%X$_\)=Z/^%??\%#_P#HX+P)_P"$N] 'O5%>"_\ "OO^"A__
M $<%X$_\)=Z/^%??\%#_ /HX+P)_X2[T >]45X+_ ,*^_P""A_\ T<%X$_\
M"7>C_A7W_!0__HX+P)_X2[T >Q>!_P#D$2_]?LW_ *%6Q7R3^SQ?_MY_%KP1
M=^)?#_QN\(6<%OKU[9/%>^&]SF2&4HS J,;2>0.M=Y_PK[_@H?\ ]'!>!/\
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MA_\ T<%X$_\ "7>@#WJBO!?^%??\%#_^C@O G_A+O1_PK[_@H?\ ]'!>!/\
MPEWH ]ZHKP7_ (5]_P %#_\ HX+P)_X2[T?\*^_X*'_]'!>!/_"7>@#WJBO!
M?^%??\%#_P#HX+P)_P"$N]'_  K[_@H?_P!'!>!/_"7>@#V+Q+_R%]'_ .OT
M_P#H)K8KY)^+=_\ MY^ O&_@7PUJWQN\(7$_B;7GLK&6V\-X2"01%]T@89*X
M&,#FN\_X5]_P4/\ ^C@O G_A+O0![U17@O\ PK[_ (*'_P#1P7@3_P )=Z/^
M%??\%#_^C@O G_A+O0![U17@O_"OO^"A_P#T<%X$_P#"7>C_ (5]_P %#_\
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M_"OO^"A__1P7@3_PEWH_X5]_P4/_ .C@O G_ (2[T >]45X+_P *^_X*'_\
M1P7@3_PEWH_X5]_P4/\ ^C@O G_A+O0![U17@O\ PK[_ (*'_P#1P7@3_P )
M=Z/^%??\%#_^C@O G_A+O0![U17@O_"OO^"A_P#T<%X$_P#"7>C_ (5]_P %
M#_\ HX+P)_X2[T >]5C^!_\ D$2_]?LW_H5>._\ "OO^"A__ $<%X$_\)=ZW
MOV+?B%XM^)7PCN]<\;7-O-?6_B?4;)I+:#RT98IB@./PH ]<HHHH **** "B
MBB@#\0?^#WG_ )-9^!__ &4#4?\ TA%%'_![S_R:S\#_ /LH&H_^D(HH \__
M .#3;_E*9^UW_P!O'_I\GK]_J_ '_@TV_P"4IG[7?_;Q_P"GR>OW^H ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX<_\$>?B_P#L&? 74Y=9\5ZI\*?$.H,]W,CZMXHUFX26XN+^X5?F>6[O&(+
M;5,JHN%55 !X5\$/AA\;OVC/^"->I_\ !3#Q9\8_%5M^T;XE\%:M\1?"_BO3
MO$5W%;:$\)GN].TBTLO,-NFG&WAA@EMWC=9A-*\F]VW#[(_8*_:>F_X*._\
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MMRS,<DDQ+DDU\,?\'0__ "@K^.G^YX;_ /4FTJON;P!_R(FB?]@BV_\ 12T
M:U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5YW^U%X&^,?Q1^$MS\,O@C\2)_!>I^(+R"RU'QE8A&O-%TYFW7<]H)%9?M31
M*T,+D$123+*0PC*GT2J^JZKI>A:7<ZYKFI6]G96=N\]Y>7<RQQ01(I9Y'=B
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MGQ)K<=]#<:M<^7YU\&:$2I*XB4$*X0\DH3@C8^)/[$WPT\;?'F/]J7P3XO\
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M23[YX6\+^&_ _AG3O!?@W0;/2M(TBQBLM*TS3[=88+2VB0)'#&B@*B*BJJJ
M   !5^B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "OB?XZ_\ !!?]CK]HGXZ^)OVC?B-\5/C4/%'BRY635;G2?BM>V<0C
M0MY-O''#M6."(.RQQCA 3CDDG[8HH ^?OV%?^":?[-G_  3T7Q5<? F7Q5?Z
MAXSELVU_6?&?BB?5KV9+595MX1-.2RQIYTQ"#C,C'O65JW_!*3]EW5[+6O 1
MO/%=M\-/$OB9_$/B+X.6>N"/PQJ&HO,)Y'> 1^>D$DZB62SCF2TD<L7@;<P/
MTM10!\\?MT_\$SO@#_P4)TKPOX=^.?BWQYIVE>$+LWFBZ5X+\7S:1;K=;0J7
M#K !ODC7*QL3^[#OMQN;/F/P,_X()_L/? ;XU^%OCOHWB;XJ^(=7\':J-2T.
MR\9_$R^U2QCNU1ECF:WF)5GC+;T/\+JI[5]JT4 >+_MS?L+?";_@H5\%[O\
M9V^/WBCQ1'X*U.2%]:T#P]J<=FFI-#/'<0F:3RFEPDL2.%5U4E06#8&/2/A;
MX /PN\":=X"7QGK6O1:7;K;VVH>()HI;HQ* J*[Q1QA]H &Y@7/5F8\UT%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _$'_@]Y
M_P"36?@?_P!E U'_ -(111_P>\_\FL_ _P#[*!J/_I"** //_P#@TV_Y2F?M
M=_\ ;Q_Z?)Z_?ZOP!_X--O\ E*9^UW_V\?\ I\GK]_J "BBB@ HHHH ****
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M#$\<1GNHI9697=_/9XQ&5B402!7:3LOA;^PS^U/\/_\ @J_\2O\ @HIJ&O\
M@&[T+Q_X$LO"\/A"+4+V.ZL8K,QM#<&Y-L4D9VC;?'Y:A1*,,WE_. ?*'_!,
M3]AWX<?MA_$O]M7X+?M+_$WXF^+/!?AO]IC5])TCP]??$W5UPD<:K#+<7:7
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M7%S:*JQJ$CSN)V+C)P!7Z%?LX_%'6_CA^SUX$^-/B7P1<>&=1\7^#=,UJ_\
M#EVY:72YKJTCG>U<D EHVD*$D Y7D#I0!V=%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X@_\'O/_
M ":S\#_^R@:C_P"D(HH_X/>?^36?@?\ ]E U'_TA%% 'G_\ P:;?\I3/VN_^
MWC_T^3U^_P!7X _\&FW_ "E,_:[_ .WC_P!/D]?O]0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5P_[17[-7P%_:V^%&H? []I/X5Z1XQ\*:IM-YHVLV^^/>
MIRDB,"'BD4\K(A5U[$5W%% 'RI\'O^"*_P#P3R^">L6>I^'/A9XBU>WTR>.7
M2-#\9?$C7=<TJQ,9#1^787]Y+;'8P#(SQLRD J017U7110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ?B#_ ,'O/_)K/P/_ .R@:C_Z0BBC_@]Y_P"36?@?_P!E U'_ -(110!Y
M_P#\&FW_ "E,_:[_ .WC_P!/D]?O]7X _P#!IM_RE,_:[_[>/_3Y/7[_ % !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MX@_\'O/_ ":S\#_^R@:C_P"D(HH_X/>?^36?@?\ ]E U'_TA%% 'G_\ P:;?
M\I3/VN_^WC_T^3U^_P!7X _\&FW_ "E,_:[_ .WC_P!/D]?O]0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK#]J;_HY7X@?^%E??_':** #_AK#]J;_ *.5^('_ (65]_\ ':/^&L/VIO\
MHY7X@?\ A97W_P =HHH /^&L/VIO^CE?B!_X65]_\=H_X:P_:F_Z.5^('_A9
M7W_QVBB@ _X:P_:F_P"CE?B!_P"%E??_ !VC_AK#]J;_ *.5^('_ (65]_\
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M;_HY7X@?^%E??_':/^&L/VIO^CE?B!_X65]_\=HHH /^&L/VIO\ HY7X@?\
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M7X@?^%E??_':** #_AK#]J;_ *.5^('_ (65]_\ ':/^&L/VIO\ HY7X@?\
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M** #_AK#]J;_ *.5^('_ (65]_\ ':/^&L/VIO\ HY7X@?\ A97W_P =HHH
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M #_AK#]J;_HY7X@?^%E??_':/^&L/VIO^CE?B!_X65]_\=HHH /^&L/VIO\
MHY7X@?\ A97W_P =H_X:P_:F_P"CE?B!_P"%E??_ !VBB@ _X:P_:F_Z.5^(
M'_A97W_QVC_AK#]J;_HY7X@?^%E??_':** #_AK#]J;_ *.5^('_ (65]_\
M':/^&L/VIO\ HY7X@?\ A97W_P =HHH /^&L/VIO^CE?B!_X65]_\=H_X:P_
M:F_Z.5^('_A97W_QVBB@ _X:P_:F_P"CE?B!_P"%E??_ !VC_AK#]J;_ *.5
M^('_ (65]_\ ':** #_AK#]J;_HY7X@?^%E??_':/^&L/VIO^CE?B!_X65]_
M\=HHH Q/&_QC^+OQ-M8+'XD?%3Q)XA@M9#);0ZYKEQ=I"Y&"RB5V"DCC(HHH
$H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634641568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 15, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-08940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ALTRIA GROUP, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3260245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6601 West Broad Street,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Richmond,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">VA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">23230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">804<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">274-2200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,785,563,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.360%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Portions of the registrant&#8217;s definitive proxy statement for use in connection with its annual meeting of shareholders to be held on May&#160;18, 2023, to be filed with the U.S. Securities and Exchange Commission on or about April 6, 2023, are incorporated by reference into Part III hereof.</span></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Tag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000764180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock0.3313ParValueMember', window );">Common Stock, $0.33 &#160;1/3 par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.33 &#160;1/3 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.700NotesDue2025Member', window );">1.700% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.700% Notes due 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock2.200NotesDue2027Member', window );">2.200% Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.200% Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock3.125NotesDue2031Member', window );">3.125% Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">3.125% Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MO31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock0.3313ParValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock0.3313ParValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock1.700NotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock1.700NotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock2.200NotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock2.200NotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_CommonStock3.125NotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_CommonStock3.125NotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634512672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Richmond, Virginia<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863635664016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,030<span></span>
</td>
<td class="nump">$ 4,544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ReceivableCommercializationRightsCurrent', window );">Receivable from the sale of IQOS System commercialization rights</a></td>
<td class="nump">1,721<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InventoryRawMaterialsPlantMaterialNetofReserves', window );">Leaf tobacco</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherInventoryRawMaterialsNetofReserves', window );">Other raw materials</a></td>
<td class="nump">186<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished product</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">1,180<span></span>
</td>
<td class="nump">1,194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">241<span></span>
</td>
<td class="nump">298<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">7,220<span></span>
</td>
<td class="nump">6,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetAbstract', window );"><strong>Property, plant and equipment, at cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LandAndLandImprovements', window );">Land and land improvements</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">123<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Buildings and building equipment</a></td>
<td class="nump">1,478<span></span>
</td>
<td class="nump">1,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and equipment</a></td>
<td class="nump">2,578<span></span>
</td>
<td class="nump">2,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">4,427<span></span>
</td>
<td class="nump">4,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="nump">2,819<span></span>
</td>
<td class="nump">2,879<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,608<span></span>
</td>
<td class="nump">1,553<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,177<span></span>
</td>
<td class="nump">5,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets, net</a></td>
<td class="nump">12,384<span></span>
</td>
<td class="nump">12,306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments in equity securities ($250 million and $1,720&#160;million at December&#160;31, 2022 and 2021, respectively, measured at fair value)</a></td>
<td class="nump">9,600<span></span>
</td>
<td class="nump">13,481<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">965<span></span>
</td>
<td class="nump">923<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">36,954<span></span>
</td>
<td class="nump">39,523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,556<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">552<span></span>
</td>
<td class="nump">449<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Accrued liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Marketing</a></td>
<td class="nump">599<span></span>
</td>
<td class="nump">664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_AccruedSettlementLiabilityCurrent', window );">Settlement charges</a></td>
<td class="nump">2,925<span></span>
</td>
<td class="nump">3,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,299<span></span>
</td>
<td class="nump">1,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividends payable</a></td>
<td class="nump">1,685<span></span>
</td>
<td class="nump">1,647<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">8,616<span></span>
</td>
<td class="nump">8,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">25,124<span></span>
</td>
<td class="nump">26,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">2,897<span></span>
</td>
<td class="nump">3,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Accrued pension costs</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent', window );">Accrued postretirement health care costs</a></td>
<td class="nump">1,083<span></span>
</td>
<td class="nump">1,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent', window );">Deferred gain from the sale of IQOS System commercialization rights</a></td>
<td class="nump">2,700<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">324<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">40,877<span></span>
</td>
<td class="nump">41,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies (Note 17)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.33 1/3&#160;per share (2,805,961,317 shares issued)</a></td>
<td class="nump">935<span></span>
</td>
<td class="nump">935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">5,887<span></span>
</td>
<td class="nump">5,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Earnings reinvested in the business</a></td>
<td class="nump">29,792<span></span>
</td>
<td class="nump">30,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive losses</a></td>
<td class="num">(2,771)<span></span>
</td>
<td class="num">(3,056)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Cost of repurchased stock (1,020,427,195 shares at December&#160;31, 2022 and 982,785,699 shares at December&#160;31, 2021)</a></td>
<td class="num">(37,816)<span></span>
</td>
<td class="num">(36,006)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity (deficit) attributable to Altria</a></td>
<td class="num">(3,973)<span></span>
</td>
<td class="num">(1,606)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity (deficit)</a></td>
<td class="num">(3,923)<span></span>
</td>
<td class="num">(1,606)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders&#8217; Equity (Deficit)</a></td>
<td class="nump">$ 36,954<span></span>
</td>
<td class="nump">$ 39,523<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AccruedSettlementLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Settlement Liability, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AccruedSettlementLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Gain On Sale Of Commercialization Rights, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InventoryRawMaterialsPlantMaterialNetofReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InventoryRawMaterialsPlantMaterialNetofReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OtherInventoryRawMaterialsNetofReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Inventory, Raw Materials, Net of Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OtherInventoryRawMaterialsNetofReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ReceivableCommercializationRightsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivable, Commercialization Rights, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ReceivableCommercializationRightsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandAndLandImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation and depletion of real estate held for productive use and additions or improvements to real estate held for productive use, examples include, but are not limited to, walkways, driveways, fences, and parking lots. Excludes land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandAndLandImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634535904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; Equity (Deficit)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Investments, fair value</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">$ 1,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (usd per share)</a></td>
<td class="nump">$ 0.3333<span></span>
</td>
<td class="nump">$ 0.3333<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">2,805,961,317<span></span>
</td>
<td class="nump">2,805,961,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Shares repurchased (in shares)</a></td>
<td class="nump">1,020,427,195<span></span>
</td>
<td class="nump">982,785,699<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629691344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Earnings - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 25,096<span></span>
</td>
<td class="nump">$ 26,013<span></span>
</td>
<td class="nump">$ 26,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">6,442<span></span>
</td>
<td class="nump">7,119<span></span>
</td>
<td class="nump">7,818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ExciseTax', window );">Excise taxes on products</a></td>
<td class="nump">4,408<span></span>
</td>
<td class="nump">4,902<span></span>
</td>
<td class="nump">5,312<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">14,246<span></span>
</td>
<td class="nump">13,992<span></span>
</td>
<td class="nump">13,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_MarketingAdministrationandResearchCosts', window );">Marketing, administration and research costs</a></td>
<td class="nump">2,327<span></span>
</td>
<td class="nump">2,432<span></span>
</td>
<td class="nump">2,150<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">11,919<span></span>
</td>
<td class="nump">11,560<span></span>
</td>
<td class="nump">10,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest and other debt expense, net</a></td>
<td class="nump">1,058<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic defined benefits expense (reversal of expense)</a></td>
<td class="num">(184)<span></span>
</td>
<td class="num">(202)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestments', window );">(Income) losses from investments in equity securities</a></td>
<td class="nump">3,641<span></span>
</td>
<td class="nump">5,979<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Loss on Cronos-related financial instruments</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">7,389<span></span>
</td>
<td class="nump">3,824<span></span>
</td>
<td class="nump">6,890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">1,625<span></span>
</td>
<td class="nump">1,349<span></span>
</td>
<td class="nump">2,436<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings</a></td>
<td class="nump">5,764<span></span>
</td>
<td class="nump">2,475<span></span>
</td>
<td class="nump">4,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net losses attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Altria</a></td>
<td class="nump">$ 5,764<span></span>
</td>
<td class="nump">$ 2,475<span></span>
</td>
<td class="nump">$ 4,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Per share data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per share attributable to Altria (in usd per share)</a></td>
<td class="nump">$ 3.19<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="nump">$ 2.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per share attributable to Altria (in usd per share)</a></td>
<td class="nump">$ 3.19<span></span>
</td>
<td class="nump">$ 1.34<span></span>
</td>
<td class="nump">$ 2.40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ExciseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Excise Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ExciseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_MarketingAdministrationandResearchCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_MarketingAdministrationandResearchCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634390864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Earnings - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="nump">$ 5,764<span></span>
</td>
<td class="nump">$ 2,475<span></span>
</td>
<td class="nump">$ 4,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive earnings (losses), net of deferred income taxes:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Benefit plans</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">808<span></span>
</td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciEquityMethodInvestmentAfterTax', window );">ABI</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">426<span></span>
</td>
<td class="num">(1,245)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax', window );">Currency translation adjustments and other</a></td>
<td class="num">(34)<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">1,285<span></span>
</td>
<td class="num">(1,477)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive earnings</a></td>
<td class="nump">6,049<span></span>
</td>
<td class="nump">3,760<span></span>
</td>
<td class="nump">2,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive losses attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive earnings attributable to Altria</a></td>
<td class="nump">$ 6,049<span></span>
</td>
<td class="nump">$ 3,760<span></span>
</td>
<td class="nump">$ 2,990<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment And Other, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciEquityMethodInvestmentAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126903467&amp;loc=d3e32472-111569<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciEquityMethodInvestmentAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629423696">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Provided by (Used in) Operating Activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,764<span></span>
</td>
<td class="nump">$ 2,475<span></span>
</td>
<td class="nump">$ 4,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to operating cash flows:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">257<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax provision (benefit)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(947)<span></span>
</td>
<td class="num">(1,160)<span></span>
</td>
<td class="num">(164)<span></span>
</td>
<td class="num">$ (164)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestments', window );">(Income) losses from investments in equity securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,641<span></span>
</td>
<td class="nump">5,979<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Dividends from ABI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Loss on Cronos-related financial instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 649<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Cash effects of changes:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="num">(149)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet', window );">Accrued liabilities and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(129)<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_IncreaseDecreaseInSettlementPayable', window );">Accrued settlement charges</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(424)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitContributions', window );">Pension plan contributions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash', window );">Pension and postretirement, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(156)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="nump">149<span></span>
</td>
<td class="nump">712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,256<span></span>
</td>
<td class="nump">8,405<span></span>
</td>
<td class="nump">8,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Provided by (Used in) Investing Activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(205)<span></span>
</td>
<td class="num">(169)<span></span>
</td>
<td class="num">(231)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ProceedsFromSaleOfCommercializationRights', window );">Proceeds from the sale of IQOS System commercialization rights</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from the Ste. Michelle Transaction, net of cash transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,176<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">205<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">782<span></span>
</td>
<td class="nump">1,212<span></span>
</td>
<td class="num">(143)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Provided by (Used in) Financing Activities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayment of short-term borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Long-term debt issued</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,472<span></span>
</td>
<td class="nump">1,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Long-term debt repaid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,105)<span></span>
</td>
<td class="num">(6,542)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchases of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,825)<span></span>
</td>
<td class="num">(1,675)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid on common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,599)<span></span>
</td>
<td class="num">(6,446)<span></span>
</td>
<td class="num">(6,290)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Premiums and fees related to early extinguishment of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(623)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(215)<span></span>
</td>
<td class="num">(99)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,541)<span></span>
</td>
<td class="num">(10,029)<span></span>
</td>
<td class="num">(5,396)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, cash equivalents and restricted cash:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(503)<span></span>
</td>
<td class="num">(412)<span></span>
</td>
<td class="nump">2,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Balance at beginning of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 5,006<span></span>
</td>
<td class="nump">4,594<span></span>
</td>
<td class="nump">5,006<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Balance at end of year</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,091<span></span>
</td>
<td class="nump">4,594<span></span>
</td>
<td class="nump">5,006<span></span>
</td>
<td class="nump">2,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid: Interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,119<span></span>
</td>
<td class="nump">1,189<span></span>
</td>
<td class="nump">1,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash Paid: Income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,657<span></span>
</td>
<td class="nump">2,673<span></span>
</td>
<td class="nump">2,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing activities:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash', window );">Deferred proceeds from the sale of IQOS System commercialization rights</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,030<span></span>
</td>
<td class="nump">4,544<span></span>
</td>
<td class="nump">4,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash included in other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash included in other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,091<span></span>
</td>
<td class="nump">$ 4,594<span></span>
</td>
<td class="nump">$ 5,006<span></span>
</td>
<td class="nump">$ 2,160<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">2021 amounts reflect changes from operations for Ste. Michelle prior to the Ste. Michelle Transaction.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">2020 primarily reflects inventory-related amounts associated with the wine business strategic reset.  For further discussion, see Note 14. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted cash consisted primarily of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals.  See Note 17.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Proceeds From Sale Of Commercialization Rights, Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncreaseDecreaseInSettlementPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change during the period in Settlement payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncreaseDecreaseInSettlementPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ProceedsFromSaleOfCommercializationRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Commercialization Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ProceedsFromSaleOfCommercializationRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current operating assets after deduction of current operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863635907872">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Earnings Reinvested in the Business [Member]</div></th>
<th class="th"><div>Accumulated Other Comprehensive Losses [Member]</div></th>
<th class="th"><div>Cost of Repurchased Stock [Member]</div></th>
<th class="th"><div>Non-Controlling Interests [Member]</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 6,319<span></span>
</td>
<td class="nump">$ 935<span></span>
</td>
<td class="nump">$ 5,970<span></span>
</td>
<td class="nump">$ 36,539<span></span>
</td>
<td class="num">$ (2,864)<span></span>
</td>
<td class="num">$ (34,358)<span></span>
</td>
<td class="nump">$ 97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,477)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,477)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,327)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,327)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balances at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,925<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,910<span></span>
</td>
<td class="nump">34,679<span></span>
</td>
<td class="num">(4,341)<span></span>
</td>
<td class="num">(34,344)<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,490)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,490)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchases of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,675)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,675)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(159)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balances at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,606)<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,857<span></span>
</td>
<td class="nump">30,664<span></span>
</td>
<td class="num">(3,056)<span></span>
</td>
<td class="num">(36,006)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,925<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,910<span></span>
</td>
<td class="nump">34,679<span></span>
</td>
<td class="num">(4,341)<span></span>
</td>
<td class="num">(34,344)<span></span>
</td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balances at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,923)<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,887<span></span>
</td>
<td class="nump">29,792<span></span>
</td>
<td class="num">(2,771)<span></span>
</td>
<td class="num">(37,816)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,606)<span></span>
</td>
<td class="nump">935<span></span>
</td>
<td class="nump">5,857<span></span>
</td>
<td class="nump">30,664<span></span>
</td>
<td class="num">(3,056)<span></span>
</td>
<td class="num">(36,006)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest', window );">Net earnings (losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet', window );">Stock award activity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends declared</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,636)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,636)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchases of common stock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,825)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,825)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balances at Dec. 31, 2022</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (3,923)<span></span>
</td>
<td class="nump">$ 935<span></span>
</td>
<td class="nump">$ 5,887<span></span>
</td>
<td class="nump">$ 29,792<span></span>
</td>
<td class="num">$ (2,771)<span></span>
</td>
<td class="num">$ (37,816)<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Represents the non-cash contribution made by JTIUH to Horizon in 2022 and the purchase of the remaining noncontrolling interest in Helix ROW and Helix in 2020 and 2021, respectively.  For additional information, see Note 1. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634515040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared (USD per share)</a></td>
<td class="nump">$ 0.94<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 3.68<span></span>
</td>
<td class="nump">$ 3.52<span></span>
</td>
<td class="nump">$ 3.40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639784880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Background and Basis of Presentation</a></td>
<td class="text">Background and Basis of Presentation<div style="margin-bottom:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When used in these notes, the terms &#8220;Altria,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to either (i) Altria Group, Inc. and its consolidated subsidiaries or (ii) Altria Group, Inc. only and not its consolidated subsidiaries, as appropriate in the context.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Background:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At December&#160;31, 2022, our wholly owned subsidiaries included Philip Morris USA Inc. (&#8220;PM USA&#8221;), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (&#8220;Middleton&#8221;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA; UST LLC (&#8220;UST&#8221;), which through its wholly owned subsidiary U.S. Smokeless Tobacco Company LLC (&#8220;USSTC&#8221;), is engaged in the manufacture and sale of moist smokeless tobacco products (&#8220;MST&#8221;) and snus products; and Helix Innovations LLC (&#8220;Helix&#8221;), which operates in the United States and Canada, and Helix Innovations GmbH and its affiliates (&#8220;Helix ROW&#8221;), which operate internationally in the rest-of-world, are engaged in the manufacture and sale of oral nicotine pouches.  Other wholly owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to our domestic tobacco operating companies; Altria Client Services LLC (&#8220;ALCS&#8221;), which provides various support services to our companies in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs; and Philip Morris Capital Corporation (&#8220;PMCC&#8221;), which completed the wind-down of its portfolio of finance assets in 2022 and had no finance assets remaining at December&#160;31, 2022.  Our access to the operating cash flows of our wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by our subsidiaries.  At December&#160;31, 2022, our significant wholly owned subsidiaries were not limited by contractual obligations in their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, Altria, through PM USA, entered into a joint venture with JTI (US) Holding, Inc. (&#8220;JTIUH&#8221;), a subsidiary of Japan Tobacco Inc., for the U.S. marketing and commercialization of heated tobacco stick (&#8220;HTS&#8221;) products.  The joint venture entity, Horizon Innovations LLC (&#8220;Horizon&#8221;), is structured to exist in perpetuity and is responsible for the U.S. commercialization of HTS products owned by either party.  PM USA holds a 75% economic interest in Horizon, with JTIUH having a 25% economic interest.  We included the 2022 financial results of Horizon, which were immaterial, in our consolidated financial statements, with the 25% economic interest held by JTIUH reported on our consolidated balance sheet as a noncontrolling interest.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, UST sold its subsidiary, International Wine &amp; Spirits Ltd. (&#8220;IWS&#8221;), which included Ste. Michelle Wine Estates Ltd. (&#8220;Ste. Michelle&#8221;) in an all-cash transaction with a net purchase price of approximately $1.2 billion and the assumption of certain liabilities of IWS and its subsidiaries (the &#8220;Ste. Michelle Transaction&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020 and April 2021, we purchased the remaining 20% interest in (i) Helix ROW and (ii) Helix, respectively.  The total purchase price of the December 2020 and April 2021 transactions was approximately $250 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had investments in the following equity securities: Anheuser-Busch InBev SA/NV (&#8220;ABI&#8221;); Cronos Group Inc. (&#8220;Cronos&#8221;); and JUUL Labs, Inc. (&#8220;JUUL&#8221;).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of our investments in equity securities, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Basis of Presentation:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The consolidated financial statements include Altria, as well as our wholly owned and majority-owned subsidiaries.  We account for our investments in equity securities in which we have the ability to exercise significant influence over the operating and financial policies of the investee, including ABI and Cronos, under the equity method of accounting using a one-quarter lag.  We account for our investment in the equity securities of JUUL at fair value.  All intercompany transactions and balances have been eliminated.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the dates of the financial statements and the reported amounts of net revenues and expenses during the reporting periods.  Significant estimates and assumptions include, among other things, pension and benefit plan assumptions, lives and valuation assumptions for goodwill, other intangible assets and investments in equity securities, marketing programs and income taxes.  Actual results could differ from those estimates.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain immaterial prior year amounts have been reclassified to conform with the current year&#8217;s presentation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022, we adopted Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU No. 2020-06&#8221;).  This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.  Our adoption of ASU No. 2020-06 did not have a material impact on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639538448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Cash and Cash Equivalents:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Cash equivalents include demand deposits with banks and all highly liquid investments with original maturities of three months or less.  We record cash equivalents at cost plus accrued interest, which approximates fair value.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Depreciation, Amortization and Impairment Testing:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record property, plant and equipment at historical costs and depreciate by the straight-line method over the estimated useful lives of the assets.  We depreciate machinery and equipment over periods up to 20 years, and buildings and building improvements over periods up to 50 years.  We amortize definite-lived intangible assets over their estimated useful lives up to 25 years.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying value of the assets may not be fully recoverable.  We perform undiscounted operating cash flow analyses to determine if an impairment exists.  For purposes of recognition and measurement of an impairment for assets held for use, we group assets and liabilities at the lowest level for which cash flows are separately identifiable.  If we determine that an impairment exists, any related impairment loss is calculated based on fair value.  We base impairment losses on assets to be disposed of, if any, on the estimated proceeds to be received, less costs of disposal.  We also review the estimated remaining useful lives of long-lived assets whenever events or changes in business circumstances indicate the lives may have changed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct a required annual review of goodwill and indefinite-lived intangible assets for potential impairment, and more frequently if an event occurs or circumstances change that would require us to perform an interim review.  We have the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit or indefinite-lived intangible asset is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative impairment test.  If necessary, we will perform a single step quantitative impairment test.  Additionally, we have the option to unconditionally bypass the qualitative assessment and perform a single step quantitative assessment.  If the carrying value of a reporting unit that includes goodwill exceeds its fair value, which is determined using discounted cash flows, goodwill is considered impaired.  We measure the amount of impairment loss as the difference between the carrying value and the fair value of a reporting unit; however, the amount of the impairment loss is limited to the total amount of goodwill allocated to a reporting unit.  If the carrying value of an indefinite-lived intangible asset exceeds its fair value, which is determined using discounted cash flows, we consider the intangible asset impaired and reduce the carrying value to fair value in the period identified.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Derivative Financial Instruments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> From time to time, we enter into derivatives to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  We use various types of derivative financial instruments, including forward contracts, options and swaps.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record derivative financial instruments at fair value on the consolidated balance sheets as either assets or liabilities.  We designate derivative financial instruments that qualify for hedge accounting as either fair value hedges, cash flow hedges or net investment hedges at the inception of the contracts.  For fair value hedges, we record changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, in the consolidated statements of earnings each period.  For cash flow hedges, we record changes in the fair value of the derivative each period in accumulated other comprehensive earnings (losses) and reclassify changes to the consolidated statements of earnings in the same periods in which operating results are affected by the respective hedged item.  For net investment hedges, we record changes in the fair value of the derivative or foreign currency transaction gains or losses on a nonderivative hedging instrument in accumulated other comprehensive earnings (losses) to offset the change in the value of the net investment being hedged.  Such amounts remain in accumulated other comprehensive earnings (losses) until the complete or substantially complete liquidation of the underlying foreign operations occurs for investments in foreign entities accounted for under the equity method of accounting.  We classify cash flows from hedging instruments in the same manner as the respective hedged item in the consolidated statements of cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To qualify for hedge accounting, the hedging relationship, both at inception of the hedge and on an ongoing basis, is expected to be highly effective at offsetting changes in the fair value of the hedged risk during the period that the hedge is designated.  We formally designate and document, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective, the strategy for undertaking the hedge transaction and method for assessing hedge effectiveness.  Additionally, for qualified hedges of forecasted transactions, if it becomes probable that a forecasted transaction will not occur, we would no longer consider the hedge effective and would record all of the derivative gains and losses in the consolidated statement of earnings in the current period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial instruments that are not designated as hedging instruments or do not qualify for hedge accounting, we record changes in fair value in the consolidated statement of earnings each period.  We do not enter into or hold derivative financial instruments for trading or speculative purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Employee Benefit Plans:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We provide a range of benefits to certain employees and retired employees, including pension, postretirement health care and postemployment benefits.  We record annual amounts relating to these plans based on calculations specified by GAAP, which include various actuarial assumptions as to discount rates, assumed rates of return on plan assets, mortality, compensation increases, turnover rates and health care cost trend rates.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the funded status of our defined benefit pension and other postretirement plans on the consolidated balance sheets and record as a component of other comprehensive earnings (losses), net of deferred income taxes, the gains or losses and prior service costs or credits that have not been recognized as components of net periodic benefit cost (income).  We subsequently amortize the gains or losses and prior service costs or credits recorded as components of other comprehensive earnings (losses) into net periodic benefit cost (income) in future years.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Environmental Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are subject to laws and regulations relating to the protection of the environment.  We provide for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  We adjust such accruals as new information develops or circumstances change.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with environmental laws and regulations, including the payment of any remediation and compliance costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on our consolidated results of operations, capital expenditures, financial position or cash flows.  See Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Environmental Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Fair Value Measurements:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We measure certain assets and liabilities at fair value.  Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  We use a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).  The three levels of inputs used to measure fair value are:</span></div><div style="margin-top:5pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt">Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt">Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Guarantees:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recognize a liability for the fair value of the obligation of qualifying guarantee activities.  See Note 17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a further discussion of guarantees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Income Taxes:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Significant judgment is required in determining income tax provisions and in evaluating tax positions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine deferred tax assets and liabilities based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.  We record a valuation allowance when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  We determine the realizability of deferred tax assets based on the weight of all available positive and negative evidence.  In reaching this determination, we consider the character of the assets and the possible sources of taxable income of the appropriate character within the available carryback and carryforward periods available under the tax law.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the financial statement benefit for uncertain income tax positions when it is more likely than not, based on the technical merits, that the position will be sustained upon examination by taxing authorities.  The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.  We recognize accrued interest and penalties associated with uncertain tax positions as part of the provision for income taxes in our consolidated statements of earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Inventories:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We use the last-in, first-out (&#8220;LIFO&#8221;) method to determine the cost of substantially all our tobacco inventories.  We determine the cost of the remaining inventories using the first-in, first-out (&#8220;FIFO&#8221;) and average cost methods.  We record inventories that are measured using the LIFO method at the lower of cost or market.  We state inventories that are measured using the FIFO and average cost methods at the lower of cost and net realizable value.  It is a generally recognized industry practice to classify leaf tobacco inventories as a current asset although part of such inventories, because of the duration of the curing and aging process, ordinarily would not be used within one year.  We determined the cost of approximately 79% and 81% of our inventories at December&#160;31, 2022 and 2021, respectively, using the LIFO&#160;method.  The recorded LIFO amounts of our inventories were approximately $0.7 billion and $0.6 billion lower than the current cost of our inventories at December&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Investments in Equity Securities:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Investments in equity securities in which we have the ability to exercise significant influence over the operating and financial policies of the investee are accounted for under the equity method of accounting or the fair value option.  The election of the fair value option is irrevocable and is made on an investment by investment basis.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected to account for our investments in ABI and Cronos under the equity method of accounting.  Our share of equity (income) losses and other adjustments associated with these equity investments are included in (income) losses from investments in equity securities in our consolidated statements of earnings.  We report the carrying value for each of our equity investments in ABI and Cronos in investments in equity securities on our consolidated balance sheets.  We report equity method investments accounted for under the equity method of accounting at cost and adjust these investments each period for our share of (income) losses and dividends paid, if any.  We report our share of ABI&#8217;s and Cronos&#8217;s results using a one-quarter lag because results are not available in time for us to record them in the concurrent period.  At the end of each reporting period, we review our equity investments accounted for under the equity method of accounting for impairment by comparing the fair value of each of our investments to their carrying value.  If the carrying value of an </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">investment exceeds its fair value and the loss in value is other than temporary, we consider the investment impaired, reduce its carrying value to its fair value and record the impairment in our consolidated statements of earnings in the period identified.  We use certain factors to make this determination including (i) the duration and magnitude of the fair value decline, (ii) the financial condition and near-term prospects of the investee and (iii) our intent and ability to hold our investment until recovery to its carrying value.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning September 30, 2022, we account for our investment in JUUL as an investment in an equity security and measure our investment in JUUL at fair value.  Our consolidated statements of earnings include any cash dividends we receive from our investment in JUUL (none received to date) and any changes in the estimated fair value of our investment, which is calculated quarterly.  See Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on how we have historically accounted for our investment in JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Litigation Contingencies and Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We record provisions in our consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  We expense litigation defense costs as incurred and include these costs in marketing, administration and research costs in our consolidated statements of earnings.  See Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Marketing Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our businesses promote their products with consumer incentives, trade promotions and consumer engagement programs.  These consumer incentive and trade promotion activities, which include discounts, coupons, rebates, in-store display incentives and volume-based incentives, do not create a distinct deliverable and are, therefore, recorded as a reduction of revenues.  We make consumer engagement program payments to third parties.  Our businesses expense these consumer engagement programs, which include event marketing, as incurred, and such expenses are included in marketing, administration and research costs in our consolidated statements of earnings.  For interim reporting purposes, our businesses charge consumer engagement programs and certain consumer incentive expenses to operations as a percentage of sales, based on estimated sales and related expenses for the full year.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Revenue Recognition:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our businesses generate substantially all of their revenue from sales contracts with customers.  While our businesses enter into separate sales contracts with each customer for each product type, all sales contracts are similarly structured.  These contracts create an obligation to transfer product to the customer.  Our businesses satisfy all performance obligations within one year; therefore, we expense costs to obtain contracts as incurred and do not disclose unsatisfied performance obligations.  There is no financing component because our businesses expect, at contract inception, that the period between when our businesses transfer product to the customer and when the customer pays for that product will be one year or less.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses define net revenues as revenues, which include excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns (also referred to as returned goods) and sales incentives.  Our businesses exclude from the transaction price sales taxes and value-added taxes imposed at the time of sale.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses recognize revenues from sales contracts with customers upon shipment of goods when control of such products is obtained by the customer.  Our businesses determine that a customer obtains control of the product upon shipment when title of such product and risk of loss transfers to the customer.  Our businesses account for shipping and handling costs as fulfillment costs and such amounts are classified as part of cost of sales in our consolidated statements of earnings.  Our businesses record an allowance for returned goods, based principally on historical volume and return rates, which is included in other accrued liabilities on our consolidated balance sheets.  Our businesses record sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction to revenues (a portion of which is based on amounts estimated as being due to wholesalers, retailers and consumers at the end of a period) based principally on historical volume, utilization and redemption rates.  We include expected payments for sales incentives in accrued marketing liabilities on our consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms vary depending on product type.  Our businesses consider payments received in advance of product shipment as deferred revenue, which we include in other accrued liabilities on our consolidated balance sheets until revenue is recognized.  PM USA receives payment in advance of a customer obtaining control of the product.  USSTC and Helix receive substantially all payments within one business day of the customer obtaining control of the product.  We include amounts due from customers in receivables on our consolidated balance sheets.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">New Accounting Guidance Not Yet Adopted: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, us:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.585%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Standards</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect on Financial Statements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2021-08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2022-03 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634638400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues from Contracts with Customers</a></td>
<td class="text">Revenues from Contracts with Customers<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate net revenues based on product type.  For further discussion, see Note 14. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate substantially all cash discounts, offered to customers for prompt payment, as a flat rate per unit based on agreed-upon payment terms.  Prior to the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a percentage of the list price based on historical experience and agreed-upon payment terms.  We record receivables net of the cash discounts on our consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record payments received by our businesses in advance of product shipment as deferred revenue.  These payments are included in other accrued liabilities on our consolidated balance sheets until control of such products is obtained by the customer.  Deferred revenue from contracts with customers was $252 million and $287 million at December&#160;31, 2022 and 2021, respectively.  When cash is received in advance of product shipment, our companies satisfy their performance obligations within three days of receiving payment.  At December&#160;31, 2022 and 2021, there were no differences between amounts recorded as deferred revenue from contracts with customers and amounts subsequently recognized as revenue.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables (excluding receivable from the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System commercialization rights) were $48 million and $47 million at December&#160;31, 2022 and 2021, respectively.  At December&#160;31, 2022 and 2021, there were no expected differences between amounts recorded and subsequently received, and we did not record an allowance for credit losses against these receivables.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record an allowance for returned goods, which is included in other accrued liabilities on our consolidated balance sheets.  It is USSTC&#8217;s policy to accept authorized sales returns from its customers for products that have passed the freshness date printed on product packaging due to the limited shelf life of USSTC&#8217;s MST and snus products.  We record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  We reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on our consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, we do not record an asset for USSTC&#8217;s right to recover goods from customers upon return.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales incentives include variable payments related to goods sold by our businesses.  We include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers.  The sales incentives that require significant estimates and judgments are as follows:</span></div><div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Price promotion payments- </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make price promotion payments, substantially all of which are made to our retail partners to incent the promotion of certain product offerings in select geographic areas.</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Wholesale and retail participation payments-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We make payments to our wholesale and retail partners to incent merchandising and sharing of sales data in accordance with our trade agreements.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates.  Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions.  Differences between actual and estimated payments are reflected in the period such information becomes available.  These differences, if any, have not had a material impact on our consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639693568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets, net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets, net</a></td>
<td class="text">Goodwill and Other Intangible Assets, net<div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other intangible assets, net, were as follows at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.453%"><tr><td style="width:1.0%"/><td style="width:32.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.486%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.486%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.486%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Intangible Assets, net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,989</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products segment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,078</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,097</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">298</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,384</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,306&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consisted of the following at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:37.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived intangible assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,411</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">470</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,854</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">470</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, substantially all of our indefinite-lived intangible assets consisted of (i) MST and snus trademarks of $8.8 billion, which consists of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Copenhagen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Skoal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and other MST and snus trademarks of $4.0 billion, $3.9 billion and $0.9 billion, respectively, and (ii) cigar trademarks of $2.6 billion from our 2009 acquisition of UST and 2007 acquisition of Middleton, respectively.  Definite-lived intangible assets, which consist primarily of intellectual property, certain cigarette trademarks and customer relationships, are amortized over a weighted-average period of 20 years.  Pre-tax amortization expense for definite-lived intangible assets during the years ended December&#160;31, 2022, 2021 and 2020, was $73 million, $72 million and $72 million, respectively.  Annual amortization expense for each of the next five years is estimated to be approximately $75 million, assuming no additional transactions occur that require the amortization of intangible assets.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, ALCS and Altria (solely with respect to certain provisions thereunder) entered into an agreement with Triaga, Inc. (&#8220;Triaga&#8221;), a subsidiary of Philip Morris International Inc. (&#8220;PMI&#8221;), and PMI (solely with respect to certain provisions thereunder), to, among other things, transition and ultimately conclude our relationship with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Tobacco Heating System</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System&#8221;) in the United States.  Under the terms of the agreement, Triaga paid ALCS $1.0 billion upon entry into the agreement and is obligated to make an additional payment of $1.7 billion (plus interest thereon from the effective date of October 19, 2022 at a per annum rate equal to 6%) to ALCS by July 15, 2023, for a total cash payment of approximately $2.7 billion (plus interest).  For the consideration received, ALCS has agreed to assign to Triaga exclusive U.S. commercialization rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System effective April 30, 2024.  PMI will not have access to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand name or other brand assets, as PM USA owns the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> trademark in the United States.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the agreement, we recorded (i) a pre-tax $2.7 billion deferred gain, which we expect to recognize in earnings when we relinquish our rights to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System, (ii) a $1.7 billion receivable and (iii) a $21 million interest receivable on our consolidated balance sheet at December&#160;31, 2022.  For the year ended December&#160;31, 2022, we recorded $21 million of interest income in our consolidated statement of earnings.  For the year ended December 31, 2022, we recorded $1.0 billion in cash received upon entry into the agreement.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in goodwill and net carrying amount of intangible assets were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:37.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Intangible Assets, net</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Intangible Assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes due to:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.51pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dispositions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,384</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,306&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisitions of certain intellectual property related to other tobacco products, which included a $50 million non-cash contribution made by JTIUH to Horizon.  For additional information regarding Horizon, see Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Dispositions related to the Ste. Michelle Transaction.  See Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021 and 2020, our annual impairment test of goodwill and indefinite-lived intangible assets resulted in no impairment charges.  At December 31, 2022 and 2021, there were no accumulated impairment losses related to goodwill.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634511520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTextBlock', window );">Investments in Equity Securities</a></td>
<td class="text">Investments in Equity Securities<div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of our investments consisted of the following at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.981%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.984%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,975</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">375</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,600</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,481&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investment in Cronos at December&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">consisted of our equity method investment in Cronos of $617 million and also included the Cronos warrant and the Fixed-price Preemptive Rights (collectively, &#8220;Investment in Cronos&#8221;), which were measured at fair value.  We irrevocably abandoned the Cronos warrant on December 15, 2022, and the Fixed-price Preemptive Rights had no value at December&#160;31, 2022.  See below for further discussion.</span></div><div style="margin-bottom:5pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Income) losses from investments in equity securities consisted of the following:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.036%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.068%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,973</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments under equity method of accounting</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,186</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments in equity securities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,641</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,979&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes our share of amounts recorded by our investees and additional adjustments, if required, related to (i) the conversion from international financial reporting standards to GAAP and (ii) adjustments to our investment required under the equity method of accounting.</span></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Investment in JUUL is accounted for as an investment in an equity security measured at fair value.  See below for further discussion.</span></div><div style="margin-bottom:5pt;margin-top:8pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investees&#8217; summarized financial data for our equity method investments was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For Altria&#8217;s Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">947</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31,588</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">525</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,653&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,438&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,879</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(521)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,434&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,879</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(521)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,434&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,266&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to equity investments</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,838</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(520)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,780&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(798)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,323&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,164</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">963</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182,087</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">274</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,082&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32,649</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,540&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96,497</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,973&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,277&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Preferred Stock</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></div></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,356&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reflects a one-quarter lag.  Other Investments reflect summarized financial data of Cronos, as well as JUUL&#8217;s financial data for the periods during which we accounted for our investment in JUUL as an equity method investment under the fair value option.</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in ABI&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:3pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had an approximate 10.0% ownership interest in ABI, consisting of 185 million restricted shares of ABI (the &#8220;Restricted Shares&#8221;) and 12 million ordinary shares of ABI.  The Restricted Shares:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">are unlisted and not admitted to trading on any stock exchange;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">are convertible by us into ordinary shares of ABI on a one-for-one basis;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">rank equally with ordinary shares of ABI with regards to dividends and voting rights; and</span></div><div style="padding-left:36pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt">have director nomination rights with respect to ABI.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of this filing, we have not elected to convert our Restricted Shares into ordinary shares of ABI.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our investment in ABI under the equity method of accounting because we have the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#8217;s board of directors and certain ABI board committees.  Through this representation, we participate in ABI&#8217;s policy making processes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report our share of ABI&#8217;s results using a one-quarter lag because ABI&#8217;s results are not available in time for us to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  We can convert our Restricted Shares to ordinary shares at our discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, the fair value of our equity investment in ABI was $11.9 billion (carrying value of $11.1 billion), which exceeded its carrying value by $0.8 billion or approximately 7%.  In the second quarter of 2022, the fair value declined below its carrying value and at June 30, 2022, the fair value was below its carrying value by $1.1 billion or approximately 9%.  We concluded that the decline in fair value below its carrying value was temporary and, therefore, we did not record an impairment charge at that time.  At September 30, 2022, the fair value of our equity investment in ABI of $9.0 billion was below its carrying value by $2.5 billion or approximately 22%.  We concluded that the decline in fair value at September 30, 2022 was other than temporary as we anticipated that the full recovery to the carrying value would take longer than previously expected.  In reaching this conclusion, we evaluated the factors related to the fair value decline, including the macroeconomic and geopolitical factors that have significantly impacted certain foreign exchange rates and global equity markets.  As a result of our conclusion, we recorded a non-cash, pre-tax impairment charge of </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.5&#160;billion during the third quarter of 2022, which was recorded to (income) losses from investments in equity securities in our consolidated statements of earnings.  This impairment charge reflected the difference between the fair value of our equity investment in ABI using ABI&#8217;s share price and the Euro to U.S dollar exchange rate at September 30, 2022 and the carrying value of our equity investment in ABI at September 30, 2022.  After recording the impairment charge, each of the fair value and carrying value at September 30, 2022 was $9.0 billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the fair value of our equity investment in ABI was $11.9 billion (carrying value of $9.0 billion), which exceeded its carrying value by approximately 33%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At September 30, 2021, the fair value of our equity investment in ABI of $11.2 billion declined below its carrying value by $6.2 billion or approximately 35%.  We concluded that the decline in fair value at September 30, 2021 was other than temporary.  As a result of our conclusion, we recorded a non-cash, pre-tax impairment charge of $6.2 billion during the third quarter of 2021, which was recorded to (income) losses from investments in equity securities in our consolidated statements of earnings.  After recording the impairment charge, each of the fair value and carrying value at September 30, 2021 was $11.2 billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, the carrying value of our equity investment in ABI exceeded its share of ABI&#8217;s net assets attributable to equity holders of ABI by approximately $2.5 billion.  Substantially all of this difference is comprised of goodwill and other indefinite-lived intangible assets (consisting primarily of trademarks).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in JUUL</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2018, we made an investment in JUUL for $12.8 billion and received a 35% economic interest in JUUL through non-voting shares, which we converted at our election into voting shares in November 2020 (&#8220;Share Conversion&#8221;), and a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the &#8220;JUUL Transaction&#8221;).  At December&#160;31, 2022, we had a 35% economic ownership interest in JUUL, consisting of 42 million voting shares.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a standstill restriction under which we may not acquire additional JUUL shares above our 35% interest and may not sell or transfer any of our JUUL shares until December 20, 2024.  Furthermore, at the time of the investment, we agreed to non-competition obligations generally requiring that we participate in the e-vapor business only through JUUL.  In January 2020, we amended certain JUUL Transaction agreements and entered into a new cooperation agreement.  One of the provisions in the amendments was the option to be released from our non-compete obligation under certain circumstances, including if the carrying value of our investment in JUUL was not more than 10% of its initial carrying value of $12.8 billion.  At June 30, 2022, the carrying value of our investment in JUUL was $450&#160;million, which was less than 10% of our initial carrying value of $12.8&#160;billion.  As a result, in September 2022, we exercised our option to be released from our JUUL non-competition obligations, resulting in (i) the permanent termination of our non-competition obligations to JUUL, (ii) the loss of our JUUL board designation rights (other than the right to designate one independent director so long as our ownership continues to be at least 10%), our preemptive rights, our consent rights and certain other rights with respect to our investment in JUUL and (iii) the conversion of our JUUL shares to single vote common stock, significantly reducing our voting power.  We do not currently intend to exercise our remaining governance rights or to vote our JUUL shares other than as a passive investor.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, as part of the amendment to certain JUUL Transaction agreements in January 2020, we agreed not to pursue any claims against JUUL for indemnification or reimbursement except for any non-contractual claims for contribution or indemnity where a judgment has been entered against us and JUUL with respect to certain litigation in which we and JUUL are both defendants against third-party plaintiffs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the U.S. Federal Trade Commission (&#8220;FTC&#8221;) issued an administrative complaint challenging our investment in JUUL.  In February 2022, the administrative law judge dismissed the FTC&#8217;s complaint.  FTC complaint counsel appealed that decision to the FTC, which appeal remains pending.  For further discussion, see Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies -&#160;Antitrust Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) issued marketing denial orders (&#8220;MDOs&#8221;) to JUUL ordering all of JUUL&#8217;s products currently marketed in the United States off the market.  In July 2022, the FDA administratively stayed the MDOs on a temporary basis, citing its determination that there are scientific issues unique to the JUUL PMTAs that warrant additional review.  This administrative stay temporarily suspends the MDOs and JUUL&#8217;s products remain on the market.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following Share Conversion in the fourth quarter of 2020, we elected to account for our equity method investment in JUUL under the fair value option.  In making this election, we believed measuring our investment at fair value provided quarterly transparency to investors as to the fair market value of our investment in JUUL, given the changes and volatility in the e-vapor category since our initial investment, as well as the lack of publicly available information regarding JUUL&#8217;s business or a market-derived valuation.  As a result of our loss of certain rights due to our exercise of our option to be released from our JUUL non-competition obligations in the third quarter of 2022, we determined that we no longer have the ability to exercise significant influence over the operating and financial policies of JUUL.  Therefore, we are no longer able to account for our investment in JUUL as an equity method investment.  Beginning with the period ended September 30, 2022, we account for our investment in JUUL as an investment in an equity security.  We will continue to measure our investment in JUUL at fair value, in accordance with GAAP.  Our consolidated statements of earnings include </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any cash dividends received from our investment in JUUL (none received to date) and any changes in the estimated fair value of our investment, which is calculated quarterly.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of our investment in JUUL, which is classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.774%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.343%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment Balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in (income) losses from investments in equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in (income) losses from investments in equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to Share Conversion, we accounted for our investment in JUUL as an investment in an equity security.  Since the JUUL shares do not have a readily determinable fair value, we elected to measure our investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There were no upward or downward adjustments to the carrying value of our investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through the date of Share Conversion.  In addition, prior to Share Conversion, we reviewed our investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of our financial statements.  If this qualitative assessment indicated that our investment in JUUL may be impaired, a quantitative assessment was performed.  If the quantitative assessment indicated the estimated fair value of the investment was less than its carrying value, the investment was written down to its estimated fair value.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Financial Activity</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">For the year ended December&#160;31, 2022, we recorded non-cash, pre-tax unrealized losses of $1,455 million as a result of changes in the estimated fair value of our investment in JUUL.  The decrease in the estimated fair value was primarily driven by (i) a decrease in the likelihood of a favorable outcome from the FDA for JUUL&#8217;s products that are currently marketed in the United States, which have received MDOs and are now under additional administrative review, (ii) a decrease in the likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, which could result in JUUL seeking protection under bankruptcy or other insolvency laws, (iii) projections of higher operating expenses resulting in lower long-term operating margins, (iv) projections of lower JUUL revenues in the United States over time due to lower JUUL volume assumptions and (v) an increase in the discount rate due to changes in market factors, partially offset by the effect of passage of time on the projected cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2021 Financial Activity</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">For the year ended December 31, 2021, we recorded no change in the estimated fair value of our investment in JUUL.  During the year ended December 31, 2021, the estimated fair value was primarily impacted by our projections of lower JUUL revenues in the United States over time due to lower JUUL volume assumptions offset by (i) the effect of passage of time on the projected cash flows and (ii) a decrease in the discount rate due to changes in market factors.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2020 Financial Activity</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">We recorded a non-cash pre-tax unrealized gain of $100 million for the fourth quarter and year ended December 31, 2020 as a result of an increase in the estimated fair value of our investment in JUUL.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">In September 2020, JUUL announced a strategic update, which included its plans for a significant global workforce reduction, its evaluation of its resource allocation and the possibility of exiting various international markets.  As part of the preparation of our financial statements for the period ended September 30, 2020, we performed a qualitative assessment of impairment indicators for our investment in JUUL and determined that JUUL&#8217;s strategic update was an indicator of impairment at September 30, 2020, given the significant deterioration in JUUL&#8217;s business prospects.</span></div><div style="margin-bottom:5pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given the existence of this impairment indicator, we performed a quantitative valuation of our investment in JUUL during the third quarter of 2020 and recorded a non-cash, pre-tax impairment charge of $2.6 billion for the year ended December 31, 2020, reported as impairment of JUUL equity securities in our consolidated statements of earnings.  The impairment charge was driven by our projections of lower JUUL revenues over time due to lower pricing assumptions and delays in JUUL achieving previously forecasted operating margin performance.  These drivers were the result of (i) JUUL&#8217;s revised international expansion plans and (ii) the evolving U.S. e-vapor category and associated competitive dynamics.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use an income approach to estimate the fair value of our investment in JUUL.  The income approach reflects the discounting of future cash flows for the U.S. and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.</span></div>In determining the estimated fair value of our investment in JUUL, in 2022, 2021 and 2020, we made certain judgments, estimates and assumptions, the most significant of which were likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, we made judgments regarding the (i) likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#8217;s products, which have received MDOs and are now under additional administrative review; (ii) likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, the absence of which could result in JUUL seeking protection under bankruptcy or other insolvency laws; (iii) risk created by the number and types of legal cases pending against JUUL; (iv) expectations for the future state of the e-vapor category, including competitive dynamics; and (v) timing of international expansion plans.  Due to these uncertainties, our future cash flow projections of JUUL are based on a range of scenarios that consider certain potential regulatory, liquidity and market outcomes.<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment in Cronos</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had a 41.1% ownership interest in Cronos, consisting of 156.6 million shares, which we account for under the equity method of accounting.  Our ownership percentage decreased from 41.8% at December&#160;31, 2021 due to the issuance of additional shares by Cronos.  We report our share of Cronos&#8217;s results using a one-quarter lag because Cronos&#8217;s results are not available in time for us to record them in the concurrent period.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2021, each of the fair value and carrying value of our equity method investment in Cronos was $617 million.  In the second quarter of 2022, the fair value of our equity method investment in Cronos declined below its carrying value and had not recovered as of June 30, 2022.  At June 30, 2022, the fair value was less than its carrying value by approximately 20%.  We concluded that the decline in fair value was other than temporary.  As a result, we recorded a non-cash, pre-tax impairment charge of $107 million in the second quarter of 2022, which was recorded to (income) losses from investments in equity securities in our consolidated statements of earnings.  The impairment charge reflects the difference between the fair value of our equity method investment in Cronos using Cronos&#8217;s share price and the Canadian dollar (&#8220;CAD&#8221;) to U.S. dollar exchange rate at June 30, 2022 and the carrying value of our equity method investment in Cronos at June 30, 2022.  After recording the impairment charge, each of the fair value and carrying value at June 30, 2022 was $437 million.  At December&#160;31, 2022, the fair value of our equity method investment in Cronos exceeded its carrying value by $22 million or approximately 6%.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2021, the fair value of our equity method investment in Cronos was less than its carrying value by approximately 25%.  We concluded that the decline in fair value at December 31, 2021 was other than temporary.  As a result, we recorded a non-cash, pre-tax impairment charge of $205&#160;million for the year ended December 31, 2021, which was recorded to (income) losses from investments in equity securities in our consolidated statement of earnings.  After recording the impairment charge, each of the fair value and carrying value at December 31, 2021 was $617&#160;million.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our Investment in Cronos, at December&#160;31, 2022, we also owned anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain our ownership percentage.  Certain of the anti-dilution protections provide us the ability to purchase additional Cronos common shares at a per share exercise price of CAD $16.25 upon the occurrence of specified events (&#8220;Fixed-price Preemptive Rights&#8221;).  Based on our assumptions as of December&#160;31, 2022, we estimate the Fixed-price Preemptive Rights allows us to purchase up to an additional approximately 7 million common shares of Cronos.  Prior to December 15, 2022, we also owned a warrant providing us the ability to purchase an additional approximate 10% of common shares of Cronos at a per share exercise price of CAD $19.00, which would have expired on March 8, 2023.  On December 15, 2022, we irrevocably abandoned the Cronos warrant, and we no longer owned the warrant as of December 31, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Fixed-price Preemptive Rights are derivative financial instruments, which are required to be recorded at fair value and are classified in Level 3 of the fair value hierarchy.  Prior to irrevocably abandoning the Cronos warrant on December 15, 2022, the Cronos warrant was also a derivative financial instrument recorded at fair value.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record in our consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur.  We recorded non-cash, pre-tax unrealized losses, representing these changes, as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.353%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.295%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI https://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI https://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634562784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text">Financial Instruments<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  We use various types of derivative financial instruments, including forward contracts, options and swaps.  We do not enter into or hold derivative financial instruments for trading or speculative purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment in ABI, whose functional currency is the Euro, exposes us to foreign currency exchange risk on the carrying value of our investment.  To manage this risk, we may designate certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively, &#8220;foreign currency contracts&#8221;), and Euro denominated unsecured long-term notes (&#8220;foreign currency denominated debt&#8221;) as net investment hedges of our investment in ABI.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, all outstanding foreign currency contracts matured and, at December 31, 2022 and 2021, we had no outstanding foreign currency contracts.  When we have foreign currency contracts in effect, counterparties are domestic and international financial institutions.  Under these contracts, we are exposed to potential losses in the event of non-performance by these counterparties.  We manage our credit risk by entering into transactions with counterparties that have investment grade credit ratings, limiting the amount of exposure we have with each counterparty and monitoring the financial condition of each counterparty.  The counterparty agreements contain provisions that require us to maintain an investment grade credit rating.  In the event our credit rating falls below investment grade, counterparties to our foreign currency contracts can require us to post collateral.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying value and fair value of our total long-term debt were as follows at December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.294%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,928</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt included in long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,540</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,114&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimate of the fair value of our total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in the fair value of our long-term debt was primarily driven by (i) rising interest rates in 2022, (ii) the August 2022 $1.1 billion repayment at maturity of senior unsecured notes and (iii) changes in Euro denominated debt resulting from the strengthening of the U.S. dollar versus the Euro during 2022.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net Investment Hedging</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effects of our net investment hedges on accumulated other comprehensive losses and our consolidated statements of earnings were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized <br/>in Net Earnings</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(281)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to U.S. dollar exchange rate in accumulated other comprehensive losses related to ABI.  We recognized gains on the foreign currency contracts arising from components excluded from effectiveness testing in interest and other debt expense, net in our consolidated statements of earnings based on an amortization approach.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863637907408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Borrowings and Borrowing Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">Short-Term Borrowings and Borrowing Arrangements</a></td>
<td class="text">Short-Term Borrowings and Borrowing Arrangements<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, we had no short-term borrowings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, we entered into an extension and amendment (the &#8220;Extension and Amendment&#8221;) to our $3.0 billion senior unsecured 5-year revolving credit agreement (as amended, the &#8220;Credit Agreement&#8221;).  The Extension and Amendment (i) extended the maturity date of the Credit Agreement from August 1, 2024 to August 1, 2025 and (ii) amended the Credit Agreement to update the benchmark interest rate to a rate based on the Term Secured Overnight Financing Rate (&#8220;Term SOFR&#8221;) and make certain other market updates.  All </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other terms and conditions of the Credit Agreement remain in full force and effect.  The Credit Agreement is used for general corporate purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022 and 2021, we had availability under the Credit Agreement for borrowings of up to an aggregate principal amount of $3.0 billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of our long-term senior unsecured debt.  We expect interest rates on borrowings under the Credit Agreement to be based on the Term SOFR plus a percentage based on the higher of the ratings of our long-term senior unsecured debt from Moody&#8217;s Investors Service, Inc. (&#8220;Moody&#8217;s&#8221;) and Standard&#160;&amp; Poor&#8217;s Financial Services LLC (&#8220;S&amp;P&#8221;).  The applicable percentage for borrowings under the Credit Agreement at December&#160;31, 2022 was 1.0% based on our long-term senior unsecured debt ratings on that date.  The Credit Agreement does not include any other rating triggers or any provisions that could require the posting of collateral.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement includes various covenants, one of which requires us to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (&#8220;EBITDA&#8221;) to Consolidated Interest Expense of not less than 4.0 to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis.  At December&#160;31, 2022, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was 11.0 to 1.0.  At December&#160;31, 2022, we were in compliance with our covenants in the Credit Agreement.  The terms &#8220;Consolidated EBITDA&#8221; and &#8220;Consolidated Interest Expense,&#8221; each as defined in the Credit Agreement, include certain adjustments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, due to the uncertainty at that time in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, we elected to borrow the full $3.0 billion available under the Credit Agreement as a precautionary measure to increase our cash position and preserve financial flexibility.  In June 2020, we repaid the full amount outstanding under the Credit Agreement using the net proceeds from the issuance of long-term senior unsecured notes issued in May 2020 and available cash.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any commercial paper issued by us and borrowings under the Credit Agreement are guaranteed by PM&#160;USA as further discussed in Note 8. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863641028256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term debt consisted of the following at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"/><td style="width:72.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes, 2.350% to 10.20%, interest payable semi-annually, due through 2061</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,098</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD debenture, 7.75%, interest payable semi-annually, due 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes, 1.000% to 3.125%, interest payable annually, due through 2031 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,540</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,044&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,556</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,124</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,939&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average coupon interest rate of and 4.4% at December&#160;31, 2022 and 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Weighted-average coupon interest rate of 2.0% at December&#160;31, 2022 and 2021.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, our outstanding long-term debt consisted of the following:</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.071%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8364;1,250</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.000%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$218</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.950%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$776</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.000%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2013</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$345</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.800%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$750</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.350%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8364;750</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.700%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,069</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.400%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2026</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$500</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.625%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD debenture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$42</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.750%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1997</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2027</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8364;1,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.200%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,906</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.800%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2029</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$750</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.400%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2030</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8364;1,250</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.125%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2031</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,750</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.450%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2032</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$177</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.950%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2008</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2038</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$208</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.200%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2009</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2039</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.800%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2039</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,500</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.400%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2041</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$900</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.250%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2012</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2042</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$650</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.500%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2043</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,800</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2013</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2044</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,500</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.875%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2046</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,500</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.950%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2049</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$500</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.450%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2050</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,250</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.700%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2051</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$271</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.200%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2059</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,000</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.000%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2061</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, aggregate maturities of our long-term debt were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.501%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.518%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Maturities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,556</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,121</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,553</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,569</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,912</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">84</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, accrued interest on long-term debt of $411 million and $429 million, respectively, was included in other accrued liabilities on our consolidated balance sheets.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, we repaid in full our 2.850% senior unsecured notes in the aggregate principal amount of $1.1 billion at maturity.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our notes are senior unsecured obligations and rank equally in right of payment with all of our existing and future senior unsecured indebtedness.  Following the occurrence of both (i) a change of control of Altria and (ii) the notes ceasing to be rated investment grade by each of Moody&#8217;s, S&amp;P and Fitch Ratings Inc., we will be required to make an offer to purchase the notes at a price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest to the date of repurchase as and to the extent set forth in the terms of the notes.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Debt Tender Offers and Redemption: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we completed debt tender offers to purchase for cash certain of our long-term senior unsecured notes in an aggregate principal amount of $4,042 million.  Details of the debt tender offers were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal Amount of Notes Purchased</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.850% Notes due 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">795</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.950% Notes due 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000% Notes due 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">624</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.800% Notes due 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">655</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.400% Notes due 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">430</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.800% Notes due 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,094</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.950% Notes due 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.200% Notes due 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.200% Notes due 2059</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,042</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2021, we also redeemed all of our outstanding 3.490% senior unsecured notes due to mature in 2022 in the aggregate principal amount of $1.0 billion.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the debt tender offers and redemption, during the first quarter of 2021, we recorded pre-tax losses on early extinguishment of debt of $649 million, which included premiums and fees of $623 million and the write-off of unamortized debt discounts and debt issuance costs of $26 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA (the &#8220;Guarantor&#8221;), which is a 100% owned subsidiary of Altria Group, Inc. (the &#8220;Parent&#8221;), has guaranteed the Parent&#8217;s obligations under its outstanding debt securities, borrowings under its Credit Agreement and amounts outstanding under its&#160;commercial paper program (the &#8220;Guarantees&#8221;).  Pursuant to&#160;the Guarantees, the Guarantor fully and unconditionally guarantees, as primary obligor, the payment and performance of the Parent&#8217;s obligations under the guaranteed debt instruments (the &#8220;Obligations&#8221;), subject to release under certain customary circumstances as noted below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Guarantees provide that the Guarantor guarantees the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations.  The liability of the Guarantor under the Guarantees is absolute and unconditional irrespective of: any lack of validity, enforceability or genuineness of any provision of any agreement or instrument relating thereto; any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to departure from any agreement or instrument relating thereto; any exchange, release or non-perfection of any collateral, or any release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Obligations; or any other circumstance that might otherwise constitute a defense available to, or a discharge of, the Parent or the Guarantor.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Parent is a holding company; therefore, its access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  Neither the Guarantor nor other 100% owned subsidiaries of the Parent that are not guarantors of the Obligations are limited by contractual obligations on their ability to pay cash dividends or make other distributions with respect to their equity interests.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of the fair value of our long-term debt and the designation of our Euro denominated senior unsecured notes as a net investment hedge of our investment in ABI, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863641024080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Stock</a></td>
<td class="text">Capital Stock<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had 12 billion shares of authorized common stock; issued, repurchased and outstanding shares of common stock consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"/><td style="width:48.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.315%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.315%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.320%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Repurchased</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Outstanding</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805,961,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(947,979,763)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857,981,554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805,961,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(947,542,152)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858,419,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,656,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,656,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805,961,317&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(982,785,699)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,823,175,618&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">514,816</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">514,816</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(38,156,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(38,156,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,805,961,317</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,020,427,195)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,785,534,122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had 26,698,134 shares of common stock reserved for stock-based awards under our stock plans.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had 10 million authorized shares of serial preferred stock, $1.00 par value; no shares of serial preferred stock have been issued.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Dividends: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the third quarter of 2022, our Board of Directors (&#8220;Board of Directors&#8221; or &#8220;Board&#8221;) approved a 4.4% increase in the quarterly dividend rate to $0.94 per share of our common stock versus the previous rate of $0.90 per share.  The current annualized dividend rate is $3.76 per share.  Future dividend payments remain subject to the discretion of our Board.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Share Repurchases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, our Board of Directors authorized a $2.0 billion share repurchase program that it expanded to $3.5 billion in October 2021 (as expanded, the &#8220;January 2021 share repurchase program&#8221;).  We completed the January 2021 share repurchase program in December 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2023, our Board of Directors authorized a new $1.0 billion share repurchase program.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of our Board.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total share repurchase activity was as follows for the years ending December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.003%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.346%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.563%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 2021 Share Repurchase Program</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost of shares repurchased</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share of shares repurchased</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.83</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.97&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.42&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any shares in 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863637766176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Plans</a></td>
<td class="text">Stock Plans<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our Board of Directors adopted, and shareholders approved, the Altria Group, Inc. 2020 Performance Incentive Plan (the &#8220;2020 Plan&#8221;) under which we may grant stock options, stock appreciation rights, restricted stock, restricted stock units (&#8220;RSUs&#8221;), performance stock units (&#8220;PSUs&#8221;) and other stock-based awards, as well as cash-based annual and long-term incentive awards to our employees.  Any awards granted under the 2020 Plan may be in the form of performance-based awards, including PSUs subject to the achievement or satisfaction of performance goals and performance cycles.  We may issue up to 25 million shares of common stock under the 2020 Plan.  In addition, under the 2015 Stock Compensation Plan for Non-Employee Directors (the &#8220;Directors Plan&#8221;), we may grant up to one million shares of common stock to members of the Board of Directors who are not employees of Altria.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had 21,972,920 and 650,121 shares available to be granted under the 2020 Plan and the Directors Plan, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">RSUs: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the vesting period, RSUs include nonforfeitable rights to dividend equivalents and may not be sold, assigned, pledged or otherwise encumbered.  RSUs are subject to forfeiture if certain employment conditions are not met.  We estimate the number of awards expected to be forfeited and adjust this estimate when subsequent information indicates that the actual number of forfeitures is likely to differ from previous estimates.  RSUs generally vest three years after the grant date.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We amortize to expense ratably over the restriction period, which is generally three years, the fair value of the RSUs at the date of grant, net of estimated forfeitures.  We recorded pre-tax compensation expense related to RSUs for the years ended December&#160;31, 2022, 2021 and 2020 of $41 million, $34 million and $31 million, respectively.  We recorded a deferred tax benefit related to this compensation expense of $10 million, $9 million and $8 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively.  The unamortized compensation expense related to RSUs was $73 million at December&#160;31, 2022, which we expect to be recognized over a weighted-average period of approximately two years.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.878%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.069%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,702,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,206,601</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">49.22</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(556,399)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51.96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(94,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,257,795</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.90</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of RSUs granted during the years ended December&#160;31, 2022, 2021 and 2020 was $59&#160;million, $48 million and $49 million, respectively, or $49.22, $45.22 and $42.59 per RSU, respectively.  The total vesting date fair value of RSUs that vested during the years ended December&#160;31, 2022, 2021 and 2020 was $29 million, $19 million and $25 million, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">PSUs: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We granted an aggregate of 215,205, 229,494 and 275,288 of PSUs during 2022, 2021 and 2020, respectively.  The payout of the PSUs is based on the extent to which we achieve certain performance measures over the three-year performance period.  Performance measures consist of our adjusted diluted earnings per share compounded annual growth rate and a cash conversion measure.  Additionally, the payout resulting from the performance measures is then adjusted up or down by a total shareholder return (&#8220;TSR&#8221;) performance multiplier, which depends on our relative TSR to a predetermined peer group.  PSUs are subject to forfeiture if certain employment conditions are not met.  At December&#160;31, 2022, we had 628,693 PSUs outstanding, with a weighted-average grant date fair value of $47.62 per PSU.  We amortize to expense over the performance period the fair value of PSUs at the date of grant, net of estimated forfeitures.  We recorded pre-tax compensation expense related to PSUs for the years ended December&#160;31, 2022, 2021 and 2020 of $9 million, $6&#160;million and $4&#160;million, respectively.  The unamortized compensation expense related to PSUs was $13 million at December 31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863641022688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings per Share</a></td>
<td class="text">Earnings per Share<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculated basic and diluted earnings per share (&#8220;EPS&#8221;) using the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:64.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.858%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.858%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.863%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Altria</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,764</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributed and undistributed earnings attributable to share-based awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings for basic and diluted EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic EPS</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,804</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: contingently issuable PSUs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for diluted EPS</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,804</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863641018512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Other Comprehensive Earnings/Losses</a></td>
<td class="text">Other Comprehensive Earnings/Losses<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.938%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments<br/>and Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,192)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,864)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(454)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,613)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(339)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,261)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,604)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of </span></div><div style="padding-left:38.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,420)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,938)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,341)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,227&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of </span></div><div style="padding-left:38.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,612)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,056)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">145</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(33)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">387</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">210</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(33)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">88</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of </span></div><div style="padding-left:38.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">deferred income taxes </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(67)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">143</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">285</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,436)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,369)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2,771)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Primarily reflected our share of ABI&#8217;s currency translation adjustments and the impact of our designated net investment hedges related to our equity investment in ABI.  For further discussion of designated net investment hedges, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:61.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.991%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.306%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.306%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.727%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts were included in net defined benefit plan costs.  For further details, see Note 15. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts were included in (income) losses from investments in equity securities.  For further information, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 amounts were included in marketing, administration and research costs and are related to the Ste. Michelle Transaction.  For further details, see Note 15. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863637929824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, the U.S. Government enacted legislation commonly referred to as the Inflation Reduction Act.  The main provisions of the Inflation Reduction Act that we anticipate may impact us are (i) a 15% corporate alternative minimum tax (&#8220;Corporate AMT&#8221;) and (ii) a 1% excise tax on share repurchases, which we expect to record in equity on our consolidated statements of stockholders&#8217; equity (deficit), in each case effective for tax years beginning after December 31, 2022.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be considered an &#8220;applicable corporation&#8221; for purposes of the new Corporate AMT.  Our regular federal income tax liability will generally exceed our Corporate AMT liability.  Certain unique circumstances, however, may result in a Corporate AMT liability, including when tax losses are reported in a different year than book losses.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (losses) before income taxes and provision (benefit) for income taxes consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.562%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,628</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,890&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,968</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,572</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,509&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(947)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,160)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,625</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our U.S. subsidiaries join in the filing of a U.S. federal consolidated income tax return.  The U.S. federal income tax statute of limitations remains open for the year 2017 and forward, with years 2017 through 2020 currently under examination by the Internal Revenue Service (&#8220;IRS&#8221;) as part of an audit conducted in the ordinary course of business.  State statutes of limitations generally remain open for the year 2017 and forward.  Certain of our state tax returns are currently under examination by various states as part of routine audits conducted in the ordinary course of business.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.562%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions due to lapse of statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at December&#160;31, 2022 was $44 million, along with $25 million affecting deferred taxes.  The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at December&#160;31, 2021 was $31 million, along with $22 million affecting deferred taxes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, 2021 and 2020, the amount of accrued interest and penalties on our consolidated balance sheets was $18 million, $11 million and $15 million, respectively.  For the years ended December&#160;31, 2022, 2021 and 2020, we recognized in our consolidated statements of earnings $8 million, $(4)&#160;million and $4 million, respectively, of gross interest (income) expense associated with uncertain tax positions.  We recognize accrued interest and penalties associated with uncertain tax positions as part of the tax provision.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxation in many jurisdictions.  Unrecognized tax benefits reflect the difference between tax positions taken or expected to be taken on income tax returns and the amounts recognized in the financial statements.  Resolution of the related tax positions with the relevant tax authorities may take many years to complete, and such timing is not entirely within our control.  It is reasonably possible that within the next 12 months certain examinations will be resolved, which could result in a decrease in unrecognized tax benefits of approximately $1 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation between actual income taxes and amounts computed by applying the federal statutory rate to earnings before income taxes was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,552</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,447&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of federal tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">435</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax basis in foreign investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in ABI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in JUUL</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Cronos</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance releases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(664)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,625</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax provision (benefit) in 2022 included tax benefits of $664 million due primarily to the release of valuation allowances related to the anticipated ability to utilize a portion of existing capital losses.  These tax benefits were partially offset by tax expense of $306 million for a valuation allowance recorded against a deferred tax asset related to the decreases in the estimated fair value of our investment in JUUL and by the state tax treatment of the impairment charge on our equity investment in ABI.</span></div><div><span><br/></span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax provision (benefit) in 2021 was impacted by the state tax treatment of the impairment charge on our equity investment in ABI.  The tax provision (benefit) in 2021 also included net tax expense of $128 million related to our Investment in Cronos, including an addition to a valuation allowance on a deferred tax asset.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax provision (benefit) in 2020 included tax expense of $612 million for a valuation allowance on a deferred tax asset related to our impairment of our investment in JUUL in the third quarter of 2020, partially offset by a $24 million tax benefit reflecting the decrease of </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a portion of the valuation allowance related to a reduction of a deferred tax asset associated with an increase in the estimated fair value of JUUL in the fourth quarter of 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences that gave rise to deferred income tax assets and liabilities consisted of the following at December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.249%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued postretirement and postemployment benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">303</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">729</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in JUUL</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,001</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Cronos</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">407</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses and tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(233)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,802)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in ABI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pension costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(115)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,493)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,891)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,800)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,097)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,822)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,665)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2022, we had estimated gross state tax net operating losses of $19 million that, if unused, will expire in 2035 through 2038. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending valuation allowances was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.607%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,097</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to valuation allowance charged to income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">429</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to valuation allowance credited to income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,800</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,097&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine deferred tax assets and liabilities based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.  We record a valuation allowance when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  We determine the realizability of deferred tax assets based on the weight of all available positive and negative evidence.  In reaching this determination, we consider the character of the assets and the possible sources of taxable income of the appropriate character within the available carryback and carryforward periods available under the tax law.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The additions to valuation allowances during 2022 were primarily due to deferred tax assets recorded in connection with decreases in the estimated fair value of our investment in JUUL.  The reductions to valuation allowances during 2022 were primarily due to the anticipated ability to utilize a portion of existing losses related to our investment in JUUL and the abandonment of our Cronos warrant.  The cumulative valuation allowance at December 31, 2022 was primarily attributable to deferred tax assets recorded in connection with our investment in JUUL ($2,394 million) and our Investment in Cronos ($379 million).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in valuation allowances during 2021 were primarily due to deferred tax assets recorded in connection with our Investment in Cronos.  The cumulative valuation allowance at December 31, 2021 was primarily attributable to deferred tax assets recorded in connection with our investment in JUUL ($2,652 million) and our Investment in Cronos ($407 million).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2020 valuation allowance was primarily attributable to deferred tax assets recorded in connection with the impairments of our investment in JUUL ($2,610 million), and our Investment in Cronos ($121 million).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion regarding the change in estimated fair value of our investment in JUUL, the impairment of our investment in ABI and the impairment of our Investment in Cronos, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863641029632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating companies&#8217; products include (i) smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton; and (ii) oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix.  These products constituted our reportable segments of smokeable products and oral tobacco products at December&#160;31, 2022.  The financial services business, the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System heated tobacco business and Helix ROW were included in all other.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the sale of our wine business on October 1, 2021, wine produced and/or sold by Ste. Michelle was a reportable segment.  For further discussion, see Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our chief operating decision maker (&#8220;CODM&#8221;) reviews operating companies income (loss) (&#8220;OCI&#8221;) to evaluate the performance of, and allocate resources to, our segments.  OCI for our segments is defined as operating income before general corporate expenses and amortization of intangibles.  Interest and other debt expense, net, along with net periodic benefit cost (income), excluding service cost, and provision for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by our CODM.  We do not disclose information about total assets by segment because such information is not reported to or used by our CODM.  Substantially all of our long-lived assets were located in the United States at December 31, 2022.  Segment goodwill and other intangible assets, net, are disclosed in Note 4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Other Intangible Assets, net.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The accounting policies of the segments were the same at December 31, 2022 as those described in Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows:</span></div><div style="margin-bottom:5pt;margin-top:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.241%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,476</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,096</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,013&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,153&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,688</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,632</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,919</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,058</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(184)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments in equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,641</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Cronos-related financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,890&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The smokeable products segment included net revenues of $21,457 million, $21,877 million and $22,135 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively, related to cigarettes and net revenues of $1,019 million, $989 million and $954 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively, related to cigars.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our net revenues for the years ended December&#160;31, 2022, 2021 and 2020 were from sales generated in the United States.  PM USA, USSTC, Helix and Middleton&#8217;s customer, Performance Food Group Company, which acquired Core-Mark Holding Company, Inc. in 2021, accounted for approximately 24% and 23% of our consolidated net revenues for the years ended December&#160;31, 2022 and 2021, respectively.  Core-Mark Holding Company, Inc. accounted for 17% of our consolidated net revenues for the year ended December&#160;31, 2020.  In addition, McLane Company, Inc., accounted for approximately 23%, 23% and 26% of our consolidated net revenues for the years ended December&#160;31, 2022, 2021 and 2020, respectively.  Substantially all of these net revenues were reported in the smokeable products and oral tobacco products segments.  No other customer accounted for more than 10% of our consolidated net revenues for the years ended December 31, 2022, 2021 and 2020.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of our depreciation expense and capital expenditures were as follows:</span></div><div style="margin-bottom:5pt;margin-top:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.241%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The comparability of OCI for our reportable segments and the all other category was affected by the following:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Non-Participating Manufacturer (&#8220;NPM&#8221;) Adjustment Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded pre-tax (income) expense for NPM adjustment items as follows: </span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.241%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(68)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the amounts in the table shown above for the smokeable products segment as (reductions) increases to cost of sales in our consolidated statements of earnings, which (increased) decreased OCI in our smokeable products segment.  NPM adjustment items result from the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the Master Settlement Agreement (such dispute resolutions are referred to as &#8220;NPM Adjustment Items&#8221; and are more fully described in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Health Care Cost Recovery Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Tobacco and Health and Certain Other Litigation Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded pre-tax charges related to tobacco and health and certain other litigation items as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.834%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.241%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the amounts shown in the table above for the smokeable products segment and general corporate expenses in marketing, administration and research costs in our consolidated statements of earnings.  For further discussion, see Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Ste. Michelle Transaction: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded pre-tax disposition-related costs of $51 million for the year ended December&#160;31, 2021 in our former wine segment, which consisted of a pre-tax charge of $41 million to record the assets and liabilities associated with the Ste. Michelle Transaction at their fair value less costs to sell and $10 million of other disposition-related costs.  We included these costs in marketing, administration and research costs in our consolidated statements of earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Acquisition-Related Costs:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We recorded pre-tax acquisition-related costs of $37 million for the year ended December&#160;31, 2021 in our oral tobacco products segment primarily for the settlement of an arbitration related to the 2019 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">on!</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> transaction.  We included these costs in marketing, administration and research costs in our consolidated statements of earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Wine Business Strategic Reset:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded pre-tax implementation costs of $411 million for the year ended December&#160;31, 2020, in our former wine segment, associated with a strategic reset initiated in the first quarter of 2020 intended to maximize Ste. Michelle&#8217;s profitability and achieve improved long-term cash flow generation.  Substantially all of the charges consisted of the following: (i) write-off of inventory ($292 million) as Ste. Michelle no longer believed that the benefit of the blending and production plans for its inventory outweighed inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believed no longer had a future economic benefit ($100 million).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">PMCC Residual Value Adjustments:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the year ended December&#160;31, 2020, we recorded pre-tax charges of $125 million (as a reduction to net revenues in the all other category) related to the decrease in unguaranteed residual values of certain PMCC leased assets.  There were no such adjustments in 2022 or 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">COVID-19 Special Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded net pre-tax charges of $50 million ($41 million in the smokeable products segment and $9 million in the oral tobacco products segment) in our consolidated statement of earnings for the year ended December&#160;31, 2020 related to the COVID-19 pandemic.  These net pre-tax charges, which were directly related to disruptions caused by or efforts to mitigate the impact of the COVID-19 pandemic, were all recorded in cost of sales and included premium pay, personal protective equipment and health screenings, which were partially offset by certain employment tax credits.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863637929824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock', window );">Benefit Plans</a></td>
<td class="text">Benefit Plans<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our subsidiaries sponsor noncontributory defined benefit pension plans covering certain employees of Altria and our subsidiaries.  Employees hired on or after a date specific to their employee group, except for certain employees of UST&#8217;s subsidiaries and Middleton, are not eligible to participate in these noncontributory defined benefit pension plans but are instead eligible to participate in a defined contribution plan with enhanced benefits.  We also provide postretirement health care and other benefits to certain retired employees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We measure the plan assets and benefit obligations of our pension plans and postretirement plans at December&#160;31 of each year.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We base the discount rates for our plans on a yield curve developed from a model portfolio of high-quality corporate bonds with durations that match the expected future cash flows of the pension and postretirement benefit obligations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Obligations and Funded Status: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefit obligations, plan assets and funded status for our pension and postretirement plans were as follows at December 31:</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"/><td style="width:60.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.851%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Benefit obligation at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,544</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,688</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Service cost</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest cost</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Benefits paid</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Plan amendments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Divestiture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,292</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Fair value of plan assets at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,793</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">185</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,748)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Employer contributions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Benefits paid</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Divestiture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,793&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Funded status at December&#160;31</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,153)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on our consolidated balance sheets were as follows:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">469</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other accrued liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued pension costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued postretirement health care costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,083)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,436)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,153)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Divestiture of benefit obligations and plan assets related to the Ste. Michelle Transaction.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table above presents the projected benefit obligation for our pension plans.  The accumulated benefit obligation, which represents benefits earned to date, for our pension plans was $6.1 billion and $8.2 billion at December&#160;31, 2022 and 2021, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actuarial (gains) losses for the years ended December&#160;31, 2022 and 2021 for our pension and postretirement plans were due primarily to changes in the discount rate.  Actuarial (gains) losses for our pension plans for the year ended 2021 were further impacted by changes to mortality rate assumptions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plan amendments to our postretirement plans for the year ended December&#160;31, 2021 included several plan changes announced in the second quarter of 2021 to our salaried retiree healthcare plans, primarily changing its post-age 65 coverage to a private medicare marketplace.  These amendments triggered a plan remeasurement in the second quarter of 2021, resulting in a reduction of $432 million (including discount rate impact and other changes) to our postretirement obligation in the second quarter of 2021 and a corresponding reduction to accumulated other comprehensive losses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For pension plans with accumulated benefit obligations in excess of plan assets at December&#160;31, 2022, our accumulated benefit obligation and fair value of plan assets were $134 million and $0 million, respectively.  For pension plans with accumulated benefit obligations in excess of plan assets at December&#160;31, 2021, our accumulated benefit obligation and fair value of plan assets were $176&#160;million and $0 million, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For pension plans with projected benefit obligations in excess of plan assets at December&#160;31, 2022, our projected benefit obligation and fair value of plan assets were $158 million and $0 million, respectively.  For pension plans with projected benefit obligations in excess of plan assets at December&#160;31, 2021, our projected benefit obligation and fair value of plan assets were $227 million and $0 million, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022 and 2021, our accumulated postretirement benefit obligations were in excess of plan assets for all postretirement plans.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used the following assumptions to determine our pension and postretirement benefit obligations at December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.737%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase - long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost trend rate assumed for next year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Ultimate trend rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Year that the rate reaches the ultimate trend rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Components of Net Periodic Benefit Cost (Income):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Net periodic benefit cost (income) consisted of the following for the years ended December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.846%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(493)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(522)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(121)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, we recorded the settlement amount as a change to net losses in other comprehensive earnings/losses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to determine our net periodic benefit cost for the years ended December&#160;31:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:37.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.352%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.357%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Service cost</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest cost </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase - long-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost trend rate</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Defined Contribution Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sponsor tax-qualified defined contribution plans covering certain salaried and hourly (non-union and union) employees.  Contributions and costs are determined generally as a percentage of earnings, as defined by our plans.  Amounts charged to expense for these defined contribution plans totaled $91 million, $90 million and $88 million in 2022, 2021 and 2020, respectively.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt">Pension and Postretirement Plan Assets: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In managing our pension assets, we implement a liability-driven investment framework that aligns plan assets with liabilities.  The current equity/fixed income allocation of 20%/80% is designed to balance pension liability hedging and asset growth in order to maintain our plan&#8217;s funded status and cover incremental service accruals and interest cost.  Liability hedging is achieved through investing in rate-sensitive fixed income securities, primarily corporate bonds and U.S. Treasuries, while growth assets are comprised of publicly traded equity securities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investment strategy for our postretirement plan assets is intended to maximize our total asset return based on the expectation that equity securities will outperform debt securities over the long term and reflects the maturity structure of our benefit obligation.  The equity/fixed income target allocation for postretirement plan assets is 55%/45%.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we implement these investment strategies in a prudent and risk-controlled manner, consistent with the fiduciary requirements of the Employee Retirement Income Security Act of 1974, by investing retirement plan assets in a well-diversified mix of equities, fixed income and other securities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual composition of our plan assets at December&#160;31, 2022 was broadly characterized with the following allocation:</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and foreign government securities and all other investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amount includes U.S Treasury and foreign government securities (19%) and asset based securities and all other investments (9%).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pension and postretirement plan asset performance is monitored on an ongoing basis to adjust the mix as necessary to achieve our target allocations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all pension and all postretirement assets can be used to make monthly benefit payments.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We implement our investment strategy for our pension and postretirement plan assets by investing in long-duration fixed income securities that primarily include U.S. corporate bonds of companies from diversified industries and U.S. Treasury securities that mirror  our pension obligation benchmark, as well as U.S. and international equity index strategies that are intended to mirror broad market indices, including, the Standard &amp; Poor&#8217;s 500 Index and Morgan Stanley Capital International (&#8220;MSCI&#8221;) Europe, Australasia, and the Far East (&#8220;EAFE&#8221;) Index.  Our pension and postretirement plans also invest in actively managed international equity securities of mid and small cap companies located in developed and emerging markets.  For pension plan assets, our allocation to below investment grade securities represented approximately 13% of the fixed income holdings or approximately 10% of our total plan assets at December&#160;31, 2022.  Our allocation to emerging markets represented less than 1% of total plan assets at December&#160;31, 2022.  For postretirement plan assets, our allocation to below investment grade securities represented approximately 12% of the fixed income holdings or approximately 5% of our total plan assets at December&#160;31, 2022.  There were no postretirement plan assets invested in emerging markets at December&#160;31, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our risk management practices for our pension and postretirement plans include (i) ongoing monitoring of asset allocation, investment performance and investment managers&#8217; compliance with their investment guidelines, (ii) periodic rebalancing between equity and debt asset classes and (iii) annual actuarial re-measurement of plan liabilities.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our expected rate of return on pension and postretirement plan assets is determined by our plan assets&#8217; historical long-term investment performance, current asset allocation and estimates of future long-term returns by asset class.  The forward-looking estimates are consistent with the long-term historical averages exhibited by returns on equity and fixed income&#160;securities.  For determining our pension and postretirement net periodic benefit cost (income), our 2023 expected rate of return assumptions are 6.1% and 7.4%, respectively.</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our pension plan assets by asset category were as follows at December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.757%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. and foreign government securities or their agencies:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agencies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,098</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,098</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. municipal bonds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government and agencies</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Above investment grade</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,747</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,747</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Below investment grade and no rating</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">756</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">756</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">591</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">591</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">243</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">917</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,287&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV as a practical expedient for fair value:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collective investment funds</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_41b4c8e3-e050-43b8-b106-4405c53c782d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_9c77b5ce-ddae-4a3d-978b-ba5336576f53">U.S. large cap</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_1ddffbe6-a65c-4290-90a9-b5306bc7faca"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_c2aa8d53-307d-44de-88c6-ccc45057da99">U.S. small cap</span></span>  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_6c58378e-c0bf-4554-a791-6444e99557ba"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_c4015aef-675a-4e45-9c95-609287b0df60">International developed markets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">49</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments measured at NAV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">436</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of plan assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,793&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 holdings and transactions were immaterial to total plan assets at December&#160;31, 2022 and 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our postretirement plan assets were as follows at December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.757%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. and foreign government securities or their agencies:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agencies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government and agencies</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt instruments:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Above investment grade</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Below investment grade and no rating</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV as a practical expedient for fair value:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collective investment funds:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_295077d8-7c2c-4293-a53f-d6212cd1c050"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_bff869f3-0247-42fe-9766-2e8c8f382544">U.S. large cap</span></span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_501091e4-8056-4777-bd80-73ee1b31781b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_eef6c587-6a34-4f41-a17b-d1245eda6984">International developed markets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments measured at NAV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of plan assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no Level 3 postretirement plan holdings or transactions during 2022 and 2021.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the fair value hierarchy and the three levels of inputs used to measure fair value, see Note 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a description of the valuation methodologies used for investments measured at fair value.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">U.S. and Foreign Government Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: U.S. and foreign government securities consist of investments in Treasury Nominal Bonds and Inflation Protected Securities and municipal securities.  Government securities are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes.  Matrix pricing, yield curves and indices are used when broker quotes are not available.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Corporate Debt Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Corporate debt instruments are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes.  Matrix pricing, yield curves and indices are used when broker quotes are not available.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Common stocks are valued based on the price of the security as listed on an open active exchange on last trade date.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Asset Backed Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Asset backed securities are fixed income securities such as mortgage backed securities and auto loans that are collateralized by pools of underlying assets that are unable to be sold individually.  They are valued at a price which is based on a compilation of primarily observable market information or a broker quote in a non-active over-the-counter market.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Collective Investment Funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Collective investment funds consist of funds that are intended to mirror indices such as Standard&#160;&amp; Poor&#8217;s 500 Index and MSCI EAFE Index.  They are valued on the basis of the relative interest of each participating investor in the fair value of the underlying assets of each of the respective collective investment funds.  The underlying assets are valued based on the net asset value (&#8220;NAV&#8221;), which is provided by the investment account manager as a practical expedient to estimate fair value.  These investments are not classified by level but are disclosed to permit reconciliation to the fair value of plan assets.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We make contributions to our pension plans to the extent that the contributions are tax deductible and pay benefits that relate to plans for salaried employees that cannot be funded under IRS regulations.  Currently, we anticipate making employer contributions to our pension and postretirement plans of up to approximately $30 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for each i</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n 2023.  However, the foregoing  estimates of 2023 contributions to our pension and postretirement plans are subject to change as a result of changes in tax and other benefit laws, changes in interest rates, as well as asset performance significantly above or below the assumed long-term rate of return for each respective plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated future benefit payments at December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:69.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.149%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">494</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">472</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">473</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2032</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">477</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comprehensive Earnings/Losses</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the following amounts in accumulated other comprehensive losses at December&#160;31, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>employment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,180)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,213)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service (cost) credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">293</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">264</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">571</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">513</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded in accumulated other comprehensive losses</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,633)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">226</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,436)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the following amounts in accumulated other comprehensive losses at December&#160;31, 2021:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>employment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,093)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,487)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service (cost) credit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded in accumulated other comprehensive losses</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,574)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,612)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2022 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>employment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings as components of net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other movements during the year:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">147</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(135)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">256</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total movements in other comprehensive earnings/losses</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">236</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:9pt;text-indent:-9.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-employment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings as components of net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other movements during the year:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total movements in other comprehensive earnings/losses</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>employment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings as components of net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other movements during the year:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total movements in other comprehensive earnings/losses</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI https://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI https://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI https://asc.fasb.org/topic&amp;trid=2127225<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863641012944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Additional Information</a></td>
<td class="text">Additional Information<div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"/><td style="width:64.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.843%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.843%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">162</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,128</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,058</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity in the allowance for discounts and allowance for returned goods was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.683%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Returned Goods</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Returned Goods</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Returned Goods</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(633)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Represents the recording of discounts and returns for which allowances were created</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639664064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal proceedings covering a wide range of matters are pending or threatened in various United States and foreign jurisdictions against Altria and certain of our subsidiaries, including PM USA and USSTC, as well as our indemnitees and investees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, income tax liability, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act (&#8220;RICO&#8221;), claims for contribution and claims of competitors, shareholders or distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrates that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.  In certain cases, plaintiffs claim that defendants&#8217; liability is joint and several.  In such cases, we may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, under certain circumstances, we may have to pay more than our proportionate share of any bonding- or judgment-related amounts.  Furthermore, in those cases where plaintiffs are successful, we also may be required to pay interest and attorneys&#8217; fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that 47 states and Puerto Rico limit the dollar amount of bonds or require no bond at all.  As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#8217;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  States, including Florida, also may seek to repeal or alter bond cap statutes through legislation.  Although we cannot predict the outcome of such challenges, it is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record provisions in our consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 17. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: (i)&#160;management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii)&#160;management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii)&#160;accordingly, management has not </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provided any amounts in our consolidated financial statements for unfavorable outcomes, if any.  Litigation defense costs are expensed as incurred.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have achieved substantial success in managing litigation.  Nevertheless, litigation is subject to uncertainty and significant challenges remain.  It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.  We believe, and have been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts.  We have defended, and will continue to defend, vigorously against litigation challenges.  However, we may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Judgments Paid and Provisions for Tobacco and Health (Including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation) and Certain Other Litigation Items: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in our accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.599%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:1.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other litigation items at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax charges for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholder class action and shareholder derivative lawsuits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related interest costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other litigation items at end of period</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes judgments, settlements and fee disputes associated with tobacco and health and certain other litigation.</span></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">hareholder Class Action and Shareholder Derivative Lawsuits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below for discussions of the shareholder class action case and related settlement and the pending settlement of the federal and state shareholder derivative lawsuits.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accrued liability for tobacco and health and certain other litigation items, including related interest costs, was included in accrued liabilities on our consolidated balance sheets.  Pre-tax charges for tobacco and health and certain other litigation were included in marketing, administration and research costs on our consolidated statements of earnings.  Pre-tax charges for related interest costs were included in interest and other debt expense, net on our consolidated statements of earnings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $954 million and interest totaling approximately $230 million as of December 31, 2022.  These amounts include payments for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny judgments (and related costs and fees) totaling approximately $432 million and related interest totaling approximately $59 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Security for Judgments: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain stays of judgments pending appeal, PM USA has posted various forms of security.  As of December 31, 2022, PM USA has posted appeal bonds totaling approximately $46 million, which have been collateralized with restricted cash and are included in assets on our consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview of Tobacco-Related Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Types and Number of U.S. Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims related to tobacco products generally fall within the following categories: (i)&#160;smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii)&#160;health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of RICO, fraud, failure to warn, design defect, negligence, antitrust and unfair trade practices; and (iv)&#160;other tobacco-related litigation described below.  Plaintiffs&#8217; theories of recovery and the defenses raised in tobacco-related litigation are discussed below.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of certain tobacco-related cases pending in the United States against us as of December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.607%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">162</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-vapor Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,283</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,296</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Tobacco-Related Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes as of December 31, 2022, 17 cases filed in Illinois, 20 cases filed in New Mexico, 37 cases filed in Massachusetts and 51 non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">case (these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> progeny cases are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  Also does not include 1,395 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#8220;ETS&#8221;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Broin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.</span></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes as of December 31, 2022, 57 class action lawsuits, 3,830 individual lawsuits and 1,396 &#8220;third party&#8221; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  The 57 class action lawsuits include 32 cases in the Northern District of California (&#8220;Multidistrict Litigation&#8221; or &#8220;MDL&#8221;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes as of December 31, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">International Tobacco-Related Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2023, (i) Altria is named as a defendant in three e-vapor class action lawsuits in Canada; (ii) PM USA is a named defendant in 10 health care cost recovery actions in Canada, eight of which also name Altria as a defendant; and (iii) PM USA and Altria are named as defendants in seven smoking and health class actions filed in various Canadian provinces.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement (defined below) between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tobacco-Related Cases Set for Trial: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2023, two </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases, two individual smoking and health case and one e-vapor case are set for trial through March 31, 2023.  Trial dates are subject to change.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trial Results: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since January 1999, excluding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases (separately discussed below), verdicts have been returned in 73 tobacco-related cases in which PM USA was a defendant.  Verdicts in favor of PM USA and other defendants were returned in 46 of the 73 cases.  These 46 cases were tried in Alaska (1), California (7), Connecticut (1), Florida (10), Louisiana (1), Massachusetts (6), Mississippi (1), Missouri (4), New Hampshire (1), New Jersey (1), New York (5), Ohio (2), Pennsylvania (1), Rhode Island (1), Tennessee (2) and West Virginia (2).  One case in Massachusetts, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Main</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, where the verdict was initially returned in favor of PM USA, was reversed on appeal and remanded for a new trial.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the 27 non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs, 23 have reached final resolution.</span></div><div style="margin-bottom:5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Liti</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">gation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of verdicts in state and federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA as of January 27, 2023.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Smoking and Health Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs&#8217; allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and consumer protection statutes and claims under the federal and state anti-racketeering statutes.  Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.  Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Litigation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Summarized below are the non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny smoking and health cases pending during 2022 (or recently concluded) in which a verdict was returned in favor of plaintiff and against PM USA.  Charts listing certain verdicts for plaintiffs in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases can be found in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Progeny Trial Results</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mendez</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA and R.J. Reynolds Tobacco Company awarding approximately $4.5 million in compensatory damages and allocating 13% of the fault to PM USA.  After </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applying comparative fault, PM USA&#8217;s portion of the compensatory damages is less than $1 million.  There was no claim for punitive damages.  The trial court denied PM USA&#8217;s post-trial motions.  Both parties have appealed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fontaine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, a jury in a Massachusetts state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $8 million in compensatory damages and $1 billion in punitive damages.  We intend to file post-trial motions challenging the award and, if necessary, an appeal.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Principe</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $11 million in compensatory damages.  There was no claim for punitive damages.  PM USA appealed the trial court verdict to the Third District Court of Appeal and, in September 2021, the appellate court reversed the trial court&#8217;s decision and found in favor of PM USA.  Plaintiff moved for a rehearing before the Third District Court of Appeal, which the court denied in March 2022.  In April 2022, plaintiff filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court.  In July 2022, the Florida Supreme Court denied plaintiff&#8217;s motion for discretionary review.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Greene</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $10 million in compensatory damages.  In May 2020, the court ruled on plaintiffs&#8217; remaining claim and trebled the compensatory damages award to approximately $30 million.  In February 2021, the trial court awarded plaintiffs attorneys&#8217; fees and costs in the amount of approximately $2.3 million.  In July 2021, following denial of PM USA&#8217;s post-trial motions, PM USA appealed the judgment to the Appeals Court of Massachusetts.  In September 2022, the Massachusetts Supreme Judicial Court issued an order taking jurisdiction over the appeal, which remains pending.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the verdict and post-trial developments in the United States of America health care cost recovery case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Class Action: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2000, in the second phase of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $145 billion against various defendants, including $74 billion against PM USA.  Following entry of judgment, PM USA appealed.  In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class.  Plaintiffs petitioned the Florida Supreme Court for further review.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within one year of issuance of the mandate.  The court further declared the following Phase I findings are entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect in such individual actions brought within one year of the issuance of the mandate: (i)&#160;that smoking causes various diseases; (ii)&#160;that nicotine in cigarettes is addictive; (iii)&#160;that defendants&#8217; cigarettes were defective and unreasonably dangerous; (iv)&#160;that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v)&#160;that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi)&#160;that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii)&#160;that all defendants sold or supplied cigarettes that were defective; and (viii)&#160;that defendants were negligent.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion.  In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effect by excluding finding (v)&#160;listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants.  In February 2008, the trial court decertified the class.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pending </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e Progeny Cases: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The deadline for filing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases expired in January 2008, at which point a total of approximately 9,300 federal and state claims were pending.  As of January 27, 2023, approximately 612 state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately 773 state court plaintiffs.  Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates.  The 2015 federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreement resolved nearly all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases pending in federal court as of the date of the agreement, and each case excluded from that agreement subsequently has been resolved.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Trial Results: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2023, 143 federal and state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> decision.  Seventy-nine verdicts were returned in favor of plaintiffs, and seven verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Skolnick</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Calloway</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Oshinsky-Blacker,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McCoy, Mahfuz, Neff </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Gloger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending.  In two cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Kaplan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">McLaughlin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sommers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the punitive damages awards were vacated on appeal and remanded for new trials.  In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sommers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the trial court entered final judgment dismissing the plaintiff&#8217;s punitive damages claim with prejudice, and plaintiff has appealed. </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fifty-six verdicts were returned in favor of PM USA, of which 46 were state cases.  In addition, there have been a number of mistrials, only some of which have resulted in new trials as of January 27, 2023.  The jury in one case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Garcia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, awarded plaintiff compensatory </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">damages and found plaintiff was entitled to punitive damages; however, the court declared a mistrial in the second phase of the trial regarding punitive damages because the jury was unable to determine the amount of the punitive damages.  Following appeals by the plaintiff and PM USA, the appellate court in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Garcia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> affirmed the compensatory damages judgment against PM USA and granted a new trial with respect to punitive damages.  The plaintiff in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Garcia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subsequently filed a motion to voluntarily dismiss the punitive damages claim and to enter final judgment on the compensatory damages claim, which the court granted.  Three verdicts (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cohen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chacon</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) that were returned in favor of PM USA were subsequently reversed for new trials.  Juries in two cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reider</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Banks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) returned zero damages verdicts in favor of PM USA.  Juries in two other cases (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Weingart</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hancock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) returned verdicts against PM USA awarding no damages, but the trial court in each case decided to award plaintiffs damages.  One case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pollari</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff.  Plaintiff and defendants appealed the verdict and the appellate court affirmed the judgment in favor of the defendants.  Three cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gloger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rintoul </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Duignan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs.  A post-trial appeal is pending in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Duignan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The verdicts in the retrials in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gloger</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rintoul</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Caprio</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) were reversed upon appeal and remanded for new trials.  Two cases, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Freeman</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Harris</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, resulted in an appellate reversal of a jury verdict in favor of plaintiff, and a judgment in favor of PM USA.  One case, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">R. Douglas</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, was dismissed with prejudice following a verdict in favor of plaintiff.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The charts below list the verdicts and post-trial developments in certain </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in which verdicts were returned in favor of plaintiffs.  The first chart lists cases that are pending as of January 27, 2023 where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated, and the second chart lists cases that have concluded in the past 12 months.  Unless otherwise noted for a particular case, the jury&#8217;s award for compensatory damages will not be reduced by any finding of plaintiff&#8217;s comparative fault.  Further, the damages noted reflect adjustments based on post-trial or appellate rulings.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">References below to &#8220;R.J. Reynolds,&#8221; &#8220;Lorillard&#8221; and &#8220;Liggett Group&#8221; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"/><td style="width:9.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Trial Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Hoffman</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5 million ($3 million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Awaiting entry of final judgment by the trial court.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Levine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1 million</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Appeals by defendants and plaintiff to Third District Court of Appeal pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Schertzer</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Appeal by defendants to the Third District Court of Appeal pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Lipp</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$15 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$28 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Garcia</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$6 million ($3 million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to the Third District Court of Appeal pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Duignan</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pinellas</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Florida Supreme Court quashed the Second District Court of Appeal&#8217;s affirmation of  judgment against the defendants and remanded the case for reconsideration in light of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McCall</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million (&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New trial on punitive damages is set for April 2023.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chadwell</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2018</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal has ordered supplemental briefing in accordance with the decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kaplan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McLaughlin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Florida Supreme Court vacated the punitive damages award in accordance with the decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.  The Fourth District Court of Appeals affirmed the compensatory damages award and granted a new trial on punitive damages.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cooper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Blackwood</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal affirmed the compensatory damages award and granted a new trial on punitive damages.</span></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PM USA&#8217;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff&#8217;s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> PM USA is not a defendant in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, which are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle Progeny Appellate Issues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle Cases Concluded Within Past 12 Months </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.180%"><tr><td style="width:1.0%"/><td style="width:9.919%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.123%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.123%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Amount for Damages (if any)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Miller</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third quarter of 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Tuttle</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third quarter of 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cuddihee</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second quarter of 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2 million</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Holliman</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth quarter of 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3 million</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">D. Brown</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2015</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third quarter of 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5 million</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2022</span></td></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Progeny Appellate Issues: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Appellate decisions in the following </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases may have wide application to other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases:</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mary Sheffield v. R.J. Reynolds Tobacco Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case against R.J. Reynolds only, the Florida Supreme Court resolved a conflict among Florida&#8217;s District Courts of Appeal finding that the 1999 amendments to Florida&#8217;s punitive damages statute (including its caps and bar on multiple punitive damages awards for the same course of conduct) apply in wrongful death cases where the decedent was injured prior to the October 1, 1999 effective date of the amendments but died from his or her injuries after such effective date.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Linda Prentice v. R.J. Reynolds Tobacco Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny case against R.J. Reynolds only, the Florida Supreme Court resolved a conflict among Florida&#8217;s District Courts of Appeal finding that in order for an </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plaintiff to prevail on fraudulent concealment and conspiracy claims, plaintiff must prove that the smoker relied to his or her detriment on a statement that concealed or omitted material information about the health risks or addictiveness of smoking.  The Florida Supreme Court declined to revisit its prior decisions giving preclusive effect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Phase I findings, described above in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Florida Bond Statute: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applies to all state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny lawsuits in the aggregate and establishes individual bond caps for individual </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> progeny cases in amounts that vary depending on the number of judgments in effect at a given time.  Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">progeny cases tried in federal court.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Smoking and Health Class Actions: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts.  In general, these cases have purported to be brought on behalf of residents of a particular state or states (although a few cases have purported to be nationwide in scope) and have raised addiction claims and, in many cases, claims of physical injury as well.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class certification has been denied or reversed by courts in 61 smoking and health class actions involving PM USA in Arkansas (1), California (1), Delaware (1), the District of Columbia (2), Florida (2), Illinois (3), Iowa (1), Kansas (1), Louisiana (1), Maryland (1), Michigan (1), Minnesota (1), Nevada (29), New Jersey (6), New York (2), Ohio (1), Oklahoma (1), Oregon (1), Pennsylvania (1), Puerto Rico (1), South Carolina (1), Texas (1)&#160;and Wisconsin (1).  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain Other Tobacco-Related Litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">below for a discussion of &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; class action cases and medical monitoring class action cases pending against PM USA.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2023, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in seven class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario.  In Saskatchewan, British Columbia (two separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants&#8217; cigarettes.  In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants&#8217; cigarettes.  In March 2019, all of these class actions were stayed as a result of three Canadian tobacco manufacturers (none of which is related to us) seeking protection under Canada&#8217;s Companies&#8217; Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the United States).  The companies entered into these proceedings following a Canadian appellate court upholding two smoking and health class action verdicts against those companies totaling approximately CAD $13 billion.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Care Cost Recovery Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages.  Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although there have been some decisions to the contrary, most judicial decisions in the United States have dismissed all or most health care cost recovery claims against cigarette manufacturers.  Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs&#8217; claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions.  The U.S. Supreme Court has refused to consider plaintiffs&#8217; appeals from the cases decided by five federal circuit courts of appeal.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the cases brought in the United States, health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (10 cases),&#160;and other entities have stated that they are considering filing such actions.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers.  PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases.  The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed.  All of these cases have been stayed pending resolution of proceedings in Canada involving three tobacco manufacturers (none of which are affiliated with us) under the Companies&#8217; Creditors Arrangement Act discussed above.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> above for a discussion of these proceedings.  See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees and Other Similar Matters</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Settlements of Health Care Cost Recovery Litigation: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 1998, PM USA and certain other tobacco product manufacturers entered into the Master Settlement Agreement (the &#8220;MSA&#8221;) with 46 states, the District of Columbia and certain United States territories to settle asserted and unasserted health care cost recovery and other claims.  PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#8220;State Settlement Agreements&#8221;).  The State Settlement Agreements require that the original participating manufacturers or &#8220;OPMs&#8221; (now PM USA, R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (&#8220;ITG&#8221;)) make annual payments of approximately $9.4 billion, subject to adjustments for several factors, including inflation, market share and industry volume.  In addition, the OPMs are required to pay settling plaintiffs&#8217; attorneys&#8217; fees, subject to an annual cap of $500 million; these quarterly payments are expected to end in 2024.  For the years ended December 31, 2022, 2021 and 2020, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $3.9 billion, $4.3 billion and $4.4 billion, respectively.  These amounts include PM USA&#8217;s estimate of amounts related to NPM Adjustments discussed below.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NPM Adjustment Disputes: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The &#8220;NPM Adjustment&#8221; is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the &#8220;participating manufacturers&#8221; or &#8220;PMs&#8221;) that applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The independent auditor (&#8220;IA&#8221;) appointed under the MSA has calculated that PM USA&#8217;s share of the maximum potential NPM Adjustments for 2004-2021 is (exclusive of interest or earnings): $388 million for 2004; $181 million for 2005; $154 million for 2006; $185 million for 2007; $250 million for 2008; $211 million for 2009; $218 million for 2010; $166 million for 2011; $214 million for 2012; $224 million for 2013; $258 million for 2014; $313 million for 2015; $292 million for 2016; $285 million for 2017; $318 million for 2018; $415 million for 2019; $573 million for 2020; and $635 million for 2021.  These maximum amounts will be substantially reduced to reflect the NPM Adjustment settlements discussed below, and potentially for current and future calculation disputes and other developments.  PM USA&#8217;s recovery for 2004 is addressed below.  In addition, PM USA&#8217;s recovery of such reduced amounts for all subsequent years will be dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Settlements of NPM Adjustment Disputes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.78pt">Multi-State Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> By the end of 2018, PM USA entered into a multi-state settlement of NPM Adjustment disputes with a total of 36 MSA states and territories in which PM USA settled the NPM Adjustment disputes through 2022 with 35 of the 36 states, and through 2024 with one state.  In March 2022, Illinois joined the multi-state settlement, settling the NPM Adjustment disputes through 2028 and bringing the total number of settling states and territories to 37.  As a result, PM USA will receive approximately $80 million for 2004-2021 ($20 million of which relates to the 2019-2021 &#8220;transition years&#8221;).  In connection with this development for Illinois, PM USA recorded $80 million as a reduction in cost of sales in the first quarter of 2022.  Pursuant to the multi-state </span></div><div style="margin-bottom:3pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">settlement, PM USA has received $1.15 billion and expects to receive approximately $410 million in credits to offset PM USA&#8217;s MSA payments through 2036.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">New York Settlement.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, PM USA entered into a separate NPM Adjustment settlement with New York in which PM USA settled the NPM Adjustment disputes with New York in perpetuity.  PM USA has received $435 million pursuant to the New York settlement and expects to receive annual credits applied against the MSA payments due to New York going forward.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Montana Settlement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In 2020, PM USA entered into a separate NPM Adjustment settlement with Montana in which PM USA settled the NPM Adjustment disputes with Montana through 2030.  This settlement resulted in a payment by PM USA of $4 million.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Continuing NPM Adjustment Disputes with States That Have Not Settled</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2004 NPM Adjustment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The PMs and the nine states that have not settled the NPM Adjustment disputes participated in a multi-state arbitration of NPM Adjustment disputes for 2004.  A tenth state, Illinois, also participated in the arbitration, but joined the multi-state settlement after the arbitration panel issued its decisions described below.  Hearings for nine of the 10 states concluded by the end of 2020.  The arbitration panels issued decisions finding that three states, Missouri, New Mexico and Washington, were not diligent in their enforcement of their escrow statutes in 2004 and, therefore, are subject to the NPM adjustment for 2004.  The arbitration panels further found that the remaining seven states were diligent in their enforcement and, therefore, are not subject to the NPM adjustment for 2004.  Washington and Missouri have challenged those determinations in their respective state courts and with the arbitration panels, and several issues remain to be resolved by the courts that may affect the final amount of the 2004 NPM adjustment PM USA and other PMs will receive.  PM USA recorded $21 million and $3 million as a reduction in cost of sales in the third quarter of 2021 and fourth quarter of 2022, respectively, for its estimate of the minimum amount of the 2004 NPM adjustment it will receive.  PM USA estimates it is entitled to interest of approximately $23 million and $5 million in connection with the 2004 NPM adjustment, which it recorded as interest income in the third quarter of 2021 and fourth quarter of 2022, respectively.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">2005-2007 NPM Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The PMs and the nine states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes before a single arbitration panel.  The arbitration encompasses three years, 2005-2007, for eight of the nine states, and one year, 2005, for one state.  As of January 27, 2023, no decisions have resulted from the arbitration.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Subsequent Years.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No assurance can be given as to when proceedings for 2008 and subsequent years will be scheduled or the precise form those proceedings will take.</span></div><div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">In July 2022, the State of Iowa filed a motion in Iowa state court against the PMs, including PM USA, claiming that the PMs wrongfully disputed the applicability of NPM Adjustments to Iowa and that all adjustment amounts to date should have been paid to Iowa rather than deposited into the disputed payments account.  A similar enforcement motion was filed by the State of New Mexico against the PMs, including PM USA, in November 2022.  PM USA has placed certain disputed NPM Adjustment amounts attributed to Iowa and New Mexico in the disputed payments account established pursuant to the terms of the MSA.  Iowa and New Mexico seek a total of approximately $133 million and $84 million, respectively, in disputed payments from all defendants combined, as well as treble and punitive damages, and other relief.  The PMs filed a cross motion to compel arbitration in the Iowa matter, which was heard in December 2022.  A decision has not yet been issued.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Disputes Under the State Settlement Agreements: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds&#8217;s acquisition of Lorillard in 2015 and its related sale of certain cigarette brands to ITG (the &#8220;ITG transferred brands&#8221;).  PM USA filed motions to enforce the State Settlement Agreements in Florida, Minnesota, Texas and Mississippi in connection with various positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  After various court decisions in each of those states that were favorable to PM USA, those motions to enforce have now been resolved either through settlement or exhaustion of appeals, although further proceedings may occur based on the resolution of certain outstanding litigation between R.J. Reynolds and ITG.  In May 2022, PM USA filed a motion to compel arbitration under the MSA regarding certain positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  In June 2022, the matter was resolved through mutual agreement of the parties.  PM USA continues to dispute how the ITG transferred brands are treated in allocating the NPM Adjustments under the MSA and related settlements and may pursue such claims.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the tax rates used in the annual calculation of the net operating profit adjustment payments starting in 2018.  The Mississippi state court held a hearing in October 2021 and issued a decision in June 2022 granting the State&#8217;s motion.  Further proceedings remain outstanding, and a final judgment has not yet been issued.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, PM USA and other PMs reached an agreement with several MSA states to waive the PMs&#8217; claim under the most favored nation provision of the MSA in connection with a settlement between those MSA states and a non-participating manufacturer, S&amp;M Brands, Inc. (&#8220;S&amp;M Brands&#8221;), under which the states released certain claims against S&amp;M Brands in exchange for receiving a portion of the funds S&amp;M Brands deposited into escrow accounts in those states pursuant to the states&#8217; escrow statutes.  In consideration for waiving its most favored nation claim, PM USA received approximately $32 million from the escrow funds paid to those MSA states under their settlement with S&amp;M Brands.  These funds were received in January 2021 and were recorded in our condensed consolidated statement of earnings (losses) for the first quarter of 2021 as a reduction in cost of sales.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Federal Government&#8217;s Lawsuit: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 1999, the U.S. government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes.  The case ultimately proceeded only under the civil provisions of RICO.  In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight &#8220;sub-schemes&#8221; to defraud that the government had alleged.  Specifically, the court found that:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants hid from the public that cigarette smoking and nicotine are addictive;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely marketed and promoted &#8220;low tar/light&#8221; cigarettes as less harmful than full-flavor cigarettes;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants falsely denied that they intentionally marketed to youth;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants publicly and falsely denied that ETS is hazardous to non-smokers; and </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">defendants suppressed scientific research.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court did not impose monetary penalties on defendants, but ordered the following relief: (i)&#160;an injunction against &#8220;committing any act of racketeering&#8221; relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii)&#160;an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii) an injunction against &#8220;making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;&#8221; (iv) an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including &#8220;lights,&#8221; &#8220;ultra lights&#8221; and &#8220;low tar,&#8221; which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v) the issuance of &#8220;corrective statements&#8221; in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking &#8220;low tar&#8221; or &#8220;light&#8221; cigarettes, defendants&#8217; manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi) the disclosure on defendants&#8217; public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until the third quarter of 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii)&#160;the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of 10 years; (viii)&#160;certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the United States; and (ix)&#160;payment of the government&#8217;s costs in bringing the action.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties&#8217; proposed consent order implementing corrective statements in newspapers and on television.  The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017.  In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts.  The corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2014, the district court ordered further briefing on corrective statements on point-of-sale signage.  In May 2019, the district court ordered a hearing on the point-of-sale signage issue.  The hearing was subsequently vacated due to the parties reaching an agreement in principle regarding the placement of corrective statements at point-of-sale.  In December 2022, the district court entered a consent order approving the settlement.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, we recorded provisions totaling approximately $28 million for the estimated costs of implementing the corrective statements on point-of-sale signage remedy.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the U.S. government filed a motion with the district court asking for clarification as to whether the court-ordered injunction that applies to cigarettes also applies to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a heated tobacco product used with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System.  In August 2020, we filed an opposition to the government&#8217;s motion and, in the alternative, a motion to modify the injunction to make clear it does not apply to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The district court heard arguments on the motions in July 2022 and has not yet issued any decisions.  Regardless of the district court&#8217;s decisions on the pending motions, the government has indicated it will not oppose a modification to the injunction that permits PM USA to use the Modified Risk Tobacco Product claim authorized by the FDA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E-vapor Product Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2023, we are defendants in 57 class action lawsuits relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.  The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices.  Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.  The 57 class action lawsuits include 32 cases involving plaintiffs whose claims were previously included in other class </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.  Three of the class action lawsuits are pending in Canada.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have been named as defendants in other lawsuits involving JUUL e-vapor products, including 3,870 individual lawsuits and 1,406 &#8220;third party&#8221; lawsuits, which include school districts, state and local governments and tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, the U.S. Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of the federal individual and class action lawsuits mentioned above in the U.S. District Court for the Northern District of California for pretrial purposes.   In December 2022, JUUL reportedly reached agreements to resolve the Multidistrict Litigation through settlement.  In January 2023, the court preliminarily approved the settlement.  We are not a party to any settlements concerning the Multidistrict Litigation.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The court has set trial dates for three cases pending in the Multidistrict Litigation.  The first trial is currently scheduled for April 2023.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We filed motions to dismiss certain claims in the class action and school district cases, including the federal RICO claim.  In October 2020, the U.S. District Court for the Northern District of California granted the motion to dismiss the RICO class action claim without prejudice.  Although it otherwise denied the motion, the court found that plaintiffs had not sufficiently alleged standing or causation with respect to their claim under California law.  The court also granted the motion to dismiss the RICO claim in the cases filed by various school districts, but denied the motion in all other respects.  The court gave plaintiffs the opportunity to amend their complaints to attempt to cure the deficiencies the court identified and plaintiffs filed their amended complaints in November 2020.  In January 2021, we filed a renewed motion to dismiss the RICO claim, which the court denied in April 2021.  In June 2022, the court granted plaintiffs&#8217; motion to certify a California state class based on state law claims against JUUL and a nationwide class based on RICO claims against Altria and other defendants.  Altria and the other defendants filed petitions with the U.S. Court of Appeals for the Ninth Circuit seeking discretionary review of the class certification order, which the court granted in October 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional group of cases is pending in California state courts.  In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JUUL also is named in a significant number of additional individual and class action lawsuits to which we are not currently named.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Four of the &#8220;third party&#8221; lawsuits noted above against us and JUUL were initiated, individually, by the attorneys general of Alaska, Hawaii, Minnesota and New Mexico alleging violations of state consumer protection and other similar laws.  We filed motions to dismiss the lawsuits.  In Alaska, Hawaii and Minnesota, the motions were denied in February 2022, May 2021 and June 2021, respectively.  Our motion to dismiss remains pending in New Mexico.  In the Alaska lawsuit, although the trial court declined to dismiss most of the plaintiff&#8217;s claims, the trial court did dismiss plaintiff&#8217;s public nuisance claim.  The trial courts in the Alaska, Hawaii and Minnesota lawsuits have set the trials for April 2024, February 2024 and March 2023, respectively.  As of January 27, 2023, the trial court in New Mexico has not set a trial date.  JUUL is also named in other attorneys general lawsuits in which we are not currently named.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, ALCS, PMI and its affiliate, Philip Morris Products S.A., in the U.S. District Court for the Eastern District of Virginia asserting claims of patent infringement based on the sale of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System electronic device and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the United States.  Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys&#8217; fees.  Altria and PMI were previously dismissed from the lawsuit, and plaintiffs&#8217; claims against the other defendants have been stayed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA, ALCS and Philip Morris Products S.A. filed counterclaims against plaintiffs in the Eastern District of Virginia lawsuit alleging patent infringement by R.J. Reynolds&#8217; e-vapor products.  In June 2022, PM USA and ALCS reached an agreement with R.J. Reynolds resulting in dismissal of their counterclaims.  In addition, ALCS filed a separate lawsuit against R.J. Reynolds in the U.S. District Court for the Middle District of North Carolina also alleging patent infringement by R.J. Reynolds&#8217; e-vapor products.  In September 2022, a jury awarded ALCS $95 million in damages for past infringement, plus supplemental damages and interest.  In January 2023, the court ordered R.J. Reynolds to pay ALCS a 5.25% royalty on future sales of its infringing product resulting in positive net income through the expiration of the relevant patents in 2035.  As gains related to this lawsuit have not yet been determined to be realized or realizable in accordance with GAAP, they have not been recognized in our financial statements for the fiscal year ended December 31, 2022.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in April 2020, a related patent infringement action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the U.S. International Trade Commission (&#8220;ITC&#8221;), but the remedies sought included a prohibition on the importation of the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System electronic device, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and component parts into the United States and on the sale of any such products previously imported into the United States.  No damages are recoverable in the proceedings before the ITC.  In September 2021, the ITC issued a limited exclusion order barring the importation of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">System electronic device,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the infringing components into the United States and a cease and desist order barring domestic sales, marketing and distribution of these imported products.  The orders became effective on November 29, 2021.  Consequently, PM USA removed the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">System electronic </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">device and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Marlboro HeatSticks</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from the marketplace.  In December 2021, defendants appealed the orders to the U.S. Court of Appeals for the Federal Circuit and, in January 2022, the court denied defendants&#8217; motion to stay the orders pending the conclusion of the appeal.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional unrelated patent infringement case regarding the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System electronic device was filed in November 2020 in the U.S. District Court for the Northern District of Georgia against PM USA and Philip Morris Products S.A. seeking damages and equitable relief.  In February 2021, defendants filed a motion to dismiss the lawsuit, which the court granted in July 2021.  In December 2021, the U.S. District Court denied plaintiff&#8217;s motion to amend the complaint and plaintiff appealed this ruling to the U.S. Court of Appeals for the Federal Circuit, which appeal remains pending.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Antitrust Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that our 35% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (&#8220;Sherman Act&#8221;) and Section 5 of the Federal Trade Commission Act of 1914, and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (&#8220;Clayton Act&#8221;).  If the FTC&#8217;s challenge is successful, the FTC may order a broad range of remedies, including divestiture of our minority investment in JUUL, rescission of the transaction and all associated agreements, a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party&#8217;s board of directors or attending meetings of the other party&#8217;s board of directors and notice to the FTC in advance of certain corporate actions, including acquisitions, mergers or certain corporate restructurings.  In February 2022, the administrative law judge dismissed the FTC&#8217;s complaint and, also in February 2022, FTC complaint counsel appealed the administrative law judge&#8217;s decision to the FTC.  Oral argument with respect to the appeal occurred in September 2022.  After oral argument, the FTC asked for additional briefing, which was completed in December 2022.  Altria can appeal any adverse ruling the FTC issues following its review to any U.S. Court of Appeals.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also as of January 27, 2023, 17 putative class action lawsuits have been filed against Altria and JUUL in the U.S. District Court for the Northern District of California.  The lawsuits initially named, in addition to the two companies, certain senior executives and certain members of the board of directors of both companies as defendants; however, those individuals currently or formerly affiliated with Altria were later dismissed.  In November 2020 these lawsuits were consolidated into three complaints (one on behalf of direct purchasers, one on behalf of indirect purchasers and one on behalf of indirect resellers).  The consolidated lawsuits, as amended, cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1, 2 and/or 3 of the Sherman Act and Section 7 of the Clayton Act and various state antitrust, consumer protection and unjust enrichment laws by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market.  Plaintiffs seek various remedies, including treble damages, attorneys&#8217; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of our minority investment in JUUL and rescission of the transaction.  We filed a motion to dismiss these lawsuits in January 2021.  In August 2021, the U.S. District Court for the Northern District of California denied our motion to dismiss except with respect to plaintiffs&#8217; claims for injunctive and equitable relief.  However, plaintiffs were granted the opportunity to replead such claims by the trial court, which plaintiffs did in September 2021.  In January 2022, the trial court ordered that the direct-purchaser plaintiffs&#8217; claims against JUUL be sent to arbitration pursuant to an arbitration provision in JUUL&#8217;s online purchase agreement.  The court granted plaintiffs&#8217; leave to replead the complaint with new direct-purchaser plaintiffs, which plaintiffs did in February 2022, substituting in four new plaintiffs.  In August 2022, the court stayed all of the cases pending any appeal to the court of appeals from the FTC&#8217;s lawsuit against Altria and JUUL.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, we exercised our rights to convert our non-voting JUUL shares to voting shares.  In September 2022, we exercised our option to be released from our JUUL non-competition obligations, resulting in (i) the permanent termination of our non-competition obligations to JUUL, (ii) the loss of our JUUL board designation rights (other than the right to appoint one independent director so long as our ownership continues to be at least 10%), our preemptive rights, our consent rights and certain other rights with respect to our investment in JUUL and (iii) the conversion of our JUUL shares to single vote common stock, significantly reducing our voting power.  We do not currently intend to exercise our remaining governance rights or to vote our JUUL shares other than as a passive investor.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Shareholder Class Action and Shareholder Derivative Lawsuits</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In October and December 2019, two purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, our former Chairman and Chief Executive Officer, and William F. Gifford, Jr., our former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the U.S. District Court for the Eastern District of New York.  In December 2019, the court consolidated the two lawsuits into a single proceeding.  The consolidated lawsuit was subsequently transferred to the U.S. District Court for the Eastern District of Virginia.  The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act.  In April 2020, JUUL, its founders and some of its current and former executives were added to the lawsuit.  The claims allege false and misleading statements and omissions relating to our investment in JUUL.  Plaintiffs seek various remedies, including damages and attorneys&#8217; fees.  In July 2020, the defendants filed motions to dismiss plaintiffs&#8217; claims, which the district court denied in March 2021.  In the fourth quarter of 2021, plaintiffs and defendants agreed upon a class action settlement under which, among other things, (i) all claims asserted against Altria and the other named defendants are resolved without any liability or wrongdoing attributed to them personally or to Altria and (ii) Altria will pay the class an aggregate amount of $90 million, which amount includes attorneys&#8217; fees.  The class is defined to include persons and entities who purchased or otherwise acquired shares of Altria between </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 25, 2018 through April 2, 2020, subject to certain exclusions.  The trial court granted final approval of the settlement in March 2022.  We recorded pre-tax provisions totaling $90 million in 2021 and, in January 2022, paid $90 million to plaintiffs&#8217; escrow account.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal and State Shareholder Derivative Lawsuits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, two purported Altria shareholders filed separate derivative lawsuits in the U.S. District Court for the Northern District of California on behalf of themselves and Altria, against Mr. Willard, Mr. Gifford, JUUL and certain of our executives and officers.  These derivative lawsuits relate to our investment in JUUL, and assert claims of breach of fiduciary duty by the Altria defendants and aiding and abetting in that alleged breach of fiduciary duty by the remaining defendants.  In March 2021, the U.S. District Court for the Northern District of California granted defendants&#8217; motion to transfer both lawsuits to the U.S. District Court for the Eastern District of Virginia.  Three additional federal derivative lawsuits were filed in October 2020, January 2021 and March 2021, respectively, in the U.S. District Court for the Eastern District of Virginia against Mr. Willard, Mr. Gifford, Mr. Crosthwaite, certain members of our Board of Directors, JUUL, its founders and some of its current and former executives.  These suits assert various claims, including breach of fiduciary duty, unjust enrichment, waste of corporate assets and violations of certain federal securities laws.  The remedies sought in these lawsuits include damages, disgorgement of profits, reformation of our corporate governance and internal procedures, and attorneys&#8217; fees.  In April 2021, the court consolidated the five cases pending in the Eastern District of Virginia into a single case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Six derivative lawsuits have been filed in Virginia state courts against Mr. Willard, Mr. Gifford, Mr. Crosthwaite (our former Chief Growth Officer and JUUL&#8217;s current Chief Executive Officer), certain members of our Board of Directors, JUUL, its founders and some of its current and former executives.  The lawsuits were filed in September 2020, May 2021, June 2021, July 2021, August 2021 and August 2021, respectively.  The lawsuits assert various claims, including breach of fiduciary duty, and seek remedies similar to those sought by plaintiffs in the cases pending in federal court in the Eastern District of Virginia.  In successive orders from July 2021, September 2021 and January 2022, five of the six state derivative cases were consolidated into a single case.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, plaintiffs and defendants in all the federal and state derivative cases agreed upon a settlement of these cases.  Under the terms of the settlement, among other things, we agreed to fund underage tobacco prevention and cessation programs, which may include positive youth development programs, led by independent third-party organizations.  In the second and third quarters of 2022, we recorded pre-tax provisions of $7 million and $20 million, respectively, for costs associated with the independent monitoring of our funding commitments and attorneys&#8217; fees.  In January 2023, the federal trial court conducted a final approval hearing, at which the court sustained an objection to a provision of the settlement, but granted the parties additional time to resolve the issue, and scheduled a second final approval hearing for February 2023.  </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Other Tobacco-Related Litigation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8220;Lights/Ultra Lights&#8221; Cases and Other Smoking and Health Class Actions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms &#8220;Lights&#8221; and/or &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages.  These class actions have been brought against PM USA and, in certain instances, Altria or our other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes.  Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment.  Twenty-one state courts in 23 &#8220;Lights&#8221; cases have refused to certify class actions, dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA.  As of January 27, 2023, two &#8220;Lights/Ultra Lights&#8221; class actions are pending in U.S. state courts.  Neither case is active.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 27, 2023, one smoking and health case alleging personal injury or seeking court-supervised programs or an ongoing medical monitoring program on behalf of individuals exposed to environmental tobacco smoke and purporting to be brought on behalf of a class of individual plaintiffs, is pending in a U.S. state court.  The case is currently inactive.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">UST Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time.  Plaintiffs&#8217; allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.  Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement.  Defenses raised in these cases have included lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations.  As of January 27, 2023, there is no such case pending against UST and/or its tobacco subsidiaries.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Regulation</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Altria and our former subsidiaries are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the United States: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#8220;Superfund&#8221;), which can impose joint and several liability on each responsible party.  Altria and our former subsidiaries are involved in several cost recovery/contribution cases subjecting them to potential costs of remediation and natural </span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resource damages under Superfund or other laws and regulations.  We expect to continue to make capital and other expenditures in connection with environmental laws and regulations.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that we may undertake in the future.  In the opinion of our management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on our consolidated results of operations, capital expenditures, financial position or cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Guarantees and Other Similar Matters</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we have agreed to indemnify a limited number of third parties in the event of future litigation.  At December&#160;31, 2022, we (i) had $46 million of unused letters of credit obtained in the ordinary course of business and (ii) were contingently liable for guarantees related to our own performance, including $19 million for surety bonds recorded on our consolidated balance sheet.  In addition, from time to time, we issue lines of credit to affiliated entities.  These items have not had, and are not expected to have, a significant impact on our liquidity.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of a distribution agreement between Altria and PMI (the &#8220;Distribution Agreement&#8221;), entered into as a result of our 2008 spin-off of our former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer.  PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.  We do not have a related liability recorded on our consolidated balance sheet at December&#160;31, 2022 as the fair value of this indemnification is insignificant.  PMI has agreed not to seek indemnification with respect to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> System patent litigation discussed above under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">IQOS Litigation, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">excluding the patent infringement case filed with the U.S. District Court for the Northern District of Georgia.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PM USA has issued guarantees relating to our obligations under our outstanding debt securities, borrowings under our $3.0 billion Credit Agreement and amounts outstanding under our commercial paper program.  For further discussion, see Note 8. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634366736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policy)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The consolidated financial statements include Altria, as well as our wholly owned and majority-owned subsidiaries.  We account for our investments in equity securities in which we have the ability to exercise significant influence over the operating and financial policies of the investee, including ABI and Cronos, under the equity method of accounting using a one-quarter lag.  We account for our investment in the equity securities of JUUL at fair value.  All intercompany transactions and balances have been eliminated.The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the dates of the financial statements and the reported amounts of net revenues and expenses during the reporting periods.  Significant estimates and assumptions include, among other things, pension and benefit plan assumptions, lives and valuation assumptions for goodwill, other intangible assets and investments in equity securities, marketing programs and income taxes.  Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">Cash equivalents include demand deposits with banks and all highly liquid investments with original maturities of three months or less.  We record cash equivalents at cost plus accrued interest, which approximates fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock', window );">Depreciation and Amortization</a></td>
<td class="text">We record property, plant and equipment at historical costs and depreciate by the straight-line method over the estimated useful lives of the assets.  We depreciate machinery and equipment over periods up to 20 years, and buildings and building improvements over periods up to 50 years.  We amortize definite-lived intangible assets over their estimated useful lives up to 25 years.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment Testing and Asset Valuation</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying value of the assets may not be fully recoverable.  We perform undiscounted operating cash flow analyses to determine if an impairment exists.  For purposes of recognition and measurement of an impairment for assets held for use, we group assets and liabilities at the lowest level for which cash flows are separately identifiable.  If we determine that an impairment exists, any related impairment loss is calculated based on fair value.  We base impairment losses on assets to be disposed of, if any, on the estimated proceeds to be received, less costs of disposal.  We also review the estimated remaining useful lives of long-lived assets whenever events or changes in business circumstances indicate the lives may have changed.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct a required annual review of goodwill and indefinite-lived intangible assets for potential impairment, and more frequently if an event occurs or circumstances change that would require us to perform an interim review.  We have the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit or indefinite-lived intangible asset is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative impairment test.  If necessary, we will perform a single step quantitative impairment test.  Additionally, we have the option to unconditionally bypass the qualitative assessment and perform a single step quantitative assessment.  If the carrying value of a reporting unit that includes goodwill exceeds its fair value, which is determined using discounted cash flows, goodwill is considered impaired.  We measure the amount of impairment loss as the difference between the carrying value and the fair value of a reporting unit; however, the amount of the impairment loss is limited to the total amount of goodwill allocated to a reporting unit.  If the carrying value of an indefinite-lived intangible asset exceeds its fair value, which is determined using discounted cash flows, we consider the intangible asset impaired and reduce the carrying value to fair value in the period identified.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">enter into derivatives to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  We use various types of derivative financial instruments, including forward contracts, options and swaps.<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record derivative financial instruments at fair value on the consolidated balance sheets as either assets or liabilities.  We designate derivative financial instruments that qualify for hedge accounting as either fair value hedges, cash flow hedges or net investment hedges at the inception of the contracts.  For fair value hedges, we record changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, in the consolidated statements of earnings each period.  For cash flow hedges, we record changes in the fair value of the derivative each period in accumulated other comprehensive earnings (losses) and reclassify changes to the consolidated statements of earnings in the same periods in which operating results are affected by the respective hedged item.  For net investment hedges, we record changes in the fair value of the derivative or foreign currency transaction gains or losses on a nonderivative hedging instrument in accumulated other comprehensive earnings (losses) to offset the change in the value of the net investment being hedged.  Such amounts remain in accumulated other comprehensive earnings (losses) until the complete or substantially complete liquidation of the underlying foreign operations occurs for investments in foreign entities accounted for under the equity method of accounting.  We classify cash flows from hedging instruments in the same manner as the respective hedged item in the consolidated statements of cash flows.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To qualify for hedge accounting, the hedging relationship, both at inception of the hedge and on an ongoing basis, is expected to be highly effective at offsetting changes in the fair value of the hedged risk during the period that the hedge is designated.  We formally designate and document, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective, the strategy for undertaking the hedge transaction and method for assessing hedge effectiveness.  Additionally, for qualified hedges of forecasted transactions, if it becomes probable that a forecasted transaction will not occur, we would no longer consider the hedge effective and would record all of the derivative gains and losses in the consolidated statement of earnings in the current period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For financial instruments that are not designated as hedging instruments or do not qualify for hedge accounting, we record changes in fair value in the consolidated statement of earnings each period.  We do not enter into or hold derivative financial instruments for trading or speculative purposes.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock', window );">Employee Benefit Plans</a></td>
<td class="text">We provide a range of benefits to certain employees and retired employees, including pension, postretirement health care and postemployment benefits.  We record annual amounts relating to these plans based on calculations specified by GAAP, which include various actuarial assumptions as to discount rates, assumed rates of return on plan assets, mortality, compensation increases, turnover rates and health care cost trend rates.We recognize the funded status of our defined benefit pension and other postretirement plans on the consolidated balance sheets and record as a component of other comprehensive earnings (losses), net of deferred income taxes, the gains or losses and prior service costs or credits that have not been recognized as components of net periodic benefit cost (income).  We subsequently amortize the gains or losses and prior service costs or credits recorded as components of other comprehensive earnings (losses) into net periodic benefit cost (income) in future years.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EnvironmentalCostsPolicy', window );">Environmental Costs</a></td>
<td class="text">We are subject to laws and regulations relating to the protection of the environment.  We provide for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  We adjust such accruals as new information develops or circumstances change.Compliance with environmental laws and regulations, including the payment of any remediation and compliance costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on our consolidated results of operations, capital expenditures, financial position or cash flows.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">We measure certain assets and liabilities at fair value.  Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  We use a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).  The three levels of inputs used to measure fair value are:<div style="margin-top:5pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt">Unadjusted quoted prices in active markets for identical assets or liabilities.</span></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt">Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies', window );">Guarantees</a></td>
<td class="text">We recognize a liability for the fair value of the obligation of qualifying guarantee activities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">Significant judgment is required in determining income tax provisions and in evaluating tax positions.<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine deferred tax assets and liabilities based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.  We record a valuation allowance when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  We determine the realizability of deferred tax assets based on the weight of all available positive and negative evidence.  In reaching this determination, we consider the character of the assets and the possible sources of taxable income of the appropriate character within the available carryback and carryforward periods available under the tax law.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the financial statement benefit for uncertain income tax positions when it is more likely than not, based on the technical merits, that the position will be sustained upon examination by taxing authorities.  The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.  We recognize accrued interest and penalties associated with uncertain tax positions as part of the provision for income taxes in our consolidated statements of earnings.</span></div>We determine deferred tax assets and liabilities based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.  We record a valuation allowance when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  We determine the realizability of deferred tax assets based on the weight of all available positive and negative evidence.  In reaching this determination, we consider the character of the assets and the possible sources of taxable income of the appropriate character within the available carryback and carryforward periods available under the tax law.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">We use the last-in, first-out (&#8220;LIFO&#8221;) method to determine the cost of substantially all our tobacco inventories.  We determine the cost of the remaining inventories using the first-in, first-out (&#8220;FIFO&#8221;) and average cost methods.  We record inventories that are measured using the LIFO method at the lower of cost or market.  We state inventories that are measured using the FIFO and average cost methods at the lower of cost and net realizable value.  It is a generally recognized industry practice to classify leaf tobacco inventories as a current asset although part of such inventories, because of the duration of the curing and aging process, ordinarily would not be used within one year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Investments in Equity Securities</a></td>
<td class="text">Investments in equity securities in which we have the ability to exercise significant influence over the operating and financial policies of the investee are accounted for under the equity method of accounting or the fair value option.  The election of the fair value option is irrevocable and is made on an investment by investment basis.We elected to account for our investments in ABI and Cronos under the equity method of accounting.  Our share of equity (income) losses and other adjustments associated with these equity investments are included in (income) losses from investments in equity securities in our consolidated statements of earnings.  We report the carrying value for each of our equity investments in ABI and Cronos in investments in equity securities on our consolidated balance sheets.  We report equity method investments accounted for under the equity method of accounting at cost and adjust these investments each period for our share of (income) losses and dividends paid, if any.  We report our share of ABI&#8217;s and Cronos&#8217;s results using a one-quarter lag because results are not available in time for us to record them in the concurrent period.  At the end of each reporting period, we review our equity investments accounted for under the equity method of accounting for impairment by comparing the fair value of each of our investments to their carrying value.  If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, we consider the investment impaired, reduce its carrying value to its fair value and record the impairment in our consolidated statements of earnings in the period identified.  We use certain factors to make this determination including (i) the duration and magnitude of the fair value decline, (ii) the financial condition and near-term prospects of the investee and (iii) our intent and ability to hold our investment until recovery to its carrying value.<div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our investment in ABI under the equity method of accounting because we have the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#8217;s board of directors and certain ABI board committees.  Through this representation, we participate in ABI&#8217;s policy making processes.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report our share of ABI&#8217;s results using a one-quarter lag because ABI&#8217;s results are not available in time for us to record them in the concurrent period.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of our equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#8217;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  We can convert our Restricted Shares to ordinary shares at our discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.</span></div>The fair value of our equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#8217;s common shares and was classified in Level 1 of the fair value hierarchy.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock', window );">Equity Securities without Readily Determinable Fair Value</a></td>
<td class="text">Note 5. <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on how we have historically accounted for our investment in JUUL.</span>Following Share Conversion in the fourth quarter of 2020, we elected to account for our equity method investment in JUUL under the fair value option.  In making this election, we believed measuring our investment at fair value provided quarterly transparency to investors as to the fair market value of our investment in JUUL, given the changes and volatility in the e-vapor category since our initial investment, as well as the lack of publicly available information regarding JUUL&#8217;s business or a market-derived valuation.  As a result of our loss of certain rights due to our exercise of our option to be released from our JUUL non-competition obligations in the third quarter of 2022, we determined that we no longer have the ability to exercise significant influence over the operating and financial policies of JUUL.  Therefore, we are no longer able to account for our investment in JUUL as an equity method investment.  Beginning with the period ended September 30, 2022, we account for our investment in JUUL as an investment in an equity security.  We will continue to measure our investment in JUUL at fair value, in accordance with GAAP.  Our consolidated statements of earnings include any cash dividends received from our investment in JUUL (none received to date) and any changes in the estimated fair value of our investment, which is calculated quarterly.Prior to Share Conversion, we accounted for our investment in JUUL as an investment in an equity security.  Since the JUUL shares do not have a readily determinable fair value, we elected to measure our investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There were no upward or downward adjustments to the carrying value of our investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through the date of Share Conversion.  In addition, prior to Share Conversion, we reviewed our investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of our financial statements.  If this qualitative assessment indicated that our investment in JUUL may be impaired, a quantitative assessment was performed.  If the quantitative assessment indicated the estimated fair value of the investment was less than its carrying value, the investment was written down to its estimated fair value.We use an income approach to estimate the fair value of our investment in JUUL.  The income approach reflects the discounting of future cash flows for the U.S. and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.In determining the estimated fair value of our investment in JUUL, in 2022, 2021 and 2020, we made certain judgments, estimates and assumptions, the most significant of which were likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, we made judgments regarding the (i) likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#8217;s products, which have received MDOs and are now under additional administrative review; (ii) likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, the absence of which could result in JUUL seeking protection under bankruptcy or other insolvency laws; (iii) risk created by the number and types of legal cases pending against JUUL; (iv) expectations for the future state of the e-vapor category, including competitive dynamics; and (v) timing of international expansion plans.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Litigation Contingencies and Costs</a></td>
<td class="text">We record provisions in our consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  We expense litigation defense costs as incurred and include these costs in marketing, administration and research costs in our consolidated statements of earnings.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_MarketingCostsPolicyTextBlock', window );">Marketing Costs</a></td>
<td class="text">Our businesses promote their products with consumer incentives, trade promotions and consumer engagement programs.  These consumer incentive and trade promotion activities, which include discounts, coupons, rebates, in-store display incentives and volume-based incentives, do not create a distinct deliverable and are, therefore, recorded as a reduction of revenues.  We make consumer engagement program payments to third parties.  Our businesses expense these consumer engagement programs, which include event marketing, as incurred, and such expenses are included in marketing, administration and research costs in our consolidated statements of earnings.  For interim reporting purposes, our businesses charge consumer engagement programs and certain consumer incentive expenses to operations as a percentage of sales, based on estimated sales and related expenses for the full year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Our businesses generate substantially all of their revenue from sales contracts with customers.  While our businesses enter into separate sales contracts with each customer for each product type, all sales contracts are similarly structured.  These contracts create an obligation to transfer product to the customer.  Our businesses satisfy all performance obligations within one year; therefore, we expense costs to obtain contracts as incurred and do not disclose unsatisfied performance obligations.  There is no financing component because our businesses expect, at contract inception, that the period between when our businesses transfer product to the customer and when the customer pays for that product will be one year or less.<div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses define net revenues as revenues, which include excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns (also referred to as returned goods) and sales incentives.  Our businesses exclude from the transaction price sales taxes and value-added taxes imposed at the time of sale.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our businesses recognize revenues from sales contracts with customers upon shipment of goods when control of such products is obtained by the customer.  Our businesses determine that a customer obtains control of the product upon shipment when title of such product and risk of loss transfers to the customer.  Our businesses account for shipping and handling costs as fulfillment costs and such amounts are classified as part of cost of sales in our consolidated statements of earnings.  Our businesses record an allowance for returned goods, based principally on historical volume and return rates, which is included in other accrued liabilities on our consolidated balance sheets.  Our businesses record sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction to revenues (a portion of which is based on amounts estimated as being due to wholesalers, retailers and consumers at the end of a period) based principally on historical volume, utilization and redemption rates.  We include expected payments for sales incentives in accrued marketing liabilities on our consolidated balance sheets.</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms vary depending on product type.  Our businesses consider payments received in advance of product shipment as deferred revenue, which we include in other accrued liabilities on our consolidated balance sheets until revenue is recognized.  PM USA receives payment in advance of a customer obtaining control of the product.  USSTC and Helix receive substantially all payments within one business day of the customer obtaining control of the product.  We include amounts due from customers in receivables on our consolidated balance sheets.</span></div>We record an allowance for returned goods, which is included in other accrued liabilities on our consolidated balance sheets.  It is USSTC&#8217;s policy to accept authorized sales returns from its customers for products that have passed the freshness date printed on product packaging due to the limited shelf life of USSTC&#8217;s MST and snus products.  We record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  We reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on our consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, we do not record an asset for USSTC&#8217;s right to recover goods from customers upon return.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements and New Accounting Guidance Not Yet Adopted</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022, we adopted Accounting Standards Update (&#8220;ASU&#8221;) 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASU No. 2020-06&#8221;).  This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#8217;s own equity.  Our adoption of ASU No. 2020-06 did not have a material impact on our consolidated financial statements.</span> The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, us:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.585%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Standards</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect on Financial Statements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2021-08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2022-03 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_CashDiscountsPolicyTextBlock', window );">Cash Discounts</a></td>
<td class="text">We calculate substantially all cash discounts, offered to customers for prompt payment, as a flat rate per unit based on agreed-upon payment terms.  Prior to the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a percentage of the list price based on historical experience and agreed-upon payment terms.  We record receivables net of the cash discounts on our consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock', window );">Deferred revenue</a></td>
<td class="text">We record payments received by our businesses in advance of product shipment as deferred revenue.  These payments are included in other accrued liabilities on our consolidated balance sheets until control of such products is obtained by the customer.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock', window );">Methodology of Determining Fair Value of Pension Assets</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following is a description of the valuation methodologies used for investments measured at fair value.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">U.S. and Foreign Government Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: U.S. and foreign government securities consist of investments in Treasury Nominal Bonds and Inflation Protected Securities and municipal securities.  Government securities are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes.  Matrix pricing, yield curves and indices are used when broker quotes are not available.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Corporate Debt Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Corporate debt instruments are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes.  Matrix pricing, yield curves and indices are used when broker quotes are not available.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Common stocks are valued based on the price of the security as listed on an open active exchange on last trade date.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Asset Backed Securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Asset backed securities are fixed income securities such as mortgage backed securities and auto loans that are collateralized by pools of underlying assets that are unable to be sold individually.  They are valued at a price which is based on a compilation of primarily observable market information or a broker quote in a non-active over-the-counter market.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Collective Investment Funds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Collective investment funds consist of funds that are intended to mirror indices such as Standard&#160;&amp; Poor&#8217;s 500 Index and MSCI EAFE Index.  They are valued on the basis of the relative interest of each participating investor in the fair value of the underlying assets of each of the respective collective investment funds.  The underlying assets are valued based on the net asset value (&#8220;NAV&#8221;), which is provided by the investment account manager as a practical expedient to estimate fair value.  These investments are not classified by level but are disclosed to permit reconciliation to the fair value of plan assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_CashDiscountsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Discounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_CashDiscountsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_MarketingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Marketing Costs [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_MarketingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Methodology of determining fair value of pension assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pension, Other Postretirement and Postemployment Plans, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Deferred Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for depreciation, depletion, and amortization of property and equipment costs, including methods used and estimated useful lives and how impairment of such assets is assessed and recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EnvironmentalCostsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for obligations that resulted from improper or other-than normal operation of a long-lived asset in the past. This accounting policy may address (1) whether the related remediation costs are expensed or capitalized, (2) whether the obligation is measured on a discounted basis, (3) the event, situation, or set of circumstances that generally triggers recognition of loss contingencies arising from the entity's environmental remediation-related obligations, and (4) the timing of recognition of any recoveries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.Y.Q4)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149879-122751<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 55<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=6571209&amp;loc=d3e13669-110860<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13185-110859<br><br>Reference 4: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=6393242&amp;loc=d3e13231-110859<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 410<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2175709<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EnvironmentalCostsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e543-108305<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639664064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Schedule of New Accounting Pronouncements and Changes in Accounting Principles</a></td>
<td class="text">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, us:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.992%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.585%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Standards</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effective Date for Public Entity</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect on Financial Statements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2021-08</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"> Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ASU 2022-03 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e765-108305<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126900757&amp;loc=d3e725-108305<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634620864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Intangible Assets and Goodwill</a></td>
<td class="text"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and other intangible assets, net, were as follows at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.453%"><tr><td style="width:1.0%"/><td style="width:32.553%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.486%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.486%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.486%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.976%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Intangible Assets, net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,989</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,017&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products segment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,078</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,097</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">298</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,384</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,306&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in goodwill and net carrying amount of intangible assets were as follows:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:37.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Intangible Assets, net</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Intangible Assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes due to:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-13.51pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Acquisitions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">151</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Dispositions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Amortization </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,177</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,384</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,177&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,306&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisitions of certain intellectual property related to other tobacco products, which included a $50 million non-cash contribution made by JTIUH to Horizon.  For additional information regarding Horizon, see Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Dispositions related to the Ste. Michelle Transaction.  See Note 1. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consisted of the following at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:37.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived intangible assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,411</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">470</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,854</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">470</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Definite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consisted of the following at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:37.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying<br/>Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite-lived intangible assets</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,443</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,443&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definite-lived intangible assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,411</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">470</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,854</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">470</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,703&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863640991248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTableTextBlock', window );">Investment</a></td>
<td class="text"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of our investments consisted of the following at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.981%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.984%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,975</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,144&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">375</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,600</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,481&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investment in Cronos at December&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">consisted of our equity method investment in Cronos of $617 million and also included the Cronos warrant and the Fixed-price Preemptive Rights (collectively, &#8220;Investment in Cronos&#8221;), which were measured at fair value.  We irrevocably abandoned the Cronos warrant on December 15, 2022, and the Fixed-price Preemptive Rights had no value at December&#160;31, 2022.  See below for further discussion.</span></div><div style="margin-bottom:5pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Income) losses from investments in equity securities consisted of the following:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.036%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.063%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.068%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,973</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments under equity method of accounting</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,186</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JUUL </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,455</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments in equity securities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,641</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,979&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes our share of amounts recorded by our investees and additional adjustments, if required, related to (i) the conversion from international financial reporting standards to GAAP and (ii) adjustments to our investment required under the equity method of accounting.</span></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Investment in JUUL is accounted for as an investment in an equity security measured at fair value.  See below for further discussion.</span></div><div style="margin-bottom:5pt;margin-top:8pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investees&#8217; summarized financial data for our equity method investments was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.173%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.785%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.787%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For Altria&#8217;s Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57,267</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">947</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,313&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,294&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31,588</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">525</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,653&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,438&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) from continuing operations</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,879</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(521)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,434&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,265&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,879</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(521)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,434&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,266&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings (losses) attributable to equity investments</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,838</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(520)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,780&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(798)</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,323&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.457%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.296%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">At September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other Investments</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,164</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">963</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,593&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term assets</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">182,087</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">274</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">190,082&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32,649</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,540&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term liabilities</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96,497</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,973&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,277&#160;</span></td><td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible Preferred Stock</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">715&#160;</span></td><td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></div></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,778</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,356&#160;</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Reflects a one-quarter lag.  Other Investments reflect summarized financial data of Cronos, as well as JUUL&#8217;s financial data for the periods during which we accounted for our investment in JUUL as an equity method investment under the fair value option.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Equity Method Investments</a></td>
<td class="text">We recorded non-cash, pre-tax unrealized losses, representing these changes, as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.353%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.295%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed-price Preemptive Rights</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos warrant</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the beginning and ending balance of our investment in JUUL, which is classified in Level 3 of the fair value hierarchy:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:79.774%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.343%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investment Balance</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in (income) losses from investments in equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,705&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gains (losses) included in (income) losses from investments in equity securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 325<br> -URI https://asc.fasb.org/topic&amp;trid=2197064<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -URI https://asc.fasb.org/topic&amp;trid=75115024<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639548816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Aggregate Fair Value and Carrying Value</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate carrying value and fair value of our total long-term debt were as follows at December 31:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.293%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.294%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,044&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,928</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,459&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt included in long-term debt:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carrying value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,540</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,165</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,114&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pre-tax effects of our net investment hedges on accumulated other comprehensive losses and our consolidated statements of earnings were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.835%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Gain) Loss Recognized <br/>in Net Earnings</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency denominated debt</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(281)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639540544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Components of Long-Term Debt</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term debt consisted of the following at December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"/><td style="width:72.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes, 2.350% to 10.20%, interest payable semi-annually, due through 2061</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,098</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,185&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD debenture, 7.75%, interest payable semi-annually, due 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">42</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes, 1.000% to 3.125%, interest payable annually, due through 2031 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,540</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,044&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,556</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,124</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,939&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average coupon interest rate of and 4.4% at December&#160;31, 2022 and 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Weighted-average coupon interest rate of 2.0% at December&#160;31, 2022 and 2021.</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, our outstanding long-term debt consisted of the following:</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.069%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.071%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Type</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Interest Rate</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Issuance</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maturity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8364;1,250</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.000%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$218</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.950%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$776</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.000%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2013</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$345</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.800%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$750</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.350%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8364;750</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.700%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,069</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.400%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2026</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$500</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.625%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD debenture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$42</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.750%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1997</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2027</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8364;1,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.200%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,906</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.800%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2029</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$750</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.400%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2030</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Euro notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8364;1,250</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.125%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2031</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,750</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.450%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2032</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$177</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9.950%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2008</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2038</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$208</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10.200%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2009</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2039</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.800%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2039</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,500</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.400%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2041</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$900</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.250%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2012</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 2042</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$650</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.500%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2013</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2043</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,800</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2013</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2044</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,500</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.875%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2016</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 2046</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$2,500</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.950%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2049</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$500</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.450%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 2050</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,250</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.700%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2051</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$271</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.200%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2059</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">USD notes</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$1,000</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.000%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2061</span></td></tr></table></div>Details of the debt tender offers were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Principal Amount of Notes Purchased</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.850% Notes due 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">795</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.950% Notes due 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.000% Notes due 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">624</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.800% Notes due 2024</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">655</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.400% Notes due 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">430</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.800% Notes due 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,094</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.950% Notes due 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.200% Notes due 2039</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.200% Notes due 2059</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,042</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Aggregate Maturities of Long-Term Debt</a></td>
<td class="text"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, aggregate maturities of our long-term debt were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.501%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.518%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate Maturities</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,556</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,121</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,553</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,569</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,113</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,912</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">148</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">debt discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">84</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">26,680</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639763968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock', window );">Schedule Components of Issued, Repurchased and Outstanding Shares</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had 12 billion shares of authorized common stock; issued, repurchased and outstanding shares of common stock consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"/><td style="width:48.284%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.315%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.315%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.320%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Repurchased</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares Outstanding</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805,961,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(947,979,763)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,857,981,554&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805,961,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(947,542,152)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858,419,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,656,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,656,116)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,805,961,317&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(982,785,699)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,823,175,618&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock award activity</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">514,816</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">514,816</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(38,156,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(38,156,312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances, December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,805,961,317</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,020,427,195)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,785,534,122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Share Repurchases</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total share repurchase activity was as follows for the years ending December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.003%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.346%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.563%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 2021 Share Repurchase Program</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total number of shares repurchased</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aggregate cost of shares repurchased</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,825</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average price per share of shares repurchased</span></div></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47.83</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.97&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.42&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639563536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of Restricted Stock Units Activity</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.878%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.069%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.070%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,702,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,206,601</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">49.22</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(556,399)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51.96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(94,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45.10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,257,795</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">46.90</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639581904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Earnings (Losses) Per Share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculated basic and diluted earnings per share (&#8220;EPS&#8221;) using the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:64.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.858%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.858%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.863%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to Altria</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,764</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Distributed and undistributed earnings attributable to share-based awards</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings for basic and diluted EPS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,751</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for basic EPS</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,804</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,858&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: contingently issuable PSUs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares for diluted EPS</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,804</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,859&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639784880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.938%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.965%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.985%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.429%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Benefit Plans</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ABI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Currency<br/>Translation<br/>Adjustments<br/>and Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Losses</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,192)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(693)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,864)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(454)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,613)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,071)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:13.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(339)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,261)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,604)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of </span></div><div style="padding-left:38.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,477)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,420)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,938)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,341)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">627&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(141)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,227&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of </span></div><div style="padding-left:38.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,612)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,512)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,056)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">145</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(33)</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">387</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(65)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">210</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(33)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">88</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings, net of </span></div><div style="padding-left:38.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">deferred income taxes </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(67)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:42.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive earnings (losses), net of deferred income taxes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">143</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">285</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances, December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,436)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(1,369)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(2,771)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Primarily reflected our share of ABI&#8217;s currency translation adjustments and the impact of our designated net investment hedges related to our equity investment in ABI.  For further discussion of designated net investment hedges, see Note 6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock', window );">Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:61.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.991%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.306%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.721%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.306%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.727%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit Plans: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABI </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(85)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency Translation Adjustments and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts were included in net defined benefit plan costs.  For further details, see Note 15. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Amounts were included in (income) losses from investments in equity securities.  For further information, see Note 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Investments in Equity Securities.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 amounts were included in marketing, administration and research costs and are related to the Ste. Michelle Transaction.  For further details, see Note 15. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Benefit Plans.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863636550912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Earnings Before Income Taxes and Provision for Income Taxes</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (losses) before income taxes and provision (benefit) for income taxes consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.562%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings (losses) before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,628</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(239)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,890&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,968</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outside United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,572</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,509&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(893)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(947)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,160)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,625</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock', window );">Reconciliation of Beginning and Ending Unrecognized Tax Benefits</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.550%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.561%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.562%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">53</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions due to lapse of statutes of limitations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">69</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of Effective Tax Rate and U.S. Federal Statutory Rate</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation between actual income taxes and amounts computed by applying the federal statutory rate to earnings before income taxes was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.522%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.369%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. federal statutory rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,552</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,447&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) resulting from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State and local income taxes, net of federal tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">435</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.9</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax basis in foreign investments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax positions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in ABI</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in JUUL</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">306</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Cronos</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance releases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(664)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(9.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(21)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,625</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,349&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Income Tax Assets and Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax effects of temporary differences that gave rise to deferred income tax assets and liabilities consisted of the following at December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.517%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.249%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.251%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued postretirement and postemployment benefits</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">303</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">729</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in JUUL</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,001</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in Cronos</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">407</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses and tax credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,323&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(233)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(216)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,849)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,802)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in ABI</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,226)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,695)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued pension costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(115)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,493)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,891)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,800)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,097)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,822)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,665)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfValuationAllowanceTextBlock', window );">Summary of Valuation Allowance</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending valuation allowances was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.607%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,097</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to valuation allowance charged to income tax expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">429</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions to valuation allowance credited to income tax benefit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,800</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,097&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,817&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits, excluding amounts pertaining to examined tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfValuationAllowanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfValuationAllowanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863641053248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Data Schedule</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data were as follows:</span></div><div style="margin-bottom:5pt;margin-top:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.241%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,476</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,866&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,089&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,580</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,608&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">25,096</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,013&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,153&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OCI:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,688</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,394&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,632</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,718&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(360)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(73)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(292)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,919</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,560&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,058</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on early extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit income, excluding service cost </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(184)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Income) losses from investments in equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,641</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,979&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of JUUL equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on Cronos-related financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,389</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,890&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock', window );">Schedule of Depreciation Expense and Capital Expenditures of Segments</a></td>
<td class="text"><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of our depreciation expense and capital expenditures were as follows:</span></div><div style="margin-bottom:5pt;margin-top:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.785%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.241%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total depreciation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">153</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">68</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oral tobacco products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total capital expenditures</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">205</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock', window );">Schedule Of Non-Participating Manufacturer Adjustment Items</a></td>
<td class="text">We recorded pre-tax (income) expense for NPM adjustment items as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.102%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.241%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(68)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock', window );">Schedule of Tobacco and Health and Certain Other Litigation Items</a></td>
<td class="text">We recorded pre-tax charges related to tobacco and health and certain other litigation items as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.834%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.238%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.241%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smokeable products segment</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">131</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Non-Participating Manufacturer Adjustment Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Tobacco and Health and Certain Other Litigation Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629557152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock', window );">Projected Benefit Obligations, Plan Assets and Funded Status of Pension Plans</a></td>
<td class="text">Benefit obligations, plan assets and funded status for our pension and postretirement plans were as follows at December 31:<div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"/><td style="width:60.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.851%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Benefit obligation at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,544</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,688</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Service cost</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest cost</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Benefits paid</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Plan amendments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Divestiture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,292</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Fair value of plan assets at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,793</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">185</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,748)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Employer contributions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Benefits paid</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Divestiture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,793&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Funded status at December&#160;31</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,153)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on our consolidated balance sheets were as follows:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">469</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other accrued liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued pension costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued postretirement health care costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,083)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,436)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,153)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Divestiture of benefit obligations and plan assets related to the Ste. Michelle Transaction.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock', window );">Net Pension Liability Recognized in Consolidated Balance Sheets</a></td>
<td class="text">Benefit obligations, plan assets and funded status for our pension and postretirement plans were as follows at December 31:<div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"/><td style="width:60.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.347%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.851%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.655%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in benefit obligation:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Benefit obligation at beginning of year</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,544</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,465&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,688</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Service cost</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Interest cost</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Benefits paid</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,060)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(523)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Plan amendments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Divestiture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(193)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit obligation at end of year</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,292</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,544&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,275</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change in plan assets:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Fair value of plan assets at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,793</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">185</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Actual return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,748)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Employer contributions</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Benefits paid</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(465)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Divestiture</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(145)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of plan assets at end of year</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,793&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Funded status at December&#160;31</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,153)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts recognized on our consolidated balance sheets were as follows:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other assets</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">469</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Other accrued liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued pension costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Accrued postretirement health care costs</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,083)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,436)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">311</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,153)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,503)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Divestiture of benefit obligations and plan assets related to the Ste. Michelle Transaction.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock', window );">Assumptions used to Determine Benefit Obligations</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used the following assumptions to determine our pension and postretirement benefit obligations at December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.140%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.737%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase - long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost trend rate assumed for next year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Ultimate trend rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Year that the rate reaches the ultimate trend rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Schedule of Net Benefit Costs</a></td>
<td class="text">Net periodic benefit cost (income) consisted of the following for the years ended December 31:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.007%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.846%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.589%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">206</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(493)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(522)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(502)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost (credit)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net periodic benefit cost (income)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(121)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock', window );">Schedule Of Assumptions To Determine Net Periodic Benefit Cost</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following assumptions were used to determine our net periodic benefit cost for the years ended December&#160;31:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:37.941%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.352%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.215%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.357%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount rates:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Service cost</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest cost </span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected rate of return on plan assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rate of compensation increase - long-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost trend rate</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Fair Value of Plan Assets by Asset Category</a></td>
<td class="text"><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actual composition of our plan assets at December&#160;31, 2022 was broadly characterized with the following allocation:</span></div><div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.889%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.517%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">52</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and foreign government securities and all other investments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amount includes U.S Treasury and foreign government securities (19%) and asset based securities and all other investments (9%).</span></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our pension plan assets by asset category were as follows at December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.757%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. and foreign government securities or their agencies:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agencies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,098</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,098</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. municipal bonds</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government and agencies</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">32</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Above investment grade</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,747</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,747</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Below investment grade and no rating</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">756</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">756</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International equities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">327</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. equities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">591</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">591</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset backed securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">161</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">244</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">243</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">917</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,120</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,037</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,287&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV as a practical expedient for fair value:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collective investment funds</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_41b4c8e3-e050-43b8-b106-4405c53c782d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_9c77b5ce-ddae-4a3d-978b-ba5336576f53">U.S. large cap</span></span></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">312</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_1ddffbe6-a65c-4290-90a9-b5306bc7faca"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_c2aa8d53-307d-44de-88c6-ccc45057da99">U.S. small cap</span></span>  </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_6c58378e-c0bf-4554-a791-6444e99557ba"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_c4015aef-675a-4e45-9c95-609287b0df60">International developed markets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">49</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments measured at NAV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">436</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of plan assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,603</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,793&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 holdings and transactions were immaterial to total plan assets at December&#160;31, 2022 and 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of our postretirement plan assets were as follows at December 31:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.757%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.892%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. and foreign government securities or their agencies:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government and agencies</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign government and agencies</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt instruments:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Above investment grade</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Below investment grade and no rating</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments measured at NAV as a practical expedient for fair value:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Collective investment funds:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_295077d8-7c2c-4293-a53f-d6212cd1c050"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_bff869f3-0247-42fe-9766-2e8c8f382544">U.S. large cap</span></span></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_501091e4-8056-4777-bd80-73ee1b31781b"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_eef6c587-6a34-4f41-a17b-d1245eda6984">International developed markets</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investments measured at NAV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">65</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Fair value of plan assets, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">122</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">185&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Estimated Future Benefit Payments</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated future benefit payments at December&#160;31, 2022 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"><tr><td style="width:1.0%"/><td style="width:69.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.146%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.149%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Postretirement</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">494</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">106</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">471</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">472</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">473</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028-2032</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,355</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">477</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Amounts Recognized in Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the following amounts in accumulated other comprehensive losses at December&#160;31, 2022:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>employment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,180)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(34)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2,213)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service (cost) credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">293</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">264</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">571</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">513</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded in accumulated other comprehensive losses</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,633)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">226</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(29)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1,436)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded the following amounts in accumulated other comprehensive losses at December&#160;31, 2021:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>employment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,093)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(362)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,487)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service (cost) credit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts recorded in accumulated other comprehensive losses</span></div></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,574)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,612)</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock', window );">Movements in Other Comprehensive Earnings/Losses</a></td>
<td class="text"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2022 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>employment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings as components of net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">127</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(20)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other movements during the year:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(183)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">345</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">147</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(135)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">256</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">110</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total movements in other comprehensive earnings/losses</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(59)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">236</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">176</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;padding-left:9pt;text-indent:-9.01pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2021 were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-employment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings as components of net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-0.01pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other movements during the year:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total movements in other comprehensive earnings/losses</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">808&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.828%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.833%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>retirement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Post-<br/>employment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts reclassified to net earnings as components of net periodic benefit cost:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other movements during the year:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(448)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior service cost/credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(204)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(339)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total movements in other comprehensive earnings/losses</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(137)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(228)</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Assumptions To Determine Net Periodic Benefit Cost [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(b)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAssumptionsUsedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAssumptionsUsedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in plan assets and benefit obligations recognized in other comprehensive income (loss) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629347664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Other Nonoperating Income (Expense)</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"/><td style="width:64.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.843%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.843%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.848%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">162</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other debt expense, net:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,128</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,058</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,162&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,209&#160;</span></td><td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock', window );">Schedule of Valuation and Qualifying Accounts</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The activity in the allowance for discounts and allowance for returned goods was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.677%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.482%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.683%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Returned Goods</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Returned Goods</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Returned Goods</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charged to costs and expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">607</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(106)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(647)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(633)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">41</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Represents the recording of discounts and returns for which allowances were created</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleofValuationandQualifyingAccountsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Valuation and Qualifying Accounts [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleofValuationandQualifyingAccountsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863641043760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock', window );">Schedule of Contingencies</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.249%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.599%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.599%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:1.575%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.603%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other litigation items at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-tax charges for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tobacco and health and certain other litigation </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholder class action and shareholder derivative lawsuits </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:27pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Related interest costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><div><span><br/></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liability for tobacco and health and certain other litigation items at end of period</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">71</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes judgments, settlements and fee disputes associated with tobacco and health and certain other litigation.</span></div><div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">hareholder Class Action and Shareholder Derivative Lawsuits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below for discussions of the shareholder class action case and related settlement and the pending settlement of the federal and state shareholder derivative lawsuits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below lists the number of certain tobacco-related cases pending in the United States against us as of December 31:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.604%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.607%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Smoking and Health Cases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">162</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Cost Recovery Actions </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-vapor Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5,283</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,296</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,563</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Tobacco-Related Cases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr></table></div><div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes as of December 31, 2022, 17 cases filed in Illinois, 20 cases filed in New Mexico, 37 cases filed in Massachusetts and 51 non-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">case (these </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> progeny cases are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Smoking and Health Litigation - Engle Class Action</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  Also does not include 1,395 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#8220;ETS&#8221;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Broin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.</span></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Health Care Cost Recovery Litigation - Federal Government&#8217;s Lawsuit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> below.</span></div><div style="margin-bottom:1pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes as of December 31, 2022, 57 class action lawsuits, 3,830 individual lawsuits and 1,396 &#8220;third party&#8221; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  The 57 class action lawsuits include 32 cases in the Northern District of California (&#8220;Multidistrict Litigation&#8221; or &#8220;MDL&#8221;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.</span></div><div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes as of December 31, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms &#8220;Lights&#8221; and &#8220;Ultra Lights&#8221; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Currently Pending Engle Cases with Verdicts Against PM USA </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"/><td style="width:9.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.159%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.282%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensatory Damages </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Punitive Damages <br/>(PM USA)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Post-Trial Status</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Hoffman</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2023</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5 million ($3 million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Awaiting entry of final judgment by the trial court.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Levine</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1 million</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Appeals by defendants and plaintiff to Third District Court of Appeal pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Schertzer</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Appeal by defendants to the Third District Court of Appeal pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Lipp</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$15 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$28 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to Third District Court of Appeal pending.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Garcia</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$6 million ($3 million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Appeal by defendant to the Third District Court of Appeal pending.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Duignan</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2020 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pinellas</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Florida Supreme Court quashed the Second District Court of Appeal&#8217;s affirmation of  judgment against the defendants and remanded the case for reconsideration in light of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McCall</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2019</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1&#160;million (&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">New trial on punitive damages is set for April 2023.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chadwell</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2018</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third District Court of Appeal has ordered supplemental briefing in accordance with the decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kaplan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">McLaughlin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">July 2018</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2&#160;million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Florida Supreme Court vacated the punitive damages award in accordance with the decision in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">.  The Fourth District Court of Appeals affirmed the compensatory damages award and granted a new trial on punitive damages.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cooper</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Blackwood</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2015</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Broward</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5&#160;million </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(&lt;$1&#160;million PM USA)</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$0</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth District Court of Appeal affirmed the compensatory damages award and granted a new trial on punitive damages.</span></td></tr></table></div><div style="margin-bottom:1pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">PM USA&#8217;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Plaintiff&#8217;s verdict following a retrial of an initial verdict in favor of plaintiff.</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> PM USA is not a defendant in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Prentice</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sheffield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">, which are discussed below in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Engle Progeny Appellate Issues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Engle Cases Concluded Within Past 12 Months </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(rounded to nearest $ million)</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.180%"><tr><td style="width:1.0%"/><td style="width:9.919%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.123%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.123%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.638%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Plaintiff</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Verdict Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Defendant(s)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Court</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accrual Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Amount for Damages (if any)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Payment Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Miller</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">September 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA and R.J. Reynolds</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third quarter of 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1 million</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">December 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Tuttle</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third quarter of 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&lt;$1 million</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">October 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Cuddihee</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2020</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Duval</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Second quarter of 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2 million</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">June 2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Holliman</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2019</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Miami-Dade</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fourth quarter of 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3 million</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">D. Brown</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2015</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PM USA</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal Court - Middle District of Florida</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Third quarter of 2022</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$5 million</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">August 2022</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12053-110248<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863635921760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background and Basis of Presentation (Background Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_NumberOfLeveragedLeasesRemaining', window );">Number of leveraged leases remaining | lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from the Ste. Michelle Transaction, net of cash transferred</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,176<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries', window );">Payments to acquire additional interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=mo_HorizonMember', window );">Horizon {Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OwnershipPercentageInConsolidatedSubsidiary', window );">Ownership percentage in consolidated subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=mo_HorizonMember', window );">Horizon {Member] | JTIUH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest, ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=mo_HelixInnovationsLLCMember', window );">Helix Innovations LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_NoncontrollingInterestRemainingInterestPurchasedByParent', window );">Noncontrolling interest, remaining interest purchased by parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_NoncontrollingInterestRemainingInterestPurchasedByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Remaining Interest Purchased By Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_NoncontrollingInterestRemainingInterestPurchasedByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_NumberOfLeveragedLeasesRemaining">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Leveraged Leases Remaining</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_NumberOfLeveragedLeasesRemaining</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OwnershipPercentageInConsolidatedSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ownership Percentage In Consolidated Subsidiary</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OwnershipPercentageInConsolidatedSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of noncontrolling interest during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mo_HorizonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mo_HorizonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_JTIUHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_JTIUHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=mo_HelixInnovationsLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=mo_HelixInnovationsLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634292128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PercentageOfLIFOInventory', window );">Inventories determined using LIFO method</a></td>
<td class="nump">79.00%<span></span>
</td>
<td class="nump">81.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue', window );">Current cost of inventories over LIFO amounts</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_RevenueContractDuration', window );">Revenue, contract duration</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming', window );">Revenue, performance obligation, description of timing</a></td>
<td class="text">three days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Definite-lived intangible assets useful life maximum, years</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Machinery and Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property, plant and equipment</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member] | Building and Building Improvements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful life of property, plant and equipment</a></td>
<td class="text">50 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_USSTCMember', window );">USSTC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming', window );">Revenue, performance obligation, description of timing</a></td>
<td class="text">one business day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_RevenueContractDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Contract Duration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_RevenueContractDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The excess of replacement or current cost over the stated LIFO (last in first out) inventory value when the LIFO inventory method is utilized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PercentageOfLIFOInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PercentageOfLIFOInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationDescriptionOfTiming</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_USSTCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_USSTCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863636727872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues from Contracts with Customers (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract with customer, liability</a></td>
<td class="nump">$ 252<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming', window );">Revenue, performance obligation, description of timing</a></td>
<td class="text">three days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationDescriptionOfTiming">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationDescriptionOfTiming</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629696128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Intangible Assets by Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 5,177<span></span>
</td>
<td class="nump">$ 5,177<span></span>
</td>
<td class="nump">$ 5,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other Intangible Assets, net</a></td>
<td class="nump">12,384<span></span>
</td>
<td class="nump">12,306<span></span>
</td>
<td class="nump">$ 12,615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other Intangible Assets, net</a></td>
<td class="nump">2,989<span></span>
</td>
<td class="nump">3,017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember', window );">Oral Tobacco Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">5,078<span></span>
</td>
<td class="nump">5,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other Intangible Assets, net</a></td>
<td class="nump">9,097<span></span>
</td>
<td class="nump">9,129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillLineItems', window );"><strong>Goodwill [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other Intangible Assets, net</a></td>
<td class="nump">$ 298<span></span>
</td>
<td class="nump">$ 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863632864832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets, net (Other Intangible Assets Disclosure) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">$ 11,443<span></span>
</td>
<td class="nump">$ 11,443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Definite-lived intangible assets</a></td>
<td class="nump">1,411<span></span>
</td>
<td class="nump">1,260<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Total other intangible assets</a></td>
<td class="nump">12,854<span></span>
</td>
<td class="nump">12,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Definite-lived intangible assets, accumulated amortization</a></td>
<td class="nump">$ 470<span></span>
</td>
<td class="nump">$ 397<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634149712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets, net (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 15, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 19, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,000,000<span></span>
</td>
<td class="nump">$ 72,000,000<span></span>
</td>
<td class="nump">$ 72,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Estimated future amortization, year 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Estimated future amortization, year 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Estimated future amortization, year 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Estimated future amortization, year 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Estimated future amortization, year 5</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Accumulated goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | IQOS Tobacco Heating System</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment', window );">Disposal group, purchase agreement, consideration, initial payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate', window );">Disposal group, purchase agreement, effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement', window );">Disposal group, deferred gain on sale of rights under an agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DisposalGroupReceivable', window );">Disposal group, receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DisposalGroupInterestReceivable', window );">Disposal group, interest receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome', window );">Disposal group, including discontinued operation, interest income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash', window );">Disposal group, including discontinued operation, cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | IQOS Tobacco Heating System | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment', window );">Disposal group, purchase agreement, consideration, additional payment</a></td>
<td class="nump">$ 1,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ProceedsFromSaleOfRightsUnderAnAgreement', window );">Proceeds from sale of rights under an agreement</a></td>
<td class="nump">$ 2,700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mo_MiddletonMember', window );">Middleton [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTrademarks', window );">Indefinite-lived trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mo_USTIncMember', window );">UST Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTrademarks', window );">Indefinite-lived trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mo_USTIncMember', window );">UST Inc. [Member] | Copenhagen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTrademarks', window );">Indefinite-lived trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mo_USTIncMember', window );">UST Inc. [Member] | Skoal [ Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTrademarks', window );">Indefinite-lived trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=mo_USTIncMember', window );">UST Inc. [Member] | Trademarks, MST [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedTrademarks', window );">Indefinite-lived trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average [Member] | Definite-Lived Intangible Assets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Definite-lived intangible assets amortization period, weighted average, in years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Deferred Gain on Sale Of Rights Under An Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupInterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Interest Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupInterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Purchase Agreement, Consideration, Additional Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Purchase Agreement, Consideration, Initial Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupPurchaseAgreementEffectiveInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Purchase Agreement, Effective Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupPurchaseAgreementEffectiveInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ProceedsFromSaleOfRightsUnderAnAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Sale Of Rights Under An Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ProceedsFromSaleOfRightsUnderAnAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand, demand deposits with banks or financial institutions, and other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedTrademarks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedTrademarks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_IQOSTobaccoHeatingSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_IQOSTobaccoHeatingSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mo_MiddletonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mo_MiddletonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=mo_USTIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=mo_USTIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mo_TrademarksCopenhagenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mo_TrademarksCopenhagenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mo_TrademarksSkoalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mo_TrademarksSkoalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mo_TrademarksMSTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=mo_TrademarksMSTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IntangibleAssetsAxis=mo_DefiniteLivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IntangibleAssetsAxis=mo_DefiniteLivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863633047616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Net Carrying Amount of Intangible Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance at beginning of period</a></td>
<td class="nump">$ 5,177<span></span>
</td>
<td class="nump">$ 5,177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions (1)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Dispositions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Balance of end of period</a></td>
<td class="nump">5,177<span></span>
</td>
<td class="nump">5,177<span></span>
</td>
<td class="nump">$ 5,177<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_IntangibleAssetsRollForward', window );"><strong>Other Intangible Assets, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Balance beginning of period</a></td>
<td class="nump">12,306<span></span>
</td>
<td class="nump">12,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired', window );">Acquisitions (1)</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit', window );">Dispositions</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(237)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization</a></td>
<td class="num">(73)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Balance end of period</a></td>
<td class="nump">12,384<span></span>
</td>
<td class="nump">$ 12,306<span></span>
</td>
<td class="nump">$ 12,615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_JTIUHMember', window );">JTIUH [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_IntangibleAssetsRollForward', window );"><strong>Other Intangible Assets, net</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1', window );">Noncash or part noncash acquisition, intangible assets acquired</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indefinite-Lived And Finite Lived Intangible Assets, Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indefinite-lived And Finite Lived Intangible Assets, Written Off Related to Sale of Business Unit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IntangibleAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IntangibleAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_JTIUHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_JTIUHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634583312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments in Equity Securities (Summary of Investments) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total</a></td>
<td class="nump">$ 9,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,481,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">8,975,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,144,000,000<span></span>
</td>
<td class="nump">$ 11,200,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent', window );">Equity securities, FV-NI</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,705,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 437,000,000<span></span>
</td>
<td class="nump">617,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights', window );">Equity method investments including warrants and fixed price preemptive rights</a></td>
<td class="nump">375,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">632,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentsFixedPreemptiveRights', window );">Equity method investments, fixed preemptive rights</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights', window );">Equity method investments including warrants and fixed price preemptive rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 617,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentsFixedPreemptiveRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Fixed Preemptive Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentsFixedPreemptiveRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Including Warrants and Fixed-Price Preemptive Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Investments [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863633898432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Earnings from Equity Investments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from investments in equity securities</a></td>
<td class="nump">$ 2,186<span></span>
</td>
<td class="nump">$ 5,979<span></span>
</td>
<td class="nump">$ 211<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestments', window );">(Income) losses from investments in equity securities</a></td>
<td class="nump">3,641<span></span>
</td>
<td class="nump">5,979<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from investments in equity securities</a></td>
<td class="nump">1,973<span></span>
</td>
<td class="nump">5,564<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from investments in equity securities</a></td>
<td class="nump">213<span></span>
</td>
<td class="nump">415<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">JUUL</a></td>
<td class="nump">$ 1,455<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (100)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Investments [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863628059072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Summary of Financial Data) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 25,096<span></span>
</td>
<td class="nump">$ 26,013<span></span>
</td>
<td class="nump">$ 26,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">14,246<span></span>
</td>
<td class="nump">13,992<span></span>
</td>
<td class="nump">13,023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations</a></td>
<td class="nump">7,389<span></span>
</td>
<td class="nump">3,824<span></span>
</td>
<td class="nump">6,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="nump">5,764<span></span>
</td>
<td class="nump">2,475<span></span>
</td>
<td class="nump">4,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings (losses) attributable to equity investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">7,220<span></span>
</td>
<td class="nump">6,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">8,616<span></span>
</td>
<td class="nump">8,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">57,267<span></span>
</td>
<td class="nump">52,864<span></span>
</td>
<td class="nump">48,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">31,588<span></span>
</td>
<td class="nump">30,653<span></span>
</td>
<td class="nump">28,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations</a></td>
<td class="nump">7,879<span></span>
</td>
<td class="nump">7,434<span></span>
</td>
<td class="nump">4,265<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="nump">7,879<span></span>
</td>
<td class="nump">7,434<span></span>
</td>
<td class="nump">4,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings (losses) attributable to equity investments</a></td>
<td class="nump">5,838<span></span>
</td>
<td class="nump">5,780<span></span>
</td>
<td class="nump">3,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,164<span></span>
</td>
<td class="nump">$ 21,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">182,087<span></span>
</td>
<td class="nump">190,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,649<span></span>
</td>
<td class="nump">33,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,497<span></span>
</td>
<td class="nump">105,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,778<span></span>
</td>
<td class="nump">11,356<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=mo_JUULAndCronosMember', window );">Other Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">947<span></span>
</td>
<td class="nump">1,313<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">757<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (losses) from continuing operations</a></td>
<td class="num">(521)<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net earnings (losses)</a></td>
<td class="num">(521)<span></span>
</td>
<td class="num">(800)<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net earnings (losses) attributable to equity investments</a></td>
<td class="num">$ (520)<span></span>
</td>
<td class="num">$ (798)<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">963<span></span>
</td>
<td class="nump">1,882<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="nump">1,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">2,277<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue', window );">Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">715<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
<td class="num">$ (3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=mo_JUULAndCronosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=mo_JUULAndCronosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863632634496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in ABI Narrative) (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Fair value of investment</a></td>
<td class="nump">$ 11,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted', window );">Equity method investment, number of shares owned, restricted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon', window );">Equity method investment, number of shares owned, common (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200<span></span>
</td>
<td class="nump">$ 8,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,144<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage', window );">Equity method investment, difference between carrying amount and fair value, percentage</a></td>
<td class="num">(22.00%)<span></span>
</td>
<td class="num">(35.00%)<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentImpairment', window );">Equity method investment, impairment</a></td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity', window );">Difference between carrying amount and underlying equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 [Member] | ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Fair value of investment</a></td>
<td class="nump">9,000<span></span>
</td>
<td class="nump">11,200<span></span>
</td>
<td class="nump">$ 11,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue', window );">Equity method investment, difference between carrying amount and fair value</a></td>
<td class="num">$ (2,500)<span></span>
</td>
<td class="num">$ (6,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,100)<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage', window );">Equity method investment, difference between carrying amount and fair value, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.00%)<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Difference Between Carrying Amount and Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Owned, Common</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesOwnedCommon</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesOwnedRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Owned, Restricted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesOwnedRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Investments [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investments accounted under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126960272&amp;loc=d3e32014-111567<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863628024256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in JUUL Narrative) (Details) - USD ($)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount', window );">Equity securities without readily determinable fair value, upward price adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount', window );">Equity securities without readily determinable fair value, downward price adjustment, cumulative amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue', window );">Payments to acquire equity securities without readily determinable fair value</a></td>
<td class="nump">$ 12,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage', window );">Equity securities without readily determinable fair value, ownership percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentOwnedBalancePercentage', window );">Investment owned, balance, percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Investment owned, balance, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue', window );">Non-compete release trigger percentage of initial investment carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount', window );">Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount</a></td>
<td class="nump">$ 12,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity securities without readily determinable fair value, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Equity securities, FV-NI, unrealized gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,455,000,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityInvestmentFairValueOption', window );">Estimated fair value of JUUL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityInvestmentFairValueOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Investment, Fair Value Option</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityInvestmentFairValueOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentOwnedBalancePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Owned, Balance, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentOwnedBalancePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Investments [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Equity Securities Without Readily Determinable Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863636812288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details) - Equity Securities - JUUL [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at beginning of period</a></td>
<td class="nump">$ 1,705<span></span>
</td>
<td class="nump">$ 1,705<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Unrealized gains (losses) included in (income) losses from investments in equity securities</a></td>
<td class="num">(1,455)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at end of period</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="nump">$ 1,705<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629538384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in Cronos Narrative) (Details)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Fair value of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment, ownership percentage (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.10%<span></span>
</td>
<td class="nump">41.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon', window );">Equity method investment, number of shares owned, common (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">$ 437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Fair value of investment</a></td>
<td class="nump">$ 437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage', window );">Equity method investment, difference between carrying amount and fair value, percentage</a></td>
<td class="num">(20.00%)<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="num">(25.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue', window );">Equity method investment, difference between carrying amount and fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentImpairment', window );">Equity method investment, impairment</a></td>
<td class="nump">$ 107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Equity Contract, Preemptive Rights [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentPricePerShareIfExercised', window );">Equity method investment, price per share if exercised | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase', window );">Equity method investment, number of shares eligible for purchase | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Equity Contract, Warrant [Member] | Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_InvestmentsLineItems', window );"><strong>Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentPricePerShareIfExercised', window );">Equity method investment, price per share if exercised | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase', window );">Equity method investment, percentage of shares eligible for purchase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Difference Between Carrying Amount and Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Impairment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Eligible For Purchase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentNumberofSharesOwnedCommon">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Number of Shares Owned, Common</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentNumberofSharesOwnedCommon</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Percentage of Shares Eligible For Purchase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquityMethodInvestmentPricePerShareIfExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Price Per Share If Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquityMethodInvestmentPricePerShareIfExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_InvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Investments [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_InvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investments accounted under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126960272&amp;loc=d3e32014-111567<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863628993056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments in Equity Securities (Investment in Cronos) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="num">$ (15)<span></span>
</td>
<td class="num">$ (148)<span></span>
</td>
<td class="num">$ (140)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember', window );">Equity Contract, Preemptive Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(45)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized gain (loss) on derivatives</a></td>
<td class="num">$ (14)<span></span>
</td>
<td class="num">$ (125)<span></span>
</td>
<td class="num">$ (95)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractPreemptiveRIghtsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_EquityContractWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863636813312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Narrative) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>contract</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>contract</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld', window );">Number of foreign currency derivatives held | contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt | $</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 1,105<span></span>
</td>
<td class="nump">$ 6,542<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfForeignCurrencyDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of foreign currency exchange rate derivatives held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfForeignCurrencyDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863628986208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Aggregate Fair Value and Carrying Value) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">$ 26,680<span></span>
</td>
<td class="nump">$ 28,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value</a></td>
<td class="nump">22,928<span></span>
</td>
<td class="nump">30,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ForeignCurrencyDenominatedDebtAbstract', window );"><strong>Foreign Currency Denominated Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">26,680<span></span>
</td>
<td class="nump">28,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_ForeignCurrencyDenominatedDebtMember', window );">Foreign Currency Denominated Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">4,540<span></span>
</td>
<td class="nump">4,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ForeignCurrencyDenominatedDebtAbstract', window );"><strong>Foreign Currency Denominated Debt [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Carrying value</a></td>
<td class="nump">4,540<span></span>
</td>
<td class="nump">4,817<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value</a></td>
<td class="nump">$ 4,165<span></span>
</td>
<td class="nump">$ 5,114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ForeignCurrencyDenominatedDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Foreign Currency Denominated Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ForeignCurrencyDenominatedDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_ForeignCurrencyDenominatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_ForeignCurrencyDenominatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629535296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details) - Net Investment Hedging [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</a></td>
<td class="num">$ (281)<span></span>
</td>
<td class="num">$ (375)<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">(Gain) Loss Recognized in Net Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign Currency Contract [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">(Gain) Loss Recognized in Net Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="num">(40)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=mo_ForeignCurrencyDenominatedDebtMember', window );">Foreign Currency Denominated Debt [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax', window );">(Gain) Loss Recognized in Accumulated Other Comprehensive Losses</a></td>
<td class="num">(281)<span></span>
</td>
<td class="num">(359)<span></span>
</td>
<td class="nump">424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">(Gain) Loss Recognized in Net Earnings</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998896-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=mo_ForeignCurrencyDenominatedDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=mo_ForeignCurrencyDenominatedDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629198768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Borrowings and Borrowing Arrangements (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum', window );">Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio', window );">Debt instrument, consolidated EBITDA to interest expense ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member] | Revolving Credit Facility Due August 2025 | Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value</a></td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit [Member] | Revolving Credit Facility Due August 2025 | Revolving Credit Facility [Member] | Term Secured Overnight Financing Rate ("Term SOFR") [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Applicable portion of interest rate for borrowing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Consolidated EBITDA to Interest Expense Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_RevolvingCreditFacilityDueAugust2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_RevolvingCreditFacilityDueAugust2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=mo_TermSecuredOvernightFinancingRateTermSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=mo_TermSecuredOvernightFinancingRateTermSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629396656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt (Summary of Long-Term Debt) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 26,680<span></span>
</td>
<td class="nump">$ 28,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less current portion of long-term debt</a></td>
<td class="nump">1,556<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt excluding current portion</a></td>
<td class="nump">25,124<span></span>
</td>
<td class="nump">26,939<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2350To1020Member', window );">Notes 2.350% To 10.20%, interest payable semi-annually, due through 2061 [Member] | Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 22,098<span></span>
</td>
<td class="nump">$ 23,185<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2350To1020Member', window );">Notes 2.350% To 10.20%, interest payable semi-annually, due through 2061 [Member] | Notes [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">2.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2350To1020Member', window );">Notes 2.350% To 10.20%, interest payable semi-annually, due through 2061 [Member] | Notes [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">10.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2350To1020Member', window );">Notes 2.350% To 10.20%, interest payable semi-annually, due through 2061 [Member] | Notes [Member] | Weighted Average [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDDebenture7750MaturingJanuary2027Member', window );">USD Debenture, 7.750%, Maturing January 2027 [Member] | Debenture [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">7.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_EuroNotes1000To3125Member', window );">Euro notes, 1.000% to 3.125%, interest payable annually, due through 2031 [Member] | Notes Payable, Other Payables [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 4,540<span></span>
</td>
<td class="nump">$ 4,817<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_EuroNotes1000To3125Member', window );">Euro notes, 1.000% to 3.125%, interest payable annually, due through 2031 [Member] | Notes Payable, Other Payables [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_EuroNotes1000To3125Member', window );">Euro notes, 1.000% to 3.125%, interest payable annually, due through 2031 [Member] | Notes Payable, Other Payables [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_EuroNotes1000To3125Member', window );">Euro notes, 1.000% to 3.125%, interest payable annually, due through 2031 [Member] | Notes Payable, Other Payables [Member] | Weighted Average [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2350To1020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes2350To1020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDebenture7750MaturingJanuary2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDebenture7750MaturingJanuary2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_EuroNotes1000To3125Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_EuroNotes1000To3125Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863627847728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt (Details of Long-Term Debt) (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 2.950%, Maturing May 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 218,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 4.000%, Maturing January 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 776,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 3.800%, Maturing February 2024 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 345,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 2.350%, Maturing May 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">2.35%<span></span>
</td>
<td class="nump">2.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 4.400%, Maturing February 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 1,069,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 2.625%, Maturing September 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 4.800%, Maturing February 2029 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 1,906,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 3.400%, Maturing May 2030 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 2.450%, Maturing February 2032 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">2.45%<span></span>
</td>
<td class="nump">2.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 9.950%, Maturing November 2038 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 177,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">9.95%<span></span>
</td>
<td class="nump">9.95%<span></span>
</td>
<td class="nump">9.95%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 10.200%, Maturing February 2039 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 208,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">10.20%<span></span>
</td>
<td class="nump">10.20%<span></span>
</td>
<td class="nump">10.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 5.800%, Maturing February 2039 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">5.80%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 3.400%, Maturing February 2041 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 4.250%, Maturing August 2042 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 4.500%, Maturing May 2043 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 650,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 5.375%, Maturing January 2044 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">5.375%<span></span>
</td>
<td class="nump">5.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 3.875%, Maturing September 2046 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.875%<span></span>
</td>
<td class="nump">3.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 5.950%, Maturing February 2049 [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 2,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">5.95%<span></span>
</td>
<td class="nump">5.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 4.450%, Maturing May 2050 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.45%<span></span>
</td>
<td class="nump">4.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 3.700%, Maturing February 2051 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 6.200%, Maturing February 2059 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 271,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">6.20%<span></span>
</td>
<td class="nump">6.20%<span></span>
</td>
<td class="nump">6.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | USD Notes, 4.000%, Maturing February 2061 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Notes Payable, Other Payables [Member] | Euro Notes, 1.000%, Maturing February 2023 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Notes Payable, Other Payables [Member] | Euro Notes, 1.700%, Maturing June 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Notes Payable, Other Payables [Member] | Euro Notes, 2.200%, Maturing June 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">2.20%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Notes Payable, Other Payables [Member] | Euro Notes, 3.125%, Maturing June 2031 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.125%<span></span>
</td>
<td class="nump">3.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Debenture [Member] | USD Debenture, 7.750%, Maturing January 2027 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 42,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">7.75%<span></span>
</td>
<td class="nump">7.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2950MaturingMay2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes2950MaturingMay2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4000MaturingJanuary2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes4000MaturingJanuary2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes3800MaturingFebruary2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes3800MaturingFebruary2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2350MaturingMay2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes2350MaturingMay2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4400MaturingFebruary2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes4400MaturingFebruary2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2625MaturingSeptember2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes2625MaturingSeptember2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4800MaturingFebruary2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes4800MaturingFebruary2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes3400MaturingMay2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes3400MaturingMay2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2450MaturingFebruary2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes2450MaturingFebruary2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes9950MaturingNovember2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes9950MaturingNovember2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes10200MaturingFebruary2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes10200MaturingFebruary2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes5800MaturingFebruary2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes5800MaturingFebruary2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes3400MaturingFebruary2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes3400MaturingFebruary2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4250MaturingAugust2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes4250MaturingAugust2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4500MaturingMay2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes4500MaturingMay2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes5375MaturingJanuary2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes5375MaturingJanuary2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes3875MaturingSeptember2046Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes3875MaturingSeptember2046Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes5950MaturingFebruary2049Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes5950MaturingFebruary2049Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4450MaturingMay2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes4450MaturingMay2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes3700MaturingFebruary2051Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes3700MaturingFebruary2051Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes6200MaturingFebruary2059Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes6200MaturingFebruary2059Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4000MaturingFebruary2061Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes4000MaturingFebruary2061Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_EuroNotes1000MaturingFebruary2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_EuroNotes1000MaturingFebruary2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_EuroNotes1700MaturingJune2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_EuroNotes1700MaturingJune2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_EuroNotes2200MaturingJune2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_EuroNotes2200MaturingJune2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_EuroNotes3125MaturingJune2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_EuroNotes3125MaturingJune2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDebenture7750MaturingJanuary2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDebenture7750MaturingJanuary2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863635704224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt (Aggregate Maturities of Long-Term Debt) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 1,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">1,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">1,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">1,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">1,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter', window );">Thereafter</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt before debt issuance costs and debt discount</a></td>
<td class="nump">26,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Less: debt issuance costs</a></td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Less: debt discounts</a></td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 26,680<span></span>
</td>
<td class="nump">$ 28,044<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term debt maturities repayments of principal thereafter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863633288560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Interest payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 411<span></span>
</td>
<td class="nump">$ 429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,105<span></span>
</td>
<td class="nump">6,542<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 649<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 649<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost', window );">Gain (loss) on extinguishment of debt, before write off of debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(623)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write off of deferred debt issuance cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes [Member] | Debt Instrument, Redemption, Period One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Required purchase price as percentage of aggregate principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesMember', window );">USD Denominated Notes [Member] | Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">2.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfUnsecuredDebt', window );">Repayments of unsecured debt</a></td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes3490PercentDue2022Member', window );">USD Denominated Notes, 3.490 Percent, Due 2022 [Member] | Senior Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.49%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfUnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfUnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes3490PercentDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDDenominatedNotes3490PercentDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863627644400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt (Debt Tender Offers and Redemption (Details) - Senior Notes [Member] - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Principal Amount of Notes Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,042,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2850MaturingAugust2022Member', window );">USD Notes, 2.850% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.85%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Principal Amount of Notes Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 795,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2950MaturingMay2023Member', window );">USD Notes, 2.950% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="nump">2.95%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Principal Amount of Notes Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 132,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4000MaturingJanuary2024Member', window );">USD Notes, 4.000% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Principal Amount of Notes Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 624,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes3800MaturingFebruary2024Member', window );">USD Notes, 3.800% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">3.80%<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Principal Amount of Notes Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 655,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4400MaturingFebruary2026Member', window );">USD Notes, 4.400% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Principal Amount of Notes Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 430,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4800MaturingFebruary2029Member', window );">USD Notes, 4.800% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Principal Amount of Notes Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,094,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes9950MaturingNovember2038Member', window );">USD Notes, 9.950% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">9.95%<span></span>
</td>
<td class="nump">9.95%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Principal Amount of Notes Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes10200MaturingFebruary2039Member', window );">USD Notes, 10.200% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">10.20%<span></span>
</td>
<td class="nump">10.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Principal Amount of Notes Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=mo_USDNotes6200MaturingFebruary2059Member', window );">USD Notes, 6.200% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest Rate</a></td>
<td class="nump">6.20%<span></span>
</td>
<td class="nump">6.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Principal Amount of Notes Purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 229,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2850MaturingAugust2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes2850MaturingAugust2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes2950MaturingMay2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes2950MaturingMay2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4000MaturingJanuary2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes4000MaturingJanuary2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes3800MaturingFebruary2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes3800MaturingFebruary2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4400MaturingFebruary2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes4400MaturingFebruary2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes4800MaturingFebruary2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes4800MaturingFebruary2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes9950MaturingNovember2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes9950MaturingNovember2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes10200MaturingFebruary2039Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes10200MaturingFebruary2039Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_USDNotes6200MaturingFebruary2059Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_USDNotes6200MaturingFebruary2059Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634198128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Oct. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_CommonStockDividendIncreasePercentage', window );">Common stock, dividend increase, percentage</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividends declared (USD per share)</a></td>
<td class="nump">$ 0.94<span></span>
</td>
<td class="nump">$ 0.90<span></span>
</td>
<td class="nump">$ 3.68<span></span>
</td>
<td class="nump">$ 3.52<span></span>
</td>
<td class="nump">$ 3.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_CommonStockDividendRateAnnualPerShare', window );">Common stock, dividend rate, annual, per share (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,156,312<span></span>
</td>
<td class="nump">35,656,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember', window );">January 2021 Share Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000,000<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,100,000<span></span>
</td>
<td class="nump">35,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mo_July2019ShareRepurchaseProgramMember', window );">July 2019 Share Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2023ShareRepurchaseProgramMember', window );">January 2023 Share Repurchase Program | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=mo_SerialPreferredStockMember', window );">Serial Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Payment Arrangement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved for stock-based awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,698,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,698,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_CommonStockDividendIncreasePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Dividend Increase, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_CommonStockDividendIncreasePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_CommonStockDividendRateAnnualPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Dividend Rate, Annual, Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_CommonStockDividendRateAnnualPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mo_July2019ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mo_July2019ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2023ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mo_January2023ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=mo_SerialPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=mo_SerialPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863635702832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Schedule of Issued Repurchased and Outstanding Shares) (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_CommonStockSharesOutstandingRollForward', window );"><strong>Common Stock, Shares Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance, Shares Issued (in shares)</a></td>
<td class="nump">2,805,961,317<span></span>
</td>
<td class="nump">2,805,961,317<span></span>
</td>
<td class="nump">2,805,961,317<span></span>
</td>
<td class="nump">2,805,961,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Beginning balance, Shares Repurchased (in shares)</a></td>
<td class="num">(982,785,699)<span></span>
</td>
<td class="num">(947,542,152)<span></span>
</td>
<td class="num">(947,979,763)<span></span>
</td>
<td class="num">(947,542,152)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, Shares Outstanding (in shares)</a></td>
<td class="nump">1,823,175,618<span></span>
</td>
<td class="nump">1,858,419,165<span></span>
</td>
<td class="nump">1,857,981,554<span></span>
</td>
<td class="nump">1,858,419,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned', window );">Stock award activity (in shares)</a></td>
<td class="nump">514,816<span></span>
</td>
<td class="nump">412,569<span></span>
</td>
<td class="nump">437,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchases of common stock (in shares)</a></td>
<td class="num">(38,156,312)<span></span>
</td>
<td class="num">(35,656,116)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance, Shares Issued (in shares)</a></td>
<td class="nump">2,805,961,317<span></span>
</td>
<td class="nump">2,805,961,317<span></span>
</td>
<td class="nump">2,805,961,317<span></span>
</td>
<td class="nump">2,805,961,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Ending balance, Shares Repurchased (in shares)</a></td>
<td class="num">(1,020,427,195)<span></span>
</td>
<td class="num">(982,785,699)<span></span>
</td>
<td class="num">(947,542,152)<span></span>
</td>
<td class="num">(1,020,427,195)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, Shares Outstanding (in shares)</a></td>
<td class="nump">1,785,534,122<span></span>
</td>
<td class="nump">1,823,175,618<span></span>
</td>
<td class="nump">1,858,419,165<span></span>
</td>
<td class="nump">1,785,534,122<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_CommonStockSharesOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Shares Outstanding [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_CommonStockSharesOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Treasury Stock Reissued (Forfeited and Returned)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863632659856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Schedule of Shares Repurchased) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total number of shares repurchased (in shares)</a></td>
<td class="nump">38,156,312<span></span>
</td>
<td class="nump">35,656,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Aggregate cost of shares repurchased</a></td>
<td class="nump">$ 1,825<span></span>
</td>
<td class="nump">$ 1,675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember', window );">January 2021 Share Repurchase Program [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Total number of shares repurchased (in shares)</a></td>
<td class="nump">38,100,000<span></span>
</td>
<td class="nump">35,700,000<span></span>
</td>
<td class="nump">73,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Aggregate cost of shares repurchased</a></td>
<td class="nump">$ 1,825<span></span>
</td>
<td class="nump">$ 1,675<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare', window );">Average price per share of shares repurchased (USD per share)</a></td>
<td class="nump">$ 47.83<span></span>
</td>
<td class="nump">$ 46.97<span></span>
</td>
<td class="nump">$ 47.42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockAcquiredAverageCostPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total cost of shares repurchased divided by the total number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockAcquiredAverageCostPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=mo_January2021ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863635747552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans (Narrative) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period, in years</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod', window );">Expense amortization period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Pre-tax compensation expense</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Deferred tax benefit</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unamortized compensation expense</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period of recognition, in years</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value, per share (in USD per share)</a></td>
<td class="nump">$ 49.22<span></span>
</td>
<td class="nump">$ 45.22<span></span>
</td>
<td class="nump">$ 42.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value vested</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 19<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted, number of shares (in shares)</a></td>
<td class="nump">1,206,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of shares remaining (in shares)</a></td>
<td class="nump">3,257,795<span></span>
</td>
<td class="nump">2,702,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Grant date fair value (in USD per share)</a></td>
<td class="nump">$ 46.90<span></span>
</td>
<td class="nump">$ 46.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period, in years</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Pre-tax compensation expense</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unamortized compensation expense</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted, number of shares (in shares)</a></td>
<td class="nump">215,205<span></span>
</td>
<td class="nump">229,494<span></span>
</td>
<td class="nump">275,288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of shares remaining (in shares)</a></td>
<td class="nump">628,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Grant date fair value (in USD per share)</a></td>
<td class="nump">$ 47.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | 2020 Performance Incentive Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum number of shares issuable under the stock compensation plan (in shares)</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available to be granted (in shares)</a></td>
<td class="nump">21,972,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member] | 2015 Directors Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Maximum number of shares issuable under the stock compensation plan (in shares)</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available to be granted (in shares)</a></td>
<td class="nump">650,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award equity instruments other than options grants in period weighted average grant date fair value total.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Expense Amortization Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mo_A2020PerformanceIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mo_A2020PerformanceIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=mo_A2015DirectorsPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=mo_A2015DirectorsPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634582848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Plans (Schedule of Restricted and Restricted Stock Units Activity) (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at beginning of year (in shares)</a></td>
<td class="nump">2,702,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">1,206,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(556,399)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(94,869)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at end of year, (in shares)</a></td>
<td class="nump">3,257,795<span></span>
</td>
<td class="nump">2,702,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at beginning of year (USD per share)</a></td>
<td class="nump">$ 46.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (USD per share)</a></td>
<td class="nump">49.22<span></span>
</td>
<td class="nump">$ 45.22<span></span>
</td>
<td class="nump">$ 42.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (USD per share)</a></td>
<td class="nump">51.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (USD per share)</a></td>
<td class="nump">45.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at end of year (USD per share)</a></td>
<td class="nump">$ 46.90<span></span>
</td>
<td class="nump">$ 46.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863636313312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per Share (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings attributable to Altria</a></td>
<td class="nump">$ 5,764<span></span>
</td>
<td class="nump">$ 2,475<span></span>
</td>
<td class="nump">$ 4,467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted', window );">Less: Distributed and undistributed earnings attributable to share-based awards</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Earnings (losses) for EPS, basic</a></td>
<td class="nump">5,751<span></span>
</td>
<td class="nump">2,464<span></span>
</td>
<td class="nump">4,459<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Earnings (losses) for EPS, diluted</a></td>
<td class="nump">$ 5,751<span></span>
</td>
<td class="nump">$ 2,464<span></span>
</td>
<td class="nump">$ 4,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares for basic EPS (in shares)</a></td>
<td class="nump">1,804<span></span>
</td>
<td class="nump">1,845<span></span>
</td>
<td class="nump">1,858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable', window );">Plus: contingently issuable PSUs (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares for diluted EPS (in shares)</a></td>
<td class="nump">1,804<span></span>
</td>
<td class="nump">1,845<span></span>
</td>
<td class="nump">1,859<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863627898064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">$ (1,606)<span></span>
</td>
<td class="nump">$ 2,925<span></span>
</td>
<td class="nump">$ 6,319<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">1,285<span></span>
</td>
<td class="num">(1,477)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balances</a></td>
<td class="num">(3,923)<span></span>
</td>
<td class="num">(1,606)<span></span>
</td>
<td class="nump">2,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(3,056)<span></span>
</td>
<td class="num">(4,341)<span></span>
</td>
<td class="num">(2,864)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="nump">387<span></span>
</td>
<td class="nump">1,613<span></span>
</td>
<td class="num">(2,071)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="num">(100)<span></span>
</td>
<td class="num">(386)<span></span>
</td>
<td class="nump">467<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="nump">287<span></span>
</td>
<td class="nump">1,227<span></span>
</td>
<td class="num">(1,604)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="num">(4)<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings, net of deferred income taxes</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">58<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">285<span></span>
</td>
<td class="nump">1,285<span></span>
</td>
<td class="num">(1,477)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balances</a></td>
<td class="num">(2,771)<span></span>
</td>
<td class="num">(3,056)<span></span>
</td>
<td class="num">(4,341)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Benefit Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,612)<span></span>
</td>
<td class="num">(2,420)<span></span>
</td>
<td class="num">(2,192)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">961<span></span>
</td>
<td class="num">(454)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(245)<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">716<span></span>
</td>
<td class="num">(339)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings, net of deferred income taxes</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">808<span></span>
</td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balances</a></td>
<td class="num">(1,436)<span></span>
</td>
<td class="num">(1,612)<span></span>
</td>
<td class="num">(2,420)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="num">(1,512)<span></span>
</td>
<td class="num">(1,938)<span></span>
</td>
<td class="num">(693)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="nump">275<span></span>
</td>
<td class="nump">627<span></span>
</td>
<td class="num">(1,613)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(141)<span></span>
</td>
<td class="nump">352<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">486<span></span>
</td>
<td class="num">(1,261)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings</a></td>
<td class="num">(85)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings, net of deferred income taxes</a></td>
<td class="num">(67)<span></span>
</td>
<td class="num">(60)<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">426<span></span>
</td>
<td class="num">(1,245)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balances</a></td>
<td class="num">(1,369)<span></span>
</td>
<td class="num">(1,512)<span></span>
</td>
<td class="num">(1,938)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember', window );">Currency Translation Adjustments and Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax', window );">Other comprehensive earnings (losses) before reclassifications</a></td>
<td class="num">(33)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes</a></td>
<td class="num">(33)<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax', window );">Amounts reclassified to net earnings</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAociCurrentPeriodTax', window );">Deferred income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to net earnings, net of deferred income taxes</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive earnings (losses), net of deferred income taxes</a></td>
<td class="num">(34)<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balances</a></td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAociCurrentPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAociCurrentPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863633899216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Comprehensive Earnings/Losses (Reclassifications) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic defined benefits expense (reversal of expense)</a></td>
<td class="num">$ (184)<span></span>
</td>
<td class="num">$ (202)<span></span>
</td>
<td class="num">$ (77)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from investments in equity securities</a></td>
<td class="nump">2,186<span></span>
</td>
<td class="nump">5,979<span></span>
</td>
<td class="nump">211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</a></td>
<td class="num">(5,764)<span></span>
</td>
<td class="num">(2,475)<span></span>
</td>
<td class="num">(4,454)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Benefit Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic defined benefits expense (reversal of expense)</a></td>
<td class="nump">88<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Net loss [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic defined benefits expense (reversal of expense)</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Prior service costs/credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic defined benefits expense (reversal of expense)</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">(Income) losses from investments in equity securities</a></td>
<td class="num">(85)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income [Member] | Currency Translation Adjustments and Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems', window );"><strong>Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_CurrencyTranslationAdjustmentsAndOther', window );">Currency translation adjustments and other</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_CurrencyTranslationAdjustmentsAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Currency Translation Adjustments And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_CurrencyTranslationAdjustmentsAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629537408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Earnings Before Income Taxes and Provision for Income Taxes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="nump">$ 7,628<span></span>
</td>
<td class="nump">$ 4,239<span></span>
</td>
<td class="nump">$ 6,842<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Outside United States</a></td>
<td class="num">(239)<span></span>
</td>
<td class="num">(415)<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">7,389<span></span>
</td>
<td class="nump">3,824<span></span>
</td>
<td class="nump">6,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">1,968<span></span>
</td>
<td class="nump">1,965<span></span>
</td>
<td class="nump">2,025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State and local</a></td>
<td class="nump">603<span></span>
</td>
<td class="nump">542<span></span>
</td>
<td class="nump">553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Outside United States</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current provision for income taxes</a></td>
<td class="nump">2,572<span></span>
</td>
<td class="nump">2,509<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(893)<span></span>
</td>
<td class="num">(1,190)<span></span>
</td>
<td class="num">(130)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State and local</a></td>
<td class="num">(54)<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred provision for income taxes</a></td>
<td class="num">(947)<span></span>
</td>
<td class="num">(1,160)<span></span>
</td>
<td class="num">(164)<span></span>
</td>
<td class="num">$ (164)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 1,625<span></span>
</td>
<td class="nump">$ 1,349<span></span>
</td>
<td class="nump">$ 2,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863641035344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Reconciliation of Beginning and Ending Unrecognized Tax Benefits) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of year</a></td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to the current year</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions of prior years</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions for tax positions due to lapse of statutes of limitations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions for tax positions of prior years</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(23)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Tax settlements</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of year</a></td>
<td class="nump">$ 69<span></span>
</td>
<td class="nump">$ 53<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629307632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits if recognized would impact effective tax rate</a></td>
<td class="nump">$ 44<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate', window );">Unrecognized tax benefits if recognized would affect deferred taxes</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Penalties and interest accrued</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest (income) expense associated with uncertain tax position</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible', window );">Potential decrease in liability for uncertain tax positions</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount', window );">Valuation allowance, deferred tax asset, capital losses, amount</a></td>
<td class="nump">664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">1,625<span></span>
</td>
<td class="nump">1,349<span></span>
</td>
<td class="nump">2,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, valuation allowance</a></td>
<td class="nump">2,800<span></span>
</td>
<td class="nump">3,097<span></span>
</td>
<td class="nump">2,817<span></span>
</td>
<td class="nump">$ 2,324<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses carry forward</a></td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance release</a></td>
<td class="nump">306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount', window );">Investment</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, valuation allowance</a></td>
<td class="nump">2,394<span></span>
</td>
<td class="nump">2,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos Group Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount', window );">Investment</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, valuation allowance</a></td>
<td class="nump">$ 379<span></span>
</td>
<td class="nump">$ 407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Valuation Allowance, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits that Would Impact Deferred Tax Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Capital Losses, Increase (Decrease), Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863628045008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Reconciliation of Effective Tax Rate and U.S. Federal Statutory Rate) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract', window );"><strong>$</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">U.S. federal statutory rate</a></td>
<td class="nump">$ 1,552<span></span>
</td>
<td class="nump">$ 803<span></span>
</td>
<td class="nump">$ 1,447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes, net of federal tax benefit</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount', window );">Tax basis in foreign investments</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Uncertain tax positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount', window );">Valuation allowance releases</a></td>
<td class="num">(664)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 1,625<span></span>
</td>
<td class="nump">$ 1,349<span></span>
</td>
<td class="nump">$ 2,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>%</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S. federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State and local income taxes, net of federal tax benefit</a></td>
<td class="nump">5.90%<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments', window );">Tax basis in foreign investments</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies', window );">Uncertain tax positions</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent', window );">Valuation allowance releases</a></td>
<td class="num">(9.00%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective tax rate</a></td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">35.30%<span></span>
</td>
<td class="nump">35.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember', window );">ABI [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract', window );"><strong>$</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount', window );">Investment</a></td>
<td class="num">$ (24)<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>%</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent', window );">Investment</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract', window );"><strong>$</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount', window );">Investment</a></td>
<td class="nump">$ 306<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 537<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>%</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent', window );">Investment</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">7.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract', window );"><strong>$</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount', window );">Investment</a></td>
<td class="nump">$ 30<span></span>
</td>
<td class="nump">$ 128<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>%</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent', window );">Investment</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">3.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Basis In Foreign Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Tax Basis In Foreign Investments, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Valuation Allowance, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Valuation Allowance, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Valuation Reversal, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Valuation Reversal, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_ABInBevMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863635774624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Deferred Income Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits', window );">Accrued postretirement and postemployment benefits</a></td>
<td class="nump">$ 303<span></span>
</td>
<td class="nump">$ 387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements', window );">Settlement charges</a></td>
<td class="nump">729<span></span>
</td>
<td class="nump">835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards', window );">Net operating losses and tax credit carryforwards</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred income tax assets</a></td>
<td class="nump">4,471<span></span>
</td>
<td class="nump">4,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="num">(233)<span></span>
</td>
<td class="num">(216)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(2,849)<span></span>
</td>
<td class="num">(2,802)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates', window );">Investment in ABI</a></td>
<td class="num">(1,226)<span></span>
</td>
<td class="num">(1,695)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld', window );">Finance assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DeferredTaxLiabilitiesAccruedPensionCosts', window );">Accrued pension costs</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(115)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(4,493)<span></span>
</td>
<td class="num">(4,891)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowances</a></td>
<td class="num">(2,800)<span></span>
</td>
<td class="num">(3,097)<span></span>
</td>
<td class="num">$ (2,817)<span></span>
</td>
<td class="num">$ (2,324)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred income tax liabilities</a></td>
<td class="num">(2,822)<span></span>
</td>
<td class="num">(3,665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DeferredTaxAssetsInvestmentsInEquitySecurities', window );">Investment in JUUL</a></td>
<td class="nump">3,001<span></span>
</td>
<td class="nump">2,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowances</a></td>
<td class="num">(2,394)<span></span>
</td>
<td class="num">(2,652)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member', window );">Cronos Group Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsEquityMethodInvestments', window );">Investment in Cronos</a></td>
<td class="nump">407<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowances</a></td>
<td class="num">$ (379)<span></span>
</td>
<td class="num">$ (407)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DeferredTaxAssetsInvestmentsInEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Investments In Equity Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DeferredTaxAssetsInvestmentsInEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets net operating losses and tax credit carryforwards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DeferredTaxLiabilitiesAccruedPensionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Accrued Pension Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DeferredTaxLiabilitiesAccruedPensionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the estimated loss from legal settlements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from interests in financial instruments continued to be held after sale or transfer of related financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments in unconsolidated subsidiaries and investments in other affiliates which are not controlled nor consolidated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863635671184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Summary of Valuation Allowance) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DeferredTaxAssetsValuationAllowanceRollForward', window );"><strong>Deferred Tax Assets, Valuation Allowance [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at beginning of year</a></td>
<td class="nump">$ 3,097<span></span>
</td>
<td class="nump">$ 2,817<span></span>
</td>
<td class="nump">$ 2,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions', window );">Additions to valuation allowance charged to income tax expense</a></td>
<td class="nump">429<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="nump">692<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ValuationAllowanceDeferredTaxAssetReductions', window );">Reductions to valuation allowance credited to income tax benefit</a></td>
<td class="num">(730)<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Balance at end of year</a></td>
<td class="nump">$ 2,800<span></span>
</td>
<td class="nump">$ 3,097<span></span>
</td>
<td class="nump">$ 2,817<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DeferredTaxAssetsValuationAllowanceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Valuation Allowance [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DeferredTaxAssetsValuationAllowanceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Additions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Foreign Currency Translation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ValuationAllowanceDeferredTaxAssetReductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Valuation Allowance, Deferred Tax Asset, Reductions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ValuationAllowanceDeferredTaxAssetReductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634915536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 25,096,000,000<span></span>
</td>
<td class="nump">$ 26,013,000,000<span></span>
</td>
<td class="nump">$ 26,153,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">6,442,000,000<span></span>
</td>
<td class="nump">7,119,000,000<span></span>
</td>
<td class="nump">7,818,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember', window );">Wine Business Strategic Reset [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Asset impairment, exit costs and implementation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">411,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember', window );">Wine Business Strategic Reset [Member] | Inventory Write-Off [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Asset impairment, exit costs and implementation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember', window );">Wine Business Strategic Reset [Member] | Purchase Commitment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Asset impairment, exit costs and implementation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations | Ste. Michelle Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts', window );">Disposal group, including discontinued operations, marketing, administration and research costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts', window );">Disposal group, including discontinued operations, disposition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisCapitalCorporationMember', window );">Philip Morris Capital Corporation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset', window );">Pre-tax expense for decrease in unguaranteed residual value of assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">125,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=mo_COVID19Member', window );">COVID-19 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Credit Concentration Risk [Member] | McLane Company Inc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Contribution of net revenues by major customer percentage</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Credit Concentration Risk [Member] | Performance Food Group Company [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Contribution of net revenues by major customer percentage</a></td>
<td class="nump">24.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark [Member] | Credit Concentration Risk [Member] | Core-Mark Holding Company, Inc. [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Contribution of net revenues by major customer percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 22,476,000,000<span></span>
</td>
<td class="nump">$ 22,866,000,000<span></span>
</td>
<td class="nump">$ 23,089,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products [Member] | COVID-19 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products [Member] | Cigarettes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">21,457,000,000<span></span>
</td>
<td class="nump">21,877,000,000<span></span>
</td>
<td class="nump">22,135,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products [Member] | Cigars [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">1,019,000,000<span></span>
</td>
<td class="nump">989,000,000<span></span>
</td>
<td class="nump">954,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember', window );">Wine [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">494,000,000<span></span>
</td>
<td class="nump">614,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember', window );">Wine [Member] | Marketing Administration And Research Costs [Member] | Disposal Group, Held-for-sale, Not Discontinued Operations | Ste. Michelle Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts', window );">Disposal group, including discontinued operations, marketing, administration and research costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember', window );">Oral Tobacco Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 2,580,000,000<span></span>
</td>
<td class="nump">2,608,000,000<span></span>
</td>
<td class="nump">2,533,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business combination, acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember', window );">Oral Tobacco Products [Member] | COVID-19 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Disposition Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operations, Marketing, Administration And Research Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Leverage Leases, Pre-Tax Expense For Decrease In Unguaranteed Residual Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=mo_WineBusinessStrategicResetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=mo_InventoryWriteOffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=mo_InventoryWriteOffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_PurchaseCommitmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_PurchaseCommitmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_SteMichelleTransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=mo_SteMichelleTransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisCapitalCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisCapitalCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=mo_COVID19Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=mo_COVID19Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mo_McLaneCompanyIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mo_McLaneCompanyIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mo_PerformanceFoodGroupCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mo_PerformanceFoodGroupCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=mo_CoreMarkHoldingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=mo_CoreMarkHoldingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mo_CigarettesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mo_CigarettesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=mo_CigarsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=mo_CigarsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mo_MarketingAdministrationAndResearchCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mo_MarketingAdministrationAndResearchCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634218592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Segment Data Schedule) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,096<span></span>
</td>
<td class="nump">$ 26,013<span></span>
</td>
<td class="nump">$ 26,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,919<span></span>
</td>
<td class="nump">11,560<span></span>
</td>
<td class="nump">10,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
<td class="num">(72)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest and other debt expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,058<span></span>
</td>
<td class="nump">1,162<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on early extinguishment of debt</a></td>
<td class="nump">$ 649<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">649<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent', window );">Net periodic benefit income, excluding service cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(184)<span></span>
</td>
<td class="num">(202)<span></span>
</td>
<td class="num">(77)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_IncomeLossFromEquityInvestments', window );">(Income) losses from investments in equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,641<span></span>
</td>
<td class="nump">5,979<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount', window );">Impairment of JUUL equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Loss on Cronos-related financial instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="nump">140<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,389<span></span>
</td>
<td class="nump">3,824<span></span>
</td>
<td class="nump">6,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General corporate expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(292)<span></span>
</td>
<td class="num">(345)<span></span>
</td>
<td class="num">(226)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,476<span></span>
</td>
<td class="nump">22,866<span></span>
</td>
<td class="nump">23,089<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember', window );">Smokeable Products [Member] | Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,688<span></span>
</td>
<td class="nump">10,394<span></span>
</td>
<td class="nump">9,985<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember', window );">Oral Tobacco Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,580<span></span>
</td>
<td class="nump">2,608<span></span>
</td>
<td class="nump">2,533<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember', window );">Oral Tobacco Products [Member] | Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,632<span></span>
</td>
<td class="nump">1,659<span></span>
</td>
<td class="nump">1,718<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember', window );">Wine [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">494<span></span>
</td>
<td class="nump">614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember', window );">Wine [Member] | Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="num">(360)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All Other [Member] | Operating Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (36)<span></span>
</td>
<td class="num">$ (97)<span></span>
</td>
<td class="num">$ (172)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_IncomeLossFromEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) from Equity Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_IncomeLossFromEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss on investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634444960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Schedule of Depreciation Expense and Capital Expenditures of Segments) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">$ 185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">169<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Smokeable Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Oral Tobacco Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Wine [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">General Corporate and Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_OralTobaccoSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_WineSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634095360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Non-Participating Manufacturer Adjustment Items) (Details) - Non-Participating Manufacturer Arbitration Panel Decision [Member] - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonParticipatingManufacturerArbitrationPanelDecisionMember', window );">NPM Adjustment to Cost Of Sales And Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">(Gain) loss related to litigation settlement</a></td>
<td class="num">$ (68)<span></span>
</td>
<td class="num">$ (76)<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments [Member] | Smokeable Products [Member] | Operating Income (Loss) [Member] | NPM Adjustment to Cost Of Sales [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">(Gain) loss related to litigation settlement</a></td>
<td class="num">(63)<span></span>
</td>
<td class="num">(53)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Interest and other debt expense, net [Member] | Interest And Other Debt Expense, Net [Member] | NPM Adjustment To Interest Expense [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">(Gain) loss related to litigation settlement</a></td>
<td class="num">$ (5)<span></span>
</td>
<td class="num">$ (23)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonParticipatingManufacturerArbitrationPanelDecisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonParticipatingManufacturerArbitrationPanelDecisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mo_NpmAdjustmentToCostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mo_NpmAdjustmentToCostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mo_InterestAndOtherDebtExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mo_InterestAndOtherDebtExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfExpenseAxis=mo_NPMAdjustmentToInterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfExpenseAxis=mo_NPMAdjustmentToInterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634209088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Schedule of Pre-tax Tobacco and Health Litigation Charges) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember', window );">Tobacco and Health Litigation Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember', window );">Tobacco and Health Litigation Cases [Member] | General Corporate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember', window );">Tobacco and Health Litigation Cases [Member] | Interest And Other Debt Expense, Net [Member] | Interest and other debt expense, net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Tobacco and Health Litigation Cases [Member] | Operating Income (Loss) [Member] | Operating Segments [Member] | Smokeable Products [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems', window );"><strong>Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_TobaccoandHealthLitigationCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=mo_InterestAndOtherDebtExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=mo_InterestAndOtherDebtExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=mo_SmokeableProductsSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863628644288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Narrative) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Amounts charged to expense for defined contribution plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,000,000<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="nump">$ 88,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,100,000,000<span></span>
</td>
<td class="nump">8,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation', window );">Accumulated benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,000,000<span></span>
</td>
<td class="nump">176,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation', window );">Projected benefit obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,000,000<span></span>
</td>
<td class="nump">227,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets', window );">Defined benefit plan, pension plan with projected benefit obligation in excess of plan assets, plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined benefit plan, plan assets, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,603,000,000<span></span>
</td>
<td class="nump">$ 8,793,000,000<span></span>
</td>
<td class="nump">$ 8,911,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.10%<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected future employer contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Emerging Markets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Below Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Plan assets, target allocation percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Fixed Income Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Plan assets, target allocation percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Fixed Income Securities [Member] | Below Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations', window );">Plan amendments</a></td>
<td class="nump">$ 432,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined benefit plan, plan assets, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,000,000<span></span>
</td>
<td class="nump">$ 185,000,000<span></span>
</td>
<td class="nump">$ 201,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Expected future employer contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Emerging Markets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Defined benefit plan, plan assets, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Below Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Equity Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Plan assets, target allocation percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Fixed Income Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Plan assets, target allocation percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Fixed Income Securities [Member] | Below Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for pension and other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=mo_EmergingMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=mo_EmergingMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExternalCreditRatingByGroupingAxis=us-gaap_ExternalCreditRatingNonInvestmentGradeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExternalCreditRatingByGroupingAxis=us-gaap_ExternalCreditRatingNonInvestmentGradeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_FixedIncomeSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634775536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Projected Benefit Obligations, Plan Assets and Funded Status of Pension Plans) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Accrued pension costs</a></td>
<td class="num">$ (133)<span></span>
</td>
<td class="num">$ (200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent', window );">Accrued postretirement health care costs</a></td>
<td class="num">(1,083)<span></span>
</td>
<td class="num">(1,436)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">8,544<span></span>
</td>
<td class="nump">9,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(462)<span></span>
</td>
<td class="num">(465)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gains) losses</a></td>
<td class="num">(2,060)<span></span>
</td>
<td class="num">(523)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Plan amendments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation', window );">Divestiture</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(193)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of year</a></td>
<td class="nump">6,292<span></span>
</td>
<td class="nump">8,544<span></span>
</td>
<td class="nump">9,465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">8,793<span></span>
</td>
<td class="nump">8,911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(1,748)<span></span>
</td>
<td class="nump">466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(462)<span></span>
</td>
<td class="num">(465)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresPlanAssets', window );">Divestiture</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">6,603<span></span>
</td>
<td class="nump">8,793<span></span>
</td>
<td class="nump">8,911<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at December&#160;31</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Other assets</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Other accrued liabilities</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Accrued pension costs</a></td>
<td class="num">(133)<span></span>
</td>
<td class="num">(200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent', window );">Accrued postretirement health care costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Defined benefit plan, amounts for asset (liability) recognized in statement of financial position</a></td>
<td class="nump">311<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Change in benefit obligation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at beginning of year</a></td>
<td class="nump">1,688<span></span>
</td>
<td class="nump">2,229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(104)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gains) losses</a></td>
<td class="num">(392)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAmendments', window );">Plan amendments</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(345)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation', window );">Divestiture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligation at end of year</a></td>
<td class="nump">1,275<span></span>
</td>
<td class="nump">1,688<span></span>
</td>
<td class="nump">2,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Change in plan assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at beginning of year</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return on plan assets</a></td>
<td class="num">(35)<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDivestituresPlanAssets', window );">Divestiture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets at end of year</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="nump">$ 201<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status at December&#160;31</a></td>
<td class="num">(1,153)<span></span>
</td>
<td class="num">(1,503)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Other assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Other accrued liabilities</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent', window );">Accrued pension costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent', window );">Accrued postretirement health care costs</a></td>
<td class="num">(1,083)<span></span>
</td>
<td class="num">(1,436)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet', window );">Defined benefit plan, amounts for asset (liability) recognized in statement of financial position</a></td>
<td class="num">$ (1,153)<span></span>
</td>
<td class="num">$ (1,503)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDivestituresBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(9)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDivestituresBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDivestituresPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in plan assets of defined benefit plan from disposal or classification as held-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDivestituresPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAmendments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAmendments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629641312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Assumptions to Determine Postretirement Benefit Obligations) (Details)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase - long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.10%<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets</a></td>
<td class="nump">6.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease', window );">Rate of compensation increase - long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear', window );">Health care cost trend rate assumed for next year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1', window );">Ultimate trend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets</a></td>
<td class="nump">7.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ultimate trend rate for health care cost for defined benefit postretirement plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863636221008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Schedule of Components of Net Periodic Pension Cost) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(493)<span></span>
</td>
<td class="num">(522)<span></span>
</td>
<td class="num">(502)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortizationAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net loss</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service cost (credit)</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost (income)</a></td>
<td class="num">(121)<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">41<span></span>
</td>
<td class="nump">38<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortizationAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Net loss</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Prior service cost (credit)</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Settlement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost (income)</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863635742688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Assumptions used to Determine Net Periodic Benefit Cost) (Details)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanDiscountRateAbstractAbstract', window );"><strong>Discount rates:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost', window );">Service cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost', window );">Interest cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.10%<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Rate of compensation increase - long-term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanDiscountRateAbstractAbstract', window );"><strong>Discount rates:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="nump">6.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanDiscountRateAbstractAbstract', window );"><strong>Discount rates:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost', window );">Service cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost', window );">Interest cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">7.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate', window );">Health care cost trend rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanDiscountRateAbstractAbstract', window );"><strong>Discount rates:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected rate of return on plan assets</a></td>
<td class="nump">7.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Ultimate Health Care Cost Trend Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DefinedBenefitPlanDiscountRateAbstractAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Discount Rate Abstract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DefinedBenefitPlanDiscountRateAbstractAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863633046192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans (Asset Allocations) (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity Securities [Member] | Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity Securities [Member] | Postretirement Benefit Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="nump">56.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate Bonds [Member] | Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="nump">52.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember', window );">Corporate Bonds [Member] | Postretirement Benefit Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="nump">33.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember', window );">US Treasury And Foreign Government Securities and all other investments [Member] | Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="nump">28.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember', window );">US Treasury And Foreign Government Securities and all other investments [Member] | Postretirement Benefit Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=mo_USTreasuryAndForeignGovernmentSecuritiesMember', window );">US Treasury and Foreign Government Securities [Member] | Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="nump">19.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=mo_AssetBasedSecuritiesAndOtherInvestmentsMember', window );">Asset Based Securities And Other Investments [Member] | Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Composition of plan assets</a></td>
<td class="nump">9.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=mo_USTreasuryAndForeignGovernmentSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=mo_USTreasuryAndForeignGovernmentSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=mo_AssetBasedSecuritiesAndOtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=mo_AssetBasedSecuritiesAndOtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863625664992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans (Fair Values of Pension and Postretirement Plan Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">$ 6,603<span></span>
</td>
<td class="nump">$ 8,793<span></span>
</td>
<td class="nump">$ 8,911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | US Treasury and Government [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">1,098<span></span>
</td>
<td class="nump">1,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Municipal Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Debt Security, Government, Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Corporate Debt Security, Above Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">2,747<span></span>
</td>
<td class="nump">3,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Corporate Debt Security, Below Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">756<span></span>
</td>
<td class="nump">1,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Common stock: International equities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">327<span></span>
</td>
<td class="nump">373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Common stock: U.S. equities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Asset-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Other, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | U S Large Cap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">$ 873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList', window );">Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible List]</a></td>
<td class="text">NAV [Member]<span></span>
</td>
<td class="text">NAV [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | U S Small Cap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList', window );">Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible List]</a></td>
<td class="text">NAV [Member]<span></span>
</td>
<td class="text">NAV [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | International Developed Markets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">$ 49<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList', window );">Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible List]</a></td>
<td class="text">NAV [Member]<span></span>
</td>
<td class="text">NAV [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Other Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">6,037<span></span>
</td>
<td class="nump">7,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">917<span></span>
</td>
<td class="nump">1,281<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 1 [Member] | US Treasury and Government [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 1 [Member] | Municipal Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 1 [Member] | Debt Security, Government, Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 1 [Member] | Corporate Debt Security, Above Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 1 [Member] | Corporate Debt Security, Below Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 1 [Member] | Common stock: International equities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">327<span></span>
</td>
<td class="nump">373<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 1 [Member] | Common stock: U.S. equities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">591<span></span>
</td>
<td class="nump">856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 1 [Member] | Asset-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 1 [Member] | Other, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">5,120<span></span>
</td>
<td class="nump">6,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 2 [Member] | US Treasury and Government [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">1,098<span></span>
</td>
<td class="nump">1,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 2 [Member] | Municipal Bonds [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 2 [Member] | Debt Security, Government, Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 2 [Member] | Corporate Debt Security, Above Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">2,747<span></span>
</td>
<td class="nump">3,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 2 [Member] | Corporate Debt Security, Below Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">756<span></span>
</td>
<td class="nump">1,032<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 2 [Member] | Common stock: International equities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 2 [Member] | Common stock: U.S. equities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 2 [Member] | Asset-Backed Securities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | Level 2 [Member] | Other, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">244<span></span>
</td>
<td class="nump">148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member] | NAV [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">436<span></span>
</td>
<td class="nump">1,460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="nump">$ 201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | US Treasury and Government [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Debt Security, Government, Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Corporate Debt Security, Above Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Corporate Debt Security, Below Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Other, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | U S Large Cap [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList', window );">Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible List]</a></td>
<td class="text">NAV [Member]<span></span>
</td>
<td class="text">NAV [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | International Developed Markets [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList', window );">Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible List]</a></td>
<td class="text">NAV [Member]<span></span>
</td>
<td class="text">NAV [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Other Investments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Fair Value, Inputs, Level 1, 2 and 3 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Level 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Level 1 [Member] | US Treasury and Government [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Level 1 [Member] | Debt Security, Government, Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Level 1 [Member] | Corporate Debt Security, Above Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Level 1 [Member] | Corporate Debt Security, Below Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Level 1 [Member] | Other, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Level 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Level 2 [Member] | US Treasury and Government [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Level 2 [Member] | Debt Security, Government, Non-US [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Level 2 [Member] | Corporate Debt Security, Above Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Level 2 [Member] | Corporate Debt Security, Below Investment Grade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | Level 2 [Member] | Other, Net [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member] | NAV [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets, net</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates level within fair value hierarchy and fair value measured at net asset value per share as practical expedient, of defined benefit plan asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MunicipalBondsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_MunicipalBondsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mo_CorporateDebtSecurityAboveInvestmentGradeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mo_CorporateDebtSecurityAboveInvestmentGradeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mo_CorporateDebtSecurityBelowInvestmentGradeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mo_CorporateDebtSecurityBelowInvestmentGradeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mo_OtherInvestmentNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mo_OtherInvestmentNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mo_USLargeCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mo_USLargeCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mo_USSmallCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mo_USSmallCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mo_InternationalDevelopedMarketsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=mo_InternationalDevelopedMarketsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel12And3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863635960416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans (Estimated Future Benefit Payments) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">473<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2028-2032</a></td>
<td class="nump">2,355<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2023</a></td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2024</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2025</a></td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2026</a></td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2027</a></td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2028-2032</a></td>
<td class="nump">$ 477<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863636219440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Benefit Plans (Amounts Recorded in Accumulated Other Comprehensive Losses) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net loss</a></td>
<td class="num">$ (2,213)<span></span>
</td>
<td class="num">$ (2,487)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service (cost) credit</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">305<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax', window );">Deferred income taxes</a></td>
<td class="nump">513<span></span>
</td>
<td class="nump">570<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Amounts recorded in accumulated other comprehensive losses</a></td>
<td class="num">(1,436)<span></span>
</td>
<td class="num">(1,612)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net loss</a></td>
<td class="num">(2,180)<span></span>
</td>
<td class="num">(2,093)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service (cost) credit</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax', window );">Deferred income taxes</a></td>
<td class="nump">571<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Amounts recorded in accumulated other comprehensive losses</a></td>
<td class="num">(1,633)<span></span>
</td>
<td class="num">(1,574)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net loss</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(362)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service (cost) credit</a></td>
<td class="nump">293<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax', window );">Deferred income taxes</a></td>
<td class="num">(68)<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Amounts recorded in accumulated other comprehensive losses</a></td>
<td class="nump">226<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PostemploymentRetirementBenefitsMember', window );">Postemployment Retirement Benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems', window );"><strong>Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Net loss</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax', window );">Prior service (cost) credit</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax', window );">Deferred income taxes</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Amounts recorded in accumulated other comprehensive losses</a></td>
<td class="num">$ (29)<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PostemploymentRetirementBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PostemploymentRetirementBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634643936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Benefit Plans (Movements in Other Comprehensive Earnings/Losses) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortizationAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Net loss</a></td>
<td class="nump">$ 127<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Prior service cost/credit</a></td>
<td class="num">(39)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other expense (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax', window );">Prior service cost/credit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax', window );">Deferred income taxes</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax', window );">Amounts reclassified to net earnings as components of net periodic benefit cost</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherMovementsDuringtheYearAbstract', window );"><strong>Other movements during the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net loss</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">624<span></span>
</td>
<td class="num">(448)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Prior service cost/credit</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">337<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax', window );">Deferred income taxes</a></td>
<td class="num">(35)<span></span>
</td>
<td class="num">(245)<span></span>
</td>
<td class="nump">115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other movements</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">716<span></span>
</td>
<td class="num">(339)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment', window );">Total movements in other comprehensive earnings/losses</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">808<span></span>
</td>
<td class="num">(228)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Pension [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortizationAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Net loss</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">131<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Prior service cost/credit</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other expense (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax', window );">Prior service cost/credit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax', window );">Deferred income taxes</a></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="num">(37)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax', window );">Amounts reclassified to net earnings as components of net periodic benefit cost</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherMovementsDuringtheYearAbstract', window );"><strong>Other movements during the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net loss</a></td>
<td class="num">(183)<span></span>
</td>
<td class="nump">465<span></span>
</td>
<td class="num">(268)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Prior service cost/credit</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax', window );">Deferred income taxes</a></td>
<td class="nump">48<span></span>
</td>
<td class="num">(118)<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other movements</a></td>
<td class="num">(135)<span></span>
</td>
<td class="nump">339<span></span>
</td>
<td class="num">(204)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment', window );">Total movements in other comprehensive earnings/losses</a></td>
<td class="num">(59)<span></span>
</td>
<td class="nump">440<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Postretirement Benefit Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortizationAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Net loss</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Prior service cost/credit</a></td>
<td class="num">(45)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other expense (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax', window );">Prior service cost/credit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax', window );">Deferred income taxes</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax', window );">Amounts reclassified to net earnings as components of net periodic benefit cost</a></td>
<td class="num">(20)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherMovementsDuringtheYearAbstract', window );"><strong>Other movements during the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net loss</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">157<span></span>
</td>
<td class="num">(162)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Prior service cost/credit</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax', window );">Deferred income taxes</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(127)<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other movements</a></td>
<td class="nump">256<span></span>
</td>
<td class="nump">375<span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment', window );">Total movements in other comprehensive earnings/losses</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="num">(137)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PostemploymentRetirementBenefitsMember', window );">Postemployment Retirement Benefits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortizationAbstract', window );"><strong>Amortization:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax', window );">Net loss</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax', window );">Prior service cost/credit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other expense (income):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax', window );">Net loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax', window );">Prior service cost/credit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax', window );">Deferred income taxes</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax', window );">Amounts reclassified to net earnings as components of net periodic benefit cost</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherMovementsDuringtheYearAbstract', window );"><strong>Other movements during the year:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax', window );">Net loss</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax', window );">Prior service cost/credit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax', window );">Deferred income taxes</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax', window );">Other movements</a></td>
<td class="num">(11)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment', window );">Total movements in other comprehensive earnings/losses</a></td>
<td class="num">$ (1)<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive (Income) Loss, Adjustment from AOCI, Pension, Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax, Including Cumulative Effect Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Other Net Gain (Loss), before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_OtherMovementsDuringtheYearAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Movements During the Year [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_OtherMovementsDuringtheYearAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax (expense) benefit for reclassification adjustment from accumulated other comprehensive (income) loss of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PostemploymentRetirementBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PostemploymentRetirementBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863627962736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional Information (Schedule of Additional Information) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development expense</a></td>
<td class="nump">$ 162<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">1,128<span></span>
</td>
<td class="nump">1,188<span></span>
</td>
<td class="nump">1,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest income</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest and other debt expense, net</a></td>
<td class="nump">$ 1,058<span></span>
</td>
<td class="nump">$ 1,162<span></span>
</td>
<td class="nump">$ 1,209<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629522800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Additional Information (Schedule of Valuation and Qualifying Accounts) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mo_AllowanceDiscountsMember', window );">Discounts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of year</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="nump">607<span></span>
</td>
<td class="nump">647<span></span>
</td>
<td class="nump">633<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(607)<span></span>
</td>
<td class="num">(647)<span></span>
</td>
<td class="num">(633)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of year</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mo_AllowanceReturnedGoodsMember', window );">Returned Goods [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of year</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged to costs and expenses</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Deductions</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of year</a></td>
<td class="nump">$ 41<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mo_AllowanceDiscountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=mo_AllowanceDiscountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=mo_AllowanceReturnedGoodsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=mo_AllowanceReturnedGoodsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639176816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (General Information) (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>state</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond', window );">Number of states that cap bond or require no bond</a></td>
<td class="nump">47<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States That Cap Bond or Require No Bond</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863632989936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">219 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liability for tobacco and health litigation items at beginning of period</a></td>
<td class="nump">$ 91<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Payments</a></td>
<td class="num">(151)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
<td class="num">(88)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Accrued liability for tobacco and health litigation items at end of period</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">91<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">$ 71<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_AgreementToResolveShareholderClassActionMember', window );">Agreement To Resolve Shareholder Class Action [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_InterestExpenseRelatedToLitigationMember', window );">Related Interest Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember', window );">Tobacco and Health Judgment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">954<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementInterest', window );">Litigation settlement interest (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember', window );">Tobacco and Health Judgment [Member] | Tobacco and Health Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesPaidValue', window );">Judgments paid (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementInterest', window );">Litigation settlement interest (approximately)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember', window );">Assets [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualRollForward', window );"><strong>Loss Contingency Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationEscrowDeposit', window );">Security posted for appeal of judgments</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationEscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Escrow Deposit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationEscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest expense (income) directly attributable to an award in settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14615-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesPaidValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages paid to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesPaidValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_AgreementToResolveShareholderClassActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_AgreementToResolveShareholderClassActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_InterestExpenseRelatedToLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_InterestExpenseRelatedToLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_TobaccoandHealthJudgmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_LitigationCasesResultsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_LitigationCasesResultsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629279040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Schedule of Pending Cases) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>case </div>
<div>claim </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember', window );">Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">162<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember', window );">Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Illinois [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember', window );">Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | New Mexico [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember', window );">Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Massachusetts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember', window );">Individual Smoking and Health Cases [Member] | Pending Litigation [Member] | Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_ETSSmokingandHealthCaseFlightAttendantsMember', window );">ETS Smoking and Health Case, Flight Attendants [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfCases', window );">Number of cases</a></td>
<td class="nump">1,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember', window );">E-vapor Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">5,283<span></span>
</td>
<td class="nump">3,296<span></span>
</td>
<td class="nump">1,563<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassActionLawsuit', window );">Number of class action lawsuits | lawsuit</a></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember', window );">E-vapor Cases [Member] | Pending Individual Lawsuits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | lawsuit</a></td>
<td class="nump">3,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember', window );">E-vapor Cases [Member] | Pending Lawsuits Filed By State Or Local Governments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | lawsuit</a></td>
<td class="nump">1,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember', window );">E-vapor Cases [Member] | Class Action Lawsuit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber', window );">Loss contingency, pending claims, consolidated for pre-trial purposes, number</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_OtherTabaccoRelatedCasesMember', window );">Other Tabacco-Related Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfInactiveCases', window );">Number of inactive cases</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfInactiveClassActionLawsuits', window );">Number of cases alleging unfair practices</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClassActionLawsuit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action Lawsuit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClassActionLawsuit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Cases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfInactiveCases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Inactive Cases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfInactiveCases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfInactiveClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Inactive Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfInactiveClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NM">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NM</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_ETSSmokingandHealthCaseFlightAttendantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_ETSSmokingandHealthCaseFlightAttendantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EvaporLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_OtherTabaccoRelatedCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_OtherTabaccoRelatedCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863628343568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Overview of Tobacco-Related Litigation Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">289 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 27, 2023 </div>
<div>case </div>
<div>claim</div>
</th>
<th class="th">
<div>Jan. 27, 2023 </div>
<div>case </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember', window );">Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">162<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember', window );">E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,283<span></span>
</td>
<td class="nump">3,296<span></span>
</td>
<td class="nump">1,563<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberofCasesSetforTrial', window );">Number of cases set for trial</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecided', window );">Number of verdicts returned</a></td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedUnfavorableNumber', window );">Number of unfavorable verdicts</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecided', window );">Number of verdicts returned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedUnfavorableNumber', window );">Number of unfavorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsResolvedNumber', window );">Number of claims resolved</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Alaska [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | California [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Connecticut [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Florida [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Louisiana [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Massachusetts [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyVerdictReversedNumber', window );">Verdicts reversed, number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Mississippi [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Missouri [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New Hampshire [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New Jersey [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | New York [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Ohio [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Pennsylvania [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Rhode Island [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | Tennessee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Non Engle Progeny Cases [Member] | West Virginia [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | Individual Smoking and Health Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberofCasesSetforTrial', window );">Number of cases set for trial</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PM USA [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberofCasesSetforTrial', window );">Number of cases set for trial</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Health Care Cost Recovery Actions [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Philip Morris USA and Altria Group [Member] | Smoking and Health Class Actions and Aggregated Claims Litigation [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedFavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Favorable, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedFavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedUnfavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Unfavorable, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedUnfavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsResolvedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Resolved, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsResolvedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofCasesSetforTrial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cases Set for Trial</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofCasesSetforTrial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyVerdictReversedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Verdict Reversed, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyVerdictReversedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_IndividualSmokingAndHealthCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EvaporLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_AK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_AK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_LA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_LA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NJ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NJ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_PA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_PA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_RI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_RI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WV">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WV</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634703584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Non-Engle Progeny Litigation) (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCaseMendezMember', window );">Non-Engle Progeny Smoking And Health Case, Mendez [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyFaultAllocationPercentage', window );">Loss contingency, fault allocation percentage</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCaseMendezMember', window );">Non-Engle Progeny Smoking And Health Case, Mendez [Member] | Philip Morris USA And R.J. Reynolds Tobacco Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCaseFontaineMember', window );">Non-Engle Progeny Smoking And Health Case, Fontaine [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCasePrincipeMember', window );">Non-Engle Progeny Smoking And Health Case, Principe [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGreeneMember', window );">Non-Engle Progeny Smoking and Health Case, Greene [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyCompensatoryDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Compensatory Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyCompensatoryDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyFaultAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Fault Allocation Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyFaultAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPunitiveDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPunitiveDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCaseMendezMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCaseMendezMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCaseFontaineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCaseFontaineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCasePrincipeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingAndHealthCasePrincipeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGreeneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_NonEngleProgenySmokingandHealthCaseGreeneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863635861008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 27, 2023 </div>
<div>USD ($) </div>
<div>plantiff </div>
<div>case </div>
<div>claim</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>claim</div>
</th>
<th class="th"><div>Jul. 31, 2006</div></th>
<th class="th">
<div>Jan. 31, 2008 </div>
<div>case</div>
</th>
<th class="th">
<div>Jul. 31, 2000 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 145,000,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember', window );">Engle Progeny Cases [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants', window );">Period for decertified class members could file individual actions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember', window );">Engle Progeny Cases, State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecided', window );">Number of verdicts returned</a></td>
<td class="nump">143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedUnfavorableNumber', window );">Number of unfavorable verdicts</a></td>
<td class="nump">79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyUnfavorableVerdictsPendingReversed', window );">Number of claims with unfavorable verdicts pending/reversed</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases Kaplan And Sommers | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyUnfavorableVerdictsPendingReversed', window );">Number of claims with unfavorable verdicts pending/reversed</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plantiff</a></td>
<td class="nump">773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, State [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Garcia [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyVerdictReversedNumber', window );">Verdicts reversed, number</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Reider and Banks [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyZeroDamagesVerdicts', window );">Zero damages verdicts</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Weingart and Hancock [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyZeroDamagesVerdictModified', window );">Zero damages verdict modified</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Pollari [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Gloger, Rintoul and Duignam [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, Freeman And Harris [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsDecidedFavorableNumber', window );">Number of favorable verdicts</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Engle Progeny Cases, R. Douglas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyClaimsDismissedNumber', window );">Number of claims dismissed | claim</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecided">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecided</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedFavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Favorable, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedFavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsDecidedUnfavorableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Decided Unfavorable, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsDecidedUnfavorableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPunitiveDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPunitiveDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyUnfavorableVerdictsPendingReversed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Unfavorable Verdicts Pending/Reversed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyUnfavorableVerdictsPendingReversed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyVerdictReversedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Verdict Reversed, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyVerdictReversedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyZeroDamagesVerdictModified">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Zero Damages Verdict Modified</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyZeroDamagesVerdictModified</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyZeroDamagesVerdicts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Zero Damages Verdicts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyZeroDamagesVerdicts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyClaimsDismissedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of claims dismissed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyClaimsDismissedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanAndSommersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanAndSommersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGarciaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesGarciaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesReiderandBanksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesReiderandBanksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesWeingartandHancockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesWeingartandHancockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesPollariMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesPollariMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerRintoulandDuignamMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesGlogerRintoulandDuignamMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesFreemanAndHarrisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesFreemanAndHarrisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesR.DouglasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863624208912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Sep. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHoffmanMember', window );">Engle Progeny Cases, Hoffman [Member] | Pending Litigation [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHoffmanMember', window );">Engle Progeny Cases, Hoffman [Member] | Pending Litigation [Member] | PM USA [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLevineMember', window );">Engle Progeny Cases, Levine [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLevineMember', window );">Engle Progeny Cases, Levine [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSchertzerMember', window );">Engle Progeny Cases, Schertzer [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSchertzerMember', window );">Engle Progeny Cases, Schertzer [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLippMember', window );">Engle Progeny Cases, Lipp [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLippMember', window );">Engle Progeny Cases, Lipp [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGarciaMember', window );">Engle Progeny Cases, Garcia [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGarciaMember', window );">Engle Progeny Cases, Garcia [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember', window );">Engle Progeny Cases, Duignan {Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember', window );">Engle Progeny Cases, Duignan {Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember', window );">Engle Progeny Cases, McCall [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember', window );">Engle Progeny Cases, McCall [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember', window );">Engle Progeny Cases, Chadwell [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember', window );">Engle Progeny Cases, Chadwell [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMember', window );">Engle Progeny Cases, Kaplan [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMember', window );">Engle Progeny Cases, Kaplan [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember', window );">Engle Progeny Cases, Cooper [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember', window );">Engle Progeny Cases, Cooper [Member] | Pending Litigation [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyCompensatoryDamagesAwardedValue', window );">Compensatory damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPunitiveDamagesAwardedValue', window );">Punitive damages awarded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember', window );">Engle Progeny Cases, Holliman [Member] | Settled Litigation [Member] | Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesTuttleMember', window );">Engle Progeny Cases, Tuttle [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMillerMember', window );">Engle Progeny Cases, Miller [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember', window );">Engle Progeny Cases, D. Brown [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember', window );">Engle Progeny Cases, Cuddihee [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyCompensatoryDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Compensatory Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyCompensatoryDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPunitiveDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Awarded, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPunitiveDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHoffmanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesHoffmanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLevineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesLevineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesSchertzerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesSchertzerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesLippMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesLippMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesGarciaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesGarciaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesDuignanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMcCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesChadwellMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesKaplanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesCooperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesHollimanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesTuttleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesTuttleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesMillerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesMillerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesD.BrownMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesCuddiheeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639599792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Florida Bond Statute) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2009 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_FL', window );">Florida [Member] | Engle Progeny Cases, State [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_MaximumBondForAllDefendants', window );">Maximum bond for all defendants</a></td>
<td class="nump">$ 200<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_MaximumBondForAllDefendants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Bond For All Defendants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_MaximumBondForAllDefendants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EngleProgenyCasesStateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863624143392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Other Smoking and Health Class Actions) (Details) - Smoking and Health Class Actions and Aggregated Claims Litigation [Member]<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">320 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>CAD ($) </div>
<div>manufacture </div>
<div>ruling</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>case </div>
<div>manufacture</div>
</th>
<th class="th">
<div>Jan. 27, 2023 </div>
<div>case</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_AR', window );">Arkansas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">California [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_DE', window );">Delaware [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_DC', window );">District of Columbia [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_FL', window );">Florida [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IL', window );">Illinois [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IA', window );">Iowa [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_KS', window );">Kansas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_LA', window );">Louisiana [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MD', window );">Maryland [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MI', window );">Michigan [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MN', window );">Minnesota [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NV', window );">Nevada [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NJ', window );">New Jersey [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NY', window );">New York [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OH', window );">Ohio [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OK', window );">Oklahoma [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_OR', window );">Oregon [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_PA', window );">Pennsylvania [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_PR', window );">Puerto Rico [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_SC', window );">South Carolina [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_TX', window );">Texas [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_WI', window );">Wisconsin [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassNotCertifiedNumber', window );">Class not certified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada [Member] | Canadian Tobacco Manufacturers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberofManufacturers', window );">Number of manufacturers | manufacture</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyVerdictsUpheld', window );">Number of verdicts upheld | ruling</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_AmountAwardedtoOtherParty', window );">Amount awarded to other party | $</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Canada [Member] | Philip Morris USA and Altria Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | British Columbia and Saskatchewan [Member] | Philip Morris USA and Altria Group [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_AmountAwardedtoOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount Awarded to Other Party</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_AmountAwardedtoOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClassNotCertifiedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Not Certified, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClassNotCertifiedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyVerdictsUpheld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Verdicts Upheld</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyVerdictsUpheld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_AR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_AR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_DE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_DE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_DC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_DC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_KS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_KS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_LA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_LA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NV">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NV</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NJ">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NJ</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OH">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OH</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OK">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OK</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_OR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_OR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_PA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_PA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_PR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_PR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_SC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_SC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAandAltriaGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=mo_BritishColumbiaSaskatchewanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=mo_BritishColumbiaSaskatchewanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863625603424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Health Care Cost Recovery Litigation) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 1998 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>claim </div>
<div>manufacture </div>
<div>case</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>manufacture</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigation', window );">Number of states with settled litigation | state</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementAnnualPaymentAmount', window );">State settlement agreements annual payments</a></td>
<td class="nump">$ 9,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementAnnualLegalFeesPayableMaximum', window );">State settlement agreements attorney fees annual cap</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada [Member] | Smoking and Health Class Actions and Aggregated Claims Litigation [Member] | Canadian Tobacco Manufacturers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberofManufacturers', window );">Number of manufacturers | manufacture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember', window );">Threatened Litigation [Member] | Canada [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementAnnualLegalFeesPayableMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Annual Legal Fees Payable, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementAnnualLegalFeesPayableMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementAnnualPaymentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Annual Payment Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementAnnualPaymentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofManufacturers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Manufacturers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofManufacturers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStateswithSettledLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States with Settled Litigation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStateswithSettledLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_CanadianTobaccoManufacturersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_ThreatenedLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863625783488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (NPM Adjustment Disputes) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="5">12 Months Ended</th>
<th class="th" colspan="1">60 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>state</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>state </div>
<div>contract</div>
</th>
<th class="th">
<div>Dec. 31, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember', window );">Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="nump">$ 4,300<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne', window );">Loss contingency, number of states with settled litigation including Illinois, subsequent expansion | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Amount ordered to be paid from other party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty', window );">Litigation settlement, amount expected to be awarded from other party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne', window );">Loss contingency, number of states with settled litigation including Illinois, subsequent expansion | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation', window );">Loss contingency, number of additional states extended with settled litigation | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation', window );">Loss contingency, number of additional states extended with settled litigation | contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettled', window );">Loss contingency, number of states not settled | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesWithConcludedHearings', window );">Loss contingency number of states with concluded hearings | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues', window );">Loss contingency, number of states not in compliance with escrow statues | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues', window );">Loss contingency, number of states in compliance with escrow statues | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, damages sought, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member] | Pending Litigation [Member] | Cost of Sales [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyReductionToCostOfSales', window );">Loss contingency, reduction to cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">258<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">318<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2021 NPM Adjustments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LitigationSettlementEstimateofPossibleGain', window );">Estimate of possible gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettled', window );">Loss contingency, number of states not settled | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member] | Pending Litigation [Member] | Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettled', window );">Loss contingency, number of states not settled | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod', window );">Loss contingency, number of states not settled arbitration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member] | Pending Litigation [Member] | Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettled', window );">Loss contingency, number of states not settled | state</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod', window );">Loss contingency, number of states not settled arbitration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NY', window );">New York [Member] | PM USA [Member] | Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member] | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IL', window );">Illinois [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IL', window );">Illinois [Member] | PM USA [Member] | Health Care Cost Recovery Actions, Transition Years 2004-2021 | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IL', window );">Illinois [Member] | PM USA [Member] | Health Care Cost Recovery Actions, Transition Years 2019-2021 | Settled Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_IA', window );">Iowa [Member] | PM USA [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, damages sought, value</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NM', window );">New Mexico [Member] | PM USA [Member] | Pending Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Loss contingency, damages sought, value</a></td>
<td class="nump">$ 84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MT', window );">MONTANA | PM USA [Member] | Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Amount Expected To Be Awarded From Other Party</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LitigationSettlementEstimateofPossibleGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Litigation Settlement, Estimate of Possible Gain</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LitigationSettlementEstimateofPossibleGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States In Compliance With Escrow Statues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States Not In Compliance With Escrow Statues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesNotSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States Not Settled</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesNotSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of States Not Settled Arbitration Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfStatesWithConcludedHearings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency Number Of States With Concluded Hearings</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfStatesWithConcludedHearings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Additional States Extended with Settled Litigation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of States with Settled Litigation, Settlement One</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyReductionToCostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Reduction To Cost Of Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyReductionToCostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ArbitrationPeriodAxis=mo_PeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ArbitrationPeriodAxis=mo_PeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_ArbitrationPeriodAxis=mo_PeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_ArbitrationPeriodAxis=mo_PeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20042020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20042020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20042021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20042021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20192021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_HealthCareCostRecoveryActionsTransitionYears20192021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_IA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_IA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NM">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NM</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639804448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Other Disputes Under the State Settlement Agreements) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jan. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember', window );">PM USA [Member] | Other Disputes Under the State Settlement Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Amount ordered to be paid from other party</a></td>
<td class="nump">$ 32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_OtherDisputesUndertheStateSettlementAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_OtherDisputesUndertheStateSettlementAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863636258160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Federal Government's Lawsuit) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2006</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_FederalGovernmentsLawsuitMember', window );">Federal Governments Lawsuit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_FederalTradeCommissionDisclosurePeriod', window );">Disclosure period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember', window );">Implementation of Corrective Communications [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_FederalTradeCommissionDisclosurePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Federal Trade Commission, Disclosure Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_FederalTradeCommissionDisclosurePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_FederalGovernmentsLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_FederalGovernmentsLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=mo_ImplementationofCorrectiveCommunicationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863627915424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (E-vapor Litigation and IQOS Litigation) (Details)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th">
<div>Jan. 27, 2023 </div>
<div>case </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>case </div>
<div>claim </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember', window );">E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,283<span></span>
</td>
<td class="nump">3,296<span></span>
</td>
<td class="nump">1,563<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_NumberOfThirdPartyLawsuits', window );">Number of third party lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_IQOSMember', window );">IQOS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded, value | $</a></td>
<td class="nump">$ 95,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyDamagesRecoverableValue', window );">Loss contingency, damages recoverable, value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | E-vapor Litigation [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | IQOS [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyRoyaltyFeePercentage', window );">Loss contingency, royalty fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingClassActionLawsuitsMember', window );">Pending Class Action Lawsuits [Member] | Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember', window );">Class Action Lawsuit [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber', window );">Loss contingency, pending claims, consolidated for pre-trial purposes, number | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember', window );">Class Action Lawsuit [Member] | Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber', window );">Loss contingency, pending claims, consolidated for pre-trial purposes, number | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingClassActionLawsuitMember', window );">Pending Class Action Lawsuit [Member] | Subsequent Event [Member] | E-vapor Litigation [Member] | Canada [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember', window );">Pending Individual Lawsuits [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember', window );">Pending Individual Lawsuits [Member] | Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitFiledBySchoolDistrictMember', window );">Pending Lawsuit Filed By School District [Member] | Subsequent Event [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation [Member] | E-vapor Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfCasesWithSetTrialDates', window );">Loss contingency, number of cases with set trial dates | case</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyDamagesRecoverableValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Damages Recoverable, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyDamagesRecoverableValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfCasesWithSetTrialDates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number of Cases With Set Trial Dates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfCasesWithSetTrialDates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyRoyaltyFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Royalty Fee Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyRoyaltyFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_NumberOfThirdPartyLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Third Party Lawsuits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_NumberOfThirdPartyLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_EvaporLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_EvaporLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_IQOSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_IQOSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingClassActionLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingClassActionLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_ClassActionLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingClassActionLawsuitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingClassActionLawsuitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingLawsuitFiledBySchoolDistrictMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingLawsuitFiledBySchoolDistrictMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863629397904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Antitrust Litigation) (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>claim</div>
</th>
<th class="th">
<div>Jan. 27, 2023 </div>
<div>lawsuit</div>
</th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>complaint</div>
</th>
<th class="th"><div>Apr. 30, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfComplaints', window );">Loss contingency, number of complaints | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | claim</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClassActionLawsuit', window );">Number of class action lawsuits | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember', window );">JUUL [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage', window );">Equity securities without readily determinable fair value, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue', window );">Non-compete release trigger percentage of initial investment carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Securities Without Readily Determinable Fair Value, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClassActionLawsuit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Class Action Lawsuit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClassActionLawsuit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfComplaints">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Complaints</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfComplaints</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mo_JUULMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863628030704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies (Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">7 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>claim</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>lawsuit </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>shareholder</div>
</th>
<th class="th">
<div>Jan. 31, 2022 </div>
<div>contract</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2021 </div>
<div>shareholder</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits', window );">Loss contingency, number of shareholders filing class action lawsuits | shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLegalSettlements', window );">Payments for legal settlements</a></td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits', window );">Loss contingency, number of shareholders filing derivative lawsuits | shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfPendingCasesConsolidated', window );">Loss contingency, number of pending cases consolidated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding', window );">Loss Contingency, Number Of Lawsuits Subsequently Consolidated Into A Single Proceeding | lawsuit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=mo_FederalAndStateShareholderDerivativeLawsuitsMember', window );">Federal And State Shareholder Derivative Lawsuits [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Provision related to litigation recorded</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Lawsuits Subsequently Consolidated Into A Single Proceeding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfPendingCasesConsolidated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Pending Cases Consolidated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfPendingCasesConsolidated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid for the settlement of litigation or for other legal issues during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_FederalAndStateShareholderDerivativeLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_FederalAndStateShareholderDerivativeLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863635792432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Lights/Ultra Lights Cases) (Details) - Subsequent Event [Member]<br></strong></div></th>
<th class="th">
<div>Jan. 27, 2023 </div>
<div>case </div>
<div>court </div>
<div>claim</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Lights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyClaimsNotCertifiedNumber', window );">Claims not certified, number | case</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Lights [Member] | PM USA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_mo_LossContingencyStateCourtsNumber', window );">Number of state courts</a></td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Smoking And Health Class Actions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | claim</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyClaimsNotCertifiedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Claims Not Certified, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyClaimsNotCertifiedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_mo_LossContingencyStateCourtsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, State Courts, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">mo_LossContingencyStateCourtsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>mo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_LightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_LightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=mo_PhilipMorrisUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=mo_PhilipMorrisUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_SmokingAndHealthClassActionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R114.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863639744048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (UST Litigations Narrative) (Details)<br></strong></div></th>
<th class="th">
<div>Jan. 27, 2023 </div>
<div>contract</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember', window );">Pending Individual Lawsuits [Member] | Subsequent Event [Member] | UST Litigation [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Claims filed, number</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=mo_PendingIndividualLawsuitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=mo_USTLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=mo_USTLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R115.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm139863634575040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Guarantees and Other Similar Matters Narrative) (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Contingent liability related to performance surety bonds</a></td>
<td class="nump">$ 19,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit line available under the agreement</a></td>
<td class="nump">46,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member] | Credit Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit line available under the agreement</a></td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12069-110248<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=mo_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=mo_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>mo-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:mo="http://www.altria.com/20221231"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="mo-20221231.xsd" xlink:type="simple"/>
    <context id="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if68a1d60201343fa81c9dac56e62fcdb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock0.3313ParValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i08bee235d9824c2493054813893719a6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock1.700NotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie32723d5c819467dbff1e1e9523aa4ed_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock2.200NotesDue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia3966dc6c234463b99c7126c8cb64ec1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:CommonStock3.125NotesDue2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0fc07528ff404f99acbe2f1625a88f2b_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i6fecf4e044e946ff90e09a30c692e5ae_I20230215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2023-02-15</instant>
        </period>
    </context>
    <context id="i4b5ad462b1fc42e3875caf97f2673a92_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i1a2f8d49dba342ea92dd045738411af3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6526b762c96848958db76b2e641f06c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i61053227470d46149283ab8a5e0978bd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i40e064b5da194d8bbe29064d490250de_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iccd540c71b2a4978b8805b946441e6f0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2289b034d6ab496e9d25b9a4e0e0ffe5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5b6e92147eea44118dbabf94df471192_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia23cc26a813c466694dadfb7e04c27d2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if73ff79a396f45c7beb9c0f45e3d64d9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibcb2c65901a147d6b22d66ec3bf6e1b2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6e5aec152bc347058ac199ade9c42ac1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4226489807b64beda01803b44b87592c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i81c616f824f34a2c82770dab642faf1f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0a061535c8074fa4b0e3bb2cb94f27ea_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibd14995a072744498777768ab05c3cf3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c8b04ab864741d0b17c502256196d58_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1f4d1ddc9b541ebbe3b22a611ae436f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie4b30e48366b42559b3e640d996b9125_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7f48333a20ec42c5ab2f1cba314394bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3dc6d82320204c0485ccfc4d8649e44b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iac019ebefddb4e73825f27700d39c2c3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b87a4d656b74f4c891d75c1fd38ce42_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icf9654d043934172838e2f4f18b13dc0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia49817e15e234846bd0a2a699c3c90b1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3328162568604ac9b6492de3b2e66b8f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i88ba8ee5cfbb4f82a668533be8a45bf1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6e83d605e794462bc2801b8a6ba0c45_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i558fc0a3383e478fb5796f93893141cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idde0e21bdbd04b0dbf2b80e3eb14a8df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic9dfca6be487498bbf8f7ce598fc0b81_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if9e71d43a1f4444a879c0a8c5f8cf8ef_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9fd0a7b22d234c68baa53019ccd50d24_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3d9278cdedf2453987ce2a196adc88b9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idceefaa1a008430bad914f7d71668fdb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i644b6f768367404baba2e476d5932a0f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i143a684a9fda4c14af97a0bf149a67f0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7503cd4479784edc962d47d00bb62206_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia66edd7cc54a4c8ea258417ee5d6a637_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05f658ff1f4945fbb64ff38b76d887eb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iab3485d42498436788bd25df431981fc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i30cb752842ae4f4197b09359b88ea9da_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HorizonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2a0870e6739645619718e0d6168ecf74_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HorizonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:JTIUHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i215587128d4845cda58b7a9194e94d1e_D20211001-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="icf697a1cd93741fbb7973dfb45f4da83_D20201201-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">mo:HelixInnovationsLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i2e549342995d4d82a096798aa533bfa9_D20201201-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i0ed594edbe8547ae96593b978a67fa53_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i96c87ceef6d7461eba332998e29357b5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i81704ddceebb4dfe86a3ec2266b22177_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1bea3c35eaff4beeba4d616c3283b50d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:USSTCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if0336e8ef9c74d2893d4e7f46f1987b7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i51e24a8227fd44f78424af2bf9ecc499_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i68ad331e56c04b3cab6eb6b46acdcb86_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i41f6a21a2abb4e77a00a22e833659f20_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1adec0aeb3214850954d7ba42cd20214_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if103da14634340edb17c23aba9feeff9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8dc9d02e492d4fab82f3ad7bd4624c68_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mo:USTIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i02811b1061214e51b307f1e6448ef953_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mo:USTIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mo:TrademarksCopenhagenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iae418119009f46f9a862f1b8651fc378_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mo:USTIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mo:TrademarksSkoalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i52300bd656f4412283014d05ee87427f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mo:USTIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">mo:TrademarksMSTMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3ba9462e81d849bdb73a266e0704643e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">mo:MiddletonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibbb8b3a48f934c52817757ed302eeb99_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mo:IntangibleAssetsAxis">mo:DefiniteLivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4ba8a2737e194f0f980c2838e67e9215_I20221019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:IQOSTobaccoHeatingSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-19</instant>
        </period>
    </context>
    <context id="iefb5652827eb457099968460ca178f35_I20230715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:IQOSTobaccoHeatingSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-15</instant>
        </period>
    </context>
    <context id="i0ad47c9ea90a4f93882e5e207392a44c_D20221019-20230715">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:IQOSTobaccoHeatingSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-19</startDate>
            <endDate>2023-07-15</endDate>
        </period>
    </context>
    <context id="i90a31ad6d0834866867bab4c41bfdd29_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:IQOSTobaccoHeatingSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iea22343d0454457485cd1cc01bcc276c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:IQOSTobaccoHeatingSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2793c14b7447420e9b9c20617d2dacdb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:JTIUHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i91ce2420785e4e54b8494cbe3fb97890_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i42e7b2a18fdf46808c830b8cad5d58a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i688c2fcd3b0343b29196c870d74f6b68_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i56c5cabbdfb44d05a0e818aa3c22c4d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i84433bab48264529a2516c2663b4fc52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia6a4fa4621c7473ba1611dbe6af67745_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25c3587d3f994622b4714f1b3124a4da_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id61401757fdc493c83aa67b7620e44d4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if803b88b013a40dfba8d352c3b38fd7a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iea2f16158f9341fd86284d599cb55729_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i13178e7cbc7c479c89b40c940101986c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3bf83008070a46eb83178baf67bbaa65_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icc2bb0b67a1f4be892d628382285683c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6ee0d2b6272e47c2b0125f423877e769_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i662e4fa2b880451fa00f79a419fcb83e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:JUULAndCronosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4408f6fff55f4f809ea62c43a15e4c2c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if3a9cfbb99324bffa0f757ecfa7e5577_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:JUULAndCronosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8513d61234ef4b449cb9e88035fd6619_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7a048f874a064a4995997da946ea095e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:JUULAndCronosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i07d379f94c904bd4b8baa4f957b160c2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8c0955d3143c4319b611181108536948_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:JUULAndCronosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6a3babb09031476eab172eb19f78a4fb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="if8367586242540b9911f25a7b7315179_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">mo:JUULAndCronosMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i0fcfe850ccf04326ba6a9f711efb4237_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86595736693849e2a2960a25c9d7f520_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4a59e8c2438f4b0990202ed160b66f3a_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i2482b7e244ca46d9be57870d2ee0a5b1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i3b2060e5902e49abb3e4469084d451c6_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if2f72a0231164ba39b3ffd8a34007855_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia645931f457b42ad968380318043c7bb_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i582f9f2ac6ca4ecda20c95fac7a2d662_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i113383343fc24b078e1605af29834efb_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i7514f17104fb4e4086fa0002209e91be_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:ABInBevMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2d58937ea5f04743a283f00ebb398d3f_D20181201-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i42640979a7ab4a48966a0d609f073992_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ie58a0d47e81141b49b488d17516ef57a_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i34f2a76702e24388ae8484f16168bdc3_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i9e8852c143984842b74a594acdc7f562_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90c02ede0bac4600ad8f45d0bae1be88_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9822021e58024e35a62e7648157e3677_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i352490c117bb4f8998f690f115171443_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i01271f593e214e02974445c5cdca8e52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibe747a76cea044caadbd3c216fee37f5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i352e13ef17314af78049d425169b5c00_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i690729cf5b294067aff036eadfaa0ae7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5b88030abdbe4a5bab225cf467fd6aec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2b902b829a4c4480963978506c931fe9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2f5bd49e3d924bbc92984ec5b9b68266_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibe6babf381df44cd9b5ccb5c5a5e58f2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractPreemptiveRIghtsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idd4d6be44a8e48fcac6b5ef35c67ddef_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3dbf8277f9b945c79b9491eacf1a07b9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i787d308d5eeb4107b0661b036cbd627c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:EquityContractWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id6d414e5e17345c0b5010b8bf3b1609d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9bb837eb6a554c7b8139c2b96eea88f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1ba18ff14a604658afe105249ab1be5c_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i676dca466c264c98a0a732b91fb9c4dd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id2b22c6277c34d6bbc04167a977d057b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i38a706a086554d389015fb9e0c90e6ab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i12be265a64cd483a8c06ad934345bfdb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1f1171f94e9a4f509d988ba58f40a86a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia3b9202eb4bc425496d496a5783142ad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">mo:ForeignCurrencyDenominatedDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if7f230b64a534de9935f50dfa188e24b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2704b95dd3964621a2f17ac3697ec1bd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i38cd1d2ff91f4c8a8a7413ed1a97f758_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib2383b8a428a43a694fd25b50b5e56d9_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="ic1ea858197df46758cab5e38cc77fc6b_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i5eaa17b2950f4f739cc9503d66958b9f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9dc86c124c5b4201b063cd0d7581dfb9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i019d8f929d47481aa9b043d3f5399d3e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">mo:TermSecuredOvernightFinancingRateTermSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if40c2ab1cec0419d8e9f4ba69b3cd0b7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i88059e2462ce4581be210352406c6935_D20200301-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:RevolvingCreditFacilityDueAugust2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3f78f34f75a64fe4bf18d076708d3591_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350To1020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8f210e7652a144c19a8bf09f7c07c740_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350To1020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ief3c0b98ac9c41609501bd13ff3613c2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350To1020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0f121d00e6394fc8a7c9088b8f4fb8f4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350To1020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i92fe93dcf2a34fecaed4dc95f41d6851_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDebenture7750MaturingJanuary2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i15baa618b8ac444882da13a33e5e3fd9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDebenture7750MaturingJanuary2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib7c66631bfad48cf9a20d10eb7a5d95c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000To3125Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i48082c430c9b492c905de5a9ccd49dd8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000To3125Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib945efb6e5fe46fbae9e80efa6cbc9ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000To3125Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifd37474dc2a14a4097a4780f47dc1ee1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000To3125Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i439835ab3a43455e96b747acea6d4d8f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350To1020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id631a5ccf3fb429cb812360331668599_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350To1020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3828073d79a24491bcaeaf36fce13056_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000To3125Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if400f8d238e54035a7cab079f344caeb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000To3125Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaaba818d157743e8b83bcea0509a84fd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1000MaturingFebruary2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iadefd780e0034b64926bdc30f75a610f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2950MaturingMay2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if9d9007ab56a458484aad403ac237294_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4000MaturingJanuary2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i63dfd595051b469195be60b2f91efc8d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes3800MaturingFebruary2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5f830258f25a4d1d84e87ead5fd45a4a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2350MaturingMay2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ice1bb82d9a41443c8498022e8e7d7779_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes1700MaturingJune2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0008e44fe6024463a3a1a558fdcee38e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4400MaturingFebruary2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iec4782d4b8074f9bacc9db3c3c30d3da_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2625MaturingSeptember2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib92f4cb6a30e4e6f9f00525310225c89_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes2200MaturingJune2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icd978ed23459400eb32a2c82f06f2a4c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4800MaturingFebruary2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5d59ad2d97184e4ca31c709f4e3635fd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes3400MaturingMay2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic57f5a35ebfa4c3fbcaa79d030ef21a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:EuroNotes3125MaturingJune2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icaac5abc8e624b32a8ec9a613c59bc47_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2450MaturingFebruary2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idc5ec60ad53c4b4783f7d38256ebf88f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes9950MaturingNovember2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie8f3c72b4651489d90df2e16ffa4a05e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes10200MaturingFebruary2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7f384896829c4943abc32d79f5210571_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes5800MaturingFebruary2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i66cedc520a05430f99dd7f092780f5c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes3400MaturingFebruary2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia75ae511ae35422b929bab49c142131a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4250MaturingAugust2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1faae93371144c7993efed37d5f5c24f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4500MaturingMay2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie6cd4d1753f74e26bc079154f136894c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes5375MaturingJanuary2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib1d7fc010c9442408c1346df432ae19b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes3875MaturingSeptember2046Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0dc37d2451ac45539913bbac9f76a69a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes5950MaturingFebruary2049Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia705d60663d745daa5a1d6310b196a7b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4450MaturingMay2050Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i39346349fd3d454fbe7d80d77da544b6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes3700MaturingFebruary2051Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8db11a63f05942319bf0d2eddaf952a7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes6200MaturingFebruary2059Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i985d9e1153d249ccbe35c8a2ed078b3a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4000MaturingFebruary2061Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1a2bb57dbcd94da09e99e9faca7b947f_I20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-31</instant>
        </period>
    </context>
    <context id="i93b4fdf778254947bb262abfd638909a_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="id4cd8efeaae34f919b123479df396a64_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i34f308ec117342cd83eb1c8c2367bffc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id8b660eda4894cb386f65ca5af40f210_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2850MaturingAugust2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i12b21493a628400c8be8f1d6a8ed3385_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes2950MaturingMay2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i539b185f58964558a12c50808bd29011_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4000MaturingJanuary2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0f6f50e4575f4c78858838ff914b03c2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes3800MaturingFebruary2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2d2e0075768e4aeb84b4d297b8930772_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4400MaturingFebruary2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5c58db1ce1ac4ff4bed80427e3ff6a6c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes4800MaturingFebruary2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7fb4aa15e8644b8dac184d5311a665f3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes9950MaturingNovember2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia123b20dbca2464d91553ad8a790922d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes10200MaturingFebruary2039Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7c75f31df572443b876910d052f325e1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDNotes6200MaturingFebruary2059Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i05610ebaa85d4ea193c96166dfd53b0c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3490PercentDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic922d20d61114cb5b818e46d2ee2f170_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:USDDenominatedNotes3490PercentDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia8e69b6b782f4aa5975697d9355b34c6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i310c0dd5c06a43918728eab4e66aae82_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1bda21fb40e34632bd2a70325195b703_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">mo:SerialPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4a80e5aa58a45bb84e8bd06eac4fa44_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id5e8e369ebdc481eb1c50facf9407ffd_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ic4318d73c3ec420f9b7ea13530338ad1_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i6dee55786a8947d5be0e870d6c2bb228_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="i55356fbd37f340dd975f11d54874fece_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2023ShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="id15c7c4db331481f86239866210c3ea8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if0e3d1499f104a538572ddf276309760_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1814a9e5885940cdb1d92fe2948219f4_D20210101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:January2021ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie2ccef0d8b6b41aea1718d46140df7ff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">mo:July2019ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idde860552f9e4af3818e1e0171c49245_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mo:A2020PerformanceIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i638d815ed9f74221b605f9614dbf0863_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">mo:A2015DirectorsPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2bde4c691bfe43909179ea90b1ba5f53_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie586f180596b4de1bfd14cd16fa40aec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i28af804fe6b74399ba55088a1f49d3aa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie5040992030f401f8d230ceec09bf4b5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0e6c90982182440887d92a56034de67f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9c7c153e8d34eda8c3f26df0b887be6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i43cdf17dccb84fe48ce2ad37ee1d8a57_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i21cecce3d56444b6aefbd78a88439a59_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8560dfc0561741c4a2fca56a741ddb31_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4baeaffb9a29402ca2ca02dd05a69d99_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib9146b84e66842f6ba646c0e65fbbf4a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i211d3ecc540f439596a522f150999ac7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iee6f716086d445da92a222c7902d8268_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0701019c847a4101bb381af56e6106e5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic1ebf54a40094d25ae6e4d46af08a702_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id9b3afb0e68543d79df286a395b0f9f4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i92833a7b324c4491889c22a95091a6eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i46578bd2fba34e508c65171225d3399b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4622585b580c4ae593332eebd185fc05_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i301bde0c886045bbbbef3861c7f3305a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if666ea56e36a46138786e8a942c8ca49_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39d9da4da1444b63abf5627b2e02b0a4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id7274c6680d2404c926a183383e0427c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i249cc5c8822b4901891591817ef402b5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic821892e2b3a4c669cc2c54ff8ccbcb0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9406c18150ae48159d08480f724ce8f5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8f2413f9f1484799837c48a31819243a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0ce6eb6dd62848bc8cd40a14488e8721_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie126f873b826412b91e1030a434f2d88_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3c8e82e2711e453788e58f2bd1c329a6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i835ff05c75554bb3a905f6d9c969a297_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i54324f38aa844a9eb47e2442a1639941_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i06ce655c080e4f76bb70784777bec240_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i58687162a9304d12bc4af830434b13f3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8e695634f71246c49246a1bc11d5adbc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i779b2d2ecbd54a6e915147670f6d0270_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9b811ce9ecd74e63a03fe63f108ba6ef_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5c382d8d16454f87a46dc4a4ad2985b5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedEquityMethodInvestmentsAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i89dc095529b8415fa2d037d1e5cc3243_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2c0fb8e2f6f94df6a4cb1166c6e8695d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i53c6e05d22124ac2a67512f6e00889ab_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">mo:AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i99171c01ef0342ea88d25cef0ba399df_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic66cd77c3dc849aca5b3b237b949276b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i17df18daf64e40e6b9d99e9a45abbaa7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i91aa1a3fbaee4d3ca09cea2198096661_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2c3c12dfb2294441a79714c48c67814a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i12f67c433715485982086bcdbfe00787_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i48f5736e8fdd4e1b9a291a912e9cd3be_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i111e309b231242cfbccc5619cb83229c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idd8c2710852f4850ae750a2d93d4e568_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i01d98d739f504698ad868c0b443af1b2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i46fc9282d17e4ce08f7ce9e03e4e9fd3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if55bb70b849b4190b6e9721bddaaf8c6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8857cf14a32848aa9b176fb4b04397e2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib2b6b1d5fe6046078463af99cc3f0ee3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9666810a94704e499168fa1e4086657b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icd98997f40d64f368230b460b98992e1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i346f9407b62340fc87ea781c6a87bc3a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i913162c559bc449289b7eb12f1b829ed_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icb973d3950d9475a923b769b439f1690_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i71a3f3b84bfc4a76b4da5d7f37f602af_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic22cd9b4e4d94780871456a2f40823af_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7975fef95c3d41c984bc01c3cd6d50c1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idc000d98c0ca4b1ab8abdbf602942f3f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic0f69c7e020f4496bb5f91ff08930975_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i617c77ba0ff242099cb5b33ab2af1d0c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia43c067e1e4b4763ac5c2b473efb3a37_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i804b801d4bd04571aaa1e6babe7ee711_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iadaebe2af5d4425f92e98085c262bdfa_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5586d1fe97814ea899ee8184c7f7d8d9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i56e043e80aaa413c8cf448a2008386a1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie7f3cf86f5874b96b40d59c3d6a49d6b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifa25332878054f3684126e72cd34954c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i49a7d33e45284663b655e6dbc1bb9919_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mo:CigarettesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1678c740bd1a4a26becf33b0f81b0ceb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mo:CigarettesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iab018587321a483bbfbc7b030fd4e0f6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mo:CigarettesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iddc198f0f36347669562a343b6ad3c9d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mo:CigarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie443febe03b14271ac779aa41af8f4fe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mo:CigarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i67cd9a14c17b43fc9f780f6a9acde202_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">mo:CigarsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9df4fbc7975c4c9c97d6d12ee87fa9e1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mo:PerformanceFoodGroupCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3185640b9c5049b5aab6f7b888f14010_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mo:PerformanceFoodGroupCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0ff1620dadbf4977afc2e21c5632a674_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mo:CoreMarkHoldingCompanyInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if2aa57c1f8964e1c832583d037aa1ede_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mo:McLaneCompanyIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1148e066b8774e5fbbbc5a24e0555f90_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mo:McLaneCompanyIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i190f8a7374534d37a6b9e683886f1340_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">mo:McLaneCompanyIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i08b51c2c0dce44e79fedb290d4c8e09e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idf9bf830fdb54a25a53b4eb9f7c6ecbe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i35b16a435c354836b674e7320f24d9cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NpmAdjustmentToCostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if0522b2a5006452dbeaa81943e951dd9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NPMAdjustmentToInterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6f14450de7304d989507ff633df9e3ae_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NPMAdjustmentToInterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2e449181bba3459d8ca0786104f7a700_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NPMAdjustmentToInterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9c43fc865fb74c7ea00634410142b30a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NPMAdjustmentToCostOfSalesAndInterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i212ae09ce10946d9855a6823c99cbf7f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NPMAdjustmentToCostOfSalesAndInterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic48649f0706c497693ac371d798bd4c2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonParticipatingManufacturerArbitrationPanelDecisionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:NatureOfExpenseAxis">mo:NPMAdjustmentToCostOfSalesAndInterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if99cc370f97e4e6c90993d5b757abf22_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i01d7b96af9e749068f5609288e32a7af_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8832deab20a344c6af9cf1f99474ac91_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46dacf8350224a54ab375b062ca77665_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i951b911c6e0e47d19655f1077b2ffe8a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iea116a43452e4fb28c83749aebd5f929_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i461f9cb50d204f0dacbd3047259cffa8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i27482b5bde934f6ca3bdd7b34b723684_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0693a15a4892422d9cda162ef2b81f7d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:InterestAndOtherDebtExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice4e4d2da69f4d9683487085e2d48d98_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i83073aaf064b4575b0b62690029a9d26_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibd676fa0f80248e282373ef461851a42_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthLitigationCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9f15b41987f746ec9de923885a23875e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">mo:MarketingAdministrationAndResearchCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:WineSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2829a0154bd2487587b9b5af05af4b95_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">mo:SteMichelleTransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idc3b5a2e320d4bf0930cfd342a0a64ce_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9cb3ae1c7eab4656a1a5ed979a5e155c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">mo:InventoryWriteOffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb407c6154934e7ca996a112282656fd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:PurchaseCommitmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">mo:WineBusinessStrategicResetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1eb37c152d544d1d9be43ff88b5b936e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisCapitalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1bff2bc4dded4f37b8c85cec3935bb80_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisCapitalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifb087beec876446cb5a5111ae91af4a1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisCapitalCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7832ad6e5ab1407caf25aa336606b119_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8a4e259acef84cbfa369320878dc84d8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:SmokeableProductsSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie155a5840f2c4f9999c5ff7d2f7a2f4b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">mo:OralTobaccoSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">mo:COVID19Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id6adba30f5e044f0b98201ca6954317b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i949403a737c24de59a13987d688282a7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i51af7141b0f74960b97071f12967601e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i00cce528acbc427a9f5dda1550d2d9fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i84846537e5f745d2987290028523bac3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i009462f76967433f92d600d008ec5c47_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if489977786fd4db69449f01c2756f802_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i708e341152674f6390a40e9721f87532_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if9ef67837f3b481b91a45102c2741bec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i218f7dbb66d94126b2f426148102feee_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1ce8f1baf1924d369a28a5bcb7cd369c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibef1d20b06414d568aea451eb1e564cf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i85712ade9dea49509d0041354e9dd058_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i46a26fe11c204936a35f2e5d15e5781e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i02d2cf1003314ab9892258dcee6449fe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifd98a90576ce475886c7adc642f71634_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">mo:USTreasuryAndForeignGovernmentSecuritiesAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5ae3153fe128440e9f61ca8201dcc8a0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">mo:USTreasuryAndForeignGovernmentSecuritiesAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic6aab89198f84ab09ff72153ef35e171_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">mo:USTreasuryAndForeignGovernmentSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34b241d0d60b4ff3a0eed6af4527dc96_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">mo:AssetBasedSecuritiesAndOtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8cc36e5d0d8e47749726e99b3dca0875_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExternalCreditRatingByGroupingAxis">us-gaap:ExternalCreditRatingNonInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i63d3cf858e354c7e92e2e0365451f300_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExternalCreditRatingByGroupingAxis">us-gaap:ExternalCreditRatingNonInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7f6a7fc0bc2d4a5eaf7ca6d75b30312e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">mo:EmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i31ed26bb32ff433080c9fdca31b03ecc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:FixedIncomeSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExternalCreditRatingByGroupingAxis">us-gaap:ExternalCreditRatingNonInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic64efbd3de4f4ab58c333a511cc0d644_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExternalCreditRatingByGroupingAxis">us-gaap:ExternalCreditRatingNonInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ed4a725235c47b887eb6679e8c3d522_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">mo:EmergingMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i87839150a2374e27a36b41a49b45c5bf_D20230101-20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="i83c8e5d5266f45fbb46737c1d2fcace0_D20230101-20231231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="i5937f04b1ddf4dd89b8d3092539fb3cd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i565d6f3baf2f4947b0dd194ac42693e9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie7d841655cc044a6b7129c58b61ec0c3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a857bd3f87c48ba9e0abfc8eebc8cc7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia8bc8d974c824ca79ceac63074634c5c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f3e5c978adf4674a37c1255333c112e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia0f669dde52c4154be5883d70c4541af_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i837fc7852b3c4ccf973ccfa3c30e16ff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb79e28764284a31a8d89f2ff43f4204_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i091fc79fcdb54ad5bac6c31650d0dc35_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43a0bf9c464a4f689b6fa2279baa3db6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if56170cb4e9e4dc3ab4c2439b1108953_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:MunicipalBondsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2d5635e4a45042f887595e208639d06c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4ab9a9711d20426494a4f993ff5497cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iac81e2e1561144d4b6fc044d55a86b44_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i98d16200be95427aaa506a07cafc1f0f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4cf80c87ecf0415e92e285f99ba853d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie09850cd158044ef9737da94ccd4932a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf7e45d2370d4822a594e626f0867b6f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i43dc5b8c106142a8a5eec96bf16c5e0c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05b7833a51e149a89ae331998c279adb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i19b8a42637c04a8fbdb6b98fcc14b74b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1df38e22ba91472f933e5f94bb462967_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i453b78fe37b14dbbb470779c2c160077_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idae2e10d00134111b2603a1ec55e2562_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9a22bcea6c7f47238753a786d43db429_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6913094e4c2a4346856f5eaa16cfbdef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3f7f03e22d4147c2979c55fcc62a5875_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if8af8a24b3b4465490365b4873d7d840_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i48edc7536f424109abdb6ba04fc667cc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i724473bb56ef42ca9368c198fabf43e2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3b271655bb784f2f8a8cb1deb35e7d4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9b66ad4089e442e8b7a70d986b26cc77_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i66066f1832f24ffb846101be04a19a87_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic09fc05c98894d629f60974a54315b5b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i057b0ef85ece430f8ddd918897d56736_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesNonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i422058d6b4d24ca3ac6e070ff71aa8e2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieb23a7abd88b4dfabbbb2aa8d76fdc64_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i15b0bb8f8f754a41a4f7dfd22ec86295_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2da6e6418c72474a99ec75fadc054776_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2bfdb9b8c6324abf8947ddb74a27e6a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic332a1659d2f405d80865e862ec27dab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic71aca398a11408da1a534b27a0c25dc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i10f3d8a40ef14a99905bccea0cfb4b72_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iad944a608a784c17b879349817b9d0dd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieefef214d38c46c39607fd46cfe43211_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i249539f1cfef460291c13bcd717ecbd8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i63684a262279489c9c4f034d04ba5aab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89925d896a8548cfb62d7b79dc5a9fae_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib1339f4ea0fe42bc9ee6d7c661e84e5a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i29227afcd5594316868d15193cb10cac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8e5c74c5bc734c1b9c970eeb6d8b1f1f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i10518c7a15dc4f21a69ded3f9d645ef6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22cca4c436d842d087f356c875896d60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib2c076e5ef854cabb8069eab488e2649_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7e3082841f894e34a24a50706f337744_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0febe181336b41b5a658c64358915bfe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i64f7dc5b917c46deaa9b0a051ea0fb75_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i620de52603d8478d83b1d097f32554e6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4feca36ee17847ab82502d9eed738030_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i39264efecc9e4ca88497194b3b7c8fc0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:USLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d478bf113ce483ebab401dd2fd6491d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:USLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i142dcd767464403ea9b22f153172c48d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:USSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia39aee97eee14867b9fd0099749071c8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:USSmallCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0411a1966ac645d8a850e70787e39e47_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:InternationalDevelopedMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5df4d26ee4254aec95af80be28802c08_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:InternationalDevelopedMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifc7229bbd58f4df69b5dea2ccab95bf5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2dd0be9d1bce45958792a2e9fbe32dcf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id36ee6f9d1124a2595ac2df42e648378_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ide5f143afc5b477a9e3945daf0484c78_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i07f902bc6dc8430c85a4b5a6902f7e69_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1dc0106f1faf462eb26fc43277eaf2cd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb735c6a79f740efb339b169181396ad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i726f9056e75f4525b26f5df7a357b0a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic341b9e0ef914a71aae1c0fe77f8d38e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i214fc2f6fc754f7c885b3d6871ae6404_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia7ac312a52d2464dae961fee29607342_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5c9735a7061a47e5985f44f2027c193e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i66baea8f8e3e44ccada2d2c6a807a3fb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1ab2d0a4619144f49e454db1495480ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27b909807cda4d008124cf98b2dfb195_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i67c6d721f139463c8a5ef2e2ac65795e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic90b8a4e1cad40c99e3c612c6aff6d10_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8ef1e5229020494cbba49f40f9408830_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1b045ef00b1c46baa8abe159f085ff7a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id683265debfa46c298eb35c208c438d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4d1961208f4440e6950aa35f0cb3a24c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53cd4ff8943f439dbee592de787cea17_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityAboveInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida49dd477308420ca136a97a189050d9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iabff1a6156384adc8cce0664586e25ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5b655b11e1ab48199a135d655b722fff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i66404ccb7de546aa8b469a4fcbbbebc8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ae13872490f4b7eb4a801adfb2d171e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i418d56b014124b6081ceffc5c76fe087_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:CorporateDebtSecurityBelowInvestmentGradeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7233bea80cc74eb8844423b368b977fa_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia9db59398fd34374bc22c5daa2fdcf89_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if248beb73395471a8d3f3cb7a01e64bc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0ce3e56286fd4ca4b41897ef25ba9373_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i14364497d94445c79d254185c8a0e260_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifb1582fd2b3f4d81b9602d7adb41a05d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:OtherInvestmentNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i441d0fa2abb74093916c6655196afd82_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id2576928a12a455283eec1278075ce78_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9ff5b3ac729140c5ab95d29557eded13_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i099176409b2d40eb9b090dd044fbd69a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id65b933eaa6f4c9589f7de89c772d624_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i92c62a510f4440e0ae76b083af678da0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel12And3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i77edbf66fcec42d282c3c8658c645b38_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:USLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6fb4e78e1b1244acb5f611d994fe511d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:USLargeCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8c1cbb128b174538ae7334de7cce2ee9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:InternationalDevelopedMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iab4e374e5b4a4126bfc6bd904d7493c0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">mo:InternationalDevelopedMarketsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib7bd5b5f81284011843bd24a1f898451_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4e916bce86724c739256a11e8d5ddfaf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5143a89f62f942d0aed69e5d5403fbdb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i146dab2f246f4239ac7c45936f953058_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherInvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i367f5ac75e4a4df58e4998eb5c85657f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie5d867da7f4441dda11c6293c01cb96b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iadc0d8691da8467d9ca4ad958399f860_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PostemploymentRetirementBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia96532ef56c74a5ab19f74aad5a85003_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PostemploymentRetirementBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PostemploymentRetirementBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PostemploymentRetirementBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PostemploymentRetirementBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i45f9dcc6444a4bbb90bbcd327eb2f366_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i90e616ef3cd34d8ebf364a0a44dbf568_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf580e88ea5e426b83cea191bb81eb11_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief312f4f79034004be1d156bc5113740_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i94c89f23c2954c9c8f50a44fa531889f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie74269f61ac244c79a9581ca1cbf6d02_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i98f16d288e9b4842b8c9feadf67a70d7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie82e469f2543472386656525fa4e487f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i33dd9b0c0e7b45d487aee81df3946294_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i03f3ddd8f45a4d4d8617839b37197b44_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idcaf546cb45c470aa6dfa50cda94fd71_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib931f8bbad2a4b7a8d8317d177be2791_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic93c01c5184d4b26964880db6a9e8ad9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3240589dec0744cebbdf4a38067cb110_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">mo:AllowanceReturnedGoodsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id322aa0288694bdb849607abacc6dabd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4739c0a3ba074dff8712b23ec3f898ad_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if96971d3062e4a31a0e27c3b191c0dde_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:LitigationCasesResultsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4fec6e69190c449a8d51b6a9ea7c1d31_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:AgreementToResolveShareholderClassActionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0d4c427ec8a94dfd836dc5b4a199c764_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:AgreementToResolveShareholderClassActionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6fd275444e894de0ab137fd15c70d71c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:AgreementToResolveShareholderClassActionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i37fa7f6256454447bca119375f7fe081_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i14301c0ea4d0417daf460f139e79a779_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4be6c8b0110c4ba9995765495afef7d6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:InterestExpenseRelatedToLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i03318a08f6694a48998709b33e36a67f_D20041001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:TobaccoandHealthJudgmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ied3d1d716af5466b9e30cf6840540284_D20041001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2004-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i480c00944cc54888a1e9a12e8d5a6c2f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a9cc9052f7342f9a5a2965a1363d918_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib803543b5610404db3d4704c2d823f5c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7443c1f2410b42f79436b4c8406d1884_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i496cf0d3b6c242988d0ca0ecf226c71f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1cb201982a874dda811f7385ce781a84_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic0dc27727fac48219ac9ec68f62e232f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3c7b5b8168e84e9f97ec53935f0e23bc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibcd3a4d726d343dc811a0c842908f852_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i815d22256b0f463899dc0f22fbf273d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8bf85127efde436391fadbb7ddd35b59_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if30834386f77477da8f843b6b5597b5c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23b3a0d3f9bb4d1490db4cd7c943b4b1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherTabaccoRelatedCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1ec68205f19b43d79d872f39a862112a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i04aef4e9d8bf47b6889ffc116b3823fe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i84f64e1272e04d79a531d39b5bcf0ca4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if4156610d169487eb2ddc1063aac958d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if1f51724e36a4d608bc658784f91ce0e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:ETSSmokingandHealthCaseFlightAttendantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0c93a8ff326144f69851e022e7d7df20_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9244ca0d63dc4969a4c903eab7d4b970_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitsFiledByStateOrLocalGovernmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i91aaf91c29514549a260f8c3b405df37_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:ClassActionLawsuitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia8ac04c172f1433fbffdd1c5a97bdc20_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="ibbca890a0ab042c4b655ce8a512d9dc0_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i44002739e29942868064a12846ec9503_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i78854af3be924b238c97cf0018613bd5_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="ib9bfd24968014e2fbddf1581242c201e_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i571a013fea1d4f7fac1f41c38c582ec2_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IndividualSmokingAndHealthCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i581f20cb6875437fbd464b63c2092b97_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i15254fcdf0474c4d91f3cdaf53416cf9_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i03552e08ecac456e9607180e0f7cea1d_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="iff9acca8e9b04ab7bbeb5f69bc352ad6_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="ia385d23e2d37444cbad3c91fd282c47b_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="ibb31d44524574239b606215996b36c53_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="ida280a8e75724cc58094fbf48eda09fa_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i325dfa71eec5476ea64d6e500e22c43e_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i322e1958ef354f998e5b9802f9a1c190_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MO</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="id5c28868e39348ea9f1dc8327b0b6efd_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="ie6f19f777880458ca0b18267c7d35b69_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i3d324cecd2fc4178abb7a986fd98c47a_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="ic85bb6de18db4b88bb50cb99cf81d8d8_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="ic3560c35b1b64649bae3cb957e859160_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i6f793a811c1c4997bb2a82a658d83b55_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:RI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i5a801284144744f8a8f5d897e3fa2fb5_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="idb6c598803cf4b6687397df90a86563f_D19990101-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WV</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1999-01-01</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="ic04846f477ef4b43b64fc0a53777f0d5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCaseMendezMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie6e2ff8e6f1647eea34f150435a9f641_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCaseMendezMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idddcb5cec584482b801338bd316d77fc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCaseFontaineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibc98656966dd42c4be583a6f2ed13108_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingAndHealthCasePrincipeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="i1410b910eefc4178acdfe4b6ce022ff7_I20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-30</instant>
        </period>
    </context>
    <context id="i5da32d8355b7469492d1e45bf26c92fe_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="ib879d27f5b6249628c06789bea384757_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:NonEngleProgenySmokingandHealthCaseGreeneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="ic794e5582af74563b80ccb6479696bc2_I20000731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2000-07-31</instant>
        </period>
    </context>
    <context id="ic921b407891d41a9a370b70f29dbbf7b_I20000731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2000-07-31</instant>
        </period>
    </context>
    <context id="i2ed199122dae41e0a7f040a1f16d427f_D20060701-20060731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2006-07-01</startDate>
            <endDate>2006-07-31</endDate>
        </period>
    </context>
    <context id="i181b032d3d8a4fb88a848af3798e1ca0_I20080131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2008-01-31</instant>
        </period>
    </context>
    <context id="i2c34362a468a45d08d7bbc1138e37393_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i28ee13b79369415fbc5464692b8c4285_D20230127-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-27</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="ie5e034628af34ae3946be21b68ea8d0e_D20230127-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-27</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i62e4a46ab1a44e6fb47d8560c1b77cd8_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanAndSommersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i7a03bc94992c4903bcda95a201871e01_D20230127-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-27</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i7a32ea824fa14aaeb1265afa3e1edf01_D20230127-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGarciaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-27</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i9840bd4343f941b0887d784405cd4d35_D20230127-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPearsonDCohenCollarChaconMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-27</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i180010a7918e4145a2f89842434e3987_D20230127-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesReiderandBanksMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-27</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i24acb3f6bdc34dee9714f9a0917ffb23_D20230127-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesWeingartandHancockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-27</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i1fd53372d12948b586896dc1e7cfd9e2_D20230127-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesPollariMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-27</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="ia6f75f0cc66b4f22a0d1523a7047668d_D20230127-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGlogerRintoulandDuignamMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-27</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i883e5919c8b041b1b6877eaa2e7575d0_D20230127-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesFreemanAndHarrisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-27</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="iea6390c8f234429087000381360f8e7c_D20230127-20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesR.DouglasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-27</startDate>
            <endDate>2023-01-27</endDate>
        </period>
    </context>
    <context id="i50e02c65827141c0988efa4815111343_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHoffmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i17a02e89bb314f8e8d214c7bfda3ab4a_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHoffmanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i6468ca3275ef46f8aa6c95127507afac_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLevineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i212ceaaf50b24da29b210c63ce60efc3_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLevineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i920cf43da0b549b1bf36382047e4921c_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSchertzerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ief08e55c7da94618b141a0544e183c7a_I20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesSchertzerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-30</instant>
        </period>
    </context>
    <context id="ie3c92225c6014643a39dde3972af7b95_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLippMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib0906996db114adb95e538086e4988cd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesLippMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i106eca6235c44aec9a053a8c1e1115f8_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGarciaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i7875bd726b2c40cf94fdd162bfc1698e_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesGarciaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="i093d8c283e0149ac94dd94b7d960043e_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="i3a7510ef6d624bce9a8bd3477d7ecbab_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesDuignanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="ie3f1fa8a229242798c2a8851ec2c6a7d_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i61bd7798d97b44e4905f83615d533665_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMcCallMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i432f8c3944d94d3088537f50fc75eec0_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="ia21796e7b1304ee59df65a9e7a9c1ae7_I20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesChadwellMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="i5185e4c3850249389a06ab7914fe67e5_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="i2c622465589840aa8eb67d8e00e12d37_I20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesKaplanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-31</instant>
        </period>
    </context>
    <context id="ic6a8429d2dfd4db9966a956a2a38a138_I20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-09-30</instant>
        </period>
    </context>
    <context id="i242b075be0904eea86cd14974d4e88e9_I20150930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCooperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-09-30</instant>
        </period>
    </context>
    <context id="i349b39aa4db540d09dd8cf5fd4305c55_D20221201-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesMillerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i66f3170db2b54fe7b125a52f2d195e80_D20221001-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesTuttleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i752ab2dec76b4648932ee8291c3fde30_D20220601-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesCuddiheeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i775477992d5148ffb8ac99f47908d6e1_D20230101-20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesHollimanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="ied8a6482d8d842548874153fd3412d3a_D20220801-20220831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesD.BrownMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="i2e77f2f208294f938fb2ec43209eee70_I20090630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EngleProgenyCasesStateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2009-06-30</instant>
        </period>
    </context>
    <context id="i2b527c47e5014c0aaaf9b0b067634552_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic10ea316eb6a47e48c3e53b43b03e6d0_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:AR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4929a66b8e9b49248e19eec92e781436_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i85f3e34a436d46d0a07b5548c997598c_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DE</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1741852180994ef68345036762c17998_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:DC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i801ebabf38fa441fb2d94c6e67e28052_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iff317a61814e4db486d1db5fda1f4175_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5febaca0c6254dfabb955e0c0034af5d_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia46c676221664155b20176ae820f2c18_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:KS</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8f12e85e557c4736862707aa26443eef_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:LA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib411bb4ee3f347218c4a11fe8e17f6ac_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0a370a52cb634e1b887970e51ba3eea2_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3a9aa66dc8c8499e838fe36896f6146e_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i884defb8144d483985e98d3102cad8d6_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NV</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i30284ad3aca0439787bbaef52a3ee87b_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NJ</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i598983dcf5714194acc23ab021d7b890_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3a8278fb3e23470e99b558bec8b8e1c3_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OH</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib90545ee4e794ecd86a7d962993031ae_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OK</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0ce7548765b949efaad6025a7bb2d39a_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:OR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if235e66a71fb40bb80e9a57ea20e104a_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:PA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1a0cae0d945242f9add4c95a9f783fff_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:PR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6e96ff7dfa4f4e3bbd38467b869c2b09_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:SC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib94a2498fbec415da80b4378db2c49aa_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id201aa07137345cc9031fe7687fb9aa8_D19960501-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WI</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1996-05-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8c3e60acf54840d5823064246d8f4255_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">mo:BritishColumbiaSaskatchewanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAandAltriaGroupMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i47f7028016ec4a9ca7c5da65de1c31cd_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i559c9c5248e14c7eac616a9c6e9b88ba_D20190301-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="iad62c741cfb14a10b14ba7e8f787e007_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:ThreatenedLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iea22c49cbb364016b9be8082d98ec8b5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:CanadianTobaccoManufacturersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i748c02005b4a4bf49a0612b63989ef03_D19981101-19981130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>1998-11-01</startDate>
            <endDate>1998-11-30</endDate>
        </period>
    </context>
    <context id="i5d208e527e4342e8a6fed1e96302bed1_I19981130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>1998-11-30</instant>
        </period>
    </context>
    <context id="i387d404d62a74acc8f6dbf3b7be9ca4b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3d696721355c4cda96236197d43ab89a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i051656e6a1684bfba293e4a15343ded2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2b29a936696b409788862a00b0672af2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib9c6e2186f1e45e786df72e8ee7ec3d3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2005NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5a685c7dcd494128be51e43eb85380b3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2006NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i79ad3a1e3b8a4470a7aca27a30ad959d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7c1a43c0fecf4f50ae6cebda59c8b404_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2008NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3976df847f6a4da191d1961d8126013e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2009NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic6602bcb2e70449fa757d0cf969d2e2a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2010NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if70775d7ed4d4bba9b45ad323909f03d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2011NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie9402356363b4f8f9a3867eb8211b078_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2012NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3b4691fe3b4e4dd7b23e74d90e241e1d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2013NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9e03b7ae06ec4c8aba2fd2c946767067_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2014NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1b55d65103bd48adbcfb2b0e11d8d4b1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2015NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4b8c44a5cad54a2f947e060d3352f19d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie4513fc58c994ac2900d640a3a2b33fd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2017NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaf7e83849a514def895afca19a8dbf72_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2018NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic1bcaad299794ce9a240e8f403e0a7cb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2019NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d5e76cb93d64980a7da87f32e2ef279_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2020NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i856b71c11be3464788fa35e57b23b454_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2021NPMAdjustmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2e156f0ff61c4547b064d2b367b1b8ae_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id9f929366f9c4db99fbbe7cc0765d8e2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie91a77817ecc4e999d0370e2c9318a18_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic3eb37f4a9f84da6819684970ef73356_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20042021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if1a23e3497624a1fa46068cc25ed067e_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20192021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3cdb4695c4e249cea22489ca33dd31a2_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:IL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic1705ce2bbd441deaa21faea57603e06_D20180101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2424508abe914dc19477786edb09c233_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i466ccb5c286b4d9d83b198edeb139479_D20150101-20151231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActionsTransitionYears20042020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NY</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2015-01-01</startDate>
            <endDate>2015-12-31</endDate>
        </period>
    </context>
    <context id="i9401b496918446c4a0bd9291e50c1846_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MT</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6e30d0f16c0e4fffb6403230045d3122_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i308b4161cd2a4761bbf2bbbea9a5b94d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifdda8a2cdb9d4db49e9b2c4177d9a7de_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i100852d80e724c41bb97050a1799cd82_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia4a2cae32e3e4d64a9d5bfb3d5339a57_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i57b16d217ed6412e9b51c342626023ec_D20221001-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions2004NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2ae59e3f662b40c2bd1cc8bfca42f60c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifd6ed63b9bb24769bbb2b79d9903289a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mo:ArbitrationPeriodAxis">mo:PeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9531c54ce48540a0a0550471e1cd3afe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:HealthCareCostRecoveryActions20052007NPMAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="mo:ArbitrationPeriodAxis">mo:PeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia8b742921dc34dc6b5591b065363c15b_D20220701-20220731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NM</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-07-31</endDate>
        </period>
    </context>
    <context id="i0dedfe3526ab465c89c9b8e67c3357a8_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:OtherDisputesUndertheStateSettlementAgreementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i0121b4c1497c443b91a2dbe5a6049059_D20060801-20060831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalGovernmentsLawsuitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2006-08-01</startDate>
            <endDate>2006-08-31</endDate>
        </period>
    </context>
    <context id="i29611429f47b4962bf5216deebdd1a1c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">mo:ImplementationofCorrectiveCommunicationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib515c9531f2c406b96d8ed470cbe6eeb_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingClassActionLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="ife1f1236593440dba4fa286c4568aa13_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:ClassActionLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i40d0f2ac213e404c8089cdf43889f21f_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingClassActionLawsuitMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i2494dd141e354811b038c1301f7dda49_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i1be89cf9f8b449fdac3da2c8fca7d5cf_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingLawsuitFiledBySchoolDistrictMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i9e946456b537477688ee4ce352a20446_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:EvaporLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34620bbc337b4ce2b6567ee643c5068f_D20220901-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IQOSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i07a9a17fedcf4c82a8a6872d1e854c64_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IQOSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i9130d99afc484bd7b97086bb83a18185_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:IQOSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i29da272e87c54a8cbab18821615bf146_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i49aa85e7288f4015a2cf251ad1ad3d1b_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i0d928ac82a174cbf9e654bf008eb8b4f_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="i9fd12ffe6e314078bec64fc03dd0d7cf_D20220201-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="ia1ab966a566641208dea895e36c2cfca_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">mo:JUULMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibf8ee6d0a42b48658f65843e7407c4ff_D20191001-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5714b7cd4a1f4abbba5201ba8cc74bb1_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd1d6e0639ad44f8812ae1cf1e390bc8_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i37dc803167004d3bbbf661d9a1d012d3_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ibeb9e2bf525e43c0844f2e9fb73929c9_D20201001-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9899ddfb78b54d8ea14e76f8bf786983_D20210401-20210430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="i8e0525ef8d214791974c2ec1841b3475_D20200901-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="id4bcc98934df473da5c7057ee93151ab_D20210701-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i4e17d631770e4e10909a4da8d0cf445c_D20220401-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalAndStateShareholderDerivativeLawsuitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="i308dd7b8074947108716f905d87a8f98_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:FederalAndStateShareholderDerivativeLawsuitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3ae0d3b51df54bbe8b1959b343c21c55_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i00d5a42df39d4763984da38514c7252f_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:SmokingAndHealthClassActionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i0a6cd34d91d14705933337c9bba7c38c_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:USTLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">mo:PendingIndividualLawsuitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <context id="i5809327a200e4dd292baa4729e1d7e5a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i19c2fc24e57144deb2090322db5badc1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">mo:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i910731a56cae4c999349f736062b8eeb_I20230127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000764180</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">mo:LightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">mo:PhilipMorrisUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-27</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="lease">
        <measure>mo:lease</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="cadPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="contract">
        <measure>mo:contract</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="state">
        <measure>mo:state</measure>
    </unit>
    <unit id="claim">
        <measure>mo:claim</measure>
    </unit>
    <unit id="case">
        <measure>mo:case</measure>
    </unit>
    <unit id="lawsuit">
        <measure>mo:lawsuit</measure>
    </unit>
    <unit id="plantiff">
        <measure>mo:plantiff</measure>
    </unit>
    <unit id="manufacture">
        <measure>mo:manufacture</measure>
    </unit>
    <unit id="ruling">
        <measure>mo:ruling</measure>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="complaint">
        <measure>mo:complaint</measure>
    </unit>
    <unit id="shareholder">
        <measure>mo:shareholder</measure>
    </unit>
    <unit id="court">
        <measure>mo:court</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl80L2ZyYWc6Mjg3OGM0ZGMxMTA1NGMyYjg4NGFmMzhlMTY1NTZhNDAvdGFibGU6YzBkNjY1ZGE3YzYyNDY0Nzg1MTYxNzBjNjlmOGYwYmYvdGFibGVyYW5nZTpjMGQ2NjVkYTdjNjI0NjQ3ODUxNjE3MGM2OWY4ZjBiZl8xLTEtMS0xLTE4NDQ2OQ_413c5a9f-75c6-4242-95f0-f9ea9805c956">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl80L2ZyYWc6Mjg3OGM0ZGMxMTA1NGMyYjg4NGFmMzhlMTY1NTZhNDAvdGFibGU6YzBkNjY1ZGE3YzYyNDY0Nzg1MTYxNzBjNjlmOGYwYmYvdGFibGVyYW5nZTpjMGQ2NjVkYTdjNjI0NjQ3ODUxNjE3MGM2OWY4ZjBiZl8yLTEtMS0xLTE4NDQ2OQ_497d18ef-f067-451b-9d0e-4ac4836dea22">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl80L2ZyYWc6Mjg3OGM0ZGMxMTA1NGMyYjg4NGFmMzhlMTY1NTZhNDAvdGFibGU6YzBkNjY1ZGE3YzYyNDY0Nzg1MTYxNzBjNjlmOGYwYmYvdGFibGVyYW5nZTpjMGQ2NjVkYTdjNjI0NjQ3ODUxNjE3MGM2OWY4ZjBiZl8zLTEtMS0xLTE4NDQ2OQ_2c9fd79a-4e77-4180-85f9-c77a052a860d">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl80L2ZyYWc6Mjg3OGM0ZGMxMTA1NGMyYjg4NGFmMzhlMTY1NTZhNDAvdGFibGU6YzBkNjY1ZGE3YzYyNDY0Nzg1MTYxNzBjNjlmOGYwYmYvdGFibGVyYW5nZTpjMGQ2NjVkYTdjNjI0NjQ3ODUxNjE3MGM2OWY4ZjBiZl80LTEtMS0xLTE4NDQ2OQ_57ba7f40-9159-430b-955f-43bad5e7cbb8">0000764180</dei:EntityCentralIndexKey>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84Mi9mcmFnOjdhMWM2MTdkY2YwZjRlZmQ5YTkxZGI0MDFhYjA3NWJkL3RhYmxlOjJlNDk2YmNmODhjMTRkNDZhNWU4ODE5MDdlM2M3MzhiL3RhYmxlcmFuZ2U6MmU0OTZiY2Y4OGMxNGQ0NmE1ZTg4MTkwN2UzYzczOGJfMi0xLTEtMS0xODQ0Njk_42ac58cb-b6a4-43d2-82d2-446b2d9ab0b3"
      unitRef="usdPerShare">0.3333</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84Mi9mcmFnOjdhMWM2MTdkY2YwZjRlZmQ5YTkxZGI0MDFhYjA3NWJkL3RhYmxlOjJlNDk2YmNmODhjMTRkNDZhNWU4ODE5MDdlM2M3MzhiL3RhYmxlcmFuZ2U6MmU0OTZiY2Y4OGMxNGQ0NmE1ZTg4MTkwN2UzYzczOGJfMi0yLTEtMS0xODQ0Njk_5b95ed31-fa95-45f1-b230-5ec079069cfd"
      unitRef="usdPerShare">0.3333</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList
      contextRef="i39264efecc9e4ca88497194b3b7c8fc0_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_41b4c8e3-e050-43b8-b106-4405c53c782d">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList>
    <us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList
      contextRef="i7d478bf113ce483ebab401dd2fd6491d_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_9c77b5ce-ddae-4a3d-978b-ba5336576f53">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList>
    <us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList
      contextRef="i142dcd767464403ea9b22f153172c48d_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_1ddffbe6-a65c-4290-90a9-b5306bc7faca">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList>
    <us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList
      contextRef="ia39aee97eee14867b9fd0099749071c8_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_c2aa8d53-307d-44de-88c6-ccc45057da99">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList>
    <us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList
      contextRef="i0411a1966ac645d8a850e70787e39e47_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_6c58378e-c0bf-4554-a791-6444e99557ba">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList>
    <us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList
      contextRef="i5df4d26ee4254aec95af80be28802c08_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_c4015aef-675a-4e45-9c95-609287b0df60">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList>
    <us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList
      contextRef="i77edbf66fcec42d282c3c8658c645b38_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_295077d8-7c2c-4293-a53f-d6212cd1c050">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList>
    <us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList
      contextRef="i6fb4e78e1b1244acb5f611d994fe511d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_bff869f3-0247-42fe-9766-2e8c8f382544">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList>
    <us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList
      contextRef="i8c1cbb128b174538ae7334de7cce2ee9_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_501091e4-8056-4777-bd80-73ee1b31781b">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList>
    <us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList
      contextRef="iab4e374e5b4a4126bfc6bd904d7493c0_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_eef6c587-6a34-4f41-a17b-d1245eda6984">http://fasb.org/us-gaap/2022#FairValueMeasuredAtNetAssetValuePerShareMember</us-gaap:DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList>
    <mo:LossContingencyStateCourtsNumber
      contextRef="i910731a56cae4c999349f736062b8eeb_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzUvZnJhZzpjMDU4MTIzNTM4YTE0ZTY4ODRhOTFkYjg0M2UxMzU1Zi90ZXh0cmVnaW9uOmMwNTgxMjM1MzhhMTRlNjg4NGE5MWRiODQzZTEzNTVmXzU_4028de03-106a-4169-aa0d-0157f464e9c8"
      unitRef="court">21</mo:LossContingencyStateCourtsNumber>
    <dei:DocumentType
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDE2_34881666-53d9-40b8-9803-3ecaeef9f24f">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDA5_dd28964d-2c23-414d-ab9a-fbf4d93163bb">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF82MDQ3MzEzOTU1ODQ0_a02f58de-fb42-41d8-8806-24a56e589324">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF82MDQ3MzEzOTU1ODQ0_c32c2e27-c313-4a07-8e4d-5701491a01dc">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDEz_28133e9f-b32f-4c41-bc2f-6aa95faa2253">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDE4_ac5864e8-96fb-4c2d-84c6-15c826099840">1-08940</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDE0_df28b17e-9aa7-4388-9ef8-4c6fc080acd8">ALTRIA GROUP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6MGIyMjA5MTQ1YmY1NDU3MjliZjIzY2JjZGRkOWVjZTAvdGFibGVyYW5nZTowYjIyMDkxNDViZjU0NTcyOWJmMjNjYmNkZGQ5ZWNlMF8wLTAtMS0xLTE4NDQ2OQ_72f6d42f-18cd-4e4d-b584-5df59947a157">VA</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6MGIyMjA5MTQ1YmY1NDU3MjliZjIzY2JjZGRkOWVjZTAvdGFibGVyYW5nZTowYjIyMDkxNDViZjU0NTcyOWJmMjNjYmNkZGQ5ZWNlMF8wLTMtMS0xLTE4NDQ2OQ_cc6a0ff1-db4f-40e6-bd50-d440d330ec5d">13-3260245</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6MGIyMjA5MTQ1YmY1NDU3MjliZjIzY2JjZGRkOWVjZTAvdGFibGVyYW5nZTowYjIyMDkxNDViZjU0NTcyOWJmMjNjYmNkZGQ5ZWNlMF8zLTAtMS0xLTE4NDQ2OQ_dab2b94c-2dce-45d9-9ba8-c111ccea1fc0">6601 West Broad Street,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6MGIyMjA5MTQ1YmY1NDU3MjliZjIzY2JjZGRkOWVjZTAvdGFibGVyYW5nZTowYjIyMDkxNDViZjU0NTcyOWJmMjNjYmNkZGQ5ZWNlMF8zLTEtMS0xLTE4NDQ2OQ_d0b3d8c2-3aa5-496b-89d0-a64dd91dd0c9">Richmond,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6MGIyMjA5MTQ1YmY1NDU3MjliZjIzY2JjZGRkOWVjZTAvdGFibGVyYW5nZTowYjIyMDkxNDViZjU0NTcyOWJmMjNjYmNkZGQ5ZWNlMF8zLTItMS0xLTE4NDQ2OQ_39a7af30-dd8c-4f5b-bbab-19c087a6e39f">VA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6MGIyMjA5MTQ1YmY1NDU3MjliZjIzY2JjZGRkOWVjZTAvdGFibGVyYW5nZTowYjIyMDkxNDViZjU0NTcyOWJmMjNjYmNkZGQ5ZWNlMF8zLTMtMS0xLTE4NDQ2OQ_afd0628e-2964-44b5-b5dc-42d7a7aeb88b">23230</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDE5_ec667c4a-e733-4269-afe7-a56df124825d">804</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDE3_78a88b06-c7bc-4c27-b7a1-53f8bd7aaebc">274-2200</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if68a1d60201343fa81c9dac56e62fcdb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl8xLTAtMS0xLTE4NDQ2OQ_5fd0cdb5-7e9c-4393-a018-6c47b8657b85">Common Stock, $0.33 &#160;1/3 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if68a1d60201343fa81c9dac56e62fcdb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl8xLTEtMS0xLTE4NDQ2OQ_07fe1ac8-f1ee-456b-a26b-d305283a6a04">MO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if68a1d60201343fa81c9dac56e62fcdb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl8xLTItMS0xLTE4NDQ2OQ_9ccdcd79-d64f-4638-a403-dd963086eb80">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i08bee235d9824c2493054813893719a6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl8zLTAtMS0xLTE4NDQ2OQ_311c66cc-5c3c-4ad9-adcc-c715a5d05312">1.700% Notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i08bee235d9824c2493054813893719a6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl8zLTEtMS0xLTE4NDQ2OQ_f0bb961b-c48a-4981-b4aa-916d8a4fec3a">MO25</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i08bee235d9824c2493054813893719a6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl8zLTItMS0xLTE4NDQ2OQ_76d71f8c-178b-4c8b-ae51-ba10a760dd78">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ie32723d5c819467dbff1e1e9523aa4ed_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl80LTAtMS0xLTE4NDQ2OQ_e8d1df49-a2ff-4f82-9429-05de54f2f3da">2.200% Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie32723d5c819467dbff1e1e9523aa4ed_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl80LTEtMS0xLTE4NDQ2OQ_0d6a0c23-7051-4c32-9bee-3e70ef2e89bb">MO27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie32723d5c819467dbff1e1e9523aa4ed_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl80LTItMS0xLTE4NDQ2OQ_90687717-726c-4e1e-87a7-5991edd18c77">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ia3966dc6c234463b99c7126c8cb64ec1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl81LTAtMS0xLTE4NDQ2OQ_9187956a-ba3e-4db6-948b-1829ac01593d">3.125% Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ia3966dc6c234463b99c7126c8cb64ec1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl81LTEtMS0xLTE4NDQ2OQ_41fc0d5c-adcd-4f13-af46-d9c67643d1e9">MO31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ia3966dc6c234463b99c7126c8cb64ec1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZGMxODViZWY4ZDYwNDQ0ODlhMGE5ZTc5MmQ0MjA5MmIvdGFibGVyYW5nZTpkYzE4NWJlZjhkNjA0NDQ4OWEwYTllNzkyZDQyMDkyYl81LTItMS0xLTE4NDQ2OQ_793d66b2-ef8d-4776-a777-2bbe04fd909f">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDEw_e8dcb533-b250-408a-89a6-29e3aeebe5a8">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDIw_0ac2f3c0-a590-4db3-ac5e-1753fa50b60b">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDEx_bfa7ecaa-d19b-45e8-b67e-c91181f3bede">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDIx_a9f31d7d-da18-48cd-bd53-44da63c28ad1">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZWYyZTNhMjQxYzY2NGQ2MWFkYWUzMWFlZTcwMjI2YjkvdGFibGVyYW5nZTplZjJlM2EyNDFjNjY0ZDYxYWRhZTMxYWVlNzAyMjZiOV8wLTAtMS0xLTE4NDQ2OQ_329da140-a5d7-432c-a833-8e431e6daeb0">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZWYyZTNhMjQxYzY2NGQ2MWFkYWUzMWFlZTcwMjI2YjkvdGFibGVyYW5nZTplZjJlM2EyNDFjNjY0ZDYxYWRhZTMxYWVlNzAyMjZiOV8xLTYtMS0xLTE4NDQ2OQ_375d007e-a20c-46c8-a7f0-6e32149393a7">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6ZWYyZTNhMjQxYzY2NGQ2MWFkYWUzMWFlZTcwMjI2YjkvdGFibGVyYW5nZTplZjJlM2EyNDFjNjY0ZDYxYWRhZTMxYWVlNzAyMjZiOV8yLTYtMS0xLTE4NDQ2OQ_c6cd049c-87eb-40ae-be11-257fad2200e5">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDEy_790260bf-8ef8-4af9-adde-adca93290dbb">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDIy_273e25e6-f840-439b-8cb5-f7c80a2fd2f7">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i0fc07528ff404f99acbe2f1625a88f2b_I20220630"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF82MDQ3MzEzOTU1ODMy_fbbf95e7-9509-4100-9f1c-952f67659295"
      unitRef="usd">75000000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i6fecf4e044e946ff90e09a30c692e5ae_I20230215"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGFibGU6Mzg0MjcwOWVmOTlmNDdkOWJmZTcxYzg5NmM3NjZkZDIvdGFibGVyYW5nZTozODQyNzA5ZWY5OWY0N2Q5YmZlNzFjODk2Yzc2NmRkMl8xLTEtMS0xLTE4NDQ2OQ_b5881d24-0521-4acb-a674-71133e2145d8"
      unitRef="shares">1785563827</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xL2ZyYWc6ZWVlYTZkMzVlNDdmNDczMjk3YjMzZTNhNmIxM2M3YWQvdGV4dHJlZ2lvbjplZWVhNmQzNWU0N2Y0NzMyOTdiMzNlM2E2YjEzYzdhZF8zMDIz_c477c328-8aaf-4761-81b4-ff634fd129b8">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.360%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:98.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Portions of the registrant&#x2019;s definitive proxy statement for use in connection with its annual meeting of shareholders to be held on May&#160;18, 2023, to be filed with the U.S. Securities and Exchange Commission on or about April 6, 2023, are incorporated by reference into Part III hereof.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i4b5ad462b1fc42e3875caf97f2673a92_D20220701-20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8yOC9mcmFnOjQ4ZjIzNTE3NzExNjQ0ZTNiMjIyMDMzNTA2OWIzYjRlL3RleHRyZWdpb246NDhmMjM1MTc3MTE2NDRlM2IyMjIwMzM1MDY5YjNiNGVfMjQxODkyNTU4MTU5ODk_b9a9c3e1-fa20-4532-b7a7-5a1e01dae923"
      unitRef="usd">133000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMi0xLTEtMS0xODQ0Njk_4dd29c93-6659-416d-be8e-e21ca64a7044"
      unitRef="usd">4030000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMi0zLTEtMS0xODQ0Njk_5a03821c-c9c3-4b43-ab16-391a3e441d96"
      unitRef="usd">4544000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <mo:ReceivableCommercializationRightsCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNC0xLTEtMS0xOTQ2MzU_76092c5d-4dc3-46f9-851e-ce99b3ed452e"
      unitRef="usd">1721000000</mo:ReceivableCommercializationRightsCurrent>
    <mo:ReceivableCommercializationRightsCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNC0zLTEtMS0xOTQ2MzU_8c997334-13ef-4121-9b2e-097f851368f8"
      unitRef="usd">0</mo:ReceivableCommercializationRightsCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMy0xLTEtMS0xODQ0Njk_5aa4c10a-4afc-4f35-9dfd-6c6bda48c962"
      unitRef="usd">48000000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMy0zLTEtMS0xODQ0Njk_446475ee-6954-480b-80e1-a4779f90859b"
      unitRef="usd">47000000</us-gaap:OtherReceivablesNetCurrent>
    <mo:InventoryRawMaterialsPlantMaterialNetofReserves
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNS0xLTEtMS0xODQ0Njk_6e80df5a-e318-402b-8308-11a24973bfdf"
      unitRef="usd">704000000</mo:InventoryRawMaterialsPlantMaterialNetofReserves>
    <mo:InventoryRawMaterialsPlantMaterialNetofReserves
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNS0zLTEtMS0xODQ0Njk_3dc0a2b9-d971-46c1-a810-12f991de6651"
      unitRef="usd">744000000</mo:InventoryRawMaterialsPlantMaterialNetofReserves>
    <mo:OtherInventoryRawMaterialsNetofReserves
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNi0xLTEtMS0xODQ0Njk_3a56a20d-b182-4f9d-9700-1a884f78f997"
      unitRef="usd">186000000</mo:OtherInventoryRawMaterialsNetofReserves>
    <mo:OtherInventoryRawMaterialsNetofReserves
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNi0zLTEtMS0xODQ0Njk_85945d07-f515-4b26-96e1-b5c0d7833644"
      unitRef="usd">166000000</mo:OtherInventoryRawMaterialsNetofReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNy0xLTEtMS0xODQ0Njk_308cdf1e-81e6-4022-aaf6-e8cd53ae3ab3"
      unitRef="usd">24000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfNy0zLTEtMS0xODQ0Njk_a1a1f16f-778a-40ff-8785-dcb346e6d7b7"
      unitRef="usd">23000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfOC0xLTEtMS0xODQ0Njk_6e81dbb4-e612-4179-ba54-2095abd6119e"
      unitRef="usd">266000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfOC0zLTEtMS0xODQ0Njk_0f86ceeb-d30d-4a69-8908-a4a63bd640d4"
      unitRef="usd">261000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfOS0xLTEtMS0xODQ0Njk_8dca5cdb-5b1a-4a7d-9f47-2b18895c1214"
      unitRef="usd">1180000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfOS0zLTEtMS0xODQ0Njk_750726b7-fc92-4914-b8da-f41d8cc6868f"
      unitRef="usd">1194000000</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTEtMS0xLTEtMTg0NDY5_93bb12b5-9a05-4d72-9556-01d247d9e8df"
      unitRef="usd">241000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTEtMy0xLTEtMTg0NDY5_18582a3b-0673-4284-97f1-b5941c9149f9"
      unitRef="usd">298000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTItMS0xLTEtMTg0NDY5_dbe96a98-3017-4a2f-88c7-bd35bc82d9aa"
      unitRef="usd">7220000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTItMy0xLTEtMTg0NDY5_70c0ff44-15f4-4e4d-8f58-dc7e2e2844d2"
      unitRef="usd">6083000000</us-gaap:AssetsCurrent>
    <us-gaap:LandAndLandImprovements
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTUtMS0xLTEtMTg0NDY5_1366e25b-a1c1-48b6-a4e4-d9f37c29fc84"
      unitRef="usd">123000000</us-gaap:LandAndLandImprovements>
    <us-gaap:LandAndLandImprovements
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTUtMy0xLTEtMTg0NDY5_7d312071-af91-4d8e-a4e3-08f41c20eaa3"
      unitRef="usd">123000000</us-gaap:LandAndLandImprovements>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTYtMS0xLTEtMTg0NDY5_16d497d4-c2a4-46a4-8beb-5e86e9792a09"
      unitRef="usd">1478000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTYtMy0xLTEtMTg0NDY5_7d4d4c52-d805-4005-a608-b31eb72f6602"
      unitRef="usd">1422000000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTctMS0xLTEtMTg0NDY5_c988ca43-6098-4285-a38d-a68c13c548fe"
      unitRef="usd">2578000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTctMy0xLTEtMTg0NDY5_6447804b-5c20-4b8e-81af-789a8a66d2c3"
      unitRef="usd">2652000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTgtMS0xLTEtMTg0NDY5_319d2792-a67b-419f-927d-48269d9018c3"
      unitRef="usd">248000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTgtMy0xLTEtMTg0NDY5_c4a64401-0ea5-4979-ae24-8b716be126ca"
      unitRef="usd">235000000</us-gaap:ConstructionInProgressGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTktMS0xLTEtMTg0NDY5_aaed0558-fca7-4189-9467-2b9a7fb8891e"
      unitRef="usd">4427000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMTktMy0xLTEtMTg0NDY5_cf26db42-3a38-403d-8910-af4ced4b8c8f"
      unitRef="usd">4432000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjAtMS0xLTEtMTg0NDY5_232f6348-8328-421c-9d24-b682de8db873"
      unitRef="usd">2819000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjAtMy0xLTEtMTg0NDY5_ceb2eb3c-fbcc-44c0-a667-d99fb2334eb6"
      unitRef="usd">2879000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjEtMS0xLTEtMTg0NDY5_53d66632-c49b-4f47-b78e-f5e018b97a1b"
      unitRef="usd">1608000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjEtMy0xLTEtMTg0NDY5_dc398929-18f6-485d-b31e-4563bf591571"
      unitRef="usd">1553000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjMtMS0xLTEtMTg0NDY5_2750a417-252f-4838-97b9-b7098f32b86a"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjMtMy0xLTEtMTg0NDY5_7e149b6d-42c2-4efa-89b7-5b12bfa27955"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjQtMS0xLTEtMTg0NDY5_fcb04a37-6354-4aa5-a8ea-9d5df72d0355"
      unitRef="usd">12384000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjQtMy0xLTEtMTg0NDY5_4b0f276e-ef1f-43df-98c1-12d4fdbf8f3b"
      unitRef="usd">12306000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjUtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246ODEzZjNkNGQ4ZTIwNDE1YjkyODAzZmY1Mjg5ODljY2RfMzg_cf04c5fc-2812-4d85-a10b-129ce9fd1a30"
      unitRef="usd">250000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjUtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246ODEzZjNkNGQ4ZTIwNDE1YjkyODAzZmY1Mjg5ODljY2RfNDU_9114896e-8adc-4d27-bdfd-2f5f51c80a4f"
      unitRef="usd">1720000000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjUtMS0xLTEtMTg0NDY5_692586f1-2392-4974-b40e-f0b5651ec552"
      unitRef="usd">9600000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjUtMy0xLTEtMTg0NDY5_e39c762c-b90f-48bb-8699-4f9dcc882de4"
      unitRef="usd">13481000000</us-gaap:Investments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjctMS0xLTEtMTg0NDY5_1f279ede-4e00-4da9-8a9e-7fcd3fedf0a4"
      unitRef="usd">965000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjctMy0xLTEtMTg0NDY5_a7fc2c6a-bd33-42d5-a4b8-0532b4d8f04d"
      unitRef="usd">923000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjgtMS0xLTEtMTg0NDY5_a83faaf2-94ab-4862-8874-49b64cf4863e"
      unitRef="usd">36954000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmRjOWQ1NzFmN2Y3YTRmYWQ5ZmZiZWI4NTNhMjhjMGRkL3RhYmxlcmFuZ2U6ZGM5ZDU3MWY3ZjdhNGZhZDlmZmJlYjg1M2EyOGMwZGRfMjgtMy0xLTEtMTg0NDY5_e69a9a07-3128-4b66-873b-f2bda7cbf874"
      unitRef="usd">39523000000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMy0xLTEtMS0xODQ0Njk_a80257db-989b-41ae-81ed-de70da1ecc85"
      unitRef="usd">1556000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMy0zLTEtMS0xODQ0Njk_09a22437-c030-42ec-af70-c12f513a59ac"
      unitRef="usd">1105000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfNC0xLTEtMS0xODQ0Njk_5461ffab-a097-4775-ae41-0aec0bef130b"
      unitRef="usd">552000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfNC0zLTEtMS0xODQ0Njk_f48adb89-b762-45c1-a6ab-fde419b2a429"
      unitRef="usd">449000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfNi0xLTEtMS0xODQ0Njk_8ef068ad-166b-42aa-b579-f0d913f5b14f"
      unitRef="usd">599000000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfNi0zLTEtMS0xODQ0Njk_97e088aa-3cd7-427c-8a4f-03e62fe70f33"
      unitRef="usd">664000000</us-gaap:AccruedMarketingCostsCurrent>
    <mo:AccruedSettlementLiabilityCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfOC0xLTEtMS0xODQ0Njk_fa370af7-3ad0-4134-ad1d-92057ec1556d"
      unitRef="usd">2925000000</mo:AccruedSettlementLiabilityCurrent>
    <mo:AccruedSettlementLiabilityCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfOC0zLTEtMS0xODQ0Njk_06023ef8-cc24-4e9c-920e-6444b21c7ff4"
      unitRef="usd">3349000000</mo:AccruedSettlementLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTAtMS0xLTEtMTg0NDY5_53e4ed9d-bb4f-4df6-8b9e-33bb841ba7cc"
      unitRef="usd">1299000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTAtMy0xLTEtMTg0NDY5_3b86114f-8494-428e-898b-ea0dbf4d4734"
      unitRef="usd">1365000000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTEtMS0xLTEtMTg0NDY5_6d83ba1c-e03a-4884-b354-216a9b6f76b6"
      unitRef="usd">1685000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTEtMy0xLTEtMTg0NDY5_50417e40-18b1-40b7-b12b-8a432ec358c0"
      unitRef="usd">1647000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTItMS0xLTEtMTg0NDY5_39301fce-94ef-4579-916d-d8fa5a67b26a"
      unitRef="usd">8616000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTItMy0xLTEtMTg0NDY5_25785f53-d1a7-4ef6-acc0-bf3e85f0b2a8"
      unitRef="usd">8579000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTQtMS0xLTEtMTg0NDY5_f468517e-70f7-4154-9764-424dd722e5a0"
      unitRef="usd">25124000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTQtMy0xLTEtMTg0NDY5_e4cff8d8-c117-4afd-8b14-1575ea8a7f75"
      unitRef="usd">26939000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTUtMS0xLTEtMTg0NDY5_d6458446-8c0b-43ee-ae62-b17500f32ea1"
      unitRef="usd">2897000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTUtMy0xLTEtMTg0NDY5_3507e538-e28b-4863-ab65-f79c6d3eaea4"
      unitRef="usd">3692000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTYtMS0xLTEtMTg0NDY5_e8b793c1-296f-47f1-9eb0-86b40039c1c2"
      unitRef="usd">133000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTYtMy0xLTEtMTg0NDY5_46cd652b-3e24-424e-84c5-ab5190227738"
      unitRef="usd">200000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTctMS0xLTEtMTg0NDY5_bded6877-556c-4c63-b48a-c0936ea3bfee"
      unitRef="usd">1083000000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
    <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTctMy0xLTEtMTg0NDY5_b014a518-53b7-4566-9040-0a1a19058c9a"
      unitRef="usd">1436000000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
    <mo:DeferredGainOnSaleOfCommercializationRightsNoncurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTktMS0xLTEtMTkwMjk3_90ad16e5-2a69-41aa-bdcf-a48d154b9177"
      unitRef="usd">2700000000</mo:DeferredGainOnSaleOfCommercializationRightsNoncurrent>
    <mo:DeferredGainOnSaleOfCommercializationRightsNoncurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTktMy0xLTEtMTkwMjk3_123c6f52-839e-49fc-8648-0d8b09171052"
      unitRef="usd">0</mo:DeferredGainOnSaleOfCommercializationRightsNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTgtMS0xLTEtMTg0NDY5_d0df75b3-7c06-4af4-8685-b369149e9e22"
      unitRef="usd">324000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTgtMy0xLTEtMTg0NDY5_9dc11e64-db85-4f46-8ab7-abc2fc41cf55"
      unitRef="usd">283000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTktMS0xLTEtMTg0NDY5_5d1b357c-860d-4145-bbc5-85f0f981065e"
      unitRef="usd">40877000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMTktMy0xLTEtMTg0NDY5_51949a79-e39c-4d46-b657-3a1d40b6cf53"
      unitRef="usd">41129000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjAtMS0xLTEtMTg0NDY5_677282ac-73ad-43b1-9773-ed54534f415e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjAtMy0xLTEtMTg0NDY5_573c20a2-0c9f-44e5-a65e-b97efc83aba4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjMtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246Yjk5ODRjNmVjYzNhNDc5Yzk1ODZkZTQyZDdjNDE0YWNfNTA_2cae0a38-1ff9-4c0e-ad2e-6694b0fa8a97"
      unitRef="shares">2805961317</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjMtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246Yjk5ODRjNmVjYzNhNDc5Yzk1ODZkZTQyZDdjNDE0YWNfNTA_3680ce31-bf29-4b4b-a840-2dd0413f67ce"
      unitRef="shares">2805961317</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjMtMS0xLTEtMTg0NDY5_f2049d85-3eeb-46b1-a8b6-15684e190881"
      unitRef="usd">935000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjMtMy0xLTEtMTg0NDY5_df69c5f7-deec-46bd-b991-49bb2455f52c"
      unitRef="usd">935000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjQtMS0xLTEtMTg0NDY5_86c8a2d9-414a-446e-8786-a92ad77922e8"
      unitRef="usd">5887000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjQtMy0xLTEtMTg0NDY5_1f94c9ae-1095-4f07-85b6-e107620b5d9b"
      unitRef="usd">5857000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjUtMS0xLTEtMTg0NDY5_a50775ad-e351-453e-bbd7-87d38f3159eb"
      unitRef="usd">29792000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjUtMy0xLTEtMTg0NDY5_590387d3-6619-4bbd-897b-c6851d0f519e"
      unitRef="usd">30664000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjYtMS0xLTEtMTg0NDY5_ac0a4801-5a69-4edb-9a7e-0070e71f8327"
      unitRef="usd">-2771000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjYtMy0xLTEtMTg0NDY5_14f4dc50-223e-4b36-a922-5d8c099b2abe"
      unitRef="usd">-3056000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjctMC0xLTEtMTg0NDY5L3RleHRyZWdpb246MmU1NzNlYzhiMmI4NDBlNmJhYzQ2Y2U0ODZjNDY1NWFfMzI_73300a0d-09b4-47af-9133-58d2826d961d"
      unitRef="shares">1020427195</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjctMC0xLTEtMTg0NDY5L3RleHRyZWdpb246MmU1NzNlYzhiMmI4NDBlNmJhYzQ2Y2U0ODZjNDY1NWFfNjg_0d9b3253-91ea-4531-b23d-df2ba793bb7e"
      unitRef="shares">982785699</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjctMS0xLTEtMTg0NDY5_f8bbb507-5997-46f4-a27e-c6af664b5c49"
      unitRef="usd">37816000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjctMy0xLTEtMTg0NDY5_87e06ce6-de0b-4bde-a70a-b7711d994d88"
      unitRef="usd">36006000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjgtMS0xLTEtMTg0NDY5_cee8c2bc-d1c3-4424-a714-d5e2571433a5"
      unitRef="usd">-3973000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjgtMy0xLTEtMTg0NDY5_f6fa8dc2-5cea-4845-9771-8be73e4b2107"
      unitRef="usd">-1606000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjktMS0xLTEtMTg0NDY5_5fd94f4d-279e-4d4d-afb1-3c319aeb7d17"
      unitRef="usd">50000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMjktMy0xLTEtMTg0NDY5_1284f237-e35c-4bfe-b506-bf64e3f3c627"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMzAtMS0xLTEtMTg0NDY5_b9e6f204-43e4-4bc4-b841-a4a18007cc15"
      unitRef="usd">-3923000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMzAtMy0xLTEtMTg0NDY5_93342fdd-62cc-4a05-9d50-72c9d73e0f7c"
      unitRef="usd">-1606000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMzEtMS0xLTEtMTg0NDY5_1810cf5c-780e-4041-ba9d-048bca678cb3"
      unitRef="usd">36954000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl83OS9mcmFnOjQ1YWE5YTVhM2Y2YTRlZWRhZmFjNzQ1N2RhODcxOTc4L3RhYmxlOmFlNjhhYjViZDM0ODRkNDhiZTVhYmNjNGI3ZDc0NmM1L3RhYmxlcmFuZ2U6YWU2OGFiNWJkMzQ4NGQ0OGJlNWFiY2M0YjdkNzQ2YzVfMzEtMy0xLTEtMTg0NDY5_794bd18e-2853-465a-8ae8-7c02099bd576"
      unitRef="usd">39523000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMS0xLTEtMS0xODQ0Njk_a5a2d936-c4d9-44c5-a732-633bf57a46e9"
      unitRef="usd">25096000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMS0zLTEtMS0xODQ0Njk_449ba8d0-92f9-43e0-a95b-d1f9b6d6b5cb"
      unitRef="usd">26013000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMS01LTEtMS0xODQ0Njk_3f4920fe-b10f-4ec5-a9d1-21097d64a353"
      unitRef="usd">26153000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMi0xLTEtMS0xODQ0Njk_4fd0e6e7-e367-47c6-ba09-30cb5ad8b8b1"
      unitRef="usd">6442000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMi0zLTEtMS0xODQ0Njk_7c9589be-4eb7-468f-9f62-c54e981c3316"
      unitRef="usd">7119000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMi01LTEtMS0xODQ0Njk_37a897a0-da98-4ac3-9ed9-4d2c4515b8f1"
      unitRef="usd">7818000000</us-gaap:CostOfGoodsAndServicesSold>
    <mo:ExciseTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMy0xLTEtMS0xODQ0Njk_9fc483d0-e9b7-44fd-9e44-a948e6549a20"
      unitRef="usd">4408000000</mo:ExciseTax>
    <mo:ExciseTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMy0zLTEtMS0xODQ0Njk_6437f969-df3c-4f75-a03b-0eaebbdd5a45"
      unitRef="usd">4902000000</mo:ExciseTax>
    <mo:ExciseTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMy01LTEtMS0xODQ0Njk_3300ef51-6acb-42ab-a122-de92911bfebb"
      unitRef="usd">5312000000</mo:ExciseTax>
    <us-gaap:GrossProfit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNC0xLTEtMS0xODQ0Njk_9bd45dad-67fe-42d4-8588-24ca5aca616a"
      unitRef="usd">14246000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNC0zLTEtMS0xODQ0Njk_91922781-db81-4c95-824c-6e60a89cf09f"
      unitRef="usd">13992000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNC01LTEtMS0xODQ0Njk_5f216bf2-257b-4d02-b354-8ba32e2e2716"
      unitRef="usd">13023000000</us-gaap:GrossProfit>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNS0xLTEtMS0xODQ0Njk_ca4a41a1-8c92-4cd0-af09-20636d3848ef"
      unitRef="usd">2327000000</mo:MarketingAdministrationandResearchCosts>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNS0zLTEtMS0xODQ0Njk_1c44816e-22a5-4fdc-b4ce-cdf7d903a291"
      unitRef="usd">2432000000</mo:MarketingAdministrationandResearchCosts>
    <mo:MarketingAdministrationandResearchCosts
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNS01LTEtMS0xODQ0Njk_264e7fcf-7226-469f-ab64-3f4c2a1813ef"
      unitRef="usd">2150000000</mo:MarketingAdministrationandResearchCosts>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNy0xLTEtMS0xODQ0Njk_3c6bf41e-a94f-43ac-8ef1-0237e6a8ccc2"
      unitRef="usd">11919000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNy0zLTEtMS0xODQ0Njk_25cbdcde-7e06-458a-85a8-d3e1cf7dbe8a"
      unitRef="usd">11560000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfNy01LTEtMS0xODQ0Njk_64946c67-6181-40f9-b5eb-6ac55b520d65"
      unitRef="usd">10873000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOC0xLTEtMS0xODQ0Njk_52e1bdf4-3b56-4c99-8ab8-d89c4b98a9cb"
      unitRef="usd">-1058000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOC0zLTEtMS0xODQ0Njk_fdf76186-bf4f-4c4b-ab28-5cf7937adb27"
      unitRef="usd">-1162000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOC01LTEtMS0xODQ0Njk_6d7d152c-18ae-4041-ac16-29ac26aec41d"
      unitRef="usd">-1209000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOS0xLTEtMS0xODkyNzA_435c66d1-665c-4426-9c1a-63c79f4e1f52"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOS0zLTEtMS0xODkyNzA_acefb7d9-56f8-4bd0-ac33-27f7bbe16b7f"
      unitRef="usd">-649000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOS01LTEtMS0xODkyNzA_6b2074c2-287e-4737-bc7a-1819a3063cc7"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOS0xLTEtMS0xODQ0Njk_1811ac59-50e2-4421-9552-bc107b617d2d"
      unitRef="usd">-184000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOS0zLTEtMS0xODQ0Njk_e355ccba-c7ca-4f3d-8a0f-04a0e00ddcd1"
      unitRef="usd">-202000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfOS01LTEtMS0xODQ0Njk_92503a24-5f00-4349-a63f-00c39ada3b71"
      unitRef="usd">-77000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTEtMS0xLTEtMTg0NDY5_18b25a00-a3f0-41a3-818f-44b5fd183f75"
      unitRef="usd">-3641000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTEtMy0xLTEtMTg0NDY5_c685f3da-bb4d-40eb-982e-54bc9ea90b72"
      unitRef="usd">-5979000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTEtNS0xLTEtMTg0NDY5_1fce8b56-6be4-46c7-a864-8ae13f0cf347"
      unitRef="usd">-111000000</mo:IncomeLossFromEquityInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTItMS0xLTEtMTg0NDY5_6ef7a4a3-f799-4549-8cfe-4db30eab9185"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTItMy0xLTEtMTg0NDY5_71e7f76c-87b7-45d2-a20c-2ce3f0610ff4"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTItNS0xLTEtMTg0NDY5_3a34c3c3-24ad-4921-835b-2a06c7513432"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTMtMS0xLTEtMTg0NDY5_9082c1c0-ed8f-4b39-b532-cae80585a03b"
      unitRef="usd">-15000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTMtMy0xLTEtMTg0NDY5_4cde7134-f697-4dc6-9c3d-63dded6cd5ce"
      unitRef="usd">-148000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTMtNS0xLTEtMTg0NDY5_ad7c66dc-7ebb-4ecf-b69b-0c46e414cb90"
      unitRef="usd">-140000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTUtMS0xLTEtMTg0NDY5_e92b631b-530e-4300-a2da-de4b4e4fbcdf"
      unitRef="usd">7389000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTUtMy0xLTEtMTg0NDY5_1f521b3d-4cdc-4773-a73c-9d6e44662bbb"
      unitRef="usd">3824000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTUtNS0xLTEtMTg0NDY5_c7b639fc-636f-423c-ae9d-b1aff94b380e"
      unitRef="usd">6890000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTYtMS0xLTEtMTg0NDY5_a68b4f34-407b-48e7-b940-090e1f24f343"
      unitRef="usd">1625000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTYtMy0xLTEtMTg0NDY5_15550530-6e50-4d0e-b855-a8c10518202a"
      unitRef="usd">1349000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTYtNS0xLTEtMTg0NDY5_bda699d3-a758-47f3-83dd-7a468a8c277a"
      unitRef="usd">2436000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTctMS0xLTEtMTg0NDY5_7bcd221b-8ee8-49ee-8acc-554a31e4b46b"
      unitRef="usd">5764000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTctMy0xLTEtMTg0NDY5_e3f1e4e1-06aa-419b-b7f7-2d94d5e73d64"
      unitRef="usd">2475000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTctNS0xLTEtMTg0NDY5_2ed83796-58f5-4a5c-925f-abd3b699e481"
      unitRef="usd">4454000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTgtMS0xLTEtMTg0NDY5_750266e5-738d-4aa3-a9cc-26005597fec5"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTgtMy0xLTEtMTg0NDY5_3f37f6cc-d881-40cd-9e9b-2e74b7517891"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTgtNS0xLTEtMTg0NDY5_83e5f3e9-b179-4c1d-9bde-84719ef22589"
      unitRef="usd">-13000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTktMS0xLTEtMTg0NDY5_5ecf8f0b-efc7-47a8-b6e0-0047de0ed1e7"
      unitRef="usd">5764000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTktMy0xLTEtMTg0NDY5_076eb2cb-0e8a-4aee-a0a8-80cdaa8e5494"
      unitRef="usd">2475000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMTktNS0xLTEtMTg0NDY5_4c82bf54-e122-4662-9dec-bd5f2ede5b23"
      unitRef="usd">4467000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMjEtMS0xLTEtMTg0NDY5_254b70a1-6695-49e2-982f-557b1a1efac1"
      unitRef="usdPerShare">3.19</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMjEtMS0xLTEtMTg0NDY5_da841c23-0c88-48b9-93d5-a118115667bb"
      unitRef="usdPerShare">3.19</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMjEtMy0xLTEtMTg0NDY5_2179852b-704a-4d8d-bd76-03f93dffdda4"
      unitRef="usdPerShare">1.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMjEtMy0xLTEtMTg0NDY5_e34b2b8e-715c-4785-ab54-1a245fb6bdd2"
      unitRef="usdPerShare">1.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMjEtNS0xLTEtMTg0NDY5_238a6b8d-52f6-4eed-a7f7-84dfe4e67724"
      unitRef="usdPerShare">2.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84NS9mcmFnOjkwODgwNzVhY2FkZTQwMzRhY2UzYWNiNjZkZjk0ODc5L3RhYmxlOjA5MzFkNGIyMjkwMDRiNjA5ODI4YmJjM2Y4M2YxZjZiL3RhYmxlcmFuZ2U6MDkzMWQ0YjIyOTAwNGI2MDk4MjhiYmMzZjgzZjFmNmJfMjEtNS0xLTEtMTg0NDY5_78c5f4d4-8154-495f-ae0a-02419f38db0c"
      unitRef="usdPerShare">2.40</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ProfitLoss
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMS0yLTEtMS0xODQ0Njk_33abc1c6-cf06-47f4-bfc5-144eaf493707"
      unitRef="usd">5764000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMS00LTEtMS0xODQ0Njk_1daf5888-377e-4439-a52d-6dbd78ddc32f"
      unitRef="usd">2475000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMS02LTEtMS0xODQ0Njk_d067e81b-2138-4bba-9368-365887f22c54"
      unitRef="usd">4454000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMy0yLTEtMS0xODQ0Njk_4cab17eb-1358-42a5-9be7-9fb1ad5d4f56"
      unitRef="usd">-176000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMy00LTEtMS0xODQ0Njk_619d23c5-23a2-4113-9dee-04c5a7ebd01d"
      unitRef="usd">-808000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMy02LTEtMS0xODQ0Njk_7b5428f7-b351-48d5-9a59-71df58585c84"
      unitRef="usd">228000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNC0yLTEtMS0xODQ0Njk_a558b27e-b253-4b20-af21-9e47eba88fa5"
      unitRef="usd">143000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNC00LTEtMS0xODQ0Njk_e33acdc1-d859-42d9-8854-f52f6e5f9bf2"
      unitRef="usd">426000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <us-gaap:OciEquityMethodInvestmentAfterTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNC02LTEtMS0xODQ0Njk_159fff23-fb38-41bb-9efb-cf74b75a5831"
      unitRef="usd">-1245000000</us-gaap:OciEquityMethodInvestmentAfterTax>
    <mo:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNS0yLTEtMS0xODQ0Njk_3fe88c8f-3797-46ef-b73f-112fac963ed3"
      unitRef="usd">-34000000</mo:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax>
    <mo:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNS00LTEtMS0xODQ0Njk_e4ce5ee6-8326-4a5e-9f83-1306fc831d00"
      unitRef="usd">51000000</mo:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax>
    <mo:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNS02LTEtMS0xODQ0Njk_77217325-452a-4cba-8a05-3b70430391db"
      unitRef="usd">-4000000</mo:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNi0yLTEtMS0xODQ0Njk_501b5538-bd28-4647-8a7e-13515bb50ea5"
      unitRef="usd">285000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNi00LTEtMS0xODQ0Njk_079f6bc4-928f-45dc-84a5-1fea584c2ad0"
      unitRef="usd">1285000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfNi02LTEtMS0xODQ0Njk_fea2e4c9-99cc-4ffe-8f5f-d5a812288173"
      unitRef="usd">-1477000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfOC0yLTEtMS0xODQ0Njk_8f920a97-b251-48c3-a212-440a7f636c37"
      unitRef="usd">6049000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfOC00LTEtMS0xODQ0Njk_ef4f9f33-722b-41dc-9075-3fe4f71ec7df"
      unitRef="usd">3760000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfOC02LTEtMS0xODQ0Njk_02dc4e7d-5131-4eda-ae3b-5633f1b697c7"
      unitRef="usd">2977000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfOS0yLTEtMS0xODQ0Njk_72323eb1-d967-4bd5-90a1-067af56846f2"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfOS00LTEtMS0xODQ0Njk_3adfbfef-9962-40e0-96d1-915094440d00"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfOS02LTEtMS0xODQ0Njk_82584eb3-ce9d-452f-b393-06d0f5e60382"
      unitRef="usd">-13000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMTAtMi0xLTEtMTg0NDY5_a3f03475-b049-4992-a9f0-1d6b235fc694"
      unitRef="usd">6049000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMTAtNC0xLTEtMTg0NDY5_947df3b7-2697-41a8-a83e-d71564b269d5"
      unitRef="usd">3760000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl84OC9mcmFnOjhhMmFkZDUxZWYzNzQzYTM5MjM1MjBiZWJmZmQxZWM0L3RhYmxlOmFhYTIxZmQxOWZkMjRlZDE4MDMxOTgzNDU1MGI3NGQzL3RhYmxlcmFuZ2U6YWFhMjFmZDE5ZmQyNGVkMTgwMzE5ODM0NTUwYjc0ZDNfMTAtNi0xLTEtMTg0NDY5_2dc07857-4c31-4726-ad96-1cb83aa62ff4"
      unitRef="usd">2990000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMi0zLTEtMS0xODQ0Njk_8427c002-60e6-47c6-8291-3dc81c888f7a"
      unitRef="usd">5764000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMi01LTEtMS0xODQ0Njk_37440407-a580-4f9e-bb85-cb13635dc732"
      unitRef="usd">2475000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMi03LTEtMS0xODQ0Njk_c156a371-14b7-4a88-87de-33fc26ea048a"
      unitRef="usd">4454000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNC0zLTEtMS0xODQ0Njk_fe56591b-8b8e-44ba-b85e-00c120afd44b"
      unitRef="usd">226000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNC01LTEtMS0xODQ0Njk_27570a6a-9f41-4df5-ae03-2fb39703f920"
      unitRef="usd">244000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNC03LTEtMS0xODQ0Njk_fa02c25a-c7cb-40ea-a227-f7592063ad55"
      unitRef="usd">257000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNS0zLTEtMS0xODQ0Njk_38d7bcfe-b0f2-40be-a827-82d25a93e7f1"
      unitRef="usd">-947000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNS01LTEtMS0xODQ0Njk_fca4ec86-45cb-4d01-aab3-5ef124a95962"
      unitRef="usd">-1160000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNS03LTEtMS0xODQ0Njk_6da8cc6a-d98b-426a-85ab-96df140103b8"
      unitRef="usd">-164000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNi0zLTEtMS0xODQ0Njk_4ef89de2-bdeb-4bf7-af7e-aa065084fbcc"
      unitRef="usd">-3641000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNi01LTEtMS0xODQ0Njk_27eee146-a589-46b5-855a-da63fbe760f8"
      unitRef="usd">-5979000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfNi03LTEtMS0xODQ0Njk_7795ebcf-b517-4ee8-add9-805b5fdc0973"
      unitRef="usd">-111000000</mo:IncomeLossFromEquityInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfOC0zLTEtMS0xODQ0Njk_e2a51546-6220-4207-82ce-91707c23b677"
      unitRef="usd">104000000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfOC01LTEtMS0xODQ0Njk_5d4a6557-c633-43c7-a06f-a5a5c92d556d"
      unitRef="usd">119000000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfOC03LTEtMS0xODQ0Njk_e12d5dee-c910-41ae-b826-f3b4147adbbd"
      unitRef="usd">108000000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTAtMy0xLTEtMTg0NDY5_00dd562b-5514-451c-80da-467136cf5541"
      unitRef="usd">-15000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTAtNS0xLTEtMTg0NDY5_f9cd533f-5c51-4e2c-9a74-b400aa36df07"
      unitRef="usd">-148000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTAtNy0xLTEtMTg0NDY5_00db4a0d-2529-4d20-bdaf-5fe7e2a2df17"
      unitRef="usd">-140000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTEtMy0xLTEtMTg0NDY5_c74ca88a-be85-4f61-a463-50739b1ea748"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTEtNS0xLTEtMTg0NDY5_a77affe2-5428-4a62-ac7a-4b9f809e8f2e"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTEtNy0xLTEtMTg0NDY5_f2c89389-5237-4563-a101-3697bea920c8"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTQtMy0xLTEtMTg0NDY5_41d38f47-a444-48fd-8c1a-cfb844fb89d3"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTQtNS0xLTEtMTg0NDY5_f3280551-3e58-4eb0-bc76-0e44024237e8"
      unitRef="usd">-649000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTQtNy0xLTEtMTg0NDY5_8a7b953c-d758-491d-8ea7-b2016bdef6d3"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtMy0xLTEtMTg0NDY5_a263de0c-6587-42c8-9396-b995575984e6"
      unitRef="usd">21000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtNS0xLTEtMTg0NDY5_3bf7ef4a-bd0c-4bcc-9072-5628558babb3"
      unitRef="usd">18000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtNy0xLTEtMTg0NDY5_203d2fd6-57a4-4f03-aa3d-ed9e380ed56e"
      unitRef="usd">-20000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctMy0xLTEtMTg0NDY5_8deaca41-7c96-4e8c-8385-7e467740c77a"
      unitRef="usd">-14000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctNS0xLTEtMTg0NDY5_759a87d9-5197-4bf2-9a65-5f2c98ba7823"
      unitRef="usd">-57000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctNy0xLTEtMTg0NDY5_2c9b888b-a91a-4bea-9f45-859a4eda9baa"
      unitRef="usd">-2000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtMy0xLTEtMTg0NDY5_b171074d-301b-42c8-91ac-1761bf0b46a0"
      unitRef="usd">92000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtNS0xLTEtMTg0NDY5_1bfff92b-7dd4-4099-b50a-3f753ee343cc"
      unitRef="usd">163000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtNy0xLTEtMTg0NDY5_e3c8c0cf-ff28-47dd-942f-6deb723d66cc"
      unitRef="usd">53000000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktMy0xLTEtMTg0NDY5_8b5b42d2-4b81-456b-8339-13cab0197645"
      unitRef="usd">-118000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktNS0xLTEtMTg0NDY5_4ec58889-7557-43b6-82b5-7dc591b1be87"
      unitRef="usd">-149000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktNy0xLTEtMTg0NDY5_cdf2c1f2-effa-4703-ad59-804c05c64b84"
      unitRef="usd">-29000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtMy0xLTEtMTg0NDY5_355d473f-1333-4c41-ad67-1e1351abf2c5"
      unitRef="usd">129000000</us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtNS0xLTEtMTg0NDY5_db920e2e-633f-4ad1-8b1a-005b5fce5b06"
      unitRef="usd">-165000000</us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtNy0xLTEtMTg0NDY5_fc7e4d1a-9a22-49f0-8d42-310f8fdd2f5e"
      unitRef="usd">15000000</us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet>
    <mo:IncreaseDecreaseInSettlementPayable
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtMy0xLTEtMTg0NDY5_69d4bbfd-3c54-4f6f-ac43-def57bedc3b7"
      unitRef="usd">-424000000</mo:IncreaseDecreaseInSettlementPayable>
    <mo:IncreaseDecreaseInSettlementPayable
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtNS0xLTEtMTg0NDY5_9dfffa66-533d-4eff-b94f-6216b81ff55e"
      unitRef="usd">-215000000</mo:IncreaseDecreaseInSettlementPayable>
    <mo:IncreaseDecreaseInSettlementPayable
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtNy0xLTEtMTg0NDY5_ad63cc97-ce3c-481c-866d-8a031b1a48df"
      unitRef="usd">218000000</mo:IncreaseDecreaseInSettlementPayable>
    <us-gaap:PensionAndOtherPostretirementBenefitContributions
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjItMy0xLTEtMTg0NDY5_e58d1c05-6437-40bb-b9cd-54a9a5e37abe"
      unitRef="usd">20000000</us-gaap:PensionAndOtherPostretirementBenefitContributions>
    <us-gaap:PensionAndOtherPostretirementBenefitContributions
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjItNS0xLTEtMTg0NDY5_1841aa2c-84dc-4038-99cd-68ea7adc5729"
      unitRef="usd">26000000</us-gaap:PensionAndOtherPostretirementBenefitContributions>
    <us-gaap:PensionAndOtherPostretirementBenefitContributions
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjItNy0xLTEtMTg0NDY5_f237bed3-989d-4e41-b879-e9fa29d902b1"
      unitRef="usd">33000000</us-gaap:PensionAndOtherPostretirementBenefitContributions>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjMtMy0xLTEtMTg0NDY5_cd08c3a4-a87f-4385-80c8-19e8d53a099a"
      unitRef="usd">-156000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjMtNS0xLTEtMTg0NDY5_c9a38e04-8dbc-45ec-b3a9-34a671e7b47f"
      unitRef="usd">-175000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjMtNy0xLTEtMTg0NDY5_adf7359a-db83-48d2-ac7c-03c7828bad25"
      unitRef="usd">-49000000</us-gaap:PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtMy0xLTEtMTg0NDY5_3a1de55c-c8c1-4c0e-8b80-3f95381a1678"
      unitRef="usd">215000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtNS0xLTEtMTg0NDY5_a9b18782-5660-4b57-b202-a8053be6f4c3"
      unitRef="usd">149000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtNy0xLTEtMTg0NDY5_c7daf6b9-586d-40ab-8e8a-700555c64c11"
      unitRef="usd">712000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjUtMy0xLTEtMTg0NDY5_235151e3-6761-4b88-852c-09b73d02a83a"
      unitRef="usd">8256000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjUtNS0xLTEtMTg0NDY5_6588857c-c585-4fd7-98c4-56bf41d8d5f1"
      unitRef="usd">8405000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjUtNy0xLTEtMTg0NDY5_5ca8a1a5-b41d-4c84-9ec5-5eb2358b83bc"
      unitRef="usd">8385000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjgtMy0xLTEtMTg0NDY5_05b6df41-4a65-4a4a-bd52-5e2dc48a06d7"
      unitRef="usd">205000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjgtNS0xLTEtMTg0NDY5_39c96bac-73e7-4064-ad55-27bbf8b49ecf"
      unitRef="usd">169000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjgtNy0xLTEtMTg0NDY5_2e389c1f-d658-40f9-b751-87a827d938a9"
      unitRef="usd">231000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <mo:ProceedsFromSaleOfCommercializationRights
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzItMy0xLTEtMTk3NDMy_e358d271-aca7-4e86-ab2c-6840ebada3dd"
      unitRef="usd">1000000000</mo:ProceedsFromSaleOfCommercializationRights>
    <mo:ProceedsFromSaleOfCommercializationRights
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzItNS0xLTEtMTk3NDMy_c7a95711-62ea-4cf3-8bd5-b68d875f9a79"
      unitRef="usd">0</mo:ProceedsFromSaleOfCommercializationRights>
    <mo:ProceedsFromSaleOfCommercializationRights
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzItNy0xLTEtMTk3NDMy_27541130-3795-4608-b9b4-ffbfd8722b87"
      unitRef="usd">0</mo:ProceedsFromSaleOfCommercializationRights>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzMtMy0xLTEtMTg0NDY5_c3e11967-89b3-4f89-be50-72ccdd3e8821"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzMtNS0xLTEtMTg0NDY5_5ff4a33e-3600-41b1-a037-84d1b46ade65"
      unitRef="usd">1176000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzMtNy0xLTEtMTg0NDY5_255eb8d9-80d4-4fb8-90ac-f5577bd747d4"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzctMy0xLTEtMTg0NDY5_03c727d0-365f-476e-8bfa-9902b2448336"
      unitRef="usd">13000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzctNS0xLTEtMTg0NDY5_2425416a-6c0d-45e9-bed6-2cf3d1495802"
      unitRef="usd">-205000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzctNy0xLTEtMTg0NDY5_17b401e0-f933-4dbb-881b-51a6488f6318"
      unitRef="usd">-88000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzgtMy0xLTEtMTg0NDY5_ec67f0d9-9f99-4ccf-b1f3-c7ee5a7200fe"
      unitRef="usd">782000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzgtNS0xLTEtMTg0NDY5_be7053a4-ac96-4e53-92d8-267768380611"
      unitRef="usd">1212000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMzgtNy0xLTEtMTg0NDY5_315780e0-ba71-4ee8-9f8c-3169db98c9d1"
      unitRef="usd">-143000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMi0zLTEtMS0xODQ0Njk_b9cd78f6-8e6a-49ef-9c24-a6d702e36798"
      unitRef="usd">0</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMi01LTEtMS0xODQ0Njk_01df31d1-4f81-41a0-a331-5f582f97a261"
      unitRef="usd">0</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMi03LTEtMS0xODQ0Njk_e3790886-4b88-4c72-ab57-3eef5ec3b4d7"
      unitRef="usd">3000000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMy0zLTEtMS0xODQ0Njk_a9c76c16-f04c-4114-a66f-acb3dcda03f1"
      unitRef="usd">0</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMy01LTEtMS0xODQ0Njk_a2a6f251-2952-4209-9b14-5c83b990410c"
      unitRef="usd">0</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMy03LTEtMS0xODQ0Njk_6c38986a-dd23-4987-9553-65f5dbb32903"
      unitRef="usd">3000000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNC0zLTEtMS0xODQ0Njk_ac0f0b33-25e5-42fe-8786-d51e682fa109"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNC01LTEtMS0xODQ0Njk_c658f146-f002-4928-b373-75a98cd71be5"
      unitRef="usd">5472000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNC03LTEtMS0xODQ0Njk_edc760fe-4e92-4b7f-988e-00242f999217"
      unitRef="usd">1993000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNS0zLTEtMS0xODQ0Njk_2208db43-715c-4305-b5d0-ef4d60f1be6e"
      unitRef="usd">1105000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNS01LTEtMS0xODQ0Njk_7284c921-151f-4127-8e18-8fcd42e225e9"
      unitRef="usd">6542000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNS03LTEtMS0xODQ0Njk_1f741d8c-29a1-4d69-8151-4441bfef72a2"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNi0zLTEtMS0xODQ0Njk_0cc69347-70e6-4f10-b0de-ae347dca11d2"
      unitRef="usd">1825000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNi01LTEtMS0xODQ0Njk_95434be4-7849-44d6-9043-99863b3e2887"
      unitRef="usd">1675000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNi03LTEtMS0xODQ0Njk_65a5d6fa-2d7a-46fc-9231-e3b5cf11c592"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNy0zLTEtMS0xODQ0Njk_4bbcbc4b-c12a-489b-94c0-981cc66723c3"
      unitRef="usd">6599000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNy01LTEtMS0xODQ0Njk_074f62aa-26d3-4ffd-ba0b-30ff02e29e61"
      unitRef="usd">6446000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfNy03LTEtMS0xODQ0Njk_04b7ddae-5987-4fa3-9beb-ecd05c3ba20f"
      unitRef="usd">6290000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTAtMy0xLTEtMTg0NDY5_01e9e7a8-4dec-4592-98cc-1e4e3ca9c12b"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTAtNS0xLTEtMTg0NDY5_2ec39768-86d5-4050-89f7-c9fb0be262cb"
      unitRef="usd">623000000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTAtNy0xLTEtMTg0NDY5_226397cd-8c29-401a-89ad-3450cb9f7b5d"
      unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTEtMy0xLTEtMTg0NDY5_dcc3b456-b23c-4b66-aaa5-3ea6ca170397"
      unitRef="usd">-12000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTEtNS0xLTEtMTg0NDY5_cec62865-e01b-47ad-954d-a9ec30a62947"
      unitRef="usd">-215000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTEtNy0xLTEtMTg0NDY5_b5feb5e8-2710-4da5-a50a-6f51c0627733"
      unitRef="usd">-99000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTItMy0xLTEtMTg0NDY5_0adc7f65-411e-4159-bca9-1edff1f97f18"
      unitRef="usd">-9541000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTItNS0xLTEtMTg0NDY5_365477cf-dec6-4ef5-a3ef-b67262e63456"
      unitRef="usd">-10029000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTItNy0xLTEtMTg0NDY5_51cee2e3-b8e8-4da2-8687-0a7bcbafeec8"
      unitRef="usd">-5396000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTQtMy0xLTEtMTg0NDY5_9f5a6a2b-75f6-4716-b685-ef68a402e827"
      unitRef="usd">-503000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTQtNS0xLTEtMTg0NDY5_1ca9a718-b2ce-4b7c-91e3-ea81b8f3fe57"
      unitRef="usd">-412000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTQtNy0xLTEtMTg0NDY5_cb61608a-b7f3-4d19-8051-0afe857b6e1c"
      unitRef="usd">2846000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTUtMy0xLTEtMTg0NDY5_3c80944b-594c-495a-ad77-f54fa2411ef7"
      unitRef="usd">4594000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTUtNS0xLTEtMTg0NDY5_325d35b2-4f94-4c52-9a9c-8ad3c42b245d"
      unitRef="usd">5006000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i40e064b5da194d8bbe29064d490250de_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTUtNy0xLTEtMTg0NDY5_cfedc2c2-b485-477f-b16c-1f806df38371"
      unitRef="usd">2160000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTYtMy0xLTEtMTg0NDY5_962f8c5b-8ed8-42ad-9fae-2a92b97f8bf2"
      unitRef="usd">4091000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTYtNS0xLTEtMTg0NDY5_fdfb549a-e1a0-4c47-bb27-0a0c0074cf90"
      unitRef="usd">4594000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTYtNy0xLTEtMTg0NDY5_69fb4229-945f-466b-be17-d7a301e0b764"
      unitRef="usd">5006000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTctMy0xLTEtMTg0NDY5_d93e619f-0452-47a0-a526-ae4db9893698"
      unitRef="usd">1119000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTctNS0xLTEtMTg0NDY5_628296ce-a202-4847-b266-d7eaabefc351"
      unitRef="usd">1189000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTctNy0xLTEtMTg0NDY5_b1ea7a18-35db-4a9b-8118-78766f9adb6a"
      unitRef="usd">1246000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTgtMy0xLTEtMTg0NDY5_d4fb2093-c187-466a-9489-f5b2dc7f1406"
      unitRef="usd">2657000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTgtNS0xLTEtMTg0NDY5_ab4b4113-bb7d-470a-9568-bf53fddb960f"
      unitRef="usd">2673000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMTgtNy0xLTEtMTg0NDY5_50e4e48c-872d-41cd-8942-c05b3e3c93d4"
      unitRef="usd">2616000000</us-gaap:IncomeTaxesPaid>
    <mo:DeferredProceedsFromSaleOfCommercializationRightsNoncash
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjItMy0xLTEtMTk1NzMx_93bd9f73-06bf-4dc7-b341-df30cffd1f09"
      unitRef="usd">1700000000</mo:DeferredProceedsFromSaleOfCommercializationRightsNoncash>
    <mo:DeferredProceedsFromSaleOfCommercializationRightsNoncash
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjItNS0xLTEtMTk1NzM5_9633ed97-2586-4908-891b-01cd0428ff00"
      unitRef="usd">0</mo:DeferredProceedsFromSaleOfCommercializationRightsNoncash>
    <mo:DeferredProceedsFromSaleOfCommercializationRightsNoncash
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjItNy0xLTEtMTk1NzUz_d57fde28-f1cf-46fa-bc49-dcdcba8bd8b9"
      unitRef="usd">0</mo:DeferredProceedsFromSaleOfCommercializationRightsNoncash>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjMtMy0xLTEtMTg0NDY5_29c9c59c-26c3-4c7a-9ff5-8465db577728"
      unitRef="usd">4030000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjMtNS0xLTEtMTg0NDY5_533ebe42-9e1a-4f4c-bdb6-e8150cfa0e04"
      unitRef="usd">4544000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjMtNy0xLTEtMTg0NDY5_9faef349-742c-408c-bee9-cf2235ecdc46"
      unitRef="usd">4945000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtMy0xLTEtMTg0NDY5_f0409233-b1e7-4ebb-9154-a390febe08d8"
      unitRef="usd">15000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtNS0xLTEtMTg0NDY5_64fa7aae-ddef-4caf-ba23-40606890a0e4"
      unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtNy0xLTEtMTg0NDY5_4ab69433-7e8a-4d7b-97a4-07872742a884"
      unitRef="usd">1000000</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtMy0xLTEtMTg0NDY5_e5f3aecf-a9ff-4428-9ed2-426d4780cd6c"
      unitRef="usd">46000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtNS0xLTEtMTg0NDY5_bd3bb9be-596a-4f1b-b189-0373023ab0e6"
      unitRef="usd">50000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtNy0xLTEtMTg0NDY5_84400522-0293-4106-b980-ec04b03e31f9"
      unitRef="usd">60000000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjYtMy0xLTEtMTg0NDY5_13f4d34a-d6de-48b4-8493-ee8ddfbca7b7"
      unitRef="usd">4091000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjYtNS0xLTEtMTg0NDY5_c7d32140-2797-4d58-9385-24891d4686bf"
      unitRef="usd">4594000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjYtNy0xLTEtMTg0NDY5_ac2e0c06-7b4d-42c0-871a-3505a43ad492"
      unitRef="usd">5006000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iccd540c71b2a4978b8805b946441e6f0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi0xLTEtMS0xODQ0Njk_88df483a-4927-4a97-b96a-118960536c0d"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2289b034d6ab496e9d25b9a4e0e0ffe5_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi0zLTEtMS0xODQ0Njk_94e216f5-ebbc-4751-ae82-52a2912eeb26"
      unitRef="usd">5970000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5b6e92147eea44118dbabf94df471192_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi01LTEtMS0xODQ0Njk_6ae1fc8d-2754-4f6f-927c-d7299a797834"
      unitRef="usd">36539000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia23cc26a813c466694dadfb7e04c27d2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi03LTEtMS0xODQ0Njk_8d70d714-9830-4ed7-9bd5-405f39c716c8"
      unitRef="usd">-2864000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if73ff79a396f45c7beb9c0f45e3d64d9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi05LTEtMS0xODQ0Njk_ba83c1e6-8bdc-4de0-962a-6e626ea4570a"
      unitRef="usd">-34358000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibcb2c65901a147d6b22d66ec3bf6e1b2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi0xMS0xLTEtMTg0NDY5_a845f51e-4159-495c-a464-4e7ce4ae60db"
      unitRef="usd">97000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i40e064b5da194d8bbe29064d490250de_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMi0xMy0xLTEtMTg0NDY5_5d450220-534d-4507-bab9-da70c2d6d585"
      unitRef="usd">6319000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i6e5aec152bc347058ac199ade9c42ac1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMy01LTEtMS0xODQ0Njk_8aa6535f-3178-434f-b436-a31a9a1fa42a"
      unitRef="usd">4467000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i4226489807b64beda01803b44b87592c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMy0xMS0xLTEtMTg0NDY5_6a2e76bf-94c7-4eb0-b1c5-72bbaafcc95f"
      unitRef="usd">-16000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMy0xMy0xLTEtMTg0NDY5_60cff785-1dcd-4e80-8b2b-27e4de033b2a"
      unitRef="usd">4451000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNC03LTEtMS0xODQ0Njk_8ac1509d-ea84-4569-b65c-a7dc0c0fe6c0"
      unitRef="usd">-1477000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNC0xMy0xLTEtMTg0NDY5_ea0152dd-c16d-4692-ab33-10c9736b1029"
      unitRef="usd">-1477000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i81c616f824f34a2c82770dab642faf1f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNS0zLTEtMS0xODQ0Njk_3ab9c2e0-bfc6-454c-8c78-4f679ed7a676"
      unitRef="usd">13000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i0a061535c8074fa4b0e3bb2cb94f27ea_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNS05LTEtMS0xODQ0Njk_650a20a8-1c34-46c0-a7da-f7dc8991885d"
      unitRef="usd">14000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNS0xMy0xLTEtMTg0NDY5_394150e4-83b4-4dd1-8061-d66340bd38e6"
      unitRef="usd">27000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNi0wLTEtMS0xODQ0NjkvdGV4dHJlZ2lvbjpjNDljZDgzNzFjYjQ0YmZjYjU0ODQ4ODU5ZmY3MjhmM18yOQ_834face7-de97-468c-b2cf-febbf36ca621"
      unitRef="usdPerShare">3.40</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="i6e5aec152bc347058ac199ade9c42ac1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNi01LTEtMS0xODQ0Njk_65a8cfb8-c5e4-4674-ab1b-a0e89df942a8"
      unitRef="usd">6327000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfNi0xMy0xLTEtMTg0NDY5_457b5dbd-8f95-4f71-b717-af9228162ef8"
      unitRef="usd">6327000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityOther
      contextRef="i81c616f824f34a2c82770dab642faf1f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0zLTEtMS0xODQ0Njk_0254c52c-e466-47e3-882e-37a450dd94f5"
      unitRef="usd">73000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i4226489807b64beda01803b44b87592c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0xMS0xLTEtMTg0NDY5_331d7980-7513-4e9b-9fea-a0de6e28adc7"
      unitRef="usd">-5000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0xMy0xLTEtMTg0NDY5_4399e170-9610-4ab2-ba0c-56afb2e2fae0"
      unitRef="usd">68000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd14995a072744498777768ab05c3cf3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS0xLTEtMS0xODQ0Njk_2c733bad-8051-4f41-a066-e03daff1de89"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2c8b04ab864741d0b17c502256196d58_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS0zLTEtMS0xODQ0Njk_caf4900e-a16c-4159-8fa4-e91b83acf5ba"
      unitRef="usd">5910000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie1f4d1ddc9b541ebbe3b22a611ae436f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS01LTEtMS0xODQ0Njk_1e72fc6a-a8e9-4525-81cc-e50da80717bf"
      unitRef="usd">34679000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie4b30e48366b42559b3e640d996b9125_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS03LTEtMS0xODQ0Njk_95d369df-dfc2-480b-ba2a-2173458fea70"
      unitRef="usd">-4341000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f48333a20ec42c5ab2f1cba314394bd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS05LTEtMS0xODQ0Njk_f94adba8-bd86-406e-be99-0e0e71b1681d"
      unitRef="usd">-34344000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3dc6d82320204c0485ccfc4d8649e44b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS0xMS0xLTEtMTg0NDY5_a86317c2-96ea-4ff1-accb-130c37d9a524"
      unitRef="usd">86000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOS0xMy0xLTEtMTg0NDY5_918f3e8e-6f8e-4a0a-85ef-d709d633ddc2"
      unitRef="usd">2925000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="iac019ebefddb4e73825f27700d39c2c3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTAtNS0xLTEtMTg0NDY5_3bdde52c-a4fe-4e75-94e3-288c63ec1157"
      unitRef="usd">2475000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i7b87a4d656b74f4c891d75c1fd38ce42_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTAtMTEtMS0xLTE4NDQ2OQ_615d2fe3-74eb-4b04-ae83-a9757d48f7f4"
      unitRef="usd">-4000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTAtMTMtMS0xLTE4NDQ2OQ_692fe0fe-dfe3-4b60-b48e-5eb8d5cfb469"
      unitRef="usd">2471000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTEtNy0xLTEtMTg0NDY5_95c6b9e6-2ea1-4e27-b700-7a2897a59368"
      unitRef="usd">1285000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTEtMTMtMS0xLTE4NDQ2OQ_bfb7dec1-22ac-4c7c-96a3-edcf5d863d8d"
      unitRef="usd">1285000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="icf9654d043934172838e2f4f18b13dc0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTItMy0xLTEtMTg0NDY5_4fe5d7dd-e3a3-4a03-b1f7-ff9736472cb5"
      unitRef="usd">24000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="ia49817e15e234846bd0a2a699c3c90b1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTItOS0xLTEtMTg0NDY5_8d8b89dd-f8fb-4dfb-8ddc-5952e5a892e1"
      unitRef="usd">13000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTItMTMtMS0xLTE4NDQ2OQ_8b5555bc-524c-4570-979c-53ae30386362"
      unitRef="usd">37000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTMtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246MzA2YTAyYTQxN2QxNDk2OTg0ZmNiZTk2NWVlYjA4OWFfMjk_32e4b8f5-dd9e-40c3-826e-0e7f5b86f57b"
      unitRef="usdPerShare">3.52</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="iac019ebefddb4e73825f27700d39c2c3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTMtNS0xLTEtMTg0NDY5_b0443315-cd29-415d-af99-4b17331a73e1"
      unitRef="usd">6490000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTMtMTMtMS0xLTE4NDQ2OQ_fc417e1f-b4fb-4e0f-a854-6937a639389a"
      unitRef="usd">6490000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ia49817e15e234846bd0a2a699c3c90b1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTQtOS0xLTEtMTg0NDY5_4718c20f-0801-4c68-808e-ef528a4a10e3"
      unitRef="usd">1675000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTQtMTMtMS0xLTE4NDQ2OQ_6723c36b-76ae-4cd9-8524-f9a6b8350fb9"
      unitRef="usd">1675000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityOther
      contextRef="icf9654d043934172838e2f4f18b13dc0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMy0xLTEtMTg0NDY5_ac11e58c-b7bb-4b55-b8f3-f2596f262f54"
      unitRef="usd">77000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i7b87a4d656b74f4c891d75c1fd38ce42_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMTEtMS0xLTE4NDQ2OQ_ba3cb69a-974d-4cce-90ea-aa5f5ba144a1"
      unitRef="usd">82000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMTMtMS0xLTE4NDQ2OQ_eaaade6c-00b9-439c-aff9-3fd93d136786"
      unitRef="usd">159000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3328162568604ac9b6492de3b2e66b8f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctMS0xLTEtMTg0NDY5_61d43ee1-0aac-45e5-8a49-a155b99d832b"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i88ba8ee5cfbb4f82a668533be8a45bf1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctMy0xLTEtMTg0NDY5_d7c6790d-1281-44b2-a4c3-cdded537326b"
      unitRef="usd">5857000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib6e83d605e794462bc2801b8a6ba0c45_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctNS0xLTEtMTg0NDY5_d7460ff1-424c-4fe7-a4e5-dbb864c837b8"
      unitRef="usd">30664000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i558fc0a3383e478fb5796f93893141cd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctNy0xLTEtMTg0NDY5_35425641-3fe8-4326-ac6d-406d3e1382fe"
      unitRef="usd">-3056000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idde0e21bdbd04b0dbf2b80e3eb14a8df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctOS0xLTEtMTg0NDY5_73d65258-e8a6-42b0-ab90-3134a32a650e"
      unitRef="usd">-36006000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic9dfca6be487498bbf8f7ce598fc0b81_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctMTEtMS0xLTE4NDQ2OQ_966a0a85-6db0-4fa7-8786-627ab3a07eb5"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTctMTMtMS0xLTE4NDQ2OQ_ebdb3098-8089-49c1-a7ba-8d359dfbaea5"
      unitRef="usd">-1606000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="if9e71d43a1f4444a879c0a8c5f8cf8ef_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTgtNS0xLTEtMTg0NDY5_37bbd49c-caf1-4867-92f6-f987274a15bb"
      unitRef="usd">5764000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i9fd0a7b22d234c68baa53019ccd50d24_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTgtMTEtMS0xLTE4NDQ2OQ_6d3b9674-89c7-4f4c-bc71-9c8ff7996000"
      unitRef="usd">0</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTgtMTMtMS0xLTE4NDQ2OQ_6074950a-8802-48d1-b46b-994632fa4fa4"
      unitRef="usd">5764000000</us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTktNy0xLTEtMTg0NDY5_b7cc7d36-5cd6-4cc4-854f-b3e0adc7505c"
      unitRef="usd">285000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTktMTMtMS0xLTE4NDQ2OQ_cba84793-6b78-47fb-8118-bff9968be9e3"
      unitRef="usd">285000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i3d9278cdedf2453987ce2a196adc88b9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjAtMy0xLTEtMTg0NDY5_e8aa8508-e94d-4260-beca-7c6cc7edd997"
      unitRef="usd">30000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="idceefaa1a008430bad914f7d71668fdb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjAtOS0xLTEtMTg0NDY5_bb7c6f9b-2a02-4b2b-a6cb-59b6bae6862f"
      unitRef="usd">15000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjAtMTMtMS0xLTE4NDQ2OQ_a8b5fe16-2735-4675-9c31-698acfb0bf67"
      unitRef="usd">45000000</mo:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjEtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246YWEwM2E4ODlkZTYzNDdiMjlmNzI3Mjg0NWJjZjE5ZjZfMjk_382a573c-ff31-44c6-81aa-23a020bbff48"
      unitRef="usdPerShare">3.68</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:DividendsCommonStockCash
      contextRef="if9e71d43a1f4444a879c0a8c5f8cf8ef_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjEtNS0xLTEtMTg0NDY5_a020ed30-6658-481e-a37b-c5550d2e07dd"
      unitRef="usd">6636000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjEtMTMtMS0xLTE4NDQ2OQ_db5e7df6-d917-42eb-8bb8-f1d7520f1b99"
      unitRef="usd">6636000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="idceefaa1a008430bad914f7d71668fdb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjItOS0xLTEtMTg0NDY5_916f2468-ede6-469a-9599-9a9501d294a5"
      unitRef="usd">1825000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjItMTMtMS0xLTE4NDQ2OQ_cdffb90d-f16f-4da3-a640-610c04f16b80"
      unitRef="usd">1825000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityOther
      contextRef="i3d9278cdedf2453987ce2a196adc88b9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMy0xLTEtMTg0NDY5_1a7b921c-90d1-46c6-904a-41981274e29a"
      unitRef="usd">0</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i9fd0a7b22d234c68baa53019ccd50d24_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMTEtMS0xLTE4NDQ2OQ_18eb84d4-39c0-48e1-8601-59a98212a535"
      unitRef="usd">-50000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMTMtMS0xLTE4NDQ2OQ_f5d76cff-b586-4505-b0cb-b9c3feb2b5a7"
      unitRef="usd">-50000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i644b6f768367404baba2e476d5932a0f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtMS0xLTEtMTg0NDY5_63ff5569-e117-4594-9207-f37e11f85c20"
      unitRef="usd">935000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i143a684a9fda4c14af97a0bf149a67f0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtMy0xLTEtMTg0NDY5_1488b14c-19e9-4ac7-89a0-e80e4b5d3750"
      unitRef="usd">5887000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7503cd4479784edc962d47d00bb62206_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtNS0xLTEtMTg0NDY5_981daa25-867c-46f2-bafd-a5194ddb5169"
      unitRef="usd">29792000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia66edd7cc54a4c8ea258417ee5d6a637_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtNy0xLTEtMTg0NDY5_7f0fd423-7fb5-4f17-9bb0-492bb0efad25"
      unitRef="usd">-2771000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i05f658ff1f4945fbb64ff38b76d887eb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtOS0xLTEtMTg0NDY5_fece82f2-0326-4c95-beae-e045c6a0585d"
      unitRef="usd">-37816000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iab3485d42498436788bd25df431981fc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtMTEtMS0xLTE4NDQ2OQ_3c85f05a-b22c-4940-9852-3d99595abf25"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjQtMTMtMS0xLTE4NDQ2OQ_a8de201b-9146-42de-bf36-ce4c0ca884c9"
      unitRef="usd">-3923000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzU3NzI_1c07b84b-3709-4312-ab4d-853e73a76d16">Background and Basis of Presentation&lt;div style="margin-bottom:15pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;When used in these notes, the terms &#x201c;Altria,&#x201d; &#x201c;we,&#x201d; &#x201c;us&#x201d; and &#x201c;our&#x201d; refer to either (i) Altria Group, Inc. and its consolidated subsidiaries or (ii) Altria Group, Inc. only and not its consolidated subsidiaries, as appropriate in the context.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Background:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; At December&#160;31, 2022, our wholly owned subsidiaries included Philip Morris USA Inc. (&#x201c;PM USA&#x201d;), which is engaged in the manufacture and sale of cigarettes in the United States; John Middleton Co. (&#x201c;Middleton&#x201d;), which is engaged in the manufacture and sale of machine-made large cigars and pipe tobacco and is a wholly owned subsidiary of PM USA; UST LLC (&#x201c;UST&#x201d;), which through its wholly owned subsidiary U.S. Smokeless Tobacco Company LLC (&#x201c;USSTC&#x201d;), is engaged in the manufacture and sale of moist smokeless tobacco products (&#x201c;MST&#x201d;) and snus products; and Helix Innovations LLC (&#x201c;Helix&#x201d;), which operates in the United States and Canada, and Helix Innovations GmbH and its affiliates (&#x201c;Helix ROW&#x201d;), which operate internationally in the rest-of-world, are engaged in the manufacture and sale of oral nicotine pouches.  Other wholly owned subsidiaries included Altria Group Distribution Company, which provides sales and distribution services to our domestic tobacco operating companies; Altria Client Services LLC (&#x201c;ALCS&#x201d;), which provides various support services to our companies in areas such as legal, regulatory, consumer engagement, finance, human resources and external affairs; and Philip Morris Capital Corporation (&#x201c;PMCC&#x201d;), which completed the wind-down of its portfolio of finance assets in 2022 and had no finance assets remaining at December&#160;31, 2022.  Our access to the operating cash flows of our wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by our subsidiaries.  At December&#160;31, 2022, our significant wholly owned subsidiaries were not limited by contractual obligations in their ability to pay cash dividends or make other distributions with respect to their equity interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2022, Altria, through PM USA, entered into a joint venture with JTI (US) Holding, Inc. (&#x201c;JTIUH&#x201d;), a subsidiary of Japan Tobacco Inc., for the U.S. marketing and commercialization of heated tobacco stick (&#x201c;HTS&#x201d;) products.  The joint venture entity, Horizon Innovations LLC (&#x201c;Horizon&#x201d;), is structured to exist in perpetuity and is responsible for the U.S. commercialization of HTS products owned by either party.  PM USA holds a 75% economic interest in Horizon, with JTIUH having a 25% economic interest.  We included the 2022 financial results of Horizon, which were immaterial, in our consolidated financial statements, with the 25% economic interest held by JTIUH reported on our consolidated balance sheet as a noncontrolling interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, UST sold its subsidiary, International Wine &amp;amp; Spirits Ltd. (&#x201c;IWS&#x201d;), which included Ste. Michelle Wine Estates Ltd. (&#x201c;Ste. Michelle&#x201d;) in an all-cash transaction with a net purchase price of approximately $1.2 billion and the assumption of certain liabilities of IWS and its subsidiaries (the &#x201c;Ste. Michelle Transaction&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020 and April 2021, we purchased the remaining 20% interest in (i) Helix ROW and (ii) Helix, respectively.  The total purchase price of the December 2020 and April 2021 transactions was approximately $250 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we had investments in the following equity securities: Anheuser-Busch InBev SA/NV (&#x201c;ABI&#x201d;); Cronos Group Inc. (&#x201c;Cronos&#x201d;); and JUUL Labs, Inc. (&#x201c;JUUL&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For further discussion of our investments in equity securities, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Basis of Presentation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The consolidated financial statements include Altria, as well as our wholly owned and majority-owned subsidiaries.  We account for our investments in equity securities in which we have the ability to exercise significant influence over the operating and financial policies of the investee, including ABI and Cronos, under the equity method of accounting using a one-quarter lag.  We account for our investment in the equity securities of JUUL at fair value.  All intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the dates of the financial statements and the reported amounts of net revenues and expenses during the reporting periods.  Significant estimates and assumptions include, among other things, pension and benefit plan assumptions, lives and valuation assumptions for goodwill, other intangible assets and investments in equity securities, marketing programs and income taxes.  Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain immaterial prior year amounts have been reclassified to conform with the current year&#x2019;s presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2022, we adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU No. 2020-06&#x201d;).  This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#x2019;s own equity.  Our adoption of ASU No. 2020-06 did not have a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <mo:NumberOfLeveragedLeasesRemaining
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzQ5NDc4MDIzNDEwMDk_8e5232c8-75eb-445a-bc87-5a0e43e7dafb"
      unitRef="lease">0</mo:NumberOfLeveragedLeasesRemaining>
    <mo:OwnershipPercentageInConsolidatedSubsidiary
      contextRef="i30cb752842ae4f4197b09359b88ea9da_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzIxOTkwMjMyNzAzMjQ_280e8250-e8fc-4647-9ae0-3d56cfd35e3f"
      unitRef="number">0.75</mo:OwnershipPercentageInConsolidatedSubsidiary>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i2a0870e6739645619718e0d6168ecf74_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzIxOTkwMjMyNzAzMzA_0e936921-93f8-4974-a89d-5ba099d095c7"
      unitRef="number">0.25</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i2a0870e6739645619718e0d6168ecf74_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzIxOTkwMjMyNzAzNzg_7cdc3fd2-f024-4c04-8dfa-d3eeb376983b"
      unitRef="number">0.25</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="i215587128d4845cda58b7a9194e94d1e_D20211001-20211031"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzIyNDc_61e9e5df-d096-435e-bedb-ea0a7c0e9704"
      unitRef="usd">1200000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <mo:NoncontrollingInterestRemainingInterestPurchasedByParent
      contextRef="icf697a1cd93741fbb7973dfb45f4da83_D20201201-20210430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzQ5NDc4MDIzMzkyODY_9340dc52-efe2-49a6-8872-4195905423a7"
      unitRef="number">0.20</mo:NoncontrollingInterestRemainingInterestPurchasedByParent>
    <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries
      contextRef="i2e549342995d4d82a096798aa533bfa9_D20201201-20210430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzI5MTc_40bd90c0-537a-4765-acb0-4cf9cfb4edc4"
      unitRef="usd">250000000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzU3NzQ_6824a849-95fd-4737-8ba0-dc2f84e81b73">The consolidated financial statements include Altria, as well as our wholly owned and majority-owned subsidiaries.  We account for our investments in equity securities in which we have the ability to exercise significant influence over the operating and financial policies of the investee, including ABI and Cronos, under the equity method of accounting using a one-quarter lag.  We account for our investment in the equity securities of JUUL at fair value.  All intercompany transactions and balances have been eliminated.The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the dates of the financial statements and the reported amounts of net revenues and expenses during the reporting periods.  Significant estimates and assumptions include, among other things, pension and benefit plan assumptions, lives and valuation assumptions for goodwill, other intangible assets and investments in equity securities, marketing programs and income taxes.  Actual results could differ from those estimates.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDAvZnJhZzo0YzE1YmM4OGU5NGE0YWU2YjQyNTQ0YTkzNTQ4YmFhYS90ZXh0cmVnaW9uOjRjMTViYzg4ZTk0YTRhZTZiNDI1NDRhOTM1NDhiYWFhXzU3NzM_ad2f4bdf-0bd3-4d91-8748-59ba78e6ef42">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2022, we adopted Accounting Standards Update (&#x201c;ASU&#x201d;) 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASU No. 2020-06&#x201d;).  This guidance simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity&#x2019;s own equity.  Our adoption of ASU No. 2020-06 did not have a material impact on our consolidated financial statements.&lt;/span&gt; The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, us:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Date for Public Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect on Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2021-08&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt; Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2022-03 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTgz_0cf412c3-196c-47e1-96e8-bc46c703e51c">Summary of Significant Accounting Policies&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Cash and Cash Equivalents:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Cash equivalents include demand deposits with banks and all highly liquid investments with original maturities of three months or less.  We record cash equivalents at cost plus accrued interest, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Depreciation, Amortization and Impairment Testing:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We record property, plant and equipment at historical costs and depreciate by the straight-line method over the estimated useful lives of the assets.  We depreciate machinery and equipment over periods up to 20 years, and buildings and building improvements over periods up to 50 years.  We amortize definite-lived intangible assets over their estimated useful lives up to 25 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying value of the assets may not be fully recoverable.  We perform undiscounted operating cash flow analyses to determine if an impairment exists.  For purposes of recognition and measurement of an impairment for assets held for use, we group assets and liabilities at the lowest level for which cash flows are separately identifiable.  If we determine that an impairment exists, any related impairment loss is calculated based on fair value.  We base impairment losses on assets to be disposed of, if any, on the estimated proceeds to be received, less costs of disposal.  We also review the estimated remaining useful lives of long-lived assets whenever events or changes in business circumstances indicate the lives may have changed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We conduct a required annual review of goodwill and indefinite-lived intangible assets for potential impairment, and more frequently if an event occurs or circumstances change that would require us to perform an interim review.  We have the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit or indefinite-lived intangible asset is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative impairment test.  If necessary, we will perform a single step quantitative impairment test.  Additionally, we have the option to unconditionally bypass the qualitative assessment and perform a single step quantitative assessment.  If the carrying value of a reporting unit that includes goodwill exceeds its fair value, which is determined using discounted cash flows, goodwill is considered impaired.  We measure the amount of impairment loss as the difference between the carrying value and the fair value of a reporting unit; however, the amount of the impairment loss is limited to the total amount of goodwill allocated to a reporting unit.  If the carrying value of an indefinite-lived intangible asset exceeds its fair value, which is determined using discounted cash flows, we consider the intangible asset impaired and reduce the carrying value to fair value in the period identified.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Derivative Financial Instruments:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; From time to time, we enter into derivatives to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  We use various types of derivative financial instruments, including forward contracts, options and swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record derivative financial instruments at fair value on the consolidated balance sheets as either assets or liabilities.  We designate derivative financial instruments that qualify for hedge accounting as either fair value hedges, cash flow hedges or net investment hedges at the inception of the contracts.  For fair value hedges, we record changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, in the consolidated statements of earnings each period.  For cash flow hedges, we record changes in the fair value of the derivative each period in accumulated other comprehensive earnings (losses) and reclassify changes to the consolidated statements of earnings in the same periods in which operating results are affected by the respective hedged item.  For net investment hedges, we record changes in the fair value of the derivative or foreign currency transaction gains or losses on a nonderivative hedging instrument in accumulated other comprehensive earnings (losses) to offset the change in the value of the net investment being hedged.  Such amounts remain in accumulated other comprehensive earnings (losses) until the complete or substantially complete liquidation of the underlying foreign operations occurs for investments in foreign entities accounted for under the equity method of accounting.  We classify cash flows from hedging instruments in the same manner as the respective hedged item in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To qualify for hedge accounting, the hedging relationship, both at inception of the hedge and on an ongoing basis, is expected to be highly effective at offsetting changes in the fair value of the hedged risk during the period that the hedge is designated.  We formally designate and document, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective, the strategy for undertaking the hedge transaction and method for assessing hedge effectiveness.  Additionally, for qualified hedges of forecasted transactions, if it becomes probable that a forecasted transaction will not occur, we would no longer consider the hedge effective and would record all of the derivative gains and losses in the consolidated statement of earnings in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial instruments that are not designated as hedging instruments or do not qualify for hedge accounting, we record changes in fair value in the consolidated statement of earnings each period.  We do not enter into or hold derivative financial instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Employee Benefit Plans:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We provide a range of benefits to certain employees and retired employees, including pension, postretirement health care and postemployment benefits.  We record annual amounts relating to these plans based on calculations specified by GAAP, which include various actuarial assumptions as to discount rates, assumed rates of return on plan assets, mortality, compensation increases, turnover rates and health care cost trend rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the funded status of our defined benefit pension and other postretirement plans on the consolidated balance sheets and record as a component of other comprehensive earnings (losses), net of deferred income taxes, the gains or losses and prior service costs or credits that have not been recognized as components of net periodic benefit cost (income).  We subsequently amortize the gains or losses and prior service costs or credits recorded as components of other comprehensive earnings (losses) into net periodic benefit cost (income) in future years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Environmental Costs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We are subject to laws and regulations relating to the protection of the environment.  We provide for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  We adjust such accruals as new information develops or circumstances change.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Compliance with environmental laws and regulations, including the payment of any remediation and compliance costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on our consolidated results of operations, capital expenditures, financial position or cash flows.  See Note 17. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Environmental Regulation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Fair Value Measurements:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We measure certain assets and liabilities at fair value.  Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  We use a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).  The three levels of inputs used to measure fair value are:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:45pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt"&gt;Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:45pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt"&gt;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:45pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt"&gt;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Guarantees:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We recognize a liability for the fair value of the obligation of qualifying guarantee activities.  See Note 17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for a further discussion of guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Significant judgment is required in determining income tax provisions and in evaluating tax positions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine deferred tax assets and liabilities based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.  We record a valuation allowance when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  We determine the realizability of deferred tax assets based on the weight of all available positive and negative evidence.  In reaching this determination, we consider the character of the assets and the possible sources of taxable income of the appropriate character within the available carryback and carryforward periods available under the tax law.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the financial statement benefit for uncertain income tax positions when it is more likely than not, based on the technical merits, that the position will be sustained upon examination by taxing authorities.  The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.  We recognize accrued interest and penalties associated with uncertain tax positions as part of the provision for income taxes in our consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Inventories:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We use the last-in, first-out (&#x201c;LIFO&#x201d;) method to determine the cost of substantially all our tobacco inventories.  We determine the cost of the remaining inventories using the first-in, first-out (&#x201c;FIFO&#x201d;) and average cost methods.  We record inventories that are measured using the LIFO method at the lower of cost or market.  We state inventories that are measured using the FIFO and average cost methods at the lower of cost and net realizable value.  It is a generally recognized industry practice to classify leaf tobacco inventories as a current asset although part of such inventories, because of the duration of the curing and aging process, ordinarily would not be used within one year.  We determined the cost of approximately 79% and 81% of our inventories at December&#160;31, 2022 and 2021, respectively, using the LIFO&#160;method.  The recorded LIFO amounts of our inventories were approximately $0.7 billion and $0.6 billion lower than the current cost of our inventories at December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Investments in Equity Securities:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Investments in equity securities in which we have the ability to exercise significant influence over the operating and financial policies of the investee are accounted for under the equity method of accounting or the fair value option.  The election of the fair value option is irrevocable and is made on an investment by investment basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We elected to account for our investments in ABI and Cronos under the equity method of accounting.  Our share of equity (income) losses and other adjustments associated with these equity investments are included in (income) losses from investments in equity securities in our consolidated statements of earnings.  We report the carrying value for each of our equity investments in ABI and Cronos in investments in equity securities on our consolidated balance sheets.  We report equity method investments accounted for under the equity method of accounting at cost and adjust these investments each period for our share of (income) losses and dividends paid, if any.  We report our share of ABI&#x2019;s and Cronos&#x2019;s results using a one-quarter lag because results are not available in time for us to record them in the concurrent period.  At the end of each reporting period, we review our equity investments accounted for under the equity method of accounting for impairment by comparing the fair value of each of our investments to their carrying value.  If the carrying value of an &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;investment exceeds its fair value and the loss in value is other than temporary, we consider the investment impaired, reduce its carrying value to its fair value and record the impairment in our consolidated statements of earnings in the period identified.  We use certain factors to make this determination including (i) the duration and magnitude of the fair value decline, (ii) the financial condition and near-term prospects of the investee and (iii) our intent and ability to hold our investment until recovery to its carrying value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning September 30, 2022, we account for our investment in JUUL as an investment in an equity security and measure our investment in JUUL at fair value.  Our consolidated statements of earnings include any cash dividends we receive from our investment in JUUL (none received to date) and any changes in the estimated fair value of our investment, which is calculated quarterly.  See Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information on how we have historically accounted for our investment in JUUL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Litigation Contingencies and Costs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We record provisions in our consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  We expense litigation defense costs as incurred and include these costs in marketing, administration and research costs in our consolidated statements of earnings.  See Note 17. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Marketing Costs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our businesses promote their products with consumer incentives, trade promotions and consumer engagement programs.  These consumer incentive and trade promotion activities, which include discounts, coupons, rebates, in-store display incentives and volume-based incentives, do not create a distinct deliverable and are, therefore, recorded as a reduction of revenues.  We make consumer engagement program payments to third parties.  Our businesses expense these consumer engagement programs, which include event marketing, as incurred, and such expenses are included in marketing, administration and research costs in our consolidated statements of earnings.  For interim reporting purposes, our businesses charge consumer engagement programs and certain consumer incentive expenses to operations as a percentage of sales, based on estimated sales and related expenses for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Revenue Recognition:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our businesses generate substantially all of their revenue from sales contracts with customers.  While our businesses enter into separate sales contracts with each customer for each product type, all sales contracts are similarly structured.  These contracts create an obligation to transfer product to the customer.  Our businesses satisfy all performance obligations within one year; therefore, we expense costs to obtain contracts as incurred and do not disclose unsatisfied performance obligations.  There is no financing component because our businesses expect, at contract inception, that the period between when our businesses transfer product to the customer and when the customer pays for that product will be one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our businesses define net revenues as revenues, which include excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns (also referred to as returned goods) and sales incentives.  Our businesses exclude from the transaction price sales taxes and value-added taxes imposed at the time of sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our businesses recognize revenues from sales contracts with customers upon shipment of goods when control of such products is obtained by the customer.  Our businesses determine that a customer obtains control of the product upon shipment when title of such product and risk of loss transfers to the customer.  Our businesses account for shipping and handling costs as fulfillment costs and such amounts are classified as part of cost of sales in our consolidated statements of earnings.  Our businesses record an allowance for returned goods, based principally on historical volume and return rates, which is included in other accrued liabilities on our consolidated balance sheets.  Our businesses record sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction to revenues (a portion of which is based on amounts estimated as being due to wholesalers, retailers and consumers at the end of a period) based principally on historical volume, utilization and redemption rates.  We include expected payments for sales incentives in accrued marketing liabilities on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment terms vary depending on product type.  Our businesses consider payments received in advance of product shipment as deferred revenue, which we include in other accrued liabilities on our consolidated balance sheets until revenue is recognized.  PM USA receives payment in advance of a customer obtaining control of the product.  USSTC and Helix receive substantially all payments within one business day of the customer obtaining control of the product.  We include amounts due from customers in receivables on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;New Accounting Guidance Not Yet Adopted: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, us:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Date for Public Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect on Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2021-08&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt; Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2022-03 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTcw_aaf44ec4-da61-4717-96a9-d64700909efc">Cash equivalents include demand deposits with banks and all highly liquid investments with original maturities of three months or less.  We record cash equivalents at cost plus accrued interest, which approximates fair value.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTgy_1c3b6870-b1a4-43b4-ba42-e8cbb2a221f3">We record property, plant and equipment at historical costs and depreciate by the straight-line method over the estimated useful lives of the assets.  We depreciate machinery and equipment over periods up to 20 years, and buildings and building improvements over periods up to 50 years.  We amortize definite-lived intangible assets over their estimated useful lives up to 25 years.</us-gaap:DepreciationDepletionAndAmortizationPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i0ed594edbe8547ae96593b978a67fa53_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzU3MQ_3846e9c7-a93c-449f-aed8-8e68da31d00b">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i96c87ceef6d7461eba332998e29357b5_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzY0MA_b6883fe4-e3b3-460f-a73c-1c3f1ea0e532">P50Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i81704ddceebb4dfe86a3ec2266b22177_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzczOA_d73351e7-f58a-4a8d-b35f-a5f71a8e4638">P25Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjQ1_e7c9c6ac-2358-4ae6-9c43-08362921d360">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review long-lived assets, including definite-lived intangible assets, for impairment whenever events or changes in business circumstances indicate that the carrying value of the assets may not be fully recoverable.  We perform undiscounted operating cash flow analyses to determine if an impairment exists.  For purposes of recognition and measurement of an impairment for assets held for use, we group assets and liabilities at the lowest level for which cash flows are separately identifiable.  If we determine that an impairment exists, any related impairment loss is calculated based on fair value.  We base impairment losses on assets to be disposed of, if any, on the estimated proceeds to be received, less costs of disposal.  We also review the estimated remaining useful lives of long-lived assets whenever events or changes in business circumstances indicate the lives may have changed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We conduct a required annual review of goodwill and indefinite-lived intangible assets for potential impairment, and more frequently if an event occurs or circumstances change that would require us to perform an interim review.  We have the option of first performing a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit or indefinite-lived intangible asset is less than its carrying amount as a basis for determining whether it is necessary to perform a quantitative impairment test.  If necessary, we will perform a single step quantitative impairment test.  Additionally, we have the option to unconditionally bypass the qualitative assessment and perform a single step quantitative assessment.  If the carrying value of a reporting unit that includes goodwill exceeds its fair value, which is determined using discounted cash flows, goodwill is considered impaired.  We measure the amount of impairment loss as the difference between the carrying value and the fair value of a reporting unit; however, the amount of the impairment loss is limited to the total amount of goodwill allocated to a reporting unit.  If the carrying value of an indefinite-lived intangible asset exceeds its fair value, which is determined using discounted cash flows, we consider the intangible asset impaired and reduce the carrying value to fair value in the period identified.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjEy_48bc856b-a793-4d37-aa06-3d6c2b6bcc33">enter into derivatives to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  We use various types of derivative financial instruments, including forward contracts, options and swaps.&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record derivative financial instruments at fair value on the consolidated balance sheets as either assets or liabilities.  We designate derivative financial instruments that qualify for hedge accounting as either fair value hedges, cash flow hedges or net investment hedges at the inception of the contracts.  For fair value hedges, we record changes in the fair value of the derivative, as well as the offsetting changes in the fair value of the hedged item, in the consolidated statements of earnings each period.  For cash flow hedges, we record changes in the fair value of the derivative each period in accumulated other comprehensive earnings (losses) and reclassify changes to the consolidated statements of earnings in the same periods in which operating results are affected by the respective hedged item.  For net investment hedges, we record changes in the fair value of the derivative or foreign currency transaction gains or losses on a nonderivative hedging instrument in accumulated other comprehensive earnings (losses) to offset the change in the value of the net investment being hedged.  Such amounts remain in accumulated other comprehensive earnings (losses) until the complete or substantially complete liquidation of the underlying foreign operations occurs for investments in foreign entities accounted for under the equity method of accounting.  We classify cash flows from hedging instruments in the same manner as the respective hedged item in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To qualify for hedge accounting, the hedging relationship, both at inception of the hedge and on an ongoing basis, is expected to be highly effective at offsetting changes in the fair value of the hedged risk during the period that the hedge is designated.  We formally designate and document, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective, the strategy for undertaking the hedge transaction and method for assessing hedge effectiveness.  Additionally, for qualified hedges of forecasted transactions, if it becomes probable that a forecasted transaction will not occur, we would no longer consider the hedge effective and would record all of the derivative gains and losses in the consolidated statement of earnings in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For financial instruments that are not designated as hedging instruments or do not qualify for hedge accounting, we record changes in fair value in the consolidated statement of earnings each period.  We do not enter into or hold derivative financial instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <mo:PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjAz_12759182-1b93-49c4-ba65-813e8307fb14">We provide a range of benefits to certain employees and retired employees, including pension, postretirement health care and postemployment benefits.  We record annual amounts relating to these plans based on calculations specified by GAAP, which include various actuarial assumptions as to discount rates, assumed rates of return on plan assets, mortality, compensation increases, turnover rates and health care cost trend rates.We recognize the funded status of our defined benefit pension and other postretirement plans on the consolidated balance sheets and record as a component of other comprehensive earnings (losses), net of deferred income taxes, the gains or losses and prior service costs or credits that have not been recognized as components of net periodic benefit cost (income).  We subsequently amortize the gains or losses and prior service costs or credits recorded as components of other comprehensive earnings (losses) into net periodic benefit cost (income) in future years.</mo:PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock>
    <us-gaap:EnvironmentalCostsPolicy
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTc4_0570c3e7-d107-486f-bd1c-5d899af1bc76">We are subject to laws and regulations relating to the protection of the environment.  We provide for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  We adjust such accruals as new information develops or circumstances change.Compliance with environmental laws and regulations, including the payment of any remediation and compliance costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on our consolidated results of operations, capital expenditures, financial position or cash flows.</us-gaap:EnvironmentalCostsPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTcx_b4b98c3a-340e-43a6-a459-41bf42a9fc11">We measure certain assets and liabilities at fair value.  Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.  We use a fair value hierarchy, which gives the highest priority to unadjusted quoted prices in active markets for identical assets and liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).  The three levels of inputs used to measure fair value are:&lt;div style="margin-top:5pt;padding-left:45pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt"&gt;Unadjusted quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:45pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt"&gt;Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:45pt;text-indent:-45pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.77pt"&gt;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjU5_587397f8-837c-419a-a407-0152665ec6c3">We recognize a liability for the fair value of the obligation of qualifying guarantee activities.</us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTcy_8f50a011-0406-437b-9fb3-736244ae15c8">Significant judgment is required in determining income tax provisions and in evaluating tax positions.&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine deferred tax assets and liabilities based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.  We record a valuation allowance when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  We determine the realizability of deferred tax assets based on the weight of all available positive and negative evidence.  In reaching this determination, we consider the character of the assets and the possible sources of taxable income of the appropriate character within the available carryback and carryforward periods available under the tax law.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize the financial statement benefit for uncertain income tax positions when it is more likely than not, based on the technical merits, that the position will be sustained upon examination by taxing authorities.  The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate settlement.  We recognize accrued interest and penalties associated with uncertain tax positions as part of the provision for income taxes in our consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;We determine deferred tax assets and liabilities based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.  We record a valuation allowance when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  We determine the realizability of deferred tax assets based on the weight of all available positive and negative evidence.  In reaching this determination, we consider the character of the assets and the possible sources of taxable income of the appropriate character within the available carryback and carryforward periods available under the tax law.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjA3_c3e890ed-bd9f-4419-8938-13ee4bf2dce3">We use the last-in, first-out (&#x201c;LIFO&#x201d;) method to determine the cost of substantially all our tobacco inventories.  We determine the cost of the remaining inventories using the first-in, first-out (&#x201c;FIFO&#x201d;) and average cost methods.  We record inventories that are measured using the LIFO method at the lower of cost or market.  We state inventories that are measured using the FIFO and average cost methods at the lower of cost and net realizable value.  It is a generally recognized industry practice to classify leaf tobacco inventories as a current asset although part of such inventories, because of the duration of the curing and aging process, ordinarily would not be used within one year.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzExMzU3_5a8bed29-4b99-4b60-9625-ee72401a4d4d"
      unitRef="number">0.79</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:PercentageOfLIFOInventory
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzExMzY0_e17c5e80-3a00-4fa6-be28-f0d5754d9b0b"
      unitRef="number">0.81</us-gaap:PercentageOfLIFOInventory>
    <us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzIxOTkwMjMyODQ2MDA_748a5218-befc-43f3-8dc7-c00dace897b0"
      unitRef="usd">700000000</us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue>
    <us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzExNjQw_efc09cab-cb2f-4787-b58f-c0710fb67005"
      unitRef="usd">600000000</us-gaap:ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTU3_2b804e20-0570-4666-bfe7-c8b02677d58b">Investments in equity securities in which we have the ability to exercise significant influence over the operating and financial policies of the investee are accounted for under the equity method of accounting or the fair value option.  The election of the fair value option is irrevocable and is made on an investment by investment basis.We elected to account for our investments in ABI and Cronos under the equity method of accounting.  Our share of equity (income) losses and other adjustments associated with these equity investments are included in (income) losses from investments in equity securities in our consolidated statements of earnings.  We report the carrying value for each of our equity investments in ABI and Cronos in investments in equity securities on our consolidated balance sheets.  We report equity method investments accounted for under the equity method of accounting at cost and adjust these investments each period for our share of (income) losses and dividends paid, if any.  We report our share of ABI&#x2019;s and Cronos&#x2019;s results using a one-quarter lag because results are not available in time for us to record them in the concurrent period.  At the end of each reporting period, we review our equity investments accounted for under the equity method of accounting for impairment by comparing the fair value of each of our investments to their carrying value.  If the carrying value of an investment exceeds its fair value and the loss in value is other than temporary, we consider the investment impaired, reduce its carrying value to its fair value and record the impairment in our consolidated statements of earnings in the period identified.  We use certain factors to make this determination including (i) the duration and magnitude of the fair value decline, (ii) the financial condition and near-term prospects of the investee and (iii) our intent and ability to hold our investment until recovery to its carrying value.&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for our investment in ABI under the equity method of accounting because we have the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#x2019;s board of directors and certain ABI board committees.  Through this representation, we participate in ABI&#x2019;s policy making processes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We report our share of ABI&#x2019;s results using a one-quarter lag because ABI&#x2019;s results are not available in time for us to record them in the concurrent period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#x2019;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  We can convert our Restricted Shares to ordinary shares at our discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.&lt;/span&gt;&lt;/div&gt;The fair value of our equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#x2019;s common shares and was classified in Level 1 of the fair value hierarchy.</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTk2_50df19c3-afa5-439c-a48c-85a5e0b8f6a6">Note 5. &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information on how we have historically accounted for our investment in JUUL.&lt;/span&gt;Following Share Conversion in the fourth quarter of 2020, we elected to account for our equity method investment in JUUL under the fair value option.  In making this election, we believed measuring our investment at fair value provided quarterly transparency to investors as to the fair market value of our investment in JUUL, given the changes and volatility in the e-vapor category since our initial investment, as well as the lack of publicly available information regarding JUUL&#x2019;s business or a market-derived valuation.  As a result of our loss of certain rights due to our exercise of our option to be released from our JUUL non-competition obligations in the third quarter of 2022, we determined that we no longer have the ability to exercise significant influence over the operating and financial policies of JUUL.  Therefore, we are no longer able to account for our investment in JUUL as an equity method investment.  Beginning with the period ended September 30, 2022, we account for our investment in JUUL as an investment in an equity security.  We will continue to measure our investment in JUUL at fair value, in accordance with GAAP.  Our consolidated statements of earnings include any cash dividends received from our investment in JUUL (none received to date) and any changes in the estimated fair value of our investment, which is calculated quarterly.Prior to Share Conversion, we accounted for our investment in JUUL as an investment in an equity security.  Since the JUUL shares do not have a readily determinable fair value, we elected to measure our investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There were no upward or downward adjustments to the carrying value of our investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through the date of Share Conversion.  In addition, prior to Share Conversion, we reviewed our investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of our financial statements.  If this qualitative assessment indicated that our investment in JUUL may be impaired, a quantitative assessment was performed.  If the quantitative assessment indicated the estimated fair value of the investment was less than its carrying value, the investment was written down to its estimated fair value.We use an income approach to estimate the fair value of our investment in JUUL.  The income approach reflects the discounting of future cash flows for the U.S. and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.In determining the estimated fair value of our investment in JUUL, in 2022, 2021 and 2020, we made certain judgments, estimates and assumptions, the most significant of which were likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, we made judgments regarding the (i) likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#x2019;s products, which have received MDOs and are now under additional administrative review; (ii) likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, the absence of which could result in JUUL seeking protection under bankruptcy or other insolvency laws; (iii) risk created by the number and types of legal cases pending against JUUL; (iv) expectations for the future state of the e-vapor category, including competitive dynamics; and (v) timing of international expansion plans.</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjYz_8b58fe9b-41da-4706-9e70-d1b21d150368">We record provisions in our consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  We expense litigation defense costs as incurred and include these costs in marketing, administration and research costs in our consolidated statements of earnings.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <mo:MarketingCostsPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTY0_08e942a2-8f81-4b69-88e0-31e9f95466f6">Our businesses promote their products with consumer incentives, trade promotions and consumer engagement programs.  These consumer incentive and trade promotion activities, which include discounts, coupons, rebates, in-store display incentives and volume-based incentives, do not create a distinct deliverable and are, therefore, recorded as a reduction of revenues.  We make consumer engagement program payments to third parties.  Our businesses expense these consumer engagement programs, which include event marketing, as incurred, and such expenses are included in marketing, administration and research costs in our consolidated statements of earnings.  For interim reporting purposes, our businesses charge consumer engagement programs and certain consumer incentive expenses to operations as a percentage of sales, based on estimated sales and related expenses for the full year.</mo:MarketingCostsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MjQy_17de309a-fbae-4d60-a578-837eb668476f">Our businesses generate substantially all of their revenue from sales contracts with customers.  While our businesses enter into separate sales contracts with each customer for each product type, all sales contracts are similarly structured.  These contracts create an obligation to transfer product to the customer.  Our businesses satisfy all performance obligations within one year; therefore, we expense costs to obtain contracts as incurred and do not disclose unsatisfied performance obligations.  There is no financing component because our businesses expect, at contract inception, that the period between when our businesses transfer product to the customer and when the customer pays for that product will be one year or less.&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our businesses define net revenues as revenues, which include excise taxes and shipping and handling charges billed to customers, net of cash discounts for prompt payment, sales returns (also referred to as returned goods) and sales incentives.  Our businesses exclude from the transaction price sales taxes and value-added taxes imposed at the time of sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our businesses recognize revenues from sales contracts with customers upon shipment of goods when control of such products is obtained by the customer.  Our businesses determine that a customer obtains control of the product upon shipment when title of such product and risk of loss transfers to the customer.  Our businesses account for shipping and handling costs as fulfillment costs and such amounts are classified as part of cost of sales in our consolidated statements of earnings.  Our businesses record an allowance for returned goods, based principally on historical volume and return rates, which is included in other accrued liabilities on our consolidated balance sheets.  Our businesses record sales incentives, which consist of consumer incentives and trade promotion activities, as a reduction to revenues (a portion of which is based on amounts estimated as being due to wholesalers, retailers and consumers at the end of a period) based principally on historical volume, utilization and redemption rates.  We include expected payments for sales incentives in accrued marketing liabilities on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment terms vary depending on product type.  Our businesses consider payments received in advance of product shipment as deferred revenue, which we include in other accrued liabilities on our consolidated balance sheets until revenue is recognized.  PM USA receives payment in advance of a customer obtaining control of the product.  USSTC and Helix receive substantially all payments within one business day of the customer obtaining control of the product.  We include amounts due from customers in receivables on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;We record an allowance for returned goods, which is included in other accrued liabilities on our consolidated balance sheets.  It is USSTC&#x2019;s policy to accept authorized sales returns from its customers for products that have passed the freshness date printed on product packaging due to the limited shelf life of USSTC&#x2019;s MST and snus products.  We record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  We reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on our consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, we do not record an asset for USSTC&#x2019;s right to recover goods from customers upon return.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <mo:RevenueContractDuration
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE2NDg5_02774069-1360-44f5-8f6e-c58f0e57cbc9">P1Y</mo:RevenueContractDuration>
    <us-gaap:RevenuePerformanceObligationDescriptionOfTiming
      contextRef="i1bea3c35eaff4beeba4d616c3283b50d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE4ODI1_e0170723-1937-40aa-b7b0-7435be732d03">one business day</us-gaap:RevenuePerformanceObligationDescriptionOfTiming>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDMvZnJhZzo1NGQ3MjJkMWJjMWQ0MGVlOGEyZjIwZjAwYWFlZWNiOS90ZXh0cmVnaW9uOjU0ZDcyMmQxYmMxZDQwZWU4YTJmMjBmMDBhYWVlY2I5XzE5MTY1_d5c17bf6-34f8-444e-a753-914c85a576f1">The following table provides a description of issued accounting guidance applicable to, but not yet adopted by, us:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.992%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Standards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effective Date for Public Entity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Effect on Financial Statements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2021-08&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt; Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance updates how an entity recognizes and measures contract assets and contract liabilities acquired in a business combination.  Acquirers will now account for related revenue contracts in accordance with Topic 606 as if it had originated the contract.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ASU 2022-03 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value.  The amendments also specify required disclosures for equity securities subject to contractual sale restrictions.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;The guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2023.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;We do not expect our adoption of this guidance to have a material impact on our consolidated financial statements and related disclosures.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0XzM5OTA_1dfcff80-2f1e-4d46-9f8d-ef9c55ea4b0d">Revenues from Contracts with Customers&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We disaggregate net revenues based on product type.  For further discussion, see Note 14. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate substantially all cash discounts, offered to customers for prompt payment, as a flat rate per unit based on agreed-upon payment terms.  Prior to the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a percentage of the list price based on historical experience and agreed-upon payment terms.  We record receivables net of the cash discounts on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record payments received by our businesses in advance of product shipment as deferred revenue.  These payments are included in other accrued liabilities on our consolidated balance sheets until control of such products is obtained by the customer.  Deferred revenue from contracts with customers was $252 million and $287 million at December&#160;31, 2022 and 2021, respectively.  When cash is received in advance of product shipment, our companies satisfy their performance obligations within three days of receiving payment.  At December&#160;31, 2022 and 2021, there were no differences between amounts recorded as deferred revenue from contracts with customers and amounts subsequently recognized as revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables (excluding receivable from the sale of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; System commercialization rights) were $48 million and $47 million at December&#160;31, 2022 and 2021, respectively.  At December&#160;31, 2022 and 2021, there were no expected differences between amounts recorded and subsequently received, and we did not record an allowance for credit losses against these receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record an allowance for returned goods, which is included in other accrued liabilities on our consolidated balance sheets.  It is USSTC&#x2019;s policy to accept authorized sales returns from its customers for products that have passed the freshness date printed on product packaging due to the limited shelf life of USSTC&#x2019;s MST and snus products.  We record estimated sales returns, which are based principally on historical volume and return rates, as a reduction to revenues.  Actual sales returns will differ from estimated sales returns to the extent actual results differ from estimated assumptions.  We reflect differences between actual and estimated sales returns in the period in which the actual amounts become known.  These differences, if any, have not had a material impact on our consolidated financial statements.  All returned goods are destroyed upon return and not included in inventory.  Consequently, we do not record an asset for USSTC&#x2019;s right to recover goods from customers upon return.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales incentives include variable payments related to goods sold by our businesses.  We include estimates of variable consideration as a reduction to revenues upon shipment of goods to customers.  The sales incentives that require significant estimates and judgments are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Price promotion payments- &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We make price promotion payments, substantially all of which are made to our retail partners to incent the promotion of certain product offerings in select geographic areas.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Wholesale and retail participation payments-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We make payments to our wholesale and retail partners to incent merchandising and sharing of sales data in accordance with our trade agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These estimates primarily include estimated wholesale to retail sales volume and historical acceptance rates.  Actual payments will differ from estimated payments to the extent actual results differ from estimated assumptions.  Differences between actual and estimated payments are reflected in the period such information becomes available.  These differences, if any, have not had a material impact on our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <mo:CashDiscountsPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0XzM5OTI_70abf2fa-d7d1-4980-9206-39aab301ccc6">We calculate substantially all cash discounts, offered to customers for prompt payment, as a flat rate per unit based on agreed-upon payment terms.  Prior to the first quarter of 2021 for USSTC and the third quarter of 2021 for PM USA, cash discounts were calculated as a percentage of the list price based on historical experience and agreed-upon payment terms.  We record receivables net of the cash discounts on our consolidated balance sheets.</mo:CashDiscountsPolicyTextBlock>
    <mo:RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0XzYwNDczMTM5NTc5NzM_77b69451-cb8e-4b8e-8c94-ca769722d323">We record payments received by our businesses in advance of product shipment as deferred revenue.  These payments are included in other accrued liabilities on our consolidated balance sheets until control of such products is obtained by the customer.</mo:RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0Xzk3MQ_460a7493-9b2d-4408-9a39-26b63c5f40b3"
      unitRef="usd">252000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0Xzk3OA_cd19234d-dc56-4b8e-bfa4-bc42273bce62"
      unitRef="usd">287000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:RevenuePerformanceObligationDescriptionOfTiming
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0XzExMjk_b05bd08e-5831-4966-969f-a3ae59b1d824">three days</us-gaap:RevenuePerformanceObligationDescriptionOfTiming>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0XzEzMDU_3b9181b5-0607-4853-b15f-99d1ca9295a1"
      unitRef="usd">48000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMDYvZnJhZzplM2FhZDk4NjkyYTk0MTkyYWQ5YWJjNDY1NzdjYTk2NC90ZXh0cmVnaW9uOmUzYWFkOTg2OTJhOTQxOTJhZDlhYmM0NjU3N2NhOTY0XzEzMTI_c2e12e29-a270-47b4-a955-de1a6374bda7"
      unitRef="usd">47000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzE4Mzc_17ee6839-c933-4aaf-afb9-a09fb84be059">Goodwill and Other Intangible Assets, net&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other intangible assets, net, were as follows at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.453%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Intangible Assets, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,078&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,097&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;298&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,384&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consisted of the following at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,411&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;470&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,854&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;470&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, substantially all of our indefinite-lived intangible assets consisted of (i) MST and snus trademarks of $8.8 billion, which consists of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Copenhagen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Skoal&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and other MST and snus trademarks of $4.0 billion, $3.9 billion and $0.9 billion, respectively, and (ii) cigar trademarks of $2.6 billion from our 2009 acquisition of UST and 2007 acquisition of Middleton, respectively.  Definite-lived intangible assets, which consist primarily of intellectual property, certain cigarette trademarks and customer relationships, are amortized over a weighted-average period of 20 years.  Pre-tax amortization expense for definite-lived intangible assets during the years ended December&#160;31, 2022, 2021 and 2020, was $73 million, $72 million and $72 million, respectively.  Annual amortization expense for each of the next five years is estimated to be approximately $75 million, assuming no additional transactions occur that require the amortization of intangible assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2022, ALCS and Altria (solely with respect to certain provisions thereunder) entered into an agreement with Triaga, Inc. (&#x201c;Triaga&#x201d;), a subsidiary of Philip Morris International Inc. (&#x201c;PMI&#x201d;), and PMI (solely with respect to certain provisions thereunder), to, among other things, transition and ultimately conclude our relationship with respect to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS Tobacco Heating System&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; System&#x201d;) in the United States.  Under the terms of the agreement, Triaga paid ALCS $1.0 billion upon entry into the agreement and is obligated to make an additional payment of $1.7 billion (plus interest thereon from the effective date of October 19, 2022 at a per annum rate equal to 6%) to ALCS by July 15, 2023, for a total cash payment of approximately $2.7 billion (plus interest).  For the consideration received, ALCS has agreed to assign to Triaga exclusive U.S. commercialization rights to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; System effective April 30, 2024.  PMI will not have access to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Marlboro&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; brand name or other brand assets, as PM USA owns the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Marlboro&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; trademark in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the agreement, we recorded (i) a pre-tax $2.7 billion deferred gain, which we expect to recognize in earnings when we relinquish our rights to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; System, (ii) a $1.7 billion receivable and (iii) a $21 million interest receivable on our consolidated balance sheet at December&#160;31, 2022.  For the year ended December&#160;31, 2022, we recorded $21 million of interest income in our consolidated statement of earnings.  For the year ended December 31, 2022, we recorded $1.0 billion in cash received upon entry into the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in goodwill and net carrying amount of intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Intangible Assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Intangible Assets, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes due to:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.51pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Acquisitions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dispositions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Amortization &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,384&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Acquisitions of certain intellectual property related to other tobacco products, which included a $50 million non-cash contribution made by JTIUH to Horizon.  For additional information regarding Horizon, see Note 1. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Background and Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Dispositions related to the Ste. Michelle Transaction.  See Note 1. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Background and Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, 2021 and 2020, our annual impairment test of goodwill and indefinite-lived intangible assets resulted in no impairment charges.  At December 31, 2022 and 2021, there were no accumulated impairment losses related to goodwill.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzE4Mzg_2ffb8bc6-6109-4c84-bba7-b0d457810d50">&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and other intangible assets, net, were as follows at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.453%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.553%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Intangible Assets, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,989&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,078&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,097&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;298&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,384&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in goodwill and net carrying amount of intangible assets were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Intangible Assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Intangible Assets, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes due to:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-13.51pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Acquisitions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;151&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Dispositions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Amortization &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,177&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,384&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Acquisitions of certain intellectual property related to other tobacco products, which included a $50 million non-cash contribution made by JTIUH to Horizon.  For additional information regarding Horizon, see Note 1. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Background and Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Dispositions related to the Ste. Michelle Transaction.  See Note 1. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Background and Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="if0336e8ef9c74d2893d4e7f46f1987b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzItMS0xLTEtMTg0NDY5_3ca4ff25-deca-4966-a20b-a92e6dddd288"
      unitRef="usd">99000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i51e24a8227fd44f78424af2bf9ecc499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzItMy0xLTEtMTg0NDY5_63d461ac-5484-4e5b-a354-6f538c2b6235"
      unitRef="usd">99000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if0336e8ef9c74d2893d4e7f46f1987b7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzItNS0xLTEtMTg0NDY5_2aa96f11-ad1e-47b0-b6db-5fd726ad6802"
      unitRef="usd">2989000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i51e24a8227fd44f78424af2bf9ecc499_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzItNy0xLTEtMTg0NDY5_495e54c1-dca3-44fe-8eca-f42374b09473"
      unitRef="usd">3017000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i68ad331e56c04b3cab6eb6b46acdcb86_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzMtMS0xLTEtMTg0NDY5_4647326b-93e6-4157-a8f2-186c8f3d240e"
      unitRef="usd">5078000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i41f6a21a2abb4e77a00a22e833659f20_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzMtMy0xLTEtMTg0NDY5_3b3cbbd7-10a1-43c1-8aff-9d517fb5c3ef"
      unitRef="usd">5078000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i68ad331e56c04b3cab6eb6b46acdcb86_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzMtNS0xLTEtMTg0NDY5_e69ef2e9-84f0-46be-8156-edb2e85a613c"
      unitRef="usd">9097000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i41f6a21a2abb4e77a00a22e833659f20_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzMtNy0xLTEtMTg0NDY5_133ddcb5-9b6b-4114-b9c2-f484b8fd9e92"
      unitRef="usd">9129000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i1adec0aeb3214850954d7ba42cd20214_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzUtMS0xLTEtMTg0NDY5_e6203799-325b-445d-acc0-0b053ec44548"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if103da14634340edb17c23aba9feeff9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzUtMy0xLTEtMTg0NDY5_5cb5dba4-1c5a-40e2-a268-c27d0d62616c"
      unitRef="usd">0</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1adec0aeb3214850954d7ba42cd20214_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzUtNS0xLTEtMTg0NDY5_230f7a85-7e44-4543-8a0f-15bcdc736747"
      unitRef="usd">298000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if103da14634340edb17c23aba9feeff9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzUtNy0xLTEtMTg0NDY5_4680c839-772d-4f1d-be73-e7a7f9c295a6"
      unitRef="usd">160000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzYtMS0xLTEtMTg0NDY5_081d6d96-614a-4895-affe-4e60a6cae84a"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzYtMy0xLTEtMTg0NDY5_e3d39ed8-6a88-43dc-990f-75001957b060"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzYtNS0xLTEtMTg0NDY5_a7a84347-fc88-40a3-9ee4-7c09c0af387c"
      unitRef="usd">12384000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo3Njk4NzYyYTQ4ZDU0ZDE3YmZiOTRmMTAwMTgwZWJlNi90YWJsZXJhbmdlOjc2OTg3NjJhNDhkNTRkMTdiZmI5NGYxMDAxODBlYmU2XzYtNy0xLTEtMTg0NDY5_f96de7bb-61e8-4ffa-81f9-b0afb7226e0c"
      unitRef="usd">12306000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzE4MzA_2ec827e1-1083-4a88-bcde-28d404a9497c">&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consisted of the following at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,411&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;470&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,854&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;470&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzE4MzE_71b07772-ee72-406c-a855-3ef535199062">&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets consisted of the following at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.119%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.831%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite-lived intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,443&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Definite-lived intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,411&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;470&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,854&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;470&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzItMS0xLTEtMTg0NDY5_dd27d3ff-1296-4357-bc66-c20a7d00bc45"
      unitRef="usd">11443000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzItNS0xLTEtMTg0NDY5_4493de2c-421c-4568-9dfd-86a35b8db789"
      unitRef="usd">11443000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzMtMS0xLTEtMTg0NDY5_f985cf4b-1301-4599-b2de-fc5526e3211d"
      unitRef="usd">1411000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzMtMy0xLTEtMTg0NDY5_c30be89c-e466-4d3f-b7a2-5790200b6319"
      unitRef="usd">470000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzMtNS0xLTEtMTg0NDY5_b42ca72a-6869-47ac-9a7d-3ca56de6559f"
      unitRef="usd">1260000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzMtNy0xLTEtMTg0NDY5_fa9e57ef-6792-4503-964d-505516558be3"
      unitRef="usd">397000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzQtMS0xLTEtMTg0NDY5_ce83d435-948c-46fb-828e-d53146bee660"
      unitRef="usd">12854000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzQtMy0xLTEtMTg0NDY5_76f3cc2e-6630-44e7-86f7-f684b89b2a04"
      unitRef="usd">470000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzQtNS0xLTEtMTg0NDY5_ec415092-71fe-49f0-923d-91c339ee4499"
      unitRef="usd">12703000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZTo5NWU0ZWNiOTljNjg0MjZjYjdlY2U4Mzc0ZDY4OTAyZi90YWJsZXJhbmdlOjk1ZTRlY2I5OWM2ODQyNmNiN2VjZTgzNzRkNjg5MDJmXzQtNy0xLTEtMTg0NDY5_7288c231-3cf9-4282-bf14-bdb39640ab23"
      unitRef="usd">397000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IndefiniteLivedTrademarks
      contextRef="i8dc9d02e492d4fab82f3ad7bd4624c68_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzMxNw_8056c22f-3d31-4893-a993-36b3b88d1b55"
      unitRef="usd">8800000000</us-gaap:IndefiniteLivedTrademarks>
    <us-gaap:IndefiniteLivedTrademarks
      contextRef="i02811b1061214e51b307f1e6448ef953_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjQ2MjI_874358ec-7fea-424f-aae3-fb36186a89fc"
      unitRef="usd">4000000000</us-gaap:IndefiniteLivedTrademarks>
    <us-gaap:IndefiniteLivedTrademarks
      contextRef="iae418119009f46f9a862f1b8651fc378_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjQ2Mzg_19e3b598-cf21-4978-980c-de73700a0c80"
      unitRef="usd">3900000000</us-gaap:IndefiniteLivedTrademarks>
    <us-gaap:IndefiniteLivedTrademarks
      contextRef="i52300bd656f4412283014d05ee87427f_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjQ2NTQ_d1c66a42-6b80-4ec3-94e3-fee007989939"
      unitRef="usd">900000000</us-gaap:IndefiniteLivedTrademarks>
    <us-gaap:IndefiniteLivedTrademarks
      contextRef="i3ba9462e81d849bdb73a266e0704643e_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzM0Mw_b82c8d78-b91c-4071-bf5d-961fa3a826de"
      unitRef="usd">2600000000</us-gaap:IndefiniteLivedTrademarks>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ibbb8b3a48f934c52817757ed302eeb99_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzYyNA_8ac21bcf-340c-4bb8-86cd-28e4607382f5">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzczNw_8dd6365e-9fbf-458a-8534-7d17f1ef6e66"
      unitRef="usd">73000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzc0MQ_2b6efa80-6c4b-4d45-9dfc-d64dcb59b857"
      unitRef="usd">72000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzc0OA_45b97548-1022-4053-a6ee-58ed219c67d7"
      unitRef="usd">72000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzg2MA_2d12fe49-2284-4f13-8a53-1441e28f721c"
      unitRef="usd">75000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzg2MA_81a37d60-c844-4d4b-9e69-19869b0649e9"
      unitRef="usd">75000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzg2MA_a7114d03-c6af-4358-9d6a-fe9c3d3d8035"
      unitRef="usd">75000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzg2MA_b82912ed-c034-42db-b5d6-9fd271e9eb3b"
      unitRef="usd">75000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5Xzg2MA_e341d452-50e0-41d7-bca5-f7c2bdd2c1a7"
      unitRef="usd">75000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <mo:DisposalGroupPurchaseAgreementConsiderationInitialPayment
      contextRef="i4ba8a2737e194f0f980c2838e67e9215_I20221019"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjIyODU_48de5e0e-6ab0-40fb-958d-9de7f216c82b"
      unitRef="usd">1000000000</mo:DisposalGroupPurchaseAgreementConsiderationInitialPayment>
    <mo:DisposalGroupPurchaseAgreementConsiderationAdditionalPayment
      contextRef="iefb5652827eb457099968460ca178f35_I20230715"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjIzMDM_c2dd6dd2-c8b5-4894-b46d-20ae932eaf4a"
      unitRef="usd">1700000000</mo:DisposalGroupPurchaseAgreementConsiderationAdditionalPayment>
    <mo:DisposalGroupPurchaseAgreementEffectiveInterestRate
      contextRef="i4ba8a2737e194f0f980c2838e67e9215_I20221019"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjIzNTE_47929f1b-bae3-445c-8c7c-6d2996f07ace"
      unitRef="number">0.06</mo:DisposalGroupPurchaseAgreementEffectiveInterestRate>
    <mo:ProceedsFromSaleOfRightsUnderAnAgreement
      contextRef="i0ad47c9ea90a4f93882e5e207392a44c_D20221019-20230715"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjIzMTk_a3f0c691-974d-409b-ae0a-28125abe513f"
      unitRef="usd">2700000000</mo:ProceedsFromSaleOfRightsUnderAnAgreement>
    <mo:DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement
      contextRef="i90a31ad6d0834866867bab4c41bfdd29_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjIzMzU_01b6b880-00a3-4eb8-b733-95ffe9781bde"
      unitRef="usd">2700000000</mo:DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement>
    <mo:DisposalGroupReceivable
      contextRef="i90a31ad6d0834866867bab4c41bfdd29_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjI4MjY_d054d1b8-7af0-40f5-b9b2-29096d5d5d54"
      unitRef="usd">1700000000</mo:DisposalGroupReceivable>
    <mo:DisposalGroupInterestReceivable
      contextRef="i90a31ad6d0834866867bab4c41bfdd29_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjMyMTc_83b2308f-735e-4ea2-8f9a-2b3a850e263f"
      unitRef="usd">21000000</mo:DisposalGroupInterestReceivable>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestIncome
      contextRef="iea22343d0454457485cd1cc01bcc276c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjI1OTc_34c0c842-2d4b-45c4-9ddb-d7a3a79d4fb9"
      unitRef="usd">21000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestIncome>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCash
      contextRef="i90a31ad6d0834866867bab4c41bfdd29_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjQwMzA_80472cec-7254-450c-8299-59158fb40f8e"
      unitRef="usd">1000000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCash>
    <us-gaap:Goodwill
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzItMS0xLTEtMTg0NDY5_2a8254a1-8ae6-47d0-a36a-6b34f5ac014e"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzItMy0xLTEtMTg0NDY5_3f65554e-c0ae-4253-b64d-8b4b1f442654"
      unitRef="usd">12306000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzItNS0xLTEtMTg0NDY5_c8959b12-08f4-4968-8800-6230797f6da6"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzItNy0xLTEtMTg0NDY5_dc83b06d-26f9-4f2f-9993-11207be20e67"
      unitRef="usd">12615000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtMS0xLTEtMTk1MzEx_6d8e786f-e2b9-4102-9841-8156b20196b5"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <mo:IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtMy0xLTEtMTk1MzEx_4e2fd113-b211-4f22-a7aa-de3e3a851aa3"
      unitRef="usd">151000000</mo:IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtNS0xLTEtMTk1MzAz_f2489afd-8da3-487d-ac0e-6caf15a1d5ac"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <mo:IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtNy0xLTEtMTk1MzAz_a4624d53-bf9d-4fd1-a64f-3c4ecd5ac5e5"
      unitRef="usd">0</mo:IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtMS0xLTEtMTg0NDY5_8862d91f-e371-40c8-8da4-e3a9c7d4aee7"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <mo:IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtMy0xLTEtMTg0NDY5_a6b05e1b-ee30-4375-8831-e9c4c63300fa"
      unitRef="usd">0</mo:IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtNS0xLTEtMTg0NDY5_36a6819d-c066-4e4b-a502-2a27da98d054"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <mo:IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzQtNy0xLTEtMTg0NDY5_77fd22cc-6df0-4f95-b7eb-60c2c6c6df13"
      unitRef="usd">237000000</mo:IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzYtMy0xLTEtMTg0NDY5_46c5d545-5051-4775-bac9-2691f4109aca"
      unitRef="usd">73000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzYtNy0xLTEtMTg0NDY5_5691a1cb-3459-4f65-a0f2-e02bb17f311a"
      unitRef="usd">72000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:Goodwill
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzctMS0xLTEtMTg0NDY5_7db7aa15-b3d7-48f2-befa-2247c6bd8b7a"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzctMy0xLTEtMTg0NDY5_6892781b-8c73-40f8-b4a3-48df9ce1622c"
      unitRef="usd">12384000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzctNS0xLTEtMTg0NDY5_6fe62b47-09f8-41f4-af77-113ff87bf216"
      unitRef="usd">5177000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90YWJsZToyYmMwNDM5ZGRkZjA0NDIxOTBkNTYzNDdjYmMxNzJhOC90YWJsZXJhbmdlOjJiYzA0MzlkZGRmMDQ0MjE5MGQ1NjM0N2NiYzE3MmE4XzctNy0xLTEtMTg0NDY5_bc63a171-53a8-48f2-8e6e-8223e39206c6"
      unitRef="usd">12306000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
      contextRef="i2793c14b7447420e9b9c20617d2dacdb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzIxOTkwMjMyNjQ0Njc_25318c24-bfb2-4cf5-8fff-ee3af294e6d1"
      unitRef="usd">50000000</us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzEyNjk_0f7d5d48-f888-44d0-a1cc-6fc035d2fa5f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzEyNjk_33337c1d-446b-4e77-9531-4709f58d8c37"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzEyNjk_be349370-3d45-4f56-8689-adb881988bb4"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzE2Mjk_6c519062-e0ce-45be-8d6b-6d38dab69662"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMTIvZnJhZzo1YzQ0NDY2ZjliNjA0MWExOTc3MDJiZmJjNDBmMzdhOS90ZXh0cmVnaW9uOjVjNDQ0NjZmOWI2MDQxYTE5NzcwMmJmYmM0MGYzN2E5XzE2Mjk_9860337d-31b2-4588-962f-d41954a3c979"
      unitRef="usd">0</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:InvestmentTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzYzNDE_6406efc5-a5a5-4631-902a-cedb493a8bff">Investments in Equity Securities&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of our investments consisted of the following at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.984%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,975&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;375&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,600&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our investment in Cronos at December&#160;31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;consisted of our equity method investment in Cronos of $617 million and also included the Cronos warrant and the Fixed-price Preemptive Rights (collectively, &#x201c;Investment in Cronos&#x201d;), which were measured at fair value.  We irrevocably abandoned the Cronos warrant on December 15, 2022, and the Fixed-price Preemptive Rights had no value at December&#160;31, 2022.  See below for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Income) losses from investments in equity securities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,973&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) losses from investments under equity method of accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,186&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-18.01pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9.01pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) losses from investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,641&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes our share of amounts recorded by our investees and additional adjustments, if required, related to (i) the conversion from international financial reporting standards to GAAP and (ii) adjustments to our investment required under the equity method of accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Investment in JUUL is accounted for as an investment in an equity security measured at fair value.  See below for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:8pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investees&#x2019; summarized financial data for our equity method investments was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For Altria&#x2019;s Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;57,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;947&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31,588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,879&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,879&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (losses) attributable to equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,838&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.756%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.756%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.756%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;At September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,164&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;963&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;182,087&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;274&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32,649&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96,497&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Reflects a one-quarter lag.  Other Investments reflect summarized financial data of Cronos, as well as JUUL&#x2019;s financial data for the periods during which we accounted for our investment in JUUL as an equity method investment under the fair value option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in ABI&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we had an approximate 10.0% ownership interest in ABI, consisting of 185 million restricted shares of ABI (the &#x201c;Restricted Shares&#x201d;) and 12 million ordinary shares of ABI.  The Restricted Shares:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;are unlisted and not admitted to trading on any stock exchange;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;are convertible by us into ordinary shares of ABI on a one-for-one basis;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;rank equally with ordinary shares of ABI with regards to dividends and voting rights; and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.96pt"&gt;have director nomination rights with respect to ABI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of this filing, we have not elected to convert our Restricted Shares into ordinary shares of ABI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for our investment in ABI under the equity method of accounting because we have the ability to exercise significant influence over the operating and financial policies of ABI, including having active representation on ABI&#x2019;s board of directors and certain ABI board committees.  Through this representation, we participate in ABI&#x2019;s policy making processes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We report our share of ABI&#x2019;s results using a one-quarter lag because ABI&#x2019;s results are not available in time for us to record them in the concurrent period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our equity investment in ABI is based on (i) unadjusted quoted prices in active markets for ABI&#x2019;s ordinary shares and was classified in Level 1 of the fair value hierarchy and (ii) observable inputs other than Level 1 prices, such as quoted prices for similar assets for the Restricted Shares, and was classified in Level 2 of the fair value hierarchy.  We can convert our Restricted Shares to ordinary shares at our discretion.  Therefore, the fair value of each Restricted Share is based on the value of an ordinary share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021, the fair value of our equity investment in ABI was $11.9 billion (carrying value of $11.1 billion), which exceeded its carrying value by $0.8 billion or approximately 7%.  In the second quarter of 2022, the fair value declined below its carrying value and at June 30, 2022, the fair value was below its carrying value by $1.1 billion or approximately 9%.  We concluded that the decline in fair value below its carrying value was temporary and, therefore, we did not record an impairment charge at that time.  At September 30, 2022, the fair value of our equity investment in ABI of $9.0 billion was below its carrying value by $2.5 billion or approximately 22%.  We concluded that the decline in fair value at September 30, 2022 was other than temporary as we anticipated that the full recovery to the carrying value would take longer than previously expected.  In reaching this conclusion, we evaluated the factors related to the fair value decline, including the macroeconomic and geopolitical factors that have significantly impacted certain foreign exchange rates and global equity markets.  As a result of our conclusion, we recorded a non-cash, pre-tax impairment charge of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$2.5&#160;billion during the third quarter of 2022, which was recorded to (income) losses from investments in equity securities in our consolidated statements of earnings.  This impairment charge reflected the difference between the fair value of our equity investment in ABI using ABI&#x2019;s share price and the Euro to U.S dollar exchange rate at September 30, 2022 and the carrying value of our equity investment in ABI at September 30, 2022.  After recording the impairment charge, each of the fair value and carrying value at September 30, 2022 was $9.0 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the fair value of our equity investment in ABI was $11.9 billion (carrying value of $9.0 billion), which exceeded its carrying value by approximately 33%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At September 30, 2021, the fair value of our equity investment in ABI of $11.2 billion declined below its carrying value by $6.2 billion or approximately 35%.  We concluded that the decline in fair value at September 30, 2021 was other than temporary.  As a result of our conclusion, we recorded a non-cash, pre-tax impairment charge of $6.2 billion during the third quarter of 2021, which was recorded to (income) losses from investments in equity securities in our consolidated statements of earnings.  After recording the impairment charge, each of the fair value and carrying value at September 30, 2021 was $11.2 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, the carrying value of our equity investment in ABI exceeded its share of ABI&#x2019;s net assets attributable to equity holders of ABI by approximately $2.5 billion.  Substantially all of this difference is comprised of goodwill and other indefinite-lived intangible assets (consisting primarily of trademarks).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in JUUL&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2018, we made an investment in JUUL for $12.8 billion and received a 35% economic interest in JUUL through non-voting shares, which we converted at our election into voting shares in November 2020 (&#x201c;Share Conversion&#x201d;), and a security convertible into additional non-voting or voting shares, as applicable, upon settlement or exercise of certain JUUL convertible securities (the &#x201c;JUUL Transaction&#x201d;).  At December&#160;31, 2022, we had a 35% economic ownership interest in JUUL, consisting of 42 million voting shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to a standstill restriction under which we may not acquire additional JUUL shares above our 35% interest and may not sell or transfer any of our JUUL shares until December 20, 2024.  Furthermore, at the time of the investment, we agreed to non-competition obligations generally requiring that we participate in the e-vapor business only through JUUL.  In January 2020, we amended certain JUUL Transaction agreements and entered into a new cooperation agreement.  One of the provisions in the amendments was the option to be released from our non-compete obligation under certain circumstances, including if the carrying value of our investment in JUUL was not more than 10% of its initial carrying value of $12.8 billion.  At June 30, 2022, the carrying value of our investment in JUUL was $450&#160;million, which was less than 10% of our initial carrying value of $12.8&#160;billion.  As a result, in September 2022, we exercised our option to be released from our JUUL non-competition obligations, resulting in (i) the permanent termination of our non-competition obligations to JUUL, (ii) the loss of our JUUL board designation rights (other than the right to designate one independent director so long as our ownership continues to be at least 10%), our preemptive rights, our consent rights and certain other rights with respect to our investment in JUUL and (iii) the conversion of our JUUL shares to single vote common stock, significantly reducing our voting power.  We do not currently intend to exercise our remaining governance rights or to vote our JUUL shares other than as a passive investor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, as part of the amendment to certain JUUL Transaction agreements in January 2020, we agreed not to pursue any claims against JUUL for indemnification or reimbursement except for any non-contractual claims for contribution or indemnity where a judgment has been entered against us and JUUL with respect to certain litigation in which we and JUUL are both defendants against third-party plaintiffs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the U.S. Federal Trade Commission (&#x201c;FTC&#x201d;) issued an administrative complaint challenging our investment in JUUL.  In February 2022, the administrative law judge dismissed the FTC&#x2019;s complaint.  FTC complaint counsel appealed that decision to the FTC, which appeal remains pending.  For further discussion, see Note 17. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies -&#160;Antitrust Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) issued marketing denial orders (&#x201c;MDOs&#x201d;) to JUUL ordering all of JUUL&#x2019;s products currently marketed in the United States off the market.  In July 2022, the FDA administratively stayed the MDOs on a temporary basis, citing its determination that there are scientific issues unique to the JUUL PMTAs that warrant additional review.  This administrative stay temporarily suspends the MDOs and JUUL&#x2019;s products remain on the market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following Share Conversion in the fourth quarter of 2020, we elected to account for our equity method investment in JUUL under the fair value option.  In making this election, we believed measuring our investment at fair value provided quarterly transparency to investors as to the fair market value of our investment in JUUL, given the changes and volatility in the e-vapor category since our initial investment, as well as the lack of publicly available information regarding JUUL&#x2019;s business or a market-derived valuation.  As a result of our loss of certain rights due to our exercise of our option to be released from our JUUL non-competition obligations in the third quarter of 2022, we determined that we no longer have the ability to exercise significant influence over the operating and financial policies of JUUL.  Therefore, we are no longer able to account for our investment in JUUL as an equity method investment.  Beginning with the period ended September 30, 2022, we account for our investment in JUUL as an investment in an equity security.  We will continue to measure our investment in JUUL at fair value, in accordance with GAAP.  Our consolidated statements of earnings include &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;any cash dividends received from our investment in JUUL (none received to date) and any changes in the estimated fair value of our investment, which is calculated quarterly.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balance of our investment in JUUL, which is classified in Level 3 of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) included in (income) losses from investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) included in (income) losses from investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to Share Conversion, we accounted for our investment in JUUL as an investment in an equity security.  Since the JUUL shares do not have a readily determinable fair value, we elected to measure our investment in JUUL at its cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.  There were no upward or downward adjustments to the carrying value of our investment in JUUL resulting from observable price changes in orderly transactions since the JUUL Transaction through the date of Share Conversion.  In addition, prior to Share Conversion, we reviewed our investment in JUUL for impairment by performing a qualitative assessment of impairment indicators on a quarterly basis in connection with the preparation of our financial statements.  If this qualitative assessment indicated that our investment in JUUL may be impaired, a quantitative assessment was performed.  If the quantitative assessment indicated the estimated fair value of the investment was less than its carrying value, the investment was written down to its estimated fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2022 Financial Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;For the year ended December&#160;31, 2022, we recorded non-cash, pre-tax unrealized losses of $1,455 million as a result of changes in the estimated fair value of our investment in JUUL.  The decrease in the estimated fair value was primarily driven by (i) a decrease in the likelihood of a favorable outcome from the FDA for JUUL&#x2019;s products that are currently marketed in the United States, which have received MDOs and are now under additional administrative review, (ii) a decrease in the likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, which could result in JUUL seeking protection under bankruptcy or other insolvency laws, (iii) projections of higher operating expenses resulting in lower long-term operating margins, (iv) projections of lower JUUL revenues in the United States over time due to lower JUUL volume assumptions and (v) an increase in the discount rate due to changes in market factors, partially offset by the effect of passage of time on the projected cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2021 Financial Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;For the year ended December 31, 2021, we recorded no change in the estimated fair value of our investment in JUUL.  During the year ended December 31, 2021, the estimated fair value was primarily impacted by our projections of lower JUUL revenues in the United States over time due to lower JUUL volume assumptions offset by (i) the effect of passage of time on the projected cash flows and (ii) a decrease in the discount rate due to changes in market factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2020 Financial Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;We recorded a non-cash pre-tax unrealized gain of $100 million for the fourth quarter and year ended December 31, 2020 as a result of an increase in the estimated fair value of our investment in JUUL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;In September 2020, JUUL announced a strategic update, which included its plans for a significant global workforce reduction, its evaluation of its resource allocation and the possibility of exiting various international markets.  As part of the preparation of our financial statements for the period ended September 30, 2020, we performed a qualitative assessment of impairment indicators for our investment in JUUL and determined that JUUL&#x2019;s strategic update was an indicator of impairment at September 30, 2020, given the significant deterioration in JUUL&#x2019;s business prospects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Given the existence of this impairment indicator, we performed a quantitative valuation of our investment in JUUL during the third quarter of 2020 and recorded a non-cash, pre-tax impairment charge of $2.6 billion for the year ended December 31, 2020, reported as impairment of JUUL equity securities in our consolidated statements of earnings.  The impairment charge was driven by our projections of lower JUUL revenues over time due to lower pricing assumptions and delays in JUUL achieving previously forecasted operating margin performance.  These drivers were the result of (i) JUUL&#x2019;s revised international expansion plans and (ii) the evolving U.S. e-vapor category and associated competitive dynamics.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use an income approach to estimate the fair value of our investment in JUUL.  The income approach reflects the discounting of future cash flows for the U.S. and international markets at a rate of return that incorporates the risk-free rate for the use of those funds, the expected rate of inflation and the risks associated with realizing future cash flows.&lt;/span&gt;&lt;/div&gt;In determining the estimated fair value of our investment in JUUL, in 2022, 2021 and 2020, we made certain judgments, estimates and assumptions, the most significant of which were likelihood of certain potential regulatory and liquidity outcomes, sales volume, operating margins, discount rates and perpetual growth rates.  All significant inputs used in the valuation are classified in Level 3 of the fair value hierarchy.  Additionally, in determining these significant assumptions, we made judgments regarding the (i) likelihood of certain potential regulatory actions impacting the e-vapor category and specifically whether the FDA will ultimately authorize JUUL&#x2019;s products, which have received MDOs and are now under additional administrative review; (ii) likelihood of JUUL maintaining adequate liquidity to fund projected cash needs, the absence of which could result in JUUL seeking protection under bankruptcy or other insolvency laws; (iii) risk created by the number and types of legal cases pending against JUUL; (iv) expectations for the future state of the e-vapor category, including competitive dynamics; and (v) timing of international expansion plans.  Due to these uncertainties, our future cash flow projections of JUUL are based on a range of scenarios that consider certain potential regulatory, liquidity and market outcomes.&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investment in Cronos&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we had a 41.1% ownership interest in Cronos, consisting of 156.6 million shares, which we account for under the equity method of accounting.  Our ownership percentage decreased from 41.8% at December&#160;31, 2021 due to the issuance of additional shares by Cronos.  We report our share of Cronos&#x2019;s results using a one-quarter lag because Cronos&#x2019;s results are not available in time for us to record them in the concurrent period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of our equity method investment in Cronos is based on unadjusted quoted prices in active markets for Cronos&#x2019;s common shares and was classified in Level 1 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2021, each of the fair value and carrying value of our equity method investment in Cronos was $617 million.  In the second quarter of 2022, the fair value of our equity method investment in Cronos declined below its carrying value and had not recovered as of June 30, 2022.  At June 30, 2022, the fair value was less than its carrying value by approximately 20%.  We concluded that the decline in fair value was other than temporary.  As a result, we recorded a non-cash, pre-tax impairment charge of $107 million in the second quarter of 2022, which was recorded to (income) losses from investments in equity securities in our consolidated statements of earnings.  The impairment charge reflects the difference between the fair value of our equity method investment in Cronos using Cronos&#x2019;s share price and the Canadian dollar (&#x201c;CAD&#x201d;) to U.S. dollar exchange rate at June 30, 2022 and the carrying value of our equity method investment in Cronos at June 30, 2022.  After recording the impairment charge, each of the fair value and carrying value at June 30, 2022 was $437 million.  At December&#160;31, 2022, the fair value of our equity method investment in Cronos exceeded its carrying value by $22 million or approximately 6%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2021, the fair value of our equity method investment in Cronos was less than its carrying value by approximately 25%.  We concluded that the decline in fair value at December 31, 2021 was other than temporary.  As a result, we recorded a non-cash, pre-tax impairment charge of $205&#160;million for the year ended December 31, 2021, which was recorded to (income) losses from investments in equity securities in our consolidated statement of earnings.  After recording the impairment charge, each of the fair value and carrying value at December 31, 2021 was $617&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of our Investment in Cronos, at December&#160;31, 2022, we also owned anti-dilution protections to purchase Cronos common shares, exercisable each quarter upon dilution, to maintain our ownership percentage.  Certain of the anti-dilution protections provide us the ability to purchase additional Cronos common shares at a per share exercise price of CAD $16.25 upon the occurrence of specified events (&#x201c;Fixed-price Preemptive Rights&#x201d;).  Based on our assumptions as of December&#160;31, 2022, we estimate the Fixed-price Preemptive Rights allows us to purchase up to an additional approximately 7 million common shares of Cronos.  Prior to December 15, 2022, we also owned a warrant providing us the ability to purchase an additional approximate 10% of common shares of Cronos at a per share exercise price of CAD $19.00, which would have expired on March 8, 2023.  On December 15, 2022, we irrevocably abandoned the Cronos warrant, and we no longer owned the warrant as of December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Fixed-price Preemptive Rights are derivative financial instruments, which are required to be recorded at fair value and are classified in Level 3 of the fair value hierarchy.  Prior to irrevocably abandoning the Cronos warrant on December 15, 2022, the Cronos warrant was also a derivative financial instrument recorded at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record in our consolidated statements of earnings any changes in the fair values of the Fixed-price Preemptive Rights and Cronos warrant as gains or losses on Cronos-related financial instruments in the periods in which the changes occur.  We recorded non-cash, pre-tax unrealized losses, representing these changes, as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.353%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentTextBlock>
    <us-gaap:InvestmentTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzYzNDg_73e294fe-cc64-4563-8cda-b416371e519e">&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of our investments consisted of the following at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.984%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,975&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;375&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,600&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our investment in Cronos at December&#160;31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;consisted of our equity method investment in Cronos of $617 million and also included the Cronos warrant and the Fixed-price Preemptive Rights (collectively, &#x201c;Investment in Cronos&#x201d;), which were measured at fair value.  We irrevocably abandoned the Cronos warrant on December 15, 2022, and the Fixed-price Preemptive Rights had no value at December&#160;31, 2022.  See below for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(Income) losses from investments in equity securities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.068%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,973&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-0.01pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) losses from investments under equity method of accounting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,186&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-18.01pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JUUL &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9.01pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) losses from investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,641&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes our share of amounts recorded by our investees and additional adjustments, if required, related to (i) the conversion from international financial reporting standards to GAAP and (ii) adjustments to our investment required under the equity method of accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Investment in JUUL is accounted for as an investment in an equity security measured at fair value.  See below for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:8pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investees&#x2019; summarized financial data for our equity method investments was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For Altria&#x2019;s Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;57,267&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;947&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31,588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) from continuing operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,879&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,879&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(521)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings (losses) attributable to equity investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,838&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(798)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.457%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.756%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.756%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.756%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;At September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,164&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;963&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;182,087&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;274&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;190,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32,649&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96,497&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible Preferred Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Reflects a one-quarter lag.  Other Investments reflect summarized financial data of Cronos, as well as JUUL&#x2019;s financial data for the periods during which we accounted for our investment in JUUL as an equity method investment under the fair value option.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentTableTextBlock>
    <us-gaap:EquityMethodInvestments
      contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzEtMi0xLTEtMTg0NDY5_e821555f-5c37-47de-82c2-97bf3a4bdc1a"
      unitRef="usd">8975000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i42e7b2a18fdf46808c830b8cad5d58a5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzEtNC0xLTEtMTg0NDY5_748944fa-3d77-4de9-aff2-2bc8ced6e8d1"
      unitRef="usd">11144000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i688c2fcd3b0343b29196c870d74f6b68_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzItMi0xLTEtMTg0NDY5_ab160da5-fd72-4088-9c62-5e7f5c64bc48"
      unitRef="usd">250000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent
      contextRef="i56c5cabbdfb44d05a0e818aa3c22c4d1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzItNC0xLTEtMTg0NDY5_4483c9c1-df0d-4d7e-aaab-80f81c73347e"
      unitRef="usd">1705000000</us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent>
    <mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights
      contextRef="i84433bab48264529a2516c2663b4fc52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzMtMi0xLTEtMTg0NDY5_71fd0638-9da6-4077-9cd2-426faabdf600"
      unitRef="usd">375000000</mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights>
    <mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights
      contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzMtNC0xLTEtMTg0NDY5_9ab01711-5509-4818-b557-b48d5c0a7186"
      unitRef="usd">632000000</mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights>
    <us-gaap:Investments
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzQtMi0xLTEtMTg0NDY5_72456102-228f-4811-afd4-511d4aba9aa6"
      unitRef="usd">9600000000</us-gaap:Investments>
    <us-gaap:Investments
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo2NzY4MjA1OTM1OTQ0ZmRiYTMzY2JjMjdhNWNiOTYzYy90YWJsZXJhbmdlOjY3NjgyMDU5MzU5NDRmZGJhMzNjYmMyN2E1Y2I5NjNjXzQtNC0xLTEtMTg0NDY5_466ca515-8d94-436a-9c72-f23e22ef1724"
      unitRef="usd">13481000000</us-gaap:Investments>
    <mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights
      contextRef="ia6a4fa4621c7473ba1611dbe6af67745_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNjIxMTc_321082c4-5c27-475a-aee4-663afd62df0b"
      unitRef="usd">617000000</mo:EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights>
    <mo:EquityMethodInvestmentsFixedPreemptiveRights
      contextRef="i84433bab48264529a2516c2663b4fc52_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzQ5NDc4MDIzNTQ4Njk_01b0a533-81cc-486f-b1ca-f834983978ca"
      unitRef="usd">0</mo:EquityMethodInvestmentsFixedPreemptiveRights>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i25c3587d3f994622b4714f1b3124a4da_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzItMS0xLTEtMTg0NDY5_979bdf4c-d1e7-4660-a721-58639be2f0f2"
      unitRef="usd">-1973000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id61401757fdc493c83aa67b7620e44d4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzItMy0xLTEtMTg0NDY5_c57b1ff0-61d4-4418-afbb-22b0dfb03daf"
      unitRef="usd">-5564000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if803b88b013a40dfba8d352c3b38fd7a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzItNS0xLTEtMTg0NDY5_55047ad4-10e5-4006-8812-098b8db9f674"
      unitRef="usd">-223000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iea2f16158f9341fd86284d599cb55729_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzMtMS0xLTEtMTg0NDY5_5d66d4ae-de4c-49c3-9e4b-bfec5919f294"
      unitRef="usd">-213000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i13178e7cbc7c479c89b40c940101986c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzMtMy0xLTEtMTg0NDY5_105f17fa-0fdc-47cd-998a-cdca34bf3c7a"
      unitRef="usd">-415000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i3bf83008070a46eb83178baf67bbaa65_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzMtNS0xLTEtMTg0NDY5_90e6e672-ee04-48d6-849f-adacc1b8c9ee"
      unitRef="usd">12000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzQtMS0xLTEtMTg0NDY5_c434aa6b-41ed-405f-ad6d-21ad03358b4f"
      unitRef="usd">-2186000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzQtMy0xLTEtMTg0NDY5_0ed9e338-74b2-46d6-ae18-9632943b9a89"
      unitRef="usd">-5979000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzQtNS0xLTEtMTg0NDY5_67087cd9-3a3e-4a8f-9962-995580e92dd6"
      unitRef="usd">-211000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="icc2bb0b67a1f4be892d628382285683c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzUtMS0xLTEtMTg0NDY5_8b9f9f9b-4ab9-413b-b879-1385a8773784"
      unitRef="usd">-1455000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i6ee0d2b6272e47c2b0125f423877e769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzUtMy0xLTEtMTg0NDY5_1b170c37-f0be-4432-9544-1aabbc73204e"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzUtNS0xLTEtMTg0NDY5_919ad116-7617-4b4c-b6d4-72d0b35ccc7d"
      unitRef="usd">100000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzYtMS0xLTEtMTg0NDY5_f23a93ef-1369-4101-8249-e2cc92da0fd6"
      unitRef="usd">-3641000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzYtMy0xLTEtMTg0NDY5_73335f23-2067-4a28-a8ef-6fc1219d57ca"
      unitRef="usd">-5979000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo0MTZhZTdhYjQ1OWY0Mzk5OTRiMTI1MjA5N2MxNmI4MS90YWJsZXJhbmdlOjQxNmFlN2FiNDU5ZjQzOTk5NGIxMjUyMDk3YzE2YjgxXzYtNS0xLTEtMTg0NDY5_a039af59-c8b2-4ead-866b-e5cc604cc131"
      unitRef="usd">-111000000</mo:IncomeLossFromEquityInvestments>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzMtMS0xLTEtMTg0NDY5_808df4ed-3806-409d-aaaa-920ed0184560"
      unitRef="usd">57267000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i662e4fa2b880451fa00f79a419fcb83e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzMtMy0xLTEtMTg0NDY5_59e11c38-7e10-41e5-bd05-c95723cf40e5"
      unitRef="usd">947000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4408f6fff55f4f809ea62c43a15e4c2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzMtNS0xLTEtMTg0NDY5_00e284d5-f1a9-4294-8683-42bc3b0c5fb1"
      unitRef="usd">52864000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if3a9cfbb99324bffa0f757ecfa7e5577_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzMtNy0xLTEtMTg0NDY5_f5ff1b14-01b8-4338-ae67-81f9af9ebcf4"
      unitRef="usd">1313000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8513d61234ef4b449cb9e88035fd6619_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzMtOS0xLTEtMTg0NDY5_93c666f1-4c49-4490-ab39-ce9533239699"
      unitRef="usd">48294000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a048f874a064a4995997da946ea095e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzMtMTEtMS0xLTE4NDQ2OQ_a4454b4d-af2c-4772-b2ed-61df4efadb7d"
      unitRef="usd">37000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:GrossProfit
      contextRef="icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzQtMS0xLTEtMTg0NDY5_e7f43035-1ea1-4dfc-bd00-7ab6d6b82db2"
      unitRef="usd">31588000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i662e4fa2b880451fa00f79a419fcb83e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzQtMy0xLTEtMTg0NDY5_d5fd2269-a561-4e5c-8f01-51df60b8eb77"
      unitRef="usd">525000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i4408f6fff55f4f809ea62c43a15e4c2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzQtNS0xLTEtMTg0NDY5_39cba526-c003-40cd-a063-5a90d01cc6aa"
      unitRef="usd">30653000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="if3a9cfbb99324bffa0f757ecfa7e5577_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzQtNy0xLTEtMTg0NDY5_88f2ca4e-6756-42c4-a052-a11dd14667d1"
      unitRef="usd">757000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i8513d61234ef4b449cb9e88035fd6619_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzQtOS0xLTEtMTg0NDY5_8e902a84-be44-4b33-b6c5-00fc0abe62d6"
      unitRef="usd">28438000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i7a048f874a064a4995997da946ea095e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzQtMTEtMS0xLTE4NDQ2OQ_10d6907d-af01-402b-89d9-85d3782acaee"
      unitRef="usd">-31000000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzUtMS0xLTEtMTg0NDY5_08103ad4-bc71-4428-9442-32d2b7ac1397"
      unitRef="usd">7879000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i662e4fa2b880451fa00f79a419fcb83e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzUtMy0xLTEtMTg0NDY5_a067a0b0-3678-4d68-bc0d-c975691c7c7c"
      unitRef="usd">-521000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4408f6fff55f4f809ea62c43a15e4c2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzUtNS0xLTEtMTg0NDY5_821441e3-db7d-41d6-80f6-55407bd4307a"
      unitRef="usd">7434000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if3a9cfbb99324bffa0f757ecfa7e5577_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzUtNy0xLTEtMTg0NDY5_9d598b8d-9b3e-4dae-95d0-1826cfccbad0"
      unitRef="usd">-800000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i8513d61234ef4b449cb9e88035fd6619_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzUtOS0xLTEtMTg0NDY5_86971ee4-91c0-4c47-87d4-19331bd28cf3"
      unitRef="usd">4265000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i7a048f874a064a4995997da946ea095e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzUtMTEtMS0xLTE4NDQ2OQ_37fdcd3a-cfd8-41c1-9e0c-f8f2acce58a4"
      unitRef="usd">99000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzYtMS0xLTEtMTg0NDY5_5751850c-1e69-4c0c-ab89-f5d2181e0b00"
      unitRef="usd">7879000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i662e4fa2b880451fa00f79a419fcb83e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzYtMy0xLTEtMTg0NDY5_22f8e43f-60bd-4c16-bc67-a3fa26534726"
      unitRef="usd">-521000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4408f6fff55f4f809ea62c43a15e4c2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzYtNS0xLTEtMTg0NDY5_cc05433f-6871-4334-b438-aa18ede7e704"
      unitRef="usd">7434000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if3a9cfbb99324bffa0f757ecfa7e5577_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzYtNy0xLTEtMTg0NDY5_cb5422a7-875d-4bb4-bb38-f35d833f4576"
      unitRef="usd">-800000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8513d61234ef4b449cb9e88035fd6619_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzYtOS0xLTEtMTg0NDY5_cd1efc85-c9d0-4022-bf0f-187d52680682"
      unitRef="usd">4266000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7a048f874a064a4995997da946ea095e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzYtMTEtMS0xLTE4NDQ2OQ_b53277db-2c58-42c7-b7e4-af8886041e9f"
      unitRef="usd">98000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzctMS0xLTEtMTg0NDY5_b23c0934-20ee-461d-94b0-3c33616364fb"
      unitRef="usd">5838000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i662e4fa2b880451fa00f79a419fcb83e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzctMy0xLTEtMTg0NDY5_d5b4e2af-a5af-4e8f-a70c-6c03867b3f6f"
      unitRef="usd">-520000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4408f6fff55f4f809ea62c43a15e4c2c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzctNS0xLTEtMTg0NDY5_4a13a43f-de83-4ef4-b46d-6b45fa6bdd83"
      unitRef="usd">5780000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if3a9cfbb99324bffa0f757ecfa7e5577_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzctNy0xLTEtMTg0NDY5_b3316ee5-da3c-4b0d-bca8-683c6250d405"
      unitRef="usd">-798000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8513d61234ef4b449cb9e88035fd6619_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzctOS0xLTEtMTg0NDY5_3d80e8d3-fdba-44c9-8af3-6163a8eb2d2d"
      unitRef="usd">3323000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i7a048f874a064a4995997da946ea095e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTpiZjdiNGNlM2M4NDM0NjE2YmM5NmEyNDM0YzNlYmEwOC90YWJsZXJhbmdlOmJmN2I0Y2UzYzg0MzQ2MTZiYzk2YTI0MzRjM2ViYTA4XzctMTEtMS0xLTE4NDQ2OQ_ac03ef34-d445-4941-9952-b6749bffed8f"
      unitRef="usd">100000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:AssetsCurrent
      contextRef="i07d379f94c904bd4b8baa4f957b160c2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzMtMS0xLTEtMTg0NDY5_db736b16-a017-4fc3-80ba-b61cae1e110e"
      unitRef="usd">24164000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i8c0955d3143c4319b611181108536948_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzMtMy0xLTEtMTg0NDY5_9889192a-7101-4c01-818c-d8a3bcf4710f"
      unitRef="usd">963000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6a3babb09031476eab172eb19f78a4fb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzMtNS0xLTEtMTg0NDY5_7bffcbac-fa0e-478b-a544-f7d46556b17f"
      unitRef="usd">21593000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if8367586242540b9911f25a7b7315179_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzMtNy0xLTEtMTg0NDY5_bef09d9c-8663-489b-b78f-0d9bae1ae97e"
      unitRef="usd">1882000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i07d379f94c904bd4b8baa4f957b160c2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzQtMS0xLTEtMTg0NDY5_03cd9edb-4c89-4c3a-bcf5-00bbef9d890e"
      unitRef="usd">182087000000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i8c0955d3143c4319b611181108536948_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzQtMy0xLTEtMTg0NDY5_bb63eb7c-15ab-4584-8902-a20bc62305b6"
      unitRef="usd">274000000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i6a3babb09031476eab172eb19f78a4fb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzQtNS0xLTEtMTg0NDY5_615839d0-8465-4761-8939-6642205af6e1"
      unitRef="usd">190082000000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="if8367586242540b9911f25a7b7315179_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzQtNy0xLTEtMTg0NDY5_ac6c44ea-8ca0-4960-9a79-46a01da18385"
      unitRef="usd">1049000000</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i07d379f94c904bd4b8baa4f957b160c2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzUtMS0xLTEtMTg0NDY5_ee16f764-dda1-4099-a3b8-0df3204aef8c"
      unitRef="usd">32649000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i8c0955d3143c4319b611181108536948_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzUtMy0xLTEtMTg0NDY5_1524d56d-676b-4b77-a3d3-15a6821491f2"
      unitRef="usd">38000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6a3babb09031476eab172eb19f78a4fb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzUtNS0xLTEtMTg0NDY5_bde933d3-d0ba-452d-9ec5-a3733f804c73"
      unitRef="usd">33540000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if8367586242540b9911f25a7b7315179_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzUtNy0xLTEtMTg0NDY5_d4819fd9-d35a-4e5b-9c8e-b68780fac108"
      unitRef="usd">451000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i07d379f94c904bd4b8baa4f957b160c2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzYtMS0xLTEtMTg0NDY5_c6b58e36-5ad8-44d0-a9a7-6108028ca6ab"
      unitRef="usd">96497000000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i8c0955d3143c4319b611181108536948_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzYtMy0xLTEtMTg0NDY5_b655bc5d-44d7-471d-adf0-288c94eb9c4e"
      unitRef="usd">8000000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i6a3babb09031476eab172eb19f78a4fb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzYtNS0xLTEtMTg0NDY5_b90840e7-ac0d-40c4-b081-7b5b28e7a792"
      unitRef="usd">105973000000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="if8367586242540b9911f25a7b7315179_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzYtNy0xLTEtMTg0NDY5_5a177d47-1448-48ce-a22d-1b04e6b6529e"
      unitRef="usd">2277000000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="i07d379f94c904bd4b8baa4f957b160c2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzctMS0xLTEtMTg0NDY5_4ecf8943-e796-4082-8769-cff3c94f5cbb"
      unitRef="usd">0</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="i8c0955d3143c4319b611181108536948_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzctMy0xLTEtMTg0NDY5_b4b669f6-a5ad-4bac-862b-7e85015872c7"
      unitRef="usd">0</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="i6a3babb09031476eab172eb19f78a4fb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzctNS0xLTEtMTg0NDY5_a8e2e618-e25b-42fb-95b4-485c6936bc86"
      unitRef="usd">0</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue
      contextRef="if8367586242540b9911f25a7b7315179_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzctNy0xLTEtMTg0NDY5_837a8c02-ce1e-4715-8d52-32b06c81c8d0"
      unitRef="usd">715000000</us-gaap:ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i07d379f94c904bd4b8baa4f957b160c2_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzgtMS0xLTEtMTg0NDY5_c67eb87b-93ef-45a9-8d61-21baf46b644f"
      unitRef="usd">11778000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i8c0955d3143c4319b611181108536948_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzgtMy0xLTEtMTg0NDY5_05173f22-541b-4d82-bceb-edd174260846"
      unitRef="usd">-3000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i6a3babb09031476eab172eb19f78a4fb_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzgtNS0xLTEtMTg0NDY5_192aac7f-4a6e-471d-a725-d7097458ecee"
      unitRef="usd">11356000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="if8367586242540b9911f25a7b7315179_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90YWJsZTo4NmQwOWI4NDc2OGI0ZDdiYjA4ZTFhNzlkNWM0NDAwMi90YWJsZXJhbmdlOjg2ZDA5Yjg0NzY4YjRkN2JiMDhlMWE3OWQ1YzQ0MDAyXzgtNy0xLTEtMTg0NDY5_6fa33686-a3c4-42a4-822c-2e1690ca8791"
      unitRef="usd">-3000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzE3MDY_fc69816f-5a7d-4d3f-ba1d-1459c5b8ec0b"
      unitRef="number">0.100</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:EquityMethodInvestmentNumberofSharesOwnedRestricted
      contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzE3NTA_efb2ce62-f3d4-41b0-b30e-e2471f2b6df2"
      unitRef="shares">185000000</mo:EquityMethodInvestmentNumberofSharesOwnedRestricted>
    <mo:EquityMethodInvestmentNumberofSharesOwnedCommon
      contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzE4MDg_285473c9-afd2-4c3a-ac2c-5770f7ad37d6"
      unitRef="shares">12000000</mo:EquityMethodInvestmentNumberofSharesOwnedCommon>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i0fcfe850ccf04326ba6a9f711efb4237_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzA0MTU_e3f8b302-56f4-4069-8808-7e8e4e1d0d29"
      unitRef="usd">11900000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestments
      contextRef="i0fcfe850ccf04326ba6a9f711efb4237_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzA0MjA_17918a30-0bad-448b-be6d-c0937db40e05"
      unitRef="usd">11100000000</us-gaap:EquityMethodInvestments>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue
      contextRef="i0fcfe850ccf04326ba6a9f711efb4237_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzA0MjQ_b2941b12-c60c-4a91-b818-bd0e4143b45c"
      unitRef="usd">800000000</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage
      contextRef="i0fcfe850ccf04326ba6a9f711efb4237_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzA0MzA_a62bb950-73c6-4e15-b8bb-49a2572b8a62"
      unitRef="number">-0.07</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue
      contextRef="i86595736693849e2a2960a25c9d7f520_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzA0MzQ_d418836a-18a3-47c0-9a99-46af63b3be3b"
      unitRef="usd">-1100000000</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage
      contextRef="i86595736693849e2a2960a25c9d7f520_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzA0NDE_1c22766e-3118-4ce5-b75f-9b9459267816"
      unitRef="number">0.09</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i4a59e8c2438f4b0990202ed160b66f3a_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODQ2NTY_c4318663-4ccd-433d-a7b2-2b3710b70565"
      unitRef="usd">9000000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue
      contextRef="i4a59e8c2438f4b0990202ed160b66f3a_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODQ2Nzk_8886b179-6901-4b9f-b3df-414689c70306"
      unitRef="usd">-2500000000</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage
      contextRef="i2482b7e244ca46d9be57870d2ee0a5b1_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODQ2NzM_5ded68e1-22b4-4022-92ec-4d0a01a39159"
      unitRef="number">0.22</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage>
    <mo:EquityMethodInvestmentImpairment
      contextRef="i3b2060e5902e49abb3e4469084d451c6_D20220701-20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNjc4ODM_864c8618-0467-4abb-a29f-bf6ac46e6354"
      unitRef="usd">2500000000</mo:EquityMethodInvestmentImpairment>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i4a59e8c2438f4b0990202ed160b66f3a_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNjkxNDc_952455de-18e3-40aa-8964-8dde07a324fa"
      unitRef="usd">9000000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="if2f72a0231164ba39b3ffd8a34007855_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzYzMzA_400c269a-34bb-48ab-ae22-abd0d9f1955d"
      unitRef="usd">11900000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestments
      contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzYzNTU_b9e5a336-538a-445f-b8cc-f972c25a4c78"
      unitRef="usd">9000000000</us-gaap:EquityMethodInvestments>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage
      contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzY0MTQ_748b3ccc-26a3-4a82-b5e8-9a9bb709c6ee"
      unitRef="number">-0.33</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="ia645931f457b42ad968380318043c7bb_I20220930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODQ3MjA_562503b0-d94e-4e70-bb5c-bf7ec25d5193"
      unitRef="usd">11200000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue
      contextRef="i582f9f2ac6ca4ecda20c95fac7a2d662_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODQ2OTU_977e5d06-df9b-4130-b1cf-361cc7421905"
      unitRef="usd">-6200000000</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage
      contextRef="i113383343fc24b078e1605af29834efb_I20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODQ3MTI_f6a74cd2-dad9-4d49-aef0-04553a17c26f"
      unitRef="number">0.35</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage>
    <mo:EquityMethodInvestmentImpairment
      contextRef="i7514f17104fb4e4086fa0002209e91be_D20210701-20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyNzIyMDg_dbe5cc09-200c-4e40-8bc9-fcd0b4cb78eb"
      unitRef="usd">6200000000</mo:EquityMethodInvestmentImpairment>
    <us-gaap:EquityMethodInvestments
      contextRef="i113383343fc24b078e1605af29834efb_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODEyMDY_7b8b0385-c820-4e78-9ef9-aa907d5008f8"
      unitRef="usd">11200000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i582f9f2ac6ca4ecda20c95fac7a2d662_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIxOTkwMjMyODEyMDY_e8f5edc9-b0e9-4fb0-844b-ab00e466558d"
      unitRef="usd">11200000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
      contextRef="i91ce2420785e4e54b8494cbe3fb97890_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjEvZnJhZzpkYmQ2NzYwYmQ1NmY0YmZlYjQ2YTZiZDk3YzQ2ZDVkZS90ZXh0cmVnaW9uOmRiZDY3NjBiZDU2ZjRiZmViNDZhNmJkOTdjNDZkNWRlXzIzMDg5NzQ0MjA2NzMy_f186aa8b-1ca0-4f11-b68c-14accf801769"
      unitRef="usd">2500000000</us-gaap:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity>
    <mo:PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue
      contextRef="i2d58937ea5f04743a283f00ebb398d3f_D20181201-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzgw_2f3f3c52-449c-48a7-8f97-9d52046f09e2"
      unitRef="usd">12800000000</mo:PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i42640979a7ab4a48966a0d609f073992_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzk4_102b1d1f-bb36-48d7-a423-8889d3ca75d1"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:InvestmentOwnedBalancePercentage
      contextRef="i688c2fcd3b0343b29196c870d74f6b68_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzQ0MA_d51dff3d-22b5-4817-bd82-e7e02930f72c"
      unitRef="number">0.35</mo:InvestmentOwnedBalancePercentage>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="i688c2fcd3b0343b29196c870d74f6b68_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzQ4NQ_d05b79fb-9062-4dea-b3ca-8c21f13d8902"
      unitRef="shares">42000000</us-gaap:InvestmentOwnedBalanceShares>
    <mo:InvestmentOwnedBalancePercentage
      contextRef="i42640979a7ab4a48966a0d609f073992_I20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzIxOTkwMjMyNzI3Nzg_1dff3da3-d0a3-4b7c-90df-aadd8506851c"
      unitRef="number">0.35</mo:InvestmentOwnedBalancePercentage>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue
      contextRef="ie58a0d47e81141b49b488d17516ef57a_I20200131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzE5NTQ_d7c020d5-b2cb-4d6c-9b14-3e78e022aaba"
      unitRef="number">0.10</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount
      contextRef="i2d58937ea5f04743a283f00ebb398d3f_D20181201-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzE5OTA_fdb441a7-0aad-4604-b771-89478d7de415"
      unitRef="usd">12800000000</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i34f2a76702e24388ae8484f16168bdc3_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzIxOTkwMjMyNzM2MDM_58f2d655-0364-43ff-a6c9-d39328c9f368"
      unitRef="usd">450000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue
      contextRef="ie58a0d47e81141b49b488d17516ef57a_I20200131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzIxOTkwMjMyNzM2Mjg_1891fc36-47e3-4878-bfaa-d269960c7349"
      unitRef="number">0.10</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount
      contextRef="i2d58937ea5f04743a283f00ebb398d3f_D20181201-20181231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzIxOTkwMjMyNzM2NjU_337e84b2-bb24-4b99-906f-7f0409fd3fc2"
      unitRef="usd">12800000000</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue
      contextRef="ie58a0d47e81141b49b488d17516ef57a_I20200131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzIxOTkwMjMyNzQwMzE_fd4c423b-e782-40d4-869d-bbcd7bcfa459"
      unitRef="number">0.10</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzEyMzU1_a653f569-a2bb-478d-87ec-bf1e2b307f06">&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the beginning and ending balance of our investment in JUUL, which is classified in Level 3 of the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.774%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.343%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Investment Balance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) included in (income) losses from investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized gains (losses) included in (income) losses from investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,455)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;250&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i9e8852c143984842b74a594acdc7f562_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90YWJsZTo3MWU4ZGU2MzI5ZDY0ZDgxOWZhYzVmM2NiNjUyZDBlMC90YWJsZXJhbmdlOjcxZThkZTYzMjlkNjRkODE5ZmFjNWYzY2I2NTJkMGUwXzEtMi0xLTEtMTg0NDY5_459c459e-168b-41d9-a074-28a57f2c3f98"
      unitRef="usd">1705000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i90c02ede0bac4600ad8f45d0bae1be88_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90YWJsZTo3MWU4ZGU2MzI5ZDY0ZDgxOWZhYzVmM2NiNjUyZDBlMC90YWJsZXJhbmdlOjcxZThkZTYzMjlkNjRkODE5ZmFjNWYzY2I2NTJkMGUwXzMtMi0xLTEtMTg0NDY5_eaa74838-338f-46b6-96c4-6dd12a5615f8"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i9822021e58024e35a62e7648157e3677_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90YWJsZTo3MWU4ZGU2MzI5ZDY0ZDgxOWZhYzVmM2NiNjUyZDBlMC90YWJsZXJhbmdlOjcxZThkZTYzMjlkNjRkODE5ZmFjNWYzY2I2NTJkMGUwXzQtMi0xLTEtMTg0NDY5_ef575bd1-b7c8-4394-9c77-84adcf8f554e"
      unitRef="usd">1705000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="i352490c117bb4f8998f690f115171443_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90YWJsZTo3MWU4ZGU2MzI5ZDY0ZDgxOWZhYzVmM2NiNjUyZDBlMC90YWJsZXJhbmdlOjcxZThkZTYzMjlkNjRkODE5ZmFjNWYzY2I2NTJkMGUwXzUtMi0xLTEtMTg0NDY5_c2d1b4b2-1333-4524-80fa-a3604dd9cd26"
      unitRef="usd">-1455000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i01271f593e214e02974445c5cdca8e52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90YWJsZTo3MWU4ZGU2MzI5ZDY0ZDgxOWZhYzVmM2NiNjUyZDBlMC90YWJsZXJhbmdlOjcxZThkZTYzMjlkNjRkODE5ZmFjNWYzY2I2NTJkMGUwXzYtMi0xLTEtMTg0NDY5_2d38f87f-74bc-4e6d-b041-c4748e5b8690"
      unitRef="usd">250000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzU2Mjg_358f5764-2ee8-4107-9267-d162fee53229"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzU2Mjg_f47eb9d0-9d2c-4197-8c10-a1b9cae883ba"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="icc2bb0b67a1f4be892d628382285683c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzIxOTkwMjMyODQxNTU_70c34bca-bf55-45a1-98d8-ae1e6ec3887e"
      unitRef="usd">-1455000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <mo:EquityInvestmentFairValueOption
      contextRef="i56c5cabbdfb44d05a0e818aa3c22c4d1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzY0NjQ_f60208ca-6a89-4b19-89cd-8696b8f4cdde"
      unitRef="usd">0</mo:EquityInvestmentFairValueOption>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzQ5NDc4MDIzNTQxMjk_08d58a75-acb3-4803-9be1-0d4ee98468bf"
      unitRef="usd">100000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjQvZnJhZzpkYmNlOThjYzRlZWQ0ZTk4YWRjNzZiMzUzMDI4YWFmYi90ZXh0cmVnaW9uOmRiY2U5OGNjNGVlZDRlOThhZGM3NmIzNTMwMjhhYWZiXzgxMjY_1fe89135-bb5a-4564-aefb-f3219e62880d"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i84433bab48264529a2516c2663b4fc52_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzQ2_4cbb4c6b-89aa-4e0e-8059-3b6c5d918c41"
      unitRef="number">0.411</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <mo:EquityMethodInvestmentNumberofSharesOwnedCommon
      contextRef="i84433bab48264529a2516c2663b4fc52_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzkz_2fbaef97-0b00-4b7b-81f7-872322c6c5f8"
      unitRef="shares">156600000</mo:EquityMethodInvestmentNumberofSharesOwnedCommon>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxNQ_ca90d13d-5b34-4b83-82f1-6ef109800f31"
      unitRef="number">0.418</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNzQ1NTY_469e1b15-f1ad-4bb1-9735-47865856afb1"
      unitRef="usd">617000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNzQ1NTY_9072d2c6-f34e-4863-a0ed-6634f82e86ce"
      unitRef="usd">617000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage
      contextRef="ibe747a76cea044caadbd3c216fee37f5_I20220630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyODE1Njk_b994feda-90bd-4d68-bb38-fac165ce5399"
      unitRef="number">0.20</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage>
    <mo:EquityMethodInvestmentImpairment
      contextRef="i352e13ef17314af78049d425169b5c00_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjY4MjA_61a6b955-537f-4427-be23-3156660b44f1"
      unitRef="usd">107000000</mo:EquityMethodInvestmentImpairment>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="ibe747a76cea044caadbd3c216fee37f5_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjc2MTI_02bd5507-930d-4b01-9944-ee708d0227d2"
      unitRef="usd">437000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:EquityMethodInvestments
      contextRef="ibe747a76cea044caadbd3c216fee37f5_I20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjc2MTI_98f38cba-0610-4779-a793-4eeb9f43ce8f"
      unitRef="usd">437000000</us-gaap:EquityMethodInvestments>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue
      contextRef="i84433bab48264529a2516c2663b4fc52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzc2OTY1ODE0MTg5NzQ_a29200f2-5779-4106-a9ac-3029918a6954"
      unitRef="usd">22000000</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage
      contextRef="i84433bab48264529a2516c2663b4fc52_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjc3NTA_3595c855-3b5e-4e59-9cf5-5f91552e1c09"
      unitRef="number">-0.06</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage>
    <mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage
      contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyODE1NjI_2b190f58-d57e-4b23-820e-2f4a47f17303"
      unitRef="number">0.25</mo:EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage>
    <mo:EquityMethodInvestmentImpairment
      contextRef="i13178e7cbc7c479c89b40c940101986c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNzA5ODk_19b95daa-88d6-4005-9fc3-003f445d345d"
      unitRef="usd">205000000</mo:EquityMethodInvestmentImpairment>
    <us-gaap:EquityMethodInvestments
      contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNzE3MjM_6ffc957a-f623-4495-9b70-f88bb9b5807d"
      unitRef="usd">617000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNzE3MjM_fd769277-f67c-45f4-8235-bf9437d4ef7b"
      unitRef="usd">617000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <mo:EquityMethodInvestmentPricePerShareIfExercised
      contextRef="i690729cf5b294067aff036eadfaa0ae7_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjEwNzg_c5d33a43-057f-4678-8c3a-68612c533f60"
      unitRef="cadPerShare">16.25</mo:EquityMethodInvestmentPricePerShareIfExercised>
    <mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase
      contextRef="i690729cf5b294067aff036eadfaa0ae7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjEzMTA_4c52ef27-1096-4fd8-bcab-5b869efdb97f"
      unitRef="shares">7000000</mo:EquityMethodInvestmentNumberofSharesEligibleForPurchase>
    <mo:EquityMethodInvestmentPercentageofSharesEligibleForPurchase
      contextRef="i5b88030abdbe4a5bab225cf467fd6aec_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjE0MjA_526a7735-939a-440a-9eaa-4d9c5f36c732"
      unitRef="number">0.10</mo:EquityMethodInvestmentPercentageofSharesEligibleForPurchase>
    <mo:EquityMethodInvestmentPricePerShareIfExercised
      contextRef="i5b88030abdbe4a5bab225cf467fd6aec_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzIxOTkwMjMyNjE1Mjk_8aa844aa-0b5d-49f7-a688-64f237cd549b"
      unitRef="cadPerShare">19.00</mo:EquityMethodInvestmentPricePerShareIfExercised>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90ZXh0cmVnaW9uOmNmMjZiNjU3MGE1OTQxMTliMzY4MmZlNTRkZDkzYmMxXzYwNDczMTM5NjcyOTc_2eff0eb4-85de-410e-badd-74e37f2fc1a3">We recorded non-cash, pre-tax unrealized losses, representing these changes, as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.353%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fixed-price Preemptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i2b902b829a4c4480963978506c931fe9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzItMS0xLTEtMTg3MDAw_57dfe1b2-ac46-4a8a-9890-9607f29f2d19"
      unitRef="usd">-1000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i2f5bd49e3d924bbc92984ec5b9b68266_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzItMy0xLTEtMTg3MDAw_74b75d23-73be-4a9e-85ae-d074feac24f6"
      unitRef="usd">-23000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ibe6babf381df44cd9b5ccb5c5a5e58f2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzItNS0xLTEtMTg3MDAw_b73bb530-6f63-4d33-bde0-50ff44842419"
      unitRef="usd">-45000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="idd4d6be44a8e48fcac6b5ef35c67ddef_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzMtMS0xLTEtMTg3MDAw_8d08db9f-3b4b-4605-9295-031320ba728e"
      unitRef="usd">-14000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i3dbf8277f9b945c79b9491eacf1a07b9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzMtMy0xLTEtMTg3MDAw_c7fb1c13-312c-4488-be2b-f38b23b806bb"
      unitRef="usd">-125000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i787d308d5eeb4107b0661b036cbd627c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzMtNS0xLTEtMTg3MDAw_551bd814-e743-46ed-a2d8-2c466a3f0bf6"
      unitRef="usd">-95000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzQtMS0xLTEtMTk2ODQ3_20e1fdc2-2f60-446e-8545-497cbba4db45"
      unitRef="usd">-15000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzQtMy0xLTEtMTk2ODQ3_8363ace4-20b2-4af9-b0dd-6c21edf4f355"
      unitRef="usd">-148000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMjcvZnJhZzpjZjI2YjY1NzBhNTk0MTE5YjM2ODJmZTU0ZGQ5M2JjMS90YWJsZTpkNzI5Y2EwZWExNTY0ODg1YjljNWZiMTNhMjBlMjZlYS90YWJsZXJhbmdlOmQ3MjljYTBlYTE1NjQ4ODViOWM1ZmIxM2EyMGUyNmVhXzQtNS0xLTEtMTk2ODQ3_a682cec6-9e51-45c8-8e6b-4ae7844613bf"
      unitRef="usd">-140000000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90ZXh0cmVnaW9uOmE5ZWMyODRmYWUyZjQzYTQ4OTE4NjdlZjkyOGQ5NmI0XzY4NTI_2b264931-85dd-4f31-8bd3-1b5fb3187071">Financial Instruments&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into derivative financial instruments to mitigate the potential impact of certain market risks, including foreign currency exchange rate risk.  We use various types of derivative financial instruments, including forward contracts, options and swaps.  We do not enter into or hold derivative financial instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment in ABI, whose functional currency is the Euro, exposes us to foreign currency exchange risk on the carrying value of our investment.  To manage this risk, we may designate certain foreign exchange contracts, including cross-currency swap contracts and forward contracts (collectively, &#x201c;foreign currency contracts&#x201d;), and Euro denominated unsecured long-term notes (&#x201c;foreign currency denominated debt&#x201d;) as net investment hedges of our investment in ABI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, all outstanding foreign currency contracts matured and, at December 31, 2022 and 2021, we had no outstanding foreign currency contracts.  When we have foreign currency contracts in effect, counterparties are domestic and international financial institutions.  Under these contracts, we are exposed to potential losses in the event of non-performance by these counterparties.  We manage our credit risk by entering into transactions with counterparties that have investment grade credit ratings, limiting the amount of exposure we have with each counterparty and monitoring the financial condition of each counterparty.  The counterparty agreements contain provisions that require us to maintain an investment grade credit rating.  In the event our credit rating falls below investment grade, counterparties to our foreign currency contracts can require us to post collateral.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying value and fair value of our total long-term debt were as follows at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt included in long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,540&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our estimate of the fair value of our total long-term debt is based on observable market information derived from a third-party pricing source and is classified in Level 2 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The decrease in the fair value of our long-term debt was primarily driven by (i) rising interest rates in 2022, (ii) the August 2022 $1.1 billion repayment at maturity of senior unsecured notes and (iii) changes in Euro denominated debt resulting from the strengthening of the U.S. dollar versus the Euro during 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Net Investment Hedging&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pre-tax effects of our net investment hedges on accumulated other comprehensive losses and our consolidated statements of earnings were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized &lt;br/&gt;in Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognized changes in the fair value of the foreign currency contracts and in the carrying value of the foreign currency denominated debt due to changes in the Euro to U.S. dollar exchange rate in accumulated other comprehensive losses related to ABI.  We recognized gains on the foreign currency contracts arising from components excluded from effectiveness testing in interest and other debt expense, net in our consolidated statements of earnings based on an amortization approach.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:NumberOfForeignCurrencyDerivativesHeld
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90ZXh0cmVnaW9uOmE5ZWMyODRmYWUyZjQzYTQ4OTE4NjdlZjkyOGQ5NmI0Xzk5NA_c614d5c9-c74c-46cb-b4dc-0dd7ebbdec65"
      unitRef="contract">0</us-gaap:NumberOfForeignCurrencyDerivativesHeld>
    <us-gaap:NumberOfForeignCurrencyDerivativesHeld
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90ZXh0cmVnaW9uOmE5ZWMyODRmYWUyZjQzYTQ4OTE4NjdlZjkyOGQ5NmI0Xzk5NA_ce9e85d9-f107-4839-9642-ae4ae23c1bfe"
      unitRef="contract">0</us-gaap:NumberOfForeignCurrencyDerivativesHeld>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90ZXh0cmVnaW9uOmE5ZWMyODRmYWUyZjQzYTQ4OTE4NjdlZjkyOGQ5NmI0XzY4NTY_93d6bf85-bcfb-468d-abbd-b2067192c74c">&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate carrying value and fair value of our total long-term debt were as follows at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.294%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,928&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt included in long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Carrying value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,540&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,165&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzEtMS0xLTEtMTg0NDY5_3c94ca8c-1e40-4275-8a34-f18ea06e248a"
      unitRef="usd">26680000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzEtMy0xLTEtMTg0NDY5_9c674e21-d981-4c49-a458-60a46b186556"
      unitRef="usd">28044000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtFairValue
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzItMS0xLTEtMTg0NDY5_9b95a301-c6c1-48b2-84a4-c2fc1888fca7"
      unitRef="usd">22928000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebtFairValue
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzItMy0xLTEtMTg0NDY5_ef6e8ee9-2fee-4cb9-9f83-39b9efb9b461"
      unitRef="usd">30459000000</us-gaap:LongTermDebtFairValue>
    <us-gaap:LongTermDebt
      contextRef="id6d414e5e17345c0b5010b8bf3b1609d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzQtMS0xLTEtMTg2OTQ5_11d47d65-51a7-4630-93b2-2312a65585dc"
      unitRef="usd">4540000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9bb837eb6a554c7b8139c2b96eea88f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzQtMy0xLTEtMTg2OTQ1_c68221dd-16b8-4a88-b3c5-b75c9b2b7661"
      unitRef="usd">4817000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id6d414e5e17345c0b5010b8bf3b1609d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzUtMS0xLTEtMTg2OTQ5_be9df4a9-9e0d-4419-ad3d-00ccd12b5060"
      unitRef="usd">4165000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i9bb837eb6a554c7b8139c2b96eea88f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTpiZWMyMGExMzc0NWI0NjI0ODFhODFhZTU5OTFjNjFlZC90YWJsZXJhbmdlOmJlYzIwYTEzNzQ1YjQ2MjQ4MWE4MWFlNTk5MWM2MWVkXzUtMy0xLTEtMTg2OTQ1_a44980e3-380d-45f6-96ef-9edf20f92429"
      unitRef="usd">5114000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i1ba18ff14a604658afe105249ab1be5c_D20220801-20220831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90ZXh0cmVnaW9uOmE5ZWMyODRmYWUyZjQzYTQ4OTE4NjdlZjkyOGQ5NmI0XzIxOTkwMjMyNjMyODg_8c9cfd9e-6040-4d2d-a9ef-4316246b18b3"
      unitRef="usd">1100000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90ZXh0cmVnaW9uOmE5ZWMyODRmYWUyZjQzYTQ4OTE4NjdlZjkyOGQ5NmI0XzY4NTU_23bde817-75b7-46db-bb2b-047a6aa0b469">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The pre-tax effects of our net investment hedges on accumulated other comprehensive losses and our consolidated statements of earnings were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized in Accumulated Other Comprehensive Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Gain) Loss Recognized &lt;br/&gt;in Net Earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency denominated debt&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i676dca466c264c98a0a732b91fb9c4dd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzMtMi0xLTEtMTg0NDY5_7ca8308a-4ec8-42eb-952c-7dd87b24b662"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="id2b22c6277c34d6bbc04167a977d057b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzMtNC0xLTEtMTg0NDY5_20982571-3a4a-4bbb-a423-aa4ac2520719"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i38a706a086554d389015fb9e0c90e6ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzMtNi0xLTEtMTg0NDY5_d44aaff6-c5bb-4ce0-b2a8-e3e5df56812c"
      unitRef="usd">79000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i676dca466c264c98a0a732b91fb9c4dd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzMtOC0xLTEtMTg0NDY5_895bf8ee-3ccb-4ff9-9c6b-3a9ae3799634"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="id2b22c6277c34d6bbc04167a977d057b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzMtMTAtMS0xLTE4NDQ2OQ_72dadc63-5084-48fb-83f7-2c38cb8eda7f"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i38a706a086554d389015fb9e0c90e6ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzMtMTItMS0xLTE4NDQ2OQ_8acc92b8-161f-4352-bc68-568b5f1c46f0"
      unitRef="usd">-40000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i12be265a64cd483a8c06ad934345bfdb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzQtMi0xLTEtMTg0NDY5_4ca7b081-1bbe-400b-8fd2-8a75764f3c77"
      unitRef="usd">-281000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i1f1171f94e9a4f509d988ba58f40a86a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzQtNC0xLTEtMTg0NDY5_5d039e3e-8eb1-4b7d-bfcc-2359e6aae7f8"
      unitRef="usd">-359000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia3b9202eb4bc425496d496a5783142ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzQtNi0xLTEtMTg0NDY5_aac9fe30-e995-4f39-ac28-2eca50d3d56e"
      unitRef="usd">424000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i12be265a64cd483a8c06ad934345bfdb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzQtOC0xLTEtMTg0NDY5_a945536d-c3bc-4e08-a7d8-2646ef951e97"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i1f1171f94e9a4f509d988ba58f40a86a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzQtMTAtMS0xLTE4NDQ2OQ_f9413a89-0b3a-4c94-8488-6c6ff2a2219a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ia3b9202eb4bc425496d496a5783142ad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzQtMTItMS0xLTE4NDQ2OQ_2b8a58be-4358-43d5-81ba-e44dc5e09d98"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="if7f230b64a534de9935f50dfa188e24b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzUtMi0xLTEtMTg0NDY5_29e26f04-a6d3-4c01-844f-0b34cb3d53b8"
      unitRef="usd">-281000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i2704b95dd3964621a2f17ac3697ec1bd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzUtNC0xLTEtMTg0NDY5_a14512f0-a4b2-4650-8621-18f4474550e6"
      unitRef="usd">-375000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax
      contextRef="i38cd1d2ff91f4c8a8a7413ed1a97f758_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzUtNi0xLTEtMTg0NDY5_e0f259b6-72a3-4cc1-9aa6-bfaa6458ad1a"
      unitRef="usd">503000000</us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="if7f230b64a534de9935f50dfa188e24b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzUtOC0xLTEtMTg0NDY5_eb0ae066-e50c-4f4c-936d-25580159f1d7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i2704b95dd3964621a2f17ac3697ec1bd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzUtMTAtMS0xLTE4NDQ2OQ_227a8540-150e-4583-a988-b472aa5c8459"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i38cd1d2ff91f4c8a8a7413ed1a97f758_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzYvZnJhZzphOWVjMjg0ZmFlMmY0M2E0ODkxODY3ZWY5MjhkOTZiNC90YWJsZTo5NmU1NTZhZDdmNWE0NWM5YjNlMDk4ZTQ1MzAwYzg1Zi90YWJsZXJhbmdlOjk2ZTU1NmFkN2Y1YTQ1YzliM2UwOThlNDUzMDBjODVmXzUtMTItMS0xLTE4NDQ2OQ_15aa74e9-fda0-4e07-b27c-dc9bae814fd5"
      unitRef="usd">-40000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:ShortTermDebtTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzM5MDQ_51c2f548-bc1e-44f8-af7e-1f49d499fff8">Short-Term Borrowings and Borrowing Arrangements&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 and 2021, we had no short-term borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, we entered into an extension and amendment (the &#x201c;Extension and Amendment&#x201d;) to our $3.0 billion senior unsecured 5-year revolving credit agreement (as amended, the &#x201c;Credit Agreement&#x201d;).  The Extension and Amendment (i) extended the maturity date of the Credit Agreement from August 1, 2024 to August 1, 2025 and (ii) amended the Credit Agreement to update the benchmark interest rate to a rate based on the Term Secured Overnight Financing Rate (&#x201c;Term SOFR&#x201d;) and make certain other market updates.  All &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;other terms and conditions of the Credit Agreement remain in full force and effect.  The Credit Agreement is used for general corporate purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2022 and 2021, we had availability under the Credit Agreement for borrowings of up to an aggregate principal amount of $3.0 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pricing for interest and fees under the Credit Agreement may be modified in the event of a change in the rating of our long-term senior unsecured debt.  We expect interest rates on borrowings under the Credit Agreement to be based on the Term SOFR plus a percentage based on the higher of the ratings of our long-term senior unsecured debt from Moody&#x2019;s Investors Service, Inc. (&#x201c;Moody&#x2019;s&#x201d;) and Standard&#160;&amp;amp; Poor&#x2019;s Financial Services LLC (&#x201c;S&amp;amp;P&#x201d;).  The applicable percentage for borrowings under the Credit Agreement at December&#160;31, 2022 was 1.0% based on our long-term senior unsecured debt ratings on that date.  The Credit Agreement does not include any other rating triggers or any provisions that could require the posting of collateral.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement includes various covenants, one of which requires us to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (&#x201c;EBITDA&#x201d;) to Consolidated Interest Expense of not less than 4.0 to 1.0, calculated as of the end of the applicable quarter on a rolling four quarters basis.  At December&#160;31, 2022, the ratio of consolidated EBITDA to Consolidated Interest Expense, calculated in accordance with the Credit Agreement, was 11.0 to 1.0.  At December&#160;31, 2022, we were in compliance with our covenants in the Credit Agreement.  The terms &#x201c;Consolidated EBITDA&#x201d; and &#x201c;Consolidated Interest Expense,&#x201d; each as defined in the Credit Agreement, include certain adjustments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, due to the uncertainty at that time in the global capital markets, including the commercial paper markets, resulting from the COVID-19 pandemic, we elected to borrow the full $3.0 billion available under the Credit Agreement as a precautionary measure to increase our cash position and preserve financial flexibility.  In June 2020, we repaid the full amount outstanding under the Credit Agreement using the net proceeds from the issuance of long-term senior unsecured notes issued in May 2020 and available cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any commercial paper issued by us and borrowings under the Credit Agreement are guaranteed by PM&#160;USA as further discussed in Note 8. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0Xzg0_02cda2ff-7bc4-43ac-8b0e-711faee1e0a9"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0Xzg0_76786856-fac6-47d3-853c-ddd424e03407"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib2383b8a428a43a694fd25b50b5e56d9_I20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzIxOTkwMjMyNjA3NDY_1f299f91-dd53-4238-a6ff-e3ded0319dc9"
      unitRef="usd">3000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentTerm
      contextRef="ic1ea858197df46758cab5e38cc77fc6b_D20220801-20220831"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzM5MDI_d3ac962b-280a-4f3e-998b-f341fd453eb8">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5eaa17b2950f4f739cc9503d66958b9f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzEwNjE_035da8ad-3d7d-4b2e-a02a-cfa66b800230"
      unitRef="usd">3000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9dc86c124c5b4201b063cd0d7581dfb9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzEwNjE_843be32b-d0ba-41ba-b3e6-901ba5d16d0e"
      unitRef="usd">3000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i019d8f929d47481aa9b043d3f5399d3e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzE3MzA_4ae4bebe-8771-4f71-a77b-3c01f87caf15"
      unitRef="number">0.010</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <mo:DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzIxMDE_f84afcd0-47e5-4abe-a3ff-e896157c5906"
      unitRef="number">4.0</mo:DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum>
    <mo:DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio
      contextRef="if40c2ab1cec0419d8e9f4ba69b3cd0b7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzIxOTkwMjMyNjA1NzM_8c7885d8-3ab0-47ed-9ac5-04e802e1747d"
      unitRef="number">11.0</mo:DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i88059e2462ce4581be210352406c6935_D20200301-20200331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xMzkvZnJhZzo5MWRjNWQzNTlmMWY0MmEwYjk3ZTM5ZTlmNTg0Y2M5NC90ZXh0cmVnaW9uOjkxZGM1ZDM1OWYxZjQyYTBiOTdlMzllOWY1ODRjYzk0XzI3NTA_a04990c0-aee1-490b-848e-891dc2b3b3fc"
      unitRef="usd">3000000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:LongTermDebtTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzQ3Njk_b83168c9-7099-478f-ae38-58bc8f7f72b2">Long-Term Debt&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our long-term debt consisted of the following at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes, 2.350% to 10.20%, interest payable semi-annually, due through 2061&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,098&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD debenture, 7.75%, interest payable semi-annually, due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro notes, 1.000% to 3.125%, interest payable annually, due through 2031 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,540&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average coupon interest rate of and 4.4% at December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Weighted-average coupon interest rate of 2.0% at December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, our outstanding long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Face Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x20ac;1,250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$218&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.950%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$776&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$345&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.800%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$750&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.350%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x20ac;750&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.700%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,069&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.400%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD debenture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.750%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1997&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x20ac;1,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.200%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,906&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.800%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$750&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.400%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x20ac;1,250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.125%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,750&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.450%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$177&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.950%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2008&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2038&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$208&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10.200%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2039&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.800%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2039&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.400%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2041&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$900&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.250%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2012&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2042&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$650&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.500%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2043&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2044&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.875%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2046&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$2,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.950%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2049&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.450%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.700%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2051&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$271&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.200%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2059&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2061&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, aggregate maturities of our long-term debt were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Maturities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,121&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,553&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,569&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,912&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;debt discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;84&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 and 2021, accrued interest on long-term debt of $411 million and $429 million, respectively, was included in other accrued liabilities on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, we repaid in full our 2.850% senior unsecured notes in the aggregate principal amount of $1.1 billion at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of our notes are senior unsecured obligations and rank equally in right of payment with all of our existing and future senior unsecured indebtedness.  Following the occurrence of both (i) a change of control of Altria and (ii) the notes ceasing to be rated investment grade by each of Moody&#x2019;s, S&amp;amp;P and Fitch Ratings Inc., we will be required to make an offer to purchase the notes at a price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest to the date of repurchase as and to the extent set forth in the terms of the notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Debt Tender Offers and Redemption: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2021, we completed debt tender offers to purchase for cash certain of our long-term senior unsecured notes in an aggregate principal amount of $4,042 million.  Details of the debt tender offers were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal Amount of Notes Purchased&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.850% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;795&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.950% Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;132&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;624&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.800% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;655&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.400% Notes due 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;430&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.800% Notes due 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,094&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.950% Notes due 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.200% Notes due 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.200% Notes due 2059&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,042&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of 2021, we also redeemed all of our outstanding 3.490% senior unsecured notes due to mature in 2022 in the aggregate principal amount of $1.0 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of the debt tender offers and redemption, during the first quarter of 2021, we recorded pre-tax losses on early extinguishment of debt of $649 million, which included premiums and fees of $623 million and the write-off of unamortized debt discounts and debt issuance costs of $26 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PM USA (the &#x201c;Guarantor&#x201d;), which is a 100% owned subsidiary of Altria Group, Inc. (the &#x201c;Parent&#x201d;), has guaranteed the Parent&#x2019;s obligations under its outstanding debt securities, borrowings under its Credit Agreement and amounts outstanding under its&#160;commercial paper program (the &#x201c;Guarantees&#x201d;).  Pursuant to&#160;the Guarantees, the Guarantor fully and unconditionally guarantees, as primary obligor, the payment and performance of the Parent&#x2019;s obligations under the guaranteed debt instruments (the &#x201c;Obligations&#x201d;), subject to release under certain customary circumstances as noted below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Guarantees provide that the Guarantor guarantees the punctual payment when due, whether at stated maturity, by acceleration or otherwise, of the Obligations.  The liability of the Guarantor under the Guarantees is absolute and unconditional irrespective of: any lack of validity, enforceability or genuineness of any provision of any agreement or instrument relating thereto; any change in the time, manner or place of payment of, or in any other term of, all or any of the Obligations, or any other amendment or waiver of or any consent to departure from any agreement or instrument relating thereto; any exchange, release or non-perfection of any collateral, or any release or amendment or waiver of or consent to departure from any other guarantee, for all or any of the Obligations; or any other circumstance that might otherwise constitute a defense available to, or a discharge of, the Parent or the Guarantor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Parent is a holding company; therefore, its access to the operating cash flows of its wholly owned subsidiaries consists of cash received from the payment of dividends and distributions, and the payment of interest on intercompany loans by its subsidiaries.  Neither the Guarantor nor other 100% owned subsidiaries of the Parent that are not guarantors of the Obligations are limited by contractual obligations on their ability to pay cash dividends or make other distributions with respect to their equity interests.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a discussion of the fair value of our long-term debt and the designation of our Euro denominated senior unsecured notes as a net investment hedge of our investment in ABI, see Note 6. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzQ3OTc_ed5a22b4-6491-440b-b7af-58f2623b9f2e">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our long-term debt consisted of the following at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes, 2.350% to 10.20%, interest payable semi-annually, due through 2061&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,098&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD debenture, 7.75%, interest payable semi-annually, due 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;42&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro notes, 1.000% to 3.125%, interest payable annually, due through 2031 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,540&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion of long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average coupon interest rate of and 4.4% at December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Weighted-average coupon interest rate of 2.0% at December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, our outstanding long-term debt consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.071%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Face Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Issuance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x20ac;1,250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$218&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.950%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$776&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$345&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.800%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$750&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.350%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x20ac;750&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1.700%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,069&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.400%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD debenture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.750%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 1997&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x20ac;1,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.200%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,906&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.800%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2029&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$750&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.400%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2030&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Euro notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x20ac;1,250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.125%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,750&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.450%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$177&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9.950%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2008&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2038&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$208&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10.200%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2009&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2039&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$2,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.800%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2039&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.400%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2041&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$900&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.250%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2012&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 2042&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$650&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.500%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2043&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,800&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 2013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2044&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.875%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 2046&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$2,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.950%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2049&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.450%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;May 2050&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,250&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.700%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2051&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$271&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.200%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2059&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;USD notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$1,000&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2061&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Details of the debt tender offers were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Principal Amount of Notes Purchased&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.850% Notes due 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;795&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.950% Notes due 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;132&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.000% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;624&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.800% Notes due 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;655&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.400% Notes due 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;430&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.800% Notes due 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,094&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.950% Notes due 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.200% Notes due 2039&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.200% Notes due 2059&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,042&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3f78f34f75a64fe4bf18d076708d3591_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzEtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246ZjA0ZTdmMzhlY2JmNGU5MmJjMzlkYTZjMjRiNzYyZWVfMTU_ba791af9-252f-4c48-a4ab-ccbf1034cf26"
      unitRef="number">0.02350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8f210e7652a144c19a8bf09f7c07c740_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzEtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246ZjA0ZTdmMzhlY2JmNGU5MmJjMzlkYTZjMjRiNzYyZWVfMjE_e609c6ec-68db-4123-b99d-4e7dad170fd0"
      unitRef="number">0.1020</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ief3c0b98ac9c41609501bd13ff3613c2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzEtMS0xLTEtMTg0NDY5_cd020366-d831-435e-9051-b857948d795e"
      unitRef="usd">22098000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i0f121d00e6394fc8a7c9088b8f4fb8f4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzEtMy0xLTEtMTg0NDY5_803e1617-ce1d-419b-9185-4920382d52c3"
      unitRef="usd">23185000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i92fe93dcf2a34fecaed4dc95f41d6851_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzItMC0xLTEtMTg0NDY5L3RleHRyZWdpb246OGQyNGI5Y2ZkZTVjNGE1MWEwMWY1M2IyMzNhYzk3ZmRfMTk_5babc572-b643-4ab8-b235-999d13d20c31"
      unitRef="number">0.0775</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="i92fe93dcf2a34fecaed4dc95f41d6851_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzItMS0xLTEtMTg0NDY5_5df6df3d-46ad-4a3e-a112-04ddc5315433"
      unitRef="usd">42000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i15baa618b8ac444882da13a33e5e3fd9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzItMy0xLTEtMTg0NDY5_84506453-b2cf-4ed6-bec0-dff02840c1b1"
      unitRef="usd">42000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib7c66631bfad48cf9a20d10eb7a5d95c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzMtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246YTFjNTc4YzlmNzI3NGU2NDkzN2Q5MGIxOGVjMmFmNWNfMTY_b7af324a-4528-4968-a145-587ff2892817"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i48082c430c9b492c905de5a9ccd49dd8_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzMtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246YTFjNTc4YzlmNzI3NGU2NDkzN2Q5MGIxOGVjMmFmNWNfMjI_a730c425-af79-4ed6-88ea-8d5eab52d570"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt
      contextRef="ib945efb6e5fe46fbae9e80efa6cbc9ac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzMtMS0xLTEtMTg0NDY5_448438b1-1e2a-4bc8-bb44-75456987a34e"
      unitRef="usd">4540000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ifd37474dc2a14a4097a4780f47dc1ee1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzMtMy0xLTEtMTg0NDY5_e0436c0d-dbfc-4261-92b6-91022ee02d8f"
      unitRef="usd">4817000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzQtMS0xLTEtMTg0NDY5_7115603e-5e69-48de-9630-c86b4c7aabe8"
      unitRef="usd">26680000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzQtMy0xLTEtMTg0NDY5_9c674e21-d981-4c49-a458-60a46b186556"
      unitRef="usd">28044000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzUtMS0xLTEtMTg0NDY5_153fd4b1-42bc-41ba-9580-a877dd95f802"
      unitRef="usd">1556000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzUtMy0xLTEtMTg0NDY5_e8c8e987-a78f-4a50-8217-dd2c2522578a"
      unitRef="usd">1105000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzYtMS0xLTEtMTg0NDY5_6a50f67b-103c-4a9d-80ef-f6bdb45ebaec"
      unitRef="usd">25124000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTplY2Y1NmIwMDM4ZDY0NWIzYTc0MjE1MGIxZmRiMTQzZi90YWJsZXJhbmdlOmVjZjU2YjAwMzhkNjQ1YjNhNzQyMTUwYjFmZGIxNDNmXzYtMy0xLTEtMTg0NDY5_cc7aeb13-bafc-4f71-aabb-fc0f8abc0c33"
      unitRef="usd">26939000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i439835ab3a43455e96b747acea6d4d8f_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzE0Nw_d97cd270-1f9f-42d1-9baa-099f1c80f97e"
      unitRef="number">0.044</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="id631a5ccf3fb429cb812360331668599_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzE0Nw_de45eca3-9518-4aea-96c4-53b6b24b3115"
      unitRef="number">0.044</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i3828073d79a24491bcaeaf36fce13056_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIyMw_5c8eba98-534b-4988-a937-d148590f370b"
      unitRef="number">0.020</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="if400f8d238e54035a7cab079f344caeb_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIyMw_f4d6381b-a760-4630-8245-92c3ab191025"
      unitRef="number">0.020</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iaaba818d157743e8b83bcea0509a84fd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzMtMS0xLTEtMTg0NDY5_f31d7154-bcca-4e26-82be-2cbf5cb4c0f3"
      unitRef="eur">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iaaba818d157743e8b83bcea0509a84fd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzMtMi0xLTEtMTg0NDY5_10027acc-ac82-4424-8f30-bcdecb670168"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iadefd780e0034b64926bdc30f75a610f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzQtMS0xLTEtMTg0NDY5_f4624b55-70a7-472c-9577-2391dbc706ee"
      unitRef="usd">218000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iadefd780e0034b64926bdc30f75a610f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzQtMi0xLTEtMTg0NDY5_64a426ac-e55c-4608-80a4-2cb186a6a7f1"
      unitRef="number">0.02950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if9d9007ab56a458484aad403ac237294_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzUtMS0xLTEtMTg0NDY5_e59bed35-9429-4c8e-9df4-390109b86566"
      unitRef="usd">776000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if9d9007ab56a458484aad403ac237294_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzUtMi0xLTEtMTg0NDY5_7fa4ccc9-1560-447b-9d96-40d89e098820"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i63dfd595051b469195be60b2f91efc8d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzYtMS0xLTEtMTg0NDY5_0077a73b-0c10-4bed-b38a-e0bcffb242e1"
      unitRef="usd">345000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i63dfd595051b469195be60b2f91efc8d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzYtMi0xLTEtMTg0NDY5_62dfc39f-8ee1-421f-b4a6-71408028f457"
      unitRef="number">0.03800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5f830258f25a4d1d84e87ead5fd45a4a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzctMS0xLTEtMTg0NDY5_dcf0f2a7-13be-4eac-abf3-6ed656b71116"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5f830258f25a4d1d84e87ead5fd45a4a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzctMi0xLTEtMTg0NDY5_4a0acb44-ad3c-4ed4-8aa9-4eef95168864"
      unitRef="number">0.02350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ice1bb82d9a41443c8498022e8e7d7779_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzgtMS0xLTEtMTg0NDY5_fb2c7f2c-0b71-4d52-825f-b2fa690a6cf8"
      unitRef="eur">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ice1bb82d9a41443c8498022e8e7d7779_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzgtMi0xLTEtMTg0NDY5_32e1d7a1-64cd-4299-bc34-f8363ea4d55f"
      unitRef="number">0.01700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0008e44fe6024463a3a1a558fdcee38e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzktMS0xLTEtMTg0NDY5_808d23d8-0fd1-4546-8459-664fe29169c3"
      unitRef="usd">1069000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0008e44fe6024463a3a1a558fdcee38e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzktMi0xLTEtMTg0NDY5_ee91ab79-a003-4f0c-85fa-d2b42abf233e"
      unitRef="number">0.04400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iec4782d4b8074f9bacc9db3c3c30d3da_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzEwLTEtMS0xLTE4NDQ2OQ_fe8266bd-192a-43c4-8d8f-006b45876635"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iec4782d4b8074f9bacc9db3c3c30d3da_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzEwLTItMS0xLTE4NDQ2OQ_35038f1d-35e1-49ce-a49d-ac00f8ccfff3"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i92fe93dcf2a34fecaed4dc95f41d6851_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzExLTEtMS0xLTE4NDQ2OQ_de88b723-b0b4-417d-99e8-6a2468baf6ad"
      unitRef="usd">42000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i92fe93dcf2a34fecaed4dc95f41d6851_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzExLTItMS0xLTE4NDQ2OQ_2cf2074a-b484-4896-a901-73a5e828a792"
      unitRef="number">0.07750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib92f4cb6a30e4e6f9f00525310225c89_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzEyLTEtMS0xLTE4NDQ2OQ_45552d9e-d293-4c0c-8220-eadd8ea708e6"
      unitRef="eur">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib92f4cb6a30e4e6f9f00525310225c89_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzEyLTItMS0xLTE4NDQ2OQ_a0f79333-7648-4d77-a1a6-17bb734cd9c1"
      unitRef="number">0.02200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icd978ed23459400eb32a2c82f06f2a4c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzEzLTEtMS0xLTE4NDQ2OQ_e96ccc57-04e4-4f89-aefb-880ab99998a1"
      unitRef="usd">1906000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icd978ed23459400eb32a2c82f06f2a4c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzEzLTItMS0xLTE4NDQ2OQ_0d28b95b-6340-4417-a6ce-6458052cebeb"
      unitRef="number">0.04800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5d59ad2d97184e4ca31c709f4e3635fd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE0LTEtMS0xLTE4NDQ2OQ_3fc2cc95-1a65-459d-829e-5a313937e453"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5d59ad2d97184e4ca31c709f4e3635fd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE0LTItMS0xLTE4NDQ2OQ_bc21c2e5-667c-4cf1-bcb6-5cb419423ce0"
      unitRef="number">0.03400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic57f5a35ebfa4c3fbcaa79d030ef21a0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE1LTEtMS0xLTE4NDQ2OQ_bb2305ef-4e39-4925-83f8-23bcbd455f29"
      unitRef="eur">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic57f5a35ebfa4c3fbcaa79d030ef21a0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE1LTItMS0xLTE4NDQ2OQ_d88be5d2-f388-4199-916b-5a2be2416dd6"
      unitRef="number">0.03125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icaac5abc8e624b32a8ec9a613c59bc47_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE2LTEtMS0xLTE4NDQ2OQ_76ea510b-7279-43c8-8753-2f7f0103f674"
      unitRef="usd">1750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="icaac5abc8e624b32a8ec9a613c59bc47_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE2LTItMS0xLTE4NDQ2OQ_6ebabc9a-a933-4554-9f82-a58f8445569b"
      unitRef="number">0.02450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="idc5ec60ad53c4b4783f7d38256ebf88f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE3LTEtMS0xLTE4NDQ2OQ_64662928-78db-4310-9adf-835ba46d6b7b"
      unitRef="usd">177000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idc5ec60ad53c4b4783f7d38256ebf88f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE3LTItMS0xLTE4NDQ2OQ_988a2c84-77ed-452d-a9b5-da1c00becf8f"
      unitRef="number">0.09950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie8f3c72b4651489d90df2e16ffa4a05e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE4LTEtMS0xLTE4NDQ2OQ_3a90f969-6993-4609-8bee-6adcd8a2277f"
      unitRef="usd">208000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie8f3c72b4651489d90df2e16ffa4a05e_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE4LTItMS0xLTE4NDQ2OQ_d62d7fce-b097-453f-b323-e9c274aee3af"
      unitRef="number">0.10200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7f384896829c4943abc32d79f5210571_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE5LTEtMS0xLTE4NDQ2OQ_137b4544-7629-4253-b3a8-27e2dc226a58"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7f384896829c4943abc32d79f5210571_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzE5LTItMS0xLTE4NDQ2OQ_88f92198-57b7-427e-8311-e1b71b0e02ae"
      unitRef="number">0.05800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i66cedc520a05430f99dd7f092780f5c3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIwLTEtMS0xLTE4NDQ2OQ_be19d546-31f1-4cbf-ac8f-434bfa87bed5"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i66cedc520a05430f99dd7f092780f5c3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIwLTItMS0xLTE4NDQ2OQ_86d322ba-2a65-4399-8ae8-8b31b78c9f05"
      unitRef="number">0.03400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia75ae511ae35422b929bab49c142131a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIxLTEtMS0xLTE4NDQ2OQ_764e0a81-9a75-48fc-b65e-161af05deab2"
      unitRef="usd">900000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia75ae511ae35422b929bab49c142131a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIxLTItMS0xLTE4NDQ2OQ_e180e921-7295-43bd-80d0-7d558db1669e"
      unitRef="number">0.04250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i1faae93371144c7993efed37d5f5c24f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIyLTEtMS0xLTE4NDQ2OQ_1b7e5f41-e08a-4a70-93cb-a8331852aec6"
      unitRef="usd">650000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1faae93371144c7993efed37d5f5c24f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIyLTItMS0xLTE4NDQ2OQ_24105f96-c7a7-45d4-8a3f-f1c48548d4ee"
      unitRef="number">0.04500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie6cd4d1753f74e26bc079154f136894c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIzLTEtMS0xLTE4NDQ2OQ_0391aa81-ea1f-4f0b-b474-1da4c32a396f"
      unitRef="usd">1800000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie6cd4d1753f74e26bc079154f136894c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzIzLTItMS0xLTE4NDQ2OQ_d5d5c23e-772d-4287-a5fa-189ad27a37e6"
      unitRef="number">0.05375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ib1d7fc010c9442408c1346df432ae19b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI0LTEtMS0xLTE4NDQ2OQ_64883302-5722-4410-b9e7-98e51e2bd9f1"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib1d7fc010c9442408c1346df432ae19b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI0LTItMS0xLTE4NDQ2OQ_94b54936-a23d-4261-bbef-3931a7dbdd4b"
      unitRef="number">0.03875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0dc37d2451ac45539913bbac9f76a69a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI1LTEtMS0xLTE4NDQ2OQ_ec5d3637-cb63-476d-a1f4-f828fd217fd6"
      unitRef="usd">2500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0dc37d2451ac45539913bbac9f76a69a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI1LTItMS0xLTE4NDQ2OQ_b6f48090-c099-4e22-b123-568ac3bd4d3c"
      unitRef="number">0.05950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia705d60663d745daa5a1d6310b196a7b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI2LTEtMS0xLTE4NDQ2OQ_ead7ac89-f140-403e-850d-0ced23fea8cf"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia705d60663d745daa5a1d6310b196a7b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI2LTItMS0xLTE4NDQ2OQ_314305e5-3e41-4eba-a3d7-1c234852db47"
      unitRef="number">0.04450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i39346349fd3d454fbe7d80d77da544b6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI3LTEtMS0xLTE4NDQ2OQ_d070ab19-0da5-40e2-803a-a7cb26106e1b"
      unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i39346349fd3d454fbe7d80d77da544b6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI3LTItMS0xLTE4NDQ2OQ_2842eafc-4bfd-43a7-b423-fbb87060d18b"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8db11a63f05942319bf0d2eddaf952a7_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI4LTEtMS0xLTE4NDQ2OQ_06882c6a-62cf-444e-9a74-68ff93d22766"
      unitRef="usd">271000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8db11a63f05942319bf0d2eddaf952a7_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI4LTItMS0xLTE4NDQ2OQ_795121d7-9207-45cd-8690-1a2f78001d11"
      unitRef="number">0.06200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i985d9e1153d249ccbe35c8a2ed078b3a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI5LTEtMS0xLTE4NDQ2OQ_563a7e90-f425-4b91-9dbb-4fd85f2651fd"
      unitRef="usd">1000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i985d9e1153d249ccbe35c8a2ed078b3a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZTo0MzIyY2I2ODA2OWY0YTQ4YTMzZTI0YzU0ZDVhNTEwMS90YWJsZXJhbmdlOjQzMjJjYjY4MDY5ZjRhNDhhMzNlMjRjNTRkNWE1MTAxXzI5LTItMS0xLTE4NDQ2OQ_52e82cbe-5682-4d97-bab6-003f245f9c26"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzQ3NzU_351c2039-b169-4eba-a007-8ad845890fcb">&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, aggregate maturities of our long-term debt were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:4.501%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate Maturities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,556&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,121&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,553&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,569&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,113&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,000&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,912&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;148&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;debt discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;84&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;26,680&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzEtMi0xLTEtMTg0NDY5_837db3a7-2e62-4880-83fb-21a45eb7d610"
      unitRef="usd">1556000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzItMi0xLTEtMTg0NDY5_7d24ca51-bc66-4f31-941c-ee2fde4bc50c"
      unitRef="usd">1121000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzMtMi0xLTEtMTg0NDY5_b0b15e93-a0a4-4dfe-b0a2-176981a3126e"
      unitRef="usd">1553000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzQtMi0xLTEtMTg0NDY5_8432ba6c-7b3f-4c17-9f6c-e8e6e5b332b5"
      unitRef="usd">1569000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzUtMi0xLTEtMTg0NDY5_db2cad5b-fb99-45e4-9aab-0433d5c6adfa"
      unitRef="usd">1113000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <mo:LongTermDebtMaturitiesRepaymentsofPrincipalThereafter
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzYtMi0xLTEtMTg0NDY5_3ca16142-fc2b-4e18-9870-12b49bf47f9c"
      unitRef="usd">20000000000</mo:LongTermDebtMaturitiesRepaymentsofPrincipalThereafter>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzctMi0xLTEtMTg0NDY5_1df65daa-d0f9-42ea-b0eb-5a93344dfb35"
      unitRef="usd">26912000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzgtMi0xLTEtMTg0NDY5_3e62e649-d4d9-4edf-885b-621691626d94"
      unitRef="usd">148000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzktMi0xLTEtMTg0NDY5_7d4dab1e-da48-4ad0-a7f2-4da521cd72de"
      unitRef="usd">84000000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:LongTermDebt
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToyOWE5MjFjMWVjMGY0NzVkOWQxNTkyNDFjZDcxMjI1MC90YWJsZXJhbmdlOjI5YTkyMWMxZWMwZjQ3NWQ5ZDE1OTI0MWNkNzEyMjUwXzEwLTItMS0xLTE4NDQ2OQ_4638d055-9048-41e8-8ad9-30093a76a11c"
      unitRef="usd">26680000000</us-gaap:LongTermDebt>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzQzOQ_6b8e935d-bfe5-4ae8-8f71-5fe59b102f95"
      unitRef="usd">411000000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzQ0Ng_7576ed69-bf5c-4c5e-aead-7772df9287f5"
      unitRef="usd">429000000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1a2bb57dbcd94da09e99e9faca7b947f_I20220831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjIwMTk_de7b51fa-3e73-424a-9513-a3626b17aae3"
      unitRef="number">0.02850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfUnsecuredDebt
      contextRef="i93b4fdf778254947bb262abfd638909a_D20220801-20220831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjIwMzI_da3d9deb-06cc-49a1-9808-fb72b96fb548"
      unitRef="usd">1100000000</us-gaap:RepaymentsOfUnsecuredDebt>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="id4cd8efeaae34f919b123479df396a64_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjQ1MzU_1f0d6ae0-15a1-41bb-b9b8-48f813f34aa0"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i34f308ec117342cd83eb1c8c2367bffc_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjIxMTQ_09659904-d804-4949-91eb-7b7f86e92556"
      unitRef="usd">4042000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id8b660eda4894cb386f65ca5af40f210_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzEtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246MWUwMmNkOWJmZGQyNDEzMTliZWM5NGJmMmQxNDEyYjVfNA_60a37194-7569-40c1-af8f-4a5c7e195fc3"
      unitRef="number">0.02850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="id8b660eda4894cb386f65ca5af40f210_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzEtMS0xLTEtMTg0NDY5_02b8aa31-4389-4998-b029-fd6a6f962178"
      unitRef="usd">795000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i12b21493a628400c8be8f1d6a8ed3385_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzItMC0xLTEtMTg0NDY5L3RleHRyZWdpb246MDdhMjlhN2IxMWYyNDgyMWEwZDhiYmYwNzc2NGFmZTlfNA_bdc3797a-8801-447e-bcfc-c28aefca30bf"
      unitRef="number">0.02950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i12b21493a628400c8be8f1d6a8ed3385_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzItMS0xLTEtMTg0NDY5_ad67fa96-fa11-44cf-973a-65820b3c727b"
      unitRef="usd">132000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i539b185f58964558a12c50808bd29011_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzMtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246MzBhNWQ1ZTZmNTg2NDNmMmIwZjFkNDg4YjAxZThjYjRfNA_9e49b71e-b7b6-4d65-bc62-6641ff3f7079"
      unitRef="number">0.04000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i539b185f58964558a12c50808bd29011_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzMtMS0xLTEtMTg0NDY5_df59d151-673a-410b-b903-c0ddedefc358"
      unitRef="usd">624000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0f6f50e4575f4c78858838ff914b03c2_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzQtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246NDE2M2U3YjVhNTAzNDc5MWIxZGQ4NzYzOTYzZTYwYjZfNA_a2965a2b-ec8a-4164-9356-11d19b9e025c"
      unitRef="number">0.03800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i0f6f50e4575f4c78858838ff914b03c2_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzQtMS0xLTEtMTg0NDY5_a32a7182-d4cd-42e3-bbd7-55b872a3e857"
      unitRef="usd">655000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2d2e0075768e4aeb84b4d297b8930772_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzUtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246ZmNlNmJhNWVmNGVmNDY1YzgzMGNlMDVhMzA1ZDIwYTZfNA_393209b2-c982-46d1-9abe-cd9e3dc8e508"
      unitRef="number">0.04400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i2d2e0075768e4aeb84b4d297b8930772_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzUtMS0xLTEtMTg0NDY5_3b27b877-80ba-4c78-abcb-35266fe21dd2"
      unitRef="usd">430000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5c58db1ce1ac4ff4bed80427e3ff6a6c_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzYtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246N2I1ZTc5NTE3ZTg3NGFlMGE3ZGQ5N2Q0Mjk3MTZiYzVfNA_c886dc6b-5721-4662-90a0-67bbbcc03f0d"
      unitRef="number">0.04800</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i5c58db1ce1ac4ff4bed80427e3ff6a6c_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzYtMS0xLTEtMTg0NDY5_32bdd165-98bd-48b2-82c8-be277ab7cae3"
      unitRef="usd">1094000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7fb4aa15e8644b8dac184d5311a665f3_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzctMC0xLTEtMTg0NDY5L3RleHRyZWdpb246OTFlZGZjZDc3OGUzNDJjY2FiNWNlMmFiYWI3MjdmZmFfNA_031b1507-14a3-4428-b98b-25f58f53bd8e"
      unitRef="number">0.09950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i7fb4aa15e8644b8dac184d5311a665f3_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzctMS0xLTEtMTg0NDY5_41a07b73-1c89-45f0-9eb6-a0b9dbccb549"
      unitRef="usd">65000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia123b20dbca2464d91553ad8a790922d_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzgtMC0xLTEtMTg0NDY5L3RleHRyZWdpb246NjhmZTAyOGRmOTE1NDNhOWFlNmFkMGQ5OTE0MWJhNWNfNA_0db0428c-a242-4ffa-bfe4-7a75457672dd"
      unitRef="number">0.10200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="ia123b20dbca2464d91553ad8a790922d_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzgtMS0xLTEtMTg0NDY5_c6e532f1-a316-4ac7-9299-608d7437430f"
      unitRef="usd">18000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7c75f31df572443b876910d052f325e1_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzktMC0xLTEtMTg0NDY5L3RleHRyZWdpb246ZjYwYzBlNTlhODU2NGFjMDgzMGJjODliZjExMzMyZDhfNA_3068ca0c-7c66-40cd-b3c4-8140f4eae760"
      unitRef="number">0.06200</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i7c75f31df572443b876910d052f325e1_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzktMS0xLTEtMTg0NDY5_5dbb3351-033d-4a01-bc1f-13e6e060891b"
      unitRef="usd">229000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i34f308ec117342cd83eb1c8c2367bffc_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90YWJsZToxYmIwMGQ4MjhkZDA0ZDgyYjhjMzUwN2JlZDgzMjRiNS90YWJsZXJhbmdlOjFiYjAwZDgyOGRkMDRkODJiOGMzNTA3YmVkODMyNGI1XzEwLTEtMS0xLTE4NDQ2OQ_570c0e75-5771-4cb1-86de-9776e54dc9b3"
      unitRef="usd">4042000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i05610ebaa85d4ea193c96166dfd53b0c_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIzNDU_4e837e3b-89dc-4678-806f-ca3846e6dfec"
      unitRef="number">0.03490</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic922d20d61114cb5b818e46d2ee2f170_D20210101-20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIzOTk_64c672f4-34d5-4e32-bab8-c3826cc9daae"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia8e69b6b782f4aa5975697d9355b34c6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjIxMzk_860f5efb-6ee8-4a25-b7fb-3ddbf48de004"
      unitRef="usd">-649000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
      contextRef="ia8e69b6b782f4aa5975697d9355b34c6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjIxODA_0ee929da-99ea-477f-85bf-b8f4229628fd"
      unitRef="usd">-623000000</us-gaap:GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost
      contextRef="ia8e69b6b782f4aa5975697d9355b34c6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDIvZnJhZzpkMmYxZGE0MjdkNmI0MzVhOTdjZmU1ZGM0ZjgyNjM4OS90ZXh0cmVnaW9uOmQyZjFkYTQyN2Q2YjQzNWE5N2NmZTVkYzRmODI2Mzg5XzIxOTkwMjMyNjIyNTk_695b355b-b9bb-4245-a197-b2a392508e1a"
      unitRef="usd">26000000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzE4MDE_2de65f76-cce1-4f89-a71e-fa2807f1572d">Capital Stock&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we had 12 billion shares of authorized common stock; issued, repurchased and outstanding shares of common stock consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares Repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares Outstanding&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805,961,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(947,979,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,857,981,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock award activity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805,961,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(947,542,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858,419,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock award activity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repurchases of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,656,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,656,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805,961,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(982,785,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,823,175,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock award activity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;514,816&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;514,816&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repurchases of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(38,156,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(38,156,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,805,961,317&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,020,427,195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,785,534,122&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we had 26,698,134 shares of common stock reserved for stock-based awards under our stock plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we had 10 million authorized shares of serial preferred stock, $1.00 par value; no shares of serial preferred stock have been issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Dividends: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the third quarter of 2022, our Board of Directors (&#x201c;Board of Directors&#x201d; or &#x201c;Board&#x201d;) approved a 4.4% increase in the quarterly dividend rate to $0.94 per share of our common stock versus the previous rate of $0.90 per share.  The current annualized dividend rate is $3.76 per share.  Future dividend payments remain subject to the discretion of our Board.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Share Repurchases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, our Board of Directors authorized a $2.0 billion share repurchase program that it expanded to $3.5 billion in October 2021 (as expanded, the &#x201c;January 2021 share repurchase program&#x201d;).  We completed the January 2021 share repurchase program in December 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2023, our Board of Directors authorized a new $1.0 billion share repurchase program.  The timing of share repurchases under this program depends upon marketplace conditions and other factors, and the program remains subject to the discretion of our Board.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total share repurchase activity was as follows for the years ending December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.003%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 2021 Share Repurchase Program&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total number of shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate cost of shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47.83&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not repurchase any shares in 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzE4MDc_9f334f24-0f88-4d17-b63d-c5f841acd2a0">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we had 12 billion shares of authorized common stock; issued, repurchased and outstanding shares of common stock consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.320%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares Repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares Outstanding&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805,961,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(947,979,763)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,857,981,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock award activity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805,961,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(947,542,152)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858,419,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock award activity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repurchases of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,656,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35,656,116)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,805,961,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(982,785,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,823,175,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock award activity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;514,816&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;514,816&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repurchases of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(38,156,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(38,156,312)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,805,961,317&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,020,427,195)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,785,534,122&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzQy_19ccecd1-51b9-4908-9430-5c0a20d82cf4"
      unitRef="shares">12000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i40e064b5da194d8bbe29064d490250de_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzQtMS0xLTEtMTg0NDY5_4e252b5b-62d5-4fac-927a-6e5fbdd6498f"
      unitRef="shares">2805961317</us-gaap:CommonStockSharesIssued>
    <us-gaap:TreasuryStockShares
      contextRef="i40e064b5da194d8bbe29064d490250de_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzQtMy0xLTEtMTg0NDY5_9e6cd452-742e-4679-826f-7b4f61194ca9"
      unitRef="shares">947979763</us-gaap:TreasuryStockShares>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i40e064b5da194d8bbe29064d490250de_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzQtNS0xLTEtMTg0NDY5_b8d4ce87-981b-4a40-b2f4-93e31273b2db"
      unitRef="shares">1857981554</us-gaap:CommonStockSharesOutstanding>
    <mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzUtMy0xLTEtMTg0NDY5_45212ffc-0781-40f4-bbb2-7678f3293764"
      unitRef="shares">437611</mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned>
    <mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzUtNS0xLTEtMTg0NDY5_3f1ec2b2-e688-4b34-a3c4-94d877e2c456"
      unitRef="shares">437611</mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned>
    <us-gaap:CommonStockSharesIssued
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzctMS0xLTEtMTg0NDY5_988195aa-c82a-49c6-9b9c-149f74b6109e"
      unitRef="shares">2805961317</us-gaap:CommonStockSharesIssued>
    <us-gaap:TreasuryStockShares
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzctMy0xLTEtMTg0NDY5_0043ea11-8e32-4d1d-a102-13b1b9a3dbcd"
      unitRef="shares">947542152</us-gaap:TreasuryStockShares>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzctNS0xLTEtMTg0NDY5_816f57a1-a0da-4fdf-8ecf-79a5121132c9"
      unitRef="shares">1858419165</us-gaap:CommonStockSharesOutstanding>
    <mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzgtMy0xLTEtMTg0NDY5_02025ef7-6cae-4a22-b6e6-dfd551ab508d"
      unitRef="shares">412569</mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned>
    <mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzgtNS0xLTEtMTg0NDY5_fda504eb-5965-4164-8a77-d77909e6f803"
      unitRef="shares">412569</mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzktMy0xLTEtMTg0NDY5_fc3ebcb8-acf9-4fd4-98ee-6dc6bb192366"
      unitRef="shares">35656116</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzktNS0xLTEtMTg0NDY5_df377634-bc1e-4f60-b06d-f06912d22a7e"
      unitRef="shares">35656116</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEwLTEtMS0xLTE4NDQ2OQ_d80629a5-8601-4454-959a-94c6c9d27db1"
      unitRef="shares">2805961317</us-gaap:CommonStockSharesIssued>
    <us-gaap:TreasuryStockShares
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEwLTMtMS0xLTE4NDQ2OQ_bd099ce6-ddff-4658-b172-eb571a3d389c"
      unitRef="shares">982785699</us-gaap:TreasuryStockShares>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEwLTUtMS0xLTE4NDQ2OQ_9f54f91c-e077-412a-862f-17766d5fafd2"
      unitRef="shares">1823175618</us-gaap:CommonStockSharesOutstanding>
    <mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzExLTMtMS0xLTE4NDQ2OQ_83c8a763-1a20-41ac-8c9e-7c83f3c0e5d4"
      unitRef="shares">514816</mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned>
    <mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzExLTUtMS0xLTE4NDQ2OQ_235d65aa-d941-48c2-abdc-53e109792ca6"
      unitRef="shares">514816</mo:StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEyLTMtMS0xLTE4NDQ2OQ_51aa082f-61ae-4849-bd27-cf270e1ced14"
      unitRef="shares">38156312</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEyLTUtMS0xLTE4NDQ2OQ_f98b82a5-6be8-4a91-8124-8b2b0bb41f9c"
      unitRef="shares">38156312</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:CommonStockSharesIssued
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEzLTEtMS0xLTE4NDQ2OQ_ba4642b1-7c0a-45fb-9b79-cbf1d0bdf701"
      unitRef="shares">2805961317</us-gaap:CommonStockSharesIssued>
    <us-gaap:TreasuryStockShares
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEzLTMtMS0xLTE4NDQ2OQ_d20fefa3-d865-4d07-8b8a-e8c074cb195b"
      unitRef="shares">1020427195</us-gaap:TreasuryStockShares>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmYmU2NDNhNWZlNmU0Njk0YTA0OWIxNTA2N2Q0NTZkNS90YWJsZXJhbmdlOmZiZTY0M2E1ZmU2ZTQ2OTRhMDQ5YjE1MDY3ZDQ1NmQ1XzEzLTUtMS0xLTE4NDQ2OQ_383c0a9b-e1fb-4e67-b7b4-562ed308a064"
      unitRef="shares">1785534122</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i310c0dd5c06a43918728eab4e66aae82_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzE3Ng_2bbcf70d-2383-4ce2-920e-7d97d9db4822"
      unitRef="shares">26698134</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i1bda21fb40e34632bd2a70325195b703_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzI2OQ_61fc81f4-5057-4661-86ee-caef35e798b6"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i1bda21fb40e34632bd2a70325195b703_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzMwNw_6eceb984-5229-44fc-9885-6532a6990ee9"
      unitRef="usdPerShare">1.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i1bda21fb40e34632bd2a70325195b703_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzM4NDgyOTA3MDA4NTQ_a775a968-cbc8-41d9-ad71-d462d79fbfc8"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <mo:CommonStockDividendIncreasePercentage
      contextRef="id4a80e5aa58a45bb84e8bd06eac4fa44_D20220701-20220930"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzUwOQ_0225a77f-3eed-4d3a-bd11-1c75e98261f7"
      unitRef="number">0.044</mo:CommonStockDividendIncreasePercentage>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id4a80e5aa58a45bb84e8bd06eac4fa44_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzU1NQ_a18eff89-aae8-4efd-b5a3-0c22636d23c4"
      unitRef="usdPerShare">0.94</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id5e8e369ebdc481eb1c50facf9407ffd_D20220401-20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzYxOQ_24e2c158-7e5b-4114-b8ef-5685f1969a6e"
      unitRef="usdPerShare">0.90</us-gaap:CommonStockDividendsPerShareDeclared>
    <mo:CommonStockDividendRateAnnualPerShare
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzY3NA_1dfc8eff-6b80-4ba1-b861-51c597251f58"
      unitRef="usdPerShare">3.76</mo:CommonStockDividendRateAnnualPerShare>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ic4318d73c3ec420f9b7ea13530338ad1_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzExMTU_084e6194-c8f2-44a6-aa36-df56692d4488"
      unitRef="usd">2000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i6dee55786a8947d5be0e870d6c2bb228_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzExNjM_604affb6-ea46-4938-aab4-b776c34c48f2"
      unitRef="usd">3500000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i55356fbd37f340dd975f11d54874fece_I20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzM4NDgyOTA3MDIyNDI_47387b5e-5ad9-46e5-9900-8f2a0df7a370"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzE4MDg_5faf50f9-f307-4956-b2e5-12de87a49078">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total share repurchase activity was as follows for the years ending December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.003%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.346%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.563%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 2021 Share Repurchase Program&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total number of shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;38.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Aggregate cost of shares repurchased&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Average price per share of shares repurchased&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47.83&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="id15c7c4db331481f86239866210c3ea8_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzItMi0xLTEtMTg0NDY5_519cb68e-1c42-45b0-9166-6f844bb62bac"
      unitRef="shares">38100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if0e3d1499f104a538572ddf276309760_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzItNC0xLTEtMTg0NDY5_d430d24d-84f4-4e17-9b0d-80c29aeacf75"
      unitRef="shares">35700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i1814a9e5885940cdb1d92fe2948219f4_D20210101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzItMTAtMS0xLTE4NDQ2OQ_5fedab07-729e-415b-b159-885ff0367e0d"
      unitRef="shares">73800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="id15c7c4db331481f86239866210c3ea8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzMtMi0xLTEtMTg0NDY5_07d6f33c-ac81-46c2-83bb-a2328803924f"
      unitRef="usd">1825000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if0e3d1499f104a538572ddf276309760_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzMtNC0xLTEtMTg0NDY5_3da4560c-5039-4d06-b86b-fe19e48aa3d1"
      unitRef="usd">1675000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1814a9e5885940cdb1d92fe2948219f4_D20210101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzMtMTAtMS0xLTE4NDQ2OQ_16c51ebf-c39f-4a1c-9607-e11c40e22145"
      unitRef="usd">3500000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="id15c7c4db331481f86239866210c3ea8_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzQtMi0xLTEtMTg0NDY5_b9ff5f3f-cba1-42f1-86e1-325ca803b410"
      unitRef="usdPerShare">47.83</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="if0e3d1499f104a538572ddf276309760_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzQtNC0xLTEtMTg0NDY5_6c6fb626-e630-4b50-8f24-f662e9b544af"
      unitRef="usdPerShare">46.97</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockAcquiredAverageCostPerShare
      contextRef="i1814a9e5885940cdb1d92fe2948219f4_D20210101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90YWJsZTpmOWY5YTkyN2U5Y2I0ZWZjYWJlMDEzM2M4ZDg2MzM3Yy90YWJsZXJhbmdlOmY5ZjlhOTI3ZTljYjRlZmNhYmUwMTMzYzhkODYzMzdjXzQtMTAtMS0xLTE4NDQ2OQ_8149fef8-9f92-46c7-bbd2-1e3622f46eb8"
      unitRef="usdPerShare">47.42</us-gaap:TreasuryStockAcquiredAverageCostPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ie2ccef0d8b6b41aea1718d46140df7ff_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDUvZnJhZzo3YzVmODAxYzhjNDM0YzIwOWM0ZTc0NDM3YzU3OWExMy90ZXh0cmVnaW9uOjdjNWY4MDFjOGM0MzRjMjA5YzRlNzQ0MzdjNTc5YTEzXzQzOTgwNDY1MTY1NDE_58b2940e-d33d-48aa-b5b6-64a9a06b8aa3"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM5NzM_02d82edd-5434-464f-b0d2-e6edda84a478">Stock Plans&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, our Board of Directors adopted, and shareholders approved, the Altria Group, Inc. 2020 Performance Incentive Plan (the &#x201c;2020 Plan&#x201d;) under which we may grant stock options, stock appreciation rights, restricted stock, restricted stock units (&#x201c;RSUs&#x201d;), performance stock units (&#x201c;PSUs&#x201d;) and other stock-based awards, as well as cash-based annual and long-term incentive awards to our employees.  Any awards granted under the 2020 Plan may be in the form of performance-based awards, including PSUs subject to the achievement or satisfaction of performance goals and performance cycles.  We may issue up to 25 million shares of common stock under the 2020 Plan.  In addition, under the 2015 Stock Compensation Plan for Non-Employee Directors (the &#x201c;Directors Plan&#x201d;), we may grant up to one million shares of common stock to members of the Board of Directors who are not employees of Altria.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we had 21,972,920 and 650,121 shares available to be granted under the 2020 Plan and the Directors Plan, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;RSUs: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the vesting period, RSUs include nonforfeitable rights to dividend equivalents and may not be sold, assigned, pledged or otherwise encumbered.  RSUs are subject to forfeiture if certain employment conditions are not met.  We estimate the number of awards expected to be forfeited and adjust this estimate when subsequent information indicates that the actual number of forfeitures is likely to differ from previous estimates.  RSUs generally vest three years after the grant date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We amortize to expense ratably over the restriction period, which is generally three years, the fair value of the RSUs at the date of grant, net of estimated forfeitures.  We recorded pre-tax compensation expense related to RSUs for the years ended December&#160;31, 2022, 2021 and 2020 of $41 million, $34 million and $31 million, respectively.  We recorded a deferred tax benefit related to this compensation expense of $10 million, $9 million and $8 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively.  The unamortized compensation expense related to RSUs was $73 million at December&#160;31, 2022, which we expect to be recognized over a weighted-average period of approximately two years.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,702,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,206,601&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;49.22&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(556,399)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51.96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(94,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;45.10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,257,795&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;46.90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant date fair value of RSUs granted during the years ended December&#160;31, 2022, 2021 and 2020 was $59&#160;million, $48 million and $49 million, respectively, or $49.22, $45.22 and $42.59 per RSU, respectively.  The total vesting date fair value of RSUs that vested during the years ended December&#160;31, 2022, 2021 and 2020 was $29 million, $19 million and $25 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;PSUs: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We granted an aggregate of 215,205, 229,494 and 275,288 of PSUs during 2022, 2021 and 2020, respectively.  The payout of the PSUs is based on the extent to which we achieve certain performance measures over the three-year performance period.  Performance measures consist of our adjusted diluted earnings per share compounded annual growth rate and a cash conversion measure.  Additionally, the payout resulting from the performance measures is then adjusted up or down by a total shareholder return (&#x201c;TSR&#x201d;) performance multiplier, which depends on our relative TSR to a predetermined peer group.  PSUs are subject to forfeiture if certain employment conditions are not met.  At December&#160;31, 2022, we had 628,693 PSUs outstanding, with a weighted-average grant date fair value of $47.62 per PSU.  We amortize to expense over the performance period the fair value of PSUs at the date of grant, net of estimated forfeitures.  We recorded pre-tax compensation expense related to PSUs for the years ended December&#160;31, 2022, 2021 and 2020 of $9 million, $6&#160;million and $4&#160;million, respectively.  The unamortized compensation expense related to PSUs was $13 million at December 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="idde860552f9e4af3818e1e0171c49245_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzgyMQ_0f1456c8-b4ed-4fe9-997f-8bcd5d86b43a"
      unitRef="shares">25000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i638d815ed9f74221b605f9614dbf0863_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzEwMDk_c28e85ef-1b51-4774-90db-fabf29be8c04"
      unitRef="shares">1000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="idde860552f9e4af3818e1e0171c49245_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzExOTE_a3f081b3-f14e-4116-86bf-5d742f0632c1"
      unitRef="shares">21972920</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i638d815ed9f74221b605f9614dbf0863_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzExOTg_0d8176f5-a674-44b3-a16c-48b0e1a76970"
      unitRef="shares">650121</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzE2OTY_6b8e3641-f2b5-40bc-bd14-914bf25c6ddb">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <mo:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM4NDgyOTA3MDIwMzQ_0988c228-03b4-4be0-83a2-20bb87e9d35a">P3Y</mo:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzE5ODM_d3675984-aa99-4395-ba4d-13e42a65378c"
      unitRef="usd">41000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2bde4c691bfe43909179ea90b1ba5f53_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzE5ODc_58309722-3aba-4b76-bbbd-89a3b70c9712"
      unitRef="usd">34000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie586f180596b4de1bfd14cd16fa40aec_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzE5OTQ_26f37bdf-3f3c-4af9-a622-b66680649afa"
      unitRef="usd">31000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzIwODg_0e089b66-2194-4c9d-a298-a3ecaa0ac34d"
      unitRef="usd">10000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="i2bde4c691bfe43909179ea90b1ba5f53_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzIwOTI_1374cce7-24b0-45f2-bb81-94547e47813c"
      unitRef="usd">9000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ie586f180596b4de1bfd14cd16fa40aec_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzIwOTk_29d7a6c2-a5e1-4851-ab19-e01817f1a02e"
      unitRef="usd">8000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i28af804fe6b74399ba55088a1f49d3aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzIyMDk_d48fb0af-4a3a-46a5-a0ad-e5f1b07acf80"
      unitRef="usd">73000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzIyOTk_6ac04c16-4d52-490c-a614-b095246591a3">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM5NjQ_9fb0be4d-1680-41ff-86f3-3f899fcbb473">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.069%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.070%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date Fair Value Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,702,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,206,601&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;49.22&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(556,399)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51.96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(94,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;45.10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,257,795&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;46.90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie5040992030f401f8d230ceec09bf4b5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzEtMS0xLTEtMTg0NDY5_a7061b0a-0b1c-4fbb-8be8-d0c320096348"
      unitRef="shares">2702462</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie5040992030f401f8d230ceec09bf4b5_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzEtMy0xLTEtMTg0NDY5_237f88b6-7672-433b-a98b-a60ac44097c6"
      unitRef="usdPerShare">46.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzItMS0xLTEtMTg0NDY5_5ee0585f-10c0-4dfa-b00d-214d7ecd24d4"
      unitRef="shares">1206601</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzItMy0xLTEtMTg0NDY5_1868031b-2d6d-4498-9a25-3af0e1473370"
      unitRef="usdPerShare">49.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzMtMS0xLTEtMTg0NDY5_e852252c-a3f4-41a3-bce6-bd6a2d7b26ed"
      unitRef="shares">556399</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzMtMy0xLTEtMTg0NDY5_a9cd59a1-d474-493d-8aef-24d3f5e98f23"
      unitRef="usdPerShare">51.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzQtMS0xLTEtMTg0NDY5_b3bb45c9-7f99-4236-8e6d-d68df43440d8"
      unitRef="shares">94869</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzQtMy0xLTEtMTg0NDY5_08465fc1-f13d-4b08-9b27-5cc12958cfd2"
      unitRef="usdPerShare">45.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i28af804fe6b74399ba55088a1f49d3aa_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzUtMS0xLTEtMTg0NDY5_94be9013-bf41-4669-be2a-984958d28318"
      unitRef="shares">3257795</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i28af804fe6b74399ba55088a1f49d3aa_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90YWJsZTplODc5OGMxNmE1MzY0MmE3OGY2ZWRkYTM4ZTEzZTljNy90YWJsZXJhbmdlOmU4Nzk4YzE2YTUzNjQyYTc4ZjZlZGRhMzhlMTNlOWM3XzUtMy0xLTEtMTg0NDY5_43237a47-f645-459f-a556-e9f7962f729b"
      unitRef="usdPerShare">46.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <mo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue
      contextRef="i28af804fe6b74399ba55088a1f49d3aa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI0MzQ_d1070734-130f-468b-afe6-93eb83a7789e"
      unitRef="usd">59000000</mo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue>
    <mo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue
      contextRef="ie5040992030f401f8d230ceec09bf4b5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI0Mzg_157e5ab7-71ec-4100-9e5b-e6726e5fe454"
      unitRef="usd">48000000</mo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue>
    <mo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue
      contextRef="i0e6c90982182440887d92a56034de67f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI0NDU_8efbb7d0-f192-41ce-bb70-775d75e9422f"
      unitRef="usd">49000000</mo:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI0NjY_7e7c02fa-8f27-46cf-860a-5179deaf51b0"
      unitRef="usdPerShare">49.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2bde4c691bfe43909179ea90b1ba5f53_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI0NzA_562aeace-09fb-4d4b-829a-d71959b3de96"
      unitRef="usdPerShare">45.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie586f180596b4de1bfd14cd16fa40aec_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI0Nzc_665d4c0d-5b9e-4bdb-9201-2279d165b675"
      unitRef="usdPerShare">42.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI1OTk_d83a9e48-9177-41ce-8d1b-8be587133574"
      unitRef="usd">29000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i2bde4c691bfe43909179ea90b1ba5f53_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI2MDM_16bbddcc-4f95-4a99-b32b-56845834a2e4"
      unitRef="usd">19000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ie586f180596b4de1bfd14cd16fa40aec_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI2MTA_45d194f5-75ed-483d-ab3b-8c229803cf9a"
      unitRef="usd">25000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ic9c7c153e8d34eda8c3f26df0b887be6_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI2NjY_b2f16880-c595-49c6-b824-5f55fd335657"
      unitRef="shares">215205</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i43cdf17dccb84fe48ce2ad37ee1d8a57_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI2NzA_2daf7918-8f12-43fc-abd1-fd816d40b56e"
      unitRef="shares">229494</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i21cecce3d56444b6aefbd78a88439a59_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzI2Nzc_c81f5b6b-4aea-4d9b-9b30-7beb89db78b5"
      unitRef="shares">275288</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic9c7c153e8d34eda8c3f26df0b887be6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM5NzU_1c0dd96c-d40c-4b59-95fe-953413395e49">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i8560dfc0561741c4a2fca56a741ddb31_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM1NDM_69ef233b-b3e8-4bd4-979f-b16b3587a74c"
      unitRef="shares">628693</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i8560dfc0561741c4a2fca56a741ddb31_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM2MTM_1bd2ff54-d926-49cc-87a2-e9ec68fd88a5"
      unitRef="usdPerShare">47.62</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic9c7c153e8d34eda8c3f26df0b887be6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM4NTM_ba45250b-0bdc-4aa3-b9e5-016fa4278ed8"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i43cdf17dccb84fe48ce2ad37ee1d8a57_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM4NTc_f161253a-dbb3-4098-8263-77fb838a9791"
      unitRef="usd">6000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i21cecce3d56444b6aefbd78a88439a59_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM4NjQ_08ddd697-f9c8-4525-a992-a94905d562ca"
      unitRef="usd">4000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i8560dfc0561741c4a2fca56a741ddb31_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNDgvZnJhZzo5ODVlMzk4MGEzZjg0YjAwYWUzZGU2ODZjOGExNTJjNi90ZXh0cmVnaW9uOjk4NWUzOTgwYTNmODRiMDBhZTNkZTY4NmM4YTE1MmM2XzM5NDA_ca9078b7-4014-4c1c-9ed7-02d2552b5f6e"
      unitRef="usd">13000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90ZXh0cmVnaW9uOmYyZDRjYjVlNTBmNjQwMDdiMmFiZGY1ZDU4MDMyODA1XzEzMA_fdd8d919-0fc4-47ea-9be5-86233f2fcd86">Earnings per Share&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculated basic and diluted earnings per share (&#x201c;EPS&#x201d;) using the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.858%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.858%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Altria&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,764&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Distributed and undistributed earnings attributable to share-based awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings for basic and diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for basic EPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,804&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: contingently issuable PSUs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for diluted EPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,804&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90ZXh0cmVnaW9uOmYyZDRjYjVlNTBmNjQwMDdiMmFiZGY1ZDU4MDMyODA1XzEzMQ_8cf2a50f-10e5-4f34-a9ad-4c1cfbaa6633">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculated basic and diluted earnings per share (&#x201c;EPS&#x201d;) using the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.858%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.858%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net earnings attributable to Altria&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,764&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Distributed and undistributed earnings attributable to share-based awards&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings for basic and diluted EPS&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for basic EPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,804&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: contingently issuable PSUs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares for diluted EPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,804&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzItMS0xLTEtMTg0NDY5_f659d229-67a7-40a2-89dd-dcb13135e365"
      unitRef="usd">5764000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzItMy0xLTEtMTg0NDY5_ecfe4d75-8c6e-435b-a1c9-b7bfcdadc668"
      unitRef="usd">2475000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzItNS0xLTEtMTg0NDY5_bd64b758-a281-450a-93ea-6a099aecccae"
      unitRef="usd">4467000000</us-gaap:NetIncomeLoss>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzMtMS0xLTEtMTg0NDY5_4b675642-a185-494a-91da-b0972d0cac27"
      unitRef="usd">13000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzMtMy0xLTEtMTg0NDY5_8a19b24d-8cb4-4f73-9f0f-d7b26024e49e"
      unitRef="usd">11000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzMtNS0xLTEtMTg0NDY5_558f562c-c284-48d6-ac47-09f3786ac799"
      unitRef="usd">8000000</mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzQtMS0xLTEtMTg0NDY5_9e0f1edc-b5e0-421f-acac-e694217d5fb6"
      unitRef="usd">5751000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzQtMS0xLTEtMTg0NDY5_d69fac48-f7d3-474f-9ec0-4377b0e4630e"
      unitRef="usd">5751000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzQtMy0xLTEtMTg0NDY5_4cfd75a7-79cd-4f63-b29b-c7f0b897f20d"
      unitRef="usd">2464000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzQtMy0xLTEtMTg0NDY5_95be44d2-ef72-426e-9ac3-6d35fa17edb4"
      unitRef="usd">2464000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzQtNS0xLTEtMTg0NDY5_69a90683-4439-4b9e-98ec-c17158c91d11"
      unitRef="usd">4459000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzQtNS0xLTEtMTg0NDY5_ab8e4a3c-c6eb-4007-986e-b8f89563f5bb"
      unitRef="usd">4459000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzUtMS0xLTEtMTg0NDY5_7953c38a-6202-4552-96df-c4c4ff2f3382"
      unitRef="shares">1804000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzUtMy0xLTEtMTg0NDY5_6dae2454-d294-4091-a0ff-878886a59a7a"
      unitRef="shares">1845000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzUtNS0xLTEtMTg0NDY5_b6039869-7a9a-4c0b-9253-b25eee4f8065"
      unitRef="shares">1858000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzYtMS0xLTEtMTg0NDY5_5a68911c-f656-429c-9ffe-7c04218f9503"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzYtMy0xLTEtMTg0NDY5_a33f1119-2965-4288-91e3-a336b137940a"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzYtNS0xLTEtMTg0NDY5_6875439e-fb47-462c-a7f3-18907c9efcfc"
      unitRef="shares">1000000</us-gaap:WeightedAverageNumberOfSharesContingentlyIssuable>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzctMS0xLTEtMTg0NDY5_a733ddca-8379-48e1-9d90-daadad16b261"
      unitRef="shares">1804000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzctMy0xLTEtMTg0NDY5_3d67a7d3-4949-4502-b9a9-c3f25ac9db9b"
      unitRef="shares">1845000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTEvZnJhZzpmMmQ0Y2I1ZTUwZjY0MDA3YjJhYmRmNWQ1ODAzMjgwNS90YWJsZTo0MmEzMzE4OWIzY2E0MWE3OGFmMDU5NWI2YTY2MDFiNC90YWJsZXJhbmdlOjQyYTMzMTg5YjNjYTQxYTc4YWYwNTk1YjZhNjYwMWI0XzctNS0xLTEtMTg0NDY5_189d1951-a27a-48b7-a226-daae9b8b7c2b"
      unitRef="shares">1859000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90ZXh0cmVnaW9uOjY2NmJhMGUxMGQ4ZTRkNDU5MTU0ODBlZjdhZTdjMTljXzEwMTU_4b961bd8-ab6b-49be-a745-86a11844e359">Other Comprehensive Earnings/Losses&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;br/&gt;and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings, net of &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:38.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:42.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings, net of &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:38.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:42.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;145&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;387&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;88&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings, net of &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:38.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;deferred income taxes &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:42.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;143&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;285&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(2,771)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Primarily reflected our share of ABI&#x2019;s currency translation adjustments and the impact of our designated net investment hedges related to our equity investment in ABI.  For further discussion of designated net investment hedges, see Note 6. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;88&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments and Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Amounts were included in net defined benefit plan costs.  For further details, see Note 15. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Amounts were included in (income) losses from investments in equity securities.  For further information, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2021 amounts were included in marketing, administration and research costs and are related to the Ste. Michelle Transaction.  For further details, see Note 15. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90ZXh0cmVnaW9uOjY2NmJhMGUxMGQ4ZTRkNDU5MTU0ODBlZjdhZTdjMTljXzEwMzI_f98f626f-9951-407c-9c82-8ee0d2944b91">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in each component of accumulated other comprehensive losses, net of deferred income taxes, attributable to Altria were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.429%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Currency&lt;br/&gt;Translation&lt;br/&gt;Adjustments&lt;br/&gt;and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Other&lt;br/&gt;Comprehensive&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(693)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,864)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(454)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,613)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,071)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:13.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings, net of &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:38.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:42.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2,420)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4,341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings, net of &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:38.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:42.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,056)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;145&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;387&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;210&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;88&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:29.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings, net of &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:38.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;deferred income taxes &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:42.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other comprehensive earnings (losses), net of deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;143&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;285&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balances, December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(1,369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;34&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(2,771)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Primarily reflected our share of ABI&#x2019;s currency translation adjustments and the impact of our designated net investment hedges related to our equity investment in ABI.  For further discussion of designated net investment hedges, see Note 6. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4baeaffb9a29402ca2ca02dd05a69d99_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzItMi0xLTEtMTg0NDY5_be124373-c802-4701-b662-2fa6110bcb48"
      unitRef="usd">-2192000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib9146b84e66842f6ba646c0e65fbbf4a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzItNC0xLTEtMTg0NDY5_aa4284c6-7898-4983-8224-715a565bd052"
      unitRef="usd">-693000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i211d3ecc540f439596a522f150999ac7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzItNi0xLTEtMTg0NDY5_1733163f-52f8-47b3-b17e-42c1ba8463ef"
      unitRef="usd">21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia23cc26a813c466694dadfb7e04c27d2_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzItOC0xLTEtMTg0NDY5_55c92cd9-4d84-4ef3-bf86-49ea44847d62"
      unitRef="usd">-2864000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzUtMi0xLTEtMTg0NDY5_e783f6f2-9ea5-426e-a3b0-d364f4f1105f"
      unitRef="usd">-454000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzUtNC0xLTEtMTg0NDY5_6fc57578-4af7-4d7a-8ade-e55c0d7b205d"
      unitRef="usd">-1613000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzUtNi0xLTEtMTg0NDY5_df1b5ffc-1127-4313-adb8-0d5947b13a37"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzUtOC0xLTEtMTg0NDY5_81ff6cfd-dc1d-4b52-9f1a-d78911f0286e"
      unitRef="usd">-2071000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzYtMi0xLTEtMTg0NDY5_2219141d-1960-465c-bb99-bb6a8ac06199"
      unitRef="usd">-115000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzYtNC0xLTEtMTg0NDY5_21de4f93-add2-4849-bca0-a54fa3a03954"
      unitRef="usd">-352000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzYtNi0xLTEtMTg0NDY5_5b2f855f-b024-4aed-aada-d33853020f72"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzYtOC0xLTEtMTg0NDY5_99a774b9-b73e-4f7e-b27c-0731a65bbe2f"
      unitRef="usd">-467000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzctMi0xLTEtMTg0NDY5_07ca5f4e-b2eb-459d-a065-8e44fadd1777"
      unitRef="usd">-339000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzctNC0xLTEtMTg0NDY5_c5b7c459-0e0c-4281-9a52-ee60d321263e"
      unitRef="usd">-1261000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzctNi0xLTEtMTg0NDY5_8b1f013e-45e5-42b7-8ed2-a19caa8f575d"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzctOC0xLTEtMTg0NDY5_8e8417df-d897-42ef-b7eb-807163b6e6a0"
      unitRef="usd">-1604000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzktMi0xLTEtMTg0NDY5_8ada7ff4-2f9d-4894-b08b-e7a448aac3da"
      unitRef="usd">-148000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzktNC0xLTEtMTg0NDY5_35b6f709-c2c2-449a-8a97-3984685a6f1a"
      unitRef="usd">-21000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzktNi0xLTEtMTg0NDY5_6be5e44c-5626-4bb1-8488-7edf00a2e476"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzktOC0xLTEtMTg0NDY5_9942c589-dbec-4b33-8e8e-39b4efcd5e3f"
      unitRef="usd">-169000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEwLTItMS0xLTE4NDQ2OQ_843adae5-073e-4538-a8ac-ee44dd925476"
      unitRef="usd">-37000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEwLTQtMS0xLTE4NDQ2OQ_6ed432fa-b666-47eb-89a2-182e23b26553"
      unitRef="usd">-5000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEwLTYtMS0xLTE4NDQ2OQ_a5be389c-2e46-4087-9374-6107a73f5bd1"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEwLTgtMS0xLTE4NDQ2OQ_c11722f7-0194-4f9b-9126-50f87cf360d4"
      unitRef="usd">-42000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzExLTItMS0xLTE4NDQ2OQ_35529c83-e64c-46b6-9585-34bc0bfe3ac4"
      unitRef="usd">-111000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzExLTQtMS0xLTE4NDQ2OQ_16bbbb03-3595-4222-bd9f-d5709ec95acb"
      unitRef="usd">-16000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzExLTYtMS0xLTE4NDQ2OQ_62e3131d-a6cb-4cf1-8816-98781d155da9"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzExLTgtMS0xLTE4NDQ2OQ_15a10cff-7741-42b9-b7df-7f5987265752"
      unitRef="usd">-127000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iee6f716086d445da92a222c7902d8268_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEzLTItMS0xLTE4NDQ2OQ_a73eaecb-9ba2-4512-a695-cd1a15599b39"
      unitRef="usd">-228000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0701019c847a4101bb381af56e6106e5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEzLTQtMS0xLTE4NDQ2OQ_27e336f5-f53a-4ca8-88a6-9a2156862c0d"
      unitRef="usd">-1245000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie8466508bd3743f2bf1717fd89ca8f01_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEzLTYtMS0xLTE4NDQ2OQ_a2ce213c-1ebd-4e28-a36a-536114982db1"
      unitRef="usd">-4000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0f1511e239084b2f91ab9d5677992684_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzEzLTgtMS0xLTE4NDQ2OQ_11241ce7-0eae-4b8a-9e5e-07036767827b"
      unitRef="usd">-1477000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1ebf54a40094d25ae6e4d46af08a702_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE0LTItMS0xLTE4NDQ2OQ_d5bfcf21-ffaa-4a90-bc91-97eb48bab107"
      unitRef="usd">-2420000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id9b3afb0e68543d79df286a395b0f9f4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE0LTQtMS0xLTE4NDQ2OQ_7661cab3-fa02-4566-9609-4e486e4dd54c"
      unitRef="usd">-1938000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i92833a7b324c4491889c22a95091a6eb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE0LTYtMS0xLTE4NDQ2OQ_9650b85c-2835-4977-b141-a8d8cd053fa4"
      unitRef="usd">17000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie4b30e48366b42559b3e640d996b9125_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE0LTgtMS0xLTE4NDQ2OQ_5f0bcbc8-d270-411e-aa6d-3363993458ed"
      unitRef="usd">-4341000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE1LTItMS0xLTE4NDQ2OQ_df291999-b315-4ced-816d-8c52486168ce"
      unitRef="usd">961000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE1LTQtMS0xLTE4NDQ2OQ_42acd5ef-2fe7-4479-9304-a2771640417f"
      unitRef="usd">627000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE1LTYtMS0xLTE4NDQ2OQ_aa7ae784-6196-494d-94bb-afada729fbb0"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE1LTgtMS0xLTE4NDQ2OQ_179d2661-a0e1-48d9-8a6e-0b3ef97700ec"
      unitRef="usd">1613000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE2LTItMS0xLTE4NDQ2OQ_792efe2b-0b59-4ca5-bb97-85ad1a59fca5"
      unitRef="usd">245000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE2LTQtMS0xLTE4NDQ2OQ_aa535901-3cbb-44fa-9442-30d19e9fde73"
      unitRef="usd">141000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE2LTYtMS0xLTE4NDQ2OQ_9207cdb7-46d9-48c2-b1ef-03261f6315e1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE2LTgtMS0xLTE4NDQ2OQ_24699aa6-a284-443a-8f79-2a0ba9dc2962"
      unitRef="usd">386000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE3LTItMS0xLTE4NDQ2OQ_47fb8a55-cae6-4ccd-b6a7-421dc37054f7"
      unitRef="usd">716000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE3LTQtMS0xLTE4NDQ2OQ_6b99e9a9-2699-4ab4-9ad4-5488935f29dd"
      unitRef="usd">486000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE3LTYtMS0xLTE4NDQ2OQ_f578f041-0b12-4fa2-82a0-04f799e0501e"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE3LTgtMS0xLTE4NDQ2OQ_7951c8b7-9e47-46d7-b5b2-44a75ddc5a5f"
      unitRef="usd">1227000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE5LTItMS0xLTE4NDQ2OQ_4b0ebe17-3d9d-459d-95d7-a9dfe2595eb3"
      unitRef="usd">-122000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE5LTQtMS0xLTE4NDQ2OQ_72d9fd8d-2b8e-4658-9666-c302ec70bfc7"
      unitRef="usd">76000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE5LTYtMS0xLTE4NDQ2OQ_aff2918b-7b3f-44ec-ba8e-1fbeed3acdea"
      unitRef="usd">-35000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzE5LTgtMS0xLTE4NDQ2OQ_8c86cb3b-388c-4f44-bad1-4ac898b535c1"
      unitRef="usd">-81000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIwLTItMS0xLTE4NDQ2OQ_abd0c025-19e4-4793-87f3-13969656a4db"
      unitRef="usd">-30000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIwLTQtMS0xLTE4NDQ2OQ_afa620c8-b9a8-41b9-872f-cc806a6f8d9b"
      unitRef="usd">16000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIwLTYtMS0xLTE4NDQ2OQ_c6949602-b126-43b0-82cc-e40f02cce28c"
      unitRef="usd">-9000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIwLTgtMS0xLTE4NDQ2OQ_c2475553-37ed-4f41-88aa-5dfbdef1522d"
      unitRef="usd">-23000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIxLTItMS0xLTE4NDQ2OQ_d35af730-ee1b-4379-84bc-61b0d128a359"
      unitRef="usd">-92000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIxLTQtMS0xLTE4NDQ2OQ_1ea43801-e48b-42fe-8635-29ce0d7b7acc"
      unitRef="usd">60000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIxLTYtMS0xLTE4NDQ2OQ_fa9ea698-fef3-4503-8de5-dc7b5a2b69ea"
      unitRef="usd">-26000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIxLTgtMS0xLTE4NDQ2OQ_1bf85a53-8c24-4a9c-819c-76b03446489b"
      unitRef="usd">-58000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3f385a711b2c4439ae4822509b6d9967_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIzLTItMS0xLTE4NDQ2OQ_27aaadd4-b1d9-4f06-b3d5-d48b488e9623"
      unitRef="usd">808000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i46578bd2fba34e508c65171225d3399b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIzLTQtMS0xLTE4NDQ2OQ_27ecf3ef-ac43-44d9-bc68-89ac9b55bd39"
      unitRef="usd">426000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4622585b580c4ae593332eebd185fc05_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIzLTYtMS0xLTE4NDQ2OQ_614afe29-cdc6-47a9-bf88-82095beeaadb"
      unitRef="usd">51000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i91d37309b65c44a9a995acb605ca18dc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzIzLTgtMS0xLTE4NDQ2OQ_656ead40-ebe6-4ee0-a1af-be896ab3f31b"
      unitRef="usd">1285000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i301bde0c886045bbbbef3861c7f3305a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI0LTItMS0xLTE4NDQ2OQ_7fb0754d-7e1a-4d31-8e35-06134daf7cd1"
      unitRef="usd">-1612000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if666ea56e36a46138786e8a942c8ca49_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI0LTQtMS0xLTE4NDQ2OQ_8d7dbb00-61cb-4908-872c-ecec48dbf07c"
      unitRef="usd">-1512000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39d9da4da1444b63abf5627b2e02b0a4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI0LTYtMS0xLTE4NDQ2OQ_e7b2d384-f524-4a7d-a78a-b67961254519"
      unitRef="usd">68000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i558fc0a3383e478fb5796f93893141cd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI0LTgtMS0xLTE4NDQ2OQ_e15245ea-a1e5-4e5e-a711-3d9e800465c7"
      unitRef="usd">-3056000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI1LTItMS0xLTE4NDQ2OQ_cc3ea299-0e3c-4381-91ec-dea1ebeddecf"
      unitRef="usd">145000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI1LTQtMS0xLTE4NDQ2OQ_5e9d695c-c29c-41d6-b2fe-3690743efa3c"
      unitRef="usd">275000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI1LTYtMS0xLTE4NDQ2OQ_2a871b08-6826-419c-ad85-b40b5932c0ba"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
      contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI1LTgtMS0xLTE4NDQ2OQ_19a55656-3217-478c-9e8b-aa597582d6f3"
      unitRef="usd">387000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI2LTItMS0xLTE4NDQ2OQ_79887ff2-9f05-40fe-a23b-eb8883014b4b"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI2LTQtMS0xLTE4NDQ2OQ_7c9a5185-acc7-498e-993e-a0e0949c358c"
      unitRef="usd">65000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI2LTYtMS0xLTE4NDQ2OQ_84e354ff-a4cf-4ecd-9c72-82f078b2a0ac"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI2LTgtMS0xLTE4NDQ2OQ_d22973d4-bf6c-4f1a-9617-b9b33d4de5c0"
      unitRef="usd">100000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI3LTItMS0xLTE4NDQ2OQ_64e2d7a5-3cf6-4e71-9ff3-54af8f6d3f1e"
      unitRef="usd">110000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI3LTQtMS0xLTE4NDQ2OQ_a3bd0cc0-5886-4ae3-b89d-bad6010e5dcd"
      unitRef="usd">210000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI3LTYtMS0xLTE4NDQ2OQ_3a4e448e-9ea6-44ea-92f4-88a999778d3b"
      unitRef="usd">-33000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI3LTgtMS0xLTE4NDQ2OQ_31449296-b1a3-4ac8-bde2-8a05e5e478b0"
      unitRef="usd">287000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI5LTItMS0xLTE4NDQ2OQ_bb4e9b44-13aa-4e3c-af7b-c4c2bef99c45"
      unitRef="usd">-88000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI5LTQtMS0xLTE4NDQ2OQ_42ea7ec5-a602-4f56-8c32-476b08275661"
      unitRef="usd">85000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI5LTYtMS0xLTE4NDQ2OQ_dd68ced7-c9f9-4975-9dbb-91be534a0595"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
      contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzI5LTgtMS0xLTE4NDQ2OQ_bdea6307-5d19-4611-bb3e-5aaa0a249cb8"
      unitRef="usd">-2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMwLTItMS0xLTE4NDQ2OQ_cdbc1b0a-9f66-494b-b089-39661d90aa1d"
      unitRef="usd">-22000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMwLTQtMS0xLTE4NDQ2OQ_605f8a2b-e223-4108-9eea-f5b49c315b34"
      unitRef="usd">18000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMwLTYtMS0xLTE4NDQ2OQ_c1660a13-b453-4462-96d4-64a6754a48a8"
      unitRef="usd">0</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAociCurrentPeriodTax
      contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMwLTgtMS0xLTE4NDQ2OQ_9d6f5a2f-e8cf-402f-a5b3-9b1b88f4850c"
      unitRef="usd">-4000000</us-gaap:ReclassificationFromAociCurrentPeriodTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMxLTItMS0xLTE4NDQ2OQ_b6eeb14a-d73d-4610-98c8-ff9772f51d32"
      unitRef="usd">-66000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMxLTQtMS0xLTE4NDQ2OQ_e26ce538-74c8-43e6-81f7-c8722a4c212f"
      unitRef="usd">67000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMxLTYtMS0xLTE4NDQ2OQ_c79ec741-1fd8-438c-ba91-acb9c67fcb71"
      unitRef="usd">1000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMxLTgtMS0xLTE4NDQ2OQ_4f03ea8a-ddca-4e6f-bace-9a28085503dd"
      unitRef="usd">2000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id7274c6680d2404c926a183383e0427c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMzLTItMS0xLTE4NDQ2OQ_3c715052-af5d-4807-ae89-e280423e7a74"
      unitRef="usd">176000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i28ffc0760c294cbf8f4b6c0bd53feb9a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMzLTQtMS0xLTE4NDQ2OQ_8c7305a6-4413-4335-8106-7a8980ffde0a"
      unitRef="usd">143000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2e0b586f193c43b68ec0ac846039068a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMzLTYtMS0xLTE4NDQ2OQ_1a417181-0fcc-4b2e-ab66-80e6bd40f902"
      unitRef="usd">-34000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzMzLTgtMS0xLTE4NDQ2OQ_237ff1a3-0136-4330-b8de-342d47151c7d"
      unitRef="usd">285000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i249cc5c8822b4901891591817ef402b5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzM0LTItMS0xLTE4NDQ2OQ_c6c2b6de-577d-47eb-8aae-5d60c7a6009a"
      unitRef="usd">-1436000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic821892e2b3a4c669cc2c54ff8ccbcb0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzM0LTQtMS0xLTE4NDQ2OQ_c92a99c6-3c6d-4fda-b605-5b583d99f1a6"
      unitRef="usd">-1369000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9406c18150ae48159d08480f724ce8f5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzM0LTYtMS0xLTE4NDQ2OQ_348da21a-84a2-4515-bd3c-70d9c371bf5b"
      unitRef="usd">34000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia66edd7cc54a4c8ea258417ee5d6a637_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo4NDViMWUxZjE4Yzg0ODkzOGQ0ODgyMzUyYTdkZjY1MS90YWJsZXJhbmdlOjg0NWIxZTFmMThjODQ4OTM4ZDQ4ODIzNTJhN2RmNjUxXzM0LTgtMS0xLTE4NDQ2OQ_9edfcbe3-67a5-4cda-9826-99e28a83a39a"
      unitRef="usd">-2771000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90ZXh0cmVnaW9uOjY2NmJhMGUxMGQ4ZTRkNDU5MTU0ODBlZjdhZTdjMTljXzEwMzA_7d52ec47-1594-47fa-8648-be294eee78f3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pre-tax amounts by component, reclassified from accumulated other comprehensive losses to net earnings were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.228%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.721%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.306%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit Plans: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;88&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ABI &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Currency Translation Adjustments and Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Amounts were included in net defined benefit plan costs.  For further details, see Note 15. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Amounts were included in (income) losses from investments in equity securities.  For further information, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2021 amounts were included in marketing, administration and research costs and are related to the Ste. Michelle Transaction.  For further details, see Note 15. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Benefit Plans.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i8f2413f9f1484799837c48a31819243a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzMtMi0xLTEtMTg0NDY5_9eea35f8-2c80-4440-8bc4-b026759c9e67"
      unitRef="usd">127000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i0ce6eb6dd62848bc8cd40a14488e8721_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzMtNC0xLTEtMTg0NDY5_d7debc9d-9fb1-42da-b8c0-a68fa5107443"
      unitRef="usd">163000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ie126f873b826412b91e1030a434f2d88_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzMtNi0xLTEtMTg0NDY5_5540487d-0cc2-4fde-b24d-a264f38ce569"
      unitRef="usd">173000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i3c8e82e2711e453788e58f2bd1c329a6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzQtMi0xLTEtMTg0NDY5_3b6cdbab-c32d-40df-9a4f-4c5fa0db834f"
      unitRef="usd">-39000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i835ff05c75554bb3a905f6d9c969a297_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzQtNC0xLTEtMTg0NDY5_8200e8fc-a342-4546-a36f-33cafec59697"
      unitRef="usd">-41000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i54324f38aa844a9eb47e2442a1639941_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzQtNi0xLTEtMTg0NDY5_bfe6b97f-8832-45be-a240-e45dd03edc65"
      unitRef="usd">-25000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i06ce655c080e4f76bb70784777bec240_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzUtMi0xLTEtMTg0NDY5_888d6a2c-d25b-4448-9ef3-5529b260515b"
      unitRef="usd">88000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i58687162a9304d12bc4af830434b13f3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzUtNC0xLTEtMTg0NDY5_e8ba6ba3-659d-4ccd-b83b-8a22d4fa4379"
      unitRef="usd">122000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i8e695634f71246c49246a1bc11d5adbc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzUtNi0xLTEtMTg0NDY5_98300e34-33d2-46d2-93be-82400e947f7b"
      unitRef="usd">148000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i779b2d2ecbd54a6e915147670f6d0270_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzctMi0xLTEtMTg0NDY5_a088786c-3953-42c6-933b-9dca7aad9f09"
      unitRef="usd">85000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9b811ce9ecd74e63a03fe63f108ba6ef_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzctNC0xLTEtMTg0NDY5_5b18fb43-cb4a-4d24-ab2c-e04c1dbff3b3"
      unitRef="usd">76000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5c382d8d16454f87a46dc4a4ad2985b5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzctNi0xLTEtMTg0NDY5_797e4525-ab36-446c-bc67-ac9bd0446406"
      unitRef="usd">-21000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <mo:CurrencyTranslationAdjustmentsAndOther
      contextRef="i89dc095529b8415fa2d037d1e5cc3243_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzktMi0xLTEtMTg0NDY5_d8659b52-8ea0-4210-bec9-d838b813d01d"
      unitRef="usd">-1000000</mo:CurrencyTranslationAdjustmentsAndOther>
    <mo:CurrencyTranslationAdjustmentsAndOther
      contextRef="i2c0fb8e2f6f94df6a4cb1166c6e8695d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzktNC0xLTEtMTg0NDY5_65ab4c29-ccfb-4aca-a960-fa325dcf7d8e"
      unitRef="usd">35000000</mo:CurrencyTranslationAdjustmentsAndOther>
    <mo:CurrencyTranslationAdjustmentsAndOther
      contextRef="i53c6e05d22124ac2a67512f6e00889ab_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzktNi0xLTEtMTg0NDY5_cd9ebdd0-66df-45ef-9339-599d5781bd5c"
      unitRef="usd">0</mo:CurrencyTranslationAdjustmentsAndOther>
    <us-gaap:ProfitLoss
      contextRef="i99171c01ef0342ea88d25cef0ba399df_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzEwLTItMS0xLTE4NDQ2OQ_4d747878-2db8-465c-aa80-fe847373ec87"
      unitRef="usd">-2000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic66cd77c3dc849aca5b3b237b949276b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzEwLTQtMS0xLTE4NDQ2OQ_49fd8f3d-0a98-46c9-aca4-cd3a661b739b"
      unitRef="usd">-81000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i17df18daf64e40e6b9d99e9a45abbaa7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTQvZnJhZzo2NjZiYTBlMTBkOGU0ZDQ1OTE1NDgwZWY3YWU3YzE5Yy90YWJsZTo1NTUzNjQxZDA2NjY0YmEzYWQ4NzY4ZDY1NTAwN2IxYi90YWJsZXJhbmdlOjU1NTM2NDFkMDY2NjRiYTNhZDg3NjhkNjU1MDA3YjFiXzEwLTYtMS0xLTE4NDQ2OQ_c46c7909-a8e6-460a-bf96-70b1833340cf"
      unitRef="usd">-169000000</us-gaap:ProfitLoss>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU2OTA_8364119a-1eee-4a37-9ffd-7e43e896f821">Income Taxes&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, the U.S. Government enacted legislation commonly referred to as the Inflation Reduction Act.  The main provisions of the Inflation Reduction Act that we anticipate may impact us are (i) a 15% corporate alternative minimum tax (&#x201c;Corporate AMT&#x201d;) and (ii) a 1% excise tax on share repurchases, which we expect to record in equity on our consolidated statements of stockholders&#x2019; equity (deficit), in each case effective for tax years beginning after December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We will be considered an &#x201c;applicable corporation&#x201d; for purposes of the new Corporate AMT.  Our regular federal income tax liability will generally exceed our Corporate AMT liability.  Certain unique circumstances, however, may result in a Corporate AMT liability, including when tax losses are reported in a different year than book losses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings (losses) before income taxes and provision (benefit) for income taxes consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,628&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision (benefit) for income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,968&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,572&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,625&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our U.S. subsidiaries join in the filing of a U.S. federal consolidated income tax return.  The U.S. federal income tax statute of limitations remains open for the year 2017 and forward, with years 2017 through 2020 currently under examination by the Internal Revenue Service (&#x201c;IRS&#x201d;) as part of an audit conducted in the ordinary course of business.  State statutes of limitations generally remain open for the year 2017 and forward.  Certain of our state tax returns are currently under examination by various states as part of routine audits conducted in the ordinary course of business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions due to lapse of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at December&#160;31, 2022 was $44 million, along with $25 million affecting deferred taxes.  The amount of unrecognized tax benefits that, if recognized, would impact the effective tax rate at December&#160;31, 2021 was $31 million, along with $22 million affecting deferred taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, 2021 and 2020, the amount of accrued interest and penalties on our consolidated balance sheets was $18 million, $11 million and $15 million, respectively.  For the years ended December&#160;31, 2022, 2021 and 2020, we recognized in our consolidated statements of earnings $8 million, $(4)&#160;million and $4 million, respectively, of gross interest (income) expense associated with uncertain tax positions.  We recognize accrued interest and penalties associated with uncertain tax positions as part of the tax provision.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to income taxation in many jurisdictions.  Unrecognized tax benefits reflect the difference between tax positions taken or expected to be taken on income tax returns and the amounts recognized in the financial statements.  Resolution of the related tax positions with the relevant tax authorities may take many years to complete, and such timing is not entirely within our control.  It is reasonably possible that within the next 12 months certain examinations will be resolved, which could result in a decrease in unrecognized tax benefits of approximately $1 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation between actual income taxes and amounts computed by applying the federal statutory rate to earnings before income taxes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,552&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;435&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax basis in foreign investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in JUUL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in Cronos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance releases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,625&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax provision (benefit) in 2022 included tax benefits of $664 million due primarily to the release of valuation allowances related to the anticipated ability to utilize a portion of existing capital losses.  These tax benefits were partially offset by tax expense of $306 million for a valuation allowance recorded against a deferred tax asset related to the decreases in the estimated fair value of our investment in JUUL and by the state tax treatment of the impairment charge on our equity investment in ABI.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax provision (benefit) in 2021 was impacted by the state tax treatment of the impairment charge on our equity investment in ABI.  The tax provision (benefit) in 2021 also included net tax expense of $128 million related to our Investment in Cronos, including an addition to a valuation allowance on a deferred tax asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax provision (benefit) in 2020 included tax expense of $612 million for a valuation allowance on a deferred tax asset related to our impairment of our investment in JUUL in the third quarter of 2020, partially offset by a $24 million tax benefit reflecting the decrease of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a portion of the valuation allowance related to a reduction of a deferred tax asset associated with an increase in the estimated fair value of JUUL in the fourth quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences that gave rise to deferred income tax assets and liabilities consisted of the following at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued postretirement and postemployment benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;303&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;729&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in JUUL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,001&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in Cronos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;407&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating losses and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(233)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued pension costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2022, we had estimated gross state tax net operating losses of $19 million that, if unused, will expire in 2035 through 2038. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending valuation allowances was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,097&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to valuation allowance charged to income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;429&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions to valuation allowance credited to income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine deferred tax assets and liabilities based on the difference between the financial statement and tax bases of assets and liabilities, using enacted tax rates in effect for the year in which the differences are expected to reverse.  We record a valuation allowance when it is more likely than not that some portion or all of a deferred tax asset will not be realized.  We determine the realizability of deferred tax assets based on the weight of all available positive and negative evidence.  In reaching this determination, we consider the character of the assets and the possible sources of taxable income of the appropriate character within the available carryback and carryforward periods available under the tax law.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The additions to valuation allowances during 2022 were primarily due to deferred tax assets recorded in connection with decreases in the estimated fair value of our investment in JUUL.  The reductions to valuation allowances during 2022 were primarily due to the anticipated ability to utilize a portion of existing losses related to our investment in JUUL and the abandonment of our Cronos warrant.  The cumulative valuation allowance at December 31, 2022 was primarily attributable to deferred tax assets recorded in connection with our investment in JUUL ($2,394 million) and our Investment in Cronos ($379 million).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in valuation allowances during 2021 were primarily due to deferred tax assets recorded in connection with our Investment in Cronos.  The cumulative valuation allowance at December 31, 2021 was primarily attributable to deferred tax assets recorded in connection with our investment in JUUL ($2,652 million) and our Investment in Cronos ($407 million).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2020 valuation allowance was primarily attributable to deferred tax assets recorded in connection with the impairments of our investment in JUUL ($2,610 million), and our Investment in Cronos ($121 million).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a discussion regarding the change in estimated fair value of our investment in JUUL, the impairment of our investment in ABI and the impairment of our Investment in Cronos, see Note 5. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments in Equity Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU2NTg_33bd1b97-f6b5-49ce-acb2-c5457375f101">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings (losses) before income taxes and provision (benefit) for income taxes consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings (losses) before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,628&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(239)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision (benefit) for income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,968&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outside United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,572&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,625&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzMtMS0xLTEtMTg0NDY5_3637e66f-7f2d-4a3a-9f0f-f61fa304c420"
      unitRef="usd">7628000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzMtMy0xLTEtMTg0NDY5_0c0645b9-4934-4aff-8cf7-7911e78bf335"
      unitRef="usd">4239000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzMtNS0xLTEtMTg0NDY5_140ae7f1-94d2-42df-a736-abb683f793fe"
      unitRef="usd">6842000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzQtMS0xLTEtMTg0NDY5_4925b456-7696-4b0d-8fa2-865b74d78d53"
      unitRef="usd">-239000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzQtMy0xLTEtMTg0NDY5_597a9071-f14d-43b8-bd09-ec59fbe48724"
      unitRef="usd">-415000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzQtNS0xLTEtMTg0NDY5_241163e4-3f27-437d-9eb8-169773a2cd02"
      unitRef="usd">48000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzUtMS0xLTEtMTg0NDY5_21061ae6-6d19-4e4c-a942-154b65bc6d72"
      unitRef="usd">7389000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzUtMy0xLTEtMTg0NDY5_6ef14050-cbfc-4eec-ac73-5864664ac1ac"
      unitRef="usd">3824000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzUtNS0xLTEtMTg0NDY5_758701df-c407-4f1f-90d9-27e40d8fd052"
      unitRef="usd">6890000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzgtMS0xLTEtMTg0NDY5_33705a97-892e-4fba-8e84-df0f8d694179"
      unitRef="usd">1968000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzgtMy0xLTEtMTg0NDY5_3bebce17-c70a-4d5b-af40-8c11d754206f"
      unitRef="usd">1965000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzgtNS0xLTEtMTg0NDY5_18c7308d-7810-4755-bdb2-503d108f1d2d"
      unitRef="usd">2025000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzktMS0xLTEtMTg0NDY5_099164fb-af2c-4c18-a279-57bf40df327e"
      unitRef="usd">603000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzktMy0xLTEtMTg0NDY5_346b2377-0dec-460f-9fd9-40bceb0d5821"
      unitRef="usd">542000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzktNS0xLTEtMTg0NDY5_57c0a083-2977-421f-a560-0ef3b0455485"
      unitRef="usd">553000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzEwLTEtMS0xLTE4NDQ2OQ_3eeb4c97-3bcf-4754-9eda-d1a4c9b9fca4"
      unitRef="usd">1000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzEwLTMtMS0xLTE4NDQ2OQ_b0ed4823-9b91-4859-b624-6c4b56dae188"
      unitRef="usd">2000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzEwLTUtMS0xLTE4NDQ2OQ_5ce74bee-c355-45a6-934b-e8852c38d7f1"
      unitRef="usd">22000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzExLTEtMS0xLTE4NDQ2OQ_ac1d07e1-1ea7-4bc3-9e5a-5d1d4788f7a6"
      unitRef="usd">2572000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzExLTMtMS0xLTE4NDQ2OQ_4c9a877b-edea-4256-990f-360359497fb2"
      unitRef="usd">2509000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzExLTUtMS0xLTE4NDQ2OQ_7e7031b3-cccf-4744-8a7b-9c8e633fdcd9"
      unitRef="usd">2600000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzEzLTEtMS0xLTE4NDQ2OQ_550b6c91-15cf-4824-9e50-ba13e6417d00"
      unitRef="usd">-893000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzEzLTMtMS0xLTE4NDQ2OQ_0f0c1fd2-fae1-4dbb-94e0-30134cb04642"
      unitRef="usd">-1190000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzEzLTUtMS0xLTE4NDQ2OQ_1f1dcf02-caca-4369-af9e-16d29350de9a"
      unitRef="usd">-130000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE0LTEtMS0xLTE4NDQ2OQ_a4f2020a-d034-4616-aede-8121321168a8"
      unitRef="usd">-54000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE0LTMtMS0xLTE4NDQ2OQ_133eecf4-11f7-4fa2-bdf7-0a912c17727a"
      unitRef="usd">30000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE0LTUtMS0xLTE4NDQ2OQ_48ffe037-ef91-40ff-9390-8d78a49b3616"
      unitRef="usd">-34000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE2LTEtMS0xLTE4NDQ2OQ_37bd14d5-8259-4e63-b6d9-4e6037ce4f89"
      unitRef="usd">-947000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE2LTMtMS0xLTE4NDQ2OQ_39a123fe-75f3-413b-81bd-f41aa74715b4"
      unitRef="usd">-1160000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i91aa1a3fbaee4d3ca09cea2198096661_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE2LTUtMS0xLTE4NDQ2OQ_d5618b16-5906-4ae7-9854-9555a68fef9d"
      unitRef="usd">-164000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE3LTEtMS0xLTE4NDQ2OQ_5c51367f-a974-4512-b497-fcea65f2dd16"
      unitRef="usd">1625000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE3LTMtMS0xLTE4NDQ2OQ_3f843a78-d904-475a-aad4-dba599e20a46"
      unitRef="usd">1349000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo3OTUzMTE3NDViMzE0M2NhOWJjNmY4YTdkNjE4ZDRkMy90YWJsZXJhbmdlOjc5NTMxMTc0NWIzMTQzY2E5YmM2ZjhhN2Q2MThkNGQzXzE3LTUtMS0xLTE4NDQ2OQ_91291ad0-683c-4cf0-91d0-38e2c35b8f33"
      unitRef="usd">2436000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU2NTQ_13452dab-7f81-48ca-945c-2ace75f6fcfa">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.550%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.561%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;53&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions due to lapse of statutes of limitations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;69&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzItMS0xLTEtMTg0NDY5_2fc996ac-b6bf-4eb0-81a0-deeeef6a381f"
      unitRef="usd">53000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzItMy0xLTEtMTg0NDY5_82bf5173-3266-4534-9a56-c96e7d749bff"
      unitRef="usd">74000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i40e064b5da194d8bbe29064d490250de_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzItNS0xLTEtMTg0NDY5_e555e951-8d22-4231-ab94-e8e894be177e"
      unitRef="usd">64000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzMtMS0xLTEtMTg0NDY5_7d06869a-e004-4da2-a844-91851c87b8e5"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzMtMy0xLTEtMTg0NDY5_d342c7bc-b195-4487-9f48-d64a770895f4"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzMtNS0xLTEtMTg0NDY5_ad77fcb4-686c-439b-afd8-6d243df55e47"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzQtMS0xLTEtMTg0NDY5_73a25a52-ce6d-4e49-8eeb-8c2a9aca639b"
      unitRef="usd">16000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzQtMy0xLTEtMTg0NDY5_95d67365-f444-4b6a-9f7c-89f56a181d4a"
      unitRef="usd">40000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzQtNS0xLTEtMTg0NDY5_b79ad3a3-04a0-4993-a079-ab2bfb669681"
      unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzUtMS0xLTEtMTg0NDY5_f42a932f-f886-48ed-8aad-4b8358b859e5"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzUtMy0xLTEtMTg0NDY5_275a5939-2c92-4e2d-adca-0c971ec6aeb9"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzUtNS0xLTEtMTg0NDY5_6913ea5b-d515-4b74-ad87-128cb6ac0019"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzYtMS0xLTEtMTg0NDY5_336bba51-952a-4092-8069-8f1eeb527177"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzYtMy0xLTEtMTg0NDY5_7268283d-8ca8-477b-a7d2-724d36c47c67"
      unitRef="usd">23000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzYtNS0xLTEtMTg0NDY5_5f542792-e3b6-4db9-a30b-5ff7470b334f"
      unitRef="usd">2000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzctMS0xLTEtMTg0NDY5_9acdecc4-0829-48cb-8efb-03f8a99d6ffe"
      unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzctMy0xLTEtMTg0NDY5_406f56d0-335f-48c7-a303-bbb528dec6e3"
      unitRef="usd">33000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzctNS0xLTEtMTg0NDY5_81970172-fcf7-485b-8de1-3185a4245847"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzgtMS0xLTEtMTg0NDY5_0ccb27cf-8fc9-42f1-9e13-1515b98b0818"
      unitRef="usd">69000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzgtMy0xLTEtMTg0NDY5_34df2977-4024-40a9-ab2d-e24ed47286a1"
      unitRef="usd">53000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5NjUxMTkwNDY0MzM0MTNjOThmMzI3ODdiZDE1MzliYi90YWJsZXJhbmdlOjk2NTExOTA0NjQzMzQxM2M5OGYzMjc4N2JkMTUzOWJiXzgtNS0xLTEtMTg0NDY5_e73b6aae-ce03-490a-95e6-71835d837a0f"
      unitRef="usd">74000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzEwNDY_dd948f35-f25f-4806-aeb3-66e32ec7c655"
      unitRef="usd">44000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <mo:UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzEwNjE_84ae2dc2-88b7-4f53-b684-df185401afad"
      unitRef="usd">25000000</mo:UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzExOTg_c397c156-f8de-4c9d-9ffc-60fca4fa61dd"
      unitRef="usd">31000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <mo:UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzEyMTM_47558aa9-870a-4c50-a72f-894eb8dc1ba4"
      unitRef="usd">22000000</mo:UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU3NzI0MzYwNDgxMDI0_58975984-ecf1-4620-ab93-28703f6e8c86"
      unitRef="usd">18000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU3NzI0MzYwNDgxMDE5_1f9f5403-ac72-4618-b08a-1d049d9f6cc8"
      unitRef="usd">11000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU3NzI0MzYwNDgxMDA1_bc81f5ab-4a19-431d-a33d-0af460a37b55"
      unitRef="usd">15000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzE0NjY_c703c8e5-c56a-43d2-940c-9c3d38c08f8e"
      unitRef="usd">8000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzE0NzA_faf6a903-632e-445e-8f42-57f3ef9d58cc"
      unitRef="usd">-4000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzE0Nzc_ac54d0ef-3cea-4894-b913-d95a72b71cb6"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzIxNTc_d4546139-7c8d-4b9a-b5e8-ea52c902e86a"
      unitRef="usd">1000000</us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU2ODY_43e13ad7-6bdc-4cab-a0fb-36866831f8be">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation between actual income taxes and amounts computed by applying the federal statutory rate to earnings before income taxes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.369%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,552&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) resulting from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State and local income taxes, net of federal tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;435&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax basis in foreign investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in JUUL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in Cronos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;0.4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance releases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(664)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(9.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effective tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,625&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzMtMi0xLTEtMTg0NDY5_b87748f8-00da-4928-a698-cf8876012e65"
      unitRef="usd">1552000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzMtNC0xLTEtMTg0NDY5_503eaa17-4fa7-4587-8396-5866b3bd600c"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzMtNi0xLTEtMTg0NDY5_b274e1d0-ecb1-4a05-9ea2-6df3cac12a5e"
      unitRef="usd">803000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzMtOC0xLTEtMTg0NDY5_142162b3-aebd-42af-b4b7-68ddcb61877e"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzMtMTAtMS0xLTE4NDQ2OQ_74a697a3-8b15-4a85-bf52-9f7b7623ce3c"
      unitRef="usd">1447000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzMtMTItMS0xLTE4NDQ2OQ_4bb9162a-0cb2-45c5-817e-8493f5a1b74b"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzUtMi0xLTEtMTg0NDY5_efb3449b-fb38-4882-8525-ed9c7bcf1641"
      unitRef="usd">435000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzUtNC0xLTEtMTg0NDY5_a6b61306-1e2e-4815-8694-18b860725239"
      unitRef="number">0.059</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzUtNi0xLTEtMTg0NDY5_1caa1eed-326e-4458-8c47-2ef4da2282a7"
      unitRef="usd">451000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzUtOC0xLTEtMTg0NDY5_a13b226b-5d1b-448a-903c-536843208530"
      unitRef="number">0.118</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzUtMTAtMS0xLTE4NDQ2OQ_240166df-18ff-4fca-897f-68fe0fb516ae"
      unitRef="usd">410000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzUtMTItMS0xLTE4NDQ2OQ_7e1978e6-ec2a-4a1a-8107-4b659feb6772"
      unitRef="number">0.060</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzYtMi0xLTEtMTg0NDY5_d248b710-6531-4bfb-b342-986e174743ad"
      unitRef="usd">11000000</mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount>
    <mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzYtNC0xLTEtMTg0NDY5_f5d1c0c0-0336-4ece-a681-8fdd7de86cf9"
      unitRef="number">0.001</mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments>
    <mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzYtNi0xLTEtMTg0NDY5_61bf2f52-84f2-49d9-9306-21dfbb6520e8"
      unitRef="usd">25000000</mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount>
    <mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzYtOC0xLTEtMTg0NDY5_45a217f4-2cd0-4a78-aa6c-716e1b38db1c"
      unitRef="number">0.007</mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments>
    <mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzYtMTAtMS0xLTE4NDQ2OQ_f0dfa4bd-7cb2-43ce-8027-9f4c2b604e91"
      unitRef="usd">23000000</mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount>
    <mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzYtMTItMS0xLTE4NDQ2OQ_d227ea1a-ae3f-41a8-b935-5390a7369f30"
      unitRef="number">0.003</mo:EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzgtMi0xLTEtMTg0NDY5_ab9be699-994e-4d4b-a583-362601dbe46a"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzgtNC0xLTEtMTg0NDY5_dfe6d2a8-2dcd-493a-b771-606a74089f6a"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzgtNi0xLTEtMTg0NDY5_418c24ed-bd94-4fe3-a441-7b73cf4ccedc"
      unitRef="usd">-25000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzgtOC0xLTEtMTg0NDY5_0b900602-7faa-4801-864b-3a37df98f428"
      unitRef="number">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzgtMTAtMS0xLTE4NDQ2OQ_b8955740-a379-4ff9-8ed5-619dd8abc4cf"
      unitRef="usd">9000000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzgtMTItMS0xLTE4NDQ2OQ_8d4d12a5-f49a-4b8a-891f-f802cd1425e4"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount
      contextRef="i25c3587d3f994622b4714f1b3124a4da_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzktMi0xLTEtMTg0NDY5_4b58470e-5c14-4f0a-ab05-ce8f04226234"
      unitRef="usd">-24000000</mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="i25c3587d3f994622b4714f1b3124a4da_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzktNC0xLTEtMTg0NDY5_45d70608-e63d-4393-bc43-d77471206b51"
      unitRef="number">-0.003</mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount
      contextRef="id61401757fdc493c83aa67b7620e44d4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzktNi0xLTEtMTg0NDY5_cd8a0a70-e7f8-4c8c-b4b6-146655e2dd24"
      unitRef="usd">-16000000</mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="id61401757fdc493c83aa67b7620e44d4_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzktOC0xLTEtMTg0NDY5_6d027b90-3b61-41e0-a9ca-c423c6f4f789"
      unitRef="number">-0.004</mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount
      contextRef="if803b88b013a40dfba8d352c3b38fd7a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzktMTAtMS0xLTE4NDQ2OQ_b0a5f300-b5dc-46d2-abdb-a75392a0d623"
      unitRef="usd">3000000</mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="if803b88b013a40dfba8d352c3b38fd7a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzktMTItMS0xLTE4NDQ2OQ_c4cc2f28-9541-4541-ba7f-86643b3eebe2"
      unitRef="number">0.001</mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount
      contextRef="icc2bb0b67a1f4be892d628382285683c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEwLTItMS0xLTE4NDQ2OQ_e5f7a91b-5921-4d95-affb-58789b4edc99"
      unitRef="usd">306000000</mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="icc2bb0b67a1f4be892d628382285683c_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEwLTQtMS0xLTE4NDQ2OQ_55a2462a-d927-4205-9a37-2854ad5c4b2d"
      unitRef="number">0.041</mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount
      contextRef="i6ee0d2b6272e47c2b0125f423877e769_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEwLTYtMS0xLTE4NDQ2OQ_3f7400b2-b306-4482-b6e5-6509a4e3125f"
      unitRef="usd">7000000</mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="i6ee0d2b6272e47c2b0125f423877e769_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEwLTgtMS0xLTE4NDQ2OQ_08d96f63-4da0-4937-b606-66fecb5dde7c"
      unitRef="number">0.002</mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount
      contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEwLTEwLTEtMS0xODQ0Njk_e3a3b3fc-d678-4c19-8360-b3085c277176"
      unitRef="usd">537000000</mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEwLTEyLTEtMS0xODQ0Njk_7a19d1bb-4156-409f-b34d-1313dd216250"
      unitRef="number">0.078</mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount
      contextRef="iea2f16158f9341fd86284d599cb55729_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzExLTItMS0xLTE4NDQ2OQ_4066900e-8957-4ad2-b5e1-2b0529b07f3e"
      unitRef="usd">30000000</mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="iea2f16158f9341fd86284d599cb55729_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzExLTQtMS0xLTE4NDQ2OQ_6aeab92c-6b0e-4265-a6bf-52351ebef214"
      unitRef="number">0.004</mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount
      contextRef="i13178e7cbc7c479c89b40c940101986c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzExLTYtMS0xLTE4NDQ2OQ_0fb7e9fc-fad9-4907-89c8-6068e55f8a59"
      unitRef="usd">128000000</mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="i13178e7cbc7c479c89b40c940101986c_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzExLTgtMS0xLTE4NDQ2OQ_56a7440d-7fc4-4710-83ba-049cfca01cfd"
      unitRef="number">0.033</mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount
      contextRef="i3bf83008070a46eb83178baf67bbaa65_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzExLTEwLTEtMS0xODQ0Njk_4ab06051-cd7d-4c7f-b4fd-ec53fc286c71"
      unitRef="usd">20000000</mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent
      contextRef="i3bf83008070a46eb83178baf67bbaa65_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzExLTEyLTEtMS0xODQ0Njk_7eb25048-b1cf-4c54-9d07-92d83cf0c7f2"
      unitRef="number">0.003</mo:EffectiveIncomeTaxRateReconciliationValuationAllowancePercent>
    <mo:EffectiveIncomeTaxRateReconciliationValuationReversalAmount
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTItMS0xLTIxNjQ0Ng_866c1045-9753-42fe-baf5-06d7cdbb8a75"
      unitRef="usd">-664000000</mo:EffectiveIncomeTaxRateReconciliationValuationReversalAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationReversalPercent
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTQtMS0xLTIxNjUyMg_13f0e6c1-c053-4698-999d-3b2b9792d2bd"
      unitRef="number">-0.090</mo:EffectiveIncomeTaxRateReconciliationValuationReversalPercent>
    <mo:EffectiveIncomeTaxRateReconciliationValuationReversalAmount
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTYtMS0xLTIxNjUzMA_333c8b9a-7dac-4498-bf04-ac7125f83169"
      unitRef="usd">-15000000</mo:EffectiveIncomeTaxRateReconciliationValuationReversalAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationReversalPercent
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTgtMS0xLTIxNjUzOA_65825cff-8b14-4a2e-86c9-89b2bdf3220a"
      unitRef="number">-0.004</mo:EffectiveIncomeTaxRateReconciliationValuationReversalPercent>
    <mo:EffectiveIncomeTaxRateReconciliationValuationReversalAmount
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTEwLTEtMS0yMTY1NDY_a76507b9-54cb-4271-9c20-6c8d06d826f4"
      unitRef="usd">-19000000</mo:EffectiveIncomeTaxRateReconciliationValuationReversalAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationReversalPercent
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTEyLTEtMS0yMTY1NTU_07b6fc82-ba49-47a3-9b56-c1c1e627ab6b"
      unitRef="number">-0.003</mo:EffectiveIncomeTaxRateReconciliationValuationReversalPercent>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTItMS0xLTE4NDQ2OQ_141a0c73-75d7-4276-8c25-57ed9214ba31"
      unitRef="usd">-21000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTQtMS0xLTE4NDQ2OQ_e4ca5f24-7eca-4b50-9df0-0e36fd871c55"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTYtMS0xLTE4NDQ2OQ_cccd3e81-a696-4315-bac3-dbf204877b70"
      unitRef="usd">-9000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTgtMS0xLTE4NDQ2OQ_d1cb5fc6-bdfb-4610-a354-5fdde2dc39c4"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTEwLTEtMS0xODQ0Njk_a5f3ec4e-c6c4-4b20-b2f5-762e714e4b47"
      unitRef="usd">6000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEyLTEyLTEtMS0xODQ0Njk_56727f5a-bc98-452a-a0bf-545609572925"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEzLTItMS0xLTE4NDQ2OQ_e2fb79d6-f8c0-4ce5-971f-36fb8e669330"
      unitRef="usd">1625000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEzLTQtMS0xLTE4NDQ2OQ_907641aa-679b-46b6-822a-8580acb97655"
      unitRef="number">0.220</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEzLTYtMS0xLTE4NDQ2OQ_e42dffb4-36ae-41e6-9df5-7892820950c4"
      unitRef="usd">1349000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEzLTgtMS0xLTE4NDQ2OQ_c7c66c3b-da3f-4997-8a96-12e860f46349"
      unitRef="number">0.353</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEzLTEwLTEtMS0xODQ0Njk_f56848a2-758f-4309-8e46-344851f379fc"
      unitRef="usd">2436000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTplZTFkZTI2NjMzNDA0MmYxYWQ3Y2YzNWMyZGQ4OGIxNC90YWJsZXJhbmdlOmVlMWRlMjY2MzM0MDQyZjFhZDdjZjM1YzJkZDg4YjE0XzEzLTEyLTEtMS0xODQ0Njk_f49e75a4-aba0-4d61-8664-231763a5c355"
      unitRef="number">0.354</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <mo:ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzIxOTkwMjMyNzIzODQ_7dbaef17-e9fa-400d-977b-7ad656d6fb8e"
      unitRef="usd">664000000</mo:ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="icc2bb0b67a1f4be892d628382285683c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzIxOTkwMjMyNzI0MDI_4604a4ec-ac3d-4e7e-b57b-00b360b64fd4"
      unitRef="usd">-306000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount
      contextRef="i13178e7cbc7c479c89b40c940101986c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzIxOTkwMjMyNjI4NjY_0fb7e9fc-fad9-4907-89c8-6068e55f8a59"
      unitRef="usd">128000000</mo:EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzI4Mjk_562ffecc-a4ef-4739-b461-d97962045f96"
      unitRef="usd">612000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzI5OTE_a77eb3e2-eed9-4a1e-9991-94f5e523d707"
      unitRef="usd">-24000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU2ODg_16c26903-77b6-4fa3-a8b4-c666fa3f0272">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax effects of temporary differences that gave rise to deferred income tax assets and liabilities consisted of the following at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued postretirement and postemployment benefits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;303&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;729&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in JUUL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,001&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in Cronos&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;407&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating losses and tax credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(233)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,849)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,802)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in ABI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued pension costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,097)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzItMS0xLTEtMTg0NDY5_91a8cc13-4d58-48d2-8047-eac87c6c8875"
      unitRef="usd">303000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzItMy0xLTEtMTg0NDY5_00697506-0506-4df1-ba4e-7296d6fd6e2e"
      unitRef="usd">387000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzMtMS0xLTEtMTg0NDY5_72130d69-ad3c-4341-bd8d-7870011bb8d3"
      unitRef="usd">729000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzMtMy0xLTEtMTg0NDY5_2c1e9620-a259-47f5-96b1-a70e1e4ec756"
      unitRef="usd">835000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements>
    <mo:DeferredTaxAssetsInvestmentsInEquitySecurities
      contextRef="i688c2fcd3b0343b29196c870d74f6b68_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzUtMS0xLTEtMTg0NDY5_1e1486d7-2a8f-4777-bf0d-3c2d0d13db2f"
      unitRef="usd">3001000000</mo:DeferredTaxAssetsInvestmentsInEquitySecurities>
    <mo:DeferredTaxAssetsInvestmentsInEquitySecurities
      contextRef="i56c5cabbdfb44d05a0e818aa3c22c4d1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzUtMy0xLTEtMTg0NDY5_aa665326-3598-48b5-beb6-35e4ca5c016d"
      unitRef="usd">2652000000</mo:DeferredTaxAssetsInvestmentsInEquitySecurities>
    <us-gaap:DeferredTaxAssetsEquityMethodInvestments
      contextRef="i84433bab48264529a2516c2663b4fc52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzYtMS0xLTEtMTg0NDY5_9fcddaff-4b67-4bf7-babf-1c1adebbc9ab"
      unitRef="usd">407000000</us-gaap:DeferredTaxAssetsEquityMethodInvestments>
    <us-gaap:DeferredTaxAssetsEquityMethodInvestments
      contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzYtMy0xLTEtMTg0NDY5_21ceb4e9-297e-43b7-817b-acfcea7eb059"
      unitRef="usd">403000000</us-gaap:DeferredTaxAssetsEquityMethodInvestments>
    <mo:DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzctMS0xLTEtMTg0NDY5_1ebfbe0f-27ae-49d2-98b0-4e19737b4387"
      unitRef="usd">31000000</mo:DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards>
    <mo:DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzctMy0xLTEtMTg0NDY5_d967753b-46c4-4c91-bf68-3f86b9cfbdb0"
      unitRef="usd">46000000</mo:DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzgtMS0xLTEtMTg0NDY5_1b19d50b-74ef-4bc3-a890-e43e291223b9"
      unitRef="usd">4471000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzgtMy0xLTEtMTg0NDY5_f1eb5565-2a64-41c8-a7fd-32fd3fd3dff2"
      unitRef="usd">4323000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzEwLTEtMS0xLTE4NDQ2OQ_19cda88e-0e22-49d7-bdab-6f9aa69fed3f"
      unitRef="usd">233000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzEwLTMtMS0xLTE4NDQ2OQ_1f1c4785-a761-4fd8-99d1-4cb6ab1ddda1"
      unitRef="usd">216000000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzExLTEtMS0xLTE4NDQ2OQ_22e8dd66-ac68-4f55-9f9e-941b00dc08d9"
      unitRef="usd">2849000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzExLTMtMS0xLTE4NDQ2OQ_a8d1f19c-9c3a-453c-926f-c9be36f08fb4"
      unitRef="usd">2802000000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzEyLTEtMS0xLTE4NDQ2OQ_53f22832-96ef-40b6-b74e-16e2a18723ee"
      unitRef="usd">1226000000</us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates>
    <us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzEyLTMtMS0xLTE4NDQ2OQ_fc1edc75-cf9d-4906-a9e0-0e813570a583"
      unitRef="usd">1695000000</us-gaap:DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates>
    <us-gaap:DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzEzLTEtMS0xLTE4NDQ2OQ_499f14f2-f4ee-4086-bbaa-0be92d7d4ae3"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld>
    <us-gaap:DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzEzLTMtMS0xLTE4NDQ2OQ_5f7e866f-bdda-4302-80bc-bca929f7bdb9"
      unitRef="usd">29000000</us-gaap:DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld>
    <mo:DeferredTaxLiabilitiesAccruedPensionCosts
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE0LTEtMS0xLTE4NDQ2OQ_535a5329-1421-4966-b5de-a6cf16e1b1f6"
      unitRef="usd">70000000</mo:DeferredTaxLiabilitiesAccruedPensionCosts>
    <mo:DeferredTaxLiabilitiesAccruedPensionCosts
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE0LTMtMS0xLTE4NDQ2OQ_0597886c-2b23-4003-92fe-af3072b77ff7"
      unitRef="usd">55000000</mo:DeferredTaxLiabilitiesAccruedPensionCosts>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE1LTEtMS0xLTE4NDQ2OQ_8a55cb2d-54c8-497c-8007-04d32dd6e82d"
      unitRef="usd">115000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE1LTMtMS0xLTE4NDQ2OQ_06006dcd-ee6d-4625-81d0-0cd760a68c27"
      unitRef="usd">94000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE2LTEtMS0xLTE4NDQ2OQ_8dd64407-17e6-4a47-b85e-c77c1234d802"
      unitRef="usd">4493000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE2LTMtMS0xLTE4NDQ2OQ_b727f537-86b7-4f66-b32f-749a61cbaf5d"
      unitRef="usd">4891000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE3LTEtMS0xLTE4NDQ2OQ_2ce874e4-3461-4bdb-b777-60ecd319fdf1"
      unitRef="usd">2800000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE3LTMtMS0xLTE4NDQ2OQ_9ff652c7-286d-4d73-a573-c05a0cf84585"
      unitRef="usd">3097000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE4LTEtMS0xLTE4NDQ2OQ_b0f79b14-4365-4ce9-a845-3287f8f8ec81"
      unitRef="usd">2822000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTpmMGY3OGJlMmQ0MWQ0MjlmYjNhZDVlNGZiOTEzZWE4Ni90YWJsZXJhbmdlOmYwZjc4YmUyZDQxZDQyOWZiM2FkNWU0ZmI5MTNlYTg2XzE4LTMtMS0xLTE4NDQ2OQ_9fe3ddc3-983a-44e8-bb39-285696f9e1e7"
      unitRef="usd">3665000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i2c3c12dfb2294441a79714c48c67814a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzQxNjA_eb40af1d-1321-458f-91e9-70a1fb8b7463"
      unitRef="usd">19000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:SummaryOfValuationAllowanceTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzU2NjQ_309cb66a-4ea5-4d82-a718-ab0c9bf7cfd5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending valuation allowances was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,097&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to valuation allowance charged to income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;429&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions to valuation allowance credited to income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(730)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfValuationAllowanceTextBlock>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzItMi0xLTEtMTg0NDY5_64486202-1ead-466b-b516-20d9142ab227"
      unitRef="usd">3097000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzItNC0xLTEtMTg0NDY5_8e3b2864-48f7-4833-8b4a-737cee41e375"
      unitRef="usd">2817000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i40e064b5da194d8bbe29064d490250de_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzItNi0xLTEtMTg0NDY5_b33dbac8-cd37-4a41-963d-62724339e7cf"
      unitRef="usd">2324000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzQtMi0xLTEtMTg0NDY5_0e35aec0-0617-4e76-97db-5c821caf4e59"
      unitRef="usd">429000000</mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions>
    <mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzQtNC0xLTEtMTg0NDY5_16a36276-43a6-4e91-93d2-f5ebfb4ba871"
      unitRef="usd">401000000</mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions>
    <mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzQtNi0xLTEtMTg0NDY5_52b51343-6dba-40e5-a5e6-4a18b6fb07a9"
      unitRef="usd">692000000</mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions>
    <mo:ValuationAllowanceDeferredTaxAssetReductions
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzUtMi0xLTEtMTg0NDY5_2d2668ac-a168-4599-87e3-a81ed398fa21"
      unitRef="usd">730000000</mo:ValuationAllowanceDeferredTaxAssetReductions>
    <mo:ValuationAllowanceDeferredTaxAssetReductions
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzUtNC0xLTEtMTg0NDY5_7a4a6e98-ac56-42a3-928f-6f2c4c979c43"
      unitRef="usd">118000000</mo:ValuationAllowanceDeferredTaxAssetReductions>
    <mo:ValuationAllowanceDeferredTaxAssetReductions
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzUtNi0xLTEtMTg0NDY5_2dc2bfe2-6368-450a-8a26-f3254b5e5183"
      unitRef="usd">200000000</mo:ValuationAllowanceDeferredTaxAssetReductions>
    <mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzYtMi0xLTEtMTg0NDY5_187a5eca-05ff-4f0a-8b2b-5060c299abf1"
      unitRef="usd">4000000</mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation>
    <mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzYtNC0xLTEtMTg0NDY5_a5c402d3-e214-4dcc-a435-8d247daedbaa"
      unitRef="usd">-3000000</mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation>
    <mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzYtNi0xLTEtMTg0NDY5_f82bf796-247a-49e2-a62b-972db8b7a9ca"
      unitRef="usd">1000000</mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzctMi0xLTEtMTg0NDY5_a90c53fb-41c2-49b4-8553-13b6fabfdd35"
      unitRef="usd">2800000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzctNC0xLTEtMTg0NDY5_40f9f280-1e5a-4cf7-b910-bab2c5d69a12"
      unitRef="usd">3097000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90YWJsZTo5Zjk1YmQxZGQzYzI0MTgwOTRiMjcxMzgwMGFhYjkyZi90YWJsZXJhbmdlOjlmOTViZDFkZDNjMjQxODA5NGIyNzEzODAwYWFiOTJmXzctNi0xLTEtMTg0NDY5_72e391b7-df7c-49f1-aed6-dfac7802eb88"
      unitRef="usd">2817000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i688c2fcd3b0343b29196c870d74f6b68_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzIxOTkwMjMyNzI0NDM_db0277bf-9288-45a2-b335-f56a0a43b0e9"
      unitRef="usd">2394000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i84433bab48264529a2516c2663b4fc52_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzIxOTkwMjMyNzI0NjE_c6006ad1-8687-40e8-8857-52b9ff373f70"
      unitRef="usd">379000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i56c5cabbdfb44d05a0e818aa3c22c4d1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzUwNTI_6e3db24a-128c-44da-9626-b9580944fa8d"
      unitRef="usd">2652000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i6ec6279eb69f48ba88be3a0c82ec347a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzUwOTQ_871237b5-da55-4b09-b4e6-9060e647c89a"
      unitRef="usd">407000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i03a506aa953a48c7b25b31d9389dbe4a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzUyNTQ_ed55d986-091e-46c6-b9fd-50aff547c51c"
      unitRef="usd">2610000000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i3bf83008070a46eb83178baf67bbaa65_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNTcvZnJhZzo2NjVkYTc5YmMwMmU0ZWMzYjUzNjUwOTFiMzAxNzBiOC90ZXh0cmVnaW9uOjY2NWRhNzliYzAyZTRlYzNiNTM2NTA5MWIzMDE3MGI4XzUyODk_23be98c4-8f03-4f0a-a166-6e61ce842179"
      unitRef="usd">121000000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc1MTg_0922f71b-a2fa-4fda-9d81-9e60e07ced0e">Segment Reporting&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our operating companies&#x2019; products include (i) smokeable tobacco products, consisting of combustible cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton; and (ii) oral tobacco products, consisting of MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix.  These products constituted our reportable segments of smokeable products and oral tobacco products at December&#160;31, 2022.  The financial services business, the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; System heated tobacco business and Helix ROW were included in all other.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the sale of our wine business on October 1, 2021, wine produced and/or sold by Ste. Michelle was a reportable segment.  For further discussion, see Note 1. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Background and Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our chief operating decision maker (&#x201c;CODM&#x201d;) reviews operating companies income (loss) (&#x201c;OCI&#x201d;) to evaluate the performance of, and allocate resources to, our segments.  OCI for our segments is defined as operating income before general corporate expenses and amortization of intangibles.  Interest and other debt expense, net, along with net periodic benefit cost (income), excluding service cost, and provision for income taxes are centrally managed at the corporate level and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by our CODM.  We do not disclose information about total assets by segment because such information is not reported to or used by our CODM.  Substantially all of our long-lived assets were located in the United States at December 31, 2022.  Segment goodwill and other intangible assets, net, are disclosed in Note 4. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Other Intangible Assets, net.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The accounting policies of the segments were the same at December 31, 2022 as those described in Note 2. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,476&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,096&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,688&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,632&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,919&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,058&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on early extinguishment of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit income, excluding service cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) losses from investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,641&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of JUUL equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on Cronos-related financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The smokeable products segment included net revenues of $21,457 million, $21,877 million and $22,135 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively, related to cigarettes and net revenues of $1,019 million, $989 million and $954 million for the years ended December&#160;31, 2022, 2021 and 2020, respectively, related to cigars.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all of our net revenues for the years ended December&#160;31, 2022, 2021 and 2020 were from sales generated in the United States.  PM USA, USSTC, Helix and Middleton&#x2019;s customer, Performance Food Group Company, which acquired Core-Mark Holding Company, Inc. in 2021, accounted for approximately 24% and 23% of our consolidated net revenues for the years ended December&#160;31, 2022 and 2021, respectively.  Core-Mark Holding Company, Inc. accounted for 17% of our consolidated net revenues for the year ended December&#160;31, 2020.  In addition, McLane Company, Inc., accounted for approximately 23%, 23% and 26% of our consolidated net revenues for the years ended December&#160;31, 2022, 2021 and 2020, respectively.  Substantially all of these net revenues were reported in the smokeable products and oral tobacco products segments.  No other customer accounted for more than 10% of our consolidated net revenues for the years ended December 31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Details of our depreciation expense and capital expenditures were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;153&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The comparability of OCI for our reportable segments and the all other category was affected by the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Non-Participating Manufacturer (&#x201c;NPM&#x201d;) Adjustment Items: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded pre-tax (income) expense for NPM adjustment items as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded the amounts in the table shown above for the smokeable products segment as (reductions) increases to cost of sales in our consolidated statements of earnings, which (increased) decreased OCI in our smokeable products segment.  NPM adjustment items result from the resolutions of certain disputes with states and territories related to the NPM adjustment provision under the Master Settlement Agreement (such dispute resolutions are referred to as &#x201c;NPM Adjustment Items&#x201d; and are more fully described in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Health Care Cost Recovery Litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in Note 17. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Tobacco and Health and Certain Other Litigation Items: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded pre-tax charges related to tobacco and health and certain other litigation items as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;131&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded the amounts shown in the table above for the smokeable products segment and general corporate expenses in marketing, administration and research costs in our consolidated statements of earnings.  For further discussion, see Note 17. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Ste. Michelle Transaction: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded pre-tax disposition-related costs of $51 million for the year ended December&#160;31, 2021 in our former wine segment, which consisted of a pre-tax charge of $41 million to record the assets and liabilities associated with the Ste. Michelle Transaction at their fair value less costs to sell and $10 million of other disposition-related costs.  We included these costs in marketing, administration and research costs in our consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Acquisition-Related Costs:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We recorded pre-tax acquisition-related costs of $37 million for the year ended December&#160;31, 2021 in our oral tobacco products segment primarily for the settlement of an arbitration related to the 2019 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;on!&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; transaction.  We included these costs in marketing, administration and research costs in our consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Wine Business Strategic Reset:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded pre-tax implementation costs of $411 million for the year ended December&#160;31, 2020, in our former wine segment, associated with a strategic reset initiated in the first quarter of 2020 intended to maximize Ste. Michelle&#x2019;s profitability and achieve improved long-term cash flow generation.  Substantially all of the charges consisted of the following: (i) write-off of inventory ($292 million) as Ste. Michelle no longer believed that the benefit of the blending and production plans for its inventory outweighed inventory carrying cost given the reduced product volume demand; and (ii) estimated losses on future non-cancelable grape purchase commitments that Ste. Michelle believed no longer had a future economic benefit ($100 million).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;PMCC Residual Value Adjustments:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For the year ended December&#160;31, 2020, we recorded pre-tax charges of $125 million (as a reduction to net revenues in the all other category) related to the decrease in unguaranteed residual values of certain PMCC leased assets.  There were no such adjustments in 2022 or 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;COVID-19 Special Items: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded net pre-tax charges of $50 million ($41 million in the smokeable products segment and $9 million in the oral tobacco products segment) in our consolidated statement of earnings for the year ended December&#160;31, 2020 related to the COVID-19 pandemic.  These net pre-tax charges, which were directly related to disruptions caused by or efforts to mitigate the impact of the COVID-19 pandemic, were all recorded in cost of sales and included premium pay, personal protective equipment and health screenings, which were partially offset by certain employment tax credits.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc1MjE_3ef934a0-8822-407c-842a-630047e28f17">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,476&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,580&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;25,096&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,688&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,632&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11,919&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,058&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on early extinguishment of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit income, excluding service cost &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(184)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Income) losses from investments in equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,641&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of JUUL equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on Cronos-related financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;15&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12f67c433715485982086bcdbfe00787_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzMtMS0xLTEtMTg0NDY5_8173f2f6-6808-4a70-b4f7-630aad4eadf2"
      unitRef="usd">22476000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48f5736e8fdd4e1b9a291a912e9cd3be_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzMtMy0xLTEtMTg0NDY5_d850bd18-0a26-4bb7-bc53-cc983f451310"
      unitRef="usd">22866000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i111e309b231242cfbccc5619cb83229c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzMtNS0xLTEtMTg0NDY5_d5f9cef5-ed48-43a9-ba31-292f15505b58"
      unitRef="usd">23089000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd8c2710852f4850ae750a2d93d4e568_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzQtMS0xLTEtMTg0NDY5_d7b034e5-1be0-466a-85c8-2874700a56df"
      unitRef="usd">2580000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01d98d739f504698ad868c0b443af1b2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzQtMy0xLTEtMTg0NDY5_d5e91c90-a5eb-4c04-b158-7f3e6f9a4935"
      unitRef="usd">2608000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46fc9282d17e4ce08f7ce9e03e4e9fd3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzQtNS0xLTEtMTg0NDY5_4616ce63-5b3c-41ac-b975-5fb10fcf615f"
      unitRef="usd">2533000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if55bb70b849b4190b6e9721bddaaf8c6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzUtMS0xLTEtMTg0NDY5_3f8e6fbd-0f56-497e-a1d9-b3fcedfe34c7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8857cf14a32848aa9b176fb4b04397e2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzUtMy0xLTEtMTg0NDY5_ac95697e-ab36-4fe0-bdea-2f9554bd6197"
      unitRef="usd">494000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2b6b1d5fe6046078463af99cc3f0ee3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzUtNS0xLTEtMTg0NDY5_43c9bea3-4401-4f51-8929-a938a8109923"
      unitRef="usd">614000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9666810a94704e499168fa1e4086657b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzYtMS0xLTEtMTg0NDY5_c0cac418-4499-458d-b1ae-ff6062de2c9e"
      unitRef="usd">40000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd98997f40d64f368230b460b98992e1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzYtMy0xLTEtMTg0NDY5_8a2accb6-f3bf-404c-a686-e37abc4ecc9b"
      unitRef="usd">45000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i346f9407b62340fc87ea781c6a87bc3a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzYtNS0xLTEtMTg0NDY5_eeef07ee-8d1a-4c7b-b67c-bbb6fe561d08"
      unitRef="usd">-83000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzctMS0xLTEtMTg0NDY5_c550eeee-66a9-4259-9f09-08cd0cd50848"
      unitRef="usd">25096000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzctMy0xLTEtMTg0NDY5_c27aa260-9449-4c94-bd8a-3a2111e5742c"
      unitRef="usd">26013000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzctNS0xLTEtMTg0NDY5_53ec5698-73ff-48d0-967e-9c17c91d0d7b"
      unitRef="usd">26153000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="i913162c559bc449289b7eb12f1b829ed_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEwLTEtMS0xLTE4NDQ2OQ_d8fc788c-c80a-40ca-8a42-8cf18fe74732"
      unitRef="usd">10688000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icb973d3950d9475a923b769b439f1690_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEwLTMtMS0xLTE4NDQ2OQ_6fb6650b-0ce8-4a9a-98d5-ead80ec742b8"
      unitRef="usd">10394000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i71a3f3b84bfc4a76b4da5d7f37f602af_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEwLTUtMS0xLTE4NDQ2OQ_6cddbb66-ca18-43cc-bf76-86e86d8561e7"
      unitRef="usd">9985000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic22cd9b4e4d94780871456a2f40823af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzExLTEtMS0xLTE4NDQ2OQ_affcd297-69da-43e6-b232-7e4f78aed03d"
      unitRef="usd">1632000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i7975fef95c3d41c984bc01c3cd6d50c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzExLTMtMS0xLTE4NDQ2OQ_7a1f4b38-cda8-4e22-87e0-da4a46b784b2"
      unitRef="usd">1659000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idc000d98c0ca4b1ab8abdbf602942f3f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzExLTUtMS0xLTE4NDQ2OQ_72929bee-720b-4a46-b752-3f8b0fbd90b8"
      unitRef="usd">1718000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic0f69c7e020f4496bb5f91ff08930975_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEyLTEtMS0xLTE4NDQ2OQ_0b4a0209-3ebe-445f-ac0e-0db2b174b838"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i617c77ba0ff242099cb5b33ab2af1d0c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEyLTMtMS0xLTE4NDQ2OQ_70666000-936c-47f1-8b85-fd2b5725a107"
      unitRef="usd">21000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia43c067e1e4b4763ac5c2b473efb3a37_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEyLTUtMS0xLTE4NDQ2OQ_4233d439-046e-4ccd-b83e-5ad066fc01f6"
      unitRef="usd">-360000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i804b801d4bd04571aaa1e6babe7ee711_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEzLTEtMS0xLTE4NDQ2OQ_3bc6c168-db22-4a71-b8ca-6336a84233cd"
      unitRef="usd">-36000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iadaebe2af5d4425f92e98085c262bdfa_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEzLTMtMS0xLTE4NDQ2OQ_182ab943-70f8-44f8-b993-8ef827f82da9"
      unitRef="usd">-97000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5586d1fe97814ea899ee8184c7f7d8d9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzEzLTUtMS0xLTE4NDQ2OQ_0f96342c-7159-48bd-b8b0-ab63fc91682f"
      unitRef="usd">-172000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE0LTEtMS0xLTE4NDQ2OQ_35afba10-df92-40e0-b717-fab15b47368e"
      unitRef="usd">73000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE0LTMtMS0xLTE4NDQ2OQ_066e1d8f-cd26-4d9d-a8a8-2fc16c7ccdb0"
      unitRef="usd">72000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE0LTUtMS0xLTE4NDQ2OQ_8d4722d5-ad3a-4c62-9ba1-6b90097e2641"
      unitRef="usd">72000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i56e043e80aaa413c8cf448a2008386a1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE1LTEtMS0xLTE4NDQ2OQ_33692e25-dbd7-4260-a104-14e64d62b198"
      unitRef="usd">292000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ie7f3cf86f5874b96b40d59c3d6a49d6b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE1LTMtMS0xLTE4NDQ2OQ_7351738f-3af0-4fad-b55c-bd710469936e"
      unitRef="usd">345000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ifa25332878054f3684126e72cd34954c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE1LTUtMS0xLTE4NDQ2OQ_5f0ee90e-c7f3-43be-a4f7-32f75fc87d40"
      unitRef="usd">226000000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE3LTEtMS0xLTE4NDQ2OQ_c36e744b-ce89-4a63-8498-3495bab28778"
      unitRef="usd">11919000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE3LTMtMS0xLTE4NDQ2OQ_dd607fef-cce1-4546-8daa-8d672d50169b"
      unitRef="usd">11560000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE3LTUtMS0xLTE4NDQ2OQ_1057273e-c10e-4321-8932-eaccec7988ab"
      unitRef="usd">10873000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE4LTEtMS0xLTE4NDQ2OQ_52e1bdf4-3b56-4c99-8ab8-d89c4b98a9cb"
      unitRef="usd">-1058000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE4LTMtMS0xLTE4NDQ2OQ_a215cf4f-6096-4520-9e67-617ea439fe84"
      unitRef="usd">-1162000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE4LTUtMS0xLTE4NDQ2OQ_be941b3f-fed6-4ae1-97b0-d57a71c159d8"
      unitRef="usd">-1209000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE5LTEtMS0xLTE4NDQ2OQ_435c66d1-665c-4426-9c1a-63c79f4e1f52"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE5LTMtMS0xLTE4NDQ2OQ_acefb7d9-56f8-4bd0-ac33-27f7bbe16b7f"
      unitRef="usd">-649000000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzE5LTUtMS0xLTE4NDQ2OQ_405ff709-24a8-4455-8dbf-7cca93b099f9"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIwLTEtMS0xLTE4NDQ2OQ_1811ac59-50e2-4421-9552-bc107b617d2d"
      unitRef="usd">-184000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIwLTMtMS0xLTE4NDQ2OQ_53737f31-4094-4ec9-a44a-4cbd2acc1c85"
      unitRef="usd">-202000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIwLTUtMS0xLTE4NDQ2OQ_7f6fb778-9e13-4c50-84ff-6a755a262717"
      unitRef="usd">-77000000</us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIxLTEtMS0xLTE4NDQ2OQ_18b25a00-a3f0-41a3-818f-44b5fd183f75"
      unitRef="usd">-3641000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIxLTMtMS0xLTE4NDQ2OQ_c52d77b8-5c7f-44b3-b678-e9ddbdda94cc"
      unitRef="usd">-5979000000</mo:IncomeLossFromEquityInvestments>
    <mo:IncomeLossFromEquityInvestments
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIxLTUtMS0xLTE4NDQ2OQ_d7357b09-e1d1-4a74-b5c2-253ea37506ab"
      unitRef="usd">-111000000</mo:IncomeLossFromEquityInvestments>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIyLTEtMS0xLTE4NDQ2OQ_85d5e396-f901-404c-bcda-e5b1ebd94b9b"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIyLTMtMS0xLTE4NDQ2OQ_84b9e631-898e-4816-92d5-2a1e42efe616"
      unitRef="usd">0</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIyLTUtMS0xLTE4NDQ2OQ_9703caa2-43ad-4a78-b848-397b566241e8"
      unitRef="usd">2600000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIzLTEtMS0xLTE4NDQ2OQ_9082c1c0-ed8f-4b39-b532-cae80585a03b"
      unitRef="usd">-15000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIzLTMtMS0xLTE4NDQ2OQ_a7518884-e4df-4c7b-84e0-cfcf73df620c"
      unitRef="usd">-148000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzIzLTUtMS0xLTE4NDQ2OQ_54f16b47-7697-4da5-9039-a0b229522b37"
      unitRef="usd">-140000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzI1LTEtMS0xLTE4NDQ2OQ_4158df40-c261-45aa-b6fd-398b7fe59e01"
      unitRef="usd">7389000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzI1LTMtMS0xLTE4NDQ2OQ_cdd268da-91af-4082-8e93-7cb3b1b61683"
      unitRef="usd">3824000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmYjNiZDRhOWYzYzM0YzgyOGNmODBhMzRiMTFjZGI4ZC90YWJsZXJhbmdlOmZiM2JkNGE5ZjNjMzRjODI4Y2Y4MGEzNGIxMWNkYjhkXzI1LTUtMS0xLTE4NDQ2OQ_3898b137-b83a-479c-86a9-13fe6cf0b67d"
      unitRef="usd">6890000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49a7d33e45284663b655e6dbc1bb9919_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzIyODg_2a752efb-1fb5-4cea-9a88-20b4d415958f"
      unitRef="usd">21457000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1678c740bd1a4a26becf33b0f81b0ceb_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzIyOTI_8637fde4-ccf1-4fad-b95c-d748033d5d0f"
      unitRef="usd">21877000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab018587321a483bbfbc7b030fd4e0f6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzIyOTk_8cf4b211-5a51-4aac-acb4-81c3f49267d4"
      unitRef="usd">22135000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iddc198f0f36347669562a343b6ad3c9d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzIzOTM_f6ec3984-f778-4d25-b947-724c79b7591d"
      unitRef="usd">1019000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie443febe03b14271ac779aa41af8f4fe_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzIzOTc_137f0474-0127-4bb2-9cb0-5bcb7d1d5815"
      unitRef="usd">989000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67cd9a14c17b43fc9f780f6a9acde202_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzI0MDQ_cfaac2fc-a959-4cf3-8901-7a28125d4e05"
      unitRef="usd">954000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9df4fbc7975c4c9c97d6d12ee87fa9e1_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MTQ4MDk_86212073-9191-49d3-8bcb-aa7d8657f4d1"
      unitRef="number">0.24</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3185640b9c5049b5aab6f7b888f14010_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MTQ4MTc_e0a36699-8d6b-4655-954f-461642d46662"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0ff1620dadbf4977afc2e21c5632a674_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MTQ5NDg_272ac48d-9a62-4a53-ac33-c942ded38a35"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if2aa57c1f8964e1c832583d037aa1ede_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzI2OTc_4fb08858-6e21-4b71-a99a-78368b423c36"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1148e066b8774e5fbbbc5a24e0555f90_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzI3MDE_25c94546-7f3b-49b3-a72b-ab3831924c0e"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i190f8a7374534d37a6b9e683886f1340_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzI3MDg_9a5cef3a-6dbe-45dd-a1fa-2dfafb0d239c"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc1Mjk_ee402990-3429-4997-ab0e-b3fc7cfaa9e4">&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Details of our depreciation expense and capital expenditures were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;153&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;68&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Oral tobacco products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;90&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;205&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock>
    <us-gaap:Depreciation
      contextRef="i913162c559bc449289b7eb12f1b829ed_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzMtMS0xLTEtMTg0NDY5_a7ae6493-fc83-49fb-a7d8-5923e7e107d7"
      unitRef="usd">87000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="icb973d3950d9475a923b769b439f1690_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzMtMy0xLTEtMTg0NDY5_fc444119-432d-44a7-b6f2-672642207e42"
      unitRef="usd">80000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i71a3f3b84bfc4a76b4da5d7f37f602af_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzMtNS0xLTEtMTg0NDY5_c57514a6-7ec9-4acb-8227-9aed9f027c31"
      unitRef="usd">81000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ic22cd9b4e4d94780871456a2f40823af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzQtMS0xLTEtMTg0NDY5_ded64db3-f0c1-4670-9a26-25433a56c5f7"
      unitRef="usd">33000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i7975fef95c3d41c984bc01c3cd6d50c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzQtMy0xLTEtMTg0NDY5_65f9e3a9-716f-4287-9b43-f2c0346b749a"
      unitRef="usd">34000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="idc000d98c0ca4b1ab8abdbf602942f3f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzQtNS0xLTEtMTg0NDY5_0f4a941d-836d-471f-90a7-43bcb96f2752"
      unitRef="usd">32000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ic0f69c7e020f4496bb5f91ff08930975_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzUtMS0xLTEtMTg0NDY5_2ec4b1d1-28ef-46b1-9982-34bb82ded569"
      unitRef="usd">0</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i617c77ba0ff242099cb5b33ab2af1d0c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzUtMy0xLTEtMTg0NDY5_43aab262-cea5-4886-a284-aadc1624f41c"
      unitRef="usd">27000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ia43c067e1e4b4763ac5c2b473efb3a37_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzUtNS0xLTEtMTg0NDY5_b7b1d15c-6e96-43ac-ae07-e8bab6437f11"
      unitRef="usd">40000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i56e043e80aaa413c8cf448a2008386a1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzctMS0xLTEtMTg0NDY5_d22a755e-1328-427f-b56e-f834ab03551b"
      unitRef="usd">33000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ie7f3cf86f5874b96b40d59c3d6a49d6b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzctMy0xLTEtMTg0NDY5_08329b5d-aaa8-4969-ba0c-7b6382dc270c"
      unitRef="usd">31000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ifa25332878054f3684126e72cd34954c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzctNS0xLTEtMTg0NDY5_63df3e8e-f356-4101-929d-16aab663a02d"
      unitRef="usd">32000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzgtMS0xLTEtMTg0NDY5_dbde8e95-60e9-49be-aec4-90b8474621be"
      unitRef="usd">153000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzgtMy0xLTEtMTg0NDY5_848e6ed0-6916-4fd5-a2cc-44282b01d566"
      unitRef="usd">172000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzgtNS0xLTEtMTg0NDY5_3c4f8bb6-1ea1-4c71-b53f-ed405f21029d"
      unitRef="usd">185000000</us-gaap:Depreciation>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i913162c559bc449289b7eb12f1b829ed_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEwLTEtMS0xLTE4NDQ2OQ_6dc917bf-5593-4b72-b7c2-62bafe014142"
      unitRef="usd">68000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="icb973d3950d9475a923b769b439f1690_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEwLTMtMS0xLTE4NDQ2OQ_46ae7274-ddb6-4682-8152-df45947924e3"
      unitRef="usd">48000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i71a3f3b84bfc4a76b4da5d7f37f602af_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEwLTUtMS0xLTE4NDQ2OQ_c73576bd-39ea-433c-afdb-e538a83228e9"
      unitRef="usd">49000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic22cd9b4e4d94780871456a2f40823af_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzExLTEtMS0xLTE4NDQ2OQ_7448c8d9-e20e-4f12-97c4-2394be333bf4"
      unitRef="usd">90000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i7975fef95c3d41c984bc01c3cd6d50c1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzExLTMtMS0xLTE4NDQ2OQ_c18ac871-10eb-4f30-91b5-f6e6280ff6a4"
      unitRef="usd">43000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idc000d98c0ca4b1ab8abdbf602942f3f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzExLTUtMS0xLTE4NDQ2OQ_d736396f-f83a-4be1-925d-771a6b6ae694"
      unitRef="usd">67000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic0f69c7e020f4496bb5f91ff08930975_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEyLTEtMS0xLTE4NDQ2OQ_f1fee4f0-6813-4045-87df-2de5a316055d"
      unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i617c77ba0ff242099cb5b33ab2af1d0c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEyLTMtMS0xLTE4NDQ2OQ_d5ee59b4-8c36-4f87-bd39-d3ce9c72be12"
      unitRef="usd">12000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia43c067e1e4b4763ac5c2b473efb3a37_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEyLTUtMS0xLTE4NDQ2OQ_ba70ac23-c8a3-452d-8acc-b708672fad48"
      unitRef="usd">31000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i56e043e80aaa413c8cf448a2008386a1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEzLTEtMS0xLTE4NDQ2OQ_a67f8674-dca3-495c-9e40-4577e1167217"
      unitRef="usd">47000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie7f3cf86f5874b96b40d59c3d6a49d6b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEzLTMtMS0xLTE4NDQ2OQ_81f8d899-17da-45f6-8e86-22f7e1ad71e2"
      unitRef="usd">66000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ifa25332878054f3684126e72cd34954c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzEzLTUtMS0xLTE4NDQ2OQ_ebde26b8-554b-4dbb-abe0-35db57b819b7"
      unitRef="usd">84000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzE0LTEtMS0xLTE4NDQ2OQ_4eba58d5-dcba-482d-b906-8d9cee6d56ed"
      unitRef="usd">205000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzE0LTMtMS0xLTE4NDQ2OQ_f9b851bd-c713-47d1-b992-65eea914f345"
      unitRef="usd">169000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZToyNGJkZTdmNDE0MjA0MDg2OWNmM2Y4YmZhYjA1NzAyYS90YWJsZXJhbmdlOjI0YmRlN2Y0MTQyMDQwODY5Y2YzZjhiZmFiMDU3MDJhXzE0LTUtMS0xLTE4NDQ2OQ_6717321d-fe31-4eff-aa18-9daa7ce51514"
      unitRef="usd">231000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <mo:ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc1MDI_6e826495-16c1-4b4a-a9a3-339869b1810c">We recorded pre-tax (income) expense for NPM adjustment items as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.102%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</mo:ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i08b51c2c0dce44e79fedb290d4c8e09e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzItMi0xLTEtMTg0NDY5_8ade9a4d-2b22-47ef-abd2-241905dbdf68"
      unitRef="usd">63000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="idf9bf830fdb54a25a53b4eb9f7c6ecbe_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzItNC0xLTEtMTg0NDY5_bcb967f3-9bf1-41e6-905b-d91c813a845d"
      unitRef="usd">53000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i35b16a435c354836b674e7320f24d9cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzItNi0xLTEtMTkwODky_27851b48-7744-4fb5-a989-978b3dc5a9f3"
      unitRef="usd">-4000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="if0522b2a5006452dbeaa81943e951dd9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzQtMi0xLTEtMTg0NDY5_692e348a-9a18-48e6-8933-dad8c885f5cf"
      unitRef="usd">5000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i6f14450de7304d989507ff633df9e3ae_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzQtNC0xLTEtMTg0NDY5_4be5643f-0cdf-4e12-9680-e374fac50ddf"
      unitRef="usd">23000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i2e449181bba3459d8ca0786104f7a700_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzQtNi0xLTEtMTkwOTAx_3da97d99-f53e-4af5-816d-df6ca81c2f31"
      unitRef="usd">0</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i9c43fc865fb74c7ea00634410142b30a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzUtMi0xLTEtMTg0NDY5_d1fda894-9db8-4dc7-b7cd-d01ed55c808f"
      unitRef="usd">68000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="i212ae09ce10946d9855a6823c99cbf7f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzUtNC0xLTEtMTg0NDY5_0f420d3c-30a6-4c0b-8c25-e93a8861b230"
      unitRef="usd">76000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement
      contextRef="ic48649f0706c497693ac371d798bd4c2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTpmNmJiZGFmYTYzZDc0ZDA2OWFkMWQyNzgwMGZhZTY4Yi90YWJsZXJhbmdlOmY2YmJkYWZhNjNkNzRkMDY5YWQxZDI3ODAwZmFlNjhiXzUtNi0xLTEtMTk1OTc1_e99570c6-1267-4538-a040-a33d90c4df9b"
      unitRef="usd">-4000000</us-gaap:GainLossRelatedToLitigationSettlement>
    <mo:ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc1MTY_4c5c010e-9501-4f18-8e58-8b1cd7e036cf">We recorded pre-tax charges related to tobacco and health and certain other litigation items as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.834%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.238%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.241%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Smokeable products segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;131&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</mo:ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="if99cc370f97e4e6c90993d5b757abf22_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzItMi0xLTEtMTg0NDY5_18c4e217-4db8-4436-8b9a-92c316d84515"
      unitRef="usd">101000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i01d7b96af9e749068f5609288e32a7af_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzItNC0xLTEtMTkxMDU5_0b20a823-85ab-46b7-b29c-cd02c6fca226"
      unitRef="usd">83000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i8832deab20a344c6af9cf1f99474ac91_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzItNi0xLTEtMTkxMDg2_edb7e666-3a3d-44ab-8e95-39930240717c"
      unitRef="usd">79000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i46dacf8350224a54ab375b062ca77665_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzMtMi0xLTEtMTg0NDY5_98672f16-ff45-4827-81a6-10836ecb7f65"
      unitRef="usd">27000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i951b911c6e0e47d19655f1077b2ffe8a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzMtNC0xLTEtMTkxMDYy_c351e17d-0dac-4b95-8350-f92beb22d11b"
      unitRef="usd">90000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="iea116a43452e4fb28c83749aebd5f929_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzMtNi0xLTEtMTg0NDY5_50fc2abe-23cc-4e24-8472-d01917173ef4"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i461f9cb50d204f0dacbd3047259cffa8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzQtMi0xLTEtMTg0NDY5_4ea24e4b-7eef-439d-a108-18f504dd5356"
      unitRef="usd">3000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i27482b5bde934f6ca3bdd7b34b723684_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzQtNC0xLTEtMTkxMDY1_885160ba-8ca7-45fb-becb-e2b48181e4db"
      unitRef="usd">9000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i0693a15a4892422d9cda162ef2b81f7d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzQtNi0xLTEtMTkxMDkz_2954d3f4-f4ad-4033-a879-641c26e4b9a4"
      unitRef="usd">4000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ice4e4d2da69f4d9683487085e2d48d98_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzUtMi0xLTEtMTg0NDY5_ff374565-523b-4152-9a3c-08b9bb4d2adc"
      unitRef="usd">131000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i83073aaf064b4575b0b62690029a9d26_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzUtNC0xLTEtMTg0NDY5_1202cced-cfbf-49c6-bd1b-54b593647c73"
      unitRef="usd">182000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ibd676fa0f80248e282373ef461851a42_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90YWJsZTo0MDE4NzM3ZjI0ZWI0NDdiYWJiYjU5ZWRmYjNmOTQwOS90YWJsZXJhbmdlOjQwMTg3MzdmMjRlYjQ0N2JhYmJiNTllZGZiM2Y5NDA5XzUtNi0xLTEtMTg0NDY5_5ff6a9ec-1468-420f-8f33-ab926dd76e8e"
      unitRef="usd">83000000</us-gaap:LossContingencyAccrualProvision>
    <mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts
      contextRef="i9f15b41987f746ec9de923885a23875e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MDk0ODY_b84c1015-3356-4c5c-88e1-b962947bfd22"
      unitRef="usd">51000000</mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts>
    <mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts
      contextRef="i2829a0154bd2487587b9b5af05af4b95_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MDk0OTA_3137d22d-0117-4bc1-9cc5-431d01a2677a"
      unitRef="usd">41000000</mo:DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts>
    <mo:DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts
      contextRef="i2829a0154bd2487587b9b5af05af4b95_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MDk1MDA_96a3f93d-5559-418d-8fb3-2c34767e677a"
      unitRef="usd">10000000</mo:DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i01d98d739f504698ad868c0b443af1b2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MDg0MjM_33f7b22b-4c5a-4ff4-8f0b-83d3abf78b9d"
      unitRef="usd">37000000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:RestructuringCharges
      contextRef="idc3b5a2e320d4bf0930cfd342a0a64ce_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MTE5NTA_a4c30494-83ca-4e86-8629-a57d323d9dde"
      unitRef="usd">411000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9cb3ae1c7eab4656a1a5ed979a5e155c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MTIwMjc_7ad6b291-7eb9-4cf4-ba56-a8c1b0893707"
      unitRef="usd">292000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="idb407c6154934e7ca996a112282656fd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzM4NDgyOTA3MTIwNzI_497b0819-6846-4a5c-8861-e6094452d4e5"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <mo:LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset
      contextRef="i1eb37c152d544d1d9be43ff88b5b936e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzczMTE_5bef0236-2f13-4185-a6de-23996f477844"
      unitRef="usd">-125000000</mo:LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset>
    <mo:LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset
      contextRef="i1bff2bc4dded4f37b8c85cec3935bb80_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc0Njc_2517b9bf-8b52-4570-92a5-9b873e3f7f2c"
      unitRef="usd">0</mo:LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset>
    <mo:LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset
      contextRef="ifb087beec876446cb5a5111ae91af4a1_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3Xzc0Njc_e7359ec1-80e4-4c56-bf58-f24f456df32e"
      unitRef="usd">0</mo:LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7832ad6e5ab1407caf25aa336606b119_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzQ5NDc4MDIzMzk5Mjk_a6cd48f6-0edb-46e4-8fd7-d1d98ea71844"
      unitRef="usd">50000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i8a4e259acef84cbfa369320878dc84d8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzQ5NDc4MDIzMzk5MzQ_fa196506-83fe-47bd-8abe-c3e5b14afaa9"
      unitRef="usd">41000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ie155a5840f2c4f9999c5ff7d2f7a2f4b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjAvZnJhZzoxNTJiM2M5ZjYwMWQ0NjY3ODBjMTNhNTQzZjU2ZWRiNy90ZXh0cmVnaW9uOjE1MmIzYzlmNjAxZDQ2Njc4MGMxM2E1NDNmNTZlZGI3XzQ5NDc4MDIzMzk5NzY_754144ef-5622-4b25-a17c-673773b197c6"
      unitRef="usd">9000000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDky_ee76def1-52b1-48b8-9bb2-4ff5137f567f">Benefit Plans&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our subsidiaries sponsor noncontributory defined benefit pension plans covering certain employees of Altria and our subsidiaries.  Employees hired on or after a date specific to their employee group, except for certain employees of UST&#x2019;s subsidiaries and Middleton, are not eligible to participate in these noncontributory defined benefit pension plans but are instead eligible to participate in a defined contribution plan with enhanced benefits.  We also provide postretirement health care and other benefits to certain retired employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We measure the plan assets and benefit obligations of our pension plans and postretirement plans at December&#160;31 of each year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We base the discount rates for our plans on a yield curve developed from a model portfolio of high-quality corporate bonds with durations that match the expected future cash flows of the pension and postretirement benefit obligations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Obligations and Funded Status: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefit obligations, plan assets and funded status for our pension and postretirement plans were as follows at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,544&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,688&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interest cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Benefits paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Actuarial (gains) losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Plan amendments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Divestiture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;185&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,748)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Employer contributions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Benefits paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Divestiture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;122&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Funded status at December&#160;31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized on our consolidated balance sheets were as follows:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;469&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Accrued pension costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Accrued postretirement health care costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Divestiture of benefit obligations and plan assets related to the Ste. Michelle Transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table above presents the projected benefit obligation for our pension plans.  The accumulated benefit obligation, which represents benefits earned to date, for our pension plans was $6.1 billion and $8.2 billion at December&#160;31, 2022 and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Actuarial (gains) losses for the years ended December&#160;31, 2022 and 2021 for our pension and postretirement plans were due primarily to changes in the discount rate.  Actuarial (gains) losses for our pension plans for the year ended 2021 were further impacted by changes to mortality rate assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plan amendments to our postretirement plans for the year ended December&#160;31, 2021 included several plan changes announced in the second quarter of 2021 to our salaried retiree healthcare plans, primarily changing its post-age 65 coverage to a private medicare marketplace.  These amendments triggered a plan remeasurement in the second quarter of 2021, resulting in a reduction of $432 million (including discount rate impact and other changes) to our postretirement obligation in the second quarter of 2021 and a corresponding reduction to accumulated other comprehensive losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For pension plans with accumulated benefit obligations in excess of plan assets at December&#160;31, 2022, our accumulated benefit obligation and fair value of plan assets were $134 million and $0 million, respectively.  For pension plans with accumulated benefit obligations in excess of plan assets at December&#160;31, 2021, our accumulated benefit obligation and fair value of plan assets were $176&#160;million and $0 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For pension plans with projected benefit obligations in excess of plan assets at December&#160;31, 2022, our projected benefit obligation and fair value of plan assets were $158 million and $0 million, respectively.  For pension plans with projected benefit obligations in excess of plan assets at December&#160;31, 2021, our projected benefit obligation and fair value of plan assets were $227 million and $0 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022 and 2021, our accumulated postretirement benefit obligations were in excess of plan assets for all postretirement plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We used the following assumptions to determine our pension and postretirement benefit obligations at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase - long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care cost trend rate assumed for next year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Ultimate trend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Year that the rate reaches the ultimate trend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Components of Net Periodic Benefit Cost (Income):&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Net periodic benefit cost (income) consisted of the following for the years ended December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the year ended December 31, 2020, we recorded the settlement amount as a change to net losses in other comprehensive earnings/losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following assumptions were used to determine our net periodic benefit cost for the years ended December&#160;31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest cost &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase - long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care cost trend rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Defined Contribution Plans: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sponsor tax-qualified defined contribution plans covering certain salaried and hourly (non-union and union) employees.  Contributions and costs are determined generally as a percentage of earnings, as defined by our plans.  Amounts charged to expense for these defined contribution plans totaled $91 million, $90 million and $88 million in 2022, 2021 and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:32.46pt"&gt;Pension and Postretirement Plan Assets: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In managing our pension assets, we implement a liability-driven investment framework that aligns plan assets with liabilities.  The current equity/fixed income allocation of 20%/80% is designed to balance pension liability hedging and asset growth in order to maintain our plan&#x2019;s funded status and cover incremental service accruals and interest cost.  Liability hedging is achieved through investing in rate-sensitive fixed income securities, primarily corporate bonds and U.S. Treasuries, while growth assets are comprised of publicly traded equity securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our investment strategy for our postretirement plan assets is intended to maximize our total asset return based on the expectation that equity securities will outperform debt securities over the long term and reflects the maturity structure of our benefit obligation.  The equity/fixed income target allocation for postretirement plan assets is 55%/45%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe that we implement these investment strategies in a prudent and risk-controlled manner, consistent with the fiduciary requirements of the Employee Retirement Income Security Act of 1974, by investing retirement plan assets in a well-diversified mix of equities, fixed income and other securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The actual composition of our plan assets at December&#160;31, 2022 was broadly characterized with the following allocation:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;56&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and foreign government securities and all other investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Amount includes U.S Treasury and foreign government securities (19%) and asset based securities and all other investments (9%).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our pension and postretirement plan asset performance is monitored on an ongoing basis to adjust the mix as necessary to achieve our target allocations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all pension and all postretirement assets can be used to make monthly benefit payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We implement our investment strategy for our pension and postretirement plan assets by investing in long-duration fixed income securities that primarily include U.S. corporate bonds of companies from diversified industries and U.S. Treasury securities that mirror  our pension obligation benchmark, as well as U.S. and international equity index strategies that are intended to mirror broad market indices, including, the Standard &amp;amp; Poor&#x2019;s 500 Index and Morgan Stanley Capital International (&#x201c;MSCI&#x201d;) Europe, Australasia, and the Far East (&#x201c;EAFE&#x201d;) Index.  Our pension and postretirement plans also invest in actively managed international equity securities of mid and small cap companies located in developed and emerging markets.  For pension plan assets, our allocation to below investment grade securities represented approximately 13% of the fixed income holdings or approximately 10% of our total plan assets at December&#160;31, 2022.  Our allocation to emerging markets represented less than 1% of total plan assets at December&#160;31, 2022.  For postretirement plan assets, our allocation to below investment grade securities represented approximately 12% of the fixed income holdings or approximately 5% of our total plan assets at December&#160;31, 2022.  There were no postretirement plan assets invested in emerging markets at December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our risk management practices for our pension and postretirement plans include (i) ongoing monitoring of asset allocation, investment performance and investment managers&#x2019; compliance with their investment guidelines, (ii) periodic rebalancing between equity and debt asset classes and (iii) annual actuarial re-measurement of plan liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our expected rate of return on pension and postretirement plan assets is determined by our plan assets&#x2019; historical long-term investment performance, current asset allocation and estimates of future long-term returns by asset class.  The forward-looking estimates are consistent with the long-term historical averages exhibited by returns on equity and fixed income&#160;securities.  For determining our pension and postretirement net periodic benefit cost (income), our 2023 expected rate of return assumptions are 6.1% and 7.4%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of our pension plan assets by asset category were as follows at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. and foreign government securities or their agencies:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,098&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,098&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. municipal bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government and agencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Above investment grade&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,747&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,747&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Below investment grade and no rating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;756&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;756&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International equities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;591&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;591&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;244&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;917&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments measured at NAV as a practical expedient for fair value:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collective investment funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_41b4c8e3-e050-43b8-b106-4405c53c782d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_9c77b5ce-ddae-4a3d-978b-ba5336576f53"&gt;U.S. large cap&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;312&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_1ddffbe6-a65c-4290-90a9-b5306bc7faca"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_c2aa8d53-307d-44de-88c6-ccc45057da99"&gt;U.S. small cap&lt;/span&gt;&lt;/span&gt;  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_6c58378e-c0bf-4554-a791-6444e99557ba"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_c4015aef-675a-4e45-9c95-609287b0df60"&gt;International developed markets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of plan assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 holdings and transactions were immaterial to total plan assets at December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of our postretirement plan assets were as follows at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. and foreign government securities or their agencies:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government and agencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Above investment grade&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Below investment grade and no rating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;54&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;54&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments measured at NAV as a practical expedient for fair value:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collective investment funds:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_295077d8-7c2c-4293-a53f-d6212cd1c050"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_bff869f3-0247-42fe-9766-2e8c8f382544"&gt;U.S. large cap&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_501091e4-8056-4777-bd80-73ee1b31781b"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_eef6c587-6a34-4f41-a17b-d1245eda6984"&gt;International developed markets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of plan assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;122&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no Level 3 postretirement plan holdings or transactions during 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For a description of the fair value hierarchy and the three levels of inputs used to measure fair value, see Note 2. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is a description of the valuation methodologies used for investments measured at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;U.S. and Foreign Government Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: U.S. and foreign government securities consist of investments in Treasury Nominal Bonds and Inflation Protected Securities and municipal securities.  Government securities are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes.  Matrix pricing, yield curves and indices are used when broker quotes are not available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Corporate Debt Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Corporate debt instruments are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes.  Matrix pricing, yield curves and indices are used when broker quotes are not available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Common Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Common stocks are valued based on the price of the security as listed on an open active exchange on last trade date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Asset Backed Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Asset backed securities are fixed income securities such as mortgage backed securities and auto loans that are collateralized by pools of underlying assets that are unable to be sold individually.  They are valued at a price which is based on a compilation of primarily observable market information or a broker quote in a non-active over-the-counter market.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Collective Investment Funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Collective investment funds consist of funds that are intended to mirror indices such as Standard&#160;&amp;amp; Poor&#x2019;s 500 Index and MSCI EAFE Index.  They are valued on the basis of the relative interest of each participating investor in the fair value of the underlying assets of each of the respective collective investment funds.  The underlying assets are valued based on the net asset value (&#x201c;NAV&#x201d;), which is provided by the investment account manager as a practical expedient to estimate fair value.  These investments are not classified by level but are disclosed to permit reconciliation to the fair value of plan assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Cash Flows: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We make contributions to our pension plans to the extent that the contributions are tax deductible and pay benefits that relate to plans for salaried employees that cannot be funded under IRS regulations.  Currently, we anticipate making employer contributions to our pension and postretirement plans of up to approximately $30 million&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for each i&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;n 2023.  However, the foregoing  estimates of 2023 contributions to our pension and postretirement plans are subject to change as a result of changes in tax and other benefit laws, changes in interest rates, as well as asset performance significantly above or below the assumed long-term rate of return for each respective plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated future benefit payments at December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;494&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;473&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028-2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;477&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Comprehensive Earnings/Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded the following amounts in accumulated other comprehensive losses at December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;employment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service (cost) credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;264&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;571&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;513&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts recorded in accumulated other comprehensive losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded the following amounts in accumulated other comprehensive losses at December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;employment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service (cost) credit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts recorded in accumulated other comprehensive losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;employment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings as components of net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;76&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other movements during the year:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;147&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;256&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total movements in other comprehensive earnings/losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;236&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:9pt;text-indent:-9.01pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-employment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings as components of net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-0.01pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other movements during the year:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total movements in other comprehensive earnings/losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;employment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings as components of net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other movements during the year:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total movements in other comprehensive earnings/losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock>
    <us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDk2_68b0a798-dec0-4852-baff-f3380c4e9e4c">Benefit obligations, plan assets and funded status for our pension and postretirement plans were as follows at December 31:&lt;div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,544&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,688&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interest cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Benefits paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Actuarial (gains) losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Plan amendments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Divestiture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;185&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,748)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Employer contributions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Benefits paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Divestiture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;122&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Funded status at December&#160;31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized on our consolidated balance sheets were as follows:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;469&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Accrued pension costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Accrued postretirement health care costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Divestiture of benefit obligations and plan assets related to the Ste. Michelle Transaction.&lt;/span&gt;&lt;/div&gt;</us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock>
    <us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMTA4_00a5ecb4-192f-4565-a2b7-46bd9bffd3ab">Benefit obligations, plan assets and funded status for our pension and postretirement plans were as follows at December 31:&lt;div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.347%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.851%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in benefit obligation:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Benefit obligation at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,544&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,688&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Interest cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Benefits paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Actuarial (gains) losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,060)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(523)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Plan amendments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(345)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Divestiture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(193)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefit obligation at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,292&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Change in plan assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Fair value of plan assets at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,793&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;185&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Actual return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,748)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Employer contributions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Benefits paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(465)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;Divestiture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(145)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;122&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Funded status at December&#160;31&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts recognized on our consolidated balance sheets were as follows:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;469&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Other accrued liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Accrued pension costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Accrued postretirement health care costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;311&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,153)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Divestiture of benefit obligations and plan assets related to the Ste. Michelle Transaction.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzMtMS0xLTEtMTg0NDY5_6bb98b9c-8db6-471e-8312-717f8669f8e7"
      unitRef="usd">8544000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i949403a737c24de59a13987d688282a7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzMtMy0xLTEtMTg0NDY5_f40864ef-8bf4-4581-b92b-ba8accfb661f"
      unitRef="usd">9465000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzMtNS0xLTEtMTg0NDY5_d748cd69-55b1-476a-86ef-3ff6adff5b6e"
      unitRef="usd">1688000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i00cce528acbc427a9f5dda1550d2d9fd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzMtNy0xLTEtMTg0NDY5_f40fa110-8c5c-4c5f-973c-35288697f1ad"
      unitRef="usd">2229000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzQtMS0xLTEtMTg0NDY5_f791f65e-8a27-4562-ba59-f24e0a203df2"
      unitRef="usd">64000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzQtMy0xLTEtMTg0NDY5_90754f69-cd09-4c3b-b83e-f9bb44ba5a5a"
      unitRef="usd">68000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzQtNS0xLTEtMTg0NDY5_d44533c1-edea-40f7-be02-9da57738c3d0"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzQtNy0xLTEtMTg0NDY5_6ac7233f-e674-4798-8b91-84f2c89d15d8"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzUtMS0xLTEtMTg0NDY5_f772f0ca-d7b7-486d-b6ba-d6b79c6f8859"
      unitRef="usd">206000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzUtMy0xLTEtMTg0NDY5_81543af4-8446-4a6f-a546-30f050408198"
      unitRef="usd">184000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzUtNS0xLTEtMTg0NDY5_fbada8df-eef5-4e6e-90b3-e528d16c6f32"
      unitRef="usd">41000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzUtNy0xLTEtMTg0NDY5_0705282b-70cb-4e97-8460-d061b6c38426"
      unitRef="usd">38000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzYtMS0xLTEtMTg0NDY5_f0392789-521c-44d9-9b20-f42d2b381459"
      unitRef="usd">462000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzYtMy0xLTEtMTg0NDY5_59943c29-42a6-42aa-9e3d-34d20ee68ad3"
      unitRef="usd">465000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzYtNS0xLTEtMTg0NDY5_a5afdfad-f1b9-400d-ac93-68db6101c634"
      unitRef="usd">87000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzYtNy0xLTEtMTg0NDY5_e9c1948b-3f17-4c1a-8811-6e23bb5e5d42"
      unitRef="usd">104000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzctMS0xLTEtMTg0NDY5_572b3efb-4c23-41d3-9732-11f7dba758ca"
      unitRef="usd">2060000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzctMy0xLTEtMTg0NDY5_ed4a1cad-6047-4f2f-a430-86365eca17d9"
      unitRef="usd">523000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzctNS0xLTEtMTg0NDY5_28c0ef28-e306-4a02-94ec-6b5517f9742e"
      unitRef="usd">392000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzctNy0xLTEtMTg0NDY5_ede15b5b-76ca-473a-b6a0-122c5f5054f1"
      unitRef="usd">150000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzgtMS0xLTEtMTg0NDY5_c873cd2d-6f03-44e8-bf6f-c13063913f5d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzgtMy0xLTEtMTg0NDY5_997aca1f-72f2-40f6-a500-f261555d6cf4"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzgtNS0xLTEtMTg0NDY5_797f8e49-0163-4287-a5b2-d8110770cd29"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanPlanAmendments
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzgtNy0xLTEtMTg0NDY5_1e3b5044-ef5c-4638-895b-8d5749905e84"
      unitRef="usd">-345000000</us-gaap:DefinedBenefitPlanPlanAmendments>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzktMS0xLTEtMTg0NDY5_05bc2785-95d8-441a-b63d-2003233e1ddf"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzktMy0xLTEtMTg0NDY5_7369deb5-b7ad-4667-9c73-d852a8dd11eb"
      unitRef="usd">193000000</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzktNS0xLTEtMTg0NDY5_8a74a6a6-c6d0-4bca-be8b-03758476ddb8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanDivestituresBenefitObligation
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzktNy0xLTEtMTg0NDY5_148177f3-03f5-4d73-82bf-836c8398346c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzExLTEtMS0xLTE4NDQ2OQ_893a4125-442d-4743-b1d1-d937db1c9e90"
      unitRef="usd">6292000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzExLTMtMS0xLTE4NDQ2OQ_e76c9eaf-2570-4ae2-a244-97c664aaacb7"
      unitRef="usd">8544000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzExLTUtMS0xLTE4NDQ2OQ_f6f4044c-0d56-4db1-88fc-7c6b649e66f6"
      unitRef="usd">1275000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzExLTctMS0xLTE4NDQ2OQ_4e5c08c1-0580-4210-90b7-9e62ae7ce7dd"
      unitRef="usd">1688000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzEzLTEtMS0xLTE4NDQ2OQ_8c4a0292-2cf3-42a5-ae6d-e1d8723e36ef"
      unitRef="usd">8793000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i949403a737c24de59a13987d688282a7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzEzLTMtMS0xLTE4NDQ2OQ_90edfc6a-207e-4a07-8350-0fc68de04424"
      unitRef="usd">8911000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzEzLTUtMS0xLTE4NDQ2OQ_d850f98a-dc7c-4f4b-a01c-5b304777a290"
      unitRef="usd">185000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i00cce528acbc427a9f5dda1550d2d9fd_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzEzLTctMS0xLTE4NDQ2OQ_83308c6d-99fa-4ce2-9c37-ef5d094c3bc9"
      unitRef="usd">201000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE0LTEtMS0xLTE4NDQ2OQ_541bf37f-58bb-46df-bc55-c33fe98c4aed"
      unitRef="usd">-1748000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE0LTMtMS0xLTE4NDQ2OQ_1879f3a5-6e55-4f16-91fa-6dd23a39330f"
      unitRef="usd">466000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE0LTUtMS0xLTE4NDQ2OQ_b1c55d09-a6bf-49c1-9ce8-7a93dc50de1c"
      unitRef="usd">-35000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE0LTctMS0xLTE4NDQ2OQ_a73082ad-e489-4dea-beef-3e26133a51ab"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE1LTEtMS0xLTE4NDQ2OQ_5d32ea99-bab9-4355-9410-fe843a004312"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE1LTMtMS0xLTE4NDQ2OQ_68cdf6ad-068c-4c96-bf2d-59e7cc76a1ed"
      unitRef="usd">26000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE1LTUtMS0xLTE4NDQ2OQ_1f06c8e7-0fe8-46db-8e29-893d9b041221"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE1LTctMS0xLTE4NDQ2OQ_77c9cf0f-455a-48e7-8904-10486a78ad7c"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE2LTEtMS0xLTE4NDQ2OQ_4eec68d0-e961-4ea4-bd19-bcccbba5f74e"
      unitRef="usd">462000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE2LTMtMS0xLTE4NDQ2OQ_9f49dac2-41cf-4db6-9733-86530288ad96"
      unitRef="usd">465000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE2LTUtMS0xLTE4NDQ2OQ_f48c7893-2e51-4f8a-9a94-2ed89c667032"
      unitRef="usd">28000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE2LTctMS0xLTE4NDQ2OQ_3d3f0be5-f54f-4704-a48e-4940255afecd"
      unitRef="usd">37000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanDivestituresPlanAssets
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE3LTEtMS0xLTE4NDQ2OQ_58196fe5-084c-43e0-9483-c723fd753718"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresPlanAssets>
    <us-gaap:DefinedBenefitPlanDivestituresPlanAssets
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE3LTMtMS0xLTE4NDQ2OQ_0163270a-7ce8-476b-bcd2-5641bea14f39"
      unitRef="usd">145000000</us-gaap:DefinedBenefitPlanDivestituresPlanAssets>
    <us-gaap:DefinedBenefitPlanDivestituresPlanAssets
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE3LTUtMS0xLTE4NDQ2OQ_6060b1af-d43b-48c8-b4f8-24d446f1bb27"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresPlanAssets>
    <us-gaap:DefinedBenefitPlanDivestituresPlanAssets
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE3LTctMS0xLTE4NDQ2OQ_e225f45a-552c-4e34-8de6-5f37052a5a7f"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanDivestituresPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE4LTEtMS0xLTE4NDQ2OQ_59ae4fca-548b-4ac0-b757-2a2abf5bb6d7"
      unitRef="usd">6603000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE4LTMtMS0xLTE4NDQ2OQ_9174082e-347d-4445-8f12-36bd460c9aba"
      unitRef="usd">8793000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE4LTUtMS0xLTE4NDQ2OQ_0089e650-4fdb-442d-ba88-40e244fba36b"
      unitRef="usd">122000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE4LTctMS0xLTE4NDQ2OQ_098be242-59ce-46a9-90b9-4da252d4daef"
      unitRef="usd">185000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE5LTEtMS0xLTE4NDQ2OQ_96ff48c5-630f-4963-9f4b-9d27e81959af"
      unitRef="usd">311000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE5LTMtMS0xLTE4NDQ2OQ_ab47dc6a-e8ed-45ab-9940-9c709a46ef12"
      unitRef="usd">249000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE5LTUtMS0xLTE4NDQ2OQ_6784b31c-ba81-41a1-ba1f-7c628d5371e9"
      unitRef="usd">-1153000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzE5LTctMS0xLTE4NDQ2OQ_8ae3de56-43bd-44b7-bffb-e3387788681f"
      unitRef="usd">-1503000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIxLTEtMS0xLTE4NDQ2OQ_1dd44b11-28bd-4fea-910e-b85506748af5"
      unitRef="usd">469000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIxLTMtMS0xLTE4NDQ2OQ_16c35f0b-88f7-4fd8-9b0f-d20c6a317cc6"
      unitRef="usd">476000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIxLTUtMS0xLTE4NDQ2OQ_089b7876-bed5-41f2-b392-d4f0b5c91ce6"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIxLTctMS0xLTE4NDQ2OQ_5a1c4ef3-1c4f-46bd-88b6-e29bf8998fc2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIyLTEtMS0xLTE4NDQ2OQ_0696ad29-a1dc-4f3f-add3-8ac031f6400b"
      unitRef="usd">25000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIyLTMtMS0xLTE4NDQ2OQ_315e7ed3-bc12-4420-845a-94b0806f1423"
      unitRef="usd">27000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIyLTUtMS0xLTE4NDQ2OQ_18e032c1-cd88-4e15-b82d-a02f8e2988af"
      unitRef="usd">70000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIyLTctMS0xLTE4NDQ2OQ_41fbe22d-08e1-42b7-9595-9ac8bd8bcc6e"
      unitRef="usd">67000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIzLTEtMS0xLTE4NDQ2OQ_e61d0fb4-601a-46fe-9cc7-2ef76cae4dc3"
      unitRef="usd">133000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIzLTMtMS0xLTE4NDQ2OQ_b7ad5fc3-d568-4e4e-a3f4-0f21f333e294"
      unitRef="usd">200000000</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIzLTUtMS0xLTE4NDQ2OQ_fc8ce8ab-1351-4176-8267-618c5cc60804"
      unitRef="usd">0</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzIzLTctMS0xLTE4NDQ2OQ_421c01bb-fb01-4d68-b2bd-966c7b2b845c"
      unitRef="usd">0</us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent>
    <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI1LTEtMS0xLTE4NDQ2OQ_1ada62a3-4533-464c-a517-f64cc7ebceae"
      unitRef="usd">0</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
    <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI1LTMtMS0xLTE4NDQ2OQ_af95a94f-5f1a-410f-b481-446a1f380c69"
      unitRef="usd">0</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
    <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI1LTUtMS0xLTE4NDQ2OQ_83d819a8-4646-4138-8e50-a92fe0718442"
      unitRef="usd">1083000000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
    <us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI1LTctMS0xLTE4NDQ2OQ_f3592048-3767-41be-b1b0-22a27f45dba1"
      unitRef="usd">1436000000</us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI2LTEtMS0xLTE4NDQ2OQ_e836cfc4-f1b9-46f5-837b-f506229d5d2b"
      unitRef="usd">311000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI2LTMtMS0xLTE4NDQ2OQ_2cd12289-e02a-4f48-a17b-10f35360ec99"
      unitRef="usd">249000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI2LTUtMS0xLTE4NDQ2OQ_14b6893a-8472-4235-97f1-4ef1d8161cd1"
      unitRef="usd">-1153000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpkYzBkZWQ4Mzc0Y2I0Yzk2Yjc5ZmQwZTRiYzBkNTgyNC90YWJsZXJhbmdlOmRjMGRlZDgzNzRjYjRjOTZiNzlmZDBlNGJjMGQ1ODI0XzI2LTctMS0xLTE4NDQ2OQ_e16ea864-0363-43c2-a9ee-71495f1811ad"
      unitRef="usd">-1503000000</us-gaap:DefinedBenefitPlanAmountsRecognizedInBalanceSheet>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzE0OTc_0606930e-177d-4296-8d26-96e70d4df17e"
      unitRef="usd">6100000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzE1MDU_56d9df3c-ac78-4d9e-88b3-b433f2266674"
      unitRef="usd">8200000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations
      contextRef="if489977786fd4db69449f01c2756f802_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzIxNTU_d8e948ef-7065-4b6a-8887-ecca1d8d892f"
      unitRef="usd">-432000000</us-gaap:IncreaseDecreaseInPensionAndPostretirementObligations>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzI1MDc_06ddb771-4bdd-446f-8d5b-2c274460e681"
      unitRef="usd">134000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzI1MTQ_ffff70f3-5812-445a-9373-cb5ddf80b682"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzI3MDQ_32aa101c-7c88-4ebe-ad56-26889e182a11"
      unitRef="usd">176000000</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzI3MTI_b339ca53-74ff-4811-b9c1-0fb34409fc96"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzI4ODQ_4e999d06-e181-4488-9d50-f8e0ba2a0b87"
      unitRef="usd">158000000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzI4OTI_9226df8e-acf1-4c1e-aa98-9ab78ebf95ce"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzMwNzc_ee613438-5653-442a-ada4-4a0a5dc488ac"
      unitRef="usd">227000000</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation>
    <us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzMwODQ_bf2c2a99-7a33-4baf-a12c-bee36578a0d0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMTE0_614b7fc8-971c-44f9-a148-b3517bf363fb">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We used the following assumptions to determine our pension and postretirement benefit obligations at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.140%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase - long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care cost trend rate assumed for next year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Ultimate trend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Year that the rate reaches the ultimate trend rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzItMS0xLTEtMTg0NDY5_fde20329-cef3-4073-b2a0-9b8e8c763b9f"
      unitRef="number">0.056</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzItMy0xLTEtMTg0NDY5_c6faa93a-2bc5-4228-80cb-7f90419bfc19"
      unitRef="number">0.030</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzItNS0xLTEtMTg0NDY5_5482c17d-cd96-46cc-b1f1-d775aadd7849"
      unitRef="number">0.056</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzItNy0xLTEtMTg0NDY5_acb37a55-8f90-4c69-bd3b-5e3395adb59d"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzMtMS0xLTEtMTg0NDY5_295f1455-c293-4f7b-8585-30bf1faa8580"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzMtMy0xLTEtMTg0NDY5_8cfb0a7f-c216-4080-90be-aebfdf588c61"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzMtNS0xLTEtMTg0NDY5_2cd9deb0-a3f5-4f16-b86a-72692db2fbda"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzMtNy0xLTEtMTg0NDY5_903dbabb-aecd-439e-97d3-deabe460f705"
      unitRef="number">0</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzQtNS0xLTEtMTg0NDY5_af4e4521-1112-4361-8d6c-19ecf790efde"
      unitRef="number">0.065</us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear>
    <us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzQtNy0xLTEtMTg0NDY5_196c0376-4725-4371-917d-fb8fe2e16d3b"
      unitRef="number">0.065</us-gaap:DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzUtNS0xLTEtMTg0NDY5_ceca9416-8768-490a-b839-a3f2d2f6f593"
      unitRef="number">0.050</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozMjVhNmYzMzhlMjE0MzljOWVlZWMzNzA5YTI2ODVlYy90YWJsZXJhbmdlOjMyNWE2ZjMzOGUyMTQzOWM5ZWVlYzM3MDlhMjY4NWVjXzUtNy0xLTEtMTg0NDY5_9ad3ef29-8457-4d79-b99f-17d0e5eb400e"
      unitRef="number">0.050</us-gaap:DefinedBenefitPlanUltimateHealthCareCostTrendRate1>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDMx_c8c5c06d-13c7-4d14-8ca1-a5f4df83a9af">Net periodic benefit cost (income) consisted of the following for the years ended December 31:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.007%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;206&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(522)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(502)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost (credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlement &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net periodic benefit cost (income)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzItMS0xLTEtMTg0NDY5_4510f85a-93d9-4b6f-a775-0f071ab3bba7"
      unitRef="usd">64000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzItMy0xLTEtMTg0NDY5_4aeeff93-9768-48bd-92a0-0debc7a43d49"
      unitRef="usd">68000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzItNS0xLTEtMTg0NDY5_4b28094c-93d9-4e8d-80f8-f6be7742de59"
      unitRef="usd">74000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzItNy0xLTEtMTg0NDY5_dac6eaaa-5e3e-444c-8181-904589b2f6d8"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzItOS0xLTEtMTg0NDY5_4a36b8d2-b7d9-44d2-97fc-ba6f660fa168"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzItMTEtMS0xLTE4NDQ2OQ_af9bc700-1f7f-48c2-9316-cb10c7740e86"
      unitRef="usd">16000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzMtMS0xLTEtMTg0NDY5_e4512fc7-a283-41fe-bc28-ae51e4111b45"
      unitRef="usd">206000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzMtMy0xLTEtMTg0NDY5_992643b1-06f1-4358-abad-38f03a0bc1f6"
      unitRef="usd">184000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzMtNS0xLTEtMTg0NDY5_976911a8-67f4-4fb9-9fc1-8b4bd647c525"
      unitRef="usd">251000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzMtNy0xLTEtMTg0NDY5_e99c2211-5ead-4621-b608-cfb516f7e3cc"
      unitRef="usd">41000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzMtOS0xLTEtMTg0NDY5_c1a73421-9ac9-43ad-a434-a10378049ba5"
      unitRef="usd">38000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzMtMTEtMS0xLTE4NDQ2OQ_bc1eaf97-2931-4324-8097-83974ff25f95"
      unitRef="usd">59000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzQtMS0xLTEtMTg0NDY5_022ea45e-dcab-44df-bdc3-da98410242e5"
      unitRef="usd">493000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzQtMy0xLTEtMTg0NDY5_9860af20-a201-4c28-a18b-f06281d84128"
      unitRef="usd">522000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzQtNS0xLTEtMTg0NDY5_23cf77ba-85b4-4096-98bb-7c5fa23be098"
      unitRef="usd">502000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzQtNy0xLTEtMTg0NDY5_5478a560-4bed-4c4b-9518-ffe311e92abc"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzQtOS0xLTEtMTg0NDY5_812bbe77-1c2c-4d3d-abd7-d452ab583298"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzQtMTEtMS0xLTE4NDQ2OQ_da6d3fa4-ca40-4647-914d-9ebf6ce3f417"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzYtMS0xLTEtMTg0NDY5_ccb60546-d2ec-4282-a0ce-aca926105996"
      unitRef="usd">-96000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzYtMy0xLTEtMTg0NDY5_77d1e4d2-466b-4a78-af0f-db7d57a5b4df"
      unitRef="usd">-131000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzYtNS0xLTEtMTg0NDY5_7ac5a8c6-d177-4e34-a2d0-9934f734267e"
      unitRef="usd">-134000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzYtNy0xLTEtMTg0NDY5_767217a9-ea69-4c2a-9404-2d8907ffb147"
      unitRef="usd">-18000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzYtOS0xLTEtMTg0NDY5_8ed88ea6-d5a8-4be6-91c4-df064a48b6f3"
      unitRef="usd">-22000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzYtMTEtMS0xLTE4NDQ2OQ_8f81edd8-7ac5-486d-ac76-32b1ddb5d174"
      unitRef="usd">-10000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzctMS0xLTEtMTg0NDY5_904cb179-0225-4597-978d-817a0e77d873"
      unitRef="usd">6000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzctMy0xLTEtMTg0NDY5_71fcc6f2-2df6-40fe-8e53-15b46aec257a"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzctNS0xLTEtMTg0NDY5_5a37b8b7-a4e8-4abf-ab0d-a11625e83a11"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzctNy0xLTEtMTg0NDY5_9e3ed0fa-86a7-4718-9ac2-ce0d5da849af"
      unitRef="usd">-45000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzctOS0xLTEtMTg0NDY5_9d03b78d-059d-408c-97a6-d5e469302117"
      unitRef="usd">-46000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzctMTEtMS0xLTE4NDQ2OQ_72f8362a-65cb-4982-8438-01890deeb69b"
      unitRef="usd">-30000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzgtMS0xLTEtMTg0NDY5_cbf9104f-5917-4a8e-bd02-ba4533d19dd5"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzgtMy0xLTEtMTg0NDY5_462ef324-c99c-4a4d-9d04-5c0600da9ee9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzgtNS0xLTEtMTg0NDY5_a9c0303e-07ae-4be5-83a3-d62fe93e1867"
      unitRef="usd">-10000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzgtNy0xLTEtMTg0NDY5_ec94a982-88bb-492a-a896-c3a4ee6eeacb"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzgtOS0xLTEtMTg0NDY5_e5159cb6-58f2-417f-a921-0bf1e90a580b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzgtMTEtMS0xLTE4NDQ2OQ_062c1235-030e-4a34-9bda-82728fcc7c23"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzktMS0xLTEtMTg0NDY5_0b2eaa57-8c54-425e-90db-f3fcc0f5b95f"
      unitRef="usd">-121000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzktMy0xLTEtMTg0NDY5_6141e980-e47a-4d32-b6a2-f282724be8e8"
      unitRef="usd">-134000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzktNS0xLTEtMTg0NDY5_d80d32b0-2729-4249-b3a5-eedd410f62f6"
      unitRef="usd">-28000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzktNy0xLTEtMTg0NDY5_40cc8506-1cc1-4c33-a3d0-698a10b546cd"
      unitRef="usd">24000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzktOS0xLTEtMTg0NDY5_d7a4aa36-e166-411c-9f1b-6167707cbccd"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozNzQ2ODU1ZjE0Yjc0ZTdmYmU4NDRhODhkMjY5ZGVjOS90YWJsZXJhbmdlOjM3NDY4NTVmMTRiNzRlN2ZiZTg0NGE4OGQyNjlkZWM5XzktMTEtMS0xLTE4NDQ2OQ_58b43e4b-f1b6-46a6-8c58-56cb24d551f9"
      unitRef="usd">41000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <mo:ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDg1_6430b134-b9ab-42fd-8615-f03c912b3d17">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following assumptions were used to determine our net periodic benefit cost for the years ended December&#160;31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.941%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.352%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.484%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount rates:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Service cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest cost &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected rate of return on plan assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase - long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care cost trend rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6.5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</mo:ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzMtMS0xLTEtMTg0NDY5_883950a4-cab0-4843-b7d2-f04bdbcd14e4"
      unitRef="number">0.032</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzMtMy0xLTEtMTg0NDY5_4da89a3a-8883-43cf-a4a3-2df13404de95"
      unitRef="number">0.031</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzMtNS0xLTEtMTg0NDY5_a63bef89-bd6c-4450-84a7-0859dad369d6"
      unitRef="number">0.037</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzMtNy0xLTEtMTg0NDY5_80f2b4e5-a8e0-4ee3-bfc9-20f13e58977b"
      unitRef="number">0.032</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzMtOS0xLTEtMTg0NDY5_a2ea9768-7f3b-40e6-900b-8a9ed54a3d08"
      unitRef="number">0.031</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzMtMTEtMS0xLTE4NDQ2OQ_c20c492c-27c0-4261-a31e-90cc5eb3dacf"
      unitRef="number">0.036</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzQtMS0xLTEtMTg0NDY5_8017e5f7-4d2b-4132-a3bc-c57920759388"
      unitRef="number">0.025</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzQtMy0xLTEtMTg0NDY5_395b6f6c-f015-4143-b850-6cbf74e56b36"
      unitRef="number">0.020</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzQtNS0xLTEtMTg0NDY5_957ac957-4593-4f60-8dcc-391ff35ddff3"
      unitRef="number">0.030</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzQtNy0xLTEtMTg0NDY5_ac350047-6614-4768-8a02-7c6f98ecde15"
      unitRef="number">0.025</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzQtOS0xLTEtMTg0NDY5_6e5891a7-5945-4690-959b-b88ecf741d66"
      unitRef="number">0.020</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzQtMTEtMS0xLTE4NDQ2OQ_23081cc6-eb23-4e77-892e-98004d79b425"
      unitRef="number">0.030</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzUtMS0xLTEtMTg0NDY5_9d59861d-d78f-4173-adbe-f3fc7957d83a"
      unitRef="number">0.061</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzUtMy0xLTEtMTg0NDY5_c21ebc11-b84e-4a38-88ec-eb5bfa0d0894"
      unitRef="number">0.066</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzUtNS0xLTEtMTg0NDY5_39c8684f-24f2-4dc6-9e20-6d5a0caddb97"
      unitRef="number">0.066</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzUtNy0xLTEtMTg0NDY5_d3d27475-0e45-487d-ab3b-aadbbdce4657"
      unitRef="number">0.077</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzUtOS0xLTEtMTg0NDY5_259171a2-6a8a-44e0-b339-3d193c15d0ec"
      unitRef="number">0.077</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzUtMTEtMS0xLTE4NDQ2OQ_b21556c0-84f9-43d0-bba3-38ae459986cb"
      unitRef="number">0.077</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzYtMS0xLTEtMTg0NDY5_242990be-5e43-4323-b04c-3d5a5f5d7f7c"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzYtMy0xLTEtMTg0NDY5_fa98db14-ab08-48ef-a8c0-5af45eb1f83a"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzYtNS0xLTEtMTg0NDY5_10fadc95-00d7-44dc-aa4b-93ba1fdcbea4"
      unitRef="number">0.040</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzctNy0xLTEtMTg0NDY5_13cb46d6-1d38-4a98-a37c-cedc2a50b97b"
      unitRef="number">0.065</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzctOS0xLTEtMTg0NDY5_89434e38-9aa1-4129-bd8a-95419a6bbb3d"
      unitRef="number">0.065</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate>
    <mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTozZjkwMTBiOTA4OTk0ZTAxYjA2MGU0MDY4YTIzZjY5Zi90YWJsZXJhbmdlOjNmOTAxMGI5MDg5OTRlMDFiMDYwZTQwNjhhMjNmNjlmXzctMTEtMS0xLTE4NDQ2OQ_8916077f-4860-4b18-9013-c27b5a9a2fcb"
      unitRef="number">0.065</mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQyMTU_03e2e940-081d-4ee4-b10a-0ec03f71b846"
      unitRef="usd">91000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQyMTk_9bfc9bab-883d-4697-8662-85fac2779cb3"
      unitRef="usd">90000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQyMjY_cbaab623-708c-43c5-8c21-2860c18435e8"
      unitRef="usd">88000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i708e341152674f6390a40e9721f87532_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQ2MjU_cdd60e21-5f89-4ccf-9348-3f00e1bcf4ea"
      unitRef="number">0.20</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="if9ef67837f3b481b91a45102c2741bec_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQ2Mjg_de36d86d-ec61-409c-8dbb-04336ebf5617"
      unitRef="number">0.80</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i218f7dbb66d94126b2f426148102feee_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzU1ODg_52b3f11a-35d6-4664-b21c-f19a217c8a1c"
      unitRef="number">0.55</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i1ce8f1baf1924d369a28a5bcb7cd369c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzU1OTE_86d56982-5519-4049-be6a-c1c26cfb3f68"
      unitRef="number">0.45</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMTIz_12568c02-65af-4369-a7e9-048f9600922c">&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The actual composition of our plan assets at December&#160;31, 2022 was broadly characterized with the following allocation:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;56&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;52&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;33&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and foreign government securities and all other investments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;28&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Amount includes U.S Treasury and foreign government securities (19%) and asset based securities and all other investments (9%).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of our pension plan assets by asset category were as follows at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. and foreign government securities or their agencies:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,098&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,098&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. municipal bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government and agencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;32&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Above investment grade&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,747&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,747&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Below investment grade and no rating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;756&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;756&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International equities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;327&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. equities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;591&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;591&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset backed securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;161&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;244&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;243&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;917&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,120&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,037&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments measured at NAV as a practical expedient for fair value:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collective investment funds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_41b4c8e3-e050-43b8-b106-4405c53c782d"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTAtMS0xLTE4NDQ2OQ_9c77b5ce-ddae-4a3d-978b-ba5336576f53"&gt;U.S. large cap&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;312&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_1ddffbe6-a65c-4290-90a9-b5306bc7faca"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTAtMS0xLTE4NDQ2OQ_c2aa8d53-307d-44de-88c6-ccc45057da99"&gt;U.S. small cap&lt;/span&gt;&lt;/span&gt;  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;75&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_6c58378e-c0bf-4554-a791-6444e99557ba"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTAtMS0xLTE4NDQ2OQ_c4015aef-675a-4e45-9c95-609287b0df60"&gt;International developed markets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;49&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of plan assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 holdings and transactions were immaterial to total plan assets at December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of our postretirement plan assets were as follows at December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.757%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.892%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. and foreign government securities or their agencies:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government and agencies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign government and agencies&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Above investment grade&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;37&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:15.75pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Below investment grade and no rating&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;54&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;54&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investments measured at NAV as a practical expedient for fair value:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Collective investment funds:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_295077d8-7c2c-4293-a53f-d6212cd1c050"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTAtMS0xLTE4NDQ2OQ_bff869f3-0247-42fe-9766-2e8c8f382544"&gt;U.S. large cap&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_501091e4-8056-4777-bd80-73ee1b31781b"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTAtMS0xLTE4NDQ2OQ_eef6c587-6a34-4f41-a17b-d1245eda6984"&gt;International developed markets&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investments measured at NAV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Fair value of plan assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;122&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ibef1d20b06414d568aea451eb1e564cf_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiMmNlZDE0OGY4NzE0NDI3OWQxMjE5OThhMWM1OGM1Ni90YWJsZXJhbmdlOmIyY2VkMTQ4Zjg3MTQ0Mjc5ZDEyMTk5OGExYzU4YzU2XzEtMS0xLTEtMTg0NDY5_9fd3aaa0-5c22-4345-a940-cadcbd86b6ee"
      unitRef="number">0.20</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i85712ade9dea49509d0041354e9dd058_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiMmNlZDE0OGY4NzE0NDI3OWQxMjE5OThhMWM1OGM1Ni90YWJsZXJhbmdlOmIyY2VkMTQ4Zjg3MTQ0Mjc5ZDEyMTk5OGExYzU4YzU2XzEtMy0xLTEtMTg0NDY5_72833b96-0f8f-4d18-a4de-61bdc54aec09"
      unitRef="number">0.56</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i46a26fe11c204936a35f2e5d15e5781e_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiMmNlZDE0OGY4NzE0NDI3OWQxMjE5OThhMWM1OGM1Ni90YWJsZXJhbmdlOmIyY2VkMTQ4Zjg3MTQ0Mjc5ZDEyMTk5OGExYzU4YzU2XzItMS0xLTEtMTg0NDY5_76fd8e9f-5941-408c-a94e-4b186e7c4bfb"
      unitRef="number">0.52</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i02d2cf1003314ab9892258dcee6449fe_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiMmNlZDE0OGY4NzE0NDI3OWQxMjE5OThhMWM1OGM1Ni90YWJsZXJhbmdlOmIyY2VkMTQ4Zjg3MTQ0Mjc5ZDEyMTk5OGExYzU4YzU2XzItMy0xLTEtMTg0NDY5_52b28410-9d69-46a8-aac0-f2f9e21839bd"
      unitRef="number">0.33</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ifd98a90576ce475886c7adc642f71634_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiMmNlZDE0OGY4NzE0NDI3OWQxMjE5OThhMWM1OGM1Ni90YWJsZXJhbmdlOmIyY2VkMTQ4Zjg3MTQ0Mjc5ZDEyMTk5OGExYzU4YzU2XzMtMS0xLTEtMTg0NDY5_3e09dbd8-5bad-450e-af3d-a3138db061fc"
      unitRef="number">0.28</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i5ae3153fe128440e9f61ca8201dcc8a0_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiMmNlZDE0OGY4NzE0NDI3OWQxMjE5OThhMWM1OGM1Ni90YWJsZXJhbmdlOmIyY2VkMTQ4Zjg3MTQ0Mjc5ZDEyMTk5OGExYzU4YzU2XzMtMy0xLTEtMTg0NDY5_00470a7b-52f6-4ba1-88dc-a452315ec7f9"
      unitRef="number">0.11</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ic6aab89198f84ab09ff72153ef35e171_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQ5NDc4MDIzNDQ5NzY_7a21db05-9560-4bb7-b4f1-8a6578bf7c80"
      unitRef="number">0.19</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i34b241d0d60b4ff3a0eed6af4527dc96_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzQ5NDc4MDIzNDQ5ODI_0088bdd5-31f8-494d-8318-7172fed26dbf"
      unitRef="number">0.09</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i8cc36e5d0d8e47749726e99b3dca0875_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzcxMzI_bc43dbc7-b17b-4bfe-beb9-a8992226c96a"
      unitRef="number">0.13</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i63d3cf858e354c7e92e2e0365451f300_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzcxODE_5eb727a2-25b4-40b5-ab85-38446520551a"
      unitRef="number">0.10</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i7f6a7fc0bc2d4a5eaf7ca6d75b30312e_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzcyNzQ_db0bd009-94e5-42e8-a6d9-828baffe1d35"
      unitRef="number">0.01</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i31ed26bb32ff433080c9fdca31b03ecc_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzc0MTY_503aa70b-d96a-4e5c-8788-e1b9b4ae59e5"
      unitRef="number">0.12</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ic64efbd3de4f4ab58c333a511cc0d644_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzc0NjU_100b00e7-04d1-4a7a-95c8-c3e95e4528ba"
      unitRef="number">0.05</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8ed4a725235c47b887eb6679e8c3d522_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzc1MTI_bb32e51c-d512-4d32-9ed2-ad4510248185"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i87839150a2374e27a36b41a49b45c5bf_D20230101-20231231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzM4NDgyOTA3MTAyMDc_3de1d8e6-47cd-46e5-a52f-279dd49875f4"
      unitRef="number">0.061</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i83c8e5d5266f45fbb46737c1d2fcace0_D20230101-20231231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzg2ODY_09fa5e85-ed19-4632-8ec9-35bfef12640c"
      unitRef="number">0.074</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5937f04b1ddf4dd89b8d3092539fb3cd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzMtMS0xLTEtMTg0NDY5_6845cc30-01f1-437f-83ee-2eaefeca6d20"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i565d6f3baf2f4947b0dd194ac42693e9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzMtMi0xLTEtMTg0NDY5_a181f123-e1db-414f-9417-6399f201ca31"
      unitRef="usd">1098000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie7d841655cc044a6b7129c58b61ec0c3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzMtNi0xLTEtMTg0NDY5_146b416e-df02-41fa-ad8b-92957cc93504"
      unitRef="usd">1098000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7a857bd3f87c48ba9e0abfc8eebc8cc7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzMtOC0xLTEtMTg0NDY5_06da783e-785f-4061-a720-692e41d976e7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia8bc8d974c824ca79ceac63074634c5c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzMtOS0xLTEtMTg0NDY5_f0fe15d2-21ed-402a-b7e9-9b523b39c48c"
      unitRef="usd">1147000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1f3e5c978adf4674a37c1255333c112e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzMtMTMtMS0xLTE4NDQ2OQ_0c018703-2d55-466d-981b-209f2e402dbe"
      unitRef="usd">1147000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia0f669dde52c4154be5883d70c4541af_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzQtMS0xLTEtMTg0NDY5_d8c72c1b-acea-475e-a261-7fc26098b598"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i837fc7852b3c4ccf973ccfa3c30e16ff_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzQtMi0xLTEtMTg0NDY5_a45cf31a-7393-4965-b4ae-1a887f0a1773"
      unitRef="usd">82000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idb79e28764284a31a8d89f2ff43f4204_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzQtNi0xLTEtMTg0NDY5_d3cdb257-0839-48c5-ab23-b6ec88cfa57a"
      unitRef="usd">82000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i091fc79fcdb54ad5bac6c31650d0dc35_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzQtOC0xLTEtMTg0NDY5_698aad4e-a0f3-4035-88b2-28da60262cd3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i43a0bf9c464a4f689b6fa2279baa3db6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzQtOS0xLTEtMTg0NDY5_f19a65a8-da76-415d-953c-0d08a2a58240"
      unitRef="usd">60000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if56170cb4e9e4dc3ab4c2439b1108953_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzQtMTMtMS0xLTE4NDQ2OQ_aac76901-f4c0-418e-a845-6361c281fe62"
      unitRef="usd">60000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2d5635e4a45042f887595e208639d06c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzUtMS0xLTEtMTg0NDY5_8ab19e81-f092-4593-a065-da806d3d525a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4ab9a9711d20426494a4f993ff5497cc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzUtMi0xLTEtMTg0NDY5_ba9c910a-486d-4b01-9641-36d446179563"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iac81e2e1561144d4b6fc044d55a86b44_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzUtNi0xLTEtMTg0NDY5_e91a2639-71a2-4fce-9d60-dff7ded70f0a"
      unitRef="usd">32000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i98d16200be95427aaa506a07cafc1f0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzUtOC0xLTEtMTg0NDY5_7a0d9401-dae4-429f-b56e-8ffbcd9c6b4d"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4cf80c87ecf0415e92e285f99ba853d6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzUtOS0xLTEtMTg0NDY5_fd0b4488-d191-4b4e-b045-9154ccd50ce4"
      unitRef="usd">88000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie09850cd158044ef9737da94ccd4932a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzUtMTMtMS0xLTE4NDQ2OQ_47122453-81bc-45c7-b8be-8c52131ddb01"
      unitRef="usd">88000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idf7e45d2370d4822a594e626f0867b6f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzctMS0xLTEtMTg0NDY5_a44af960-0f1d-4d43-b5e1-41e16c31543b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i43dc5b8c106142a8a5eec96bf16c5e0c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzctMi0xLTEtMTg0NDY5_9f115096-7f07-40c6-a169-1c3e52bba9e0"
      unitRef="usd">2747000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i05b7833a51e149a89ae331998c279adb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzctNi0xLTEtMTg0NDY5_15bb578a-0dc9-4ba3-bc8d-3e77346c9e7e"
      unitRef="usd">2747000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i19b8a42637c04a8fbdb6b98fcc14b74b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzctOC0xLTEtMTg0NDY5_982574e2-d1e0-4f32-aea2-6ab8a0ce2ec0"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1df38e22ba91472f933e5f94bb462967_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzctOS0xLTEtMTg0NDY5_3dd54c33-38f5-42ce-8359-11ad2bcdca6d"
      unitRef="usd">3442000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i453b78fe37b14dbbb470779c2c160077_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzctMTMtMS0xLTE4NDQ2OQ_3bb6707c-2080-4d97-9dae-da8b0e9a985e"
      unitRef="usd">3442000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idae2e10d00134111b2603a1ec55e2562_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzgtMS0xLTEtMTg0NDY5_697de4fb-272e-4438-b040-023cfe072857"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9a22bcea6c7f47238753a786d43db429_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzgtMi0xLTEtMTg0NDY5_37701626-7d39-4d38-b81c-75f5d0deba2c"
      unitRef="usd">756000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6913094e4c2a4346856f5eaa16cfbdef_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzgtNi0xLTEtMTg0NDY5_bf18eb84-2ec6-4d5c-990a-ddc5e8194c37"
      unitRef="usd">756000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3f7f03e22d4147c2979c55fcc62a5875_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzgtOC0xLTEtMTg0NDY5_e19dc0ae-35af-4a8a-bd27-2dfaab1691c2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if8af8a24b3b4465490365b4873d7d840_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzgtOS0xLTEtMTg0NDY5_5ae263f2-6797-466a-ab56-07cd2c0f0daf"
      unitRef="usd">1032000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i48edc7536f424109abdb6ba04fc667cc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzgtMTMtMS0xLTE4NDQ2OQ_3ef1afa5-49b8-4e35-8241-ef0865657316"
      unitRef="usd">1032000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i724473bb56ef42ca9368c198fabf43e2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzEwLTEtMS0xLTE4NDQ2OQ_73808a7f-8ef1-424f-acd8-6b2d4cf285ef"
      unitRef="usd">327000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3b271655bb784f2f8a8cb1deb35e7d4f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzEwLTItMS0xLTE4NDQ2OQ_50354d45-cf10-4cfd-b80f-9077d4b48bf2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9b66ad4089e442e8b7a70d986b26cc77_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzEwLTYtMS0xLTE4NDQ2OQ_041158a3-ebce-4c37-bb15-1ed5649da4d7"
      unitRef="usd">327000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i66066f1832f24ffb846101be04a19a87_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzEwLTgtMS0xLTE4NDQ2OQ_6dc45552-2fc2-4e5e-aab0-41aab2acf4ce"
      unitRef="usd">373000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic09fc05c98894d629f60974a54315b5b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzEwLTktMS0xLTE4NDQ2OQ_1cbba55a-db9c-4eae-b726-722de5e93e2b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i057b0ef85ece430f8ddd918897d56736_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzEwLTEzLTEtMS0xODQ0Njk_41558392-7105-4b8d-b4e1-51bc7da6d9b7"
      unitRef="usd">373000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i422058d6b4d24ca3ac6e070ff71aa8e2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzExLTEtMS0xLTE4NDQ2OQ_2c8874d5-931a-4d61-b9ab-1a109c8bdab7"
      unitRef="usd">591000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieb23a7abd88b4dfabbbb2aa8d76fdc64_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzExLTItMS0xLTE4NDQ2OQ_d03101b7-9aad-4fe9-9521-2e96d9f471cf"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i15b0bb8f8f754a41a4f7dfd22ec86295_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzExLTYtMS0xLTE4NDQ2OQ_977decc9-7573-4db8-961c-693f2c2369ee"
      unitRef="usd">591000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2da6e6418c72474a99ec75fadc054776_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzExLTgtMS0xLTE4NDQ2OQ_3baaf993-c313-4755-a8f9-c0da4a700ff1"
      unitRef="usd">856000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2bfdb9b8c6324abf8947ddb74a27e6a0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzExLTktMS0xLTE4NDQ2OQ_7288f645-c883-4352-a660-289afff3f9aa"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic332a1659d2f405d80865e862ec27dab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzExLTEzLTEtMS0xODQ0Njk_5469e591-e197-4e76-8200-c7bb53d95876"
      unitRef="usd">856000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic71aca398a11408da1a534b27a0c25dc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE0LTEtMS0xLTE4NDQ2OQ_96c9c1a0-cf90-4f70-a3dd-a24b6d847da4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i10f3d8a40ef14a99905bccea0cfb4b72_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE0LTItMS0xLTE4NDQ2OQ_5dd7026b-90ec-485d-b397-a729763e8427"
      unitRef="usd">161000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iad944a608a784c17b879349817b9d0dd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE0LTYtMS0xLTIxNTExNQ_9b44f8eb-4d60-4031-947e-aae6f02b7945"
      unitRef="usd">161000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ieefef214d38c46c39607fd46cfe43211_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE0LTgtMS0xLTE4NDQ2OQ_55e96f24-5495-4f40-ac13-9e160158109e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i249539f1cfef460291c13bcd717ecbd8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE0LTktMS0xLTE4NDQ2OQ_b4498c55-5137-49b1-8966-b33668dd39eb"
      unitRef="usd">89000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i63684a262279489c9c4f034d04ba5aab_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE0LTEzLTEtMS0yMTAxOTg_158ddb7a-4f9c-4632-9635-63b6887067d9"
      unitRef="usd">89000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i89925d896a8548cfb62d7b79dc5a9fae_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE3LTEtMS0xLTE4NDQ2OQ_ba7b715d-0001-4777-8379-2fd1a65d5f93"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib1339f4ea0fe42bc9ee6d7c661e84e5a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE3LTItMS0xLTE4NDQ2OQ_ba45e27c-e09e-48f2-a5f7-3516d6da671c"
      unitRef="usd">244000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i29227afcd5594316868d15193cb10cac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE3LTYtMS0xLTE4NDQ2OQ_9e914234-dc03-4338-a18b-8db853423939"
      unitRef="usd">243000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8e5c74c5bc734c1b9c970eeb6d8b1f1f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE3LTgtMS0xLTE4NDQ2OQ_fd9590e0-2ec4-4553-8230-321ec14afcfa"
      unitRef="usd">52000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i10518c7a15dc4f21a69ded3f9d645ef6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE3LTktMS0xLTE4NDQ2OQ_cd238a28-1f2a-4f4f-a8a8-67c99008112d"
      unitRef="usd">148000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i22cca4c436d842d087f356c875896d60_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE3LTEzLTEtMS0xODQ0Njk_e105eb61-b58c-4574-a4ce-dac0c4b78ced"
      unitRef="usd">200000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib2c076e5ef854cabb8069eab488e2649_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE4LTEtMS0xLTE4NDQ2OQ_c1a87f3e-f0cc-4a8a-8f64-eb45284617d5"
      unitRef="usd">917000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7e3082841f894e34a24a50706f337744_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE4LTItMS0xLTE4NDQ2OQ_d91874c5-8a8d-4129-b725-9a534d7ffa0a"
      unitRef="usd">5120000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0febe181336b41b5a658c64358915bfe_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE4LTYtMS0xLTE4NDQ2OQ_2866db6c-8781-4949-b8f5-97a6872a6fb2"
      unitRef="usd">6037000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i64f7dc5b917c46deaa9b0a051ea0fb75_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE4LTgtMS0xLTE4NDQ2OQ_68e20afb-de38-4b8a-bcdc-1586835cde7d"
      unitRef="usd">1281000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i620de52603d8478d83b1d097f32554e6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE4LTktMS0xLTE4NDQ2OQ_017d0e2e-ce22-4336-8e89-f5fa5736c716"
      unitRef="usd">6006000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4feca36ee17847ab82502d9eed738030_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzE4LTEzLTEtMS0xODQ0Njk_490ee6a5-e668-4e13-a993-ba449810c655"
      unitRef="usd">7287000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7d478bf113ce483ebab401dd2fd6491d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTYtMS0xLTE4NDQ2OQ_e7ce4838-0fef-40c4-88cf-b7db2e5afc97"
      unitRef="usd">312000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i39264efecc9e4ca88497194b3b7c8fc0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIxLTEzLTEtMS0xODQ0Njk_f4cd916e-297d-4d86-8ade-79dff12ad4c2"
      unitRef="usd">873000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i142dcd767464403ea9b22f153172c48d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTYtMS0xLTE4NDQ2OQ_a0cb3b34-8824-4af0-96ec-aa14d0a05921"
      unitRef="usd">75000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia39aee97eee14867b9fd0099749071c8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIyLTEzLTEtMS0xODQ0Njk_e9cc458d-3367-4265-9cbd-9018c1455ded"
      unitRef="usd">462000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5df4d26ee4254aec95af80be28802c08_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTYtMS0xLTE4NDQ2OQ_20b0a511-869a-472f-abd2-d0f026ce5d17"
      unitRef="usd">49000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0411a1966ac645d8a850e70787e39e47_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzIzLTEzLTEtMS0xODQ0Njk_e766579c-22e4-46b3-96cd-961f635c28d2"
      unitRef="usd">125000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifc7229bbd58f4df69b5dea2ccab95bf5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzI0LTYtMS0xLTE4NDQ2OQ_f9ccfa2f-747d-4636-8882-db5fb64b1c17"
      unitRef="usd">436000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i2dd0be9d1bce45958792a2e9fbe32dcf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzI0LTEzLTEtMS0xODQ0Njk_958bb163-018b-48b4-bba0-881f00b53e5a"
      unitRef="usd">1460000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id36ee6f9d1124a2595ac2df42e648378_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzI2LTYtMS0xLTE4NDQ2OQ_7990e7b4-6c8a-483a-a2e2-39ab0a0093f6"
      unitRef="usd">130000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ide5f143afc5b477a9e3945daf0484c78_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzI2LTEzLTEtMS0xODQ0Njk_1e17e1c0-0c01-4f3f-aa9a-8f2b239d98fd"
      unitRef="usd">46000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzI3LTYtMS0xLTE4NDQ2OQ_3c7024ec-0315-4691-aec8-422379ea4377"
      unitRef="usd">6603000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpiZjFmYWExZmEzOTc0NzRiYjVmZGQ4YWIwMjIzNDU2Ni90YWJsZXJhbmdlOmJmMWZhYTFmYTM5NzQ3NGJiNWZkZDhhYjAyMjM0NTY2XzI3LTEzLTEtMS0xODQ0Njk_42f11e5a-fcdc-414a-89df-902e054d0e61"
      unitRef="usd">8793000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i07f902bc6dc8430c85a4b5a6902f7e69_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzMtMS0xLTEtMTg0NDY5_48acb65b-e567-4a04-89fb-b9a986f37200"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1dc0106f1faf462eb26fc43277eaf2cd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzMtMi0xLTEtMTg0NDY5_e21820a5-b069-424f-a55a-3fa8bd08dd92"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idb735c6a79f740efb339b169181396ad_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzMtNC0xLTEtMTg0NDY5_d1a05fab-02ba-4fae-b82e-65c27aa246a9"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i726f9056e75f4525b26f5df7a357b0a1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzMtNi0xLTEtMTg0NDY5_bdb58ce9-c883-4dd0-ba96-702b422c7d14"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic341b9e0ef914a71aae1c0fe77f8d38e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzMtNy0xLTEtMTg0NDY5_31b10850-3aa5-43cd-8c19-0cbc23c9b798"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i214fc2f6fc754f7c885b3d6871ae6404_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzMtOS0xLTEtMTg0NDY5_449efdba-3792-4a9d-b3eb-b1be240dd0a0"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia7ac312a52d2464dae961fee29607342_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzUtMS0xLTEtMTg0NDY5_e5faac0d-4a3b-4d54-8552-07f11ec3a0f8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5c9735a7061a47e5985f44f2027c193e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzUtMi0xLTEtMTg0NDY5_c07cad57-872e-4288-a62c-42df7a13acc2"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i66baea8f8e3e44ccada2d2c6a807a3fb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzUtNC0xLTEtMTg0NDY5_8d450862-39df-4d55-b951-9c22be62d44b"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1ab2d0a4619144f49e454db1495480ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzUtNi0xLTEtMTg0NDY5_41ed9c87-3fe2-4835-8a3c-b066af89678b"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i27b909807cda4d008124cf98b2dfb195_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzUtNy0xLTEtMTg0NDY5_7fa4829f-d9de-4ad4-911f-5429691deee4"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i67c6d721f139463c8a5ef2e2ac65795e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzUtOS0xLTEtMTg0NDY5_daaa7917-812b-4e6f-a248-6ae4ebd81320"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic90b8a4e1cad40c99e3c612c6aff6d10_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzctMS0xLTEtMTg0NDY5_02381b4e-a6a2-4ccf-ae41-c2e67c3f96d9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8ef1e5229020494cbba49f40f9408830_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzctMi0xLTEtMTg0NDY5_acccc6c5-8d7b-4d4b-b08a-58891d5232ac"
      unitRef="usd">37000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1b045ef00b1c46baa8abe159f085ff7a_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzctNC0xLTEtMTg0NDY5_fb31c0de-f5d2-4fc6-adc2-d21ad8eb4bd9"
      unitRef="usd">37000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id683265debfa46c298eb35c208c438d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzctNi0xLTEtMTg0NDY5_f1076562-49c7-4483-b5e3-ec52d1755d72"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4d1961208f4440e6950aa35f0cb3a24c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzctNy0xLTEtMTg0NDY5_3abc2cf4-eab8-4f75-b903-a5eddb1ee82f"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i53cd4ff8943f439dbee592de787cea17_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzctOS0xLTEtMTg0NDY5_862088c9-ff19-4b07-b9b7-913cfe73f5be"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ida49dd477308420ca136a97a189050d9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzgtMS0xLTEtMTg0NDY5_c4a7ca4d-e7d8-42a6-a0c4-2a1d09b25495"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iabff1a6156384adc8cce0664586e25ec_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzgtMi0xLTEtMTg0NDY5_1071e67b-445a-4fa6-80e1-ed36ae44ebbf"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5b655b11e1ab48199a135d655b722fff_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzgtNC0xLTEtMTg0NDY5_1fbe7df8-525f-4fe0-9ffd-83998d07a80a"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i66404ccb7de546aa8b469a4fcbbbebc8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzgtNi0xLTEtMTg0NDY5_3b6e4876-6539-46b0-a769-ecb48275e7b8"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i3ae13872490f4b7eb4a801adfb2d171e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzgtNy0xLTEtMTg0NDY5_c0ddb86a-ee7a-4257-8779-79cae330f5a0"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i418d56b014124b6081ceffc5c76fe087_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzgtOS0xLTEtMTg0NDY5_26a4069e-3c33-47cb-8ecd-7ed857e73e22"
      unitRef="usd">10000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i7233bea80cc74eb8844423b368b977fa_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzktMS0xLTEtMTg0NDY5_df5dba2b-2c35-4df0-b9fb-d8023cd3fb9a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia9db59398fd34374bc22c5daa2fdcf89_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzktMi0xLTEtMTg0NDY5_29f50a1e-d399-4600-bd16-1d1fa0e9ff77"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="if248beb73395471a8d3f3cb7a01e64bc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzktNC0xLTEtMTg0NDY5_763c9be7-4993-4fec-b7cf-69b8da36738a"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0ce3e56286fd4ca4b41897ef25ba9373_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzktNi0xLTEtMTg0NDY5_0c9c1073-5fe3-4bba-93c3-41a8759b5692"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i14364497d94445c79d254185c8a0e260_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzktNy0xLTEtMTg0NDY5_9075cb90-8cee-4d72-a0dd-385956c7cfb2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ifb1582fd2b3f4d81b9602d7adb41a05d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzktOS0xLTEtMTg0NDY5_a0cfb335-ac30-4c4c-ba4b-5646c7cb0d01"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i441d0fa2abb74093916c6655196afd82_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEwLTEtMS0xLTE4NDQ2OQ_eebb68b4-ec77-4ac9-b263-269365145282"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id2576928a12a455283eec1278075ce78_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEwLTItMS0xLTE4NDQ2OQ_bc910bb7-fca6-414d-a9fd-4533b7fa3fdf"
      unitRef="usd">54000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i9ff5b3ac729140c5ab95d29557eded13_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEwLTQtMS0xLTE4NDQ2OQ_dfb32106-06ea-4fbb-b421-5bb5b786886f"
      unitRef="usd">54000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i099176409b2d40eb9b090dd044fbd69a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEwLTYtMS0xLTE4NDQ2OQ_05a03d5d-b486-4265-8403-e31f17a22347"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id65b933eaa6f4c9589f7de89c772d624_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEwLTctMS0xLTE4NDQ2OQ_62ebdd64-eea3-4e5a-8501-bed0d055781d"
      unitRef="usd">73000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i92c62a510f4440e0ae76b083af678da0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEwLTktMS0xLTE4NDQ2OQ_b5db4aba-c289-48bd-9f49-fac1aa8c5620"
      unitRef="usd">73000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i77edbf66fcec42d282c3c8658c645b38_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTQtMS0xLTE4NDQ2OQ_75125b58-ed4e-4540-b70f-9dc567d5036a"
      unitRef="usd">47000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6fb4e78e1b1244acb5f611d994fe511d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzEzLTktMS0xLTE4NDQ2OQ_99ff43dd-9869-41c7-a6f8-32561c855b73"
      unitRef="usd">84000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8c1cbb128b174538ae7334de7cce2ee9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTQtMS0xLTE4NDQ2OQ_43f0173d-0a97-4809-90e0-4fb88179860f"
      unitRef="usd">18000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iab4e374e5b4a4126bfc6bd904d7493c0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE0LTktMS0xLTE4NDQ2OQ_9c322472-2f8c-40b5-9de0-63ba2c7bf5d0"
      unitRef="usd">25000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib7bd5b5f81284011843bd24a1f898451_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE1LTQtMS0xLTE4NDQ2OQ_3efd1090-0705-49ad-b037-58eb9b9cac9f"
      unitRef="usd">65000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i4e916bce86724c739256a11e8d5ddfaf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE1LTktMS0xLTE4NDQ2OQ_2bf2310c-6735-4e4c-a816-89f3ce1a0645"
      unitRef="usd">109000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5143a89f62f942d0aed69e5d5403fbdb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE3LTQtMS0xLTE4NDQ2OQ_8d5c9895-0ca3-4b1d-9d0a-eb28f67b38d3"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i146dab2f246f4239ac7c45936f953058_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE3LTktMS0xLTE4NDQ2OQ_b6f5ecba-a593-49bf-b39e-311ef8f2e7ca"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE4LTQtMS0xLTE4NDQ2OQ_c462fc14-14e8-4ffc-a4a8-fb23061b64ef"
      unitRef="usd">122000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTpmZGJiZTUzY2VlZjg0NmE1YmQwNzVjMDc5OGE0ZmY2My90YWJsZXJhbmdlOmZkYmJlNTNjZWVmODQ2YTViZDA3NWMwNzk4YTRmZjYzXzE4LTktMS0xLTE4NDQ2OQ_b225c362-8a93-4a61-a8bf-2d2e02192aa4"
      unitRef="usd">185000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <mo:MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDQ4_a344ea75-b112-40ee-8afa-a514830b5263">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following is a description of the valuation methodologies used for investments measured at fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;U.S. and Foreign Government Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: U.S. and foreign government securities consist of investments in Treasury Nominal Bonds and Inflation Protected Securities and municipal securities.  Government securities are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes.  Matrix pricing, yield curves and indices are used when broker quotes are not available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Corporate Debt Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Corporate debt instruments are valued at a price that is based on a compilation of primarily observable market information, such as broker quotes.  Matrix pricing, yield curves and indices are used when broker quotes are not available.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Common Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Common stocks are valued based on the price of the security as listed on an open active exchange on last trade date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Asset Backed Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Asset backed securities are fixed income securities such as mortgage backed securities and auto loans that are collateralized by pools of underlying assets that are unable to be sold individually.  They are valued at a price which is based on a compilation of primarily observable market information or a broker quote in a non-active over-the-counter market.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Collective Investment Funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Collective investment funds consist of funds that are intended to mirror indices such as Standard&#160;&amp;amp; Poor&#x2019;s 500 Index and MSCI EAFE Index.  They are valued on the basis of the relative interest of each participating investor in the fair value of the underlying assets of each of the respective collective investment funds.  The underlying assets are valued based on the net asset value (&#x201c;NAV&#x201d;), which is provided by the investment account manager as a practical expedient to estimate fair value.  These investments are not classified by level but are disclosed to permit reconciliation to the fair value of plan assets.&lt;/span&gt;&lt;/div&gt;</mo:MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="i367f5ac75e4a4df58e4998eb5c85657f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzExMTEx_29176ae6-eeff-43cd-baef-e18c06c0f719"
      unitRef="usd">30000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="ie5d867da7f4441dda11c6293c01cb96b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzExMTEx_c7b48eff-19ee-4381-b49e-c6a39cc69d08"
      unitRef="usd">30000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMTI2_1e59f997-433b-40c6-83e4-a6ef934a2c76">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated future benefit payments at December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.726%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.146%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Postretirement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;494&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;106&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;471&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;473&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028-2032&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;477&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzEtMS0xLTEtMTg0NDY5_b086e137-4e68-4178-80d2-5814bf44eb84"
      unitRef="usd">494000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzEtMy0xLTEtMTg0NDY5_fbeff2aa-018d-424d-bbcf-60190654d12c"
      unitRef="usd">106000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzItMS0xLTEtMTg0NDY5_4983b02c-8eda-48c6-91bf-c59e61b53647"
      unitRef="usd">471000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzItMy0xLTEtMTg0NDY5_66ed9770-e4fd-44e7-8ffe-f04c0a0de117"
      unitRef="usd">100000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzMtMS0xLTEtMTg0NDY5_5d8c8672-cacc-4319-94d7-5762caa092ef"
      unitRef="usd">471000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzMtMy0xLTEtMTg0NDY5_0ed42a6c-7d98-45d4-911a-e1a41a59ec61"
      unitRef="usd">96000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzQtMS0xLTEtMTg0NDY5_110f3d01-c0d0-4b81-be06-d02fe0d5b3f7"
      unitRef="usd">472000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzQtMy0xLTEtMTg0NDY5_6aa5a74e-2d98-4726-9596-4a5126b3de20"
      unitRef="usd">95000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzUtMS0xLTEtMTg0NDY5_950e054a-2ccb-4955-a5af-b87cbe7494b7"
      unitRef="usd">473000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzUtMy0xLTEtMTg0NDY5_daa01fd2-5e57-4770-a062-3af72b469015"
      unitRef="usd">95000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzYtMS0xLTEtMTg0NDY5_b591eb67-e753-4e4c-a54f-e60f0d544f44"
      unitRef="usd">2355000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo0NTI2NjQxZjZlODU0MjU4OTM5NTVhODBlMDc2ZGNjOC90YWJsZXJhbmdlOjQ1MjY2NDFmNmU4NTQyNTg5Mzk1NWE4MGUwNzZkY2M4XzYtMy0xLTEtMTg0NDY5_ff85bd49-d06d-41ad-906d-02c170d996d6"
      unitRef="usd">477000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDQ5_00d3f07a-7e67-48e8-b82f-3561703e56dd">&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded the following amounts in accumulated other comprehensive losses at December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;employment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,180)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2,213)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service (cost) credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;293&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;264&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;571&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;513&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts recorded in accumulated other comprehensive losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;226&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1,436)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded the following amounts in accumulated other comprehensive losses at December&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;employment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,093)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(362)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,487)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service (cost) credit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt;text-indent:-4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts recorded in accumulated other comprehensive losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,574)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzItMS0xLTEtMTg0NDY5_5c486c77-4b00-446f-b356-c8174ff751b3"
      unitRef="usd">-2180000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzItMy0xLTEtMTg0NDY5_4f75fc8c-dcdc-4135-a9a6-0cc345ddd033"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="iadc0d8691da8467d9ca4ad958399f860_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzItNS0xLTEtMTg0NDY5_bbdf6dc8-e47d-4f57-ad8e-71f75b5b3df3"
      unitRef="usd">-34000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzItNy0xLTEtMTg0NDY5_d84c0777-710d-40ca-8603-9e9f93d74e4f"
      unitRef="usd">-2213000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzMtMS0xLTEtMTg0NDY5_5624959c-2ddf-4bd4-97eb-6d4103f55c4e"
      unitRef="usd">24000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzMtMy0xLTEtMTg0NDY5_400df363-f5d2-4684-8bd5-c37cdeec07fc"
      unitRef="usd">-293000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="iadc0d8691da8467d9ca4ad958399f860_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzMtNS0xLTEtMTg0NDY5_b58486e4-0d73-4beb-8778-46bdc16ad5bb"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzMtNy0xLTEtMTg0NDY5_1261ad38-4f47-4f14-8162-fd447f95fd92"
      unitRef="usd">-264000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzQtMS0xLTEtMTg0NDY5_44c2f147-074a-42ce-80bb-855369f9bb9f"
      unitRef="usd">571000000</mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax>
    <mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzQtMy0xLTEtMTg0NDY5_10ed0dac-a0a6-4c65-856d-59348da9c2ba"
      unitRef="usd">-68000000</mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax>
    <mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax
      contextRef="iadc0d8691da8467d9ca4ad958399f860_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzQtNS0xLTEtMTg0NDY5_ed28b69a-70d7-4a8f-a6f3-c35f97bb0894"
      unitRef="usd">10000000</mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax>
    <mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzQtNy0xLTEtMTg0NDY5_1d06bcb6-4e4b-40a8-9351-15e8e8ed964b"
      unitRef="usd">513000000</mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i84846537e5f745d2987290028523bac3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzUtMS0xLTEtMTg0NDY5_960b0a33-e489-48a6-9665-95cf2c899a99"
      unitRef="usd">1633000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i009462f76967433f92d600d008ec5c47_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzUtMy0xLTEtMTg0NDY5_24bc976d-be2d-4e39-a6bb-5fe7fa0f212c"
      unitRef="usd">-226000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="iadc0d8691da8467d9ca4ad958399f860_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzUtNS0xLTEtMTg0NDY5_18c84f7a-b568-4621-aaad-c953a7e54bd2"
      unitRef="usd">29000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplOGE2NWM5NmNhMmU0NGQxOThkYTZiNmU3NGY5NjMwOS90YWJsZXJhbmdlOmU4YTY1Yzk2Y2EyZTQ0ZDE5OGRhNmI2ZTc0Zjk2MzA5XzUtNy0xLTEtMTg0NDY5_9a6579c7-32b7-49f1-a334-7e632d05ddd8"
      unitRef="usd">1436000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzEtMS0xLTEtMTg0NDY5_3e9a557c-0da8-4461-bf82-5a964e17a78c"
      unitRef="usd">-2093000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzEtMy0xLTEtMTg0NDY5_06af15ba-6a9f-4080-8714-e356dfccbd90"
      unitRef="usd">-362000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="ia96532ef56c74a5ab19f74aad5a85003_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzEtNS0xLTEtMTg0NDY5_554d117e-1ae2-466e-8569-7f752ce099c6"
      unitRef="usd">-32000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzEtNy0xLTEtMTg0NDY5_a515d333-943b-4722-9646-0dc61bcd0785"
      unitRef="usd">-2487000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzItMS0xLTEtMTg0NDY5_ae02b550-4ae9-48e7-859d-e1ae8412776b"
      unitRef="usd">30000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzItMy0xLTEtMTg0NDY5_3609bf07-b8e6-4734-9f7a-b61518c1f1af"
      unitRef="usd">-340000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="ia96532ef56c74a5ab19f74aad5a85003_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzItNS0xLTEtMTg0NDY5_940afd05-863d-4e6c-88d9-7bd0cd7641a0"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzItNy0xLTEtMTg0NDY5_d44b6dee-e514-4cc0-9646-9a790068b5a7"
      unitRef="usd">-305000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax>
    <mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzMtMS0xLTEtMTg0NDY5_cd01775f-372b-43ef-9725-23924b5a0a24"
      unitRef="usd">549000000</mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax>
    <mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzMtMy0xLTEtMTg0NDY5_d6a238a1-fc1a-478b-bb35-1d89fb3835df"
      unitRef="usd">12000000</mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax>
    <mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax
      contextRef="ia96532ef56c74a5ab19f74aad5a85003_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzMtNS0xLTEtMTg0NDY5_d95eeabe-183d-4a39-8e51-b28efe657418"
      unitRef="usd">9000000</mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax>
    <mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzMtNy0xLTEtMTg0NDY5_ada2e535-feb2-41a3-81e9-96cffacd9736"
      unitRef="usd">570000000</mo:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="id6adba30f5e044f0b98201ca6954317b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzQtMS0xLTEtMTg0NDY5_9c70e4ef-a4b7-4327-8ecf-175ca1b7418b"
      unitRef="usd">1574000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i51af7141b0f74960b97071f12967601e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzQtMy0xLTEtMTg0NDY5_295441a3-8420-45a8-89cb-e2972759b7a7"
      unitRef="usd">10000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="ia96532ef56c74a5ab19f74aad5a85003_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzQtNS0xLTEtMTg0NDY5_248e57d3-6912-471a-a52e-44125cb73ba2"
      unitRef="usd">28000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo1OTQ0ZTMyZjMzM2I0ZmZlODBhYmYzYzA1MTllZTc2OC90YWJsZXJhbmdlOjU5NDRlMzJmMzMzYjRmZmU4MGFiZjNjMDUxOWVlNzY4XzQtNy0xLTEtMTg0NDY5_90dc579e-e52f-45da-a1bb-c9f2f18e8721"
      unitRef="usd">1612000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90ZXh0cmVnaW9uOmViM2VhMDQyNzQwODRmNDliODI1ZDNiNjQxM2YyZWVhXzEyMDkw_b38581e7-eba7-4983-b400-4b108ec0dabd">&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;employment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings as components of net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;96&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;18&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;76&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;66&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other movements during the year:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(183)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;147&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;48&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;256&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;110&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total movements in other comprehensive earnings/losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;236&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;176&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;padding-left:9pt;text-indent:-9.01pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-employment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings as components of net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-0.01pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other movements during the year:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total movements in other comprehensive earnings/losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The movements in other comprehensive earnings/losses for the year ended December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.833%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Pension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;retirement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Post-&lt;br/&gt;employment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.51pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to net earnings as components of net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense (income):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other movements during the year:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(448)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior service cost/credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(204)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(339)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total movements in other comprehensive earnings/losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(228)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzMtMS0xLTEtMTg0NDY5_b3608013-f017-469e-8ed5-9baeb69eee01"
      unitRef="usd">-96000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzMtMy0xLTEtMTg0NDY5_afa45dc4-feaa-422c-a066-c6fff8042384"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzMtNS0xLTEtMTg0NDY5_651e3507-8558-4c74-af0b-f2beb519af05"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzMtNy0xLTEtMTg0NDY5_489d8c22-c0a7-4491-90b7-7abfd5e1a2fa"
      unitRef="usd">-127000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzQtMS0xLTEtMTg0NDY5_7079b0de-050a-4527-878f-823c689ec6a1"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzQtMy0xLTEtMTg0NDY5_63b63c48-c2d1-4b09-a65f-25474b55601a"
      unitRef="usd">-45000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzQtNS0xLTEtMTg0NDY5_d0ee2a2d-202d-4403-89e4-4d4c5d06f728"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzQtNy0xLTEtMTg0NDY5_66d054a7-5b0a-4d7c-9a39-5b8d2442d612"
      unitRef="usd">-39000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzYtMS0xLTEtMTg0NDY5_8812e19a-e69a-469c-86cd-01cbc2c25ef3"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax>
    <mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzYtMy0xLTEtMTg0NDY5_9481585f-f784-4f35-bb35-ff12816bf01f"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax>
    <mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax
      contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzYtNS0xLTEtMTg0NDY5_50b1d5b9-e0c0-4770-bd84-cf25c389e900"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax>
    <mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzYtNy0xLTEtMTg0NDY5_5735f22b-54f5-4f9c-acef-9b5007df8e37"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax>
    <mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzctMS0xLTEtMTg0NDY5_052e2f40-9db3-4d64-b11e-cae3b935a3ce"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax>
    <mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzctMy0xLTEtMTg0NDY5_5e07e30b-8140-4f3d-9291-5e4c33f5c08c"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax>
    <mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax
      contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzctNS0xLTEtMTg0NDY5_5af21577-3d83-4657-9145-eb13f62b4a88"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax>
    <mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzctNy0xLTEtMTg0NDY5_d04fe54a-1acf-4182-8071-64ae0e03e9bf"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzgtMS0xLTEtMTg0NDY5_e386d543-33aa-4142-9112-1376a783899d"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzgtMy0xLTEtMTg0NDY5_372e13f3-56c0-4a94-82cf-23151a46ce69"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzgtNS0xLTEtMTg0NDY5_ad385923-3933-4ecb-b101-fa5b202b879a"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzgtNy0xLTEtMTg0NDY5_b6c071a3-56f8-45a9-a45c-73bf0a7b5ead"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzktMS0xLTEtMTg0NDY5_7f9a50d6-79ed-4e89-ac2e-c17df6e28e9b"
      unitRef="usd">76000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzktMy0xLTEtMTg0NDY5_cf3e8f2c-fb48-4b36-a940-04c859e9410c"
      unitRef="usd">-20000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzktNS0xLTEtMTg0NDY5_44be45ef-fc14-45cd-9f1d-a62ccd3fa5da"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzktNy0xLTEtMTg0NDY5_60acf627-fce6-4123-b72e-01fcd7a52644"
      unitRef="usd">66000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzExLTEtMS0xLTE4NDQ2OQ_3829fc4d-845c-44ee-ba35-daaaf22f2367"
      unitRef="usd">-183000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzExLTMtMS0xLTE4NDQ2OQ_40b9f895-c86a-4ec7-833e-03265215e124"
      unitRef="usd">345000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzExLTUtMS0xLTE4NDQ2OQ_3fa147b8-5de7-4e9f-a71a-37920db59576"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzExLTctMS0xLTE4NDQ2OQ_b59aa464-5562-450c-973d-89353294046d"
      unitRef="usd">147000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEyLTEtMS0xLTE4NDQ2OQ_c6576d72-d03c-4ee6-8941-2880f8325681"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEyLTMtMS0xLTE4NDQ2OQ_ed7fedec-33f6-47b0-b60a-7415ad32834d"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEyLTUtMS0xLTE4NDQ2OQ_53b7d725-df68-4729-9f8e-a685f66ff909"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEyLTctMS0xLTE4NDQ2OQ_8394d340-5880-453c-8276-1c291cfd0546"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEzLTEtMS0xLTE4NDQ2OQ_dd761889-38c8-419a-b152-6f4e557da8cf"
      unitRef="usd">48000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEzLTMtMS0xLTE4NDQ2OQ_e72b6db3-8757-4dd8-a0ee-8593e1b50194"
      unitRef="usd">-87000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax
      contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEzLTUtMS0xLTE4NDQ2OQ_7fb95299-719a-4367-b9e5-ed65aa11021e"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzEzLTctMS0xLTE4NDQ2OQ_99a99efb-766f-40ac-a78a-2edf9cd25a28"
      unitRef="usd">-35000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE0LTEtMS0xLTE4NDQ2OQ_599c5438-b0d8-443a-bdf0-88ad9b3f2fc5"
      unitRef="usd">135000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE0LTMtMS0xLTE4NDQ2OQ_09db3ef4-6ce9-4956-92fc-43bb62050d8f"
      unitRef="usd">-256000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE0LTUtMS0xLTE4NDQ2OQ_ca69b9e1-fab1-4de3-a9c2-6a207e22d174"
      unitRef="usd">11000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE0LTctMS0xLTE4NDQ2OQ_7c3ac639-17c0-4e99-8f1b-f4b73f09b68a"
      unitRef="usd">-110000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment
      contextRef="i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE1LTEtMS0xLTE4NDQ2OQ_124c9b79-50af-439b-abf5-f2c24f8d4c9f"
      unitRef="usd">59000000</mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment>
    <mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment
      contextRef="i94108a15a46540f0ae9cf71cf26d31cc_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE1LTMtMS0xLTE4NDQ2OQ_a2b31aad-c3e6-464a-a783-d4d3bb424379"
      unitRef="usd">-236000000</mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment>
    <mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment
      contextRef="i296b14c1386b4c818e7d9e64a5737e08_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE1LTUtMS0xLTE4NDQ2OQ_e8773562-112d-466d-b607-6f3fb2e2159d"
      unitRef="usd">1000000</mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment>
    <mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTo5YmIzOTUwMGE0MzA0Y2QyOTU4NjQ4NWRkZGVlYjkzYS90YWJsZXJhbmdlOjliYjM5NTAwYTQzMDRjZDI5NTg2NDg1ZGRkZWViOTNhXzE1LTctMS0xLTE4NDQ2OQ_118c34e4-55d1-4447-816a-8a950d85f022"
      unitRef="usd">-176000000</mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzMtMS0xLTEtMTg0NDY5_5d3de799-deb4-4572-b00a-154f80a9344b"
      unitRef="usd">-131000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzMtMy0xLTEtMTg0NDY5_3aa9321d-d366-4a5c-9df9-012cd70ddf8b"
      unitRef="usd">-22000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzMtNS0xLTEtMTg0NDY5_f7923640-049c-4db0-a5d9-24f0d5ed1d12"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzMtNy0xLTEtMTg0NDY5_1ad3e0e6-5376-468b-a85c-c89864aae818"
      unitRef="usd">-163000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzQtMS0xLTEtMTg0NDY5_2730a099-c557-4588-b0ec-dbcc2052acab"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzQtMy0xLTEtMTg0NDY5_2e141d1a-ab7b-423a-ad6c-a3907bf40670"
      unitRef="usd">-46000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzQtNS0xLTEtMTg0NDY5_51850647-fe06-4506-a334-2b3eee707fce"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzQtNy0xLTEtMTg0NDY5_5cc249f2-dbfb-4bee-94e2-a79e46b3c665"
      unitRef="usd">-41000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzYtMS0xLTEtMTg0NDY5_53edc122-7e55-4d4a-9d95-2b51f40a8033"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax>
    <mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzYtMy0xLTEtMTg0NDY5_480e2a52-b962-48f0-ba29-74a843defe63"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax>
    <mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax
      contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzYtNS0xLTEtMTg0NDY5_2c85d057-efa7-4fa0-8ab0-6b7df89c3ac3"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax>
    <mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzYtNy0xLTEtMTg0NDY5_0ebbce0a-c3cb-4c8e-860f-382e365f2a35"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax>
    <mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzctMS0xLTEtMTg0NDY5_1b178bc5-9431-41d1-a5eb-b3708b90d42c"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax>
    <mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzctMy0xLTEtMTg0NDY5_10c240cc-0ea6-46bb-888a-d6c2e71637d6"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax>
    <mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax
      contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzctNS0xLTEtMTg0NDY5_65cedca1-0112-4052-bb91-f10ee1833181"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax>
    <mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzctNy0xLTEtMTg0NDY5_0a11f69d-b9a8-49e2-a228-a0206ecedf29"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzgtMS0xLTEtMTg0NDY5_8cb0ef69-fa93-4eb0-aa4a-eadcdc09c5be"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzgtMy0xLTEtMTg0NDY5_d747e619-1bc3-40dc-b1ce-956079655d62"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzgtNS0xLTEtMTg0NDY5_75351b13-cbcc-4ac7-ac9b-1087bd173eba"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzgtNy0xLTEtMTg0NDY5_3736cc1d-8976-42fe-83b6-799d0359bf9e"
      unitRef="usd">30000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzktMS0xLTEtMTg0NDY5_43ea9232-ab63-4ecc-a1bb-aa6b9b3d6255"
      unitRef="usd">101000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzktMy0xLTEtMTg0NDY5_1f99e412-bc4e-4b3e-82ed-627e823ebef2"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzktNS0xLTEtMTg0NDY5_32686b8d-dadb-44af-bf80-70bf4b312410"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzktNy0xLTEtMTg0NDY5_90fbec3b-a6f6-4125-8945-e4a37266db35"
      unitRef="usd">92000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEyLTEtMS0xLTE4NDQ2OQ_d40295c1-bb0e-401d-b133-ac879a815505"
      unitRef="usd">465000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEyLTMtMS0xLTE4NDQ2OQ_a63098bc-146e-4bde-bcb8-3ddaf86be6b7"
      unitRef="usd">157000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEyLTUtMS0xLTE4NDQ2OQ_2c30eb6d-9405-4764-b5a7-44d096bd5184"
      unitRef="usd">2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEyLTctMS0xLTE4NDQ2OQ_7edb1f04-84f8-4c10-adca-651c6d423588"
      unitRef="usd">624000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEzLTEtMS0xLTE4NDQ2OQ_5ec4ef9d-06d8-4a63-a406-7730213d98a0"
      unitRef="usd">8000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEzLTMtMS0xLTE4NDQ2OQ_c9e6baf7-a55b-4c01-956e-d03e8dcd6952"
      unitRef="usd">-345000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEzLTUtMS0xLTE4NDQ2OQ_bbe34b10-be4c-42bf-9aef-3d47395baf9e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzEzLTctMS0xLTE4NDQ2OQ_541285b1-3dd7-4468-91ce-6f110f172723"
      unitRef="usd">-337000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE0LTEtMS0xLTE4NDQ2OQ_426d8a58-fc64-43c9-9eb8-ab992dae8b2e"
      unitRef="usd">-118000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE0LTMtMS0xLTE4NDQ2OQ_93bd8533-e846-4d1c-8d59-e1a40bd49871"
      unitRef="usd">-127000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax
      contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE0LTUtMS0xLTE4NDQ2OQ_25d9e6d9-77c1-42f7-a770-ab26aef08d5c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE0LTctMS0xLTE4NDQ2OQ_ece2e75e-17dd-44c8-b88c-2c98e4b801c4"
      unitRef="usd">-245000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE1LTEtMS0xLTE4NDQ2OQ_7ecd45ee-3353-4a6c-b03b-8fb52d14f8e9"
      unitRef="usd">-339000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE1LTMtMS0xLTE4NDQ2OQ_293bdac7-d524-4aec-9234-45279c1756c3"
      unitRef="usd">-375000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE1LTUtMS0xLTE4NDQ2OQ_a88618a7-9170-4bc9-ab11-ffcec29ec477"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE1LTctMS0xLTE4NDQ2OQ_84d45938-c6e2-44a9-8784-42b205fb8c25"
      unitRef="usd">-716000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment
      contextRef="i127dccfd323b4d1ab1e92531d41ae9cd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE2LTEtMS0xLTE4NDQ2OQ_77469022-cb70-4e79-a702-b2cf7284b731"
      unitRef="usd">-440000000</mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment>
    <mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment
      contextRef="ie02cd650ca004817af14b6b162a227f8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE2LTMtMS0xLTE4NDQ2OQ_5579f6b5-79bf-4b25-b76e-2aba6ee8414d"
      unitRef="usd">-358000000</mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment>
    <mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment
      contextRef="ife33c3cc6d144577b138f88f8037a11e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE2LTUtMS0xLTE4NDQ2OQ_df3ad8da-6bdd-444f-8466-7cf88cfeb5cd"
      unitRef="usd">-10000000</mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment>
    <mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTplYWE2MTMzZGRiOGM0YWIwYTRhMGM0NjYxNmJkYWZkZC90YWJsZXJhbmdlOmVhYTYxMzNkZGI4YzRhYjBhNGEwYzQ2NjE2YmRhZmRkXzE2LTctMS0xLTE4NDQ2OQ_70ae855b-ec8f-4e22-ba4b-f9c4e2e0c023"
      unitRef="usd">-808000000</mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzMtMS0xLTEtMTg0NDY5_b8fa14a6-d820-42e6-8ad5-5146a26a4415"
      unitRef="usd">-134000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzMtMy0xLTEtMTg0NDY5_9cdfc88c-65d1-46cc-8fd8-3705683fd0b0"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzMtNS0xLTEtMTg0NDY5_30d21e75-c846-43a2-887b-8c3d0fb6e5c7"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzMtNy0xLTEtMTg0NDY5_0bc484a3-dab5-465d-90f3-981306a036b0"
      unitRef="usd">-163000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzQtMS0xLTEtMTg0NDY5_d2908f07-2d1d-42f9-8bff-c12ab0d49aba"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzQtMy0xLTEtMTg0NDY5_bb9fc5a8-d5db-461f-b9bb-dcc12b46ab5f"
      unitRef="usd">-30000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzQtNS0xLTEtMTg0NDY5_e3671a41-1248-4fb8-9525-ae8564b695e7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzQtNy0xLTEtMTg0NDY5_2e0718b7-d7cf-4721-91b3-4a01c1789863"
      unitRef="usd">-25000000</us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax>
    <mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzYtMS0xLTEtMTg0NDY5_21ec70b0-ed46-4edb-aee3-4786196f908a"
      unitRef="usd">-10000000</mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax>
    <mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzYtMy0xLTEtMTg0NDY5_e6e8ce06-1356-4af4-8b47-8d79b7f7f980"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax>
    <mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax
      contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzYtNS0xLTEtMTg0NDY5_0860be8d-446f-434f-a8a0-70b2869b0d0c"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax>
    <mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzYtNy0xLTEtMTg0NDY5_389a49c2-4a12-409a-83ab-57b924f2fe48"
      unitRef="usd">-10000000</mo:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax>
    <mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzctMS0xLTEtMTg0NDY5_1cdb0c20-d396-4b3f-a55e-11e9412de672"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax>
    <mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzctMy0xLTEtMTg0NDY5_bfd69591-3b5b-4d55-9ff0-a67ec095a41d"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax>
    <mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax
      contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzctNS0xLTEtMTg0NDY5_6721677d-b64e-4c2d-b563-f420606140fe"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax>
    <mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzctNy0xLTEtMTg0NDY5_39d5d2aa-cd8f-40f9-925c-45ba293301ce"
      unitRef="usd">0</mo:OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzgtMS0xLTEtMTg0NDY5_d94e96cd-1cb7-4fc5-8e4a-65ac62fa60a9"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzgtMy0xLTEtMTg0NDY5_dec2f8e8-36cc-4b8d-88c3-14a56bd4016d"
      unitRef="usd">-5000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzgtNS0xLTEtMTg0NDY5_7ab968e5-6d64-44da-a26f-c0ef3c768fc6"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzgtNy0xLTEtMTg0NDY5_4db5cda3-9b70-448e-b456-92609bd707ba"
      unitRef="usd">37000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzktMS0xLTEtMTg0NDY5_d48a8e04-c34f-49e2-ab14-993144897a29"
      unitRef="usd">112000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzktMy0xLTEtMTg0NDY5_3a90c398-7134-460f-bf87-b637b9b41d26"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzktNS0xLTEtMTg0NDY5_6690c320-91ee-49bf-af89-576952ee6f83"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzktNy0xLTEtMTg0NDY5_4b852a8b-16f4-46a9-85a3-b6cf7df833ff"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzExLTEtMS0xLTE4NDQ2OQ_58188b7e-1dad-4e0c-859b-f17da0f6e092"
      unitRef="usd">-268000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzExLTMtMS0xLTE4NDQ2OQ_ed048f22-e08c-479f-8f8c-880b8ab21828"
      unitRef="usd">-162000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzExLTUtMS0xLTE4NDQ2OQ_1fb6d841-de65-4ed2-9780-f0099c80b01f"
      unitRef="usd">-18000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzExLTctMS0xLTE4NDQ2OQ_4abd35c0-46a5-4fbb-a3aa-db5f55cf17b4"
      unitRef="usd">-448000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEyLTEtMS0xLTE4NDQ2OQ_e176538c-0d1f-4357-92eb-7aba6a398251"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEyLTMtMS0xLTE4NDQ2OQ_ba67cfc2-6778-4c12-8769-a676ed235988"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEyLTUtMS0xLTE4NDQ2OQ_9e74a7aa-85bc-4817-9cdf-1cf4d8f68576"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEyLTctMS0xLTE4NDQ2OQ_4fc1074f-dcd4-491f-b498-06883657cd4c"
      unitRef="usd">6000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEzLTEtMS0xLTE4NDQ2OQ_2208e2bb-f62b-46c1-881e-968ca78d8a78"
      unitRef="usd">69000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEzLTMtMS0xLTE4NDQ2OQ_01c039bd-4b03-4fc9-888c-5d6f6c098373"
      unitRef="usd">41000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax
      contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEzLTUtMS0xLTE4NDQ2OQ_490a042b-7301-402c-b4e0-2510425292a8"
      unitRef="usd">5000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzEzLTctMS0xLTE4NDQ2OQ_bfb3a38f-cba4-4bab-80f6-44a10e212b17"
      unitRef="usd">115000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE0LTEtMS0xLTE4NDQ2OQ_7db00fd4-84b6-43f9-9d23-c868353c98c0"
      unitRef="usd">204000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE0LTMtMS0xLTE4NDQ2OQ_fe188d10-157e-4d63-acbd-479225846bb1"
      unitRef="usd">122000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE0LTUtMS0xLTE4NDQ2OQ_ce4b6dca-9dfb-4c09-a48b-94eb603303e1"
      unitRef="usd">13000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE0LTctMS0xLTE4NDQ2OQ_e199648b-0744-4ea1-bf27-7c0b7ef22ac2"
      unitRef="usd">339000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax>
    <mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment
      contextRef="ibffada0026e34900a6dea6c2d8d24515_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE1LTEtMS0xLTE4NDQ2OQ_3dbf4509-d9f9-4322-b3fc-7a1ee49008bf"
      unitRef="usd">92000000</mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment>
    <mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment
      contextRef="i33a5f6c17cc44cf9ba8debf305fea8e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE1LTMtMS0xLTE4NDQ2OQ_d1aa7138-c041-4f0b-9f8a-3dcb391b4642"
      unitRef="usd">137000000</mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment>
    <mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment
      contextRef="i88411f16e8e047edad4ed4277cb3c4c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE1LTUtMS0xLTE4NDQ2OQ_9d70b9c6-cfe5-4d13-82ee-36c2bca6e662"
      unitRef="usd">-1000000</mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment>
    <mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjMvZnJhZzplYjNlYTA0Mjc0MDg0ZjQ5YjgyNWQzYjY0MTNmMmVlYS90YWJsZTowNDIxZDMzZDUxOTc0NzQ2ODM0ZTUyMmEyZTFiNGZkZS90YWJsZXJhbmdlOjA0MjFkMzNkNTE5NzQ3NDY4MzRlNTIyYTJlMWI0ZmRlXzE1LTctMS0xLTE4NDQ2OQ_c5c6fe1d-416a-4be9-943d-8888ef235e6d"
      unitRef="usd">228000000</mo:OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90ZXh0cmVnaW9uOmVkMWUxZGIwOThiNzRkNTY4OGQyYjBhYWE1NzNkMDFkXzIzMw_8009b06b-e077-4c6c-91b8-213fd4cbc442">Additional Information&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;162&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,128&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,058&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activity in the allowance for discounts and allowance for returned goods was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Returned Goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Returned Goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Returned Goods&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Represents the recording of discounts and returns for which allowances were created&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90ZXh0cmVnaW9uOmVkMWUxZGIwOThiNzRkNTY4OGQyYjBhYWE1NzNkMDFkXzIzNA_87b2ec29-eb72-4775-85bf-86202296f67e">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;162&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest and other debt expense, net:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,128&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,058&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzItMS0xLTEtMTg0NDY5_46c3957d-7c84-484d-bcfe-34d255aa4ae3"
      unitRef="usd">162000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzItMy0xLTEtMTg0NDY5_1a80275f-94ac-433d-8567-10bbb417cf31"
      unitRef="usd">145000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzItNS0xLTEtMTg0NDY5_062acf59-066b-4805-84f9-4a8477af0db9"
      unitRef="usd">131000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:InterestExpense
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzQtMS0xLTEtMTg0NDY5_d8affefb-b4d3-49d5-8a9f-ea31f0e2168c"
      unitRef="usd">1128000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzQtMy0xLTEtMTg0NDY5_cd6a407c-1172-46a9-b32b-07f2541d0497"
      unitRef="usd">1188000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzQtNS0xLTEtMTg0NDY5_b4079db5-f4de-4f0b-a7a2-018cc6aafa8f"
      unitRef="usd">1223000000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeOther
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzUtMS0xLTEtMTg0NDY5_bab0ff18-c9eb-49f2-9c00-e26d8212e8be"
      unitRef="usd">70000000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzUtMy0xLTEtMTg0NDY5_c312a5b0-1907-4520-8572-bc0d0d24dd40"
      unitRef="usd">26000000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeOther
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzUtNS0xLTEtMTg0NDY5_94b6f85c-622c-4181-9615-bedf832445d8"
      unitRef="usd">14000000</us-gaap:InterestIncomeOther>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzYtMS0xLTEtMTg0NDY5_73a13545-2445-4f59-8407-2bb3c3011fc8"
      unitRef="usd">-1058000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzYtMy0xLTEtMTg0NDY5_43ef76f5-f611-4bac-863a-bc19e0d5394c"
      unitRef="usd">-1162000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTphNzkxMzEzODAwZWU0MTBkYjA0MGMzZTk5ZjBhYjVkNC90YWJsZXJhbmdlOmE3OTEzMTM4MDBlZTQxMGRiMDQwYzNlOTlmMGFiNWQ0XzYtNS0xLTEtMTg0NDY5_33d1f1c7-55ef-4cce-bda5-fbc62acceea3"
      unitRef="usd">-1209000000</us-gaap:InterestIncomeExpenseNet>
    <mo:ScheduleofValuationandQualifyingAccountsTableTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90ZXh0cmVnaW9uOmVkMWUxZGIwOThiNzRkNTY4OGQyYjBhYWE1NzNkMDFkXzIzOA_f1ab5518-c904-423c-adc8-6156da29d6a2">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The activity in the allowance for discounts and allowance for returned goods was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:27.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.573%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.482%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.683%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Returned Goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Returned Goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Returned Goods&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;50&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Charged to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;607&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(647)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;41&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Represents the recording of discounts and returns for which allowances were created&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;</mo:ScheduleofValuationandQualifyingAccountsTableTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i45f9dcc6444a4bbb90bbcd327eb2f366_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzMtMi0xLTEtMTg0NDY5_08a399b5-8351-406a-a0d2-a7ecb7c55e71"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i90e616ef3cd34d8ebf364a0a44dbf568_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzMtNC0xLTEtMTg0NDY5_4f8a7326-24f9-41a3-b905-ec52b4bc986d"
      unitRef="usd">50000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibf580e88ea5e426b83cea191bb81eb11_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzMtNi0xLTEtMTg0NDY5_fe087c9f-1af6-439e-a16b-1fcdab080c1f"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ief312f4f79034004be1d156bc5113740_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzMtOC0xLTEtMTg0NDY5_85d6cfc8-6a33-4497-9bd7-0c470c4d5bfe"
      unitRef="usd">40000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i94c89f23c2954c9c8f50a44fa531889f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzMtMTAtMS0xLTE4NDQ2OQ_5010bf1c-b06d-4933-84e8-665275e89676"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ie74269f61ac244c79a9581ca1cbf6d02_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzMtMTItMS0xLTE4NDQ2OQ_c3a1f4b4-dd58-4d6d-9d78-753a29c691ee"
      unitRef="usd">32000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i98f16d288e9b4842b8c9feadf67a70d7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzQtMi0xLTEtMTg0NDY5_aae6e4aa-7a3d-4e31-b44f-7d0a8c26109b"
      unitRef="usd">607000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ie82e469f2543472386656525fa4e487f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzQtNC0xLTEtMTg0NDY5_497e95dd-4a30-4c2a-a927-db342321093b"
      unitRef="usd">97000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i33dd9b0c0e7b45d487aee81df3946294_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzQtNi0xLTEtMTg0NDY5_17f127b9-d3ea-4280-ad05-a20a396efe3b"
      unitRef="usd">647000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i03f3ddd8f45a4d4d8617839b37197b44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzQtOC0xLTEtMTg0NDY5_ea1fe007-496f-49ba-9cd8-142fa1470753"
      unitRef="usd">124000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="idcaf546cb45c470aa6dfa50cda94fd71_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzQtMTAtMS0xLTE4NDQ2OQ_31e06b0d-e9c9-4566-b725-6cd361a0fd0a"
      unitRef="usd">633000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ib931f8bbad2a4b7a8d8317d177be2791_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzQtMTItMS0xLTE4NDQ2OQ_e635886c-cce5-4013-948e-c5756f8a469d"
      unitRef="usd">98000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i98f16d288e9b4842b8c9feadf67a70d7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzUtMi0xLTEtMTg0NDY5_4f02d170-633e-4d4f-8f0f-e0766e734c68"
      unitRef="usd">607000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ie82e469f2543472386656525fa4e487f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzUtNC0xLTEtMTg0NDY5_c9cec8c2-c482-46a6-b1bd-d2d7eb56c119"
      unitRef="usd">106000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i33dd9b0c0e7b45d487aee81df3946294_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzUtNi0xLTEtMTg0NDY5_5e0f6116-dded-4425-bfcc-694f8f9953fb"
      unitRef="usd">647000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i03f3ddd8f45a4d4d8617839b37197b44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzUtOC0xLTEtMTg0NDY5_6dced52f-389a-47da-86b6-990f10ca1e7d"
      unitRef="usd">114000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="idcaf546cb45c470aa6dfa50cda94fd71_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzUtMTAtMS0xLTE4NDQ2OQ_d7a9fa81-6582-4733-a34c-fa9c879ab829"
      unitRef="usd">633000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ib931f8bbad2a4b7a8d8317d177be2791_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzUtMTItMS0xLTE4NDQ2OQ_4a9f61a4-d374-4667-86fb-41f15e2e182f"
      unitRef="usd">90000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ic93c01c5184d4b26964880db6a9e8ad9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzYtMi0xLTEtMTg0NDY5_e22cd6b1-822c-4b75-bb40-811725840e0f"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i3240589dec0744cebbdf4a38067cb110_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzYtNC0xLTEtMTg0NDY5_540e9cef-e630-420e-812b-a3f92aabe871"
      unitRef="usd">41000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i45f9dcc6444a4bbb90bbcd327eb2f366_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzYtNi0xLTEtMTg0NDY5_f67b7951-d8b8-488e-8310-ad60ee499b3e"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i90e616ef3cd34d8ebf364a0a44dbf568_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzYtOC0xLTEtMTg0NDY5_c9ef224c-49db-439e-b693-87514a489e43"
      unitRef="usd">50000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ibf580e88ea5e426b83cea191bb81eb11_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzYtMTAtMS0xLTE4NDQ2OQ_dc50311c-5c24-49e2-9fe0-1c2df97158ca"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ief312f4f79034004be1d156bc5113740_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNjkvZnJhZzplZDFlMWRiMDk4Yjc0ZDU2ODhkMmIwYWFhNTczZDAxZC90YWJsZTozNjk3MGRkYTNlYWU0YTljOGEwNTNjYzc3YzU1Y2E0Yy90YWJsZXJhbmdlOjM2OTcwZGRhM2VhZTRhOWM4YTA1M2NjNzdjNTVjYTRjXzYtMTItMS0xLTE4NDQ2OQ_ca467726-a9af-41ed-827c-30001e961330"
      unitRef="usd">40000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzY2MzQ0_62028cd8-9c5c-4533-bf9f-e1de46bde680">Contingencies&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Legal proceedings covering a wide range of matters are pending or threatened in various United States and foreign jurisdictions against Altria and certain of our subsidiaries, including PM USA and USSTC, as well as our indemnitees and investees.  Various types of claims may be raised in these proceedings, including product liability, unfair trade practices, antitrust, income tax liability, contraband shipments, patent infringement, employment matters, claims alleging violation of the Racketeer Influenced and Corrupt Organizations Act (&#x201c;RICO&#x201d;), claims for contribution and claims of competitors, shareholders or distributors.  Legislative action, such as changes to tort law, also may expand the types of claims and remedies available to plaintiffs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Litigation is subject to uncertainty and it is possible that there could be adverse developments in pending or future cases.  An unfavorable outcome or settlement of pending tobacco-related or other litigation could encourage the commencement of additional litigation.  Damages claimed in some tobacco-related and other litigation are or can be significant and, in certain cases, have ranged in the billions of dollars.  The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrates that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome.  In certain cases, plaintiffs claim that defendants&#x2019; liability is joint and several.  In such cases, we may face the risk that one or more co-defendants decline or otherwise fail to participate in the bonding required for an appeal or to pay their proportionate or jury-allocated share of a judgment.  As a result, under certain circumstances, we may have to pay more than our proportionate share of any bonding- or judgment-related amounts.  Furthermore, in those cases where plaintiffs are successful, we also may be required to pay interest and attorneys&#x2019; fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although PM USA has historically been able to obtain required bonds or relief from bonding requirements in order to prevent plaintiffs from seeking to collect judgments while adverse verdicts have been appealed, there remains a risk that such relief may not be obtainable in all cases.  This risk has been substantially reduced given that 47 states and Puerto Rico limit the dollar amount of bonds or require no bond at all.  As discussed below, however, tobacco litigation plaintiffs have challenged the constitutionality of Florida&#x2019;s bond cap statute in several cases and plaintiffs may challenge state bond cap statutes in other jurisdictions as well.  Such challenges may include the applicability of state bond caps in federal court.  States, including Florida, also may seek to repeal or alter bond cap statutes through legislation.  Although we cannot predict the outcome of such challenges, it is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome of one or more such challenges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record provisions in our consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated.  At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, except to the extent discussed elsewhere in this Note 17. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: (i)&#160;management has concluded that it is not probable that a loss has been incurred in any of the pending cases; (ii)&#160;management is unable to estimate the possible loss or range of loss that could result from an unfavorable outcome in any of the pending cases; and (iii)&#160;accordingly, management has not &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;provided any amounts in our consolidated financial statements for unfavorable outcomes, if any.  Litigation defense costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have achieved substantial success in managing litigation.  Nevertheless, litigation is subject to uncertainty and significant challenges remain.  It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation.  We believe, and have been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts.  We have defended, and will continue to defend, vigorously against litigation challenges.  However, we may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Judgments Paid and Provisions for Tobacco and Health (Including &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Progeny Litigation) and Certain Other Litigation Items: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The changes in our accrued liability for tobacco and health and certain other litigation items, including related interest costs, for the periods specified below are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health and certain other litigation items at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax charges for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tobacco and health and certain other litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shareholder class action and shareholder derivative lawsuits &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related interest costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health and certain other litigation items at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;71&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes judgments, settlements and fee disputes associated with tobacco and health and certain other litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See S&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;hareholder Class Action and Shareholder Derivative Lawsuits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; below for discussions of the shareholder class action case and related settlement and the pending settlement of the federal and state shareholder derivative lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accrued liability for tobacco and health and certain other litigation items, including related interest costs, was included in accrued liabilities on our consolidated balance sheets.  Pre-tax charges for tobacco and health and certain other litigation were included in marketing, administration and research costs on our consolidated statements of earnings.  Pre-tax charges for related interest costs were included in interest and other debt expense, net on our consolidated statements of earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After exhausting all appeals in those cases resulting in adverse verdicts associated with tobacco-related litigation, since October 2004, PM USA has paid judgments and settlements (including related costs and fees) totaling approximately $954 million and interest totaling approximately $230 million as of December 31, 2022.  These amounts include payments for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny judgments (and related costs and fees) totaling approximately $432 million and related interest totaling approximately $59 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Security for Judgments: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To obtain stays of judgments pending appeal, PM USA has posted various forms of security.  As of December 31, 2022, PM USA has posted appeal bonds totaling approximately $46 million, which have been collateralized with restricted cash and are included in assets on our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Overview of Tobacco-Related Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Types and Number of U.S. Cases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Claims related to tobacco products generally fall within the following categories: (i)&#160;smoking and health cases alleging personal injury brought on behalf of individual plaintiffs; (ii)&#160;health care cost recovery cases brought by governmental (both domestic and foreign) plaintiffs seeking reimbursement for health care expenditures allegedly caused by cigarette smoking and/or disgorgement of profits; (iii) e-vapor cases alleging violation of RICO, fraud, failure to warn, design defect, negligence, antitrust and unfair trade practices; and (iv)&#160;other tobacco-related litigation described below.  Plaintiffs&#x2019; theories of recovery and the defenses raised in tobacco-related litigation are discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below lists the number of certain tobacco-related cases pending in the United States against us as of December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.419%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Smoking and Health Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Cost Recovery Actions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E-vapor Cases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,283&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,296&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Tobacco-Related Cases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes as of December 31, 2022, 17 cases filed in Illinois, 20 cases filed in New Mexico, 37 cases filed in Massachusetts and 51 non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;case (these &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; progeny cases are discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Class Action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  Also does not include 1,395 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#x201c;ETS&#x201d;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Broin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation - Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes as of December 31, 2022, 57 class action lawsuits, 3,830 individual lawsuits and 1,396 &#x201c;third party&#x201d; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  The 57 class action lawsuits include 32 cases in the Northern District of California (&#x201c;Multidistrict Litigation&#x201d; or &#x201c;MDL&#x201d;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes as of December 31, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms &#x201c;Lights&#x201d; and &#x201c;Ultra Lights&#x201d; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;International Tobacco-Related Cases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 27, 2023, (i) Altria is named as a defendant in three e-vapor class action lawsuits in Canada; (ii) PM USA is a named defendant in 10 health care cost recovery actions in Canada, eight of which also name Altria as a defendant; and (iii) PM USA and Altria are named as defendants in seven smoking and health class actions filed in various Canadian provinces.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the Distribution Agreement (defined below) between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Tobacco-Related Cases Set for Trial: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 27, 2023, two &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases, two individual smoking and health case and one e-vapor case are set for trial through March 31, 2023.  Trial dates are subject to change.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Trial Results: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since January 1999, excluding the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases (separately discussed below), verdicts have been returned in 73 tobacco-related cases in which PM USA was a defendant.  Verdicts in favor of PM USA and other defendants were returned in 46 of the 73 cases.  These 46 cases were tried in Alaska (1), California (7), Connecticut (1), Florida (10), Louisiana (1), Massachusetts (6), Mississippi (1), Missouri (4), New Hampshire (1), New Jersey (1), New York (5), Ohio (2), Pennsylvania (1), Rhode Island (1), Tennessee (2) and West Virginia (2).  One case in Massachusetts, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Main&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, where the verdict was initially returned in favor of PM USA, was reversed on appeal and remanded for a new trial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the 27 non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases in which verdicts were returned in favor of plaintiffs, 23 have reached final resolution.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Liti&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;gation - Engle Progeny Trial Results&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of verdicts in state and federal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases involving PM USA as of January 27, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Smoking and Health Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Overview: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plaintiffs&#x2019; allegations of liability in smoking and health cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, nuisance, breach of express and implied warranties, breach of special duty, conspiracy, concert of action, violations of unfair trade practice laws and consumer protection statutes and claims under the federal and state anti-racketeering statutes.  Plaintiffs in the smoking and health cases seek various forms of relief, including compensatory and punitive damages, treble/multiple damages and other statutory damages and penalties, creation of medical monitoring and smoking cessation funds, disgorgement of profits, and injunctive and equitable relief.  Defenses raised in these cases include lack of proximate cause, assumption of the risk, comparative fault and/or contributory negligence, statutes of limitations and preemption by the Federal Cigarette Labeling and Advertising Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Progeny Litigation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Summarized below are the non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny smoking and health cases pending during 2022 (or recently concluded) in which a verdict was returned in favor of plaintiff and against PM USA.  Charts listing certain verdicts for plaintiffs in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases can be found in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Progeny Trial Results&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mendez&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA and R.J. Reynolds Tobacco Company awarding approximately $4.5 million in compensatory damages and allocating 13% of the fault to PM USA.  After &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;applying comparative fault, PM USA&#x2019;s portion of the compensatory damages is less than $1 million.  There was no claim for punitive damages.  The trial court denied PM USA&#x2019;s post-trial motions.  Both parties have appealed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fontaine&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2022, a jury in a Massachusetts state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $8 million in compensatory damages and $1 billion in punitive damages.  We intend to file post-trial motions challenging the award and, if necessary, an appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Principe&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In February 2020, a jury in a Florida state court returned a verdict in favor of plaintiff and against PM USA, awarding approximately $11 million in compensatory damages.  There was no claim for punitive damages.  PM USA appealed the trial court verdict to the Third District Court of Appeal and, in September 2021, the appellate court reversed the trial court&#x2019;s decision and found in favor of PM USA.  Plaintiff moved for a rehearing before the Third District Court of Appeal, which the court denied in March 2022.  In April 2022, plaintiff filed a notice to invoke the discretionary jurisdiction of the Florida Supreme Court.  In July 2022, the Florida Supreme Court denied plaintiff&#x2019;s motion for discretionary review.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Greene&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: In September 2019, a jury in a Massachusetts state court returned a verdict in favor of plaintiffs and against PM USA, awarding approximately $10 million in compensatory damages.  In May 2020, the court ruled on plaintiffs&#x2019; remaining claim and trebled the compensatory damages award to approximately $30 million.  In February 2021, the trial court awarded plaintiffs attorneys&#x2019; fees and costs in the amount of approximately $2.3 million.  In July 2021, following denial of PM USA&#x2019;s post-trial motions, PM USA appealed the judgment to the Appeals Court of Massachusetts.  In September 2022, the Massachusetts Supreme Judicial Court issued an order taking jurisdiction over the appeal, which remains pending.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation - Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the verdict and post-trial developments in the United States of America health care cost recovery case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Class Action: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2000, in the second phase of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; smoking and health class action in Florida, a jury returned a verdict assessing punitive damages totaling approximately $145 billion against various defendants, including $74 billion against PM USA.  Following entry of judgment, PM USA appealed.  In May 2003, the Florida Third District Court of Appeal reversed the judgment entered by the trial court and instructed the trial court to order the decertification of the class.  Plaintiffs petitioned the Florida Supreme Court for further review.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2006, the Florida Supreme Court ordered that the punitive damages award be vacated, that the class approved by the trial court be decertified and that members of the decertified class could file individual actions against defendants within one year of issuance of the mandate.  The court further declared the following Phase I findings are entitled to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;res judicata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; effect in such individual actions brought within one year of the issuance of the mandate: (i)&#160;that smoking causes various diseases; (ii)&#160;that nicotine in cigarettes is addictive; (iii)&#160;that defendants&#x2019; cigarettes were defective and unreasonably dangerous; (iv)&#160;that defendants concealed or omitted material information not otherwise known or available knowing that the material was false or misleading or failed to disclose a material fact concerning the health effects or addictive nature of smoking; (v)&#160;that defendants agreed to misrepresent information regarding the health effects or addictive nature of cigarettes with the intention of causing the public to rely on this information to their detriment; (vi)&#160;that defendants agreed to conceal or omit information regarding the health effects of cigarettes or their addictive nature with the intention that smokers would rely on the information to their detriment; (vii)&#160;that all defendants sold or supplied cigarettes that were defective; and (viii)&#160;that defendants were negligent.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2006, PM USA and plaintiffs sought rehearing from the Florida Supreme Court on parts of its July 2006 opinion.  In December 2006, the Florida Supreme Court refused to revise its July 2006 ruling, except that it revised the set of Phase I findings entitled to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;res judicata&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; effect by excluding finding (v)&#160;listed above (relating to agreement to misrepresent information), and added the finding that defendants sold or supplied cigarettes that, at the time of sale or supply, did not conform to the representations of fact made by defendants.  In February 2008, the trial court decertified the class.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Pending &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;e Progeny Cases: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The deadline for filing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases expired in January 2008, at which point a total of approximately 9,300 federal and state claims were pending.  As of January 27, 2023, approximately 612 state court cases were pending against PM USA or Altria asserting individual claims by or on behalf of approximately 773 state court plaintiffs.  Because of a number of factors, including docketing delays, duplicated filings and overlapping dismissal orders, these numbers are estimates.  The 2015 federal &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;agreement resolved nearly all &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases pending in federal court as of the date of the agreement, and each case excluded from that agreement subsequently has been resolved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Progeny Trial Results: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 27, 2023, 143 federal and state &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases involving PM USA have resulted in verdicts since the Florida Supreme Court &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; decision.  Seventy-nine verdicts were returned in favor of plaintiffs, and seven verdicts (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Skolnick&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Calloway&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Oshinsky-Blacker,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;McCoy, Mahfuz, Neff &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Gloger&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) that were initially returned in favor of plaintiffs were reversed post-trial or on appeal and remain pending.  In two cases, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Kaplan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;McLaughlin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sommers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the punitive damages awards were vacated on appeal and remanded for new trials.  In &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sommers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the trial court entered final judgment dismissing the plaintiff&#x2019;s punitive damages claim with prejudice, and plaintiff has appealed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fifty-six verdicts were returned in favor of PM USA, of which 46 were state cases.  In addition, there have been a number of mistrials, only some of which have resulted in new trials as of January 27, 2023.  The jury in one case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Garcia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, awarded plaintiff compensatory &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;damages and found plaintiff was entitled to punitive damages; however, the court declared a mistrial in the second phase of the trial regarding punitive damages because the jury was unable to determine the amount of the punitive damages.  Following appeals by the plaintiff and PM USA, the appellate court in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Garcia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; affirmed the compensatory damages judgment against PM USA and granted a new trial with respect to punitive damages.  The plaintiff in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Garcia&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; subsequently filed a motion to voluntarily dismiss the punitive damages claim and to enter final judgment on the compensatory damages claim, which the court granted.  Three verdicts (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cohen&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collar&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chacon&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) that were returned in favor of PM USA were subsequently reversed for new trials.  Juries in two cases (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reider&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Banks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) returned zero damages verdicts in favor of PM USA.  Juries in two other cases (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Weingart&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Hancock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) returned verdicts against PM USA awarding no damages, but the trial court in each case decided to award plaintiffs damages.  One case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Pollari&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, resulted in a verdict in favor of PM USA following a retrial of an initial verdict returned in favor of plaintiff.  Plaintiff and defendants appealed the verdict and the appellate court affirmed the judgment in favor of the defendants.  Three cases, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gloger&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rintoul &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Caprio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Duignan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, resulted in verdicts in favor of plaintiffs following retrial of initial verdicts returned in favor of plaintiffs.  A post-trial appeal is pending in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Duignan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The verdicts in the retrials in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Gloger&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rintoul&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Caprio&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) were reversed upon appeal and remanded for new trials.  Two cases, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Freeman&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Harris&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, resulted in an appellate reversal of a jury verdict in favor of plaintiff, and a judgment in favor of PM USA.  One case, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;R. Douglas&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, was dismissed with prejudice following a verdict in favor of plaintiff.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The charts below list the verdicts and post-trial developments in certain &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases in which verdicts were returned in favor of plaintiffs.  The first chart lists cases that are pending as of January 27, 2023 where PM USA has determined an unfavorable outcome is not probable and the amount of loss cannot be reasonably estimated, and the second chart lists cases that have concluded in the past 12 months.  Unless otherwise noted for a particular case, the jury&#x2019;s award for compensatory damages will not be reduced by any finding of plaintiff&#x2019;s comparative fault.  Further, the damages noted reflect adjustments based on post-trial or appellate rulings.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;References below to &#x201c;R.J. Reynolds,&#x201d; &#x201c;Lorillard&#x201d; and &#x201c;Liggett Group&#x201d; are to R.J. Reynolds Tobacco Company, Lorillard Tobacco Company and Liggett Group, LLC, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Currently Pending Engle Cases with Verdicts Against PM USA &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Post-Trial Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Hoffman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5 million ($3 million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Awaiting entry of final judgment by the trial court.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Levine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Appeals by defendants and plaintiff to Third District Court of Appeal pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Schertzer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;April 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Appeal by defendants to the Third District Court of Appeal pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Lipp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$15 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$28 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Garcia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$6 million ($3 million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to the Third District Court of Appeal pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Duignan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pinellas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$12&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Florida Supreme Court quashed the Second District Court of Appeal&#x2019;s affirmation of  judgment against the defendants and remanded the case for reconsideration in light of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;McCall&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million (&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New trial on punitive damages is set for April 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Chadwell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third District Court of Appeal has ordered supplemental briefing in accordance with the decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Kaplan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;McLaughlin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Florida Supreme Court vacated the punitive damages award in accordance with the decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;.  The Fourth District Court of Appeals affirmed the compensatory damages award and granted a new trial on punitive damages.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cooper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Blackwood&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5&#160;million &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal affirmed the compensatory damages award and granted a new trial on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;PM USA&#x2019;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Plaintiff&#x2019;s verdict following a retrial of an initial verdict in favor of plaintiff.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; PM USA is not a defendant in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, which are discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle Progeny Appellate Issues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle Cases Concluded Within Past 12 Months &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.180%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.919%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrual Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Amount for Damages (if any)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Miller&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third quarter of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Tuttle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;August 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third quarter of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cuddihee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Second quarter of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;June 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Holliman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth quarter of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;D. Brown&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third quarter of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;August 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; Progeny Appellate Issues: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Appellate decisions in the following &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases may have wide application to other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Mary Sheffield v. R.J. Reynolds Tobacco Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny case against R.J. Reynolds only, the Florida Supreme Court resolved a conflict among Florida&#x2019;s District Courts of Appeal finding that the 1999 amendments to Florida&#x2019;s punitive damages statute (including its caps and bar on multiple punitive damages awards for the same course of conduct) apply in wrongful death cases where the decedent was injured prior to the October 1, 1999 effective date of the amendments but died from his or her injuries after such effective date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Linda Prentice v. R.J. Reynolds Tobacco Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny case against R.J. Reynolds only, the Florida Supreme Court resolved a conflict among Florida&#x2019;s District Courts of Appeal finding that in order for an &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; plaintiff to prevail on fraudulent concealment and conspiracy claims, plaintiff must prove that the smoker relied to his or her detriment on a statement that concealed or omitted material information about the health risks or addictiveness of smoking.  The Florida Supreme Court declined to revisit its prior decisions giving preclusive effect to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Phase I findings, described above in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Engle Class Action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Florida Bond Statute: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2009, Florida amended its existing bond cap statute by adding a $200 million bond cap that applies to all state &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny lawsuits in the aggregate and establishes individual bond caps for individual &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; progeny cases in amounts that vary depending on the number of judgments in effect at a given time.  Plaintiffs have been unsuccessful in various challenges to the bond cap statute in Florida state court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No federal court has yet addressed the constitutionality of the bond cap statute or the applicability of the bond cap to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;progeny cases tried in federal court.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, legislation has been presented to the Florida legislature that would repeal the bond cap statute; however to date, no legislation repealing the statute has passed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Smoking and Health Class Actions: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the dismissal in May 1996 of a purported nationwide class action brought on behalf of allegedly addicted smokers, plaintiffs have filed numerous putative smoking and health class action suits in various state and federal courts.  In general, these cases have purported to be brought on behalf of residents of a particular state or states (although a few cases have purported to be nationwide in scope) and have raised addiction claims and, in many cases, claims of physical injury as well.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Class certification has been denied or reversed by courts in 61 smoking and health class actions involving PM USA in Arkansas (1), California (1), Delaware (1), the District of Columbia (2), Florida (2), Illinois (3), Iowa (1), Kansas (1), Louisiana (1), Maryland (1), Michigan (1), Minnesota (1), Nevada (29), New Jersey (6), New York (2), Ohio (1), Oklahoma (1), Oregon (1), Pennsylvania (1), Puerto Rico (1), South Carolina (1), Texas (1)&#160;and Wisconsin (1).  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Certain Other Tobacco-Related Litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;below for a discussion of &#x201c;Lights&#x201d; and &#x201c;Ultra Lights&#x201d; class action cases and medical monitoring class action cases pending against PM USA.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 27, 2023, PM USA and Altria are named as defendants, along with other cigarette manufacturers, in seven class actions filed in the Canadian provinces of Alberta, Manitoba, Nova Scotia, Saskatchewan, British Columbia and Ontario.  In Saskatchewan, British Columbia (two separate cases) and Ontario, plaintiffs seek class certification on behalf of individuals who suffer or have suffered from various diseases, including chronic obstructive pulmonary disease, emphysema, heart disease or cancer, after smoking defendants&#x2019; cigarettes.  In the actions filed in Alberta, Manitoba and Nova Scotia, plaintiffs seek certification of classes of all individuals who smoked defendants&#x2019; cigarettes.  In March 2019, all of these class actions were stayed as a result of three Canadian tobacco manufacturers (none of which is related to us) seeking protection under Canada&#x2019;s Companies&#x2019; Creditors Arrangement Act (which is similar to Chapter 11 bankruptcy in the United States).  The companies entered into these proceedings following a Canadian appellate court upholding two smoking and health class action verdicts against those companies totaling approximately CAD $13 billion.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the Distribution Agreement between Altria and PMI, which provides for indemnities for certain liabilities concerning tobacco products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Health Care Cost Recovery Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Overview: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the health care cost recovery litigation, governmental entities seek reimbursement of health care cost expenditures allegedly caused by tobacco products and, in some cases, of future expenditures and damages.  Relief sought by some but not all plaintiffs includes punitive damages, multiple damages and other statutory damages and penalties, injunctions prohibiting alleged marketing and sales to minors, disclosure of research, disgorgement of profits, funding of anti-smoking programs, additional disclosure of nicotine yields, and payment of attorney and expert witness fees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although there have been some decisions to the contrary, most judicial decisions in the United States have dismissed all or most health care cost recovery claims against cigarette manufacturers.  Nine federal circuit courts of appeals and eight state appellate courts, relying primarily on grounds that plaintiffs&#x2019; claims were too remote, have ordered or affirmed dismissals of health care cost recovery actions.  The U.S. Supreme Court has refused to consider plaintiffs&#x2019; appeals from the cases decided by five federal circuit courts of appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the cases brought in the United States, health care cost recovery actions have also been brought against tobacco industry participants, including PM USA and Altria, in Canada (10 cases),&#160;and other entities have stated that they are considering filing such actions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the beginning of 2008, the Canadian Provinces of British Columbia, New Brunswick, Ontario, Newfoundland and Labrador, Quebec, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia have brought health care reimbursement claims against cigarette manufacturers.  PM USA is named as a defendant in the British Columbia and Quebec cases, while both Altria and PM USA are named as defendants in the New Brunswick, Ontario, Newfoundland and Labrador, Alberta, Manitoba, Saskatchewan, Prince Edward Island and Nova Scotia cases.  The Nunavut Territory and Northwest Territory have passed legislation permitting similar claims, but lawsuits based on this legislation have not been filed.  All of these cases have been stayed pending resolution of proceedings in Canada involving three tobacco manufacturers (none of which are affiliated with us) under the Companies&#x2019; Creditors Arrangement Act discussed above.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Other Smoking and Health Class Actions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; above for a discussion of these proceedings.  See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; below for a discussion of the Distribution Agreement between Altria and PMI that provides for indemnities for certain liabilities concerning tobacco products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Settlements of Health Care Cost Recovery Litigation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 1998, PM USA and certain other tobacco product manufacturers entered into the Master Settlement Agreement (the &#x201c;MSA&#x201d;) with 46 states, the District of Columbia and certain United States territories to settle asserted and unasserted health care cost recovery and other claims.  PM USA and certain other tobacco product manufacturers had previously entered into agreements to settle similar claims brought by Mississippi, Florida, Texas and Minnesota (together with the MSA, the &#x201c;State Settlement Agreements&#x201d;).  The State Settlement Agreements require that the original participating manufacturers or &#x201c;OPMs&#x201d; (now PM USA, R.J. Reynolds and, with respect to certain brands, ITG Brands, LLC (&#x201c;ITG&#x201d;)) make annual payments of approximately $9.4 billion, subject to adjustments for several factors, including inflation, market share and industry volume.  In addition, the OPMs are required to pay settling plaintiffs&#x2019; attorneys&#x2019; fees, subject to an annual cap of $500 million; these quarterly payments are expected to end in 2024.  For the years ended December 31, 2022, 2021 and 2020, the aggregate amount recorded in cost of sales with respect to the State Settlement Agreements was approximately $3.9 billion, $4.3 billion and $4.4 billion, respectively.  These amounts include PM USA&#x2019;s estimate of amounts related to NPM Adjustments discussed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NPM Adjustment Disputes: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The &#x201c;NPM Adjustment&#x201d; is a reduction in MSA payments made by the OPMs and those manufacturers that are subsequent signatories to the MSA (collectively, the &#x201c;participating manufacturers&#x201d; or &#x201c;PMs&#x201d;) that applies if the PMs collectively lose at least a specified level of market share to non-participating manufacturers since 1997, subject to certain conditions and defenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The independent auditor (&#x201c;IA&#x201d;) appointed under the MSA has calculated that PM USA&#x2019;s share of the maximum potential NPM Adjustments for 2004-2021 is (exclusive of interest or earnings): $388 million for 2004; $181 million for 2005; $154 million for 2006; $185 million for 2007; $250 million for 2008; $211 million for 2009; $218 million for 2010; $166 million for 2011; $214 million for 2012; $224 million for 2013; $258 million for 2014; $313 million for 2015; $292 million for 2016; $285 million for 2017; $318 million for 2018; $415 million for 2019; $573 million for 2020; and $635 million for 2021.  These maximum amounts will be substantially reduced to reflect the NPM Adjustment settlements discussed below, and potentially for current and future calculation disputes and other developments.  PM USA&#x2019;s recovery for 2004 is addressed below.  In addition, PM USA&#x2019;s recovery of such reduced amounts for all subsequent years will be dependent upon subsequent determinations regarding state-specific defenses and disputes with other PMs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Settlements of NPM Adjustment Disputes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.78pt"&gt;Multi-State Settlement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; By the end of 2018, PM USA entered into a multi-state settlement of NPM Adjustment disputes with a total of 36 MSA states and territories in which PM USA settled the NPM Adjustment disputes through 2022 with 35 of the 36 states, and through 2024 with one state.  In March 2022, Illinois joined the multi-state settlement, settling the NPM Adjustment disputes through 2028 and bringing the total number of settling states and territories to 37.  As a result, PM USA will receive approximately $80 million for 2004-2021 ($20 million of which relates to the 2019-2021 &#x201c;transition years&#x201d;).  In connection with this development for Illinois, PM USA recorded $80 million as a reduction in cost of sales in the first quarter of 2022.  Pursuant to the multi-state &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;settlement, PM USA has received $1.15 billion and expects to receive approximately $410 million in credits to offset PM USA&#x2019;s MSA payments through 2036.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;New York Settlement.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2015, PM USA entered into a separate NPM Adjustment settlement with New York in which PM USA settled the NPM Adjustment disputes with New York in perpetuity.  PM USA has received $435 million pursuant to the New York settlement and expects to receive annual credits applied against the MSA payments due to New York going forward.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Montana Settlement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  In 2020, PM USA entered into a separate NPM Adjustment settlement with Montana in which PM USA settled the NPM Adjustment disputes with Montana through 2030.  This settlement resulted in a payment by PM USA of $4 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Continuing NPM Adjustment Disputes with States That Have Not Settled&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;2004 NPM Adjustment.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The PMs and the nine states that have not settled the NPM Adjustment disputes participated in a multi-state arbitration of NPM Adjustment disputes for 2004.  A tenth state, Illinois, also participated in the arbitration, but joined the multi-state settlement after the arbitration panel issued its decisions described below.  Hearings for nine of the 10 states concluded by the end of 2020.  The arbitration panels issued decisions finding that three states, Missouri, New Mexico and Washington, were not diligent in their enforcement of their escrow statutes in 2004 and, therefore, are subject to the NPM adjustment for 2004.  The arbitration panels further found that the remaining seven states were diligent in their enforcement and, therefore, are not subject to the NPM adjustment for 2004.  Washington and Missouri have challenged those determinations in their respective state courts and with the arbitration panels, and several issues remain to be resolved by the courts that may affect the final amount of the 2004 NPM adjustment PM USA and other PMs will receive.  PM USA recorded $21 million and $3 million as a reduction in cost of sales in the third quarter of 2021 and fourth quarter of 2022, respectively, for its estimate of the minimum amount of the 2004 NPM adjustment it will receive.  PM USA estimates it is entitled to interest of approximately $23 million and $5 million in connection with the 2004 NPM adjustment, which it recorded as interest income in the third quarter of 2021 and fourth quarter of 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;2005-2007 NPM Adjustments.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  The PMs and the nine states that have not settled the NPM Adjustment disputes are currently arbitrating NPM Adjustment disputes before a single arbitration panel.  The arbitration encompasses three years, 2005-2007, for eight of the nine states, and one year, 2005, for one state.  As of January 27, 2023, no decisions have resulted from the arbitration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Subsequent Years.  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No assurance can be given as to when proceedings for 2008 and subsequent years will be scheduled or the precise form those proceedings will take.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;In July 2022, the State of Iowa filed a motion in Iowa state court against the PMs, including PM USA, claiming that the PMs wrongfully disputed the applicability of NPM Adjustments to Iowa and that all adjustment amounts to date should have been paid to Iowa rather than deposited into the disputed payments account.  A similar enforcement motion was filed by the State of New Mexico against the PMs, including PM USA, in November 2022.  PM USA has placed certain disputed NPM Adjustment amounts attributed to Iowa and New Mexico in the disputed payments account established pursuant to the terms of the MSA.  Iowa and New Mexico seek a total of approximately $133 million and $84 million, respectively, in disputed payments from all defendants combined, as well as treble and punitive damages, and other relief.  The PMs filed a cross motion to compel arbitration in the Iowa matter, which was heard in December 2022.  A decision has not yet been issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Disputes Under the State Settlement Agreements: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The payment obligations of the tobacco product manufacturers that are parties to the State Settlement Agreements, as well as the allocations of any NPM Adjustments and related settlements, have been and may continue to be affected by R.J. Reynolds&#x2019;s acquisition of Lorillard in 2015 and its related sale of certain cigarette brands to ITG (the &#x201c;ITG transferred brands&#x201d;).  PM USA filed motions to enforce the State Settlement Agreements in Florida, Minnesota, Texas and Mississippi in connection with various positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  After various court decisions in each of those states that were favorable to PM USA, those motions to enforce have now been resolved either through settlement or exhaustion of appeals, although further proceedings may occur based on the resolution of certain outstanding litigation between R.J. Reynolds and ITG.  In May 2022, PM USA filed a motion to compel arbitration under the MSA regarding certain positions that R.J. Reynolds and ITG took with regard to the ITG transferred brands.  In June 2022, the matter was resolved through mutual agreement of the parties.  PM USA continues to dispute how the ITG transferred brands are treated in allocating the NPM Adjustments under the MSA and related settlements and may pursue such claims.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the State of Mississippi filed a motion in Mississippi state court seeking to enforce the Mississippi State Settlement Agreement against PM USA, R.J. Reynolds and ITG concerning the tax rates used in the annual calculation of the net operating profit adjustment payments starting in 2018.  The Mississippi state court held a hearing in October 2021 and issued a decision in June 2022 granting the State&#x2019;s motion.  Further proceedings remain outstanding, and a final judgment has not yet been issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, PM USA and other PMs reached an agreement with several MSA states to waive the PMs&#x2019; claim under the most favored nation provision of the MSA in connection with a settlement between those MSA states and a non-participating manufacturer, S&amp;amp;M Brands, Inc. (&#x201c;S&amp;amp;M Brands&#x201d;), under which the states released certain claims against S&amp;amp;M Brands in exchange for receiving a portion of the funds S&amp;amp;M Brands deposited into escrow accounts in those states pursuant to the states&#x2019; escrow statutes.  In consideration for waiving its most favored nation claim, PM USA received approximately $32 million from the escrow funds paid to those MSA states under their settlement with S&amp;amp;M Brands.  These funds were received in January 2021 and were recorded in our condensed consolidated statement of earnings (losses) for the first quarter of 2021 as a reduction in cost of sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Federal Government&#x2019;s Lawsuit: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 1999, the U.S. government filed a lawsuit in the U.S. District Court for the District of Columbia against various cigarette manufacturers, including PM USA, and others, including Altria, asserting claims under three federal statutes.  The case ultimately proceeded only under the civil provisions of RICO.  In August 2006, the district court held that certain defendants, including Altria and PM USA, violated RICO and engaged in seven of the eight &#x201c;sub-schemes&#x201d; to defraud that the government had alleged.  Specifically, the court found that:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely denied, distorted and minimized the significant adverse health consequences of smoking;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants hid from the public that cigarette smoking and nicotine are addictive;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely denied that they control the level of nicotine delivered to create and sustain addiction;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely marketed and promoted &#x201c;low tar/light&#x201d; cigarettes as less harmful than full-flavor cigarettes;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants falsely denied that they intentionally marketed to youth;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants publicly and falsely denied that ETS is hazardous to non-smokers; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;defendants suppressed scientific research.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The court did not impose monetary penalties on defendants, but ordered the following relief: (i)&#160;an injunction against &#x201c;committing any act of racketeering&#x201d; relating to the manufacturing, marketing, promotion, health consequences or sale of cigarettes in the United States; (ii)&#160;an injunction against participating directly or indirectly in the management or control of the Council for Tobacco Research, the Tobacco Institute, or the Center for Indoor Air Research, or any successor or affiliated entities of each; (iii) an injunction against &#x201c;making, or causing to be made in any way, any material false, misleading, or deceptive statement or representation or engaging in any public relations or marketing endeavor that is disseminated to the United States public and that misrepresents or suppresses information concerning cigarettes;&#x201d; (iv) an injunction against conveying any express or implied health message or health descriptors on cigarette packaging or in cigarette advertising or promotional material, including &#x201c;lights,&#x201d; &#x201c;ultra lights&#x201d; and &#x201c;low tar,&#x201d; which the court found could cause consumers to believe one cigarette brand is less hazardous than another brand; (v) the issuance of &#x201c;corrective statements&#x201d; in various media regarding the adverse health effects of smoking, the addictiveness of smoking and nicotine, the lack of any significant health benefit from smoking &#x201c;low tar&#x201d; or &#x201c;light&#x201d; cigarettes, defendants&#x2019; manipulation of cigarette design to ensure optimum nicotine delivery and the adverse health effects of exposure to ETS; (vi) the disclosure on defendants&#x2019; public document websites and in the Minnesota document repository of all documents produced to the government in the lawsuit or produced in any future court or administrative action concerning smoking and health until the third quarter of 2021, with certain additional requirements as to documents withheld from production under a claim of privilege or confidentiality; (vii)&#160;the disclosure of disaggregated marketing data to the government in the same form and on the same schedule as defendants now follow in disclosing such data to the FTC for a period of 10 years; (viii)&#160;certain restrictions on the sale or transfer by defendants of any cigarette brands, brand names, formulas or cigarette businesses within the United States; and (ix)&#160;payment of the government&#x2019;s costs in bringing the action.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following several years of appeals relating to the content of the corrective statements remedy described above, in October 2017, the district court approved the parties&#x2019; proposed consent order implementing corrective statements in newspapers and on television.  The corrective statements began appearing in newspapers and on television in the fourth quarter of 2017.  In April 2018, the parties reached agreement on the implementation details of the corrective statements on websites and onserts.  The corrective statements began appearing on websites in the second quarter of 2018 and the onserts began appearing in the fourth quarter of 2018.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2014, the district court ordered further briefing on corrective statements on point-of-sale signage.  In May 2019, the district court ordered a hearing on the point-of-sale signage issue.  The hearing was subsequently vacated due to the parties reaching an agreement in principle regarding the placement of corrective statements at point-of-sale.  In December 2022, the district court entered a consent order approving the settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2022, we recorded provisions totaling approximately $28 million for the estimated costs of implementing the corrective statements on point-of-sale signage remedy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, the U.S. government filed a motion with the district court asking for clarification as to whether the court-ordered injunction that applies to cigarettes also applies to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; a heated tobacco product used with the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; System.  In August 2020, we filed an opposition to the government&#x2019;s motion and, in the alternative, a motion to modify the injunction to make clear it does not apply to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.  The district court heard arguments on the motions in July 2022 and has not yet issued any decisions.  Regardless of the district court&#x2019;s decisions on the pending motions, the government has indicated it will not oppose a modification to the injunction that permits PM USA to use the Modified Risk Tobacco Product claim authorized by the FDA for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;E-vapor Product Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 27, 2023, we are defendants in 57 class action lawsuits relating to JUUL e-vapor products.  JUUL is an additional named defendant in each of these lawsuits.  The theories of recovery include violation of RICO, fraud, failure to warn, design defect, negligence and unfair trade practices.  Plaintiffs seek various remedies, including compensatory and punitive damages and an injunction prohibiting product sales.  The 57 class action lawsuits include 32 cases involving plaintiffs whose claims were previously included in other class &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.  Three of the class action lawsuits are pending in Canada.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also have been named as defendants in other lawsuits involving JUUL e-vapor products, including 3,870 individual lawsuits and 1,406 &#x201c;third party&#x201d; lawsuits, which include school districts, state and local governments and tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2019, the U.S. Judicial Panel on Multidistrict Litigation ordered the coordination or consolidation of the federal individual and class action lawsuits mentioned above in the U.S. District Court for the Northern District of California for pretrial purposes.   In December 2022, JUUL reportedly reached agreements to resolve the Multidistrict Litigation through settlement.  In January 2023, the court preliminarily approved the settlement.  We are not a party to any settlements concerning the Multidistrict Litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The court has set trial dates for three cases pending in the Multidistrict Litigation.  The first trial is currently scheduled for April 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We filed motions to dismiss certain claims in the class action and school district cases, including the federal RICO claim.  In October 2020, the U.S. District Court for the Northern District of California granted the motion to dismiss the RICO class action claim without prejudice.  Although it otherwise denied the motion, the court found that plaintiffs had not sufficiently alleged standing or causation with respect to their claim under California law.  The court also granted the motion to dismiss the RICO claim in the cases filed by various school districts, but denied the motion in all other respects.  The court gave plaintiffs the opportunity to amend their complaints to attempt to cure the deficiencies the court identified and plaintiffs filed their amended complaints in November 2020.  In January 2021, we filed a renewed motion to dismiss the RICO claim, which the court denied in April 2021.  In June 2022, the court granted plaintiffs&#x2019; motion to certify a California state class based on state law claims against JUUL and a nationwide class based on RICO claims against Altria and other defendants.  Altria and the other defendants filed petitions with the U.S. Court of Appeals for the Ninth Circuit seeking discretionary review of the class certification order, which the court granted in October 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An additional group of cases is pending in California state courts.  In January 2020, the Judicial Council of California determined that this group of cases was appropriate for coordination and assigned the group to the Superior Court of California, Los Angeles County, for pretrial purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;JUUL also is named in a significant number of additional individual and class action lawsuits to which we are not currently named.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Four of the &#x201c;third party&#x201d; lawsuits noted above against us and JUUL were initiated, individually, by the attorneys general of Alaska, Hawaii, Minnesota and New Mexico alleging violations of state consumer protection and other similar laws.  We filed motions to dismiss the lawsuits.  In Alaska, Hawaii and Minnesota, the motions were denied in February 2022, May 2021 and June 2021, respectively.  Our motion to dismiss remains pending in New Mexico.  In the Alaska lawsuit, although the trial court declined to dismiss most of the plaintiff&#x2019;s claims, the trial court did dismiss plaintiff&#x2019;s public nuisance claim.  The trial courts in the Alaska, Hawaii and Minnesota lawsuits have set the trials for April 2024, February 2024 and March 2023, respectively.  As of January 27, 2023, the trial court in New Mexico has not set a trial date.  JUUL is also named in other attorneys general lawsuits in which we are not currently named.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;IQOS &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, RAI Strategic Holdings, Inc. and R.J. Reynolds Vapor Co., which are affiliates of R.J. Reynolds, filed a lawsuit against Altria, PM USA, ALCS, PMI and its affiliate, Philip Morris Products S.A., in the U.S. District Court for the Eastern District of Virginia asserting claims of patent infringement based on the sale of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; System electronic device and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Marlboro HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; in the United States.  Plaintiffs seek various remedies, including preliminary and permanent injunctive relief, treble damages and attorneys&#x2019; fees.  Altria and PMI were previously dismissed from the lawsuit, and plaintiffs&#x2019; claims against the other defendants have been stayed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PM USA, ALCS and Philip Morris Products S.A. filed counterclaims against plaintiffs in the Eastern District of Virginia lawsuit alleging patent infringement by R.J. Reynolds&#x2019; e-vapor products.  In June 2022, PM USA and ALCS reached an agreement with R.J. Reynolds resulting in dismissal of their counterclaims.  In addition, ALCS filed a separate lawsuit against R.J. Reynolds in the U.S. District Court for the Middle District of North Carolina also alleging patent infringement by R.J. Reynolds&#x2019; e-vapor products.  In September 2022, a jury awarded ALCS $95 million in damages for past infringement, plus supplemental damages and interest.  In January 2023, the court ordered R.J. Reynolds to pay ALCS a 5.25% royalty on future sales of its infringing product resulting in positive net income through the expiration of the relevant patents in 2035.  As gains related to this lawsuit have not yet been determined to be realized or realizable in accordance with GAAP, they have not been recognized in our financial statements for the fiscal year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also in April 2020, a related patent infringement action was filed against the same defendants by the same plaintiffs, as well as R.J. Reynolds, with the U.S. International Trade Commission (&#x201c;ITC&#x201d;), but the remedies sought included a prohibition on the importation of the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; System electronic device, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Marlboro HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and component parts into the United States and on the sale of any such products previously imported into the United States.  No damages are recoverable in the proceedings before the ITC.  In September 2021, the ITC issued a limited exclusion order barring the importation of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;System electronic device,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Marlboro HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and the infringing components into the United States and a cease and desist order barring domestic sales, marketing and distribution of these imported products.  The orders became effective on November 29, 2021.  Consequently, PM USA removed the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;System electronic &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;device and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Marlboro HeatSticks&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; from the marketplace.  In December 2021, defendants appealed the orders to the U.S. Court of Appeals for the Federal Circuit and, in January 2022, the court denied defendants&#x2019; motion to stay the orders pending the conclusion of the appeal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An additional unrelated patent infringement case regarding the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; System electronic device was filed in November 2020 in the U.S. District Court for the Northern District of Georgia against PM USA and Philip Morris Products S.A. seeking damages and equitable relief.  In February 2021, defendants filed a motion to dismiss the lawsuit, which the court granted in July 2021.  In December 2021, the U.S. District Court denied plaintiff&#x2019;s motion to amend the complaint and plaintiff appealed this ruling to the U.S. Court of Appeals for the Federal Circuit, which appeal remains pending.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Antitrust Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2020, the FTC issued an administrative complaint against Altria and JUUL alleging that our 35% investment in JUUL and the associated agreements constitute an unreasonable restraint of trade in violation of Section 1 of the Sherman Antitrust Act of 1890 (&#x201c;Sherman Act&#x201d;) and Section 5 of the Federal Trade Commission Act of 1914, and substantially lessened competition in violation of Section 7 of the Clayton Antitrust Act (&#x201c;Clayton Act&#x201d;).  If the FTC&#x2019;s challenge is successful, the FTC may order a broad range of remedies, including divestiture of our minority investment in JUUL, rescission of the transaction and all associated agreements, a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party&#x2019;s board of directors or attending meetings of the other party&#x2019;s board of directors and notice to the FTC in advance of certain corporate actions, including acquisitions, mergers or certain corporate restructurings.  In February 2022, the administrative law judge dismissed the FTC&#x2019;s complaint and, also in February 2022, FTC complaint counsel appealed the administrative law judge&#x2019;s decision to the FTC.  Oral argument with respect to the appeal occurred in September 2022.  After oral argument, the FTC asked for additional briefing, which was completed in December 2022.  Altria can appeal any adverse ruling the FTC issues following its review to any U.S. Court of Appeals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also as of January 27, 2023, 17 putative class action lawsuits have been filed against Altria and JUUL in the U.S. District Court for the Northern District of California.  The lawsuits initially named, in addition to the two companies, certain senior executives and certain members of the board of directors of both companies as defendants; however, those individuals currently or formerly affiliated with Altria were later dismissed.  In November 2020 these lawsuits were consolidated into three complaints (one on behalf of direct purchasers, one on behalf of indirect purchasers and one on behalf of indirect resellers).  The consolidated lawsuits, as amended, cite the FTC administrative complaint and allege that Altria and JUUL violated Sections 1, 2 and/or 3 of the Sherman Act and Section 7 of the Clayton Act and various state antitrust, consumer protection and unjust enrichment laws by restraining trade and/or substantially lessening competition in the U.S. closed-system electronic cigarette market.  Plaintiffs seek various remedies, including treble damages, attorneys&#x2019; fees, a declaration that the agreements between Altria and JUUL are invalid, divestiture of our minority investment in JUUL and rescission of the transaction.  We filed a motion to dismiss these lawsuits in January 2021.  In August 2021, the U.S. District Court for the Northern District of California denied our motion to dismiss except with respect to plaintiffs&#x2019; claims for injunctive and equitable relief.  However, plaintiffs were granted the opportunity to replead such claims by the trial court, which plaintiffs did in September 2021.  In January 2022, the trial court ordered that the direct-purchaser plaintiffs&#x2019; claims against JUUL be sent to arbitration pursuant to an arbitration provision in JUUL&#x2019;s online purchase agreement.  The court granted plaintiffs&#x2019; leave to replead the complaint with new direct-purchaser plaintiffs, which plaintiffs did in February 2022, substituting in four new plaintiffs.  In August 2022, the court stayed all of the cases pending any appeal to the court of appeals from the FTC&#x2019;s lawsuit against Altria and JUUL.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020, we exercised our rights to convert our non-voting JUUL shares to voting shares.  In September 2022, we exercised our option to be released from our JUUL non-competition obligations, resulting in (i) the permanent termination of our non-competition obligations to JUUL, (ii) the loss of our JUUL board designation rights (other than the right to appoint one independent director so long as our ownership continues to be at least 10%), our preemptive rights, our consent rights and certain other rights with respect to our investment in JUUL and (iii) the conversion of our JUUL shares to single vote common stock, significantly reducing our voting power.  We do not currently intend to exercise our remaining governance rights or to vote our JUUL shares other than as a passive investor.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Shareholder Class Action and Shareholder Derivative Lawsuits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shareholder Class Action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In October and December 2019, two purported Altria shareholders filed putative class action lawsuits against Altria, Howard A. Willard III, our former Chairman and Chief Executive Officer, and William F. Gifford, Jr., our former Vice Chairman and Chief Financial Officer and current Chief Executive Officer, in the U.S. District Court for the Eastern District of New York.  In December 2019, the court consolidated the two lawsuits into a single proceeding.  The consolidated lawsuit was subsequently transferred to the U.S. District Court for the Eastern District of Virginia.  The lawsuit asserts claims under Sections 10(b) and 20(a) and under Rule 10b-5 of the Exchange Act.  In April 2020, JUUL, its founders and some of its current and former executives were added to the lawsuit.  The claims allege false and misleading statements and omissions relating to our investment in JUUL.  Plaintiffs seek various remedies, including damages and attorneys&#x2019; fees.  In July 2020, the defendants filed motions to dismiss plaintiffs&#x2019; claims, which the district court denied in March 2021.  In the fourth quarter of 2021, plaintiffs and defendants agreed upon a class action settlement under which, among other things, (i) all claims asserted against Altria and the other named defendants are resolved without any liability or wrongdoing attributed to them personally or to Altria and (ii) Altria will pay the class an aggregate amount of $90 million, which amount includes attorneys&#x2019; fees.  The class is defined to include persons and entities who purchased or otherwise acquired shares of Altria between &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;October 25, 2018 through April 2, 2020, subject to certain exclusions.  The trial court granted final approval of the settlement in March 2022.  We recorded pre-tax provisions totaling $90 million in 2021 and, in January 2022, paid $90 million to plaintiffs&#x2019; escrow account.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Federal and State Shareholder Derivative Lawsuits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, two purported Altria shareholders filed separate derivative lawsuits in the U.S. District Court for the Northern District of California on behalf of themselves and Altria, against Mr. Willard, Mr. Gifford, JUUL and certain of our executives and officers.  These derivative lawsuits relate to our investment in JUUL, and assert claims of breach of fiduciary duty by the Altria defendants and aiding and abetting in that alleged breach of fiduciary duty by the remaining defendants.  In March 2021, the U.S. District Court for the Northern District of California granted defendants&#x2019; motion to transfer both lawsuits to the U.S. District Court for the Eastern District of Virginia.  Three additional federal derivative lawsuits were filed in October 2020, January 2021 and March 2021, respectively, in the U.S. District Court for the Eastern District of Virginia against Mr. Willard, Mr. Gifford, Mr. Crosthwaite, certain members of our Board of Directors, JUUL, its founders and some of its current and former executives.  These suits assert various claims, including breach of fiduciary duty, unjust enrichment, waste of corporate assets and violations of certain federal securities laws.  The remedies sought in these lawsuits include damages, disgorgement of profits, reformation of our corporate governance and internal procedures, and attorneys&#x2019; fees.  In April 2021, the court consolidated the five cases pending in the Eastern District of Virginia into a single case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Six derivative lawsuits have been filed in Virginia state courts against Mr. Willard, Mr. Gifford, Mr. Crosthwaite (our former Chief Growth Officer and JUUL&#x2019;s current Chief Executive Officer), certain members of our Board of Directors, JUUL, its founders and some of its current and former executives.  The lawsuits were filed in September 2020, May 2021, June 2021, July 2021, August 2021 and August 2021, respectively.  The lawsuits assert various claims, including breach of fiduciary duty, and seek remedies similar to those sought by plaintiffs in the cases pending in federal court in the Eastern District of Virginia.  In successive orders from July 2021, September 2021 and January 2022, five of the six state derivative cases were consolidated into a single case.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2022, plaintiffs and defendants in all the federal and state derivative cases agreed upon a settlement of these cases.  Under the terms of the settlement, among other things, we agreed to fund underage tobacco prevention and cessation programs, which may include positive youth development programs, led by independent third-party organizations.  In the second and third quarters of 2022, we recorded pre-tax provisions of $7 million and $20 million, respectively, for costs associated with the independent monitoring of our funding commitments and attorneys&#x2019; fees.  In January 2023, the federal trial court conducted a final approval hearing, at which the court sustained an objection to a provision of the settlement, but granted the parties additional time to resolve the issue, and scheduled a second final approval hearing for February 2023.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Certain Other Tobacco-Related Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x201c;Lights/Ultra Lights&#x201d; Cases and Other Smoking and Health Class Actions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Plaintiffs have sought certification of their cases as class actions, alleging among other things, that the uses of the terms &#x201c;Lights&#x201d; and/or &#x201c;Ultra Lights&#x201d; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment or breach of warranty, and have sought injunctive and equitable relief, including restitution and, in certain cases, punitive damages.  These class actions have been brought against PM USA and, in certain instances, Altria or our other subsidiaries, on behalf of individuals who purchased and consumed various brands of cigarettes.  Defenses raised in these cases include lack of misrepresentation, lack of causation, injury and damages, the statute of limitations, non-liability under state statutory provisions exempting conduct that complies with federal regulatory directives, and the First Amendment.  Twenty-one state courts in 23 &#x201c;Lights&#x201d; cases have refused to certify class actions, dismissed class action allegations, reversed prior class certification decisions or have entered judgment in favor of PM USA.  As of January 27, 2023, two &#x201c;Lights/Ultra Lights&#x201d; class actions are pending in U.S. state courts.  Neither case is active.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of January 27, 2023, one smoking and health case alleging personal injury or seeking court-supervised programs or an ongoing medical monitoring program on behalf of individuals exposed to environmental tobacco smoke and purporting to be brought on behalf of a class of individual plaintiffs, is pending in a U.S. state court.  The case is currently inactive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;UST Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UST and/or its tobacco subsidiaries have been named in a number of individual tobacco and health lawsuits over time.  Plaintiffs&#x2019; allegations of liability in these cases have been based on various theories of recovery, such as negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of implied warranty, addiction and breach of consumer protection statutes.  Plaintiffs have typically sought various forms of relief, including compensatory and punitive damages, and certain equitable relief, including but not limited to disgorgement.  Defenses raised in these cases have included lack of causation, assumption of the risk, comparative fault and/or contributory negligence, and statutes of limitations.  As of January 27, 2023, there is no such case pending against UST and/or its tobacco subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Environmental Regulation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Altria and our former subsidiaries are subject to various federal, state and local laws and regulations concerning the discharge of materials into the environment, or otherwise related to environmental protection, including, in the United States: the Clean Air Act, the Clean Water Act, the Resource Conservation and Recovery Act and the Comprehensive Environmental Response, Compensation and Liability Act (commonly known as &#x201c;Superfund&#x201d;), which can impose joint and several liability on each responsible party.  Altria and our former subsidiaries are involved in several cost recovery/contribution cases subjecting them to potential costs of remediation and natural &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;resource damages under Superfund or other laws and regulations.  We expect to continue to make capital and other expenditures in connection with environmental laws and regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide for expenses associated with environmental remediation obligations on an undiscounted basis when such amounts are probable and can be reasonably estimated.  Such accruals are adjusted as new information develops or circumstances change.  Other than those amounts, it is not possible to reasonably estimate the cost of any environmental remediation and compliance efforts that we may undertake in the future.  In the opinion of our management, however, compliance with environmental laws and regulations, including the payment of any remediation costs or damages and the making of related expenditures, has not had, and is not expected to have, a material adverse effect on our consolidated results of operations, capital expenditures, financial position or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Guarantees and Other Similar Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, we have agreed to indemnify a limited number of third parties in the event of future litigation.  At December&#160;31, 2022, we (i) had $46 million of unused letters of credit obtained in the ordinary course of business and (ii) were contingently liable for guarantees related to our own performance, including $19 million for surety bonds recorded on our consolidated balance sheet.  In addition, from time to time, we issue lines of credit to affiliated entities.  These items have not had, and are not expected to have, a significant impact on our liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of a distribution agreement between Altria and PMI (the &#x201c;Distribution Agreement&#x201d;), entered into as a result of our 2008 spin-off of our former subsidiary PMI, liabilities concerning tobacco products will be allocated based in substantial part on the manufacturer.  PMI will indemnify Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for liabilities related to tobacco products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.  We do not have a related liability recorded on our consolidated balance sheet at December&#160;31, 2022 as the fair value of this indemnification is insignificant.  PMI has agreed not to seek indemnification with respect to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; System patent litigation discussed above under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;IQOS Litigation, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;excluding the patent infringement case filed with the U.S. District Court for the Northern District of Georgia.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PM USA has issued guarantees relating to our obligations under our outstanding debt securities, borrowings under our $3.0 billion Credit Agreement and amounts outstanding under our commercial paper program.  For further discussion, see Note 8. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMjY2NTg_3e90dccc-19d4-4450-8ebf-1dd1452460c0"
      unitRef="state">47</mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond>
    <us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzY2MzQ1_d788a6e1-67d5-4fd5-9a80-e7f58c703e92">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.249%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.599%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.575%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health and certain other litigation items at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;91&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-tax charges for:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tobacco and health and certain other litigation &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shareholder class action and shareholder derivative lawsuits &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:27pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Related interest costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(151)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 14.5pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued liability for tobacco and health and certain other litigation items at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;71&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes judgments, settlements and fee disputes associated with tobacco and health and certain other litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See S&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;hareholder Class Action and Shareholder Derivative Lawsuits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; below for discussions of the shareholder class action case and related settlement and the pending settlement of the federal and state shareholder derivative lawsuits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below lists the number of certain tobacco-related cases pending in the United States against us as of December 31:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.419%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.604%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Smoking and Health Cases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health Care Cost Recovery Actions &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E-vapor Cases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5,283&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,296&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Tobacco-Related Cases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:2pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes as of December 31, 2022, 17 cases filed in Illinois, 20 cases filed in New Mexico, 37 cases filed in Massachusetts and 51 non-&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;cases filed in Florida.  Does not include individual smoking and health cases brought by or on behalf of plaintiffs in Florida state and federal courts following the decertification of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;case (these &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; progeny cases are discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Smoking and Health Litigation - Engle Class Action&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  Also does not include 1,395 cases brought by flight attendants seeking compensatory damages for personal injuries allegedly caused by exposure to environmental tobacco smoke (&#x201c;ETS&#x201d;).  The flight attendants allege that they are members of an ETS smoking and health class action in Florida, which was settled in 1997 (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Broin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;).  The terms of the court-approved settlement in that case allowed class members to file individual lawsuits seeking compensatory damages but prohibited them from seeking punitive damages.  Class members were prohibited from filing individual lawsuits after 2000 under the court-approved settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; See &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Health Care Cost Recovery Litigation - Federal Government&#x2019;s Lawsuit&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes as of December 31, 2022, 57 class action lawsuits, 3,830 individual lawsuits and 1,396 &#x201c;third party&#x201d; lawsuits relating to JUUL e-vapor products, which include school districts, state and local government, tribal and healthcare organization lawsuits.  JUUL is an additional named defendant in each of these lawsuits.  The 57 class action lawsuits include 32 cases in the Northern District of California (&#x201c;Multidistrict Litigation&#x201d; or &#x201c;MDL&#x201d;) involving plaintiffs whose claims were previously included in other class action complaints but were refiled as separate stand-alone class actions for procedural and other reasons.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes as of December 31, 2022, one inactive smoking and health case alleging personal injury and purporting to be brought on behalf of a class of individual plaintiffs and two inactive class action lawsuits alleging that use of the terms &#x201c;Lights&#x201d; and &#x201c;Ultra Lights&#x201d; constitute deceptive and unfair trade practices, common law or statutory fraud, unjust enrichment, breach of warranty or violations of RICO.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Currently Pending Engle Cases with Verdicts Against PM USA &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.707%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.159%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Compensatory Damages &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Punitive Damages &lt;br/&gt;(PM USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Post-Trial Status&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Hoffman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5 million ($3 million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Awaiting entry of final judgment by the trial court.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Levine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Appeals by defendants and plaintiff to Third District Court of Appeal pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Schertzer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;April 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Appeal by defendants to the Third District Court of Appeal pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Lipp&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$15 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$28 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to Third District Court of Appeal pending.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Garcia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;May 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$6 million ($3 million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Appeal by defendant to the Third District Court of Appeal pending.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Duignan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2020 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Pinellas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$12&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Florida Supreme Court quashed the Second District Court of Appeal&#x2019;s affirmation of  judgment against the defendants and remanded the case for reconsideration in light of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;McCall&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;March 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1&#160;million (&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;New trial on punitive damages is set for April 2023.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Chadwell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third District Court of Appeal has ordered supplemental briefing in accordance with the decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Kaplan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;McLaughlin&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;July 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;Florida Supreme Court vacated the punitive damages award in accordance with the decision in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"&gt;Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;.  The Fourth District Court of Appeals affirmed the compensatory damages award and granted a new trial on punitive damages.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cooper&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt; (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Blackwood&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Broward&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5&#160;million &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(&amp;lt;$1&#160;million PM USA)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$0&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth District Court of Appeal affirmed the compensatory damages award and granted a new trial on punitive damages.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;PM USA&#x2019;s portion of the compensatory damages award is noted parenthetically where the court has ruled that comparative fault applies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Plaintiff&#x2019;s verdict following a retrial of an initial verdict in favor of plaintiff.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; PM USA is not a defendant in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prentice&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; or &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sheffield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;, which are discussed below in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Engle Progeny Appellate Issues&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Engle Cases Concluded Within Past 12 Months &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(rounded to nearest $ million)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.180%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.919%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.638%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Plaintiff&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Verdict Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Defendant(s)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Court&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accrual Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Amount for Damages (if any)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Miller&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;September 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA and R.J. Reynolds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third quarter of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;December 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Tuttle&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;August 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third quarter of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&amp;lt;$1 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;October 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Cuddihee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Duval&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Second quarter of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$2 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;June 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;Holliman&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;February 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Miami-Dade&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Fourth quarter of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$3 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%"&gt;D. Brown&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;January 2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PM USA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal Court - Middle District of Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Third quarter of 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$5 million&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;August 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzItMS0xLTEtMTg0NDY5_827d6899-8929-43cd-9d5c-ea5039b983a1"
      unitRef="usd">91000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzItMy0xLTEtMTg0NDY5_15bd50c5-5794-42db-a40e-0bdec35ba182"
      unitRef="usd">9000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i40e064b5da194d8bbe29064d490250de_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzItOS0xLTEtMTg0NDY5_d513d8c6-a626-4407-9d80-7ca71bbb3766"
      unitRef="usd">14000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="id322aa0288694bdb849607abacc6dabd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzQtMS0xLTEtMTg0NDY5_f2e8d804-0123-40d5-be51-e49514915228"
      unitRef="usd">101000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i4739c0a3ba074dff8712b23ec3f898ad_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzQtMy0xLTEtMTg0NDY5_59ed010c-e79d-4953-9995-c621656c0a73"
      unitRef="usd">83000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="if96971d3062e4a31a0e27c3b191c0dde_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzQtOS0xLTEtMTg0NDY5_3ec61ad9-259f-4958-afc3-0dc58239d47f"
      unitRef="usd">79000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i4fec6e69190c449a8d51b6a9ea7c1d31_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzUtMS0xLTEtMTg0NDY5_36919450-c6cc-40f0-a145-a039be2dbc5f"
      unitRef="usd">27000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i0d4c427ec8a94dfd836dc5b4a199c764_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzUtMy0xLTEtMTg0NDY5_e0110d5a-673f-4f16-8d4a-f12676205e0c"
      unitRef="usd">90000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i6fd275444e894de0ab137fd15c70d71c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzUtOS0xLTEtMTg0NDY5_36c4bedf-f7d8-40ec-9f69-a0dc6a727797"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i37fa7f6256454447bca119375f7fe081_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzYtMS0xLTEtMTg0NDY5_5f48b7ff-8a5c-43a2-be21-bfa3fbd68d85"
      unitRef="usd">3000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i14301c0ea4d0417daf460f139e79a779_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzYtMy0xLTEtMTg0NDY5_188ea8fc-3f9b-4620-a509-8c92e4f7ebd1"
      unitRef="usd">9000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i4be6c8b0110c4ba9995765495afef7d6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzYtOS0xLTEtMTg0NDY5_96f4ae7e-93d3-4292-a976-a9ecb54fe0eb"
      unitRef="usd">4000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzEwLTEtMS0xLTE4NDQ2OQ_6df2b7f2-b89a-4cf8-8e16-7a9efefc2811"
      unitRef="usd">151000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzEwLTMtMS0xLTE4NDQ2OQ_d75763e3-b9a3-41d0-8270-3e918c5cd168"
      unitRef="usd">100000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="i61053227470d46149283ab8a5e0978bd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzEwLTktMS0xLTE4NDQ2OQ_ad0d1fe8-4f6c-4d81-97e8-2b1702019ffe"
      unitRef="usd">88000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzExLTEtMS0xLTE4NDQ2OQ_f85282fd-b568-4f16-b318-2964cb83e3c0"
      unitRef="usd">71000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i6526b762c96848958db76b2e641f06c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzExLTMtMS0xLTE4NDQ2OQ_dab85197-2aa1-4726-a3f4-7ad030b5e027"
      unitRef="usd">91000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo1OTE5ZWEzZDMxNjI0NjUyOGZkYzRlNmU4ODMxOWYyMC90YWJsZXJhbmdlOjU5MTllYTNkMzE2MjQ2NTI4ZmRjNGU2ZTg4MzE5ZjIwXzExLTktMS0xLTE4NDQ2OQ_2eb8919c-a3b9-450d-97de-bf2491f8a8e6"
      unitRef="usd">9000000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="i03318a08f6694a48998709b33e36a67f_D20041001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzQxODI_c160a10e-c777-4e4f-9045-fcd1db03a69e"
      unitRef="usd">954000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LitigationSettlementInterest
      contextRef="i03318a08f6694a48998709b33e36a67f_D20041001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzQxNzQ_09441235-9e98-4690-a8bc-da48ace647be"
      unitRef="usd">230000000</us-gaap:LitigationSettlementInterest>
    <us-gaap:LossContingencyDamagesPaidValue
      contextRef="ied3d1d716af5466b9e30cf6840540284_D20041001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzQxNzg_5e3fa5f2-2f1e-44ff-97fa-7572a7841204"
      unitRef="usd">432000000</us-gaap:LossContingencyDamagesPaidValue>
    <us-gaap:LitigationSettlementInterest
      contextRef="ied3d1d716af5466b9e30cf6840540284_D20041001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzQxODY_9cb86876-8459-4958-a506-87fd6c72ffd6"
      unitRef="usd">59000000</us-gaap:LitigationSettlementInterest>
    <mo:LitigationEscrowDeposit
      contextRef="i480c00944cc54888a1e9a12e8d5a6c2f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzQxOTA_3525a8a4-2481-46fd-8a5e-a4f407b8133f"
      unitRef="usd">46000000</mo:LitigationEscrowDeposit>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i7a9cc9052f7342f9a5a2965a1363d918_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzEtMS0xLTEtMTg0NDY5_b2191c32-4388-4432-9965-37e78b5ca01d"
      unitRef="claim">162</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ib803543b5610404db3d4704c2d823f5c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzEtMy0xLTEtMTg0NDY5_2656e4c6-d797-4702-b570-c31e9c9fdd08"
      unitRef="claim">176</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i7443c1f2410b42f79436b4c8406d1884_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzEtNS0xLTEtMTg0NDY5_535915e3-86a0-422c-9162-b895b44b30cc"
      unitRef="claim">148</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i496cf0d3b6c242988d0ca0ecf226c71f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzItMS0xLTEtMTg0NDY5_fc1ad6d2-806d-416c-ad0d-9747837191ef"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i1cb201982a874dda811f7385ce781a84_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzItMy0xLTEtMTg0NDY5_e47f3ad6-d546-4c06-8f72-ebe48952e806"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ic0dc27727fac48219ac9ec68f62e232f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzItNS0xLTEtMTg0NDY5_9fe2a57e-1c00-4e8d-8cca-9f51706fb648"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i3c7b5b8168e84e9f97ec53935f0e23bc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzMtMS0xLTEtMTg0NDY5_f8c8ed96-ab01-4fa3-bf2e-3b7dd592337d"
      unitRef="claim">5283</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ibcd3a4d726d343dc811a0c842908f852_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzMtMy0xLTEtMTg0NDY5_29748a6a-33a7-44d6-9d90-7527ee76e2d6"
      unitRef="claim">3296</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i815d22256b0f463899dc0f22fbf273d4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzMtNS0xLTEtMTg0NDY5_a41c1c76-ed45-4d07-ba30-eda783634d2c"
      unitRef="claim">1563</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i8bf85127efde436391fadbb7ddd35b59_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzQtMS0xLTEtMTg0NDY5_5797fc80-7a87-43a9-9151-d7caf8ecb4c5"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if30834386f77477da8f843b6b5597b5c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzQtMy0xLTEtMTg0NDY5_2bb075c3-d382-4609-b997-8dceefba23ec"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i23b3a0d3f9bb4d1490db4cd7c943b4b1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpjMWM4Zjc5MGM5NmQ0ZTVlYjA3Mzc0MmRkYjM5NGZjMC90YWJsZXJhbmdlOmMxYzhmNzkwYzk2ZDRlNWViMDczNzQyZGRiMzk0ZmMwXzQtNS0xLTEtMTg0NDY5_96ae19d9-71a7-4b55-8f15-39a58c5546cd"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i1ec68205f19b43d79d872f39a862112a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkyODk_811fbf8b-cbcc-4f7e-a1f0-ef7ad51e6749"
      unitRef="case">17</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i04aef4e9d8bf47b6889ffc116b3823fe_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkyOTM_dc79c871-6f98-484e-969c-cb90e1f88a1b"
      unitRef="case">20</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i84f64e1272e04d79a531d39b5bcf0ca4_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkyOTc_216634fb-2440-46b4-a0b2-169c74cfe3af"
      unitRef="case">37</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="if4156610d169487eb2ddc1063aac958d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMDA_7d70b6c7-38e0-4cb9-9696-4e4cdb8aa929"
      unitRef="case">51</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberOfCases
      contextRef="if1f51724e36a4d608bc658784f91ce0e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMDM_340ef39e-ad0a-401d-92c7-15b24f26271c"
      unitRef="case">1395</mo:LossContingencyNumberOfCases>
    <mo:LossContingencyClassActionLawsuit
      contextRef="i3c7b5b8168e84e9f97ec53935f0e23bc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMjI_155db0ad-a30f-4f1d-bde0-533c7d0da497"
      unitRef="lawsuit">57</mo:LossContingencyClassActionLawsuit>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i0c93a8ff326144f69851e022e7d7df20_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMDk_93c61444-e526-44ff-b808-f89c59dd10cf"
      unitRef="lawsuit">3830</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i9244ca0d63dc4969a4c903eab7d4b970_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMTM_fc60697d-518b-40de-ae12-d6f4bd4d767c"
      unitRef="lawsuit">1396</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyClassActionLawsuit
      contextRef="i3c7b5b8168e84e9f97ec53935f0e23bc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMTg_155db0ad-a30f-4f1d-bde0-533c7d0da497"
      unitRef="lawsuit">57</mo:LossContingencyClassActionLawsuit>
    <mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber
      contextRef="i91aaf91c29514549a260f8c3b405df37_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMjY_8dd8fcf0-0dd6-48b4-94f3-fbcc433f6ec3"
      unitRef="case">32</mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber>
    <mo:LossContingencyNumberOfInactiveCases
      contextRef="i8bf85127efde436391fadbb7ddd35b59_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMzA_e384b895-1a39-4ce2-818c-dbe3699f6ee8"
      unitRef="case">1</mo:LossContingencyNumberOfInactiveCases>
    <mo:LossContingencyNumberOfInactiveClassActionLawsuits
      contextRef="i8bf85127efde436391fadbb7ddd35b59_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzMzkzMzQ_5f56b28a-8a0d-4fab-89e6-0df32545570d"
      unitRef="case">2</mo:LossContingencyNumberOfInactiveClassActionLawsuits>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ia8ac04c172f1433fbffdd1c5a97bdc20_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDYwMzU_ee0983b8-424f-445a-a6d2-82864fa0cbb5"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ibbca890a0ab042c4b655ce8a512d9dc0_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDYwMzk_9581234d-94e9-46a8-a950-662511be4a35"
      unitRef="case">10</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i44002739e29942868064a12846ec9503_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDYwNDM_808f87b2-9972-453e-8a33-b1c6a8b578a4"
      unitRef="case">8</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i78854af3be924b238c97cf0018613bd5_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDYwNDc_22672022-0114-4191-b34c-a28c8811dcfa"
      unitRef="case">7</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofCasesSetforTrial
      contextRef="ib9bfd24968014e2fbddf1581242c201e_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDU1OTA_16ff2619-708c-4adb-ab22-88b11fd9c756"
      unitRef="case">2</mo:LossContingencyNumberofCasesSetforTrial>
    <mo:LossContingencyNumberofCasesSetforTrial
      contextRef="i571a013fea1d4f7fac1f41c38c582ec2_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjEyOTg_9c48dd1d-7e27-4025-8a6d-5f4204aa1c21"
      unitRef="case">2</mo:LossContingencyNumberofCasesSetforTrial>
    <mo:LossContingencyNumberofCasesSetforTrial
      contextRef="i581f20cb6875437fbd464b63c2092b97_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjEzMDI_5d90e470-98a4-4bbe-87c7-66276b00f58e"
      unitRef="case">1</mo:LossContingencyNumberofCasesSetforTrial>
    <mo:LossContingencyClaimsDecided
      contextRef="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNDU_cb7d68da-144b-472e-b8cf-c896862bbcee"
      unitRef="case">73</mo:LossContingencyClaimsDecided>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNDk_ea1f0752-c4fb-4137-9726-392aa64f26c9"
      unitRef="case">46</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecided
      contextRef="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNTM_cb7d68da-144b-472e-b8cf-c896862bbcee"
      unitRef="case">73</mo:LossContingencyClaimsDecided>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNTc_ea1f0752-c4fb-4137-9726-392aa64f26c9"
      unitRef="case">46</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i15254fcdf0474c4d91f3cdaf53416cf9_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNjE_ca64a026-9633-4700-ae05-4e8cec08afd9"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i03552e08ecac456e9607180e0f7cea1d_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNjU_27b67b35-085d-4f20-b308-e93d61a4abc0"
      unitRef="case">7</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="iff9acca8e9b04ab7bbeb5f69bc352ad6_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNjk_e71aba69-8807-4b28-b1df-f006659c6b9c"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ia385d23e2d37444cbad3c91fd282c47b_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNzM_60bc8c03-b122-4cce-8121-29b05b42bcb1"
      unitRef="case">10</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ibb31d44524574239b606215996b36c53_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxNzc_2d1f66bb-1f3e-41f1-a107-ab5560c39a15"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ida280a8e75724cc58094fbf48eda09fa_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxODE_0021ebbf-0cf1-49a2-9060-b4a988710d49"
      unitRef="case">6</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i325dfa71eec5476ea64d6e500e22c43e_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxODU_ac28c293-5cc7-4a40-b1aa-a5387dc59559"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i322e1958ef354f998e5b9802f9a1c190_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxODk_1c590f6f-d6f9-485d-be71-6954b53f0984"
      unitRef="case">4</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="id5c28868e39348ea9f1dc8327b0b6efd_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxOTM_34e2b38d-f372-4be2-92e9-698aa919742f"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ie6f19f777880458ca0b18267c7d35b69_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcxOTc_f3add56e-8447-4f3a-83f8-496097255e01"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i3d324cecd2fc4178abb7a986fd98c47a_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcyMDE_75f4e23e-2fc8-4967-8cd7-8939679b6728"
      unitRef="case">5</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ic85bb6de18db4b88bb50cb99cf81d8d8_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcyMDU_5f3d13b5-d781-4e73-bf06-9d2efa29e92c"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ic3560c35b1b64649bae3cb957e859160_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcyMDk_0d984879-36b8-4ee6-ae7f-dd4efb499a02"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i6f793a811c1c4997bb2a82a658d83b55_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcyMTM_1c4edec8-96f1-4ac0-a0c4-7bfe61017f2b"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i5a801284144744f8a8f5d897e3fa2fb5_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcyMTc_67e9a974-87ee-4c6b-b9a8-7fdb8638d233"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="idb6c598803cf4b6687397df90a86563f_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDcyMjE_5735a411-5858-4c14-9fb7-41b732005d5a"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyVerdictReversedNumber
      contextRef="ida280a8e75724cc58094fbf48eda09fa_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzY1OTcwNjk5OTYyOTg_3e718562-a7dd-44b3-8e06-f7407b9d5c46"
      unitRef="case">1</mo:LossContingencyVerdictReversedNumber>
    <mo:LossContingencyClaimsDecidedUnfavorableNumber
      contextRef="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDY3MDI_8057eb94-d69a-4720-b1df-04770ea6287d"
      unitRef="case">27</mo:LossContingencyClaimsDecidedUnfavorableNumber>
    <mo:LossContingencyClaimsResolvedNumber
      contextRef="ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNDY3MDY_c7e7fc84-12c4-4b0f-8951-653cb4ea9c6a"
      unitRef="case">23</mo:LossContingencyClaimsResolvedNumber>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ic04846f477ef4b43b64fc0a53777f0d5_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjEzMDU_d95d0129-55f4-4c29-b578-00e337eb9472"
      unitRef="usd">4500000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyFaultAllocationPercentage
      contextRef="ie6e2ff8e6f1647eea34f150435a9f641_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjEzNDg_6898cdb9-bee7-4942-ad91-c683edbe84c9"
      unitRef="number">0.13</mo:LossContingencyFaultAllocationPercentage>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ie6e2ff8e6f1647eea34f150435a9f641_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjE0Njk_204685fb-542f-4d97-98bd-b98b00b5a64a"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ie6e2ff8e6f1647eea34f150435a9f641_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjE0ODU_032f2c4a-bdc0-4c87-bb2c-573370edb6f1"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="idddcb5cec584482b801338bd316d77fc_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjE3MTA_089a28c2-fe10-435f-a4ba-51cf5aa0baab"
      unitRef="usd">8000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="idddcb5cec584482b801338bd316d77fc_I20220930"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjE3NDI_b30236b4-1cc4-416f-a86e-250f5fb7b0a7"
      unitRef="usd">1000000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ibc98656966dd42c4be583a6f2ed13108_I20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTI2NjA_27e2f8d1-9858-43d2-b896-b600e26c2039"
      unitRef="usd">11000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ibc98656966dd42c4be583a6f2ed13108_I20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTI2NjQ_d274439a-5e1a-4450-b8e0-e3a9ac0da7bb"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i1410b910eefc4178acdfe4b6ce022ff7_I20190930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTIxMDE_553b9aa9-a4fa-4339-a89c-9e5ce9b0be8a"
      unitRef="usd">10000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i5da32d8355b7469492d1e45bf26c92fe_I20200531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTIxMDU_31a526cc-6252-4e8d-b306-370d769a1efc"
      unitRef="usd">30000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ib879d27f5b6249628c06789bea384757_I20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTIxMDk_abf76bb3-64a4-4290-90a7-3eacc473d4f7"
      unitRef="usd">2300000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ic794e5582af74563b80ccb6479696bc2_I20000731"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTY1MDA_21d28cd1-156c-42c0-9606-63d2aa9150a3"
      unitRef="usd">145000000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ic921b407891d41a9a370b70f29dbbf7b_I20000731"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTY1MDQ_d0273843-9e22-402e-8f30-2c9e049fa1e2"
      unitRef="usd">74000000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants
      contextRef="i2ed199122dae41e0a7f040a1f16d427f_D20060701-20060731"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTY1MDg_df85d1be-5aa2-4757-84d8-baba32051bed">P1Y</mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants>
    <mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants
      contextRef="i2ed199122dae41e0a7f040a1f16d427f_D20060701-20060731"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTY1MTI_dca0ffe0-29be-4f2a-ac5d-655ef91aaeab">P1Y</mo:LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i181b032d3d8a4fb88a848af3798e1ca0_I20080131"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTk3Nzk_77157d95-642c-45a9-8221-4fda019adeb8"
      unitRef="case">9300</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i2c34362a468a45d08d7bbc1138e37393_I20230127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTk3ODM_51c27fea-53a3-49e0-b682-6baa01eecd9e"
      unitRef="case">612</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i28ee13b79369415fbc5464692b8c4285_D20230127-20230127"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNTk3ODc_33758b40-da01-4112-b7a3-132b9a1802d3"
      unitRef="plantiff">773</us-gaap:LossContingencyNumberOfPlaintiffs>
    <mo:LossContingencyClaimsDecided
      contextRef="ie5e034628af34ae3946be21b68ea8d0e_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQwNDE_c2723234-517b-449d-b301-bc0b6aada38a"
      unitRef="case">143</mo:LossContingencyClaimsDecided>
    <mo:LossContingencyClaimsDecidedUnfavorableNumber
      contextRef="ie5e034628af34ae3946be21b68ea8d0e_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQwNDU_944b943c-ff49-499f-9ef7-420c0320f284"
      unitRef="case">79</mo:LossContingencyClaimsDecidedUnfavorableNumber>
    <mo:LossContingencyUnfavorableVerdictsPendingReversed
      contextRef="ib9bfd24968014e2fbddf1581242c201e_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQwNDk_7dcb0186-56a4-4589-83e6-405c4202ce82"
      unitRef="case">7</mo:LossContingencyUnfavorableVerdictsPendingReversed>
    <mo:LossContingencyUnfavorableVerdictsPendingReversed
      contextRef="i62e4a46ab1a44e6fb47d8560c1b77cd8_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjIzOTc_7c45be98-9cc1-47d2-9d39-f17cc095fcba"
      unitRef="case">2</mo:LossContingencyUnfavorableVerdictsPendingReversed>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ie5e034628af34ae3946be21b68ea8d0e_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQ0ODM_9fdfeef4-ca35-4528-a6f4-72d53e250cd2"
      unitRef="case">56</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i7a03bc94992c4903bcda95a201871e01_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQ0ODc_6a46f112-b9d2-4223-863f-477a90276906"
      unitRef="case">46</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i7a32ea824fa14aaeb1265afa3e1edf01_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzY1OTcwNjk5OTIwODA_afc49a9e-c63f-4e0a-a769-a2e397ae451e"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyVerdictReversedNumber
      contextRef="i9840bd4343f941b0887d784405cd4d35_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQ5OTA_a724808f-fd64-4cf4-9954-e0e75c0d9b35"
      unitRef="case">3</mo:LossContingencyVerdictReversedNumber>
    <mo:LossContingencyZeroDamagesVerdicts
      contextRef="i180010a7918e4145a2f89842434e3987_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQ5OTQ_fd9d4d81-3200-4415-81ab-bdca23e47660"
      unitRef="case">2</mo:LossContingencyZeroDamagesVerdicts>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i180010a7918e4145a2f89842434e3987_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjQ5OTg_c34832f5-ab05-4a10-a9be-e3e7ae52cbd0"
      unitRef="usd">0</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:LossContingencyZeroDamagesVerdictModified
      contextRef="i24acb3f6bdc34dee9714f9a0917ffb23_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjUwMDI_b80b3489-908c-43c9-96b9-33f7fe3efc57"
      unitRef="case">2</mo:LossContingencyZeroDamagesVerdictModified>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i24acb3f6bdc34dee9714f9a0917ffb23_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjUwMDY_c56ae169-91dd-49ac-8a57-0e51c751868c"
      unitRef="usd">0</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i1fd53372d12948b586896dc1e7cfd9e2_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjUwMTA_6c502668-5a32-48fe-ac07-02a0caad374c"
      unitRef="case">1</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="ia6f75f0cc66b4f22a0d1523a7047668d_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjUwMTQ_76721486-cfdf-4531-9061-1161f3487a71"
      unitRef="case">3</mo:LossContingencyClaimsDecidedFavorableNumber>
    <mo:LossContingencyClaimsDecidedFavorableNumber
      contextRef="i883e5919c8b041b1b6877eaa2e7575d0_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNjUwMTg_09ce0b9f-5467-4e52-a746-53e1b5763b3e"
      unitRef="case">2</mo:LossContingencyClaimsDecidedFavorableNumber>
    <us-gaap:LossContingencyClaimsDismissedNumber
      contextRef="iea6390c8f234429087000381360f8e7c_D20230127-20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjI0MDE_972f8823-0e5c-4b88-abee-3a1dcae89d99"
      unitRef="claim">1</us-gaap:LossContingencyClaimsDismissedNumber>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i50e02c65827141c0988efa4815111343_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEtNC0xLTEtMjE0MDk0L3RleHRyZWdpb246ZmZmMDllYjI0YTRkNDc5MWJkZjk2MjViNTlhNWQxYTVfNDk0NzgwMjMyNTAzNg_d4dbf1bc-17f0-4a46-9507-3b4a77da12f0"
      unitRef="usd">5000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i17a02e89bb314f8e8d214c7bfda3ab4a_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEtNC0xLTEtMjE0MDk0L3RleHRyZWdpb246ZmZmMDllYjI0YTRkNDc5MWJkZjk2MjViNTlhNWQxYTVfNDk0NzgwMjMyNTA1MQ_25bd4940-d471-40b6-8118-5868bae9d27a"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i17a02e89bb314f8e8d214c7bfda3ab4a_I20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEtNS0xLTEtMjE0MDk0L3RleHRyZWdpb246NWU0ZjA5NTY0ZGRhNDkxY2E2YzBlZWMzZTI5YTJiMGRfNDk0NzgwMjMyNTAwMA_2019acad-8075-4aff-a6c6-e065f9a8cda8"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i6468ca3275ef46f8aa6c95127507afac_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246NTc1YTdlNjY1YTI1NGExMTkwNjI0MGFlYTdhZWQyNTFfNA_421d7949-37ec-40b5-989e-cb32c0f1cfaf"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i212ceaaf50b24da29b210c63ce60efc3_I20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEtNS0xLTEtMTg1OTM5L3RleHRyZWdpb246NmQ4YWJiNTFhYzVjNGFlMmFlMTllM2U1OTViMDIyNTRfNA_170c2745-728a-4c90-91f6-94b735bb46ef"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i920cf43da0b549b1bf36382047e4921c_I20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzItNC0xLTEtMTg1OTM5L3RleHRyZWdpb246NGRkNDkyZmIzYmUzNGQyNzgzYmNmZWE1MzcwMzI3OGFfNA_f67c9427-f219-42c3-9b98-fc64957ab5ee"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ief08e55c7da94618b141a0544e183c7a_I20220430"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzItNS0xLTEtMTg1OTM5L3RleHRyZWdpb246MzI2OGVhODg3ZGNlNGZjZjgwMTMzMjQ1NjY2YmUwNWZfNA_47acb683-0337-4534-aae7-0e0ab2cbef3f"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ie3c92225c6014643a39dde3972af7b95_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzMtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246NDVkZTc4MjNiYzM5NDM4YWIyYTI5MzYxZGU2MWVmNGRfNA_a0272f96-0402-443a-a117-c93b041a32fe"
      unitRef="usd">15000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ib0906996db114adb95e538086e4988cd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzMtNS0xLTEtMTg1OTM5L3RleHRyZWdpb246YzhlZWNlYmIxMjEyNGQyZDg3YjYzZWVjMzE1ZDI2NDlfNA_84bdb072-e623-4dc8-9c40-18357a7ea0b1"
      unitRef="usd">28000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i106eca6235c44aec9a053a8c1e1115f8_I20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzQtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246MjlkYTc3ZTEzN2VhNGQ5ZmJhZmRiODJmNTE2ZDY2YmZfMjE5OTAyMzI1NTU4Ng_886d838e-7962-4ae0-bf71-61b085246ac7"
      unitRef="usd">6000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i7875bd726b2c40cf94fdd162bfc1698e_I20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzQtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246MjlkYTc3ZTEzN2VhNGQ5ZmJhZmRiODJmNTE2ZDY2YmZfMjE5OTAyMzI1NTU5OQ_ed3d86bc-ce30-4bb4-b34d-81f7dacdb3d9"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i7875bd726b2c40cf94fdd162bfc1698e_I20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzQtNS0xLTEtMjAzNDc5L3RleHRyZWdpb246NTI5MTZiYjM3ZTI0NDEyYmFiM2M2YTZkM2E5NDY2ODRfMjE5OTAyMzI1NTU1OA_c14a6fb4-654c-4438-8c53-05863d7b6148"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i093d8c283e0149ac94dd94b7d960043e_I20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzUtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246YTI2NTBmYThkMmFiNDg1MGEyNmRmYWFhMDc4ZDY4NDJfNA_206a6b7c-8e73-4fac-98c8-07d5dcace950"
      unitRef="usd">3000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i3a7510ef6d624bce9a8bd3477d7ecbab_I20200229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzUtNS0xLTEtMTg1OTM5L3RleHRyZWdpb246YzA4MzIwMGJlNTBhNGFiNmFjMzhkN2UyMmIyZjBlNTVfNA_15a7d400-dbad-4f8d-9d74-e4602c7e7d86"
      unitRef="usd">12000000</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ie3f1fa8a229242798c2a8851ec2c6a7d_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzYtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246YzUwNTU0M2JlZjU2NDkxNTk4YTE2YWU5Y2EwNjgxNjVfNQ_f0d543d8-de26-41cf-92a0-e901c0f1648f"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i61bd7798d97b44e4905f83615d533665_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzYtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246YzUwNTU0M2JlZjU2NDkxNTk4YTE2YWU5Y2EwNjgxNjVfMTA_35997eab-ca40-43d9-b43c-fa37899b8186"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i61bd7798d97b44e4905f83615d533665_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzYtNS0xLTEtMTg1OTM5L3RleHRyZWdpb246YTg0OWUwMzNjOWMxNGZjNzlmYjM1ZDA3M2M2YTRjZWFfNA_9f4bac67-5ca6-4f8c-aa4f-9d59d5ffadc3"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i432f8c3944d94d3088537f50fc75eec0_I20180930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzgtNC0xLTEtMTg1OTM5L3RleHRyZWdpb246MjdlMTM4OTA5NTc3NGE5NDg5YjA2YmM1YTA1YTRlMjZfNA_50a13929-5341-4999-b83c-72fad59da5cd"
      unitRef="usd">2000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="ia21796e7b1304ee59df65a9e7a9c1ae7_I20180930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzgtNS0xLTEtMTg1OTM5L3RleHRyZWdpb246ZmUwNTE3M2M5YWExNGRiNmIwNjRkMDUyZWRlNTNiMmZfNA_9da0ac70-e6c0-4538-8914-458db64fbed2"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i5185e4c3850249389a06ab7914fe67e5_I20180731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzktNC0xLTEtMTg1OTM5L3RleHRyZWdpb246Yjk3ZDYyNzQ0ZDZiNDNjMmJmNWFkZjIyOTYxNTYyZmJfNA_1dfd9233-c33c-45f7-86c5-641ada0c0f5b"
      unitRef="usd">2000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i2c622465589840aa8eb67d8e00e12d37_I20180731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzktNS0xLTEtMTg1OTM5L3RleHRyZWdpb246NDY2ZGI2NmE1NGIwNDMzMmE5NmQxZjFlOGE4MjczNWNfNA_2cf9f435-2c0a-4984-adf3-3248ac5fd733"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="ic6a8429d2dfd4db9966a956a2a38a138_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEwLTQtMS0xLTE4NTkzOS90ZXh0cmVnaW9uOmM2YzFjYjE1ZTZlZTRmOWI5YTFjYTllNGZhOWQzY2RiXzQ_2001f162-dffc-4a8d-b7be-466ecd9706c9"
      unitRef="usd">5000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyCompensatoryDamagesAwardedValue
      contextRef="i242b075be0904eea86cd14974d4e88e9_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEwLTQtMS0xLTE4NTkzOS90ZXh0cmVnaW9uOmM2YzFjYjE1ZTZlZTRmOWI5YTFjYTllNGZhOWQzY2RiXzEw_911a050a-628f-4f5d-9c1c-f02482207d4d"
      unitRef="usd">1000000</mo:LossContingencyCompensatoryDamagesAwardedValue>
    <mo:LossContingencyPunitiveDamagesAwardedValue
      contextRef="i242b075be0904eea86cd14974d4e88e9_I20150930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTpmOTc4NTJhMjQzZTU0YmRiYjg4MzIzNWI0ZjM1YzUxZi90YWJsZXJhbmdlOmY5Nzg1MmEyNDNlNTRiZGJiODgzMjM1YjRmMzVjNTFmXzEwLTUtMS0xLTE4NTkzOS90ZXh0cmVnaW9uOmNmMjMyMzQ5MzQxYTRmMzY5MmRiOGJkNDU0YWQ5NTIyXzQ_4b5f90b7-a2ea-4793-a0da-f4162f9741b4"
      unitRef="usd">0</mo:LossContingencyPunitiveDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i349b39aa4db540d09dd8cf5fd4305c55_D20221201-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo2OTE1Y2NjMzQxOGU0ZDE5OWE0NGQzM2JhNzY1YzEyYi90YWJsZXJhbmdlOjY5MTVjY2MzNDE4ZTRkMTk5YTQ0ZDMzYmE3NjVjMTJiXzEtNS0xLTEtMjAzMzY1L3RleHRyZWdpb246MTNkNDYwZjMyNjRjNDAwZDlmNjgxZmU2OTI1N2ZiNjdfNDk0NzgwMjMyNTAwMQ_b4a23e39-88db-4619-9e85-163d08860e21"
      unitRef="usd">1000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i66f3170db2b54fe7b125a52f2d195e80_D20221001-20221031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo2OTE1Y2NjMzQxOGU0ZDE5OWE0NGQzM2JhNzY1YzEyYi90YWJsZXJhbmdlOjY5MTVjY2MzNDE4ZTRkMTk5YTQ0ZDMzYmE3NjVjMTJiXzEtNS0xLTEtMTg1OTM5L3RleHRyZWdpb246OTBhMzFlMjFmZGZmNDk1OThmZTljMTUxOTg0MGRiYmFfNQ_1d8e6ff4-5b16-459e-92b3-93f2844d510b"
      unitRef="usd">1000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i752ab2dec76b4648932ee8291c3fde30_D20220601-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo2OTE1Y2NjMzQxOGU0ZDE5OWE0NGQzM2JhNzY1YzEyYi90YWJsZXJhbmdlOjY5MTVjY2MzNDE4ZTRkMTk5YTQ0ZDMzYmE3NjVjMTJiXzItNS0xLTEtMTg1OTM5_a5c97709-d77f-4158-b95a-6d8e19bdd10d"
      unitRef="usd">2000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i775477992d5148ffb8ac99f47908d6e1_D20230101-20230131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo2OTE1Y2NjMzQxOGU0ZDE5OWE0NGQzM2JhNzY1YzEyYi90YWJsZXJhbmdlOjY5MTVjY2MzNDE4ZTRkMTk5YTQ0ZDMzYmE3NjVjMTJiXzQtNS0xLTEtMjEzMzQw_f72830f0-23a9-4847-b05a-cd2a6e5bc3ab"
      unitRef="usd">3000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="ied8a6482d8d842548874153fd3412d3a_D20220801-20220831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90YWJsZTo2OTE1Y2NjMzQxOGU0ZDE5OWE0NGQzM2JhNzY1YzEyYi90YWJsZXJhbmdlOjY5MTVjY2MzNDE4ZTRkMTk5YTQ0ZDMzYmE3NjVjMTJiXzMtNS0xLTEtMjAyNjEy_0e09ce6b-fa03-4f6c-b8cb-555a308ffb55"
      unitRef="usd">5000000</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:MaximumBondForAllDefendants
      contextRef="i2e77f2f208294f938fb2ec43209eee70_I20090630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzQzMjc_7f918198-ff40-4a29-8d3e-f3b5f09ec1f0"
      unitRef="usd">200000000</mo:MaximumBondForAllDefendants>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i2b527c47e5014c0aaaf9b0b067634552_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzMjI_18235942-2b1a-4f21-9cbf-512fd5ae8e57"
      unitRef="case">61</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ic10ea316eb6a47e48c3e53b43b03e6d0_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzMjY_59c026ea-4258-4a33-8dad-1066f3417c6a"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i4929a66b8e9b49248e19eec92e781436_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNDI_11cd2e47-8bdf-4275-b1d9-df51e269e545"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i85f3e34a436d46d0a07b5548c997598c_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNDY_c0ca1f31-0b26-4432-9032-d8644ff1b14e"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i1741852180994ef68345036762c17998_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNTg_d42b1239-1aba-4fc8-889e-6fb64151b3d6"
      unitRef="case">2</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i801ebabf38fa441fb2d94c6e67e28052_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNjI_23b39ca8-9462-41a4-b61b-bb7caf6e7486"
      unitRef="case">2</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="iff317a61814e4db486d1db5fda1f4175_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNjY_c45a4e4a-a418-4781-833a-49ee3360952d"
      unitRef="case">3</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i5febaca0c6254dfabb955e0c0034af5d_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNzA_53ced588-7d6d-4046-81a9-14f82247d574"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ia46c676221664155b20176ae820f2c18_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNzQ_acc74a6b-016c-4588-89c5-b7f1ea84ccd1"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i8f12e85e557c4736862707aa26443eef_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzNzg_b7fd60c1-7046-4f52-b69e-6f9aeda9e075"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ib411bb4ee3f347218c4a11fe8e17f6ac_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzODI_f61d3625-5a4c-4466-b027-d34a37587b50"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i0a370a52cb634e1b887970e51ba3eea2_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzODY_8d73b3a7-0b10-4442-b363-5913f995e51d"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i3a9aa66dc8c8499e838fe36896f6146e_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzOTA_7fb99280-8c09-4581-8ece-821652c1416f"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i884defb8144d483985e98d3102cad8d6_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzOTQ_16552e57-b3e4-40a1-b2ef-923b23c857c7"
      unitRef="case">29</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i30284ad3aca0439787bbaef52a3ee87b_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzYzOTg_10c5ffd4-4ca5-4844-91c3-c77f7c12625f"
      unitRef="case">6</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i598983dcf5714194acc23ab021d7b890_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MDI_53908a19-ce93-491c-877f-1bd9abf9ec01"
      unitRef="case">2</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i3a8278fb3e23470e99b558bec8b8e1c3_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MDY_d4676613-4173-4b4b-8263-5c01fabce30f"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ib90545ee4e794ecd86a7d962993031ae_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MTA_3cb6e0ed-8fcc-46e3-a2ee-1817efc8100e"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i0ce7548765b949efaad6025a7bb2d39a_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MTQ_ff83f0a5-f1ad-4b06-88bf-c5df613a5d25"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="if235e66a71fb40bb80e9a57ea20e104a_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MTg_3c3179f9-5362-4493-b8f8-c6202b58ea0f"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i1a0cae0d945242f9add4c95a9f783fff_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MjI_abfb327b-5a04-4757-957c-10e498d8aca9"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="i6e96ff7dfa4f4e3bbd38467b869c2b09_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MjY_8ec1e4d5-9ac2-4e1d-a737-7c89492b9c8b"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="ib94a2498fbec415da80b4378db2c49aa_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MzA_7818a12b-cb4e-4498-9f20-c9e87717acda"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <mo:LossContingencyClassNotCertifiedNumber
      contextRef="id201aa07137345cc9031fe7687fb9aa8_D19960501-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzY0MzQ_4cd086a2-3068-4f0b-97b1-94e4b366af3b"
      unitRef="case">1</mo:LossContingencyClassNotCertifiedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i78854af3be924b238c97cf0018613bd5_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzg0NTQ_22672022-0114-4191-b34c-a28c8811dcfa"
      unitRef="case">7</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i8c3e60acf54840d5823064246d8f4255_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzg0NTg_be6fe49f-7df4-4295-a242-1351f5303f29"
      unitRef="case">2</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofManufacturers
      contextRef="i47f7028016ec4a9ca7c5da65de1c31cd_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzg0NjI_099f5d13-4710-40da-b5ea-5e944c458fdf"
      unitRef="manufacture">3</mo:LossContingencyNumberofManufacturers>
    <mo:LossContingencyVerdictsUpheld
      contextRef="i47f7028016ec4a9ca7c5da65de1c31cd_I20190331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzg0NzA_1c751b8c-b4d4-4803-ba8a-3b3833b83f94"
      unitRef="ruling">2</mo:LossContingencyVerdictsUpheld>
    <mo:AmountAwardedtoOtherParty
      contextRef="i559c9c5248e14c7eac616a9c6e9b88ba_D20190301-20190331"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzNzg0NzQ_63e14248-109a-402f-82f2-3fa33ea002dc"
      unitRef="cad">13000000000</mo:AmountAwardedtoOtherParty>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="iad62c741cfb14a10b14ba7e8f787e007_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODM2ODY_a92d4149-0981-4c17-8f58-691d9aaa755c"
      unitRef="case">10</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberofManufacturers
      contextRef="iea22c49cbb364016b9be8082d98ec8b5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODM2OTA_4461619b-a9a4-407a-adb6-62197e752882"
      unitRef="manufacture">3</mo:LossContingencyNumberofManufacturers>
    <mo:LossContingencyNumberofStateswithSettledLitigation
      contextRef="i748c02005b4a4bf49a0612b63989ef03_D19981101-19981130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODY4MjA_a0372f87-b335-46ce-b7ea-b4b9d489a9f9"
      unitRef="state">46</mo:LossContingencyNumberofStateswithSettledLitigation>
    <mo:LitigationSettlementAnnualPaymentAmount
      contextRef="i748c02005b4a4bf49a0612b63989ef03_D19981101-19981130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODY4MjQ_4c137a5b-4a1b-43a0-854d-bc4e8cdafa86"
      unitRef="usd">9400000000</mo:LitigationSettlementAnnualPaymentAmount>
    <mo:LitigationSettlementAnnualLegalFeesPayableMaximum
      contextRef="i5d208e527e4342e8a6fed1e96302bed1_I19981130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODY4Mjg_e058f41b-9ca1-48d2-9d6c-9f557651ba0f"
      unitRef="usd">500000000</mo:LitigationSettlementAnnualLegalFeesPayableMaximum>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i387d404d62a74acc8f6dbf3b7be9ca4b_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0ODEwMjU_02b45b49-b102-42be-8c3a-4aac91b383f7"
      unitRef="usd">3900000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i3d696721355c4cda96236197d43ab89a_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjcwMDg_f7257e98-8778-4433-b071-7def017f11bf"
      unitRef="usd">4300000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i051656e6a1684bfba293e4a15343ded2_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjcwMjQ_5e2f8b7f-08f3-4c16-9de0-e371693ba29e"
      unitRef="usd">4400000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i2b29a936696b409788862a00b0672af2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0NTU_37418176-575a-4ee5-a899-0854652077a8"
      unitRef="usd">388000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="ib9c6e2186f1e45e786df72e8ee7ec3d3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0NTk_a13d9f24-f52a-4c28-8c4c-db65d399a0de"
      unitRef="usd">181000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i5a685c7dcd494128be51e43eb85380b3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0NjM_dfc27b20-5194-4bb7-b16a-f4add84c1f19"
      unitRef="usd">154000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i79ad3a1e3b8a4470a7aca27a30ad959d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0Njc_a0807881-4a32-48bb-99bd-5d8644132fe8"
      unitRef="usd">185000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i7c1a43c0fecf4f50ae6cebda59c8b404_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0NzE_e8e8d2a2-4c3b-4773-9709-2a15cb4b2e46"
      unitRef="usd">250000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i3976df847f6a4da191d1961d8126013e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0NzU_3752b3c9-d6b4-42bc-ae39-bec02afca601"
      unitRef="usd">211000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="ic6602bcb2e70449fa757d0cf969d2e2a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0Nzk_0f4ece14-2aa3-419a-b47b-69e26d6e7c4c"
      unitRef="usd">218000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="if70775d7ed4d4bba9b45ad323909f03d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0OTA_565860b0-e5fe-4096-9475-37276a6bca25"
      unitRef="usd">166000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="ie9402356363b4f8f9a3867eb8211b078_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0OTQ_a6e1f8fb-674b-4bba-b90a-304a9e033c0e"
      unitRef="usd">214000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i3b4691fe3b4e4dd7b23e74d90e241e1d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk0OTg_3deae15c-cfbc-43a3-987e-414a0f29d25f"
      unitRef="usd">224000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i9e03b7ae06ec4c8aba2fd2c946767067_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk1MDI_0d971b12-5a30-4de4-b525-1115db42a25c"
      unitRef="usd">258000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i1b55d65103bd48adbcfb2b0e11d8d4b1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk1MDY_c6e287cd-582c-4c3b-9b6c-ecf2c9194c71"
      unitRef="usd">313000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i4b8c44a5cad54a2f947e060d3352f19d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk1MTA_3ce52ab6-cbce-441f-827b-863afeccc707"
      unitRef="usd">292000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="ie4513fc58c994ac2900d640a3a2b33fd_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk1MjE_957368af-3910-47ea-9463-2e91d2fef301"
      unitRef="usd">285000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="iaf7e83849a514def895afca19a8dbf72_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk1MjU_1425ed75-d208-4efe-8be2-73f54dd1c0cf"
      unitRef="usd">318000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="ic1bcaad299794ce9a240e8f403e0a7cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzODk1Mjk_08a2963b-2e01-4499-85ee-e48a8aa4d408"
      unitRef="usd">415000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i9d5e76cb93d64980a7da87f32e2ef279_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ5NjI_59e37bc7-f612-4190-b11f-b1b81f27a32d"
      unitRef="usd">573000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LitigationSettlementEstimateofPossibleGain
      contextRef="i856b71c11be3464788fa35e57b23b454_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQxNzM_db6f6199-991f-4ea4-a756-de5d0c4cb431"
      unitRef="usd">635000000</mo:LitigationSettlementEstimateofPossibleGain>
    <mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne
      contextRef="i2e156f0ff61c4547b064d2b367b1b8ae_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyMjM_a828a0ae-9323-44dc-a94f-dfa40485c81b"
      unitRef="state">36</mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne>
    <mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation
      contextRef="i2e156f0ff61c4547b064d2b367b1b8ae_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyMjc_2b7db042-0b26-4d74-bb73-6653f1599aab"
      unitRef="state">35</mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation>
    <mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne
      contextRef="i2e156f0ff61c4547b064d2b367b1b8ae_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyMzE_d191c04b-999e-4367-9914-f6fd44748250"
      unitRef="state">36</mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne>
    <mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation
      contextRef="id9f929366f9c4db99fbbe7cc0765d8e2_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyMzU_7c3290fe-8125-488a-b4e2-4aed3be2dca7"
      unitRef="contract">1</mo:LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation>
    <mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne
      contextRef="ie91a77817ecc4e999d0370e2c9318a18_D20220301-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzQ5NDc4MDI1NTQ2Njg_0c923d73-de7a-4f0c-98de-9910d5fb3bf9"
      unitRef="state">37</mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="ic3eb37f4a9f84da6819684970ef73356_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQyMjM_181ac755-5746-4aac-bd71-c74a1a719e35"
      unitRef="usd">80000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="if1a23e3497624a1fa46068cc25ed067e_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQyNDI_23751b4b-eabf-41c5-9b5c-c55fcf75572a"
      unitRef="usd">20000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i3cdb4695c4e249cea22489ca33dd31a2_D20220101-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQzNjg_55687536-432c-4068-8c7f-5ae0cc8d52f0"
      unitRef="usd">80000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="ic1705ce2bbd441deaa21faea57603e06_D20180101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyNDA_5c8be469-c370-4a02-8ecf-45a938caae67"
      unitRef="usd">1150000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <mo:LitigationSettlementAmountExpectedToBeAwardedFromOtherParty
      contextRef="i2424508abe914dc19477786edb09c233_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyNDQ_8be924ce-8a97-4b2a-9b0b-25a4740dd1b8"
      unitRef="usd">410000000</mo:LitigationSettlementAmountExpectedToBeAwardedFromOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i466ccb5c286b4d9d83b198edeb139479_D20150101-20151231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyNDg_5337f39c-31ad-481d-9f1c-3dd74ee092eb"
      unitRef="usd">435000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i9401b496918446c4a0bd9291e50c1846_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTIyNTI_ec323221-252d-4d96-b67e-f38b8c827a15"
      unitRef="usd">4000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="i6e30d0f16c0e4fffb6403230045d3122_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ2ODY_56b64f98-1b35-4ab4-8f11-5edb4ef1ccbf"
      unitRef="state">9</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesWithConcludedHearings
      contextRef="i308b4161cd2a4761bbf2bbbea9a5b94d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTYyNDA_c3051cf3-181c-4224-83c0-65980ebdd789"
      unitRef="state">9</mo:LossContingencyNumberOfStatesWithConcludedHearings>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="i308b4161cd2a4761bbf2bbbea9a5b94d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTYyNjc_20c1edf4-2be5-4932-b3d3-3171b13632e5"
      unitRef="state">10</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues
      contextRef="i6e30d0f16c0e4fffb6403230045d3122_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTYyNzE_4b383ef3-8f81-4a74-9696-3ae054645cfe"
      unitRef="state">3</mo:LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues>
    <mo:LossContingencyNumberOfStatesInComplianceWithEscrowStatues
      contextRef="i6e30d0f16c0e4fffb6403230045d3122_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTYyNzU_ae83a79a-092d-47d7-8a70-cc0c4df98821"
      unitRef="state">7</mo:LossContingencyNumberOfStatesInComplianceWithEscrowStatues>
    <mo:LossContingencyReductionToCostOfSales
      contextRef="ifdda8a2cdb9d4db49e9b2c4177d9a7de_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTYyNzk_f6751872-34da-468e-8585-58e374e99074"
      unitRef="usd">21000000</mo:LossContingencyReductionToCostOfSales>
    <mo:LossContingencyReductionToCostOfSales
      contextRef="i100852d80e724c41bb97050a1799cd82_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzQ5NDc4MDI1NTMyMTk_896e202f-70eb-4ad9-8117-b1a94985db31"
      unitRef="usd">3000000</mo:LossContingencyReductionToCostOfSales>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="ia4a2cae32e3e4d64a9d5bfb3d5339a57_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTYyODM_78234710-b4d8-46d1-bbaa-53962964d39d"
      unitRef="usd">23000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i57b16d217ed6412e9b51c342626023ec_D20221001-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzQ5NDc4MDI1NTMyMDQ_2f2d388e-2caf-4726-8577-9fa7e06bc8ba"
      unitRef="usd">5000000</us-gaap:LossContingencyDamagesSoughtValue>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="i2ae59e3f662b40c2bd1cc8bfca42f60c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTc3NTc_f589da05-ee95-4f94-b17a-435e9e32e652"
      unitRef="state">9</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod
      contextRef="ifd6ed63b9bb24769bbb2b79d9903289a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzYwNDczMTQxNjQyMjE_cba891df-9345-4025-bd0e-9a31227579a6">P3Y</mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="ifd6ed63b9bb24769bbb2b79d9903289a_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTc3NzE_d5771178-0582-4228-b3f2-554c6ce078bd"
      unitRef="state">8</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="i2ae59e3f662b40c2bd1cc8bfca42f60c_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTc3NzU_676ff725-95c2-4ebf-988e-ec0a2ddd0ad9"
      unitRef="state">9</mo:LossContingencyNumberOfStatesNotSettled>
    <mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod
      contextRef="i9531c54ce48540a0a0550471e1cd3afe_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzYwNDczMTQxNjQyMjI_2fe88029-8ad5-41c2-9a01-c79f46c676ee">P1Y</mo:LossContingencyNumberOfStatesNotSettledArbitrationPeriod>
    <mo:LossContingencyNumberOfStatesNotSettled
      contextRef="i9531c54ce48540a0a0550471e1cd3afe_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjMzOTc3ODg_0fd22e16-9cd0-4775-a7c8-a2f166ac6716"
      unitRef="state">1</mo:LossContingencyNumberOfStatesNotSettled>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i4b5ad462b1fc42e3875caf97f2673a92_D20220701-20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ2OTE_b9a9c3e1-fa20-4532-b7a7-5a1e01dae923"
      unitRef="usd">133000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="ia8b742921dc34dc6b5591b065363c15b_D20220701-20220731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0ODEwMDc_0e498933-4ea8-48e1-aca4-956c216ad979"
      unitRef="usd">84000000</us-gaap:LossContingencyDamagesSoughtValue>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i0dedfe3526ab465c89c9b8e67c3357a8_D20210101-20210131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MDA5ODg_9ee5bfc9-8640-4b82-93af-c38540b13da2"
      unitRef="usd">32000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <mo:FederalTradeCommissionDisclosurePeriod
      contextRef="i0121b4c1497c443b91a2dbe5a6049059_D20060801-20060831"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MTA0Njc_2ceff658-c44c-4492-9729-992bed510066">P10Y</mo:FederalTradeCommissionDisclosurePeriod>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i29611429f47b4962bf5216deebdd1a1c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0ODA5ODg_fe318a1e-5bb1-4a22-a4d1-4f32490cbe7f"
      unitRef="usd">28000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ib515c9531f2c406b96d8ed470cbe6eeb_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MTc4ODY_b42e4511-408f-4268-9d3b-47aeb93e1d49"
      unitRef="claim">57</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ib515c9531f2c406b96d8ed470cbe6eeb_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MTc4OTA_8bf509b0-0458-4da4-9f04-0722d852dda7"
      unitRef="claim">57</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber
      contextRef="ife1f1236593440dba4fa286c4568aa13_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MTc4OTQ_7b6a0526-c7f3-42de-ac71-877085453fc2"
      unitRef="case">32</mo:LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i40d0f2ac213e404c8089cdf43889f21f_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ2OTY_1730a22f-d5e4-4cb2-91e9-0aef9fd18599"
      unitRef="claim">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i2494dd141e354811b038c1301f7dda49_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MTkyODI_cca2b514-171b-4cf9-88e1-321acfd2b164"
      unitRef="claim">3870</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i1be89cf9f8b449fdac3da2c8fca7d5cf_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MTkyODY_096270e6-9e76-4079-b5ae-991c8a36988d"
      unitRef="claim">1406</us-gaap:LossContingencyPendingClaimsNumber>
    <mo:LossContingencyNumberOfCasesWithSetTrialDates
      contextRef="i9e946456b537477688ee4ce352a20446_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIwODkwNzIxMTQ1NzQw_4294cafd-94c5-41f6-aaa0-c03cda743923"
      unitRef="case">3</mo:LossContingencyNumberOfCasesWithSetTrialDates>
    <mo:NumberOfThirdPartyLawsuits
      contextRef="i3c7b5b8168e84e9f97ec53935f0e23bc_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MjQ1Njg_6501fca1-5b54-4909-9e0a-f0fefeec06a5"
      unitRef="lawsuit">4</mo:NumberOfThirdPartyLawsuits>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i34620bbc337b4ce2b6567ee643c5068f_D20220901-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ3MDg_b4448f56-435c-49bd-9e92-3e891f5c48e5"
      unitRef="usd">95000000</us-gaap:LossContingencyDamagesAwardedValue>
    <mo:LossContingencyRoyaltyFeePercentage
      contextRef="i07a9a17fedcf4c82a8a6872d1e854c64_I20230131"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzQ5NDc4MDI1NTQ1Nzk_11e8d139-8a15-40be-a6b4-7139e5fe0a25"
      unitRef="number">0.0525</mo:LossContingencyRoyaltyFeePercentage>
    <mo:LossContingencyDamagesRecoverableValue
      contextRef="i9130d99afc484bd7b97086bb83a18185_D20200401-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0Mjg5MTQ_6f41fc52-8e0d-439d-940d-5a81b76d0b79"
      unitRef="usd">0</mo:LossContingencyDamagesRecoverableValue>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage
      contextRef="i29da272e87c54a8cbab18821615bf146_I20200430"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MzYwOTY_09b41661-8b95-46f0-b2fd-8caafd35eee7"
      unitRef="number">0.35</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage>
    <mo:LossContingencyClassActionLawsuit
      contextRef="i49aa85e7288f4015a2cf251ad1ad3d1b_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MzYxMDE_c564c2d2-0396-43ea-b34c-459ad59e0ef7"
      unitRef="lawsuit">17</mo:LossContingencyClassActionLawsuit>
    <mo:LossContingencyNumberOfComplaints
      contextRef="i0d928ac82a174cbf9e654bf008eb8b4f_I20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0MzYxMDk_21e0f7db-e084-4ea5-8de0-c838614fce8f"
      unitRef="complaint">3</mo:LossContingencyNumberOfComplaints>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="i9fd12ffe6e314078bec64fc03dd0d7cf_D20220201-20220228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ3MTM_fc4fc91e-e381-4e8d-a911-49ac32fdaa2d"
      unitRef="claim">4</us-gaap:LossContingencyNumberOfPlaintiffs>
    <mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue
      contextRef="ia1ab966a566641208dea895e36c2cfca_I20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ3MTc_fe5c1de0-694d-4099-85e5-8ede649668a6"
      unitRef="number">0.10</mo:EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue>
    <mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits
      contextRef="ibf8ee6d0a42b48658f65843e7407c4ff_D20191001-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDE3OTg_ac666a67-b291-4898-8533-008e7238c4af"
      unitRef="shareholder">2</mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits>
    <mo:LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding
      contextRef="ibf8ee6d0a42b48658f65843e7407c4ff_D20191001-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzQ5NDc4MDI1NTQ2NjA_6a6cc4ad-c0ee-4a82-9592-3fafb6b37e67"
      unitRef="lawsuit">2</mo:LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty
      contextRef="i5714b7cd4a1f4abbba5201ba8cc74bb1_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDE4MDY_05cc7cf9-ce82-4825-8be9-5245cb060ed2"
      unitRef="usd">90000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDE4MTA_1d93c8dc-d6aa-44a9-af2e-67762a82ae80"
      unitRef="usd">90000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:PaymentsForLegalSettlements
      contextRef="idd1d6e0639ad44f8812ae1cf1e390bc8_D20220101-20220131"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDE4MTQ_366aae3f-1579-4cb4-a4c8-41d7705d0804"
      unitRef="usd">90000000</us-gaap:PaymentsForLegalSettlements>
    <mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits
      contextRef="i37dc803167004d3bbbf661d9a1d012d3_D20200801-20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDY4OTk_35c10be8-359b-4e19-93d0-05db4893182b"
      unitRef="shareholder">2</mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits>
    <mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits
      contextRef="ibeb9e2bf525e43c0844f2e9fb73929c9_D20201001-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDY5MDM_9d0a7f19-f9df-43e6-afe5-5aeb4ff0579e"
      unitRef="shareholder">3</mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits>
    <mo:LossContingencyNumberOfPendingCasesConsolidated
      contextRef="i9899ddfb78b54d8ea14e76f8bf786983_D20210401-20210430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDY5MDc_13e50659-6022-47ed-a127-e7927146fdee"
      unitRef="claim">5</mo:LossContingencyNumberOfPendingCasesConsolidated>
    <mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits
      contextRef="i8e0525ef8d214791974c2ec1841b3475_D20200901-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NDg0NDc_793e45be-2779-44ea-b042-f0532e85c066"
      unitRef="shareholder">6</mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits>
    <mo:LossContingencyNumberOfPendingCasesConsolidated
      contextRef="id4bcc98934df473da5c7057ee93151ab_D20210701-20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzQ5NDc4MDI1NTQ1ODg_ce0efc3b-ed27-44ed-8fa1-05f5d0b70a22"
      unitRef="contract">5</mo:LossContingencyNumberOfPendingCasesConsolidated>
    <mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits
      contextRef="i8e0525ef8d214791974c2ec1841b3475_D20200901-20210831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NjQ3MjE_7387295e-de8d-40b8-aefa-555ebbc4b333"
      unitRef="shareholder">6</mo:LossContingencyNumberOfShareholdersFilingDerivativeLawsuits>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i4e17d631770e4e10909a4da8d0cf445c_D20220401-20220630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIwODkwNzIxMTU1MjMz_2ab69480-77fd-4874-91eb-977731ad3856"
      unitRef="usd">7000000</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i308dd7b8074947108716f905d87a8f98_D20220701-20220930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIwODkwNzIxMTU1MjQx_e33e160b-0146-49a5-9038-f8b0bee21ea6"
      unitRef="usd">20000000</us-gaap:LossContingencyAccrualProvision>
    <mo:LossContingencyClaimsNotCertifiedNumber
      contextRef="i3ae0d3b51df54bbe8b1959b343c21c55_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTE3MjE_b9b7ae22-71b3-454d-b4a2-c1ffeefa5272"
      unitRef="case">23</mo:LossContingencyClaimsNotCertifiedNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i3ae0d3b51df54bbe8b1959b343c21c55_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTE3MjU_4e4f9303-ddd1-4654-80f0-b70eeab1eeed"
      unitRef="court">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i00d5a42df39d4763984da38514c7252f_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTE3Mjk_68038c63-f1c9-4e27-b678-d9bb034b4030"
      unitRef="claim">1</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i0a6cd34d91d14705933337c9bba7c38c_I20230127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTMzMjI_c0765a3d-c3bb-4f83-9a7a-eeed7e65e329"
      unitRef="contract">0</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5809327a200e4dd292baa4729e1d7e5a_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTkzNjA_2b099e16-69ef-4f21-9ffe-8197ff2aa6b8"
      unitRef="usd">46000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:GuaranteeObligationsMaximumExposure
      contextRef="i1a2f8d49dba342ea92dd045738411af3_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTkzNjQ_40b789f1-18f3-4feb-9e68-2818fed24f12"
      unitRef="usd">19000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i19c2fc24e57144deb2090322db5badc1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xNzIvZnJhZzo3YzhkNTVhMzk2NmI0YzhkYjczMDVkYWU0MDQ4MTJkMy90ZXh0cmVnaW9uOjdjOGQ1NWEzOTY2YjRjOGRiNzMwNWRhZTQwNDgxMmQzXzIxOTkwMjM0NTkzODA_f8c4773a-17af-4eaf-9989-41b6345d6b31"
      unitRef="usd">3000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <dei:AuditorName
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xOTMvZnJhZzoyOTcxZGRlZWQ2ZTY0ZGYzOTlmZDQxZTdmMDZiMTVlNi90ZXh0cmVnaW9uOjI5NzFkZGVlZDZlNjRkZjM5OWZkNDFlN2YwNmIxNWU2XzE2NjU5_8472f1a7-b56f-481d-bcda-686ff657238e">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8xOTMvZnJhZzoyOTcxZGRlZWQ2ZTY0ZGYzOTlmZDQxZTdmMDZiMTVlNi90ZXh0cmVnaW9uOjI5NzFkZGVlZDZlNjRkZjM5OWZkNDFlN2YwNmIxNWU2XzE2NjYx_d1aa9f8c-31e1-4fb3-928b-1497c8f1b4b8">Richmond, Virginia</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl8yMjkvZnJhZzo1MDgyZmU1YWZlMTA0NjE2OWM3Nzg3NzkzOWE3NmUwNS90YWJsZTowMTA4NjhkMjQ5ZDE0ZjY0YTk2ZTRmZmI0NmRlMDBlYS90YWJsZXJhbmdlOjAxMDg2OGQyNDlkMTRmNjRhOTZlNGZmYjQ2ZGUwMGVhXzEzLTAtMS0xLTE4NDQ2OS90ZXh0cmVnaW9uOjYyM2QxZjI4M2FlOTRlZDU4OTA4YWQxZDgwZDU5MzFiXzcw_f6dfff66-6e5e-4081-b428-35b539e87494">238</dei:AuditorFirmId>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtNS0xLTEtMTg0NDY5_a9b18782-5660-4b57-b202-a8053be6f4c3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtNS0xLTEtMTg0NDY5_a9b18782-5660-4b57-b202-a8053be6f4c3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtNy0xLTEtMTg0NDY5_c7daf6b9-586d-40ab-8e8a-700555c64c11"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtNy0xLTEtMTg0NDY5_c7daf6b9-586d-40ab-8e8a-700555c64c11"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtMy0xLTEtMTg0NDY5_3a1de55c-c8c1-4c0e-8b80-3f95381a1678"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtMy0xLTEtMTg0NDY5_3a1de55c-c8c1-4c0e-8b80-3f95381a1678"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE4_025e2d0e-4c97-4f92-9795-be87a61ae169" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE4_025e2d0e-4c97-4f92-9795-be87a61ae169" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">2020 primarily reflects inventory-related amounts associated with the wine business strategic reset.  For further discussion, see Note 14. <xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtNS0xLTEtMTg0NDY5_a9b18782-5660-4b57-b202-a8053be6f4c3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE4_025e2d0e-4c97-4f92-9795-be87a61ae169"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtNy0xLTEtMTg0NDY5_c7daf6b9-586d-40ab-8e8a-700555c64c11"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE4_025e2d0e-4c97-4f92-9795-be87a61ae169"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjQtMy0xLTEtMTg0NDY5_3a1de55c-c8c1-4c0e-8b80-3f95381a1678"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE4_025e2d0e-4c97-4f92-9795-be87a61ae169"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtNy0xLTEtMTg0NDY5_e3c8c0cf-ff28-47dd-942f-6deb723d66cc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtNy0xLTEtMTg0NDY5_e3c8c0cf-ff28-47dd-942f-6deb723d66cc"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtNy0xLTEtMTg0NDY5_ad63cc97-ce3c-481c-866d-8a031b1a48df"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtNy0xLTEtMTg0NDY5_ad63cc97-ce3c-481c-866d-8a031b1a48df"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtMy0xLTEtMTg0NDY5_b171074d-301b-42c8-91ac-1761bf0b46a0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtMy0xLTEtMTg0NDY5_b171074d-301b-42c8-91ac-1761bf0b46a0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtMy0xLTEtMTg0NDY5_a263de0c-6587-42c8-9396-b995575984e6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtMy0xLTEtMTg0NDY5_a263de0c-6587-42c8-9396-b995575984e6"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtNy0xLTEtMTg0NDY5_fc7e4d1a-9a22-49f0-8d42-310f8fdd2f5e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtNy0xLTEtMTg0NDY5_fc7e4d1a-9a22-49f0-8d42-310f8fdd2f5e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtNS0xLTEtMTg0NDY5_1bfff92b-7dd4-4099-b50a-3f753ee343cc"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtNS0xLTEtMTg0NDY5_1bfff92b-7dd4-4099-b50a-3f753ee343cc"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktNy0xLTEtMTg0NDY5_cdf2c1f2-effa-4703-ad59-804c05c64b84"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktNy0xLTEtMTg0NDY5_cdf2c1f2-effa-4703-ad59-804c05c64b84"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtNS0xLTEtMTg0NDY5_9dfffa66-533d-4eff-b94f-6216b81ff55e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtNS0xLTEtMTg0NDY5_9dfffa66-533d-4eff-b94f-6216b81ff55e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtMy0xLTEtMTg0NDY5_69d4bbfd-3c54-4f6f-ac43-def57bedc3b7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtMy0xLTEtMTg0NDY5_69d4bbfd-3c54-4f6f-ac43-def57bedc3b7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtNy0xLTEtMTg0NDY5_203d2fd6-57a4-4f03-aa3d-ed9e380ed56e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtNy0xLTEtMTg0NDY5_203d2fd6-57a4-4f03-aa3d-ed9e380ed56e"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctNy0xLTEtMTg0NDY5_2c9b888b-a91a-4bea-9f45-859a4eda9baa"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctNy0xLTEtMTg0NDY5_2c9b888b-a91a-4bea-9f45-859a4eda9baa"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctMy0xLTEtMTg0NDY5_8deaca41-7c96-4e8c-8385-7e467740c77a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctMy0xLTEtMTg0NDY5_8deaca41-7c96-4e8c-8385-7e467740c77a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtMy0xLTEtMTg0NDY5_355d473f-1333-4c41-ad67-1e1351abf2c5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtMy0xLTEtMTg0NDY5_355d473f-1333-4c41-ad67-1e1351abf2c5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctNS0xLTEtMTg0NDY5_759a87d9-5197-4bf2-9a65-5f2c98ba7823"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctNS0xLTEtMTg0NDY5_759a87d9-5197-4bf2-9a65-5f2c98ba7823"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtNS0xLTEtMTg0NDY5_3bf7ef4a-bd0c-4bcc-9072-5628558babb3"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtNS0xLTEtMTg0NDY5_3bf7ef4a-bd0c-4bcc-9072-5628558babb3"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktMy0xLTEtMTg0NDY5_8b5b42d2-4b81-456b-8339-13cab0197645"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktMy0xLTEtMTg0NDY5_8b5b42d2-4b81-456b-8339-13cab0197645"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtNS0xLTEtMTg0NDY5_db920e2e-633f-4ad1-8b1a-005b5fce5b06"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtNS0xLTEtMTg0NDY5_db920e2e-633f-4ad1-8b1a-005b5fce5b06"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktNS0xLTEtMTg0NDY5_4ec58889-7557-43b6-82b5-7dc591b1be87"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktNS0xLTEtMTg0NDY5_4ec58889-7557-43b6-82b5-7dc591b1be87"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">2021 amounts reflect changes from operations for Ste. Michelle prior to the Ste. Michelle Transaction.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtNy0xLTEtMTg0NDY5_e3c8c0cf-ff28-47dd-942f-6deb723d66cc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtNy0xLTEtMTg0NDY5_ad63cc97-ce3c-481c-866d-8a031b1a48df"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtMy0xLTEtMTg0NDY5_b171074d-301b-42c8-91ac-1761bf0b46a0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtMy0xLTEtMTg0NDY5_a263de0c-6587-42c8-9396-b995575984e6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtNy0xLTEtMTg0NDY5_fc7e4d1a-9a22-49f0-8d42-310f8fdd2f5e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTgtNS0xLTEtMTg0NDY5_1bfff92b-7dd4-4099-b50a-3f753ee343cc"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktNy0xLTEtMTg0NDY5_cdf2c1f2-effa-4703-ad59-804c05c64b84"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtNS0xLTEtMTg0NDY5_9dfffa66-533d-4eff-b94f-6216b81ff55e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjEtMy0xLTEtMTg0NDY5_69d4bbfd-3c54-4f6f-ac43-def57bedc3b7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtNy0xLTEtMTg0NDY5_203d2fd6-57a4-4f03-aa3d-ed9e380ed56e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctNy0xLTEtMTg0NDY5_2c9b888b-a91a-4bea-9f45-859a4eda9baa"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctMy0xLTEtMTg0NDY5_8deaca41-7c96-4e8c-8385-7e467740c77a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtMy0xLTEtMTg0NDY5_355d473f-1333-4c41-ad67-1e1351abf2c5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTctNS0xLTEtMTg0NDY5_759a87d9-5197-4bf2-9a65-5f2c98ba7823"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTYtNS0xLTEtMTg0NDY5_3bf7ef4a-bd0c-4bcc-9072-5628558babb3"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktMy0xLTEtMTg0NDY5_8b5b42d2-4b81-456b-8339-13cab0197645"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMjAtNS0xLTEtMTg0NDY5_db920e2e-633f-4ad1-8b1a-005b5fce5b06"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOmI0YWU4NTUxY2U5ZjRjOTRhZTFiMzI5N2U3N2EwN2ExL3RhYmxlcmFuZ2U6YjRhZTg1NTFjZTlmNGM5NGFlMWIzMjk3ZTc3YTA3YTFfMTktNS0xLTEtMTg0NDY5_4ec58889-7557-43b6-82b5-7dc591b1be87"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE3_62c842bf-dbe5-4a76-9f37-193d1003ac07"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMy0xLTEtMTg0NDY5_1a7b921c-90d1-46c6-904a-41981274e29a"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMy0xLTEtMTg0NDY5_1a7b921c-90d1-46c6-904a-41981274e29a"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMTMtMS0xLTE4NDQ2OQ_eaaade6c-00b9-439c-aff9-3fd93d136786"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMTMtMS0xLTE4NDQ2OQ_eaaade6c-00b9-439c-aff9-3fd93d136786"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0xMy0xLTEtMTg0NDY5_4399e170-9610-4ab2-ba0c-56afb2e2fae0"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0xMy0xLTEtMTg0NDY5_4399e170-9610-4ab2-ba0c-56afb2e2fae0"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0zLTEtMS0xODQ0Njk_0254c52c-e466-47e3-882e-37a450dd94f5"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0zLTEtMS0xODQ0Njk_0254c52c-e466-47e3-882e-37a450dd94f5"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMTMtMS0xLTE4NDQ2OQ_f5d76cff-b586-4505-b0cb-b9c3feb2b5a7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMTMtMS0xLTE4NDQ2OQ_f5d76cff-b586-4505-b0cb-b9c3feb2b5a7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0xMS0xLTEtMTg0NDY5_331d7980-7513-4e9b-9fea-a0de6e28adc7"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0xMS0xLTEtMTg0NDY5_331d7980-7513-4e9b-9fea-a0de6e28adc7"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMTEtMS0xLTE4NDQ2OQ_18eb84d4-39c0-48e1-8601-59a98212a535"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMTEtMS0xLTE4NDQ2OQ_18eb84d4-39c0-48e1-8601-59a98212a535"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMTEtMS0xLTE4NDQ2OQ_ba3cb69a-974d-4cce-90ea-aa5f5ba144a1"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMTEtMS0xLTE4NDQ2OQ_ba3cb69a-974d-4cce-90ea-aa5f5ba144a1"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMy0xLTEtMTg0NDY5_ac11e58c-b7bb-4b55-b8f3-f2596f262f54"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMy0xLTEtMTg0NDY5_ac11e58c-b7bb-4b55-b8f3-f2596f262f54"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the non-cash contribution made by JTIUH to Horizon in 2022 and the purchase of the remaining noncontrolling interest in Helix ROW and Helix in 2020 and 2021, respectively.  For additional information, see Note 1. <xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Background and Basis of Presentation</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMy0xLTEtMTg0NDY5_1a7b921c-90d1-46c6-904a-41981274e29a"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMTMtMS0xLTE4NDQ2OQ_eaaade6c-00b9-439c-aff9-3fd93d136786"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0xMy0xLTEtMTg0NDY5_4399e170-9610-4ab2-ba0c-56afb2e2fae0"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0zLTEtMS0xODQ0Njk_0254c52c-e466-47e3-882e-37a450dd94f5"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMTMtMS0xLTE4NDQ2OQ_f5d76cff-b586-4505-b0cb-b9c3feb2b5a7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfOC0xMS0xLTEtMTg0NDY5_331d7980-7513-4e9b-9fea-a0de6e28adc7"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMjMtMTEtMS0xLTE4NDQ2OQ_18eb84d4-39c0-48e1-8601-59a98212a535"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMTEtMS0xLTE4NDQ2OQ_ba3cb69a-974d-4cce-90ea-aa5f5ba144a1"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RhYmxlOjNlNTk5ZDA0ZTQxZjRhNzA4ODg1NWM3YzFlNjg3M2VmL3RhYmxlcmFuZ2U6M2U1OTlkMDRlNDFmNGE3MDg4ODU1YzdjMWU2ODczZWZfMTYtMy0xLTEtMTg0NDY5_ac11e58c-b7bb-4b55-b8f3-f2596f262f54"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85NC9mcmFnOmIyZjBhZjk4YjMxOTRlNjc4MjYyY2Y2YzRmOWJiZWE2L3RleHRyZWdpb246YjJmMGFmOThiMzE5NGU2NzgyNjJjZjZjNGY5YmJlYTZfNjA0NzMxMzk1NDIzOQ_9e289509-6b90-4d91-95c1-a7b052459b1a"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtNS0xLTEtMTg0NDY5_64fa7aae-ddef-4caf-ba23-40606890a0e4"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtNS0xLTEtMTg0NDY5_64fa7aae-ddef-4caf-ba23-40606890a0e4"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtNy0xLTEtMTg0NDY5_84400522-0293-4106-b980-ec04b03e31f9"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtNy0xLTEtMTg0NDY5_84400522-0293-4106-b980-ec04b03e31f9"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtMy0xLTEtMTg0NDY5_f0409233-b1e7-4ebb-9154-a390febe08d8"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtMy0xLTEtMTg0NDY5_f0409233-b1e7-4ebb-9154-a390febe08d8"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtNy0xLTEtMTg0NDY5_4ab69433-7e8a-4d7b-97a4-07872742a884"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtNy0xLTEtMTg0NDY5_4ab69433-7e8a-4d7b-97a4-07872742a884"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtMy0xLTEtMTg0NDY5_e5f3aecf-a9ff-4428-9ed2-426d4780cd6c"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtMy0xLTEtMTg0NDY5_e5f3aecf-a9ff-4428-9ed2-426d4780cd6c"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtNS0xLTEtMTg0NDY5_bd3bb9be-596a-4f1b-b189-0373023ab0e6"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtNS0xLTEtMTg0NDY5_bd3bb9be-596a-4f1b-b189-0373023ab0e6"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE0_c105be61-2fc6-4089-a6be-9d171ba7904e" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE0_c105be61-2fc6-4089-a6be-9d171ba7904e" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Restricted cash consisted primarily of cash deposits collateralizing appeal bonds posted by PM USA to obtain stays of judgments pending appeals.  See Note 17.</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</xhtml:span><xhtml:span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtNS0xLTEtMTg0NDY5_64fa7aae-ddef-4caf-ba23-40606890a0e4"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE0_c105be61-2fc6-4089-a6be-9d171ba7904e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtNy0xLTEtMTg0NDY5_84400522-0293-4106-b980-ec04b03e31f9"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE0_c105be61-2fc6-4089-a6be-9d171ba7904e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtMy0xLTEtMTg0NDY5_f0409233-b1e7-4ebb-9154-a390febe08d8"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE0_c105be61-2fc6-4089-a6be-9d171ba7904e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjQtNy0xLTEtMTg0NDY5_4ab69433-7e8a-4d7b-97a4-07872742a884"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE0_c105be61-2fc6-4089-a6be-9d171ba7904e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtMy0xLTEtMTg0NDY5_e5f3aecf-a9ff-4428-9ed2-426d4780cd6c"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE0_c105be61-2fc6-4089-a6be-9d171ba7904e"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RhYmxlOjA5MGI4MzZiMjM4ZDRlNWM5MzFmNDU1YWJhMmFmYTg1L3RhYmxlcmFuZ2U6MDkwYjgzNmIyMzhkNGU1YzkzMWY0NTVhYmEyYWZhODVfMjUtNS0xLTEtMTg0NDY5_bd3bb9be-596a-4f1b-b189-0373023ab0e6"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjE1MDYyY2E5ODIyNzQzNDA4NjE0MWI0MjY0NTBhNWNiL3NlYzoxNTA2MmNhOTgyMjc0MzQwODYxNDFiNDI2NDUwYTVjYl85MS9mcmFnOmViOTMxYzgxMjc1OTQ4YTViYTE2ODdlMDgxYmE0OWFlL3RleHRyZWdpb246ZWI5MzFjODEyNzU5NDhhNWJhMTY4N2UwODFiYTQ5YWVfODE0_c105be61-2fc6-4089-a6be-9d171ba7904e"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>135
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M WU89V+',$3.P9(IO9'YF=AVH48],[W<]7<E,;,KHXYA@1QI@9Q6%L@#: R
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M@JXB,V2O(;1QK;2Q6VIO0Z9"(O.J=J:S.S$[,*C<S@X%R*M2Q[;$/@^)M?
M*&*2'P,H8H[/Q%?SF^6]6J\3MU[_LJF;+_.T0!DOI&#CE3Q4OG0[.Y5K8HOJ
M<S-3&H$@XQ9K#($"<TGQU?@FT[4\)VYYOF5:3UE+7DI!)1/5F'BGJQ4@W5Z5
M.;$UM9HPS+O5(,HJ#$$H<U%)?#6_27@MSXE;GG_6Z\(A;F];C+\3<+)Q6YT<
M$5N;6[/(" #9ZS< ZF,SS_75^&8\:IU/G"*S*H96Q;?E?@U\M:V!UQ6ZU%D#
M=U_EY! $%G$#8@\* !5VK4$!H(*!N23[:G\S"K44)V'[W19X%\)#58-HWX5
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M)>\341KR/@$-^TQ]&AQ+&7EMN'-''A-L>5+^'F9('Q,L0 +KT<3=T\0]/ML
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M0.Z2O\S1(Y]-*)V(U;($,Z"'BN:CH@7Z\O<ITDEZ5"_I_3\"4PO9/_JC"DR
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M>E^PP8BJO583Q?.R':RXPN92#F/\(@&A'?#]FG.UG^@%FF\<_R]02P,$%
M  @ %7);5AJ?MH:P"@  U1L  !D   !X;"]W;W)K<VAE971S+W-H965T,3 N
M>&ULI5EI<QLW$OTK*&;CLJM&I$1?6>NHHNA#<LFQRI2B#UO[ 9P!.8AF@#&
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MKP?,A!^1PANG*__#S5P[ITO_$JL>>A8=P.<+C2DBOB$%[2]Y)W\#4$L#!!0
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MHQ!(8YD05GT#98R743C=**9=WR8;J-,!V*0[F*1IS[XG(!:D3Y1<L@%](VX
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M3BY_)4!NQ674(EP9>X!95U)*+ZDV_8+(*'A)']V#R'$#<-\IYP1\#)ZGI.8
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MPO$-N5G)6]7N?Y^?&-^S,L.%;9=7,F=EH?@A'Q+[3HT-U5*2\#AYDVJ^!P=
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M>[M07JU-0;K]]<L"K.Q[XV>!R5AJ\0)2S!N'_"3_LO8,T#KY1RJ.A"TL%D=
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M<<9QCZE HFF:@.\KA=A5 UJ@^<%[]1]02P,$%     @ %7);5FCS:_VG&0
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MGJ1W:2+S1(<2=P73ON3X\@5_9'=8"0H\$W+B<46BE1>42K,U-@];P&H#F2?
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M!G_]99%^6K>]E9=N ]6^$"_L[1#J#B!>78;0*N&+EI=)FNEIOJ9&JLQ<(9W
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M]C"3QMQ ;UI*[_5<QR@_H+!*D3SA7J&1;Y<6ZXK/% H/+FVHXC"0_?PBM_
M+NL24).7ADCA1)\20:QI 47@N9@C"5&:^Q"!#!FY;W(<UF/R7XT'8S&+!8$:
MK>6**QUEPVRN$3 <\<IH' RV<RE.(XH=6J$V#E0V=C#-V&\XA'</[BV"E-S
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M'$7C-^?IYT)=<P<W)]FQAFL:7D7JY@>QH8AR%*HP$ LSWVPIAWN$G>7P<7*
MMQB9L?=>W#XM2V-PXAR".?M/Y&59XPR P\/@J5?28>?30J5<SA]0?!S7\2M#
MN]I^H[F/GR:VXO$#ST?I<D*N5'-L'0TNISW0*W\TB7^"K?E#Q<R&8"N^+11.
M!XX$\'QNP9#K/V2@_7)U]S]02P,$%     @ %7);5N?K;S"[!@  +!$  !D
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MU 6J(4I=/:>\:;Y>--!EH 8(%RN+3MO>FOM5?EC=8' 7O2,F1@]B=3G$JI]
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M4RH-AQ1$WSMYNF4WV F@R\8T_?(1\*91DIS*(73#7Z"H,[PQ:($?%D>/H-Q
MWF,$Q0WBDW#@N;,0&H1G+2>U!&\G9G="Z59;2>B-NT+BQ/(C,?%[#_PN?$>J
MK$6'U0;[5]WRTD9C5W&AX2!PDWC,^*DU+0(8"!N^P=N(056";CMXCYG_@^X@
MT(0D+S0:::\:/6;KDX=PV,8V+AH;EM\Y0E(;6ZA[(S'*(@X'ONOM-O)1CT:'
MR*7B%4+B!@H#XK[A=#1;WP9N-'"B!5]1.B6P;1*'7 _$CK6H#^T8X5Y]V]"[
M\$-0L)I24/\G,6_B)SA#05%6NH^<$[S-.37> ZF,7G50EQBFJ.B H>IZ1+>M
M?"P9/8#,14/U!&V#DO$2>RL,]H.,+,:3BF*ONS,2[5:PX!:@8Y>Z9.W$= FD
MWYQ!7_'32#KEGU@S-.DUA@]_W4FK;3<CF1O!T46B.T=''>MX-RR/<Q.N>ZB'
M&)>^EZ$AXCX3C1E59XYWSJ.^9Y.<[Q9E]U^W5M?6MWKG)A&D+H,@<A-( C>%
MB^52B2558B:UV<-S8 ^KR(YQ0F/@1-@P+[ ?X ,"W5M@*'9:Q[-2PL1- QIC
M=Y9T\]"GO,V+'%NNV?%OO=D*04_0\>\^=^>;CF[@E5!+^\[0:$Q;F^XR/JP.
M3YF+[@;_0-Z]@[YPM:3D*,4"63TWB2:@NK=%-S&RL??YN33X.K"?*WR."44$
MN+^0TFPGI&!XX)W_!U!+ P04    "  5<EM6(0K^<M\'  #.%   &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q.2YX;6R]6-USVS82_U<PJJ>3SM"22'U82FS/
MV''3ZT,[FKA-'F[Z )$K$@T)J  H6??7W^Z"I*A$=M/VYAYLD0!V][??"U[O
MC?WD"@ OGJI2NYM!X?WV]6CDT@(JZ89F"QIW-L96TN.KS4=N:T%F3%25HV0\
MGH\JJ?3@]IK75O;VVM2^5!I65KBZJJ0]W$-I]C>#>- NO%=YX6EA='N]E3D\
M@O]UN[+X-NJX9*H"[931PL+F9G 7O[Z?TGD^\$'!WO6>!6FR-N83O?R8W0S&
M! A*2#UQD/BS@[=0EL0(8?S1\!QT(HFP_]QR?\>ZHRYKZ>"M*3^JS!<W@\5
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M@]HYT/>%4G:KN 3-#VS\$U!+ P04    "  5<EM6F5.KH]$%   1$0  &0
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M!\G9@*[3JEG7UFPATES*#<-MS(LH8[[NW!7)9$]@_3 EZ'BP&=J/Y/-L/!&
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M^VJN5E"Q%1_4QF16IZL7%Q9DZ9\784GBM2/A'R#A^>+:I':=BQ_32$6[!"[
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M^KJA7EG*!47<8OE_&:]>WZ/*0AD>3<^1]A'5!*FZ"M GA?5 3$50Q[(W\+B
M^.Z\0Z'LHG<GH)\>RF#FR&B1E 24J,@)@,RB1*>:WM;8JI>@V9O,X,04]M\2
M[D\9"S]RP,;_=F?/'S.9YI+3T7X?HQ S.</.NK%T'%/#-/3VMD,'8))724D-
M@BJGZ*4^JR16OMR@MPE+(1^X.I\9-&?"X1W#SJIN?D?*C;4KN20Z'AL"&B#)
M^8F6'E1".4_5X!'=N*#9-8U4\[P4&B?FJIS+G7K]FA/">94]]NN+)Z!U=^PP
M<&WZO\Q5*JM?4K]5LO6A9(ORV(',(EO+'UM],/Y#5C\*W/$ K4JFD7CKX&L2
M/_D"=)$M=*67!^7$I\;=I'\3MK'E_U?C##%?5Z^(YD1=K72(P@&Y]FM=)QLG
MKV.D47C@?5.<H0T[%F@/ T**O.:.!*<A#DS?'@PL=8;\^VL!6 ER8(F3O49B
M9@8LO=A$JZE_>Q!:]7Q@]PT!5UMZ&X54"Z%1^T&$)_$@GP#QYFNQ1#FJ)A1L
MS$.]9%T&=U+' W!,+X.WP"+JW"R7;JZ)_LX2K.Z<^E._4N\9U<+=[) :9@UR
M+U1,+),OE:]=JI%A>2 *1<HS@?)53@GTQ":&4[HW.NQ-U=&FL%OZY((573T,
M99;=NQ=MT/D*G71:@B_W+K&D*^X >1*:U2<XK?76&)62F_ZHFD>2TQ0$_B%*
M>A[29";FFK;*Y :5K8"C2XZ-)-'ER)(EW-5#+7VCD+6$'2OB\.;4)*TY:@<)
MLLZ0+01T>SV;41CHJ$!"^(53;(/+6A#DN(MOCR B'N;YS1RQ4[YBK0P"A]UI
M\DLW?]QTG3U,-!6PIBU%ND)$P"65XI3A!.*:L8./6>#8P7%7I/BU#73&G3[T
MR6BV@<-Y.?;RZ646I=!&>;.;7Z[>G"/9S3>*9[M[\"&_A-RCD6%3KSKM,GIX
MWM(&.Z?3AQN.)O2SXUFSG32?E-,>&J)6Q ;,*?A=]6G"'NDK<,'JCC049>/[
M-D%4[:S8N :"WS2ZUX=@9@G>7-U/'&IV+]&0M5!DJKA_Q$NWG.' GVJKZ/1!
MAT=*K<L3.$YTD8#"?9=>2>0FA7*A5.NF:?PR8%,;H\3VZ%"4VFD"^=P-M?^<
M)I'M**%#F,H9%8J,N6="K"$$!9)2;]]7/Q>M3[)01E;\X1GE68!G]W56_;3^
MMNW2?=+5+'<?QEW##AK*C=426_N]\?!$9.YC,_?#F@U_X+4PUIJ$;R$C6D%:
M@/\O#311_J #ZB_^7OT74$L#!!0    ( !5R6U;B$'Y+9!<  (9.   9
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MR>VB$H]Z2Q+IZ_!40A'E\:9.WI4]\81_!:<JCU8/3<1<KEAZEA ,$=XXW53
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MW/FCW [F"<2YD%OJ3;>KMN4;YWD&P)U8C\%Z.X[YZ//G+ XP_M:O3AQ/A@S
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MO 'M;[1VAXD/T/__BW\!4$L#!!0    ( !5R6U;?"!77J"D   ^&   9
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M703UJ.1Q<8 *?B]!YA(9G6DF+<23)C'D</Z5>=NHZ]/LL_:2GKGG@J8=DCO
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MGW1IA*IX@'Y?EL2+] ,6N"9KF;?W\K\ 4$L#!!0    ( !5R6U9:H:\=L!\
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M2LZ(8-C#1B 6:=FROZ'0$OG $'?4($FPDOE:P6<<?=!2;8)W7<.\RFL2)%"
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M+^C"10DVR2G&? 2S^$O.-+/-6,-YT*@B&72#@^ABR6UDM3EL'&S8O<_#J-^
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M@W3 <KD0=>'>Z^UOLO4G1GV9+BP=V;9=ZP]85ENGRU88+"A5U9S%US8.WR/
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M*>7<O[SOL8)>!9<CCVU7*ENQK302K!86RC)'7Q="&;8112W/V5^2*6/D1F<
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MTA\%:B= WU=*V?W&$;3_*/-_ 5!+ P04    "  5<EM6+9(WK* %  "E#P
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MQI-OF#WL-8/AN2@*4>N6\]=4"Z,#>_83*UN^?O^\YP?H;?%Q) .*"+$W,=4
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M=<O;4O.*/&B1?2<7W_BF G6Y<#5BFQUN-N#<]#C>"1SFD2^BT84B'YL<\M<
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M[IY?T3_YV"F6!3-XJ<0#SVTQ"GH!Y+ADE;!W:O,9M_%T'%ZFA/$K;&K==A1
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MPS&V!NV_%O@'VVS<"7W16#SON]LUR (T#<#?EPW&W3Z0@^Z3S?1?4$L#!!0
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M=L<HNA$M@/>;JE+-@]Z@_;1X]Q]02P,$%     @ %7);5N,,GI*A!0  +0\
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M,LAI5!C%V 8!3G&]QK%N1_29,^;E+*='G/B479:&<-E8%(NQP)NR)UB*N=T
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MCB*_/E?4\5&+*9$RY!NIA>"@[C;M;MNK%W6+>A&O&_T'2K @)!(WI)I<CZB
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M,)46X'ZNP2GQ!QW0OIV]^"]02P,$%     @ %7);5E,UIR?W!   4QX  !D
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MJ7Y1J7ZAHP\^+Y,9,*5Y#"M@<DP,B_;-Y?"G!EB2+M!_!YO\4$L_5F^3,*^
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M98N%6'&"6=P(FN4G;C,J!$WRRPAP"$P5D._GE(K-C7)0G2,/_@=02P,$%
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M*&V ^9X+H7<3NT%WG\8_ 5!+ P04    "  5<EM6S/M_GZ(#   ,%   &0
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M;W)K<VAE971S+W-H965T-#8N>&ULK55=3]LP%/TK5H8FD(!\-F4LC02MQGA
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M]/<1A"G0ZPO.U?/$M.#^BYO^!E!+ P04    "  5<EM6(Z]VR%X(   _4
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MAT"!6\*YC7"N5KCW=W/TXPO-'BGO7;M:]*5K%Y(L@"0+@<A:%@P:"P9@J60
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ML:I?+EDR9[P"R.\712&>WU0;V#U%.OD?4$L#!!0    ( !5R6U;MU@F[.@4
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MNI_.B%PP 3GM(8PBW7WD.?E4?YWVE"YYYK_GEZ6\+4II[REEGSSP1"TD<9,
M@J9]3]>XJK;]7NU;NQ7X!.D%Z5OGQ+9LVU">N\/-J<'<:3=WP-?F=*]WM]W\
MSV726GCO<.^TI2W[51?JY[S^ 5WH^Q?]D=PKB.6_)ID+TL!,RF;1*YDR'ZX[
M>IJ4(%;0F?WV"QU9OYLTPH0YF# 7$^8AP1K:#BIM!VWTF<="058L6@+A<SV&
MWY4V:5N0ACDI6]!6,TKU C?MK>JBM?H[5C1,F(L)\Y!@#=&&E6C#5M&R.?K[
M \3/((R#L-7ZV$&("7,P82XFS$."-?0<57J.T";8$::VF# '$^9BPCPD6$/;
MRTK;R]:Q6FZX8E +'M0FV'/"UPD(N0A3DH+P=9+>Z),N2U/!7T.]I8;H[<S4
M UK]'=L#,&%. 9O4%@CK@C:7!Q?3H8<$:P@[KH0=GRALLLQFYFP]+7?*F=+!
MN3ZG225"7T% NGJW7'PT2MSJ^5B),6%. 1O5]P#CX9;$F X])%A#XDDE\019
M8I_'L3Y.?R!OJ]=CY<6$.9-=>>TM=3']>4BPAKK4VAR-K9/T-1]@6UG'JE;2
M/MA,.X9LX\GE]H!#+9IG+!H=#"JGS=:N!2+HB:,I".=S$)#X0)Y!K0$2XC,A
MWL+DA;"8+Q-%6!*0>756.:\MF4:MVDO2M>T+R_K5-#;O/C+M#_>9.J5I<_WK
M][?%:G5PM%A(M*:F]D93^T1-PSC5<NT[2I;8>A^SASM'24.ND6&,M!;QV(TG
M*LW#HC7EV01N:&OL8.8<-K"620 BRE,A%]0H&6IH!Y7FE+3V[N2B^O2P:$UI
M-W$;VAZX^0(KB BMX@#D/_)16*"=>+2"J($>5)J+2O.P:$VE-\$>.D2+#E#4
MT \JS4&EN:@T#XO6E'@3_Z&M(8BCHK EJKY'GUB[2^=N+N/^<F38ZTUV9T[4
M<(RQ;'6GS5;<1%KH::$6\W8>-8R"2G-0:2XJS2MI3?'H7O$VT11Z:CCEZ-.!
M4>[Q3D?_;-IQ&K*9MIR8(0[7Y+31I&7+[V8;[VWW38B#GAKCP#^5H<8]4&D.
M*LW]H,V[DWUG2*^T;)XAK4NK\4.W1._5K@?$(%[RBQR2^)E&Q;_,J]3JLLA-
M?D5B*_V67MT55SXVF.(&R@,3+V$B201SC;0N+G4W%,6ECN)%\32_A/#,E>)Q
M_K@ IL\560;]?<ZY>G_)'%17:V;_ U!+ P04    "  5<EM6=EY>HPX&  "S
M,@  &0   'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6RUFUMOFT@8AO_*R+M:
M)5(2>_ A3C:QU(9CU511HW0OJKV8X+$]6TZ9&>*FOWZ'0\#8>(*K+[VH ?,^
M,Y@'&/+!U3KF/\2*4HE^AD$DKGLK*9/+?E_X*QH2<18G-%+?+&(>$JEF^;(O
M$D[)/ ^%0=\8#";]D+"H-[O*E]WQV56<RH!%](XCD88AX2\?:1"OKWNX][K@
M*UNN9+:@/[M*R)+>4_F0W'$UUZ\H<Q;22+ X0IPNKGL?\*6'IUD@7^,;HVNQ
M,8VR37F,XQ_9C#>_[@VR'M& ^C)#$/7Q3&]H$&0DU8^G$MJKVLR"F].O=#O?
M>+4QCT30FSCXA\WEZKHW[:$Y79 TD%_CM4O+#1IG/#\.1/X_6I?K#GK(3X6,
MPS*L>A"RJ/@D/\L?8B. )WL"1ADPN@:&96"X'1CM"8S*P&@[,-X3&)>!<=<6
M)F5@TC5P7@;.NP:F96#:-7!1!BYR'8K]E^]\DT@RN^+Q&O%L;47+)G*#\K3:
MYRS*9+^77'W+5$[.O.B9"JGLE0*Q"%E/*9,OZ)[Z*6>248&.ZC6R%3X]/'Q&
M7PCG))/T&!V95!(6B&-TBA[N373TYS$2*\)ICKME0:"4%E=]J?J:M=CWRWY]
M+/IE[.D71K=Q)%<"6=&<SEOR-V_D#0V@KWZDZI<R7G^ICX:6:%+_# WQ"3(&
M>-K6H<YQPVB)F]WCN"5N=8\/6N*V/GY/$Q4?[.V\HX]_2B-MW-7'/R2\BK=U
MWGNC=1+MV_:&",/JD!GFO&&'0^;[9_4E\B0-Q;]MDA>D43LINY!=BH3X]+JG
MKE2"\F?:F_WU!YX,_FX3#!)F0L(L2)@-"7,@82XDS ."-10>50J/=/19>9H7
M]6E^S>1*C850-F!BP8L:+TC*U?6&/ 84+0CCZ)D$*3U!:;(F?(X2SGR*R/R_
MM#@4VN37]N%0^2%A)B3,*F#C'):-+9]GZBSSO&DT9',.),R%A'E L(;1X\KH
M\7L9/8_74:O3)VH %J9!/M)!)(S3=LVU'3M4<TB8"0FS"MA$HSED<PXDS(6$
M>4"PAN:32O.)5G,O3)2Y^6 \7A2#<;IM?INC6NJACD[>.N&9;ZYA379L,B:#
M\M^65I!]=R!A+B3, X(UM#JOM#K7:I6+]/V6AH^4MXYCM?%#_8&$F9 P"Q)F
M0\(<2)@+"?. 8 UOIY6W4[!;L2FDPI P$Q)F0<)L2)@#"7,A81X0K*'P1:7P
MA?;4>T=>"G]EC(BOKN6<[E[2NPYFV[R_V+D68V/:?JF]T7;U4*TA818DS(:$
M.9 P%Q+F <$:6N-!_8?EP7O=D:D;,LK%BB4HH=Q71P=9MJI=]N!B<YQY-AQO
M2:WOYZ%6@](L4)H-2G- :6ZG?>5!M=ET=J,8@O6W5W6M(W-P?H(>24 B7SGY
MAHFXDXE=UC+U?3S8,$B:#4IS0&DN*,V#HC5--&H3C=\UL2RO';&HG#QN-5++
M/W2\6](V[]='QK:WD"U:H#0;E.: TEQ0F@=%:WI;U\:PMFXQ^Q)'IWX<)NK2
MKJ[S 26"(LG9<DGYQBDT^^,5B]2H@ 3JLS+=)YR_L&BY?S"K;_U@JT$K:J T
M"Y1FE[3FE0<W#V 'M$D7E.:]L0%-6^LR&'ZW.MA32B+)9%D<$((*D3N\63X@
M490JP_>7#O!N[6C_S9E^6PZV%;0&!DJS06D.*,T%I7E0M*;_==$,OUO53",U
M:$$,E&:"TBQ0F@U*<TK:YJEE-&X]L;B@#7M0M*;2=8$,ZRMD.TJ?(/O;Z1?O
M!*61DCI@O^@<+8D:/!\%L=@S=@8ME^'=:M@I'HW';?O"!&W:PKME-KRGR@;:
ML -*<T%I'A2M*6A=:L/Z6ILE) N)5!;6I]/78FZKC*"U-U":6=)TA5[0!FU0
MF@-*<T%I'A2M:6E=6,/:HL=O/VB@QQYL*VB=#91FE;1-]_<^P@#:L@-*<T%I
M'A2MT+:_\6![2/DR?RM"(#\;>A9/;E=+JS<O/N3O&VPMO\&75O'^1(TI7N>X
M)7S)(H$"NE#(P=FYVJ&\>$.BF)%QDC\^_QA+&8?YY$H-CBG/5E#?+^)8OLYD
M#53OJ<S^!U!+ P04    "  5<EM6I;JX12$#  #?!P  &0   'AL+W=O<FMS
M:&5E=',O<VAE970U-"YX;6RM5=MNVS ,_17"*X86:.M++ANZQ$"3;MB&!B@:
M9'LH]J#83"),ECQ)3M9]_2@Y==/6R?JPEU@7\N@<,B0'&Z5_FA6BA=^%D&88
MK*PM+\+09"LLF#E7)4JZ62A=,$M;O0Q-J9'EWJD081)%_;!@7 ;IP)_=Z'2@
M*BNXQ!L-IBH*IN]'*-1F&,3!P\$M7ZZL.PC30<F6.$4[*V\T[<(&)><%2L.5
M!(V+87 97XS[SMX;?..X,3MK<$KF2OUTFR_Y,(@<(12868? Z+/&,0KA@(C&
MKRUFT#SI''?7#^B?O';2,F<&QTI\Y[E=#8/W >2X8)6PMVKS&;=Z>@XO4\+X
M7]AL;:, LLI856R=B4'!9?UEO[=QV'&(^WL<DJU#\MRAN\>ALW7H>*$U,R_K
MBEF6#K3:@';6A.86/C;>F]1PZ;(XM9IN.?G9](M<H[&4%FN 2_CXJ^+V'J:8
M59I;C@:.O\YFU_!H!F/!C.$+CCDP ]>X1@&=$SB^0LNX,"=PUH)R!A[F;H+%
M'/4/VL^F5W!\= )'[MD)%X*2:@:A)4V.69AM^8]J_LD>_G$"$R7MRL!'F6/^
M%""D8#0121XB,DH.(EYA=@Z=^!22*$E:"(U?[QX?H--I$M3Q>)T]>)\8U_"-
MB0I/X=(8I#Q-D)E*4_RI#&Y=C#672Q@QP\TIS*2:&]1K-A=(:2LKZVR4S+C@
MS%7.*8R9R"KA-W!WJX0 JH@-T_F/MOC7]+KM]%R3N3 ERW 84!=Q#V.0OGT3
M]Z,/;;'[3V!/(MEM(MD]A)Z.F& R0V 6YKCD4KJHJ064J+G*VZ37>#V/Y]KA
M.HW?1;U!N-Z5] ^C)U1[#=7>0:HS21U9\#^4XR5U8JI"H2CW5%Q<9J*B/[JK
MFF/:J )/H+Z$A58%G3\I:*Q+T32EV*:S)M/?D7 6=WO/A;ZTBMI5]AN5_=<F
M!&5^.!7]%U%.>M$S@B]M6C(1[O3* O72CQ #F:JDK9M$<]I,J4O?G)^=CVAZ
MU</F$:8>?1.FERYI A<$&9V_(TJZ'B?UQJK2=^2YLM3?_7)%$QBU,Z#[A5+V
M8>,>:&9Z^A=02P,$%     @ %7);5L9H$?,F!@  O#   !D   !X;"]W;W)K
M<VAE971S+W-H965T-34N>&ULM9M=3^,X%(;_BM5E5R"A-DF_@"V5AC;),!I6
M:! [%Z.]".EI:TT29VR7@K0_?IT/DB9-38/.WD"3^CS'B5_BXS=FLF7\IU@#
M2/(2!I&X[JREC*]Z/>&O(?1$E\40J6^6C(>>5(=\U1,Q!V^1!H5!SS*,42_T
M:-293M)S]WPZ81L9T CN.1&;,/3XZPT$;'O=,3MO)[[1U5HF)WK32>RMX 'D
M8WS/U5&OH"QH")&@+"(<EM>=3^:5:UE)0-KB;PI;L?.9))?RQ-C/Y.!V<=TQ
MDAY! +Y,$)[Z]0PS"(*$I/KQ*X=VBIQ)X.[G-[J37KRZF"=/P(P%W^E"KJ\[
M%QVR@*6W">0WMOT,^04-$Y[/ I'^)-N\K=$A_D9(%N;!J@<AC;+?WDM^(W8"
MU(4V!UAY@%4/N#P0T,\#^L=F&.0!@V,#AGG L!XP/! PR@-&QV88YP'C=+"R
MNYL.S=R3WG3"V9;PI+6B)1_2\4VCU8C0*)'B@^3J6ZKBY/0V>@8AE;:D(#0B
M]J\-E:_D ?P-IY*"(*=EBZ3!C+.("?*7Q[F7B.B,G,Y!>C009T2L/0XIYHX&
M@1*:."<GNX>3GE1=3A+W_+Q[-UGWK /=ZY,[%LFU(':T@$5#_$P?;UH:0$_=
MJ^*&66\W[,;2$K]LHB[I&^?$,BR+/#[,R>G)65/'])@Y^ IC5C'Y'6R@S8^G
MF9I.V<=C# W&:7-M)Z1W^+I</>D!XO=N=F40^X7J^RFW?X3J?WQ57Y);":'X
MITF@&6G03$IFBBL1>SY<=]14(( _0V?ZQV_FR/BS2128L#DFS,:$.9@P%PE6
M$<J@$,I 1Y\Z'N7DV0LV0-A2/<K>9-,D%"VIK5 P87-,F(T)<S!A;@8;IK"D
M!'N>FJ8JR2:]YP8%# L%#+4*N UCI8%T^E,*^/+X^)5 -DF*8I)L4H.6VE8-
MP[TK*Z\J&^)W6]C[+:R146OD8/;:18)5AFU4#-M(.VQYG?+C#L(GX(T/=BV@
M[0AAPN:8,!L3YF#"7"1811_C0A]CM I@C"D43-@<$V9CPAQ,F(L$JPCEHA#*
MA?9!DJ^(0I!KMMBI ,X)VT; Q9K&) ;NJU-JZ4Y.O3CF[(6J13($KTW%\XTV
M7ULY93#3W'WP=P>F69L>#C2[J,T1F%US,&$N$JPB@<M" I<?E$"T26:7I##(
MU[Z))A;GQ&=AR")RJM:^V1=GY-_#BZ ;;?JVBLA@IK5;!@U'W5%-$9@Y;4R8
M@PESD6 5W9A&::X8'U).LQ-B[%5H@_ZX.FPS?<*V\T=#RI%92VFCIG10:2X6
MK3J^.^:9B;8\S%'O#*\V7^OAW4_9,+R8*1U4FHM%JPZO50ZO]<$'_X(NE\ A
M\H$\@=P"1,3W.'^ET8IX(=NHU:(7+<BRT,?Y3I'0J Y]3TXMHVL8OS<:C7GH
M965N-^K/^W<3# \EL/6AK16"27.Q:%6%E#ZBJ76?,!72J I4\S&G52P JRX3
M5%,1E>:@TEPL6E4YI;%HZIW%P\JAA>/4*(D&E\O8FT90[<.&E)8QK$\CJ+X@
M*LW%HE6'NG003;V%F _UC$62>[X:X7L.$,;)ZS.2OOLM?2JU3#C"N=+G:_U8
MP*3-46DV*LU!I;E8M*JJ2H/3'*$Y6":JUXE*FZ/2;%2:@TISL6A5P92.IZGU
MR30S3LRI*E-4@9IY%(0N";RH<I4*6*@GDO8-[HT^:VMMH?JCJ#0;E>;DM(O=
MB7S4M6KSJHN5M"J:TOTT/VI_[GE?$- 5?0J +!DG\8;[:T^ UO?2YVXMG8PV
MVKFAXWIUBYG01J4YJ#07BU:53>F8FD=9IF7)\SW9,*36/"T+'51G%)4V1Z79
MJ#0'E>9BT:K[K4H3U3+0"AT+TUV<H=+FJ#0;E>:@TEPL6E4PI2MKZ5W9_ZG0
MT6=MK2U4IQ>59J/2'&O?A38O:U4.5L:J8DJCU_JHT;OS:O>=2J=1,IA>Y\QJ
M,GKK;WI14]JH- >5YF+1,LWT=O90A\!7Z?9X0?S$J<UV!Q=GBRWXG]*-Y[7S
M,_/*SC;2EYAL7_^=QU<T$B2 I4(:W;'ZD^#95OGL0+(XW:G]Q*1D8?IQ#=X"
M>-) ?;]D3+X=) F*?UB8_@=02P,$%     @ %7);5HJ20 ]% P  P@T  !D
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MRCNV^0E%0!W-%S$JS!-M"EO'0M%*2)868.5!2K+\C9\+(78 ;O< P"L WC[
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M@;("^'TJI5EMK(+Z9A7_!5!+ P04    "  5<EM65VI<IQD#   \#   &0
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MQ_7(HK0N&EJL\F)S)C26KOGC$F@,TAC@^%P(_= P$U0?.";_ E!+ P04
M"  5<EM60==4=I@$   J&P  &0   'AL+W=O<FMS:&5E=',O<VAE970V,"YX
M;6R]F5MOHS@4Q[^*Q:Y6K=0IEUQZV212$JBFTG:F2F=V'T;[X,!)8@U@UC9)
M*^V''QL("1GJ#9*U?6@P^/QLG[]]S,&C'67?^09 H-<D3OG8V@B1W=LV#S>0
M8'Y-,TCEDQ5E"1:RR-8VSQC@J#!*8MMSG*&=8)):DU%Q[YE-1C07,4GAF2&>
M)PEF;S.(Z6YLN=;^QH*L-T+=L">C#*_A!<37[)G)DEU3(I) R@E-$8/5V)JZ
M]X$[5 9%C3\)[/C1-5)#65+Z714>H['EJ!Y!#*%0""Q_MC"'.%8DV8]_*JA5
MMZD,CZ_W](=B\'(P2\QA3N._2"0V8^O60A&L<!Z+!=U]A&I  \4+:<R+_VA7
MU74L%.9<T*0RECU(2%K^XM?*$4<&DM-NX%4&WKD&O<J@=VHP?,>@7QGTSVUA
M4!D40[?+L1>.\[' DQ&C.\14;4E3%X7W"VOI+Y*JB?(BF'Q*I)V8O&PH$Q^^
M $O0C#)I3-(U1SB-#D4T90RG:Y#30W!T\0G+HE+W$EWX(#")^27Z@+Z^^.CB
MU\N1+62O%-L.JQ[,RAYX[_3 14\T%1N.@C2"J,7>_P][3P.PY1!JGWA[G\P\
M+7&:KZ]1S[U"GN-Y+1V:Z\V?,*O-G;;QZ,U]"+6M!^>;NQIG].H)TBMX/>T$
M$6J"^+ 4Z-L?L@)Z%)#PO]O$+FG]=IH*>_<\PR&,+1G7.+ M6)/??G&'SN]M
MCC8)\TW" D.PAB3]6I*^CGXLR;)>LVU::#%=M3 )\TO8H("IO6P[D2ME>^Q@
M78V&UP:UUP9:KQ6SEZ1<L%Q%LBL4TBVDN+Q*.8U)A 5$*)@]?O&G2%!96?H8
MN$#P*O=E#DC%/7JEPC!)\J3-X]HN=/6X29A?PH9'_NR?>-Q0<PUQAK4X0ZTX
M"]C2>*LVFSF#B CT@$,2$_&&OCU!L@36&FNTS*[>-@GS3<("0["&,#>U,#=&
MP_^-24E,PGR3L, 0K"');2W);== UB%\M8FF;:^K:"9A_NU/4<MU3\*6H?8:
M4MS54MQII2@6 UWM@]8^5J%_T?L!S<\!R3=,^6JO7M$&VKJZX*?M65?13,)\
MD[# $*PAK^L<LB/':/BK<(94,4KSC=("4[2F,$=IJZM=>7*) -KB.(=6&=R?
MWAY[SOZO&3_F^H8Z._G\EH/SZC8=Y!T<Y&D=5*3T,C1%<MJVNDAO/D!O@%E;
M5C'76W9VF$E:8(K6=/HA5W:U>=_DF=$0(.)HQ6B"".<Y3D/0RF T7ZYHY\P^
MWVC+@2E:T_&'C-C5I\3_UT8L*Q4+ZP7"7%9!G[? 4O4M$CT0F4N&RG8AW\/0
MA576^_RPL"ZU^[A^9)UG@-$TW2@M,$5KSI%#_N\.S.[E1I-YHS3?*"TP16L*
M<\C]77WR/\VRF(1X&0/*I$3J_$ NY3I]86H]K2@[?.QJ5<OHQP"C-+^BW1U_
MS+IV3A,94VV6*MA'9P()L'5Q&,-EKIBGHOP47M^M#WRFQ3''R?V9>S\OCVT.
MF/(4Z0FSM<Q#40PKB72N;^0T8N7!3%D0-"M.'I94")H4EQO $3!503Y?42KV
M!=5 ?3PV^0%02P,$%     @ %7);5CUJ*KA*!0  H2(  !D   !X;"]W;W)K
M<VAE971S+W-H965T-C$N>&ULQ5I;;]LV%/XKA-8.">!8(B7YDMD&VF3#,C1;
MD+3K0]$'VF9LH9+HDE2< /OQ(R5%M\ATE-+-BZT+S\?S'9XC?J0TV5+VC:\)
M$> ^"F,^M=9";$YMFR_6),*\3S<DEG=N*8NPD*=L9?,-(WB9&D6AC1QG8$<X
MB*W9)+UVQ683FH@PB,D5 SR)(LP>WI.0;J<6M!XO7 >KM5 7[-ED@U?DAHA/
MFRLFS^P"91E$).8!C0$CMU/K'3P]<UUED+;X-R!;7CD&BLJ<TF_JY&(YM1SE
M$0G)0B@(+/_NR!D)0X4D_?B>@UI%G\JP>OR(_D=*7I*98T[.:/@Y6(KUU!I9
M8$EN<1**:[K]D^2$?(6WH"%/?\$V;^M88)%P0:/<6'H0!7'VC^_S0%0,H+?#
M .4&Z+D&;FZ01L[./$MIG6.!9Q-&MX"IUA)-':2Q2:TEFR!6PW@CF+P;2#LQ
M^T#CU<E'PB)P3N8"'-UDPPGH+:C?.@9'YT3@(.3'X 1\NCD'1V^.P1L0Q. R
M"$,Y)'QB"^F1PK47>>_OL][1CM[/R:(/7-@#R$&HQ?SL^>:P;F[+.!3!0$4P
M4(KG[L23(;B(N6")S%0!OGR0#<"%(!'_VD8N0_/:T50!GO(-7I"I)2N,$W9'
MK-FOO\"!\UL;54-@->)N0=S5H6=9(-10+V4(VJAF]GYJKQX-=S,T&(R<B7U7
MY=#2:N1X7M&JYIQ7..?IG2.<RU)@3 W)AK*T_&5^AGN=SG '%7>@[P\:/K<T
M@H[?[K)?N.QWB"<@]XLP60;QJDFCS6G_B3_(A\AK>-W2:C!VQ^UN#PJW!UJW
M_Z:"<(#ZKN^\!1\I@$X?.6][LL8E%\*EV_@!ST,".(F"$QS'"0[#AQY8)@2(
M-:/):BU+<0#!ETL2S0G["OX#&>;CA3;"6I^Z5I$AL%KXAD7XAD8?'T.3Q V!
MU8B/"N*C'WQ\C)X^&) S'C62NJ65"T<[:G%<.#=^Y:26%RZ#.(B22)OG6C>[
M#K<AL%I$H5.*!L=HIN=PAKB;0JN3KR@FJ$VHB\?$N<:"M++-)1>L)++3=Y#K
M-_)=W]%+B91J!VHUQ4^J#'R_MS+T?G9.CT,H*5A**>B:K0VM-.M,WA!:G7PI
MU:!>J^VO#:^M-J"#FJ6A[>>E/$K]!O4"[J>4QN=TC4F6X-T=87+-K*\1K<.=
MT\006CV\I<Z$ [,U8E0CFD*KDR]5(M1JL5DQ[#@?]B*IV*ZB&;9.*%YS4;"_
M7=WE4M]!O<!3RWTY9G*H$D9Z8-@?^JH:+K$\5\N:O[ L /:@UN'#:H87-OK4
MUG;>>70-H=5#5:I-.#:;VD9EH2FT^O9)J0N15GH]8R&0 U0UOM=\]NO;U%TK
M51OZ0=6&VE7;<-A4;?J.7AKCRAZ57K7]GC *8C67] #L.XZ<H 0%;A\BOVV"
MVC4WN2USTU5FTP/_B#5ACZ?ZU;O>V\Z;8(?0;JC4;LBL=D-&M9LIM#KY4KNA
M/?ML^XO7>UJ8OM?<!&QK-8+#'05<2C*DEV2OF/?/7.#K"73.AD-(-%1*-&16
MHB&C$LT46IU\*=&07J+MGRPR^W%]KH#-2CC$IAPJ51O2J[97KIAG+/SU!#HG
MS2&4'RJ5'S*K_)!1Y6<*K?[^J%1^KE[Y[:V8W!ZZ]9)Q93(V7R(=8GO/+86B
MJQ>*KULUG?8$]$RZ9I IM'K<2UWKFGWYZAH5GJ;0ZN0K[U_U+V"[[PGD@(T9
MJ+F4VM<J<]>N?#^@/MZXQ&P5Q!R$Y%::.7*U;P&6?0^1G0BZ23\IF%,A:)0>
MK@E>$J8:R/NW5.9[?J*^4BB^2IG]#U!+ P04    "  5<EM65D4Q"M<+  "F
MA   &0   'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6RU76MSVS86_2L<=;>3
MSF0E$@!?J>V9-FAFTVFZF633_9#9#[0-VYI(HDM1<3.S/WXIF1((/BX?./*'
M1+* <X$CX?K<0PB\>$JS+]L'I7+GK_5JL[V</>3YXZO%8GOSH-;)=IX^JDWQ
MREV:K9.\>)K=+[:/F4IN#YW6JP5SW6"Q3I:;V=7%X7?OLZN+=)>OEAOU/G.V
MN_4ZR;[]K%;IT^7,FQU_\6%Y_Y#O?[&XNGA,[M5'E7]Z?)\5SQ8GE-OE6FVV
MRW3C9.KN<O:3]TIZ;KSO<6CRQU(];2N/G?U<KM/TR_[)V]O+F;L?DEJIFWR/
MD13_?56OU6JUARH&\F>).CL%W7>L/CZBOSG,OIC-=;)5K]/5?Y:W^</E+)HY
MM^HNV:WR#^G3/U4Y(W^/=Y.NMH=_G:>RK3MS;G;;/%V7G8L1K)>;Y_^3OTHF
M*AT8Z^C R@YL: =>=N"U#I[HZ"#*#N+ S/-4#CS()$^N+K+TR<GVK0NT_8,#
MF8?>Q?27F_T;_S'/BE>71;_\ZK=T<_^/?ZML[4AUG3LOI,J3Y6KKI'>.^=(/
MI]=^N%CD1>1]_\5-&>7GYRBL(XI4-W.'>R\=YC+F?/HHG1=_:X-Y/0;FET\?
MG!???Q?Q0/S8!B9IL'=)=@+SS.Z+@L03D^S$)#O@B0Z\CVJS3#/G]S176^?S
M.[6^5ME_G?\=9GOX91%I'OONWU\Z[Y)\ERTW]\6#;_OP_-2^C5HR[#XQO-H^
M)C?J<E:L_*W*OJK9U???>8'[8QO!2# ) C/HYB>Z^0&==WX6BH_KV\TVSW9%
M'LJ=S[\5#9RWN5IO6UGD2!:18!($9K H3BP*\D/[I@!V_DA6.]7&V7-?_]!W
M_Q?DZQ7S(O?P<['X6B6$C#*6$!"808A_(L0G"7F[R56!FCL?DKR5D^?NGE<A
MQ9V[+/9KC QL)_O;&?,(3O,(;+.1F!?O8S4;_9IL=L4?_WU&$F1&(D./74M(
M, D",R@/3Y2'T(P4(EE$@DD0F,%B=&(QLLA(42,CA6'0FI'(*&,) 8$9A,0G
M0F*[C/3</383B*C1,:21[&ED#-]SM<)T;5,1GT=F*GJCKK-AN8@./G890=$D
M"LTDOB+M/6A"*N%05"+1) K-I%)K>X\6]W16*CM7TQ(7?FM:HN.,9N4<"MS3
M$MPCM6E_:BK[U]4-C^JL#&LG^]N9,]$RV*-U\*#BC;<6;SZ=GI#*^#443:+0
M3,ZUTO9\;'HBE?MH*I%H$H5F4JG%OD>K_9[T%#154YF=&ND)JL91:"8K6H][
MI% =D)["]N*+UXNYH0TE/:*I,];:V:/%\Z"J3W1+K8#.94A-_1J*)E%H)O%:
MHWLQ-I>1FG\TE4@TB4(S751=+C"Z7*!S6=FYFLL\-XA;DQD=:+39>0XQS[28
M9Z3"[4]F9?]ZCA+U2G!@.]G?SIQ)Q2<'&.4!\ZM)ZJ-ZS \-^[,4'7VT7XXU
MS,^AUYG6ZPSKF3.H:0Y%DR@TDTI=,# ;XYPUG?.CX&HD*:BD1Z&9K&A)SRS=
M\[*_QVM"JECN=5Z&MI3TF*;.66MO!G#:"7LKIK,9U&N'HDD4FDF\EO<,Z[<S
MJ.$.19,H-)-*73<P&].=-5UW+W;;;7<ZT&A:SJ'JF5;US-)Z+_LW-%+=WQK8
M3O:W,Z^5:U'- 1Y\K3!\]K>X2^8G.N[HZ^I0Q8Y",SG7BIUC[7<.M=^A:!*%
M9E*I2P9N8[_SIOW>Y6_1<4:S<I8-,)4=,);V.^^PR^LEX<!VDA[/U/EJS<T!
M)KWPNY069W0F@SKU4#2)0C.)U[*>8YUZ#G7JH6@2A692J:L%;N/4\Z93[W6F
M,JB61Z&9M&@MSRVM>M[AP(MZW3BTH:1'-'7&6G)S:ZL^KF\7_3W]>C3!>$0G
M,ZA5#T63*#23>"WJ.=:JYU"K'HHF46CFWE%=50@;JUZT6/5AV+Y]%*K[46@F
M*UKW"TNG7K0[ZW%\\@CW/UZ=HRF]Y-A>YIRU0!?6GK[GSEFG"\9I%XR./G8-
M0M$D"LUD7A<! NOI"ZBG#T63*#23RLI>>!M/7S0]?>9V[(:'BG\4FLF*%O_"
MTM,7K5O8/9?561G63O:W,V>BM;>P=NI]PJGORU%0IQZ*)E%H)O%:W0NL4R^@
M3CT43:+03"IUV2!LG'K1=.K9Z8]\?3E"13T*S:1%BWIAZ=2+=F?=KSOU ]M)
M>CQ3OZ2DE;>/]_,KJ4QX9"JC@X]=?U TB4(SB=?BWL>:^C[4U(>B212:2:6N
M&7P;4]]OFOI>UQX*.M!H6LXAZ'TMZ'U+5]\?Z.H/;"?I\4R=KU;=OK6K+^;,
M-,)^VMWO"H:*1$9[^G3HT:L/*NM1:";ME>^Y8CU]'^KI0]$D"LVD4M<5OHVG
M[S<]_;@KCT%%/PK-9$6+?M_2TO?;G7K1V HVM*&D1S1UQEJ;^X#=]W[;)@M!
MGP!!QQV]]J#"'X5F<JZ%OX]U\WVHFP]%DR@T\\  75,$-FY^T'3S@XXKDW2<
MT5_I/X?@#[3@#RS=_*!CGWP]BPUL)^GQ3)VO5N6!M9/OSWGHMQ\<(7H.CH#Z
M^% TB4(S>=>R/\#Z^ '4QX>B212:2:6N* (;'S]H^OC'0VV:F0RJ^%%H)BU:
M\0>61G[0ON7>+U9[G9>A+24]IJESKIR"8VWY\WD4=G[72-#?-:*CCUZ$V*-P
MSB'_ RW_ ZSG'T ]?RB:1*&95.JZ(K#Q_(.6W?E=1AD=:#0MYY#^@9;^@:7G
M7_:O9RD>-?/9T):2'M/$.8=:HX?6OK]?WS56]?UCY_.Z.YW1P<>N02B:1*&9
MQ.LR(,3Z_B'4]X>B212:2:6N,$(;WS]L^OZL*YW1@4;3<HX"(-0%0&CI^X?M
M?K[?.'IP:$-)CVCJC+5.#P'.OV@[=,>GOY1$QQV]^*!%  K-Y%P7 2'6]@^A
MMC\43:+03"IU;1':V/YAT_;O3&-0W8]",UFI'()I:?N''6Y^PS ;VE#2(YHZ
M8RW/0VO;G\_#SKT8/KT7@PX^>@%""P 4FDF\+@!"K/<?0KU_*)I$H9EGKNJZ
M(K+Q_J.6G?RLP_RG XVE!85FTJ)5?V1I_D?MICX/ZZP,:R?I\4R=KY;FD;7Y
M'Q"[^'UZARP=?.SZ@Z))%)I)O!;_$=;]CZ#N/Q1-HM!,*G55$=FX_U'3_6>A
MUY[)H+H?A6:RHG5_9&G^1^T'T0?U7?P#V\G^=N9,M.R.\"?;5W)40,LM.OCH
MA055]B@TDWBM[".LHQ]!'7THFD2AF516SKBW.N2^Q='OVL5/!QI-RSD$?:0%
M?63IZ$>#SKH?U$K28YDXUU@K[IA6W,_YZWWR+;E>J9?.O_('E1V?&GGMEUV6
MGKY#222VGKL(T<,9NQJA:!*%9KX56N7'6&\_AGK[4#2)0C.IU 5$/-3;+SZY
MY;VY6BF$E@(EFB<&%*@2%=ID2"O]V-+F+_O7LE?]V^"#6DEZ+%/GJJ5X3$OQ
MB3FNYI7]NBM68^]!^_101G^BH-H?A6:^#5K[QUC//X9Z_E TB4(SJ=3%1SS4
M\^_);] RHD0S\EO'L4 2%=DD2!<)L:7]'[>[^E[=,1O83M+CF3I?K>1C6LE/
M2G&L[J$=4UQ(ISCHI0 HFD2AF6]#Y1Y9V$L!,?12 !1-HM!JM^NJWJ]KZ,4
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M]FZ 06(5DW8LD:G&^U.%/7,*1$JL^AB(Y_G02J0?U40EIKNF&&4B(>TKWE8
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M+A?,>-[B'%; []M;*F;FB)*5-32L) VBL%X85_9E8EO205G\7<*6[8R1I/)
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M;L:Z:$336C8#Q;>VV5IRI5LW^[G1[3@( ]#K*\[586 VZ!K\[']02P,$%
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M?Q^)#^GC[[PV-"WB!6F4EW_18ZUU1BC8YR*-Z\*R!G&85/_]KW4B&@6PVU&
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M$.GPH=@,V^&L3^/\0*\$F,IH.U,SG>N>(8#K&J,*S;"=S4X$I!B ,(-( 1&
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M<P_0=+6P8CIF9[K^G=2$*Z.3 I"VT#W8PK0]*$1C=D0[#9<RB*MTQZ;&X#-
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M7E4 \7Q-"'\=5#_0GL;._P=02P,$%     @ %7);5CGSVEIS P  TPL  !D
M  !X;"]W;W)K<VAE971S+W-H965T-S4N>&ULK99M3^,X$,>_BI5%)U8ZR$/;
M%+@V$B6[NGV!A.#8?6V2:6NM8^?L*67WTY_MA- F::A.O&D=9^;O^<TDDYEM
MI?JIUP!(7@HN]-Q;(Y97OJ^S-114G\L2A+FSE*J@:"[5RM>E IH[IX+[41#$
M?D&9\)*9V[M3R4QND#,!=XKH35%0]6L!7&[G7NB];MRSU1KMAI_,2KJ"!\#'
M\DZ9*[]1R5D!0C,IB(+EW+L.K](PL [.XCN#K=Y9$XOR).5/>_$MGWN!C0@X
M9&@EJ/E[AAO@W"J9./ZM1;WF3.NXNWY5_^K@#<P3U7 C^0^6XWKN77@DAR7=
M<+R7V[^A!II8O4QR[7[)MK8-/))M-,JB=C81%$Q4__2E3L2.0Q@?<(AJAZCM
M,#[@,*H=1L<ZC&N'L<M,A>+RD%*DR4S)+5'6VJC9A4NF\S;X3-BZ/Z R=YGQ
MP^2;R&0!Y!_Z IJ<WD,F1<8XHZXH<DD6L&)",+$B5.3DB\CM\E$H8[@2[#?D
MUM58"5@RU)_):0I(&3>K,_+XD)+3D\_DA#!!;AGG1E//?#1AV\/]K YQ4848
M'0@QC,BM%+C6]GC(]P5\P]M 1Z_0BVA0,87LG(S"/TD41%%/0#?'NX<][NGQ
M[L$ S:@IX<CIC0[H=8MVL#Y]R:_$Q_WBMNU<Z9)F,/=,7]&@GL%+_O@4QL%?
M?8G[2+'T@\3VDCINDCH>4D\6E%.1 :%(GII7P*3V%U#5E\5*;>+4;*]]3B:C
MF?^\FYNNR72\;Y)V3>(WDSV.2<,Q&>2XSG-F'POMNF-.S ."YH$HI:ZW%7"*
MY@9*@FLP+4<I$'B0LSHMWHDP;&%V+8(6Y9#%'F3<0,9'0IH/88O/U*Q4S&Q;
MHMX7(.XBQ2VFKLFX#=6C$O5331NJZ2#5/>2;[!!6O@%;,DY+#991(\4-@N/E
MK&#HFD$O[_2] MUT+<XF+=PAD3W:BX;VXO_3OE_$BW>ANA9G4>L53?ML^K$N
M&ZS+02S;?34@<C##4G\#ONP>VGZG>DQ&[=B[-@<J$@9OLT%P;!,$\_4?:'^U
MT%[GNFQ!]-BT>V3:8S-M=T!_9]HI0*W<U*A))C<"JQF@V6TFTVLWC[7V%W9B
M=5/4FTPU[MY297J^)AR61C(XGYJ 5#5!5A<H2S=3/4DT$YI;KLW4#<H:F/M+
M*?'UPA[0S/')?U!+ P04    "  5<EM6?V1631T&  "K)@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970W-BYX;6S%6EUOVS84_2N$5PP)D,8B9<MVEAAH(FU+
MT11!LW0/Q1X8F;:)2J1+TG:Z7S_J(Y9%,43<,MA+HH][#Z_.)2]Y:)YON?@J
MEX0H\)AG3%[TEDJMSOI]F2Y)CN4I7Q&FW\RYR+'2MV+1ERM!\*QTRK,^"H*H
MGV/*>M/S\MFMF)[SM<HH([<"R'6>8_']DF1\>]&#O:<'G^ABJ8H'_>GY"B_(
M'5'WJUNA[_H[E!G-"9.4,R#(_*+W#IXE*"H<2HO/E&SEWC4H/N6!\Z_%S?7L
MHA<4$9&,I*J P/K?AER1+"N0=!S?:M#>KLW"<?_Z"?WW\N/UQSQ@2:YX]C>=
MJ>5%;]P#,S+'ZTQ]XML_2?U!PP(OY9DL_X)M;1OT0+J6BN>ULXX@IZSZCQ]K
M(O8<8/2, ZH=D.DP>,8AK!W"ESH,:H?!2QV&M4/YZ?WJVTOB8JSP]%SP+1"%
MM48K+DKV2V_-%V5%1[E30K^EVD]-KUG*<P+^PH]$@J./6 A<9.X8',5$89K)
M8_ 6W-_%X.C-,7@#* ,W-,MTBN5Y7^GV"Y1^6K=U6;6%GFD+(G##F5I*D+ 9
MF;4!^CKP7?3H*?I+Y$2,27H*0G@"4("0):"KE[M#BWO\<O? XIZ\V!U.'&2$
MNU2&)5[XDE1^^:#?@FM%<OF/+5,5U, .552G,[G"*;GHZ?(CB=B0WO377V 4
M_&9CV2=8[!,L\036RL=@EX^!"WUZSP1)^8+1?\D,*/P('@@C<ZHDH'.P]VK+
MU]D,T%P'H@"9STE9.TL//1B)+7M5P\.RX6(JV$P'@_/^9C\G79,0MDUB9_B'
M,NT)K,7T<,?TT"/3N*2XF$V($)4#L5:SJM%HCT(T-%BVF""#96?HA[+L":S%
M<K1C.7*R?$L8SA35Q04SW5^9(KH-I:?Z5*S-:EX1&'78@6.#0(N)V4VC3D^&
M1AH29^ _2,MH1\O(2<OU$Q%'M"S QX \ZF6<) !+R5.JA[#N>50MP9JE1.A)
ME95]=,4E+=9*-N)&'59,WKH6;XT*$'=-#(O$^6$_2-MX1]O8W9NX(DQ1G.F!
MF.HEKN9+$Y-1_$ SJKX#O09^AC#K6!UW^Y'!F#.<0R<IGV"))[!6&B:[-$R<
M:?B,LS6NENR9%@U8,W[2*HU%+R;J!*1X197.5L;UO3P!..=KIFRIF'12$47F
M[.0,ZM!D^ 1+/(&UD@&#9C4>N$>%X!M:BK"B_U<%Y?D)J@9K]?JH,T?9K,+!
MQ*@6%BLT"".C8KC#_U%Z]L0*=-(3=SJF[HF;;A>VD@6['S@. I.LKE483$8F
M638L.#+)@IV9"X6H&0IM$E!# G*2<*?TE%+.P1]XJD?D^[6@<D8KX?WEAN0/
M1%C7_&[<0Q?]7M%BKVB)+[1VAAHA!CTJ,>A5BGE%B[VB);[0VEEIY!ATZ[&/
M1 &^(L4&!UO4\YB>UH0H%QM;+*QKV!JT53TG9M'PJ:1BKVB)+[0VZ8TR@VYI
M]O[^_H.[*/G41U=>T6*O:(DOM'8F&O4&(X]%R9.BJK/B$RWVBI;X0FMGI1&/
MT*T>+>MO($A6Z"%K7KJB+@PBLQQYTG4UW=TFD2DD?;78)K&1DM"M):_91@OP
MG-CU".QJ0PMG7:/.HJ]K,@P[:[[7$'.P47/0+><.U \^E=.55[086F0D1";;
MKZ'64*/6D%NM_8P<01:]%4Y,G6RSBH;F%J,[S$,KHB^T-JF-QD-NC9?L=L";
M[EMNA)<[N2RE&2WI/0'I$K-%N6W4W;"0MCRX=BW<41TZ%KRBQ<@B-R-H2-?$
M5YOMO#6R%+EEZ97@C$OPA^#K%="+C5/GLL\-=C#=7K6H5[3$%UH[+8T611ZU
M*/*J1;VBQ5[1$E]H[:PT6A2YM:A[Q8*ZFC,T-ZHL-A"-S8FA:X0Z9>,U!")J
M!")R"\2?FD.'W1\Y1Z8XMQ@- G-MYP[RX,[U&DH/-4H/N7^H^[]F4*^:T2M:
MC"P_(B)HC@2O4K"_=R@G)V)1GH:2("WHJTZX[)[N3ER]*\\9&<\OX5E<G9MJ
M8*IC7#=8+"B3("-S#1F<CO3WB>ID5'6C^*H\^O/ E>)Y>;DD>$9$8:#?SSE7
M3S=% [OS:=/_ %!+ P04    "  5<EM6336U0P &  "5(P  &0   'AL+W=O
M<FMS:&5E=',O<VAE970W-RYX;6RU6EUOVS84_2N$UPX)T-HB*<EVEAAHK!;+
ML&!%LG0/PQX8F8Z%2J)'T4GZ[T=]1+(HDHX#[B61Y'N/[KDD[SVB=/[$^/=B
M0ZD SUF:%Q>CC1#;L\FDB#<T(\68;6DN?UDSGA$A3_G#I-AR2E:54Y9.D.>%
MDXPD^6AQ7EW[RA?G;"?2)*=?.2AV64;XCTN:LJ>+$1R]7+A)'C:BO#!9G&_)
M [VEXF[[E<NS28NR2C*:%PG+ :?KB]$G>!9AOW2H++XE]*G8.P8EE7O&OI<G
M5ZN+D5=&1%,:BQ*"R'^/=$G3M$22<?S;@([:>Y:.^\<OZ%\J\I+,/2GHDJ5_
M)2NQN1C-1F!%UV27BAOV]"MM" 4E7LS2HOH+GAI;;P3B72%8UCC+"+(DK_^3
MYR81>PXP-#B@Q@&I#K[! 3<.^+4.?N-0I7I24ZGR$!%!%N></0%>6DNT\J!*
M9N4MZ2=Y.>ZW@LM?$^DG%E=YS#(*_B3/M  G-S1F>9RD":D&A:W!Y_6:5D-3
MFH ;(B@@^0K<C6_'X M=44Y2<"N(V G&?U2_GX*3B J2I,4I^ CN;B-P\NX4
MO -)#JZ3-)6XQ?E$R-#+ "9Q$^9E'28RA D1N&:YV!3@<[ZBJS[ 1')NB:,7
MXI?(BAC1> PP_ "0AY FH.7KW:'&/7J]NV=A@]MAQ!4>-N"]TZ6T=O'U+F5!
M.2NV)*87(UDQ"LH?Z6CQ\T\P]'[1I<,E6.0(K)<JOTV5;T-?5%-WW4S=HIVZ
M7$Y=71)KL* "*XOHXP(&@9PPC_O)&1K-/-RWB31 OC]MC7I<@I9+8.52KKQZ
M0:8LEG22>C6+<C5_ +EL&W()OW"55\$]S>DZ$3JB]9W"O?A\'"@\-38!5'AJ
M;*"GIQFV-$,KS;+TR.*>%&41D;U.%O-<'C[20L@6)+3U)!R$ 95(ET,3I!".
M-"98SV7:<IG:IU\>4R[+8UZ-QY85B3"5Q.G@YI["8&CQ<4!A:#/7,YBU#&96
M!M](NJO[ TFE;""2D%0 *97=5TMC-@PR#'V%B<8(JDQT-@8N\Y;+W,KE#[&A
M7!?T7)-9=?YH;.9*R$.34!\P]+J&[=D7 Q-R,6\Y>TPJ\2770V_=:YNK-RP^
MH3I3ECHK[*N4-%;(QR9:>SH$6CO8>VW<T&4+<XH6N4+KYPMU^4(NVUB#-M\O
M)N/!C'Z5573(JL^HDS#0VO:=-K/F5A#V8O2"N4I8:P?A3*6,-90]TZ3OI BT
M:Y&W-+8&4J7F#<;28#=5J1GL#'T.=MH$VL7)$9VN09I;6MV!FYUXXZGW_E2[
M4(-#">L3[%0)M,N28QOA ;B3N0Q*2V%YR-,;^R;R!SWQP+.?CD[80+NR,?;2
M WXR!F3B_5;/J/%\]:!WX@?:U4_W0%S.:F.YG>E*I/K8T%@I0>) ?70PV?D&
M,IWZ@7;Y\^GR"OQ]3;-[RO_1TK"Z']U_7:)%KM#ZNP>=#$/>\4_<R"K=CLV7
M4[3(%5H_7YV^0U8]M+AJNYHV<7 @*C\B]1E!9P1#9:UHC R=#'5:"Z'CM2FR
MZK.CQ]HE6N0*K9^O3LDANY([,-9V9VU+:I)TT-/4!I%>#YK: >H4'+(KN-_N
M[GZWEE"[_]'3Q"5:Y JMG[M.(*+@#274JO..SI=+M,@56C]?G=Y$=K%V8%F%
MP\+GA6H)'1JISP,:DP ;]BE1)PZ17:J]9=?"#GGT5'")%C5H^UD*(3)DJ1.7
M:/:&1F,5I$>GP25:Y JMGZ].OR*[?CVP(N;:HN^K3\H&.P^I*T-O-YWIAQUW
M6A+;M_26G.6LL+81.\+1+W.<*DM7:/WL=<H2VW<.]>^^G.X<.D6+7*'U\]6I
M66S?.;0OFL:YWT:4!:.Q@4C=,M,8(<-[(+SWFM/^GE-;(+';%YUNWW3^'Z\Z
M<2=/L5V>'AAKP]:?^N!EL,/J/H4)3WT F^Q]KY!1_E!]]U& F.UR4;_!;Z^V
MWY9\JKZH4*Y?PK.H_D*D@ZD_6+DF_"')"Y#2M83TQE,Y#WG]#4A](MBV^BKB
MG@G!LNIP0\F*\M) _KYF3+R<E#=HO\19_ =02P,$%     @ %7);5N1[7L/
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M\7*-T0(S&2"^7U+*7]_(AW_VCY--_@-02P,$%     @ %7);5J<S_7]' P
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M>PZ4!>#Z4DKS-+ ;M"_$["]02P,$%     @ %7);5NU#*ZD$"0  1TL  !D
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M3,5G]O([70_(+?%BEA;57_2RLAUX/10O"\&RM;.\@RS)5_^CUS41.PX21^]
MU@Y$==AW!7OM8*L.SAX'9^W@'.O@KAVJH?=78Z^("R(1C:XX>T&\M)9HY8>*
M_<I;\I7D9:(\"BZ_3:2?&#W2F0R[0)_I@G&1Y#-TMCE5XJ%'F9F394K?HK.
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MK!A^%S><[O)Q\(IR3N/\<@LD )8!Q/,UI?QXDVU0_0MB_@-02P,$%     @
M%7);5G>]B7#0 P  7!   !D   !X;"]W;W)K<VAE971S+W-H965T.#,N>&UL
MM5C;;N,V$/T50ET4#K")+KYE4]N $Z6M@75BQ$W[4/2!EL8V&XI423I.@7Y\
M24I6)*^L30#EQ>+ES!'G#(?4>+3GXDEN 11Z22B38V>K5'KENC+:0H+E!4^!
MZ9DU%PE6NBLVKDP%X-@:)=0-/&_@)I@P9S*R8PLQ&?&=HH3!0B"Y2Q(L_KT&
MRO=CQW<. P]DLU5FP)V,4KR!):C'="%TSRU88I( DX0S)& ]=J;^5>A; XOX
MG<!>EMK(N++B_,ET9O'8\<R*@$*D# 76CV>X 4H-DU['/SFI4[S3&);;!_:?
MK?/:F166<,/I'R16V[%SZ: 8UGA'U0/?_PJY0WW#%W$J[2_:YUC/0=%.*I[D
MQGH%"6'9$[_D0I0,_,$)@R W"(X->B<,NKE!]ZT&O=R@9Y7)7+$ZA%CAR4CP
M/1(&K=E,PXIIK;7[A)FX+Y70LT3;J<D2-CJ*"CU RH4B;(,Z=YR=+[#N1"3%
M=FB.V6ZM([03(- T_ELORQK-%"3R#'5"4)A0W3I'WS,6*Z($MB%?8 84A1 1
MNXG^G$.R O&7)GE<AJCSZ0Q]0H2A.:%4S\N1J[2_9M5NE/MVG?D6G/#-#]"<
M,[65Z);%$%<)7"U4H59P4.LZ:&34B[U 7?\S"KP@J%G0S=O-_1KS\.WF7H,W
MW2+V7<O7.\%WMYB7HZDXNN%2H?LU6F(*$DU9C&9,@0 ]>ONBCQH)19CJPM'X
M.G."7<D41S!V]!$E03R#,_GQ!W_@_50G99MD84MD%9E[A<P]R]Y]<XK-6'9@
MVVW_5<.S3*K5M->FIFV2A2V1533M%YKV&[=NYQ=]I9TARJ74MP_%"F*S?RE1
M9)/I*D$I"D;X.E4S]KYE-U?C\^1\<#ERG\MBU6"&@RHF_!;3*Q 5QP:%8X-&
MQ^Y3$-FYF6\;^7HP_H>6"7\"O** %H+'NZ@Z^VH[8Q%/ '6^:GW.RI#OI7P)
MJI&/RVECOC>Z\MZ]V299V!)9)83#(H3##\SW89N:MDD6MD16T?2RT/3R0_,]
M8Q]4\KU[E.\UF/X1)OP6<R+?OQ2.?6ETK+A?L;YLN=KJ;Z085@I!=MU^1DQ_
M^Y>RLL";R_G>XD.#OSW@[ZKXHX3_C;_O1F]<_'MW8YMD84MDE:#YWNM7L_>!
M.9Z3MR1KJVQA6VQ584OEB/^AB9[35V[M_E&BUV&"XTRO 7E'J>Z6RJX$Q,:6
MKQ)%?,=45E,4HT6)/+6%X='XM2F=;3GW2I/5W7,L-H1)1&&M*;V+H5Z/R$K9
MK*-X:HN[%5>Z5+3-K2[_01B GE]SK@X=\X+B#X7)_U!+ P04    "  5<EM6
M+Z+]O"H$  #"%@  &0   'AL+W=O<FMS:&5E=',O<VAE970X-"YX;6S%6-MN
MVT80_94!&Q0.D)@W75U)@"VFC0&K$:RF?2CZL")'(F&2J^ZN)!?(QV>7I"E2
MHAFKV< O$B\S9W?.7+@SHSUE#SQ$%/"8Q"D?&Z$0FRO3Y'Z(">&7=(.I?+.B
M+"%"WK*UR3<,29 I);'I6%;/3$B4&I-1]FS.)B.Z%7&4XIP!WR8)8?_=8$SW
M8\,VGA[<1^M0J ?F9+0A:UR@^+R9,WEGEBA!E&#*(YH"P]78N+:O/+NG%#*)
M/R/<\\HU*%.6E#ZHF]M@;%AJ1QBC+Q0$D7\[G&(<*R2YCW\+4*-<4RE6KY_0
M?\V,E\8L"<<IC?^* A&.C8$! :[(-A;W=/\1"X.Z"L^G,<]^85_(6@;X6RYH
M4BC+'211FO^3QX*(BH(TM%G!*12<8X7.,PINH>"^5*%3*'0R9G)3,AX\(LAD
MQ.@>F)*6:.HB(S/3EN9'J?+[0C#Y-I)Z8K+ M?2B@'O<4":B= T7"QE;P39&
MH"N8,WPOR"/\09?$]RF0-("/2&(1PETDHC7)G#<-"5LC?PL7'@H2Q?+J/7Q>
M>'#QYBV\@2B%613'4I*/3"$WK98V_6*#-_D&G6<V:#LPHZD(.7Q( PSJ *:T
MMC39>3+YQFE%]-"_!-=^!X[E. T;FKY<W6Y0]UZN;K58XY8.=#,\]SD'_E]O
MP=]W$@IN!2;\GR:_Y.MVFM=5]>B*;XB/8T,6'(YLA\;DYY_LGO5+$Z<ZP3Q-
M8#6^.R7?G3;TR9S17514O9@(#$!0B _L,O0I.PG4G-%6Y',9S<&Z&9BJ[KO)
M4,;3KLJ3IO5J/'5+GKJM/'TC!F6IEA$XPV2)K#'Z6M'/Y4HGF*<)K,9JKV2U
M]TK9WM/)MTXP3Q-8C>]^R7?_AV5[_R1!;=>N9^@TE^E590;.41:?X@S<4J1F
MU:"T:J M-^$+_(8I,A+#E#)Y2) LM"9NZ]+G!I).,$\36(WR84GY\)42=ZB3
M;YU@GB:P&M^V=3C86C\L=0OH:EXZ_:/4;9 Y^0 WR%C-J6M7#NRVSN2]305*
M>@5<2_E/(D0&'BX%?'B4K2/'=_"[;"Z;Y!4^S>0#)8]/\FE%OI&[UNV?&Y!:
MT3Q=:'77.0?7.:]4!(J%=9&N$\W3A58G_= ?V:WMP/?5 ?<D?]WC,G J,CRN
M J<BG6>JP*$+L;_1ALQD@WU=3=PSZ\*GC?RF9PW_;>K3!.'BCG+9N#>*%%."
M&L BH0](EC*:)</!UA?MY_EV>\Z.4)UHGBZTNB\/G9+=?:VRH+6+THKFZ4*K
MDWYHI.S6ON'[RD+O]&AO'1_M&X0&[G%E.)7I#X]*@UD9[B4HW:Z&I!Q\NDU%
M/O0JGY:#V.ML_'CT_$8-:+.AX0$FG^[.9#1%*8<85Q+2NNS+#;%\8)K?"+K)
M1HA+*@1-LLL028!,"<CW*TK%TXU:H!Q;3[X"4$L#!!0    ( !5R6U:%/S $
M!@H  -UR   9    >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;,V=6V_;.!J&
M_PKA70Q:H%/K:#N=)$ ;DKM=;!;!%+-[,9@+1682;77P2'22 OOC5Y(5TY09
MVG)?8:87C0_D0TDO^8EZ]=$Z?RK*K]6#$)(\9VE>74P>I%Q]F$ZK^$%D4?6^
M6(F\_N:N*+-(UF_+^VFU*D6T;"MEZ=1SG-DTBY)\<GG>?G937IX7:YDFN;@I
M2;7.LJC\]DFDQ=/%Q)V\?/!S<O\@FP^FE^>KZ%Y\$?*7U4U9OYMN*<LD$WF5
M%#DIQ=W%Y*/[@<^<ID);XM^)>*IV7I-F5VZ+XFOSYO/R8N(T6R12$<L&$=5_
M'L652-.&5&_'[QUTLFVSJ;C[^H7.VYVO=^8VJL15D?XG6<J'B\EB0I;B+EJG
M\N?BZ>^BVZ&PX<5%6K7_DZ>NK#,A\;J21=95KK<@2_+-W^BY.Q [%6J.N8+7
M5?#Z%6:O5/"["OZQ+01=A>#8"F%7(3RVPJRK,&N/_>9@M4>:1C*Z/"^+)U(V
MI6M:\Z*5JZU='^ D;WK6%UG6WR9U/7GY2>3B+I'D)HWRBKSY5U264:/U6_*&
M"ADE:?66_$A^^4+)F[^^/9_*NLFFXC3N\)\V>.\5O$^NBUP^5(3E2[$TU+^R
MUW<]"V!:[^MVA[V7'?[D68G_6.?OB>^\(Y[CN:8-LE>G(JZKNVUUWU"='E_=
M,U1GQU<W;3P_OKIC.9;^MO/X+<]_E7=7?[(DNYV(T*2*TZ):EX+\^L_Z:_)9
MBJSZS=1W-O3 3&]BZH=J%<7B8E('S4J4CV)R^<-?W)GSDTDW)(PB80P)XR"8
MIG>PU3NPT2\_9L4ZEQ6)'Z+ROM9=%D0\U^>X2I#Z'-<$]+8[Q/6(+9/;=7OJ
M6#6!Q22^M:FAXB-A= ,+6UAS9GZ\/'.=]M_Y]'%76$-!QU20[Q=<+'H%-4'"
MK2"A59";[A3_Z[7(;D5I'&16PM#CC(11)(PA81P$TS2=;36=C1I49TB]D3"*
MA#$DC(-@FM[SK=YS>U"-XW6V3B-9:W[;:5[<ILE]U,1/D\)6WE"%D3"Z@<UV
MXMRLBYQ[L7._Z,(S%^6@3=3466S568#5L?*&JH.$T<7>(7?]P"B.H>1\9M0&
MM(&:-F=;;<ZLVO H*<ECE*X%*>[:B0:)JDI(XW3#BAHJ"Q)&S_8.=E^.@R4X
M:(,T&5Q'74,Z]FE(6?Q7Q,</$3MNJ!A0&NUH6M\/^Y.UC2R&HIXW-PX3U#;J
M NU<Y+M6@5[F%"_R-&/E'5EUL\=VY#PE\H&L+$*2)*]G^[&HJMYH>W=HZ-DW
M;K#<2!KM:+;1=[@(1VV3+J^GY/5.D7=7HJB]=#.J8V4/5@=)HQUM]\)I-G-\
M\VC<+[N8GQG+<E/9,[=_D:>KH4P1UWH-_HH:M1#K;-4,I(JLJ^8J.4KC9F*1
MY/<D%W4Q42;%,HFW]>*BDN_:"^QV1*9%?O^C%&5&RGHVTHS!4LAUF9.7$6P9
M@%"C!4JC'<UU=X?7>V?F]N5]I=RL+^W!<KJLROMP[>9'_UJ;_(_PHA1Q5$GK
M];<=._C@0YT.*(U!:1Q%T^56SHH;CGH9[D)]%RB-0FD,2N,HFBZ[,E]<Z[7^
MGS%X0PV=CG8HW%)HJPQ*XRB:WD647^/:#1O#B> Z>DZR=68_#T!M&RB-0FD,
M2N,HFJZV\G_<Q;CG :@?!*51*(U!:1Q%TV57UI)K]Y;82^2^6\M&9I&MTN*;
M*+6;6^9X#76:H#3:T7:O>WRS/0MMEZ-H^AU_Y4]Y!_RI_8C-,E'>-V?OZZC\
M6I]YK:';CA\J*91&H30&I7$439==N5Z>.VKH]J"^%91&H30&I7$439==N6&>
MW0V[*K)5426M9WGXOH =-EADJ/W5T<[TN7K?&8&VR5$T73QEGGEV\\P0JMOT
M1_(Y?Q25S$0NR=_*:"GL 1MJ>$%I%$IC4!I'T73QE<7F!>,&;*C5!J51*(U!
M:1Q%TV575IMGSV(:&+"AQAJ41CN:'K#WXC74+T/1=.V47^;9_3+3U/KW=2*_
MD2\B7I>UJ.+ W!IJ;T%I%$IC4!I'T73=E0GFS<<-U5 W#$JC4!J#TCB*ILNN
MW##/G@YULWM/6399P))$:5K$FQ2!E2CC>H86W0NCYE K#$JC'4V/W%X_<D,=
M+A1-EU(Y7)[=X3+=STR>ZR'].8^+3!P=OZ%V%Y1&H30&I7$435^XH2PQWQDU
M?OM02PQ*HU :@](XBJ;+KBPQWYX(]EWQV\X>K#G4#^MH>OQ>].(WM$F.HNE2
M*IO+M]M<)\3OT\P4^W8,EAWJD$%I#$KC*)K>/W;6YHV\. ^[.@^[/ ^[/@^[
M0&\,#\U7'IIO3U,;9J;888-%ACIF':UGIOC]F YUPE T73SEA/D'UO,5E2R%
M3$K1QF9MZ%I#--03@](HE,:@-(ZBZ7(K\\P?=ZF?#_7.H#0*I3$HC:-HNNS*
M._,/))"U,;D>X<MFE)OC\GPO42/P/5.FQI6]L<&R0;TO*(VC:+ILROOR[=[7
M=ZVRL+,'#U6H]]71=CN;ZQD[&S,5783&-1:&HIYC76+A*^_*MWM7?[XL7?L&
M#]87:H-UM'[.[WS>%_>X<OQP.?W7)90I%1S(TSIB^G/LL@M[4T,%@=(HE,:@
M-(ZBZ5U &53!N#E; =2C@M(HE,:@-(ZBZ;(K,RLX907C'QG0[1L\N"-YYI 9
M])9=0%ME4!I'T?0NHORLX$!FV'$GAV.68MA;&JPMU-J"TAB4QE$TO0?L_/K4
MN.EA =3L@M(HE,:@-(ZBZ;(K4RRPFV*G+\6P@P<+#K7%.MH12S&@[7(431=3
M65[!@7RQXZ+XH.49]B8'RPRUP: T!J5Q%$WO"LH&"\9-(0N@*610&H72&)3&
M431==F6C!2/::';V8,VA-EJP;WCMA7)H AF*I@NI3+C@0 +9<:'\A(P#>\.#
M58:::5 :@](XBJ;_%JFR[\)Q<\I"J&4'I5$HC4%I'$7395>676C/*1N6<6"'
M#189:M"%IB0R)^P%<6B;'$73Q5/&6W@@B^S(^?B@-1WV-@=K#,T8@](8E,91
M-+TO*(<M'#=C+(3::E :A=(8E,91-%UV9:N%]HRQ[\H)MK,':P[UU$)3 EFX
M%\ZA7AF*IFNY\WOPWY] =N)"#WO+@Y7&_I(\]J?DL;\E/X;A%BK#+1PWQRR$
MFFM0&H72&)3&431==F6NA<?DF)T:U*'.&I1&.YH>U(.]H YUS% T74OEF(4'
M%EUB@OII7HQ]VP;W!:CC!J4Q*(VC:'J?4>9<>#9NV(=:<% :A=(8E,91-/W1
M,<J"F]DSZ(9Y,7;84)&A--K1>JL_^BNRH6UR%&TCWG3GJ7S-[<SV^8D5B9M[
M&YOGU6T_W3ZC\6/[9,+>YU?N![YYTJ+";![\>!TU=TDKDHJ[&NF\G]=SS7+S
M+,7-&UFLVF?_W192%EG[\D'4(;]L"M3?WQ6%?'G3-+!]HN7E_P%02P,$%
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M)43UB8\\*H*(B3T']/57=1O=28B%L:KNF%4=D\P;B:Q1U6E9U>G@?'Q4?#0
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M#&+8,L2/4438/VL(Z6EI8./\X#G8'T3ZP%PM$K*'%Q"_)5LF[\R2Q0\BB'E
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M91K&&?NH*ZT!]^@Q%H@1 7S>EH6QSBSH)'-TDKF:R&I9F)19F"@GPXOD"SQ
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M7PS.@A9AM5\+*.>!HC$4FEQ:SGD6:.W70A=VZ2X3AB"#RP2=F^_8.2E9> K
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M..4J"6RJ"+R[0(&E4% X!H-3ZBM0J *^NT!A]YV9$<,LF7F/7: WM)]]B#N
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M7M#K2\[5R\0T357/&_\&4$L#!!0    ( !5R6U85F3!U8P0  "D6   9
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MWTHV:7^4!(^]QJ=KBO(FOOG3Q5ZUBGM]:EF!5J?1%#-3D-^A%OC$;^!^]*S
MJ8L5;G(T! 63#H[5,H^MRV'/FE8\K"%7?E.;C6'#4=!13+7X8OOJ:QEEJ];9
M8<^=VK[0ZDVHEGH<?""]PU;C<7;K>D*KMZ[R']AN0&R:A]N&HC6A[9"!'W:L
MU;AR'=AN.\X5O+9E()/6!+:#_*!+\"I;@>V^XOV"-VIW*APW.;:#NHP/KLP
MMBZ:?>O=N-UKTK1PAJ ![NIUM3QC^_JLQQC27<)^Y&/\T)IH89<\*_K9<]L3
M6OVG:F4)B/>!)(]8_<G9OU9[0JNWKO(HQ.Y1;))'VHYCX#>MDS&H8TS)R>Z#
MW9:<J7G$8"B&3:+6F#K/RG$0N^-XM^(5.#4Q:QIF0TR'OR.5&R#V7_[]ZEWQ
ML/KNQ*19ABEHW"C$/=G'TYNH]Y0_Q6H:$]BH+.]JI-+Y<5_R>"+9+M_:6S$I
M69H?;H&N@>L =7_#F'P[T;N%Y>[P_#]02P,$%     @ %7);5MOEJ^P3"
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M6K5_T6.'G8S0XKZJBZQKK'J0)?GV?_RQ"\1> QSU-"!= V(W8#T-:-> 'MJ
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M'0"&84L'@"$<UA'M=$3>6;M=3>1'M6-5$KU*\D61R=?@_(U"SM^09"(0F1'
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MH"P OR^D-(\=.T%_8\K^ 5!+ P04    "  5<EM6**HGB]<#  !2$   &0
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M-?W M8%ZOF),'B=Z@_+?")/_ %!+ P04    "  5<EM6@LFM4AL"  !*!
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M*-T7L?F2:FKXVK1H9=22:VQQ$P]MOJ"T )060M&:N<%5;O"Q1IB"#)4C2%H
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M?:#0;&Z,^_'<]N?#U_M#<C_1*LX_"Z,+I31C+%7'3@"MS$):HQDH&H5"L_O
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MM#@;VR9%#Z]2]- N!:KEJ"903:*:0C6-:@;5"E2SJ.90S:-:B6H5J@5*B_]
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MG=,.+62@FD UB6H*U32J&50K4,VBFD,UCVHEJE6H%B@M#L:VNS$>X",M6L)
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M2-7Z3J47[66;;G55Z;R].9=B*DWS@OKY.ZVKISO- K:7"CO_$U!+ P04
M"  5<EM6I\$3HSX%  !<)@  &@   'AL+W=O<FMS:&5E=',O<VAE970Q,#8N
M>&ULK9I;;^(X%,>_BI4=K5IIU%RX%+J U)++C%1&53NS^[#:!S<Q$#6)6=O
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MJCE4\Y065H\ZLMCOXVT"&D!$M0S5!*I)5%.HIE$M1S6#:A;5'*IY2@MK01U
M[,?OF=BN34"CAZB6H9I -8EJ"M5T_^'JQ9VT>:<C=$B#:A;5'*IY2@LG=YTH
M[,<3A2]M$[JMV@0TB8AJ&:H)5).HIE!-HUJ.:@;5+*HY5/.4%E:/.K+8'^%M
M AI 1+4,U02J2513J*91+4<U@VH6U1RJ>4H+:T$=0.S'[YG8KDU HX>HEJ&:
M0#6):@K5]%8+VH3.@S8!312BFD4UAVJ>TH+)/:@3A8-76:,Y?72-YGU%(;X/
M;8L"JF6H)E!-HII"-8UJ.:H95+.HYE#-4UI8/>K(X@!?;'F !A!1+4,U@6H2
MU12J:53+4<V@FD4UAVJ>TL):4 <0!_%[)K9J$^)6ZRJ 1@]13:":1#6%:GJK
MA7<Z:EZ;@ YI4,VBFD,U3VGAY*X3A8-7684Y;:["O(KW"6@4$=4R5!.H)E%-
MH9I&M1S5#*I95'.HYBDM+!]U9G'0P_L$,G5U@FH9J@E4DZBF4$VC6HYJ!M4L
MJCE4\Y06UH(Z@3@ EV&.6ZVK )H]1#6!:A+5%*KIK;;;)W33;K-/0".%J&91
MS:&:I[1P<M>1PL&K+,.<-I=A?J)/0+.(J):AFD UB6H*U32JY:AF4,VBFD,U
M3VEA^:A#BP-\'>8!&D%$M0S5!*I)5%.HIE$M1S6#:A;5'*IY2@MK01U!'(#K
M,,>MUE4 #1^BFD UB6H*U?3@X3K,G7&GV2>@F4)4LZCF4,U36CBYZTSAX%76
M84Z;ZS _T2>@8414RU!-H)I$-85J&M5R5#.H9E'-H9JGM*!\#.O4XA!?B'F(
M9A!1+4,U@6H2U12J:53+4<V@FD4UAVJ>TL):4&<0A^!"S'&K=15 TX>H)E!-
MHII"-3U\N!!SY\%"S.B0!M4LJCE4\Y063NXZ5#A\E868T^9"S/$^(;X3K:L"
MFD9$-8%J$M44JFE4RU'-H)I%-8=JGM+"\E''%H?X2LQ#-(.(:AFJ"523J*90
M3:-:CFH&U2RJ.53SE!;6@CJ#.(SFFEKV"63BZ@35,E03J"913:&:WFIA[JAY
M?0(ZI$$UBVH.U3REA9.[#A4.7V4EYK2Y$O,3?0*:1D2U#-4$JDE44ZBF42U'
M-8-J%M4<JGE*"\M''5L<XDLQ#]$,(JIEJ"903:*:0C6-:CFJ&52SJ.90S5-:
M6 OJ#.(07(HY;K6N FCZ$-4$JDE44ZBFAP^78NZE#]Y/0$.%J&91S:&:I[1P
M<M>APN&K+,7<:2[%_$2?@*8142U#-8%J$M44JFE4RU'-H)I%-8=JGM+"\E''
M%H?X6LQ#-(.(:AFJ"523J*903:-:CFH&U2RJ.53SE!;4@E&=01R!:S''K;95
M -4R5!.H)E%-H9H>/5R+N3]L7L>,#FE0S:*:0S5/:>'DKD.%HU=9B[G37(LY
MWB?$=Z)U54#3B*@F4$VBFD(UC6HYJAE4LZCF4,U36E@^ZMCB"%^,>81F$%$M
M0S6!:A+5%*II5,M1S:":136':I[2PEI09Q!'X&+,<:MU%4#3AZ@F4$VBFD(U
MO=7Z.WW"H-M\/P$=TJ":136':I[2PLE=API'T5S32_N$H_Y?JW^:%S/O,I^*
M^5EU\)"X:3D]GZPWC'<29)CK!-4R5!.H)E%-H9I&M1S5#*I95'.HYBDM+#!U
ML'&$K]<\0E.*J):AFD UB6H*U32JY:AF4,VBFD,U3VEA+:A3BJ/XS14WM>#T
MOA9\?Y/,K]='!.O.8E56+<8JF2_*9%64Y:PXJPXB-@_N+1%H>!'5,E03J"91
M3:&:'CU<S'G<;#+01"*J651SJ.8I+9SW=2)Q]"I+.?]0D['YZG*Z.$O^-M]?
M0M#D(ZIEJ"903:*:0C6-:CFJ&52SJ.90S5-:6&WJB.0(7_IYA.8=42U#-8%J
M$M44JFE4RU'-H)I%-8=JGM+"6E#G'4?QVS2"'0<:@T2U#-4$JDE44ZBF1P_7
MA6Y>3HT.:%#-HII#-4]IP;P?U]G&<3S;V'+>3Y9?IN7RMH&XVG0-^TI ?,RV
M)0#5,E03J"913:&:?N+OJ)M\+R;+U;XC G0_#*I95'.HYBDMK QU,'+\*L%(
MZ%S$KS>+O94%S5&B6H9J M4DJBE4TZB6HYI!-8MJ#M4\I875ILY1CO$<Y1C-
M4:):AFH"U22J*533J):CFD$UBVH.U3REA;6@SE&.XSE*[EQ$?*#6)0(-6:*:
M0#6):@K5]%;;/1>1-LY%H ,:5+.HYE#-4UHX[^N(Y3B:L'JE<Q%D1NP$U3)4
M$Z@F44VAFG[B[RC=G(O8>T! [H9!-8MJ#M4\I86%H8Y&CN/W?/RYN$G^OEC^
M'IPG>,GIB5^7D_EJNJD8?U^?KEJ?K^C]=7/7EQWH\[; /#.1'=_YUA4&36&B
MFD UB6H*U32JY:AF4,VBFD,U3VEAV:E3F&/\7I%C-&Z):AFJ"523J*903:-:
MCFH&U2RJ.53SE!;6@CJ9.8XG,W>.!6[[C_6[&GLK )J61+4,U02J2513J*91
M+4<U@VH6U=Q6V[T>MM>\'M930X83NPY!CN/WB<QGU2.+Z2K26^R=YF@0$M4R
M5!.H)E%-H9I&M1S5#*I95'.HYBDMK =U$'*,W_AQC"8>42U#-8%J$M44JFE4
MRU'-H)I%-8=JGM*"6I >U>G(]<?(8?\34-LBP'(9RXD[;O? ;G04'M=)=DS%
M<IKE<I8S+&=9SK&<Q[C&+$]W9GD\ZOB,'N 'WU](V[^M\,1.MZ\H:-B1Y03+
M2993+*=9+F<YPW*6Y1S+>8QKU)[.3NW!@X]W)%89T.@CRPF6DRRG6$ZS7,YR
MAN4LRSF6\QC7J S=G<KP1 SR^;T'&G.\XV)']QD[IF YR7**Y33+Y2QG6,ZR
MG&,YCW&-6=[;F>7QL-IK]A[I^,6]!QD?.V&YC.4$RTF64RRG62YG.<-REN4<
MRWF,:]2>_D[MP6\Y>4=BE0&-.[*<8#G)<HKE-,OE+&=8SK*<8SF/<8W*,-BI
M#$_<@/+YO0>:>+SC=GN/SL/> TTRLIQD.<5RFN5REC,L9UG.L9S'N,8L'^[,
M\GBH,5_<3.)]1\N;TS\Q8/MJ@,8?64ZPG&0YQ7*:Y7*6,RQG6<ZQG,>X1MT8
M[=0-_,:1=R16&=#$),L)EI,LIUA.LUS.<H;E+,LYEO,8UZ@,XYW*T/8VDF>3
MR\EY52!6B^OSB_)-\FTRN]Y[KX8[>O?0/^TV5ED]>6('VD]\-!_)<I+E%,MI
MELM9SK"<93G'<A[CPHF?[@0ETWA0<GV)MB_^F)XNV(8B/FSKPP:4RUA.L)QD
M.<5RFN5REC,L9UG.L9S'N$;UV E@IBG>4*1L/!+E,I83+"=93K&<9KF<Y0S+
M699S+.<QKE$9=N*1:31F]4,-Q98.<DR]9C\1'[_]O&?#CR@G64ZQG&:YG.4,
MRUF6<RSG,:XQ[W?"CVD\_.C_]O.O'W[^\-(PU/JZB\=N0;V_5K 12I3+6$ZP
MG&0YQ7*:Y7*6,RQG6<ZQG,>X1E79"5NF/;[/($-?)RR7L9Q@.<ERBN4TR^4L
M9UC.LIQC.8]QC<JP$X5,X[>8?'[@*0ZUKP=L !+E!,M)EE,LIUDN9SESQP4W
M4PJ;6<L.Z5C.8]SM)#]<711%F4W*R?&[RV)Y7IP4L]GZ7,'UO%P/LO-HLBR^
MKFO VP^=@\,'CW],WYZD>Q[/TK=JW^,Z?>LVCQ_6PQZ_NYJ<%WZR/)_.5\FL
M^%KMPM%/P^H;7D[/+^X_*1=755DZ2+XLRG)QN?GPHIB<%<OU$ZJO?UTLRKM/
MU@/<+):_;[[-XW\!4$L#!!0    ( !5R6U:<-!D><P(  ,L%   :    >&PO
M=V]R:W-H965T<R]S:&5E=#$P."YX;6RU5%%OVD ,_BM65DVM-#40H)LZB 1E
MTSH5#16Q/51[.!)#3LW=97<&6FD_?KX+9%0J/$S:2V)?[,_?YXO=WQK[Z I$
M@B=5:C>("J+J.HY=5J 2[M)4J/G+TE@EB%V[BEUE4>0A295QTFI=Q4I(':7]
M<#:U:=^LJ90:IQ;<6BEAGT=8FNT@:D?[@WNY*L@?Q&F_$BN<(<VKJ64O;E!R
MJ5 [:3187 ZB8?MZU//Q(>"[Q*T[L,$K61CSZ)W;?!"U/"$L,2./(/BUP1LL
M2P_$-'[M,*.FI$\\M/?HGX-VUK(0#F],^4/F5 RB#Q'DN!3KDN[-]@ON] 2"
MF2E=>,)V%]N*(%L[,FJ7S R4U/5;/.WZ<)"0)$<2DEU"$GC7A0++L2"1]JW9
M@O71C.:-(#5D,SFI_:7,R/)7R7F4WAA-4J]09Q(=G'^C BV,I:O6Q/Y<Y^SR
M&<Q($#^1J$2^$X+ARF*PW 6<CY&$+-DZ ZEA(LN2.^[Z,3%#7R?.=FQ&-9OD
M")LV3)A/X> 3%\Y?YL>LK)&7[.6-DI. 7X6^A$[['22MI WSV1C.SRY.X'::
MMG4";O<([G3"8$-XF*!:H/T)O^%?.M?DO]:IDP3\K%Z[2F0XB'@8'=H-1NG;
M-^VKUL<3\KJ-O&Y [QR1=V><@Y>_QL,=Q\ MH7*OTNW^![J]AF[OY&T,E5ES
M8XWEGF,.9&"!4 F9P](:!29<324L/;_&O,;N!6R_PS9I)^G'FT,^\<& *;2K
ML$8<9+YL/6O-:;.IAO6 _@VOU]Q$V)74#DI<<FKK\CT7MO7JJ!TR51C7A2$>
M_F 6O&W1^@#^OC2&]HXOT.SO] ]02P,$%     @ %7);5@<(->I' P  U0X
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M.$*?T/U=A X/CM !(CF:$4K5+(JQ*U6?--F-Z_8OJO:#'>W[:*9ZL!#H2YY
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M4S[5,9N)(UXQ5< WPSPE:H]3F"ND=WRBAL>K&*K*2%:8J.*1216CF.1"Q9W
M=07U?<Z87&=T TTD&_X&4$L#!!0    ( !5R6U8SV3_+=0@  -AE   :
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M6Q\ACN(8;J<3.'C_!":TSM0>Q;5'L<=M/X-[J8R!?]VZN[0R<$&8FY_[B):
MQ_L!75N<F(*E. ILW1O4:PR2#^]:W>A3 ]UV3;?=A/XW 02"LQD7G!YMM0M&
MF $I*%#[UI,IVL[1:&]G2F9FGQ^EI8ZWY+IQG;0&D7^&X7H/Q^.:XW$CQTMT
MB0<UA['&C!/<76$^0[TWF(U0+PQFIR;:>>W<=]Z ;K>FVVW.?1E-=PQL;?N(
MS03"2F8VV+;S@"TTHOT'I'W$2^CN3K*/NTW)[M6D>HVD;G"MQ-H&L$KV.4O+
MJJRR#K^KJ].*8&-%--I[88C[M3?]UZZ(_AO0'=1T!V]7$8/_VK\=5<^3F@AW
M)H8;OE=,+[@T('!NE:.CGD71Y4 K-Z0*/T1FBNQ(\LNE_09 [03L_5PIJC9N
M+M5?%<D?4$L#!!0    ( !5R6U8T:,BN; ,  *X6   -    >&PO<W1Y;&5S
M+GAM;-U876_:,!3]*U&Z3JTT-82L@:R M"%5FK1-E=J'O56&.&#)^9AC.NCC
M?L]^U7[)?.V0!.J+:!]66%")?8_/N<?V#4DZ*.6*T]LYI=)9ICPKA^Y<RN*#
MYY73.4U)>9$7-%-(DHN42-45,Z\L!"5Q":24>]U.)_12PC)W-,@6Z74J2V>:
M+S(Y=*,ZY)C3YWCH^N%[US%RXSRF0_?^[.V/12ZOWCCF?/+NY*1S?WZU'3_3
MP+GK644O]Q"]Z*@#5=8H)A_N)[]+')/N;4KKX:=*R!!/,5I_+T<[#&'"D<6/
MLM]8@@Y"[G6LY!85(_KVK)MI\;Q=^VK\^?4;J:H&:=655Q7P:)#D65/'@6L"
M*C-)J?- ^- =$\XF@@$K(2GC*Q/N0F":\UPX4EU RHH/D?+1P+[IP;55Z:0L
MRX7.;3*8[TDU? M8]\ @X[PVV'5-8#0HB)149->JHP?KX!/(J=IWJT(YG FR
M\KN7;D/0)Y5DDHN8BCJ-[ZY#HP&G"=@1;#:'L\P+#T I\U0U8D9F>4:TAS6C
M:BC9*>7\%GYXOB<;VLNDM:>ZDK*ZJ0Q532-C.J#?5C/:;=GP1;I.P1YR^6FA
MII/I/E0*O1$T84O=7R:U 4S=Q]5)4?#51\YF64K-Y/=..!J0-<^9YX(]JFQ0
M*E,5H,)U'JB0;-J._!2DN*-+N2ZG98)[[AZAYW^[SC.:44%XV[2J_4->Y1<[
MKN[4K^%9_ZQL.[::#'J'[[%Z.CETD^$QF#R*[>X?@\GH"$SV7NU7\SDF_6,P
MV3U\D\%AEJ17/5.V'EPW'EOKJ .O!T/W&[R(\":I,UDP+EE6]>8LCFGVY.E5
MR4LR42_C&_IJ?$P3LN#RK@:';M/^2F.V2*-ZU TL1#6J:7^!Z:E'X?6[B<K%
MLI@N:3RNNF(VT4U'-536Z@#"-G*M#SN"<0QF1P##\F .,(YA87G^I_GTT?D8
M#//6MR)]E--'.89E0\;Z@^6Q<R)UV&<:14$0AMB*CL=6!V-LW<(0_NQJF#=@
M8'D@T_/6&M]MO$)VUP&VI[LJ!)LI7HG83/&U!L2^;L"((OMN8WF @>T"5CN0
MWYX':LK."0+85<P;=@7C2!1A"-2BO4;#$%F=$#[V_<&NDB"((CL"F-U!$& (
M7(TX@CD #Q@2!/H^N'4_\M;W*:_Y#_7H+U!+ P04    "  5<EM6EXJ[',
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M\5]B_?Z<E_G<L.9/>ZUX/&FRS9=U65[X?7?J5O-B]XJIW>NQ/OX#4$L#!!0
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M*=T&L-L4;P/H[55O#]#;J]X>H+?O?FP#]/:JMP?H[55O#]#;J]X>H+=7O3U
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M4;T+0.^J>E> WE7UK@"]J^I= 7I7U;L"]*ZJ=P7H757O"M"[JMX5H'=5O2M
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MKF-AC.5<R.+<R.)<R?JO=[*^C^/^'\<OS[BOVN$U/UG^T>#F)U!+ 0(4 Q0
M   ( !5R6U8'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ %7);5J X8,+O    *P(  !$
M     ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ %7);5IE<
MG",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX
M;6Q02P$"% ,4    "  5<EM6%[7+;5 )  "A1   &               @($.
M"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ %7);5O7>
ML=T\ @  P 4  !@              ("!E!$  'AL+W=O<FMS:&5E=',O<VAE
M970R+GAM;%!+ 0(4 Q0    ( !5R6U9L.^"6VP@  .\H   8
M  " @084  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    "  5
M<EM6,CO4Q[\"  !"!P  &               @($7'0  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ %7);5N!L<JBU!0   Q<  !@
M         ("!#"   'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( !5R6U;->=72RP,  /$-   8              " @?<E  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  5<EM637Q3[;8,   D50
M&               @('X*0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ %7);5M:62FBA"   5#X  !@              ("!Y#8  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( !5R6U8UF4ZMU (
M .\(   8              " @;L_  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    "  5<EM6&I^VAK *  #5&P  &0              @('%
M0@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( !5R6U9Y
M!OL3P1D  'U2   9              " @:Q-  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ %7);5F^RJWA6!P  IA,  !D
M     ("!I&<  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !5R6U9RT_S16PL  % >   9              "
M@1Z@  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ %7);
M5F,UD/F#!0  [ T  !D              ("!L*L  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    "  5<EM6(0K^<M\'  #.%   &0
M        @(%JL0  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( !5R6U;,YYO0]@(  ,P&   9              " @8"Y  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ %7);5IE3JZ/1!0  $1$
M !D              ("!K;P  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    "  5<EM683&\VTL.  "Y*@  &0              @(&UP@
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( !5R6U9!FJC^
MWPT  /TG   9              " @3?1  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ %7);5N(0?DMD%P  ADX  !D
M ("!3=\  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    "  5
M<EM6 CC\U6T#   +"   &0              @('H]@  >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( !5R6U;?"!77J"D   ^&   9
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M970S,"YX;6Q02P$"% ,4    "  5<EM6@^"B&K$#  "O"   &0
M    @(&450$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M !5R6U8MDC>LH 4  *4/   9              " @7Q9 0!X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ %7);5K]"*^/K P  OPD  !D
M             ("!4U\! 'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    "  5<EM6-ZR@K\,"  #8!0  &0              @(%U8P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( !5R6U;VP,;9 0,
M ,L&   9              " @6]F 0!X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ %7);5LSSP(D%!@  OA$  !D              ("!
MIVD! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    "  5<EM6
M3 2/R'('  !F%   &0              @('C;P$ >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( !5R6U;C#)Z2H04  "T/   9
M      " @8QW 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ %7);5@*[V].8#   U3   !D              ("!9'T! 'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    "  5<EM62@R#Q; #  #-"
M&0              @($SB@$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( !5R6U8FLBT<^ H  *D=   9              " @1J. 0!X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ %7);5E,UIR?W
M!   4QX  !D              ("!29D! 'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    "  5<EM6C!WZ4%<$  "O%   &0
M@(%WG@$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( !5R
M6U9N6U74M (  %L'   9              " @06C 0!X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ %7);5LS[?Y^B P  #!0  !D
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M=#0Y+GAM;%!+ 0(4 Q0    ( !5R6U:KDZ+$D0,  +@1   9
M  " @=Z] 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @
M%7);5A.+'V*=!P  43H  !D              ("!IL$! 'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6Q02P$"% ,4    "  5<EM6[=8)NSH%  !F(P  &0
M            @(%ZR0$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4
M Q0    ( !5R6U9V7EZC#@8  +,R   9              " @>O. 0!X;"]W
M;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ %7);5J6ZN$4A P
MWP<  !D              ("!,-4! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6Q02P$"% ,4    "  5<EM6QF@1\R8&  "\,   &0              @(&(
MV $ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( !5R6U:*
MDD /10,  ,(-   9              " @>7> 0!X;"]W;W)K<VAE971S+W-H
M965T-38N>&UL4$L! A0#%     @ %7);5B%["GKZ @  90D  !D
M     ("!8>(! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !5R6U9613$*UPL  *:$   9              "
M@2SW 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ %7);
M5GPAH+TC P  "0P  !D              ("!.@," 'AL+W=O<FMS:&5E=',O
M<VAE970V,RYX;6Q02P$"% ,4    "  5<EM6)3.+_U0%   2)   &0
M        @(&4!@( >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0
M   ( !5R6U97N I9 P4  -XD   9              " @1\, @!X;"]W;W)K
M<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ %7);5N.F2Q-Z!P  >T\
M !D              ("!61$" 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q0
M2P$"% ,4    "  5<EM6OC"^#.8#   J$   &0              @($*&0(
M>&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( !5R6U:)\8NM
M@0,  )(-   9              " @2<= @!X;"]W;W)K<VAE971S+W-H965T
M-C@N>&UL4$L! A0#%     @ %7);5FR4Y2M[!@  F2<  !D
M ("!WR " 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    "  5
M<EM6 ] [D_D#   C$@  &0              @(&1)P( >&PO=V]R:W-H965T
M<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( !5R6U95D-8AA ,  .P+   9
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M970W-2YX;6Q02P$"% ,4    "  5<EM6?V1631T&  "K)@  &0
M    @($L10( >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    (
M !5R6U9--;5#  8  )4C   9              " @8!+ @!X;"]W;W)K<VAE
M971S+W-H965T-S<N>&UL4$L! A0#%     @ %7);5N1[7L/ !0  6B8  !D
M             ("!MU$" 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"
M% ,4    "  5<EM6IS/]?T<#   M"@  &0              @(&N5P( >&PO
M=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( !5R6U;M0RNI! D
M $=+   9              " @2Q; @!X;"]W;W)K<VAE971S+W-H965T.# N
M>&UL4$L! A0#%     @ %7);5M5NX">7!P  /3D  !D              ("!
M9V0" 'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6Q02P$"% ,4    "  5<EM6
MFO<TR'$$  ".&   &0              @($U; ( >&PO=V]R:W-H965T<R]S
M:&5E=#@R+GAM;%!+ 0(4 Q0    ( !5R6U9WO8EPT ,  %P0   9
M      " @=UP @!X;"]W;W)K<VAE971S+W-H965T.#,N>&UL4$L! A0#%
M  @ %7);5B^B_;PJ!   PA8  !D              ("!Y'0" 'AL+W=O<FMS
M:&5E=',O<VAE970X-"YX;6Q02P$"% ,4    "  5<EM6A3\P! 8*  #=<@
M&0              @(%%>0( >&PO=V]R:W-H965T<R]S:&5E=#@U+GAM;%!+
M 0(4 Q0    ( !5R6U:1FKY&% @  !LU   9              " @8*# @!X
M;"]W;W)K<VAE971S+W-H965T.#8N>&UL4$L! A0#%     @ %7);5C1#H:W6
M!   A"   !D              ("!S8L" 'AL+W=O<FMS:&5E=',O<VAE970X
M-RYX;6Q02P$"% ,4    "  5<EM6?/IWTY,$   -%P  &0
M@(':D ( >&PO=V]R:W-H965T<R]S:&5E=#@X+GAM;%!+ 0(4 Q0    ( !5R
M6U9L>YU!E@0  )0=   9              " @:25 @!X;"]W;W)K<VAE971S
M+W-H965T.#DN>&UL4$L! A0#%     @ %7);5M[3$ABE P  V1,  !D
M         ("!<9H" 'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6Q02P$"% ,4
M    "  5<EM6(4[7A <2  ";ZP  &0              @(%-G@( >&PO=V]R
M:W-H965T<R]S:&5E=#DQ+GAM;%!+ 0(4 Q0    ( !5R6U:VY?.D  ,  /\*
M   9              " @8NP @!X;"]W;W)K<VAE971S+W-H965T.3(N>&UL
M4$L! A0#%     @ %7);5A69,'5C!   *18  !D              ("!PK,"
M 'AL+W=O<FMS:&5E=',O<VAE970Y,RYX;6Q02P$"% ,4    "  5<EM6V^6K
M[!,(  ##.@  &0              @(%<N ( >&PO=V]R:W-H965T<R]S:&5E
M=#DT+GAM;%!+ 0(4 Q0    ( !5R6U9:6I*8$@,  #T)   9
M  " @:;  @!X;"]W;W)K<VAE971S+W-H965T.34N>&UL4$L! A0#%     @
M%7);5BBJ)XO7 P  4A   !D              ("![\," 'AL+W=O<FMS:&5E
M=',O<VAE970Y-BYX;6Q02P$"% ,4    "  5<EM6@LFM4AL"  !*!   &0
M            @(']QP( >&PO=V]R:W-H965T<R]S:&5E=#DW+GAM;%!+ 0(4
M Q0    ( !5R6U;%)'*3Y@4  &,J   9              " @4_* @!X;"]W
M;W)K<VAE971S+W-H965T.3@N>&UL4$L! A0#%     @ %7);5A<^DT.3!@
M1#4  !D              ("!;- " 'AL+W=O<FMS:&5E=',O<VAE970Y.2YX
M;6Q02P$"% ,4    "  5<EM6B,.T9?(,   *K   &@              @($V
MUP( >&PO=V]R:W-H965T<R]S:&5E=#$P,"YX;6Q02P$"% ,4    "  5<EM6
M^]5N">H$   V*   &@              @(%@Y ( >&PO=V]R:W-H965T<R]S
M:&5E=#$P,2YX;6Q02P$"% ,4    "  5<EM6G!_'0'()  #F:P  &@
M        @(&"Z0( >&PO=V]R:W-H965T<R]S:&5E=#$P,BYX;6Q02P$"% ,4
M    "  5<EM6\(*MYY(3  "#F@$ &@              @($L\P( >&PO=V]R
M:W-H965T<R]S:&5E=#$P,RYX;6Q02P$"% ,4    "  5<EM6A</=7D$"  #\
M!   &@              @('V!@, >&PO=V]R:W-H965T<R]S:&5E=#$P-"YX
M;6Q02P$"% ,4    "  5<EM6_WWSZM$)   V;   &@              @(%O
M"0, >&PO=V]R:W-H965T<R]S:&5E=#$P-2YX;6Q02P$"% ,4    "  5<EM6
MI\$3HSX%  !<)@  &@              @(%X$P, >&PO=V]R:W-H965T<R]S
M:&5E=#$P-BYX;6Q02P$"% ,4    "  5<EM6ILH+H!L8  !;U0$ &@
M        @('N& , >&PO=V]R:W-H965T<R]S:&5E=#$P-RYX;6Q02P$"% ,4
M    "  5<EM6G#09'G,"  #+!0  &@              @(%!,0, >&PO=V]R
M:W-H965T<R]S:&5E=#$P."YX;6Q02P$"% ,4    "  5<EM6!P@UZD<#  #5
M#@  &@              @('L,P, >&PO=V]R:W-H965T<R]S:&5E=#$P.2YX
M;6Q02P$"% ,4    "  5<EM6,]D_RW4(  #890  &@              @(%K
M-P, >&PO=V]R:W-H965T<R]S:&5E=#$Q,"YX;6Q02P$"% ,4    "  5<EM6
MT'6FQHH$  !I'@  &@              @($80 , >&PO=V]R:W-H965T<R]S
M:&5E=#$Q,2YX;6Q02P$"% ,4    "  5<EM6-^"4:\X%  !\,0  &@
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M<F5L<R\N<F5L<U!+ 0(4 Q0    ( !5R6U94IA\L20@  *)+   /
M      "  =57 P!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  5<EM6,)0:
M5S,#  ""0P  &@              @ %+8 , >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    "  5<EM610\$_HD"  #90   $P
M    @ &V8P, 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     >P![ .0A  !P
%9@,    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>724</ContextCount>
  <ElementCount>574</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>285</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>19</UnitCount>
  <MyReports>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Statements of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ConsolidatedStatementsofEarnings</Role>
      <ShortName>Consolidated Statements of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Statements of Comprehensive Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings</Role>
      <ShortName>Consolidated Statements of Comprehensive Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Background and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentation</Role>
      <ShortName>Background and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Revenues from Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/RevenuesfromContractswithCustomers</Role>
      <ShortName>Revenues from Contracts with Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Goodwill and Other Intangible Assets, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnet</Role>
      <ShortName>Goodwill and Other Intangible Assets, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Investments in Equity Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecurities</Role>
      <ShortName>Investments in Equity Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Short-Term Borrowings and Borrowing Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangements</Role>
      <ShortName>Short-Term Borrowings and Borrowing Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Capital Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CapitalStock</Role>
      <ShortName>Capital Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Stock Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/StockPlans</Role>
      <ShortName>Stock Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Earnings per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/EarningsperShare</Role>
      <ShortName>Earnings per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Other Comprehensive Earnings/Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLosses</Role>
      <ShortName>Other Comprehensive Earnings/Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlans</Role>
      <ShortName>Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Additional Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AdditionalInformation</Role>
      <ShortName>Additional Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Summary of Significant Accounting Policies (Policy)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy</Role>
      <ShortName>Summary of Significant Accounting Policies (Policy)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.altria.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Goodwill and Other Intangible Assets, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetTables</Role>
      <ShortName>Goodwill and Other Intangible Assets, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Investments in Equity Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</Role>
      <ShortName>Investments in Equity Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecurities</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstruments</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Long-term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/LongtermDebtTables</Role>
      <ShortName>Long-term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Capital Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CapitalStockTables</Role>
      <ShortName>Capital Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/CapitalStock</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Stock Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/StockPlansTables</Role>
      <ShortName>Stock Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/StockPlans</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Earnings per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/EarningsperShareTables</Role>
      <ShortName>Earnings per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/EarningsperShare</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Other Comprehensive Earnings/losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningslossesTables</Role>
      <ShortName>Other Comprehensive Earnings/losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/OtherComprehensiveEarningsLosses</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/IncomeTaxes</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReporting</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansTables</Role>
      <ShortName>Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlans</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Additional Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AdditionalInformationTables</Role>
      <ShortName>Additional Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/AdditionalInformation</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesTables</Role>
      <ShortName>Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.altria.com/role/Contingencies</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Background and Basis of Presentation (Background Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails</Role>
      <ShortName>Background and Basis of Presentation (Background Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BackgroundandBasisofPresentation</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails</Role>
      <ShortName>Revenues from Contracts with Customers (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/RevenuesfromContractswithCustomers</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Intangible Assets by Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Intangible Assets by Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Goodwill and Other Intangible Assets, net (Other Intangible Assets Disclosure) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets, net (Other Intangible Assets Disclosure) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Goodwill and Other Intangible Assets, net (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets, net (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Net Carrying Amount of Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Net Carrying Amount of Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails</Role>
      <ShortName>Investments in Equity Securities (Summary of Investments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Investments in Equity Securities (Earnings from Equity Investments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails</Role>
      <ShortName>Investments in Equity Securities (Earnings from Equity Investments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Investments in Equity Securities (Summary of Financial Data) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails</Role>
      <ShortName>Investments in Equity Securities (Summary of Financial Data) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in ABI Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in JUUL Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details</Role>
      <ShortName>Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in Cronos Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Investments in Equity Securities (Investment in Cronos) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails</Role>
      <ShortName>Investments in Equity Securities (Investment in Cronos) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/InvestmentsinEquitySecuritiesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Financial Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails</Role>
      <ShortName>Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails</Role>
      <ShortName>Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Short-Term Borrowings and Borrowing Arrangements (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails</Role>
      <ShortName>Short-Term Borrowings and Borrowing Arrangements (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangements</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Long-Term Debt (Summary of Long-Term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails</Role>
      <ShortName>Long-Term Debt (Summary of Long-Term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/LongTermDebt</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Long-Term Debt (Details of Long-Term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails</Role>
      <ShortName>Long-Term Debt (Details of Long-Term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/LongTermDebt</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Long-Term Debt (Aggregate Maturities of Long-Term Debt) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails</Role>
      <ShortName>Long-Term Debt (Aggregate Maturities of Long-Term Debt) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/LongTermDebt</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Long-Term Debt (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/LongTermDebt</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Long-Term Debt (Debt Tender Offers and Redemption (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails</Role>
      <ShortName>Long-Term Debt (Debt Tender Offers and Redemption (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/LongTermDebt</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Capital Stock (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CapitalStockNarrativeDetails</Role>
      <ShortName>Capital Stock (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/CapitalStockTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Capital Stock (Schedule of Issued Repurchased and Outstanding Shares) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails</Role>
      <ShortName>Capital Stock (Schedule of Issued Repurchased and Outstanding Shares) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/CapitalStockTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Capital Stock (Schedule of Shares Repurchased) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails</Role>
      <ShortName>Capital Stock (Schedule of Shares Repurchased) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/CapitalStockTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Stock Plans (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/StockPlansNarrativeDetails</Role>
      <ShortName>Stock Plans (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/StockPlansTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Stock Plans (Schedule of Restricted and Restricted Stock Units Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails</Role>
      <ShortName>Stock Plans (Schedule of Restricted and Restricted Stock Units Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/StockPlansTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Earnings per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/EarningsperShareDetails</Role>
      <ShortName>Earnings per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/EarningsperShareTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails</Role>
      <ShortName>Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/OtherComprehensiveEarningslossesTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails</Role>
      <ShortName>Other Comprehensive Earnings/Losses (Reclassifications) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/OtherComprehensiveEarningslossesTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Income Taxes (Schedule of Earnings Before Income Taxes and Provision for Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Schedule of Earnings Before Income Taxes and Provision for Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/IncomeTaxesTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Income Taxes (Reconciliation of Beginning and Ending Unrecognized Tax Benefits) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes (Reconciliation of Beginning and Ending Unrecognized Tax Benefits) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/IncomeTaxesTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/IncomeTaxesTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Income Taxes (Reconciliation of Effective Tax Rate and U.S. Federal Statutory Rate) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails</Role>
      <ShortName>Income Taxes (Reconciliation of Effective Tax Rate and U.S. Federal Statutory Rate) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/IncomeTaxesTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - Income Taxes (Schedule of Deferred Income Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes (Schedule of Deferred Income Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/IncomeTaxesTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - Income Taxes (Summary of Valuation Allowance) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/IncomeTaxesSummaryofValuationAllowanceDetails</Role>
      <ShortName>Income Taxes (Summary of Valuation Allowance) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/IncomeTaxesTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - Segment Reporting (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingNarrativeDetails</Role>
      <ShortName>Segment Reporting (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails</Role>
      <ShortName>Segment Reporting (Segment Data Schedule) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>81</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - Segment Reporting (Schedule of Depreciation Expense and Capital Expenditures of Segments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails</Role>
      <ShortName>Segment Reporting (Schedule of Depreciation Expense and Capital Expenditures of Segments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - Segment Reporting (Non-Participating Manufacturer Adjustment Items) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails</Role>
      <ShortName>Segment Reporting (Non-Participating Manufacturer Adjustment Items) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>83</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - Segment Reporting (Schedule of Pre-tax Tobacco and Health Litigation Charges) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails</Role>
      <ShortName>Segment Reporting (Schedule of Pre-tax Tobacco and Health Litigation Charges) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/SegmentReportingTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - Benefit Plans (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansNarrativeDetails</Role>
      <ShortName>Benefit Plans (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>85</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - Benefit Plans (Projected Benefit Obligations, Plan Assets and Funded Status of Pension Plans) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails</Role>
      <ShortName>Benefit Plans (Projected Benefit Obligations, Plan Assets and Funded Status of Pension Plans) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>86</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - Benefit Plans (Assumptions to Determine Postretirement Benefit Obligations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails</Role>
      <ShortName>Benefit Plans (Assumptions to Determine Postretirement Benefit Obligations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - Benefit Plans (Schedule of Components of Net Periodic Pension Cost) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails</Role>
      <ShortName>Benefit Plans (Schedule of Components of Net Periodic Pension Cost) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - Benefit Plans (Assumptions used to Determine Net Periodic Benefit Cost) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails</Role>
      <ShortName>Benefit Plans (Assumptions used to Determine Net Periodic Benefit Cost) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - Benefit Plans (Asset Allocations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansAssetAllocationsDetails</Role>
      <ShortName>Benefit Plans (Asset Allocations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>90</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - Benefit Plans (Fair Values of Pension and Postretirement Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails</Role>
      <ShortName>Benefit Plans (Fair Values of Pension and Postretirement Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>91</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - Benefit Plans (Estimated Future Benefit Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails</Role>
      <ShortName>Benefit Plans (Estimated Future Benefit Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>92</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - Benefit Plans (Amounts Recorded in Accumulated Other Comprehensive Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails</Role>
      <ShortName>Benefit Plans (Amounts Recorded in Accumulated Other Comprehensive Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - Benefit Plans (Movements in Other Comprehensive Earnings/Losses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails</Role>
      <ShortName>Benefit Plans (Movements in Other Comprehensive Earnings/Losses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/BenefitPlansTables</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - Additional Information (Schedule of Additional Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails</Role>
      <ShortName>Additional Information (Schedule of Additional Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/AdditionalInformationTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - Additional Information (Schedule of Valuation and Qualifying Accounts) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails</Role>
      <ShortName>Additional Information (Schedule of Valuation and Qualifying Accounts) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/AdditionalInformationTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - Contingencies (General Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesGeneralInformationDetails</Role>
      <ShortName>Contingencies (General Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails</Role>
      <ShortName>Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>98</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails</Role>
      <ShortName>Contingencies (Schedule of Pending Cases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>99</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - Contingencies (Overview of Tobacco-Related Litigation Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails</Role>
      <ShortName>Contingencies (Overview of Tobacco-Related Litigation Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0000101 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails</Role>
      <ShortName>Contingencies (Non-Engle Progeny Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>0000102 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails</Role>
      <ShortName>Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>0000103 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails</Role>
      <ShortName>Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>0000104 - Disclosure - Contingencies (Florida Bond Statute) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails</Role>
      <ShortName>Contingencies (Florida Bond Statute) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>0000105 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails</Role>
      <ShortName>Contingencies (Other Smoking and Health Class Actions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>0000106 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails</Role>
      <ShortName>Contingencies (Health Care Cost Recovery Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>0000107 - Disclosure - Contingencies (NPM Adjustment Disputes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails</Role>
      <ShortName>Contingencies (NPM Adjustment Disputes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>107</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>0000108 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails</Role>
      <ShortName>Contingencies (Other Disputes Under the State Settlement Agreements) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>0000109 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails</Role>
      <ShortName>Contingencies (Federal Government's Lawsuit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>109</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>0000110 - Disclosure - Contingencies (E-vapor Litigation and IQOS Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails</Role>
      <ShortName>Contingencies (E-vapor Litigation and IQOS Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>110</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>0000111 - Disclosure - Contingencies (Antitrust Litigation) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesAntitrustLitigationDetails</Role>
      <ShortName>Contingencies (Antitrust Litigation) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>0000112 - Disclosure - Contingencies (Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails</Role>
      <ShortName>Contingencies (Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>0000113 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails</Role>
      <ShortName>Contingencies (Lights/Ultra Lights Cases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>113</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R114.htm</HtmlFileName>
      <LongName>0000114 - Disclosure - Contingencies (UST Litigations Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails</Role>
      <ShortName>Contingencies (UST Litigations Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>114</Position>
    </Report>
    <Report instance="mo-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R115.htm</HtmlFileName>
      <LongName>0000115 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails</Role>
      <ShortName>Contingencies (Guarantees and Other Similar Matters Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.altria.com/role/ContingenciesTables</ParentRole>
      <Position>115</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: mo:LossContingencyStateCourtsNumber, us-gaap:CommonStockParOrStatedValuePerShare -  mo-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="mo-20221231.htm">mo-20221231.htm</File>
    <File>exhibit1038timesharingagre.htm</File>
    <File>exhibit21altriagroupincsub.htm</File>
    <File>exhibit23consentofindepend.htm</File>
    <File>exhibit24powersofattorney2.htm</File>
    <File>exhibit311q42022-annual.htm</File>
    <File>exhibit312q42022-annual.htm</File>
    <File>exhibit321q42022-annual.htm</File>
    <File>exhibit322q42022-annual.htm</File>
    <File>exhibit41descriptionofregi.htm</File>
    <File>exhibit991q42022-annual.htm</File>
    <File>exhibit992q42022-annual.htm</File>
    <File>mo-20221231.xsd</File>
    <File>mo-20221231_cal.xml</File>
    <File>mo-20221231_def.xml</File>
    <File>mo-20221231_lab.xml</File>
    <File>mo-20221231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mo-20221231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1778">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="46">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>141
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mo-20221231.htm": {
   "axisCustom": 2,
   "axisStandard": 50,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1778,
    "http://xbrl.sec.gov/dei/2022": 46
   },
   "contextCount": 724,
   "dts": {
    "calculationLink": {
     "local": [
      "mo-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "mo-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "mo-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mo-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mo-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mo-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd"
     ]
    }
   },
   "elementCount": 1066,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 12,
    "http://www.altria.com/20221231": 1,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 17
   },
   "keyCustom": 135,
   "keyStandard": 439,
   "memberCustom": 180,
   "memberStandard": 99,
   "nsprefix": "mo",
   "nsuri": "http://www.altria.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.altria.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Background and Basis of Presentation",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentation",
     "shortName": "Background and Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i496cf0d3b6c242988d0ca0ecf226c71f_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - Contingencies (Overview of Tobacco-Related Litigation Narrative) (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
     "shortName": "Contingencies (Overview of Tobacco-Related Litigation Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ibe7f62ed8ab74d7e9b1a432b029326b1_D19990101-20230127",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyClaimsDecided",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ie6e2ff8e6f1647eea34f150435a9f641_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyCompensatoryDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - Contingencies (Non-Engle Progeny Litigation) (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
     "shortName": "Contingencies (Non-Engle Progeny Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ie6e2ff8e6f1647eea34f150435a9f641_I20220930",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyCompensatoryDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i9fd12ffe6e314078bec64fc03dd0d7cf_D20220201-20220228",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyNumberOfPlaintiffs",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
     "shortName": "Contingencies (Engle Class Action And Engle Progeny Trial Results) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ic794e5582af74563b80ccb6479696bc2_I20000731",
      "decimals": "-9",
      "lang": "en-US",
      "name": "mo:LossContingencyPunitiveDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000103 - Disclosure - Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
     "shortName": "Contingencies (Engle Progeny Cases Trial Results - Pending and Concluded) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i50e02c65827141c0988efa4815111343_I20230131",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:LossContingencyCompensatoryDamagesAwardedValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2e77f2f208294f938fb2ec43209eee70_I20090630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:MaximumBondForAllDefendants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000104 - Disclosure - Contingencies (Florida Bond Statute) (Details)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
     "shortName": "Contingencies (Florida Bond Statute) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2e77f2f208294f938fb2ec43209eee70_I20090630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "mo:MaximumBondForAllDefendants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2b527c47e5014c0aaaf9b0b067634552_D19960501-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyClassNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000105 - Disclosure - Contingencies (Other Smoking and Health Class Actions) (Details)",
     "menuCat": "Details",
     "order": "105",
     "role": "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
     "shortName": "Contingencies (Other Smoking and Health Class Actions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2b527c47e5014c0aaaf9b0b067634552_D19960501-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyClassNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i5714b7cd4a1f4abbba5201ba8cc74bb1_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000106 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details)",
     "menuCat": "Details",
     "order": "106",
     "role": "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
     "shortName": "Contingencies (Health Care Cost Recovery Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i748c02005b4a4bf49a0612b63989ef03_D19981101-19981130",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStateswithSettledLitigation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i5714b7cd4a1f4abbba5201ba8cc74bb1_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000107 - Disclosure - Contingencies (NPM Adjustment Disputes) (Details)",
     "menuCat": "Details",
     "order": "107",
     "role": "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
     "shortName": "Contingencies (NPM Adjustment Disputes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ie91a77817ecc4e999d0370e2c9318a18_D20220301-20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStateswithSettledLitigationSettlementOne",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i0dedfe3526ab465c89c9b8e67c3357a8_D20210101-20210131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedFromOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000108 - Disclosure - Contingencies (Other Disputes Under the State Settlement Agreements) (Details)",
     "menuCat": "Details",
     "order": "108",
     "role": "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
     "shortName": "Contingencies (Other Disputes Under the State Settlement Agreements) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i0dedfe3526ab465c89c9b8e67c3357a8_D20210101-20210131",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LitigationSettlementAmountAwardedFromOtherParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000109 - Disclosure - Contingencies (Federal Government's Lawsuit) (Details)",
     "menuCat": "Details",
     "order": "109",
     "role": "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
     "shortName": "Contingencies (Federal Government's Lawsuit) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i0121b4c1497c443b91a2dbe5a6049059_D20060801-20060831",
      "decimals": null,
      "lang": "en-US",
      "name": "mo:FederalTradeCommissionDisclosurePeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.altria.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i3c7b5b8168e84e9f97ec53935f0e23bc_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000110 - Disclosure - Contingencies (E-vapor Litigation and IQOS Litigation) (Details)",
     "menuCat": "Details",
     "order": "110",
     "role": "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
     "shortName": "Contingencies (E-vapor Litigation and IQOS Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i3c7b5b8168e84e9f97ec53935f0e23bc_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "mo:NumberOfThirdPartyLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lawsuit",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i0d928ac82a174cbf9e654bf008eb8b4f_I20201130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberOfComplaints",
      "reportCount": 1,
      "unique": true,
      "unitRef": "complaint",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000111 - Disclosure - Contingencies (Antitrust Litigation) (Details)",
     "menuCat": "Details",
     "order": "111",
     "role": "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
     "shortName": "Contingencies (Antitrust Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i0d928ac82a174cbf9e654bf008eb8b4f_I20201130",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberOfComplaints",
      "reportCount": 1,
      "unique": true,
      "unitRef": "complaint",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ibf8ee6d0a42b48658f65843e7407c4ff_D20191001-20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shareholder",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000112 - Disclosure - Contingencies (Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)",
     "menuCat": "Details",
     "order": "112",
     "role": "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails",
     "shortName": "Contingencies (Shareholder Class Action and Shareholder Derivative Lawsuits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ibf8ee6d0a42b48658f65843e7407c4ff_D20191001-20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberOfShareholdersFilingClassActionLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shareholder",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i3ae0d3b51df54bbe8b1959b343c21c55_I20230127",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyClaimsNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000113 - Disclosure - Contingencies (Lights/Ultra Lights Cases) (Details)",
     "menuCat": "Details",
     "order": "113",
     "role": "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
     "shortName": "Contingencies (Lights/Ultra Lights Cases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i3ae0d3b51df54bbe8b1959b343c21c55_I20230127",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyClaimsNotCertifiedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    },
    "R114": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i0a6cd34d91d14705933337c9bba7c38c_I20230127",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contract",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000114 - Disclosure - Contingencies (UST Litigations Narrative) (Details)",
     "menuCat": "Details",
     "order": "114",
     "role": "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
     "shortName": "Contingencies (UST Litigations Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i0a6cd34d91d14705933337c9bba7c38c_I20230127",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contract",
      "xsiNil": "false"
     }
    },
    "R115": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000115 - Disclosure - Contingencies (Guarantees and Other Similar Matters Narrative) (Details)",
     "menuCat": "Details",
     "order": "115",
     "role": "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
     "shortName": "Contingencies (Guarantees and Other Similar Matters Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Revenues from Contracts with Customers",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.altria.com/role/RevenuesfromContractswithCustomers",
     "shortName": "Revenues from Contracts with Customers",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Goodwill and Other Intangible Assets, net",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnet",
     "shortName": "Goodwill and Other Intangible Assets, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Investments in Equity Securities",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecurities",
     "shortName": "Investments in Equity Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Financial Instruments",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.altria.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Short-Term Borrowings and Borrowing Arrangements",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangements",
     "shortName": "Short-Term Borrowings and Borrowing Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Long-Term Debt",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.altria.com/role/LongTermDebt",
     "shortName": "Long-Term Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Capital Stock",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.altria.com/role/CapitalStock",
     "shortName": "Capital Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Stock Plans",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.altria.com/role/StockPlans",
     "shortName": "Stock Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.altria.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Earnings per Share",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.altria.com/role/EarningsperShare",
     "shortName": "Earnings per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Other Comprehensive Earnings/Losses",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLosses",
     "shortName": "Other Comprehensive Earnings/Losses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.altria.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Segment Reporting",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.altria.com/role/SegmentReporting",
     "shortName": "Segment Reporting",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Benefit Plans",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.altria.com/role/BenefitPlans",
     "shortName": "Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Additional Information",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.altria.com/role/AdditionalInformation",
     "shortName": "Additional Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Contingencies",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.altria.com/role/Contingencies",
     "shortName": "Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Summary of Significant Accounting Policies (Policy)",
     "menuCat": "Policies",
     "order": "27",
     "role": "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy",
     "shortName": "Summary of Significant Accounting Policies (Policy)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Goodwill and Other Intangible Assets, net (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetTables",
     "shortName": "Goodwill and Other Intangible Assets, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.altria.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:ReceivableCommercializationRightsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Investments in Equity Securities (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesTables",
     "shortName": "Investments in Equity Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.altria.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Long-term Debt (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.altria.com/role/LongtermDebtTables",
     "shortName": "Long-term Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Capital Stock (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.altria.com/role/CapitalStockTables",
     "shortName": "Capital Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Stock Plans (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.altria.com/role/StockPlansTables",
     "shortName": "Stock Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Earnings per Share (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.altria.com/role/EarningsperShareTables",
     "shortName": "Earnings per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Other Comprehensive Earnings/losses (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningslossesTables",
     "shortName": "Other Comprehensive Earnings/losses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Income Taxes (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.altria.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Segment Reporting (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.altria.com/role/SegmentReportingTables",
     "shortName": "Segment Reporting (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Benefit Plans (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.altria.com/role/BenefitPlansTables",
     "shortName": "Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.altria.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Additional Information (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.altria.com/role/AdditionalInformationTables",
     "shortName": "Additional Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Contingencies (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.altria.com/role/ContingenciesTables",
     "shortName": "Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:NumberOfLeveragedLeasesRemaining",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Background and Basis of Presentation (Background Narrative) (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails",
     "shortName": "Background and Basis of Presentation (Background Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:NumberOfLeveragedLeasesRemaining",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PercentageOfLIFOInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PercentageOfLIFOInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Revenues from Contracts with Customers (Narrative) (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails",
     "shortName": "Revenues from Contracts with Customers (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Intangible Assets by Segment) (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails",
     "shortName": "Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Intangible Assets by Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "if0336e8ef9c74d2893d4e7f46f1987b7_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Goodwill and Other Intangible Assets, net (Other Intangible Assets Disclosure) (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails",
     "shortName": "Goodwill and Other Intangible Assets, net (Other Intangible Assets Disclosure) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Goodwill and Other Intangible Assets, net (Narrative) (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails",
     "shortName": "Goodwill and Other Intangible Assets, net (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i6526b762c96848958db76b2e641f06c4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Net Carrying Amount of Intangible Assets) (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets, net (Schedule of Goodwill and Net Carrying Amount of Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Investments in Equity Securities (Summary of Investments) (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails",
     "shortName": "Investments in Equity Securities (Summary of Investments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i688c2fcd3b0343b29196c870d74f6b68_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Statements of Earnings",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
     "shortName": "Consolidated Statements of Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:ExciseTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Investments in Equity Securities (Earnings from Equity Investments) (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails",
     "shortName": "Investments in Equity Securities (Earnings from Equity Investments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i25c3587d3f994622b4714f1b3124a4da_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromEquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Investments in Equity Securities (Summary of Financial Data) (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails",
     "shortName": "Investments in Equity Securities (Summary of Financial Data) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "icf3d416fb86c41d09ab5cb96624091f2_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ia645931f457b42ad968380318043c7bb_I20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Investments in Equity Securities (Investment in ABI Narrative) (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
     "shortName": "Investments in Equity Securities (Investment in ABI Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i91ce2420785e4e54b8494cbe3fb97890_I20221231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount",
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Investments in Equity Securities (Investment in JUUL Narrative) (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
     "shortName": "Investments in Equity Securities (Investment in JUUL Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount",
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i32a10d2ccba9487a97ebf4d43b4f2a15_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i9822021e58024e35a62e7648157e3677_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
     "shortName": "Investments in Equity Securities (JUUL Investment Classified as Level 3) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i9e8852c143984842b74a594acdc7f562_I20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ia645931f457b42ad968380318043c7bb_I20220930",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Investments in Equity Securities (Investment in Cronos Narrative) (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
     "shortName": "Investments in Equity Securities (Investment in Cronos Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i84433bab48264529a2516c2663b4fc52_I20221231",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Investments in Equity Securities (Investment in Cronos) (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
     "shortName": "Investments in Equity Securities (Investment in Cronos) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrealizedGainLossOnDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NumberOfForeignCurrencyDerivativesHeld",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfForeignCurrencyDerivativesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contract",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Financial Instruments (Narrative) (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
     "shortName": "Financial Instruments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NumberOfForeignCurrencyDerivativesHeld",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfForeignCurrencyDerivativesHeld",
      "reportCount": 1,
      "unique": true,
      "unitRef": "contract",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails",
     "shortName": "Financial Instruments (Aggregate Fair Value and Carrying Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "if7f230b64a534de9935f50dfa188e24b_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
     "shortName": "Financial Instruments (Effects of Net Investment Hedges on Accumulated Other Comprehensive Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "if7f230b64a534de9935f50dfa188e24b_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Statements of Comprehensive Earnings",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings",
     "shortName": "Consolidated Statements of Comprehensive Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Short-Term Borrowings and Borrowing Arrangements (Narrative) (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails",
     "shortName": "Short-Term Borrowings and Borrowing Arrangements (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Long-Term Debt (Summary of Long-Term Debt) (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails",
     "shortName": "Long-Term Debt (Summary of Long-Term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ief3c0b98ac9c41609501bd13ff3613c2_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "iadefd780e0034b64926bdc30f75a610f_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Long-Term Debt (Details of Long-Term Debt) (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
     "shortName": "Long-Term Debt (Details of Long-Term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "iadefd780e0034b64926bdc30f75a610f_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Long-Term Debt (Aggregate Maturities of Long-Term Debt) (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails",
     "shortName": "Long-Term Debt (Aggregate Maturities of Long-Term Debt) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPayableCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Long-Term Debt (Narrative) (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.altria.com/role/LongTermDebtNarrativeDetails",
     "shortName": "Long-Term Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestPayableCurrentAndNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i34f308ec117342cd83eb1c8c2367bffc_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRepurchasedFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Long-Term Debt (Debt Tender Offers and Redemption (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
     "shortName": "Long-Term Debt (Debt Tender Offers and Redemption (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i34f308ec117342cd83eb1c8c2367bffc_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRepurchasedFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Capital Stock (Narrative) (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.altria.com/role/CapitalStockNarrativeDetails",
     "shortName": "Capital Stock (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "id4a80e5aa58a45bb84e8bd06eac4fa44_D20220701-20220930",
      "decimals": "3",
      "lang": "en-US",
      "name": "mo:CommonStockDividendIncreasePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i6526b762c96848958db76b2e641f06c4_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Capital Stock (Schedule of Issued Repurchased and Outstanding Shares) (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails",
     "shortName": "Capital Stock (Schedule of Issued Repurchased and Outstanding Shares) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i40e064b5da194d8bbe29064d490250de_I20191231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Capital Stock (Schedule of Shares Repurchased) (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails",
     "shortName": "Capital Stock (Schedule of Shares Repurchased) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "id15c7c4db331481f86239866210c3ea8_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockValueAcquiredCostMethod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Stock Plans (Narrative) (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.altria.com/role/StockPlansNarrativeDetails",
     "shortName": "Stock Plans (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.altria.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ie5040992030f401f8d230ceec09bf4b5_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Stock Plans (Schedule of Restricted and Restricted Stock Units Activity) (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails",
     "shortName": "Stock Plans (Schedule of Restricted and Restricted Stock Units Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i9b4137bbf0de4961870723241e0a40fa_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Earnings per Share (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.altria.com/role/EarningsperShareDetails",
     "shortName": "Earnings per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i6526b762c96848958db76b2e641f06c4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
     "shortName": "Other Comprehensive Earnings/Losses (Changes in Each Component of Accumulated Other Comprehensive Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i9cdc1a25a2374d6f8ed20468167fa0c3_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Other Comprehensive Earnings/Losses (Reclassifications) (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails",
     "shortName": "Other Comprehensive Earnings/Losses (Reclassifications) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i99171c01ef0342ea88d25cef0ba399df_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Income Taxes (Schedule of Earnings Before Income Taxes and Provision for Income Taxes) (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes (Schedule of Earnings Before Income Taxes and Provision for Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i6526b762c96848958db76b2e641f06c4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Income Taxes (Reconciliation of Beginning and Ending Unrecognized Tax Benefits) (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.altria.com/role/IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes (Reconciliation of Beginning and Ending Unrecognized Tax Benefits) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i40e064b5da194d8bbe29064d490250de_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Income Taxes (Narrative) (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Income Taxes (Reconciliation of Effective Tax Rate and U.S. Federal Statutory Rate) (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails",
     "shortName": "Income Taxes (Reconciliation of Effective Tax Rate and U.S. Federal Statutory Rate) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - Income Taxes (Schedule of Deferred Income Tax Assets and Liabilities) (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes (Schedule of Deferred Income Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i6526b762c96848958db76b2e641f06c4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - Income Taxes (Summary of Valuation Allowance) (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.altria.com/role/IncomeTaxesSummaryofValuationAllowanceDetails",
     "shortName": "Income Taxes (Summary of Valuation Allowance) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfValuationAllowanceTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "mo:ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i40e064b5da194d8bbe29064d490250de_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Stockholders' Equity (Deficit)",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
     "shortName": "Consolidated Statements of Stockholders' Equity (Deficit)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "iccd540c71b2a4978b8805b946441e6f0_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - Segment Reporting (Narrative) (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.altria.com/role/SegmentReportingNarrativeDetails",
     "shortName": "Segment Reporting (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "idc3b5a2e320d4bf0930cfd342a0a64ce_D20200101-20201231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - Segment Reporting (Segment Data Schedule) (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails",
     "shortName": "Segment Reporting (Segment Data Schedule) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i56e043e80aaa413c8cf448a2008386a1_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - Segment Reporting (Schedule of Depreciation Expense and Capital Expenditures of Segments) (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails",
     "shortName": "Segment Reporting (Schedule of Depreciation Expense and Capital Expenditures of Segments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i9c43fc865fb74c7ea00634410142b30a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossRelatedToLitigationSettlement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - Segment Reporting (Non-Participating Manufacturer Adjustment Items) (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
     "shortName": "Segment Reporting (Non-Participating Manufacturer Adjustment Items) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i9c43fc865fb74c7ea00634410142b30a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainLossRelatedToLitigationSettlement",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ib1fe6f24b44845df934e64f8514af12e_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - Segment Reporting (Schedule of Pre-tax Tobacco and Health Litigation Charges) (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails",
     "shortName": "Segment Reporting (Schedule of Pre-tax Tobacco and Health Litigation Charges) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ice4e4d2da69f4d9683487085e2d48d98_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualProvision",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - Benefit Plans (Narrative) (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.altria.com/role/BenefitPlansNarrativeDetails",
     "shortName": "Benefit Plans (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - Benefit Plans (Projected Benefit Obligations, Plan Assets and Funded Status of Pension Plans) (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails",
     "shortName": "Benefit Plans (Projected Benefit Obligations, Plan Assets and Funded Status of Pension Plans) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i84846537e5f745d2987290028523bac3_I20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - Benefit Plans (Assumptions to Determine Postretirement Benefit Obligations) (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails",
     "shortName": "Benefit Plans (Assumptions to Determine Postretirement Benefit Obligations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAssumptionsUsedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i84846537e5f745d2987290028523bac3_I20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - Benefit Plans (Schedule of Components of Net Periodic Pension Cost) (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails",
     "shortName": "Benefit Plans (Schedule of Components of Net Periodic Pension Cost) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mo:ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - Benefit Plans (Assumptions used to Determine Net Periodic Benefit Cost) (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails",
     "shortName": "Benefit Plans (Assumptions used to Determine Net Periodic Benefit Cost) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mo:ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a43eb5093344eb890ec8dad299884e2_D20220101-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "mo:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "id4a80e5aa58a45bb84e8bd06eac4fa44_D20220701-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000009 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)",
     "menuCat": "Statements",
     "order": "9",
     "role": "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
     "shortName": "Consolidated Statements of Stockholders' Equity (Deficit) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ibef1d20b06414d568aea451eb1e564cf_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - Benefit Plans (Asset Allocations) (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails",
     "shortName": "Benefit Plans (Asset Allocations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ibef1d20b06414d568aea451eb1e564cf_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i84846537e5f745d2987290028523bac3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - Benefit Plans (Fair Values of Pension and Postretirement Plan Assets) (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
     "shortName": "Benefit Plans (Fair Values of Pension and Postretirement Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "ie7d841655cc044a6b7129c58b61ec0c3_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i84846537e5f745d2987290028523bac3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - Benefit Plans (Estimated Future Benefit Payments) (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails",
     "shortName": "Benefit Plans (Estimated Future Benefit Payments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i84846537e5f745d2987290028523bac3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - Benefit Plans (Amounts Recorded in Accumulated Other Comprehensive Losses) (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails",
     "shortName": "Benefit Plans (Amounts Recorded in Accumulated Other Comprehensive Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - Benefit Plans (Movements in Other Comprehensive Earnings/Losses) (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails",
     "shortName": "Benefit Plans (Movements in Other Comprehensive Earnings/Losses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - Additional Information (Schedule of Additional Information) (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails",
     "shortName": "Additional Information (Schedule of Additional Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i2f50a7da8422410fb1f128d6dd0b902a_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mo:ScheduleofValuationandQualifyingAccountsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i45f9dcc6444a4bbb90bbcd327eb2f366_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - Additional Information (Schedule of Valuation and Qualifying Accounts) (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails",
     "shortName": "Additional Information (Schedule of Valuation and Qualifying Accounts) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "mo:ScheduleofValuationandQualifyingAccountsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i94c89f23c2954c9c8f50a44fa531889f_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - Contingencies (General Information) (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.altria.com/role/ContingenciesGeneralInformationDetails",
     "shortName": "Contingencies (General Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1a2f8d49dba342ea92dd045738411af3_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "mo:LossContingencyNumberofStatesThatCapBondorRequireNoBond",
      "reportCount": 1,
      "unique": true,
      "unitRef": "state",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i6526b762c96848958db76b2e641f06c4_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
     "shortName": "Contingencies (Judgments Paid and Provisions for Tobacco and Health Litigation) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLossContingenciesByContingencyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i40e064b5da194d8bbe29064d490250de_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyAccrualAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i7a9cc9052f7342f9a5a2965a1363d918_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unitRef": "claim",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - Contingencies (Schedule of Pending Cases) (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
     "shortName": "Contingencies (Schedule of Pending Cases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "mo-20221231.htm",
      "contextRef": "i1ec68205f19b43d79d872f39a862112a_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "case",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 285,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada [Member]"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_PR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PUERTO RICO",
        "terseLabel": "Puerto Rico [Member]"
       }
      }
     },
     "localname": "PR",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Tag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r873",
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r873",
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r873",
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r873",
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r876"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r871"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails",
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r877"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r870"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r873",
      "r874",
      "r875"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails",
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r869"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r872"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "mo_A2015DirectorsPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Directors Plan [Member]",
        "label": "2015 Directors Plan [Member]",
        "terseLabel": "2015 Directors Plan [Member]"
       }
      }
     },
     "localname": "A2015DirectorsPlanMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_A2020PerformanceIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Performance Incentive Plan",
        "label": "2020 Performance Incentive Plan [Member]",
        "terseLabel": "2020 Performance Incentive Plan [Member]"
       }
      }
     },
     "localname": "A2020PerformanceIncentivePlanMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ABInBevMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AB InBev [Member]",
        "label": "AB InBev [Member]",
        "terseLabel": "ABI [Member]"
       }
      }
     },
     "localname": "ABInBevMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AccruedSettlementLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Settlement Liability, Current",
        "label": "Accrued Settlement Liability, Current",
        "terseLabel": "Settlement charges"
       }
      }
     },
     "localname": "AccruedSettlementLiabilityCurrent",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_AccumulatedEquityMethodInvestmentsAttributableToParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Equity Method Investments Attributable To Parent [Member]",
        "label": "Accumulated Equity Method Investments Attributable To Parent [Member]",
        "verboseLabel": "ABI [Member]"
       }
      }
     },
     "localname": "AccumulatedEquityMethodInvestmentsAttributableToParentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Foreign Currency Adjustment And Other Attributable to Parent",
        "label": "Accumulated Foreign Currency Adjustment And Other Attributable to Parent [Member]",
        "terseLabel": "Currency Translation Adjustments and Other [Member]"
       }
      }
     },
     "localname": "AccumulatedForeignCurrencyAdjustmentAndOtherAttributableToParentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment To Additional Paid In Capital, Share Based Compensation, Restricted And Deferred Stock Awards and the tax benefits associated with vestings of prior period restricted and deferred stock awards",
        "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition and Income Tax Effect, Net",
        "terseLabel": "Stock award activity"
       }
      }
     },
     "localname": "AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationRequisiteServicePeriodRecognitionandIncomeTaxEffectNet",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_AgreementToResolveShareholderClassActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement To Resolve Shareholder Class Action",
        "label": "Agreement To Resolve Shareholder Class Action [Member]",
        "terseLabel": "Agreement To Resolve Shareholder Class Action [Member]"
       }
      }
     },
     "localname": "AgreementToResolveShareholderClassActionMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AllowanceDiscountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance, Discounts [Member]",
        "label": "Allowance, Discounts [Member]",
        "terseLabel": "Discounts [Member]"
       }
      }
     },
     "localname": "AllowanceDiscountsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AllowanceReturnedGoodsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance, Returned Goods [Member]",
        "label": "Allowance, Returned Goods [Member]",
        "terseLabel": "Returned Goods [Member]"
       }
      }
     },
     "localname": "AllowanceReturnedGoodsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AmountAwardedtoOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount Awarded to Other Party",
        "label": "Amount Awarded to Other Party",
        "terseLabel": "Amount awarded to other party"
       }
      }
     },
     "localname": "AmountAwardedtoOtherParty",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ArbitrationPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arbitration Period",
        "label": "Arbitration Period [Axis]",
        "terseLabel": "Arbitration Period [Axis]"
       }
      }
     },
     "localname": "ArbitrationPeriodAxis",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ArbitrationPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arbitration Period [Domain]",
        "label": "Arbitration Period [Domain]",
        "terseLabel": "Arbitration Period [Domain]"
       }
      }
     },
     "localname": "ArbitrationPeriodDomain",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AssetBasedSecuritiesAndOtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Based Securities And Other Investments",
        "label": "Asset Based Securities And Other Investments [Member]",
        "terseLabel": "Asset Based Securities And Other Investments [Member]"
       }
      }
     },
     "localname": "AssetBasedSecuritiesAndOtherInvestmentsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]",
        "terseLabel": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.altria.com/20221231",
     "xbrltype": "stringItemType"
    },
    "mo_BritishColumbiaSaskatchewanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "British Columbia, Saskatchewan [Member]",
        "label": "British Columbia, Saskatchewan [Member]",
        "terseLabel": "British Columbia and Saskatchewan [Member]"
       }
      }
     },
     "localname": "BritishColumbiaSaskatchewanMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_COVID19Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 [Member]",
        "label": "COVID-19 [Member]",
        "terseLabel": "COVID-19 [Member]"
       }
      }
     },
     "localname": "COVID19Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CanadianTobaccoManufacturersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Canadian Tobacco Manufacturers [Member]",
        "label": "Canadian Tobacco Manufacturers [Member]",
        "terseLabel": "Canadian Tobacco Manufacturers [Member]"
       }
      }
     },
     "localname": "CanadianTobaccoManufacturersMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CashDiscountsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Discounts",
        "label": "Cash Discounts [Policy Text Block]",
        "terseLabel": "Cash Discounts"
       }
      }
     },
     "localname": "CashDiscountsPolicyTextBlock",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_CigarettesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cigarettes [Member]",
        "label": "Cigarettes [Member]",
        "terseLabel": "Cigarettes [Member]"
       }
      }
     },
     "localname": "CigarettesMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CigarsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cigars [Member]",
        "label": "Cigars [Member]",
        "terseLabel": "Cigars [Member]"
       }
      }
     },
     "localname": "CigarsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ClassActionLawsuitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Action Lawsuit",
        "label": "Class Action Lawsuit [Member]",
        "terseLabel": "Class Action Lawsuit [Member]"
       }
      }
     },
     "localname": "ClassActionLawsuitMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock0.3313ParValueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 0.33 1/3 Par Value [Member]",
        "label": "Common Stock, 0.33 1/3 Par Value [Member]",
        "terseLabel": "Common Stock, $0.33 \u00a01/3 par value"
       }
      }
     },
     "localname": "CommonStock0.3313ParValueMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock1.700NotesDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 1.700% Notes Due 2025 [Member]",
        "label": "Common Stock, 1.700% Notes Due 2025 [Member]",
        "terseLabel": "1.700% Notes due 2025"
       }
      }
     },
     "localname": "CommonStock1.700NotesDue2025Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock2.200NotesDue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 2.200% Notes Due 2027 [Member]",
        "label": "Common Stock, 2.200% Notes Due 2027 [Member]",
        "terseLabel": "2.200% Notes due 2027"
       }
      }
     },
     "localname": "CommonStock2.200NotesDue2027Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStock3.125NotesDue2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, 3.125% Notes Due 2031 [Member]",
        "label": "Common Stock, 3.125% Notes Due 2031 [Member]",
        "terseLabel": "3.125% Notes due 2031"
       }
      }
     },
     "localname": "CommonStock3.125NotesDue2031Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/CoverPage"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CommonStockDividendIncreasePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Dividend Increase, Percentage",
        "label": "Common Stock, Dividend Increase, Percentage",
        "terseLabel": "Common stock, dividend increase, percentage"
       }
      }
     },
     "localname": "CommonStockDividendIncreasePercentage",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_CommonStockDividendRateAnnualPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Dividend Rate, Annual, Per Share",
        "label": "Common Stock, Dividend Rate, Annual, Per Share",
        "terseLabel": "Common stock, dividend rate, annual, per share (USD per share)"
       }
      }
     },
     "localname": "CommonStockDividendRateAnnualPerShare",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mo_CommonStockSharesOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Shares Outstanding [Roll Forward]",
        "label": "Common Stock, Shares Outstanding [Roll Forward]",
        "terseLabel": "Common Stock, Shares Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "CommonStockSharesOutstandingRollForward",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_CoreMarkHoldingCompanyInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Core-Mark Holding Company, Inc. [Member]",
        "label": "Core-Mark Holding Company, Inc. [Member]",
        "terseLabel": "Core-Mark Holding Company, Inc. [Member]"
       }
      }
     },
     "localname": "CoreMarkHoldingCompanyInc.Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CorporateDebtSecurityAboveInvestmentGradeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Debt Security, Above Investment Grade [Member]",
        "label": "Corporate Debt Security, Above Investment Grade [Member]",
        "terseLabel": "Corporate Debt Security, Above Investment Grade [Member]"
       }
      }
     },
     "localname": "CorporateDebtSecurityAboveInvestmentGradeMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CorporateDebtSecurityBelowInvestmentGradeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate Debt Security, Below Investment Grade [Member]",
        "label": "Corporate Debt Security, Below Investment Grade [Member]",
        "terseLabel": "Corporate Debt Security, Below Investment Grade [Member]"
       }
      }
     },
     "localname": "CorporateDebtSecurityBelowInvestmentGradeMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement [Member]",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement [Member]"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CronosGroupInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Group Inc. [Member]",
        "label": "Cronos Group Inc. [Member]",
        "terseLabel": "Cronos Group Inc. [Member]",
        "verboseLabel": "Cronos [Member]"
       }
      }
     },
     "localname": "CronosGroupInc.Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails",
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_CurrencyTranslationAdjustmentsAndOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency Translation Adjustments And Other",
        "label": "Currency Translation Adjustments And Other",
        "terseLabel": "Currency translation adjustments and other"
       }
      }
     },
     "localname": "CurrencyTranslationAdjustmentsAndOther",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Consolidated EBITDA to Interest Expense Ratio",
        "label": "Debt Instrument, Consolidated EBITDA to Interest Expense Ratio",
        "terseLabel": "Debt instrument, consolidated EBITDA to interest expense ratio"
       }
      }
     },
     "localname": "DebtInstrumentConsolidatedEBITDAtoInterestExpenseRatio",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mo_DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum",
        "label": "Debt Instrument, Covenant, Consolidated EBITDA to Interest Expense Ratio, Minimum",
        "terseLabel": "Debt instrument, covenant, consolidated EBITDA to interest expense ratio, minimum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantConsolidatedEBITDAtoInterestExpenseRatioMinimum",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "mo_DeferredGainOnSaleOfCommercializationRightsNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Gain On Sale Of Commercialization Rights, Noncurrent",
        "label": "Deferred Gain On Sale Of Commercialization Rights, Noncurrent",
        "terseLabel": "Deferred gain from the sale of IQOS System commercialization rights"
       }
      }
     },
     "localname": "DeferredGainOnSaleOfCommercializationRightsNoncurrent",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DeferredProceedsFromSaleOfCommercializationRightsNoncash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Proceeds From Sale Of Commercialization Rights, Noncash",
        "label": "Deferred Proceeds From Sale Of Commercialization Rights, Noncash",
        "terseLabel": "Deferred proceeds from the sale of IQOS System commercialization rights"
       }
      }
     },
     "localname": "DeferredProceedsFromSaleOfCommercializationRightsNoncash",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DeferredTaxAssetsInvestmentsInEquitySecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Investments In Equity Securities",
        "label": "Deferred Tax Assets, Investments In Equity Securities",
        "terseLabel": "Investment in JUUL"
       }
      }
     },
     "localname": "DeferredTaxAssetsInvestmentsInEquitySecurities",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets net operating losses and tax credit carryforwards",
        "label": "Deferred Tax Assets, Operating Loss and Tax Credit Carryforwards",
        "terseLabel": "Net operating losses and tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossandTaxCreditCarryforwards",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DeferredTaxAssetsValuationAllowanceRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Valuation Allowance [Roll Forward]",
        "label": "Deferred Tax Assets, Valuation Allowance [Roll Forward]",
        "terseLabel": "Deferred Tax Assets, Valuation Allowance [Roll Forward]"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowanceRollForward",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_DeferredTaxLiabilitiesAccruedPensionCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Accrued Pension Costs",
        "label": "Deferred Tax Liabilities, Accrued Pension Costs",
        "negatedTerseLabel": "Accrued pension costs"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAccruedPensionCosts",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income, Deferred Income Tax",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeDeferredIncomeTax",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Interest Cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateInterestCost",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate, Service Cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRateServiceCost",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Ultimate Health Care Cost Trend Rate",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Ultimate Health Care Cost Trend Rate",
        "terseLabel": "Health care cost trend rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostUltimateHealthCareCostTrendRate",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_DefinedBenefitPlanDiscountRateAbstractAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Benefit Plan, Discount Rate Abstract",
        "label": "Defined Benefit Plan, Discount Rate Abstract [Abstract]",
        "terseLabel": "Discount rates:"
       }
      }
     },
     "localname": "DefinedBenefitPlanDiscountRateAbstractAbstract",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_DefiniteLivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Definite Lived Intangible Assets [Member]",
        "label": "Definite Lived Intangible Assets [Member]",
        "terseLabel": "Definite-Lived Intangible Assets [Member]"
       }
      }
     },
     "localname": "DefiniteLivedIntangibleAssetsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Deferred Gain on Sale Of Rights Under An Agreement",
        "label": "Disposal Group, Deferred Gain on Sale Of Rights Under An Agreement",
        "terseLabel": "Disposal group, deferred gain on sale of rights under an agreement"
       }
      }
     },
     "localname": "DisposalGroupDeferredGainOnSaleOfRightsUnderAnAgreement",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Disposition Related Costs",
        "label": "Disposal Group, Including Discontinued Operations, Disposition Related Costs",
        "terseLabel": "Disposal group, including discontinued operations, disposition related costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsDispositionRelatedCosts",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operations, Marketing, Administration And Research Costs",
        "label": "Disposal Group, Including Discontinued Operations, Marketing, Administration And Research Costs",
        "terseLabel": "Disposal group, including discontinued operations, marketing, administration and research costs"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationsMarketingAdministrationAndResearchCosts",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DisposalGroupInterestReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Interest Receivable",
        "label": "Disposal Group, Interest Receivable",
        "terseLabel": "Disposal group, interest receivable"
       }
      }
     },
     "localname": "DisposalGroupInterestReceivable",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DisposalGroupPurchaseAgreementConsiderationAdditionalPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Purchase Agreement, Consideration, Additional Payment",
        "label": "Disposal Group, Purchase Agreement, Consideration, Additional Payment",
        "terseLabel": "Disposal group, purchase agreement, consideration, additional payment"
       }
      }
     },
     "localname": "DisposalGroupPurchaseAgreementConsiderationAdditionalPayment",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DisposalGroupPurchaseAgreementConsiderationInitialPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Purchase Agreement, Consideration, Initial Payment",
        "label": "Disposal Group, Purchase Agreement, Consideration, Initial Payment",
        "terseLabel": "Disposal group, purchase agreement, consideration, initial payment"
       }
      }
     },
     "localname": "DisposalGroupPurchaseAgreementConsiderationInitialPayment",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_DisposalGroupPurchaseAgreementEffectiveInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Purchase Agreement, Effective Interest Rate",
        "label": "Disposal Group, Purchase Agreement, Effective Interest Rate",
        "terseLabel": "Disposal group, purchase agreement, effective interest rate"
       }
      }
     },
     "localname": "DisposalGroupPurchaseAgreementEffectiveInterestRate",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_DisposalGroupReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Receivable",
        "label": "Disposal Group, Receivable",
        "terseLabel": "Disposal group, receivable"
       }
      }
     },
     "localname": "DisposalGroupReceivable",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ETSSmokingandHealthCaseFlightAttendantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ETS Smoking and Health Case, Flight Attendants [Member]",
        "label": "ETS Smoking and Health Case, Flight Attendants [Member]",
        "terseLabel": "ETS Smoking and Health Case, Flight Attendants [Member]"
       }
      }
     },
     "localname": "ETSSmokingandHealthCaseFlightAttendantsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Basis In Foreign Investments",
        "label": "Effective Income Tax Rate Reconciliation, Tax Basis In Foreign Investments",
        "terseLabel": "Tax basis in foreign investments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestments",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Tax Basis In Foreign Investments, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Tax Basis In Foreign Investments, Amount",
        "terseLabel": "Tax basis in foreign investments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxBasisInForeignInvestmentsAmount",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Valuation Allowance, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Valuation Allowance, Amount",
        "terseLabel": "Investment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationValuationAllowanceAmount",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EffectiveIncomeTaxRateReconciliationValuationAllowancePercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Valuation Allowance, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Valuation Allowance, Percent",
        "terseLabel": "Investment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationValuationAllowancePercent",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EffectiveIncomeTaxRateReconciliationValuationReversalAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Valuation Reversal, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Valuation Reversal, Amount",
        "terseLabel": "Valuation allowance releases"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationValuationReversalAmount",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EffectiveIncomeTaxRateReconciliationValuationReversalPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Valuation Reversal, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Valuation Reversal, Percent",
        "terseLabel": "Valuation allowance releases"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationValuationReversalPercent",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EmergingMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Markets [Member]",
        "label": "Emerging Markets [Member]",
        "terseLabel": "Emerging Markets [Member]"
       }
      }
     },
     "localname": "EmergingMarketsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesChadwellMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Chadwell [Member] [Member]",
        "label": "Engle Progeny Cases, Chadwell [Member]",
        "terseLabel": "Engle Progeny Cases, Chadwell [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesChadwellMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesCooperMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Cooper [Member]",
        "label": "Engle Progeny Cases, Cooper [Member]",
        "terseLabel": "Engle Progeny Cases, Cooper [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesCooperMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesCuddiheeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Cuddihee",
        "label": "Engle Progeny Cases, Cuddihee [Member]",
        "terseLabel": "Engle Progeny Cases, Cuddihee [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesCuddiheeMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesD.BrownMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, D. Brown [Member]",
        "label": "Engle Progeny Cases, D. Brown [Member]",
        "terseLabel": "Engle Progeny Cases, D. Brown [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesD.BrownMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesDuignanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Duignan",
        "label": "Engle Progeny Cases, Duignan [Member]",
        "terseLabel": "Engle Progeny Cases, Duignan {Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesDuignanMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesFreemanAndHarrisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Freeman And Harris",
        "label": "Engle Progeny Cases, Freeman And Harris [Member]",
        "terseLabel": "Engle Progeny Cases, Freeman And Harris [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesFreemanAndHarrisMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesGarciaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Garcia",
        "label": "Engle Progeny Cases, Garcia [Member]",
        "terseLabel": "Engle Progeny Cases, Garcia [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesGarciaMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesGlogerRintoulandDuignamMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]",
        "label": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]",
        "terseLabel": "Engle Progeny Cases, Gloger, Rintoul and Duignam [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesGlogerRintoulandDuignamMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesHoffmanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Hoffman",
        "label": "Engle Progeny Cases, Hoffman [Member]",
        "terseLabel": "Engle Progeny Cases, Hoffman [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesHoffmanMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesHollimanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Holliman [Member]",
        "label": "Engle Progeny Cases, Holliman [Member]",
        "terseLabel": "Engle Progeny Cases, Holliman [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesHollimanMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesKaplanAndSommersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases Kaplan And Sommers",
        "label": "Engle Progeny Cases Kaplan And Sommers [Member]",
        "terseLabel": "Engle Progeny Cases Kaplan And Sommers"
       }
      }
     },
     "localname": "EngleProgenyCasesKaplanAndSommersMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesKaplanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Kaplan [Member]",
        "label": "Engle Progeny Cases, Kaplan [Member]",
        "terseLabel": "Engle Progeny Cases, Kaplan [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesKaplanMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesLevineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Levine",
        "label": "Engle Progeny Cases, Levine [Member]",
        "terseLabel": "Engle Progeny Cases, Levine [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesLevineMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesLippMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Lipp",
        "label": "Engle Progeny Cases, Lipp [Member]",
        "terseLabel": "Engle Progeny Cases, Lipp [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesLippMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesMcCallMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, McCall [Member]",
        "label": "Engle Progeny Cases, McCall [Member]",
        "terseLabel": "Engle Progeny Cases, McCall [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesMcCallMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases [Member]",
        "label": "Engle Progeny Cases [Member]",
        "terseLabel": "Engle Progeny Cases [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesMillerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Miller",
        "label": "Engle Progeny Cases, Miller [Member]",
        "terseLabel": "Engle Progeny Cases, Miller [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesMillerMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesPearsonDCohenCollarChaconMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]",
        "label": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member] [Member]",
        "terseLabel": "Engle Progeny Cases, Pearson, D Cohen, Collar, Chacon [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesPearsonDCohenCollarChaconMemberMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesPollariMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Pollari [Member]",
        "label": "Engle Progeny Cases, Pollari [Member]",
        "terseLabel": "Engle Progeny Cases, Pollari [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesPollariMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesR.DouglasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, R. Douglas [Member]",
        "label": "Engle Progeny Cases, R. Douglas [Member]",
        "terseLabel": "Engle Progeny Cases, R. Douglas [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesR.DouglasMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesReiderandBanksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Reider and Banks [Member]",
        "label": "Engle Progeny Cases, Reider and Banks [Member]",
        "terseLabel": "Engle Progeny Cases, Reider and Banks [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesReiderandBanksMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesSchertzerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Schertzer",
        "label": "Engle Progeny Cases, Schertzer [Member]",
        "terseLabel": "Engle Progeny Cases, Schertzer [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesSchertzerMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesStateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, State [Member]",
        "label": "Engle Progeny Cases, State [Member]",
        "terseLabel": "Engle Progeny Cases, State [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesStateMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesTuttleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Tuttle",
        "label": "Engle Progeny Cases, Tuttle [Member]",
        "terseLabel": "Engle Progeny Cases, Tuttle [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesTuttleMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EngleProgenyCasesWeingartandHancockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Engle Progeny Cases, Weingart and Hancock [Member]",
        "label": "Engle Progeny Cases, Weingart and Hancock [Member]",
        "terseLabel": "Engle Progeny Cases, Weingart and Hancock [Member]"
       }
      }
     },
     "localname": "EngleProgenyCasesWeingartandHancockMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityContractPreemptiveRIghtsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Contract, Preemptive RIghts [Member]",
        "label": "Equity Contract, Preemptive RIghts [Member]",
        "terseLabel": "Equity Contract, Preemptive Rights [Member]"
       }
      }
     },
     "localname": "EquityContractPreemptiveRIghtsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityContractWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Contract, Warrant [Member]",
        "label": "Equity Contract, Warrant [Member]",
        "terseLabel": "Equity Contract, Warrant [Member]",
        "verboseLabel": "Warrant [Member]"
       }
      }
     },
     "localname": "EquityContractWarrantMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EquityInvestmentFairValueOption": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Investment, Fair Value Option",
        "label": "Equity Investment, Fair Value Option",
        "verboseLabel": "Estimated fair value of JUUL"
       }
      }
     },
     "localname": "EquityInvestmentFairValueOption",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Difference Between Carrying Amount and Fair Value",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Fair Value",
        "terseLabel": "Equity method investment, difference between carrying amount and fair value"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValue",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Fair Value, Percentage",
        "negatedTerseLabel": "Equity method investment, difference between carrying amount and fair value, percentage",
        "terseLabel": "Equity method investment, difference between carrying amount and fair value, percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndFairValuePercentage",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquityMethodInvestmentImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Impairment",
        "label": "Equity Method Investment, Impairment",
        "terseLabel": "Equity method investment, impairment"
       }
      }
     },
     "localname": "EquityMethodInvestmentImpairment",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquityMethodInvestmentNumberofSharesEligibleForPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Number of Shares Eligible For Purchase",
        "label": "Equity Method Investment, Number of Shares Eligible For Purchase",
        "terseLabel": "Equity method investment, number of shares eligible for purchase"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofSharesEligibleForPurchase",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentNumberofSharesOwnedCommon": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Number of Shares Owned, Common",
        "label": "Equity Method Investment, Number of Shares Owned, Common",
        "terseLabel": "Equity method investment, number of shares owned, common (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofSharesOwnedCommon",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentNumberofSharesOwnedRestricted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Number of Shares Owned, Restricted",
        "label": "Equity Method Investment, Number of Shares Owned, Restricted",
        "terseLabel": "Equity method investment, number of shares owned, restricted (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentNumberofSharesOwnedRestricted",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_EquityMethodInvestmentPercentageofSharesEligibleForPurchase": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Percentage of Shares Eligible For Purchase",
        "label": "Equity Method Investment, Percentage of Shares Eligible For Purchase",
        "terseLabel": "Equity method investment, percentage of shares eligible for purchase"
       }
      }
     },
     "localname": "EquityMethodInvestmentPercentageofSharesEligibleForPurchase",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquityMethodInvestmentPricePerShareIfExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Price Per Share If Exercised",
        "label": "Equity Method Investment, Price Per Share If Exercised",
        "terseLabel": "Equity method investment, price per share if exercised"
       }
      }
     },
     "localname": "EquityMethodInvestmentPricePerShareIfExercised",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "mo_EquityMethodInvestmentsFixedPreemptiveRights": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Fixed Preemptive Rights",
        "label": "Equity Method Investments, Fixed Preemptive Rights",
        "terseLabel": "Equity method investments, fixed preemptive rights"
       }
      }
     },
     "localname": "EquityMethodInvestmentsFixedPreemptiveRights",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Including Warrants and Fixed-Price Preemptive Rights",
        "label": "Equity Method Investments, Including Warrants and Fixed-Price Preemptive Rights",
        "terseLabel": "Equity method investments including warrants and fixed price preemptive rights"
       }
      }
     },
     "localname": "EquityMethodInvestmentsIncludingWarrantsAndFixedPricePreemptiveRights",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value",
        "label": "Equity Securities Without Readily Determinable Fair Value, Non-Compete Release Trigger Percentage Of Investment Carrying Value",
        "terseLabel": "Non-compete release trigger percentage of initial investment carrying value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueNonCompeteReleaseTriggerPercentageOfInvestmentCarryingValue",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Ownership Percentage",
        "label": "Equity Securities Without Readily Determinable Fair Value, Ownership Percentage",
        "terseLabel": "Equity securities without readily determinable fair value, ownership percentage"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueOwnershipPercentage",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount",
        "label": "Equity Securities Without Readily Determinable Fair Value, Quantitative Assessment Adjustment, Annual Amount",
        "terseLabel": "Equity securities without readily determinable fair value, quantitative assessment adjustment, annual amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueQuantitativeAssessmentAdjustmentAnnualAmount",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_EuroNotes1000MaturingFebruary2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Notes, 1.000%, Maturing February 2023",
        "label": "Euro Notes, 1.000%, Maturing February 2023 [Member]",
        "terseLabel": "Euro Notes, 1.000%, Maturing February 2023 [Member]"
       }
      }
     },
     "localname": "EuroNotes1000MaturingFebruary2023Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EuroNotes1000To3125Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Notes, 1.000% to 3.125% [Member]",
        "label": "Euro Notes, 1.000% to 3.125% [Member]",
        "terseLabel": "Euro notes, 1.000% to 3.125%, interest payable annually, due through 2031 [Member]"
       }
      }
     },
     "localname": "EuroNotes1000To3125Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EuroNotes1700MaturingJune2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Notes, 1.700%, Maturing June 2025",
        "label": "Euro Notes, 1.700%, Maturing June 2025 [Member]",
        "terseLabel": "Euro Notes, 1.700%, Maturing June 2025 [Member]"
       }
      }
     },
     "localname": "EuroNotes1700MaturingJune2025Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EuroNotes2200MaturingJune2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Notes, 2.200%, Maturing June 2027",
        "label": "Euro Notes, 2.200%, Maturing June 2027 [Member]",
        "terseLabel": "Euro Notes, 2.200%, Maturing June 2027 [Member]"
       }
      }
     },
     "localname": "EuroNotes2200MaturingJune2027Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EuroNotes3125MaturingJune2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Euro Notes, 3.125%, Maturing June 2031",
        "label": "Euro Notes, 3.125%, Maturing June 2031 [Member]",
        "terseLabel": "Euro Notes, 3.125%, Maturing June 2031 [Member]"
       }
      }
     },
     "localname": "EuroNotes3125MaturingJune2031Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_EvaporLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E-vapor Litigation [Member]",
        "label": "E-vapor Litigation [Member]",
        "terseLabel": "E-vapor Litigation [Member]",
        "verboseLabel": "E-vapor Cases [Member]"
       }
      }
     },
     "localname": "EvaporLitigationMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ExciseTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excise Tax",
        "label": "Excise Tax",
        "terseLabel": "Excise taxes on products"
       }
      }
     },
     "localname": "ExciseTax",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_FederalAndStateShareholderDerivativeLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal And State Shareholder Derivative Lawsuits",
        "label": "Federal And State Shareholder Derivative Lawsuits [Member]",
        "terseLabel": "Federal And State Shareholder Derivative Lawsuits [Member]"
       }
      }
     },
     "localname": "FederalAndStateShareholderDerivativeLawsuitsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_FederalGovernmentsLawsuitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Government's Lawsuit [Member]",
        "label": "Federal Governments Lawsuit [Member]",
        "terseLabel": "Federal Governments Lawsuit [Member]"
       }
      }
     },
     "localname": "FederalGovernmentsLawsuitMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_FederalTradeCommissionDisclosurePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Trade Commission, Disclosure Period",
        "label": "Federal Trade Commission, Disclosure Period",
        "terseLabel": "Disclosure period"
       }
      }
     },
     "localname": "FederalTradeCommissionDisclosurePeriod",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_ForeignCurrencyDenominatedDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Denominated Debt",
        "label": "Foreign Currency Denominated Debt [Abstract]",
        "terseLabel": "Foreign Currency Denominated Debt [Abstract]"
       }
      }
     },
     "localname": "ForeignCurrencyDenominatedDebtAbstract",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ForeignCurrencyDenominatedDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign Currency Denominated Debt [Member]",
        "label": "Foreign Currency Denominated Debt [Member]",
        "terseLabel": "Foreign Currency Denominated Debt [Member]"
       }
      }
     },
     "localname": "ForeignCurrencyDenominatedDebtMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails",
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2004NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2004 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2004NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions20052007NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment",
        "label": "Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2005-2007 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions20052007NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2005NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2005 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2005NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2006NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2006 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2006NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2007NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2007 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2007NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2008NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2008 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2008NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2009NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2009 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2009NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2010NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2010 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2010NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2011NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2011 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2011NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2012NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2012 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2012NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2013NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2013 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2013NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2014NPMAdjustmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]",
        "label": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2014 NPM Adjustment [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2014NPMAdjustmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2015NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2015 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2015NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member] [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2016 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2016NPMAdjustmentsMemberMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2017NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2017 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2017NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2018NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2018 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2018NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2019NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]",
        "label": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2019 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2019NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2020NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2020 NPM Adjustments",
        "label": "Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2020 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2020NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActions2021NPMAdjustmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, 2021 NPM Adjustments",
        "label": "Health Care Cost Recovery Actions, 2021 NPM Adjustments [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, 2021 NPM Adjustments [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActions2021NPMAdjustmentsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions [Member]",
        "label": "Health Care Cost Recovery Actions [Member]",
        "terseLabel": "Health Care Cost Recovery Actions [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActionsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActionsTransitionYears20042020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, Transition Years 2004-2020",
        "label": "Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, Transition Years 2004-2020 [Member]"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActionsTransitionYears20042020Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActionsTransitionYears20042021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, Transition Years 2004-2021",
        "label": "Health Care Cost Recovery Actions, Transition Years 2004-2021 [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, Transition Years 2004-2021"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActionsTransitionYears20042021Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HealthCareCostRecoveryActionsTransitionYears20192021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Cost Recovery Actions, Transition Years 2019-2021",
        "label": "Health Care Cost Recovery Actions, Transition Years 2019-2021 [Member]",
        "terseLabel": "Health Care Cost Recovery Actions, Transition Years 2019-2021"
       }
      }
     },
     "localname": "HealthCareCostRecoveryActionsTransitionYears20192021Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HelixInnovationsLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Helix Innovations LLC [Member]",
        "label": "Helix Innovations LLC [Member]",
        "terseLabel": "Helix Innovations LLC [Member]"
       }
      }
     },
     "localname": "HelixInnovationsLLCMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_HorizonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Horizon",
        "label": "Horizon [Member]",
        "terseLabel": "Horizon {Member]"
       }
      }
     },
     "localname": "HorizonMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_IQOSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IQOS",
        "label": "IQOS [Member]",
        "terseLabel": "IQOS [Member]"
       }
      }
     },
     "localname": "IQOSMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_IQOSTobaccoHeatingSystemMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "IQOS Tobacco Heating System",
        "label": "IQOS Tobacco Heating System [Member]",
        "terseLabel": "IQOS Tobacco Heating System"
       }
      }
     },
     "localname": "IQOSTobaccoHeatingSystemMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ImplementationofCorrectiveCommunicationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Implementation of Corrective Communications [Member]",
        "label": "Implementation of Corrective Communications [Member]",
        "terseLabel": "Implementation of Corrective Communications [Member]"
       }
      }
     },
     "localname": "ImplementationofCorrectiveCommunicationsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_IncomeLossFromEquityInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) from Equity Investments",
        "label": "Income (Loss) from Equity Investments",
        "negatedLabel": "(Income) losses from investments in equity securities",
        "negatedTotalLabel": "(Income) losses from investments in equity securities"
       }
      }
     },
     "localname": "IncomeLossFromEquityInvestments",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_IncreaseDecreaseInSettlementPayable": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change during the period in Settlement payable.",
        "label": "Increase (Decrease) In Settlement Payable",
        "terseLabel": "Accrued settlement charges"
       }
      }
     },
     "localname": "IncreaseDecreaseInSettlementPayable",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-Lived And Finite Lived Intangible Assets, Acquired",
        "label": "Indefinite-Lived And Finite Lived Intangible Assets, Acquired",
        "terseLabel": "Acquisitions (1)"
       }
      }
     },
     "localname": "IndefiniteLivedAndFiniteLivedIntangibleAssetsAcquired",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indefinite-lived And Finite Lived Intangible Assets, Written Off Related to Sale of Business Unit",
        "label": "Indefinite-lived And Finite Lived Intangible Assets, Written Off Related to Sale of Business Unit",
        "negatedTerseLabel": "Dispositions"
       }
      }
     },
     "localname": "IndefiniteLivedAndFiniteLivedIntangibleAssetsWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_IndividualSmokingAndHealthCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individual Smoking and Health Cases [Member]",
        "label": "Individual Smoking And Health Cases [Member]",
        "terseLabel": "Individual Smoking and Health Cases [Member]"
       }
      }
     },
     "localname": "IndividualSmokingAndHealthCasesMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_IntangibleAssetsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets [Axis]",
        "label": "Intangible Assets [Axis]",
        "terseLabel": "Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IntangibleAssetsAxis",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_IntangibleAssetsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Intangible Assets [Axis]",
        "label": "Intangible Assets [Domain]",
        "terseLabel": "Intangible Assets [Domain]"
       }
      }
     },
     "localname": "IntangibleAssetsDomain",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_IntangibleAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets [Roll Forward]",
        "label": "Intangible Assets [Roll Forward]",
        "terseLabel": "Other Intangible Assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsRollForward",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_InterestAndOtherDebtExpenseNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest And Other Debt Expense, Net [Member]",
        "label": "Interest And Other Debt Expense, Net [Member]",
        "terseLabel": "Interest And Other Debt Expense, Net [Member]"
       }
      }
     },
     "localname": "InterestAndOtherDebtExpenseNetMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InterestExpenseRelatedToLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Expense Related To Litigation [Member]",
        "label": "Interest Expense Related To Litigation [Member]",
        "terseLabel": "Related Interest Costs [Member]"
       }
      }
     },
     "localname": "InterestExpenseRelatedToLitigationMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InternationalDevelopedMarketsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Developed Markets [Member]",
        "label": "International Developed Markets [Member]",
        "terseLabel": "International Developed Markets [Member]"
       }
      }
     },
     "localname": "InternationalDevelopedMarketsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InventoryRawMaterialsPlantMaterialNetofReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of products consisting of plant matter that is not used in the growth of plant goods",
        "label": "Inventory, Raw Materials, Plant Material, Net of Reserves",
        "terseLabel": "Leaf tobacco"
       }
      }
     },
     "localname": "InventoryRawMaterialsPlantMaterialNetofReserves",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_InventoryWriteOffMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory Write-Off [Member]",
        "label": "Inventory Write-Off [Member]",
        "terseLabel": "Inventory Write-Off [Member]"
       }
      }
     },
     "localname": "InventoryWriteOffMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_InvestmentOwnedBalancePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment Owned, Balance, Percentage",
        "label": "Investment Owned, Balance, Percentage",
        "terseLabel": "Investment owned, balance, percentage"
       }
      }
     },
     "localname": "InvestmentOwnedBalancePercentage",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_InvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Investments [Table]",
        "label": "Investments [Line Items]",
        "terseLabel": "Investments [Line Items]"
       }
      }
     },
     "localname": "InvestmentsLineItems",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails",
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_InvestmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments [Table]",
        "label": "Investments [Table]",
        "terseLabel": "Investment [Table]"
       }
      }
     },
     "localname": "InvestmentsTable",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails",
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_JTIUHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "JTIUH",
        "label": "JTIUH [Member]",
        "terseLabel": "JTIUH [Member]"
       }
      }
     },
     "localname": "JTIUHMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_JUULAndCronosMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "JUUL and Cronos",
        "label": "JUUL and Cronos [Member]",
        "terseLabel": "Other Investments [Member]"
       }
      }
     },
     "localname": "JUULAndCronosMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_JUULMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "JUUL [Member]",
        "label": "JUUL [Member]",
        "terseLabel": "JUUL [Member]"
       }
      }
     },
     "localname": "JUULMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails",
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_January2021ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2021 Share Repurchase Program",
        "label": "January 2021 Share Repurchase Program [Member]",
        "terseLabel": "January 2021 Share Repurchase Program [Member]"
       }
      }
     },
     "localname": "January2021ShareRepurchaseProgramMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_January2023ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2023 Share Repurchase Program",
        "label": "January 2023 Share Repurchase Program [Member]",
        "terseLabel": "January 2023 Share Repurchase Program"
       }
      }
     },
     "localname": "January2023ShareRepurchaseProgramMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_July2019ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "July 2019 Share Repurchase Program [Member]",
        "label": "July 2019 Share Repurchase Program [Member]",
        "terseLabel": "July 2019 Share Repurchase Program [Member]"
       }
      }
     },
     "localname": "July2019ShareRepurchaseProgramMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Leases, Pre-Tax Expense For Decrease In Unguaranteed Residual Asset",
        "label": "Leverage Leases, Pre-Tax Expense For Decrease In Unguaranteed Residual Asset",
        "negatedTerseLabel": "Pre-tax expense for decrease in unguaranteed residual value of assets"
       }
      }
     },
     "localname": "LeverageLeasesPreTaxExpenseForDecreaseInUnguaranteedResidualAsset",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lights [Member]",
        "label": "Lights [Member]",
        "terseLabel": "Lights [Member]"
       }
      }
     },
     "localname": "LightsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LitigationCasesResultsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Cases Results [Member]",
        "label": "Litigation Cases Results [Member]",
        "terseLabel": "Tobacco and Health Litigation [Member]"
       }
      }
     },
     "localname": "LitigationCasesResultsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_LitigationEscrowDeposit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Escrow Deposit",
        "label": "Litigation Escrow Deposit",
        "terseLabel": "Security posted for appeal of judgments"
       }
      }
     },
     "localname": "LitigationEscrowDeposit",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementAmountExpectedToBeAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Amount Expected To Be Awarded From Other Party",
        "label": "Litigation Settlement, Amount Expected To Be Awarded From Other Party",
        "terseLabel": "Litigation settlement, amount expected to be awarded from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountExpectedToBeAwardedFromOtherParty",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementAnnualLegalFeesPayableMaximum": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Annual Legal Fees Payable, Maximum",
        "label": "Litigation Settlement, Annual Legal Fees Payable, Maximum",
        "terseLabel": "State settlement agreements attorney fees annual cap"
       }
      }
     },
     "localname": "LitigationSettlementAnnualLegalFeesPayableMaximum",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementAnnualPaymentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Annual Payment Amount",
        "label": "Litigation Settlement, Annual Payment Amount",
        "terseLabel": "State settlement agreements annual payments"
       }
      }
     },
     "localname": "LitigationSettlementAnnualPaymentAmount",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LitigationSettlementEstimateofPossibleGain": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Litigation Settlement, Estimate of Possible Gain",
        "label": "Litigation Settlement, Estimate of Possible Gain",
        "terseLabel": "Estimate of possible gain"
       }
      }
     },
     "localname": "LitigationSettlementEstimateofPossibleGain",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LongTermDebtMaturitiesRepaymentsofPrincipalThereafter": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt maturities repayments of principal thereafter.",
        "label": "Long Term Debt Maturities Repayments of Principal Thereafter",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsofPrincipalThereafter",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyClaimsDecided": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Decided",
        "label": "Loss Contingency, Claims Decided",
        "terseLabel": "Number of verdicts returned"
       }
      }
     },
     "localname": "LossContingencyClaimsDecided",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsDecidedFavorableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Decided Favorable, Number",
        "label": "Loss Contingency, Claims Decided Favorable, Number",
        "terseLabel": "Number of favorable verdicts"
       }
      }
     },
     "localname": "LossContingencyClaimsDecidedFavorableNumber",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsDecidedUnfavorableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Decided Unfavorable, Number",
        "label": "Loss Contingency, Claims Decided Unfavorable, Number",
        "terseLabel": "Number of unfavorable verdicts"
       }
      }
     },
     "localname": "LossContingencyClaimsDecidedUnfavorableNumber",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsNotCertifiedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Not Certified, Number",
        "label": "Loss Contingency, Claims Not Certified, Number",
        "terseLabel": "Claims not certified, number"
       }
      }
     },
     "localname": "LossContingencyClaimsNotCertifiedNumber",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClaimsResolvedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Claims Resolved, Number",
        "label": "Loss Contingency, Claims Resolved, Number",
        "terseLabel": "Number of claims resolved"
       }
      }
     },
     "localname": "LossContingencyClaimsResolvedNumber",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClassActionLawsuit": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Action Lawsuit",
        "label": "Loss Contingency, Class Action Lawsuit",
        "terseLabel": "Number of class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyClassActionLawsuit",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyClassNotCertifiedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Class Not Certified, Number",
        "label": "Loss Contingency, Class Not Certified, Number",
        "terseLabel": "Class not certified"
       }
      }
     },
     "localname": "LossContingencyClassNotCertifiedNumber",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyCompensatoryDamagesAwardedValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Compensatory Damages Awarded, Value",
        "label": "Loss Contingency, Compensatory Damages Awarded, Value",
        "terseLabel": "Compensatory damages awarded"
       }
      }
     },
     "localname": "LossContingencyCompensatoryDamagesAwardedValue",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyDamagesRecoverableValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Damages Recoverable, Value",
        "label": "Loss Contingency, Damages Recoverable, Value",
        "terseLabel": "Loss contingency, damages recoverable, value"
       }
      }
     },
     "localname": "LossContingencyDamagesRecoverableValue",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyFaultAllocationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Fault Allocation Percentage",
        "label": "Loss Contingency, Fault Allocation Percentage",
        "terseLabel": "Loss contingency, fault allocation percentage"
       }
      }
     },
     "localname": "LossContingencyFaultAllocationPercentage",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_LossContingencyNumberOfCases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Cases",
        "label": "Loss Contingency, Number Of Cases",
        "terseLabel": "Number of cases"
       }
      }
     },
     "localname": "LossContingencyNumberOfCases",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfCasesWithSetTrialDates": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Cases With Set Trial Dates",
        "label": "Loss Contingency, Number of Cases With Set Trial Dates",
        "terseLabel": "Loss contingency, number of cases with set trial dates"
       }
      }
     },
     "localname": "LossContingencyNumberOfCasesWithSetTrialDates",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfComplaints": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Complaints",
        "label": "Loss Contingency, Number Of Complaints",
        "terseLabel": "Loss contingency, number of complaints"
       }
      }
     },
     "localname": "LossContingencyNumberOfComplaints",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfInactiveCases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Inactive Cases",
        "label": "Loss Contingency, Number Of Inactive Cases",
        "terseLabel": "Number of inactive cases"
       }
      }
     },
     "localname": "LossContingencyNumberOfInactiveCases",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfInactiveClassActionLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Inactive Class Action Lawsuits",
        "label": "Loss Contingency, Number Of Inactive Class Action Lawsuits",
        "terseLabel": "Number of cases alleging unfair practices"
       }
      }
     },
     "localname": "LossContingencyNumberOfInactiveClassActionLawsuits",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Lawsuits Subsequently Consolidated Into A Single Proceeding",
        "label": "Loss Contingency, Number Of Lawsuits Subsequently Consolidated Into A Single Proceeding",
        "terseLabel": "Loss Contingency, Number Of Lawsuits Subsequently Consolidated Into A Single Proceeding"
       }
      }
     },
     "localname": "LossContingencyNumberOfLawsuitsSubsequentlyConsolidatedIntoASingleProceeding",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfPendingCasesConsolidated": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Pending Cases Consolidated",
        "label": "Loss Contingency, Number Of Pending Cases Consolidated",
        "terseLabel": "Loss contingency, number of pending cases consolidated"
       }
      }
     },
     "localname": "LossContingencyNumberOfPendingCasesConsolidated",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfShareholdersFilingClassActionLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits",
        "label": "Loss Contingency, Number Of Shareholders Filing Class Action Lawsuits",
        "terseLabel": "Loss contingency, number of shareholders filing class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfShareholdersFilingClassActionLawsuits",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfShareholdersFilingDerivativeLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits",
        "label": "Loss Contingency, Number Of Shareholders Filing Derivative Lawsuits",
        "terseLabel": "Loss contingency, number of shareholders filing derivative lawsuits"
       }
      }
     },
     "localname": "LossContingencyNumberOfShareholdersFilingDerivativeLawsuits",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfStatesInComplianceWithEscrowStatues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States In Compliance With Escrow Statues",
        "label": "Loss Contingency, Number Of States In Compliance With Escrow Statues",
        "terseLabel": "Loss contingency, number of states in compliance with escrow statues"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesInComplianceWithEscrowStatues",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States Not In Compliance With Escrow Statues",
        "label": "Loss Contingency, Number Of States Not In Compliance With Escrow Statues",
        "terseLabel": "Loss contingency, number of states not in compliance with escrow statues"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesNotInComplianceWithEscrowStatues",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfStatesNotSettled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States Not Settled",
        "label": "Loss Contingency, Number Of States Not Settled",
        "terseLabel": "Loss contingency, number of states not settled"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesNotSettled",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberOfStatesNotSettledArbitrationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number Of States Not Settled Arbitration Period",
        "label": "Loss Contingency, Number Of States Not Settled Arbitration Period",
        "terseLabel": "Loss contingency, number of states not settled arbitration period"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesNotSettledArbitrationPeriod",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_LossContingencyNumberOfStatesWithConcludedHearings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency Number Of States With Concluded Hearings",
        "label": "Loss Contingency Number Of States With Concluded Hearings",
        "terseLabel": "Loss contingency number of states with concluded hearings"
       }
      }
     },
     "localname": "LossContingencyNumberOfStatesWithConcludedHearings",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Additional States Extended with Settled Litigation",
        "label": "Loss Contingency, Number of Additional States Extended with Settled Litigation",
        "terseLabel": "Loss contingency, number of additional states extended with settled litigation"
       }
      }
     },
     "localname": "LossContingencyNumberofAdditionalStatesExtendedwithSettledLitigation",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofCasesSetforTrial": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Cases Set for Trial",
        "label": "Loss Contingency, Number of Cases Set for Trial",
        "terseLabel": "Number of cases set for trial"
       }
      }
     },
     "localname": "LossContingencyNumberofCasesSetforTrial",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofManufacturers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of Manufacturers",
        "label": "Loss Contingency, Number of Manufacturers",
        "terseLabel": "Number of manufacturers"
       }
      }
     },
     "localname": "LossContingencyNumberofManufacturers",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStatesThatCapBondorRequireNoBond": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States That Cap Bond or Require No Bond",
        "label": "Loss Contingency, Number of States That Cap Bond or Require No Bond",
        "terseLabel": "Number of states that cap bond or require no bond"
       }
      }
     },
     "localname": "LossContingencyNumberofStatesThatCapBondorRequireNoBond",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGeneralInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStateswithSettledLitigation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States with Settled Litigation",
        "label": "Loss Contingency, Number of States with Settled Litigation",
        "terseLabel": "Number of states with settled litigation"
       }
      }
     },
     "localname": "LossContingencyNumberofStateswithSettledLitigation",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyNumberofStateswithSettledLitigationSettlementOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Number of States with Settled Litigation, Settlement One",
        "label": "Loss Contingency, Number of States with Settled Litigation, Settlement One",
        "terseLabel": "Loss contingency, number of states with settled litigation including Illinois, subsequent expansion"
       }
      }
     },
     "localname": "LossContingencyNumberofStateswithSettledLitigationSettlementOne",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number",
        "label": "Loss Contingency, Pending Claims, Consolidated For Pre-Trial Purposes, Number",
        "terseLabel": "Loss contingency, pending claims, consolidated for pre-trial purposes, number"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsConsolidatedForPreTrialPurposesNumber",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants",
        "label": "Loss Contingency, Period for Decertified Class Members to File Individual Actions Against Defendants",
        "terseLabel": "Period for decertified class members could file individual actions"
       }
      }
     },
     "localname": "LossContingencyPeriodforDecertifiedClassMemberstoFileIndividualActionsAgainstDefendants",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_LossContingencyPunitiveDamagesAwardedValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Punitive Damages Awarded, Value",
        "label": "Loss Contingency, Punitive Damages Awarded, Value",
        "terseLabel": "Punitive damages awarded"
       }
      }
     },
     "localname": "LossContingencyPunitiveDamagesAwardedValue",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyReductionToCostOfSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Reduction To Cost Of Sales",
        "label": "Loss Contingency, Reduction To Cost Of Sales",
        "terseLabel": "Loss contingency, reduction to cost of sales"
       }
      }
     },
     "localname": "LossContingencyReductionToCostOfSales",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_LossContingencyRoyaltyFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Royalty Fee Percentage",
        "label": "Loss Contingency, Royalty Fee Percentage",
        "terseLabel": "Loss contingency, royalty fee percentage"
       }
      }
     },
     "localname": "LossContingencyRoyaltyFeePercentage",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_LossContingencyStateCourtsNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, State Courts, Number",
        "label": "Loss Contingency, State Courts, Number",
        "terseLabel": "Number of state courts"
       }
      }
     },
     "localname": "LossContingencyStateCourtsNumber",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyUnfavorableVerdictsPendingReversed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Unfavorable Verdicts Pending/Reversed",
        "label": "Loss Contingency, Unfavorable Verdicts Pending/Reversed",
        "terseLabel": "Number of claims with unfavorable verdicts pending/reversed"
       }
      }
     },
     "localname": "LossContingencyUnfavorableVerdictsPendingReversed",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyVerdictReversedNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Verdict Reversed, Number",
        "label": "Loss Contingency, Verdict Reversed, Number",
        "terseLabel": "Verdicts reversed, number"
       }
      }
     },
     "localname": "LossContingencyVerdictReversedNumber",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyVerdictsUpheld": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Verdicts Upheld",
        "label": "Loss Contingency, Verdicts Upheld",
        "terseLabel": "Number of verdicts upheld"
       }
      }
     },
     "localname": "LossContingencyVerdictsUpheld",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyZeroDamagesVerdictModified": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Zero Damages Verdict Modified",
        "label": "Loss Contingency, Zero Damages Verdict Modified",
        "terseLabel": "Zero damages verdict modified"
       }
      }
     },
     "localname": "LossContingencyZeroDamagesVerdictModified",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_LossContingencyZeroDamagesVerdicts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Zero Damages Verdicts",
        "label": "Loss Contingency, Zero Damages Verdicts",
        "terseLabel": "Zero damages verdicts"
       }
      }
     },
     "localname": "LossContingencyZeroDamagesVerdicts",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_MarketingAdministrationAndResearchCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketing Administration And Research Costs [Member]",
        "label": "Marketing Administration And Research Costs [Member]",
        "terseLabel": "Marketing Administration And Research Costs [Member]"
       }
      }
     },
     "localname": "MarketingAdministrationAndResearchCostsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_MarketingAdministrationandResearchCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies when the technological feasibility has not been reached. General and administrative expenses include salaries of nonsales personnel, rent, utilities, communication, etc.",
        "label": "Marketing, Administration and Research Costs",
        "terseLabel": "Marketing, administration and research costs"
       }
      }
     },
     "localname": "MarketingAdministrationandResearchCosts",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_MarketingCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketing Costs [Policy Text Block]",
        "label": "Marketing Costs [Policy Text Block]",
        "terseLabel": "Marketing Costs"
       }
      }
     },
     "localname": "MarketingCostsPolicyTextBlock",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_MaximumBondForAllDefendants": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Bond For All Defendants",
        "label": "Maximum Bond For All Defendants",
        "terseLabel": "Maximum bond for all defendants"
       }
      }
     },
     "localname": "MaximumBondForAllDefendants",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_McLaneCompanyIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "McLane Company Inc [Member]",
        "label": "McLane Company Inc [Member]",
        "terseLabel": "McLane Company Inc [Member]"
       }
      }
     },
     "localname": "McLaneCompanyIncMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Methodology of determining fair value of pension assets",
        "label": "Methodology of Determining Fair Value of Pension Assets [Policy Text Block]",
        "terseLabel": "Methodology of Determining Fair Value of Pension Assets"
       }
      }
     },
     "localname": "MethodologyofDeterminingFairValueofPensionAssetsPolicyTextBlock",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_MiddletonMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Middleton [Member]",
        "label": "Middleton [Member]",
        "terseLabel": "Middleton [Member]"
       }
      }
     },
     "localname": "MiddletonMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NPMAdjustmentToCostOfSalesAndInterestExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NPM Adjustment to Cost Of Sales And Interest Expense",
        "label": "NPM Adjustment to Cost Of Sales And Interest Expense [Member]",
        "terseLabel": "NPM Adjustment to Cost Of Sales And Interest Expense [Member]"
       }
      }
     },
     "localname": "NPMAdjustmentToCostOfSalesAndInterestExpenseMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NPMAdjustmentToInterestExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NPM Adjustment To Interest Expense",
        "label": "NPM Adjustment To Interest Expense [Member]",
        "terseLabel": "NPM Adjustment To Interest Expense [Member]"
       }
      }
     },
     "localname": "NPMAdjustmentToInterestExpenseMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenyCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Engle Progeny Cases [Member]",
        "label": "Non Engle Progeny Cases [Member]",
        "terseLabel": "Non Engle Progeny Cases [Member]"
       }
      }
     },
     "localname": "NonEngleProgenyCasesMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingAndHealthCaseFontaineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking And Health Case, Fontaine",
        "label": "Non-Engle Progeny Smoking And Health Case, Fontaine [Member]",
        "terseLabel": "Non-Engle Progeny Smoking And Health Case, Fontaine [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingAndHealthCaseFontaineMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingAndHealthCaseMendezMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking And Health Case, Mendez",
        "label": "Non-Engle Progeny Smoking And Health Case, Mendez [Member]",
        "terseLabel": "Non-Engle Progeny Smoking And Health Case, Mendez [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingAndHealthCaseMendezMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingAndHealthCasePrincipeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking And Health Case, Principe",
        "label": "Non-Engle Progeny Smoking And Health Case, Principe [Member]",
        "terseLabel": "Non-Engle Progeny Smoking And Health Case, Principe [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingAndHealthCasePrincipeMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonEngleProgenySmokingandHealthCaseGreeneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Engle Progeny Smoking and Health Case, Greene [Member]",
        "label": "Non-Engle Progeny Smoking and Health Case, Greene [Member]",
        "terseLabel": "Non-Engle Progeny Smoking and Health Case, Greene [Member]"
       }
      }
     },
     "localname": "NonEngleProgenySmokingandHealthCaseGreeneMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NonParticipatingManufacturerArbitrationPanelDecisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Participating Manufacturer Arbitration Panel Decision [Member]",
        "label": "Non-Participating Manufacturer Arbitration Panel Decision [Member]",
        "terseLabel": "Non-Participating Manufacturer Arbitration Panel Decision [Member]"
       }
      }
     },
     "localname": "NonParticipatingManufacturerArbitrationPanelDecisionMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NoncontrollingInterestRemainingInterestPurchasedByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Remaining Interest Purchased By Parent",
        "label": "Noncontrolling Interest, Remaining Interest Purchased By Parent",
        "terseLabel": "Noncontrolling interest, remaining interest purchased by parent"
       }
      }
     },
     "localname": "NoncontrollingInterestRemainingInterestPurchasedByParent",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_NpmAdjustmentToCostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NPM Adjustment to Cost Of Sales [Member]",
        "label": "NPM Adjustment to Cost Of Sales [Member]",
        "terseLabel": "NPM Adjustment to Cost Of Sales [Member]"
       }
      }
     },
     "localname": "NpmAdjustmentToCostOfSalesMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_NumberOfLeveragedLeasesRemaining": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Leveraged Leases Remaining",
        "label": "Number Of Leveraged Leases Remaining",
        "terseLabel": "Number of leveraged leases remaining"
       }
      }
     },
     "localname": "NumberOfLeveragedLeasesRemaining",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_NumberOfThirdPartyLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Third Party Lawsuits",
        "label": "Number of Third Party Lawsuits",
        "terseLabel": "Number of third party lawsuits"
       }
      }
     },
     "localname": "NumberOfThirdPartyLawsuits",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "mo_OralTobaccoSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Oral Tobacco Segment [Member]",
        "label": "Oral Tobacco Segment [Member]",
        "terseLabel": "Oral Tobacco Products [Member]"
       }
      }
     },
     "localname": "OralTobaccoSegmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive (Income) Loss, Adjustment from AOCI, Pension, Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax",
        "label": "Other Comprehensive (Income) Loss, Adjustment from AOCI, Pension, Other Postretirement and Postemployment Benefit Plans, for Net Prior Service Cost (Credit), before Tax",
        "terseLabel": "Prior service cost/credit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAdjustmentfromAOCIPensionOtherPostretirementandPostemploymentBenefitPlansforNetPriorServiceCostCreditbeforeTax",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax, Including Cumulative Effect Adjustment",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax, Including Cumulative Effect Adjustment",
        "negatedTotalLabel": "Total movements in other comprehensive earnings/losses"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment And Other, Net of Tax",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment And Other, Net of Tax",
        "terseLabel": "Currency translation adjustments and other"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentAndOtherNetOfTax",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Other Net Gain (Loss), before Tax",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Other Net Gain (Loss), before Tax",
        "negatedTerseLabel": "Net loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforOtherNetGainLossbeforeTax",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_OtherDisputesUndertheStateSettlementAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Disputes Under the State Settlement Agreements [Member]",
        "label": "Other Disputes Under the State Settlement Agreements [Member]",
        "terseLabel": "Other Disputes Under the State Settlement Agreements [Member]"
       }
      }
     },
     "localname": "OtherDisputesUndertheStateSettlementAgreementsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_OtherInventoryRawMaterialsNetofReserves": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Inventory, Raw Materials, Net of Reserves",
        "label": "Other Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Other raw materials"
       }
      }
     },
     "localname": "OtherInventoryRawMaterialsNetofReserves",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_OtherInvestmentNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Investments, Net [Member]",
        "label": "Other Investment, Net [Member]",
        "terseLabel": "Other, Net [Member]"
       }
      }
     },
     "localname": "OtherInvestmentNetMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_OtherMovementsDuringtheYearAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Movements During the Year [Abstract]",
        "label": "Other Movements During the Year [Abstract]",
        "terseLabel": "Other movements during the year:"
       }
      }
     },
     "localname": "OtherMovementsDuringtheYearAbstract",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_OtherTabaccoRelatedCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Tabacco-Related Cases [Member]",
        "label": "Other Tabacco-Related Cases [Member]",
        "terseLabel": "Other Tabacco-Related Cases [Member]"
       }
      }
     },
     "localname": "OtherTabaccoRelatedCasesMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_OwnershipPercentageInConsolidatedSubsidiary": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership Percentage In Consolidated Subsidiary",
        "label": "Ownership Percentage In Consolidated Subsidiary",
        "terseLabel": "Ownership percentage in consolidated subsidiary"
       }
      }
     },
     "localname": "OwnershipPercentageInConsolidatedSubsidiary",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "mo_ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/EarningsperShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Basic and Diluted",
        "negatedLabel": "Less: Distributed and undistributed earnings attributable to share-based awards"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedandUndistributedEarningsLossBasicandDiluted",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Equity Securities Without Readily Determinable Fair Value",
        "label": "Payments to Acquire Equity Securities Without Readily Determinable Fair Value",
        "terseLabel": "Payments to acquire equity securities without readily determinable fair value"
       }
      }
     },
     "localname": "PaymentstoAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_PendingClassActionLawsuitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending Class Action Lawsuit",
        "label": "Pending Class Action Lawsuit [Member]",
        "terseLabel": "Pending Class Action Lawsuit [Member]"
       }
      }
     },
     "localname": "PendingClassActionLawsuitMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PendingClassActionLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending Class Action Lawsuits [Member]",
        "label": "Pending Class Action Lawsuits [Member]",
        "terseLabel": "Pending Class Action Lawsuits [Member]"
       }
      }
     },
     "localname": "PendingClassActionLawsuitsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PendingIndividualLawsuitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending Individual Lawsuits [Member]",
        "label": "Pending Individual Lawsuits [Member]",
        "terseLabel": "Pending Individual Lawsuits [Member]"
       }
      }
     },
     "localname": "PendingIndividualLawsuitsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PendingLawsuitFiledBySchoolDistrictMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending Lawsuit Filed By School District [Member]",
        "label": "Pending Lawsuit Filed By School District [Member]",
        "terseLabel": "Pending Lawsuit Filed By School District [Member]"
       }
      }
     },
     "localname": "PendingLawsuitFiledBySchoolDistrictMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PendingLawsuitsFiledByStateOrLocalGovernmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pending Lawsuits Filed By State Or Local Governments [Member]",
        "label": "Pending Lawsuits Filed By State Or Local Governments [Member]",
        "terseLabel": "Pending Lawsuits Filed By State Or Local Governments [Member]"
       }
      }
     },
     "localname": "PendingLawsuitsFiledByStateOrLocalGovernmentsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pension, Other Postretirement and Postemployment Plans, Policy [Policy Text Block]",
        "label": "Pension, Other Postretirement and Postemployment Plans, Policy [Policy Text Block]",
        "terseLabel": "Employee Benefit Plans"
       }
      }
     },
     "localname": "PensionOtherPostretirementandPostemploymentPlansPolicyPolicyTextBlock",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_PerformanceFoodGroupCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Food Group Company",
        "label": "Performance Food Group Company [Member]",
        "terseLabel": "Performance Food Group Company [Member]"
       }
      }
     },
     "localname": "PerformanceFoodGroupCompanyMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period One",
        "label": "Period One [Member]",
        "terseLabel": "Period One"
       }
      }
     },
     "localname": "PeriodOneMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period Two",
        "label": "Period Two [Member]",
        "terseLabel": "Period Two"
       }
      }
     },
     "localname": "PeriodTwoMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PhilipMorrisCapitalCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Philip Morris Capital Corporation",
        "label": "Philip Morris Capital Corporation [Member]",
        "terseLabel": "Philip Morris Capital Corporation [Member]"
       }
      }
     },
     "localname": "PhilipMorrisCapitalCorporationMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Philip Morris USA And R.J. Reynolds Tobacco Company",
        "label": "Philip Morris USA And R.J. Reynolds Tobacco Company [Member]",
        "terseLabel": "Philip Morris USA And R.J. Reynolds Tobacco Company"
       }
      }
     },
     "localname": "PhilipMorrisUSAAndRJReynoldsTobaccoCompanyMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PhilipMorrisUSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Philip Morris USA [Member]",
        "label": "Philip Morris USA [Member]",
        "terseLabel": "PM USA [Member]"
       }
      }
     },
     "localname": "PhilipMorrisUSAMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_PhilipMorrisUSAandAltriaGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Philip Morris USA and Altria Group [Member]",
        "label": "Philip Morris USA and Altria Group [Member]",
        "terseLabel": "Philip Morris USA and Altria Group [Member]"
       }
      }
     },
     "localname": "PhilipMorrisUSAandAltriaGroupMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ProceedsFromSaleOfCommercializationRights": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sale Of Commercialization Rights",
        "label": "Proceeds From Sale Of Commercialization Rights",
        "terseLabel": "Proceeds from the sale of IQOS System commercialization rights"
       }
      }
     },
     "localname": "ProceedsFromSaleOfCommercializationRights",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ProceedsFromSaleOfRightsUnderAnAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Sale Of Rights Under An Agreement",
        "label": "Proceeds from Sale Of Rights Under An Agreement",
        "terseLabel": "Proceeds from sale of rights under an agreement"
       }
      }
     },
     "localname": "ProceedsFromSaleOfRightsUnderAnAgreement",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ReceivableCommercializationRightsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Receivable, Commercialization Rights, Current",
        "label": "Receivable, Commercialization Rights, Current",
        "terseLabel": "Receivable from the sale of IQOS System commercialization rights"
       }
      }
     },
     "localname": "ReceivableCommercializationRightsCurrent",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_RevenueContractDuration": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue, Contract Duration",
        "label": "Revenue, Contract Duration",
        "terseLabel": "Revenue, contract duration"
       }
      }
     },
     "localname": "RevenueContractDuration",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Deferred Revenue",
        "label": "Revenue From Contract With Customer, Deferred Revenue [Policy Text Block]",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerDeferredRevenuePolicyTextBlock",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_RevolvingCreditFacilityDueAugust2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility Due August 2025",
        "label": "Revolving Credit Facility Due August 2025 [Member]",
        "terseLabel": "Revolving Credit Facility Due August 2025"
       }
      }
     },
     "localname": "RevolvingCreditFacilityDueAugust2025Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Assumptions To Determine Net Periodic Benefit Cost [Text Block]",
        "label": "Schedule Of Assumptions To Determine Net Periodic Benefit Cost [Table Text Block]",
        "terseLabel": "Schedule Of Assumptions To Determine Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsToDetermineNetPeriodicBenefitCostTableTextBlock",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Non-Participating Manufacturer Adjustment Items",
        "label": "Schedule Of Non-Participating Manufacturer Adjustment Items [Table Text Block]",
        "terseLabel": "Schedule Of Non-Participating Manufacturer Adjustment Items"
       }
      }
     },
     "localname": "ScheduleOfNonParticipatingManufacturerAdjustmentItemsTableTextBlock",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Tobacco and Health and Certain Other Litigation Items",
        "label": "Schedule of Tobacco and Health and Certain Other Litigation Items [Table Text Block]",
        "terseLabel": "Schedule of Tobacco and Health and Certain Other Litigation Items"
       }
      }
     },
     "localname": "ScheduleOfTobaccoAndHealthAndCertainOtherLitigationItemsTableTextBlock",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]",
        "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Line Items]"
       }
      }
     },
     "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesLineItems",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ScheduleofPretaxTobaccoandHealthLitigationChargesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "label": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]",
        "terseLabel": "Schedule of Pre-tax Tobacco and Health Litigation Charges [Table]"
       }
      }
     },
     "localname": "ScheduleofPretaxTobaccoandHealthLitigationChargesTable",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "mo_ScheduleofValuationandQualifyingAccountsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Valuation and Qualifying Accounts [Table Text Block]",
        "label": "Schedule of Valuation and Qualifying Accounts [Table Text Block]",
        "terseLabel": "Schedule of Valuation and Qualifying Accounts"
       }
      }
     },
     "localname": "ScheduleofValuationandQualifyingAccountsTableTextBlock",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "mo_SerialPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Serial Preferred Stock [Member]",
        "label": "Serial Preferred Stock [Member]",
        "terseLabel": "Serial Preferred Stock [Member]"
       }
      }
     },
     "localname": "SerialPreferredStockMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options grants in period weighted average grant date fair value total.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Aggregate Weighted Average Grant Date Fair Value",
        "verboseLabel": "Weighted-average grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodAggregateWeightedAverageGrantDateFairValue",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Expense Amortization Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Expense Amortization Period",
        "terseLabel": "Expense amortization period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpenseAmortizationPeriod",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "mo_SmokeableProductsSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smokeable Products Segment [Member]",
        "label": "Smokeable Products Segment [Member]",
        "terseLabel": "Smokeable Products [Member]"
       }
      }
     },
     "localname": "SmokeableProductsSegmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smoking and Health Class Actions and Aggregated Claims Litigation [Member]",
        "label": "Smoking And Health Class Actions And Aggregated Claims Litigation [Member]",
        "terseLabel": "Smoking and Health Class Actions and Aggregated Claims Litigation [Member]"
       }
      }
     },
     "localname": "SmokingAndHealthClassActionsAndAggregatedClaimsLitigationMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_SmokingAndHealthClassActionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smoking And Health Class Actions",
        "label": "Smoking And Health Class Actions [Member]",
        "terseLabel": "Smoking And Health Class Actions [Member]"
       }
      }
     },
     "localname": "SmokingAndHealthClassActionsMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_SteMichelleTransactionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ste. Michelle Transaction",
        "label": "Ste. Michelle Transaction [Member]",
        "terseLabel": "Ste. Michelle Transaction"
       }
      }
     },
     "localname": "SteMichelleTransactionMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Treasury Stock Reissued (Forfeited and Returned)",
        "label": "Stock Issued During Period, Shares, Treasury Stock Reissued (Forfeited and Returned)",
        "terseLabel": "Stock award activity (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissuedForfeitedandReturned",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "mo_TermSecuredOvernightFinancingRateTermSOFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Secured Overnight Financing Rate (\"Term SOFR\")",
        "label": "Term Secured Overnight Financing Rate (\"Term SOFR\") [Member]",
        "terseLabel": "Term Secured Overnight Financing Rate (\"Term SOFR\") [Member]"
       }
      }
     },
     "localname": "TermSecuredOvernightFinancingRateTermSOFRMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_TobaccoandHealthJudgmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tobacco and Health Judgment [Member]",
        "label": "Tobacco and Health Judgment [Member]",
        "terseLabel": "Tobacco and Health Judgment [Member]"
       }
      }
     },
     "localname": "TobaccoandHealthJudgmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_TobaccoandHealthLitigationCasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tobacco and Health Litigation Cases [Member]",
        "label": "Tobacco and Health Litigation Cases [Member]",
        "terseLabel": "Tobacco and Health Litigation Cases [Member]"
       }
      }
     },
     "localname": "TobaccoandHealthLitigationCasesMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_TrademarksCopenhagenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trademarks, Copenhagen",
        "label": "Trademarks, Copenhagen [Member]",
        "terseLabel": "Copenhagen [Member]"
       }
      }
     },
     "localname": "TrademarksCopenhagenMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_TrademarksMSTMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trademarks, MST",
        "label": "Trademarks, MST [Member]",
        "terseLabel": "Trademarks, MST [Member]"
       }
      }
     },
     "localname": "TrademarksMSTMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_TrademarksSkoalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trademarks, Skoal",
        "label": "Trademarks, Skoal [Member]",
        "terseLabel": "Skoal [ Member]"
       }
      }
     },
     "localname": "TrademarksSkoalMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDebenture7750MaturingJanuary2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Debenture, 7.750%, Maturing January 2027",
        "label": "USD Debenture, 7.750%, Maturing January 2027 [Member]",
        "terseLabel": "USD Debenture, 7.750%, Maturing January 2027 [Member]"
       }
      }
     },
     "localname": "USDDebenture7750MaturingJanuary2027Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotes3490PercentDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes, 3.490 Percent, Due 2022",
        "label": "USD Denominated Notes, 3.490 Percent, Due 2022 [Member]",
        "terseLabel": "USD Denominated Notes, 3.490 Percent, Due 2022 [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotes3490PercentDue2022Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDDenominatedNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Denominated Notes [Member]",
        "label": "USD Denominated Notes [Member]",
        "terseLabel": "USD Denominated Notes [Member]"
       }
      }
     },
     "localname": "USDDenominatedNotesMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes10200MaturingFebruary2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 10.200%, Maturing February 2039",
        "label": "USD Notes, 10.200%, Maturing February 2039 [Member]",
        "terseLabel": "USD Notes, 10.200%, Maturing February 2039 [Member]",
        "verboseLabel": "USD Notes, 10.200% [Member]"
       }
      }
     },
     "localname": "USDNotes10200MaturingFebruary2039Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes2350MaturingMay2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 2.350%, Maturing May 2025",
        "label": "USD Notes, 2.350%, Maturing May 2025 [Member]",
        "terseLabel": "USD Notes, 2.350%, Maturing May 2025 [Member]"
       }
      }
     },
     "localname": "USDNotes2350MaturingMay2025Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes2350To1020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 2.350% to 10.20%",
        "label": "USD Notes, 2.350% to 10.20% [Member]",
        "terseLabel": "Notes 2.350% To 10.20%, interest payable semi-annually, due through 2061 [Member]"
       }
      }
     },
     "localname": "USDNotes2350To1020Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes2450MaturingFebruary2032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 2.450%, Maturing February 2032",
        "label": "USD Notes, 2.450%, Maturing February 2032 [Member]",
        "terseLabel": "USD Notes, 2.450%, Maturing February 2032 [Member]"
       }
      }
     },
     "localname": "USDNotes2450MaturingFebruary2032Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes2625MaturingSeptember2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 2.625%, Maturing September 2026",
        "label": "USD Notes, 2.625%, Maturing September 2026 [Member]",
        "terseLabel": "USD Notes, 2.625%, Maturing September 2026 [Member]"
       }
      }
     },
     "localname": "USDNotes2625MaturingSeptember2026Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes2850MaturingAugust2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 2.850%, Maturing August 2022",
        "label": "USD Notes, 2.850%, Maturing August 2022 [Member]",
        "verboseLabel": "USD Notes, 2.850% [Member]"
       }
      }
     },
     "localname": "USDNotes2850MaturingAugust2022Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes2950MaturingMay2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 2.950%, Maturing May 2023",
        "label": "USD Notes, 2.950%, Maturing May 2023 [Member]",
        "terseLabel": "USD Notes, 2.950%, Maturing May 2023 [Member]",
        "verboseLabel": "USD Notes, 2.950% [Member]"
       }
      }
     },
     "localname": "USDNotes2950MaturingMay2023Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes3400MaturingFebruary2041Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 3.400%, Maturing February 2041",
        "label": "USD Notes, 3.400%, Maturing February 2041 [Member]",
        "terseLabel": "USD Notes, 3.400%, Maturing February 2041 [Member]"
       }
      }
     },
     "localname": "USDNotes3400MaturingFebruary2041Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes3400MaturingMay2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 3.400%, Maturing May 2030",
        "label": "USD Notes, 3.400%, Maturing May 2030 [Member]",
        "terseLabel": "USD Notes, 3.400%, Maturing May 2030 [Member]"
       }
      }
     },
     "localname": "USDNotes3400MaturingMay2030Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes3700MaturingFebruary2051Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 3.700%, Maturing February 2051",
        "label": "USD Notes, 3.700%, Maturing February 2051 [Member]",
        "terseLabel": "USD Notes, 3.700%, Maturing February 2051 [Member]"
       }
      }
     },
     "localname": "USDNotes3700MaturingFebruary2051Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes3800MaturingFebruary2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 3.800%, Maturing February 2024",
        "label": "USD Notes, 3.800%, Maturing February 2024 [Member]",
        "netLabel": "USD Notes, 3.800%, Maturing February 2024 [Member]",
        "verboseLabel": "USD Notes, 3.800% [Member]"
       }
      }
     },
     "localname": "USDNotes3800MaturingFebruary2024Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes3875MaturingSeptember2046Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 3.875%, Maturing September 2046",
        "label": "USD Notes, 3.875%, Maturing September 2046 [Member]",
        "terseLabel": "USD Notes, 3.875%, Maturing September 2046 [Member]"
       }
      }
     },
     "localname": "USDNotes3875MaturingSeptember2046Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes4000MaturingFebruary2061Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 4.000%, Maturing February 2061",
        "label": "USD Notes, 4.000%, Maturing February 2061 [Member]",
        "terseLabel": "USD Notes, 4.000%, Maturing February 2061 [Member]"
       }
      }
     },
     "localname": "USDNotes4000MaturingFebruary2061Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes4000MaturingJanuary2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 4.000%, Maturing January 2024",
        "label": "USD Notes, 4.000%, Maturing January 2024 [Member]",
        "terseLabel": "USD Notes, 4.000% [Member]",
        "verboseLabel": "USD Notes, 4.000%, Maturing January 2024 [Member]"
       }
      }
     },
     "localname": "USDNotes4000MaturingJanuary2024Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes4250MaturingAugust2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 4.250%, Maturing August 2042",
        "label": "USD Notes, 4.250%, Maturing August 2042 [Member]",
        "terseLabel": "USD Notes, 4.250%, Maturing August 2042 [Member]"
       }
      }
     },
     "localname": "USDNotes4250MaturingAugust2042Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes4400MaturingFebruary2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 4.400%, Maturing February 2026",
        "label": "USD Notes, 4.400%, Maturing February 2026 [Member]",
        "terseLabel": "USD Notes, 4.400%, Maturing February 2026 [Member]",
        "verboseLabel": "USD Notes, 4.400% [Member]"
       }
      }
     },
     "localname": "USDNotes4400MaturingFebruary2026Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes4450MaturingMay2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 4.450%, Maturing May 2050",
        "label": "USD Notes, 4.450%, Maturing May 2050 [Member]",
        "terseLabel": "USD Notes, 4.450%, Maturing May 2050 [Member]"
       }
      }
     },
     "localname": "USDNotes4450MaturingMay2050Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes4500MaturingMay2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 4.500%, Maturing May 2043",
        "label": "USD Notes, 4.500%, Maturing May 2043 [Member]",
        "terseLabel": "USD Notes, 4.500%, Maturing May 2043 [Member]"
       }
      }
     },
     "localname": "USDNotes4500MaturingMay2043Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes4800MaturingFebruary2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 4.800%, Maturing February 2029",
        "label": "USD Notes, 4.800%, Maturing February 2029 [Member]",
        "terseLabel": "USD Notes, 4.800%, Maturing February 2029 [Member]",
        "verboseLabel": "USD Notes, 4.800% [Member]"
       }
      }
     },
     "localname": "USDNotes4800MaturingFebruary2029Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes5375MaturingJanuary2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 5.375%, Maturing January 2044",
        "label": "USD Notes, 5.375%, Maturing January 2044 [Member]",
        "terseLabel": "USD Notes, 5.375%, Maturing January 2044 [Member]"
       }
      }
     },
     "localname": "USDNotes5375MaturingJanuary2044Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes5800MaturingFebruary2039Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 5.800%, Maturing February 2039",
        "label": "USD Notes, 5.800%, Maturing February 2039 [Member]",
        "terseLabel": "USD Notes, 5.800%, Maturing February 2039 [Member]"
       }
      }
     },
     "localname": "USDNotes5800MaturingFebruary2039Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes5950MaturingFebruary2049Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 5.950%, Maturing February 2049",
        "label": "USD Notes, 5.950%, Maturing February 2049 [Member]",
        "terseLabel": "USD Notes, 5.950%, Maturing February 2049 [member]"
       }
      }
     },
     "localname": "USDNotes5950MaturingFebruary2049Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes6200MaturingFebruary2059Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 6.200%, Maturing February 2059",
        "label": "USD Notes, 6.200%, Maturing February 2059 [Member]",
        "terseLabel": "USD Notes, 6.200%, Maturing February 2059 [Member]",
        "verboseLabel": "USD Notes, 6.200% [Member]"
       }
      }
     },
     "localname": "USDNotes6200MaturingFebruary2059Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USDNotes9950MaturingNovember2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USD Notes, 9.950%, Maturing November 2038",
        "label": "USD Notes, 9.950%, Maturing November 2038 [Member]",
        "terseLabel": "USD Notes, 9.950%, Maturing November 2038 [Member]",
        "verboseLabel": "USD Notes, 9.950% [Member]"
       }
      }
     },
     "localname": "USDNotes9950MaturingNovember2038Member",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USLargeCapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Large Cap [Member]",
        "label": "U S Large Cap [Member]",
        "terseLabel": "U S Large Cap [Member]"
       }
      }
     },
     "localname": "USLargeCapMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USSTCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "USSTC [Member]",
        "label": "USSTC [Member]",
        "terseLabel": "USSTC [Member]"
       }
      }
     },
     "localname": "USSTCMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USSmallCapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. Small Cap [Member]",
        "label": "U S Small Cap [Member]",
        "terseLabel": "U S Small Cap [Member]"
       }
      }
     },
     "localname": "USSmallCapMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USTIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UST Inc.",
        "label": "UST Inc. [Member]",
        "terseLabel": "UST Inc. [Member]"
       }
      }
     },
     "localname": "USTIncMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USTLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UST Litigation [Member]",
        "label": "UST Litigation [Member]",
        "terseLabel": "UST Litigation [Member]"
       }
      }
     },
     "localname": "USTLitigationMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USTreasuryAndForeignGovernmentSecuritiesAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Treasury and Foreign Government Securities [Member]",
        "label": "US Treasury and Foreign Government Securities And Other [Member]",
        "terseLabel": "US Treasury And Foreign Government Securities and all other investments [Member]"
       }
      }
     },
     "localname": "USTreasuryAndForeignGovernmentSecuritiesAndOtherMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_USTreasuryAndForeignGovernmentSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Treasury and Foreign Government Securities",
        "label": "US Treasury and Foreign Government Securities [Member]",
        "terseLabel": "US Treasury and Foreign Government Securities [Member]"
       }
      }
     },
     "localname": "USTreasuryAndForeignGovernmentSecuritiesMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits that Would Impact Deferred Tax Rate",
        "label": "Unrecognized Tax Benefits that Would Impact Deferred Tax Rate",
        "terseLabel": "Unrecognized tax benefits if recognized would affect deferred taxes"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsthatWouldImpactDeferredTaxRate",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Capital Losses, Increase (Decrease), Amount",
        "label": "Valuation Allowance, Deferred Tax Asset, Capital Losses, Increase (Decrease), Amount",
        "terseLabel": "Valuation allowance, deferred tax asset, capital losses, amount"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetCapitalLossesIncreaseDecreaseAmount",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Additions",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Additions",
        "terseLabel": "Additions to valuation allowance charged to income tax expense"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetIncreaseDecreaseAdditions",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Foreign Currency Translation",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Foreign Currency Translation",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetIncreaseDecreaseForeignCurrencyTranslation",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_ValuationAllowanceDeferredTaxAssetReductions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation Allowance, Deferred Tax Asset, Reductions",
        "label": "Valuation Allowance, Deferred Tax Asset, Reductions",
        "negatedTerseLabel": "Reductions to valuation allowance credited to income tax benefit"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetReductions",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "mo_WineBusinessStrategicResetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Wine Business Strategic Reset [Member]",
        "label": "Wine Business Strategic Reset [Member]",
        "terseLabel": "Wine Business Strategic Reset [Member]"
       }
      }
     },
     "localname": "WineBusinessStrategicResetMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "mo_WineSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Wine Segment [Member]",
        "label": "Wine Segment [Member]",
        "terseLabel": "Wine [Member]"
       }
      }
     },
     "localname": "WineSegmentMember",
     "nsuri": "http://www.altria.com/20221231",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r336",
      "r384",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r406",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r477",
      "r479",
      "r480",
      "r931",
      "r932"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r336",
      "r384",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r402",
      "r406",
      "r469",
      "r470",
      "r471",
      "r472",
      "r474",
      "r475",
      "r477",
      "r479",
      "r480",
      "r931",
      "r932"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails",
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]",
        "verboseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r412",
      "r845",
      "r935",
      "r994"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r465",
      "r466",
      "r467",
      "r468",
      "r611",
      "r760",
      "r782",
      "r819",
      "r820",
      "r842",
      "r856",
      "r865",
      "r933",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum [Member]"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails",
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r465",
      "r466",
      "r467",
      "r468",
      "r611",
      "r760",
      "r782",
      "r819",
      "r820",
      "r842",
      "r856",
      "r865",
      "r933",
      "r986",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r412",
      "r845",
      "r935",
      "r994"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r408",
      "r762",
      "r843",
      "r863",
      "r929",
      "r930",
      "r935",
      "r993"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r408",
      "r762",
      "r843",
      "r863",
      "r929",
      "r930",
      "r935",
      "r993"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service, Name [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r465",
      "r466",
      "r467",
      "r468",
      "r565",
      "r611",
      "r639",
      "r640",
      "r641",
      "r736",
      "r760",
      "r782",
      "r819",
      "r820",
      "r842",
      "r856",
      "r865",
      "r923",
      "r933",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails",
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r465",
      "r466",
      "r467",
      "r468",
      "r565",
      "r611",
      "r639",
      "r640",
      "r641",
      "r736",
      "r760",
      "r782",
      "r819",
      "r820",
      "r842",
      "r856",
      "r865",
      "r923",
      "r933",
      "r987",
      "r988",
      "r989",
      "r990",
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails",
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r612",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast [Member]"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r356",
      "r612",
      "r881",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails",
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r409",
      "r410",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r844",
      "r864",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r409",
      "r410",
      "r806",
      "r810",
      "r811",
      "r812",
      "r813",
      "r814",
      "r815",
      "r816",
      "r817",
      "r818",
      "r844",
      "r864",
      "r935"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r356",
      "r612",
      "r881",
      "r882",
      "r904"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r819",
      "r820",
      "r986",
      "r988",
      "r991"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average [Member]"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_AK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ALASKA",
        "terseLabel": "Alaska [Member]"
       }
      }
     },
     "localname": "AK",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_AR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ARKANSAS",
        "terseLabel": "Arkansas [Member]"
       }
      }
     },
     "localname": "AR",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CALIFORNIA",
        "terseLabel": "California [Member]"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_CT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CONNECTICUT",
        "terseLabel": "Connecticut [Member]"
       }
      }
     },
     "localname": "CT",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_DC": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DISTRICT OF COLUMBIA",
        "terseLabel": "District of Columbia [Member]"
       }
      }
     },
     "localname": "DC",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_DE": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DELAWARE",
        "terseLabel": "Delaware [Member]"
       }
      }
     },
     "localname": "DE",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_FL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FLORIDA",
        "terseLabel": "Florida [Member]"
       }
      }
     },
     "localname": "FL",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_IA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IOWA",
        "terseLabel": "Iowa [Member]"
       }
      }
     },
     "localname": "IA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ILLINOIS",
        "terseLabel": "Illinois [Member]"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_KS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "KANSAS",
        "terseLabel": "Kansas [Member]"
       }
      }
     },
     "localname": "KS",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_LA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LOUISIANA",
        "terseLabel": "Louisiana [Member]"
       }
      }
     },
     "localname": "LA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MASSACHUSETTS",
        "verboseLabel": "Massachusetts [Member]"
       }
      }
     },
     "localname": "MA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MARYLAND",
        "terseLabel": "Maryland [Member]"
       }
      }
     },
     "localname": "MD",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MICHIGAN",
        "terseLabel": "Michigan [Member]"
       }
      }
     },
     "localname": "MI",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MINNESOTA",
        "terseLabel": "Minnesota [Member]"
       }
      }
     },
     "localname": "MN",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MO": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MISSOURI",
        "terseLabel": "Missouri [Member]"
       }
      }
     },
     "localname": "MO",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MS": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MISSISSIPPI",
        "terseLabel": "Mississippi [Member]"
       }
      }
     },
     "localname": "MS",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MT": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MONTANA",
        "terseLabel": "MONTANA"
       }
      }
     },
     "localname": "MT",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW HAMPSHIRE",
        "terseLabel": "New Hampshire [Member]"
       }
      }
     },
     "localname": "NH",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NJ": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW JERSEY",
        "terseLabel": "New Jersey [Member]"
       }
      }
     },
     "localname": "NJ",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NM": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW MEXICO",
        "terseLabel": "New Mexico [Member]"
       }
      }
     },
     "localname": "NM",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NV": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEVADA",
        "terseLabel": "Nevada [Member]"
       }
      }
     },
     "localname": "NV",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_NY": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "NEW YORK",
        "terseLabel": "New York [Member]"
       }
      }
     },
     "localname": "NY",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OH": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OHIO",
        "terseLabel": "Ohio [Member]"
       }
      }
     },
     "localname": "OH",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OK": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OKLAHOMA",
        "terseLabel": "Oklahoma [Member]"
       }
      }
     },
     "localname": "OK",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_OR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OREGON",
        "terseLabel": "Oregon [Member]"
       }
      }
     },
     "localname": "OR",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_PA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "PENNSYLVANIA",
        "terseLabel": "Pennsylvania [Member]"
       }
      }
     },
     "localname": "PA",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_RI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "RHODE ISLAND",
        "terseLabel": "Rhode Island [Member]"
       }
      }
     },
     "localname": "RI",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_SC": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SOUTH CAROLINA",
        "terseLabel": "South Carolina [Member]"
       }
      }
     },
     "localname": "SC",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TENNESSEE",
        "terseLabel": "Tennessee [Member]"
       }
      }
     },
     "localname": "TN",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_TX": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "TEXAS",
        "terseLabel": "Texas [Member]"
       }
      }
     },
     "localname": "TX",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WI": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WISCONSIN",
        "terseLabel": "Wisconsin [Member]"
       }
      }
     },
     "localname": "WI",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_WV": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "WEST VIRGINIA",
        "terseLabel": "West Virginia [Member]"
       }
      }
     },
     "localname": "WV",
     "nsuri": "http://xbrl.sec.gov/stpr/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r21",
      "r862"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Accrued liabilities:"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Marketing Costs, Current",
        "terseLabel": "Marketing"
       }
      }
     },
     "localname": "AccruedMarketingCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r37",
      "r44",
      "r202",
      "r887",
      "r888",
      "r889"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Benefit Plans [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": {
     "auth_ref": [
      "r39",
      "r44",
      "r202",
      "r316",
      "r317",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]",
        "terseLabel": "Prior service costs/credit [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember": {
     "auth_ref": [
      "r36",
      "r44",
      "r202",
      "r316",
      "r317",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent [Member]",
        "terseLabel": "Net loss [Member]"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r122",
      "r290"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "auth_ref": [
      "r38",
      "r44",
      "r941"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "negatedTotalLabel": "Amounts recorded in accumulated other comprehensive losses"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r41",
      "r43",
      "r44",
      "r300",
      "r774",
      "r787",
      "r788"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive losses"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r315",
      "r316",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r40",
      "r44",
      "r202",
      "r728",
      "r783",
      "r784",
      "r887",
      "r888",
      "r889",
      "r901",
      "r902",
      "r903"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Losses [Member]",
        "verboseLabel": "AOCI Attributable to Parent [Member]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "terseLabel": "Additional Information"
       }
      }
     },
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r648",
      "r649",
      "r650",
      "r901",
      "r902",
      "r903",
      "r980"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization [Abstract]",
        "terseLabel": "Amortization:"
       }
      }
     },
     "localname": "AdjustmentForAmortizationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails",
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to operating cash flows:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r380",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All Other [Member]",
        "verboseLabel": "Other [Member]"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r643"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "verboseLabel": "Pre-tax compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r70",
      "r108",
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedLabel": "Amortization of intangibles",
        "negatedTerseLabel": "Amortization",
        "terseLabel": "Amortization of intangibles"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r846",
      "r910"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "terseLabel": "Asset-Backed Securities [Member]"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r242",
      "r262",
      "r294",
      "r331",
      "r392",
      "r398",
      "r404",
      "r422",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r476",
      "r478",
      "r480",
      "r481",
      "r693",
      "r697",
      "r717",
      "r862",
      "r931",
      "r932",
      "r984"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r285",
      "r305",
      "r331",
      "r422",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r476",
      "r478",
      "r480",
      "r481",
      "r693",
      "r697",
      "r717",
      "r862",
      "r931",
      "r932",
      "r984"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets [Member]",
        "terseLabel": "Assets [Member]"
       }
      }
     },
     "localname": "AssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r331",
      "r422",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r476",
      "r478",
      "r480",
      "r481",
      "r693",
      "r697",
      "r717",
      "r931",
      "r932",
      "r984"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "terseLabel": "Long-term assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/StockPlansNarrativeDetails",
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r214",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and Building Improvements [Member]"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Buildings and building equipment"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r691",
      "r850",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r193",
      "r194",
      "r691",
      "r850",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r192"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Business combination, acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r72",
      "r288",
      "r822"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets",
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r65",
      "r72",
      "r78"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year",
        "totalLabel": "Cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Cash, cash equivalents and restricted cash:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r65",
      "r234"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase (decrease)"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation, fair value of plan assets, and funded status of pension plans or other employee benefit plans.",
        "label": "Changes in Projected Benefit Obligations, Fair Value of Plan Assets, and Funded Status of Plan [Table Text Block]",
        "terseLabel": "Projected Benefit Obligations, Plan Assets and Funded Status of Pension Plans"
       }
      }
     },
     "localname": "ChangesInProjectedBenefitObligationsFairValueOfPlanAssetsAndFundedStatusOfPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r331",
      "r360",
      "r361",
      "r368",
      "r370",
      "r378",
      "r379",
      "r422",
      "r469",
      "r472",
      "r473",
      "r474",
      "r480",
      "r481",
      "r501",
      "r502",
      "r505",
      "r509",
      "r516",
      "r717",
      "r821",
      "r879",
      "r896",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/CoverPage",
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r31",
      "r250",
      "r271"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "verboseLabel": "Contingencies (Note 17)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "Litigation Contingencies and Costs"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "verboseLabel": "Shares of common stock reserved for stock-based awards (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividends declared (USD per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r901",
      "r902",
      "r980"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails",
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value (usd per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CommonStockSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Ending balance, Shares Issued (in shares)",
        "periodStartLabel": "Beginning balance, Shares Issued (in shares)",
        "verboseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails",
      "http://www.altria.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r15",
      "r144"
     ],
     "calculation": {
      "http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance, Shares Outstanding (in shares)",
        "periodStartLabel": "Beginning balance, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r15",
      "r862"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.33 1/3\u00a0per share (2,805,961,317 shares issued)"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock": {
     "auth_ref": [
      "r157",
      "r160",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of an entity's employee compensation and benefit plans, excluding share-based compensation and including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans, Other than Share-Based Compensation [Text Block]",
        "terseLabel": "Benefit Plans"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansOtherThanShareBasedCompensationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Components of Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "localname": "ComponentsOfIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r46",
      "r311",
      "r313",
      "r322",
      "r769",
      "r778"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive earnings attributable to Altria"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r198",
      "r199",
      "r205",
      "r311",
      "r313",
      "r321",
      "r768",
      "r777"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Comprehensive losses attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r197",
      "r205",
      "r311",
      "r313",
      "r320",
      "r767",
      "r776"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive earnings"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r56",
      "r319",
      "r766",
      "r775"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Other Comprehensive Earnings/Losses"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLosses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r87",
      "r88",
      "r231",
      "r232",
      "r412",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r87",
      "r88",
      "r231",
      "r232",
      "r412",
      "r789",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r87",
      "r88",
      "r231",
      "r232",
      "r412",
      "r808",
      "r996"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r87",
      "r88",
      "r231",
      "r232",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Contribution of net revenues by major customer percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r87",
      "r88",
      "r231",
      "r232",
      "r412",
      "r808"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r518",
      "r519",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract with customer, liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue": {
     "auth_ref": [
      "r14",
      "r145"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer.",
        "label": "Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate Bonds [Member]"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r94",
      "r397",
      "r398",
      "r399",
      "r400",
      "r406",
      "r909"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "netLabel": "Corporate, Non-Segment [Member]",
        "terseLabel": "General Corporate [Member]",
        "verboseLabel": "General Corporate and Other [Member]"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r52",
      "r762"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r899",
      "r975",
      "r977"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r899",
      "r975"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Outside United States"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r191",
      "r675",
      "r683",
      "r899"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current provision for income taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r899",
      "r975",
      "r977"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r86",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Credit Concentration Risk [Member]"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r243",
      "r245",
      "r259",
      "r336",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r727",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails",
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
      "http://www.altria.com/role/LongTermDebtNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails",
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Applicable portion of interest rate for borrowing"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r8",
      "r245",
      "r259",
      "r499"
     ],
     "calculation": {
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-Term Debt, Gross",
        "totalLabel": "Long-term debt before debt issuance costs and debt discount"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r236",
      "r239",
      "r482",
      "r727",
      "r838",
      "r839"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face Value",
        "verboseLabel": "Face value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r490",
      "r716",
      "r838",
      "r839"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r28",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest Rate",
        "verboseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
      "http://www.altria.com/role/LongTermDebtNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
      "http://www.altria.com/role/LongTermDebtNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r29",
      "r336",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r727",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails",
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
      "http://www.altria.com/role/LongTermDebtNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails",
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One [Member]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Required purchase price as percentage of aggregate principal amount"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Principal Amount of Notes Purchased"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r29",
      "r145",
      "r148",
      "r149",
      "r150",
      "r235",
      "r236",
      "r239",
      "r257",
      "r336",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r727",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r897"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
      "http://www.altria.com/role/LongTermDebtNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term of debt"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r934"
     ],
     "calculation": {
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "terseLabel": "Less: debt discounts"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible": {
     "auth_ref": [
      "r182"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease reasonably possible in the next twelve months for the unrecognized tax benefit.",
        "label": "Decrease in Unrecognized Tax Benefits is Reasonably Possible",
        "terseLabel": "Potential decrease in liability for uncertain tax positions"
       }
      }
     },
     "localname": "DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r899",
      "r976",
      "r977"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r237",
      "r934"
     ],
     "calculation": {
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Less: debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r70",
      "r191",
      "r676",
      "r682",
      "r683",
      "r899"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax provision (benefit)",
        "totalLabel": "Total deferred provision for income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r12",
      "r13",
      "r244",
      "r258",
      "r669"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r655",
      "r656"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r899",
      "r976",
      "r977"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State and local"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsEquityMethodInvestments": {
     "auth_ref": [
      "r189",
      "r974"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from equity method investments.",
        "label": "Deferred Tax Assets, Equity Method Investments",
        "terseLabel": "Investment in Cronos"
       }
      }
     },
     "localname": "DeferredTaxAssetsEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r670"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits": {
     "auth_ref": [
      "r974"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from postretirement benefits.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits",
        "terseLabel": "Accrued postretirement and postemployment benefits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements": {
     "auth_ref": [
      "r189",
      "r974"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the estimated loss from legal settlements.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements",
        "terseLabel": "Settlement charges"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r671"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowances",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year",
        "terseLabel": "Deferred tax assets, valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails",
      "http://www.altria.com/role/IncomeTaxesSummaryofValuationAllowanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r180",
      "r973"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r189",
      "r974"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld": {
     "auth_ref": [
      "r189",
      "r974"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from interests in financial instruments continued to be held after sale or transfer of related financial instruments.",
        "label": "Deferred Tax Liabilities, Interests in Financial Assets Continued to be Held",
        "negatedLabel": "Finance assets, net"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInterestsInFinancialAssetsContinuedToBeHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates": {
     "auth_ref": [
      "r189",
      "r974"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments in unconsolidated subsidiaries and investments in other affiliates which are not controlled nor consolidated.",
        "label": "Deferred Tax Liabilities, Investment in Noncontrolled Affiliates",
        "negatedLabel": "Investment in ABI"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestmentInNoncontrolledAffiliates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r189",
      "r974"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r189",
      "r974"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r10",
      "r161",
      "r162",
      "r164"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      },
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension plan, classified as noncurrent. Excludes other postretirement benefit plan.",
        "label": "Liability, Defined Benefit Pension Plan, Noncurrent",
        "negatedTerseLabel": "Accrued pension costs",
        "terseLabel": "Accrued pension costs"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails",
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r573"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "verboseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r44",
      "r585"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r44",
      "r585"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax",
        "negatedTerseLabel": "Prior service (cost) credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r556",
      "r848"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r549"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "negatedTerseLabel": "Actuarial (gains) losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r543",
      "r580",
      "r601",
      "r848",
      "r849"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedTerseLabel": "Net loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r543",
      "r581",
      "r602",
      "r848",
      "r849"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "terseLabel": "Prior service cost (credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet": {
     "auth_ref": [
      "r161",
      "r164"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset (liability), recognized in statement of financial position, for defined benefit pension and other postretirement plans.",
        "label": "Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position",
        "totalLabel": "Defined benefit plan, amounts for asset (liability) recognized in statement of financial position"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r241",
      "r261",
      "r541",
      "r542",
      "r564",
      "r848"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate": {
     "auth_ref": [
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate",
        "verboseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate increase of compensation, used to determine benefit obligation of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase - long-term"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingBenefitObligationRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r589",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets",
        "terseLabel": "Defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets",
        "verboseLabel": "Expected rate of return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Rate of compensation increase - long-term"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r544"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "periodEndLabel": "Benefit obligation at end of year",
        "periodStartLabel": "Benefit obligation at beginning of year"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r551",
      "r607"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r592",
      "r846",
      "r847",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan by Plan Asset Categories [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Change in benefit obligation:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Change in plan assets:"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r558",
      "r567",
      "r605",
      "r846",
      "r847",
      "r848",
      "r849"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails",
      "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails",
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails",
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanDivestituresBenefitObligation": {
     "auth_ref": [
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in benefit obligation of defined benefit plan from disposal or classification as held-for-sale.",
        "label": "Defined Benefit Plan, Benefit Obligation, Divestiture",
        "negatedTerseLabel": "Divestiture"
       }
      }
     },
     "localname": "DefinedBenefitPlanDivestituresBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDivestituresPlanAssets": {
     "auth_ref": [
      "r562"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in plan assets of defined benefit plan from disposal or classification as held-for-sale.",
        "label": "Defined Benefit Plan, Plan Assets, Divestiture",
        "negatedTerseLabel": "Divestiture"
       }
      }
     },
     "localname": "DefinedBenefitPlanDivestituresPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": {
     "auth_ref": [
      "r846",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities [Member]",
        "terseLabel": "Equity Securities [Member]"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesNonUsMember": {
     "auth_ref": [
      "r846",
      "r847",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity, not domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities, Non-US [Member]",
        "terseLabel": "Common stock: International equities [Member]"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesNonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesUsMember": {
     "auth_ref": [
      "r846",
      "r847",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity, domiciled in United States of America (US), for which ownership is represented by share of stock; in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities, US [Member]",
        "terseLabel": "Common stock: U.S. equities [Member]"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesUsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2028-2032"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r574"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r575",
      "r849"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Expected future employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r543",
      "r579",
      "r600",
      "r848",
      "r849"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedTerseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r555",
      "r566",
      "r567",
      "r568",
      "r846",
      "r847",
      "r848"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "periodEndLabel": "Fair value of plan assets at end of year",
        "periodStartLabel": "Fair value of plan assets at beginning of year",
        "terseLabel": "Defined benefit plan, plan assets, amount",
        "verboseLabel": "Fair value of plan assets, net"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r541",
      "r564",
      "r848"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status at December\u00a031"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assumed rate, for next fiscal year, based on annual change in cost of health care cost benefits used to measure expected cost of benefits covered by defined benefit postretirement plan. Factors include, but are not limited to, estimate of health care inflation, change in health care utilization or delivery pattern, technological advances, and change in health status of participant. Excludes factors for change in composition of plan population by age and dependency status.",
        "label": "Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year",
        "verboseLabel": "Health care cost trend rate assumed for next year"
       }
      }
     },
     "localname": "DefinedBenefitPlanHealthCareCostTrendRateAssumedNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r543",
      "r547",
      "r578",
      "r599",
      "r848",
      "r849"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "terseLabel": "Interest cost",
        "verboseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails",
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r576",
      "r597",
      "r848",
      "r849"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost (income)"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets": {
     "auth_ref": [
      "r595",
      "r848"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of plan asset for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "terseLabel": "Defined benefit plan, pension plan with projected benefit obligation in excess of plan assets, plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation": {
     "auth_ref": [
      "r595",
      "r848"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of projected benefit obligation for defined benefit pension plan with projected benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation",
        "terseLabel": "Projected benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlanWithProjectedBenefitObligationInExcessOfPlanAssetsProjectedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation": {
     "auth_ref": [
      "r595",
      "r596",
      "r848"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated benefit obligation for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation",
        "terseLabel": "Accumulated benefit obligation"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets": {
     "auth_ref": [
      "r595",
      "r596",
      "r848"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of plan asset for defined benefit plan with accumulated benefit obligation in excess of plan assets.",
        "label": "Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAmendments": {
     "auth_ref": [
      "r552"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in benefit obligation of defined benefit plan from change in terms of existing plan or initiation of new plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Increase (Decrease) for Plan Amendment",
        "verboseLabel": "Plan amendments"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAmendments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r560",
      "r943"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList": {
     "auth_ref": [
      "r567",
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates level within fair value hierarchy and fair value measured at net asset value per share as practical expedient, of defined benefit plan asset.",
        "label": "Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible Enumeration]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Fair Value by Hierarchy and NAV [Extensible List]"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsFairValueByHierarchyAndNavExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r565",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Plan assets, target allocation percentage"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "auth_ref": [
      "r936",
      "r940",
      "r942"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "negatedTerseLabel": "Settlement"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r545",
      "r577",
      "r598",
      "r848",
      "r849"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "terseLabel": "Service cost",
        "verboseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails",
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanUltimateHealthCareCostTrendRate1": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ultimate trend rate for health care cost for defined benefit postretirement plan.",
        "label": "Defined Benefit Plan, Ultimate Health Care Cost Trend Rate",
        "terseLabel": "Ultimate trend rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanUltimateHealthCareCostTrendRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Composition of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures and provisions pertaining to defined benefit pension plans or other postretirement defined benefit plans. The arrangements are generally based on terms and conditions stipulated by the entity, and which contain a promise by the employer to pay certain amounts or awards at designated future dates, including a period after retirement, upon compliance with stipulated requirements. Excludes disclosures pertaining to defined contribution plans.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]",
        "terseLabel": "Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAndOtherPostretirementBenefitPlansTableTextBlockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r608"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Amounts charged to expense for defined contribution plans"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r70",
      "r120"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r70",
      "r387"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock": {
     "auth_ref": [
      "r827"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for depreciation, depletion, and amortization of property and equipment costs, including methods used and estimated useful lives and how impairment of such assets is assessed and recognized.",
        "label": "Depreciation, Depletion, and Amortization [Policy Text Block]",
        "terseLabel": "Depreciation and Amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortizationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r979"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "negatedLabel": "Loss on Cronos-related financial instruments",
        "negatedTerseLabel": "Loss on Cronos-related financial instruments"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r215",
      "r216",
      "r219",
      "r220",
      "r826"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r227",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r212",
      "r215",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r212",
      "r215",
      "r219",
      "r220",
      "r225",
      "r226",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r207",
      "r209",
      "r210",
      "r212",
      "r213",
      "r218",
      "r219",
      "r222",
      "r224",
      "r226",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r207",
      "r209",
      "r212",
      "r213",
      "r223",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r616",
      "r644",
      "r645",
      "r647",
      "r651",
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "verboseLabel": "Stock Plans"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r119",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r118",
      "r124",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand, demand deposits with banks or financial institutions, and other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group.",
        "label": "Disposal Group, Including Discontinued Operation, Cash",
        "terseLabel": "Disposal group, including discontinued operation, cash"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInterestIncome": {
     "auth_ref": [
      "r0"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Interest Income",
        "terseLabel": "Disposal group, including discontinued operation, interest income"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInterestIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r850",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Per share data:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r323",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r357",
      "r360",
      "r368",
      "r369",
      "r370",
      "r374",
      "r708",
      "r709",
      "r770",
      "r779",
      "r830"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic earnings per share attributable to Altria (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r323",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r360",
      "r368",
      "r369",
      "r370",
      "r374",
      "r708",
      "r709",
      "r770",
      "r779",
      "r830"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted earnings per share attributable to Altria (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r371",
      "r372",
      "r373",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r658"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "%"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r333",
      "r658",
      "r685"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S. federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r971",
      "r978"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r971",
      "r978"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State and local income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxContingencies": {
     "auth_ref": [
      "r971",
      "r978"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income tax contingencies. Includes, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Percent",
        "terseLabel": "Uncertain tax positions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "verboseLabel": "Weighted-average period of recognition, in years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r970"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "verboseLabel": "Unamortized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r643"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "verboseLabel": "Deferred tax benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EnvironmentalCostsPolicy": {
     "auth_ref": [
      "r454",
      "r455",
      "r468",
      "r835",
      "r880"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for obligations that resulted from improper or other-than normal operation of a long-lived asset in the past. This accounting policy may address (1) whether the related remediation costs are expensed or capitalized, (2) whether the obligation is measured on a discounted basis, (3) the event, situation, or set of circumstances that generally triggers recognition of loss contingencies arising from the entity's environmental remediation-related obligations, and (4) the timing of recognition of any recoveries.",
        "label": "Environmental Costs, Policy [Policy Text Block]",
        "terseLabel": "Environmental Costs"
       }
      }
     },
     "localname": "EnvironmentalCostsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r144",
      "r280",
      "r315",
      "r316",
      "r317",
      "r343",
      "r344",
      "r345",
      "r347",
      "r353",
      "r355",
      "r377",
      "r423",
      "r517",
      "r648",
      "r649",
      "r650",
      "r678",
      "r679",
      "r707",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r724",
      "r728",
      "r783",
      "r784",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.",
        "label": "Equity Method Investment, Difference Between Carrying Amount and Underlying Equity",
        "terseLabel": "Difference between carrying amount and underlying equity"
       }
      }
     },
     "localname": "EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r49",
      "r64",
      "r70",
      "r274"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "terseLabel": "Dividends from ABI"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r284",
      "r331",
      "r422",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r284",
      "r331",
      "r422",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment, ownership percentage (approximately)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r99",
      "r393",
      "r884"
     ],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "verboseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investments accounted under the equity method.",
        "label": "Equity Method Investments, Fair Value Disclosure",
        "terseLabel": "Fair value of investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r64",
      "r101",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Investments in Equity Securities"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNiCurrentAndNoncurrent": {
     "auth_ref": [
      "r295",
      "r715"
     ],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Equity securities, FV-NI"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r915"
     ],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "mo_IncomeLossFromEquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "negatedTerseLabel": "JUUL"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r780",
      "r915"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Equity securities, FV-NI, unrealized gain (loss)"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r97",
      "r260",
      "r866",
      "r867",
      "r868"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "terseLabel": "Equity securities without readily determinable fair value, amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r417"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative loss from downward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Cumulative Amount",
        "terseLabel": "Equity securities without readily determinable fair value, downward price adjustment, cumulative amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount",
        "terseLabel": "Impairment of JUUL equity securities",
        "verboseLabel": "Impairment of JUUL equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in equity security without readily determinable fair value, which does not qualify for practical expedient to estimate fair value using net asset value per share. Includes, but is not limited to, information considered for determining upward and downward adjustment from observable price change.",
        "label": "Equity Securities without Readily Determinable Fair Value [Policy Text Block]",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValuePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount": {
     "auth_ref": [
      "r418"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative gain from upward price adjustment on investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Cumulative Amount",
        "terseLabel": "Equity securities without readily determinable fair value, upward price adjustment"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The excess of replacement or current cost over the stated LIFO (last in first out) inventory value when the LIFO inventory method is utilized.",
        "label": "Excess of Replacement or Current Costs over Stated LIFO Value",
        "verboseLabel": "Current cost of inventories over LIFO amounts"
       }
      }
     },
     "localname": "ExcessOfReplacementOrCurrentCostsOverStatedLIFOValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ExternalCreditRatingByGroupingAxis": {
     "auth_ref": [
      "r95",
      "r703",
      "r836",
      "r920"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by external rating classified as investment grade or non investment grade.",
        "label": "External Credit Rating by Grouping [Axis]",
        "terseLabel": "External Credit Rating by Grouping [Axis]"
       }
      }
     },
     "localname": "ExternalCreditRatingByGroupingAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExternalCreditRatingByGroupingDomain": {
     "auth_ref": [
      "r128",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External credit rating classified as investment grade or non-investment grade.",
        "label": "External Credit Rating by Grouping [Domain]",
        "terseLabel": "External Credit Rating by Grouping [Domain]"
       }
      }
     },
     "localname": "ExternalCreditRatingByGroupingDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExternalCreditRatingNonInvestmentGradeMember": {
     "auth_ref": [
      "r128",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "External credit-rating that could be used to describe the current status of the payment and performance risk of credit derivatives and guarantee obligations that connote non-investment grade.",
        "label": "External Credit Rating, Non Investment Grade [Member]",
        "terseLabel": "Below Investment Grade [Member]"
       }
      }
     },
     "localname": "ExternalCreditRatingNonInvestmentGradeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r229",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r228",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r490",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r712",
      "r733",
      "r734",
      "r735",
      "r838",
      "r839",
      "r846",
      "r847",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel12And3Member": {
     "auth_ref": [
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measurement input including quoted price in active market for identical asset or liability reporting entity can access at measurement date (level 1), input other than quoted price included within level 1 either directly or indirectly observable for asset or liability (level 2) and unobservable input reflecting entity's own assumption (level 3).",
        "label": "Fair Value, Inputs, Level 1, Level 2, and Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 1, 2 and 3 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel12And3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r490",
      "r567",
      "r572",
      "r712",
      "r733",
      "r846",
      "r847",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r490",
      "r567",
      "r572",
      "r712",
      "r734",
      "r838",
      "r839",
      "r846",
      "r847",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2 [Member]"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasuredAtNetAssetValuePerShareMember": {
     "auth_ref": [
      "r567",
      "r710",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Measured at Net Asset Value Per Share [Member]",
        "terseLabel": "NAV [Member]"
       }
      }
     },
     "localname": "FairValueMeasuredAtNetAssetValuePerShareMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r713"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Unrealized gains (losses) included in (income) losses from investments in equity securities"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesJUULInvestmentClassifiedasLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r490",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r733",
      "r734",
      "r735",
      "r838",
      "r839",
      "r846",
      "r847",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinABINarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r414",
      "r415",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r498",
      "r514",
      "r705",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r833",
      "r912",
      "r913",
      "r914",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Definite-lived intangible assets useful life maximum, years",
        "verboseLabel": "Definite-lived intangible assets amortization period, weighted average, in years"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails",
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r292",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "verboseLabel": "Definite-lived intangible assets, accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "verboseLabel": "Estimated future amortization, year 1"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "verboseLabel": "Estimated future amortization, year 5"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "verboseLabel": "Estimated future amortization, year 4"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "verboseLabel": "Estimated future amortization, year 3"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "verboseLabel": "Estimated future amortization, year 2"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r448",
      "r449",
      "r450",
      "r451",
      "r763",
      "r764"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r112",
      "r764"
     ],
     "calculation": {
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Definite-lived intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r109",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FixedIncomeSecuritiesMember": {
     "auth_ref": [
      "r848",
      "r938"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity.",
        "label": "Fixed Income Securities [Member]",
        "terseLabel": "Fixed Income Securities [Member]"
       }
      }
     },
     "localname": "FixedIncomeSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r826",
      "r846",
      "r861"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "verboseLabel": "Foreign Currency Contract [Member]"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r938",
      "r995"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by government not domiciled in United States of America (US).",
        "label": "Debt Security, Government, Non-US [Member]",
        "terseLabel": "Debt Security, Government, Non-US [Member]"
       }
      }
     },
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "auth_ref": [
      "r925"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.",
        "label": "Gain (Loss) Related to Litigation Settlement",
        "negatedLabel": "(Gain) loss related to litigation settlement"
       }
      }
     },
     "localname": "GainLossRelatedToLitigationSettlement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r70",
      "r133",
      "r134"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on early extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/LongTermDebtNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r133",
      "r134"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the difference between the fair value of payments made to legally extinguish a debt and its carrying value at that time. This item excludes the write-off of amounts previously capitalized as debt issuance costs.",
        "label": "Gain (Loss) on Extinguishment of Debt, before Write off of Debt Issuance Cost",
        "terseLabel": "Gain (loss) on extinguishment of debt, before write off of debt issuance cost"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "negatedLabel": "General corporate expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r291",
      "r435",
      "r765",
      "r834",
      "r862",
      "r921",
      "r922"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Balance of end of period",
        "periodStartLabel": "Balance at beginning of period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r438",
      "r834"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions (1)"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Goodwill and Other Intangible Assets, net"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "auth_ref": [
      "r437",
      "r444",
      "r834"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "verboseLabel": "Accumulated goodwill impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r70",
      "r436",
      "r441",
      "r447",
      "r834"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r440",
      "r834"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "terseLabel": "Dispositions"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r51",
      "r331",
      "r392",
      "r397",
      "r403",
      "r406",
      "r422",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r476",
      "r478",
      "r480",
      "r481",
      "r717",
      "r832",
      "r931"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "terseLabel": "Contingent liability related to performance surety bonds"
       }
      }
     },
     "localname": "GuaranteeObligationsMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.",
        "label": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]",
        "terseLabel": "Guarantees"
       }
      }
     },
     "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment Testing and Asset Valuation"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r332",
      "r684"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r48",
      "r240",
      "r252",
      "r276",
      "r392",
      "r397",
      "r403",
      "r406",
      "r771",
      "r832"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings (losses) from continuing operations",
        "totalLabel": "Earnings before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r332",
      "r684"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Outside United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r49",
      "r70",
      "r99",
      "r251",
      "r274",
      "r389"
     ],
     "calculation": {
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "mo_IncomeLossFromEquityInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "(Income) losses from investments in equity securities"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesEarningsfromEquityInvestmentsDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r850",
      "r853"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r452",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Examination by Jurisdiction [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r333",
      "r659",
      "r667",
      "r674",
      "r680",
      "r686",
      "r688",
      "r689",
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r972"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "terseLabel": "Penalties and interest accrued"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r334",
      "r354",
      "r355",
      "r390",
      "r657",
      "r681",
      "r687",
      "r781"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails",
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails",
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Provision (benefit) for income taxes:"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesScheduleofEarningsBeforeIncomeTaxesandProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r314",
      "r653",
      "r654",
      "r667",
      "r668",
      "r673",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r971"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "verboseLabel": "Effective income tax rate reconciliation, change in deferred tax assets valuation allowance, amount"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r658"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "U.S. federal statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount [Abstract]",
        "terseLabel": "$"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r971"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r971"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State and local income taxes, net of federal tax benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "auth_ref": [
      "r971"
     ],
     "calculation": {
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "terseLabel": "Uncertain tax positions"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofEffectiveTaxRateandUSFederalStatutoryRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r66",
      "r74"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "verboseLabel": "Cash Paid: Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Cash effects of changes:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current operating assets after deduction of current operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Assets and Liabilities, Net",
        "negatedLabel": "Accrued liabilities and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPensionAndPostretirementObligations": {
     "auth_ref": [
      "r69"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for pension and other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Increase (Decrease) in Obligation, Pension and Other Postretirement Benefits",
        "negatedTerseLabel": "Plan amendments"
       }
      }
     },
     "localname": "IncreaseDecreaseInPensionAndPostretirementObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "verboseLabel": "Indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedTrademarks": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style for a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Trademarks",
        "terseLabel": "Indefinite-lived trademarks"
       }
      }
     },
     "localname": "IndefiniteLivedTrademarks",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Total other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetOtherIntangibleAssetsDisclosureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r107",
      "r110"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "periodEndLabel": "Balance end of period",
        "periodStartLabel": "Balance beginning of period",
        "terseLabel": "Other Intangible Assets, net",
        "verboseLabel": "Other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r237",
      "r255",
      "r318",
      "r386",
      "r726"
     ],
     "calculation": {
      "http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r254"
     ],
     "calculation": {
      "http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedLabel": "Interest and other debt expense, net",
        "negatedNetLabel": "Interest and other debt expense, net",
        "negatedTotalLabel": "Interest and other debt expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails",
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest income earned from interest bearing assets classified as other.",
        "label": "Interest Income, Other",
        "negatedTerseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestIncomeOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r324",
      "r327",
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid: Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r249",
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.",
        "label": "Interest Payable",
        "terseLabel": "Interest payable"
       }
      }
     },
     "localname": "InterestPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterimPeriodCostsNotAllocableDomain": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred.",
        "label": "Interim Period, Costs Not Allocable [Domain]",
        "terseLabel": "Interim Period, Costs Not Allocable [Domain]"
       }
      }
     },
     "localname": "InterimPeriodCostsNotAllocableDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r105",
      "r824"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished product"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r303",
      "r823",
      "r862"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Inventory, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "verboseLabel": "Inventories:"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r287",
      "r301",
      "r376",
      "r432",
      "r433",
      "r434",
      "r761",
      "r828"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r105",
      "r825"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedBalanceShares": {
     "auth_ref": [
      "r277",
      "r793"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance held at close of period in number of shares.",
        "label": "Investment Owned, Balance, Shares",
        "terseLabel": "Investment owned, balance, shares (in shares)"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinJUULNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InvestmentTableTextBlock": {
     "auth_ref": [
      "r911",
      "r916",
      "r918",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment.",
        "label": "Investment [Table Text Block]",
        "terseLabel": "Investment"
       }
      }
     },
     "localname": "InvestmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTextBlock": {
     "auth_ref": [
      "r911",
      "r916",
      "r918",
      "r919"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investment.",
        "label": "Investment [Text Block]",
        "terseLabel": "Investments in Equity Securities"
       }
      }
     },
     "localname": "InvestmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r790",
      "r791",
      "r792",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r790",
      "r791",
      "r792",
      "r794",
      "r795",
      "r796",
      "r797",
      "r798",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r272"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments in equity securities ($250 million and $1,720\u00a0million at December\u00a031, 2022 and 2021, respectively, measured at fair value)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r711"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Investments, fair value"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandAndLandImprovements": {
     "auth_ref": [
      "r885"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation and depletion of real estate held for productive use and additions or improvements to real estate held for productive use, examples include, but are not limited to, walkways, driveways, fences, and parking lots. Excludes land held for sale.",
        "label": "Land and Land Improvements",
        "terseLabel": "Land and land improvements"
       }
      }
     },
     "localname": "LandAndLandImprovements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "terseLabel": "Contingencies"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/Contingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit [Member]"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r25",
      "r331",
      "r422",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r476",
      "r478",
      "r480",
      "r481",
      "r694",
      "r697",
      "r698",
      "r717",
      "r831",
      "r931",
      "r984",
      "r985"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r20",
      "r248",
      "r268",
      "r862",
      "r898",
      "r917",
      "r981"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders\u2019 Equity (Deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r27",
      "r286",
      "r331",
      "r422",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r476",
      "r478",
      "r480",
      "r481",
      "r694",
      "r697",
      "r698",
      "r717",
      "r862",
      "r931",
      "r984",
      "r985"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r8",
      "r9",
      "r331",
      "r422",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r476",
      "r478",
      "r480",
      "r481",
      "r694",
      "r697",
      "r698",
      "r717",
      "r931",
      "r984",
      "r985"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "terseLabel": "Long-term liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r22"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit line available under the agreement"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit [Member]"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Amount ordered to be paid from other party"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded to other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "terseLabel": "Litigation settlement"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest expense (income) directly attributable to an award in settlement of litigation.",
        "label": "Litigation Settlement Interest",
        "netLabel": "Litigation settlement interest (approximately)"
       }
      }
     },
     "localname": "LitigationSettlementInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Debenture [Member]"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r8",
      "r245",
      "r264",
      "r489",
      "r500",
      "r838",
      "r839"
     ],
     "calculation": {
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "terseLabel": "Carrying value",
        "totalLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails",
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Less current portion of long-term debt",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.",
        "label": "Long-Term Debt, Fair Value",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "LongTermDebtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsAggregateFairValueandCarryingValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r131",
      "r336",
      "r493"
     ],
     "calculation": {
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r131",
      "r336",
      "r493"
     ],
     "calculation": {
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r131",
      "r336",
      "r493"
     ],
     "calculation": {
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r131",
      "r336",
      "r493"
     ],
     "calculation": {
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r131",
      "r336",
      "r493"
     ],
     "calculation": {
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtAggregateMaturitiesofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r296"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt excluding current portion",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-term debt.",
        "label": "Long-Term Debt [Text Block]",
        "verboseLabel": "Long-Term Debt"
       }
      }
     },
     "localname": "LongTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
      "http://www.altria.com/role/LongTermDebtNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails",
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r29",
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
      "http://www.altria.com/role/LongTermDebtNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails",
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r126",
      "r127",
      "r464",
      "r465",
      "r466",
      "r926",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r126",
      "r127",
      "r464",
      "r465",
      "r466",
      "r926",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesFloridaBondStatuteDetails",
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesNonEngleProgenyLitigationDetails",
      "http://www.altria.com/role/ContingenciesOtherDisputesUndertheStateSettlementAgreementsDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r464",
      "r881"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "periodEndLabel": "Accrued liability for tobacco and health litigation items at end of period",
        "periodStartLabel": "Accrued liability for tobacco and health litigation items at beginning of period"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "auth_ref": [
      "r925"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow reducing loss contingency liability.",
        "label": "Loss Contingency Accrual, Payments",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "LossContingencyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r925"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Provision related to litigation recorded"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyAccrualRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Loss Contingency Accrual [Roll Forward]",
        "terseLabel": "Loss Contingency Accrual [Roll Forward]"
       }
      }
     },
     "localname": "LossContingencyAccrualRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyClaimsDismissedNumber": {
     "auth_ref": [
      "r926",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of claims dismissed.",
        "label": "Loss Contingency, Claims Dismissed, Number",
        "terseLabel": "Number of claims dismissed"
       }
      }
     },
     "localname": "LossContingencyClaimsDismissedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r925",
      "r926",
      "r928"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Damages awarded, value"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesPaidValue": {
     "auth_ref": [
      "r925",
      "r926",
      "r928"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of damages paid to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Paid, Value",
        "terseLabel": "Judgments paid (approximately)"
       }
      }
     },
     "localname": "LossContingencyDamagesPaidValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r925",
      "r926",
      "r928"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Loss contingency, damages sought, value"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r126",
      "r127",
      "r464",
      "r465",
      "r466",
      "r926",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesFederalGovernmentsLawsuitDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [
      "r926",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of plaintiffs"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r926",
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Claims filed, number",
        "verboseLabel": "Number of cases pending"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and Equipment [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Interest and other debt expense, net [Member]"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r35",
      "r247",
      "r267",
      "r331",
      "r422",
      "r469",
      "r472",
      "r473",
      "r474",
      "r480",
      "r481",
      "r717"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Noncontrolling interest, ownership percentage by noncontrolling owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]"
       }
      }
     },
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MunicipalBondsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments.",
        "label": "Municipal Bonds [Member]",
        "terseLabel": "Municipal Bonds [Member]"
       }
      }
     },
     "localname": "MunicipalBondsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfExpenseAxis": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cost or expense.",
        "label": "Nature of Expense [Axis]",
        "terseLabel": "Nature of Expense [Axis]"
       }
      }
     },
     "localname": "NatureOfExpenseAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r326"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Provided by (Used in) Financing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r326"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Provided by (Used in) Investing Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r65",
      "r68",
      "r71"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by (used in) operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Cash Provided by (Used in) Operating Activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r50",
      "r71",
      "r253",
      "r275",
      "r284",
      "r309",
      "r312",
      "r317",
      "r331",
      "r346",
      "r348",
      "r349",
      "r350",
      "r351",
      "r354",
      "r355",
      "r366",
      "r392",
      "r397",
      "r403",
      "r406",
      "r422",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r476",
      "r478",
      "r480",
      "r481",
      "r709",
      "r717",
      "r832",
      "r931"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.altria.com/role/EarningsperShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net earnings attributable to Altria",
        "verboseLabel": "Net earnings attributable to Altria"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/EarningsperShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r200",
      "r204",
      "r309",
      "r312",
      "r354",
      "r355",
      "r889"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedLabel": "Net losses attributable to noncontrolling interests",
        "terseLabel": "Net earnings (losses) attributable to equity investments"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r348",
      "r349",
      "r350",
      "r351",
      "r357",
      "r358",
      "r367",
      "r370",
      "r392",
      "r397",
      "r403",
      "r406",
      "r832"
     ],
     "calculation": {
      "http://www.altria.com/role/EarningsperShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Earnings (losses) for EPS, basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r359",
      "r362",
      "r363",
      "r364",
      "r365",
      "r367",
      "r370"
     ],
     "calculation": {
      "http://www.altria.com/role/EarningsperShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Earnings (losses) for EPS, diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest": {
     "auth_ref": [
      "r139",
      "r200",
      "r201"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity.",
        "label": "Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest",
        "terseLabel": "Net earnings (losses)"
       }
      }
     },
     "localname": "NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgingMember": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedges of a net investment in a foreign operation.",
        "label": "Net Investment Hedging [Member]",
        "terseLabel": "Net Investment Hedging [Member]"
       }
      }
     },
     "localname": "NetInvestmentHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent": {
     "auth_ref": [
      "r543"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for net periodic benefit cost components, excluding service cost component, of defined benefit plan. Amount includes, but is not limited to, interest cost, expected (return) loss on plan asset, amortization of prior service cost (credit), amortization of (gain) loss, amortization of transition (asset) obligation, settlement (gain) loss, curtailment (gain) loss and certain termination benefits.",
        "label": "Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component",
        "terseLabel": "Net periodic defined benefits expense (reversal of expense)",
        "verboseLabel": "Net periodic benefit income, excluding service cost"
       }
      }
     },
     "localname": "NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements and New Accounting Guidance Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non-cash investing activities:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1": {
     "auth_ref": [
      "r75",
      "r76",
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of intangibles that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Intangible Assets Acquired",
        "terseLabel": "Noncash or part noncash acquisition, intangible assets acquired"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r195",
      "r517",
      "r901",
      "r902",
      "r903"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-Controlling Interests [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Notes Payable, Other Payables [Member]"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfForeignCurrencyDerivativesHeld": {
     "auth_ref": [
      "r208",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of foreign currency exchange rate derivatives held by the entity at the reporting date.",
        "label": "Number of Foreign Currency Derivatives Held",
        "terseLabel": "Number of foreign currency derivatives held"
       }
      }
     },
     "localname": "NumberOfForeignCurrencyDerivativesHeld",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciEquityMethodInvestmentAfterTax": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of other comprehensive income (loss) (OCI) for proportionate share of equity method investee's OCI.",
        "label": "OCI, Equity Method Investment, after Tax",
        "terseLabel": "ABI"
       }
      }
     },
     "localname": "OciEquityMethodInvestmentAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r392",
      "r397",
      "r403",
      "r406",
      "r832"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Operating income",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing operating income (loss).",
        "label": "Operating Income (Loss) [Member]",
        "terseLabel": "Operating Income (Loss) [Member]"
       }
      }
     },
     "localname": "OperatingIncomeLossMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating losses carry forward"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments [Member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r1",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Background and Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r304",
      "r862"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r293"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r39",
      "r41",
      "r584"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), before Tax",
        "negatedLabel": "Prior service cost/credit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostCreditArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax": {
     "auth_ref": [
      "r41",
      "r45",
      "r308",
      "r584"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive (income) loss for prior service cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax",
        "terseLabel": "Prior service cost/credit"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": {
     "auth_ref": [
      "r44",
      "r316",
      "r718",
      "r720",
      "r724",
      "r887"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax",
        "verboseLabel": "Other comprehensive earnings (losses) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r44",
      "r47",
      "r316",
      "r718",
      "r720",
      "r724",
      "r887"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "totalLabel": "Other comprehensive earnings (losses) before reclassifications, net of deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r42",
      "r315"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": {
     "auth_ref": [
      "r306",
      "r307",
      "r699",
      "r701",
      "r704"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax",
        "verboseLabel": "(Gain) Loss Recognized in Net Earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r700"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge.",
        "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "(Gain) Loss Recognized in Accumulated Other Comprehensive Losses"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsEffectsofNetInvestmentHedgesonAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r47",
      "r144",
      "r310",
      "r313",
      "r319",
      "r718",
      "r723",
      "r724",
      "r766",
      "r775",
      "r887",
      "r888"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive earnings (losses), net of deferred income taxes",
        "verboseLabel": "Other comprehensive earnings (losses), net of deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings",
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive earnings (losses), net of deferred income taxes:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax": {
     "auth_ref": [
      "r38",
      "r41"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails": {
       "order": 1.0,
       "parentTag": "mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, before reclassification adjustment, of (increase) decrease in accumulated other comprehensive income of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, after Tax",
        "negatedLabel": "Other movements"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r38",
      "r41"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedLabel": "Benefit plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax": {
     "auth_ref": [
      "r38",
      "r42",
      "r197"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment, Tax",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBeforeReclassificationAdjustmentsTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r36",
      "r41",
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax": {
     "auth_ref": [
      "r41",
      "r45",
      "r308",
      "r584"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, before Tax",
        "negatedLabel": "Net loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax": {
     "auth_ref": [
      "r41",
      "r45",
      "r168",
      "r308"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails": {
       "order": 2.0,
       "parentTag": "mo_OtherComprehensiveIncomeLossDefinedBenefitPlanafterReclassificationAdjustmentafterTaxIncludingCumulativeEffectAdjustment",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive (income) loss for net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, after Tax",
        "totalLabel": "Amounts reclassified to net earnings as components of net periodic benefit cost"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r42",
      "r197"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax (expense) benefit for reclassification adjustment from accumulated other comprehensive (income) loss of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax",
        "negatedTerseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Income and Expenses [Abstract]",
        "terseLabel": "Other expense (income):"
       }
      }
     },
     "localname": "OtherIncomeAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other investments.",
        "label": "Other Investments [Member]",
        "terseLabel": "Other Investments [Member]"
       }
      }
     },
     "localname": "OtherInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r159",
      "r541",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r587",
      "r589",
      "r590",
      "r592",
      "r593",
      "r594",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r608",
      "r609",
      "r610",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "terseLabel": "Postretirement Benefit Plan [Member]"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails",
      "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails",
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails",
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent": {
     "auth_ref": [
      "r10",
      "r161",
      "r162",
      "r164"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      },
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit other postretirement plan, classified as noncurrent. Excludes pension plan.",
        "label": "Liability, Other Postretirement Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Accrued postretirement health care costs",
        "terseLabel": "Accrued postretirement health care costs"
       }
      }
     },
     "localname": "OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails",
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForLegalSettlements": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid for the settlement of litigation or for other legal issues during the period.",
        "label": "Payments for Legal Settlements",
        "terseLabel": "Payments for legal settlements"
       }
      }
     },
     "localname": "PaymentsForLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesShareholderClassActionandShareholderDerivativeLawsuitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r890",
      "r891"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchases of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "negatedTerseLabel": "Premiums and fees related to early extinguishment of debt"
       }
      }
     },
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid on common stock"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of noncontrolling interest during the period.",
        "label": "Payments to Acquire Additional Interest in Subsidiaries",
        "terseLabel": "Payments to acquire additional interest in subsidiaries"
       }
      }
     },
     "localname": "PaymentsToAcquireAdditionalInterestInSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation [Member]"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesJudgmentsPaidandProvisionsforTobaccoandHealthLitigationDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails",
      "http://www.altria.com/role/ContingenciesScheduleofPendingCasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitContributions": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree.",
        "label": "Payment for Pension and Other Postretirement Benefits",
        "negatedLabel": "Pension plan contributions"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitContributions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense (reversal of expense) for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash",
        "terseLabel": "Pension and postretirement, net"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r7",
      "r541",
      "r542",
      "r564",
      "r848"
     ],
     "calculation": {
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanAmountsRecognizedInBalanceSheet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r158",
      "r541",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r587",
      "r589",
      "r590",
      "r592",
      "r593",
      "r594",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r608",
      "r609",
      "r613",
      "r848",
      "r849",
      "r853",
      "r854",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "terseLabel": "Pension [Member]"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails",
      "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails",
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails",
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PercentageOfLIFOInventory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of LIFO (last in first out) inventory to total inventory as of the balance sheet date if other than 100 percent.",
        "label": "Percentage of LIFO Inventory",
        "verboseLabel": "Inventories determined using LIFO method"
       }
      }
     },
     "localname": "PercentageOfLIFOInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares [Member]"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r592",
      "r846",
      "r847",
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r957",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r967",
      "r968",
      "r969"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentRetirementBenefitsMember": {
     "auth_ref": [
      "r158",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Special and contractual termination benefits provided in connection with termination of employment and payable upon retirement, but not payable from defined benefit plan. Excludes benefits payable upon termination from defined benefit pension and other postretirement plan, and postemployment benefits payable before retirement.",
        "label": "Postemployment Retirement Benefits [Member]",
        "terseLabel": "Postemployment Retirement Benefits [Member]"
       }
      }
     },
     "localname": "PostemploymentRetirementBenefitsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r14",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "verboseLabel": "Preferred stock, par value (USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "verboseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r14",
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from the Ste. Michelle Transaction, net of cash transferred"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails",
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r892"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "terseLabel": "Long-term debt issued"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r893",
      "r894"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-Term Debt",
        "terseLabel": "Proceeds from short-term borrowings"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r284",
      "r309",
      "r312",
      "r325",
      "r331",
      "r346",
      "r354",
      "r355",
      "r392",
      "r397",
      "r403",
      "r406",
      "r422",
      "r469",
      "r470",
      "r472",
      "r473",
      "r474",
      "r476",
      "r478",
      "r480",
      "r481",
      "r692",
      "r695",
      "r696",
      "r709",
      "r717",
      "r771",
      "r832",
      "r859",
      "r860",
      "r889",
      "r931"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "negatedLabel": "Pre-tax amounts reclassified from accumulated other comprehensive losses to net earnings",
        "terseLabel": "Net earnings (losses)",
        "totalLabel": "Net earnings",
        "verboseLabel": "Net earnings (losses)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/ConsolidatedStatementsofComprehensiveEarnings",
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r121",
      "r289"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r123",
      "r270",
      "r773",
      "r862"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net [Abstract]",
        "terseLabel": "Property, plant and equipment, at cost:"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Useful life of property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PurchaseCommitmentMember": {
     "auth_ref": [
      "r11",
      "r246",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier. Excludes long-term commitments.",
        "label": "Purchase Commitment [Member]",
        "terseLabel": "Purchase Commitment [Member]"
       }
      }
     },
     "localname": "PurchaseCommitmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r269",
      "r278",
      "r862"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "verboseLabel": "Receivables"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]",
        "terseLabel": "Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": {
     "auth_ref": [
      "r44",
      "r316",
      "r718",
      "r722",
      "r724",
      "r887"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax",
        "negatedLabel": "Amounts reclassified to net earnings"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r44",
      "r47",
      "r316",
      "r718",
      "r722",
      "r724",
      "r887"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTotalLabel": "Amounts reclassified to net earnings, net of deferred income taxes"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAociCurrentPeriodTax": {
     "auth_ref": [
      "r42",
      "r308",
      "r315"
     ],
     "calculation": {
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Reclassification from AOCI, Current Period, Tax",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "ReclassificationFromAociCurrentPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Member]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable": {
     "auth_ref": [
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Table]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningslossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r91",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of each significant reconciling item, other than profit (loss), revenues, or assets, in the reconciliation of totals of such items in reportable segments to the entity's corresponding consolidated amount.",
        "label": "Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Schedule of Depreciation Expense and Capital Expenditures of Segments"
       }
      }
     },
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r137",
      "r138",
      "r140",
      "r141"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Long-term debt repaid",
        "terseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.altria.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-Term Debt",
        "negatedTerseLabel": "Repayment of short-term borrowings"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfUnsecuredDebt": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.",
        "label": "Repayments of Unsecured Debt",
        "terseLabel": "Repayments of unsecured debt"
       }
      }
     },
     "localname": "RepaymentsOfUnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r179",
      "r279",
      "r992"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashCurrent": {
     "auth_ref": [
      "r883",
      "r895"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Current",
        "terseLabel": "Restricted cash included in other current assets"
       }
      }
     },
     "localname": "RestrictedCashCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r807",
      "r886",
      "r895"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash included in other assets"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs) [Member]"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails",
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r70",
      "r460",
      "r461",
      "r924"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "verboseLabel": "Asset impairment, exit costs and implementation costs"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [
      "r456",
      "r457",
      "r461",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r17",
      "r151",
      "r266",
      "r786",
      "r788",
      "r862"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Earnings reinvested in the business"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r280",
      "r343",
      "r344",
      "r345",
      "r347",
      "r353",
      "r355",
      "r423",
      "r648",
      "r649",
      "r650",
      "r678",
      "r679",
      "r707",
      "r783",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Earnings Reinvested in the Business [Member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r158",
      "r159",
      "r541",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r587",
      "r589",
      "r590",
      "r592",
      "r593",
      "r594",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r608",
      "r609",
      "r610",
      "r613",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails",
      "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails",
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails",
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r158",
      "r159",
      "r541",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r587",
      "r589",
      "r590",
      "r592",
      "r593",
      "r594",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r603",
      "r604",
      "r605",
      "r606",
      "r608",
      "r609",
      "r610",
      "r613",
      "r848",
      "r849",
      "r850",
      "r851",
      "r852",
      "r853",
      "r854",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAmountsRecordedinAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails",
      "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails",
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
      "http://www.altria.com/role/BenefitPlansMovementsinOtherComprehensiveEarningsLossesDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails",
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r383",
      "r384",
      "r396",
      "r401",
      "r402",
      "r408",
      "r409",
      "r412",
      "r536",
      "r537",
      "r762"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofEarnings",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r540",
      "r829"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesPolicy"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r539",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenues from Contracts with Customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomers"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuePerformanceObligationDescriptionOfTiming": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of timing for satisfying performance obligation in contract with customer. Includes, but is not limited to, as services are rendered, and upon shipment, delivery or completion of service.",
        "label": "Revenue, Performance Obligation, Description of Timing",
        "terseLabel": "Revenue, performance obligation, description of timing"
       }
      }
     },
     "localname": "RevenuePerformanceObligationDescriptionOfTiming",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/RevenuesfromContractswithCustomersNarrativeDetails",
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesGuaranteesandOtherSimilarMattersNarrativeDetails",
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r412",
      "r908"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark [Member]"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r44",
      "r982",
      "r983"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/OtherComprehensiveEarningslossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans. This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Plan Assets by Asset Category"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts that are recognized in the balance sheet (or statement of financial position) for pension plans and/or other employee benefit plans, showing separately the assets and current and noncurrent liabilities (if applicable) recognized.",
        "label": "Schedule of Amounts Recognized in Balance Sheet [Table Text Block]",
        "terseLabel": "Net Pension Liability Recognized in Consolidated Balance Sheets"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInBalanceSheetTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the net gain (loss) and net prior service cost or credit recognized in other comprehensive income (loss) for the period for pension plans and/or other employee benefit plans, and reclassification adjustments of other comprehensive income (loss) for the period, as those amounts, including amortization of the net transition asset or obligation, are recognized as components of net periodic benefit cost.",
        "label": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Movements in Other Comprehensive Earnings/Losses"
       }
      }
     },
     "localname": "ScheduleOfAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAssumptionsUsedTableTextBlock": {
     "auth_ref": [
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assumption used to determine benefit obligation and net periodic benefit cost of defined benefit plan. Includes, but is not limited to, discount rate, rate of compensation increase, expected long-term rate of return on plan assets and interest crediting rate.",
        "label": "Defined Benefit Plan, Assumptions [Table Text Block]",
        "terseLabel": "Assumptions used to Determine Benefit Obligations"
       }
      }
     },
     "localname": "ScheduleOfAssumptionsUsedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in common stock outstanding.",
        "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]",
        "terseLabel": "Schedule Components of Issued, Repurchased and Outstanding Shares"
       }
      }
     },
     "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Earnings Before Income Taxes and Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r29",
      "r145",
      "r148",
      "r149",
      "r150",
      "r235",
      "r236",
      "r239",
      "r257",
      "r838",
      "r840",
      "r900"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "verboseLabel": "Components of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongtermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Aggregate Fair Value and Carrying Value"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Income Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in plan assets and benefit obligations recognized in other comprehensive income (loss) during the period.",
        "label": "Schedule of Defined Benefit Plan Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Amounts Recognized in Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r169",
      "r170",
      "r171",
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansAssetAllocationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionstoDeterminePostretirementBenefitObligationsDetails",
      "http://www.altria.com/role/BenefitPlansAssumptionsusedtoDetermineNetPeriodicBenefitCostDetails",
      "http://www.altria.com/role/BenefitPlansEstimatedFutureBenefitPaymentsDetails",
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails",
      "http://www.altria.com/role/BenefitPlansNarrativeDetails",
      "http://www.altria.com/role/BenefitPlansProjectedBenefitObligationsPlanAssetsandFundedStatusofPensionPlansDetails",
      "http://www.altria.com/role/BenefitPlansScheduleofComponentsofNetPeriodicPensionCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r215",
      "r219",
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r906"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Earnings (Losses) Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Effective Tax Rate and U.S. Federal Statutory Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r103",
      "r284",
      "r331",
      "r422",
      "r717"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BackgroundandBasisofPresentationBackgroundNarrativeDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails",
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofFinancialDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Estimated Future Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r109",
      "r111",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r109",
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Definite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r834"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails",
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandNetCarryingAmountofIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r115",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLossContingenciesByContingencyTextBlock": {
     "auth_ref": [
      "r126",
      "r127",
      "r925",
      "r927",
      "r929"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the loss contingencies that were reported in the period or disclosed as of the balance sheet date.",
        "label": "Schedule of Loss Contingencies by Contingency [Table Text Block]",
        "terseLabel": "Schedule of Contingencies"
       }
      }
     },
     "localname": "ScheduleOfLossContingenciesByContingencyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "verboseLabel": "Aggregate Maturities of Long-Term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongtermDebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "terseLabel": "Schedule of Net Benefit Costs"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r80",
      "r81",
      "r83",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "terseLabel": "Schedule of New Accounting Pronouncements and Changes in Accounting Principles"
       }
      }
     },
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "terseLabel": "Schedule of Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r89",
      "r90",
      "r92",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r89",
      "r90",
      "r92",
      "r106"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Data Schedule"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r175",
      "r176",
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "verboseLabel": "Schedule of Restricted Stock Units Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r614",
      "r615",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails",
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r136",
      "r142",
      "r143",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r297",
      "r298",
      "r299",
      "r378",
      "r501",
      "r502",
      "r503",
      "r505",
      "r509",
      "r514",
      "r516",
      "r842",
      "r879",
      "r896"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Share Repurchases"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock": {
     "auth_ref": [
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits, excluding amounts pertaining to examined tax returns.",
        "label": "Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block]",
        "terseLabel": "Reconciliation of Beginning and Ending Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r380",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r406",
      "r412",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r459",
      "r463",
      "r834",
      "r993"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r380",
      "r381",
      "r382",
      "r392",
      "r395",
      "r400",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r411",
      "r412",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReporting"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes [Member]",
        "verboseLabel": "Notes [Member]"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtDebtTenderOffersandRedemptionDetails",
      "http://www.altria.com/role/LongTermDebtDetailsofLongTermDebtDetails",
      "http://www.altria.com/role/LongTermDebtNarrativeDetails",
      "http://www.altria.com/role/LongTermDebtSummaryofLongTermDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation [Member]"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesNPMAdjustmentDisputesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "verboseLabel": "Vesting period, in years"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted, number of shares (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails",
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r631"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value, per share (in USD per share)",
        "verboseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails",
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r628",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Balance at end of year, (in shares)",
        "periodStartLabel": "Balance at beginning of year (in shares)",
        "terseLabel": "Number of shares remaining (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails",
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r628",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Balance at end of year (USD per share)",
        "periodStartLabel": "Balance at beginning of year (USD per share)",
        "terseLabel": "Grant date fair value (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails",
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value Per Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r635"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "verboseLabel": "Total fair value vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Vested (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails",
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r858"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "verboseLabel": "Maximum number of shares issuable under the stock compensation plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available to be granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/StockPlansNarrativeDetails",
      "http://www.altria.com/role/StockPlansScheduleofRestrictedandRestrictedStockUnitsActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r5",
      "r243",
      "r263",
      "r862"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term borrowings"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTextBlock": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for short-term debt.",
        "label": "Short-Term Debt [Text Block]",
        "verboseLabel": "Short-Term Borrowings and Borrowing Arrangements"
       }
      }
     },
     "localname": "ShortTermDebtTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r79",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction [Member]"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r282",
      "r380",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r406",
      "r412",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r453",
      "r459",
      "r463",
      "r834",
      "r993"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/GoodwillandOtherIntangibleAssetsnetScheduleofGoodwillandIntangibleAssetsbySegmentDetails",
      "http://www.altria.com/role/SegmentReportingNarrativeDetails",
      "http://www.altria.com/role/SegmentReportingNonParticipatingManufacturerAdjustmentItemsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofDepreciationExpenseandCapitalExpendituresofSegmentsDetails",
      "http://www.altria.com/role/SegmentReportingScheduleofPretaxTobaccoandHealthLitigationChargesDetails",
      "http://www.altria.com/role/SegmentReportingSegmentDataScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r297",
      "r298",
      "r299",
      "r331",
      "r360",
      "r361",
      "r368",
      "r370",
      "r378",
      "r379",
      "r422",
      "r469",
      "r472",
      "r473",
      "r474",
      "r480",
      "r481",
      "r501",
      "r502",
      "r505",
      "r509",
      "r516",
      "r717",
      "r821",
      "r879",
      "r896",
      "r905"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/CoverPage",
      "http://www.altria.com/role/StockPlansNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r34",
      "r144",
      "r280",
      "r315",
      "r316",
      "r317",
      "r343",
      "r344",
      "r345",
      "r347",
      "r353",
      "r355",
      "r377",
      "r423",
      "r517",
      "r648",
      "r649",
      "r650",
      "r678",
      "r679",
      "r707",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r724",
      "r728",
      "r783",
      "r784",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]",
        "verboseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesReclassificationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r377",
      "r762"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r907"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-Based Payment Arrangement [Member]",
        "terseLabel": "Share-based Payment Arrangement [Member]"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r15",
      "r18",
      "r19",
      "r96",
      "r862",
      "r898",
      "r917",
      "r981"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 equity (deficit) attributable to Altria"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r195",
      "r196",
      "r203",
      "r280",
      "r281",
      "r316",
      "r343",
      "r344",
      "r345",
      "r347",
      "r353",
      "r423",
      "r517",
      "r648",
      "r649",
      "r650",
      "r678",
      "r679",
      "r707",
      "r718",
      "r719",
      "r724",
      "r728",
      "r784",
      "r785",
      "r898",
      "r917",
      "r981"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balances",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets",
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.altria.com/role/OtherComprehensiveEarningsLossesChangesinEachComponentofAccumulatedOtherComprehensiveLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity (Deficit)"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets",
      "http://www.altria.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r156",
      "r330",
      "r502",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r515",
      "r517",
      "r706"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Capital Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r725",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r725",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r725",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/ContingenciesAntitrustLitigationDetails",
      "http://www.altria.com/role/ContingenciesEngleClassActionAndEngleProgenyTrialResultsDetails",
      "http://www.altria.com/role/ContingenciesEngleProgenyCasesTrialResultsPendingandConcludedDetails",
      "http://www.altria.com/role/ContingenciesEvaporLitigationandIQOSLitigationDetails",
      "http://www.altria.com/role/ContingenciesLightsUltraLightsCasesDetails",
      "http://www.altria.com/role/ContingenciesOtherSmokingandHealthClassActionsDetails",
      "http://www.altria.com/role/ContingenciesOverviewofTobaccoRelatedLitigationNarrativeDetails",
      "http://www.altria.com/role/ContingenciesUSTLitigationsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfValuationAllowanceTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of valuation allowances to reduce deferred tax assets to net realizable value, including identification of the deferred tax asset more likely than not will not be fully realized and the corresponding amount of the valuation allowance.",
        "label": "Summary of Valuation Allowance [Table Text Block]",
        "terseLabel": "Summary of Valuation Allowance"
       }
      }
     },
     "localname": "SummaryOfValuationAllowanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental cash flow information:"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TextBlockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Text Block [Abstract]"
       }
      }
     },
     "localname": "TextBlockAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ThreatenedLitigationMember": {
     "auth_ref": [
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of threatened litigation against the entity.",
        "label": "Threatened Litigation [Member]",
        "terseLabel": "Threatened Litigation [Member]"
       }
      }
     },
     "localname": "ThreatenedLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r414",
      "r415",
      "r498",
      "r514",
      "r705",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758",
      "r759",
      "r912",
      "r913",
      "r914",
      "r997",
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesSummaryofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockAcquiredAverageCostPerShare": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.",
        "label": "Treasury Stock Acquired, Average Cost Per Share",
        "terseLabel": "Average price per share of shares repurchased (USD per share)"
       }
      }
     },
     "localname": "TreasuryStockAcquiredAverageCostPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r33",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Cost of Repurchased Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r33",
      "r152"
     ],
     "calculation": {
      "http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CommonStockSharesOutstanding",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "negatedPeriodEndLabel": "Ending balance, Shares Repurchased (in shares)",
        "negatedPeriodStartLabel": "Beginning balance, Shares Repurchased (in shares)",
        "terseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails",
      "http://www.altria.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r15",
      "r144",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Repurchases of common stock (in shares)",
        "terseLabel": "Repurchase of common stock (in shares)",
        "verboseLabel": "Total number of shares repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockNarrativeDetails",
      "http://www.altria.com/role/CapitalStockScheduleofIssuedRepurchasedandOutstandingSharesDetails",
      "http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r33",
      "r152",
      "r155"
     ],
     "calculation": {
      "http://www.altria.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Cost of repurchased stock (1,020,427,195 shares at December\u00a031, 2022 and 982,785,699 shares at December\u00a031, 2021)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r144",
      "r151",
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Repurchases of common stock",
        "verboseLabel": "Aggregate cost of shares repurchased"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/CapitalStockScheduleofSharesRepurchasedDetails",
      "http://www.altria.com/role/ConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [
      "r456",
      "r457",
      "r461",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r772",
      "r846",
      "r995"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "US Treasury and Government [Member]"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/BenefitPlansFairValuesofPensionandPostretirementPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "terseLabel": "Unrealized gain (loss) on derivatives"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/InvestmentsinEquitySecuritiesInvestmentinCronosDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r652",
      "r661"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r662"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Reductions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r664"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Tax settlements"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r660"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Interest (income) expense associated with uncertain tax position"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r663"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions based on tax positions related to the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r662"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r665"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Reductions for tax positions due to lapse of statutes of limitations"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesReconciliationofBeginningandEndingUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits if recognized would impact effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/SegmentReportingNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r672"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "negatedTerseLabel": "Valuation allowance release"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r337",
      "r342"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at end of year",
        "periodStartLabel": "Balance at beginning of year"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged to costs and expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r341"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "negatedTerseLabel": "Deductions"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/AdditionalInformationScheduleofValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/ShortTermBorrowingsandBorrowingArrangementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r359",
      "r370"
     ],
     "calculation": {
      "http://www.altria.com/role/EarningsperShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Weighted-average shares for diluted EPS (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesContingentlyIssuable": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://www.altria.com/role/EarningsperShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares issuable for little or no cash consideration upon the satisfaction of certain conditions (contingently issuable shares) are considered outstanding common shares and included in the computation of basic Earnings Per Share as of the date that all necessary conditions have been satisfied (in essence, when issuance of the shares is no longer contingent). Outstanding common shares that are contingently returnable (that is, subject to recall) are treated in the same manner as contingently issuable shares. Contingently issuable shares include shares that (a) will be issued in the future upon the satisfaction of specified conditions, (b) have been placed in escrow and all or part must be returned if specified conditions are not met, or (c) have been issued but the holder must return all or part if specified conditions are not met. The number of contingently issuable shares is determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares, Contingently Issuable",
        "terseLabel": "Plus: contingently issuable PSUs (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesContingentlyIssuable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r357",
      "r370"
     ],
     "calculation": {
      "http://www.altria.com/role/EarningsperShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average shares for basic EPS (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/EarningsperShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.",
        "label": "Write off of Deferred Debt Issuance Cost",
        "terseLabel": "Write off of deferred debt issuance cost"
       }
      }
     },
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.altria.com/role/LongTermDebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 19
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1000": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1001": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1002": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r1003": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2599-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(3)",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "https://asc.fasb.org/topic&trid=2127225",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "https://asc.fasb.org/topic&trid=2197446",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(b)(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "https://asc.fasb.org/topic&trid=2235017",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(iii)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28567-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(17))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126903467&loc=d3e32472-111569",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13185-110859",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/subtopic&trid=2175709",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(10)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(9)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(8)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=29639808&loc=d3e29008-114946",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450691-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998896-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r815": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r816": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r817": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r818": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r819": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2646-109256",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r821": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r822": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r823": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r824": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e725-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6571209&loc=d3e13669-110860",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e765-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e639-108305",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r869": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r871": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r872": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r873": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r874": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r875": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r876": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r877": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r878": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13231-110859",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "321",
   "URI": "https://asc.fasb.org/topic&trid=75115024",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "325",
   "URI": "https://asc.fasb.org/topic&trid=2197064",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r945": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r946": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r947": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r951": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r952": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r953": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r954": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r955": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r956": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r957": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r958": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r959": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r960": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r961": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r962": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r963": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r964": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r965": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r966": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r967": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r968": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r969": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r970": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r971": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r972": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r973": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r974": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r975": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r976": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r977": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r978": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r979": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=126960272&loc=d3e32014-111567",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r980": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r981": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r982": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r983": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r984": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r985": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r986": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r987": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r988": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r989": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r990": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r991": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r992": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r993": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r994": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r995": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r996": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r997": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r998": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r999": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>142
<FILENAME>0000764180-23-000020-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000764180-23-000020-xbrl.zip
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MG&X ( 5BTP76G1(>=44\$<+_J1-93LZ6%T,GK.I)/&+:(KR5/>"B%Q?5P@;
M,I'Q$ #"@!F&(B(J.CJ"X_1&1#$["P/NLG8,Y BT>/CN/7-D;S@*?+? /EN
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M_MO!\7O3<D5)C.T%5?\MNQ='N&+R6 [KCG)# &J)GT18,,!+!@,\O. I 0%
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M\[.NBYP[0(.TUNXWCME%U/IES9/EN7J.,_]V W<*?X;QR/OX_U!+ P04
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M>I70-\56EVU=SM:]A^6QV@8Q&S*=_P!02P,$%     @ %7);5K?JE$F1 P
M^ D  !X   !E>&AI8FET,C-C;VYS96YT;V9I;F1E<&5N9"YH=&W55FUOVS80
M_KY?<56P=@,L2]2+)3FN@<R64V.I8SCN@GT:*(FVB,JD0-)QO5\_2I23=IF1
M#L,ZS!^(H^[NN?<S1Z^FMY/UK\L42K6K8/GAIYOY!"S;<>[]B>-,UU-XMWY_
M T'?1; 6F$FJ*&>X<IQT88%5*E4/'>=P./0/?I^+K;->.0U4X%2<2](O5&&-
M1\T7?1)<C+\;O;)MF/)\OR-,02X(5J2 O:1L"_<%D1_!MCNI":^/@FY+!9[K
M^7#/Q4?Z@ U?4561\0EGY)C[R&F-C#)>',>C@CX +=Y:=!.&19@/\CA+<!"1
M+(O#,".>&^(H0W&4_8:TDXX6-SI2'2ORUMI19I>DL3\,O'X4UNKR0 M5#I'K
M?F^UHN/1AC.E[0FM;T@#\QP,BZW&R[A2?#=LL+HOBM?M59%/RL85W;)A&[-E
ML$_Z.:^X&%ZX[>^RX=@;O*/5<?AF37=$PH(<8,5WF+WI25TG6Q)!-T90TM^)
M=EH;::\'$U.D<2K*R"E&Y#51I9]*FE&=<1^^C.AY+(WGR9>>Y[H61/PGKALW
M"I)S@9L>'>Y9040C98TGMXN[=+&&VQG,%]-TF>I#7U?I]?QNG:[2Z:GSKR:3
MVP^+]7QQ#;/YZOU79L ZVP8OJ?Q[*0K^LKKW!$HB2':$G#/9#*#BH$H"E.F\
MU5WJ0/,%V6A!EC<L6'*I['2S(;FB#P2N],@5[?@N>/_U!1JXE\@_(:W(EDK5
M =TI/=VMI+[,N-C!G8T"^&%&*_*D[-G)  7)CX!9T9@[#R,_P_&?8,#W?=L+
MDBCP#4@G$C^*R$XF'OBHITD;N1Z*#>5[R#54$ X,-XBCV%!A@MRDURH'?A#%
MCV0<&!)Y<9"<:#\)/;^C@]B-W([6N'&GB@91B 8=';DH#@WMN4$012<ZT9PV
MDO;JQR'2D?$-7%5*4 S7@N_K'LQ9WF^^\KW0!=/E4U"TZW1&,K''X@@ZB'9W
M"E+I5.H5VU5I0QEF.<65[L#'W#;V&B8Y59H1*1M\VDRUWOI-URC!*^ /1'R&
M86QK^!X<2IJ7@.N:8"%-,:DT]4"N_7/_Q:UR=D/^G2E[">1;S]WKBR"ZE.T)
M2T%S<M!)%R7?2S+AO"8Z53<WRW^<FV\=UDK7>L=9T8-?:...[LS_6PB/D^)%
M9E2>!? U;?>G9T+-S3MI:,;N@3Q[.)P4NW2X3RHXD[S:J_,JY_YNS[Y"NM.\
MB=K7V?@/4$L#!!0    ( !5R6U8O8RS0XP<  'J>   >    97AH:6)I=#(T
M<&]W97)S;V9A='1O<FYE>3(N:'1M[9UM4]O&%L??]U.<FFEZ[XR?;4(PE!F!
M!1AL.15.*'W364MK:XND=5<KC//I[]F5G;2A$-].,Q',R0L'R;M['OZ[9_4;
M+^;P^_[X9'+SUH5()S&\?7<\')Q I=9H7'=.&HW^I _GD]$0NO5F"R:*I9G0
M0J8L;C1<KP*52.M%K]%8+I?U9:<NU;PQ\1MFJ&XCEC+C]5"'E:-#<P=?.0N/
MOCO\OE:#O@SRA*<: L69YB'DF4CG<!WR[!9JM76K$[E8*3&/-+2;[0Y<2W4K
M[ECQOA8ZYD>;<0X;Q?5APQHYG,IP=708BCL0X4\5P7B7-UN\O;_/=KM\_\W^
M?OAZO]79#5[/.MT6"W]KH9,-;%[TR?0JYC]5$I'6(F[L][KM^M[N0A\L1:BC
M7JO9_*%BFQX=SF2JT9["_L6/Q3 /!V-JCN--I=8RZ9FQUG>T7-A+S>]UC<5B
MGO9LS)5B[$W_0,92]7::]M^!>:<V8XF(5[T?)R+A&7A\";Y,6/IC-4.=:AE7
M8E8TS,0'WFNUT8B]7!8Q[>$XL4CY)L96VT3EWD=B*C#C7?AK1'^*Y4^N!IA\
MKKZ)KT7&0AY(Q<RD[.5IR)5I53EZ.[YV?1B?@C.9C'W/O=DFEM_S3(O9JO*H
MJ/^\V[^=G^9G^>G^K9:O=EJOFP</7S?N?5W-_MZG2<3!"I5A[GA8!09]H7B@
MI0(Y R?62C X4S)?5&&0!G73XKTP2P7OH]:+M=SP'XU#O=IYTVXW#TYDLF#I
MREZU#OY;A5"BRQ%7?+K"3BDJI'/-@:4AL,5""@S\6L2Q8 F<UN%,S&92H3,7
M"NV-<J78"GR\SU0J@MLJ7+'XCJ&+'$8L#?),5NU0UW4X%W'(IU@90PU7N<*8
MU'H8# A= IER\V-B.F. Z'12A4ADH%5>.!2SY2R/@6%E4"E?50%]P1:)?5.D
MMG'*$EZ%1<R"HD^FL<Y504O@]SS T*J D:(Z.8N-N1D+,H'R<3!Y9CI7V(+'
MF&<E,20TCAHF(LM,)DWJT2^U%!FV,FEU4CN0SS';&D. 4ZD2:#5KE^L88)UQ
MZZNY7G&F@*.P(?1YP),I5\5DZ[2JIGRWB]QC#XPD#4W1SHSA+%\L8EY<8C09
M$^%GUDT_?"=@><:MJ0Q','>F'&8880A+H2/[SA6F0N$.A=J;7NY]$+%T;IU=
MQVI2-N<FV**7<8@7)2_#Q(L4Y15H.].X+15>V70'$0_S&,<5:1#G)DH3M_4!
M[ZQG)=Y%$12?X;Q+ ^NLX@)MKB?B').NS3ZW"70C>08X 6)8R"5719YR'4F,
M9&6:AM+>6W U,RHP;&FN^1U7F,U@G:'(#+R,F,ZD>0?=^",7N%W;V8?[JE!L
M&F_R%II9B5/+VIK*7-OT+13'-)GD%0Y9Z\8<+I>/J5CD&.RZD?[K8H;$;M9H
M+Y!Y'!K'T0;ZG<E/23"K=[8RSIK1<&W.A$KLI8DK6%NQX608CPBBSW.5X.+$
MH8V98DY\"@G'OQ-*YYNEEMF@,G2^_DA-IGK]]// P(/KP<1SKZ[@^MSUW?'I
MM]P]J@^F7,2*.I^G9E%Q;:ME5-0:7+<<U[(VM]I[N-I#G#DX,4ZQ8.=,K6QA
MZOR3F?$<9DW97K_.O-DF1T\]*;[:Z>X=9/85!HX'P_JD#B=#Q[]T2=\2Z+M=
M71BP=*U<S-0M_]=6]":.SS 0-T#+P3W%8YQ1=_P!&&XZKGFO^:D+FV8RQ@>V
M1[L\1E>/4N8G;[>#W>Y'V(W4QNB"S7EMBC!^6V,SM-EC\9*MLLK7 V*"R.<-
MD9-ON=X)(A/[0/TEB%SCA(%(_)$@DB"2()(@DB#RBQ")<Y\@LH2OY8?(D>-?
MC/V!"R.DD;'GN</APP='$KFL)#EBZG?<-+F53Z8IQQV,</(IG-PCG"2<))Q\
M_CA)GTD23A).$DX23M)GDD0:)<%)W/%'^, (?>?]X(K4+8&ZVU4%HQMN#]!G
M=R(C@'SR\&V3")((D@B2")((D@B2")((D@B2"+($_/ R"/+".1EXDS%<X+;N
M^I[C]=U?2>02B+Q=<;A@@3!5P,C'%>[D(?] //DD3W:()XDGB2>?/T_2 5?B
M2>))XDGB23K@2JA1$I[LN\>^8W#DTAQMK;F>1Q],ED+D[8I#WSR'6?G,T=::
MFZ;T^>07>'*?>))XDGB2>))XDGB2>))XDGB2>+($&/$R>/+2F9S[-QX<UV%T
M\O,[IT]?O%,&B;<K#9=,1VJ56O&"GW,6_G_?O?,B>;'=)EXD7B1>?/Z\2.=9
MB1>)%XD7B1?I/"O!1$EX\<P=^V<NC-Z]VFDW]P_&=)BU# IO5QG.N%2XTX]R
MU*[;.I!TDO5IDMPEDB22))(DDB22))(DDB22))(DDBP!0[P,DO2<X\$0;NIP
MY5Q>.L>D;PGTW:XN>&PJ8JL<N[UE4Z+()RGR#5$D4211Y/.G2#J_2A1)%$D4
M211)YU>),DI"D>\'_MG &SC@(HZ<.]XE_39D&23>KC1\?$8TXF$!N*7?A7R2
M)3LM8DEB26))8DEB26))8DEB26))8LD20,3+8$EW.'0]L^]?37SG?#AR/)*X
M!!)O5QK<..:I%0^?;:(8QR->W.WN[^WNOFEU6Z_I[T02.1(YO@!RI+.L1(Y$
MCD2.1(YTEI6PHB3D.#)_)_(7N/G5.7LW\'WZ#ITR"+Q=83#2L7NX^<#FN5#J
MQ7Z#3F,JPQ7^%^DD/OH?4$L#!!0    ( !5R6U9CO\^-; @  !XN   ;
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M29H$E+JTV^XM8>B"<2L)K8 ^U=<24<4D4*2OE1MB#VR60HS .('/0KE8&U=
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M8]Z%]YW1A5_N\L1=Y?(WW)RF.]Q'_P=02P,$%     @ %7);5B^-"X5>"
M,"\  !L   !E>&AI8FET,S$R<30R,#(R+6%N;G5A;"YH=&WM6FMSV[82_=Y?
M@<IS4V=&[X?MR(YG7-NYU].\)G&;Z:<[(+&44(,$"X"2U5_?78!ZV))BN74:
M.74^*"8)+!;@.;MG01Q]?_;N]/+7]^=LZ%+%WO_\X^N+4U:I-1J?.J>-QMGE
M&?O?Y9O7K%MOMMBEX9F53NJ,JT;C_&V%58;.Y?U&8SP>U\>=NC:#QN6'!IGJ
M-I36%NK"B<KQ$=W!7^#B^+NC[VLU=J;C(H7,L=@ =R!8864V8)\$V"M6JY6M
M3G4^,7(P=*S=;'?8)VVNY(B'YTXZ!<=3.T>-<'W4\(,<15I,CH^$'#$I7E9D
MW-KCO6;4V1<'O6Y\D'"^QYO=I"/X7J?5[G;^WT(G&]@\]+%NHN!E)959;0@T
M?K_;KN_W<G<XEL(-^ZUF\S\5W_3X*-&9P_$,]@]_!C-+QAQ<NQI7<I#U_90J
MH>OT<:R5-OV=IO]W2$]J"4^EFO1_N)0I6/86QNR#3GGV0]7B:ZA9,#()#:W\
M ] G=,]?CH/+^VA'R0RF4VBUR>GSZZ&,I&.=5KU]T^.[?5TQS85..1<"WV%-
M08*#[=4/]M&AZ4T37"CO+MB/\>6!^>*+T5VY&*=@G$QDS G3]LZ9E9/H!2@L
M3.*WPJ*=R5>:!7NLCE]4V4>N1MQI ^P-S^+"ZBJ+_4N9,#?D[ME.[^!P0\0=
M+,/MK@G?!]#W,1]NR4P@N/LUZOJ55KA5G\[NGQ_]\.;Z->L]6H8+-N0C8 9&
M$L88]]U06L:SK. *;^;:.*8S]DJ;E+6:M9^83MB)<D9R]E^CB[S*+K*XCK!X
ML2DLRI?TA(R;R&AO'3)^Y!;Q@"\_G;"K3(\5B %4 T!*9 B-+F0:50..P&6&
MP)FP(G.F )P!Z@@O*1 RG*5XA:A1+.$QWC),IYCUG [MEAID$(.UW$RH2<JO
M ,==L&GQGD!G<$CE]0B.00UB:5!_8+,,NZ,G @P;#V4\9+:@GWG_,6","T9H
M JFT"H4*:9ZQ=$.<H,TA]@Z2W1Q=TP*G.<)N@D63Q65X0O_?1G_G\: ?6"(S
MQ!=!=8ZG*D(?F^-CL_!<9@D&3J]F\.]8%0)M(F87P%-%O$NC)BQ'R!%;B$5*
MS>E0(M'>&AH9)[STKU*+0F$#Y(!&H ;QY/V)N1VR1.FQG1+$P$!:AW6#8YQN
M!K_1R^H"SNW4F25OOR#4UV+QFP=_=^O ?WD#*<]V#MJM_4-;PKO4@Q0J=8)B
M'<RN?>YA=,&X 0]8!*",%!"P&"!+(B7MD'I0LQ0S!64+NA;2QDK; OM1#C%:
M!>3F1L<@\+9ENPA4 8C\@,;SZWC(LP&P$PS/'PJ%+5H=7FOU=B%XT>J)<!4N
M)=4S66 ,V6<4PQ>(%(!-OFP\4')CH 0'HGG>IA>V(&GUI23S0_"EUWV,?-GE
MS[>%,'OU%RU:AS.PN%*(&R\S[@9UE110S N[>1>2(A$@0,N1@KC1A4$#&+9'
MTOID@*T@\W:H7INGD<549$!QC_A2W<Q16RW3%#V4F%+0%ZN5%'Y+R!:1E4)R
M(VD",F@PGQPSLE18TD4^1E@OHGSJT!;0(8>IBCKE'*D6%XI3QL-I>2?F^@I[
M!+6V*#+QKPBH(28E[ _B'DFHL_>7 4Y=_S6,BK:(49WN,J,V#N)+Q-H\_&_,
M+^3D2 JB#;<ZXY3GN$7*4=%!7.)&3'&-3),\DDJZ"2FP5<,2RST%/+H#06\T
M72A:?#J]+B>4%R9'=EFO&.-8&^$=\.7+ #(4@@I)AD\@)_92$RS- I&0Y3+'
MC/9$I0>G4KQ%5 K)Z7S$5>$C..$,D@3+"3E"A-@59<%,[&V0D<+EZDK!,P<[
M8C:QH1Z)=.'6>[!)SN2SUD#%5G)W:<ZB:1GG@P&$E4!_//!I@(?:J_WV@2VV
M"-AEC@B86<8>;4.5XMT_60GP>V0&4E(ZC@M#"%N0+2NLIMHZO$^?4="6C='0
M[P6J'C2]NZ9+@E3!F'VK=>DXEO#@=]"RF[NRSX-70VYG&H^BO:<6")\&_7J4
M*6K"E+P"56ZGW6I?_=M+-*/3W=\^ @4.ZD_;8,L<ZWT[.P'^JX*8$K0Z#\24
M%Q9),H_)!/-["+VEXF7F'<<"QFEC9]K*WT"3:2J= _A,UHLTJC=Z+B3ZYXWL
M(I4PR5A*8O@_E5%3_L/OA43W/=>++/8;;\^?"OY_0<%_HE"8XUKYK]7H$NT;
MQ1(0I*4NFA7>8^!7)'2"4/=2QY<8_AO(=+OV7M O:^2PU[8BOG.!'2W,POM:
MFI2%"79!K&/]4 UJRZ+4LD6:8J'_!_C)E&EUY<;VYDK*+V"W^84C_R.%^/95
MX"<HHA*#H;.*@ ,?\!&R_F-9B>UJT" R&VDU A(B&1^4W_Q,F2,@S96> #X=
M#W7("OP&<Q#I#Z+2Z@]V[&(SL&WI&8XS?#<^ S'V"B)3T"?4]G[5']A:.R>D
M^D!F-:?S_B(Y/1SV5QT<VE]_;LCY#9'2<(11!4P-)Z]X;J$__>,0E4&N^*0O
M,S\%W^FP="/2SNG4>S(BA8&JN!S$CQ<>ER>_7F! ;K^@PU\.WYD3TX'+<V%U
M?RZLX<3RL[UNO=D[6/NX66^M??8YLYU.?;_;WLALP[L<W,:%L3G/7E8ZE5M
MZS>9SS@S>Y]IVLZOJ?'B>Z%W>'L9PPI6/@/K=G=[8-W$ .7]$)2D?,[I^\TY
M:E4Y?K;3Q3CA?]G'D]>_G%R^^W#.WIR\/?WYX[M;9P"?5OT^JUXY7CH-]BC7
M\RLMWODUQ 5M<[%?L#1B[PW*/M(9FY7)VS"#TZ&$A+V:Y=IWH<A;!X*&C^+_
M;/[=)LKX_/MLI[77/'R\OVO7_=;!ZUR'D^?]\#%Q!$M'L><:P*?SYKP+CZQ6
MA5ON<L?I[?(WG"7WI]J/_P102P,$%     @ %7);5GR,&"PS!   FQ$  !L
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MS<LG7$Q/3J:#]V59GTXFL_D(R_K\T5C[KS?- UWJJ8;S0&]]JN%,Z%(61&[
M:Y6'%_^'W,_EL=9MWG>NW8W^NX/MUTS^V7_\3%27'!U).='4W_G7OS-<"J5$
MTG%N3<@R%[Q0=TW^X:)@^ZRN+<H+E/Y?4$L#!!0    ( !5R6U;G?]I:. 0
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M0J;@V,;OD A9.<TQ1!$#S6+L3R,:T71!Y>L]Y\CNMYRF;DDND (2QE%^&TI
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MC&O8A:-:5]F4+ZRS?VL8$PR//JYXQ(_A.7E6:#.#TS,<]*L/\VR2-;"?I^&
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MCNDSE:_4NO[J3XMN;(T5=@G,[^A:O=<E$ ^<.K-[.WC&_JF >;:U[YF",]$
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M\KW1D0]O]/E-F#I.[[6O,R80-9Z]F_OVGJX5XU'A1^ZB%B<A1(-WU?=[C2D
M4;L4U5B UPH3/[R#JHP^&<E&1F_7FMY5LZUI/6U>;]S:X=]1#!%]2-BU*PN]
M_C)ZSM40'Y9[WD*EFC-@O"/@C<'9W;4G_/HGSD3_\+5II5:%^"8)K17?Q&XR
M ;)S7C&\Q_?X6:+F1.Y*AS!VTHT,US K6C$K;M>X!_'Q!M#V@M[GR@]#BB+A
M>U_&7TE4<)<]W\7#<1V8+#;ON1IR;X:.FV&']A\X,A;=#ZF(7.I>3).#G*.N
M(^-Q-3F9E( =TBCZZ]0DRS&!>&PF4Q(!\!R!9,RS129)96#-F;1(VT60R<M"
M'(<8W/B^ +T^J-]Q!Y_]1E.00"W'1(DI27*('2/G5X'N*A2L!@A_9\$>#8<F
MAK<>87:PWN_:W'0.N=!'I_RGF[^7[OCJ@]#;)6OZIT_/+ZB;GUH@CTMCLY?^
MA1(9MXF+M7L>]1&6?J.2R2Y1!WE]YQAA)OO@/13)=Y%;XO)%(:WQO(G;C0^<
MM52V(T1PQU,%Y-4_XL3_7,= $\6D;.;.I"D2[L8/KYG"X#V#;$QXAL_W=+/5
MX&[CBMVVX/C9%^42>4;7-K(+]/%A-E\/"]21R#T'BP?_)JN:5@=K9!9A%\\:
MMJ@$XEIB9<6X[+ME"_%/%S=A?FA444?=FUU?V[M$)K.JNRIA2O> D"ML:8I=
MG'NO@7S5E,MG#T<:!3=<\F*\]Q40]Q%VA%7+6C\S?SQ/LWJ9J_6SK* 9TDW/
MPQ?B"V[0NDU4+B^A]_'/S@..I7_H!6_ ZFQ2\V;Y^9A^>M"D0[\]O;@8_?7D
M^'3#G>-//3M^>O+HHS_UZ>GQDX?C/_N/?4#KP&L!RUTO5?%?7YU_U;':GYTM
M/T2GX1:B(=]=<5[L3T_J)TSJ7$6 _UHJE?G_\:D!$7^F>1V<'GY)TZ'0(6A"
M2<,EZ/)WK7(P<C!G$Q/<Q%T1,Q+^V@!<LRZ#W$#">]&!9Q:!@%MQY>I"5S-Q
MJ978,B9+E6 P9-SW%Z._9>77VIGL?B]HC*5W4Y/J@<UM0>-M,N[IZ]I#J!I,
MU]IU*N"/\J/?$C>6-L2D^% ]?FP<*<*EN66<[=#K34UT\$2:.N-2<.%G]R6A
MHW]_PG?B2!R<?7$GO)L40,F(7C[&@9>Z8SHVD(5J*FOA^K%3+&:%L1RDPX>I
M^<*4+#I'H,#!>1%OZT07&NUO+ 1:%9@8%G;+0'-,ZM!.S].C<U/XE;KO'G9M
M--_>(G@79&3YVF=K^9IXB$OP?<A($Z35>S;T34FF=MV4R7O'Z()OLP*8 ,\5
M[PY_0W.=4O@SKM!P"X:?M R4.B;)GS&J?G4K#F%YVK+$G.=*>8P'%67;=:6>
M@\TWQF,>D%JV3^; ,3W>D62.O8J^5]$_N0#_DF3=P?D7);I7VA<=))G)O4BB
MF-U;)-TP"==)VMCF0K/@]1Y1=YY1=QXBL&+6'<6Q$#^K105Z0V8Z>HF#8J,@
MY7@,+BZ7Q);X7B<,C8<\]IUU5OAR)*E9AY$7,TY_3"N*!J&D9/EHQA4*=6^0
MV6*AJ6=@[B'Z]![K4E-Y?2M]VVPP8W:A?BM]8)%P$/P=B/V;C!I'R8;)]@V8
M94MX;=$XPV/D ?Z,.#EXQK]+Q\6!^?T%+)4OB3,<7'Q1C(X<FUCYRF!7EJOT
MSL]"H_)KS_1WI:HP_SMZ2>>#H"(J\B7[H=_4_,A9#V6UI_-=(8R#AU\<G:M4
M*KBX,#)712^XFV?_:L6\1O8/RCP96ET/6_=2DD*4,01\'P001K PCXBZ>++(
M\,IJ;K<4MS>.\J9L4'&Q(IP#(Y6>E>3"")64X;A>5MQ@\^K!2&=&\+E\FE9:
M/!<8&.]+9/0<YNLC]&*DSO6WYLWM+'X'4=<B]XSX8#M%-5W5@21X]PV^Y/?"
M:!29]9:$$"0"%RKI$=A#4RJ*O9?W_1M#"E/O'?"UA>RYX["*TF@P!T%^39>(
MV;W4=R/=S^MSUT7=Q5CL-55J3[,B,ZQFK.+(N+?9 Z@)O7->87Z SY4^;IC
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M"U2-;[))+R9XVWO@SIZZ9'_JMOK4#1ZVH5YVH>A0L@[PHD[J'_JSQ,,GO7R
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M_F:*D>+H[.3T*9GI9*>9%&V!4Y,V2JP7C9CO7>-3^DB%LBK0Y-2DO#&82J)
M'6TL_7#]'<:=2?O>NY]$)OA\9XR86*HSCZL%1HHXX@ OMT#(*<)QR2VF ^I=
M^>A 0N3'E"M>&K:KH,:.9=+TQ*L!D]LG;9YC/0P"[#"Y8[2,&PW#2U##XH*;
MSBI12LG .G3/6%O'H;"+G3B.;Y%J66W%(D?TR.LKT;P06CHAT#&9TPI6J<$Q
M+K/".#AA>$M-9P4TQAEE1[5%K<F\"VLG"Y/$#LS%[V.XP)!AQDD%$]N@41I1
M_AFL*/Y2^RU3>SS6>EHO7?BW-IUQ[U2!V1)?)JV-WR8O08V#:I H 9%/'VY\
MRWT(.8Y#$4?I@U%[ !1$E+OHL'H]Q573'W1%B2R$CKYTP<)AV\OYM4TO\D[+
M<17V#0>U2+A983@.G@OI-1ZYON*N :OO+)5A>-:3<1'<ZU!F4QM)W0%;_G6-
M4:B$*/I56Y6[:,*_1C1)25E&Z#;"<?,3>I"1!<W+J?<VSE;:D>:YRQVDS?6,
M9&MA^P+*7DW)/-R]N%C[=K*/*Q(3K9FT1WGW<<2' G]J"W.\RPGB.O+@B'<+
MT_7:]'JP-6:.MHURV*>6$DODS%#<T:)6&GA^XRGT^@LD696TBYKRT]"=ORZ+
MU(>XZ3JS?$QF V8$EY:++*'U^ZDL0"A6:Y3V5(U5F;1VG*3@A"(PBS99W&WM
MV"(57DK H0Y2'3:\A(\XJ=J$,:U3]SX.%V4P'8:]6/N! @I[:-NRVFNYAN,1
M_(Q,VA^86*V$AD2 9YPV+#)SHHKWDD6_: N*V=", HH+T\?<[AD$&Z(QN.B7
MXZOC*,7&-A7BU#19'BRCFB'E=(0%!;!*6E+JU<P:A[_%<5 #*S1JD7@:2Z]N
M/)UN#\&PI+R>()<6B)S1N+VD"[\7'_D[#:<=-HCQ%97KDYJ7+ FM;!5 R9HR
M3-S7B!+D82X32J^^484KD&;HR\KJ5MS#XY:1S!5'/^S@%4^&$4Y@WC6GB(D*
MJNK,#IUIM:P;"HW!J[R5^?O7%X^?TT[9HT>/==LET0Y_1K]SRF0&BAIB("U$
M8:& *IS8!'%],9AS.9K&Z.BP+H=)T(:<74>06]K&6P N/BG20U[R)&Q"%+78
M!N&024:X$_A%:1/H7#IF/<?3Q*>=>'"]1*@FT7*G1H-7>6+SF"IO+\?Z0UL4
M]1V0XB_\/G1Q])-M4'>E\@V(4MLKTG^Q)&.I)(X*H8@5$\+;GZ)?KB[)>]_M
M#<11:DJW*01!1(1;&%MD?&<NTN($;#HE<@K0 RA9V)EH@X+DW &_YH(O^ BG
M:FT@2R2BVA;HY2>?^?A&!$;1Q>/CLX=['\EM/A*.<[KME#8/$]<_W!T),=!-
MG\(5N>"8?KB2Q^9YLJI&M),:1B4[*9U8$M*Y2"$(X<$#$K+/=P@_G??\#LJB
M])R0A$T0G**K&((E!>KV6#C[CVR8&R/?9KI# 5%Y/M;0UC2NNEW@0QC*N(5I
M:4ES\\ZKEWD2AJHH%24UL B+K%TP%)91NP]"3]" #T+TE$-25"2+,;398&TI
M0U<@&!@^)0%!4R@W)&^P,OE9JV ;4=9()G_/)A7)CP$__)95+(^6.LE(L504
MR'@P&0,3]N[%"N[O9-WSD+O%WH9;@K'*895_!%6)7AFMYJ5H-8,P55UBX4BO
MJ$3B^^.7&A2^*J(^E421!"A>$;"]R>TR'5>*W@#$S4=ZSQP8BRZ$#4Q\B/,_
MB]K^BD&OT^T/>NW/_9UU!PNZ&$A4DFR!)0)61J5%UHU).@)X3O6BR*9K(UB
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M$!V 4CC,0\'!&J.O1*,W GD\$QI7O]UA-G>?B8&>&O+SC T[]@Z0P>?R[/S
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M/% O"^[WI$!LX_?V X6FC;\">J":J;V@*!^MEW1HHK1A%P#CV#$"%_1Z"J@
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M!=D1UKM=BRVMG%V;RMG6$M9:,M"DS?O]51K"%N<9QJ&"03#_P%V'N=NH\O6
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MW=\Q+/VP."S=[4A[!'\YON=^^7]02P,$%     @ %7);5H!_C*@$!   #QX
M !L   !E>&AI8FET.3DR<30R,#(R+6%N;G5A;"YH=&WM65MOZC@0?M]?,2='
MN^>EN1+@$"@2AW+42KT)J*I]6CF)(58=.W*<4O;7KW/KMDOIH==M$3Q$))X9
MSS<>>[Z1>U\.SH;3/\]'$,F8POG%C^.C(6BZ:5XVAJ9Y,#V P^G),;B&9<-4
M()8223A#U#1'IQIHD92)9YJ+Q<)8- PNYN9T;.:F7)-RGF(CE*'6[^5?U!.C
ML/];[XNNPP$/LA@S"8' 2.(0LI2P.5R&.+T"7:^DACQ9"C*/)#B6TX!++J[(
M-2K')9$4]VL[/;-\[YG%)#V?A\M^+R370,)]C02!W;0ZULQN=[Z[+1OY@8O\
M=JN%FN[,;2'\EZV<-)5XJ9/*)<7[6DR8'N%\?L]UC'8SD=T%"67DV9;UNW9/
M5.(;J2-*YLPK'%:C,\ZD<D0HP^7?%?MKE.KA@%,NO*]6\>OF(_H,Q80NO6]3
M$N,43O$"QCQ&[-M>JE9&3[$@LU(P)7]CY:;RN'A=E"C:R@XE#->H;"?',;J)
MB$\D=#J&\U1?'P"X&D8DYBJ2DB=>1SETQU*@5@Z+C6*UH9'WCMUT?#0XALGP
M<'1P<3R"GV=C&([&T\'1*0P'D]$$5@ ] :S/I>2QE^?='?BNH3Z\.5SW0;@_
M,.4+("D@2(,(AQG%>X!2X#/XB7V1(;$$I[%7;-<]2+&4^:Z><2$C\)<0JPDB
MD!$&EL4^%KD>80HX"3-$(8WY52Z/6 AJ&U,E&Z!4>8_FB+!4PGE$*$G@A NA
M?+B8#."(!88RB"0@@6]]"O,IP<\D,"[5#" %4?9E)'@VCV"0"$*A895^&JMK
M].1U^)3+66ZB$ =<H/Q0]S(68I%+:?T\,-L<EL*B1Z0Z0H(-\G[$YA370/Z/
MC0>)X'/,EG]\M5M6]^,\G[>X.6BUMA+Y%-<*/A<J^W054(J2%'OUGVY(TH2B
MI4=8$99"J;MJ_AH+20)$JZI0Y'8Y7!5MIVG8;BNOVU(EI0SKB:N2;A0EW93A
MZEB[93A.<^VP9=AKQQXSZ]A&L[V96;-PN71;!29-$-O7&EJMD* P5 >GYR0W
M8-^OCA3/5F)3AN7]SYR"-=5UXC9S*NQ/@U46_0\%S+J'J%JQVHE:LCS4'H=K
MY6"UC2)S3W2+DN0$B2#:N@RQ=QGR:K$L.-S698BSFB%F4?!^66%=PWT6[;JK
M]]ZD9K"N<5 =@F+S.:-G'-Z8=GU6)EBU1G5S8VPS6W\T(&=YMJA&\+:-G)1M
M9$U3&]^[<%AVD\\#UZG [>CJCJYN3ZG9T=4=7=W1U1U=?0FJQK/I:O.E%P&?
MAKXRSO0/2&'?FE8_ZL'+*.QKM#JOQ'4?-K/)%/^Y5TQX>;'J"4R1)-=X[4UC
MY93UKPKR4TXSN:KRBRNZZEE>E1:7MOU_ %!+ P04    "  5<EM6!?AF'C?J
M!0#\)4( #P   &UO+3(P,C(Q,C,Q+FAT;>Q];7L31]+N]^=7Y.1\/4[ZI?JE
MN'9S+L# DH-M B8L?-FKNKO:%L@2*\D$\^M/M6P#)DYP0/;,*&(78EFCF='<
M=U?=55U=_8__^^YH_-U;GLU'T\D_O]<_J.^_^[\__>-_;6W]^\Z31]]M3_/Q
M$4\6W]V=,2VX?/?;:''XW?/"\]??U=GTZ+OGT]GKT5O:VEI^YN[TS<EL='"X
M^,XH8S][<W:KU&1(&[>EDHY;4$O=(HIURT0*['+% OA_#FZI:()!;[> 5=H"
MLGXK!H"MX$$G*H2<R_\IM[13WF3":$P "RIZ+>^#\> 4N9S:90\7\NWD&T[F
MM]ZEV;B,_OG]X6+QYM://[:7/TQG!S\:I?R/IV]^?W[H>#1Y_>'(WW[[[8??
M[/)8C8@_+M\]/W0TGX+1X<+!GY[:_GAVQ/D'YK/%AX,KS=/R0/FE'&S,^4&_
MN_[%4[:W$\WYPTV\6UQ^]&@BAW)#\L?%C";S.IT=T4*0;E=36\ILZ0_7S-/C
MR6)V<O$!S3G_<#!]^^/9FQ=NLATP^K,O/IDO:)+/[_*/GV<#Z</C6;R977X+
M[9T+US^>;QT0O?G]TSQ[X^+-SD>7W8#<J/[QWSN/GN9#/J*MSV[Y5N'1Y3<C
M;UPXO2"P)>]=N,3YL7\&@I:Q$+>L_GB>/WJ@VGYRHO/#CZ87#J?Q8C:B'_+T
M:'ESVIR=^-:8)@?__)XG6\^>?B^#@JG\](\C7M!W[<-;_-_CT=M_?G]W.EG(
M4-_:/WDC#R"?OOKG]PM^M_AQ"=&//_W/__S//Q:CQ9A_.IING5_B'S^>_NH?
M/YZ>.$W+R4__**.WW\T7)V/^Y_=E-'\SII-;D^F$Y?*C=[?:@3P[_7%4"D^6
M/\K[NV)M9J-\>O5WBR=<__G]R%09T*%0!&- JYITU2867XI*J S]9[O=BM)*
M;WW\VA,Z:I?FT:W;8L!*,V+WQW3P_7>GCU].^VYQJX[><=FJ-&YC:53DE\7^
M>I*VIV\?F2=O7]B=X_+JWMN7#_#5WJM[>F?[Q<D+<\_M;3\\V7W_R_O=[=NP
M^^J>VGG^4.V\>J%V]^\<[C[?'3VRN^,7[Z?O=O=OFYVCW<.]_8.3G5=9[;S_
MY;>][1?O=K?OCW:W'YK=[6>_O=C_]=6+<52/S,N3%\^SWWEU8/<>[*B7#W;>
M[>S?UKL/=DY>O#J W0?WCW;>'XYW]E_HW?V7AW+MM^7!_5%Z\,R_>'_G]>ZK
M%_KE@WOVQ?L7)[O;<B_O#[0<^V[W_9U7NZ_&1WL/7OSVXNC%V6=^E6NYR<O]
M-Z]V'OQB=E_]^OK%?I'C'JK=5[_8O>UG[^1[V9T'.V;O^0MX^>K.Z.4XOGNT
M?V^Q\U2U_\+N]B]F[Y?_@+;9$=:MX++? @-F"UU56Q59#+-R&9W__J?[MQ\]
MO?>/'R] ?)V(GWNM^Z-YIO$+IME]^<U\ _&7(#ZY#&(,14>N6U7YL 5.IRTL
MBL4O9XC6%R8Q@S\U&#I#^+&<?UHV&%\)X_>78&PRUA*01'$%P5A'M15=Q:T<
M BEG*'I59!B_N$&$[TW$JYS<%8QG-'XX*?SN__')!MTOH:LN0=>%1*&"VD+M
M< NLB&ITKLI/HJ8=AYQ2_/XG)7^:PH[J#U"^/Z/<9,MWQY/1*<;'\R)#[^DA
MS<X%PSGXFDR-HN9+(@M&?($1V,$%&T%KJO8_#S]B7CB/CL0%__/[A[OWSREP
MIN%NW9T>'4TG3Q?3_/HQS?9F3Q<M#/F5QL?\\=+-!LAG5+?T@)T1'N6C^Y.]
M5^5PY_F.V=DOKU^8%[^]?/5D_/+H%_=B__6[EP_D.MOW#U^\NFUWG__\^I%]
M<OCBZ-UX[]7/X]WMU^;%T>[1WO;AJYW])Z]WMX5"SY_!WO8]M[-=QG)&*_0:
MG7]&KG7\TCSS.T?/U-[^RY%<"X26[W8?_*)VC^[IE_L'L+/_^K==\^S]B_?Y
M_=Z#G^O.2'WPXWO;<MRKU_\!0]E%"9B2)Q!6%+,5C?P#X),I2$DE*_SXP<J?
M<VZ<D^%KR.&=\2E([(8^0D07B[Q*AH5\XF,R+,FA-^3H@APGGY/#)71<K!:5
MC$[<?]5;R5BUY3BK@,ICKN5+Y+C4/UB42)TKYXP,F6(4H:$1DDTAQYK5IRRX
M"/LV5XF#RAV>R ^+QQ+<M+^WYW->S._3:+8DP)V3?XUX1K-\>')[4G;I[;UW
M$L_,1VG,CT;S1;=L$,N]\_;EY.?#E^_?C%^\DL_OWU;+SVP?J)>OA VO#DYV
MG__R_H5<9V=_]VCGZ-?QBZ>H7CS_>2X>8?3RU?VC%\_OO7MY=._]WGX63_)D
M].+5KT<O'_P"+YX__&WGU4.YWV=F=W3VF7__?)B.RGCOZ.>CG><O#U_LR^?W
M=YQ\+[O[X.?1[O.7KU]N'S;FR;WOR'=[8?[]_J&8BMN_E_P)<F2[Q<JIYD/B
M5M)*Q#^(W'<V![$=W__T9S'Y__X T@[3_'C&Y?9BEQ=+ "\,WAT^2CS[*Z(C
M% @Q52UA"8LZY40)E"[%U.(!=?G4[VQ(U1]2H2C-Y#)OE4(MM+!E"P7(K43.
M6N^"K\YV1BH-IN02?  O)+>B9I(Q53NK@Y$8:$.J'I#JY!)2R;BO-;'?(N_R
M%A@4!:P(MY*SRJ<<*F7JC%1DD9@Q,+.&Z$.2"$PIQ "H@LYQX_[Z2:ILB&)Q
M=LNJ4,3I%=Z*,?NMG#,XY23@1>R,5*I%5QJ]I^S!E4C1*0XJQ,!65%;8D*I[
M4KV_A%1>XB\;(F]EE20N=PZV**#>$G\#C!*L2P3?&:E<J5",9P;C@#BCHQI5
M8A.C,EG%C?OK)ZFR*%]'7+=\<"VS!VX+!;PMK]#$D%2I7G4GU .75+VOF;/(
M*Q--MCEZ%YOA2G9#JC\AE9#GY]'+?8G;S:_CEZ\.EO'\BZ-??MM]_^NKG>WL
M]A[<4R^/7IB=D\])]?+UBZ.?Q[O[NZ]>/O_U2&)\(_<T>KG=\@T[\OG7\&+_
MR='+5R_>__O]O<M(9="I$$K<"MDL-97=$HE>MXH7L'+168+"SDCE:P(6,ZJ3
M-@"4DZM>ZX((E9T^B_XV[J]WI$JU1H_5;BD#04A56:(_[[<,QQRKC>)WH#-2
MQ:QS$D+%I ,X&XF#M2+[0LYL1,%O+%7WI%*7D,HIK5 S;$7E_!:$$+92B6HK
M6(FXDL3N4:?NHC\Q5#8 NP0$VOA4LT\%%12)_^PF^=E74C'7IM7#EB<+6U!!
M;Y$.::N(PW%<R&.\$4OU^^F6/#V>+3Z;:$&M@M7D?":&C(@6L ;KE3<I,J<E
MRZS2)OS!1,O1]-:CZ7S>*H-&DP.>Y)/E%,O==JVYW)+<8%\F6-[MOG]VSBIA
MP3/8V1=EO;\CB H;]E_ WO83.<_]U\(NM6.>O=MY_TR_%-7]\M^'*A_].J'G
M>+QW)"S8/W@GREKOO#\\W-E_,MY=3NS><SO/GXR$,>]?[M^3\_YZ]._WS_X#
MRL3"RFYIY45B:X];1*ILB? .%;S$;CE^_Y/1OY\8^?%BZ=.,*\_D^?+\DGJM
M5NYW:[ZL4!-<OUO6']Y:G+R1ASX?';T9MW*UY>\.9PWV3TJS?G@W+W*"'R^>
MX?3J'R]Y=@=S077Y:EG8=^N,2:>@?LUD_OF)>#F3?_YJ5-KK*N;IN^4-\:4U
M<W<?_K^+,]*??_BG\U]=//N;927(^:OY@F:+;2'LLCQ%4)'_GW_NXWL?;K-\
M/%2;+:L_7N+TG?/7YQ?Y\<*#NO2Y51])%Z]:_1[82E%G+)2=9V]J+JF#YW;V
M]?F@U<^<OBQRL7=OQJ,\6IQ:G>_*Z*CYBU82?.YXEB._?>;NF.;SO;J<=KW]
M;C3__B<Q$Y],Q;:Y0&T?T[F5.S5CEU[GPS/\<#N#0%7%Q&RL*Q@-9",>6SF(
MVD:T02/Y=415_Q"4VITN>+Y]S/*MW#H"R]8$8XO+42/X4"0PT:P9G;%$P&4=
M@34_F O AG4$EBQZ7[+/Q@)XFQ!S$-F=8T[BI;->1V#M#]JXC\!:O8[ JII5
M<";6"@HJ(N7$IFIO',58S:G$-<I;U0,]<KJ\8''VL/R6_7BBLW>N]@2:Z%]^
M_>.EO#O]Y=%I./'3V7J36\^>;I]__/RM\]?M\Y<^35\Y5V#59AW UXJ*%9)5
MV:-A1WP6,!CM^O4T[7(IB_O&ISEO8=?\=P_TC,[+-__R$X7DJ(#$6[IF,&QC
M<)DJAFI\L(3FS/"$,\/3XK6^&9[Y;/'1Z#S@Z<&,WAR.).@[-3IM7<ZMA[?_
MT*Q<V; ]&BU&!\N%,>UJQ_/3TY^_^UB,A,2@'P_Z@C7[XF5;D?$C/J#Q::7Q
M!POZ^' T'KW9F<YFH_FSI[>OWVB&*QM-.70E1O,O5.?V:IA_YC;^VC"_:.BN
M7H+:JR>@O^4)?.HV/M3'GK]91F_EMCX]=)ERHL5T]I4>YG>?;[_<YLGT:#2Y
M[+17M;,73O'CQ;O_DCD6,\R^&D@ $5RI:$$PK]%IH*H-+\VQ/M>!?2' !8NA
MKRZS],IDEM?*V;;.-BCQ9AK01$LIDA-]$&(Z#8S4^7-3?7QNZNK/3:WLN5E#
M6A63<R*$& @#IPH%;((J;[FEG>G+X_K$SJB565H0">E%!162D+K$)/(<Y1?B
M?91QJBPEI<;>/0&-*WL".1<'2N+-9 C::(E1N82MF%2+,5(W]P3^JO+[7<AY
M[[_';5'6].C-="(O/Y-HG\2>JU=-UP*-,1&3LE \)4#/6(P@0Q(!L:J5W=I
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ME#QK"=<@Q>#0Y/5#]:8&8??8JJJ=UFPLJ@C)5-24L#@? J+Q$=8/VTX$2_=
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M"%%5""5K9MU_^;-AQ&JU3]OTP#I*EMKR*\?H4VOTFIF\A$NQ#IT1*PR4+_%
MS[G-57*Y_99G=/ EO?NW#<6+B&MR.5?;]ES'G-I>0KY-?'F)Q!&'[H@V).N!
M;[/11!5L"1*^ :!.F9BJ]36SMLKYH9/L)I7US5)NP'H*E*JQ&!O9@1(_&C(E
M%;#:UB.=T]"]YX9S_7.F1(FBCD6[$,!R3-&FUI7?*:0(=0"ML0:@X<_3I_<Y
MS<[RI[:_-NE#+S8^GOVN#=MYB^Y[SYZ<?_S*;=BH<"T2(+)2%I('-+[M7:>6
M12%:#;X6OH-I-/R8F]^AGO/JHJ_#@H(0)><)7-LICZB(TZ-L;# (&R[\52[
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MV+I(YI)T:1N&&X1H-%:X".]F]-X(O*L;O6QRYJI:B6,"3:*%@^AC\%I<>95
M8@FO.H=7#1G>X[%@J[$3;-75L54KP[84CEXY9RHR4+4M':Q9"<(9T(#K?]JC
MY9AVZ8@_@'B[/:#'/*O3V1%-,C^<M#SLZ"U?(1MU=2+]<;+E_)"[TZ.CZ61(
MB19O8XG:<<$:0%!/PHR*,LY+JBKZ >3 +B.#=MNC&>?%=#;?,. +#$ Q\#:D
MMA:609"7:#H8:T!, H&J-" =_@<YZB<\7\Q&>7&6 GTV&2WF3YX^6T?5;9*
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MUP(@FF@MA60-9 #444RN,82BE#5Y3FL&8$\,[K5 ::N-CH+6R0B4%HDA&B-
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M.J3^2QO.WCQG.Q$-;4L7YZV86&W +WM >M(IMV[=5-*0VDQM.'OSG.U$&X2
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MIS?H"-P"(]=D0BNKE5*(4(TX_9B3+IRLXU"@!]G/X.B[HF!=81J3]U1 160
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M+:(T)5,4@=>2,$$%9'!0D@9T$!67)8TLEY"H)8H'%I@XA80*Q3KF0E"4BMI
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MUW5Z,]X]VNV)_1!O(S%-H= FGW4I$M1D;UK.)<D]^L$%W3 >J&0E1* N%$'
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M"U-Y0N/=SRU,S5_X[H6I%)5U8)/S6H&"DFR!H"";$HVM+G?WQ$9'I;S ,J$
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M PTP# 9HX<S9C,88E[W2X,&2Q5+88FA']!*ZD].9'?1XUR3^[W*TX_W]2^5
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MV@I!\Q4/[4XG;5P7J;GL+F?7%'XM-I51W8@&+VI9W?GGBMSB5@5!Z03H44<
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MDHCR_&4]+9,H446"],CXV^X?YUFZHCMD>77U70:!*@.U7!;Y$FY2:9XUC3_
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M,=H07*BTUOU?=E_%1*XM&T:O;B 0GB;:[YLB.FN.?:VG[M<>[I6#N[U>LMN
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M)3QTZK0RF1283<:JYE1;Z5KU\4VE%-7,?;]$LR<'R":'TW+\X3I1!$B52"R
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M',"_ZZ0@$0C3O,2NB/A+BI62&V1I19XZXD3_!AJO"/D%>!8"WF"ID)/1"Z*
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M%<^R". _,9F<9R)RP-'< Y])=W<;GMFI^%WI]>2W%M],A;14C8O<%["=[ 3
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M+>I(VS(%AF5-!QFFG\<MFV$&(9?GI*G4N[7C*A;@T B\V@(5?B<O]D=.HG.
MO<ZS F@K\Q3=2 KS=[V]M*"TI\LT86-+%=-$C@IS#EK^%O=2[*? .516PREE
M\-<[('GC[H-HWY:X@!E\3HG(N%GBVB-&D.L\(.-\F* &QA.BB*I.FT8K=K/"
M&)XYN!SE$4T#\3E+]Q7) PR,W;)&(>G_QO-5I =XYT\,ZR1U-S"D1S(4;* 2
MG,R*A%TC&.P;BLUB!.74CRW@F6I 1=AUIRS-?26H[;L90L9L;N257K$6:97-
M>8-OO&:R:=2.]XE/=!M7/X<_86+( /., ?;MQ? TH"U+8NF/CQ>.N;AQI-SL
M2FQ!\UA/A:"ZL'4\CN&,.3M9Q1FB)-FXK461L%_LDX*Q$#'5=Y(*$1NF/\RH
MS(W1QA&4GN_D@:-6E8)D=S=&W(Z$77$>,?$P),B=/R16G3,[WJX>%[;(U_;4
M35=M)UJ9)@Z)'!^S/)=J*!NA8\)1$]:2,%Z>M49'/-2$VB'?TAT\&U_< 7?L
M+7NA)*_FY<NY1+S% V%TBS#IF"V WI/TV$&HW!1=C)I6I57N^=:4U7)6DIEB
M2#8N+R]W%/EO.S"%?RT:%_9BOAX(A0-VGR8CH2;MBD)9K>Z8>L4T N--A=5/
MPE#H5TQ6.8&+)4H#=F>E0S&Y4$58I]?T9+M,RK5@FFK@YMN6+5MN117G:9+C
MA4T]PPV]O79#*-LF6B7&H.+N"@-RK>U;N*'[AXK[J8^#SN#)F3;=P^%EI!+/
MD:F;<;0?X0\GD+S)^K-D#K9P02-]>UNX8 _&LH4+WJ?1;^&"WUQ-=1]:!K7F
MJ7<;,H C<HDY+*3FHEZ;:*05U(*2\KPP\-EJ$'S(\LOA/+^D7B"AW,2V7DE\
M<V$IYH)MNHLF\]II3$$A>#*EN[PD'%I\"ZU*X1XXE5XSC:$)6\A-S\VM7?C%
M[$+FHQ,"1]MLY<Z9O5I>%F9E,:<2<_/) 1,Y2N\EQ"VDZK*4^+WK&,/!C";]
M9]>%4CQF$"I&X!RDPX-)(A%GO^+,6S[@+RMYHG8:3."/)?BQT,TOGCAHZ>=*
MJXG/&:XY%-LY=6+S'*.2&]P3FM,GS/:='S^0Y%W$>KS2H<$72"I]T-E!] <F
M34HUK,%)4F"1W,#[Z#<<C_O0 +'P@,7 BH-^O=4$8UY1NRN?BZG0<YT1:<F+
MQA@E5* 'ZXQ-OUA8,_7.0BQOGJ4K.LD0/6T(H,YK1+> D>!U8:6@&P8I$B+-
MD<Z\' @BO$20VKMCV:6"RWTR,.HM*Z?N+20CR2XP2$\A$?,@(8XR B/K32'-
M95X)<"7,RTI::2UTE+A)R!0'2 W[7A"I!16=<C<?^^ZN1_D&U;CV)I@S-\D4
M2F)KRVEH0LC./L"+,:1(';^2]7;+3<';,(235D2)"'@GO>,WKA<+M*5@,<Z]
M$HN3D&*"3'T$=TKN./GYN<3'$V^W./0_H2QPK3F$0-'.RL!JFHOL2VH^!0=?
M]!H)+HJG=/-#:U%1N2=H $$>4:.HTMB44XJ<<_4QA16Q%CS'>/H*P]R4=XP(
M'H2_#<.B1LU(FIA*1#%#61)&T@]E"EZ)D?=)$=8+T^P0NX;,"&HAQ=XJD]BM
M# QT)-$#8AL14!^L$@A[MS8N68224IZ8F]L\2::;@<2-;0)G+I7*C=V)->ZT
MQ2O<D**RN?,&1[N(V&*99&+G^#2!<Q-D:B='KM^E+<9SK/(Q)1'X<O[KB,HJ
MK$;R.S+X^@(&I$Q+EHC!HC*WK((D!Z*P :=R7@'U+RQ-BA;%RH]\#2PK)^9P
M;,A]8'57<P1N9YC(%8D%%F/%B+>\2U-E?*/6!2>V)L?C;;X7!A;1;%.'$UKH
M.*'-CJ7@ P_@R$A)[I52<,* 7-6/*U^9^1ZKV^HV.4W@G',-]W'5"B\^\GYG
MND=V#"RTZ\6I!^U"I#E\8K-#U #FC%).N@(M"=L3S3K.8H GNS/++WC[X@E*
M/VB-G'-6;J#N308;7L41DL-0:[0;"&5JLHA8P91+GQZ-_CIL9P1RXP0ROIP@
M;? 2V"DHF_7#=[Y.1,CH<$5G!-Q#M*S8P[17#:J!*K-D*1XWTTE/Z$MD!.?H
M"=*"#X*_6Q$S>2BX8>.BOX/Q*9+7><G1\'\X(0$K%PDD(Y<30Q:<I)J,L+@&
MFY[8%8GL$4T'N/B<C25YY.YC]02O'>\_CIZ8SCF>V%J11<,7OAX?[^YQWF'!
M720>XP]$AOV+W9F.!:(Y%1GZIY9DQ_F\Q0 W06.:<D3[DXYIJXIQ?PV\E\/C
ML<K9%P!9HP/)ETQ/%$4,W19%V9RN@HNDY&J?5D80MM6]D5S4%_[>E2,*_0A!
MYXB@EG+@"2'$'//4>/Y-D30$CU0FL"!Z,1#6CG9%.5'TF@1KQ&XAGLBL0>PL
MRU[R9WOS/'JI&6+:B%<RD<_^:UK\]=GZ[Y+HOQ_=(/1Z_.A.%FURHW/4-HAJ
M=(CJO[#Y\5_&,:_%'Z@-EJ#MI<4WJ1,;OT56%,+<,(8>F=VK 9F:9JOC.<+V
MEN)8L+&R3$(V!ZV146D)\;W:%CC8XYK!;!P'CN%&0G0I"@Z5Y88!$O@6?OU[
M7L/NR.L4#4G5YJ<E8(:A@4%<=USC>+N\423053; U^#BD29E6$0S3'-NW>T9
M&'*2>Y"'?G68N$8A-92&M4J:[V>B3@30) O<V,[""I!SH()(HJ39GV<_MRJ)
M6 %Y3[#21A9_@J<"E9KARI6RR!29,7+"LG'%FL!Q43,CSF6.R"E3O2('H"D@
M&1AN</F<WZUL?VRB'6M?\-NW/G0M^]:^,BT4VY]?)FFZ-A9Q%]<NQGYYX(:L
M#Q,S,EFT/L@B_Z/KK;!,8NU#;R';E]=)1!P-K<^9\,RRK+L%YIE'&J4$!%<5
MF.+)N&&$65"F4O!6=6%PLC&ATX3L;15$.<D&^XI434%=S-$)=.*2N]:)+#F]
MWWU8U@Q^#;S9#$Q.$!PM#'=X3F\4[P#%18(>*3P-/>04;$NT=2\;$&;*]DT1
M4;PLN"!?@%>R;:V,L;(&]V&QM*$W:HJBC2\ON]HH]^9Q(MT4FRJZ=4L#HZ.:
ME@LM!%R@)$)8-!@#FH2QZ'L"</OW,H<-O"U9E4G,H8Z4VK"XUT#,H?=(?I)[
MQJ!]1H5T<C#UEW^BD0<E 1[7@;-YWDRU*EC?8Q?*A-XV6*%D"\O850J*&)SG
MFJ-)AFB"5J>0 A/Y3%NP7&FM_4;;=:/2L&T)>#_3O#!;D2)T)4?8V&%X4W#I
MJ><X_ +_<!P./!E4T\Z#.-ZG0)_=GU[QM1RIN*0#CZLN7;'9R;W=9S-T37'6
M>9I#A3JYPTH VR!$,+ ?2J)36>QB@V'R:1M9.KWR\ &1UURUDOY!S5*T8/8+
MXG*\:L=9,YGM%6V+ 9BRKM0=<V,L!Y;H2U)I%FF/D,FFJ3 0 +'4JLH<6H?-
M=-B24+.O;4U3BXZDGKE,,)BX(72H;5^(]5ZL+J'IQ\I(^&;-V/!A<S.X8DW>
MY]W14#$@:>ZMS9>FC3FC^4(4 .9X_EUK[I2S<H_"F]HMUFP@FR9E)8J%Z2(J
M63$Y/UQX% $$RXAS;E>I6GJ92RT6[P<M\@2' #GT^"_60R\K=ILE9L58AU3<
MYE1=;DGX[)FWOT75]6 L6U3=?1K]%E7WC9,G5^WBMW2@<\4F4YY02RHY?C^'
MQO].6EQ?]:K6IGCMBE[H]7OD677'['[C(WN*U8="#!37:4"DXV+/NW9^".*(
M9"TY,DYVCHHX[F6*J9CX$(T8(@H.#;=57<"/2G2TP-]*\L(W8PGYS[84D^F;
M<!K,=Y8ODK#1H5Y *&3F, /0%TANFH0E1>/7DIK]=Y)?-[B3+-#.E//9NHS2
MIWU?<F4]Y_RI2W?*S)G8-XT:8L$R+I)Z$6 GRL@C6^P7M.05> /@:^1W"1P9
M]&Q.3D$:LCE8B-F=PFEP[_=K8LX_Y"J]RSEAQ-8-]*8FT)MCDRT%"V=Z.F#)
M?TX=>86*U-X-X[9YP4$0S*9A+ RNRZ1A6?>SF0'(Z.GFSJ<^NZ13V7%;X!,[
MM;/3ZM@BUR%T+)V2^1'6V7)Y(N%ND&@FYU"HO<2%MSCECW6D[K;-UA*-$T*"
M>OD4490(8]KPPD+$R1\LI4FHF0'JQV+05F8>I%B7_>H4JWZ'H"U#2C4VE:H_
M%:ZEA%N:3D7L8:8HI(OH_L24Y=JAW8_CR M$^7008DG@QP@M8]8T$'22XPV;
MHFT\X#2J=/4G"V.(B5^=48/938+)"W<KLX7[3I3&B/!>ASLG:Y8)PSCM#"A,
M]MF.<V8?<3NL=6&BAI/"9B%BX)_6LK-)QH9+[@W)B#XC1[Z<P61,D?S#L@P6
M'W1EI]G025[H3L&K,!RCI=EW]X81O&NLDA3CW!A+Q-)M4R[I?>X"PCSK5ZVN
MF_.!87LR TLN# >V@*Y]0C$6=DLAR7#!4EU0RIY_@PV31&'J<O#]&HT;[7^*
MM[8ISW5E"GX%Q.\MK.FUXV_I;SJM=E!7!KK[-/FWLMCE,VUX$\0BIR6Y:)0K
MX&X\[UZY0'],2D/UZ^4'C((AQFID)*Q4B:D'VB@#^[7CG1V(#J$"!V[,Q!WG
ML6#<\F/S]G34[KQO$],CMU% _LWLGFL\HFM$.C$Y"W_"1= S3-C(9=PNB[L
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MG<DXZZQ]X-99<W.*QX3-,=$5SP4[+T'R3H&F-\PTFD'4!&U=3UW%.-$$0=Y
M,]U<#W54CW7HH\\)X=Q'Q62XUJ\T#S8=K'Y*I%UF3W_/5&EM ] &O&D05P7'
M9,$P8FYG7<Z1XV]&3;[<'C";?S%5J;*L,-3T",GU%#$Y*N.GOO]0( <A-_]!
MQ#\%^/(BC2Z3IM4@-T_5BO'_7D-U ]XU44V3%39R0=K9<*HC[;JOG?S^(X.K
M3G7CYOC'^N.XZ59YVTFX=,SH%&@O$/\%6P*&=]3463YI!Q;\2O>N%497-Z24
MJV55]/N@2 =OKWR3$FUICOU_D[ T;C)';@4[B:[3D%TG4VP#MR*LI.=2%HTH
MA!\K\,&R6S"8V:R'6S!8#\:R!8/=I]%OP6#?ON>DK>5-V@PH%$^M!3?!_4&E
MV S/!6G5PG99ZP#M/#.YAV!Q08X0!^W@1;#47V490I1ML+WWAEC# _(\,ZE<
M6HN]='ELE.^DC@[,T&]<-&L3XW%Z,PNF7#=A-JV 5[V+?,*P^CK2;9.]U&GJ
M"BSB=L"B$5+V7$AZ>_-ZK;<B5@<]Q$^7J6);Q*=ES]$?M065!*R'S01&6&G,
M"P*L+Q6V0#0IOPT3(85C*BE:+P;V*K>"-*-RTV6L,T;$BW5&WF#CY?LOF9LJ
M[+$_*.- Q(*V5CP%#5)]07$*ZA4:&9_?$&^5E>/@*<%-9_KP#O(=L*8U&H9@
M.3-6T$0XDZPC,N5SC+1:LTHF61)SA&QQ(\!%9'[J1EV,C<88V;/O IIJQCYL
M1MF>LM$72X@+0(R5].ZX;:Z?(@?65+;FNDLH^%UBV"VU- K] I1T9P(V,=D4
M^!I49A+#@QK%RBK$76<;( 3E@GHWV6J4#WJUR5]9DPWV]LSAX7P8WNK8T.VC
MI,"<W\C@#QF&X>,W=Z \I'EZX^&-<V[SH[_?PL_;41T1^12'%I-LS@1Y%(F3
MYIJ=LM-4%-]$DC ,;W,&#&3A5(+)'\ BK>!Y0]!V!$>&8Y]1]/"BD48GW?K3
MG@QRXI>$H13$D_]J7N+<!.]BF_.5-NI>.P+O.O^=/TE^F\_K9*DJO#9IWCO)
M(>E2)8W'P0UG.;$\%L[8\PF2&D.W& 5'WV$012LV.QL9+:_9:@IG-+V$C<8C
M:%;B&G7FTV&ZH-'ZR*A<T 4;\=U73V1SMQ6UMPP$=/'79,,D#CY;,-T1 N?N
MDI5<I3'8KXJ$E&_(X5X,Q2Q3SK27 P8(4-8><8LJD_X1#)V18C[;?=T5!G:K
M4K0"W>MB;K_  Y[M-3_>?+4X?8+DM.Y_U5:_F>!O*0(WU^S[+"B7!;8)1?XR
M# (CO2-UO@3KNU6HCTE>#+M*\!E6D+IXF9PLV^',O73[8'WGI/=_HC="]9@"
M5]J%PO]B:D8BN3&Z*XC?L[N(&Z3B)".<SJ#O6FM!S"P8H8\EA<*334FCI+3/
M,)FQ%O:YU,39:S2 O[!<?Y*V<@UK"0:?E->#^GHUPN7 !X^8JAA##U P*T^3
M-N]6?*(>8!#;>:%C@B4S)F$$V@K63#:K#U;RJ4>Q0^A"$ <?L2Z+?5ELOR.>
M(A;@X!H(UAWD/IG-J)H*9IU;>VNO4&)MG0S$R5LCAC)*;09M.LJ+#2Q@#495
M^XL:I#D#];Z;C;118TG#,HW&&!UV3?6%LHB;K,D'\1E@[V5=2:KL 9P#FTNV
MVK-*C>[SPC>]6G4B=3E@T&UCNHWV%\5FH.)$EF&0-=0E2Q5RX"_AH6C^RW22
ML4-:BK !68P[(#*IP&3*I7%DZA'\42)0EB$0WE:90BP767!99-0KLGB#8)&4
MQ 4DA0CP2]33E'D_L3^1-Z0J*_,9.#$N'2^Q$JK+>8SJ@KOS>80*6"LA;(N@
MQ9+*&)I>J9]@#;E,A[33%"^O'5Y]4SE8@MK%Q&O(CI4A"X#5V&QEUU.XH21S
M,WD<L5@]8?0U_,5;B&MWD%UIL+$J9(%RY0&K,!(G[/ ^%R:UGVA2:ICG"2[*
MUH.(_MWNWVNIGIL]C;V5E3H9O4S(897(M+BO7J@.E^'T]3_.G@_'Q_9[:<"-
ME_!2.,3^0JN2R@.DO-##  [ MX]PW0?"#X>_27,T')QCA[>:F7@A:)Q 8V?P
M4%N"$1FXE,0Q.AV#SQQRQ]JDJ"!';ZX7W[%YWZW6T:63%1]T!"O\N$NC.#"
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M85K/KYRBNWRA.=JK\=[.%4;@\T4B9";(MPEN#'R=1:FQ.;TTE42W&#E?T5U
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MG5F20(/%'#"UI3%7),A+OM*:@>2U:&1V5&,W.!X5K,GQ6,316B)0DNX@%!_
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M3)BR1>9P\.(PCB:6ZX^ &U(\ZX'A4N<[W<S"$56PG,,FC$Q'G#6-$#C2)\4
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M&L[#MR1ILU"WW?XSB[@7@^^JIEGD"N*>6>QKAG?H2/_\F'#(Z!9V S#CZ"3
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M;G3[2(PR,/^WUM,,LYQE/D2QY2 ^L)LE":+]P?*7C9(@ AUK$ OGNQ?=TGW
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MO#)ADY* 9\=_[4KPGYF5I%.1BIJGF8PDUW!Y/I)M^<,-,X-L<P,L)LW*3_)
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M1)6XI9SJ!*J#YBO0(C&IV#\RJ'BRA(I,DV3L3VE;WT1!-A&J:'4Y68B>*U<
MK%#8U%R(!8H:@IJ )3V&@</W8-+9T''3+$:SB8O8J2*>+T\%ZF=^"E]+4T8]
M0;=0/!*;F%,[6H_W)J>S.XE)9RQ-]R2OE3MH89;T ZY-]4ETZ<3?!3M!'&_B
MAWZ2QHZ&@P'U'XX\D!W,%P;96H:WXZ#;Z&PA%PYRCPJ3=RGX#+Q;+L!42%=!
MDD2@Q*5**,.7JJ7[6A?__G2U4PWG:I:@2CL64H=@M =%_6I1R]ZIF<"\-1*A
M0' C4 JG6'XE5)B[8K3:.>J0@1FUB!%%)_PZ6%$K#Z4"Y-0^B]=/<'ZR0U(:
M&? ?)4([O1-3M2H_>"1!(OT>]LBL01Q#SUK.VM6GX 46G8"IP^8-6Q/H5Y S
ML$F)+!Q,75/5:JXXSGWU:JGU%!U>])6)DRKT$#X/I?L CR#TR>>7Y$+I=\KU
MEN:3O(JTY]OU?24GF3XSJWFJ[50 R5,-: NF"KIQ_+]87:%P\Q[P\U;IM\J$
M Z[%..P-;&+<\J_;=J=S; B1$Y8B=!NK4A@UHN 3H=Z"A,V?+@;9-"C$(M["
M0;YW)#L[RH!;A&] OH6'WACBQYSIJA2S\B,ACZ4MXO[P;L7=2"\G9]^]H'KV
M!@;F<QS=^(ER3N4>+)JY%H;MHW[.'>WF$L-3F7JJ:EB"()4O1\X_"VXS;8BB
M8Y5^3V$@J>(*O&3PB;0BT2Y;A?:Q?YZD\@7[0G@7LD [QYE*T]@?9%P2#4MQ
M%L"_'7) ]NRC?GZ4F7J#W3X^,6W6)IQR_W?Y,;>9H%F^OC:M8"##88+"86(A
M'$;'IE0$[47UA5]J%X>V9I&B(5+\-;0"X!Q-](&3^*Y$.$6(#L]Z__EJ%?5!
M'SN!.;+;3%(>N%\2>_Y8WV1M"2-5L#O!B7'V64H0*"LQ2JK"QHR O $;']M'
MW789&[?;'4,V-?JK1-.G=Q>;+[X>ZII+WFT<=XNKW8.UMN?6VMF$ -NM]<O#
MHSE:CD>#P_6]O[^Z&_>DUWM5@]B\5!";ARY-6\_'9EF+FWA-9CU^M5'6(9DW
M>=KAXZ8BM=:*C>6^C2_2)P$B\U?EW;UB+\0&*5<[R+$JGYA"QKT"JTE4Z$0N
M'ZVF^/OPQ@<M:C.J[VC05]D$AC);<YQ/ <&]O)?,U\950[LQ_= #WHS1#L+(
MO6.%&0$*@I32@0W25,0('6YCL)X$V:/IV$FML7,CT*<$@V%81 ^Q\M!$UXUI
M\.&),\.D%=A;K'JL>()LISS0I[R#:.'R]HQ"^)EL]"%H3W E-I1KI2K@K_@B
M(ZH/JJ\O;C@O]S]D:8)*Q8""^:S !D,302,[8OJNM- XLV 2X2\B=?S Z.YA
M<[9-ZXQF2W_OV"H^?2>X5,X4<YDF_?FD[-;QSACG2;-PRM/"3=JTNA+$3 ?0
MR%9'\UQ@$H@!<XY7!C(C5^91D_5U6J_+(ZX+VC.Q+TL=V-6<DQ[=)I&T2= &
M_W#U^?K=F:U"M"L>/.!?V*@6X3"*78[A<_U#\L:02P,A0ELZISDE*$LSV+ZW
M8*3!17MA%.=G-4\\)D]@5@86-X28UALQ[?/D'6VJ)I2K>RM@E>"_IO\3;D+G
M"29WR+ #_^1,IO7N?LJ5'#AZ<QJ[%82M4BNR1)C;:X1MN4B3@_6'/_,PTS3V
M;RB EZ"O0?K=^)*83(-H!MI!O9:/N9;L<!H*#T.JMG1VLW/*A=7*ET[)6*79
MK .<N6QE>MUZ938[0Z.P$$I5-0CSZ0AV,> ZGZP >U$]&;,66]QX=SQ.$5T,
M=&#X+?;_HDA5@![V9"%M;^%A^*;Z-ABBWYT1W LDVGY[UTRTSJ&;5Q66\1/9
M7RG80U*'AM6:1"HQ>WX)ZY5Z?$%<IB3)==#1)##&_20PTQI'&?_S%/]=K](C
MKE)!E>'PH[0T:SWED4]#E$$DN_ D@?]FLB0O$#<B(!^1"TL!YYI*2KJ\NKZ_
M[*H79XW%R<.,8@A&.6L:ZOA UU\<854[5NNHQ6%QI_3_1+AI%.>V@9%,7:JH
MO$&?GDJB4 <;GV@W<+=R_.&'LJ1<'Y%%4(:/$+.PLM#',4I5A[@,*T'3<1QE
M(TQG\V/O$!-)9I;GCS#3S)J"[,4NH36//2J/&9X Q\.D1H._:)6L:1;#30FZ
M?L;.C1_%NE0(GQH&F0A=-DAOG-B/L@2]WBDJKTF&WM[$FCAN' EX833Q77PQ
M*T\%?L0WD<!_8Q=KCZ0]ZPIKY$QEZ3X\._:GH%>C#UPF8RZ= (P#V,X=RX)_
MR@Y@5!#OX72QFM?6X#44#)@@$<RH2%RDE'IHA0YY$!%M(\A3P5%>C**8THUR
M-C&?\_P$A)\#.L-(%.H@]8$E&4?[P!8R,,BTRFN6#!-PSM>--P*3!/Y0QDOP
M7C\,HQO*MRBQ&!7SB\,;9RHKWBG7'40AV (AYE[B+37K/<E1&@2^ZZ<(Z^,Q
M5M'\SM] QU\ ^JF78)V@4H3I&3X!\5!XTO1"TT9%'_6\GO$GV&WX]US7L*62
M$SNW.N;)QP0*ARC$C8RJ1$%N+&_563R<\#4C 18B[G^7JB'4:57]M+N+4,,=
M47"6@S0P@Y#AL?+: 5"L0+A209^XB8(;!M8I/_YC+#H75()NAILY79S>-A_V
MYGZD Q%0;)AB1XZ5^*/0'P)-87GR</CJ(QL[S=&IO7@DH/XYP;3N:4#3X8+\
M!7649'<\VTQ4%YXND=E4N7Y&(Z?*FKA(&8(.XU6@=%K#?H*KH-P$68(#D2HT
MO>)P&(N%H<%Y*-OBW>39_93[(IV&1MB]\LP)''$;Q=\I4T&(5 (!;,)]Z".P
M4A@3ZIH>FJ?1E%BX4)V,_Y35JC*5-^$S'W_(7;8@0XB&?B@A$=+$]PB>P/H:
M^M2Z*R6K2MDHBH.D0L R:!1'M_ B*H<5HZ*)A0N&)1;.%%U.,5;O@'Q#N(61
MC+OB]VTK,FL,4"39; ]Q8KU([H$KLA0V^<DJVW99!70C0=VF3@*<=1MQ9S.9
MH*Z<?3?"=/9%("J,DJT\2P6$671KA6+DS%?+2!90E212A$A1A:+P/,?&R$*I
M7J8SU0\^S_VA\+H;<R4N'V>Y3.'?U5>8P\%"=H5=^EG*<@9!29894#XO<)%%
MZ9YPD6 H?UJ-]D^KP$OR-JBN@KB  5'K9\NZ6(4+8NMQZ80H_GRBOD]F8_<G
MT,'_S(1N XN[UKA^]).%^D*6R$@(#!\G%WFZE'3N=/]P?C:_H)$2F1(H#Z>
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MD.4K'8_?M)R#;SZ-I*K60"P3-19%J\M[45G.*."!=$I!!0';*8]Y6U>YF[L
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MUY>T")UI\)]-4KLPH8S$T K8QSC]KI]EKSZ59]KR1N, 82ZFYD4PWYY(5-?
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M[Q4Z</0>I9$6EW39;3A,Z('E+9:<"D!;)P;5Q#B"I)XZN&#F=$_W3>"OKJ8
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M#[$$/T2J%9]]$35EB)MA,R5M*9MTGFV T30+UE,0K(;1@ V0J^R,R%=O=$[
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M"_KU)U%ZN9;^8]?2CU=X)./2@4_=LK_XWGECW)M/2\>]Q?/76\=M7@&$NR[
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M%.)XE! H05PO3*.Z:X(+6SL"5CU\F6YFNED#NIDQ8]684:&?Q%FHL5' *8$
MY38R3XD@0#@HA9SGG*&(&0^/"J@I_ZP]6RE5K]9 ?VUUI^)P+]+2!--\'4A+
M.=\+42@#S[V!9T&T)M&,:PP=,$AB0(-R0,7U!TA+28.0$7[$U@Z2O,ED);OQ
M-IJL9*Q8"5942(IDBC('!0@,,4 -YD!QCX!A%CHA">$ILAOQ*E9D3]U:Q.Y]
M?_ Y%:PZ&_2M']Z/H#1!0WIT@C(UR%^"3IKY-[T_Q_,>4><PH\Z]4&>!\XY
M:5U 'DCD>3*G8*!UX,#'EQG1GFA#MG9PMJ9D:THM"4K&BI5A186A:*110#P
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M:T>T$:J6W\WRO#'RO'3E)LOS6N2YJL,(+970$#BM)*#:$J!\LM$[;"E#S,B
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MV (D]:25J;:( ZRTQ5Q[2Y%+8HWA@ZO U""-JTD:35+T4[4(KP>=BZC')!/
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MSU\7VG-W UQ$UG=IRRS7$(<K%<PG>W1ZN[WQWKVD.C!3G9]3G=,%+1TQHT9
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MF)02$"$\H)0HH!EV@#OCA'3.$AQRBF6&P R!N8#M9D @GH= ![GP$AF $9&
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MB 4'^/3PCO_JG*>Y_+,_*"W%,RTTC_H'_5X:V:#?B0_TZ4TJT.J'HWS@+^O
M/UP09"N#PE KD8)L4UZ )4#'-0:4QDT1..&6B*T=WH9T46^[IADV<KC>4[!
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M!H$X%AAIDQ3R)CGL(I74 W)(>I-&DH5I'V%<K&@!M\[+TUH I1)XV0>D/37
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M53IPHS-=.V5C\-SV>J>P;/_8]G$LT8+%V5=;LRFWU'CCA?&(2L\0]\HBDY)
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M0@<@UN@5AO#LJ-NO(QQ/>[%M!ZVO\5FNN(?H6I[ ]'+9?LP/ ,E$;N*76]K
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MY&AU*[6\A5=</J\3>&^M[[9;A[6\@'?5T8N,Q\#77=<&*3Z4$$.X;L&".H"
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MFKA"V\OUD?8\M^?Y[G2"]HS?S1F_F#OC.G;'=C%<'Y0#7<$1I&%I$;/<VWC
M"W^%S?%X9[SUB*[@^<D5Z$_7\T-OX_E9LN ;A\R;8ZW-:UI_#[OCL>^_"^&O
MN&3>'0PRS]8OYR,8\&@46<]:6+YS5U 5Q))24*=(0)Z58,)A*Z,2QN%/K6SI
MN/:Q</H9N(*6P_*]JGVKQB9:<'DL5U +/H_C/ZK 1PN#"T\,\IYAQ%E9("D9
M05Y9;@5C& ?=@D\+/D_#YFPUF\UP*M69XD(+253L%"8$XIX;I M,$=441(V2
MD1GQS@S.]H _\ %_\12\2BLB0'O2;^A:JDYZ609'J8UM'2+':5 %,J4W2&!+
MK;#P*F%;.Y0MYB8OD%8\Q &_QJ-4<R;!./W5F-!^<O:3=Y2KE0$0+_'9S?O?
M-@H1E^1C-;L.7DJB\-2##LNMSXE<?S(V0AN7>FCVHL=T?S;/YKLPKSBT.L%:
M.L'AHFN!"QNIS0M4X((@7I:@$VBK$!6*!%A!I:W>VBG9+52"]L ^.* F3&]Q
M=;.7Z5%,LQ97[P57%VRM O!3$VL0XT4L>A(%TCA0Y#$UAI2!$1)QE6X&KMXT
M>%_56544M72AU.IZJK9G&/9O\%XU2/#79+ZZ[01O>F7L;4E:[GQ^-D56W#I(
M2#0-TG'EC&:<>JVHB\T\2B8Y8$Y@U_60:2D#[D]0V,7$@M*94FL":C=S)>(2
M9(3Q02.PGTHKC)/P]C-@SKKK\_I 48,[&>_*= <MZ+>@_[B@W](E/+A F+<<
MA%0T=G>,';A9[$0GD>$IW1_,/NN)H-1FYB[)6XG02H0G+1%N2Y#S;"7"K=-U
M6@+=34;]A2P<$;R@AI<(*P!\6"..="A+1 @+098F4')7S&$M\+; VP+OQ@-O
MJXH_."C/J^+&"J9)25#!M,R^&>F%1Y)2YIFBL)SB4A+=)XK**13PK]2!;N?*
M_G81RQ[<!5^\E-?6M]&KZMO(==1&]U.6IU;J53A###4('0OCU-W<2+K7\W9\
MKGN=L^'@#%Z_Z QSKF1G/.@,4@^3\0"VE1W$3[AS&UN8?#WIVI/8T!=@ SZY
M7C-R6BIF"3<EYR6GV"NC+&QY4CKJM'5F[5R._4$_]GA]-_Q3#\?5'XU'OJS6
MF#QOE+NC1KSP'7M$"T:DI1R98"CB-A1( JK$NA$=J.)>P&SN%$OZ\-:-H.%%
ME!KQQJTP[)KSM$M.M?,=<]'YX^#MQ_^*&^Z_!L/N]T&_:OT<42!^#G9GMY_7
M*GYKZ(_U,.)#_?'MSLC[SOY@[#ODY3T?M'3!5]TQ''&[PM'[90+(J3/H+WK4
M34?PSZ$? 9BE!WI$9)AK>'PI(C\UO)T6%#_"I'9FRK$;<!I[37\8^Y>=/8#/
MB+R=@R'<)I\5V/,?VEU\%[OXRK;=B]UO%WKK/K AD!XA$]U4#>VC(I\F.G(1
M;W<&YP"%_7X4TMW3,]T=QE;EG;$?I:[",YV'NY/R"-1+[<X7>P[#DIWWQNFM
MSL-E8+[=_^TR#]#;R3/]>S :/=N"K)O+XS<@A[\<X5"ZPG&)@I1@-/#8"HG$
MHHM@,2L<#;H(ZQF4!!<LM@,OL>."<$4ETT;JPF-52N/2BN)Z11<XL=L5O>V*
M,OBOM,3!8@J#N"]+I$#10K @*H!]+RTK'[*4LEW1VZZH\8PK5F+$'"\0#X5
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M#KO6_SGT_O0L;H>_XL WB+3Q20#QWJ)B5Y+@L&"@SCDM0+&+B;[6@8I'10!
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M<AGN\+#=>0AWJ:&33L&\.3(3E,4O,5FB<C_JF;PNI0YFQ<\G;P]"[/\3VS3
M'%R:8+ "!\(MB%*?M$%QR]:6K7=Z<S#P_:*U83GC(*,,XL0[Q$$) ?@3#E&B
M'6:LD(8'L#:VB11/Q]YXKES./P!<W=H0NF67SQ:N-@JNYJTD[)WRC$E4\M@5
M4(#*ICV)K0$959P9I:6*P315JB?!@-Q"Q@9 QBU;/;>^DP=&A05#3I18EM8I
MQ#3SB&L9D%*"PH^BD-A'DA017::W+K3>:%;T&V4UWRB#E\CY%%XBD[GXB*3I
M]U,_?*]1JQ=T]:#5+5=]XT#[UF:IM=08;$2I2>#&2SCD G!;4BH+(9F]N5FZ
MC)_Y=]WM+[9K;M6[VP#YQT5K5!H5X']@C6JCP"1E!AE9*D28++0L2U;*2)JQ
MS8LG30:Z+F _(!/27:N63QNE[H!:U&-'C: E];P$R +ML0B<,MC,OA1J!6OT
MIN#TC(K8'QR7%H)SAI0X-CL+V(""R1GHE@7GB&AMC"T9Q=Q'%) @9WZ^6S:?
M%AV>&#JL$SG$3!=8:*T*IKFTI:&%8;$CME3.>+Y*1N,Z\-#"P%HPL!@P)$H[
M0@0J!2D1-]PB(QQ')778L,):6SI03Y8P.5X6,7RDTW_+(.-2AK%U(Y#JN@BD
M>H(1R&6D'C?T+MQFDC<MY_UNZS=O-3.;(CPV,"Y[.ECJL&RC&_<B7PX7S=]
MF5;,![!W131_8>DDY0IY:JVB3N,0_9AL6_!%3^83,G_O7I@\3-CEIB.]86G3
M<Q( =UOT]"P$P 9&NEL!\, "8-[/4#+&"I "L& "# Q-)=(2Y($(EE"B7%%&
MAKU["&^W(-R"< O"&Y$[L H(MSB[%LXN.'(T9DJ'0B$K8QJ1UPY)(0SRA;4"
M<VL)2YW4[SAAX#%0=B5.]I:!_5YXQ3,U-UPN<HJ/3O30IW3TTYB-/NH,O8TK
M[SKF(GT@^Y$\?#SQ1L-*Q"?6/?@U$KFFH[_=Z0;X(B#"T+OM3IJ-2-8\Z+SH
M_I0X)@&=8#HB96[MG1K[85]7EPK=ON[;+OPV]&>#8<R)ASF!^^FA&\7+_+Z[
M^V>Z_XLN7+!QY_CF8)91OAY'E7<?[WY%[OW-&7R?W[:DC[PMFZSA*7FF.ZI7
M"I8S,C#KN OGF._UO'/SXG)>\37YG"N8W3\_A2>R^>\H9[O]<YW=&XW]4CT,
MCW.\N (3"N+_F,U@JK87GGY%&\#:\_'E7UE@?WPD+FE!YF:K\?-D.$W1.O;(
M#+W^@G2 P;[2O:_Z8K3UK]G#!N>J.8&7/?OBH5Q*+'W)=(1P;].1Q^$B>*:M
M\2JA3SY8_ZDW9BR=DV%4$/]/EQ184*N5C%HBXUB"ED@,C[SV6!?6'!&\M7.0
M^+D!+W^-RB7 [7_^2^\L6_2Y<U'I?P9,_M(18HWGTE*-0P&*AY766^ZTSCHK
M?,>[W6BZ2\T]PT4A&<%<4*.U(U1RK)E@BI7%UB7W*0A6FC.KXPV##SJ&*GWI
M70@ZT%!<MX,:L"X? ]97/&YO:T&< OKESYW1^2D,':[@&@+4Z;%.X'95PY#8
M/&$4P33SN(^N97%?/EM%FHLG0^).^4M2WHS _$JJ<?RRO"&#^=7O<=D.MAUL
M.]@TV/)!N/S9 AMWA4UK\4]O("=WY/K?[8V'75U)CU&B_;\EZ_^E>2+73K2Z
M1?K5-;._5J?H!U6C+Z?EOQ^[:XF]N&P(MW!CW%F+Z_58&-MM='6G@GLN-EEO
M$UU-D=9N_';CWUV[B7;C/\+&;UL#/?F6+8V.(VV7F]6F[%UR'3?BG^T$MGNN
MW7.;/8'MGKOC/;<)K;W@(H^4D;/O8[CY']\_OW$]Q1-+UKKOEE>;F8]U>UJ
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MW,,$Z%L=[Y[@;R'P+GULVR,Y,IYSQ UCR A;((R#Q=IX05,7:[G-V:+_LD7
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M(%X0CXR/&%&EG.;!:L?#UNN-=KW6X+KNX%K'@JV/Z[7FML^#O//>5XT5QZ%
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MN'3%I7'=3K*B.I=-E\V@T]!)YU\Y0GYTW_R>^8APXB@0!ISH0_:>#P_C$M6
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MD=R"<699C%X9("<IE48L29NI)?]9/=+'7],1&RR!HU(;Q'@Z6%,&5&0 :]H
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ME#/T9SE]1]WFZ6GHCK'D,([19NCYJ^S;GQ=DWHJ#(U"IA8,5\0)9ZE*?40G
M8@E'+!0*&!<UQIK406)1_XB8G<?)V9:JBSXN+O4I/1\/D*'W@^1[[.<DPYUT
MB-E+LK*3JT;FG]J (*U5NBS^?$X1>(^CG9/H+>?$% B;5+%,8HYL41"D-"_
M./:!$W&'7Z2TW184_UD)QU;**..1FD(6F(:4,J),4%SQ2"21RGK'EI3_F6/V
M#Y"\S>K<^3V9T#[=W]T_$2I2+X5 F$F..(M @J33R#/-J'(Z,JG !A#SB%4Z
M 2I+8#*6H96H0ZWM?B9!.@=*K32)+OGLBI2&I J%;#0&>2JUEM@5C.OEFJ\$
MGEKSU9IO3K@.SC^<,%A0Q2U%UE*>ZJGHY+.(J( U!B/9IX"A)5IP*AMV.MPO
M4?N)L*61+W/H0/59+.^P*+*"O,4(VZX>ENV'LGYVU8+PTK23DJV$J/Q>G+%2
MYFTZ&$?I>LO%K].M4IC8E+%9EHOW(45#3_5F^&4R!!*^F7^=&VA4UX94,#T?
M^EZ%W -CW.FAU\EE/9+_.<_*R"DX/$WM55,$YF6:HWZ-_C_%!GU_O?_U+=!4
M[CAE%H&=0Q&'A41*:@_[U?G"NFBX6(+^OVYG>;I*)O]5V2XA"^OV*)PQB6$E
MP).-$4I97M)U9%GOSK)H?+5QW.B89I&O!NZ2$L=;(7DY0^Z^D(Y:4M^F[9DZ
M,=W@!R[[P >C\YJKSG7HEK'+OI.] %67@%17)M6M\%,]*-(WN^$27BQ]^305
MVDE])H:SD9U+G7(DLP.=V-3I<*AQE<K2?QZZC#K=]??+[HR\J:V;?,*5G%-#
MM\_(R9/[K=S#P]1<Y*$J_65I&> N5X-N+\>QWJ0B_LU+F+53N"M@UBC,(&'@
M9;G$_2HSH1N:EQ:^61ZTI8BOJ[)'2;I/"=GM?I+K02(QY7W3Q_G7*=ZKND]U
MZ_X-<.:0?,F-\X$_S3<]RZ7C0GOD(1N.:U#*?FF-S<CZ<$Y25:/*GP7_&C>U
M'7XON;YAJ<\ /B-,J<G>N.K^.4 9I6F_:5S!T '28]P C_Y>N[%SU6VVJI5.
M\O+AQ5\O&N^"3Y[/)"(^G<=>7C9[>:,/#VK?';T9-5.$CP:A;-;J04,T>_UN
MYF\Y.BI/1HJ(;K5"^W2XR>>QI72-O@NV.Y2\RLJ>N6?+7.?U3I4M>FE459V+
M:D Y5G#TW.08/GHS.0[@C;W02D?  ;1/E0V1]&&O(BG5O88&67EA!2VPL6#A
MX1W2?4$28^ETSFTE!KTRWZ$70N,@P0PI7C2>N?G4BA%.;S+3. WMW'4'E<QN
M)]'M+K#KQK]&\O_]>F9MO=Z(/9.=06,1+;=,IU-V+MSM#DX;.Q-2.[EM=G=F
MMTU9ZBQM#"",R7[+/=Q[HZ_L[QZ.^Y96[+6\)K?H*4,3I[IV7W4[H$]3&N%(
M8Y8/*3NMY!&GD$3?^*N?ZZ]U8JS*O:6KJD.*06MR%\+ 9W9B*S5A-#?5]DNC
M++O^C0OBY9Y_VPW7+,D[#,B'2;8^S$3J5L>*()8)-U,$2IJ:=-S3_.\@#'=E
M?O$_]H]VJH)SUT G4\NIB;/$5"LO7 ]+X\P@1QKM:'0IQK(WZ%WEKG>C%QAB
M_?Q4E@ P[/M23=3:B^KB"$]A+-4Z"L>QY5&EVM!8Y/RIP D.=#;"TRO-#9@7
M@5G%P;#0-CDK"JDES))*);S>=5JMSG5:Y=D GJ' Q4["RID4GI);3+2#F^U<
MMK1+_)#"W-8M/HMQU:4KA^X.(Y+R4VUH-4,*=+L$NZ7,-)I13"!B$S?-IV<^
MC+*0TLE>XD^@\P%0<U''(6'L)0HV66.Q%)>[W,3;C5,0TZHI5BZ<-.S'F*H-
MMLK ^:F#1N!6X;236@XU<\>U"2?0Y'EG+DR9PI)+26\9=Y%&<34 L]BE\.:)
MAEVE1R7;O+D_9)J7J1TQ/MP$XE:]&4I@E.:RK#HYYR@8OO/0TAXRKHJ;^W*/
MYP6?B+UZ N?!<,*65>X*(T0:4H'KU,-L6(#SN;O>5;SG:*H*=]E&;3B$88[#
M[3W]2GZ:Q&7IEH'G_!8 E+)]E"EPY49I=M*!<I+L196\K^]J)SCQZ.D/S&R6
M7=6_*T?(#P$FO5JY </2>T]NP^VR1UK*N\O677Z1WW=V_DA'W?=+WZO.HT-C
M01A]71=T>5U05M<%K>N"WM)L]:XTD-FT$8>]4:DA@I><:J,)5EJR(%(3#>GQ
M>M8%7?SN=Q*DF7<OK#'"VW3"JW@4VL2BH(;%0A),F1-;K[-KQ?3.)EHSCR+S
M1]IO 5C^TDX.Z-&ER34-&/AK&3V=[EGQBB&1@"UTF;%ROGS-5,14MH53OI-I
MN4%91'K$@U[<!:2ER_)@< ES[F9.FR((8 &"P"D%[ADMB80J+[W'5F-JJMJI
MI*J=6IXV31]RCX^N<S[5?JE-_&'[SZ1V$K'[+=DA']KC1I=[J<_EGRE UX%>
MST,^@B']UNJXBY_.&?WV!NY%3HP4+ JID:&I&%RA/%)%2)5L2*"6X2)BN04"
MX\Q5TDK=0=B(=LBY5>O(.BE31BLJ7_+322$8NDSMB"B5T7:9!=LR)/0V_C[>
M)@M:F[+;6IN^?$R+[_*M1A0CN0: $+=:YJH77@Y_>.6;O:N6N7G9;.=9RE]Z
M-7_WG.$ V[S2LEFYE!^/U?0+7*KJ?A?^\\,G5Q^_R!_]O>_G/ROTBZ+@2S_&
M+\@#/^.*/>B;MPV6%"\8O]]M_YXGHIP,F.^TDO_?%ML:DZ+<!_XEO?K2(-,D
M)K6&GYWR<K:??;\4L_LEK^DO(*]53$KOUY%05A-PR[OA]&9;][ITP324S':M
M)F(B';0*!I^:C3N6W(*-?=H%L\FC:L#.A0 LL-J>:?/"'#2RL=(8OLUZ"LH<
ML.;YJ28EF6>C>.PJHPG?0VX>-T&STO9DLXX;FS#W_SL[P4_W_I/OG=TS:_7B
MJU1P"$H)Z@AG.@5/4END(MS<..\*X#EEQ11\=W;4B%Y6Q#(A0HJ,F..3O6E"
M.<T^,S==(8=Y4T,KCS_^L_?IJ,/V/W[@GW[_0/>_[HE/N\?XT^[IE\./G\Z.
MO_[[<I\>- _./]Q\VOVMM?^F^LY__GEF+WWK\-Q]^71T=O'IZ/CK_GGKXN#\
MSXO#W;?BT^6[\X./QU^/*8SSZ)\7^[]_N ;JVM]OXB__.H*_CT[QP>ZQ..%"
M._@OH!0JBSCQ0&AQP1%51A21.A:UVGI-M@N\K/#_L^VM].F*>^QAJB;F_VV4
M-OG0[@88QE<@S/E$O?%+6;SKUZ&WSI?!7P^H[/4@930SA4O9#5UM&1:JE\V&
M6>Q2)X. ;>JJ@;'Q*G(!UKL)Q ($5]7W*@-^O@?W<^+M[R!)_P))V:M$:*_]
MMO(!DVD4CLTOP:.OH=NI 7@E -Z?!^!@3 'FF$*,J8BXM!)IZ3B2WA-JA"0B
ME3[+QTGTU6,A>#'2?1N4_8D(/?GFA/Y> /LDY'ZST3=%B%"2?.^4!R:,I*&0
M7!%1!":+)8WL:Y*[21C[?@'&1E$(ZPFRA5,(+!R.M"L*I+CQ+JHH! \UR5T[
MA*U)[CHY^'Y9)2%34 Y,EY#"IH@IK564&D="!"D(YVSA,=4TX,Z4UO^>=+?&
MX\?@\8=Y/';4$YO2JPAC#'$0%J1P-,@PB;GWVGDJ$QYS,8_'<T[V#2"[U7$1
MG=($RW7$1H'T+328/@$-?NC4/=#C_9B56C=?^&(8?Z@O_%$SL]Z:;07%A@DM
M2!2:!4IX*FE6<,Z%$\X[HX*@]ZTA]O0&1*V35M!)Q_,ZB7JFHBHB*KA-#1BD
M1Q9S@APO.*RL54!@ME[3!84)OE/V1Q;=1UDGCU1+#]>D?\_!%)-QH^-XIPT*
M8[LS+&TFC(UAQZ/DDG ?N7=!,1F<B-%P6,2"DZW7?W2;9>+E;%K 9&!QBCY[
M@M#BOW(,_"A1I$KNK')'<R1W"O?)N<SC/)04.#,973R=CG!W9')NUM7I]1MP
ML\%D,^;M5.S*M&^V&U>M00Z6+Z\8!N"-D]K+<+X12E9ME2<"];+\#M,-RCU:
M)D;FNF8IRSQ)9QF/WVN"M)BIT5911SW ZS*OICL,.8>WA3]6,8.H(=A3YZS1
M7!5&%\'"RG-F4\$:(A:?J>X=O'N"PC2[G>OVM>GZ/]+TC.M!O!E<#LJ@ZT4U
M(18X]O&&*I2'!_A]R/5%F%!1%)(C&H)"G. ":2H+Y(FD,03!*-4K48?O*0P?
MKFI1>+@H1 Y+I3U&&I8/1$$72#F"D2%6.Q.48JG(6KMSCW8E@[P0"7M\M3\;
M9K0@HR2H>Q?*>BPJ]J9UP&2"^[ ,8^Y\EBMUQ#FM5*:,#?,)4X^RV]17F6Q8
M53E94FU_HBF4O4G9-DDD<V!IBI]N585N<BN(LM)-+F,W_E*S[5,&?<HIR\F5
MX^2SG%R9G@6;LEU5VAZG]73#E>E.U4099R"-TV+2^U9M+9:,IGK^,#MJR9NF
M,IYVV $K^.URH*,Z/I,W3 6NJFD(?OC\L/3RR><O#U>?+O Y4T1KOI_F]J(O
M7 /X]$,[RW%.YH.O+7K>G='N:T?W;DM62=9=X]U(-'9 CCX#&*\0C5R1:)0<
M R^9''H+FKG\S4M$U'<CN?_W/UIR^NK[);-/SPWA+[A,D_&NHFXW 8A:F7EW
M2V'X46>[^=:)@_%Y0G56L&*M+^>HM=C*PI#(;5":>DD54Y0J(15S#W=KS^KT
M=Y\/FN/CCZ&G^L=V2S]%?:##W?=?4GOV CL&=KQ!-@J!N# $:>45,H$$,+J8
M4D58YF$>51LWTQFY#\H%FBC7<53V$.VFG-Q;;Y(Q?]39R'=SEC.HPU3+R\S=
MHM6\"*WF6:JF $\W<*// %PY-6W03R=C)3<8%B5(6G9QRG[66$EOW[,,PC!_
M(]N*HQ2J45V ,B_WNDHYGR@Z,%-FH*0%57VQNUZO4I^I*U19N<AXL&P3/6DU
M80OY*NDXPD/3BYV7IFG.#&N'X$=C!D.ZY8=K.U3+O1 NRJY2G7Z8+,MN3?NB
M.[CJNYO$W(:=JGJ=UN><RMXRU[WMJLY3]=#,KF"\9P!N*8-ZE-P<OER%=F_*
MH$VE=%+QIIS"C!)[G[B^5"#Y]I_G[EY^K6*",);!6#IG"E;D+.M4WKO*'9_X
MYN=.:W"92<3@\JJ\=2Y;]?G7TI$PO1RI=$O.;NZF2:_N-K$SJM3]:%(1-QAV
M+ON=2X)W8NR%3.NRX,>8R@FEM'IXLBG;V)8%R-O#ZMN3JQ=AQ&M?'^@.YD!J
MYK VS&$4JC5-&E9I,2J=<,9:'RWG'@N#@R+*&.8H==R3NV*)1A4$QYDSXSY-
M>2/^L$&7#]?T,-[S]R=18HH5:'=IE$;<$HV4=CZ5 )161>Z\#PL-\@JI'JS"
M=\<MEF^7J7OJ]F0!9HP#5"RK$GX3?!]#\; \Z(/@>%C><)':7DU/;#BPXX<#
M.ZN!_0' _G$"LLW(TEMDZ)WF*E2KF7F8&8&E,5HPPY4K+!66$:^9TMX&7B;9
MXZ&9=X^<J-JZ>U3O*'&PZSC<"W[_'IY_<8*5%\H4 AEG4^UOS)"V@2#L>0A:
M<9F+;!$\?U8[LNV&YT$S=;82HMV"['C6)ES D%=4*C5./"-.[,W4V\;;P[J\
M;5!.+J-'-D3#:=,U!E?)T3TJ2S"*,07;^*IEJD-$,U7(ZK35L0#ZUYWN!7R8
MRN>FTKRE-SQ[1$<5OH;]5D!V0!)2P%2KU:F*O2:IRTH64*!9E<Y*%9B^E)4
M/P-9Z*33TI3T7=8"A&>6&K175@Z;+&![3V?V: O<7M.JK#DW<D$_P!%_VV%U
MV\]5%)MR3LPN3N9/>=-5MY]Y+'Q_T1N,"\5-+EY^<K-2Z<,QS1=N ^J3:]^N
MPE+F]^IWVIF_C]X<I*G7#U5%CGR&L6BY%JWV^*1A2IJ7K*D?<^1%9>3PL&WN
MK/8>^VDGQ@6,L7NZ<D^&9U?@]SARW1N]1-+M=1N&>W1EAF<>GY 8E"9,(&N%
M05Q(CDR(%D5&B0Z2*H5]:D<OE_=ECG>;_3BU2;CJE/UWIW;"T,DXES*0#U'O
M5S*O<O;.RW%"K[$_]YX6WQ+C+IWP9@_HC./.AY:YZ8TAUITUP^?2K0E_@QX!
MNS,53X0]E]Y@UM4XW/PIJ+=\#Z V><S=7AD DSLYC!A0LB"G<#,]I5<VVYO0
M5N$+@%\N<%JJTI'IF*$);-0\Q%P8>*Y:9_8F]WH=4&#9 !W6K@1 \C>P49MN
M[0W(92%D=X:$S820:<YX$;DVF%FN!+!@&@.1'DLB"\=--HT&O:JA??;^FRN0
M,9""7(RSXJ9S%6#O.+:8O54WQ!3UU9LR]:NFO''03S%@$VZ"X7[,JYL6<R&1
M2;K;E.X"N$LWP%VJDL?IZ=U4A3BY.LH^(KT+%+LAE)</[S_H5;JM S^D(X!>
MY8CY<E6Z+H8W3^5'IYE7NF-O4LBJHO?)0LOA%;,O=>>Q=ET-<ZH:)J^K8=;5
M,#<+F^^LN#E;H9.:&+VACBG!E1(F*!MLC+K0-F 9ECWG;DP',W9H)0VI]6I>
MAEP&N R1R.=0"?9&MMUE:EDQ+#$]; T"T#E\1&^H@(<THT35RQ3&.VE.P=.'
M34"ZL^>VP]M?=9)L-'/I^=,4?3C4[^/CV^K4&I[2 R+<J_S7VXO.1*><S.4P
MX2(@!ZDCRFFW<YTP/'V4C.16:Z8$=<JN2#IC=+H]MF[R*?BJ-0G30Z8:RS3G
MEFVF#/;4G Y78K0"$Q7%TR,3T5IE4BM261XQC,1F$;=*UFT>4CJFO3X+57^?
M,EX@EY].)]5)%%+Q\P'HURYLKL51!$\:%/"JI(A/'0)05BCO#6WA9XH(>%5%
M!"1JT4@NPNJ<)SV][$A6LH^;JS(0J06KG9H1IN" JFW*5)N@5V4(0$EFS'14
M>T5/LC4R%-'9I9YL++V(0K\:'?O#6E=<[E8.OX "I1.R8?\)D/7D8LLBFNRG
MLL'6+)&:-8#&G8-RY?H<Q-G-9W;P80\X3/*%5;$JR1)K3C;27K01MB?$HFRA
MG@^>ABASK_#$#--W:T%:;-U>\OEN!;&8NMU)5KYQ8YR]*07SIMMI=WHK^,;6
MHM#M3O^V*,(SDUQ3JW445)PS9@WH\"030!BH(-)1*5.$OUN6&\@6^YKV<S^"
M\40?#OL?CEL%KE-'0#?T%9U_.M^CQ^?'Y. KW._H N\?O17'Y_OT</>?EY^.
M/N!/O[\7^_2?Y_M_S?J*#B[WSS^E!#^V__M;<IC.>HY:S?VOQWS_\E/KX.C/
MBT^[%U^/+_>__.?K>WK"G;7<28N4-@;Q@ -26&C$K'3":Z)<RJCBY 59U )V
MU$XR0QQ,\EB2MTM@Z0T-VJ524*9,/8D4(#$7%C(K 0=9YCHQQ];WDCSX-[E'
MX*:<&WYK&;GX>D*C-0'P%6&+,>*V &DAL4"JH(Q2!X*2BFL1(1>Y$X='A>4R
M;T]TN)MH\#%NJ#/=2"2=#;JA6Z1JMC$6NJO1)AX%3E1UZE>#'!F<I(4.5NK(
ME34*% HSV"D:'!@59G$,4@TY#Q&GO2\'[T] _V-/F$?"LM086#&D:"1(ADBP
M5F"JLQ)TYAL#_VVR1,*4RB%#QVY.LP";8%@W?8(?5^F9P!]+D"I[PY0^[$RL
M\@79_LZ?3[AC$Z--ADZ91M,!13@\D6F9TX8-SB3'V9*OE82]/]7SJ'1&9^G/
M*4OE84X:_>70E$HYZV44<76\N,K9V5KP@\44#@L:/"ZP<%X!SG,EHW.RH%%R
M38-U50'].9/\ML9<Y<RG,O@CSCMHEUEAN6U$)_V5\[EZ93>?3-N'7M.T##-K
M-VP=6XI,(KWIW&&1/4MNM6<W+G-G.:N#/T-R7,^_;F[QNS#?[AYKEN9UE8/)
MA^'ULO/(6<#>F BB;P_=$_VCR<'1\0F7.A!+!(K$>,!Q2Y NF$A]/*100IIH
MR4K9O<^\LN.T[F;/M3HIR[Y>[/LNML8%]<#V4&0\(,!LA@P.'@$GYQ$62$D'
MMK<DQ3T2>"M26&:^YH"25)]E0:^\Q2=L]\ 46,%6CH:Q(?E'YM,Q,V0E S7I
MY:1[/Y>MFTO_2>JT.FQ'ESR2_>E?S0WLKN3/1#GRN=^7H0=P-8IJ0P'B7\ 4
M&\RY,\9;SQPE,H; BEBFO5,L&9[<&/1.<VBW&6-(K23#;Z%_'4+[337L,LAB
MI^U'>Z;FK]/[XG#W+3DXOSBQ6O,8O$$:6P!!+Q6REBG0S(Y(X8)@6J?XYGDJ
M6[+/1/+*$+EA9]JA\"9QGI&QB:[QHXZWTUTOIS,QGB4PB %](PRX>L$(-[%0
MF&O/DX6NK7 85PF<O$K@G)7*!<D;LV(Y#ONI\?E.?#Z'S\]W3B0QTFHAD !
M0)S3 ME &6)@F$N)+>>1I'#>>7P>V>C-V\&X,MU-;RQ?8+<\J'+H4X0!S81/
M#($,$#\CV<-U1VGDS9@#I658%H08QCN\,6!A-$U*WV^E^C?#YMEO=G8G>V?G
MB(WJDO"E2I[)411F1J^,[OQ@+CU[QP0.*0B@6K+A"=;<;*["[.=&O2J!?Y@V
MJVG>\\*(H_M'>R>86B]$JM/#<.+T .*@X#@*H<#*P[(4GJ[$Z9]YL>N5O>_*
M:A69<M8@+ D&&ZW0R!2:(1Z"!7.+N:#BUFO.5B/PMYP /1B  21#&"8-S!/I
M5:#F@0<)=U.4%9AS+:*+1=31PZ-C CP:[G\JX'U.#-44XTB12-+)"9;(:.,0
MPU1KHHS4@@.7ILLI3,HM>82=]3!QH7,526J#ZUEPC,%83YC0PBD@NLR* .@E
M--(N N^-FHADFC@,!M?\4=3?5L@2^_Z.UYDTZ ?AZ'-[)1[FKJN]$L_NE=@[
MH99H'(5"7A2P22Q-1VPX(!JYX44RW3%+A7@?[958U+AG?5P5A)%"A<)95SA>
M:*>TY=AIGK*6M)+NWHW":E?%D[B2=^"=+DZ(MEIX8Y!27B* 0H%T= QAS"+G
MPC/X+[G,EO61F4T_OJ,RR;=R6\QX+9[#[EZ\U>K#LXW:!&\9_'TB8W1:% 9%
M">#,N89-8 N,(JR(U58H7/CZ\.P'6>SH"ZEI4<!B%PYQ$3FHXY2>&348W)Z'
M6-A['IY-0> &4-IQ6GU"SD5!K]M+8WK*,%*0TTX.^P*2T.XWD6^V!GDSC /*
M<P3-U: +H#J*PIF.X "@_0)<L=G+X3<9=(<.[L$57#6\Z78NP5X%QN<A+PHX
M WA_4X5+5]"]?&3P\^>F#SG,)\?,EZ4))@<\$:*T:.QE4A\\O?)"5V\R=$>G
M<*6=W5NT@#,>>'(.>9S%C'2JFZPG2X$4R<+$B)D,QD=CL G%8GMWHISV4EZ4
MRV0/G[H7WU9#]FM4!_M[FK)OKP^^GIXXX#K,<& ^(IW9R$(AY9A!4DE"G6 L
M2KSUFL@7"XAZ*;9)HCJNC!(K1:'*0X'-DE*?@<@,3R7>Y=)GI<C\T0TAY<Q\
M#HT_TV;M#<\K0+!_&\9/)>&?RHO.YS*W;-2IQ-A;'Y?K=ESWJM"WT3X87*5_
MFO943LO]#-2%8<0/$^][L/[I,.*WK>9I,Y4MZ'3_J%ZE5HWWV -?]X]V3K@3
M-$1:(((U& /1*V2=L2@WBPG16UW$K=>WG%I.0^4H=A,D>=0(9$2;B5BB5X!'
M=[LIFZQ$ZT2Z;\/K91*ZH@,%WE%AAHW-!36$-992X2( 0?32!/<(^!VIJEN%
MM':99$'$Z0!=4&F*%+ZFF39 R+%!.J2D"*^=B$RZ@M%T@+XH$2(ND\+G4]W/
M*#NUZKY56DBJGJ:,49R#>& K/.(Z%LA(I9#DD;+"><$U,'JB7RRHGS;R2>1L
MR9SD&;Y<I28&2>WNI[CAALI Q5+20WL)?C5!Z7_N %:FA%)KVK[3KEH6C/R_
M&=.VR^CE%(*>JR.';H5ZZ=(A[DTK]U'SP?4O"7)T-]?H)N=EM_FYS(H=E_%*
M6:'=096H72Y)NK:;_#[=TDUD)SV4_5D'S4,SG$>*:<$2#EU%TVN8!&.!%"RX
M,-?V2IK-W/722]YL_9=\5+ARA3"BU!9KMOC\^)U[PP6[0Y)@S6>F&V:[;*O<
MZ8[Z(0P-6Y2+D:2DI$4B-QQ%F=J1_UG*8 X JD::N3U(S#^FVKM-:P(:!3:%
M!SRBE!,<+8F$*B^]QU9C:A8V5+B7S^<(GO%;J^,N?CK /[X^V'7 3_?%P;F[
M.3QR)T!2(PZ6(R5\2&?3 5D@@:C@*8R%1D<,FRUFX3F7FC@A#0U<A:B8"%9A
MIZ4GTFNU!2:3,U<I3[D["-,56>_1>2.7WP*Z$=K]<6F$2G*VDV3&3C:S7LYU
M!YS=X4L2=>X<_^M_Y":$X]HZN>NA2[%N5[WP<OC#*]_L7;7,S<MF.^_F_*57
M\SE+,TT/<_)V^?&X/@THU)Q95#42KIY<??PB?S33P;'\C*L73+"E'^,79.EG
MM]V6B!=4/^RVMW_&53U8JL6];GM'9^D[>\T3,7?M@B[$9>VGM6JZ.ZS-?PQJ
MKM=X.W<$-M73])ZSM G]EW])Q<]+^[\WU\M\48/LAW0)7\/UOF\_\)4[>__8
M<T;J.5MYSO JV'%7D^3Y";EC3KXCXBSN$7VK8?# UM%W-7QOK-?$+!:5_WVF
ME_]ANMW39(191;7ACG.%M62Z4 )+IQF)03^\W]U\]X/#]N[(YN]M_#%#V<[^
MZN+@ZYZ L5U_^O@6GGN,#W=/R?%YZ_S@XZ?F_M'!V?[Y;RTP[5K'?\VTL[]\
MS_;ANN.CWUK'1RDP[CT_W/UW\_#C/OETN?=EG[Z]V?_]P\W!Y;_/_O-UK[__
MUZB=/=O?W;D^$86/@5B*C.,2<:,,TDICI"4&DT]'ZHG>>CU?&F=CF]D_4[_Z
MIU(:2U7QCPFXBQ?X1P?<Q6^]"N!&83W7@7E-N;5.4ZUX<,)J*Q65\AY!GS7@
M?AO O9D!W(+;0GC*4,%L ,#5 :4*?\CC@L=@'.51 CME2Z*B:M2K4>]G13T;
MI#4V,D5\Y-SYE(OOX#]A1! JTGNTZZA1[YN@WL$LS;2 =E8PC&24#''/&+(^
M8"1PA*54G/)$,_FR</CU0KV5/04Q_V^CG '39X!+G4MTM;=>",0;;?IZS[VT
M@8/E%+B*SCAI18A,.%EX'V)M^JX')NW/F[[*8^6MCHA9;A&7*4>':H$P(XQB
M:PJJ4N]WOLFV[V+D>5:N-_/(I2[E38>.1],9YFU4M"BBMIH+5Z2_- $3(!*#
M"ZMK(VYMH&/6B'-%M,215'J(.@0$1J5*1*GYF+*4686E3:%Q"V+:Z_W[P^S?
M0A6>I1:S(5A.8,=B*8G%3#KK)2U<;8ZLR_Z=,T>$(-8KPE$H.)@C,GADJ%>(
M.BZE81';Y(31Z[1]'WD\684@T;D3RA_F^/*HTS>M!QJ*J\_.6ON7GO88\[&3
MLRZ __ACSH=$H=: _\T!__V$K7<!XWG/3B@.)'I'$8T2 V&3R>O.!>*Z<-8:
M[BT7J<'#)MMZ3[IKO^V)P",&^\ 3@Q\,\9_V1.%'0?S'GSB0&&2DW"8?M?!1
M,QXDCTJDJL"$AMI$7QO$OYE!?,4D,RYP6!A+$2R71A9[CZ2C)/C((Q,)\?E\
M Y:?''9KS*TQ]WMBKB18L-0[L< ^-3S75#%CE1$!ZT)97[M5U@5S#V99MI&*
MNN DTD$0Q(532 5I 7U#H8!T$V9CPMSY?.%-Q-SLD?E[3O1:U,;]'NW=E[;N
M?/T/V_W[\BY*/U];>+&\+?P*C5>9'#5>K9O)U\WDGRO%F]SE>,HR?=#IAX9\
M_L3GL8;;&V=F[[3]_PO^-!6<36WB<NG'<=6[M4F*_GH\5(1GAQ__?;Y_?HH_
M7;YK[5\>8U!&H-@NOL!WV:>/QV+__.SB\.A3\^#-;%+T6_'I8RH;^^?E\<</
M-Y_.WW\]/@+%=O06QNE;G\XO;@Y!B1Y<[N'_?#WF!T>IM"R(F68D)4)[!*8"
M_&0]0\2*:!E1!2[(;"*TCHHK[2-6 8.T$EL$8PIB.'>%Y+R8381^-TJ8GUB6
MV[.8%R8PW_G<=:UOD/5):JO;N;-T12Y8!S)Z.JR\-6[@7;:MG^QR7S7N3NW4
M>Y.]S&.G"R-H-ZI*8C<SC4K2]65AX-3E\G-J'Y[*(PV[KM]=76/J2=>FZ[.
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MN<UW=YU!RP.?_>^@V2UM<^"@0_QQZ8B[GVCJ^L/S8L)=3DNO\1F$N0,XYCJ
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M@.=+DY4&6^F3GB/Y64G!GXW\+$CH*_(S5ST8)3^,1A*4)4AR'Q"GQB#G&4?
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M<:XW-+^\ZB57A@6<MU_A-V:X"@[-N<_9LHK!W,[;"Y7 CHKH<B%7EIRW5ID
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M2P-Y[E7R:;17B5#8XZ@$$DH1Q+TC2,L0D5$*'"<>O''LKL)B*P3F\]/C)]F
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MY/.V=C1F74OVF,Z.7*]3S>??V5&L,R(>==O[/^.:58.E<^V9.9JXO?(M*$O
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MQU8K_]?;WN'PTZ*67_'55N?D /5C-]?C&4[2H!M OU.L36R?MCH7,?8 T3;
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MU\24^Q_)-@?-+(=QFI*HE20G#)I,%39HK782BYH$0^X2;G*>DI1ULYKG=A%
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M'K#J^-'ISM^N/VC2;(>_#8^.AL<O)\/P?EKP/OX"Z#6HM2ZTG\/V:A/-+,5
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M -.*-P-/3J<@B5.4$\A2$1,$_E8HQ@S74BF& +-*PF,5\ X+^+HS'JN WZZ
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M31D"(BEB6-8D&,VY@X!+FA&VVL4CM<2LPL9F93Y5V%@:-MI1.6U3T, (R['
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M>2UL*5Q:\ZE9A=@*L15B5X18IF-F)KJL( $MQ=K1VF0=2.>]<WKYC(4*L2M
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M<6N;/Z"\2R!UKQHR-/4?36^XP3"T_>4KI99>M4"O.IASH*E9@)WC^.\R_7,
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MZ\"Y%C=IDE(F*QDQD7,"N!#$>0LDF60L^,1TPTB^,3BWIJ;!G0:>'1SJ-(W
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M^O/S@>\<QZ=G3[0S?<(J.I>P$XN]4QSWZ0&:@6\_[3Y^2M](8[6TJ.Q3R(R
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MS)T%^\TEP7Y_LK7_B;"$(\@V\C@+MC0:&6,"8HXZHX#04!=6ULU:W4 I@MT
MP6YBEX>BK1]8J/<N"_7IUHM/C#&OG;$(T-HCSD&H7<(<6:]R7#P8GS*?#92V
M#T]"IA^F[4-1U@\NU_M7Y'KGQ2<I-!4^):1=+L5J:41:>H.T 6T=$@/V9><M
M!%4$NS&"?2_-'XJR?ERA/C\B.-G:W2/;&WN?K)("*V>0X-Z!;:T(,IYB)+T.
M8%]K*E.NVEAO"U&$>@F%^IY:0A1M_>B"?7)%L'???P*AELGGC&3+#>+*,F2<
MD,@33Z*DRCKIYBVQ7'(C[BJB.\.#V"_)$$MV%'!#UZIJ45^$S\>CK)?2M>KN
MOO_SH"3"B<5>,:1$R/5:E$3:4X&$BL%0PIUE.82A7JZE5)]=0B%^&-?_++VK
MKI7I0DYF]OM?5'7CWHI$.5+1Y]Y5 B,3$D8X,IF"5L0+,;W(0I'J!DAU$_W^
M134_E*/_HO2L]X%%39"51B+.B !;PS,47**8:Z6<PM,:2A897D(9;EY[YZ*9
M%^?D/Y?I0+P3R4OD0G*(2Y+;Q0J.1 HATN"9\;QHYB63Z@8V>"[Z>'&^_//(
MX-S<(7H>D9<Y@<=1C!P83TA)&A7A$7!:K:S72R67:/\EE=_&='@NNGB!+OQS
M>192496$1<X;C;B@%EF<4_:YD-CD"@Q4/)7>#J[7#[&/1A>#$0Q;@UZG'5IG
MTC5^?]@[>D9J;TX,O-&>_W-Q:@WM]U8?1&F>C( [3]NU6/I@"S45?!]QN:;[
M*O\YZV'8XN:G*4II[K)4"SB(N894OOI^%+N#^'OLQM0>KK12KW]HAW#+[\-G
MH!Q1Z W1^$*%8<ZFD4ZG=>.@R2D3)$K:8\1]S"D9)"$FD]-12L,87EDGJY+6
MHSN7J(K,/:BDAXAV6;PNF"5.9OZ[-Y*1+Z*.UOP'6+=AY"_AENWN,<SDSE'L
M5[2\\/ [H%[MM,I@)3FQ%DEELD_,2:0I<'$M-+;>&27S:16E4])4?B+0FQ?Q
M'D.,__634.]&\^[IN_?A>'<S2??<GMP%'+$6TOT(ZJ=VS!HY#2DY#BS;QMR
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MLMS_XD:Z_]?<4BH?EL"_OG,<8J@^.'YWT.JEUC\?XX3ZL/>L7OYT(Z;8[\<
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M.K P-OBC8N/=:2U5>JGUSQFDFWKF"0W)46HXY\0JHPCW7'NI-.'VMA3K2@^
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M*E02+8CEUR&E+,A[J\A;2V2G)*V)'A$N->(4)Z13#O$X0V4(2D8=UW%RH2G
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M;?K!J&8$38PFT._94-J(*7(YP%U%NW,U_!A>+E=R3"R^:BZJ5\U5<*W3=NS
M[AL/ON38^)?8Z9_ CDB#?A<^[/9#!$,(K+ $MF0_3\0Q/ G]W]A6%1OG)R!=
MOQ>&DRT;QM.B^TGR&'P#/SEMD$])^FST31/%WPLZAC-;;K9&"U9GP<HN8S==
MM3A7&4[3RZ83R[/Q,RM:?UK9KF 6_CYKTEZ=^+YPU?0I^/P2Z\ 8'X^NOJ36
MN/B>-H_2<Y-ZX>?QX)R7^B@B-XCV,ZJ@^ZGM?+6GPZW?+L\Y3/C%";SJW5>S
M,U.ZM>F8C"-D)Z+:44_'8'@/\K=@.+8Q8VD=#[*Y^U_7,/3QULY!%6( @<MG
M<W-@^E^_V9U%B[[04/JIX3-O*$5-K1$V$&5A%,F)X+TFREFJJ7=DLA-*VO]B
M-/O5!>65D?#/<>6;OP,G?GS/0>W;]K; V#F*PY>]UX/^ITI73 W["U/RIVT/
MJE*(5RE;^U4^*P>E)K,TF:3)1]5.?^3N%_THM8-E,3IC!P;W2U#D;$HH,::Q
MY]%$[FM2ZZGWAELOM.+PB_921VY8Q#P)X>F\^W7+V^*=/XYAW($5?S:A<'@+
M,'C4@WT;7O;^L)UL(;\[CG%45OS@&?^( >RC=QP10Q.JF $M=2KW6 W&I91/
MP<RO.,,6=(9CE-+(G<7:6$4B!:3'6EFCKG*X+YAC3VK6>)H U["2R7/C\VHC
M;V*73L)WPVF=[B63O,7(T[I[O[2[_]/]?<5U/YVE']@U.; U_4NF:KG2S)D0
MDGRW)"MN%X#WCCT9QJ>S7W[/AR@[]O1INU>!='71[W5#:H[7I7K@Y..I-6;,
MMI8L(_N4_'?ZX*FMMEV!_AQ3S>0SB;>%D5=^C+?)E9_]Z+9J6PIQH[O^^#/&
MU8:,E6QK<=,K[WY>N6:W,E9]K;O^A+;ZI]SRIO;5!;1K$X>L47R^KR<8>@T^
MZH<[!9=4QZ69N.:N:!;#WN*W_"4?8ISD_X:_7H=^_(9\ZPU<X&P-KNN-K]S]
M#W7F2)FYLN?N=<_=M&W>!G:,6#PCDV!&SO+48]=/K[/)5IJAZ^R^\H#R@"4>
M<-,>,<T4VA]U):C_K,<[<EC"1?"W<PE0CJ?G[. J_4F;1OF\IA8KC61M7KE+
M2I V.,MP$A%SGK SFF+BK32",Z+<QY?7X__9G:3_+]03U2+>FU)A>;-HYX3-
M^>3SX=D?GS_\\X;OG7E\2%_BP[//]/"3%Q^Z;[Y^.'C;SI_OPSCVG\^Q.7??
M?MK[ZVWGP^[1V?[9VT^'G]Y^>G7PH;U_UNE^V/VCL__7_\+G;PB\,\YMB??>
MS;$Y2P=KYXQ'.CB)N"(1:48H4D0E+:5).JJM'?U$\'J_KLWKG]*@'N>;C(UK
MHL-O)#:NS&AON.&86<64ISQ$82QA1JL@M:::6E5AXS6*S@LVWC4VGLYWELHU
M!+ED7;O$$1<Z,^=2AYS5UOODI"1I:\<\X;)^=K?@4['=FFF["6*3RI4Q."EN
M)-AN"JN<E39224QBL=T:BD_[\[9;4%S[( T2(I>6*VF1E@!7+'?H""D))^/6
M#GD"FJ?8;@4;B^WV<X);['T4%-2[\YPJ:Y((P1(A<*#!I%!LMZ9BXP+;+5E"
M,-*YZP'W(B&CF$<,5E=+HQ*Q86N'/J%TY>;Q:\2GFV8-;AICO%"N<ZD8T]Q'
M^?X5$<CI<=OJ!.-<H>X\I-/E9FHA-&^T;4<L9]$);!CC/#IM</0ZV$"-T9I'
MNG3WXCJ039<C'XDN*+442KVI1]^2,B1)$9&V5.5:Q5R=*DPF7(G84LQ"HEL[
M<J-#;XLAZE;-M[E'7IDGVG2\6-G>(50%GPF0*7,\$.M(-%0P$GCF9O)A:4+_
M@A=KQ8MYJ\9@)7@"C\\'G)E=F4-.LXA2[G3. 3K@?X 7=7>OR&Q39'9E'6\X
MP1I\$LNE ",79T%-BOA$96#$^Z+C[U5FZU$:S@5CGJ 8HD6P8@JYB"DRP0JE
MF/8L8/!$ZOU2BXXO>+$&'0][S0<IL+<8<TV4380[Z8BDEE*5=-'Q]XL7\SI>
M6J\H8PE%J3CB^>R:=H8@S1/UV@0B@LX%APW2\7==&K4)88N7N48U#D>KQBVN
M&U+>:)OF#N(6L_4H(+4T2/V]*'"A: *5@H+*1RNU# AT"OQ3.F6\3%H+DT%*
M;K)5T[S$TX-!C$V(7!3$6 4QYLT:343N$LG!CJE::<B$K(#?&+BP O/<90/,
M&J+KL<XBM4V1VDV(712I74%J:\&+Y&RP.H S$I- /,J(#'8,Y21Y(!(T/:,+
MZ7V+FB^ L1G!BP(8JP#&O)K'"@,T4(<4]@X PRA0^!*C@"5QTC/-J=S:82MG
M*$K1Q:U&+_Z8\66>V'9XE%47OS0K?%&K'YNMT&M8H );2\'6X8)X!F:&*FV0
MH,0CSH-!QE&,$J>!.J8)S_$,+NLM,VNT%"5)TA0[8RD1OOUX0A'AM8KPO.4A
MC.',4X,XM3+_L,A$%A#C@>(8I;:!91&NG]4I(MP $5Y="]]!<*&(\#I%N!9M
ML,*FD&Q B>3&U1@'9+UA2.;#R;!N7C*^M:-5D> F2O#J2O@.O/TBP6N5X'DE
M#)!+#-<.L404XIY8I#4A2$:PJYR((G":&V;7H_SW(L)K*ER82")N^!FONI?_
MS(_&=I [1OYR9-N]X:^M3G\XC,,KZ9DV/1ZY$:[^]U7Y"];DW[ @Y:C8^C#+
MUWU_H<##C\D!7-'<H#NP?%2,(D*2"LXJH;W-1\6PK-=<71^U2I:AP8;''7C_
M"Z2Z".YR@ELS-@*WQ(.[(#$'8R/1A "=,=*221&])2J8K1VQH+2ZB&T#Q'8C
M//XBMJN*;<W+I]KCF*A&D>%<"93/0O#HD71"$)6,XKG+/#.KQ-J+V#98V]Z!
MFU_$=F6QK6O;2(03#BGI+>**6>2DQ8A0ZD426/!$P+5?T.[]7L1V35G]377M
M7U?-:+JQ%[J3+F<W\.@W(>BX"4</*D#ZOA27O?G4_A8#.HN#?D&HI1#JJ.[(
M>ZV8#Q3\@83!D>=1(Y=D0IZ H<$,84F$+"L:5O'W3:Y8+$F,YE8LWD$H81Y/
M"FXLAQLU5@6CK+<D(443S2>T);("8P1N)!%"!.E33CLVZ,!ED=K-.YA0I'8E
MJ:V%$90!5S%R@S"1H.VI5B"UCJ*@"<%*8; $\A'$HN<+8C0UBC&$%X;?"G;<
M-G;,:WP2<\=NSE%,F1U2,HVT$0[I(!0W!HNH0>,SWI!:P4=>IK#;_A*'H_9H
M/(B/K#*A67&,"^LP_ F?;0EKW!"L/M?#&E@X3Y46R(B@$0<_$CG) BPC!B>3
M11)">A!AC9*T:;"Y<P=QC9_@2\&1Y7!DWNA13)H *@(Y90,8/5(AXQ4#ATE0
MJT,@)+JM'6(VNUSBVOU"N^T0.G'=DJ>N)WCDZF[&FPXUFQ"+*9;,72!0+62C
MK>)66HF\#!AQY\&2B=HAS)307,D0G"Z63+%D-IU2HL#+G<!++:J3EU,E!GB2
MR6H"V#::NH0TDUXSHQF7_FIX:2P!16@/3SKV- \V_A@5RC<O?W/M3=@W,Z*V
MN'MS[(6K^C8O$^6_WEPU3HVL;*5JKL$^92J*I+@(U&A%#<84G"D&D\6J5E'K
M.61<SO^L3VV\F*B,B67*]W??T%=O/FK#+"<4= :GX!DKSI C@:!@F J.>!,-
MWMJ13^B"FN0-LDIOA&ZWG&C\^6!624%N*#BM;..6_NP;"TY[\^ 4E00 L@E1
MH<!IMI$B2SE'1GDIN;76NRL[M#]D@'CD&+&R 8.QX9(F)8T$A<>2H4%B'##6
MT0O/53%@&HL1?\]C1)*) ]![A(.0X/DZ@K1.'@%$.,E-E#+)W F8JGI%0S%@
MB@'3. .F-"G?6'#R\^#$H_!8>X*PT&# 4((SA[1" $O41N6C"N&J-N5-!(B;
M5F-=>U0-"28MMC">']O>46RU>ZV3ZHC9<!A'PZ=71I#6,B]7(FBY>[G[=>Y^
MUQ3/S:B;G/S\T[8'K2^V,XXYW'M!:',0V,6C=J\'K[B.4'"C39*5_:7;BZGD
M%7J?%^A5J@J]J]4I9LD:S9*S14%?GZDG#$74IWQ^Q IDHPPHDJ 599')F')<
M12THB-H\GZF<(6F@EV.XX9A9Q92G/$1A+&%&JP"6,-743D(PN$!*0R&E%JHU
M.(;DI444JYB9;1323&"$X8\Z9+5!\T'2)X;4&^84L6Z*6*]L*=Q>\.(*L2Z2
MNZ3DU@*H00N<C+8H>.413]PA"\8=$HYAKI2R-&> B7X(X=."&0TT!3"&UQ14
M6^\\I\J:)$*P1 @<:# IK-T4*)BQ)&;4XIJ:,:P]> S&)(NXCQ09SU0^4QJP
MX9XY7_7 ;9*N?^0G22M:N$YK$$?C0:_5OQ3#?&0',NZ8]/K:1]TG2_2V6J%7
MO>*\W J<X07Q$ $&:V(J(:&=0UR&A)P7 GG&4C0Y6A*K-(WB]33-)AT0*R<C
M[IL%>Z%T%P%>4H!KT0>BE4G,"B0CB"U/1")#P#*1(5!F&8 W3KD!EFS0T8<B
MPPWDQ%Z#KB[2O*0TUR(2CH#R!3\"6>D2XL83\"ZB1N :LN#!+8S$;^VP51AJ
MBAPW5Q??%4=VD=YU2&\M-F 5PYK:@"+7!O$0\TGGF!"+5!(&2AJLJZT=NG)H
MH'F$V0^J#?:+[DFG?QH'E6P.VFZ<U^@\4O"8^F$WBXKJ^<7U^.-TMDX%NI:#
M+K(H#@#^7[3&(&=S$TX&OD2V*5&*FK.LC1BA.:Q9,B$E$[*A48B"'NM"CUH0
M0FH?D@3#!\-OB'LCD4LT(&&B\EY)2W(4D:X<@R@2W%S]?P<$3E=*<.%669-D
MUP(2)&'I=50(@R60\P,.Z4@-TH8%XS GL)(/@KRI0$MSC8,["(L4:+EM:*E%
M2Y3RH"%P0EP(BW@&&7 :.2*PQM(J;8-:'W%3\ZHI'E3(9"I)P]:);8<5(B6;
M$.5M1&7%M7H'5('=V=*\AI4IL+4<;-$%D1(>8Z[KQB@:21"/EB,7B$'.>^^<
MS<10,2=<2R/31DKO1G!B%^E=D_36#VLD;H+U%''P3#-GAD1&,8:T% Q3#4:'
MD5EZ2X:UD=+;B$J)(KUW)+UUQANNO=*&(1H%Z-ZD+3+6</AGT,9+J3#+68I2
MJMA(X6U$]ZTBO'<DO#5_GP66L(L")<%!]2IP]2UX_2@?AZ5"V!1]V-IAJAG"
M^\@[B:_:?6L3XI*;4/)PD53^JF,1)2QY4YABBRHA-#$R 4QAS3V"!<;(<,V0
M5Y2EH 13Y&&TJR@9CP9;.G?<>*O4@:X (;4@0^Y-3!6V2.7:;:ZD0\X'BH3D
MQ$5+>&)F:X<TI='H^DH_'T[/K4U F4THV2CVRRV#3RU&(K'$CMB$ F<.<>TU
M<CQI1'G@7";B'%7%?BGVRZ97;!1DN65DJ05P(J4B<6&1$!0\H\@XTB%*)!)3
M6% KK/I!2^+-*]AX8 VA?D@)NFI?J*6FK'%XU^"^4(73[[:ACB\* AD;>?(
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MK1VZO6:NWPV$J^M8=G?=#_4^WC@+7BY_R<>O8V\X.]P].;[?0JU.OW>$<IW
MC8*-F]"3Z*'$$_-*ODK/+ZSCC(VA .MRP+I7CR[2S.K( 5@]-0SQI!S20@O$
ML$L$O&GX!][:X0M<Y@VR04OCLT;;:TV(Q!6062/(S%MOVB>'K4H ,@0<7:PQ
M,CB?(HXNA22T]I(L!IDBZ$T1](<2P_J1H/_D*$L!@&L"0"W217TP(3J,+$L"
MK Q  :>E18I*V ..)A=LZ9=> .@Q1(8* -T! ,U;( 8S,#&= Y/#!\29B<BH
MP%"(UD4N83M@T<1NZC>M"]ND2,W_J^@J6Q7-I.\/1ZW1(/;"!:[0&*J#?CUX
MAXI;<Y7RL$9#W&(;Z_NNW!@MN'@3WD4KG74D3QJ]1:Y:GVJ+E&5JRC(UVEN:
M .YSP-OG +<'&6VS4?)L@K7[,( _V]GB. 2L+;;'<K;'F[KS8Q./7%""",E4
M@DP2I(/TB)CHDS(XIE 1YHM-=GP*ECQ.QZ=@R:UBR;P?0XSTF"F)N*("L$01
M9'(%47(Z11J)#,PMQI+[D^?'D&V>S&[]Y]^=$<@2.#+G/LTCRS=OGO=28G@;
MX;V497J<WLL,4J^P/$BQ,I:S,OZN>RP^>FLXD4@KJ1$WV"*GF<G9&QIHDDD8
ME@N32U%(P8^-\U@*?JP=/VK9%AM83-0@S85"/"B#G#$)@:>"HX@.]D=<C!^;
MEVGY60_C16-3VTILA$.3O?;6Z-B.*L*M*B,SB-8?QTF?T?&:O)L;3&7C,.^A
M>#\K;.M;#O1==TAK.#BSF5OP%G)##W$;K!_4F[(!KB2;T6LXK58F_+H2!Q.N
MZN=M?JMH'"_2$9_3H5;,DG>^.^@$'HSD=Z6A%@UAMK8HVT!/&=WF,F^C7"#5
M[U7-1?L)GC1JO8:[]T/;MZ;&?"O;[:U?7O9\OQM_?7I/.K::Q-:=L=O"1$Q?
M/[_]L+#;[NY]^^BU%Q[+@ CSV=\@'&EO";(B\9 TL\:F><9B3)A2FD0=G.8&
MEL*%0)G743$=5%#S;+AY!Y[,=N",.+8J5\I=2/,.S \8MH=5Y\\TQU#[H_[/
M$YK9.3Q8+^WL0H[GG\[ !M'5,@E77H]4=#FJ4J%OAU:5EK'>"K7NS>Y:YO5^
MQGH](N15"5^)V%02W/7Q &_N'*Q,!-RL^H'%;PDVQ*P3S/#7=7&J;L8"%Q;9
MPEQ\#S.'R\P5:2W2NB$SAY=1_ ^?+?M=''QI^\EQJ5NC-EJ8WVB<Y?3?M_?^
M38DR+UF.5>\B22QGT0EL&.,\.FUP]#K80(W1FD>Z, *Y7#O)Z8[,0<F-;_TX
MJY^ \=!7NW^3#S">0[CNPT'H'G;_YON[;X]?[1Y_AO&)#W^]__3J7:U^@NWO
M'O+]@_?=O8.W[?VSMYU]^J'](=='_/6"O_KKS>G^I\[G#__LB864WUP0G+2P
MR+!@$'<R(:N40#AA1:QCSEFUM2/Y)I=?W0'1VIU1,SY8R%V\TH\ <I>L8%L
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M8F\M]QHT!KQU& '2&K![N4&.68%B#*!"<9(TR:T=6N>R*M!;H+>$'!YNMKP
M[GH MU;8AKW7 DL$RY1[<3*&+ L820,+BIW@T@< W+JMNT$9[X+XCQ?QB[&]
MJ84*!?'7@OBUBH.@++>6212)E(@3XI%)Q"%)I%)8>><KQ%^YO+&@;D'=@KJ;
M5B-24'<]0>5ZL8?0CK/('0*P!=R55N;DGD9">D=Y$((DL[7#5^Z>T0C<K2I$
M?AM9UXD[U0OE?=SNC>W4=PCM+SO_@A^SU^C:P5&[-QNMJ"#TCH619F'\LS]H
MC8YCZS3:02OV0@RMW>ACU\5!BY$GK2Q63UI?8VL0?9[ 4'U[>'Y6UW9A+> _
MPY9M^6/;.XJM4;_5F[8:@X&V>ZT^7#, R>Z>#.)Q[ W;7V(+GM>#21_^-OG:
M]O?EKF9JLB/VQUUX*W\9$V@2V*I,I$)ICI YD@C508: G<'4+O2])RC0[3]]
MYX]C&'?BJ_1L.!QW3_+R# _ZNW$4!UV8G<5P<)#7]0"&\$>G[S]O*"1\^,\Q
M]MWW/?N/&;_JOF_OT??'>[MO\OC@66^[^[N=-HR7?-C=;^]_>O-MCQZ>?OCG
M_?%_SEZ<PKW)1\D9=H1QY(QUB-,4D)9$H(29-X0Z%HC::D5 SA.8[-%@'+<:
MN></8 >G?J?3_PH;$';N]WT ^WP06^-AWN5]T"/3/='JCP?5CEY<Y)0NB-!P
M3H8F4,;(T\O;NSXI&9;F&'P_C8>C=CJ%2:I@Y3L 3G ,)JMC3X;QZ>R7WT-[
M>-*QIT_;O>J5JXM^K\WY/(Q5#YQ\_/O7=A@=/S5F6U&9%?6TXFWZX,FG9+O2
MX7.H//F,J6W#R94?X^VK/_O1;?4V$_1&=_WQ9USS6Q@K)>)1CY5L:[$I8]VD
M>;VML3*AKG77G]3 _K3@G8C:=Q?X<!YLBCAH5%[@=;98^KUK=$E^P', BFX0
M1^U!9?1=FHI5]\6%*,55%OH"([WA\Y4MS^NTU;[.&S^ZF2-EYFXX<[C,7)'6
M(JT;,G-X&3UZY?FFF\Y)XZ+EN^VAKV)) SN*PZ?7V58KS<EU]EMY0'E ><!&
M/6!-;;6N#9478GG36Z#\_:=F=H]V+X#Z>8K,?00\+Y0/7?7SW8667)?#E ^.
M"WC)PK_>.,=PUWO:D%U(1BR@_ST/1O\]C.&Y[?AQQXY@0A<G)F8Z\RVHS L\
MP=_3EXAN:+)BEK_\\.GSU[V#/]JO#I[Q5P>?\8>#9]\./\'S__H;[G'(#P]>
MPG<.Q8?V?/YROPO7?-O[ZZ6 9XE7!V\[>S ^N.;KAX,W7_<_'1_OP7?V/W6Z
M_SG;JQ](U)H9@2U'WCJ,N.8,.14H2IB[X'P@//*M';9=;P^Z>86"*R9 [T-F
M_^=&YN'CYCQ?$N=6.]E7<*Z9.%>KAPY6&\LLTH!XB#.?D.66Y?YBA'',0S0B
MX]RZRC0:C36+Y:9@S6UCS8HGV0K6-!)KZD2CDKF8M$$N2(\X%QAI;A7"6ABP
MH)DT06:L405K"M;<EO^VXMFM@C7-Q)IYNT;C1!V/ ED=P7^+$?RWY VL*=@U
M46BCE"O^6_'?&HESZ["I5CRQ5'"ND3A7.]UD:;1&28U48@YQ'"4" ]HA;4T,
M@N>SK;KX;P5K;A5K5CRG4["FD5BSX$R/I]AS0SVBRH-5125!EI',U>>]B(X%
MZU-&FWHOS$>*-G?=N6_CLY$O<Z5.'$[/5JR0C]P$$NT'G8^<K60!W^7!]\V"
MA"0F*HJD$ \4##W"*$"O\\@+92A6PC -AA[=KC<6WR"'MA#V-]K.:VQ.L&#-
M2E@S'SQC1C@)!CU*F C FES\H 5&TKND>!32L<Q*MUU:@CUL>6]L7J[(^RKR
M7DO,&:&LAQ^(@QF!>)(8:0!ZQ Q)B8D0X&=VZXJ\-U?>'W1NK,C[2O(^K]^M
M9P)CKI"4A".>P\?:8HJ4E\GHZ$,DHO@2!6L>97ZJ8,TJ6%-+4,F<;"=6(6$X
M^!+28&2$<>!0 -" -T&"++[$(Y#WQN:(BKRO%#NH)XDHPQJ,18FBH^!-1*60
M-C0BHP'I@S*.4]$T;Z*<&JN)]XMO)]&/8JC.X[;ZJ36(H_&@UP))/P&1R\19
M<30L)\;N+$-S-8GELO W6]I_]WM'!W'0?5NM[*M\'UC2 H++@>#?]62-"<)H
M20(*2J?<Y9@A&URLVMDI(U30S&[MR 55.1OD8*TG1U^*<AJ>K"FPTUC8F8_K
M>$JB\X2 <\6K_LH:92\+##'ADL4!:\,S[#2D/*>(?L/S-D7TFRKZM10.,UY+
MS1.B/%'$ [A?)E*,9! 6>]CPSJ@B^LT6_2:E<(KH-U;TY[5^8($JK@3",4=8
MM0K(.N:0!9?#!1]A)X#HJP7'*HNS46"G6=F< CM-A9U:8H<*0Q2Q%$FK+>(\
M8N08,X@%8I@G(N#X_[/W[LU-'<OZ\%=1^5PJJ6*<N?3<X"U7L0/)CU/;L+/C
M) ?^H7IN6$&V?"0YX'SZMV?)!MN2 6,9+=FS*QN$M-:L63/33]^[XW+8::1_
META_58Z=1OI])?TE/IX@A=8FU@(.Q3.H'31#0,640Q)"O'<FAKX1_XIR<>8T
MS)<X>RX[;GI%U/\^]>+4-CSY<-HU)AH,#^,DXS0/V&!$Q,)JQY,KLR4WW8M]
M-WTY=5]?E!_/[>JSTTUM0'<]H'NYZ,>10!O+0V8Z0ZV.)14+'"+).)J8GDZV
M6))Q8(DK>X-4JQ8XTVOYJG]^G 8Y*X2<R]:<@MZE((!AX(Z!RX6A(T%+8P&=
M@RB=ZW@9Y#2ROTMDWS\?3B/[U9']@O]&<-KNZ#7C/%D&D")#A,"\"BA*BB$C
M-++O-]DO5S#^^S\<Z0&/FD#8CLC5^],=D;9-;9MN)4KY<[VQ[W 4\__+.)KM
M#R).YATN!K-)/IS'--\\=/DZZ]J[,WY7N-77G?%OX3[ZTBG=Q+VTT4=PE3#;
MCD$[!NT8;/(QZ%/XVTJR#'\;S6C<69[+(#^2"%*_W:L"2+6E-*O)]:PF<3'T
M3:@8P"3#1%*. 7K'4-G(8DY1HN;!URK?9K,+&31(VUA(ZU-H78.T/D+:0EB=
M\Z @$YIY1,% R-HNQ2'S&H1'$T)0:3FD-5AIL+*A]1@:K*P85I:$[#E/\&!M
M8> ,9Q $00P7BD5I@T:/LL0K9*7^ DMG$/UAAF&4/]CQYI-_?GQ QRQ>L%$>
MX.3-\/!L1IJ(ZO2;VEY8?P,3Y8*&(^?BH#?PK4QNRZ;PZ(+Q5LEM,'4Q3LEZ
M\"/=/AF&XPY4*G5/'P[6)#YWZ_5''DR/"%G&D\$,W[/_.Z:3488TT70ZX7A^
MPK56Q92^HG-$KSB(=)QP2'/&$4[J37B8!OOCX\GH9/ =G1M&J$EWU6^[3]\/
M\L'1:'R2\W1[<&$IIMU%U:9,GR:9GEZC)[L)O"%DF^"(AD3Z;7"4)S$?SO!-
M%X"9<7)(,YD^J#^>33F<#&@.\\G2<QX?U.HT-.U].J#T\VP\R.^KVST/2GWM
M_3S-GWK=V7A&>)D&_WDE3SB>IDL,01;-T29T("5IT26((J1+)B52H[C$SZC.
MS%P1<7!^S>KIZ4()<AR_.:0]ITG0"Q'TTP3>SQX2IV)I/&.GPW[ ?;.AL/_J
M?_=Y//C]$/_PQR\.?A_NRM_W=Y_\4N='S_KWP?,GHR'-5[QZ\GSX_,]?WN_*
MER>O_OA]_W___N5D=^^WUUQEF3UPQIU(M8L5L" X,IXC5\6*X,!L[?C%,A(#
MHKL1?7APK2- 6YY-D1  '.A4/$FB!HK3 DCKD/DSJD8[ BL_ F]?^]JV+&!@
MSJE4ZZ=9YHR1S.F"Q+JMCT'1$5B,"SD[ AU,7><4&,&UDC6ED"<P KQT"H-#
MG;FW+J3/2(;M%*SZ%/SY\G4,B,%(Q2QWL;;IU<Q%21M LEP4#I3.;FO'N:M/
M ?&\"ML/ZI^B.Q-U\QX,)GE:LV6&?^71R?9%E^BG1*<F*UV0E?Y%O/F,UOY%
MYWJ29\-)/B"NWTE,@WGJT7KEIF>' QH#WU0QJ!,VSN;<S>W!X%T>#$G6F<\:
M!Z,AAN%H.#MA:4*GHYZ@O_)TUOU:)D3@[\:3MR2*(%U<1?/I^;)@@W?#V?Z'
M(8:=\+2WGP?Q>#*I ^3_.Z:1?RC#]R2E# _C^"#3**-QG.>ED)AT/6V6R"(K
M$$)+8Z$8Y3D"S]Y*49PE-'O];)G,\NSY3Y\/DSS59^FE]JHP-GO\89K_^B#7
M;;Z">@. DKM__O8ZIF1X)D32M<$OQ%@820^.J<)Y%B$6R+BU(Q?9U'_]<+V=
M+CX78YVJ_>[ B> %@A9<$B\$$7)L.WVK._WF=<K*)&<2R]$(!MQ'YE((C(-2
M)H>BC;#$BI;L]&!8%9XI8<5<I0FD@QW&_ &(/B#.8#^G#J8JG': ,G@S&;\C
M1"$NUID5ZNT'I,=UNMR9YM1YC.VCZ: <'Z9<+10X.SY3TTC_FZ>[50##T6 Z
M;PTWP!@GI$'.+QN>[SY%D/7/A1G1*V#<'^:_ZBOL3\;';_9/@;'[];"++"*$
MIC>J/'5P >&FF?"O@\,'@Z,)'<T)H3P]:W(T[HHLAO%AFD_DM^U?MP=[-;B:
M;JB7O]L?CO+9*IQB[#RFZ8!&FM(S"#./CL-H&&G(V03K LQ1]MQC^\3@ES.I
M%\>3\XR&."DMS)N33NWM]ODB<SW/<FAKZOYU6]\=C_?# WIR=UNG$)\>I=,Z
ME@&[53NLVG2G7<?9G/ET+&UAZ8BCC48TUHRT^2JITDD.L_._=R>LCE4S*0?5
M%M#MY"27$0T][7XB^;9>?E+?ZSC2Y\XB4"<8YC T&-,.ONGF<<HQEW'*60=/
MYQEF79Y/+\WU4%8*5RQ1M3')@Y FR%*[_1'@<EERS@UE;PUE?Q,OGKQYK650
M10AD2B=#:I\AS5^*R(KP2" 7'8JXM:,7C;77Y:<B9E=$(/W>2TC*T/"DZH48
M;*S_:OST5G=Z[^EK8J7:>">9UH(D)PZ>A6R011&EB86.@2'5#I;L=/_1_ _B
M:7E4N>4<52^H&',KYB+85S E1HK$(H]3IXM4&!U.W[+.TCD>5<LF3>TP3Q[4
MLSP=3F?ULD[EJ"A;ANDX#G%R0N!+Z#G'PVE%VOKKTU-[[N#?'['RV1Q7?YVC
M^<G@<9S5RX6W\*#:9C]R^*L ML[W71Z-&.U"GDSG!NF#X?O.XELAO./B%_4=
M>JTQS6AR-8.N6UY?>GAXC/.PE7.;?+K24!T9A/W#>L'#2:Y^MK_RHW?#--L_
M\PR>N^OT3/"/MV"8CD?'LZMO.>>3J51+$+*>TU1ER@NK<^[/_<G'2/0WF042
MG=XR+#39ASAZAR?3K1\N4@B1Q_D%O.K=%WU&YU;CSV,Z%.7DZN4HY=:68SX/
M0N0J.M9MK#+OI%Y%T\'>S&6P/ZELYC^&0G,C(Q+0D:*F@#N2)D0@H0(T1QW#
M:\&W=O:J)Z^23+455J+]_W[ G66;?HDNYIRCF$2Z8)!<UR3]$FJ+"4G#NY *
M6AI_<'I/3H^KG=&HHI!GRXM'4)*4&N-$2=HEYPM).Q]<ZJ?.Q!7X2RZRS%\C
MJ17'H_RB?&2-+\IYMDG+L4=/_ ?]^O;>\<>G)[M[S_Y^+:0V+G+)C,;"@(02
MAC9[4CA=\89S+V6\O+72QHP%3:HV;(@JT'7*HRD^Q&*19(U,<L=1!;?)<?X,
MR:\)[JKT3ZR>E--.RSN%ZS.%X3SW(<[Z),=<I;NYKUZ)SLXK!^]P.@B3,::J
M9^YC%1UH,G\3$_K(+8FACM]UVO:'0_CP"R4+L>!#7PZ/G8?^(P?J @-H&4=X
M-,T/SSX\2L,IO=7)P^%AMQC=38\6 ?A21$#WP/G/'U%\F\^1_#19ZO3)IS]O
M=S]=BF.8_V;LMG/^RI_YMKCRMT\-*]2V%O:KAOWT([75MS/9+UN#SR2D?390
M:_'2)9%6<YFC5T'II^;^*TLEW8<EN&!M6$G3^U-@J$@B+H0+?76"XEKZIERV
M'-VDH-:52]+[&,559'.$7$22/' # DA+=IBKL3\'D;4A"6^Y;4)^WC+Q1S<G
MDA5H;4A=Z*2MCR+8G2D1>#2DYXQ>/7G*7_S\$I[__933^.K%'R1D_4GSW=O?
MW_UC5[SX>5<\OQQO>/",WNGWM[M[O\"K/]\H^KL^5]-8-2I!O_CYZ?N7?_\&
M]'])@MJ2#B@E*43D3$<I26@#S; &LD1,,9"D'4S.2_U!&Y28<5T:_8HHQW70
MZ']] 5N[V6+<I&[ _49$IZV0F+)/A(1><Y\X!Z$TT#>):]<0L3>(>#E7S4JG
M5/"&\5)[0B7A&$+*S(B0H@;,D?NM';W8H*$AXKII]+]N)MXNKV%[EZIL_'C1
MA=V: GX6R,&@-"4+$24'KPPJ76362>BLK1-7.%@;D']K('^V*-I:4Y++OM2.
MQC4 QL4JVN8NI<9D&R&40$ N-QG(5U-V>_U8W0K^KQZZN$PR%KI3*0$8O/-2
M:I>(]1L 7QIT]0>Z+LN@6@;I0'#FD_&,>!#)H!@Y*[+X+(53/J2M':4:=*T?
MNFYH1;V/Q=[.1TV>=/$593RA"PX';VITWN$\RN1CR%X77EJC^KHHC(^1*-/;
MB=,WV_H+7F-)+$=5I)C:7N+\JD&,<Y__=^+[&XC=7W%V[B1O*\D[]%Q;$S-8
M[9R)%E,T((L51D'C;?W@;;N+8KG*W*>0'-,!$P/-,\.B$D,EE$N!&U'BUHY<
M3)':(-[V=1"_>;SOEEC>"NS.]Q<:-68EM"I9D A9DZN*$1&=Y"+%Z) W:.P-
M-%X6^SD'R]$&IF4Q# (*YERM, ^:MDOG:(O?VA&+:>0-&GM IDO4@HLE3[ZT
MQ(E8O6"NM]UG95KY*9E6?$ZH'=R.+.Z_* 1O7H>C!FR/CA.-2@K&=?2+[ZZ'
ML-$@!N>%=\4!!NY+L9(@-Q>EL["B(>PMY#3JYT\B[#YY1N]!G_]^^=JB%"0N
M:N9U5R<I6!:@$&*BT=:%8J/C!)9^,1_C^W/YBO/LLB_2-:]Y2A0$"2+Q9#C-
MJXM@SLG4[D"U490W[93<]BFA:XBE.A=2TDR)XAAX2,PIX9@55I:<I$FA;.TL
M.R1+4CR^M%[5&G,RC\X5.+@RT7!PFAO99?4.IX.#,9UD0L@NS9(N&A^^&==
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M6-E6!["G2++@6<G"I\@Q,Z6Q,$"'+"1IF4P%,0CB#%&V.H ]I\;BD/Z3$%0
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M!YY=Q@'-E88$FL4B."/*3RPX7ICGEG8R@ OE$U;(A@7-X-)3C/+!&$S G<\
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MGD6>$)"X2"FU-\N2C--^T&VCN5!2\,%%HR1@*,Z#32D0]4F;#=YNCEC3)6Y
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MX8A[C^O(A;'*8"RU$U9EN[TIZ25W<\OB$\\Q=_/"I%LT,%$2JJT&93/*9OF
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M"7%F'+(N"92HISSI %?3UK8P2RN@LCSZ/TUN_IGMO;NQBV;M+Q!_YA!?Z:)
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M+U8R_IPGXM[KO[5R-'IJ4'2*(JZ4R%FV$M(R]ZZ12:HX/;'^55DFU\J_LH:
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MC0D>)TH3:#_%POW&P+<"=G\"-@?:+2>>>"51#%P@'K!"SC(,_[1*,\EXH#E
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M1V88J'=K$@E>,W NL),Q;5VY!R?]?FYW%JEC.J#$<@ZHBZ#I:31 ^MQ3E!B
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M3)@SC8>BYL'3DU1&VP&L4&7Q?[NSI)4!Q)6$DWE*)=4>2Z6-BY9IKD0U8XV
MKM3;_)L?RGZG+>N2DLXQ)'D>M48-1@9;A5BTWG/%\M3$)\_ILP6EE#/\-T94
MP'NIUV[WSLM<74!0P((3>'G#\<7.0NQ\,@I'9:5"#9@K9#FX@IHSH*!:R?4@
M=;YN%CN,8=Z[$6"%O(;J=L5@,,H@ @!DORPIL64>Z"RT_%+7FM@9C%OI]4F2
M\F-$@.,*B3?Y%;MYTR?4^M.>#T;%<'L0LQD',9LW5+M.DWZ9"QQ>@F@W/M85
M;;.9TYO-8K=,WAY[%F5]T97Z"N!WMWMG^64F)O,36$)0)'\/;5V?]*(#2_+V
MJJ"A'TLC.ZG\*Q/C-UMK;&K5S\MR+/T+O_YZGRLKB/'.I*00*)PYYCAW^!D/
M5MLHX5U_"?:BFI^2JC6RA*VL(S23B, "EQ\NB(.R@N]Z8 [00]Z,[TLA5X9'
M(32U27$AF=/8>R>Y,M)(5PV2AO^I:Q[4]H#PH>#K ;S;BQ8E ;R)0! 1T@-\
M]0!?)7A/D@6:^V<+;!FX]WQ!^OCXB' <#QJ7]UX-P9RN[%V)5PPECF/P<$C@
MQ!H+OIQ3.%$3',!MM^65-?#*AU; 5(&_R9")>8X.IA'IQ#"BWD3,30)7FSYY
MKN;;[,^QRB18_GKBZH#]![4$"G[LLLPY--,!(\QF \^W' 3,!/<G/E&9,)Z+
M2R_FW?TRN@]W&_GA@F,(\*9J%R<'TF,N:BQ2X>UT]+S4P+-5\F=Q6.:UUW=<
M'#7/^"G!#[F2?8/BX7>UW/*F$X%RT\JWM\/R:W.6IHK5.8"+UN<!O3M7WZU-
M6K9 7Q93S4T1HW1$ZR=U2G=V,*;,]'>JF\+E[5 E,A3@@'XIPB@?'_FZ(K[F
MVNGIOL7P^&JF[]ZHQ*>S2BP?3IJ<[QULY"1BJQ+FV))$9.!4I=9NWBVLROY6
M^8>LS9;J+[A_+P!K[%ZMO01NS>K5AKW7L/BWD[57<&[PHEKY[F3A\[THPZ@_
MZ47YBVNXHU9(6@3B(A+6@H930B'-@T;..LLH%O!1>/(<!+AQ$6U_K.=J\I=S
M?W,,)#<#&?-:[HL(?%SGI59L.I9NX,.V[=?*X"KH\U<)==_FYEK9<E;]3T!7
M%<,RJM/;,/C;AYN?Y$"0'=JUHN"8<H.6LI/,R!\O$F37[XW@@JWT_H32N_^V
M%;S%P ,X#_:+>:JG1=:+@*00,1EB;<S)D#=);Q;$)1+\>^-I\=O_^2\B\1^E
M39DTB,E]6097X+<8Q%RC_P=\?>;[W<+W@!_*+K5^W$2EK'&QH0R.?HGE-3,7
M75F<\1G#U*5E2\:J*]&XX<RHVX>G][K6M?/Q%W ?<'RYEB^+;ULU&2K#Q?FL
MMU,,,]S)[EUI5HMNQ7 9UG1[PZJ_SCF\8N.TVSO/<=Z&_6*+=ED;E7]5Y?K5
M!GMRFYSNDP"CQWQ!IQBTHRU]@HQT;%%KM1PQ:O?@._;JP@226_=!ZH[3"&L'
MMY+V0;F$\0:"  YS:Z;<5JDB#[SZLC>W1_U8/7FZY]/,*_?C47VT??<'3Q,(
MU$S%4F7%6(T-,\.,;WDV<J!D\QKZV9_NY9!',9A90Q6X+[*U *B3<6M^IR5<
M,O52-6''9%WAO6;>H=>O'S_WK@O>;B(8&6R=EYCJZKWB75YKYKULNSW];H->
MN^32P>BL:J@UM<SR^[,"\4<I$?F>RS:K_/ZX)=)&]2Q:BK)?C(Y&@$0KG#W5
M 6#J6')0V;BKA*/4[W5NPN3=LN2E)'P!?TV ?*-W5G0GYU/9=-6'0C=C_'Y,
MHT'%@]E]R7VY9^[:'^5(TDXC?O7Q;%A1KAC6WPUUS*]TWN: T!8$W14$@7,$
M^UN'7NK]NU*%N1E/]H\<.%*-IU5==E8&O4I_C \,E^G%WZIF9Z 1QMBU?L!U
M ;M-8N$^E:48PAZ46MNVX^2"B]QL+91V!Y19?OKX%'.V0U_)N:6EZ.1&>/#J
M5TN8.]O'>OYL?]H?O/+<-T@=+([<_U4W=-J\-F;K/,^XZBST,N.P]9YH[)?1
M!AOR)U5@I\C*;[-T5V/]!QBS[:WBU[.B7^6Y3OK&EH*;;7R9+G#6 VL'0+$\
MEYA/K5FE#3G1Q&%& PO:\N2TMIIKFY@R.A)P*,I8<ZYFFHTU3QJ5C ;HR-JS
M>9>O%,ZJ$?F".2!+ \V_='?R_5.V=WG:4HH(%8Q DE./N+ &:4H)N'3!8F)
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M-36NGJIF@$^*JNK3ITF&ZUSSKSE259U\RG32LWXLL^CBSFQ68QG4OZH#VX2
M_HV[M9'AH=?;X-"JOCW."08FA11CXLA;)L"WIQI9"?]4- @6J< ^@&__NDC#
M"V"2K]\4&1KW4H,?JPRG53A(6<R<-]P8ZKG)/P=KA*68:$4B)@_'05LNJ;G$
MMR0@]%2F!QA @)Q2AK1D"0"AL@93)0V63YYS.<\>)5?4R0(9$%86*.?;5T.?
MAV7+U#*,7YYK3N<,=,J*5R CL$X7G)9!KTJDK9AH+O1_9>:6S66OT@'&30-7
MXT)&06-1GBSAUD9'J!0V619)#.DAN7"KQQ9PZ $!Y^1\[^14O-]_"^MZT;()
MM(,U$?F2+R.VR );(DO!Z"@;N2"Q+(]:[*ALFI_RQO9]L=9D^YWYKG"S#0BW
M$].6;YXVVXEID^W83DR;DHMZ8MIM$]"N3TQ3@3(BK'!1\)2L]B1ZSZ0( *(E
MXYLY,6UZW$;54_I*E>2JR>F*I^N.TQ^-X]YYCM9-]TZ=U)3;"3:XJ9-2]86K
M>L YY\S5N8K#,2K(JQIU2]+FHLT(0MG)U0VSK2X7^>0S[3YLW8BP[N(P.VY@
MC(87]>G>N''7Z[=##9M2T>_<U )WXIXOF!Y\U+?=8=4G? P/*V\<D.-9K)JM
M+YFS=46V+5D6M.6:3DL<]V*O>Y_#GGX!0]T=VGZ1:[6KJ,GB6-94J^->%7:Y
M'G2I"VP7DKZ\>KZ7?$WU%7-9C.;8!5#Y+!G0^%AK%93F^9@[\,!N2T:_$>37
M!Q'C X@MNK^K_PD(']"]HEQCG5 *,L^!3AP9(SB*."KA<3".B5R0UH\WY:YL
M6.3]9>\XKC7HOFE.STLPH':MAZ4;> KQ\MB"DMJ4$^0;XGMUJ&?:+$P.D.=.
M(=Z-^D69S[EB.2/&!%MEB(X FX6E28/2IJ"RP<O7ZGL4]&'L]^H&>N-#XZUZ
MOI-Z_M!*P8"!U 0QBC'BG BDB75Y]JFE+'(E);[IE'C3-//'6(3U9FTT-B^5
MY=^V>[K64[K?KK3/*M-7[DUG+*DQ_)8A6UNE<=3RC&M&DT#688&X)1C9W-HJ
MLJAL%-2[ $HC;]N\UAC#_PFT6SBLZMN,#.76.Y8D*"_&0XQ&$9Z,Q8:HE!QE
M]VMDFKU0]N;8VII;V>;3>3,/_=38 ><89+#VB#,//TEG$&-))>"=Y(5:8FO*
M!E^;:7$^1^ 0VU]OB_O- [__L5W?6V^.]I35F6B;ZW&F\8RP%<S2_6F9K5FZ
M1_URT/)"VD@D:!42 N+&>J2M4 A'0;P21$OM%\]^K(W23L.-AG,)16"$KNI]
M0W766_:D*EL"3V7>7L4@5_*,4A",*1H(-5P[ :LT,G@2E0=P'NGV?'J=;+7_
MHB6]P%1*C81E%'&=(K(> UM1B[VU@2D.;/7^L9Q/_U6&:HKU1J^FDS\6#W>L
M%?15^^$\J[1.9,^G,>.,^,G%-^?%SPQ S=9RNCGE]&2JZ7$PB\YY9LXT)H'N
MZ6=6K;RG.KVMH@VL3$HD[+V4CB<*+!:(H,PJG%UQ';;:8*W:X$-+244)UQ*!
M=DZ("T8 SDJ"")$D ;I55I&E\>R-3*Q??Z'+INW(1] 3O=&#MU"Y<0T;YN6\
MM&?]HK>M,YA=T^ZH..JNMRAE9W$/A27%85?F=,J87K.D@]M*S'*3NNG"LKIX
MH9CIJK,EU+4EU*D)TQ2J>L;6B:\;MV?KMPL;*/&U:=B6H6V6:9@M>AV=W;6D
M:A5HKC6+PA#CM<.<N%P)HU2TED8EE AX"\W7"LV/6MCXB)U)2'"I$(^"(JNX
M1()%XH22S+$(T/S15+R^SGWDUESRNGD:^#^VWR_67',X$[[H3L4(*A54QRBJ
MQ-1%P8T)EJH[UB\.)$Q.PY9KJ:PVKM?M6<D,]CI1QO/8;ZU@-Y@F3.*DH_+?
M'9ZN=565&;C-A[M[63[<\U7+*)JTIBQ'I3WB3FMD78R(61*\C=H$8QY1-/'C
ML\9N;W34MFN6R)S^'<8L>:UH=R:(>*,X;D1+SEL[]_OC<BY*-=8ZS\R8#EP.
M;AMDG6=*V(US-M;?1>]ZN\(Z,WFE]FFUCY>*/A"E)%-)GT%]TZH]['0G[X7%
MCO#D_*Q)G\3!53E#'AX)ZG_2)*71&PU]KJT$YSL/)(&7<.7O)^'K2>E#NY<'
M2MIN_IK+;S(9R#5NNAQV)I?5-1E+7J&LW\R#G*K6M[4G>V;AI0EM=&"OC_-6
M?.JV(SSS:C@7/+H&X;:<[5/X4=OV:[TVKN28%.17YVOYVPOSQ\^+=KLQ>9DP
M\M7L3=N]F,Q]F:;-Y+;Y9K9?UJ\!"<&,Y_J/:O+A3MWWMWI M=I^3.U<;&!#
M+L2JI,C90=6V8;:[SA0,*&<);=2LEF7I<@E8K>OC6)T,>XV\4Q3_\?'9NV>-
MC_&BVVN'P4[Y2_+'^,,_>_TB'R.%\>\SXXP_*XZ.XG#8>-/OC<XFG_?+NIR9
MFS;V@5F][S5>9I)T+W8:D]M>_ZB\_\R-X<M_OMP9UX( ,=L7U[9[8?F6$(J9
MZ%7$@7"LG<.6)J$#HR01I>?*MQP62:2H4]*21Y.LC490*@G5A*=T8_D6F2WD
M>^BRQA5;.;\<]?M5KN]X8$_5H_ME-7 @6]!Q-FWCQ6S6Q%*VWMRW?=K/56S5
MP7UND@XZK_'?C4XU__FWE5YH6"K82:5K[F6/?#Y4/1O$W\<__ %@!'3/Q>]%
MMUQ,>=$?\X6>7_+ !D#']4/*YU4?U]6BQCS3DN6"T6$?_@OC!]>UI,_*6M)_
M#</\9^89$6;II_@96?K937<EY)FD]-YO:YXIK![@KM3(A]@"K,0#+/8AZ,7H
M,ZKO1J]_E1Q6<1GP<1:)__\3T(BSK'ZEW/(<M2(TLCC_47\X[)U=^R1_>):;
M1G2/?J=G7QO7E&([ICDAJ)YPWZK#W-9?OBS+GB0)3%1"O6N_ZH;4-J"Q"[AF
MNR?5GDPF'S\=_+;=DVI/RM;L&[D9I4U?RXY,>2UU3N?#>-WBF19W6-*"!AYY
MIQ$#PS,/1;*34W5Z>$I^N]XR9)/HNPXK,2Z%GI#5]?_U_&D%C[<J8;Q+V3NN
MYK3\/;3#T6!F8VY#&]:?'I6@'=7+]3[&E);OSJI; W=XL'VY>_2KW*G_]%*:
M.NFYB7$>];;<N E7,S4I^[5WHM(CO_8>- NX*=JUX4ZH\P?MP\-#B<6;\=\K
ME*<('#'U4FBJ""<>&ZUCLEP300AA?#+M\]K@6'E#<L(4D+FU-F79_%CY2,_^
M#CZ_&QSNGW7>[WN^M__NN'GRX?)P_Q,^Z'PL#DZ.>//R[>4>K._PI$D.+C]]
M/2SJ:_[GW;'KA/;[SH'8NSPBS<ZKB[W=O?;>_L?B\,V[XOWNT64S7W/RL=.\
M_.=D;_]UYW\N7PWW7N*O?^Z_&C;S>^^>XC_9QW;\S\>+P\_AS%$N#SN'G>9N
MNWUP NO>_WBZM^M%\_.[T\.34]H\^:?8VV_#'GWX"N^=]N!Z>'8^?[R O;K<
M.VH%'EPBSB.B$D:Y?3LR BO$'+=*!4MHPD^>B_G#QSI4UGBZ"B\293&-VCC'
M"$\ZZD )]\JE8)F%)VYY\5?E1=+\T*+"!6[R#%.N".+82:0)T2B70#D;3:#*
M/GF^8/;:F!>OX^U;?9-':R9N/\Y9V4[<OVR.O:*%<KD5O=5$[^^;16\/UG=X
M\D+L[1_@PS<?CT&\OL*>T8/+?[<//S=A;6_%P?Z[HOGFXW71.V^^:-$\KMS;
M@#16N8(_)62EERAB*9*QV@>KGSR?GV+^"XC:K8B,Y&@Z,'=1#D".W2'X+'E,
M\FSKL[J!X%0AZ;,%F[>R$YS*_VT2BE_1U?TS?BG'U'T#IM^\=[_Q3?^.9\-8
M-L0&14I_A3>>:MXX<]#_*[S[=_JKW_.VC\$KE5QJ;QE5(B8ND[9@;HP@\&^L
M;+*^1!L4&X:WGL FPI&Q)[!_1-[O-\4<'-GWY& _M/=.#N#OMV3OS:NOS?W3
M\S+K]<WK-GQV?/CY \"/UVGO18M3$I3A!C$5?4;^ AF=.\ [1CU.Q">;GCPG
M2Y'_=\"0GUW0**$^6IL$!KH$2XVC!'O)?)0X)L]6%[0MK'\ 6+],CCH?.-P?
M/.?7QP?Y.I"=9@?^VV^WF_037/-/T<S[M_\QRQ%1V%/%!5)46\2]P<B0))'A
M3C'A')<QW3.,?V3R4X'UJZ;>TVT?9KJ:#WN-_>.B'QJ[97MR/ZR'C0.RKRZ?
MS$F\#Q@_[PSA9V)C _4K0OR__3&L[?*J=O0[_<1-WIH;-^+%6;]H?SOZ_XEV
MXEX]@Y]H7^[]E.M^=N(Q !U#L4^<!0OHD1M'7&*2:8JYBMQ0,O8H^-:CV$ D
M]/9VC^)-/D\XO3CLO+T\Z'RZW'L#WL/E$?R\USG\#'MXZ<]A3>S]F]*C2%)Y
MPZE"B1*#./4,&6<T2EYR(Y1U(L:;SA+N-;#YZPAA3%A'(;P*UG!)M".<6"PX
MCT0SK^SJ0KCU-NY1QF[Q-N!Y]/V;?X[A>G;X!N[WYO#D\.3HO+G?A/M](.#-
M4Y"]\[W/AZ77KJQW4C.$&5.Y]15'UL;<7Q%;1[V+B=VWM_$3R=:4)W+-$0'7
M(Q\5_$#WHW;B'@F"6O6$H3@[^YX8["/9E;N?/9!??3>^(Y_N)]J%^SFA^!E4
M\>HPAWE#*15>8L(E9Y:9$/)T4FJ3<D:4,(=L3R\V$@<U;_<U8(V'L);FR5YQ
M<-D4>[M-?O#Y[<7!_EO1O#SX>OCF$VU^_J>S]Z:,NEI,%4U&(LPQ11S8 5E"
M%/*&Y<Y0EM$$O@99GD3W_>'77U(*'398&B.#(X3; '(7!=-82W#XM?9A=2F\
MT=G82N ]2N MG@BLM7WX&=Z_\_9K\P3N"=[^(7@E!R<'EX>?_SEI7KXBA^6[
MM[,$:NZ"PXJB*"E#/'B-C.<8@=,)OKZ*%CORY#G5CTD"UQ*?GO-&ON4<9'L"
M<GUC9X=\;H3'NP[ :2^^W?WXB?;A7LMY'NTN;(\ZOCU5&\OH+9@ZX3FWT1N+
M!2LGB1-"1-(U\!';,HH-!#\?;G4_FB?MTX-]SP[W7UWNT7^. ?R(PPZ\%ZSG
M_>Z[SM[^*WJXFT.QAPG 41ZK>P%K)'O[G_C>44MK&333$2DCP1VQ$2.7%$$R
MST$6<'_KU9/G\IY*>I16P@5%I:. N'PR/(5 )'7)$VETW/+BK\J+XOV'5@PL
M:.D\\I%AQ)WCR#$>D"9)!>N#8\'\\)*>7\=0W+]P;H_C[E'V)C4]+RYSJ=Q\
M$NU;T=P_A&<W0?[>XKW=5Q<'G==%DS;IP?[A:1/V;P]D[_WNQ^NR1]Z_:'G"
MK4P@<5)PG\-2&FDO&,)"2Q:4DX0_?$W/XY:U)0[Q]G3N_ESC:Y,X-B+TLBYV
M>QU=?]SR O^PUD"+UO+-K8'H]YCJQ\7H/[STZ:?8%_A->ZH[^$;LPV. <M@
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M7SG?TSYZK<E3D?UJL >QGW7WV6A837(93.U>[4O//'ABT,=:O]+C^>LS0C@
MZP'(&X0U_ZX,^H#K5XEMN8"K=P2&=''Q&P'_%Z&T4M6^V'QN/FK;?OW87OW#
MH/$T+S7? ;Z6@%0W/&EJ3^$]!KYW%G^KWC=_NV^+K,[KN &LIHIRY"_LY.\#
M!]3J9V?\41ZE<GPQR"?Z56@8"#!HG,=V>Y-D9C$_5J+A<T)"&I]?3O0/;'U1
M15_Z6764DR<N:OJ6TR>6>41Y?ZZ[1$Y0Y;F* A/NL;4V&8<=EDHR+@1M[6;^
MQV)))ZVW>Z]O&,J87V*O-WQ9O48,>R7.F;A"^)=VA0[ %7K;(IHR83A%U!&+
M>*($&>\2$H2F(&S44:@GS^6"I@:WJ(3,"5]Z[3(2-IYWTVV\Z)\"5P(C/5V%
M23S!T3(BHY,66(5KSZ)@CC.'690!;YGD(9GDH"6,QU3F27Q4:/"7&0-_V09$
M<&Z1PHGRTBYJ?/';3N,E8 ?PV+J%78WDW%!CI70Z&@<_\US/&:,W-"I-.)-;
MDC\<R6$]+4)\H)$KI%U(0'<ED"/!H) $B52:*+A80O+=V,Z'N'$U@FN16&3<
M FT#!YFV6#DA0-2-4<)HOR7X0Q+\H.6QMR0Q@K"C$G'.*#(8_@A:<IX2<83'
M)03/L'4ZX?MEKPW[NZK$$\6)%I1H; R/26JP_Y@!#J">*&/TE@$>D 'VCUJ!
M P2@S"!B748"7B.M340R.<F)((X%N:B6_K>KZ/EJ H])=-8EII/EG"1'@^%>
M1JDBU7B+_!Z4WH#\*'/,>*N1X9(B3BQ'3A*'G%/>)AD5U\OH_;8-'D.O6!'%
MI=Q-S4H"]CORX.#V@00G4@"] QA"; G^D 0'#<^%A9VWR(*B11QP%-*,@:@#
ML&),8B-H6%2=F0G>.U]1ND4"X?86>TD%#\DZ9X2(V&,,-CZ)L"7V Q+[\D5+
M,!^#T!JI( /BF$NDB07ESI.FE*L@%%]BSO_?-WAHEDN?334E,AL+X2@F2H+[
M2'$"^[TUW@]*[@\MZ[WB5CJ$B?2(9\)KXP&SJT2BU=S[L+#A-)#[S]ZH&!2V
MNZKY3H1&+:(0.7S#I)94864M!;C(8DQ;BC\DQ8]:0-D@L2=(9=GF25 PWR5<
M,S8&:R)6RQRTG"_>SF&;E0CN."'.<; 5X/(KP.F>6T)2!,]<)6FW#MH#$AS>
MJ94D"0RL*0(K#B+.I40.4X4"&%2FA 9W&2\C>.&/BR/;78W@&&Z+K:#>2<8C
M<5HKHW $3\""@-LM0']0@A^T=,@34JT"CYQ@(#@'"6>2(6$(2\: ZB5A*<&[
MW3CH#5?4Z<P::Z4,7GO-C8D:?+,(JMU(8#XNXY;B#TCQ_1<ME9PQX/PB[;')
M5AP0>O01:8!5((>$$YF64'PO?K$K>^":AY@<^&,\<,T,6'.C R.8>AMTV,98
M'Y3<'UI 5$&C4"#6D0-&MP0Y&A,RX)I3YC4@*P4>N%E,[_/&NWSV=K&BB&/Z
M_['WY<]Q&TFZ_TJ'-MZ&'-'0H( "4&6_4 1'DCV:,"W9DG?"/S'J)"$U&UR@
M6Q3]U[_,.G#T0;+E@_1S[XYMB>S&4965YY=?,BITCK$9S7D%9D,* ]X#ZG3X
MRW'/_\@]/S\CJ2JLU;#=2A1(D403Y!]-5%792I$,##P<\7+?EO_2M!\/#,0Y
MXRS7RA85Z ].(5+(<@&> ]&59/Q8._OC-ARN^1H"<9XR07BB#,\3"IN=,"0K
M)5)S(2TW*B5[TFQO+NKF4 /.LHI9T"<9^.BIX5P6!9-&,0ENNLJ/F_U';O8O
M9YJ655D2V&=2P;\DE6"[T66#3;9"*I.G^PSXFX\+<=%<'FC")4\+6AA#3<6I
M49J5HM*\S#C/TYR(H\?V1VXX>&PY!$<F-3IA5D%05IH\$9DQ"6&D,E8QDJ;[
MJF9O6G/>'!J2*5,5E%5E(3GEQ@JARS0K!!CQ3.=<'+?[C]SN'\^L9;F%F#BQ
M1&@XWVF9,"9MH@H-$5(N"IWM2[J\-<ME=[/X) Z&0M@L+TP)!YM825,I&>AU
M4500@:>&I/2XZ7_HII_#&<])Q2U/BAP+913,N&26):J$Y98%,V*O4G^[AG5M
M9C_5ZD!#3D2JA$DUIT5&,\N%UE3Q0G!;@03:8W;UC]SS#Z_/P#.3>5;)I( P
M*:$5!&D<PK&$I(9"C,P@?.)[]OQ=LT9LL6B;17UH4KTTO+2VTE902TTNI<X9
MN!22E5QE,N7';?\CM_V7,V84,507"1<*CKHA.A%57B658F!O,\G!D=ZS[>_-
MYT.+9F##10;B9,%!IZ30@J62YA73,E.4BZ-B_R-W^]>3LXH1B,PRF2A)#2IV
MEG";I8GB!D(T4@FE=\,:__N_2)E^@Q64_]0==O?4!_IQ.DN)$&E%\BJGA5(<
MG'5KJI)A!E"(8[GT#]WY'\^HTBF$2EF2IR5+J$UEPBM)$HBAJ,S!U[+Y[G/^
M;#9[9QY;:R?NM  1](TN@1 E^<D@D9N>?5^OZG./X'_(#A=I%LVU)]S 'A>U
M[I L >&"R-Z1I=]\CQ_NW%_(-PY5'G[Q\V+5BMGTUY/F$]_4@=^X--JU6UPV
M</B:%K'G.SX9NQ\C&XF'IS_^IHP3UU/2LS=7<T<5/H_P>ER $U@KB"\0?8OZ
M06/'B>X[Q.<SL4#:E.L:/!3/1:= -EJS6AGL8%E;6*=UZSJ##NSCJ!@K*!X;
MPS,JLYPI7BF;IH1!7"1U@:WMR.&?57L4V1YJU;=^KUZXEIJHR49][K"6"GO=
MKYM6=V9YU').RYW#L_]XEF5EA>8C20D!)Y9PDLB<JD1D3#%&B%86[%MG/IGE
M=GO'M)?#]X6%ANT78BET+9:.T@4;USS1SD*B'D)X 1X^"7_ZH?DD9N]4LZKA
M+^]$]U&LU(6Y%LOY[)\MJ*7N8L *H_2^6:ZP?<SWB-WQ^<,J72HW92J4+2BC
MJ2X8B&)),UIJ9FE6'*7S3Y?.\S-I2@O!E$T@W 'IS'@!@DFSA.0%L46>YC:#
M$&MUW>QH/3)7HG5]XJC/OQK+SJ2EL3/F8Q#D:2O;I)MP(!- XKAFUJVMQ6[X
MUG?^^;]&NK?8WP@FS/ANOX'H3EVT8'?4K)'=JEU[UK>K]0*,D>NZ]]^8S\PE
MM@6:2S@3%T8@KY#_#=Y1"3A.[3PRR(46JT&#!Z:K06V'ADK7-;YY5K=.I%NH
MR:'<6JSI,EF_>OZ ([/%UEIA(ZF^QP.>BE9=N %2<W<AW]3>F0T]<XV\?=U*
MW'C3);#5<[UP705[S_O(<&TV$56V2C.6DA("+,&5J!1$666AL19"E,9C3\#W
M/L"[]H>\L:=C:WD\\_<Y\Q]>GZ6<VT)C?:1"2$NJ12(+(Y+"<$H5+9C5%L[\
M18NS;S=/?6]V5H'R;^*QS)["AQU=X_5%#:)6=\@M)D)_[QJT! JXY^5J5B;*
M$++ N0L/)'*>2; VO2R_@-./[F0W.VE; 7+@N,A.U&KVM+]75X/#)UP;_8L+
M<86GEY"9%,N/[?IJI6ZB[?P9I-9X"B307(%N3,4[SK"MOW6GU[?VPP&!QU7&
M.&*L$0FS&)9#]*3-GH1B?771+)Q"VGMDVC5V]/_QI^5_3(O]TMW/5Q=FH8_'
MY#['Y->3,Z*J@DBF$DD1*<#2/)&"B227.<MSR7++Z3[3>$>C_J>P(WWPL[IH
MNK$$KIJ5IWL L6J;SS42ZRUN9B].7MY"=:7$)M5547#%5>$:-ZFJC% E*4&H
M2L,E8]*-7$!A<AF.;:E*^$BH3AR#39BNL&I<F/L6#.?-_1BO^-]>HGX\*W/8
M!MB,A*1<@.+-;,(RFR6Y%7EN1)IF6CUY3G:,YI*>\.I1)CZ^@T 8G X3HO]
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MVT[ @=JPJ"0I=48J Z) ,C",!5$YS<JL3+/<J'MKPZ,T_+[J\.6/9YG-=,[
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M"O[578N*#_LMR$NM!0*(ETO3@8\QG[TWGT77XQOQ?U=7]:Z"]2?1ULT:W*I
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MI38WG%0%-T3E"NRQ*,J'[GS<?0IZ),FEUS6= UV&UNV0B$$/Z$JTCJ4323Q
M7AUD:F3"/*^L:]+3:RS,CLG91.?C^(-<&HJ#5#.A,I(;FE+%8 .4MC1GC-N,
MV-_5I3FR7M^#+/*7,U+EJ<@RF^C"T(0JF26<&)ZDPEAN-6$%YPCXW3DR.-9^
M=SH^CI8M)&O AKT02Z'%8PKU=Y^>_QB?)!^HW7R4,X49]49YY.=%"[\SAAK'
M%@<=FHQRJC6H0I,7E!$BTYPI J?$5N"*4OY''9J]-;._\ZDY??_Q!M[I3"F1
M08!&$YSF#J?&\H0AL6:>$:&LSB0I*;B#<U;M&/".V<E/M4:^J.&P#%,D[B<6
M1!I0GG!$F:1@RK10R".BP)Z)2A?J#].E1['8*Q:_G*6\S*K4E DW59G0M.*)
M+(1).">*B;SDC.DGS\D<XOEML0@07 _L1-S#303B1BGIQ_>%D+)3%TVSZ#/G
M\'M/$(;"A&QSBU%>/ Q@:VL9++E'E"K4TDU[+I;UKV*BOW^7I,^CU_:O)W"P
M,1O#OT%7*VP]>(LSPK#Z<(K<!7V98D@!3_I95-,@"*7O/!@H<<:T58$@8:0)
M<$MVV]%+WV 7(6SWX8+XH7$(H.64% )"$OC LA;!L3,KUUIQ%:)^V*X=^!<G
M XB)QB9X"$NWX&&NC!RH%7U]9-\R;3-?!L;&@64H'],?7&%'$'9=M#4VMHU!
M>9-+_,?TT]>%/SCX2 X6/^).W*#QV_>4C]]!&9JO+IP;OYKY?=2N$>76F30[
M4DW<< H15BF+O*)558(9,U0AL9C(4DI+9T>^;!+-"\Q\_*=>7;PS*Y=?>HE/
M>/3,=QL3>):/UW#?SZ?OX3OP;&<TXU0)JQ/X#PXILF4BA$@3E>9*"XB1'8_[
M:K=K[M-.(__[5J'W^6E/Q>6E"=3^,&9Q&!V"XA61HUG^^ _+?\PVIS$L ,+O
M-]D(PQI-E+"C$YA:6;^R8W=^K-$=<8R[H-=M(T[.,2[H"_6V8^P,*G! 0,3W
MP9_&^P^OX O2B%EIUDZG?D##YJ8517)A[%?!^U[C-)B^:3C>8C<CS3B/B6PV
M;G[GVMK:];.BOO;T-K.>=3AT_(D!_A1HY4,)OFXG9)BCUP93V".&'48*X[/[
MKP5<,NZM.Q3]<)!8_]GVHS!ALK40@<:WSX&XA^\F3W:.0>-H91P:^0J-)^I@
M;Y? '.GXOD.*!G^S6IG+*[<<RI6[+EQYUJVH<GBM_CZ^[<:A$%QM:KBC?SE_
M>7<KA\;K;[,QU"3=LL!D#->!EUR:Z_[T[%_@^5:?7EB]>@":9V0G07-8N+";
MPYOT?68#RS3V(%J0K+%L!$I<)_$]#;;_(8C-)M.H\V8" :H3Q&M8R<UO#Z\U
M?'%$%N6W?\@%^),4?^MV?.,383FOS"I07O<(,J<,O Z DWX2&AYZ=0!+<3%[
M4;<*6\HBUS'V-('OALYXB_[8IQI4Y203XQ<J ER<=[J]07'%I\3!V>-7Z2>3
M:.0<?,HKA_'V=99NFG/:E!-\]6Y+Z(-J[EW^V%0]U;[:X)@='&@1"3#@;AOW
M1TR[\U1!Z/&&#L<Y#@F<\'58O@ZZQ5\@SBU8NUZT=I")X?[S&?A9LQ/PL19P
M(WS$U<U\CRO_Z#?1'T34X["&/J)$[3II9%TZ/])U @W[?:^0R0%EW;R/(308
MO!EWN\>_1'N]^/":&XY\KBI92$9*9A@UW/+*J"+G>6%3D^52W<>1CY[[>\Q!
M.)K?0)5X]-KO3 %]@.]\.#\KBY18)4A2R((FE*<\X285B4TMV .CTE(4V/6V
M;O>FT^].!*% ]_F :*+6/L7C3I8K]M0(6,$2_WQT:I!A,$ 2P=\ Q6)N0(F!
MF6_]2+ 3.% ?0=?\2UR+NAX-\]B<)>;\.]2S/6[']ZL'/>M[\C']O3*#+^TM
M8QS>AJ_CX_>]/OJHISJH[>D#AMDB_<"1,2[5+<+@AWQK9!L5/O@>8:R%YS6.
M/@F9SCJ".[Y9MSN\'T^!/[$UP]+XY\0G\<\:7V TSL-U<#N5W0\C67C#,MSC
M,A >AVXF[Q8-79_./YEO7ZG6_16VOQ5ZXI?KNO/3)4.D\GYZE3X8NFVQ!VET
MI1*7B(B7Z::!(IU/5I_Z"R')2$CZ;"SZ/LSBYLM.EKV''>.3B%%29)S)1(O3
MFQLOC=O'8%33^6O8D;VHW]UH5NP4^).X;W<_P%\(/COJE$4W\:>3U[-W2-D
MND_-_M4LW$B,,!X!I7HZ0^1_7 WP1?,L^M^.8#)2Z'ABV_$7YEO,O], 9-Y3
MU9Y\_^(=_NUU/Q^JORS\^ +^=#4[;=H6A#Z EKO9NV<GS^;WR1^_$MUJ,PWQ
M/S5N"$8YF]2_R LA5KX?TV)G9QA ,1Y*%(F3CFTS>]IF9N#5JU7;+)&R!&*Z
M@&5]7&L%*GLAF[:9/8Z^@9W<6P?B?(<B0X#Y0H@GEEZ8/;#73>M&:K)YG%TX
M00!'ZQ'S%>#D;:0$\)!NHON"B1X/ !^\A.6N/,A&0F)GGF' +( ;=O-(C-.M
M6SA69WZQ]JNNH!O=&!?3;JS'* 46I.)6)=:KU^C%[M1@NV?V[<+'3_-:HW%!
M[L7V3PJ:F@L_%3XXE$%$1*1Z<_G"T:O[N\;0."QA-!\]NFO3CDQO> ];<%IK
MO9C2R[LT]>R%:!O84!%Z2G^_A7QGKE;C$J28?5CCZ?1C:/Q['M)ZGM,R2Z54
M>5Y)JDPFRZ*LC"EIKHJT9#:TGO,XG);GZ9<,IPUC<H[3:>^+/\M/7YZ?24HI
MLT69T+Q0$"]+#?$RSY+<,$YLH2@S$"_S8G_W.1Z5H)!=,@R._43ZYJ ;UIYS
M,_"7+"8:O'9T#MT=Q>A8XY^>'PC7KB".]-IK?]UU&7 T4SZI2G!!*FNTLE2Q
M3#!1LBK3Q+""JI)&!,\T84/WUUU_:FX@P+SYUB"9%.*PX15[64NROYVP_5C\
M\%+1TY>OR0^NI/KQC,#::I+SA E2)#25)A&EI$D%/S.%-:G(0-B*9]FVN/V?
M6>N7%SW:0.7F>GL<RX&+%6WD7XJ]/Q-U[M'TG_Q 0/ _FDO3(R(<><+GJ[J=
MH$1P;-HGX48$KB*#4);FA0^0G3[OIT2Z_#$2' 9U'V:0CF;OC;/7CG 3C-+"
M=:@ZQDS\L\-68QI6(06(2Q X(_7=R<E;=Q9NANN&V::J.5^ZBX194#@!<.ER
MZ"-VAV'4$PJC(WB:^<I4#S;)R?RO4GYP2>MI5"CZ?=AE_8(VP-) ,,\C'\YQ
MV8U<N)";<S\>?)K)T.*-B'%:3'J]#'WR+EONZ.9F ]]</\'O]?L7P]@^K'9Z
M@?/^\:QS<]:'%A0QM+:A>/9\4. 'C"7V<04KLT<;V<V/8=WM]!M+7[-NEGY
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MPQSC46'MMD)A#Y4>I?EQ ,;*Z7I?S?7'<@Q+FA[+#;[6W9BT6V'5D121[-0
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M,;=JXR>'"38<A6+*:'0&.XL&X]Q95L;/5RCC$*-&,2L</)Z<A>46R#UL$;X
MM/ (L#@/#V\^&.V8_.7-@2[$,P!9U-]XN"7&Z2E3=MJ40'U$3YL0A";.HZ&E
MG1],!39+!U08)A^6'3_@O8MA_OM07;@X:IT?1OHZ=S)[A%>]9'F;,E=5DO])
MO!_V@R'XTJ*(NM ?L(*U/MQ*C>F4=H5E>,ULLIP P5=@/_H^W!$64)94(?%(
M[-ON >VA4UI$R16MAU5#B=9=.I_A<+ ^0N  <@"'E_D,AB&34YO7CN>Q,&S,
MV;O 7X$1.5'4)I8AF'F,W7\ Y8'OQH2'@&ZBI,$B&GDDEIT"R8OA+87P@28+
M*J8Z'00D>R+3$=HJ;GF,-@'EP"-=9:6JDO+E<1ZM"#[A#X]]B+-\JGE:-R_*
MP(Z>@.MA'J._<I8V?NE&T[FB/;!"&6R;$9LUMDL$,DMWAYTC]W2\'=Q8D-R4
MHEK HJ>I]@D!VK!TH<:T%Y[,PUAJ8/^Q_*&-X5812?9#G>1;#)\/@VG*HCG@
M\S>"\%6)&OE,<"#)P3HB/!J6JTE %Y-#E0W@N*4+E_Z[\ H7\X9L<?J1.;>V
MZ\I6VWC48P89C** .9M"U]-V>@%;C:'YA$X\+_@4K<D[8OQ$C8/<TSU0D"3!
MR'&&A(6QX3G1N%NS,YFL#JW47<*-&:<0FP5AT[1%ZZ9>6M88LL^R(:0UBW.(
M<T*7)>RJ#D$67&\>+CTYZ)[I @-(<[[E "YM#"+]P)#!>A JP=*Y+078MJ4N
MWX9ZW9:4T1?F1C/C_)NPR[:4X:,U1^"T82O+]_DB9TJ:6!6)&W@<!2%_/LQE
M'"6?Q+D"1:&%I;<S9$G<;5@:C*C] XP?C)UM27U),$<DHB08(9XR1*)"/-M'
MIA0&AT)97-QU('!]R@D&N"J+*@-A98TX30.H4W [VCND 38)_:)=@%[,X&QO
M,QX#9H4",Y6-*C(6;:;K)>0Q8KN/,#Z%&SNO^Q0B. [ 1Q;[O'9Z&5-B[!6>
M1&"-^3X";V"I$+ <;32W3YA%82/#O7U(K"G?=V-)8O&^8K,'!(EI8"?$[-V$
M)A@S.K6>;!.5SL]L=(4G:W$P>3#Y0R,:"8Q$7NXR<A#:)CKQ/*\-@]Q%>W H
MJ-;M\X#@&:0INYX\V0L-"I<WGWM.%CBS31&L&.Z 45I/W(8I;>GIAKU# GP:
M8;T6RP%*"R>(TRUN+N:0 H8Y9QY/7/'XM,3T5Y];- LPWYRTV _3S[C.P*8E
MKAT@FSWFP3"3[%(2?UQ5X<WUL5D#*GD3.*K01?S/#!+?!E'?V6E5Y$>RV'$?
METE(>&J2&WYR6DQ/0TP6@.;&= QX,0P 4/?15VX12O<QI<K $9SR@0ZAA4KJ
M=@E;C9W:]X:BZ4R_GK"F8QS6S+%XU#>QW;LU-N#1Z*5MP+LT0(,T3>(SFL$Q
ML/#4PQ)'8-GP&E;<"Q0>SC8[]G-+#R9)2>O,]1:M>;'+',K8NX:A$S+<O$%%
MBDH \ZW>Y]M:>()FYS4VIVR_8L]]G;E-(4'V9I9DU.U",A"LT Q6*0OU*[I3
MV#9Q;O",+,@_;IE*@1L#N0]95T6%LVAJ^:ZV HE,E["48L,&IA90LNB&"!YE
MZ?PHE VY+YF=T&2C%^2?.RQSZ&[LVJ2PNMY ]N)!FSFK2A[9F58U#=T+1&14
M%L#L*H$G-Y6L0$]4W0K\"(EF/W:4)DL.QA4/ #M=Y --W%#=J 3+G&_ J4B/
MV3(6XE+BV^0%/:+<)N4B8LZ'&]K1 *2AJP]1-IO$I_,[8,XE3);0ZD*?VL!A
M G2BO%HV,3'E![F_T/Y&CWM@FT#')O/-X+J1*;#QQ$AQDPH>:X&@E4-O*_?B
M$[""_YA119/S?$;%7Q<"GH23P0I\J8R1R#X,232HLD+\@(0E5<43A)U,JH6P
MJ5<%+8BB5U*R'G+@2)8=/-U.,)&:J9L.%NZXI2B&,#0+V+';C_/D1(X?H4K3
M)>8_0)^3&*0!S#6RXP84Z!O@]P0:SZ7)M"(F1IEL5F;52'H+<O;$LE,Q!&3=
MD]#5^>]*)2I*EAQ(!7Z%L643SM@C=3TB[EDWL.!EPW0_L#6X8/3$Q%PR%=E]
M;DBHRK KHL(5O:+W?< CA32OD$P'"=/,F8(MD"B%Q%1RCQ#.'7P#'VLY>&0R
MA0++)U@LIH11"\.,H9G<N!J/OIDQ8R"X,&7>HG"(L 5PJ!+"B1](ECN>0HZG
MNC5#^9CF1N9+9A.%&I?SPN)@\G$#\Z:)[Q%^SZTD,J'=8*!#TUDJ=J('K3#<
M&,VLB>AZXQ9CX2<3B,*D"*<PV44M9W:N%\5I?$>+>9GAE)"H$""N@U1@A(>$
M,&%1C9A3F"&C:#SZ/$9"-!X&"W^,JW0@>0@V71>"*!/NGWD.UM_$"G!C.O*2
MV1+[1ALBFB\=7RU1#XE1>L&CDH=\P:G+ADORZX<< M&XA!@:GU<HQ<1C$_@@
M+0_!Q^@XOM4<L.E%(XXQY(?Z.(&:S'8PEEF57G,P%QHAK4HY>6$QA"$^Y"%G
MSP-C'SU[4Y1HO*(->KU.9YJ>%(G A3.TSSQFH2;0((IGH*6%QW"LL;BL"M]@
M3#%)D3$B+B(Q7C/T5,B8EC"/*"AQ07H86T(]E97Y8B]BM/I28DQ"AV++)J%O
ML8"+6"5BNH(!.1?6+K./!6&OD^(UF?H>D;IOTC.N,4#\O<5FD=$&"O\W4Y'Y
M+TPGA/.=3VPN_3^);8U=UV0^J$3E0"BM\% GB$Z"'+SH-L(4$_J=CUP;6.A]
MY-,4_7\0).,A INT4T#F[=+K_=D(4JV )G[5V*\?[+48DI:3[>>O7T^54V/@
M\]PX$5 +GX?QM$6JA2_L19AZ""0QWR*2&$(? ><JF*!T>W&3CKV^PE)CJEL<
M?E?F>L2.I<(X(N+1K7"4X-TX V![=18N&([(^N/!QG3GIB*!Q$!&(%'TK#B#
M);P&CUAZ5=W@C'42,0"%LAJP) M)?YCY/'*.HAI*/12S-89CH1;P\!$_W+!%
MB$7$T+B06A1&6DL@Q"OLTJ7S$^(+\ C%#%40VH)Z!SMPT49 K1X,0Q2N[2(&
M\.+MXOG<B<V.>D BS'.J0D(R\7#+&=D1E6L4:+K(DTNARK9^H0*UV"G&KR:K
MN?BF<#P7F98VF<>ELQ(&F@C+2>A-*4A!F1@2'Y;_X/U=L@6@D@GSA@ZX.'Z*
M$B816[M4^1%9_P5!FW30\@T(&*6:QPR(Y*(@1H8"K*(?K@G%"YM);YK22:4O
MN/'<.QA=@]5K:5$5(\8/YTQG 0]'Y<I_% L!AQ&LR(1U'.'Z*= #*V4QS-+
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M4PI\GF?Y<<3#FU;@G8H U'@MO..OR_$NJWA7SA7 ;.&=VJQ2S*NK98"^6OV
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M [-,_U2;FV)I>1LLK0O2SDQ@Z>H0[AQ+,X*ES11@Z2YZ?HEY:,PM2Z7% %!
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M)$A1_CKLG2H=QP^0E:[M#F>8I5%$-=<2GYOB<].E+7#<0#&F4TBCH"(#-W:
M?(CB )S;VT9@*!B?-"!#8^;3QP0^>T]@W% 5VR,*!/69$.-X9P7C\!E1@\3[
M2K')>=ORE[E-%N2O?_1'+G_*I7'O.NYDKAS?!\3Q0=^$W6EBY.O_#:\ 6/]'
MK=-\_2>M_R/#'LYL=O8ZM9R? ZJ8Y=+PAM<#2$/[^"27AB1I:).1Y5BY,&1E
M.8 PG+8.<V%($H938T#L7 ZRL!) #BYZQ[D<),G!A4<@62#7D3*S(#0U#0D
MN^CYD4N;HEP8-ZML3>^PLD+ "\%;DN0 X<B0OL"@GYA@L#IFMF&%@LO[!'%9
MR?6]S"+,AZ\(8_5!:X@!M#!KYT,1/GG]\4)&[O]2E=%Q _I ^B@Z:FB\@U&
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M6G^<4D66=PJ:_I=R==WZ]+73RVR*BS@<^R_3_TV22):)$-\Z0.PG^/]7>9$
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MFVM9X,:<+ND/N;2DX5+8E=?8X+51*WE;<\I5U3;ABTU(%0VPXDZ_V\IQF/
M,0RI!Q#;X KO1G0V7<Q*7M>+ZY5YG7(6*L4 *2>EM5/A2CKT[76>W<[G<\6W
MNS76<B<Z)4]5/C:.O9B+G^+?L5'NH>E\/$ =4/X#G%YXBJ/(%^&H\9QA;!YA
MWP =)>-57C6Y<:=T'4'8X;^) YK_;T;;R8GOI"),;J!_A7TO$)-RA9[#F)AE
MS9FA5/):Y5!+K\WG)/XU=!(B.YZ&YT]H15E^AG$MYO+WF^DFSF9MU"H>'ZK\
M9^?[@E315P;:&%#;'<_%J1KS?T>,'WB;X&\',B5'59ZR#/>.?Z7@ U0J7%"?
M;VD%BX;+>N'#&6;D2;B)DUUNG6#'6O244J#RFQ6HE+UGL+J+'_,^I%O[[KS&
MX169+Z+P@3,8R7^N&?KJQJ?DMLH;)G&^%_@=^<<N])7,SL/T/M\(>]Z!-$&H
M9*;*[\7Q%[;NK7].LYPV$B.&@@B+8H/27466Q$?L&D419IM@KS$))<-5SK"<
MHBP_+WUCDJB34-TB*?C'^Y?P"UJM2#"C\(O\.PBH[+OXB?^"$SL39&1)__MA
M>O:-<I/TY.CCB7S_)IC_A@(^M:^C@^/C:[Q\Q&S/08\AWR/=Z.<]KB/A/2=
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MY H$89UZJ1IPF$>L:OOYT+3]K+>C=:*T+P*YF5S(@ V"&/E).2B%(J8-OX9
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M[GW&_4H9^5-5,Z;2R#X/*X];&+V$,9Q15&7EM]B;J[5F%93]<34GA)T1KA3
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M:;0I 5MKF+MH^18N3 X)D[WE,HA%VK":?7IRV\J],=:S*$$D3SJOR%SO4TA
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M@$\(-<(.3D1RVMI0*P/ZS*;V$$*T@*@",[02YUJ?U>U'Z9A2SR."VZ.%^'2
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MD9K@6B]WUB[,M'3)64+%-"NE_;SS;90TOR"^N4HK!3>6L>J76%"<\WH7F02
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MF-2\R\$]4 Z5>=*6^Q9R/79>R?5<EIU>EL79KO;01:<78;W4-OB:354=4E:
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M7E*GR1RR"*9X<L]2XBJW[JN\!\S#9];UI%.KP<J^*>NC@OID/)V^G8S+<#;
MH.NJP&G"D99X0RA<<;0IZV)#"(S,JN9%U&^&/UFMV%?$O52BO1UY?;'H 5V3
M3*^;0#_',I[@XGNDGCA]]87TF,:GA7[R=2Z,>N>V:O?XG(8Y>SV:X80$-L""
M@0>K #DG5TQ@@=H3 X)$IJ11.LB'2IYT/PYK.IV3U<;'H@(]W)Q=O&/SDZ'
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M)96F.9G5*M%OB50D4'E^'Y(@TH^(%]5Z>3-Y=_WSZ^GT$B=O/E5._B.<7^(
M$X$5-;)C?:D)W *\E"09[VRMOJ=T\Y)@#6"?K)X=FM*[6NF[AX27T-9;S0OY
M?=L]=*"T4<IX\L]*%*!"=N!UO;\;=!&ZJ"2PM?&Z#\Z3U;O>25L3)^P<%MXH
MFT76E^76*FDX*$9+->W8M%X;7LAI\[Z^#4RZUIOC=L@.5:G^0#K4 QW'3LQ\
MN/#GXE69CL^'N7;&69YH+ZI-(RD%^03@DZ%%N/@$H00%2>J2BXG*F-:QO9U!
M'K]6?CM%V:I2:RO">CCTV GPLI[\%I![*LRT!]SCU%_J61&ZJ%T'%A^) D;I
M)"KE@25R@Y5G$3Q:!<(H[JW,#&-KJ^W1*-Z&<DJ/7^]V(:_/]-%DHTM.)S""
M/!4EF 8?H@9N'5=(*(-]M 4(#B;_^_)*=Q%>^\H$ST9YD2JYO(2/QM/P'%+)
M%A1F#8$;LAX+.03)B9S$YKNR:QY\TH1V%>2][^:A\AAO_C@<D7;^6NM7U\*V
M_60R;AJMWUS&G>:ZDLV8'7-%9>M1>(4FA&"#\E*+E(/GRCZ<S;AIY+:WWKDI
M*=8^!M9XLKV-*A"Y1@C,":5S4LS:C6]R'PF'ZU_,-W^,<#+]./STEKP0^AS.
M<.!S40R+!UM2+?Q;XQ3,92C)"^EX4?0R'<0X60/N^+=B=R%X.VNC*P=MMZ=[
M%O#+*J5Q>?\Q3'!:$>=W]*?),-%R/G"9"55#6=F$NH +<CBE\.!,9(8S%KS8
MW+A^CX&?IC8<0,B'Z("Q!NVBLN3 )<N%K3UAK9H?]L;Z4X#B,VJL%WK4YM[E
M.PYZ^JJPAW![R,*[KS1_&$[FAR@OA],:7[R<(-EBCI'-I:%6P@45781@R"JK
M7:H,>6G6A-8G[-NC>YKZTC,+/:3RW5OBQ3@;Z7TG+[U$\K]H(?,R2<A.,&11
M1X'V,,IQDIJPDWS;=L58C^CEL!2<X"CA<YS]@3CZ]DBL]NQ9*N_ %"4E!@.F
MU(:37M62=(EFX1Q'B]K(PO;</W: \33UXN $-$S5:X']E@UMDW91DL&$NMZ]
M(<^1;*5Z>]P%G[,U+F+I7XV>NN]R1%(:)@+>.XO7%Y\(Y<4\1U%JSDUFP+U)
MH%BRX#EG(+FQP1>>_6J!AJWUY6:4$U."/<770W[?ODKZVXC&/Z^_6CQA$+Q+
M+ @-Z&K% =+6&HVTP%/120J.;+537T^6R>[8GZ9R'97!AMF%ZPHG>2:S2$D
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MCJ-/CF2S>_!TQV*7P_:65%W#^!;9;MJO\Q^HE6HI(MF1,A00O(9Z2O;@@Q9
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M]2P55#K9UL'#+7".KY:?GM_K3+T&S!H@-+T(4]3]WU=F%R<.62E)10N6A4S
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M'9QNG>;1&=SQ[8T&S.ROJ^S!B0&R+NX!_;%2&O,/.*8OYHL.YJ_R_]S,YO4
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MIA_YC4[6E;)2%6$%&.WIOK5T+ /' I(S9XA.G-O6#1OW0WK\RZRU+#U6LX[
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M)J)'X/?QA/>!SGQ/^[DRVB9+N$#YFE$M+=+9IE..I#T5;4/4?#"#M1O$%RN
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M(.S028XG!WT(W59%J'V:OW5=KQD:^&&4:G[&JC&,M%R7H#(]AHR@A?JB):G
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MJ1VS<$Q(>B@<&GJ>Z>(/)F<HH?9=2X'IYATSGWLP]! Y&II%9QP,Y2Q)BZI
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M]1<JV1<JK/ JUT9<6=>\$F5(^?$N@E$IRV206=YZ5/$6.)>N+;3FR !CMS9
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MZR;IGC7W"Q>J"N5H6A8]E.1T^M=?%/6P+%$D#UGGB*32L\9M.VD5"ANG"B@
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MI<$P#NI-V06#R7N79'3>%-5..,=?AZT64M4!=*TD?4J-%N+X#62/WJ41[6.
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MVD3]<&,/BV8BZBHJ5I#HFO<:'*2L(@1AK":I68RT@Q%U$F\Z>QO9&M;9W$M
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MP<-*)[Z 16R79AR"S)09I6WD>LUIQD&X;9M:VD7I4QJ%DN2DBWP<&]O:LK2
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M$S[&/SUDG@T]UFY/!6W)\B4A9-:\O3:%- ?^HT;3&H,8E-X#DD;>TJNP^I>
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M=B3)?BK- [JD;60:$O .@ONER"U[X/,LU'LJM^-9O%:V4H.@-BRO9KWL'4^
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M'WJ7<]8YLFB%T[?I[X?'5$3>3^0PM&;!V_2MNAXC@9:*?$I(E' CD.O7.&Y
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MFFPE9958-Y3E$# <,(*R"X1#5-:YPV'E@$7G$DGG,JB@*YA8"B2/&2KOR:9
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M=@2_O7'GWBPN;\[;F=(Q!ITRD$2<W#;!(-29=LQ+4^]]T.% ]_GA8D_"&B;
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M9])!%L9:>IP@; LV[%-IRNREV$Y-F7T /EA'7A>AGEM39B]%=6K-&X+RP4S
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MGE]43^EGG"_71?IO_[C(R]6G^9<[[1I"!E.8M?3\]"I6U@((@1G(7L2DZKQ
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M-V>J7A"LG^+-[*Z<&DYV,ZX+-1Y2;TH_K&RER+]4V$TC <U:5!/M!ZI6ABJ
MZH(0C,QGG)=,T<_*\HB,Z[EZY-?,KP.1"*^&AM35P\6AB[;XYS?X56ZZO'[[
MO4C45@^9B1MF&6Y<$W9-9LFXU#7VWG=2&A,K;S.Y(J=9;$2R3/20)MF9EA//
M9,.\BY3FC*1:'APY5_(":[Y$8!""P&\XK6_QTE%)J_6']DHZZ-1^F>7Z$]7@
M<$_:8;@5.\P$MW5#\J7+%^-/3:!7#&1&4@IP2A%B#(!$0PA9SCP.Z0G&)"R'
MKO541M$T?FR%:NH:+?E+],ZY$'Y:SYOZ22:IQ9S6?U1EPF@\,'J_>X._5'D(
M#? @<QAX.;>(PHJE&O] >NN80./5I[/5ZHL)FS2>4YYIENU^TW+PYJPW1FRQ
MWGVI5>EZKF'P/O"'AR,QZ6Y]8I"X8?GQ#$:5="WK8B'KC%JMI2(CI^QW\G[?
M)O($!,?7C,>T%-RG)TL&LN$_VJ:RPW?\Q#5P*7, TV+/HS@@.@XAVYL4:7+]
M&I0H@.T9'.*S(T/Q@0P^5]8?.]VT^T5LEXG=64@$NKT[#RM4A)A&MNP[3/V6
MO%[H<9+-NR$B<#F?#^1.H(.UTQ!7&%4,T)T).3+:'JWP7X:_'TC-M'CT2*AX
M ZD,P4V &>!/S&=VD<_W:#_LQN!:2-X-TD.JJCA7C(EX >TY-I VO@?O=7F6
M]FV71)U=Z%78+ZDE8@72[FK6\'4U(;@YS<XX38;[6A:N3ZRDC279#S)IF&$%
M"B+6K9SF!Y:M0BXX/4I[9&+PN\V^\D]*/Y2L#*7R!]/8Y( =4$Q,Z9K;B4:)
M_SD;=IT<+U@Q.N-'8ZZ[LC[F>/6CO%3BY]?"@:<Y/KNMO,M8Z/N,[-!N/:[/
MOD=H]+T19MIT!A!A"^@)F"7518 B$P_&2=I_FIB#SL\^#6 N$CS">F%1BO[8
M1+'[U'(@G%E'([-=F\O<1YVVZ!EG&KL?Y0H 95?1N-C<DX1K .1"7MHUVS]7
M:H7@R7#ER+/%[3GV$U)1AFT9 G7>KTQ$&Y/MX2<^AIU@V0K1U!!X%PF&(:_@
MYPN3[HSSO4B7&W+SG@C(SI77R$[7NG[9=1BE9I!>'J;D0EU[;K/G^Z7<\K.!
MADE6>206HO%Q?VUKE@BX8)E00V/SR4,,8!NXDZB<2RGQ-%F"7F4I&=I-.TV8
MGNG9(@4^*.=_EDSVN*:=D;)J)6E5,;_<IRL*..'D,;_Q11)<17=F[1W)1D_T
M./67<DK/%Z"8)1R[/DA TLJ23 ;VV)M+C*+E$EO>7F?^"OX K@F,+:-)(;XC
M6?7.DW,/-P+YKQ'ZS-7U9%.OJ>V736?[-^:&^D27?NM6X)-H]+1PT-"B%I.Y
M@>5"@>62 3[%U!]-8UTF<B_O9SYOY70GFEL1]KM,<=OJF(W=8:;&RT*IIRS*
MWMY4M/:6% -Q*>#)-S@:Z^O#[#G?X+RLV9^6LI4$A>0)7[=NEXXY;Q9DJV5C
M;5_XMUW80$.[BI?$EIUN)"6G$+JXN-DRMP/Q]Z[L0Y*5I[?_ NO> 11PIP;^
MT#4AZ)">U:'PJ!3_WV"#%"N"699NL_X?18XI:6C-ROC]U[JWZ2 MIHF,RYF!
M57 (Q9*<!S1%!J+(.1VSH\^AYMO+A(]42YFD"S]JZU]MO'@P9N1.,J\YPY90
MYP>5L_ZN<_V%"75M3S$LIHG$'E==MG]/=J)K54U WHRK[)WGG)F:4/6="A53
MU:8<G]UBJ>!JS4.K<FT[GPZ7Q;EPW\AX?7C0$A2SMLQ-Y?.CL0;+;!\G+"OQ
MSZ(Z^1G7:__0B$]S/O5/?#F=MBW=QLX)$F5/)<^D>O&J\_J ,(*7=]%Q:!\4
M65ZY!TN6S'R.Q'V1H]P=P8_PSEW]W8:OC!,QCZFM)V"\'X<-^:O5;EZMS4P=
MV.3?543[?!-W."/Y);&TLVQ-+4_Q=I"-6]SA]X<AFT83I-#2 5*2CG5P4$/K
MFJR!O))?)(OU63.N^0IJZY!/2.M^P[>CP$_MCP#_VB"PV1 J/XITF7"PK< <
MRY569J2+@2:H1G@I"604!=8:5V5(_@VH%/O&*BDYP"K)!S68[E@+5W?O:NJ!
M5X*YC/_(R)I=+1#R*AFM&/*>*KU1\OZ676$12\@^1!9H=)NQ#2Q4@30::VRI
M-U*(Q@ZW(DRA"5T]]KNS9=E%SW :VIQTT)#DX]1O92>K6J\E/KI[>?<^YS<[
MY'%GS$S#@H60N$_8&M=*8MYR6&_"66CWH5F+>GHYV=R4L-V6J U=2%U\:*UR
M2_+YN\OGPQ1?,KM+'EVE!"#Z4=SH ,BL7R^DF@[J?COY0->R0%5]>M$B;'R'
M_X52Q0_D$[ET,+B;OQB?A-1"$VZ-8%J6P%2>(AI;&I* ),4IYWD+'0Z2-9:2
MWE6#)2;*>NY.7-/D>#5P,^JVV-S@16R[PF%.E,I%<:)?Q^VNBX,$&Y^UM^PV
M5K'ROH42+UN,-S16_;(Y>X?ZK1\A*.CX%Z7V#%G7@]-""@I_]]-!T$KW RB-
M#4O,(7TX0K4SKB_J'J4B%)P<R)L.Q(M9^!$6F 0 X^H'ZTO^QKOK%TZ7ZBAT
M]G._OPQ_8_,L@6MYG@[RQ+)2$82PSIRS&J1L<ET1;+!7A2G'=N)/))/JIJ9+
MWC\_KHFD.JD])+\>7EU(%8H59Z6H/Z.$TJ:=4-M]Q3S!A&5\629-@"S,LWK6
M>"\HWH$H0KK[.\D] /=ZY8;.4]VMZ0)DQTV(/QT$=/H=NI#[(WRT"5>]<:B5
MB[@L;O3/K4*>]N+/M^?.U7-=FV$_.SRCXV[X0'T>W$4DBWDX:7)Q=[A]M!:5
M*U(O[K EU87;7**-#=CEEX]\'[?ULN(]\.G^LRQ;I'NSP/O/)&8P+! RL# 2
M\ E]X8\YQIW&ED+4H;&"*Y ==_NV8_6>+<$DFZ=;(03T;4)&QJ*(*1N&.F?B
MISWTX"#5>%-LK SK\\TEH4,J_@<=Q ;D7)V> '&'RM/B"*30IR'";-$D7*FP
MWV])F67&;([/V6BIGH?UE*=)6#@N)VB^GZ-))\OLR9[Y*<TB!JX'JNM+3CU'
M!KYO"G[?<RDWNT.(\C7=+>X9$.NO\,]YZ\DOO=]\$%ZW*7X(_3U/*7Q)?4"0
MV6ZAA-,P:((1]W,LP3H01%L\!!9N]2)0+":2#I["(;BKYU79K;W=45O?#M3W
M7.[LU.8*[;D^$ICYF+@M>:1 !S$#8-=AA5 "CK<AGG00[R"1#C+_$B@"8W%H
MJ)JH>Z\R>S?!KB%7&N;E;;_R\DZ??.,_I[>M/CZR">QVY2!"N!Z2=#2*[=)O
MW2TMTY.X%,J_;@.O1QQIRO4TZ<M=MS*MG5S^_'E5U<\V235[U=[9M]V4)H.=
ML,>;;[\ D JHDU'1B"XLP7XP95:T&UHK1I,C>^$KP63$U7OJ!/&,PW)22NC9
M](5N-O_M92PD+4C2V/V4X]-S<KJ1HH2])7NJF&,%H+JU+H]&ST@LR?4L6:;<
M);+(GD!Z(8Z**%AW,C%8^=C4-K>60R9DG>^LS3OP6[DLL.'>RKQTNU(Q[^WR
M9;)VB!\^5S[MO<^UR:B7*,D+VD%O2AIK_UI5-UNE^LN\"S:^DA/C+CW1Y)H3
MTC+MOB_=:D*B'+73&) =6@B0*QQ!_ELZH#1EZ??QUV,&IP/'-@_%C!\*IZ_$
M*@YWR\MGR'S0FX,.>5'/NE ,895+*53^=U26Y@DI%VY\?.R6_P-%#=K.=M@/
MP\BKO9#V=:5:+PS3P8C0,SV1'T3S;A%',WDS39B!K>_NNHP9ET*&<MZ;@C/8
M3_[EEN&%EW$/D_/#GBA;[R!GTDBU@"?' 4^X_T23EPG12QHQ2,^1:+O#Q/IL
M]6*6Z ]$YM*25O_X6SV$W=53",-WBK*B*S:/#=EWH.!]%%F194N*D&E+GL1#
M7]"XCPIK79@[388BNIY@H\:[LJF/B<5>V6/^5S&+:]Y,F LGFM@>!SR0.X"2
MI?NZN+FI(L#:"/@9<C ^QV&I_@O9)Z\UUP%D$J24'VRN?';11S+X]VI;[=.O
MI:!K8M&6/6+A&59+ Q.7A,T$M4)%4F.\FT^OOM<T7J1)8!W74NT?V5J;KA<F
M?HS-^?"NQ.1]^>^#/W,$W2LTU@+B#M 1U($!54=(L>2"T),8.BB!JJNF9%KN
M/R6;ONAXZ7D)B*U$P/ 1/Z]1O]X:]#S@D.N*NGX4(%@76\V7S&=0?7MDD<!8
M)P7H+W7T[.,PTMXU4F);?G$H^Y*N,86-WT,^2_%#,; G:*<8*)&T6:#CLT;/
M[BT=]0%+)T,\IO]<=>T<['*5^$&]4G3C8LYJQX6:<"6&N, L(8F;NO=/Y,>)
MS0PS=!.YN3WA@1G#Z8K-&5)=K_=*WDP:O_YYYW5TBJ*[E<9*FH]TJK_D?)!Q
MDH-;49B&*#:O>KKR]6&X/N(BLH/Q^&8PBF#!/9=).IR$>.U@PI8*,\MA3_J^
M'F9\J)]R%:JN":R[%NPGHD>^9]<KB;@2C?(%/!$="\$588$&%8C*M@S^*B,I
MX.BC1'Q7^Q7"1'8*2;T2?U;EU_IXC]:+5#DG;(1!E]^]Z]]%P[Y?8XAL@C'T
M6A!%Q 3DR:&)[Y7]A$:L9QMG!^87!S;L$I[T*&FTO<X>>KC#3%2'-S28T+RV
M3 7(7<#V53@J 91M0#)#W" GD!WZ2FA?<TX8^^W)G%LO ^,6Q0CE[Q>Z+1><
MA5Z2-DA+<H(^^1Y,V\LWXR"J\IDS#B34270 E*P [(D^&FO19]H8EH%VGJR!
MV\IE(?S..VI9DAJ],%'9ZEXRT[W[+:/*6$1)9?833_0%Q53A]YWR!D_KK0A7
M=),-#37#D_DVQBH(>ZC:8E];ZP9%=&CXPJ_W K:1I;NN1G20SUBHBYY1L-.Z
MHV\['33<MVDK\-<%@+YI9(<3Q <ZM]NUQ-(!P;1T?X$E0 FA=;D%>;"L$+)_
M47-MUL^7M[P<>"ZXBY;IWY'UY%5?,HZ".]/8 +QD NI3U"M:+Y B]J+(F;FO
MV-H'(JBH0%U]_-Y)IX;HD+R0C(95YHR%@N0%#?^]L[9?.1L"C.XZ-(N?"'J/
MN-KW,*4N3\R.-[,^[1%*<AW#14@MG!L+&C-6#FV^NW=;N[./QVM0)B#3? 1Z
M@;31JD%C,UQ&)Z%.(>^AGJ/$D%YTT'.[=G&BT%.JW&=8LA!Z]%Y[%$E'Q]$K
MPI'WNGH\:U<QTZVS!M?($!H7P#NB$FD+:((I%$Q5G49[@E->>.11K]=.ZB\^
M*X'9F[8D=_IQ?ZD@>Z1BAQ3.M<P/;)$]=&Y9"2!2R75$ZU[460@."^6E^I!?
M?^X+6P(+TOKMLWN;P@2:K]>XS).#5M,[S[$];:G"?&!XQW!'&!HO7&_^[)MF
M'I^\VD,8]:;;F4V9WQ,_W_E>#YGPAPUH:\DTCWTO7I:;>._$MF%I3U6MN4V$
MDC5T:&P%%"=DATD%XI(^Q6)31&"&X.3-<H/6,VHU$H@9SEL+Q)A1C[(5G]P]
MG%Z?1(@B.[*P1 K% #FMS(J\ZMG6@M.@"@0OVU/YYVAL041NDA !W-N&Q&7&
MPF7\BGOP.97LL'N=>_;3,E5-I\T.[$42-7@PC-\3Q!X6?Y4=^\T8AH5UX!]4
M(92"F,3BDG3561C,8ITR3*V+6"WR%SZ:J:0]2GM3?@9=)Z=:,7P'?7;P:?Y&
M_8KTV._]R)')YI]Z>M3'9"A%!2Y*%.JK3*3)Q!L21F+_]"N'.J\__Z:/=[^&
MRC6\]_FY5EBH9;_ 7R F)SN N+0C,$^4J0(UW6B""02SO!0#Y@N)(<8_U[WZ
M$=:[=K/^2WM=XSAB8EV!_;Y^JE;J[#-#CH%=:;#OJT6 (K%$+"!&<T6(W)U'
M.E R'43"QKLJY-AD&I CBKP-AJ_JK7;JG)NVMP=[O]K@;6J-C.GC[2R-M7)9
M:+V=\/7V0-'+)N2I57+SPV3Y[$JV-W]_EHRNO,'6M/(ESKM!EC[+[C94M@BO
MVZM&?1WA,5/:;5$]A$#0!2.SV%FOY?<-VSH4=1@W*:&&,/>+0%[KM!/9<K)I
MN/ZXQODSKQO/*_EX>;!H?>)R 2( 0&%9-.X#BN" Q3#2V,*7*Y\!.([MU)GC
MCF^&.Z5!9^;)EQ_X4Y4DK>Y-GFOE47 )CS]U,M7XOH'*1[;\Z1IDQWD(D.]S
MX<A[@;&+,D0O*K_0MCC;5#O'N@G>G-4;RZ8Z9S+"I9HQ-?*@D^8C(X2X[3O*
MHWCFE99[W=/*-Q <T&H0' +)LO;;0<"^56XYRH#XF"=@7-OP+9RB3CYNM82"
M]#2CJWGR^3GX) >.G]O#6I7.4K@R/:&+RV=6:A_", Z^@=B<BA*W3P56PRFU
M'YI*I(2$]>Z_RP,C+!Y9O7R;*8?_.__IYZ'3B/\6B5:&F+"$QD$ <\GR8*K
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MONMIED'P(0U_98^]AB5$MW;->9O(_$1FQJ(VA#S5[?C.)K+#D [RVB$KN28
MA?GGE)X"S+U;CQ>9H"?THV)?&"[$U+;0^[ZX+2:YX/67ZE,5 X$6S"OSH%]Z
M@/.C0R&X,CI(#(G+IX/8X4$X),9.073D#%P[Q\R3J!2;[93D.D:X<U*EZPQ/
M_FA;3=SED@N*+V*8'!K66+:/Z""%.]Y8D@M-#/GK/2_:BY#2)?LS]SR1FYUH
MQION^_8.I]-+8M*MXLK[ZQ-%TDWI>*M-_),*CR%191UP$NFML>TOHP(YJ;FV
M<4K*.G-[,&!,(5!O;[0* 78,'J6&FF,TNC$,4W5:RI_&X'(?PFD6$Z%:Z1C-
M!<)C@V+^ZB9&G7OGX-WVH^F$>*K85<H)N,U1._IN)=D0P>RS\YG<\)4FF="=
M[1G+!S^LM9P;.4D:C>[(''SW+;I4U9GEH@) E;H2N3E7[X1GN@7_W;V[9L=6
M&IC^J*&VH$C1N?I-1=.]N>:Z$7MA^1^=PS:9K1EQE5NSA$$:&XIR@PHBH+=E
MEL%D.:X<O$M8;S9319L;#LT%EQX+^,.I+OK9#N;__O>5B*"8$([-1_%:H"\,
MV=-;4I2[B'DZB \28/X"60W9+B9,=])$VL@1N/<JAYW+G>)^,["$;0WKSY/G
M?/;D;ZZ+?'A>-;,N435_"MI3298>H8H)4^XC.]3*_9%>T(1<WL"S,)9KC7X0
MLK[N]1&?4N_S#O%1&/R;6C<N9)"*=L5"Z0K'].^1+4:*'ZT;3+ R\C@JI8,\
M%WQ^$CU2XI=_M!KE^Z(:)U5S/-_.&S)]9\ARA ^M2%__%7S._MM#2 @1VM6N
M0*#ENNO.*7QT9K15B^O&_QJ/^K1PJS$X0K/3F. Z1 F(]("96;5D9CWK^=&C
M*1_L:Q(R%S;N0MT?6_2F$H& UAWS>J HYZ&^L%#Y?9">W/%8 =W+)3!GFP33
M"8#Y;RLS7R/E.$<T.9JV:#>,?,D#D4\FWO>2I$W:[P$=#XON_((CLL-=U6]0
M@;DY&\P,"\?7&;)YN@5IG6+%\<+Z]ROSCDDGMD&&*KA)8^U;-H]#@ZFFE-LP
M]2YCXO>#1!0[50L?$9$$T8\(/(_I75I=NJ)&^OE.P:R29S[9W:'#&JK?G<N-
MUYR+)6O'&>W?D;XB'%<JIZ7L2>1+E!OT#5EY_*EP/C]/("(XV$@F7:S3P7<F
MWCK;,C'S?4;;+"5('SY9 M!'565NP%*%#X#)F;ZN)QJ;8FE"3N1"*,?L;2.*
MS0\#Q(!D!R8J;,9#_O$'Y=IE 0*DPWPNC;0!R,< )U[2NWS,]^%"E)!--+>N
M&P%-N;='.PV4;%%C$8%6.[M/^VY[ 1^.<23@GST.W(6TM]] #3AA[EA=HW?X
MTJ62@3-/^(-X.H=#M3"VJW]ME(P%I.YO#TF_L9TJKTVQJM!.4O]4,7=GRJ7]
M,<3=NW(83=8(IK$U$8MH;"X$^]Y%\:,\I0<7X1Z$)8IY\EZW=N@GYXOE?D\:
MF(52SWR]F>4T=;?WTN=KMV7/K?V$DF4;J()(&AL+Y<3Q\^U B,?:43Y7%6'$
MD,@5'8PD81E]'OFRF#2_G%I:Y?SA?#[,)L/&[I^R?Z!+JVVM-5^3U8<T-R_A
MSQB_"6K4U$Y-+-!S[/SA,QY4I+ G_\K'2!_C+)WM.*+:=8.=PZ"U^C$=%#_=
MCVJ:L%^)+.I)(6NV]$ )UI X3-]S!$\'/O 936+*OT+-G,/GU?I!1K99W!#M
MM6#>8YOOV5$W]DY7G!Z,?2XP7S=*FP3:NYTD+ !TI>W'CTEOT+H7U>([5I2A
M-,' [ID_FQ%S@[9Q0SL!2HH7FHS.&3I8#ZKTB\4/OY*UY;F, ).C9_=O>VB?
M>> I4HLHU[5U'"O=/A]?8+:!P%@DU'Z:;+I;^',A+W* ]B/_TUQB1FNQFN<<
M!DMX@,B87H92A1)H;,!F8 )2),H3,2,"[41'0?E;U2+Q*#ZR@1*B<]J!$,)K
M7G1E87ZN#OWV3'B);NS=G\Q_OVGUFI>3A6ALURC_T+J/B0 9@LO$UG'W;*)?
MB#,1%^K> ,GB4[E>_Q@SG!D<*AJN/JWLP7%I/F_>4)*A]<,L+.=<@!,92N,&
MT4%I>V1@/]U_R7VD[2MPV/>L7=BJ$U;U='"/>E7,E4\X-OV)?U_N^UN:BRK&
M05:)>9(3:9:I/N7WQN%:N6J##%IC 2J)98>J-,,_0KBKK@?=XLRCH=OZ;^:A
M/NK3?&_NG-CAK;G[6%BZKI0(IK&54ER1'7YTD!OV&925#O)[B_3>82-K=+5+
M-=:-^R,$81%=&=/H6? O3YC5[NZ&C$:UKJ7FFZ),$<WNNU'B:"/T_12 \<30
M5) =EX_;/"9^<@]3^[,B9"=G:#FY7N>2DTZX8N*HRW/;Y"6.^MUP;R/W)GO)
M7:3$$I)U;RLE_DO6ODAMU1FXK8]%2M6;_&5'+<1VT:E"K&)JR/S2=GYV4&![
MLG:Z4W7^N)G\(6F'#N**E-)'F" [@*;T 7INA,8>2;RP--U=#B$53B&8R8P=
M5A@,[$J7ZTD"+3-49WX^(2[99#"!XH,)$KD>=VMZT)$#K?P&:.EIIXH ;3^0
M6RB6<"0QD\JW29ITD8:^6.1L1*<8$UU3O.NK_)8&@CDGK/YIO/G^EHI<HKRN
M&^WFY97#&C03K$:R:_6BK9Q->6;O&Z*-FUS3:)+#GO1<5,Q?V[:BFG=_=<?\
M374'8@TY1:R;$R)TX#OK(;# [4E@R>-W=%XA^L $.V?H3)@QN0:?%-$9)BY#
MH%JZNI(OGJH8ROU(\H1EO:YJ@T__@^-XRL6PA/93^-L.G+= !PWT'&H<)2)8
MZ* ?#S;W(33VP>.W1:: ;$,QU.IPQV3;QM)!W2CQ^?EK^*KBWOL-XTH?;"CZ
M?UY'Z?9:*QJ)\ ID#9[M5#<XNM%MSN7>[<#%]I6PRO;N<E:<4'8 3Y*:UJ[U
MFQ+S="GO"A\-?X&M9C&'VUY5&=*V^7_=E+3G(GDV(00[U$ML;>#6#D40UD?*
M/,K1DYLA(^T)@DD7"_10);!'2M>QMM<D_^GMF762*%WU]]#-$#[)]O> QCD'
MF/ 6,0$E6 7&H?G@EA2SC6:E26QLW9#>M)&V>G*];]40QS E*JUQ18BE#F:X
MK80+),OO]U%YP-W8.I8^\SF#P:6SZ!2:<$\)>00_W(0;%!48"]G$BU4-NH=[
M5WUI>B;Y(E>.OWMYR)9M('$2C1M6_BN!$H-L^8S207^RE]Z1^<X/(%*:?DOD
M==VK<KACJVU9:<R=#6[-+^(*'R^R+&URG.WI==W*'F47L"OT,[KHW6L9,#(Z
M^PL#\?Q5^5WY%++C-DT7V6$*P96T2QY%(>]7)FA .6F"5+6Q?=%*8=AFUV%D
M^G!=Y:"?KEUR1K5KAZ[@CYRL4=N8V]MB 92X?9MQP 5 2VVNI[,.(5A7OH 0
M;J'GV/LL82.VA*/M>117^SF]+*;WO_,"^15"E (EZF_&KE!$_WZZ>7-5^$;
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M0!)ENSLS]\UQ'W);UD*%8XN0V)B(NH]N78!NH= G8.NOM?<AQ<8W\1;XAU!
M?/SE/L3AC+<!90"4HE/1)%BG]TG ?72C25@Z6:VA8!AYD:_3P;_8JB9%LB91
M5-79N._F1?,)89SO//GN/@0X"VO% C(N787 +F63F@4\]PQR*RA*SW>SD6S)
MX?^$<4SIE24T5F3-[*;>[IC-2EIW@1SZ.R<"I+<WG2$5057Z+Y4",XHBZ59Z
MY41S^C.]4R7=/;YQ<R8/2AH+S_!E:EUBM>5Y[E-LK&?F-FE;'(B<W8>PFJ-[
ME+780)KQKV@?LI*Q50S(+<"%D;?!4'53FMP5OO$KQU3LZ-@FLLS'J+D9&^OU
MZ=.I0]U])WN4K^U@R_8AGLF ^&4P,WAC(F#<+8?H(8QR>IAB/)G)HKY9M++W
M0&4UR#"9UVY&N1;69"7:VW94IY=_9A)K?T WF>TVT/5#M&LVJ-X\0: :&XQO
M^W(?QZKS@D#-B+ 56LZV_O52E4?_5[Z1:N)VE+@O9!'B:T28$^H!Z8=?^9D
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M4F\?\E4#SI1JR;ZJKC?D?:D(_^>,-],"V51=_M>@,'T$_8\W>A\BKQ6'[<<
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MUUZO\Q']49Y'(/EXBJL:<C+8F8KKL&)M!#/3OH&;.$-8B^/YBJ/RMKE@DG3
MF9'5+2DV_I;8CFM*D;B:SC71K8SDNT6Y4^U+T9Z1++YD^B5.17VC*+H,PXI9
MA.-,Z/$S'="MJT*\SE/Z79A$%]BMQ5HY.]L/-^@17R36JB8Z\WV $PIW8D>/
MQH5DZ:[+=$,HI_ ?8XF#9.XHNCK<BEEB!"%B(+X31@:%@XG--N7[\[\.G;(V
MNO[I2LJ9>'5[N3P'KVC9L4%H-7*QC;(\@R9'T,^Q1C@$\\05F0"5,SKX!'3L
M.3M,&@\@I3YTE7D9(GAQ\G$N-ZV$D$%$..?+)(M5:_429&$,F07*= =MXV+?
MPS#X*>9C\LQ8'6;B3*>)YBABK_N4^<XZO5>XQF%GUU#$T< K2<EK]M> 35C>
M6-IW<)**9@E.@1"ZR@)+#_O0C8HG2WI1H)T3)+?J3^X^!S[I)$ /R'V:?&CH
M^)T:*)C7 PU&MDF:' *#.5H89U[F4KT7?]+/^M^3AW!R=<_!;!OJO1SDC2J;
M()GI3_..^CL4=PQUA<E-:#2IF 3#2U]5JWWAPQ'N(6N=6F&@?@UAK'/*@OB]
M,(BJ3X1UEVMF(%0H<1+/\%&W/QW._W \0M3B4L!LEG:"8T/F <LV8'V)M=V
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M"MG6YU-?#7)$L%6"/^^MH'K%J_.>*@<.-%T[<*CRC0JW '&P0R@!S0O?$TB
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MZ$I4Y,C?8? ;]W3)[RI<OY#:QXI(S9]R2\B%-YI???[$[_]4^D.,ZA;^8D0
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M<+U<J=AH7C@54Y:6=1(0_V'2P(&4>0OXNMPM',+BP].-PF-)K *QHIT,9_6
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M@!QJ>5@^H0B(96@L19\ E$@O8"YES-,C!54/+33W*K_XLA_JD%>ZZZ40(IU
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M6[-A%V;=!]=U==LW"<)$_<DKON<7JDV.:<;P0UX'=,E*9L*V'.:E5KP@&&9
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MJ5>N0#_3U"7MU\&18PU)<W?@H3V)YY@/O-?1[7"J 6)\E*,8!)M=R(C]R+O
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M,:GW>T9/XJB'V)!4)$?C\Q0S1>W)-LSX: 7F<4"UV'C3$I]]=OK(L#/WV\
MO2I8K,D)#@<R!&Q(IQD&%!^&+=(!*+_#AJ!396_07!8F+F]3:FO'9^=;Y=;+
MV9#:T\]P#^*RRB<>LB&3Q1PK(XU8C-\_NSWW85AX&\_/2W+?+#2-V;)Q[X93
M U0[E84Z[5#M'(/T"R6JHUUA4HQ87%V2T$>7ZIVD!PC7VCIY/.D]+/N-S_9
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MJPIIDB#?$F,'$SX,)TH.MFKB22S7L8I6](PR+,K-.P[:CKZ;>A!N(_(-A8\
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M/[IWNV22NCK9E:LJ1^2.:Q:*5%FCS!4$_S8GRBAT7,X])-'<,J7)D6<S)L>
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M2E'MQF5( 727UN#C48D^=)W"QHO*0Z%!'T(2, 6W6S/S2L55[ H*M9"4X)Q
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M!*1SNX.E ?>SVU&O-,U3)GX6JX9_R_-=>Y3;;S1:G^,;'>N%HCJI4B2;M+&
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M#YGBP?>,(W8I=A4O'E"(IQ>Q:G0"5YGRK ?!]N>AO[V<M&DF]:]FMT7K=Q3
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MZ(6:ZM5PQ_1<+XU4*%^Y<A(]Y#8V"T!"*QRTVVKM\#;><[P\N#!B72&\XBE
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M*=3V.F$7/=B&G28&8CGX=*]Q$G!RZC8?81T(1,516B"&-S"Y[0E0J$^E?&+
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M_2>Z+=*9Y[V>?QH>-/=>."K;UTIF>OI38()&7 _0GF-$R;>(\3!(<;&T=ND
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M;AA07X293P/"B,OJP)1:OLT2YU^V_J >8_Z;M9EPHX:!7[UX 3ZB_T0WL/C
M_(0\\'<RX^/N8_Z;'/K=_^ZD@_^A+=C6O1KNJ$;=JZORY"P[W!7[LXY5);5A
M3M$W#:R>AHD@WXC/(UO:P=TX[O:,D;$J/D(P']]JZQ\68B[[R XCSE6N3:78
M]';)%Y-^2!]_N8+1>$K67R)]F'B-; = /T^N>"3[^E<^XGTV=Y<"CH5.\N0C
MY(<%>%FU>A*/WSY#5I/R&[;_UI0[&M4U ?=29#Q0?PWC-/)K;3$,\YPR5692
MBX]@+8T _83&R<*"2DZS@?1$(4UN_IN!GC1OR]O[:#50@H\06)MA4$9K!41
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M1<<V,'73Z4>LE_'VMFE7S+,L,MT5#U1LT5&>_\*N[FUSZ4&EPS>R(-P'F*;
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M8K5GM*E.SY':K4ET(.&FT55C&=(A]=C8<%$ W;/:OI9GCI<-.!/#J>^5PNY
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M?07:05O<. Y?99Y!O4S-PJC=OM\XB:7CKW_KD,BP.KZ/H?^&!]<>2Q0!ZC=
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MHZ8T(*K E(CN1OB FQBU_.O5QQ$YKI62 C$JR##PRZ6!UF)2+(*"*!3P*W7
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MH1\(]/+ZY5>@H8UG-F@YJOG=BZ1:^#_[. KX!_(WBN"1T=]::+*P _D!4^J
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MFNDUV'H:Z(F']/S2&[30(FDS,%V.8R@LY=@$VTP+/!W(=ZF%89.R$*'9U>$
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M#J(5$0B4/XN!-H1SG7B[WHM1Y-MJHA4.?),T4^J\ZBV?D,AO!@<,9^012\I
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MC,H,HXI1_4H(1MU='D&!E?KXGM!;@:*H65M&F$G:!)$;/4;:8V88$T-6>'#
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MBC_E*<NW.I)+86Z=E0^&S$J3XO?OZ_S>=%<EL)A)%0B)LM1X<1%$2)BZ9XS
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M[1*US*U$&>!ZN0LZWV0M=7996>%^TN/G&\V!^?C%@+1V /H&="0OX&E@O7@
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M4^;<V=0_K2K&Q93A,.(I3)C(("*"019A"@,JTS2D@D1N5<P?M3ZU9:P2KJG
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MY(VK\W&ISRM9EO.Z3)')1:R?UW\X7Y>WRSI!\8RG-$[B.(0TC E$"1:0<!+
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MZNM"OZ-_446P7<FRG%=Q;.<WA93M3&MIFD0!20F,DBPPE;%2B%/)(0Y)&(L
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M5VIDY8>%"5PWK7Z1]_J3OC478][K+_7\;KE>E#.12D8U$4)&S;V3),&0TH#
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M*3*]LY7F6%<; <%W*R'X7HL_E9*B)[\*1VM\\B,]M'4_6KG1!I!=N=$9L'B
M&I!_AM*C+@,Z^4*D)Y7X'U*6U&6@QBM2ZB1-7V]R^;"RI=X^K99?U:WMOCT9
M042H3*<$9C*F$+-<0X8I@UF<9DF*8YE+;+90:U=/\I%^_+9"Z\&]R*V8]<TD
MV$KJ>?1T'MM(Y-IL1QF,,HH@CA,,[?T^2"+%22YXE&?2S]RX#-]Q"XRKI2J-
M3; 5N7>M%1>@8ZHS'MLTRPIB+ EDE.:0B(0B11!)XMCO0"0 S&.X,E^"'!I:
MU^.0 ( -?AC2;]+W. PY T:PHY!C_8Q\$')&W9?'(.=>\ ]D6=XNE#U04<O'
MMV;AK7XU;Q>L_8;C3&E&S(XOC?/Z7K79]E%B."*.8T8SCA,<N8:PG.IH:NQ0
M"PM::4$M[@PT O<(LS@)\?E8E5# #1VE,AYF[D$IH; ;*QSE.(9A8E!<\#@>
M?7+R[='B3EQTV(\X<7J^W^[@XZJJFEJWM[:,TSMVSVY5]76UN;U;-RZ2+$<2
MI5K!1. ,8AUQR(30,$.9EE@*DO/<Q\ ZV^/4J-0*7&?:;26> =G(#*I:Z%GC
M]O*SNL[C[F9]!45S8'ZM@7R[#V0K+OC: AG8S>,,3B"K['Q_HUIGSNH_M]+<
M7[P@I=&!\P;;[V?[B]6RJR+W-,/$7FH)>VOS#_.UK<IU\=]*_LJ*I7W]JBPJ
M(_:[.BKO^1$CUSC#+(G-+MS>])9(0&(VY#"E&',:R8BIS#L?TOAZ3(T@[67G
MQ:F8LDE]!&Z\^D\PM .S]?'S9O"35>/GV9&$/U;/]A'0Z@H:90<]GW[E$0N9
M4.@5M!@_&]'K#=7!5$:O*(ZWRV-;DKS.9?"%_?B=&9XOV,)*L=HEW<BHU"06
M"#*5QA#'B$(J4P7-0J<%QCDEU,DWZM[EU):FAL1*]@/<=_(Z[^!=43[K_Q@
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MSS3U/8?-C6A'&(R!2;;_. 0\^0X$9ZAD]SVE&#?[_650O4B'?V%S?2_@=$$
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MK=: U6I[YHP:[DMQ8]-IC/_ 3-P._=>70]_J"?85!3OOR@QTRH):V[WK:+;
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M13S&-.7M&+Q?RM<8@:[; 7FR 7A\\-V6HE!P#KS:-&(VX6<=AK-]$ />I'1
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M/W_$-WNQ:%,^[CD$YX@SS7 LH$B3!&(1&V,5Y1D4+.5QQG3"(B_7Q($^IK8
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M,Q8E-$8Y% D2Q@BSQ8%USJ"F*C:6+J**)]U9PKCP/SU2&'@ _O82ZTMKLA\
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MQBH@ DFG(,\ LDR-)(RL@%MA;4R];L0U/YX/70X^2&<W@6-"/S ';54!C2[
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M70(!AADQGYP?XX[<>/E QAI!SX0AX> ^E4PD0"\C)AH)A\G3)"0!V^T;W?'
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MJWM6+.<)533.90(1T1AB12ED.D8PXI+%6-(D5EY%K5TZG=H4ZV3N:GLV4MM
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M,*%^'&&]-N$JT^HLGW&:G]W4!5*SS?+!-?%F55(58,<1QCX2!R7NR?YS@1
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MVE1 PY+6.S;3J$I+@>5=G:/RB&&ODTT)W_96<![[$49)&L(@P10BYG*(DS2
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MB9^0@(0I\M6<I*<GFYY;\UU#\4^@:6O>5!K*-A1+)Q;?K8:N?+UR"ON042=
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M;/('PM>YG[=M;ZZM^T ]6[OTH2T,,RB;,X&/V_PZWS(A>/%1Z5.:M%5_NH(
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M/ -L.EW:=&[+#)@2&D@EM3(:Y3:_+Q?DO]E&#QL@;S;S7>,Y,2,\@U++"[3
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M[_=Y_26B//'"E$'D>SH3")*0!KZR4GV1H#2DA)J5$NWN8FG45(MY41JC6E#
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MS3T',,UDQ@V!R\8NZT&BT][J>F\N.ZI'[I9]U/>D-=7]_OW]U^U.%,CSO*I
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M[G.X]L.S':F=D+!].G;JSW;$PD6V^K#99;NG2\[5@!57ZL=O^8_MGYN5[[-
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M6!BG<9"E2;#8%!NZM+-!CO3A-$5W/8UX7]R*"/)*1C=CXQB(2HE,T(#"C(D
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M<Y7[^-)5[FP)SLHY[F/E'&?HW33\;N?T2[,H"<P5 Y>"0A2%&+(D#C3+ZHT
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M76T6 18H)$A"QF4$48 4Q"@6,(RY_D.B?R;*S2'C5%?S\\@PLM6U8UTS#)X
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M7 C% D:# -)8QA"E.(,,AR$T>89"E=(DXDZQ1NXBS,Z6;^0%&R-B53'XTL+
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M1_VIZHT;B07""$91C(P[;  Q(1R21%(D!4<I3]T.O ?),;^=Q%DCS., V)V
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MG#1W%NS>_XOR!EQ0&-]_:\"Y)OY=XM7.!ES/U53I?A4^$S*O_O2C*:=@P]V
MY#\+3KSE_5V2-7'*GX7:I]E^-@]=&P"N^Q#KH4VK+#-VU1^;)4+BA#$H8VTV
MD*3:;$0R,[5?B!(H#O1/AH5V.R3.SXTH"L#;H2%1-]3>')#?5#6OAP;QNLAW
MC;%ZH'3RZ&G3GOQSF\W+7<H'LCDTV.F!U5<+8PY@]XK89 ]3ME''KF%>*9[8
MHU5WI+#OP<'WO>1F(\57^KU*D?ME8UIM95%&"4E#*%48Z"U>0B&)(PDC'*@@
M4R)((^)R,^"\F'G>!Q U5NVOE)&9+?T.: G:^6+6.6KM_+SK"1O9]C8 @4:X
MSZXL07J]^'2!!'^WF,X)F?I*T@5%S]PONO1I9^>M/E H3.'0+W0I[Y1IH2XW
M/*?+^HKIY_S^85LL% KUWB\)(#4=RE"&!:0$A3 A/,!9@J/(NE*5M="YN7 -
M\*I:[O9!@D+#-Y'>#__W[@OX\EQLY:/V\8Z4 9M2&VLWQ'Y2>OVZ4:@>V;SL
M63:@@4%M3D]/<(//8[%J[=^-PNY$+IXGEEV</&>Z.OT\^Y&F<O6<=6MY>^[/
M#G/X/LIM?42@UXS;;S1?&E?RZ]I(6Z_:E\+>Y<O=5HJ%:4S)0Y5"14WM^8!0
M2!%!$ <A1B3(I,1.OJ S@KFYB3_3S4H[Y07X85FF7/P(U'H#?O[TQ32V*A&[
M.8KN4V+G0XY*],CVWR2 U2>C31_)1@'31+)2X<5577/]_C+YSO[G8 (]N:;N
M\B?U6@?3<^S0#A]HF UL7N!/<O/E@6YD\UI11I1(]#97\30SX4D&6<81Y!%.
M9)1PG"GBEK+4(<GE19LJ :D$!F1CVY[D!A0&,J!'#5QOE_KO%/R0K\"N$(</
M.EZ*[YH$.]OF@=B1+=A^E= 008EQ! O50X,G.]0E95)KTZ/JL4WI^[A[_]CZ
M[MV]7#V_I7K9_S_T24]XT\";!6F$,(9I@!*(1$8@B5D(!<I0G,4IPW:]+_H$
MS6TW_'-S2=6@!27<&U !=J]8<YGBWGVN-^+&M@S3<6;?\](7=U-UL;R&0Z>6
ME#;$=#>9O/CT9&TC;71H-X*T^KRW!//#=;:3;,A%Q"6B0@F889Z8QF<!I%@J
M**1,0AQD>@,JKLXBOP!@?IY:^S[I:7.0JW/'+TV&]='%2 2/?Z1Q+@N\Q?=I
MTO>H6=X6M(V7RGU)^&OG:UL08Y&4;3.*LYOXY7']=]-4:27^4]+E]N&MN<E[
MR\O<[Z:09!R)"&,)6:+-&6)";S.30,&,,)H()$6:)I:^8K^TN3F,-6*@(8,*
M,RA!@QJUNP=DP7BOZ^B7QY'MU*M0:.U)^J5R(G>RCU(OKJ0],YW^I,404SF5
M]MJT/$N'AP8VIS1[_3?4%-E8/S[)55$E4&PVIJ63^2*]>3Y\Y!-]-C^Z-0V=
MRE_^*@MSW>:3W.1K$2YXEH8H""4,DD@;:I)Q2"+.8"05T_YGHI+0T?GT"6]^
MKFF-SX0$-< ;<^'W65+7?KQ>I]#.97VM:1E[H3"880D:M!4#+<U,L<KVYVKM
M0*G93?4;:":V4M%CG\X1>/?5V],GM&G[@8Y ZDD/T3%DN+>7.61(:^EEOEN9
M3A4CB5$FC&]-]2]88$AC*F$F,\2SB$N26K>7.2]B;E[U"Y15%JE3=MH%,B];
M4#\4C6P'![#CU'#F,@%7-)SI&'BRAC.7%6LWG.GYI/,V^L-*OS;:3/S\W5@7
M^5F6^_2OZU_S;;U%;PY>*&5I&J0P"ZDR-Y43O9GF""8\S'#&4T2Y5:,9!YES
M>_EKH*#!K]?Z8CM@%VC->>]V>@PF1[81>_)JS*!A]>L:'&"/2*KU!GL,<B?:
M9OLBV677[4I7Y][;>J"I=N"NFK7VX<Z/#FZJ@\[V?8B:[B,!8W$8BP2&G!&(
MJ)*04.VYQ3B(28(E4Y(Y-M6Y+'%NQKO5G 1=:$X27=$ IF<*2(Q5$L888D48
M1%$:0&P2NC/"(IP%,B !MXMRC#()TX0N3J9A-+I[%T__%(Z\=+[^5]BYAY$_
M;J?O87298Z\]C.QHZNUAU#/,U#V,[+0ZT\/(\L%AD>NRE$^5S_5VM]GHK]0B
M0U'&8T0@B4PP0\8"$DXP#$B8"<$(Q\AJ<>P6,;?5L"J0Q2MP@[(NS]!H%P.^
MCIR136S%R[Z)987/7QRV6W=/T=0S B:-B78K>!S9O/#)8>_U[RM3VN%^E?^C
MS-BLKQH4BR1%2H8H@!+%"40LQ9!&7$"6!8DII2-CSA;52<J7+=UL[5[Q#FDN
M7^5CF>-]J]]0_5=N;I@#)N_SE;FP:Q(IS:&1VUO?1;*06) D"V'$(TUR$A+M
MV](09@'6'B]6,8Y13?+/*\MR1=XH;B1.0K!<";_4VEE5#V2-[;VV$);)[ U&
M?^:UAP1/-K9+RJ2&MD?58VO;]_&KBUJT:M[_LEZ+/_/E\G9EJNGJKT#.EK*R
M],=_7[ X"4.1(BB9B2J'$D&2(0YY+"4-.8T)%FY%SJ[&9/7*3%H([8#PVOH8
M V?)S@1-P_PK5-UH:7,#6I-Q>WDRKBG#<1V!_BMV#,3S6L4]KJ/O0AV0*P<>
MF$99=@WY(O5VK91<!V,2*N-,F6UJE@J(HB2$-$D2&(>,18&B8<BMBKQ=%C.W
MG6O=(>@ TS$;\CR7=A;N>H9&-ELGY'@\XK$CP5<FY'DATR9"7E3T) _R\J>=
MSW4^?OKM4([:I&@7VSME"E84E<%I'RLU!PPLI3%/%119F&EG2OM1&.$ 8HXC
M3@),>6);]=%=^MSLA-:@722^K&50;$W9E5*-\@;RR3&I<]Q\P"SUGDN,R_W(
M%FBVM%L?78Q+_T3'&$.FP<N)QG#V.D\W!@PYU4G'<&U;IQY7#'+%W?W/\DE_
MV1YH42:@;NAC=:.3$HHPE3!F:0 1#1@D*)(PY '&01CC%$D7G[);U-S6BQ(I
M.$ %-=9!S0<N,&SG:?KA;61;/Y2R8=?7+[+A\S+Z>4'37RV_J/#9B^*7GQC<
MI* N&&0JIE5U<G?YZO[N26[*1:QX(]5Z4_=#T5MD6;S3?RBV.5\H+D,IP@"&
M*.80X32%!%,,,Q+$"4Y9F'*K^^$>L,S-W/R^RLU]O"_:$1C0WF#PC-A9GXEX
M'MD\O2QK5E81/:@"#KH 5BK3E$$KU;D!C4)>VR=<RZJ_Y@J#D4S=>N%:RLXT
M9KAZ2/>V#?OKGE_D=KLL,W=N5ZL=738Y.X^F%_DB3#A&84R@*68$480D9#3A
M,,2A"@*L4(AMJQM9BIR;72P-(BCVD &]W\CR3Z;!M8$/GBK\]L5H;=GOW9F/
MP.G(-K!UV?L ^094H \YB"5L[WS:MV[PS^M4O1M\\.O4N\&-JN[F#9;C3-:]
MP4VO=OL&QR>=C??%BB9=C0&;,Z/],K)($J8R$B8PB?2N&B&60!J@& ;2Y%$E
M21I&RM*V^T$T-]/_[K0?A*UK[&^6>M> Z;D?_ZB[IQI3=S=5[28WDW;PGJ>>
M,NME9OJIFV@5FFX*798JOW1WKF2>Q$RUT/EEI;4.>A[XBLOUY_KDZOU6M:\Z
M[KE;_]B\R*&(9<A8# 4E&.I]$((,Q11R$2A&)!&1<"P#<PT<E_=\FMRI^M+^
MBY=8GM3(KZ,9FV/%!ESO'SJ1=E&FJ29GY/7S0J_Q*O1TTTS)B3K[?_%B<GWR
MZC,=82B4Z1,7KB3M;(K#M6.ZV6$A\\7/JVV^?;X50G_+B_JW7_72$"ZH9"&/
MTA1F2DB(S#Z$B4S!&(<B2F06*&RU!;DH96[;B@HHJ"'>-'\ !BRX6UDVK+Q,
M[&6#YXVND2W98*:L3905$V=L3R'Y3_?K;_]+/U^9'?V'@[6Y/.HD9L1*L<8^
MV'UXF -F MH;RK=_R[</;W?%5IN;37-I]7F192+F,9,P9)Q#A$@*<1)$D#$2
MAC&G"B.G*Z,7I<W-$#1@P9\:+> UW!NP; "[>4B7F;9S@;SQ-[)E>$G=VSUU
MO_92Y^R]6%'BR3VY+&M2_\-*[6,'P^ZA88:D#IX67]>W_+]W^49J(Y4;'X4N
MFSM)'U9?=JS(14XWN2P6:1K%!$E3WR*E$,7Z3PPG O(X3E$:B90AY&)<G!',
MS> T"ICK=[12 ="]#B!O[M_E*U"TU' S0^[S9&>:1F5_9'/5)KY&#P[P#Q<?
M-?%?;(AW-F*#R?-DV-SE3VKL!M-S; "'#^1> _/39BUV?'NW^2(WWW(NR]M\
M+.-1$,H$8A%KFZ>D@BS1UB\)I8Q"$A,IK2M@GA,P.Y-6801T)4 -T[G^Y5DB
M+QLE'_2,;7/<F7&J?7E)_2LJ7YX==K*ZEY>4:E>]O/BY8?Z-"<)4MW_NY8H_
MOUW2_+%XEQ>/>5%(\7%7)@W@.$BQQ"D,J*D=H60*B1X-1C1*]1N>$AH2%Y?&
M1NC<7OD*E:EIP$NX0#1XW1P5*\+M?!/?-(YL&@Q<T,)[ RK$8 _Y!E2@_7D@
M+A1Y<CJL1$[J9[B0<.Q:.#WKLWS"1[F]946YKUN(+(DHBCB,<$1-E6T,:9@0
MR()0Q9**(+0KL&TM<6[&Y\R=D'V\1B/_WSXJ(;0)M[,_7FD<V?AT5S(PK9__
M:!![S-:P9F?4,@5M>3,H0W!&?;LR ^<>'!@:-D=-=ZIL\_QN_4CSU2)35##"
M0A@' D$4$Y,Q+!DD 9+$A'-H9E74NUO$W Q*U6U(.S,E1O!'A=(QO>L,DY;Q
MWJOX&3O(ZTB->VBW4WM?\=Q3 =,&<3L5/(G<=G_25[M/DS'*MU)\EMO=9G6W
M*F\$5?5\$H4P#F@ PUB&$(5I!FDJ,I@E22+CF$FN@J;JTE<G[\(:@]7W_F65
MI:]3'!;7@,&F1 S6*U"VNAU8=\E^2JP=#[\,O^85TSW7%?8F44M3;OY]C.I*
MSMR-UO7S@NA7[OG93TI_QT^+,88FH[[(AE^$H4(Q"B*8")9!1'$*F=#N3,8B
MJMV:6&4R=$LP?3'^W)R7_<&%[*G88$6>G<FY@I*1K8K_^A4].GO+OGPY^L09
ME6=5.\V2//^Q:PJ8_2:W#VOQ8?5-5J4NBD_K9<Z?%TJA%)$4P9ADYMPX)GH3
M0H1^DT7 LU"@(+2ZE68E;7ZO]!Z@.8[T4MVLBVB[%]X;?2.__C55%5#0YO&/
M"BOX*K]OP1O][?^[]_)G/?1XK8+6)>L5BJ'UJ'V^)EK?0\-LBO8M\DV9[&>\
MBZ]ZD/(<4:I()(P%$,<RUAY!Q"")F38FF,411H%($Z>(Z7DQ<[,B!Y25[VQP
M#BI<T\&JG>6XGJN13<80FIP-Q&46/%F&#B&3FH3+BA[;@IY/#ZQDQ1^DV"WE
MG7HGV?;#JMAN=M6%$&WZ2\N_X"3AB!EW(B82(F%Z2R,>0QH(_5^JB,#(L;=T
MKU"7K_PTJ4,F"V&]*E?'M0*_KE?W\*O</ *C@6-IJW[*[:R%7QI'MAP-V%/V
M0 LY^.,K-86A1W$\[/GR50RK7^"T1;&L"3@ICF7_Y# []!OE#_E*;IYO5\(X
M/4]F]+KP9)I)287@D HFS?8F@3A!'(:I2F1&*=._N7@D%V3-S2W90RUO1>W!
M.M;[M"'9SN1XHFYD6S.8-6>38L&')UMR2=*D1L1"Y6/K8?.(_VSIX]3 0XE0
M4[?J]N[MAT_F$?T/JRJ[^]-:F[6]D]6*QIHCY#ME\G(1"0D*DPR&D=X2H216
M>G.42)A0_0-)LX2:ZI[K+5W:F:*)\3N9M[T6X[VH56&9HI5J+86Y<KZ2VT->
M-BW*C.V#\V7^M>I+E'/ ZA,1KI7WEZ ]QG?'SL+.^!LQLM4^EP;^0Z7\C\"H
M7Q;:.',,=DQ+NVYS6;30,',#J-(K]G2)XB-.U@2YY6.@GTTZ^HA3XY+!/B8,
M7W<@WN]60IH6>]M=<:?,3Q8DPYPDC)H.GQE$F8HA#8,8IJ&( D4"*4+FL@;:
M")W;PE4A!$4)T32M>R=YZ<_\ZS^':?#O<7CM18<SO ^]X' =FZ]RL:&F]X??
M5ZK\TX^@@F]6?_.),>\T=-,UVEV&,R)?^0Y#-PG]=Q<N/.M<.; Z_]AGZ=+-
MANYWK%SA*$:2PT 2"I%,0DAP)B 5/"-A)$A $\MR@!?$S"TB4!_:-5AO0(W6
MO07()6X#BL-(I@%,0IQ %$61*;7(($]Y(*@44@:A7<S7'[O3Q'E'H?.RZ?9'
MT30'QB-_]ZRK$7HB;:(2@\/)<RD9:,%)9QW 2\].5=S/ G^K8I_-I]U+C1_E
M+6GG7;OAAO+G=_21WLOB]D^JAQ)_I<N=7$0<"Q*B!,:$$HA4F$'"HAB*1%"D
M?T$ILJXX[B1Y;BM3&RX0%5Y *\#VE;'=R.\UK.-1.K*M/9/RV.:W!@]J]#>@
MQ#\6S?9UR$>C>ZIRY%YI=ZI+/HBZ[O+D;L--5J5\D);M8N7#!K@NOW1?W+65
M5K:0>LN!HS2#(A(Q1 E!D/)8P(!QDK&4!D%$]SD@3N&03IE6+\Q1SL<$T9!2
M!A"7,TV')9J>9=XZ$G(=D:^=7OK+1G_7_6>57N+#<T+I65&ODDMZ2>FN--*+
MSPR]<_E-KG:R:9QS7'ILGT6-TX@@'B:0)BR"B), XC".((MX'"L5HS3$;I<P
MK>3.S:6L81]:3YV6T+-)P+YJ*NR,S0@$CVQW/'$[X':G$U/>KGO:29WX_J<3
M%:<70MT>'V:RONH9T([$2HI#GY@Z4H.5]CEC2B%#DD(4)8%IMA7!C!']?S+0
M_Y2Y6*EN47,S3 >DH-7 :-BMK L$V]D>/[2-;&X&,N9L7OK)\&11+@B:U(CT
M*WQL-RR><#^H44KR[?YX6SM-G[6(S](HH5VG4H;9D95_,(9K4]!EW>4LIEF&
M(X$ACDSZ&L$A9(HAR+(@%"+"(J-694^O@S$W$[.'">ARN?Z3ZB\#V,BEI(5#
M3Z=KIJ7_T&(:LL<^U&BT:'7O 481\%*3*M93S4BCS(UKX[]KYL/^7&2:>9GJ
MW&3,^7$Z6KF>UNZCERO&GNQHYGK]VT<W'D8;&-3+O^5"KD3QB3Z;9).W.[W9
MU^]7))'$*E-ZIVV:)\5(FJL$"50IH8R@) T5<RH5=U[.W-:9/4S3%M;@= S4
M=;!I&:.[GJ.QPW-[>FJ(-Z &Z3$R=YD%7T&Y#BG3QN,NJWH2BNOY^# +\)%N
M=QMYI^K:#&6";H+2!*="0<)C!9'2VUB*PP#RD&1<)4IQ[M38XXR,N;WY%41S
MIZX&.2CA^1R9=B__E12-_.([L^/\VE_0W],K?T["I*_[!16/7_5+'W7>CO[^
MY=W']586)B;UFQDX7]W?[NYWQ38*4%1'5Y3><T8!SR"5YN:&4 K2%"602\QC
MAC&+N560W5+>W%Y_C1F4H&\ ^DGC_I<;T$ '%79@P+M?[K(BOW=WZ9O2D<W%
MZ[)IO3?TS>I$FT!+=KWL\UPHZMS060TRU<[-1:/6%LWIL8'EZ!Z?:+XQ7Z"[
MS;N\>%KK3=Z=,O4!?M5;0U&5O-,[Q.5.:.$?]/=L=9]K/[#ZAZH,3O7KH7A"
M3%%":4JA$$*;]21@D#"F8$H2(3*!$DR=JF&-@'%N2\%!1?!5%N9N39DY76IP
M"*LX%LL;86KM_,I7GK"1%YK67*TWH-%O7U:C5+$N_7D#]EJ"@YK[?ZR+?(U:
M[&O$N?!53' $A-,6)!R/XI.BAB.*<O;Q_U/2Y?;A+=W(M^MB:R*'WTR) 5ZV
M =9$XH^??CND5-:.$F(\3KF0,(TSI!<'4]@L"CF,%)6(AVFH4JO%8:#\N1G^
M2@=@E !&"]"H 6H];H#1!&A5VEG5SD[LH+GJW2*,/0,C6_)9DV^]HQA[$B;:
M88PU&2X[CVNH[-R)#!ITJIW)-1JW=BI7#3-LY_(^7^5;62Y[Q^O<[>-ZL\W_
M47YAZVC6_Y-T\UY_=A'0D"0H)*9UM+GK4 :<$8:,10'G,LFR3+D5TQL&Q.4-
MG";Q\F>][W@T-]:!VI615]I"?P.>-7"0N&U!!LZ1W2YC?-Y'7GXJ!>H-P_'V
MH-5<X/;%/!A%@-'$WQ[A.B8];0,&@IC4T[^.J&-G_LK1KLZK-+5/*A/]*_VS
MV.7;1<8BR600FTJCQC@&'!)),AB(.$E9$&&6#$VE/!$V-T_\19/(H@"T! N6
M%5K[&U_]+/>ZU5ZY&]F(G>T,J7]4X04U8(_L#4Z%O(K%U\M^=&'SFG3'3GJL
M,QQ/1WBMI,9.72[D,78_XVQHJTL2_/GKAJZ*Y5%IJ:(I)K6(<:2DP!QR111$
MF1"0,I1"GH8A$8@1*:U:\UI+G)O);5"#[0$VH ?<90Q\;9!;VP]+ZGM-L']"
M1[;#>RY;B%O[9&U"-)=W8W!I;9#]<SJ15?; K8ME=N.ITSQ;#C.5C7;3JF6H
M'1\<6(;_@6[D&UI(L4]H-W),/9/[JMC?\^$CG^BS^5&9YUY50&D5Y"[1?'V@
MJ[NG,OKQ<5VV#9'B;S*_?]"_W^KM/+V7OYA2*>_T?OL]S3=EKOSG]7+Y?KTQ
MHRYPS!F-@P1*1*4Y0\6FVA^'F"A!49!02:T\\9GJ-[>5J,$.:_"@1 \,?&#P
M5V4FP">]02AI<FPX,"_R;;L;S OUC-;:4FU8Z@W:W( 6.8 ]@_;G:H*JPB4W
M39>L=N>%JOSN5M,$:IYNP)ZI&]!P!2Y_1<?(&)[I-\%7DXB9:3=M1XJ9*=\1
M*ILKS"N*YM]ROMF9#-!]:8LF<T.%J11*<1C26$#$A(G"I0%$% E*$4D2:5G[
MT4[@_(XB'/8IEIS:+7G^>!IY!:K6BAKIRZ(UWI-C[$CQ61*]6]CT%<Q[%3];
M<+S_*>^W;="Y2P0A3R*2(@JS,&80I3R!S-2RD1@Q3&6 LMCVAOT0^7-S\^WN
M&*#1+WR<G:NK;]M<.P.SN&WS2N1[NVUS[23,ZK:-^V3XO&USB<K!MVW.#CJ7
MVS:7-':X;7-QF&$NZ\O3$KV>O7EN\L5:ARAE[B') I4*3"#FYII-&*60JD!"
M*5@2RD!2D3FE<=N+GMMR<WR:!^J4QB%9G@X38.?KCD/KQ*?-EHPZ^[SNY'CR
M?QT$3^H+NQ-R[!</&&&8J?I%KO0.?GF[$K?B,5_E)AQFZES4]V@649:J-,L2
MF$:<0Y1@J2T5DY &61(@*@3!85,VULY"]4BT>G]>%HT=V3#5@ %?;Y[6&Q-!
ME!54QR*Q?53;62(?]$UC?AK>RMRL%UB;''5_)LB2%4]VIT_:I,;&4O5C"V/[
MV+BUU6Z;8F%UU:B$QT$210K&-,2FN%H$<101&&4(JS2DB*6C%%<[PC$WW^A#
M&79]O!2I\CH-O;OKJ<@=V40-J=:UUV;<<FK'4S)./;4KIF;&!=7LIVBTBFH=
MQ/HIJ78\^"QKJG4P,+2H6M=P0W?HJWMMN!]-?_BO>HAWZT>:Z]<*A4+(@,-0
M!12B. L@3B6&B4@)4APS_>]NN_%S8N:VNI29V 8F,#AO@$$*_JBP.F^\S_)J
MN\F^EJW1-]2:J*^N1 W83U_BP=O>^:R0B??)EQ0]W1-?_+2SHWK[YL/JC?S6
M5 <G 0H19C"6,H4("P)IEG(8\4"F+)64)-32\WPQ\-Q>=@W._93@)56]WN%@
M D9^?V_?@!+8M018^V*#B9C(N;(GQ,51.JMUI^?S\M-3N3)G,;9\D_/_/LS9
M>'$+9R4^[WMBO\L+OEP7NXW<]^^@+$ BT7M?&B$)4<HBR$SX346QRA0A01)+
M%P_$0?;<+-4!*ZC[]1:#VZ>X3(&=LS(2L2-;P(&<.KLP ]CQY->X2)[4V1E
MR;$'-&0(]_C=UR]?'M=_SU?W="6:P]-"OE^:&W^WVZU<";K:%O52F,8)RF*$
M8!)Q89JJ:'L5IC$4C,8I"52 TM V8.<B>&[&2H,'-?HRX+V_,E#(&U"I  XZ
M#&A![#0K_?&[L;@>.V W*YKM8W)CT3U5$,XS[4YAMR'<=<?9G$:;++ V1,=V
M)&W0\^Y+PVZS+FML1EJ_IL;F7W8KJ5G.ZG<B8V$61B2&6:CT@D 2!*E,$JA_
M1*@BF<0)MUT0^L7-;AG0D)O2K]%/6G:[]*N!#@SV 7;)@OE^H^^7S[%-_2M2
M:6_8_5(ZE3FWHM:/];8GJ-MF6XPQF:6VUZ=MGQV>&IB2J[\SY5;@3GW9KOG?
M']9+_7!19?0<H@MQ%@L4A%#(S 0Y8PQ90 1,J I#JAA.W&X;6DF=FXW>@S;E
M:]JP_ZU)-!P:9;";!+OX@G=J1S;77EAU3[9T8<E7"J25S&D3$UUH.$D7='K8
MV6EL*N_^LEGOGC[IK]N#]DQO[S>RE/EVO2IR/4Y=J4#DYG>ZK+,2%VD6249)
M"%4<88@85Y"@A$!),$4IB5$6VWJ3U^"8FPG;U]&^-\K<@*=:'4 ;?6X ;VMT
M ^A>)],YR^DJT54SV.N53C4O(]N__93\4DU)HPFX/4S)VY=3<E"G27B?9DJL
MO=NIIF8BMW?<*7+QBGT0V^DN7S7X5'ZT#P9:#K:7X=SC(=]Y7IA[2XM )(I+
MH2"F40)1@#*(PR2 * S2,%,L1-BV%N1^T+DM.A4PL*7?90'6*_"T68L==RCV
M>*"K/U0QA(2Q Q*5_AK4 (WM(PI#-)\J;M#/@%-LX%C5[@C _I.3[?./L;5W
M\R?_-K H=U,LXS=)S=F=F<&_Y=N'WU=K5LC--]-"\L/J:;<M7MZ)U'_;;4P$
MX0TM\J*L@5L.LPCC$$<T5)"'YO8\#S)(,HP@5CA*,:%1I-3B26[RM=!._V9K
MM\GW#=/EBWT,=KSO]ANZ+)N6TRU@\CY?K4PL3&]E*P2.E;Q]3RQ!.(M5C&!
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M/;G/+U+C%ED0!UR(& J4$7.Y!D-3^!B&1,4)%RQ2H=/M<*_HYK9X_/[3EY^
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MD^]7R7B@L S!9,<<2F*%MSCHO['H?NAX6<G/PZ4Z"E!\/@VSV>NS%4EC1:)
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M($F. P2_39>G[_+$E)2#=[3->%E;7-;\O"H4V'B%A&4FY)'[^8WEAFGDU",
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MLW-9?9G)D<=L01A39Q]:LO7)!] ^&OK*DX/>NIW[ ^2,%%J'JO[VR7PC/8P
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M7G!]%59?SI3S-I=H0&+VH )#<+GV(LL^F2QT-J[U0]>>) Z#YO-].1A38AT
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ML);C:I YBQ)M">Q^E6 [S#7>2R?]0H^#VF, GE+N'>#_OOMQG5]KA12.O$E
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M9N'U)J[UIJ;PAU1O I,-.1/)(<08$^B<0RS.8,;="2./?_ZT4#A6:(O6'.Q
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M.]B?3/5=Y-0.X+;RR81#%"4"JQU,*D5) O8!2F*"Q$VG'%O7<!Y&Z;CAY,\
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M=G\;-#=790<^>*,<:4[14[AA0=.Y)/_*9PA)14A,)Z&D2S*TGJUQPI2Y_]M
M? 0X]#M99UO;R@^!^&!M/$]^TPF:<W;C<J"6F^!\T(1BKV6%LI 0,6OP.;%<
M(K?6MFY":=MR\U!X[Z[HL.YPPM=E#SS102DHH$1+46NRY/$H7L"DXH.-EALU
M]"O\7@3W4(I\$':V^:W#J:W#^&U79E=-!)ZSDK2+4%:)1AMJS3?9_!RMQNPY
M1C5T^F$?>OMZ(1\05HT O;>.SQC/F]X%ACJBS!1F1I9!!<; R>(@JV*+Y#:(
MU+KJ_CB*SQ/3^R.K$:0/4/,9@_JZW-9H*UUM\N>2HM)Z+3K&-9AH45NT5HK6
M UN/H_@\07T(MAK!^@!%=P#K+1V*FIO(M 2CDB#SD"*9AY" S *SOG!70NN'
M[.,[A$]6:'0Z[Z&=EKHH&7J\9S'D8DSV$6)*')0R!D+1 70RQ!]72C:?+7A^
M+</[J'JGEN%]I-Z!O=JS&S KDYPW'$H('I2O6R0MXZ %=RK6/9*B=27Q.75P
M-H#$<=V:^^CGC-#W%I=_3L.7FK#]7\S_(*'65-Z&9^FD)*8CH).KSBL!/I*O
MPDLJ:*-T3@S8RWXPW=VT<C3'U8$0;J;D\P+V^_ED-O^(\V^3A"]GB^5+HG9R
M+7?'>;V%+%U(@9$+7 I$KDD*WGN>LU'!C-4QOX7T;IKQ.H)W,U6?<:.]PAPY
MBQX0ZV->,1X\9A*Z2+:(;#'9!YN6?JI&^W8>PBD5\9,TU4=OLZ[M3NBJMU^8
MAR#H']P4Z0*:D-->V#O;IOJA4'@JY71PPS],7MSRNFL:X\U-FVS$9$K=UL.,
M%75R08# R,/) >OT%1U\:!VI-R2_KX:>\9Z@3H6 #L!??9E5L<HDW?=Y%J_^
MJLNO\ .2Y5^$RW=E\X-7?VVJ;NZZ/]?VY\)%Q80Q$3+GM<^C$/O.DN_#&2KM
M"_G[K;/YC5GH*[U_,BC^N-%@-%QT<"QNJR=KW=L3+MD%$2XQ2@O621)P\F1S
MLDQ0BG792Q_T[9JY1F#?B;"^'@/&@G!['8[:?D/^V;4W]L><XM'+!\)=7'MF
M%UAD,-X74))'J ][$$UBH)G6.9IHO-KN'._V77UY#*=&VC JZ<#\O9_/R-2O
M%LP%D2F&8 YDJ0D5LN(0!4684D6F!3=.\=9UCK??WE<#[EB&[$!M-+1636N7
MK[WVOW#Q,7W&?'6)LW)=V+ONB[SS1\(T$__?)@OZ3OJM.[]S<$ES:P(:5#H/
M*I-&!= W7_/K9)$N9XNK.^LZ8DK1:B_JI#P$Y46AZ$MR(&!+$T41)K?N$GJ&
MG+;>WWIOS15IXMU7G-^=2G)7\/2+Q7*2+I!;XYS58%?SA4U2X#F2I1>.9*%E
M+F%8GW O<L<-=EHAZGG/;SC]=7!3'\#J)K5WP= 5U-4)R2J33^(221@C:!MR
M],K;]G,@#Z=VW)"F(Z >HKWSQ.FKOTC I-G)-,R_K[RH)UJZ?+8QJ6P@!ET'
M6Y-0 J("R7GPO)0B?.N!20.R,VY(U1'2!]%_!WVM-RQN$F>;Q-IC,KD1?<DR
M.V8<V%+7Y!7BSB6?0"2=9&+:1]4Z"CN S''#M6&A.YR^.K#.FZ[=0SBU-D;G
MLH40#7%:5TW%&"P4$5)P2D=I6M=L'4YM)^[N4$":C:+5?O#[&Y("P^4/K%[H
M+ NK+A+W7H$*),58G\<YJBBB-H9^;QB0/D72N$@\%3(>!V03-?6#NE5=^HMI
M?D-_X1&FH@ZB).TAJ,!K_M=#K"5A,A!DE- YY-9MJ#L1-FY$-2X"&ZJL'QQN
M(L,?V2'71PI1%UHP00(S"B$([4![F8L+SKKFO4I;2!HWQAG9^K504S^H>T**
M%^2?,!5S'3:DZKLJL12$$""]HG^IS*QL7>_\/$7C!B?C8JZ%DCJ(G'_=?.TA
M4O0F>Q%T)(^B>%#:<HA!*9*B$-8ZZS&U=@&/(+>3=.>) I53Z;4#JWG-ZL8'
M?NI@1L&38<20054'"CHZ_0X-6-21)"I]:+[G8S?*QHU;3@:4)P#:4&L=8?&>
M-_P4;UHXD856%(S1(5>6'.,H28:!,^^Y,3F9UI7-^] WKL$<&Y?--=@1.I]B
MIR@43@825#8UI5N3NT%(@A%CZ-"JV/S59PM)XT8U8V.PA9XZ\#&?8H.,MPV6
MR6K;Z_#44%MJ@@?BQZ)WK#C>^D;N$F:G]@U;Z*,9K(:J@_N :39-D\O)ZB-G
MY1?\-)G6VJ\PK5-$Z1=_3N?T9SY-:T,U_97K8OP6-7!'?WG;^K>VLCA![9MP
M)FDM",ZY* JBF:D-[1JJ[?0L&I?L8):A?>W;??&_*T\(^Z;;X\67V=5TN7B/
M<Y)^5=,?LU=_A2^U8X3^^ =<7LVGBP^SR\O?9O/_"?-\H6402G&Z:R*2&X*\
MU!)6A,RD\3FZDK5J+*ZA>>KD6?%(;#[2%=</$CIP2)_@_\*&G'U0 72LS;9<
M9HC::D#ZI2L2E6C>\O8$*:.WKG6$EUE[Y76S0?,)9L@0S#&LYF(OKB[)'?NT
MJK5ZL,/E_6PQ6;EG%\PHIC,Y8XG<>U".)!O$JE_<:^6RXR:V3M&WH7ST_K:S
MP_F0T.C7-#_.]6IVRR,\(^KH$S>$VE6+JDK@71U2J5WP(G+'?!SS.#Q!]^@M
M>#_)86@!BWZ/P@?,5VG%T#VFWX2O"WQ77GS]>CE)=8Y"S21>+>E';R9?)FL8
M+2YT\76M- =A$HG D3\9,]=@A0Z>2Z6P>0'! &R,WDQX=@?E9* Y>B?6T,?G
M5]S'9"2OE"W>@K5N-0#'0C3%0=%2)&=<+O)$YV4OND=?\WEV!V0X6)SIB?B(
MR^7E:DCOXI^3Y6?Z\U535\O/LSD) >M8?8U:,@7!2@DJ<KI(:Z53MB(J"K@D
M9ZV;SIHR,/KBT)_DC#0%2O>'Y<+:[,E_]+6&*U,41;_RQDF0AON<I'"!G2C4
M'GT-Z-D!>"_E];LR[LX3R]LPKT]TW[#%\]$/'];V.>AY6D_PO*.]YT&+ZK@F
MTKZK>[J\YI!#YM%I$DMLO3]RP.>=S>OL]%-MQ7Q)LOU>UB=GL1ZCIT,H+DH&
MG,D$JG;+.2DC2(OU"=<R(ULW&FXAJ=_'E7V0\</"UH9Z&#'KL)@O+ZX'EKPK
MC\_8^O&GB&_#9LV2"*:(',F8HJN5)\I X(6!Y5P;QZ7&LM/C*1%R!VOT7[<X
M.Y;&<0'8%"BS$;0V,CJ?XF,S*5<ER80EY[)N?ZT3DR-X;@48K5'XX"3'G>*1
M+?A[GHIQ$'9:%,P&4<FXX]/_[Y]_OMG,/*9#Z%RQ'IQE= P#Q2P.M8,@"I,A
M&295>-ZENO=YXR&BI7)FQTIJ7/6^G,^FL\4_YK.KK^0&_-OU=&M9K&-8QUGG
M2!$&Q:0^E Q.)YZRSNB3V*KI1S]ZG&?-X91^O/PZ>$^Y<0"ODQ/?5[;/<N^%
M(4$8[2G.Y&XU?40 %ZP4)#94\^6RCU,R[EOX$-Y)0\EWB9_-H8HLL]I^!WXU
M$M30KZ)A!9AUOA1O>9##(ZB'O6XM]+P5.@<(O0/PW.OK^+]7\\DB3U8/<AM;
MR@S&K*T%)CD99BGJL[3A=-!"H*M4!-U\,> 6DGJ#TB%Z?VS%9",E=("IITWV
MFYMIM>AX,=XBF%+[@CFY]S'Z3&B0Y*8)QGEJ7=*X UGC5KH,>=6UUDD','LB
MF?['Y[#\Y^SJ,K_^\C6DY2LRY:EF=VLVGX[9A;)2%;'R+3T#976@F!(+2,Z<
M(0%P;EMW=1U&::]9H0,!L]M32$OMC1O;/<'@\CZ#U[UMU_Q%BG]RD"1#%+:^
M+FF(M:8^6N^==S8ENSW*/^BK>W7SCX/;2131@3&\T\16'R]7>GN/TW!9G[K)
MM;@>9?DBI?D5Y@OM>10Y%DC9$WLL)@@J(_#5_'?%,QMNG/9N)/9Z%[<Q?T/J
MJP,X/ET7N^;Z,58W[9<75F84VA6PP4HR\>1).V<2L,(M"4%Z_7"YR(!5TEO)
M';?F<Z1;NKD>.X#L=171Z^E33"\^T._/IN2+?W]/XIZL?')K4Y%U!ZRPIFZ#
M%1!18WVAE1$I,&,I- ;K082.6WDY-$R'U]VXON1_A,NKM;(N+V?_$Z8)[[@K
M+Q8+7+X,7R>UDYQXPYOV@VNQK&N<+K0V)F%B("-Y,XJ%3"Z-D&!8=MD($P/?
MOK6I"2GCUC@.Z&N>7E$=6,X=F/X<II_H=&[X\Z'(Q!-=!1K)F='DQP3G%& =
M0\<CYX6W3BKN2^.X18Q#V\M!-39^K2P=Q)O$P8VK4J.Z^\6A/TIAPVU*CFE=
MQP([MEINS""*F($%541V@GY7;364QU"P$_K<N:'OE&KIP"P^-5>&8Y+)%0L4
MLI%U-\*"8R9#0>5MT(R.6>OXYI@Y/_[<8-92_AW Z&DQ77B*J8KD$G2N[T*,
M,P@R:-#!V*R2+5;(QDAZFIK=TM7L7-'42 T= .KA5;_XT>!>:&:SE:* X:&R
MY"0X4Q)PYA6+.<7\L-BLV>B[9\C:#6)G^R326C$=8.WVFK]WQ5][E[MP["PB
MIE0@69Y 92/I=%E-0;OFWNE,3+=^*3Z>ZMV0>G:O*2.I]6 @?\-YG-V#\JGF
MZSU\N S3_.?'S7#?=3/[;/Z]_L80\_7V_O)AY^L=)XL3-&"EI*T,7(-$6<BH
MENH1>L*BBD5*YJ-M/GUB@ 8L"J_NK)W?E(R(4EQ0&3 Y7J^+ E$G!3(*J7U.
M)IKM*;^'G]I)!=:1BKP3E1XEMG/NC<K.%A$<14'1UV7?*0(%1@)D8FAU#&AW
MZ\7[Z7JCC@9%JSZH?334=Q^4(XNBLDM@/:_9F^3 !5,=61Z-9=+QL%.7Z]^Q
M#VHO%.S>![6/2L9] 'OQR^OI+_AM4P_K#;,B6)*$CQ&4S!FB3!)*]G1S171)
M;&^0N?>1W79#[:6B60-Y==/O5HI7!8N :+FORP0HTK66 TN,ZV"DL)IM5?*>
M_6YCM#X=J.$#)=5COYLW6"@0+771.(6"1AIP7DD0(0>.R(F_[4[JX?UNS6O(
MAE/Z\?)K&$H?&Z'<IB)$9"P&<JJLUS6II0-$)BP8$S3G@CF-;BL 'OOD<0Y]
M*^>QA;@ZR &^G'WY.IM6%MZ50W8[).&08U1DWD*NYLU C"Q *246%9$GU7H\
MRI$D]Q"S' B7A]O]3JB[#J#Z1%[S[:PFH.J@2CK*&^[O+$^T!BVYY5E&!@IC
M7:II-+ <,;NH>(JMGTH.('/D;="GA-%NN>IF.NT7MD](^L7R8>[U7C'&A8MH
M$VH+O*[1429F\DU\G8O'G%,J>/(K3P/HPQCH)#TY%-QV@_<)=-\O\!]?5H>+
M"Z-MLL0'!<*UL%):K(MNR2DC%[EH&Z+F@W7$[T9B)VM9QP5O$_V-&^GN4NA6
MZ]/#8K)X/=UL[+[COFU*WC P&61P8&TT]4&C@&-6DZR%3Y&E&E8TJ43<3DLG
M2^$&1N8XJNO7E-(/UI[9)Z0?TA$4G@MD-H#QQM3A2G0$)1W!5!A+R)F3K/5R
MK1U)&[<3JQ/3>92^^C>93]8&N^AKSE,0A]S470"N+FM$8,GF6JXN*% 8OV1[
ML :KSLQC$S6=$1H_X#?ZSG"YX5(%+6Q*'H+T=0R_XN"S=D!@P]JP&TUHW#]P
MGX!QVZMZQ>(12NKW?GZW_(SS%_D_KS;.QT64SOB2%>12EZ(4F<!%(2%9BMXH
MAK.9#U;+]#QIX[94=7(_'Z6OGF#XH*D""WD2LE9RVCK!/G(+7L9(;H;*!=$*
MC7DHV!W0U#)8[]1H,#M"'QWL1'_<D#^6$W[4QM^(4D;G62P>XFI@<'$%5BN\
M2:A,6A>=SJV'.S4B?=S$SY@)^C%TWX$EW<5WV9JN]::D(NM4;$-'G>L"7C,!
M3AC$J(M..IT$[GN1/6Z"?A2X[03YX71_)G!_,N]KL^2&3 R0G:G)7Y4@,,U!
MA**UE9:NR-9OK,?0.ZXM/Q> -]%V_TF"YU+%%ZQH[H)S4&(=ZV5K/B1S Y*A
M8\I;7^3VTK=CJ1@WLS\F7$^MPC.QPS\DD0,/T@04@++N(<K14)"J"N@2C"J:
M95?&\#/Z>@$X%[M[E';[M[<_YI[?XSR1_BYRQI1]Y5,KI)A8"_#.T9FE$RR\
MR,C%4&\$&Q+&?20X TO;1GEG!-+KI/0UFRRX*% **(EX55X8\#D'X)B,#*'6
M.0ST=+ /1 =[.S@GB!ZCNC-Q!'[(5J.,P7(6B;-06TV2!T^W!%AMK=!%>A]:
M#V,XA,YQGQK.Q1$X2KO=(O@Q.5_XI(N7(E-(:4B .@J(V7%@.DF9@I0>3X/;
MQZ@;]\6B7[0>K<EF#QM#30VY;@J>E>N1*;?[95:#4\(TOYF$2,*N0Y9;S HY
M\"O;3@AIP?<)YH(4+"J9R"$8P0G27(!3W()-QJO"$'D<;%+?L'-!K"U&2N(,
M_>H4>0DAU$G(3JI<LL_\X3U^UG-!]E'D<W-!]A';.<\%88&CJ!4Q+M5-0UHI
MB+(.2V32Q3K.3N[FYOTMYH+L!8I6<T'VT5#?<T%2B-*(4"!R<C65)!DZ[1/(
MA"Q[PV0T.PVQ_#O.!=D+!;O/!=E')=W,B\@J%!L4@D6]FH)@(7B7Z51F#!J+
M,&7[E78&^Y'W4LZC\R+VD52/\R),4"F%1"& 5"2!E"($29$&KJ9_L>1LV3XN
MX+SV(Q^H]./E-Z[^'^UGUSY:)1'!H,W5F>,U$YR(A^S)Z#E.UF\?W_5-?],B
M#G$I6HBK@Z3.#[-#W^+RQH_7Y+2+6#+H$$@NQ4=P5G@@>5CD.?F<6C<?/4=/
M#S[H@8K>-GKX4*GWB* :$VY^MBEIK.6.].^UJJ;Y>DO0^QEQC,O)'*MHKW]Z
MP4IV)00!,:C5#*TZNT759=$!66 H,;9.'K;F8=S0O!VZML'VE*H^#ZA_(%7/
MOZT6M*UV"8;+Q1O\%"X_XG)YB>N\OS \.Z<*>*P%  Z)_WKQ9+3*.Q62"JWS
M7&TH'[?0;DQ8MU;KN'[>#PS?N>!>3]>^\4=,5_-5.OC"9Z-8IOLM>*UKZQ;2
M ;4:Z@!\KU-!%'FK![C?=XY;(]<<:</*O$?+^'AV97&14PPBFP".HZ_%3W1(
M2K:0<F'6BVCQ8:]F>]OW!&WCEK.=SKJU4$UG]NO> H8PK;_QDGY_LKR_.29@
MD)PD"0$=UDR,(PY=A,1=*E$75^SV4/; +Q^W%NTD%FT +?1HVOXQ)_8N@LW1
M&1T 0ZSE1Z7.QC$<F)1%"169B:UK=!^G9-P*LM.9K?W%WD&CY1TN[CRPWY51
M4=%EGLA-S#Z0U17D/TII0+,82D0AB:7A</0X43UDYIHG6AK(OR]K=(>A]_,9
MV=[E]_>78;JD&*5>\5^K&"^2E(J":0,^Q?I05>AZST4!*R8IIW-*WIT$7D^2
MV$VNI 5 =H)?&VT=N_=U0#C^8S;+_S.YO%QOJ0_33[4-_SKJN?_?%Q&U"XIB
M99:TJ0L7 O@L(W ;#*,+A$E73@+0/8CN)@]R,L@.I=&.07Q[%[VN\R32;+JD
M;[[$_**4534F1>EHO"9'1D$.T9(WDNGD1F2 )DM&MQ6ZYK-;#R:VFY3*R4#;
M6H-=@Y5<#&*V]DQ.IF&:)N%R?1PW5;WT%V:_X+_C9;ZPTCO!Z5:105/\I9B!
MD+(#S,%%*9(T^C0NP1Y$=Y.;.2%XA]'HJ""^GS6XP^TJJ8[Y/4X7I-.7LT7-
MIWNO T<)S'(ZFIKB2%?7D4N?1)"%HS;;*XQV_KIN\C,-$3:8N(\%T1\#QT.K
M5IL+9>OXI2"@Z"C)FV8%Z#2(.I"3E2*%5\TWOS]#3C=YFI.9L/VUT-4->U/A
M?H>E"YN$H%A,@2*K2OZ"J>,'2H3B/2.NLE>B]4CSY^@9M_/N-* Z6@]'6ZLA
MTH%/;FKF)6:FZ#)/ HFS.KTU8N;DH"J7?0[)8*^[X)M'#R>IO3I2!UW9K >G
M!&.T6IH,+)903XD Y^NH0^N"=<PAVM/$I^/X[Z?+*.\EZ=;V:+!VR:LO7\+\
M^ZS\>$*:M$9N__C&;9![\G."ED=AO&#9<]"FU.&AA6 C6=U3F&7!S$ATY]'R
MN(-5_3"[O/QM_0A\D<D!<(DQ2,K6BNN4(6:TP*6-GGD46NX5V^WPG?VV2^X#
M@N?>W]N)O*^'KB>O:2:Y<3H$"*M98$($($=0U)T?VAID/(K!*X4/=)6&*%,?
M$A '.%'[:.=@P'W%^626/R[#?'EL9NJQ6^$^EW2(YQ@6]//UOU_D/%F/25":
M%V*VYHT57?]<('A&P4Y!QU 8E<+#5,,C]NP( D9[L3\!YDZHFG'+VK9S^6$]
MU+RR):56444/*4='D;6I4SNC 8P4 FOG ].V >)NOW&T"+ 7B!TH_/%SI0<=
MH,WHS9=7](>FZ?L?\S!=7*X^HHYW0&\]0C),T8GR&@*GLQ5)M ;K8X,/ QB[
MIRD:+;KL!9H#*>],W,#(0JPSWR"8XHDE;L$%I4"*0)*MI<MR\)KR ]W Y@]*
M_;F!^VCG2#?PU30/E1;YB)]J$ND#?IW-:XGSVS"OM<[?#L^$;/W$!LF/_:AN
ME.]X^*4W<6X@0$7GZ)K4,1,2C(/(O0=3M'1"!:=DZ\*#IV@YUBS=CA%Y^ VO
MIV4V_[+2U"_?-[^Y[C)GQC%6=PUI4^>LER3!>6U >J.S$T:FAXWTQ[._/YGC
MIDF:8.>AE1I:61U<DZOA_JO6VJO%9(J+Q8:9Q6IN3;#,BF(S,)-#W068@&(?
M7LOG,WJ/RJ76CY;/$C0RQH:&PT/X-=--#T!;T[Z9DY*+"TF9 "0+BH-B9!!3
M3"!UJMUB)NC<>@W9/0)&!E([Q3Z$S,%2'C>#\?'+[+^P'ICW\UD-EJ\ELIF$
M$Z(1S/H$%&KH6FRIP#,;(;B4E=,ED$>X-7!\_CNZN+X.T=ML""&.BX9_TJ&X
M3[MP1DE5.#A3]Y9YYVMI> '-I$S&QE#$]E%2/WSLN.7X371^G*C&5?.[>;C\
M8Q9#2K/[+"AF43KF0'AE09G,(<KL 5WP7#,1A/5;M?W4IX];SMY$Z4T$-_*T
MR8V->C?_B/-OD[2>D^@RD@RX@" # Z4D!Z^X!Y>9D885R?5.)4Q;9DP^]MTC
MVX(3N99-)-\'<NI(E0T'B\UQ,D%%;S"!M84DHDP=<DX^5#*R&(/"(=LI3[ ;
M?'XD8+Q9E,?K]$> '"G@D2=23CZ1T)9+7&Q,HR>'IW@5*?J7$I0P"H)R :+3
M/">DWV9IZYWR\%-'5_BQ.IJU$5@'NKXFFRD5;+$*K%EUPGI5^_S)2')G"^E2
M";5]>=3=3QQOUN@P.CY$4!WD#U[.IG5[SWJ]Q(?)XK]^^?X+3M/G+V'^7^NP
M.1J>(SE/JZ!&"9')]ZE[J(I21><4;&B=)-Y&T\BNYHG354TUU"7BKKG9G$(*
MHPM+JM0"$?*VDS?@1'9@G0LB*9V#\X,C[CY-XV8QVB)@*[R.4$<'\/H8+G%1
M=Y--K_ M7D=P1NNL8TETS?*ZXY%'\"'P.O(H"*5#2:5U$\>CA/0&I&-T_3!'
M>K3@.T#/(T?M#_JK:[]?JQ)\W0RF3$T;>PE1"P&<66E+\MRJUJ\VSY S;@=V
M!Y?@07KI$6*5D<WY8R;%D+P%YD5-,BH-0="106^X$=$S8^W0$+LEIS=C=:#*
MMT'I0/GW *6KQ7+V!><_L+0QOE9))9US=>^3H5C$>G"*CETR"I7++&!N[DD]
M3U)GD#I4]0\AU5 /(V<!?P__.9M?\[-^.)4^,\W)*3"6I37U,1(?6)U+3 J9
MV@E%6])_/W[SN",@3ID[/E+J(V.F+FIY5^[QL#E4*%G,FG&0& 20K=;@9%+T
MC\RES"%K+AI YTD"QDLD'JO166OQCIM+_#V]"=/5,H(P_?YZFC:&,86H778>
M2HZKJ=ITCXL806.6+%AMLWXP;/.1K.+CGSV>ZAOI:]92>.-J_SW.5Q:3;L??
M9K.\6LBT8>?ZA=4Y99W)="_6R;1<*O!9>& E))42<I.WMS!L_9KQ<L[-,=%6
MI",_-,SF^'N8_]>_SRXS7:^W0+_>V$6^OF.R!."U?5%ER2%ZQ8&TGPR3/LJ'
M0UX>>WS8\BWC9)4' 4=3@780Y_PYO5I<A<MW<_*\YOC?5R3/.CABG?LLQ0N3
M(^':YSH:)(%7!H$\:QN"-SX\?)@Z.L9YAIQQATJ=.BO32B_]0NPZ+\I#=E(%
MD*JN%XTL@M<"ZR9")YU(R3=O%7B6H''#Z&9JWPU.!^A@Y/OLW7^\_I7[Z^!?
M&\^3)FIEK&Z_".!2J6NX@_*2)1_*]JJ[>Q_9I?8/T=*L@<@ZL!WK62(WU>=O
MZE^HRJCG(:?B@F4,>$8RKTPYB#G371ZR#-85"@-;5^0_0\ZXX^E.?3VUTDN_
M$-L<.B]L3D)3)%AB;6U@2.>%C&[.(:HBM(RV]>Z39PGJ8;1/ [7O!J<#=#!R
M+H8B UPU\^4OD^EDL<E7OYCFNE6/J/J\&D"[L<5H8S!U&!NNMN@)Z<$[R\"(
MK(,0FANMMEY?>WUEE^@Y1,NS$XA\1"AEG%RLEBZ^FBXGR^_K\[4:?8T4L')&
MIXK^"3$2$T$EKHSES-KG)D M,/W;I]FW_T,?O39"](M;V_/(%^Z$%7?N%]JQ
MDAX9)&NJKT^0UU:CEY""(@<1N0)O _VG,/0_6:P,>!1"[G[;.*;D:'7-&LAN
MY(PO26;R]??9?#Y9O Q?)\MP^7(VI\.Q$OYU*73(H1@*$X6J$4)A"IR6$CSF
MPBVGL$%NS_[O\DWCP>!P]<V&DV4'_NROD\77V2)<KO/6EV&QF)3)'3\M%4D.
MF:YI24/W; P,0IU9(KG0=%PT&<J='@[W&2'S/$D[8<B?^TTSA'[ZAMOF;%H=
M53"^0$97SV;)X O)SMBD/9U+PWCS]9';B!IY$UM+".P.KP/TT1O Z@X8.I3T
MG_AVMJP#9J\WQ&PVLLZFUZY^89'[XAD9Z[J,P3$ZHSERR#9DI% CAX?M4VUA
MMSNIW8+Q$, \!\>!M-<!2!^$MK^$R_I\_/$S8MUZ>#VA,US>CD1>_/+]GFP6
M]!&75_5-\7&YK R#*<:99$CTPM15$)'"UZ@,6"0_UWB3BG[.PV^0C1J(L]V.
M /M9?( .X=+!(=J+P?JRO[%/NAB5$J>;4FA' 6 T$ H6X-X6ES%PC,U7/QQ&
M:E?YMRY0]]QU,1 $1IX;M,3?)V1N+B]Q-:LTI#NAIC!%.[.Z7[D 9>.J>,2!
M+(RA]3R9AWTPCTT->N8;.G(UAM+NK+VH.["-'W"QG%^EY=6<!%:W*:^.6M01
MHPA8MR$2$T)%\$IY2,EE8Y+BT;3NFWJ4D-U@]=.,N3M>&3TB:G/8!"N):YW
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M^L_]$?Y"\DV6\T :I1,X_[Z2[-O9M$X9( HO5[)?!X 70:<HF4W@ OG>RKH
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MJ5KII5^(73<A%*&RXAH0!441B9CQ10?@Q47G6-"A^82K9PD:U[]NIO;=X'2
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MS5K(;V3%WW3]?$PX#?/);(7^7+A7J=2-[VXU;%E"L%&!%%Y'X;/1N-,$G"T
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MZ]!XD"2@6HVB(3!OP(ID@Z<EV;"[$>6 @>8Y]"="PL&2[(IB:7,0ZNR]E$%
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MEVV,*002I=_Q-CEFN/E:W4R.F"82[@PU;S=GYO)Z(2E:[H5@P%3M^N*4K&U
M5"6G%L8GG[G97>ZV?8SY>N1,?QGM+<O.0/'+*?UY_6YY=K&Z)&\NO[Q<?C@+
MGZX7Y@7GJ!)Y_-9$.B.M!Y\8@E?.9Q6-L /2^,:-.5_/G>FMX&:R[@Q$K]:(
MGS:A@%]#39^^V18A)Y9U@AQ\;5[!R1:C54")JB1?,)2LQZ/G\<%F[.(S.6X:
MB+<SP+S[MY>KRP^GX78IC"NK;03AM :5-L2DL@!/$4767@23]K!ROQUEQA9
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M%[Q00-,7D%V*,= RO"O38Z?GA.11JAZ<D#Q&[OT!Z(85S6O&351@$]8W-%?
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M=4AJ5$0$8:45P1@WI&G,(Q^^6%^8!L+:(_D)G%NX+^%VVZ_/\ZW=S5VF6U*
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M.X;C7>5;;8^2,-I+9CS(Y+>O!;1[# 581$E. IVO$(;@Y3AI>$^=W3#E7FK
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M0':(.9=C0Z:'U)/Y$CX F0GL7C@2>.T!O*2OGU;I"D_O=8% E%*4A""%J-Z
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MXCC^:_W-'^J7@!?Y?_^W_P]02P$"% ,4    "  5<EM69<$V%3 B   VX0
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M>3(N:'1M4$L! A0#%     @ %7);5F._SXUL"   'BX  !L
M ( !W#(  &5X:&EB:70S,3%Q-#(P,C(M86YN=6%L+FAT;5!+ 0(4 Q0    (
M !5R6U8OC0N%7@@  # O   ;              "  8$[  !E>&AI8FET,S$R
M<30R,#(R+6%N;G5A;"YH=&U02P$"% ,4    "  5<EM6?(P8+#,$  ";$0
M&P              @ $81   97AH:6)I=#,R,7$T,C R,BUA;FYU86PN:'1M
M4$L! A0#%     @ %7);5N=_VEHX!   !A(  !L              ( !A$@
M &5X:&EB:70S,C)Q-#(P,C(M86YN=6%L+FAT;5!+ 0(4 Q0    ( !5R6U8#
MUU)G?$X  /;M 0 >              "  ?5,  !E>&AI8FET-#%D97-C<FEP
M=&EO;F]F<F5G:2YH=&U02P$"% ,4    "  5<EM6LD5+.8L5   $U   &P
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M,C R,C$R,S$N>'-D4$L! A0#%     @ %7);5MQ$J'F'-   ?QH" !,
M         ( !"LX& &UO+3(P,C(Q,C,Q7V-A;"YX;6Q02P$"% ,4    "  5
M<EM6_RW0_+0@ 0!^Q0P $P              @ '" @< ;6\M,C R,C$R,S%?
M9&5F+GAM;%!+ 0(4 Q0    ( !5R6U;IC6@RG)$! (0R @ 2
M  "  :<C" !M;RTR,#(R,3(S,5]G,2YJ<&=02P$"% ,4    "  5<EM6#"S+
MO&@* @#-GQ4 $P              @ %SM0D ;6\M,C R,C$R,S%?;&%B+GAM
M;%!+ 0(4 Q0    ( !5R6U:8=L4LD68! "]7$  3              "  0S
K"P!M;RTR,#(R,3(S,5]P<F4N>&UL4$L%!@     2 !( \ 0  ,XF#0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
